FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Srinivasan, B
   Kumar, R
   Shanmugam, K
   Sivagnam, UT
   Reddy, NP
   Sehgal, PK
AF Srinivasan, Balaji
   Kumar, Ramadhar
   Shanmugam, Kirubanandan
   Sivagnam, Uma Tiruchirapalli
   Reddy, Neelakanta Puily
   Sehgal, Praveen Kumar
TI Porous Keratin Scaffold-Promising Biomaterial for Tissue Engineering and
   Drug Delivery
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE keratin; porous scaffold; horn meal; tissue engineering
ID EXTRACELLULAR-MATRIX; ACID
AB A porous keratin scaffold, prepared from the reduced keratin solution, has shown good cell viability which makes it a potential candidate for cell seeding. An aqueous solution of reduced keratin was extracted from horn meal using a mixture of urea, sodium dodecyl sulfate, mercaptoethanol, and water at 60 degrees C. The molecular mass of the extracted keratin is found to be ranging between 225 and 150 KDa. The CD spectrum of aqueous solution of keratin shows the presence of infinity-helical structure with beta-turns as negative absorption band at 225 nm and as positive absorption band at 195 nm. The FTIR spectrum of the same confirms infinity-helical structure with beta-turns. Its characteristic absorption hands are assigned mainly to the peptide bonds for amide I, II, and III respectively. DSC and TGA data of the reduced keratin peaks fall in region 200 degrees C-250 degrees C and 200 degrees C-400 degrees C temperatures, respectively. They correspond to the infinity-helix denaturation of the material. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 5-12, 2010
C1 [Srinivasan, Balaji; Kumar, Ramadhar; Shanmugam, Kirubanandan; Sivagnam, Uma Tiruchirapalli; Sehgal, Praveen Kumar] Cent Leather Res Inst, Bioprod Lab, Biomat Div, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
   [Reddy, Neelakanta Puily] Cent Leather Res Inst, Bioorgan Lab, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
   [Reddy, Neelakanta Puily] Cent Leather Res Inst, Dept Neurochem, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
RP Sehgal, PK (reprint author), Cent Leather Res Inst, Bioprod Lab, Biomat Div, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
OI Shanmugam, Kirubanandan/0000-0002-3461-9958
CR AKIRA T, 2002, J BIOTECHNOL, V93, P165
   Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   AYAKO K, 2003, J BIOSCI BIO ENG, V96, P307
   Badylak S., 2008, PRINC REGENERATIVE M, P594, DOI DOI 10.1016/13978-012369410-2.50036
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   BRENDAN AC, 2008, J BIOPHYS, V95, P4013
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   DOWLING LM, 1986, BIOCHEM J, V236, P705, DOI 10.1042/bj2360705
   FEUGHELMAN M, 1985, ENCY POLYM SCI ENG, V8, P566
   Karthikeyan R, 2008, CLEAN TECHNOL ENVIR, V10, P295, DOI 10.1007/s10098-007-0119-2
   KIYOSHI Y, 2003, MAT SCI ENG C, V23, P467
   KIYOSHI Y, 1996, J BIOMED MATER RES B, V31, P439
   KUMAR R, J APPL BIOC IN PRESS, DOI DOI 10.1007/S12010-008-8452-4
   KWANGWOO N, 2007, BIOMATERIALS, V28, P1
   LIZA GO, 2007, CLIN DERMATOL, V25, P33
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARC AM, 2008, P MAT SCI, V53, P1
   MARSHALL RC, 1991, ELECTRON MICROSC REV, V4, P47, DOI 10.1016/0892-0354(91)90016-6
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PETER XM, 2004, MATER TODAY, V7, P30
   Salminen E, 2002, BIORESOURCE TECHNOL, V83, P13, DOI 10.1016/S0960-8524(01)00199-7
   Scott J., 2005, NAT MATER, V4, P518
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   SPEI M, 1989, COLLOID POLYM SCI, V267, P549, DOI 10.1007/BF01416064
   SPEI M, 1987, COLLOID POLYM SCI, V265, P965, DOI 10.1007/BF01412398
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   TAKAYUKI A, 1982, INT J BIOL MACROMOL, V4, P165
   TOSHIZUMI T, 2002, BIOMATERIALS, V23, P817
   Wojciechowska E, 1999, J MOL STRUCT, V511, P307, DOI 10.1016/S0022-2860(99)00173-8
   XIANYAN W, 2005, MATER TODAY, V9, P44
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
NR 32
TC 33
Z9 33
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2010
VL 92B
IS 1
BP 5
EP 12
DI 10.1002/jbm.b.31483
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 534KW
UT WOS:000272896500002
PM 19637379
DA 2018-10-20
ER

PT J
AU Bullens, PHJ
   Schreuder, HWB
   Malefijt, MCD
   Verdonschot, N
   Buma, P
AF Bullens, Pieter H. J.
   Schreuder, H. W. Bart
   Malefijt, Maarten C. de Waal
   Verdonschot, Nico
   Buma, Pieter
TI The Presence of Periosteum Is Essential for the Healing of Large
   Diaphyseal Segmental Bone Defects Reconstructed With Trabecular Metal: A
   Study in the Femur of Goats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tantalum; defect; periosteum; nail; goat; femur
ID POROUS TANTALUM BIOMATERIAL; RETRIEVED HUMAN ALLOGRAFTS; TUMOR-EXCISION;
   GRAFT; FIXATION; MANAGEMENT; INGROWTH; REPAIR
AB Large segmental diaphyseal bone defects can be reconstructed with massive structural allografts, but this technique is associated with high complication rates. Tantalum tabecular metal implants have been successfully used to restore bone defects associated with revision total knee or hip arthroplasties. The aim of this study was to investigate if tantalum cylinders could be used to reconstruct large load bearing segmental diaphyseal bone defects in the presence or absence of a periosteum coverage. Segmental bone defects were reconstructed with tantalum cylinders with or without preservation of the periosteum and stabilized by an intramedullary nail. Radiological analysis was performed postop and at 26 weeks follow-up. New bone was labeled with fluorochromes at 13 and 26 weeks follow-up. Reconstructions were tested mechanically and subsequently investigated histologically. Contra-lateral femurs were used as controls. Clinically all goats returned to normal functional loading after 2 weeks allowing unlimited weight bearing. Radiologically, all tantalum cylinders with periosteum coverage united with the host bone. Reconstructions with cylinders without periosteum coverage lead to radiological nonunion in five out of six cases. The strengths of the reconstruction with and without periosteum preservation were respectively 102.1% and 24.5% compared to controls. In the periosteum covered implants, bone contact was found at all levels of the tantalum cylinder and more and deeper bone ingrowth was found in this group. Tantalum cylinders seem a safe and reliable alternative for a massive cortical graft to reconstruct large diaphyseal bone defects in a goat model if healthy periosteum is present. (C) 2009 Wiley Periodicils, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 24-31, 2010
C1 [Bullens, Pieter H. J.; Verdonschot, Nico; Buma, Pieter] Radboud Univ Nijmegen, Orthopaed Res Lab, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Bullens, Pieter H. J.; Schreuder, H. W. Bart; Malefijt, Maarten C. de Waal] Radboud Univ Nijmegen, Dept Orthopaed, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
RP Buma, P (reprint author), Radboud Univ Nijmegen, Orthopaed Res Lab, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
EM P.Buma@orthop.umcn.nl
RI Buma, P./H-8019-2014; Verdonschot, N.J.J./H-8104-2014; Buma,
   Pieter/C-9828-2013; Schreuder, H.W.B./L-4638-2015; Waal Malefijt,
   M.C./L-4738-2015
CR Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 2005, J BONE JOINT SURG BR, V87B, P416, DOI 10.1302/0301-620X.87B3
   Bullens PHJ, 2009, CLIN ORTHOP RELAT R, V467, P783, DOI 10.1007/s11999-008-0686-5
   Ceruso M, 2008, INJURY, V39, pS68, DOI 10.1016/j.injury.2008.05.014
   Chalkin B, 2005, J ARTHROPLASTY, V20, P127, DOI 10.1016/j.arth.2004.09.029
   Claes L, 1999, CLIN ORTHOP RELAT R, P221
   Claes LE, 1998, CLIN ORTHOP RELAT R, pS132
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   den Boer FC, 1999, J ORTHOPAED RES, V17, P654, DOI 10.1002/jor.1100170506
   Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001
   ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002
   ENNEKING WF, 1975, J BONE JOINT SURG AM, VA 57, P237, DOI 10.2106/00004623-197557020-00018
   Garcia-Cimbrelo E, 2004, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000118181.23225.49
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Huh JY, 2005, ORAL SURG ORAL MED O, V100, P296, DOI 10.1016/j.tripleo.2004.12.015
   Keijser LCM, 2002, CLIN ORTHOP RELAT R, P215
   McKee MD, 1998, J BONE JOINT SURG BR, V80B, P360, DOI 10.1302/0301-620X.80B2.8192
   Mekhail AO, 2004, J TRAUMA, V56, P368, DOI 10.1097/01.TA.0000057234.48501.30
   Muscolo DL, 2006, ORTHOP CLIN N AM, V37, P65, DOI 10.1016/j.ocl.2005.08.003
   Nishida J, 2008, MED SCI MONITOR, V14, pRA107
   Nishida J, 2006, CLIN ORTHOP RELAT R, P145, DOI 10.1097/01.blo.0000203485.90711.1b
   ODonnell RJ, 1996, J ORTHOPAED RES, V14, P108, DOI 10.1002/jor.1100140118
   Pruss A, 2004, NEW ENGL J MED, V351, P1358
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Schimmel JW, 1998, J ARTHROPLASTY, V13, P438, DOI 10.1016/S0883-5403(98)90010-9
   Sporer SM, 2006, J ARTHROPLASTY, V21, P83, DOI 10.1016/j.arth.2006.05.008
   TANZER K, 2005, CLIN ORTHOP RELAT R, V441, P30
   Wagner Michael, 2004, Surg Technol Int, V12, P271
   Wagner Michael, 2003, Injury, V34 Suppl 2, pB31
   Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50
   Zhu L, 2006, TISSUE ENG, V12, P423, DOI 10.1089/ten.2006.12.423
   Zou XN, 2005, SPINE, V30, pE392, DOI 10.1097/01.brs.0000170588.80377.3f
NR 34
TC 11
Z9 12
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2010
VL 92B
IS 1
BP 24
EP 31
DI 10.1002/jbm.b.31485
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 534KW
UT WOS:000272896500004
PM 19637371
DA 2018-10-20
ER

PT J
AU Kishimoto, S
   Oonuma, F
   Nakamura, S
   Hattori, H
   Nakamura, S
   Mori, Y
   Tanaka, Y
   Harada, Y
   Tagawa, M
   Ishihara, M
AF Kishimoto, Satoko
   Oonuma, Fumie
   Nakamura, Shingo
   Hattori, Hidemi
   Nakamura, Shin-ichiro
   Mori, Yasutaka
   Tanaka, Yoshihiro
   Harada, Yasuji
   Tagawa, Masahiro
   Ishihara, Masayuki
TI Immobilization, Stabilization, and Activation of Human Stem Cell Factor
   (SCF) on Fragmin/Protamine Microparticle (F/P MP)-Coated Plates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell culture; cytokines; extracellular matrix; heparin-like
ID FIBROBLAST GROWTH FACTOR-2; HEPARAN-SULFATE; CONTROLLED-RELEASE; FGF-2;
   VASCULARIZATION; REQUIREMENTS; CYTOKINE; HYDROGEL; RESIDUES; BINDING
AB Fragmin (low-molecular-weight heparin)/protamine microparticles (F/P MPs) immobilize to culture plates, thereby retaining the binding of heparin-binding cytokines such as human stem cell factor (SCF). The purpose of this study was to evaluate the ability of F/P MP-coating to immobilize, stabilize, and enhance SCF-activity. Cell assays showed that SCF and preimmobilized SCIF on F/P MP-coated plates significantly stimulated the proliferation of human erythroleukemia cell line TF-1 in a concentration A e pendent manner. Heparin and fragmin enhanced SCF-induced proliferation of chlorate-treated TF-1. cells, in which the biosynthesis of endogenous sulfated polysaccharides was blocked, on noncoated plates at a range of concentrations (2-8 mu g/mL). However, heparin and fragmin had no effect on SCF-induced proliferation of chlorate-treated TF-1 cells on F/P MP-coated plates. The interaction of SCIF with fragmin and F/P MPs prolonged the half-life of SCIF bioactivity, and immobilized and protected SCF from inactivation, such as from heat and proteolysis. These results suggest that F/P MP-coated plates protect SCF and enhance its activity, and F/P MP-coating provides an excellent biomaterial to immobilize and retain heparin-binding cytokines, including SCF, in bioactive form for optimal expansion of hematopoietic cells. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part 13: Appl Biomater 92B: 32-39, 2010
C1 [Kishimoto, Satoko; Oonuma, Fumie; Hattori, Hidemi; Mori, Yasutaka; Tanaka, Yoshihiro; Ishihara, Masayuki] Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   [Nakamura, Shingo] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan.
   [Nakamura, Shin-ichiro] Natl Def Med Coll, Dept Plast & Reconstruct Surg, Tokorozawa, Saitama 3598513, Japan.
   [Kishimoto, Satoko; Harada, Yasuji; Tagawa, Masahiro] Nippon Vet & Life Sci Univ, Grad Sch, Dept Surg, Tokyo 1808602, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
EM ishihara@ndmc.ac.jp
CR Farndale R.W., 1986, BIOCHIM BIOPHYS ACTA, V883, P173
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0
   GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317
   GUIMOND S, 1993, J BIOL CHEM, V268, P23906
   Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538
   HUMPHRIES DE, 1988, BIOCHEM BIOPH RES CO, V154, P365, DOI 10.1016/0006-291X(88)90694-8
   Ishihara M, 1997, J BIOCHEM-TOKYO, V121, P345
   ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P817, DOI 10.1093/glycob/4.6.817
   ISHIHARA M, 1995, J BIOCHEM-TOKYO, V118, P1255, DOI 10.1093/oxfordjournals.jbchem.a125015
   Ishihara M, 1998, TRENDS GLYCOSCI GLYC, V10, P223, DOI 10.4052/tigg.10.223
   Kishimoto S, 2009, J BIOCHEM, V145, P275, DOI 10.1093/jb/mvn169
   Kishimoto S, 2009, J CONTROL RELEASE, V133, P185, DOI 10.1016/j.jconrel.2008.10.005
   LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   NAKAMURA S, J BIOMED A IN PRESS
   Nakamura S, 2008, J BIOMED MATER RES A, V85A, P619, DOI 10.1002/jbm.a.31563
   Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705
   PESCE M, 1993, DEVELOPMENT, V118, P1089
   ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0
   Salmivirta M, 1996, FASEB J, V10, P1270
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
NR 22
TC 6
Z9 6
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2010
VL 92B
IS 1
BP 32
EP 39
DI 10.1002/jbm.b.31486
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 534KW
UT WOS:000272896500005
PM 19637375
DA 2018-10-20
ER

PT J
AU Oliveira, AL
   Pedro, AJ
   Arroyo, CS
   Mano, JF
   Rodriguez, G
   San Roman, J
   Reis, RL
AF Oliveira, A. L.
   Pedro, A. J.
   Arroyo, C. Saiz
   Mano, J. F.
   Rodriguez, G.
   San Roman, J.
   Reis, R. L.
TI Biomimetic Ca-P Coatings Incorporating Bisphosphonates Produced on
   Starch-Based Degradable Biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biodegradable polymers; starch; biomimetic coating; calcium phosphate;
   sodium silicate; bisphosphonate; drug therapy
ID TOTAL HIP-ARTHROPLASTY; SPRAYED HYDROXYAPATITE COATINGS;
   CALCIUM-PHOSPHATE COATINGS; PERIPROSTHETIC BONE LOSS; IN-VITRO;
   CARBONATED APATITE; DISSOLUTION; POLYMERS; DELIVERY; SURFACE
AB In this study, sodium clodronate, a well-known therapeutic agent from the family of bisphosphonates (BP's), is incorporated in a biomimetic calcium phosphate (CaP) coating, previously formed on the surface of a starch-based biomaterial by a sodium silicate methodology, as a strategy to develop a site-specific drug delivery system for bone tissue regeneration applications. The effects on the resulting CaP coatings were evaluated in terms of morphology, chemistry, and structure. The dissolution of Ca and P from the coating and the release profiles of sodium clodronate was also assessed. As a preliminary approach, this first study also aimed at evaluating the effects of this BP on the viability of a human osteoblastic cell line since there is still little information available on the interaction between BP's and this type of cells. Sodium clodronate was successfully incorporated, at different doses, in the structure of a biomimetic CaP layer previously formed by a sodium silicate process. This type of BP's had a stimulatory effect on osteoblastic activity, particularly at the specific concentration of 0.32 mg/mL. It is foreseen that these coatings can, for instances, be produced on the surface of degradable polymers and then used for regulating the equilibrium on osteoblastic/osteoclastic activity, leading to a controlled regenerative effect at the interface between the biomaterial and bone. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 55-67, 2010
C1 [Oliveira, A. L.; Pedro, A. J.; Arroyo, C. Saiz; Mano, J. F.; Reis, R. L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Guimaraes, Portugal.
   [Oliveira, A. L.; Pedro, A. J.; Arroyo, C. Saiz; Mano, J. F.; Reis, R. L.] PT Associated Lab, Inst Biotechnol & Bioengn, Guimaraes, Portugal.
   [Oliveira, A. L.; Rodriguez, G.; San Roman, J.] CSIC, Inst Polymer Sci & Technol, Macromol Chem Dept, E-28006 Madrid, Spain.
RP Oliveira, AL (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Guimaraes, Portugal.
EM analeite@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Xu, Qingguo/C-1962-2014; Rodriguez Crespo,
   Gema/E-9674-2013; Pedro, Adriano/B-5519-2012; Oliveira, Ana/J-3404-2013;
   Reis, Rui L./A-8938-2008; Mano, Joao/A-4418-2009
OI Group, 3Bs/0000-0002-5195-3456; Xu, Qingguo/0000-0003-3191-0771;
   Rodriguez Crespo, Gema/0000-0003-1851-9794; Pedro,
   Adriano/0000-0002-1653-1725; Oliveira, Ana/0000-0001-8012-4203; Reis,
   Rui L./0000-0002-4295-6129; Mano, Joao/0000-0002-2342-3765
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Adami S, 1996, DRUG SAFETY, V14, P158, DOI 10.2165/00002018-199614030-00003
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Body JJ, 1998, J CLIN ONCOL, V16, P3890, DOI 10.1200/JCO.1998.16.12.3890
   BUDZ JA, 1988, J CRYST GROWTH, V91, P490, DOI 10.1016/0022-0248(88)90116-9
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Conte P, 2004, ONCOLOGIST, V9, P28, DOI 10.1634/theoncologist.9-90004-28
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Duncan AR, 2003, J PAIN SYMPTOM MANAG, V26, P592, DOI 10.1016/S0885-3924(03)00225-2
   Eekhoff MEMW, 2003, BONE, V33, P831, DOI 10.1016/j.bone.2003.03.001
   Ezra A, 2000, ADV DRUG DELIVER REV, V42, P175, DOI 10.1016/S0169-409X(00)00061-2
   Fisher JE, 2000, ENDOCRINOLOGY, V141, P4793, DOI 10.1210/en.141.12.4793
   Fleisch H, 2001, EXPERT OPIN THER PAT, V11, P1371, DOI 10.1517/13543776.11.9.1371
   Ganguli A, 2002, J MATER SCI-MATER M, V13, P923, DOI 10.1023/A:1019892109411
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Henneman ZJ, 2008, J BIOMED MATER RES A, V85A, P993, DOI 10.1002/jbm.a.31599
   Josse S, 2005, BIOMATERIALS, V26, P2073, DOI 10.1016/j.biomaterials.2004.05.019
   Kajiwara H, 2005, BIOMATERIALS, V26, P581, DOI 10.1016/j.biomaterials.2004.02.072
   Kohn DH, 1998, CURR OPIN SOLID ST M, V3, P309, DOI 10.1016/S1359-0286(98)80107-1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kontturi M., 2005, POLYHEDRON, V24, P305
   Leonor IB, 2007, J MATER SCI-MATER M, V18, P1923, DOI 10.1007/s10856-007-3106-6
   Leonor IB, 2004, NATO SCI SER II-MATH, V171, P123
   Liu Y, 2004, ANN BIOMED ENG, V32, P398, DOI 10.1023/B:ABME.0000017536.10767.0f
   Mastrandrea Lucy D, 2006, Endocr Pract, V12, P670
   Matsuoka H, 1998, J BIOMED MATER RES, V42, P278, DOI 10.1002/(SICI)1097-4636(199811)42:2<278::AID-JBM13>3.0.CO;2-F
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   Nehme A, 2003, REV CHIR ORTHOP, V89, P593
   Nishikawa M, 1996, BONE, V18, P9, DOI 10.1016/8756-3282(95)00426-2
   Oliveira AL, 2007, J MATER SCI-MATER M, V18, P211, DOI 10.1007/s10856-006-0683-8
   Oliveira AL, 2004, J MATER SCI-MATER M, V15, P533, DOI 10.1023/B:JMSM.0000021134.34651.d3
   Oliveira AL, 2003, CURR OPIN SOLID ST M, V7, P309, DOI 10.1016/j.cossms.2003.10.009
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   OLIVEIRA AL, 2005, BIOCERAMICS, V17, P615
   OLIVEIRA AL, 2003, BIOCERAMICS, V15, P240
   OLIVEIRA AL, 2000, BIOCERAMICS, V192, P75
   OSTERMAN T, 1991, PHARMACOL TOXICOL, V69, P369
   Peter B, 2005, BONE, V36, P52, DOI 10.1016/j.bone.2004.10.004
   Peter B, 2006, J BIOMED MATER RES A, V76A, P133, DOI 10.1002/jbm.a.30456
   PLOSKER GL, 1994, DRUGS, V47, P945, DOI 10.2165/00003495-199447060-00007
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   Reis RL, 1996, J MATER SCI-MATER M, V7, P407, DOI 10.1007/BF00122009
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Seshima H, 2006, J BIOMED MATER RES B, V78B, P215, DOI 10.1002/jbm.b.30446
   Sousa RA, 2003, COMPOS SCI TECHNOL, V63, P389, DOI 10.1016/S0266-3538(02)00213-0
   Stigter M, 2002, BIOMATERIALS, V23, P4143, DOI 10.1016/S0142-9612(02)00157-6
   SUTTON SC, 1993, PHARMACEUT RES, V10, P924, DOI 10.1023/A:1018981832261
   Tuzlakoglu K, 2007, J MATER SCI-MATER M, V18, P1279, DOI 10.1007/s10856-006-0063-4
   Venesmaa PK, 2001, J BONE MINER RES, V16, P1056, DOI 10.1359/jbmr.2001.16.6.1056
   Venesmaa PK, 2001, J BONE MINER RES, V16, P2126, DOI 10.1359/jbmr.2001.16.11.2126
   Walker P, 1997, ANN ONCOL, V8, P915, DOI 10.1023/A:1008274608267
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Yamaguchi K, 2003, BONE, V33, P144, DOI 10.1016/S8756-3282(03)00085-1
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
   Zhang QY, 2003, BIOMATERIALS, V24, P4741, DOI 10.1016/S0142-9612(03)00371-5
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 63
TC 18
Z9 19
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2010
VL 92B
IS 1
BP 55
EP 67
DI 10.1002/jbm.b.31489
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 534KW
UT WOS:000272896500008
PM 19701915
DA 2018-10-20
ER

PT J
AU Kawasaki, Y
   Sotome, S
   Yoshii, T
   Torigoe, I
   Maehara, H
   Sugata, Y
   Hirano, M
   Mochizuki, N
   Shinomiya, K
   Okawa, A
AF Kawasaki, Yuichi
   Sotome, Shinichi
   Yoshii, Toshitaka
   Torigoe, Ichiro
   Maehara, Hidetsugu
   Sugata, Yumi
   Hirano, Masahiro
   Mochizuki, Naomi
   Shinomiya, Kenichi
   Okawa, Atsushi
TI Effects of Gamma-Ray Irradiation on Mechanical Properties,
   Osteoconductivity, and Absorption of Porous Hydroxyapatite/Collagen
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE gamma ray irradiation; osteoconduction; bioabsorption; hydroxyapatite
   composite; collagen
ID BONE-GRAFT SUBSTITUTES; CLINICAL-OUTCOMES; IN-VITRO; COMPOSITE;
   STERILIZATION; BIOMATERIAL; CARRIER; VIVO
AB In this study, the effects of gamma-ray irradiation on the mechanical properties, absorbability, and osteoconductivity of porous hydroxyapatite/collagen (HAp/Col) were investigated. Porous HAp/Col was exposed to 16, 25, 35, or 50 kGy of gamma-ray irradiation. The compressive elastic modulus showed irradiation dose-dependence, with a particularly pronounced decrease in the 50-kGy treatment group. An in vitro enzymatic digestion test showed that gamma-ray irradiation of porous HAp/Col resulted in accelerated degradation by collagenase. For in vivo studies, porous HAp/Col was transplanted into the back muscles or bone defects in the femoral condyle of rats. Specimens were obtained at 2, 4, and 8 weeks postoperatively. Absorption of the implants in the muscle was time- and irradiation dose-dependent, with notable absorption for the 35- and 50-kGy groups at 2 weeks. At the skeletal sites, porous HAp/Col demonstrated high osteoconductivity in all irradiation treatment groups. Interestingly, not only implant absorption but also bone formation was irradiation dose-dependent at early time points. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 161-167. 2010
C1 [Kawasaki, Yuichi; Sotome, Shinichi; Yoshii, Toshitaka; Torigoe, Ichiro; Maehara, Hidetsugu; Sugata, Yumi; Shinomiya, Kenichi; Okawa, Atsushi] Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Bunkyo Ku, Tokyo 1138519, Japan.
   [Sotome, Shinichi] Tokyo Med & Dent Univ, Grad Sch, Dept Regenerat Therapeut Spine & Spinal Cord, Bunkyo Ku, Tokyo 1138519, Japan.
   [Sugata, Yumi; Shinomiya, Kenichi] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Bunkyo Ku, Tokyo 1138519, Japan.
   [Hirano, Masahiro; Mochizuki, Naomi] HOYA Corp, PENTAX New Ceram Div, Tokyo 1748639, Japan.
   [Shinomiya, Kenichi] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Chiyoda Ku, Tokyo 1010062, Japan.
   [Shinomiya, Kenichi] Tokyo Med & Dent Univ, Core Core Program Adv Bone & Joint Sci, Chiyoda Ku, Tokyo 1010062, Japan.
RP Sotome, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Bunkyo Ku, Tokyo 1138519, Japan.
EM sotome.orth@tmd.ac.jp
FU The Ministry of Education, Culture, sports, Science and Technology of
   Japan
FX Contract grant sponsor: The Ministry of Education, Culture, sports,
   Science and Technology of Japan
CR Donos N, 2008, J CLIN PERIODONTOL, V35, P173, DOI 10.1111/j.1600-051X.2008.01269.x
   Draenert GF, 2007, BIOMATERIALS, V28, P1531, DOI 10.1016/j.biomaterials.2006.11.029
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Jinno T, 2000, CLIN ORTHOP RELAT R, P275
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P93, DOI 10.1007/s10561-006-9020-1
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   Sotome S, 2004, MAT SCI ENG C-BIO S, V24, P341, DOI 10.1016/j.msec.2003.12.003
   Sotome S, 2002, KEY ENG MAT, V218-2, P153, DOI 10.4028/www.scientific.net/KEM.218-220.153
   SOTOME S, 2005, KEY ENG MATER, V309, P977
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   XIAODU W, 2001, J ORTHOP RES, V19, P1021
   YUNOKI S, 2006, J AM CERAM SOC, V89, P297
   Yunoki S, 2007, J MATER SCI-MATER M, V18, P2179, DOI 10.1007/s10856-007-3011-z
   Yunoki S, 2007, J BIOMAT SCI-POLYM E, V18, P393, DOI 10.1163/156856207780425077
   Yunoki S, 2007, J BIOMED MATER RES B, V80B, P166, DOI 10.1002/jbm.b.30581
NR 22
TC 10
Z9 10
U1 2
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2010
VL 92B
IS 1
BP 161
EP 167
DI 10.1002/jbm.b.31502
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 534KW
UT WOS:000272896500020
PM 19802840
DA 2018-10-20
ER

PT J
AU Jeong, HS
   Moon, MS
   Lee, HK
   Kim, KS
AF Jeong, Hii-Sun
   Moon, Min-Seon
   Lee, Hye-Kyung
   Kim, Keun-Sik
TI Use of Fibrin Glue for Open Comminuted Nasal Bone Fractures
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Comminuted fracture; biocompatible materials; open reduction; general
   anesthesia
ID MANAGEMENT; REDUCTION; FIXATION
AB Nasal bone fractures are the most common type of facial fracture. Closed reduction has been used as the standard treatment modality for nasal fractures for many years. In cases of nasal fracture with lacerations at the fracture sites, bioabsorbable/metallic plate or interfragment wire fixation can be used with accurate alignment through the openings created by the lacerations. However, in cases of severe comminuted nasal fractures that are difficult to drill and fix, this type of fixation may not be feasible. We performed in 5 patients open reduction with internal fixation through laceration openings using the biomaterial Greenplast (Greencross Corporation, Seoul, Republic of Korea; human plasma fibrinogen, thrombin, aprotinin, and calcium chloride) under general anesthesia. Both structural and aesthetic outcomes were satisfactory. Open reduction through laceration openings and internal fixation with fibrin glue under general anesthesia may be a simpler and more effective method than those currently in general use for the repair of complicated comminuted open nasal fractures.
C1 [Jeong, Hii-Sun; Moon, Min-Seon; Kim, Keun-Sik] Kwandong Univ, Coll Med, Dept Plast & Reconstruct Surg, Goyang City 412270, Gyeonggi Do, South Korea.
   [Lee, Hye-Kyung] Merit Plast Surg Clin, Seoul, South Korea.
RP Jeong, HS (reprint author), Kwandong Univ, Coll Med, Dept Plast & Reconstruct Surg, 697-24 Hwajeong Dong, Goyang City 412270, Gyeonggi Do, South Korea.
EM hiisunj@gmail.com
OI JEONG, HII-SUN/0000-0001-9408-8207
CR Davis BR, 1998, J OTOLARYNGOL, V27, P107
   Ferlito A, 2005, AM J OTOLARYNG, V26, P181, DOI 10.1016/j.amjoto.2004.11.006
   Gosain AK, 2002, PLAST RECONSTR SURG, V110, P1581, DOI 10.1097/01.PRS.0000033993.30838.3E
   Green KMJ, 2001, RHINOLOGY, V39, P43
   Kim MG, 2008, J PLAST RECONSTR AES, V61, P696, DOI 10.1016/j.bjps.2006.12.005
   KURIHARA K, 1990, ANN PLAS SURG, V24, P179, DOI 10.1097/00000637-199002000-00014
   Owen G. O., 1992, Rhinology (Utrecht), V30, P89
   RENNER GJ, OTOLARYNGOL CLIN N A, V24, P195
   Rohrich RJ, 2000, PLAST RECONSTR SURG, V106, P266, DOI 10.1097/00006534-200008000-00003
   SALTZ R, 1991, PLAST RECONSTR SURG, V88, P1005, DOI 10.1097/00006534-199112000-00009
   Stranc M F, 1979, Ann Plast Surg, V2, P468, DOI 10.1097/00000637-197906000-00004
   Verwoerd C D, 1992, Facial Plast Surg, V8, P220, DOI 10.1055/s-2008-1064653
   WATSON DJ, 1988, CLIN OTOLARYNGOL, V13, P491, DOI 10.1111/j.1365-2273.1988.tb00323.x
NR 13
TC 7
Z9 10
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2010
VL 21
IS 1
BP 75
EP 78
DI 10.1097/SCS.0b013e3181c3ba30
PG 4
WC Surgery
SC Surgery
GA 547PV
UT WOS:000273902400016
PM 20061971
DA 2018-10-20
ER

PT J
AU Hu, WW
   Ward, BB
   Wang, Z
   Krebsbach, PH
AF Hu, W. -W.
   Ward, B. B.
   Wang, Z.
   Krebsbach, P. H.
TI Bone Regeneration in Defects Compromised by Radiotherapy
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE tissue engineering; gene delivery; lyophilization; radiotherapy; bone
   regeneration; gene therapy
ID VIVO GENE-THERAPY; IN-VIVO; MANDIBLE RECONSTRUCTION; MORPHOGENETIC
   PROTEIN-2; RADIATION; TISSUE; VECTOR; CELLS
AB Because bone reconstruction in irradiated sites is less than ideal, we applied a regenerative gene therapy method in which a cell-signaling virus was localized to biomaterial scaffolds to regenerate wounds compromised by radiation therapy. Critical-sized defects were created in rat calvariae previously treated with radiation. Gelatin scaffolds containing lyophilized adenovirus encoding BMP-2 (AdBMP-2) or freely suspended AdBMP-2 were transplanted. Lyophilized AdBMP-2 significantly improved bone quality and quantity over free AdBMP-2. Bone mineral density was reduced after radiotherapy. Histological analyses demonstrated that radiation damage led to less bone regeneration. The woven bone and immature marrow formed in the radiated defects indicated that irradiation retarded normal bone development. Finally, we stored the scaffolds with lyophilized AdBMP-2 at -80 degrees C to determine adenovirus stability. Micro-CT quantification demonstrated no significant differences between bone regeneration treated with lyophilized AdBMP-2 before and after storage, suggesting that virus-loaded scaffolds may be convenient for application as pre-made constructs.
C1 [Hu, W. -W.; Wang, Z.; Krebsbach, P. H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   [Ward, B. B.] Univ Michigan, Sch Dent, Dept Oral & Maxillofacial Surg, Ann Arbor, MI 48109 USA.
   [Hu, W. -W.] Natl Cent Univ, Dept Chem & Mat Engn, Chungli 320, Taiwan.
RP Krebsbach, PH (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, K1030,1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM paulk@umich.edu
FU National Institutes of Health [RO1 DE018890]
FX The research was supported by a grant from the National Institutes of
   Health (RO1 DE018890) (PHK). The authors acknowledge and thank Dr. Renny
   Franceschi for the use of the AdBMP construct.
CR Chang SCN, 2003, PLAST RECONSTR SURG, V112, P1841, DOI 10.1097/01.PRS.0000091168.73462.1A
   Deutsch M, 1999, ANN PLAS SURG, V42, P662, DOI 10.1097/00000637-199906000-00014
   Disa JJ, 2000, SEMIN SURG ONCOL, V19, P226, DOI 10.1002/1098-2388(200010/11)19:3<226::AID-SSU4>3.0.CO;2-N
   Ehrhart NP, 2005, AM J VET RES, V66, P1039, DOI 10.2460/ajvr.2005.66.1039
   Emerick KS, 2007, EXPERT REV ANTICANC, V7, P1781, DOI 10.1586/14737140.7-12.1781
   Fields MT, 2000, INT J RADIAT ONCOL, V47, P785, DOI 10.1016/S0360-3016(00)00447-8
   Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204
   Gysin R, 2002, GENE THER, V9, P991, DOI 10.1038/sj.gt.3301772
   Hardy S, 1997, J VIROL, V71, P1842
   Howard BK, 1998, ARCH OTOLARYNGOL, V124, P985, DOI 10.1001/archotol.124.9.985
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Hu WW, 2008, J GENE MED, V10, P1102, DOI 10.1002/jgm.1233
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Khouri RK, 1996, PLAST RECONSTR SURG, V98, P103, DOI 10.1097/00006534-199607000-00017
   Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Nussenbaum B, 2005, LARYNGOSCOPE, V115, P1170, DOI 10.1097/01.MLG.0000166513.74247.CC
   Nussenbaum B, 2003, HUM GENE THER, V14, P1107, DOI 10.1089/104303403322124819
   Reuther T, 2003, INT J ORAL MAX SURG, V32, P289, DOI 10.1054/ijom.2002.0332
   Wurzler KK, 1998, J CRANIOFAC SURG, V9, P131
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
NR 22
TC 15
Z9 15
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD JAN
PY 2010
VL 89
IS 1
BP 77
EP 81
DI 10.1177/0022034509352151
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 530SG
UT WOS:000272612000013
PM 19966040
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU Cen, FF
   Li, SP
AF Cen, Fangfang
   Li, Shuping
TI Hydrothermal Synthesis of Glutamic Acid/Layered Double Hydroxide
   Compounds
SO JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Biomaterial; Glu-LDH compounds; layered double hydroxide
ID LAYERED DOUBLE HYDROXIDE; AMINO-ACIDS; NANOHYBRIDS; BEHAVIOR; NITRATE;
   ANIONS
AB In this article, glutamic acid (Glu) was intercalated into the Zn-Al layered double hydroxides (Zn-Al LDHs) by hydrothermal method. The influence of the molar ratio of Zn/Al/Glu (R values for short), the aging time, and the pH value of the washing solution was systematically studied. The resulting Glu-LDH compounds were characterized by x-ray diffraction (XRD), fourier transform infrared spectroscopy (FTIR), and scanning electron micrograph (SEM). The XRD results showed that the relative diffraction intensity first increased then decreased as the R value and the pH value of the washing solution increased. Moreover, the crystallinity degree decreased gradually with the increase of the aging time. The absorption peaks attributed to the stretch of (R-COO-) were observed in the FTIR spectra. SEM graphs indicated that the morphology of the particles was largely influenced by the synthesis conditions.
C1 [Cen, Fangfang; Li, Shuping] Nanjing Normal Univ, Coll Chem & Environm Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210097, Peoples R China.
RP Li, SP (reprint author), Nanjing Normal Univ, Coll Chem & Environm Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210097, Peoples R China.
EM lishuping@njnu.edu.cn
FU NSF of Jiangsu Province of China [BK2007223]
FX The authors are grateful for the financial support of Project BK2007223
   by the NSF of Jiangsu Province of China.
CR Aisawa S, 2004, J SOLID STATE CHEM, V177, P3987, DOI 10.1016/j.jssc.2004.07.024
   BOOKIN AS, 1993, CLAY CLAY MINER, V41, P551, DOI 10.1346/CCMN.1993.0410504
   CAO GT, 2007, J CHIN CERAM SOC, V11, P1546
   Choy JH, 1999, J AM CHEM SOC, V121, P1399, DOI 10.1021/ja981823f
   Choy JH, 2001, J MATER CHEM, V11, P1671, DOI 10.1039/b008680k
   Choy JH, 2004, BIOMATERIALS, V25, P3059, DOI 10.1016/j.biomaterials.2003.09.083
   Fudala A, 1999, INORG CHEM, V38, P4653, DOI 10.1021/ic981176t
   Lakraimi M, 2000, J MATER CHEM, V10, P1007, DOI 10.1039/a909047i
   Li SP, 2006, COLLOID SURFACE A, V290, P56, DOI 10.1016/j.colsurfa.2006.05.001
   Li SP, 2003, LANGMUIR, V19, P3172, DOI 10.1021/la026669w
   Ogawa M, 2000, CHEM MATER, V12, P3253, DOI 10.1021/cm000455n
   Vaysse C, 2002, INORG CHEM, V41, P6905, DOI 10.1021/ic025542r
   Whilton NT, 1997, J MATER CHEM, V7, P1623, DOI 10.1039/a701237c
   Wu QL, 2005, J MATER CHEM, V15, P4695, DOI 10.1039/b511184f
   Xu ZP, 2001, J PHYS CHEM B, V105, P1743, DOI 10.1021/jp0029257
NR 15
TC 4
Z9 5
U1 2
U2 21
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0193-2691
J9 J DISPER SCI TECHNOL
JI J. Dispersion Sci. Technol.
PY 2010
VL 31
IS 8
BP 1055
EP 1060
AR PII 924821460
DI 10.1080/01932690903224797
PG 6
WC Chemistry, Physical
SC Chemistry
GA 631YI
UT WOS:000280386300007
DA 2018-10-20
ER

PT J
AU Zambito, Y
   Di Colo, G
AF Zambito, Y.
   Di Colo, G.
TI Chitosan and its derivatives as intraocular penetration enhancers
SO JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
LA English
DT Review
DE Intraocular drug delivery; Topical ocular administration; Ocular
   bioavailability enhancement; Corneal permeability enhancement; Chitosan;
   Chitosan derivatives; In situ gelling systems
ID OCULAR DRUG-DELIVERY; EPITHELIAL-CELLS CACO-2; MOLECULAR-WEIGHT;
   IN-VITRO; POLY(ETHYLENE OXIDE); GLAUCOMA THERAPY; ERODIBLE INSERTS;
   CHLORIDE; ABSORPTION; OFLOXACIN
AB An overview of literature information on the research on chitosan and its derivatives as promoters of intraocular penetration of topically administered drugs is presented. The main objective of this research has been increasing the intraocular bioavailability of drugs administered via eye drops. This has been pursued using cornea-permeabilizing water-soluble chitosan and derivatives, e.g. N-trimethylchitosan or quaternary ammonium-chitosan conjugates, which have enhanced the intraocular bioavailability of hydrophilic and lipophilic drugs administered to rabbits via eye drops, in situ gelling systems, or liposomes. Also the potential of chitosan-based formulations has been confirmed by proving their safety to ocular structures. The results illustrated in this overview have indicated chitosan as a biomaterial on which to build to innovate ophthalmic formulations.
C1 [Zambito, Y.; Di Colo, G.] Univ Pisa, Dept Pharmaceut Sci, I-56126 Pisa, Italy.
RP Zambito, Y (reprint author), Univ Pisa, Dept Pharmaceut Sci, Via Bonanno 33, I-56126 Pisa, Italy.
EM zambito@farm.unipi.it
OI ZAMBITO, YLENIA/0000-0003-0064-233X
CR Alonso MJ, 2003, J PHARM PHARMACOL, V55, P1451, DOI 10.1211/0022357022476
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   CAMBER O, 1985, ACTA PHARM SUEC, V22, P335
   Cao YX, 2007, J CONTROL RELEASE, V120, P186, DOI 10.1016/j.jconrel.2007.05.009
   Chan V, 2001, LANGMUIR, V17, P3749, DOI 10.1021/la001754u
   CHRAI SS, 1974, J PHARM SCI, V63, P1218, DOI 10.1002/jps.2600630810
   Di Colo G, 2002, INT J PHARM, V248, P115, DOI 10.1016/S0378-5173(02)00421-0
   Di Colo G, 2004, INT J PHARM, V273, P37, DOI 10.1016/j.ijpharm.2003.12.018
   Di Colo G, 2004, J PHARM SCI-US, V93, P2851, DOI 10.1002/jps.20197
   Di Colo G, 2001, INT J PHARM, V220, P169, DOI 10.1016/S0378-5173(01)00668-8
   Di Colo G, 2001, INT J PHARM, V215, P101, DOI 10.1016/S0378-5173(00)00671-2
   Di Colo G, 2008, J PHARM SCI-US, V97, P1652, DOI 10.1002/jps.21043
   DICOLO G, 2009, DRUG DEV IN IN PRESS
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Gupta H, 2007, DRUG DELIV, V14, P507, DOI 10.1080/10717540701606426
   Hamman JH, 2003, DRUG DEV IND PHARM, V29, P161, DOI 10.1081/DDC-120016724
   Hsiue GH, 2003, BIOMATERIALS, V24, P2423, DOI 10.1016/S0142-9612(03)00035-8
   Hsiue GH, 2002, BIOMATERIALS, V23, P457, DOI 10.1016/S0142-9612(01)00127-2
   HUI HW, 1985, INT J PHARM, V26, P203, DOI 10.1016/0378-5173(85)90230-3
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   Kotze AF, 1998, J CONTROL RELEASE, V51, P35, DOI 10.1016/S0168-3659(97)00154-5
   Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708
   Lee V H, 1986, J Ocul Pharmacol, V2, P67, DOI 10.1089/jop.1986.2.67
   Li N, 2009, INT J PHARMACEUT, V379, P131, DOI 10.1016/j.ijpharm.2009.06.020
   Macha S, 2001, J OCUL PHARMACOL TH, V17, P485, DOI 10.1089/108076801753266866
   Maeda T, 2006, BIOMACROMOLECULES, V7, P545, DOI 10.1021/bm050829b
   Majumdar S, 2008, INT J PHARM, V348, P175, DOI 10.1016/j.ijpharm.2007.08.017
   Monti D, 2002, INT J PHARM, V232, P139, DOI 10.1016/S0378-5173(01)00907-3
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   Nagarwal RC, 2009, J CONTROL RELEASE, V136, P2, DOI 10.1016/j.jconrel.2008.12.018
   Paolicelli P, 2009, EXPERT OPIN DRUG DEL, V6, P239, DOI 10.1517/17425240902762818
   PATTON TF, 1975, J PHARM SCI, V64, P1312, DOI 10.1002/jps.2600640811
   Paul W, 2000, STP PHARMA SCI, V10, P5
   Rittenhouse KD, 1999, PHARMACEUT RES, V16, P736, DOI 10.1023/A:1018884826943
   Rittenhouse KD, 2000, ADV DRUG DELIVER REV, V45, P229, DOI 10.1016/S0169-409X(00)00112-5
   SAETTONE MF, 1984, INT J PHARM, V20, P187, DOI 10.1016/0378-5173(84)90229-1
   SAETTONE MF, 1995, ADV DRUG DELIVER REV, V16, P95, DOI 10.1016/0169-409X(95)00014-X
   SAETTONE MF, 1982, J PHARM PHARMACOL, V34, P464, DOI 10.1111/j.2042-7158.1982.tb04762.x
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Snyman D, 2002, CARBOHYD POLYM, V50, P145, DOI 10.1016/S0144-8617(02)00008-5
   Snyman D, 2003, DRUG DEV IND PHARM, V29, P61, DOI 10.1081/DDC-120016684
   Taravella MJ, 1999, J CATARACT REFR SURG, V25, P562, DOI 10.1016/S0886-3350(99)80056-X
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   Thanou M, 2001, J PHARM SCI, V90, P38, DOI 10.1002/1520-6017(200101)90:1<38::AID-JPS5>3.3.CO;2-V
   Thanou M, 2000, PHARMACEUT RES, V17, P27, DOI 10.1023/A:1007558206506
   TRUEBLOOD JH, 1975, ARCH OPHTHALMOL-CHIC, V93, P127, DOI 10.1001/archopht.1975.01010020133008
   Wei G, 2006, BIOMED CHROMATOGR, V20, P67, DOI 10.1002/bmc.529
   WINFIELD AJ, 1990, BRIT J OPHTHALMOL, V74, P477, DOI 10.1136/bjo.74.8.477
   Zambito Y, 2007, J DRUG DELIV SCI TEC, V17, P19, DOI 10.1016/S1773-2247(07)50003-1
   Zambito Y, 2006, EUR J PHARM BIOPHARM, V64, P16, DOI 10.1016/j.ejpb.2006.01.004
   Zambito Y, 2006, EUR J PHARM SCI, V29, P460, DOI 10.1016/j.ejps.2006.09.001
NR 55
TC 11
Z9 11
U1 2
U2 16
PU EDITIONS SANTE
PI PARIS
PA 47 RUE GALILEE, 75116 PARIS, FRANCE
SN 1773-2247
J9 J DRUG DELIV SCI TEC
JI J. Drug Deliv. Sci. Technol.
PD JAN-FEB
PY 2010
VL 20
IS 1
SI SI
BP 45
EP 52
DI 10.1016/S1773-2247(10)50005-4
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 558CA
UT WOS:000274716700006
DA 2018-10-20
ER

PT J
AU Lee, WF
   Lee, HH
AF Lee, Wen-Fu
   Lee, Heng-Hsien
TI Surface Graft Modification of Styrene-Butadiene-Styrene Triblock
   Copolymer Membrane by Ultraviolet Irradiation
SO JOURNAL OF ELASTOMERS AND PLASTICS
LA English
DT Article
DE styrene-butadiene-styrene triblock copolymer; hydrophilic monomer;
   photografting; surface modification
ID ACRYLIC-ACID; 2-HYDROXYETHYL METHACRYLATE; POLY(VINYL CHLORIDE);
   POLYETHYLENE FILM; CORONA DISCHARGE; SBS; POLYMERIZATION;
   BIOCOMPATIBILITY; BIOMATERIAL; RUBBER
AB To improve the wettability or hydrophilicity of the styrene-butadiene-styrene (SBS) triblock copolymer membrane using as transdermal patches, a series of graft copolymers were prepared by grafting hydrophilic monomers onto SBS membrane through ultraviolet irradiation technique. The characterization of the grafted membranes and the influence of various grafting factors on grafting percentage were studied. Infrared and X-ray photoelectron spectroscopy techniques were used to elucidate the surface properties of the grafted membrane. Scanning electron microscopy was used to observe the surface morphology of the grafted membrane. Experimental results showed that the grafting percentage and extent of grafting per area (mg/cm(2)) were about linearly increased with an increase of the molar ratio of hydrophilic monomer. In addition, the grafting percentage and extent of grafting per area for the grafted membranes were also approximately linearly increased with increase in irradiation time until 40 min. Decreasing contact angle and increasing equilibrium water content confirmed that the wettability of modified SBS membrane was improved.
C1 [Lee, Wen-Fu; Lee, Heng-Hsien] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan.
RP Lee, WF (reprint author), Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan.
EM wflee@ttu.edu.tw
FU Tatung University, Taipei, Taiwan [B91-1413-01]
FX The authors gratefully acknowledge financial support of this research by
   the Tatung University, Taipei, Taiwan, under grant number B91-1413-01.
CR Aliev R, 2000, RADIAT PHYS CHEM, V58, P299, DOI 10.1016/S0969-806X(99)00375-8
   Carenza M, 1996, RADIAT PHYS CHEM, V48, P231, DOI 10.1016/0969-806X(95)00421-S
   DALSIN JL, 2004, THESIS NW U EVANSTON
   HaddadiAsl V, 1996, RADIAT PHYS CHEM, V47, P907, DOI 10.1016/0969-806X(95)00165-T
   HSIUE GH, 1994, BIOMATERIALS, V15, P163
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Jiang DD, 1998, EUR POLYM J, V34, P997, DOI 10.1016/S0014-3057(97)00222-X
   JONG A, 1988, J APPL POLYM SCI, V36, P87, DOI 10.1002/app.1988.070360108
   Kojima M, 1999, POLYM DEGRAD STABIL, V63, P147, DOI 10.1016/S0141-3910(98)00084-6
   LEE WF, 1995, J APPL POLYM SCI, V55, P1197, DOI 10.1002/app.1995.070550807
   LEE WF, 1994, J APPL POLYM SCI, V51, P2175, DOI 10.1002/app.1994.070511309
   Lei JX, 2001, J APPL POLYM SCI, V81, P2881, DOI 10.1002/app.1738
   Ranby B, 1999, NUCL INSTRUM METH B, V151, P301, DOI 10.1016/S0168-583X(99)00158-5
   Richey T, 2000, BIOMATERIALS, V21, P1057, DOI 10.1016/S0142-9612(99)00281-1
   Seto F, 1998, J APPL POLYM SCI, V68, P1773, DOI 10.1002/(SICI)1097-4628(19980613)68:11<1773::AID-APP8>3.3.CO;2-1
   Shtanko NI, 1999, NUCL INSTRUM METH B, V151, P416, DOI 10.1016/S0168-583X(99)00108-1
   Taher NH, 1998, RADIAT PHYS CHEM, V53, P437, DOI 10.1016/S0969-806X(98)00008-5
   VIGO F, 1988, J APPL POLYM SCI, V35, P1893, DOI 10.1002/app.1988.070350714
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
NR 22
TC 2
Z9 3
U1 3
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0095-2443
J9 J ELASTOM PLAST
JI J. Elastomer Plast.
PD JAN
PY 2010
VL 42
IS 1
BP 49
EP 64
DI 10.1177/0095244309349473
PG 16
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA 551EN
UT WOS:000274189200003
DA 2018-10-20
ER

PT J
AU Vargun, E
   Sankir, M
   Aran, B
   Sankir, ND
   Usanmaz, A
AF Vargun, Elif
   Sankir, Mehmet
   Aran, Bengi
   Sankir, Nurdan D.
   Usanmaz, Ali
TI Synthesis and Characterization of 2-Hydroxyethyl Methacrylate (HEMA) and
   Methyl Methacrylate (MMA) Copolymer Used as Biomaterial
SO JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE Methyl methacrylate; hydroxyethyl methacrylate; emulsion polymerization;
   copolymers; equilibrium swelling ratio
ID SOLID POLYMERIC MATRICES; SWELLING BEHAVIOR; ACRYLIC ACID; HYDROGELS;
   LASER; MICROSPHERES; RELEASE; WATER; DYE
AB A series of poly(methyl methacrylate-co-hydroxyethyl methacrylate) (PMMA-co-PHEMA), copolymers were synthesized by an emulsion polymerization technique. Copolymer compositions were determined by FT-IR and 1H-NMR spectroscopy. It was found that comonomer ratios used in the recipes were comparable within the actual copolymers. Glass transition temperatures (Tg) of PMMA-co-PHEMA copolymers were varied from 119 degrees C to 100 degrees C by increasing HEMA content. Thermogravimetric analysis showed that the copolymers were stable up to 330 degrees C. High intrinsic viscosity values of copolymer resulted in ductile solution-cast films. The hydrophilicity of the films was analyzed by water uptake measurements.
C1 [Vargun, Elif; Aran, Bengi; Usanmaz, Ali] Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey.
   [Sankir, Mehmet; Aran, Bengi; Sankir, Nurdan D.] TOBB Univ Econ & Technol, Nanotechnol & Membrane Sci Lab, Sogutozu Ankara, Turkey.
   [Vargun, Elif] Mugla Univ, Dept Chem, Mugla, Turkey.
RP Usanmaz, A (reprint author), Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey.
EM usanmaz@metu.edu.tr
CR Abedin KM, 2003, OPT COMMUN, V218, P359, DOI 10.1016/S0030-4018(03)01207-0
   Arimoto M, 2004, POWDER TECHNOL, V141, P177, DOI 10.1016/j.powtec.2003.10.018
   Atai M, 2005, BIOMATERIALS, V26, P5015, DOI 10.1016/j.biomaterials.2005.01.022
   Ayhan H, 2002, J BIOACT COMPAT POL, V17, P271, DOI 10.1106/088391102026487
   Bar FW, 2000, J BIOMED MATER RES, V52, P193, DOI 10.1002/1097-4636(200010)52:1<193::AID-JBM25>3.0.CO;2-7
   Bhawal S, 2004, J APPL POLYM SCI, V92, P402, DOI 10.1002/app.13666
   CHIENG TH, 1995, POLYMER, V36, P1941, DOI 10.1016/0032-3861(95)91436-B
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Denizli A, 1997, J APPL POLYM SCI, V63, P27, DOI 10.1002/(SICI)1097-4628(19970103)63:1<27::AID-APP5>3.0.CO;2-U
   Ernest AD, 2005, J PHYS CONF SER, V15, P270, DOI 10.1088/1742-6596/15/1/045
   KABRA BG, 1991, J APPL POLYM SCI, V42, P2409, DOI 10.1002/app.1991.070420906
   Karlgard CCS, 2004, APPL SURF SCI, V230, P106, DOI 10.1016/j.apsusc.2004.02.020
   Kasarova SN, 2007, OPT MATER, V29, P1481, DOI 10.1016/j.optmat.2006.07.010
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   Lee WF, 2001, J APPL POLYM SCI, V81, P1360, DOI 10.1002/app.1561
   Nonell S, 2001, APPL PHYS B-LASERS O, V72, P355, DOI 10.1007/s003400100481
   Ozer F, 2001, J APPL POLYM SCI, V82, P237, DOI 10.1002/app.1843
   Pons M, 2002, APPL PHYS B-LASERS O, V75, P687, DOI 10.1007/s00340-002-1028-z
   Rayment EA, 2008, BIOMATERIALS, V29, P1785, DOI 10.1016/j.biomaterials.2007.12.043
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Sivakumar M, 2002, J APPL POLYM SCI, V83, P3045, DOI 10.1002/app.10310
   Susdorf T, 2007, APPL PHYS B-LASERS O, V86, P537, DOI 10.1007/s00340-006-2439-z
   Yin YH, 2008, CARBOHYD POLYM, V71, P682, DOI 10.1016/j.carbpol.2007.07.012
NR 23
TC 11
Z9 11
U1 3
U2 39
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1060-1325
J9 J MACROMOL SCI A
JI J. Macromol. Sci. Part A-Pure Appl. Chem.
PY 2010
VL 47
IS 3
BP 235
EP 240
AR PII 918957190
DI 10.1080/10601320903526998
PG 6
WC Polymer Science
SC Polymer Science
GA 551PE
UT WOS:000274220700009
DA 2018-10-20
ER

PT J
AU Choi, YY
   Jang, JH
   Park, MH
   Choi, BG
   Chi, B
   Jeong, B
AF Choi, Yun Young
   Jang, Ji Hye
   Park, Min Hee
   Choi, Bo Gyu
   Chi, Bo
   Jeong, Byeongmoon
TI Block length affects secondary structure, nanoassembly and
   thermosensitivity of poly(ethylene glycol)-poly(L-alanine) block
   copolymers
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID CIRCULAR-DICHROISM; AQUEOUS-SOLUTIONS; DRUG-DELIVERY; MULTIBLOCK
   COPOLYMERS; REVERSIBLE HYDROGELS; DIBLOCK COPOLYMERS; PEPTIDE SEQUENCES;
   BETA-SHEETS; PEG; POLYMERS
AB Poly(ethylene glycol)-conjugated polypeptides have been drawing attention as a biomaterial as well as a pharmaceutical agent. In this paper, we synthesized a series of poly(ethylene glycol)-poly(L-alanine) block copolymers (PEG-L-PA) and investigated the block length effect on (1) the secondary structure of the PA, (2) the nanostructure of the self-assembled amphiphilic PEG-L-PA, and (3) the thermosensitivity of the PEG-L-PA aqueous solution. First, the molecular weight of the L-PA was fixed at 700-760 Daltons and that of the conjugated PEG varied over 1,000, 2,000, and 5,000 Daltons. L-PA with an antiparallel beta-sheet structure in water transformed into an alpha-helical structure, and the self-assembled nanostructure of PEG-L-PA changed from a fibrous structure to a spherical micellar structure as the molecular weight of conjugated PEG increased. Then, when the molecular weight changed from 700 to 1,500 Daltons at a fixed molecular weight of PEG at 2,000, similar transitions involving antiparallel beta-sheets changing to alpha-helices, and fibers to spherical micelles were observed. The polymer aqueous solution underwent a sol-to-gel transition as the temperature increased in a high polymer concentration range of 3-14 wt%. Interestingly, the transition temperature did not follow the simple rule that a more hydrophobic polymer has a lower transition temperature. This paper suggests that the control of PEG molecular weight in PEG-conjugated polypeptide biomaterials is important in that it affects the secondary structure of the polypeptide, the nanoassembled morphology, and the thermosensitivity of the polymer.
C1 [Choi, Yun Young; Jang, Ji Hye; Park, Min Hee; Choi, Bo Gyu; Chi, Bo; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nanosci, Dept Bioinspired Sci, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nanosci, Dept Bioinspired Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU Korean Government [2009-0080447, 313-2008-2-C00590, 2007-0055790]
FX This work was supported by the National Research Foundation of Korea
   Grant funded by the Korean Government (2009-0080447, 313-2008-2-C00590,
   and 2007-0055790).
CR Baginska K, 2008, J PEPT SCI, V14, P283, DOI 10.1002/psc.923
   Bell SJ, 2008, BIOCONJUGATE CHEM, V19, P299, DOI 10.1021/bc070131q
   Burkoth TS, 1998, J AM CHEM SOC, V120, P7655, DOI 10.1021/ja980566b
   Castelletto V, 2009, BIOPHYS CHEM, V141, P169, DOI 10.1016/j.bpc.2009.01.008
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Choi YY, 2009, MACROMOL BIOSCI, V9, P869, DOI 10.1002/mabi.200900095
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431
   Du ZX, 2007, MACROMOLECULES, V40, P7633, DOI 10.1021/ma070977p
   Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1
   Hamley IW, 2008, ADV MATER, V20, P4394, DOI 10.1002/adma.200800266
   Han JO, 2009, MACROMOLECULES, V42, P6710, DOI 10.1021/ma901089s
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hentschel J, 2007, MACROMOLECULES, V40, P9224, DOI 10.1021/ma071810z
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Klok HA, 2005, FARADAY DISCUSS, V128, P29, DOI 10.1039/b402273d
   Klok HA, 2002, ANGEW CHEM INT EDIT, V41, P1509, DOI 10.1002/1521-3773(20020503)41:9<1509::AID-ANIE1509>3.0.CO;2-K
   Kubelka J, 2001, J AM CHEM SOC, V123, P12048, DOI 10.1021/ja0116627
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Lee SH, 2005, BIOCONJUGATE CHEM, V16, P377, DOI 10.1021/bc049735+
   Lim YB, 2008, J MATER CHEM, V18, P2909, DOI 10.1039/b802639d
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Radu LC, 2009, MACROMOL BIOSCI, V9, P36, DOI 10.1002/mabi.200800193
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355
   Rosler A, 2003, BIOMACROMOLECULES, V4, P859, DOI 10.1021/bm034058s
   Tzokova N, 2009, LANGMUIR, V25, P11082, DOI 10.1021/la901413n
   Urry D. W., 1997, PROTEIN BASED MAT
   Vandermeulen GWM, 2005, MACROMOLECULES, V38, P761, DOI 10.1021/ma0485538
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
NR 45
TC 66
Z9 66
U1 2
U2 59
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2010
VL 20
IS 17
BP 3416
EP 3421
DI 10.1039/b922956f
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 581VO
UT WOS:000276553300010
DA 2018-10-20
ER

PT J
AU de Leeuw, NH
AF de Leeuw, N. H.
TI Computer simulations of structures and properties of the biomaterial
   hydroxyapatite
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID DENSITY-FUNCTIONAL THEORY; MOLECULAR-DYNAMICS SIMULATIONS; TOTAL-ENERGY
   CALCULATIONS; WAVE BASIS-SET; CITRIC-ACID; MECHANICAL-PROPERTIES;
   SURFACE-STRUCTURE; CARBONATED HYDROXYAPATITE; THERMODYNAMIC PROPERTIES;
   01(1)OVER-BAR0 SURFACES
AB Carbonated hydroxyapatite is the major mineral phase in natural bone and teeth and is therefore an attractive material for use in tissue replacement applications. However, its successful application as a biomaterial requires a detailed understanding of its bulk and surface structures, defect chemistry, growth and dissolution behaviour and interaction with complex biomolecules. Computer modelling can aid experiment by investigating at the atomic level highly complex structures, properties and processes, which are still difficult or impossible to access with experimental techniques. Here, we describe our use of a combination of complementary computational techniques to investigate a number of topical issues relevant to the use of hydroxyapatite in biomaterials applications, including the bulk and surface structures of the pure material; the structure and location of carbonate impurities in the lattice; the uptake of fluoride and its effect on hydroxyapatite dissolution; and crystal growth inhibition by citric acid.
C1 [de Leeuw, N. H.] UCL, Dept Chem, London WC1H 0AJ, England.
   [de Leeuw, N. H.] Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Stanmore HA7 4LP, Middx, England.
RP de Leeuw, NH (reprint author), UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England.
EM n.h.deleeuw@ucl.ac.uk
FU Engineering and Physical Sciences Research Council [EP/D504872,
   EP/F067496]; Natural Environment Research Council; Medical Research
   Council; Wellcome Trust; Royal Society; Engineering and Physical
   Sciences Research Council [GR/S77714/02]
FX NHdL acknowledges the Engineering and Physical Sciences Research
   Council, the Natural Environment Research Council, the Medical Research
   Council, the Wellcome Trust and the Royal Society for funding, and
   thanks Dr Jeremy Rabone for useful discussions. Computer resources on
   the HPCx and HECToR services were provided via membership of the UK's
   HPC Materials Chemistry Consortium and funded by EPSRC (portfolio grant
   EP/D504872 and EP/F067496).
CR Almora-Barrios N, 2010, CRYSTENGCOMM, V12, P960, DOI 10.1039/b917179g
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Ascencio JA, 2002, COMP MATER SCI, V25, P413, DOI 10.1016/S0927-0256(02)00243-4
   Astala R, 2006, CHEM MATER, V18, P413, DOI 10.1021/cm051989x
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   Baig AA, 1999, CALCIFIED TISSUE INT, V64, P437, DOI 10.1007/PL00005826
   Balac I, 2002, J BIOMED MATER RES, V63, P793, DOI 10.1002/jbm.10407
   Barbarand J, 2003, CHEM GEOL, V198, P107, DOI 10.1016/S0009-2541(02)00424-2
   Barbour ME, 2003, EUR J ORAL SCI, V111, P428, DOI 10.1034/j.1600-0722.2003.00059.x
   Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Bates SP, 1998, SURF SCI, V409, P336, DOI 10.1016/S0039-6028(98)00278-7
   Bhowmik R, 2007, J MATER SCI, V42, P8795, DOI 10.1007/s10853-007-1914-1
   Bhowmik R, 2009, J ENG MECH, V135, P413, DOI 10.1061/(ASCE)0733-9399(2009)135:5(413)
   Born M, 1954, DYNAMICAL THEORY CRY
   BROWN WE, 1976, ANNU REV MATER SCI, V6, P213, DOI 10.1146/annurev.ms.06.080176.001241
   CATLOW CRA, 1997, COMPUTER MODELLING I, P1
   Chappell H, 2008, PHYS CHEM CHEM PHYS, V10, P600, DOI 10.1039/b714512h
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Ching WY, 2009, ACTA BIOMATER, V5, P3067, DOI 10.1016/j.actbio.2009.04.030
   CLARKSON BH, 1986, J DENT RES, V65, P963, DOI 10.1177/00220345860650071301
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Cruz FJAL, 2006, J PHYS CHEM B, V110, P4387, DOI 10.1021/jp055808q
   Cruz FJAL, 2005, J PHYS CHEM B, V109, P24473, DOI 10.1021/jp054304p
   DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106
   de Andrade A. V. C., 2004, Ceramic Engineering and Science Proceedings, V25, P639
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   de Leeuw NH, 2004, PHYS CHEM CHEM PHYS, V6, P1860, DOI 10.1039/b313242k
   de Leeuw NH, 2004, J PHYS CHEM B, V108, P1809, DOI 10.1021/jp036784v
   de Leeuw NH, 2003, J MATER CHEM, V13, P93, DOI 10.1039/b208004d
   de Leeuw NH, 2002, PHYS CHEM CHEM PHYS, V4, P3865, DOI 10.1039/b203114k
   de Leeuw NH, 2002, CHEM MATER, V14, P435, DOI 10.1021/cm011221m
   de Leeuw NH, 2001, CHEM COMMUN, P1646, DOI 10.1039/b104850n
   de Leeuw NH, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.195417
   de Leeuw NH, 2007, FARADAY DISCUSS, V134, P195, DOI 10.1039/b602012g
   Deer W.A., 1992, INTRO ROCK FORMING M
   DICK BG, 1958, PHYS REV, V112, P90, DOI 10.1103/PhysRev.112.90
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Dyshlovenko S, 2006, SURF COAT TECH, V200, P3757, DOI 10.1016/j.surfcoat.2005.04.002
   ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   Fleet ME, 2004, AM MINERAL, V89, P1422
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Grau-Crespo R, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035116
   Guild FJ, 1998, J MATER SCI-MATER M, V9, P497, DOI 10.1023/A:1008831720198
   GUILD FJ, 1993, BIOMATERIALS, V14, P985, DOI 10.1016/0142-9612(93)90190-D
   HARRIES JE, 1987, CALCIFIED TISSUE INT, V41, P346, DOI 10.1007/BF02556675
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Haverty D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.094103
   Hench LL, 2004, BIOMATERIALS SCI INT, P153
   Hochrein O, 2005, CHEM MATER, V17, P1978, DOI 10.1021/cm0401903
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Huq NL, 2000, J MOL MODEL, V6, P35
   JORIS SJ, 1971, J PHYS CHEM-US, V75, P3172, DOI 10.1021/j100689a025
   Kaflak-Hachulska A, 2003, CALCIFIED TISSUE INT, V73, P476, DOI 10.1007/s00223-002-2111-5
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim HM, 2000, J MATER SCI-MATER M, V11, P421, DOI 10.1023/A:1008935924847
   KNAPPWOST A, 1956, ANGEW CHEM INT EDIT, V68, P371, DOI 10.1002/ange.19560681103
   Kolodziejski W, 2005, TOP CURR CHEM, V246, P235, DOI 10.1007/b98652
   KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251
   Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169
   KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558
   Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0
   Lee WT, 2000, J PHYS-CONDENS MAT, V12, P9829, DOI 10.1088/0953-8984/12/48/302
   LeGeros RZ, 1995, CONNECT TISSUE RES, V32, P525
   LEWIS DW, 1994, COMMUNITY DENT ORAL, V22, P153, DOI 10.1111/j.1600-0528.1994.tb01833.x
   Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   Branda MM, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216102
   Matsunaga K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014102
   Matsunaga K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094101
   Matsunaga K, 2009, J PHYS CHEM B, V113, P3584, DOI 10.1021/jp808713m
   Matsunaga K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940337
   McLean D., 1957, GRAIN BOUNDARIES MET
   MEYER JL, 1982, INORG CHEM, V21, P3029, DOI 10.1021/ic00138a021
   Miranda P, 2008, ACTA BIOMATER, V4, P1715, DOI 10.1016/j.actbio.2008.05.020
   Mkhonto D, 2002, J MATER CHEM, V12, P2633, DOI 10.1039/b204111a
   Moens P, 1996, PHYS REV B, V53, P5190, DOI 10.1103/PhysRevB.53.5190
   MOENS PD, 1994, J CHEM SOC FARADAY T, V90, P2653, DOI 10.1039/ft9949002653
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Morgan EF, 1997, J MATER SCI-MATER M, V8, P559, DOI 10.1023/A:1018550831834
   Mostafa NY, 2007, J PHYS CHEM SOLIDS, V68, P431, DOI 10.1016/j.jpcs.2006.12.011
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   NELSON DGA, 1982, J DENT RES, V61, P1274, DOI 10.1177/00220345820610111301
   Neyman KM, 2005, CATAL TODAY, V105, P2, DOI 10.1016/j.cattod.2005.04.006
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   OKAZAKI M, 1982, J BIOMED MATER RES, V16, P851, DOI 10.1002/jbm.820160610
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671
   Peroos S, 2006, BIOMATERIALS, V27, P2150, DOI 10.1016/j.biomaterials.2005.09.025
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   Rabone JAL, 2007, PHYS CHEM MINER, V34, P495, DOI 10.1007/s00269-007-0165-7
   Rabone JAL, 2006, J COMPUT CHEM, V27, P253, DOI 10.1002/jcc.20323
   Ramraj A, 2010, CHEM PHYS LETT, V484, P295, DOI 10.1016/j.cplett.2009.11.068
   Renaudin G, 2008, J MATER CHEM, V18, P3593, DOI 10.1039/b804140g
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Rohanizadeh R, 1999, CALCIFIED TISSUE INT, V64, P430, DOI 10.1007/PL00005825
   Rulis P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155104
   Rulis P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245410
   Sarda S, 2002, J BIOMED MATER RES, V61, P653, DOI 10.1002/jbm.10264
   Schramm D. U., 2001, Physical Review B (Condensed Matter), V63, p024107/1, DOI 10.1103/PhysRevB.63.024107
   SHARMA VK, 1992, LANGMUIR, V8, P676, DOI 10.1021/la00038a062
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Skepo M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3002317
   Smith W, 1996, J MOL GRAPHICS, V14, P136, DOI 10.1016/S0263-7855(96)00043-4
   Snyders R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2738386
   Stork L, 2005, Z KRISTALLOGR, V220, P201, DOI 10.1524/zkri.220.2.201.59118
   Suetsugu Y, 2000, J SOLID STATE CHEM, V155, P292, DOI 10.1006/jssc.2000.8887
   TEW WP, 1980, BIOCHEMISTRY-US, V19, P1983, DOI 10.1021/bi00550a039
   Thiagarajan G, 2007, J BIOMED MATER RES A, V83A, P332, DOI 10.1002/jbm.a.31241
   Van Cleynenbreugel T, 2006, MED BIOL ENG COMPUT, V44, P517, DOI 10.1007/s11517-006-0071-z
   VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892
   VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98
   VIGNOLES M, 1988, CALCIFIED TISSUE INT, V43, P33, DOI 10.1007/BF02555165
   Wang F, 2007, J BIOMED MATER RES A, V80A, P146, DOI 10.1002/jbm.a.30855
   Watson GW, 1996, J CHEM SOC FARADAY T, V92, P433, DOI 10.1039/ft9969200433
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F
   Wierzbicki A, 2000, J MOL STRUC-THEOCHEM, V529, P73, DOI 10.1016/S0166-1280(00)00534-0
   WILLIAMS G, 1979, BIOCHEM J, V184, P181, DOI 10.1042/bj1840181
   Yasukawa A, 2003, CALCIFIED TISSUE INT, V72, P243, DOI 10.1007/s00223-002-2032-3
   Zahn D, 2008, J SOLID STATE CHEM, V181, P1712, DOI 10.1016/j.jssc.2008.03.035
   Zhang HP, 2009, ACTA BIOMATER, V5, P1169, DOI 10.1016/j.actbio.2008.11.014
   Zhou H, 2007, BIOCHEM BIOPH RES CO, V361, P91, DOI 10.1016/j.bbrc.2007.06.169
NR 125
TC 35
Z9 36
U1 1
U2 71
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2010
VL 20
IS 26
BP 5376
EP 5389
DI 10.1039/b921400c
PG 14
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 614HM
UT WOS:000279046200002
DA 2018-10-20
ER

PT J
AU Cheang, TY
   Wang, SM
   Hu, ZJ
   Xing, ZH
   Chang, GQ
   Yao, C
   Liu, Y
   Zhang, H
   Xu, AW
AF Cheang, Tuck-yun
   Wang, Sheng-ming
   Hu, Zuo-jun
   Xing, Zhou-Hao
   Chang, Guang-qi
   Yao, Chen
   Liu, Yong
   Zhang, Hui
   Xu, An-Wu
TI Calcium carbonate/CaIP6 nanocomposite particles as gene delivery
   vehicles for human vascular smooth muscle cells
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID PHOSPHATE PRECIPITATE FORMATION; MAMMALIAN-CELLS; GOLD NANOPARTICLES;
   NONVIRAL VECTORS; PLASMID DELIVERY; SURFACE-CHARGE; PHYTIC ACID;
   IN-VIVO; DNA; TRANSFECTION
AB Gene therapy provides great opportunities for treating diseases from genetic disorders to immune system diseases and cancer. Much work has focused on bioactive macromolecules and nanoparticles, which can interact with low-molecular-mass drugs or DNA molecules to form complexes, and have been used for local delivery of therapeutic factors for tissue regeneration or gene therapy. In this study, inorganic amorphous calcium carbonate (ACC) hybrid nanospheres functionalized with a small amount of Ca(II)-IP6 compound (CaIP6) were prepared on a large scale by a facile gas-diffusion method. The results of in vitro transfection experiments show that the obtained functional calcium carbonate/phosphate nanocomposite particles had higher transfection efficiency and lower cytotoxicity level than commercial Lipofectamine 2000. From these results alternative new vectors for gene delivery could be developed. In addition, functionalized inorganic nanocomposite particles are biocompatible and biodegradable, thus the as-prepared hybrid nanospheres are promising for biomedical applications as a safe biomaterial.
C1 [Cheang, Tuck-yun; Wang, Sheng-ming; Hu, Zuo-jun; Chang, Guang-qi; Yao, Chen; Liu, Yong; Zhang, Hui] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510080, Guangdong, Peoples R China.
   [Xing, Zhou-Hao; Xu, An-Wu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Div Nanomat & Chem, Hefei 230026, Peoples R China.
RP Wang, SM (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510080, Guangdong, Peoples R China.
EM Shenmingwang@vip.sohu.com; zuojunhu@hotmail.com; anwuxu@ustc.edu.cn
FU Science and Technology of Guangdong Province [2005B31201001]; Doctorate
   Funding Program for Higher Education; Ministry of Education of China
   [20050558053]; National Natural Science Foundation of China [20671096];
   Chinese Academy of Sciences
FX This work was supported by the Key Induction Project of Science and
   Technology of Guangdong Province (2005B31201001), the Doctorate Funding
   Program for Higher Education, the Ministry of Education of China
   (20050558053), the National Natural Science Foundation of China
   (20671096) and the 100 Talents program of the Chinese Academy of
   Sciences.
CR Akinc A, 2003, J AM CHEM SOC, V125, P5316, DOI 10.1021/ja034429c
   Anderson WF, 1998, NATURE, V392, P25
   Byk T, 1998, HUM GENE THER, V9, P2493, DOI 10.1089/10430349850019337
   CAPLEN NJ, 1995, NAT MED, V1, P39, DOI 10.1038/nm0195-39
   Chen GY, 2008, J PHYS CHEM C, V112, P16818, DOI 10.1021/jp805881e
   Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X
   Douglas KL, 2005, J BIOMAT SCI-POLYM E, V16, P43, DOI 10.1163/1568562052843339
   Epple M, 2010, J MATER CHEM, V20, P18, DOI 10.1039/b910885h
   Fu HH, 2005, J BIOMED MATER RES A, V74A, P40, DOI 10.1002/jbm.a.30267
   Gan Q, 2005, COLLOID SURFACE B, V44, P65, DOI 10.1016/j.colsurfb.2005.06.001
   Ghosh PS, 2008, ACS NANO, V2, P2213, DOI 10.1021/nn800507t
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   He XW, 2008, CANCER GENE THER, V15, P193, DOI 10.1038/sj.cgt.7701122
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   Jere D, 2008, PHARM RES, V25, P875, DOI 10.1007/s11095-007-9448-4
   Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596
   Jordan M, 1998, CYTOTECHNOLOGY, V26, P39, DOI 10.1023/A:1007917318181
   Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k
   Kang JH, 2008, J AM CHEM SOC, V130, P14906, DOI 10.1021/ja805364s
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   LACOMBE C, 1977, NUCLEIC ACIDS RES, V4, P1783, DOI 10.1093/nar/4.6.1783
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Maitra A, 2005, EXPERT REV MOL DIAGN, V5, P893, DOI 10.1586/14737159.5.6.893
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Moudgil S, 2007, ADV MATER, V19, P3130, DOI 10.1002/adma.200701969
   Mozafari MR, 2007, J PHARM SCI-US, V96, P1955, DOI 10.1002/jps.20902
   NABEL GJ, 1993, P NATL ACAD SCI USA, V90, P11307, DOI 10.1073/pnas.90.23.11307
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559
   Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101
   Salem AK, 2003, NAT MATER, V2, P668, DOI 10.1038/nmat974
   Sokolova V, 2008, ANGEW CHEM INT EDIT, V47, P1382, DOI 10.1002/anie.200703039
   Tseng WC, 1997, J BIOL CHEM, V272, P25641, DOI 10.1074/jbc.272.41.25641
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   Verma A, 2005, CHEM COMMUN, P303, DOI 10.1039/b410889b
   Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410
   WILSON SP, 1995, ANAL BIOCHEM, V226, P212, DOI 10.1006/abio.1995.1216
   Xu AW, 2005, ADV MATER, V17, P2217, DOI 10.1002/adma.200500747
   Yang HF, 2004, J PHYS CHEM B, V108, P17412, DOI 10.1021/jp049739b
   Yu SB, 2008, ANAL CHIM ACTA, V611, P173, DOI 10.1016/j.aca.2008.01.050
NR 41
TC 34
Z9 34
U1 2
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2010
VL 20
IS 37
BP 8050
EP 8055
DI 10.1039/c0jm00852d
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 648XB
UT WOS:000281726600021
DA 2018-10-20
ER

PT J
AU Mukherjee, S
   Venugopal, JR
   Ravichandran, R
   Ramakrishna, S
   Raghunath, M
AF Mukherjee, Shayanti
   Venugopal, Jayarama Reddy
   Ravichandran, Rajeswari
   Ramakrishna, Seeram
   Raghunath, Michael
TI Multimodal biomaterial strategies for regeneration of infarcted
   myocardium
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS;
   LEFT-VENTRICULAR FUNCTION; SKELETAL MYOBLAST TRANSPLANTATION; ASSEMBLING
   PEPTIDE NANOFIBERS; RANDOMIZED CONTROLLED-TRIAL; SMOOTH-MUSCLE-CELLS;
   HEART-FAILURE; CARDIAC TISSUE; EXTRACELLULAR-MATRIX
AB Myocardial tissue engineering (MTE) is an exciting front of research which is both highly competitive and extremely challenging for researchers. MTE aims to attenuate the functional set back in terms of cardiac output faced by the heart undergoing myocardial infarction (MI). MI results in substantial death of cardiomyocytes in the infarct zone followed by a strong inflammatory response and heart transplantation is the most common corrective measure for cardiac tissue engineering. Researchers are continuously striving to develop a better alternative to this highly invasive technique. Although numerous cell-based and cell-free strategies have been employed to bring about the repair of myocardium in recent times, the quest for optimal biomaterial still continues, owing to hurdles in design and fabrication of fully functional and efficiently engineered construct. In order to fabricate the constructs for myocardial repair, several biodegradable and non-biodegradable polymeric biomaterials have been analyzed over the years for their mechanical properties, biocompatibility with various cell types and functionality upon implantation. A hallmark of functional myocardium is its ability to propagate electrical impulses and respond to these impulses by synchronized contractions that generate forces for pumping blood for all metabolic activities of the body. For biomaterials to influence the myocardium microenvironment, suitable designs for cell recruitment and formation of functional conductive bundles are expected. The unique tissue structure and functioning of heart have prevented constructs from being proficient enough to be taken to clinical trials. Nonetheless, various tissue engineering strategies have evolved such as 3D implants, 2D patches and injectables, whose positive indications render optimism to investigators, that the tissue engineered regimen, would bring new treatments for patients who have suffered from agonizing MI. Focusing on biomaterials, this review provides an insight into such multi-modal research strategies, major advances and promising paradigm shifts in the field of myocardial tissue engineering.
C1 [Mukherjee, Shayanti; Venugopal, Jayarama Reddy; Ramakrishna, Seeram] Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, HEM Lab, Singapore 117576, Singapore.
   [Mukherjee, Shayanti; Raghunath, Michael] Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
   [Ravichandran, Rajeswari; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   [Ramakrishna, Seeram] ASTAR, Inst Mat Res & Engn, Singapore, Singapore.
   [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117576, Singapore.
RP Venugopal, JR (reprint author), Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, HEM Lab, 2 Engn Dr 3, Singapore 117576, Singapore.
EM nnijrv@nus.edu.sg
RI Ravichandran, Rajeswari/C-9313-2012; Raghunath, Michael/E-6483-2010
OI Raghunath, Michael/0000-0002-2138-6614; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-063-592]; Division of Bioengineering (National
   University of Singapore); Nanoscience and Nanotechnology Initiative
   (National University of Singapore)
FX The authors would like to acknowledge financial support from
   NRF-Technion (Grant No.: R-398-001-063-592), Division of Bioengineering
   (National University of Singapore) and Nanoscience and Nanotechnology
   Initiative (National University of Singapore).
CR Adabag AS, 2008, JAMA-J AM MED ASSOC, V300, P2022, DOI 10.1001/jama.2008.553
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Akins RE, 2007, DNA CELL BIOL, V26, P425, DOI 10.1089/dna.2006.0543
   Amado LC, 2006, J AM COLL CARDIOL, V48, P2116, DOI 10.1016/j.jacc.2006.06.073
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1
   Arminan A, 2010, J AM COLL CARDIOL, V55, P2244, DOI 10.1016/j.jacc.2009.08.092
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Bar A, 2007, SCAND J SURG, V96, P154
   Baig MK, 1999, HEART LUNG, V28, P87, DOI 10.1053/hl.1999.v28.a97762
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Bartholomew A, 2009, TRANSPLANTATION, V87, pS55, DOI 10.1097/TP.0b013e3181a287e6
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B
   Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006
   Bilodeau K, 2006, TISSUE ENG, V12, P2367, DOI 10.1089/ten.2006.12.2367
   Bing OHL, 1997, J MOL CELL CARDIOL, V29, P2335, DOI 10.1006/jmcc.1997.0465
   BISHOP JE, 1995, EUR HEART J, V16, P38, DOI 10.1093/eurheartj/16.suppl_C.38
   Blom AS, 2005, CIRCULATION, V112, P1274, DOI 10.1161/CIRCULATIONAHA.104.499202
   BORDIN DS, 2009, EKSP KLIN GASTROENTE, V4, P77
   BORG TK, 1983, DEV BIOL, V97, P417, DOI 10.1016/0012-1606(83)90098-2
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Bowen FW, 2001, ANN THORAC SURG, V72, P1950, DOI 10.1016/S0003-4975(01)03282-9
   Bowers SLK, 2010, J MOL CELL CARDIOL, V48, P474, DOI 10.1016/j.yjmcc.2009.08.024
   Brehant O, 2009, WORLD J SURG, V33, P1795, DOI 10.1007/s00268-009-0106-3
   Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006
   Buckberg GD, 2002, J THORAC CARDIOV SUR, V124, P863, DOI 10.1067/mtc.2002.122439
   CAIRNS JA, 1991, CIRCULATION, V84, P550, DOI 10.1161/01.CIR.84.2.550
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chaudhry PA, 2000, ANN THORAC SURG, V70, P1275, DOI 10.1016/S0003-4975(00)01755-0
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x
   Cheng Andrew S, 2008, Ann Thorac Surg, V86, P1276, DOI 10.1016/j.athoracsur.2008.07.011
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cope JT, 2001, ANN THORAC SURG, V72, P1298, DOI 10.1016/S0003-4975(01)02997-6
   Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001
   Dinsmore JH, 2008, J CARDIOVASC TRANSL, V1, P41, DOI 10.1007/s12265-007-9008-7
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3
   Eisenbarth E, 2007, ADV ENG MATER, V9, P1051, DOI 10.1002/adem.200700287
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Eschenhagen T, 1997, FASEB J, V11, P683
   Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P49, DOI 10.1016/j.carpath.2005.01.005
   Feng YJ, 1999, CIRC RES, V85, P1118
   FERRANS VJ, 1987, Z KARDIOL, V76, P20
   FONSECA MJ, 1996, BIOCHIM BIOPHYS ACTA, V127, P259
   Franco-Cereceda A, 2004, SCAND CARDIOVASC J, V38, P159, DOI 10.1080/14017430410031155
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095
   Gonen-Wadmany M, 2004, ANN NY ACAD SCI, V1015, P299, DOI 10.1196/annals.1302.025
   Guo XM, 2006, METHOD ENZYMOL, V420, P316, DOI 10.1016/S0076-6879(06)20015-6
   Gwak SJ, 2009, CELL BIOCHEM FUNCT, V27, P148, DOI 10.1002/cbf.1547
   Gyoengyoesi M, 2009, NAT CLIN PRACT CARD, V6, P70, DOI 10.1038/ncpcardio1388
   HAGEMAN TC, 1975, ARCH BIOCHEM BIOPHYS, V171, P327, DOI 10.1016/0003-9861(75)90039-9
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996
   Hilgemann DW, 2004, AM J PHYSIOL-CELL PH, V287, pC1167, DOI 10.1152/ajpcell.00288.2004
   Hodges P, 2009, CRIT CARE NURS Q, V32, P24, DOI 10.1097/01.CNQ.0000343131.27318.36
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Jin Jian-gang, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P339
   Johansson B, 2008, INT J CARDIOL, V126, P252, DOI 10.1016/j.ijcard.2007.04.003
   Kao Race L, 2009, Asian Cardiovasc Thorac Ann, V17, P89, DOI 10.1177/0218492309104144
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kasseroller RG, 2010, SUPPORT CARE CANCER, V18, P343, DOI 10.1007/s00520-009-0658-7
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   KENAR H, 2009, J MATER SCI-MATER M, V21, P989
   Khait L, 2008, ANN BIOMED ENG, V36, P713, DOI 10.1007/s10439-008-9459-2
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kofidis T, 2003, EUR J CARDIO-THORAC, V24, P906, DOI 10.1016/S1010-7940(03)00577-3
   Konertz WF, 2001, CIRCULATION, V104, pI270
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   KUBO SH, 1993, J AM COLL CARDIOL, V21, P975, DOI 10.1016/0735-1097(93)90356-6
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee KY, 2000, NATURE, V408, P998
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   LI JKJ, 1986, J THEOR BIOL, V118, P339
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li RK, 1999, CIRCULATION, V100, P63
   Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036
   Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   Maggiori L, 2010, BRIT J SURG, V97, P479, DOI 10.1002/bjs.6917
   Mancini M, 1999, J FOOD ENG, V39, P369, DOI 10.1016/S0260-8774(99)00022-9
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MARSANO A, 2008, C P IEEE ENG MED BIO, P3590
   Martinez Eliana C, 2009, Expert Rev Cardiovasc Ther, V7, P921, DOI 10.1586/erc.09.81
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Miller LW, 2008, J CARDIOVASC TRANSL, V1, P185, DOI 10.1007/s12265-008-9042-0
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Moskowitz AJ, 2001, ANN THORAC SURG, V71, pS195, DOI 10.1016/S0003-4975(00)02621-7
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Olsson A, 2005, EUR J CARDIO-THORAC, V28, P448, DOI 10.1016/j.ejcts.2005.05.027
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Packer M, 2002, J CARD FAIL, V8, P193, DOI 10.1054/jcaf.2002.128001
   Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Perin Emerson C, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS110, DOI 10.1038/ncpcardio0447
   Pietra BA, 2000, PROG PEDIATR CARDIOL, V11, P115, DOI 10.1016/S1058-9813(00)00043-6
   Pilla JJ, 2003, J THORAC CARDIOV SUR, V126, P1467, DOI 10.1016/S0022-5223(03)00739-6
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Poole-Wilson PA, 2002, J AM COLL CARDIOL, V40, P1104, DOI 10.1016/S0735-1097(02)02112-5
   Post MJ, 2001, CARDIOVASC RES, V49, P522, DOI 10.1016/S0008-6363(00)00216-9
   Raake P, 2004, J AM COLL CARDIOL, V44, P1124, DOI 10.1016/j.jacc.2004.05.074
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Ramshaw J. A. M., 2000, BIOMATERIALS BIOENGI, P717
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
   ROBINSON TF, 1988, CIRC RES, V63, P577, DOI 10.1161/01.RES.63.3.577
   ROBINSON TF, 1983, LAB INVEST, V49, P482
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Saavedra WF, 2002, J AM COLL CARDIOL, V39, P2069, DOI 10.1016/S0735-1097(02)01890-9
   Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Sanchez-Bustamante CD, 2008, TISSUE ENG PT A, V14, P1969, DOI 10.1089/ten.tea.2007.0302
   Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007
   Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Siminiak T, 2005, EUR HEART J, V26, P1188, DOI 10.1093/eurheartj/ehi159
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   SMAILL B, 1991, THEORY OF HEART, P1
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183
   Srinivasan A, 2010, TISSUE ENG PART C-ME, V16, P895, DOI [10.1089/ten.tec.2009.0475, 10.1089/ten.TEC.2009.0475]
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tyagi, 2000, Pathophysiology, V7, P177, DOI 10.1016/S0928-4680(00)00046-8
   ULRICH S, 1992, CLIN MAT, V9, P169
   Uusimaa P, 1997, CIRCULATION, V96, P2565, DOI 10.1161/01.CIR.96.8.2565
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   VAN TOMME, 2008, INT J PHARMACEUT, V355, P1
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Walsh RG, 2005, HEART FAIL REV, V10, P101, DOI 10.1007/s10741-005-4637-x
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WILLIAMS DA, 1992, AM J PHYSIOL, V262, pC731
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Yockman JW, 2009, GENE THER, V16, P127, DOI 10.1038/gt.2008.146
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   YOUNGANDR JB, 2004, CLIN MANAGEMENT HEAR
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhao YS, 2005, J HEART LUNG TRANSPL, V24, P1091, DOI 10.1016/j.healun.2004.07.010
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
   Zwaan C, 2001, NETH HEART J, V9, P30
NR 209
TC 13
Z9 13
U1 0
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2010
VL 20
IS 40
BP 8819
EP 8831
DI 10.1039/c0jm00805b
PG 13
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 658VM
UT WOS:000282518200009
DA 2018-10-20
ER

PT J
AU Forciniti, L
   Guimard, NK
   Lee, S
   Schmidt, CE
AF Forciniti, Leandro
   Guimard, Nathalie K.
   Lee, Sueyeon
   Schmidt, Christine E.
TI Unique electrochemically synthesized polypyrrole:
   poly(lactic-co-glycolic acid) blends for biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; CONDUCTING-POLYMER; IN-VIVO;
   BIODEGRADABLE SCAFFOLDS; MICROELECTRODE ARRAYS; SURFACE MODIFICATION;
   LEACHING METHOD; DRUG-DELIVERY; NEURAL PROBES; GROWTH-FACTOR
AB A novel semiconducting biomaterial composed of salt leached poly(lactic-co-glycolic acid) (PLGA) and chloride-doped polypyrrole (PPy-Cl) was created using a simple, yet flexible, synthesis technique. The three-step method consists of (1) spin casting a solution of PLGA-salt, (2) salt leaching combined with pyrrole infusion, and (3) electrochemical synthesis of PPy-Cl. This technique resulted in unique micron-and nano-scale surface morphology that can be modulated by altering the synthesis conditions and endows the films with electrical properties beneficial for microelectrode applications. Specifically, for all conditions that created a subsequent PPy: PLGA film, advantageous electrical properties were quantified by a decrease in impedance and good conductance, as compared to negative controls. This decrease in impedance measured up to 87 percent versus plain PPy films. Since the biocompatibility of both PPy and PLGA is well known, the PPy: PLGA blends may have several biomedical engineering applications, where good conductance and low impedance are desired. Also, the films generated can be easily removed from their conducting substrate for tissue engineering applications or can remain on their conducting substrates for neural probe applications that would benefit from the unique surface morphology of these hybrid films.
C1 [Forciniti, Leandro; Schmidt, Christine E.] Univ Texas Austin, Dept Chem Engn, Univ Stn, Austin, TX 78712 USA.
   [Guimard, Nathalie K.; Lee, Sueyeon; Schmidt, Christine E.] Univ Texas Austin, Dept Biomed Engn, Univ Stn, Austin, TX 78712 USA.
RP Forciniti, L (reprint author), Univ Texas Austin, Dept Chem Engn, Univ Stn, MC C0400, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
FU NIH [EB003416]
FX The authors would like to thank Dr Hugo Celio for his assistance with
   XPS and STEM. The authors would also like to acknowledge the Center for
   Nano & Molecular Science & Technology (CNM) at the University of Texas
   at Austin for use of their facilities. This study was financially
   supported by NIH EB003416.
CR Ateh DD, 2006, TISSUE ENG, V12, P645, DOI 10.1089/ten.2006.12.645
   Cassagneau T, 2002, ADV MATER, V14, P1837, DOI 10.1002/adma.200290014
   Chansai P, 2009, ADV SCI TECH, V57, P170
   Chehimi MM, 2004, SYNTHETIC MET, V145, P15, DOI 10.1016/j.synthmet.2004.03.015
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   DIAZ AF, 1983, IBM J RES DEV, V27, P342, DOI 10.1147/rd.274.0342
   FONNER JM, 2008, BIOMED MATER, V3
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   George PM, 2006, ADV MATER, V18, P577, DOI 10.1002/adma.200501242
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jiang XP, 2002, TISSUE ENG, V8, P635, DOI 10.1089/107632702760240553
   Justin G, 2010, J BIOACT COMPAT POL, V25, P121, DOI 10.1177/0883911509350660
   Justin G, 2009, BIOMACROMOLECULES, V10, P2539, DOI 10.1021/bm900486d
   Korri-Youssoufi H, 2002, ANAL CHIM ACTA, V469, P85, DOI 10.1016/S0003-2670(02)00539-1
   Kuo YC, 2006, BIOTECHNOL PROGR, V22, P1664, DOI 10.1021/bp0602303
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee SB, 2005, BIOMATERIALS, V26, P1961, DOI 10.1016/j.biomaterials.2004.06.032
   Leung L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025006
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Mattioli-Belmonte M, 2008, J BIOMED MATER RES A, V85A, P466, DOI 10.1002/jbm.a.31483
   Mattoso LHC, 2009, J NANOSCI NANOTECHNO, V9, P2917, DOI 10.1166/jnn.2009.dk24
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Mostany J, 1997, SYNTHETIC MET, V87, P179, DOI 10.1016/S0379-6779(97)80105-1
   Onoda M, 2009, THIN SOLID FILMS, V518, P743, DOI 10.1016/j.tsf.2009.07.126
   Qaiser AA, 2009, J PHYS CHEM B, V113, P14986, DOI 10.1021/jp9038336
   Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165
   Razola SS, 2002, BIOSENS BIOELECTRON, V17, P921, DOI 10.1016/S0956-5663(02)00083-0
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   Shustak G, 2007, NEW J CHEM, V31, P163, DOI 10.1039/b611700g
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Sirivisoot S, 2009, SOLID STATE PHENOMEN, V151, P197, DOI 10.4028/www.scientific.net/SSP.151.197
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Taqvi S, 2006, BIOMATERIALS, V27, P6024, DOI 10.1016/j.biomaterials.2006.05.052
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Welzel HP, 1996, MACROMOL CHEM PHYSIC, V197, P3355, DOI 10.1002/macp.1996.021971023
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Xiao YH, 2006, APPL BIOCHEM BIOTECH, V128, P117, DOI 10.1385/ABAB:128:2:117
   Xiao YH, 2004, J ELECTROANAL CHEM, V573, P43, DOI 10.1016/j.jelechem.2004.06.024
   YANG J, 2003, APS M AM PHYS SOC AU
   Yang JY, 2005, ACTA BIOMATER, V1, P125, DOI 10.1016/j.actbio.2004.09.006
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
   Zhu MZ, 2005, SENSOR ACTUAT B-CHEM, V110, P382, DOI 10.1016/j.snb.2005.02.036
NR 54
TC 12
Z9 12
U1 0
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2010
VL 20
IS 40
BP 8865
EP 8874
DI 10.1039/c0jm01015d
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 658VM
UT WOS:000282518200013
DA 2018-10-20
ER

PT J
AU Garrigues, NW
   Little, D
   O'Conor, CJ
   Guilak, F
AF Garrigues, N. William
   Little, Dianne
   O'Conor, Christopher J.
   Guilak, Farshid
TI Use of an insulating mask for controlling anisotropy in multilayer
   electrospun scaffolds for tissue engineering
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID UNIAXIALLY ALIGNED ARRAYS; FAST FOURIER-TRANSFORM; ADULT STEM-CELLS;
   NANOFIBROUS SCAFFOLDS; ANNULUS FIBROSUS; FIBER ALIGNMENT;
   DIFFERENTIATION; MATURATION; MORPHOLOGY; CARTILAGE
AB Tissue engineering of various musculoskeletal or cardiovascular tissues requires scaffolds with controllable mechanical anisotropy. However, native tissues also exhibit significant inhomogeneity in their mechanical properties, and the principal axes of anisotropy may vary with site or depth from the tissue surface. Thus, techniques to produce multilayered biomaterial scaffolds with controllable anisotropy may provide improved biomimetic properties for functional tissue replacements. In this study, poly(3-caprolactone) scaffolds were electrospun onto a collecting electrode that was partially covered by rectangular or square shaped insulating masks. The use of a rectangular mask resulted in aligned scaffolds that were significantly stiffer in tension in the axial direction than the transverse direction at 0 strain (22.9 +/- 1.3 MPa axial, 16.1 +/- 0.9 MPa transverse), and at 0.1 strain (4.8 +/- 0.3 MPa axial, 3.5 +/- 0.2 MPa transverse). The unaligned scaffolds, produced using a square mask, did not show this anisotropy, with similar stiffness in the axial and transverse directions at 0 strain (19.7 +/- 1.4 MPa axial, 20.8 +/- 1.3 MPa transverse) and 0.1 strain (4.4 +/- 0.2 MPa axial, 4.6 +/- 0.3 MPa, transverse). Aligned scaffolds also induced alignment of adipose stem cells near the expected axis on aligned scaffolds (0.015 +/- 0.056 rad), while on the unaligned scaffolds, their orientation showed more variation and was not along the expected axis (1.005 +/- 0.225 rad). This method provides a novel means of creating multilayered electrospun scaffolds with controlled anisotropy for each layer, potentially providing a means to mimic the complex mechanical properties of various native tissues.
C1 [Garrigues, N. William; Little, Dianne; O'Conor, Christopher J.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Orthopaed Res Labs, Durham, NC 27710 USA.
   [Garrigues, N. William; Guilak, Farshid] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Orthopaed Res Labs, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Little, Dianne/H-5994-2011
OI Little, Dianne/0000-0002-6948-2453; Guilak, Farshid/0000-0001-7380-0330
FU NIH [AR48852, AG15768, AR48182, AR50245, GM008719]; Duke Translational
   Research Institute [RR24128]; Synthes, Inc.
FX Supported in part by NIH grants AR48852, AG15768, AR48182, and AR50245,
   GM008719, the Duke Translational Research Institute (RR24128), and by an
   unrestricted fellowship grant from Synthes, Inc. The authors would like
   to thank Jason Klein, Ian Gao and Frank Moutos for their contributions
   to the anisotropic electrospinning development.
CR Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014
   Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643
   Ayres CE, 2007, ACTA BIOMATER, V3, P651, DOI 10.1016/j.actbio.2007.02.010
   Baker BM, 2009, OSTEOARTHR CARTILAGE, V17, P336, DOI 10.1016/j.joca.2008.08.001
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Carnell LS, 2008, MACROMOLECULES, V41, P5345, DOI 10.1021/ma8000143
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Dong B, 2009, MACROMOL RAPID COMM, V30, P539, DOI 10.1002/marc.200800634
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   HUANG CY, 1999, T ORTHOP RES SOC, V24, P95
   Hwang CM, 2009, BIOMED MICRODEVICES, V11, P739, DOI 10.1007/s10544-009-9287-7
   Jayasinghe SN, 2006, LAB CHIP, V6, P1086, DOI 10.1039/b606508m
   Kim GH, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025010
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li D, 2004, ADV MATER, V16, P361, DOI 10.1002/adma.200306226
   Li D, 2005, NANO LETT, V5, P913, DOI 10.1021/nl0504235
   Li D, 2005, SMALL, V1, P83, DOI 10.1002/smll.200400056
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   McCullen SD, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035002
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nerurkar Nandan L, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P787
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sanders JE, 2003, J BIOMED MATER RES A, V65A, P462, DOI 10.1002/jbm.a.10525
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029
   Verteramo A, 2004, BIORHEOLOGY, V41, P203
   Xie JW, 2008, MACROMOL RAPID COMM, V29, P1775, DOI 10.1002/marc.200800381
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   YIN Z, BIOMATERIALS, V31, P2163
NR 47
TC 13
Z9 13
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2010
VL 20
IS 40
BP 8962
EP 8968
DI 10.1039/c0jm01880e
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 658VM
UT WOS:000282518200024
PM 21072247
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Frisman, I
   Orbach, R
   Seliktar, D
   Bianco-Peled, H
AF Frisman, Ilya
   Orbach, Ron
   Seliktar, Dror
   Bianco-Peled, Havazelet
TI Structural investigation of PEG-fibrinogen conjugates
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BLOCK-COPOLYMER MICELLES; HYDROGEL SCAFFOLDS; CELL-ADHESIVE; SCATTERING;
   PEGYLATION; STIMULATION; HEMOGLOBIN; MATRICES; REPAIR; GLYCOL
AB Controllable bio-synthetic polymeric hydrogels made from fibrinogen-poly(ethylene glycol) adducts have been successfully employed in tissue engineering. The structural consequences of PEG conjugation to fibrinogen (i.e., PEGylation) in such a hydrogel network are not fully understood. The current investigation details the structural alterations caused to the reduced fibrinogen polypeptides by the covalent attachment of linear or branched PEG chains. The structure of PEGylated fibrinogen polypeptides were comprehensively characterized using small angle X-ray scattering, light scattering, and cryo-transmission electron microscopy. These characterizations concur that the bio-synthetic hybrids self-assemble into elongated objects, having a protein core of about 50 in diameter decorated with multiple PEG chains. Conjugates with branched PEG chains were shorter, and have lower average molecular weight compared to conjugates with linear chains. The diameter of the protein core of both samples was similar, suggesting a tail-to-head aggregation of the PEGylated fibrinogen polypeptide. A more complete understanding of this unique structural arrangement can provide further insight into the full extent of biofunctional accessibility in a biomaterial that combines the advantages of synthetic polymers with bioactive proteins.
C1 [Frisman, Ilya; Bianco-Peled, Havazelet] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
   [Orbach, Ron] Tel Aviv Univ, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.
   [Seliktar, Dror] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel.
   [Seliktar, Dror; Bianco-Peled, Havazelet] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel.
RP Bianco-Peled, H (reprint author), Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
EM bianco@tx.technion.ac.il
OI Orbach, Ron/0000-0001-6989-5488; Seliktar, Dror/0000-0001-6964-8567
FU European Commission [RII3-CT-2003-505925]; Israel Science Foundation
   [1140/04]
FX The authors wish to thank Dr. Richard Heenan and Dr. Stephen King at
   ISIS facility of the Rutherford Appleton Laboratory (RAL, Chilton, UK)
   for their help with data collection and Dr. Daniel Dikovsky for his
   support with sample preparation. This research project has been
   supported by the European Commission under the Framework Program through
   the Key Action: Strengthening the European Research Area, Research
   Infrastructures. Contract no: RII3-CT-2003-505925. The authors
   gratefully acknowledge the financial support of the Israel Science
   Foundation ( grant no. 1140/04).
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   An QX, 2007, BIOMOL ENG, V24, P643, DOI 10.1016/j.bioeng.2007.10.002
   Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100
   DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025
   GLATTER O, 1982, SMALL ANGLE XRAY SCA
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Hammouda B., 1995, TUTORIAL SMALL ANGLE
   Krsko P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)71223-2
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Pedersen JS, 1996, MACROMOLECULES, V29, P1363, DOI 10.1021/ma9512115
   Pedersen JS, 2000, J APPL CRYSTALLOGR, V33, P637, DOI 10.1107/S0021889899012248
   Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Prabhakaran M, 2006, ARTIF CELL BLOOD SUB, V34, P381, DOI 10.1080/10731190600769164
   Richtering W, 1996, COLLOID POLYM SCI, V274, P85, DOI 10.1007/BF00658914
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Schmidt O, 2006, BIOTECHNOL BIOENG, V95, P1061, DOI 10.1002/bit.21072
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Svergun DI, 2008, BIOPHYS J, V94, P173, DOI 10.1529/biophysj.107.114314
   Talmon Y, 1999, SURF SCI SERIES, V83, P147
   Tirelli N., 2002, REV MOL BIOTECHNOL, V90, P3, DOI DOI 10.1016/S1389-0352(01)00057-5
   Upchurch GR, 1998, J THROMB THROMBOLYS, V5, P9, DOI 10.1023/A:1008859729045
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   Yu PZ, 2007, BIOORGAN MED CHEM, V15, P5396, DOI 10.1016/j.bmc.2007.05.061
   ZIMM BH, 1948, J CHEM PHYS, V16, P1099, DOI 10.1063/1.1746740
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 33
TC 19
Z9 19
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2010
VL 21
IS 1
BP 73
EP 80
DI 10.1007/s10856-009-3848-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 543QB
UT WOS:000273592200009
PM 19693654
DA 2018-10-20
ER

PT J
AU Dubey, DK
   Tomar, V
AF Dubey, Devendra K.
   Tomar, Vikas
TI Effect of changes in tropocollagen residue sequence and hydroxyapatite
   mineral texture on the strength of ideal nanoscale
   tropocollagen-hydroxyapatite biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COLLAGEN-LIKE PEPTIDE; X-RAY-SCATTERING; BONE MATERIAL PROPERTIES;
   OSTEOGENESIS-IMPERFECTA; MOLECULAR-DYNAMICS; MECHANICAL-PROPERTIES;
   BIOLOGICAL-MATERIALS; ELASTIC PROPERTIES; YOUNGS MODULUS; FIBRILS
AB Changes in mineral texture (e.g. hydroxyapatite (HAP) or aragonite) and polypeptide (e.g. tropocollagen (TC)) residue sequence are characteristic features of a disease known as osteogenesis imperfecta (OI). In OI, different possibilities of changes in polypeptide residue sequence as well as changes in polypeptide helix replacement (e.g. 3 alpha 1 chains instead of 2 alpha 1 and 1 alpha 2 chain in OI murine) exist. The cross section of the HAP crystals could be needle like or plate like. Such texture and residue sequence related changes can significantly affect the material strength at the nanoscale. In this work, a mechanistic understanding of such factors in determining strength of nanoscale TC-HAP biomaterials is presented using three dimensional molecular dynamics (MD) simulations. Analyses point out that the peak interfacial strength for failure is the highest for supercells with plate shaped HAP crystals. TC molecules with higher number of side chain functional groups impart higher strength to the TC-HAP biomaterials at the nanoscale. Overall, HAP crystal shape variation, the direction of applied loading with respect to the relative TC-HAP orientation, and the number of side chain functional groups in TC molecules are the factor that affect TC-HAP biomaterial strength in a significant manner.
C1 [Dubey, Devendra K.; Tomar, Vikas] Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
RP Tomar, V (reprint author), Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
EM tomar@purdue.edu
CR Anderson D, 2005, THESIS U TORONTO
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Berryman JG, 2005, J MECH PHYS SOLIDS, V53, P2141, DOI 10.1016/j.jmps.2005.05.004
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   BILTZ RM, 1969, J BONE JOINT SURG AM, VA 51, P456, DOI 10.2106/00004623-196951030-00003
   BONUCCI E, 2000, MECH TESTING BONE BO, P3
   Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Currey J.D., 2002, BONES STRUCTURE MECH
   Dong XN, 2004, J BIOMECH, V37, P1281, DOI [10.1016/j.biomech.2003.12.011, 10.1016/j.jbiomech.2003.12.011]
   Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002
   Dubey DK, 2009, ACTA BIOMATER, V5, P2704, DOI 10.1016/j.actbio.2009.02.035
   Dubey DK, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/205103
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fan ZF, 2007, CONNECT TISSUE RES, V48, P70, DOI 10.1080/03008200601090949
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Fratzl P, 1996, J CLIN INVEST, V97, P396, DOI 10.1172/JCI118428
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Grabner B, 2001, BONE, V29, P453, DOI 10.1016/S8756-3282(01)00594-4
   Gupta HS, 2006, INT J FRACTURE, V139, P425, DOI 10.1007/s10704-006-6635-y
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   Handgraaf JW, 2006, PROTEINS, V64, P711, DOI 10.1002/prot.21019
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   Huang C C, 1998, Pac Symp Biocomput, P349
   Israelowitz M, 2005, PROTEIN ENG DES SEL, V18, P329, DOI 10.1093/protein/gzi037
   Jager I, 2000, BIOPHYS J, V79, P1737
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   KHILLIAN J, 1991, J BIOL CHEM, V226, P23373
   Klein TE, 1999, BIOPOLYMERS, V49, P167
   Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Lorenzo AC, 2005, J BIOMECH, V38, P1527, DOI 10.1016/j.jbiomech.2004.07.011
   MATSUSHIMA N, 1982, JPN J APPL PHYS 1, V21, P186, DOI 10.1143/JJAP.21.186
   McBride DJ, 1997, J MOL BIOL, V270, P275, DOI 10.1006/jmbi.1997.1106
   MUELLER KH, 1966, J BONE JOINT SURG AM, VA 48, P140, DOI 10.2106/00004623-196648010-00014
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ponder J. W., 2003, PROTEIN SIMULATIONS, P27
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Radmer RJ, 2006, BIOPHYS J, V90, P578, DOI 10.1529/biophysj.105.065276
   Radmer RJ, 2004, BIOCHEMISTRY-US, V43, P5314, DOI 10.1021/bi035676w
   Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0
   Rodriguez-Navarro AB, 2006, J STRUCT BIOL, V156, P355, DOI 10.1016/j.jsb.2006.04.009
   Sarathchandra P, 2005, MICRON, V36, P696, DOI 10.1016/j.micron.2005.07.011
   SASAKI N, 1995, J BIOMECH, V28, P809, DOI 10.1016/0021-9290(94)00130-V
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024
   TIMMINS PA, 1977, CALC TISS RES, V23, P1, DOI 10.1007/BF02012759
   Tomar V, 2007, J MECH PHYS SOLIDS, V55, P1053, DOI 10.1016/j.jmps.2006.10.005
   Vesentini S, 2005, BIOMECH MODEL MECHAN, V3, P224, DOI 10.1007/s10237-004-0064-5
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   Wirtz DC, 2000, J BIOMECH, V33, P1325, DOI 10.1016/S0021-9290(00)00069-5
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
   Zhou M, 2003, P ROY SOC A-MATH PHY, V459, P2347, DOI 10.1098/rspa.2003.1127
NR 65
TC 13
Z9 13
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2010
VL 21
IS 1
BP 161
EP 171
DI 10.1007/s10856-009-3837-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 543QB
UT WOS:000273592200019
PM 19655234
DA 2018-10-20
ER

PT J
AU Ignjatovic, NL
   Ninkov, P
   Sabetrasekh, R
   Uskokovic, DP
AF Ignjatovic, Nenad L.
   Ninkov, Petar
   Sabetrasekh, Roya
   Uskokovic, Dragan P.
TI A novel nano drug delivery system based on tigecycline-loaded
   calciumphosphate coated with poly-dl-lactide-co-glycolide
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE; IN-VITRO; CONTROLLED-RELEASE; ASCORBIC-ACID;
   BONE-CEMENT; COMPOSITE; TISSUE; TETRACYCLINE; BIOMATERIAL;
   POLY(DL-LACTIDE-CO-GLYCOLIDE)
AB The purpose of the study presented in this paper has been to examine the possibility of the synthesis of a new nanoparticulate system for controlled and systemic drug delivery with double effect. In the first step, a drug is released from bioresorbable polymer; in the second stage, after resorption of the polymer, non-bioresorbable calcium phosphate remains the chief part of the particle and takes the role of a filler, filling a bone defect. The obtained tigecycline-loaded calcium-phosphate(CP)/poly(dl-lactide-co-glycolide)(PLGA) nanoparticles contain calcium phosphate coated with bioresorbable polymer. The composite was analyzed by FT-IR, XRD and AFM methods. The average particle size of the nanocomposite ranges between 65 and 95 nm. Release profiles of tigecycline were obtained by UV-VIS spectroscopy in physiological solution at 37A degrees C. Experimental results were analyzed using Peppas and Weibull mathematical models. Based on kinetic parameters, tigecycline release was defined as non-Fickian transport. The cytotoxicity of the nanocomposite was examined on standard cell lines of MC3T3-E1, in vitro. The obtained low values of lactate dehydrogenase (LDH) activity (under 37%) indicate low cytotoxicity level. The behaviour of the composite under real-life conditions was analyzed through implantation of the nanocomposite into living organisms, in vivo. The system with the lowest tigecycline content proved to be an adequate system for local and controlled release. Having in mind the registered antibiotics concentration in other tissues, delivery systems with a higher tigecycline content show both local and systemic effects.
C1 [Ignjatovic, Nenad L.; Uskokovic, Dragan P.] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
   [Ninkov, Petar; Sabetrasekh, Roya] Univ Oslo, Fac Dent, Dept Biomat, Oslo, Norway.
RP Uskokovic, DP (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
EM dragan.uskokovic@itn.sanu.ac.rs
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
FU Ministry of Science and Technological Development of the Republic of
   Serbia [142006]
FX This study was supported by the Ministry of Science and Technological
   Development of the Republic of Serbia, under Grant No. 142006: Synthesis
   of functional materials with controlled structure on molecular and
   nano-levels. The authors would like to thank to Dr. D.
   Vasiljevic-Radovic for AFM analysis, Dr. M. Mitric for his kind help
   help in X ray measurements and Dr. M. Dramicanin for DLS analysis. The
   study is a result of joint research carried out by the Department of
   Biomaterials, Faculty of Dentistry, University of Oslo, under the
   guidance of Prof. Dr. Petter Lyngstadaas and Institute of Technical
   Sciences of the Serbian Academy of Sciences and Arts.
CR Ahn JS, 2002, BIOMATERIALS, V23, P1411, DOI 10.1016/S0142-9612(01)00261-7
   Ajdukovic Z, 2007, J BIOMATER APPL, V21, P317, DOI 10.1177/0885328207073760
   Bettany J T, 1998, Adv Dent Res, V12, P136
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Costantino L, 2006, BIOMATERIALS, V27, P4635, DOI 10.1016/j.biomaterials.2006.04.026
   Edwards DA, 1996, J POLYM SCI POL PHYS, V34, P981, DOI 10.1002/(SICI)1099-0488(19960415)34:5<981::AID-POLB16>3.0.CO;2-7
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   El-Kamel AH, 2007, DRUG DELIV, V14, P349, DOI 10.1080/10717540601098716
   Gbureck U, 2008, ACTA BIOMATER, V4, P1480, DOI 10.1016/j.actbio.2008.02.027
   HARRIS R, 2006, P & T, V31, P18
   Hasimi A, 2008, EUR POLYM J, V44, P4098, DOI 10.1016/j.eurpolymj.2008.09.011
   Hylands Jane, 2008, Intensive Crit Care Nurs, V24, P260, DOI 10.1016/j.iccn.2008.03.006
   Ignjatovic N, 2008, ADV APPL CERAM, V107, P142, DOI 10.1179/174367608X263421
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic N, 2004, SPECTROSC-INT J, V18, P553, DOI 10.1155/2004/917656
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Ignjatovic N, 2006, MICROSC RES TECHNIQ, V69, P976, DOI 10.1002/jemt.20374
   *INT CTR DIFFR DAT, 9432 JCPDS INT CTR D
   JORGENSEN K, 1992, INT J PHARM, V88, P23, DOI 10.1016/0378-5173(92)90300-Q
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Lee DK, 2007, J BIOCHEM MOL BIOL, V40, P881
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Markovic S, 2008, ULTRASON SONOCHEM, V15, P16, DOI 10.1016/j.ultsonch.2007.07.008
   Martinez-Sancho C, 2004, J CONTROL RELEASE, V99, P41, DOI 10.1016/j.jconrel.2004.06.004
   Miyai T, 2008, BIOMATERIALS, V29, P350, DOI 10.1016/j.biomaterials.2007.09.040
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Pataro AL, 2007, INT J PHARMACEUT, V336, P75, DOI 10.1016/j.ijpharm.2006.11.038
   Polson A, 2005, J APPL RES CLIN DENT, V2, P32
   Ratier A, 2004, INT J PHARM, V274, P261, DOI 10.1016/j.ijpharm.2004.01.021
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Saettone MF, 1995, INT J PHARM, V126, P79, DOI 10.1016/0378-5173(95)04096-X
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P4, DOI 10.1002/term.2
   Stevanovic M, 2007, COLLOID SURFACE B, V59, P215, DOI 10.1016/j.colsurfb.2007.05.011
   Stevanovic MM, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/84965
   Suslick K. S., 1994, YB SCI FUTURE, P138
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Whitener CJ, 2004, CLIN INFECT DIS, V38, P1049, DOI 10.1086/382357
   Xu QG, 2008, J CONTROL RELEASE, V127, P146, DOI 10.1016/j.jconrel.2009.01.017
NR 43
TC 25
Z9 25
U1 0
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2010
VL 21
IS 1
BP 231
EP 239
DI 10.1007/s10856-009-3854-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 543QB
UT WOS:000273592200026
PM 19707858
DA 2018-10-20
ER

PT J
AU Myllymaa, S
   Kaivosoja, E
   Myllymaa, K
   Sillat, T
   Korhonen, H
   Lappalainen, R
   Konttinen, YT
AF Myllymaa, Sami
   Kaivosoja, Emilia
   Myllymaa, Katja
   Sillat, Tarvo
   Korhonen, Hannu
   Lappalainen, Reijo
   Konttinen, Yrjo T.
TI Adhesion, spreading and osteogenic differentiation of mesenchymal stem
   cells cultured on micropatterned amorphous diamond, titanium, tantalum
   and chromium coatings on silicon
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSTEOPROGENITOR RESPONSE; IN-VITRO; SURFACES; BONE; PROLIFERATION;
   FILMS; NANOTOPOGRAPHIES; POLARIZATION; FIBROBLAST; GRADIENTS
AB It was hypothesized that human mesenchymal stromal cell (hMSC) can be guided by patterned and plain amorphous diamond (AD), titanium (Ti), tantalum (Ta) and chromium (Cr) coatings, produced on silicon wafer using physical vapour deposition and photolithography. At 7.5 h hMSCs density was 3.0-3.5x higher (P < 0.0003, except Ti) and cells were smaller (68 vs. 102 mu m, P 0.000006-0.02) on patterns than on silicon background. HMSC-covered surface of the background silicon was lower on Ti than AD patterns (P = 0.015), but at 5 days this had reversed (P = 0.006). At 7.5 h focal vinculin adhesions and actin cytoskeleton were outgoing from pattern edges so cells assumed geometric square shapes. Patterns allowed induced osteogenesis, but less effectively than plain surfaces, except for AD, which could be used to avoid osseointegration. All these biomaterial patterns exert direct early, intermediate and late guidance on hMSCs and osteogenic differentiation, but indirect interactions exist with cells on silicon background.
C1 [Myllymaa, Sami; Myllymaa, Katja; Korhonen, Hannu; Lappalainen, Reijo] Univ Kuopio, Dept Phys, Kuopio 70210, Finland.
   [Kaivosoja, Emilia; Konttinen, Yrjo T.] Univ Helsinki, Cent Hosp, Dept Med, Inst Clin Med, Helsinki 00029, Finland.
   [Myllymaa, Katja] Savonia Univ Appl Sci, Microsensor Lab, Sch Engn & Technol, Kuopio 70201, Finland.
   [Sillat, Tarvo] Univ Helsinki, Dept Anat, Inst Biomed, FIN-00014 Helsinki, Finland.
   [Konttinen, Yrjo T.] ORTON Orthopaed Hosp Invalid Fdn, Helsinki 00280, Finland.
   [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere 33520, Finland.
RP Lappalainen, R (reprint author), Univ Kuopio, Dept Phys, Yliopistonranta 1 F, Kuopio 70210, Finland.
EM sami.myllymaa@uku.fi; reijo.lappalainen@uku.fi
RI Peltola, Emilia/L-9969-2013
OI Peltola, Emilia/0000-0002-8868-9273; Sillat, Tarvo/0000-0003-3950-5121
FU Finska Lakaresallskapet; National Graduate School of Musculoskeletal
   Diseases and Biomaterials; NMT ERA Net; MATERA; ESF; TEKES; EVO; Sigrid
   Juselius Foundation
FX The work was supported by Finska Lakaresallskapet, the National Graduate
   School of Musculoskeletal Diseases and Biomaterials, NMT ERA Net project
   "A new generation of titanium biomaterials'', MATERA "Bioactive
   nanocomposite constructs for regeneration of articular cartilage'', ESF
   "Regenerative Medicine'', TEKES "Nanorobotics for medical diagnostics
   and therapy'', EVO grants and Sigrid Juselius Foundation. The authors
   acknowledge the staff of the Microsensor Laboratory of Applied Sciences
   for assistance with the microfabrication processes and AFM imaging. We
   thank Electron Microscopy Unit of the Institute of
   Biotechnology-University of Helsinki for providing laboratory facilities
   and VTT Technical Research Centre of Finland for sterilizing samples.
CR ANTTILA A, 1995, MATER LETT, V24, P153, DOI 10.1016/0167-577X(95)00071-2
   Anttila A, 1997, ADV MATER, V9, P1161, DOI 10.1002/adma.19970091507
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Berry CC, 2007, IEEE T NANOBIOSCI, V6, P201, DOI 10.1109/TNB.2007.903457
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Chan EWL, 2008, MOL BIOSYST, V4, P746, DOI 10.1039/b801394b
   Chaubey A, 2008, J BIOMED MATER RES B, V84B, P70, DOI 10.1002/jbm.b.30846
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Eriksson C, 2004, BIOMATERIALS, V25, P4759, DOI 10.1016/j.biomaterials.2003.12.006
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Hart A, 2007, J MATER SCI-MATER M, V18, P1211, DOI 10.1007/s10856-007-0157-7
   Hoover DK, 2008, J AM CHEM SOC, V130, P3280, DOI 10.1021/ja711016m
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim SJ, 2008, J MATER SCI-MATER M, V19, P2953, DOI 10.1007/s10856-008-3413-6
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   Lappalainen R, 2008, WOODHEAD PUBL MATER, P176, DOI 10.1533/9781845694807.2.176
   LEHTO VP, 1985, CELL DIFFER DEV, V16, P153, DOI 10.1016/0045-6039(85)90512-3
   LEVON J, J BIOMED MATER RES A
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Luo W, 2008, LANGMUIR, V24, P12129, DOI 10.1021/la802836g
   Malaval L, 1999, J CELL BIOCHEM, V74, P616
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mwenifumbo S, 2007, J MATER SCI-MATER M, V18, P9, DOI 10.1007/s10856-006-0658-9
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Pirone DM, 2008, BIOMED MICRODEVICES, V10, P561, DOI 10.1007/s10544-008-9166-7
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
NR 39
TC 44
Z9 44
U1 1
U2 28
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2010
VL 21
IS 1
BP 329
EP 341
DI 10.1007/s10856-009-3836-8
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 543QB
UT WOS:000273592200036
PM 19655235
DA 2018-10-20
ER

PT J
AU Kohara, H
   Tabata, Y
AF Kohara, Hiroshi
   Tabata, Yasuhiko
TI Review: Tissue Engineering Technology to Enhance Cell Recruitment for
   Regeneration Therapy
SO JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING
LA English
DT Review
DE Chemoattractant; Recruitment; Tissue engineering; Regenerative medicine
ID CHEMOKINE RECEPTOR CXCR4; NERVE GROWTH-FACTOR; ARTIFICIAL JUXTACRINE
   STIMULATION; BONE MORPHOGENETIC PROTEIN-4; OSTEOBLAST PROGENITOR CELLS;
   MESENCHYMAL STEM-CELLS; GENE-RELATED PEPTIDE; NEUROPEPTIDE
   SECRETONEURIN; SUBSTANCE-P; ENDOTHELIAL-CELLS
AB Tissue engineering can be classified into two strategic approaches with or without cell transplantation to induce tissue regeneration. Cell transplantation involves problems to be improved, such as low rates of cell survival and the consequently low therapeutic efficacy, and the shortage of cell source. As one trial of regenerative therapy, it is practically possible to make use of host cells present in the body. For example, efficient manipulation of in vivo local environment necessary for recruitment of host cells and their functioning will enhance the cell-induced natural healing of tissues. Peripheral blood contains several types of primitive cells with high potentials for natural healing. The in vivo recruitment of these circulating cells is being tried with biomaterials to assist and enhance the cell recruitment and retention as well as release chemoattractants. In situ tissue regeneration based on the natural self-healing potential of the body may be possible by making use of biomaterial technologies to regulate cell recruitment and their functions.
C1 [Kohara, Hiroshi; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto 6068507, Japan.
EM yasuhiko@frontier.kyoto-u.ac.jp
CR ACHMAD TH, 1992, BIOCHEM BIOPH RES CO, V189, P994
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200
   Ara T, 2005, BLOOD, V105, P3155, DOI 10.1182/blood-2004-07-2563
   Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Bladergroen BA, 2009, TISSUE ENG PT A, V15, P1591, DOI 10.1089/ten.tea.2008.0348
   Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C220176200
   Brun P, 2005, AM J PHYSIOL-GASTR L, V288, pG621, DOI 10.1152/ajpgi.00140.2004
   BURGESS AW, 1977, J BIOL CHEM, V252, P1998
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   Chiba K, 1998, J IMMUNOL, V160, P5037
   Colangelo AM, 2005, P NATL ACAD SCI USA, V102, P18658, DOI 10.1073/pnas.0508734102
   Cool SM, 2006, J CELL BIOCHEM, V99, P1040, DOI 10.1002/jcb.20936
   CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6
   Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098
   De Clercq E, 2000, MOL PHARMACOL, V57, P833
   Decressac M, 2009, NEUROBIOL DIS, V34, P441, DOI 10.1016/j.nbd.2009.02.017
   DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259
   Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373
   Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dunzendorfer S, 1998, BLOOD, V91, P1527
   Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828
   Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6
   Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264
   ELFERINK JGR, 1994, BIOCHEM PHARMACOL, V48, P865, DOI 10.1016/0006-2952(94)90356-5
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   Feistritzer C, 2005, REGUL PEPTIDES, V126, P195, DOI 10.1016/j.regpep.2004.10.001
   Feistritzer C, 2003, REGUL PEPTIDES, V116, P119, DOI 10.1016/S0167-0115(03)00193-9
   Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890
   Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x
   Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591
   Ghersi G, 2001, PEPTIDES, V22, P453, DOI 10.1016/S0196-9781(01)00340-0
   Gill M, 2001, CIRC RES, V88, P167
   Goncalves RM, 2009, BIOMATERIALS, V30, P6879, DOI 10.1016/j.biomaterials.2009.09.010
   GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Gu Y, 2001, CELL TRANSPLANT, V10, P453
   Gugasyan R, 1998, IMMUNOLOGY, V93, P398
   HEAGY W, 1990, J EXP MED, V171, P1625, DOI 10.1084/jem.171.5.1625
   Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004
   Hor Y, 2009, BIOMATERIALS, V30, P6757, DOI 10.1016/j.biomaterials.2009.08.037
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   HORIKAWA T, 1995, J INVEST DERMATOL, V104, P256, DOI 10.1111/1523-1747.ep12612795
   Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113
   Irvine DJ, 2008, SEMIN IMMUNOL, V20, P137, DOI 10.1016/j.smim.2007.10.010
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Ito Y, 1998, J BIOMAT SCI-POLYM E, V9, P879, DOI 10.1163/156856298X00217
   Kahler CM, 1996, EUR J PHARMACOL, V304, P135, DOI 10.1016/0014-2999(96)00135-5
   Kahler CM, 1999, EUR J PHARMACOL, V365, P65, DOI 10.1016/S0014-2999(98)00814-0
   Kahler CM, 1997, ARTERIOSCL THROM VAS, V17, P2029, DOI 10.1161/01.ATV.17.10.2029
   KAHLER CM, 1993, EUR J PHARMACOL, V249, P281, DOI 10.1016/0014-2999(93)90523-K
   Kahler CM, 2002, REGUL PEPTIDES, V105, P35, DOI 10.1016/S0167-0115(01)00379-2
   Kim JS, 1997, AM J RESP CELL MOL, V16, P259, DOI 10.1165/ajrcmb.16.3.9070610
   KIMURA Y, 2009, TISSUE ENG A
   Kishimoto S, 2010, J BIOMED MATER RES B, V92B, P32, DOI 10.1002/jbm.b.31486
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722
   Kohara H, 2007, BLOOD, V110, P4153, DOI 10.1182/blood-2007-04-084210
   Krause DS, 2002, GENE THER, V9, P754, DOI 10.1038/sj.gt.3301760
   Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004
   Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006
   Kupperman E, 2000, NATURE, V406, P192
   Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170
   Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200
   Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071
   Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238
   Mansilla E, 2006, TRANSPLANT P, V38, P967, DOI 10.1016/j.transproceed.2006.02.053
   MARASCO WA, 1981, BIOCHEM BIOPH RES CO, V99, P1065, DOI 10.1016/0006-291X(81)90727-0
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Mikelis C, 2008, CONNECT TISSUE RES, V49, P149, DOI 10.1080/03008200802148652
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   MORBIDELLI L, 1995, AM J PHYSIOL-HEART C, V269, pH686
   Moriyama M, 2006, AM J PHYSIOL-LUNG C, V290, pL971, DOI 10.1152/ajplung.00345.2005
   Muessel MJ, 2008, J IMMUNOL, V180, P8354, DOI 10.4049/jimmunol.180.12.8354
   Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780
   NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321
   Nagase T., 1996, DNA RES, V3, P341
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   NUMAO T, 1992, J IMMUNOL, V149, P3309
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576
   Ono M, 1999, CANCER CHEMOTH PHARM, V43, pS69, DOI 10.1007/s002800051101
   Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515
   Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226
   Oulyadi H, 1997, EUR J BIOCHEM, V246, P665
   Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221
   Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   QI X, 2010, EUR J PHARM
   REINISCH N, 1993, FEBS LETT, V334, P41, DOI 10.1016/0014-5793(93)81676-Q
   Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458
   Rodgers KD, 2008, DEV DYNAM, V237, P2622, DOI 10.1002/dvdy.21593
   Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650
   ROSS DD, 1980, EXP HEMATOL, V8, P954
   RUFF MR, 1985, PEPTIDES, V6, P107, DOI 10.1016/0196-9781(85)90142-1
   Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640
   Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101
   Seta Noriyuki, 2007, Keio Journal of Medicine, V56, P41, DOI 10.2302/kjm.56.41
   Shi Q, 1998, BLOOD, V92, P362
   Shim H, 2009, SEMIN CANCER BIOL, V19, P123, DOI 10.1016/j.semcancer.2008.11.004
   SINKELDAM EJ, 1988, FOOD CHEM TOXICOL, V26, P195, DOI 10.1016/0278-6915(88)90119-6
   Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103
   Stefonek-Puccinelli TJ, 2008, ANN BIOMED ENG, V36, P2121, DOI 10.1007/s10439-008-9581-1
   Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261
   Talme T, 2008, J NEUROIMMUNOL, V196, P60, DOI 10.1016/j.jneuroim.2008.02.007
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x
   Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VANEPPS DE, 1984, J IMMUNOL, V132, P3046
   Varnum-Finney B, 2000, J CELL SCI, V113, P4313
   Vasita R, 2006, EXPERT REV MED DEVIC, V3, P29, DOI 10.1586/17434440.3.1.29
   VERMA DS, 1980, AM J HEMATOL, V9, P185, DOI 10.1002/ajh.2830090206
   WANG HH, 2010, J NEUROCHEM
   WANG J M, 1988, Behring Institute Mitteilungen, P270
   Wang Y, 2006, HEART, V92, P768, DOI 10.1136/hrt.2005.069799
   Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846
   Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
   Yang D, 2001, J LEUKOCYTE BIOL, V69, P691
   Yule KA, 1999, EXP LUNG RES, V25, P261
   Zeng W, 2010, BIOMATERIALS, V31, P1636, DOI 10.1016/j.biomaterials.2009.11.037
   Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018
   ZICHE M, 1991, LIFE SCI, V48, pPL7, DOI 10.1016/0024-3205(91)90417-A
   Zippel Nina, 2010, Recent Pat Biotechnol, V4, P1, DOI 10.2174/187220810790069497
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 153
TC 10
Z9 10
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1609-0985
EI 2199-4757
J9 J MED BIOL ENG
JI J. Med. Biol. Eng.
PY 2010
VL 30
IS 5
BP 267
EP 276
DI 10.5405/jmbe.30.5.01
PG 10
WC Engineering, Biomedical
SC Engineering
GA 677NO
UT WOS:000283999300001
DA 2018-10-20
ER

PT J
AU Niu, L
   Zou, R
   Liu, QD
   Li, QL
   Chen, XM
   Chen, ZQ
AF Niu, Lin
   Zou, Rui
   Liu, Qida
   Li, Quanli
   Chen, Xinmin
   Chen, Zhiqing
TI A Novel Nanocomposite Particle of Hydroxyapatite and Silk Fibroin:
   Biomimetic Synthesis and Its Biocompatibility
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID CHITOSAN POLYELECTROLYTE COMPLEX; IN-VIVO; SURFACE-ROUGHNESS; CELL;
   GROWTH; VITRO; MINERALIZATION; GLUTARALDEHYDE; NANOCRYSTALS; COMPOSITES
AB A novel bone-like biomaterial of hydroxyapatite (HAP) and silk fibroin (SF) composite was developed by biomimetic synthesis. The composite was precipitated from drops of Ca(OH)(2) suspension and H(3)PO(4) solution with SF. With this method, the HAP nanocrystals were obtained by self-assembling on a SF surface whose c-axis was aligned with the long-axis direction of SF in microstructures; this shares the same misconstrues of collagen and HAP with that in the natural bone. The HAP/SF composite then demonstrated that it could promote osteoblast proliferation in vitro and new bone formation in vivo. The novel biomaterial is a promising material for bone replacement and regeneration.
C1 [Liu, Qida] Xi An Jiao Tong Univ, SV Lab, Sch Aerosp, Xian 710049, Peoples R China.
   [Li, Quanli] Anhui Med Univ, Fac Stomatol, Hefei 230032, Peoples R China.
   [Chen, Xinmin; Chen, Zhiqing] Sichuan Univ, W China Coll Stomatol, Chengdu 610041, Peoples R China.
   [Niu, Lin; Zou, Rui] Xi An Jiao Tong Univ, Stomatol Hosp, Xian 710004, Peoples R China.
RP Zou, R (reprint author), Xi An Jiao Tong Univ, Stomatol Hosp, Xian 710004, Peoples R China.
EM rainy@mail.xjtu.edu.cn
RI Qida, Liu/O-4604-2014
OI Qida, Liu/0000-0001-6473-428X
FU Programs for Science and Technology Development of Shaanxi province,
   China [200814k-03]; National Natural Science Foundation of China
   [30772440]; Key Programs for Science and Technology Development of Anhui
   province, China [08010302196]; Xi'an Jiaotong University
FX This paper was supported in part by the Programs for Science and
   Technology Development of Shaanxi province, China (Grant no.
   200814k-03), the National Natural Science Foundation of China (Grant no.
   30772440), Key Programs for Science and Technology Development of Anhui
   province, China (Grant no. 08010302196), and Stomatology College Youth
   Fund of Xi'an Jiaotong University.
CR Akari T., 2003, J BIOMED MATER RES A, V65, P283
   Chang MC, 2003, BIOMATERIALS, V24, P3087, DOI 10.1016/S0142-9612(03)00150-9
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Li QL, 2008, J BIOACT COMPAT POL, V23, P520, DOI 10.1177/0883911508097370
   Li QL, 2006, MATER LETT, V60, P3533, DOI 10.1016/j.matlet.2006.03.046
   Li QL, 2009, J BIOACT COMPAT POL, V24, P129, DOI 10.1177/0883911508101553
   Li YC, 2008, APPL SURF SCI, V255, P1681, DOI 10.1016/j.apsusc.2008.06.009
   MASAMI T, 1997, J BIOMED MATER RES, V34, P305
   MASUHIRO T, 1994, J APPL POLYM SCI, V54, P507
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Rhee SH, 2002, J MATER SCI-MATER M, V13, P597, DOI 10.1023/A:1015135112302
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   TSUTOMU F, 2000, J BIOMEDICAL MAT RES, V50, P344
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2004, J EUR CERAM SOC, V24, P2707, DOI 10.1016/j.jeurceramsoc.2003.09.006
   Wang SH, 2005, WATER AIR SOIL POLL, V164, P1, DOI 10.1007/s11270-005-1658-y
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
NR 29
TC 13
Z9 13
U1 1
U2 36
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
J9 J NANOMATER
JI J. Nanomater.
PY 2010
AR 729457
DI 10.1155/2010/729457
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 644EJ
UT WOS:000281355700001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Han, J
   Su, HL
   Dong, Q
   Zhang, D
   Ma, XX
   Zhang, CF
AF Han, Jie
   Su, Huilan
   Dong, Qun
   Zhang, Di
   Ma, Xiaoxiao
   Zhang, Chunfu
TI Patterning and photoluminescence of CdS nanocrystallites on silk fibroin
   fiber
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Chalcogenides; Nanostructures; Chemical synthesis; Photoluminescence
   spectroscopy; Bio-inspired; Quantum dots
ID CADMIUM-SULFIDE; QUANTUM DOTS; SELF-ORGANIZATION; NANOPARTICLES;
   NANOCLUSTERS; SUPERLATTICES; TEMPERATURE; NANOFIBERS; NANOTUBES;
   ELECTRON
AB CdS nanocrystallites could be formed and assembled into nanoparticle strings and hexagons on natural silk fibroin fiber (SFF) through a room-temperature bio-inspired process. Herein, the biomaterial SFF served as reactive substrate, not only provides the in situ formation sites for CdS nanocrystallites, but also directs the arrangement of nanocrystalline CdS simultaneously. The photoluminescence (PL) of the resulting nanocomposites CdS/SFF is investigated extensively. The PL peaks observed from CdS nanoparticle strings are similar to those of separate CdS nanoparticles, corresponding to the band-edge emission of their individual building blocks (QD-CdS). Moreover, CdS nanoparticle hexagons perform a red-shifted and broadened emission peak.
C1 [Han, Jie; Su, Huilan; Dong, Qun; Zhang, Di; Ma, Xiaoxiao] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
   [Zhang, Chunfu] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200240, Peoples R China.
RP Su, HL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
EM hlsu@sjtu.edu.cn; zhangdi@sjtu.edu.cn
RI Zhang, Chunfu/P-7553-2014
FU national Science Foundations of China [50671065, 30870682]; Major
   Fundamental Research Project of Shanghai Science and Technology
   Committee [07DJ14001, 08ZR1411100]
FX Financial supports from the national Science Foundations of China (no.
   50671065, no. 30870682) and the Major Fundamental Research Project of
   Shanghai Science and Technology Committee (no. 07DJ14001, no.
   08ZR1411100) are gratefully acknowledged. The authors also thank SJTU
   Instrument Analysis Center for the measurements.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arachchige IU, 2006, J AM CHEM SOC, V128, P7964, DOI 10.1021/ja061561e
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   BAWENDI MG, 1990, ANNU REV PHYS CHEM, V41, P477, DOI 10.1146/annurev.pc.41.100190.002401
   Berman A, 2003, LANGMUIR, V19, P10962, DOI 10.1021/la035419s
   Berman A, 1999, ADV MATER, V11, P296, DOI 10.1002/(SICI)1521-4095(199903)11:4<296::AID-ADMA296>3.0.CO;2-F
   BRUS LE, 1984, J CHEM PHYS, V80, P4403, DOI 10.1063/1.447218
   Cavallini M, 2007, J PHYS CHEM C, V111, P1061, DOI 10.1021/jp0668908
   Chen YF, 2002, ANAL CHEM, V74, P5132, DOI 10.1021/ac0258251
   Dollefeld H, 2002, J PHYS CHEM B, V106, P5604, DOI 10.1021/jp013234t
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   Du H, 2002, CHEM MATER, V14, P4473, DOI 10.1021/cm010622z
   HENGLEIN A, 1989, CHEM REV, V89, P1861, DOI 10.1021/cr00098a010
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kagan CR, 1996, PHYS REV B, V54, P8633, DOI 10.1103/PhysRevB.54.8633
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Li CS, 2006, CARBON, V44, P2021, DOI 10.1016/j.carbon.2006.01.033
   Lin Y, 2002, APPL PHYS LETT, V81, P3134, DOI 10.1063/1.1515881
   Liu B, 2005, J AM CHEM SOC, V127, P18262, DOI 10.1021/ja055734w
   Murray CB, 2001, IBM J RES DEV, V45, P47, DOI 10.1147/rd.451.0047
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   NAG BR, 2000, PHYS QUANTUM WELL DE, P105
   Niemeyer CM, 2003, ANGEW CHEM INT EDIT, V42, P5796, DOI 10.1002/anie.200301703
   Sapra S, 2001, CHEM COMMUN, P2188, DOI 10.1039/b106420g
   Sone ED, 2004, J AM CHEM SOC, V126, P12756, DOI 10.1021/ja0499344
   VOSSMEYER T, 1994, J PHYS CHEM-US, V98, P7665, DOI 10.1021/j100082a044
   Wang CW, 2005, CHEM MATER, V17, P3871, DOI 10.1021/cm0506252
   Wang CW, 2004, LANGMUIR, V20, P11784, DOI 10.1021/la048390g
   Xue PC, 2004, LANGMUIR, V20, P6470, DOI 10.1021/la0493520
   Zhang YH, 2006, SMALL, V2, P1314, DOI 10.1002/smll.200600067
   Zhou Y, 2006, CHEM MATER, V18, P403, DOI 10.1021/cm051928z
   Zimnitsky D, 2007, LANGMUIR, V23, P4509, DOI 10.1021/la0636917
NR 33
TC 6
Z9 10
U1 2
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD JAN
PY 2010
VL 12
IS 1
SI SI
BP 347
EP 356
DI 10.1007/s11051-009-9622-1
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 563XK
UT WOS:000275170800036
DA 2018-10-20
ER

PT J
AU Straley, KS
   Foo, CWP
   Heilshorn, SC
AF Straley, Karin S.
   Foo, Cheryl Wong Po
   Heilshorn, Sarah C.
TI Biomaterial Design Strategies for the Treatment of Spinal Cord Injuries
SO JOURNAL OF NEUROTRAUMA
LA English
DT Review
DE biomaterials; peripheral nerve injury; regeneration; spinal cord injury;
   therapeutic approaches for the treatment of CNS injury
ID PERIPHERAL-NERVE REGENERATION; TISSUE ENGINEERING APPLICATIONS;
   ELECTRICALLY CONDUCTING POLYMER; ENSHEATHING GLIA TRANSPLANTS; PEPTIDE
   SURFACE MODIFICATION; GUIDE NEURITE OUTGROWTH; SCHWANN-CELL GRAFTS;
   AXONAL REGENERATION; GUIDANCE CHANNELS; ADULT-RAT
AB The highly debilitating nature of spinal cord injuries has provided much inspiration for the design of novel biomaterials that can stimulate cellular regeneration and functional recovery. Many experts agree that the greatest hope for treatment of spinal cord injuries will involve a combinatorial approach that integrates biomaterial scaffolds, cell transplantation, and molecule delivery. This manuscript presents a comprehensive review of biomaterial-scaffold design strategies currently being applied to the development of nerve guidance channels and hydrogels that more effectively stimulate spinal cord tissue regeneration. To enhance the regenerative capacity of these two scaffold types, researchers are focusing on optimizing the mechanical properties, cell-adhesivity, biodegradability, electrical activity, and topography of synthetic and natural materials, and are developing mechanisms to use these scaffolds to deliver cells and biomolecules. Developing scaffolds that address several of these key design parameters will lead to more successful therapies for the regeneration of spinal cord tissue.
C1 [Foo, Cheryl Wong Po; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   [Straley, Karin S.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, Dept Mat Sci & Engn, 476 Lomita Mall,McCullough Bldg,Room 246, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
CR Ahmed M. Rafiuddin, 2003, Brain Research, V993, P208
   Ao Q, 2006, J BIOMED MATER RES A, V77A, P11, DOI 10.1002/jbm.a.30593
   AVELLINO AM, 1995, EXP NEUROL, V136, P183, DOI 10.1006/exnr.1995.1095
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Benowitz L, 2008, EXP NEUROL, V209, P389, DOI 10.1016/j.expneurol.2007.05.025
   BERGER A, 1991, WORLD J SURG, V15, P493, DOI 10.1007/BF01675646
   Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409
   Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934
   Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007
   Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778
   BORGENS RB, 1981, SCIENCE, V213, P611, DOI 10.1126/science.7256258
   Borgens RB, 2002, J EXP BIOL, V205, P1
   BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001
   Bunge MB, 2002, PROG BRAIN RES, V137, P275
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Cheng MY, 2004, J BIOMATER APPL, V19, P59, DOI 10.1177/0885328204043450
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Crompton KE, 2006, J MATER SCI-MATER M, V17, P633, DOI 10.1007/s10856-006-9226-6
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   DANIELSEN N, 1993, BIOMATERIALS, V14, P1180, DOI 10.1016/0142-9612(93)90164-W
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   FINE EG, 1991, BIOMATERIALS, V12, P775, DOI 10.1016/0142-9612(91)90029-A
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   GRILLO HERMES C., 1962, JOUR SURG RES, V2, P69, DOI 10.1016/S0022-4804(62)80035-3
   GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641
   Hynds DL, 1999, EXP NEUROL, V160, P244, DOI 10.1006/exnr.1999.7212
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Kassar-Duchossoy L, 2001, BRAIN RES, V908, P25, DOI 10.1016/S0006-8993(01)02554-9
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   Katayama Y, 2006, BIOMATERIALS, V27, P505, DOI 10.1016/j.biomaterials.2005.07.016
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Kofuji K, 2003, J BIOMAT SCI-POLYM E, V14, P1243, DOI 10.1163/156856203322553464
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007
   Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x
   Liu S, 1998, J NEUROSCI RES, V51, P723, DOI 10.1002/(SICI)1097-4547(19980315)51:6<723::AID-JNR6>3.0.CO;2-D
   Ljungberg C, 1999, MICROSURG, V19, P259, DOI 10.1002/(SICI)1098-2752(1999)19:6<259::AID-MICR1>3.3.CO;2-H
   LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074
   LONGO FM, 1983, EXP NEUROL, V81, P756, DOI 10.1016/0014-4886(83)90342-4
   Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004
   LUNDBORG G, 1982, BRAIN RES, V232, P157, DOI 10.1016/0006-8993(82)90618-7
   Luo J, 2007, BRAIN RES, V1155, P10, DOI 10.1016/j.brainres.2007.03.091
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   MACKINNON SE, 1984, ANN PLAS SURG, V13, P112, DOI 10.1097/00000637-198408000-00004
   MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   MARMOR L, 1964, J BONE JOINT SURG AM, V46, P383, DOI 10.2106/00004623-196446020-00011
   Meiners S, 2003, MOL NEUROBIOL, V27, P177, DOI 10.1385/MN:27:2:177
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   MILLESI H, 1981, SURG CLIN N AM, V61, P321
   MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004
   Moon LDF, 2006, RESTOR NEUROL NEUROS, V24, P147
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Musoke-Zawedde P, 2006, BIOMED MATER, V1, P162, DOI 10.1088/1748-6041/1/3/011
   Narotam PK, 2004, SPINE, V29, P2861, DOI 10.1097/01.brs.0000148049.69541.ad
   National Spinal Cord Injury Statistical Center, 2009, SPIN CORD INJ FACTS
   Newman KD, 2006, INT J ARTIF ORGANS, V29, P1082
   NIX WA, 1983, BRAIN RES, V272, P21, DOI 10.1016/0006-8993(83)90360-8
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   O Halloran DM, 2006, TISSUE ENG, V12, P1467, DOI 10.1089/ten.2006.12.1467
   Oakland RJ, 2006, P I MECH ENG H, V220, P489, DOI [10.1243/09544119JEIMI135, 10.1243/09544119JETM135]
   ORTIGUELA ME, 1987, J HAND SURG-AM, V12A, P1119, DOI 10.1016/S0363-5023(87)80129-6
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   PARK TG, 1995, J CONTROL RELEASE, V33, P211, DOI 10.1016/0168-3659(94)00084-8
   PATEL N, 1982, J NEUROSCI, V2, P483
   Petter-Puchner AH, 2007, EXP TOXICOL PATHOL, V58, P237, DOI 10.1016/j.etp.2006.07.004
   Pitta MC, 2001, J ORAL MAXIL SURG, V59, P493, DOI 10.1053/joms.2001.22671
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   Pogrel MA, 1998, J ORAL MAXIL SURG, V56, P319, DOI 10.1016/S0278-2391(98)90107-0
   POLLARD JD, 1973, ACTA NEUROPATHOL, V23, P152, DOI 10.1007/BF00685769
   Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rivlin A S, 1978, Surg Neurol, V10, P38
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SEDDON HJ, 1963, J BONE JOINT SURG BR, V45, P447
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Shaw D, 2003, J CRANIOFAC SURG, V14, P308, DOI 10.1097/00001665-200305000-00008
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SMETANA K, 1987, J BIOMED MATER RES, V21, P1247, DOI 10.1002/jbm.820211007
   Stanec S, 1998, BRIT J PLAST SURG, V51, P637, DOI 10.1054/bjps.1998.9996
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Sun T, 2008, BIOTECHNOL BIOENG, V99, P1250, DOI 10.1002/bit.21669
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tuszynski MH, 1997, ANN NY ACAD SCI, V835, P1, DOI 10.1111/j.1749-6632.1997.tb48613.x
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   VALENTINI RF, 1989, BRAIN RES, V480, P300, DOI 10.1016/0006-8993(89)90196-0
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Verdu E, 2002, RESTOR NEUROL NEUROS, V20, P169
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   Wang S, 2009, BIOMED MICRODEVICES, V11, P1127, DOI 10.1007/s10544-009-9329-1
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   WONG PFC, 2009, P ACAD SCI US, DOI DOI 10.1073/PNAS.0904851106
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056
   Yamaguchi I, 2003, BIOMATERIALS, V24, P2031, DOI 10.1016/S0142-9612(02)00633-6
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang YM, 2004, BIOTECHNOL LETT, V26, P1793, DOI 10.1007/s10529-004-4611-z
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yu XJ, 2001, J NEUROSCI RES, V66, P303, DOI 10.1002/jnr.1225
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 189
TC 130
Z9 134
U1 7
U2 116
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
J9 J NEUROTRAUM
JI J. Neurotrauma
PD JAN
PY 2010
VL 27
IS 1
BP 1
EP 19
DI 10.1089/neu.2009.0948
PG 19
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA 548RF
UT WOS:000273983200001
PM 19698073
OA Green Published
DA 2018-10-20
ER

PT J
AU Kon, E
   Delcogliano, M
   Filardo, G
   Fini, M
   Giavaresi, G
   Francioli, S
   Martin, I
   Pressato, D
   Arcangeli, E
   Quarto, R
   Sandri, M
   Marcacci, M
AF Kon, Elizaveta
   Delcogliano, Marco
   Filardo, Giuseppe
   Fini, Milena
   Giavaresi, Gianluca
   Francioli, Silvia
   Martin, Ivan
   Pressato, Daniele
   Arcangeli, Elena
   Quarto, Rodolfo
   Sandri, Monica
   Marcacci, Maurillo
TI Orderly Osteochondral Regeneration in a Sheep Model Using a Novel
   Nano-Composite Multilayered Biomaterial
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE osteochondral defect; biomimetic scaffold; cartilage regeneration;
   autologous chondrocytes
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE REPAIR;
   FOLLOW-UP; DEFECTS; TISSUE; KNEE; COLLAGEN; MATRIX; SCAFFOLDS; MEMBRANE
AB The objective of this article was to investigate the safety and regenerative potential of a newly developed biomimetic scaffold when applied to osteochondral defects in an animal model. A new multilayer gradient nano-composite scaffold was obtained by nucleating collagen fibrils with hydroxyapatite nanoparticles. In the femoral condyles of 12 sheep, 24 osteochondral lesions were created. Animals were randomized into three treatment groups: scaffold alone, scaffold colonized in vitro with autologous chondrocytes and empty defects. Six months after surgery, the animals were sacrificed and the lesions were histologically evaluated. Histologic and gross evaluation of specimens showed good integration of the chondral surface in all groups except for the control group. Significantly better bone regeneration was observed both in the group receiving the scaffold alone and in the group with scaffold loaded with autologous chondrocytes. No difference in cartilage surface reconstruction and osteochondral defect filling was noted between cell-seeded and cell-free groups. In the control group, no bone or cartilage defect healing occurred, and the defects were filled with fibrous tissue. Quantitative macroscopic and histological score evaluations confirmed the qualitative trends observed. The results of the present study showed that this novel osteochondral scaffold is safe and easy to use, and may represent a suitable matrix to direct and coordinate the process of bone and hyaline-like cartilage regeneration. The comparable regeneration process observed with or without autologous chondrocytes suggests that the main mode of action of the scaffold is based on the recruitment of local cells. (C) 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 28:116-124, 2010
C1 [Kon, Elizaveta; Delcogliano, Marco; Filardo, Giuseppe; Fini, Milena; Giavaresi, Gianluca; Marcacci, Maurillo] Rizzoli Orthopaed Inst, Lab Biomeccan, I-40136 Bologna, Italy.
   [Quarto, Rodolfo] Univ Genoa, Adv Biotechnol Ctr, Stem Cells Lab, Genoa, Italy.
   [Pressato, Daniele; Arcangeli, Elena] Fin Ceram Faenza SpA, Faenza, Italy.
   [Francioli, Silvia; Martin, Ivan] Univ Basel Hosp, CH-4031 Basel, Switzerland.
   [Sandri, Monica] Natl Res Inst, Inst Sci & Technol Ceram Mat, ISTEC CNR, Faenza, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Lab Biomeccan, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Sandri, Monica/0000-0001-5782-3137;
   Quarto, Rodolfo/0000-0002-1146-894X; Giavaresi,
   Gianluca/0000-0001-7843-5969; Filardo, Giuseppe/0000-0002-8136-0977
FU Fin-Ceramica Faenza S.p.A., Faenza, Italy
FX We acknowledge Angela Montaperrto, Laura Bragonzoni, Giulio Altadonna,
   Elettra Pignotti, Keith Smith, Matilde Tschon, and Nicolo Nicoli Aldini
   at the Istituti Ortopedici Rizzoli, Bologna, Italy for their help. We
   are thankful for the financial support from Fin-Ceramica Faenza S.p.A.,
   Faenza, Italy (for providing biomaterial, costs of animals, and animal
   housing).
CR Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P330, DOI 10.1302/0301-620X.87B3.15552
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167
   Frenkel SR, 2005, OSTEOARTHR CARTILAGE, V13, P798, DOI 10.1016/j.joca.2005.04.018
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Kramer J, 2006, CELL MOL LIFE SCI, V63, P616, DOI 10.1007/s00018-005-5527-z
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Marcacci M, 2007, AM J SPORT MED, V35, P2014, DOI 10.1177/0363546507305455
   Marcacci M, 2007, KNEE SURG SPORT TR A, V15, P610, DOI 10.1007/s00167-006-0265-9
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Miot S, 2006, J ORTHOP RES, V24, P1078, DOI 10.1002/jor.20098
   Nagura I, 2007, J BONE JOINT SURG BR, V89B, P258, DOI 10.1302/0301-620X.89B2.17754
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Schumann Detlef, 2007, V140, P101
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Sharpe JR, 2005, J BONE JOINT SURG BR, V87B, P730, DOI 10.1302/0301-620X.87B5.14936
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Siebert CH, 2003, ARTHROSCOPY, V19, P182, DOI 10.1053/jars.2003.50000
   Szerb I, 2005, BULL HOSP JT DIS, V63, P54
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Williams RJ, 2007, J BONE JOINT SURG AM, V89A, P718, DOI 10.2106/JBJS.F.00625
   Zeeman R, 2000, J BIOMED MATER RES, V51, P541, DOI 10.1002/1097-4636(20000915)51:4<541::AID-JBM1>3.3.CO;2-G
NR 31
TC 104
Z9 106
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD JAN
PY 2010
VL 28
IS 1
BP 116
EP 124
DI 10.1002/jor.20958
PG 9
WC Orthopedics
SC Orthopedics
GA 536WG
UT WOS:000273074000019
PM 19623663
OA Bronze
DA 2018-10-20
ER

PT J
AU Nitta, Y
   Okamoto, K
   Nakatani, T
   Mochizuki, A
AF Nitta, Yuki
   Okamoto, Keishi
   Nakatani, Tatsuyuki
   Mochizuki, Akira
TI Development of Novel DLC Film using Plasma Technique for Medical
   Material
SO JOURNAL OF PHOTOPOLYMER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Diamond-like carbon; plasma surface treatment; biomaterial;
   bio-compatibility; stent; medical device; zeta potential
ID DIAMOND-LIKE-CARBON; DIFFERENT ELECTRICAL RESISTIVITIES;
   INTERNAL-REFLECTION GEOMETRY; RAY PHOTOELECTRON ANALYSIS; DRUG-ELUTING
   STENT; INFRARED-SPECTROSCOPY; SURFACE; COATINGS
AB Coronary Stent has been used for the revascularization of occluded coronary artery, but bare metal stent often caused restenosis by thrombosis attached on stent or the abnormal proliferation of smooth muscle cells. To decrease the restenosis, the coat of diamond-like carbon (DLC) thin film on the stent has been expected. DLC film has been known as one of biocompatible materials for medical devices because of its chemical stability. The application of DLC films on a coronary stent is specifically required and the improvement of the plasma processing is required for the preparation of more excellent bio-compatible DLC films. Our knowledge and experience bring about an innovative bio-compatible DLC film, which is realized through the precise control of plasma processing. The newly developed biomimetic DLC film will be applied to metalic medical devices as one of the best coating.
C1 [Nitta, Yuki; Okamoto, Keishi; Nakatani, Tatsuyuki] Toyo Adv Technol Co Ltd, Minami Ku, Hiroshima 7348501, Japan.
   [Mochizuki, Akira] Tokai Univ, Dept Biomed Engn, Shizuoka 4100395, Japan.
RP Nitta, Y (reprint author), Toyo Adv Technol Co Ltd, Minami Ku, 5-3-38 Ujina Higashi, Hiroshima 7348501, Japan.
EM nakatani.t@toyo-at.co.jp
OI Mochizuki, Akira/0000-0001-8104-7764
CR Antoniucci D, 2000, AM J CARDIOL, V85, P821, DOI 10.1016/S0002-9149(99)00874-7
   BALRAM B, 2006, CATHETERIZATION CARD, V67, P698
   HASEBE T, 2006, CHEM CHEM IND, V59, P1064
   Hauert R, 2004, TRIBOL INT, V37, P991, DOI 10.1016/j.triboint.2004.07.017
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Nakatani T., 2010, IND PLASMA TECHNOLOG, P301
   NAKATANI T, 2009, KINZOKU MAT SCI TECH, V79, P124
   NAKATANI T, 2009, JAPAN SOC MECH ENG N, V20, P7
   NAKATANI T, 2010, NEW DIAMOND, V26, P64
   Nakatani T, 2008, J PHOTOPOLYM SCI TEC, V21, P225, DOI 10.2494/photopolymer.21.225
   Nakatani T, 2007, NEW DIAM FRONT C TEC, V17, P289
   Nakatani T, 2007, J PHOTOPOLYM SCI TEC, V20, P221, DOI 10.2494/photopolymer.20.221
   Nakatani T, 2006, NEW DIAM FRONT C TEC, V16, P187
   Nakatani T, 2009, J PHOTOPOLYM SCI TEC, V22, P455, DOI 10.2494/photopolymer.22.455
   Nitta Y, 2008, DIAM RELAT MATER, V17, P1972, DOI 10.1016/j.diamond.2008.05.004
   Nurdin N., 2003, European Cells & Materials, V5, P17
   Okamoto K, 2008, SURF COAT TECH, V202, P5750, DOI 10.1016/j.surfcoat.2008.06.153
   SHINOHARA M, 2007, T MAT RES SOC JAPAN, V32, P473
   Shinohara M, 2008, THIN SOLID FILMS, V516, P4379, DOI 10.1016/j.tsf.2007.10.014
   Shinohara M, 2007, APPL SURF SCI, V253, P6242, DOI 10.1016/j.apsusc.2007.01.067
   Shinohara M, 2009, J VAC SCI TECHNOL A, V27, P813, DOI 10.1116/1.3077278
   Shirakura A, 2006, THIN SOLID FILMS, V494, P84, DOI 10.1016/j.tsf.2005.08.366
   Takabayashi S, 2008, TANSO, V235, P280
   Takabayashi S, 2008, JPN J APPL PHYS, V47, P3376, DOI 10.1143/JJAP.47.3376
   Takabayashi S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2735416
   Takabayashi S, 2008, APPL SURF SCI, V254, P2666, DOI 10.1016/j.apsusc.2007.10.002
   Takabayashi S, 2010, SURF INTERFACE ANAL, V42, P77, DOI 10.1002/sia.3156
   Takabayashi S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.092304
   Takabayashi S, 2008, J APPL PHYS, V104, DOI 10.1063/1.2969792
   WEISSMANTEL C, 1982, THIN SOLID FILMS, V96, P31, DOI 10.1016/0040-6090(82)90210-3
NR 31
TC 5
Z9 5
U1 0
U2 13
PU TECHNICAL ASSOC PHOTOPOLYMERS,JAPAN
PI CHIBA
PA CHIBA UNIV, FACULTY ENGINEERING, YAYOICHO, CHIBA, 263-8522, JAPAN
SN 0914-9244
J9 J PHOTOPOLYM SCI TEC
JI J. Photopolym Sci. Technol.
PY 2010
VL 23
IS 2
BP 245
EP 250
DI 10.2494/photopolymer.23.245
PG 6
WC Polymer Science
SC Polymer Science
GA 634RG
UT WOS:000280600700018
OA Bronze
DA 2018-10-20
ER

PT J
AU Rerat, V
   Pourcelle, V
   Devouge, S
   Nysten, B
   Marchand-Brynaert, J
AF Rerat, Vincent
   Pourcelle, Vincent
   Devouge, Sabrina
   Nysten, Bernard
   Marchand-Brynaert, Jacqueline
TI Surface Grafting on Poly(ethylene terephthalate) Track-Etched
   Microporous Membrane by Activation with Trifluorotriazine: Application
   to the Biofunctionalization with GRGDS Peptide
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE atomic force microscopy (AFM); biomaterial; contact angle; endothelial
   cells adhesion; ESCA/XPS; functionalization of polymers; liquid
   scintillation counting; membranes; polyesters; poly(ethylene
   terephthalate); RGD peptide; surface chemistry; surfaces; track-etched
   membrane; trifluorotriazine; X-ray photoelectron spectroscopy
ID CONTROLLED WET CHEMISTRY; POLYETHYLENE TEREPHTHALATE; RGD
   PEPTIDOMIMETICS; CHAIN-ENDS; X-RAY; FUNCTIONALIZATION; FILMS; POLYMERS;
   ADHESION; POLYMERIZATION
AB A two-step wet chemistry protocol has been developed for the surface derivatization of poly(ethylene terephthalate) (PET) track-etched membrane used as cell culturing support, that is, (a) activation by trifluorotriazine (1 M in acetonitrile (ACN), 30 degrees C, 3 h); (b) coupling to amine-terminated molecules, namely 3,5-bis(trifluoromethyl)benzylamine ((F)Tag), (L)-4,5-[H-3]-lysine, and Gly-Arg-Gly-Asp-Ser (GRGDS) pentapeptide (10(-3) M in PB-ACN, 1:1 (v/v), 20 degrees C, 17 h). The grafting rates determined by X-ray photoelectron spectroscopy, from the F/C and N/C atomic ratios, are in the range of 100-140 pmol/cm(2) (apparent surface), whereas the liquid scintillation counting assays give higher values (180-d230 pmol/cm(2)) corresponding to the open surface reactivity. PET-g-(F)Tag is reasonably stable under two usual sterilization conditions of biomaterials, that is, steam heating at 121 degrees C and gamma-irradiation at 25 kGy. On the other hand, PET-g-GRGDS is found to be stable only under ionization radiation (84% of remaining peptide molecules), but damaged in a large extent by the autoclave treatment (23% of remaining peptide molecules). The surfaces of the sterilized PET and PET-g-GRGDS samples have been characterized by water contact angle measurement and by atomic force microscopy analysis in air and under water. Comparatively to the corresponding nonsterilized surfaces, gamma-irradiated surfaces are slightly more hydrophilic and also slightly more rough and jagged. (C) 2009 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 48: 195-208, 2010
C1 [Rerat, Vincent; Pourcelle, Vincent; Devouge, Sabrina; Marchand-Brynaert, Jacqueline] Catholic Univ Louvain, Unite Chim Organ & Med, B-1348 Louvain, Belgium.
   [Nysten, Bernard] Catholic Univ Louvain, Unite Phys & Chim Hauts Polymeres, B-1348 Louvain, Belgium.
RP Marchand-Brynaert, J (reprint author), Catholic Univ Louvain, Unite Chim Organ & Med, Batiment Lavoisier,Pl Louis Pasteur 1, B-1348 Louvain, Belgium.
EM jacqueline.marchand@uclouvain.be
FU F.R.I.A.-FNRS, Belgium; Wallonia Government, Belgium [415661]
FX This work has been supported by the F.R.I.A.-FNRS, Belgium (fellowship
   to V. Rerat), the F.R.S.-FNRS, Belgium (J. Marchand-Brynaert and B.
   Nysten are senior research associates), and the Wallonia Government,
   Belgium (Winnomat contract no. 415661). The authors thank In Michel
   Genet for advice and access to the XPS facilities of EPL-UCL. Gamma
   sterilizations and cell cultivations have been performed by In Reine
   Bareille (Laboratory of Prof. Laurence Bordenave, University of Bordeaux
   2, France).
CR Akelah A., 1990, FUNCTIONALIZED POLYM
   Biltresse S, 2000, J POLYM SCI POL CHEM, V38, P3510, DOI 10.1002/1099-0518(20001001)38:19<3510::AID-POLA70>3.0.CO;2-L
   Biltresse S, 2005, BIOMATERIALS, V26, P4576, DOI 10.1016/j.biomaterials.2004.11.042
   Biltresse S, 2002, J POLYM SCI POL CHEM, V40, P770, DOI 10.1002/pola.10156
   Blotny G, 2006, TETRAHEDRON, V62, P9507, DOI 10.1016/j.tet.2006.07.039
   Bollinne C, 2003, EUR PHYS J E, V12, P389, DOI 10.1140/epje/e2004-00007-6
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Boxus T, 1996, POLYM ADVAN TECHNOL, V7, P589, DOI 10.1002/(SICI)1099-1581(199607)7:7<589::AID-PAT551>3.3.CO;2-2
   Buchalla R, 2006, RADIAT PHYS CHEM, V75, P129, DOI 10.1016/j.radphyschem.2005.05.012
   Buczkowski M, 2001, RADIAT MEAS, V34, P597, DOI 10.1016/S1350-4487(01)00236-0
   CARPINO LA, 1990, J AM CHEM SOC, V112, P9651, DOI 10.1021/ja00182a041
   Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   DELDIME M, 1995, J APPL SURF SCI, V90, P1
   FERAIN E, 1994, NUCL INSTRUM METH B, V84, P331, DOI 10.1016/0168-583X(94)95725-8
   FERRUTI P, 1991, OLIGOMERIC PRODURUGS, P539
   Friebe A, 2007, LANGMUIR, V23, P10316, DOI 10.1021/la7016962
   Gauthier MA, 2009, ANGEW CHEM INT EDIT, V48, P48, DOI 10.1002/anie.200801951
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311
   JaumotteThelen S, 1996, J BIOMED MATER RES, V32, P569, DOI 10.1002/(SICI)1097-4636(199612)32:4<569::AID-JBM10>3.0.CO;2-9
   Jeon DH, 2004, RADIAT PHYS CHEM, V71, P1059, DOI 10.1016/j.radphyschem.2003.10.009
   JIA YP, 2007, BIOMED MATER, V2, pR24
   Jollivet C, 2004, BIOMATERIALS, V25, P933, DOI 10.1016/S0142-9612(03)00601-X
   Kang XH, 2005, TISSUE ENG, V11, P458, DOI 10.1089/ten.2005.11.458
   KANNAN RY, 2009, FUNDAMENTALS TISSUE, P685
   Lequieu W, 2005, J MEMBRANE SCI, V256, P64, DOI 10.1016/j.memsci.2005.02.007
   Liu Y, 2008, J BIOMAT SCI-POLYM E, V19, P497, DOI 10.1163/156856208783719545
   Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1
   MARCHANDBRYNAERT J, 1995, J COLLOID INTERF SCI, V173, P236, DOI 10.1006/jcis.1995.1319
   Momtaz M, 2005, J MEMBRANE SCI, V250, P29, DOI 10.1016/j.memsci.2004.10.011
   Mougenot P, 1996, J COLLOID INTERF SCI, V177, P162, DOI 10.1006/jcis.1996.0017
   NAIR PD, 1984, BIOMATERIALS, V5, P305, DOI 10.1016/0142-9612(84)90079-6
   OLAH GA, 1973, SYNTHESIS-STUTTGART, P487, DOI 10.1055/s-1973-22238
   Pentimalli M, 2000, POLYMER, V41, P2871, DOI 10.1016/S0032-3861(99)00473-5
   Pourcelle V, 2007, BIOMACROMOLECULES, V8, P3977, DOI 10.1021/bm700841y
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   RATNER BD, 1996, BIOMATERIALS SCI INT, P415
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   SALAMONE JC, 1999, CONCISE POLYM MAT EN, P1178
   Salvagnini C, 2007, J BIOMAT SCI-POLYM E, V18, P1491
   SINHA SK, 1988, PHYS REV B, V38, P2297, DOI 10.1103/PhysRevB.38.2297
   Stone VW, 1999, PHYS REV B, V60, P5883, DOI 10.1103/PhysRevB.60.5883
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Wirsen A, 2005, BIOMACROMOLECULES, V6, P2281, DOI 10.1021/bm050170+
NR 45
TC 10
Z9 10
U1 3
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JAN 1
PY 2010
VL 48
IS 1
BP 195
EP 208
DI 10.1002/pola.23778
PG 14
WC Polymer Science
SC Polymer Science
GA 539JI
UT WOS:000273249800021
DA 2018-10-20
ER

PT J
AU Kumar, MS
   Kirubanandan, S
   Sripriya, R
   Sehgal, PK
AF Kumar, Muthusamy Senthil
   Kirubanandan, Shanmugam
   Sripriya, Ramasamy
   Sehgal, Praveen Kumar
TI Triphala Incorporated Collagen Sponge-A Smart Biomaterial for Infected
   Dermal Wound Healing
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE collagen sponge; drug delivery; triphala; wound infection
ID RESISTANT STAPHYLOCOCCUS-AUREUS; EXPRESSION; MECHANISM
AB Background. Wound infection is a major problem in the medical community since many types of wounds are more prone to microbial contamination leading to infection. Triphala (a traditional ayurvedic herbal formulation) incorporated collagen sponge was investigated for its healing potential on infected dermal wound in albino rats.
   Materials and Methods. Methanol extract of triphala was prepared and analyzed for the presence of catechin by high-pressure liquid chromatography analysis. Collagen sponge was prepared by incorporating triphala into collagen sponge. The triphala incorporated collagen was characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry, and water uptake analysis. Infected wound was dressed with triphala incorporated collagen sponge. Wound reduction rate, collagen content, and matrix metalloproteinases in the granulation tissue, histology, and Fourier transform electron microscopy analysis were done to obtain the healing pattern.
   Results. High-pressure liquid chromatography analysis showed the presence of (-)epigallocatechin gallate. FT-IR spectroscopy study revealed the interaction of polyphenols with the collagen. Triphala incorporated collagen sponge has shown to increase thermal stability and water uptake capability, faster wound closure, improved tissue regeneration, collagen content at the wound site, and supporting histopathological parameters pertaining to wound healing. Matrix metalloproteinases expression was correlated well with reduction in the inflammatory phase, thus confirming efficacy of the dressing.
   Conclusions. Better healing efficacy of triphala incorporated collagen sponge may provides a scientific rationale for the use of this dressing as an effective wound cover in the management of infected dermal wound. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Kumar, Muthusamy Senthil; Sripriya, Ramasamy; Sehgal, Praveen Kumar] Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Kirubanandan, Shanmugam] Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India.
RP Sehgal, PK (reprint author), Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
RI Muthusamy, Senthilkumar/G-7875-2015; KIRUBANANDAN, SHANMUGAM/Q-7683-2018
OI Muthusamy, Senthilkumar/0000-0003-1603-9965; KIRUBANANDAN,
   SHANMUGAM/0000-0002-3461-9958
FU CSIR, Government of India
FX The authors are grateful to Dr. A. B. Mandal, Director, CLRI, Chennai,
   for his kind permission to publish this work. MSK and RS gratefully
   acknowledge the financial assistance in the form of fellowships received
   from CSIR, Government of India.
CR ADAMSONS RJ, 1964, SURG GYNECOL OBSTET, V119, P323
   Ahmad I, 1998, J ETHNOPHARMACOL, V62, P183, DOI 10.1016/S0378-8741(98)00055-5
   ANSELME K, 1990, J BIOMED MATER RES, V24, P689, DOI 10.1002/jbm.820240605
   BADMAEV V, 2000, PHYTOTHER RES, V4, P245
   BERTHIAUME F, 1995, BIOMEDICAL ENG HDB, P1556
   Botha AJ, 1997, INTENS CARE MED, V23, P504, DOI 10.1007/s001340050365
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   Dutta BK, 1998, MYCOSES, V41, P535
   Gorham S. D., 1991, BIOMATERIALS, P55
   Jones V, 2001, CHRONIC WOUND CARE C, P245
   Kumar MS, 2008, J SURG RES, V144, P94, DOI 10.1016/j.jss.2007.02.049
   LAATO M, 1988, EUR SURG RES, V20, P33, DOI 10.1159/000128738
   Lee JE, 2002, ARTIF ORGANS, V26, P521, DOI 10.1046/j.1525-1594.2002.06890.x
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   MATSUZAKI TL, 1985, NIPPON NOGEIKAGAKU K, V59, P12934
   MCMANUS JGA, 1964, STAINING METHODS HIS, P8
   Mizgerd JP, 1996, J EXP MED, V184, P639, DOI 10.1084/jem.184.2.639
   Nadkarni AK, 1976, INDIAN MAT MED, P1308
   *NAT COMM CLIN LAB, 2000, M7A5 NAT COMM CLIN L
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   PANDURANGA RK, 1995, J BIOMAT SCI-POLYM E, V7, P623
   Phillips C, 1992, WOUND HEALING BIOCH, P252
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   PRIVALOV PL, 1970, BIOPOLYMERS, V9, P127, DOI 10.1002/bip.1970.360090202
   ROBSON MC, 1973, J TRAUMA, V13, P213, DOI 10.1097/00005373-197303000-00005
   Rutten HJT, 1997, EUR J SURG, V163, P31
   Sato Y, 1997, BIOL PHARM BULL, V20, P401
   SHARMA RK, 1998, CARKA SAMHITA, V2
   Sripriya R, 2004, J BIOMED MATER RES B, V70B, P389, DOI 10.1002/jbm.b.30051
   Sripriya R, 2003, J APPL POLYM SCI, V87, P2186, DOI 10.1002/app.11651
   Stemberger H., 1997, EUR J SURG, V163, P17
   TAKAGI N, 1996, Patent No. 199610070
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   VAIDYA ADB, 1998, BANG IND P SCI M ORG, P15
   Wall SJ, 2002, J INVEST DERMATOL, V119, P91, DOI 10.1046/j.1523-1747.2002.01779.x
   WIDMER MS, 1998, FRONTIERS TISSUE ENG, P107
   WITTOSASSAT V, 2000, LAB INVEST, V80, P617
   Zhao WH, 2001, ANTIMICROB AGENTS CH, V45, P1737, DOI 10.1128/AAC.45.6.1737-1742.2001
NR 40
TC 25
Z9 30
U1 2
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD JAN
PY 2010
VL 158
IS 1
BP 162
EP 170
DI 10.1016/j.jss.2008.07.006
PG 9
WC Surgery
SC Surgery
GA 583CJ
UT WOS:000276650000025
PM 19118845
DA 2018-10-20
ER

PT J
AU Zhao, CQ
   Zhang, XY
   Song, D
   Zheng, LX
   Chen, WY
AF Zhao Changqing
   Zhang Xiaoyan
   Song Dan
   Zheng Liuxian
   Chen Wuyong
TI REMOVAL OF CHROMIUM(VI) FROM TANNERY WASTEWATER BY IMMOBILIZED BACILLUS
   FUSIFORMIS
SO JOURNAL OF THE SOCIETY OF LEATHER TECHNOLOGISTS AND CHEMISTS
LA English
DT Article
AB Bacillus fusiformis was embedded in powdered activated carbon to prepare immobilized granules. Then, the immobilized granules were Used to remove Cr(VI) in tannery wastewater at different pH, temperature and initial Cr(VI) concentrations to optimize the process. At the optimum condition, the Cr(VI) in tannery wastewater was treated with the granules With the powdered activated carbon and the Bacillus fusiformis as controls. After treatment. the Bacillus fusiformis in the Was observed by SEM. The results showed that the removal Of Cr(VI) by the immobilized Bacillus fusiformis was better than either using powdered activated carbon or Bacillus fusiformis alone. The SEM images showed that the Bacillus fusiformis in the granules grew Well. In the experiment, the total chromium and the Cr(VI) in the solution and the granules were measured before and after 48 hours' treatment. It Was found that both the Cr(VI) in the solution and the granules decreased, bin the total chromium Was unchanged, which indicated that removal of Cr(VI) With the granules was mainly as the results of both the adsorption of activated carbon and the chromate reduction of Bacillus fusiformis. The kinetic data of Cr(VI) removed by the immobilized Bacillus fusiformis could be described by the pseudo-second order rate model. The experiments demonstrated that the immobilized Bacillus fusiformis could be used as a new biomaterial to remove Cr(VI) in tannery wastewater.
C1 [Zhao Changqing; Zhang Xiaoyan; Song Dan; Zheng Liuxian; Chen Wuyong] Sichuan Univ, Natl Engn Lab Clean Technol Leather Manufacture, Chengdu 610065, Peoples R China.
RP Chen, WY (reprint author), Sichuan Univ, Natl Engn Lab Clean Technol Leather Manufacture, Chengdu 610065, Peoples R China.
EM wuyong.chen@163.com
CR Aksu Z, 2004, PROCESS BIOCHEM, V39, P599, DOI 10.1016/S0032-9592(03)00132-8
   [Anonymous], 1995, J SOC LEATHER TECHNO, V79, P57
   CHANDRA BNK, 2005, CLEAN PROD, V13, P1189
   Chirayu D., 2008, BIORESOURCE TECHNOLO, V99, P6059
   Garbisu C, 1998, BIODEGRADATION, V9, P133, DOI 10.1023/A:1008358816529
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   Kapoor A, 1998, J ENVIRON SCI HEAL A, V33, P1507, DOI 10.1080/10934529809376801
   [瞿建国 Qu Jianguo], 2005, [化工环保, Environmental Protection of Chemical Industry], V25, P1
   Zhao C.Q., 2008, LEATHER SCI ENG, V18, P39
NR 9
TC 2
Z9 2
U1 0
U2 2
PU SOC LEATHER TECHNOL CHEMISTS
PI MOULTON
PA 8 COPPER LEAF CLOSE, MOULTON NN3 7HS, NORTHAMPTON, ENGLAND
SN 0144-0322
J9 J SOC LEATH TECH CH
JI J. Soc. Leather Technol. Chem.
PD JAN-FEB
PY 2010
VL 94
IS 1
BP 21
EP 25
PG 5
WC Materials Science, Textiles
SC Materials Science
GA 558SM
UT WOS:000274766200004
DA 2018-10-20
ER

PT J
AU Ben-David, D
   Kizhner, T
   Livne, E
   Srouji, S
AF Ben-David, D.
   Kizhner, T.
   Livne, E.
   Srouji, S.
TI A tissue-like construct of human bone marrow MSCs composite scaffold
   support in vivo ectopic bone formation
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE hydrogel scaffold; MSCs; osteoprogenitor cells; in vivo transplants;
   bone repair
ID MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; ENGINEERING BONE;
   HYDROGEL; CULTURE; REPAIR
AB Biocompatible and osteoconductive cell-scaffold constructs comprise the first and most important step towards successful in vivo bone repair. This study reports on a new cell-scaffold construct composed of gelatin-based hydrogel and ceramic (CaCO(3)/beta-TCP) particles loaded with human MSCs producing a tissue-like construct applied as a transplant for in vivo bone formation. Bone marrow-derived human MSCs were cultured in osteogenic induction medium. 5 x 10(5) (P(2)) cells were loaded on a mixture of hydrogel microspheres and ceramic particles, cultured in a rotating dynamic culture for up to 3 weeks. Both hydrogel microspheres and ceramic particles coalesced together to form a tissue-like construct, shown by histology to contain elongated spindle-like cells forming the new tissue between the individual particles. Cell proliferation and cell viability were confirmed by Alamar blue assay and by staining with CFDA, respectively. FACS analysis conducted before loading the cells, and after formation of the construct, revealed that the profile of cell surface markers remained unchanged throughout the dynamic culture. The osteogenic potential of the cells composing the tissue-like construct was further validated by subcutaneous transplants in athymic nude mice. After 8 weeks a substantial amount of new bone formation was observed in the cell-construct transplants, whereas no bone formation was observed in transplants containing no cells. This new cell construct provides a system for in vivo bone transplants. It can be tailored for a specific size and shape as needed for various transplant sites and for all aspects of regenerative medicine and biomaterial science. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Ben-David, D.; Kizhner, T.; Livne, E.; Srouji, S.] Technion Israel Inst Technol, Rappaport Fac Med, Dept Anat & Cell Biol, IL-31096 Haifa, Israel.
   [Srouji, S.] Carmel Hosp, Dept Oral & Maxillofacial Surg, Haifa, Israel.
RP Livne, E (reprint author), Technion Israel Inst Technol, Fac Med, Dept Anat & Cell Biol, POB 9649, IL-31096 Haifa, Israel.
EM livne@tx.technion.ac.il
FU EU Genostem [LSHB-CT-3003-503161]
FX This study was supported by EU Genostem Grant No. LSHB-CT-3003-503161.
   The authors wish to acknowledge the excellent technical work of Mrs
   Pessia Shenzer and Janette Zavin.
CR Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Hasegawa S, 2007, J BIOMED MATER RES A, V81A, P930, DOI 10.1002/jbm.a.31109
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Leong Natalie L, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2651
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Randle WL, 2007, TISSUE ENG, V13, P2957, DOI 10.1089/ten.2007.0072
   Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z
   Srouji S, 2005, MICROSC RES TECHNIQ, V66, P132, DOI 10.1002/jemt.20144
   Srouji S, 2005, J CRANIO MAXILL SURG, V33, P79, DOI 10.1016/j.jcms.2004.09.003
   Srouji S, 2006, REGEN MED, V1, P519, DOI 10.2217/17460751.1.4.519
   SUMANASINGHE RD, 2008, J BIOMED MATER RES A, V88, P778
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
NR 23
TC 18
Z9 18
U1 0
U2 11
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2010
VL 4
IS 1
BP 30
EP 37
DI 10.1002/term.213
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 542MQ
UT WOS:000273498100004
PM 19842114
DA 2018-10-20
ER

PT J
AU Liu, TL
   Miao, JC
   Sheng, WH
   Xie, YF
   Huang, Q
   Shan, YB
   Yang, JC
AF Liu, Tie-lian
   Miao, Jing-cheng
   Sheng, Wei-hua
   Xie, Yu-feng
   Huang, Quan
   Shan, Yun-bo
   Yang, Ji-cheng
TI Cytocompatibility of regenerated silk fibroin film: a medical
   biomaterial applicable to wound healing
SO JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
LA English
DT Article
DE Regenerated silk fibroin film; Cytocompatibility; Cytotoxicity
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; SCAFFOLDS; CELLS; VIVO; VEGF
AB To explore the feasibility of using regenerated silk fibroin membrane to construct artificial skin substitutes for wound healing, it is necessary to evaluate its cytocompatibility.
   The effects of regenerated silk fibroin film on cytotoxicity, adhesion, cell cycle, and apoptosis of L929 cells, growth and vascular endothelial growth factor (VEGF) expression of ECV304 cells, and VEGF, angiopoietin-1 (Ang-1), platelet-derived growth factor (PDGF) and fibroblast growth factor 2 (FGF2) expression of WI-38 cells were assessed by 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay, viable cell counting, flow cytometry (FCM), and enzyme-linked immunosorbant assay (ELISA).
   We showed that the regenerated silk fibroin film was not cytotoxic to L929 cells and had no adverse influence on their adhesion, cell cycle or apoptosis; it had no adverse influence on the growth and VEGF secretion of ECV304 cells and no effect on the secretion of VEGF, Ang-1, PDGF and FGF2 by WI-38 cells.
   The regenerated silk fibroin film should be an excellent biomaterial with good cytocompatibility, providing a framework for reparation after trauma in clinical applications.
C1 [Liu, Tie-lian; Miao, Jing-cheng; Sheng, Wei-hua; Xie, Yu-feng; Shan, Yun-bo; Yang, Ji-cheng] Soochow Univ, Coll Med, Inst Cell & Mol Biol, Suzhou 215123, Peoples R China.
   [Liu, Tie-lian] So Med Univ, Affiliated Hosp 3, Dept Lab, Guangzhou 510630, Guangdong, Peoples R China.
   [Huang, Quan] Nantong Municipal 1 Peoples Hosp, Dept Renal Med, Nantong 226001, Peoples R China.
RP Yang, JC (reprint author), Soochow Univ, Coll Med, Inst Cell & Mol Biol, Suzhou 215123, Peoples R China.
EM jcyang@suda.edu.cn
FU National Basic Research Program (973) of China [2005CB623906]; Medical
   Development Foundation of Soochow University, China [EE134702]
FX Project supported by the National Basic Research Program (973) of China
   (No. 2005CB623906) and the Medical Development Foundation of Soochow
   University (No. EE134702), China
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Augustin Hellmut G., 2003, Thrombosis and Haemostasis, V89, P190
   BUFFONI F, 1993, J PHARM PHARMACOL, V45, P784, DOI 10.1111/j.2042-7158.1993.tb05685.x
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   [龚爱华 Gong Aihua], 2005, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V24, P38
   HALSTED W, 1892, ANN SURG, V16, P505
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jiang WG, 1998, INT J MOL MED, V2, P203
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   LI MZ, 2001, SILK, V13, P10
   Li Ning, 2000, CHIN J REP RECONSTR, V14, P44
   LU SZ, 2000, SILK, V3, P7
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Miao JC, 2007, KEY ENG MATER, V342-343, P257, DOI 10.4028/www.scientific.net/KEM.342-343.257
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   NANGIA A, 1990, BURNS, V16, P368, DOI 10.1016/0305-4179(90)90010-T
   Neufeld G, 1999, FASEB J, V13, P9
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   Olofsson B, 1999, CURR OPIN BIOTECH, V10, P528, DOI 10.1016/S0958-1669(99)00024-5
   Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013
   [盛伟华 Sheng Weihua], 2005, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V24, P277
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
NR 27
TC 36
Z9 43
U1 0
U2 20
PU ZHEJIANG UNIV
PI HANGZHOU
PA EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA
SN 1673-1581
EI 1862-1783
J9 J ZHEJIANG UNIV-SC B
JI J. Zhejiang Univ.-SCI. B
PD JAN
PY 2010
VL 11
IS 1
BP 10
EP 16
DI 10.1631/jzus.B0900163
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Research & Experimental Medicine
GA 539LY
UT WOS:000273257300002
PM 20043346
OA Green Published
DA 2018-10-20
ER

PT J
AU Tuglu, MI
   Ozdal-Kurt, F
   Koca, H
   Sarac, A
   Barut, T
   Kazanc, A
AF Tuglu, Mehmet Ibrahim
   Ozdal-Kurt, Feyzan
   Koca, Huseyin
   Sarac, Aydin
   Barut, Turgay
   Kazanc, Aycan
TI The Contribution of Differentiated Bone Marrow Stromal Stem Cell-Loaded
   Biomaterial to Treatment in Critical Size Defect Model in Rats
SO KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI
LA English
DT Article
DE Bone marrow stromal cell; Healing; Critical size defect; Tissue
   engineering; Hydroxyapatite gel; NOS; Apoptosis
ID STABILIZED TRICALCIUM PHOSPHATE; IN-VITRO; REGENERATION; REPAIR;
   CULTURE; GROWTH; HYDROXYAPATITE; CERAMICS; PROTEIN; HYDROXYLAPATITE
AB Mandibular fractures present a challenge in maxillo-facial surgery due to difficulties in healing and complications. In recent years, advances in bio-engineering as well as stem-cell studies suggest that it may be possible to treat these fractures by stem cell treatment with biomaterials. In the present study, we explored the efficacy of differentiated stem cells placed on biomaterials on fracture treatment and its relation with oxidative stress and apoptosis. A 4 mm circular defect was made on the mandibulae of 20 adults Wistar rats. Hydroxyapatite gel (control, n=5) and bone marrow stromal cells differentiated into osteoblast-seeded hydroxyapatite gel (n=5) were implanted within these defects. We were also used empty cavities (n=5) and cavities filled with only cells (n=5) for negative controls. Animals were sacrificed after a 6-week healing period and samples were examined blindly by histological, immunohistochemical, radiological and morphometric methods. Compared to the control cavities that underwent no procedure or filled with just cells, there were significant (P<0.001) healings in both groups. Hydroxyapatite gel with differentiated stem cells on, however, yielded significantly (P<0.05) better new bone formation and osteoid production decreased fibrous tissue and increased cellular activity. Differentiated stromal cells combined with biomaterial accelerated the treatment in defects of critical volume within a 6-week period of healing, activated and resulted in significant formation of bone of higher quality. Promotion of bone formation by the helps of bioengineering and stromal cells has gained importance in the treatment and reconstruction of fractures.
C1 [Tuglu, Mehmet Ibrahim; Barut, Turgay] Celal Bayar Univ, Fac Med, Dept Histol & Embryol, TR-45020 Manisa, Turkey.
   [Ozdal-Kurt, Feyzan] Celal Bayar Univ, Fac Sci, Dept Biol, TR-45140 Manisa, Turkey.
   [Koca, Huseyin; Sarac, Aydin; Kazanc, Aycan] Ege Univ Fac Dent, Dept Oral & Maxillofacial Surg, TR-35100 Izmir, Turkey.
RP Tuglu, MI (reprint author), Celal Bayar Univ, Fac Med, Dept Histol & Embryol, TR-45020 Manisa, Turkey.
EM mituglu@yahoo.com
CR Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI [10.1089/ten.tea.2007.0339, 10.1089/tea.2007.0339]
   Arosarena OA, 2003, ARCH OTOLARYNGOL, V129, P1125, DOI 10.1001/archotol.129.10.1125
   Arosarena Oneida A, 2003, Arch Facial Plast Surg, V5, P103
   BAB I, 1988, ENDOCRINOLOGY, V123, P345, DOI 10.1210/endo-123-1-345
   BEIRNE OR, 1986, INT J ORAL SURG, V15, P267
   BELL R, 1988, J ORAL MAXIL SURG, V46, P589, DOI 10.1016/0278-2391(88)90150-4
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Deliloglu-Gurhan I, 2006, SAUDI MED J, V27, P305
   Deliloglu-Gurhan SI, 2006, ACTA HISTOCHEM, V108, P49, DOI 10.1016/j.acthis.2005.11.001
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Ergun G, 2009, KAFKAS UNIV VET FAK, V15, P481
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Hong L, 2000, J NEUROSURG, V92, P315, DOI 10.3171/jns.2000.92.2.0315
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   KABAN LB, 1979, SURG FORUM, V30, P519
   KABAN LB, 1981, J DENT RES, V60, P1356, DOI 10.1177/00220345810600071201
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   Li IWS, 1996, J CELL PHYSIOL, V169, P115, DOI 10.1002/(SICI)1097-4652(199610)169:1<115::AID-JCP12>3.0.CO;2-C
   Lian J B, 1993, J Oral Implantol, V19, P95
   Liu P, 1999, CALCIFIED TISSUE INT, V65, P173, DOI 10.1007/s002239900678
   LOMBARDI LJ, 1991, IMMUNOLOGY INFECT DI, P114
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.0.CO;2-I
   Porter RM, 2003, J CELL BIOCHEM, V90, P13, DOI 10.1002/jcb.10592
   REDDI AH, 1998, CLIN ORTHOP S, V355, pS66
   RIPAMONTI U, 1992, MATRIX, V12, P369, DOI 10.1016/S0934-8832(11)80033-8
   Saito N, 2001, J BONE JOINT SURG AM, V83A, pS92
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Shi ST, 1996, J BONE MINER RES, V11, P1139, DOI 10.1002/jbmr.5650110813
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SWEENEY TM, 1995, J NEUROSURG, V83, P710, DOI 10.3171/jns.1995.83.4.0710
   Topcu I, 2007, ACTA HISTOCHEM, V109, P322, DOI 10.1016/j.acthis.2006.10.007
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   WLODARSKI KH, 1990, CLIN ORTHOP RELAT R, P276
   Wlodarski Krzysztof H, 2008, Ortop Traumatol Rehabil, V10, P201
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
NR 51
TC 6
Z9 6
U1 0
U2 11
PU KAFKAS UNIV, VETERINER FAKULTESI DERGISI
PI KARS
PA KAFKAS UNIV, VETERINER FAKULTESI DERGISI, KARS, 36040, TURKEY
SN 1300-6045
J9 KAFKAS UNIV VET FAK
JI Kafkas Univ. Vet. Fak. Derg.
PY 2010
VL 16
IS 5
BP 783
EP 792
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 662PP
UT WOS:000282824100012
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Koev, ST
   Dykstra, PH
   Luo, X
   Rubloff, GW
   Bentley, WE
   Payne, GF
   Ghodssi, R
AF Koev, S. T.
   Dykstra, P. H.
   Luo, X.
   Rubloff, G. W.
   Bentley, W. E.
   Payne, G. F.
   Ghodssi, R.
TI Chitosan: an integrative biomaterial for lab-on-a-chip devices
SO LAB ON A CHIP
LA English
DT Review
ID HYDROGEN-PEROXIDE BIOSENSOR; SELF-ASSEMBLED MONOLAYERS; NUCLEIC-ACID
   HYBRIDIZATION; BY-LAYER FILMS; GLUCOSE BIOSENSOR; CARBON NANOTUBES;
   HORSERADISH-PEROXIDASE; IN-SITU; IMMOBILIZATION MATRIX; PATTERNED
   SURFACES
AB Chitosan is a naturally derived polymer with applications in a variety of industrial and biomedical fields. Recently, it has emerged as a promising material for biological functionalization of microelectromechanical systems (bioMEMS). Due to its unique chemical properties and film forming ability, chitosan serves as a matrix for the assembly of biomolecules, cells, nanoparticles, and other substances. The addition of these components to bioMEMS devices enables them to perform functions such as specific biorecognition, enzymatic catalysis, and controlled drug release. The chitosan film can be integrated in the device by several methods compatible with standard microfabrication technology, including solution casting, spin casting, electrodeposition, and nanoimprinting. This article surveys the usage of chitosan in bioMEMS to date. We discuss the common methods for fabrication, modification, and characterization of chitosan films, and we review a number of demonstrated chitosan-based microdevices. We also highlight the advantages of chitosan over some other functionalization materials for micro-scale devices.
C1 [Koev, S. T.; Dykstra, P. H.; Ghodssi, R.] Univ Maryland, Syst Res Inst, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
   [Luo, X.; Bentley, W. E.; Payne, G. F.] Univ Maryland, Ctr Biosyst Res, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Rubloff, G. W.] Univ Maryland, Syst Res Inst, Dept Mat Sci & Engn, College Pk, MD 20742 USA.
RP Ghodssi, R (reprint author), Univ Maryland, Syst Res Inst, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
EM ghodssi@umd.edu
RI beyazkilic, pinar/G-6781-2011; Luo, Xiaolong/A-6260-2010; Rubloff,
   Gary/D-4142-2009
OI Rubloff, Gary/0000-0002-1901-3982; Luo, Xiaolong/0000-0002-9939-2766
FU National Science Foundation (EFRI); R. W. Deutsch foundation; Laboratory
   for Physical Sciences; Fablab; NispLab; NSF
FX This work was supported in part by the National Science Foundation
   (EFRI), the R. W. Deutsch foundation and the Laboratory for Physical
   Sciences. The authors also appreciate the support of the Maryland
   NanoCenter and both its Fablab and NispLab. The NispLab is supported in
   part by the NSF as a MRSEC Shared Experimental Facility.
CR Abdullah J, 2006, SENSOR ACTUAT B-CHEM, V114, P604, DOI 10.1016/j.snb.2005.06.019
   Abdullah J, 2007, SENSORS-BASEL, V7, P2238, DOI 10.3390/s7102238
   Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Amorim RVS, 2003, BIORESOURCE TECHNOL, V89, P35, DOI 10.1016/S0960-8524(03)00035-X
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Arias P, 2009, J ELECTROANAL CHEM, V634, P123, DOI 10.1016/j.jelechem.2009.07.022
   BADILITA V, 2007, 14 INT C SOL STAT SE, P1095
   BADILITA V, 2007, P SPIE INT SOC OPT E, V6464
   Bai JM, 2006, BIOMED MICRODEVICES, V8, P317, DOI 10.1007/s10544-006-9820-x
   Bayramoglu G, 2003, BIOCHEM ENG J, V13, P35, DOI 10.1016/S1369-703X(02)00098-0
   Bayramoglu G, 2002, COLLOID SURFACE A, V202, P41, DOI 10.1016/S0927-7757(01)01055-X
   Bayramoglu G, 2002, CHEM ENG SCI, V57, P2323, DOI 10.1016/S0009-2509(02)00141-0
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Borato CE, 2006, IEEE T DIELECT EL IN, V13, P1101, DOI 10.1109/TDEI.2006.1714936
   Boributh S, 2009, J MEMBRANE SCI, V342, P97, DOI 10.1016/j.memsci.2009.06.022
   Buckhout-White SL, 2009, SOFT MATTER, V5, P3677, DOI 10.1039/b820356c
   Cai ZC, 2009, CARBOHYD POLYM, V78, P488, DOI 10.1016/j.carbpol.2009.05.009
   Cai ZJ, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/3/035028
   Casagrande T, 2008, MATER CHEM PHYS, V111, P42, DOI 10.1016/j.matchemphys.2008.03.010
   Cetinus SA, 2000, ENZYME MICROB TECH, V26, P497, DOI 10.1016/S0141-0229(99)00189-1
   Chaki NK, 2002, BIOSENS BIOELECTRON, V17, P1, DOI 10.1016/S0956-5663(01)00277-9
   Chen L, 2001, ANAL CHEM, V73, P2862, DOI 10.1021/ac010009z
   Chen Q, 2004, SENS LETT, V2, P102, DOI 10.1166/sl.2004.030
   Chen TH, 2003, LANGMUIR, V19, P9382, DOI 10.1021/la0347098
   Chen X, 2003, ELECTROANAL, V15, P608, DOI 10.1002/elan.200390076
   Cheng JC, 2008, J MICROELECTROMECH S, V17, P402, DOI 10.1109/JMEMS.2008.916325
   Cheng Y, 2010, SOFT MATTER, V6, P3177, DOI 10.1039/c0sm00124d
   Choi JW, 1997, P ANN INT IEEE EMBS, V19, P2264, DOI 10.1109/IEMBS.1997.758812
   Co CC, 2005, J AM CHEM SOC, V127, P1598, DOI 10.1021/ja044382a
   Cowan SE, 2001, BIOTECHNOL LETT, V23, P1235, DOI 10.1023/A:1010581503842
   Cruz J, 2000, ANAL CHEM, V72, P680, DOI 10.1021/ac990954b
   Deng T, 2004, SENSOR ACTUAT B-CHEM, V99, P123, DOI 10.1016/j.snb.2003.11.005
   Du D, 2007, COLLOID SURFACE B, V58, P145, DOI 10.1016/j.colsurfb.2007.03.006
   Du D, 2007, J ELECTROANAL CHEM, V605, P53, DOI 10.1016/j.jelechem.2007.03.013
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   Dykstra P, 2009, SENSOR ACTUAT B-CHEM, V138, P64, DOI 10.1016/j.snb.2009.01.065
   Fan Q, 2007, BIOSENS BIOELECTRON, V22, P816, DOI 10.1016/j.bios.2006.03.002
   Felse PA, 1999, BIOPROCESS ENG, V20, P505, DOI 10.1007/s004490050622
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Feng J, 2004, THIN SOLID FILMS, V460, P286, DOI 10.1016/j.tsf.2004.01.082
   Fernandes R, 2004, LANGMUIR, V20, P906, DOI 10.1021/la0357312
   Fernandes R, 2003, LANGMUIR, V19, P4058, DOI 10.1021/la027052h
   Fernandes R, 2010, LAB CHIP, V10, P1128, DOI 10.1039/b926846d
   Flynn NT, 2003, LANGMUIR, V19, P10909, DOI 10.1021/la035331e
   Gao XJ, 2007, SENSOR ACTUAT B-CHEM, V128, P161, DOI 10.1016/j.snb.2007.05.045
   Gerbino L, 2008, SENSOR ACTUAT B-CHEM, V131, P455, DOI 10.1016/j.snb.2007.12.006
   GRAYSON ACR, 2004, P IEEE, P92
   He XL, 2008, J BIOCHEM BIOPH METH, V70, P823, DOI 10.1016/j.jbbm.2007.06.002
   Hsieh BC, 2003, MAR BIOTECHNOL, V5, P119, DOI 10.1007/s10126-002-0094-x
   Huang H, 2002, ANAL BIOCHEM, V308, P141, DOI 10.1016/S0003-2697(02)00242-7
   Huguenin F, 2005, J PHYS CHEM B, V109, P12837, DOI 10.1021/jp0504165
   Ismail YA, 2008, SENSOR ACTUAT B-CHEM, V129, P834, DOI 10.1016/j.snb.2007.09.083
   JANEGITZ BC, 2009, SENSOR ACTUAT B-CHEM, DOI DOI 10.1016/J.SNB.2009.1008.1033
   Kam HM, 1999, J BIOMED MATER RES, V48, P881, DOI 10.1002/(SICI)1097-4636(1999)48:6<881::AID-JBM18>3.0.CO;2-2
   Kastantin MJ, 2003, SENSOR MATER, V15, P295
   Kim B, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2898576
   KIM HS, 2007, EXPT TECHNIQUES  JUL, P15
   Kim J, 2007, CELLULOSE, V14, P439, DOI 10.1007/s10570-007-9134-z
   Kim SJ, 2005, J MACROMOL SCI PURE, VA42, P1073, DOI 10.1081/MA-200065934
   Kim SJ, 2004, J APPL POLYM SCI, V91, P2876, DOI 10.1002/app.13516
   KOEV ST, 2006, P 10 INT C MIN CHEM, P1250
   Koev ST, 2007, LAB CHIP, V7, P103, DOI 10.1039/b609149k
   Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013
   Lei CX, 2003, TALANTA, V59, P981, DOI 10.1016/S0039-9140(02)00641-0
   Lewandowski AT, 2008, BIOTECHNOL BIOENG, V99, P499, DOI 10.1002/bit.21580
   LEWANDOWSKI AT, 2007, LANGMUIR UNPUB   MAR
   Li WJ, 2008, J BIOCHEM BIOPH METH, V70, P830, DOI 10.1016/j.jprot.2007.11.010
   Lin JH, 2004, J IMMUNOL METHODS, V291, P165, DOI 10.1016/j.jim.2004.06.001
   Luo X, 2008, BIOMED MICRODEVICES, V10, P899, DOI 10.1007/s10544-008-9204-5
   Luo XL, 2008, LAB CHIP, V8, P420, DOI 10.1039/b713756g
   Luo XL, 2010, LAB CHIP, V10, P59, DOI 10.1039/b916548g
   MA X, 2006, J MEMBRANE SCI, V280, P99
   MACK AC, 2005, P IEEE SENS C IRV CA, P912
   Magalhaes JMCS, 1998, TALANTA, V47, P183, DOI 10.1016/S0039-9140(98)00066-6
   Magalhaes JMCS, 2002, ANALYST, V127, P1069, DOI 10.1039/b201173e
   Mao JS, 2006, BIOTECHNOL BIOENG, V95, P333, DOI 10.1002/bit.20755
   Miao Y, 2001, ANAL CHIM ACTA, V437, P87, DOI 10.1016/S0003-2670(01)00986-2
   Miao Y, 2001, ELECTROANAL, V13, P347, DOI 10.1002/1521-4109(200103)13:4<347::AID-ELAN347>3.3.CO;2-Q
   Miao YQ, 2000, ANALYST, V125, P1591, DOI 10.1039/b003483p
   MRKSICH M, 1995, TRENDS BIOTECHNOL, V13, P228, DOI 10.1016/S0167-7799(00)88950-7
   Nagarale RK, 2009, ELECTROCHIM ACTA, V54, P6508, DOI 10.1016/j.electacta.2009.06.027
   Ng LT, 2001, J APPL POLYM SCI, V79, P466
   Nitayaphat W, 2009, CARBOHYD POLYM, V78, P444, DOI 10.1016/j.carbpol.2009.04.027
   Odaci D, 2008, SENSOR ACTUAT B-CHEM, V134, P89, DOI 10.1016/j.snb.2008.04.013
   OGAWA K, 2004, FOODS FOOD INGRED J, P209
   Park I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709914
   Park JJ, 2006, LAB CHIP, V6, P1315, DOI 10.1039/b603101c
   Paul W, 2000, STP PHARMA SCI, V10, P5
   Payne GF, 1996, POLYMER, V37, P4643, DOI 10.1016/0032-3861(96)00338-2
   Pearce TM, 2005, LAB CHIP, V5, P97, DOI 10.1039/b407871c
   Pedano ML, 2004, ANAL LETT, V37, P2235, DOI 10.1081/AL-200028021
   Pirrung MC, 2002, ANGEW CHEM INT EDIT, V41, P1277
   Popovtzer R, 2006, SENSOR ACTUAT B-CHEM, V119, P664, DOI 10.1016/j.snb.2006.01.037
   Powers MA, 2005, P SOC PHOTO-OPT INS, V5839, P119, DOI 10.1117/12.608531
   Powers MA, 2005, LAB CHIP, V5, P583, DOI 10.1039/b503112e
   POWERS MA, 2006, THESIS U MARYLAND CO
   Zhou QM, 2007, J PHYS CHEM B, V111, P11276, DOI 10.1021/jp073884i
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Saliterman S.S., 2006, FUNDAMENTALS BIOMEMS
   Schneider HJ, 2007, SENSORS-BASEL, V7, P1578, DOI 10.3390/s7081578
   Schreiber F, 2004, J PHYS-CONDENS MAT, V16, pR881, DOI 10.1088/0953-8984/16/28/R01
   Seo KW, 2004, J IND ENG CHEM, V10, P794
   Shi MH, 2007, BIOSENS BIOELECTRON, V22, P2841, DOI 10.1016/j.bios.2006.11.023
   Shi XW, 2008, MACROMOL BIOSCI, V8, P451, DOI 10.1002/mabi.200700220
   SHIN SR, 2006, P S NAN MAT HYBR COM, P11
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Siqueira JR, 2006, J PHYS CHEM B, V110, P22690, DOI 10.1021/jp0649089
   Slavik GJ, 2007, J MATER CHEM, V17, P4095, DOI 10.1039/b706726g
   Spinks GA, 2007, SENSOR ACTUAT B-CHEM, V121, P616, DOI 10.1016/j.snb.2006.04.103
   Sugawara K, 2000, ANAL SCI, V16, P1139, DOI 10.2116/analsci.16.1139
   Suresha KM, 2008, COMPOS INTERFACE, V15, P679, DOI 10.1163/156855408786778393
   Swayampakula K, 2009, J HAZARD MATER, V170, P680, DOI 10.1016/j.jhazmat.2009.05.106
   Tan L, 2004, J VAC SCI TECHNOL B, V22, P2486, DOI 10.1116/1.1800353
   Tan TW, 2002, J MOL CATAL B-ENZYM, V18, P325, DOI 10.1016/S1381-1177(02)00113-3
   Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694
   Wang G, 2002, BIOELECTROCHEMISTRY, V57, P33, DOI 10.1016/S1567-5394(01)00174-8
   Wang HS, 2005, SENSORS-BASEL, V5, P266, DOI 10.3390/s5040266
   Wang SF, 2008, BIOSENS BIOELECTRON, V23, P1781, DOI 10.1016/j.bios.2008.02.014
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   Wang YT, 2003, MEAS SCI TECHNOL, V14, P831, DOI 10.1088/0957-0233/14/6/317
   We X, 2003, ANAL CHEM, V75, P2060, DOI 10.1021/ac020765k
   Wei DW, 2006, J NANOSCI NANOTECHNO, V6, P2508, DOI 10.1166/jnn.2006.530
   Wei X, 2002, ANAL CHEM, V74, P5039, DOI 10.1021/ac020216e
   Wen GM, 2007, BIOSENS BIOELECTRON, V23, P121, DOI 10.1016/j.bios.2007.03.024
   Williams JC, 2005, J NEURAL ENG, V2, pL23, DOI 10.1088/1741-2560/2/4/L03
   Wu BY, 2007, BIOSENS BIOELECTRON, V22, P838, DOI 10.1016/j.bios.2006.03.009
   Wu HC, 2009, BIOTECHNOL BIOENG, V103, P231, DOI 10.1002/bit.22238
   Wu LQ, 2006, ADV FUNCT MATER, V16, P1967, DOI 10.1002/adfm.200500792
   Wu LQ, 2002, LANGMUIR, V18, P8620, DOI 10.1021/la020381p
   Wu LQ, 2005, ADV FUNCT MATER, V15, P189, DOI 10.1002/adfm.200400279
   Wu LQ, 2003, LANGMUIR, V19, P519, DOI 10.1021/la026518t
   Wu LQ, 2001, BIOTECHNOL BIOENG, V76, P325, DOI 10.1002/bit.10099
   WU LQ, 2003, P 12 INT C SOL STAT, P1871
   Xie Y, 2005, NANOMED-NANOTECHNOL, V1, P184, DOI 10.1016/j.nano.2005.03.001
   Xiong HY, 2007, ELECTROCHEM COMMUN, V9, P2671, DOI 10.1016/j.elecom.2007.08.020
   Xu C, 2001, FRESEN J ANAL CHEM, V369, P428, DOI 10.1007/s002160000673
   Xu C, 2009, COLLOID SURFACE B, V73, P360, DOI 10.1016/j.colsurfb.2009.06.001
   Xu XH, 2003, J MATER SCI LETT, V22, P695, DOI 10.1023/A:1023627329738
   Yang LJ, 2005, LAB CHIP, V5, P979, DOI 10.1039/b505193b
   Yang MH, 2004, SENSOR ACTUAT B-CHEM, V101, P269, DOI 10.1016/j.snb.2004.01.003
   Yang R, 2005, SENSOR ACTUAT B-CHEM, V106, P506, DOI 10.1016/j.snb.2004.07.017
   Yao DC, 2003, ANAL CHIM ACTA, V478, P23, DOI 10.1016/S0003-2670(02)01484-8
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yi HM, 2005, NANO LETT, V5, P1931, DOI 10.1021/nl051254r
   Yi HM, 2005, LANGMUIR, V21, P2104, DOI 10.1021/la047529k
   Yi HM, 2004, ANAL CHEM, V76, P365, DOI 10.1021/ac034662t
   Yi HM, 2003, BIOTECHNOL BIOENG, V83, P646, DOI 10.1002/bit.10712
   Yusof NA, 2002, SENSOR ACTUAT B-CHEM, V86, P127, DOI 10.1016/S0925-4005(02)00157-0
   Zangmeister RA, 2006, ELECTROCHIM ACTA, V51, P5324, DOI 10.1016/j.electacta.2006.02.003
   Zhang MG, 2007, ANAL CHEM, V79, P2446, DOI 10.1021/ac061698n
   Zhang MG, 2005, J AM CHEM SOC, V127, P2058, DOI 10.1021/ja044764g
   Zhang MG, 2005, ANAL CHEM, V77, P3960, DOI 10.1021/ac050059u
   Zhang MG, 2004, ANAL CHEM, V76, P5045, DOI 10.1021/ac049519u
   Zhang MG, 2005, ANAL CHEM, V77, P6396, DOI 10.1021/ac0508752
   Zhang MG, 2005, ELECTROANAL, V17, P2114, DOI 10.1002/elan.200503348
   Zhao CZ, 2002, SENSOR ACTUAT B-CHEM, V81, P218, DOI 10.1016/S0925-4005(01)00955-8
   Zhitomirsky I, 2007, J MATER PROCESS TECH, V191, P68, DOI 10.1016/j.jmatprotec.2007.03.043
   Zhu C, 2007, LANGMUIR, V23, P286, DOI 10.1021/la061421i
   Zhu JH, 2002, SENSORS, V2, P127, DOI 10.3390/s20400127
   Zhu JZ, 2002, SENSOR MATER, V14, P209
   Zou YJ, 2008, BIOSENS BIOELECTRON, V23, P1010, DOI 10.1016/j.bios.2007.10.009
NR 162
TC 109
Z9 109
U1 4
U2 100
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2010
VL 10
IS 22
BP 3026
EP 3042
DI 10.1039/c0lc00047g
PG 17
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 672QC
UT WOS:000283600900002
PM 20877781
DA 2018-10-20
ER

PT S
AU Liu, ZM
   Gu, QY
   Barry, A
   Xu, ZK
   Groth, T
AF Liu, Zhen-Mei
   Gu, Qin-Yi
   Barry, Aminatou
   Xu, Zhi-Kang
   Groth, Thomas
BE Michler, GH
   Henning, S
TI Biogenic Polyelectrolyte Multilayers on Poly(L-lactide) Films for
   Control of Osteoblast Adhesion
SO LAYERED NANOSTRUCTURES - POLYMERS WITH IMPROVED PROPERTIES
SE Macromolecular Symposia
LA English
DT Proceedings Paper
CT Symposium on Layered Nanostructures
CY MAY 12-13, 2009
CL Leucorea, Lutherstadt Wittenberg, GERMANY
HO Leucorea
DE biocompatibility; layer-by-layer assembly; poly(L-lactide);
   polyelectrolytes; primary osteoblasts
ID BIOLOGICAL CHARACTERIZATION; HYALURONIC-ACID; LAYER; BIOMATERIALS;
   NANOTUBES; CHEMISTRY; RELEASE; HEPARIN
AB Cell adhesion and spreading are important events during cell-biomaterial interaction, which control survival, growth and differentiation of cells. Layer-by-layer technique was used to generate multilayer coatings for regulating adhesion of primary osteoblasts on biomaterials. Polyelectrolyte multilayers (PEM) were based on poly (ethylene imine) as primary polycation layer. PEM were then prepared from chitosan (CHI) as polycation and heparin (HEP), or sulfated HA (sHA) as polyanions. It was observed that attachment and spreading of primary osteoblasts (pOB) was highly dependent on the composition of multilayers, as well as pH values of polyelectrolyte solutions. Results presented in this paper may pave the way for application of PEM surface coatings for bone-contacting implant materials.
C1 [Liu, Zhen-Mei; Gu, Qin-Yi; Barry, Aminatou; Groth, Thomas] Univ Halle Wittenberg, Inst Pharm, Biomed Mat Grp, Heinrich Damerow Str 4, D-06120 Halle, Saale, Germany.
   [Liu, Zhen-Mei; Xu, Zhi-Kang] Zhejiang Univ, Inst Polymer Sci, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Liu, ZM (reprint author), Univ Halle Wittenberg, Inst Pharm, Biomed Mat Grp, Heinrich Damerow Str 4, D-06120 Halle, Saale, Germany.
EM zmliu@zju.edu.cn; thomas.groth@pharmazie.uni-halle.de
OI Groth, Thomas/0000-0001-6647-9657
FU Marie-Curie Incoming International Fellowship of the European Community
   [MIF1-CT-2005-021854]
FX This work was supported by the Marie-Curie Incoming International
   Fellowship (Contract No. MIF1-CT-2005-021854) of the European Community
   and Project Based Personnel Exchange Program with China Scholarship
   Council (CSC) and German Academic Exchange Service (DAAD). The authors
   thank Dr. Bernstein (Department of Orthopedics, Martin-Luther-University
   Halle-Wittenberg, Halle, Germany) for kind donation of human primary
   osteoblasts. Dr. Schnabelrauch from INNOVENT e.V., Department
   Biomaterials, Prussingstrasse 27B, D-07745 Jena, Germany is acknowledged
   for supplying the sulphated hyaluronan.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Ariga K, 2008, MACROMOL BIOSCI, V8, P981, DOI 10.1002/mabi.200800102
   BARBUCCI R, 1994, J MATER SCI-MATER M, V5, P830, DOI 10.1007/BF00213143
   Bongaerts JHH, 2009, BIOMACROMOLECULES, V10, P1287, DOI 10.1021/bm801079a
   Boudou T, 2009, ADV MATER, V21, P1
   Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5
   Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189
   Groth T, 1999, J BIOMED MATER RES, V44, P341
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kirchhof K, 2009, J MATER SCI-MATER M, V20, P897, DOI 10.1007/s10856-008-3639-3
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Landoulsi J, 2009, BIOMACROMOLECULES, V10, P1021, DOI 10.1021/bm900245h
   Liu ZM, 2010, J BIOMAT SCI-POLYM E, V21, P893, DOI 10.1163/156856209X450748
   Liu ZM, 2009, J MATER SCI-MATER M, V20, P2317, DOI 10.1007/s10856-009-3806-1
   Magnani A, 2003, MAT SCI ENG C-BIO S, V23, P315, DOI 10.1016/S0928-4931(02)00284-9
   Magnani A, 1998, POLYM INT, V46, P225, DOI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
   Mansouri S, 2009, EXPERT OPIN DRUG DEL, V6, P585, DOI 10.1517/17425240902967599
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Muzzarelli RAA, 2005, ADV POLYM SCI, V186, P151, DOI 10.1007/b136820
   NAGASAWA K, 1986, CARBOHYD RES, V158, P183, DOI 10.1016/0008-6215(86)84016-2
   Niepel MS, 2009, BIOMATERIALS, V30, P4939, DOI 10.1016/j.biomaterials.2009.06.014
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Satoh T, 2004, POLYM ADVAN TECHNOL, V15, P720, DOI 10.1002/pat.486
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Siqueira JR, 2009, J PHYS CHEM C, V113, P14765, DOI 10.1021/jp904777t
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thunemann AF, 2004, ADV POLYM SCI, V166, P113, DOI 10.1007/b11350
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilson CG, 2009, J MATER CHEM, V19, P6332, DOI 10.1039/b902760b
   Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004
NR 33
TC 1
Z9 1
U1 1
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
PY 2010
VL 294-I
BP 133
EP +
DI 10.1002/masy.201050812
PG 3
WC Polymer Science
SC Polymer Science
GA BRJ63
UT WOS:000282840400012
DA 2018-10-20
ER

PT J
AU Zafar, F
   Kashif, M
   Sharmin, E
   Ahmad, S
AF Zafar, Fahmina
   Kashif, Mohammad
   Sharmin, Eram
   Ahmad, Sharif
TI Studies on Boron Containing Poly(urethane fattyamide)
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 17th Annual POLYCHAR World Forum on Advanced Materials
CY APR 20-24, 2009
CL Rouen, FRANCE
DE coatings; poly(urethane fattyamide); Pongamia glabra oil; renewable
   resource; resin; synthesis
ID SUSTAINABLE RESOURCE; LINSEED OIL; POLYMERS; POLYESTERAMIDE; PRECURSORS;
   POLYOL; RESIN
AB An attempt has been made to synthesize boron containing poly (urethane-fattyamide) [B-PUPGFA] through the incorporation of boron in the backbone of non drying oil such as Pongamia glabra oil derived poly (urethane-fattyamide). The synthesis route involves 50% reduction in the use of harmful volatile organic contents [VOCs] and was carried out in situ by condensation reaction between N, N'-bis (2-hydroxyethyl) Pongamia glabra fattyamide and boric acid without solvent followed by the addition polymerization with toluene diisocyanate in minimum solvent. Spectral (FTIR, 1H-NMR and 13C-NMR), physico-chemical, physico-mechanical and chemical resistance of B-PUPGFA was carried out by standard laboratory methods. The antibacterial performance of B-PUPGFA was done by agar diffusion method against E. coli and S. aureus. The aforementioned performance of B-PUPGFA was compared with Pongamia glabra oil based virgin poly (urethane-fattyamide) [PUPGFA]. It is observed that the incorporation of boron has a significant influence on the overall performance of B-PUPGFA film, which shows antibacterial activity against E. coli and S. aureus. Therefore, B-PUPGFA serves as novel and promising biomaterial candidate for use as anticorrosive and antibacterial coating material.
C1 [Zafar, Fahmina; Kashif, Mohammad; Sharmin, Eram; Ahmad, Sharif] Jamia Millia Islamia, Mat Res Lab, Dept Chem, New Delhi 110025, India.
RP Ahmad, S (reprint author), Jamia Millia Islamia, Mat Res Lab, Dept Chem, New Delhi 110025, India.
EM sharifahmad_jmi@yahoo.co.in
RI Ahmad, Sharif/K-1249-2012; Zafar, Fahmina/H-2135-2016
OI Zafar, Fahmina/0000-0001-5454-3981
CR AbdElAziz AS, 2007, MACROMOL CONTAIN MET, V8, P1
   Ahmad S, 2004, EUR POLYM J, V40, P2097, DOI 10.1016/j.eurpolymj.2004.05.013
   Ahmad S, 2003, PROG ORG COAT, V47, P95, DOI 10.1016/S0300-9440(03)00015-8
   Akram D, 2008, PROG ORG COAT, V63, P25, DOI 10.1016/j.porgcoat.2008.04.003
   Akram D, 2009, MACROMOL SYMP, V277, P130, DOI 10.1002/masy.200950316
   Alam J, 2009, CURR APPL PHYS, V9, P80, DOI 10.1016/j.cap.2007.11.015
   Ambadas G, 2002, J MATER SCI LETT, V21, P1003, DOI 10.1023/A:1016004522824
   Andjelkovic DD, 2006, BIOMACROMOLECULES, V7, P927, DOI 10.1021/bm050787r
   Dai HH, 2009, J AM OIL CHEM SOC, V86, P261, DOI 10.1007/s11746-008-1342-7
   Dong HY, 2008, J MATER SCI, V43, P4247, DOI 10.1007/s10853-008-2615-0
   Gao J., 2005, INT J POLYM MATER, V54, P949
   Gao JG, 2001, EUR POLYM J, V37, P207, DOI 10.1016/S0014-3057(00)00095-1
   Guner FS, 2006, PROG POLYM SCI, V31, P633, DOI 10.1016/j.progpolymsci.2006.07.001
   KASHIF M, J APPL POLY IN PRESS
   Kaushika A, 2008, BIOSENS BIOELECTRON, V24, P676, DOI 10.1016/j.bios.2008.06.032
   LIGADAS G, 2006, BIOMACROMOLECULES, V7, P2420
   Martin C, 2006, REACT FUNCT POLYM, V66, P1047, DOI 10.1016/j.reactfunctpolym.2006.01.013
   Martin C, 2006, POLYM DEGRAD STABIL, V91, P747, DOI 10.1016/j.polymdegradstab.2005.05.025
   Matsumoto F, 2006, PURE APPL CHEM, V78, P1407, DOI 10.1351/pac200678071407
   MOSIEWICKI MA, 2009, POLYM ENG SCI, P685
   NYLEN ES, 1965, MODERN SURFACE COATI
   Prescott L. M., 2005, MICROBIOLOGY
   Sharma V, 2008, PROG POLYM SCI, V33, P1199, DOI 10.1016/j.progpolymsci.2008.07.004
   SIMOLA JU, 2007, J APPL CLIN MED PHY, V8, P114
   SNEDDON LG, 1991, PURE APPL CHEM, V63, P407, DOI 10.1351/pac199163030407
   Uslu I, 2007, E-POLYMERS, V133, P1
   Uslu I., 2007, E-POLYMERS, V145, P1
   Wang DC, 2008, POLYM DEGRAD STABIL, V93, P125, DOI 10.1016/j.polymdegradstab.2007.10.021
   Wideman T, 1998, CHEM MATER, V10, P412, DOI 10.1021/cm970572r
   Yadav S, 2009, PROG ORG COAT, V64, P27, DOI 10.1016/j.porgcoat.2008.07.006
   Zafar F, 2008, J APPL POLYM SCI, V110, P584, DOI 10.1002/app.28667
   Zafar F, 2008, CHEM CHEM TECHOL, V2, P285
   ZAIDI MJ, 2005, J ELECTROCHEM SOC A, V1590, P152
NR 33
TC 7
Z9 7
U1 2
U2 12
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2010
VL 290
BP 79
EP 84
DI 10.1002/masy.201050409
PG 6
WC Polymer Science
SC Polymer Science
GA 590TD
UT WOS:000277250000010
DA 2018-10-20
ER

PT J
AU Albano, C
   Parra, C
   Gonzalez, G
AF Albano, C.
   Parra, C.
   Gonzalez, G.
TI Comparison Between Different Syntesis Methods of PMMA/HA Using
   Ultrasonic Radiation
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 17th Annual POLYCHAR World Forum on Advanced Materials
CY APR 20-24, 2009
CL Rouen, FRANCE
DE characterization; composites; HA; PMMA; ultrasonic irradiation
ID POLYMERIZATION
AB The use of PMMA as dental and osseous cement and also in the fabrication of intraocular lenses has been widely reported. The combination of its excellent properties with those of hydroxyapatite (HA) to form a composite material, can result in very interesting properties as a biomaterial. The key is to obtain a good filler dispersion and interface bonding. Ultrasonic radiation seems to be a very versatile method for the synthesis of these materials, since the use of conventional initiators can be avoided, the filler dispersion improved and the interface interaction can be promoted. In the present work PMMA/HA composite materials were prepared by three different synthesis routes using ultrasonic radiation, in order to study the effect of the synthesis method on the final microstructure. Method I: in situ synthesis of PMMA and HA, under ultrasonic radiation by emulsion polymerization of MMA and HA precursors. Method II: in situ synthesis of HA, (from its precursors) by high frequency ultrasound in commercial PMMA solution Method III: in situ polymerization of MMA under high frequency ultrasonic radiation and adding HA to the solution and Method IV Mixing of hydroxyapatite nanocrystals, in different proportions, in a solution of commercial PMMA, by different periods from 10 min to 7 h, under low frequency (conventional) ultrasonic radiation, to compare the effect of high frequency and conventional ultrasound radiation. The different materials were characterized by FTIR, SEM, TEM, DRX, (1)H NMR and TGA. The results showed that, all the composites prepared by in situ synthesis showed an interaction between HA and PMMA, manifested by a bonding of the phosphate groups with the polar groups of the polymer matrix observed by FTIR. On the other hand, when the synthesis was carried out simultaneously adding HA and PMMA precursors a inhibition of the polymerization reaction of MMA was observed.
C1 [Albano, C.] Fac Ingn, Escuela Ingn Quim, IVIC, Ctr Quim,Lab Polimeros, Caracas, Venezuela.
   [Gonzalez, G.] Fac Ingn, Escuela Fis, IVIC, Dept Ciencia Mat, Caracas, Venezuela.
   [Parra, C.] Inst Univ Tecnol Dr Federico Rivero Palacio, Dept Quim, Caracas, Venezuela.
RP Albano, C (reprint author), Fac Ingn, Escuela Ingn Quim, IVIC, Ctr Quim,Lab Polimeros, Caracas, Venezuela.
EM calbano@ivic.ve; cristina.parra@cien.ucv.ve; gemagonz@ivic.ve
CR Alexandre M, 2001, CHEM MATER, V13, P236, DOI 10.1021/cm001167u
   Cho K, 2002, POLYMER, V43, P1407, DOI 10.1016/S0032-3861(01)00729-7
   HAWTHORNE DG, 1974, J MACROMOL SCI CHEM, VA  8, P649, DOI 10.1080/00222337408065856
   HENGLEIN A, 1954, MAKROMOL CHEM, V14, P14
   MAKINO K, 1983, J PHYS CHEM-US, V87, P1369, DOI 10.1021/j100231a020
   MASON TJ, 1999, SONOCHEMISTRY, P1
   PARRA C, 2009, MACROMOLECU IN PRESS
   PRICE GJ, 1992, MACROMOLECULES, V25, P6447, DOI 10.1021/ma00050a010
   SPADAVECCHIA URSULA, 2007, Rev. Fac. Ing. UCV, V22, P37
   Stevens M. P., 1990, POLYM CHEM INTRO
   Suslick KS, 1999, ANNU REV MATER SCI, V29, P295, DOI 10.1146/annurev.matsci.29.1.295
   Xia HS, 2001, J APPL POLYM SCI, V80, P1130, DOI 10.1002/app.1196
   Yi Z, 2007, MAT SCI ENG A-STRUCT, V452-453, P512
NR 13
TC 2
Z9 2
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2010
VL 290
BP 95
EP 106
DI 10.1002/masy.201050411
PG 12
WC Polymer Science
SC Polymer Science
GA 590TD
UT WOS:000277250000012
DA 2018-10-20
ER

PT J
AU Satyanarayana, G
AF Satyanarayana, G.
TI Biodegradable polymer composites based on brazilian lignocellulosic
SO MATERIA-RIO DE JANEIRO
LA English
DT Article
DE Biopolymers; lignocellulosic fibers; processing of composites
AB Use of eco friendly and energy saving biomaterials and processes have enabled to overcome the effects of growing urbanization and population along with increasing agro-industrial wastes. This has led to a new approach to the industrial design of products and processes along with the implementation of sustainable manufacturing strategies to "optimize the total material cycle from virgin material to finished material, to component, to product, to waste product and to ultimate disposal". Developing countries such as Brazil possess abundantly available but underutilized biomaterial resources, which may possibly give excellent opportunities for scientists to discover methods for their better utilization. This talk presents attempts made so far on the developments of biodegradable composites based on biomaterials of Brazil, with details on their processing matrix-reinforcement combinations, morphology properties and market. Some results of the studies carried out by the author and his colleagues at UFPR-Curitiba are also included.
RP Satyanarayana, G (reprint author), Acharya Res & Dev Ctr, Bangalore 560000, Karnataka, India.
CR Bogoeva-Gaceva G, 2007, POLYM COMPOSITE, V28, P98, DOI 10.1002/pc.20270
   Branciforti Marcia C, 2009, Sustainability, V1, P1431, DOI 10.3390/su1041431
   Corradini E, 2009, J POLYM ENVIRON, V17, P1, DOI 10.1007/s10924-009-0115-1
   Gomes A, 2004, JSME INT J A-SOLID M, V47, P541, DOI 10.1299/jsmea.47.541
   Guimaraes JL, 2010, CARBOHYD POLYM, V80, P130, DOI 10.1016/j.carbpol.2009.11.002
   Guimaraes JL, 2009, IND CROP PROD, V30, P407, DOI 10.1016/j.indcrop.2009.07.013
   ROSA MF, 2008, J APPL POLYM SCI, V111, P612
   Satyanarayana K.G., 2009, NATURAL FIBRE REINFO, P473
   Satyanarayana KG, 2009, PROG POLYM SCI, V34, P982, DOI 10.1016/j.progpolymsci.2008.12.002
   SATYANARAYANA KG, 2007, TEXTILES SUSTAINABLE, V1, P247
   SILVA PCE, 2009, COMPOS PART A-APPL S, V40, P573
NR 11
TC 0
Z9 0
U1 0
U2 9
PU UNIV FED RIO DE JANEIRO, LAB HIDROGENIO
PI RIO DE JANEIRO RJ
PA CIDADE UNIV, ILHA DO FUNDAO, BLOCO I 2000, S L I 146, RIO DE JANEIRO RJ,
   CEP21941-972, BRAZIL
SN 1517-7076
J9 MATERIA-BRAZIL
JI Materia
PY 2010
VL 15
IS 2
BP 88
EP 95
DI 10.1590/S1517-70762010000200001
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 653BS
UT WOS:000282059100001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Andrade, A
   Morcelli, A
   Lobo, R
AF Andrade, A.
   Morcelli, A.
   Lobo, R.
TI DEFORMATION AND FRACTURE OF AN ALPHA/BETA TITANIUM ALLOY
SO MATERIA-RIO DE JANEIRO
LA English
DT Article
DE alpha/beta titanium alloy; Ti-6Al-4V; transmission electron microscopy
ID TI-6AL-4V ALLOY; FATIGUE
AB Titanium alloys are used in the aero-spatial, energy and biomaterial industries among others and exhibit high specific strength and fracture toughness. Their mechanical properties show a strong dependence on the microstructure, especially on the size and morphology of the constituent phases. An experimental evaluation was done to a better understanding of that influence using some techniques like as transmission electron microscopy (TEM), both low and high resolution (HR), scanning electron microscopy (SEM),coupled to electron back-scattering diffraction (EBSD), X-ray diffraction (XRD) and optical microscopy (OM). Some in-situ TEM deformation studies were also done. The alloy was submitted to two heat treatment conditions to get different phases distribution. An hcp phase (alpha) in coexistence with a bcc phase (beta) was observed after both treatments as well the occurrence of twins, stacking faults and dislocations arrangements. The work then discusses the influence of these features on the overall alloy strength.
C1 [Andrade, A.; Morcelli, A.; Lobo, R.] Sci Res Nucl & Energy Res Inst IPEN CNEN SP, Ctr Mat Sci & Technol CCTM, Sao Paulo, Brazil.
RP Andrade, A (reprint author), Sci Res Nucl & Energy Res Inst IPEN CNEN SP, Ctr Mat Sci & Technol CCTM, Sao Paulo, Brazil.
EM aandrade@ipen.br
CR Bantounas I, 2007, ACTA MATER, V55, P5655, DOI 10.1016/j.actamat.2007.06.034
   Bridier F, 2005, ACTA MATER, V53, P555, DOI 10.1016/j.actamat.2004.09.040
   Castany P, 2008, MAT SCI ENG A-STRUCT, V483-84, P719, DOI 10.1016/j.msea.2006.10.183
   Ding R, 2002, MAT SCI ENG A-STRUCT, V327, P233, DOI 10.1016/S0921-5093(01)01531-3
   Manero JM, 2000, ACTA MATER, V48, P3353, DOI 10.1016/S1359-6454(00)00152-X
   MARKOVSKY PE, 1995, MAT SCI ENG A-STRUCT, V190, P9
   SEMIANTIN SL, 1998, ROYAL SOC A, V357, P1487
NR 7
TC 0
Z9 0
U1 0
U2 10
PU UNIV FED RIO DE JANEIRO, LAB HIDROGENIO
PI RIO DE JANEIRO RJ
PA CIDADE UNIV, ILHA DO FUNDAO, BLOCO I 2000, S L I 146, RIO DE JANEIRO RJ,
   CEP21941-972, BRAZIL
SN 1517-7076
J9 MATERIA-BRAZIL
JI Materia
PY 2010
VL 15
IS 2
BP 396
EP 404
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 653BS
UT WOS:000282059100040
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Miao, XG
   Sun, D
AF Miao, Xigeng
   Sun, Dan
TI Graded/Gradient Porous Biomaterials
SO MATERIALS
LA English
DT Review
DE graded; gradient; porosity; pore size; bone; biomaterials
ID FUNCTIONALLY GRADED MATERIAL; TAILORED POROSITY GRADIENTS; PORE-SIZE
   GRADIENT; HYDROXYAPATITE CERAMICS; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; DRUG-DELIVERY; IN-VITRO; BIOCERAMICS; FABRICATION
AB Biomaterials include bioceramics, biometals, biopolymers and biocomposites and they play important roles in the replacement and regeneration of human tissues. However, dense bioceramics and dense biometals pose the problem of stress shielding due to their high Young's moduli compared to those of bones. On the other hand, porous biomaterials exhibit the potential of bone ingrowth, which will depend on porous parameters such as pore size, pore interconnectivity, and porosity. Unfortunately, a highly porous biomaterial results in poor mechanical properties. To optimise the mechanical and the biological properties, porous biomaterials with graded/gradient porosity, pores size, and/or composition have been developed. Graded/gradient porous biomaterials have many advantages over graded/gradient dense biomaterials and uniform or homogenous porous biomaterials. The internal pore surfaces of graded/gradient porous biomaterials can be modified with organic, inorganic, or biological coatings and the internal pores themselves can also be filled with biocompatible and biodegradable materials or living cells. However, graded/gradient porous biomaterials are generally more difficult to fabricate than uniform or homogenous porous biomaterials. With the development of cost-effective processing techniques, graded/gradient porous biomaterials can find wide applications in bone defect filling, implant fixation, bone replacement, drug delivery, and tissue engineering.
C1 [Miao, Xigeng] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Sun, Dan] Univ Ulster, NIBEC, Co Antrim BT37 0QB, North Ireland.
RP Miao, XG (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM x.miao@qut.edu.au; D.Sun@ulster.ac.uk
CR Ahmad Z, 2008, J R SOC INTERFACE, V5, P1255, DOI 10.1098/rsif.2008.0247
   Ben-Nissan B, 2002, J CERAM SOC JPN, V110, P601, DOI 10.2109/jcersj.110.601
   Bin Choy Y, 2008, MACROMOL BIOSCI, V8, P758, DOI 10.1002/mabi.200700316
   Blaker JJ, 2008, ACTA BIOMATER, V4, P264, DOI 10.1016/j.actbio.2007.09.011
   Boughton P, 2001, CERAM ENG SCI PROC, V22, P593
   Bretcanu O, 2008, J MATER SCI, V43, P4127, DOI 10.1007/s10853-008-2536-y
   Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P118, DOI 10.1016/j.msec.2005.07.024
   Choi SW, 2009, ADV FUNCT MATER, V19, P2943, DOI 10.1002/adfm.200900763
   Cichocki FR, 1998, J AM CERAM SOC, V81, P1661
   COLLIER JP, 1979, Patent No. 4156943
   Corbin SF, 1999, MAT SCI ENG A-STRUCT, V262, P192, DOI 10.1016/S0921-5093(98)01019-3
   Droschel M, 2000, KEY ENG MAT, V175-1, P149
   Farook U, 2008, J MICROENCAPSUL, V25, P241, DOI [10.1080/02652040801896666, 10.1080/02652040801896666 ]
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Furukawa KS, 2004, MAT SCI ENG C-BIO S, V24, P437, DOI 10.1016/j.msec.2003.11.010
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   Hench LL, 1998, AM CERAM SOC BULL, V77, P67
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hsu YH, 2007, J MATER SCI-MATER M, V18, P2251, DOI 10.1007/s10856-007-3126-2
   Hulbert S. F., 1982, Ceramics International, V8, P131, DOI 10.1016/0272-8842(82)90003-7
   Iwata M, 1998, J JPN I MET, V62, P1088, DOI 10.2320/jinstmet1952.62.11_1088
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   KITAGUCHI S, 1993, NIPPON STEEL TECHNIC, V57, P28
   Kwan YBP, 2002, J MATER SCI, V37, P2557, DOI 10.1023/A:1015460127828
   Late P. J., 1985, US Patent, Patent No. [US4542539 A, 4542539]
   Lee BT, 2006, J EUR CERAM SOC, V26, P3525, DOI 10.1016/j.jeurceramsoc.2005.12.017
   Li RD, 2010, J MATER ENG PERFORM, V19, P666, DOI 10.1007/s11665-009-9535-2
   Lu G, 1999, J POROUS MAT, V6, P359, DOI 10.1023/A:1009669730778
   Lu WW, 2003, J MATER SCI-MATER M, V14, P1039, DOI 10.1023/B:JMSM.0000004000.56814.9e
   Luciani A, 2008, BIOMATERIALS, V29, P4800, DOI 10.1016/j.biomaterials.2008.09.007
   Macchetta A, 2009, ACTA BIOMATER, V5, P1319, DOI 10.1016/j.actbio.2008.11.009
   Martin RB, 1999, MATER SCI FORUM, V293, P5, DOI 10.4028/www.scientific.net/MSF.293.5
   Mercier NR, 2005, BIOMATERIALS, V26, P1945, DOI 10.1016/j.biomaterials.2004.06.030
   Miao X, 2003, KEY ENG MAT, V240-2, P595, DOI 10.4028/www.scientific.net/KEM.240-242.595
   Muthutantri A, 2008, J R SOC INTERFACE, V5, P1459, DOI 10.1098/rsif.2008.0092
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Pompe W., 1999, Materials Science Forum, V308-311, P325
   Rice R. W., 2002, Ceramic Engineering and Science Proceedings, V23, P149
   Rice R.W., 1998, POROSITY CERAMICS
   Rodriguez-Lorenzo LM, 2004, MATER RES BULL, V39, P83, DOI 10.1016/j.materresbull.2003.09.014
   Shackelford JF, 1999, MATER SCI FORUM, V293, P1, DOI 10.4028/www.scientific.net/MSF.293.1
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   SHERWOOD JK, 2002, Patent No. 6454811
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   Suk MJ, 2003, MET MATER-INT, V9, P599, DOI 10.1007/BF03027261
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Vales F, 1999, J MATER SCI, V34, P4081, DOI 10.1023/A:1004632503249
   Wang SB, 2004, MACROMOL BIOSCI, V4, P27, DOI 10.1002/mabi.200300043
   Wang XL, 2010, CARBOHYD POLYM, V79, P989, DOI 10.1016/j.carbpol.2009.10.025
   Watari F, 2003, MATER SCI FORUM, V423-4, P321, DOI 10.4028/www.scientific.net/MSF.423-425.321
   Weihe S, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P488, DOI 10.1515/bmte.2002.47.s1a.488
   Wen BY, 2003, MATER SCI FORUM, V423-4, P509, DOI 10.4028/www.scientific.net/MSF.423-425.509
   Werner J, 2002, BIOMATERIALS, V23, P4285, DOI 10.1016/S0142-9612(02)00191-6
   Wise D. L., 1995, ENCY HDB BIOMATERI A
   Wong LH, 2002, MAT SCI ENG C-BIO S, V20, P111, DOI 10.1016/S0928-4931(02)00020-6
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Yeo LY, 2005, BIOMATERIALS, V26, P6122, DOI 10.1016/j.biomaterials.2005.03.033
   Zhang M, 2003, MATER SCI FORUM, V423-4, P599, DOI 10.4028/www.scientific.net/MSF.423-425.599
NR 61
TC 84
Z9 86
U1 11
U2 112
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2010
VL 3
IS 1
BP 26
EP 47
DI 10.3390/ma3010026
PG 22
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864KY
UT WOS:000298240100003
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Horst, M
   Madduri, S
   Gobet, R
   Sulser, T
   Hall, H
   Eberli, D
AF Horst, Maya
   Madduri, Srinivas
   Gobet, Rita
   Sulser, Tullio
   Hall, Heike
   Eberli, Daniel
TI Scaffold Characteristics for Functional Hollow Organ Regeneration
SO MATERIALS
LA English
DT Review
DE scaffold; regeneration; tissue engineering; biomaterials; hollow organs;
   regenerative medicine
ID SMALL-INTESTINAL SUBMUCOSA; NERVE GROWTH-FACTOR; BLADDER ACELLULAR
   MATRIX; EMBRYONIC STEM-CELLS; TISSUE-ENGINEERED INTESTINE; LONG-TERM
   CULTURE; BASEMENT-MEMBRANE COMPONENTS; BRUSH-BORDER ENZYMES;
   SMOOTH-MUSCLE-CELLS; IN-VITRO
AB Many medical conditions require surgical reconstruction of hollow organs. Tissue engineering of organs and tissues is a promising new technique without harvest site morbidity. An ideal biomaterial should be biocompatible, support tissue formation and provide adequate structural support. It should degrade gradually and provide an environment allowing for cell-cell interaction, adhesion, proliferation, migration, and differentiation. Although tissue formation is feasible, functionality has never been demonstrated. Mainly the lack of proper innervation and vascularisation are hindering contractility and normal function. In this chapter we critically review the current state of engineering hollow organs with a special focus on innervation and vascularisation.
C1 [Horst, Maya; Madduri, Srinivas; Sulser, Tullio; Eberli, Daniel] Univ Zurich Hosp, Dept Urol, Lab Urol Tissue Engn & Stem Cell Therapy, CH-8091 Zurich, Switzerland.
   [Hall, Heike] Swiss Fed Inst Technol, Dept Mat, Zurich, Switzerland.
   [Gobet, Rita] Univ Childrens Hosp, Dept Pediat Surg, Div Pediat Urol, Zurich, Switzerland.
RP Eberli, D (reprint author), Univ Zurich Hosp, Dept Urol, Lab Urol Tissue Engn & Stem Cell Therapy, CH-8091 Zurich, Switzerland.
EM maya.horst@usz.ch; sirinivas.madduri@usz.ch; rita.gobet@kispi.uzh.ch;
   tullio.sulser@usz.ch; heike.hall@mat.ethz.ch; daniel.eberli@usz.ch
RI Madduri, Srinivas/I-1202-2013
CR Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Ansaloni L, 2006, TRANSPLANT P, V38, P1844, DOI 10.1016/j.transproceed.2006.05.004
   Ashammakhi N, 1997, BIOMATERIALS, V18, P3, DOI 10.1016/S0142-9612(96)00107-X
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2001, BJU INT, V88, P765, DOI 10.1046/j.1464-4096.2001.atala.2467.x
   Atala A, 2008, PEDIATR RES, V63, P569, DOI 10.1203/PDR.0b013e3181660639
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229
   Baumert H, 2007, EUR UROL, V52, P884, DOI 10.1016/j.eururo.2006.11.044
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Bisson I, 2002, UROLOGY, V60, P176, DOI 10.1016/S0090-4295(02)01642-4
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Bono A V, 1966, Minerva Urol, V18, P43
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940
   Brown AL, 2005, BIOMATERIALS, V26, P529, DOI 10.1016/j.biomaterials.2004.02.055
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Caldamone AA, 2001, J UROLOGY, V165, P2224, DOI 10.1016/S0022-5347(05)66170-8
   Chancellor MB, 2000, NEUROUROL URODYNAM, V19, P279, DOI 10.1002/(SICI)1520-6777(2000)19:3<279::AID-NAU9>3.0.CO;2-M
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen MK, 2004, BIOMATERIALS, V25, P1675, DOI 10.1016/S0142-9612(03)00517-9
   Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304
   Choi RS, 1997, TRANSPLANT P, V29, P848, DOI 10.1016/S0041-1345(96)00164-9
   Choi RS, 1998, J PEDIATR SURG, V33, P991, DOI 10.1016/S0022-3468(98)90520-6
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Danielsson C, 2006, BIOMATERIALS, V27, P1410, DOI 10.1016/j.biomaterials.2005.08.026
   Dawson RA, 1996, BURNS, V22, P93, DOI 10.1016/0305-4179(95)00092-5
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103
   de Filippo RE, 2003, TISSUE ENG, V9, P301, DOI 10.1089/107632703764664765
   Eberli D, 2006, METHOD ENZYMOL, V420, P287, DOI 10.1016/S0076-6879(06)20013-2
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   EVANS GS, 1992, J CELL SCI, V101, P219
   Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Frimberger D, 2006, UROLOGY, V67, P1298, DOI 10.1016/j.urology.2005.12.005
   FUJITA K, 1978, INVEST UROL, V15, P355
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697
   HARMON JW, 1979, SURG FORUM, V30, P365
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664
   Hirata A, 2002, BRAIN RES, V944, P146, DOI 10.1016/S0006-8993(02)02739-7
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hori Y, 2002, J SURG RES, V102, P156, DOI 10.1006/jsre.2001.6294
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Kaihara S, 2000, TRANSPLANTATION, V69, P1927, DOI 10.1097/00007890-200005150-00031
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kashiba H, 1998, NEUROSCI LETT, V252, P107, DOI 10.1016/S0304-3940(98)00558-8
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kingham PJ, 2006, J ANAT, V209, P511, DOI 10.1111/j.1469-7580.2006.00623.x
   Ko H, 2007, EUR CELLS MATER, V14, P18
   Ko HCH, 2007, EUR CELLS MATER, V14, P1
   Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   KUDISH HG, 1957, J UROLOGY, V78, P232, DOI 10.1016/S0022-5347(17)66428-0
   Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351
   Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085
   Lee M, 2008, J SURG RES, V147, P168, DOI 10.1016/j.jss.2008.03.012
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Ludwikowski B, 1999, BJU INT, V84, P507
   Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Madduri S, 2009, NEUROSCI RES, V65, P88, DOI 10.1016/j.neures.2009.06.003
   McConnell MP, 2004, TISSUE ENG, V10, P1492, DOI 10.1089/1076327042500463
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005
   Mohamed F, 2008, J PHARM SCI-US, V97, P71, DOI 10.1002/jps.21082
   Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nakanishi Y, 2003, J PEDIATR SURG, V38, P1781, DOI 10.1016/S0022-3468(03)00632-8
   Nakase Y, 2007, J SURG RES, V137, P61, DOI 10.1016/j.jss.2006.06.019
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Piquilloud G, 2007, EUR J NEUROSCI, V26, P1109, DOI 10.1111/j.1460-9568.2007.05748.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014
   Reddy PP, 2000, J UROLOGY, V164, P936, DOI 10.1016/S0022-5347(05)67221-7
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Sasaki K, 2004, DIABETES, V53, P2723, DOI 10.2337/diabetes.53.10.2723
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   Schultheiss D, 2005, J UROLOGY, V173, P276, DOI 10.1097/01.ju.0000145882.80339.18
   Schwartz MZ, 1998, J PEDIATR SURG, V33, P996
   Scriven SD, 2001, J MATER SCI-MATER M, V12, P991, DOI 10.1023/A:1012869318205
   Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1097/01.ju.0000025338.65642.09
   Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   Southgate J, 2003, P I MECH ENG H, V217, P311, DOI 10.1243/095441103322060776
   Sudan D, 2009, CURR OPIN ORGAN TRAN, V14, P274, DOI 10.1097/MOT.0b013e32832b1033
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215
   Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778
   Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Urita Y, 2007, PEDIATR SURG INT, V23, P21, DOI 10.1007/s00383-006-1799-0
   VACANTI JP, 1999, LANCET S1, V354, pS132
   WATSON LC, 1980, J SURG RES, V28, P280, DOI 10.1016/0022-4804(80)90127-4
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yamanaka M, 2002, J UROLOGY, V168, P2296, DOI 10.1097/01.ju.0000033837.19244.b1
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x
   Zhang YY, 2001, IN VITRO CELL DEV-AN, V37, P419
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 135
TC 7
Z9 7
U1 0
U2 14
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2010
VL 3
IS 1
BP 241
EP 263
DI 10.3390/ma3010241
PG 23
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864KY
UT WOS:000298240100016
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Schopka, S
   Schmid, T
   Schmid, C
   Lehle, K
AF Schopka, Simon
   Schmid, Thomas
   Schmid, Christof
   Lehle, Karla
TI Current Strategies in Cardiovascular Biomaterial Functionalization
SO MATERIALS
LA English
DT Review
DE tissue engineering; cardiovascular; biomaterials; biofunctionalization
ID ENDOTHELIAL PROGENITOR CELLS; IN-VITRO HEMOCOMPATIBILITY;
   STAINLESS-STEEL STENT; PROTEIN ADSORPTION; VASCULAR GRAFTS; HUMAN
   THROMBOMODULIN; ADSORBED FIBRINOGEN; PLATELET-ADHESION; CARDIOPULMONARY
   BYPASS; ARTIFICIAL SURFACES
AB Prevention of the coagulation cascade and platelet activation is the foremost demand for biomaterials in contact with blood. In this review we describe the underlying mechanisms of these processes and offer the current state of antithrombotic strategies. We give an overview of methods to prevent protein and platelet adhesion, as well as techniques to immobilize biochemically active molecules on biomaterial surfaces. Finally, recent strategies in biofunctionalization by endothelial cell seeding as well as their possible clinical applications are discussed.
C1 [Schopka, Simon; Schmid, Christof; Lehle, Karla] Univ Med Ctr Regensburg, Dept Cardiothorac Surg, D-93042 Regensburg, Germany.
   [Schmid, Thomas] German Aerosp Ctr, Inst Robot & Mechatron Robot & Mechatron Robot Sy, D-82234 Oberpfaffenhofen, Germany.
RP Schopka, S (reprint author), Univ Med Ctr Regensburg, Dept Cardiothorac Surg, D-93042 Regensburg, Germany.
EM Simon.Schopka@klinik.uni-regensburg.de; Thomas.Schmid@dlr.de;
   Christof.Schmid@klinik.uni-regensburg.de;
   Karla.Lehle@klinik.uni-regensburg.de
CR Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Alobaid N, 2005, CLIN HEMORHEOL MICRO, V33, P209
   Andersson AS, 2003, J BIOMED MATER RES A, V64A, P622, DOI 10.1002/jbm.a.10442
   Arabi H, 2004, INT J ARTIF ORGANS, V27, P691
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   BARNES MJ, 1979, HAEMOSTASIS, V8, P158
   Bartorelli AL, 2002, CATHETER CARDIO INTE, V55, P150, DOI 10.1002/ccd.10037
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   BUNTING S, 1977, LANCET, V2, P1075
   CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   Colman RW, 1997, BLOOD, V90, P3819
   COLMAN RW, 2000, HEMOSTASIS THROMBOSI, P103
   Consigny PM, 1999, J VASC INTERV RADIOL, V10, P155, DOI 10.1016/S1051-0443(99)70458-6
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   DEBSKI R, 1982, T AM SOC ART INT ORG, V28, P456
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   Edmunds LH, 2006, ANN THORAC SURG, V82, P2315, DOI 10.1016/j.athoracsur.2006.06.072
   ELGUE G, 1993, THROMB HAEMOSTASIS, V70, P289
   Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082
   Garcia-Honduvilla N, 2008, ANN VASC SURG, V22, P255, DOI 10.1016/j.avsg.2007.12.007
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRAHAM LM, 1980, ARCH SURG-CHICAGO, V115, P1289
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Gulbins H, 2005, THORAC CARDIOV SURG, V53, P96, DOI 10.1055/s-2004-830325
   Guo KT, 2006, STEM CELLS, V24, P2220, DOI 10.1634/stemcells.2006-0015
   HAKIM RM, 1985, AM J MED, V78, P575, DOI 10.1016/0002-9343(85)90398-5
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1993, CARDIOVASC PATHOL, V2, pS157
   HERRING MB, 1979, ANN SURG, V190, P84, DOI 10.1097/00000658-197907000-00019
   Hoffmann J, 2008, J BIOMED MATER RES A, V84A, P614, DOI 10.1002/jbm.a.31309
   Hsu LC, 2001, PERFUSION-UK, V16, P417, DOI 10.1177/026765910101600512
   Hsu SH, 2004, J BIOTECHNOL, V111, P143, DOI 10.1016/j.jbiotec.2004.03.014
   IP WF, 1991, J BIOMED MATER RES, V25, P1321, DOI 10.1002/jbm.820251012
   Jevon M, 2008, CELL PROLIFERAT, V41, P146, DOI 10.1111/j.1365-2184.2008.00488.x
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Jordan SW, 2006, BIOMATERIALS, V27, P3473, DOI 10.1016/j.biomaterials.2006.01.009
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kim YH, 2005, AM HEART J, V149, P336, DOI 10.1016/j.ahj.2004.02.018
   KISHIDA A, 1994, BIOMATERIALS, V15, P1170, DOI 10.1016/0142-9612(94)90238-0
   Knight RL, 2008, P I MECH ENG H, V222, P129, DOI 10.1243/09544119JEIM230
   KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kornowski R, 2009, CATHETER CARDIO INTE, V73, P249, DOI 10.1002/ccd.21958
   Krenning G, 2008, TRENDS CARDIOVAS MED, V18, P312, DOI 10.1016/j.tcm.2009.01.004
   Kutryk MJB, 2003, AM J CARDIOL, V92, p94L
   Laredo J, 2003, AM J SURG, V186, P556, DOI 10.1016/j.amjsurg.2003.07.015
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Lee DJ, 2009, TISSUE ENG PT A, V15, P807, DOI 10.1089/ten.tea.2008.0250
   Lehle K, 2003, J BIOMED MATER RES A, V65A, P393, DOI 10.1002/jbm.a.10492
   Lehle K, 2009, J BIOMED MATER RES B, V90B, P312, DOI 10.1002/jbm.b.31287
   Lichtenberg A, 2006, CIRCULATION, V114, pI559, DOI 10.1161/CIRCULATIONAHA.105.001206
   Lu JR, 2001, LANGMUIR, V17, P3382, DOI 10.1021/la0017429
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Markway BD, 2008, TISSUE ENG PT C-METH, V14, P97, DOI 10.1089/ten.tec.2007.0300
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   MERRILL EW, 1983, ASAIO J, V6, P1
   Mirensky TL, 2009, J PEDIATR SURG, V44, P1127, DOI 10.1016/j.jpedsurg.2009.02.035
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   PASCHE B, 1991, ARTIF ORGANS, V15, P481
   Patel S, 2007, J BIOMED MATER RES A, V83A, P423, DOI 10.1002/jbm.a.31320
   Perea H, 2006, CELLS TISSUES ORGANS, V183, P156, DOI 10.1159/000095989
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Pislaru SV, 2006, CIRCULATION, V114, pI314, DOI 10.1161/CIRCULATIONAHA.105.001446
   Prunotto M, 2005, J MATER SCI-MATER M, V16, P1231, DOI 10.1007/s10856-005-4733-4
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   ROSSI ML, 2009, INT J CARDI IN PRESS
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rothmans J.I., 2006, CAN J CARDIOL, V22, P929
   SAMUEL M, 1992, J BIOL CHEM, V267, P19691
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617
   Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159
   Seifalian AM, 2002, ARTIF ORGANS, V26, P209, DOI 10.1046/j.1525-1594.2002.00878.x
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SHINOKA T, 2008, YALE J BIOL MED, V1, P161
   Sick PB, 2005, AM HEART J, V149, P681, DOI 10.1016/j.ahj.2004.07.011
   Sick PB, 2004, AM J CARDIOL, V93, P1351, DOI 10.1016/j.amjcard.2004.02.029
   SIMON P, 1987, NEPHRON, V45, P172, DOI 10.1159/000184109
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Tang C, 2009, J BIOMED MATER RES A, V88A, P348, DOI 10.1002/jbm.a.31888
   Teebken OE, 2009, EUR J VASC ENDOVASC, V37, P92, DOI 10.1016/j.ejvs.2008.10.012
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Vasilets VN, 1997, BIOMATERIALS, V18, P1139, DOI 10.1016/S0142-9612(97)00045-8
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   vonSegesser LK, 1996, ANN THORAC SURG, V61, P330, DOI 10.1016/0003-4975(95)01011-4
   WACHTFOGEL YT, 1995, AM J PHYSIOL-HEART C, V268, pH1352
   WENDEL HP, 2009, INT J CARDI IN PRESS
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Wu YF, 2008, CARDIOVASC REVASCULA, V9, P238, DOI 10.1016/j.carrev.2008.01.005
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Yeh HY, 2009, J BIOMAT SCI-POLYM E, V20, P807, DOI 10.1163/156856209X426952
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 105
TC 21
Z9 21
U1 1
U2 31
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2010
VL 3
IS 1
BP 638
EP 655
DI 10.3390/ma3010638
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864KY
UT WOS:000298240100035
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Peng, WX
   Wang, LS
   Wu, QD
   Xiang, SL
AF Peng Wan-xi
   Wang Lan-sheng
   Wu Qing-ding
   Xiang Shi-long
BE Yi, X
   Mi, L
TI Analysis on Health Risk of Volatile Organic Compounds of Poplar
   Composite Biomaterial by GC-MS
SO MATERIALS AND MANUFACTURING TECHNOLOGY, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Material and Manufacturing Technology
CY SEP 17-19, 2010
CL Chongqing, PEOPLES R CHINA
SP Int Assoc Comp Sci & Informat Technol
DE Health risk; Composite biomaterial; Volatile organic compounds; Poplar;
   GC-MS
AB Poplar composite biomaterial. which self bonded under high temperature and pressure. is a new indoors materials. In order to evaluate its potential health risk to human settlements, the volatile organic compounds of poplar composite biomaterial were adsorbed and determined by TD-GC-MS. The result were: (1) The main constituents of volatiles at 40 degrees C were acetic acid(50.6%). 1,2-benzenedicarboxylic acid. mono(2-ethylhexyl) ester(8.48%), [1,1':3',1 ''-terphenyl]-2'-ol(3.98%). 1,2-propanediol, 3-benzyloxy-1,2-d iacetyl-(3.12%). etc. (2) The main constituents of volatiles at 60 degrees C were acetic acid(46.7%). 1,2-benzenedicarboxylic acid, mono(2-ethylhexyl) ester(7.93%), cedrol(5.53%), butane. 1-(benzyloxy)-2-[(benzylox y)methyl]- (5.43%), [1,1':3',1 ''-terphenyl]-2'-ol(3.72%), 1-propene, 3-(2-cyclopentenyl)-2-m ethyl-1,1- diphenyl-(3.18%), etc. Generally, the poplar composite biomaterial was safe under 40-60 degrees C.
C1 [Peng Wan-xi; Wang Lan-sheng; Wu Qing-ding; Xiang Shi-long] Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China.
RP Peng, WX (reprint author), Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China.
EM pengwanxi@163.com
CR BAOTONG L, 2003, J PLANT PROTECTION, V30, P166
   *GAO, 2009, CHEM ANAL METERAGE, V18, P64
   LI Z, 2006, EXPT TECHNOLOGY MANA, V23, P122
   PING W, 2007, HLTH REV A, V10, P11
   ZHIYONG H, 2005, FOOD SCI TECHNOLOGY, P98
   ZHONGSHAN Y, 2001, TECHNIGUES EQUIPMENT, V2, P10
NR 6
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-243-5
J9 ADV MATER RES-SWITZ
PY 2010
VL 129-131
BP 60
EP 64
DI 10.4028/www.scientific.net/AMR.129-131.60
PG 5
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BUE45
UT WOS:000289025100013
DA 2018-10-20
ER

PT J
AU Sevilla, P
   Sandino, C
   Arciniegas, M
   Martinez-Gomis, J
   Peraire, M
   Gil, FJ
AF Sevilla, Pablo
   Sandino, Clara
   Arciniegas, Milena
   Martinez-Gomis, Jordi
   Peraire, Maria
   Gil, Francisco Javier
TI Evaluating mechanical properties and degradation of YTZP dental implants
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Y-TZP; Dental implants; Fatigue and fracture; Degradation;
   Nanoindentation
ID YTTRIA-STABILIZED ZIRCONIA; AGING SENSITIVITY; FATIGUE; INDENTATION;
   BIOMATERIAL; COATINGS; CERAMICS; LIFETIME
AB Lately new biomedical grade yttria stabilized zirconia (YTZP) dental implants have appeared in the implantology market. This material has better aesthetical properties than conventional titanium used for implants but long term behaviour of these new implants is not yet well known. The aim of this paper is to quantify the mechanical response of YTZP dental implants previously degraded under different time conditions and compare the toughness and fatigue strength with titanium implants. Mechanical response has been studied by means of mechanical testing following the ISO 14801 for Standards for dental implants and by finite element analysis. Accelerated hydrothermal degradation has been achieved by means of water vapour and studied by X-ray diffraction and nanoindentation tests. The results show that the degradation suffered by YTZP dental implants will not have a significant effect on the mechanical behaviour. Otherwise the fracture toughness of YTZP ceramics is still insufficient in certain implantation conditions. Published by Elsevier B.V.
C1 [Sevilla, Pablo; Sandino, Clara; Arciniegas, Milena; Gil, Francisco Javier] Tech Univ Catalonia, Dept Mat Sci & Met, Biomat & Biomech Div, Girona, Spain.
   [Martinez-Gomis, Jordi; Peraire, Maria] Univ Barcelona, Fac Odontol, Dept Prosthodont, E-08007 Barcelona, Spain.
RP Sevilla, P (reprint author), Tech Univ Catalonia, Dept Mat Sci & Met, Biomat & Biomech Div, Girona, Spain.
EM pablo.sevilla@upc.edu
RI Martinez-Gomis, Jordi/B-4784-2015
OI Martinez-Gomis, Jordi/0000-0003-3497-093X; Sevilla,
   Pablo/0000-0002-8335-0318; Arciniegas, Milena
   Patricia/0000-0002-7454-8891
CR [Anonymous], 2007, 14801 ISO
   Bec S, 1996, PHILOS MAG A, V74, P1061, DOI 10.1080/01418619608239707
   CASELLAS D, 1999, P 7 INT FAT C BEIJ P, P1527
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Feder A, 2005, J EUR CERAM SOC, V25, P3117, DOI 10.1016/j.jeurceramsoc.2004.06.022
   Fernandez-Fairen M, 2006, BIO-MED MATER ENG, V16, P415
   Gaillard Y, 2006, PHILOS MAG, V86, P5441, DOI 10.1080/14786430600778674
   GARVIE RC, 1972, J AM CERAM SOC, V55
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Glassman AH, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000246541.41951.20
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   JYUNGDONG L, 2002, MATER CHEM PHYS, V78, P253
   Kimel RA, 2002, J AM CERAM SOC, V85, P1403, DOI 10.1111/j.1151-2916.2002.tb00288.x
   Kulmer S, 1999, J ORAL REHABIL, V26, P650, DOI 10.1046/j.1365-2842.1999.00430.x
   LIU SY, 1991, J AM CERAM SOC, V74, P1206, DOI 10.1111/j.1151-2916.1991.tb04089.x
   LIU SY, 1991, J AM CERAM SOC, V74, P1197, DOI 10.1111/j.1151-2916.1991.tb04088.x
   Mohan P, 2007, J AM CERAM SOC, V90, P3601, DOI 10.1111/j.1551-2916.2007.01941.x
   Pharr GM, 1998, MAT SCI ENG A-STRUCT, V253, P151, DOI 10.1016/S0921-5093(98)00724-2
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   TADA H, 1985, STRESS ANAL CRACKS H, P253
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Zhu P, 2004, INT J FATIGUE, V26, P1109, DOI 10.1016/j.ijfatigue.2004.03.008
NR 24
TC 22
Z9 23
U1 6
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2010
VL 30
IS 1
BP 14
EP 19
DI 10.1016/j.msec.2009.08.002
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 541AR
UT WOS:000273383500003
DA 2018-10-20
ER

PT J
AU Zhu, HL
   Shen, JY
   Feng, XX
   Zhang, HP
   Guo, YH
   Chen, JY
AF Zhu, Hailin
   Shen, Jinyu
   Feng, Xinxing
   Zhang, Huapeng
   Guo, Yuhai
   Chen, Jianyong
TI Fabrication and characterization of bioactive silk fibroin/wollastonite
   composite scaffolds
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk fibroin; Wollastonite; Composite scaffold; Bioactivity
ID SIMULATED BODY-FLUID; IN-VITRO; BONE TISSUE; POROUS SCAFFOLDS; CALCIUM
   SILICATE; FIBROIN; REGENERATION; BIOCERAMICS; ADSORPTION; CERAMICS
AB Composite scaffolds of silk fibroin (SF) with bioactive wollastonite were prepared by freeze-drying. X-ray diffraction (XRD) and Fourier transform infrared (FT-IR) spectroscopy analysis showed that random coil and beta-sheet structure co-existed in the SF scaffold. The mechanical performance, surface hydrophilicity and water-uptake capacity of the composite scaffolds were improved compared with those of pure SF scaffold. The bioactivity of the composite scaffold was evaluated by soaking in a simulated body fluid (SBF), and formation of a hydroxycarbonate apatite (HCA) layer was determined by FT-IR and XRD. The results showed that the SF/wollastonite composite scaffold was bioactive as it induced the formation of HCA on the surface of the composite scaffold after soaking in SBF for 5 days. In vitro cell attachment and proliferation tests showed that the composite scaffold was a good matrix for the growth of L929 mouse fibroblast cells. Consequently, the incorporation of wollastonite into the SF scaffold can enhance both the mechanical strength and bioactivity of the scaffold. which suggests that the SF/wollastonite composite scaffold may be a potential biomaterial for tissue engineering. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Zhu, Hailin; Shen, Jinyu; Feng, Xinxing; Zhang, Huapeng; Guo, Yuhai; Chen, Jianyong] Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Zhejiang, Peoples R China.
   [Zhu, Hailin] Zhejiang Sci Tech Univ, Dept Chem, Hangzhou 310018, Zhejiang, Peoples R China.
RP Chen, JY (reprint author), Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Zhejiang, Peoples R China.
EM cjy@zstu.edu.cn
FU National Natural Science Foundation of China [50903073, 50973096];
   Changjiang Scholars and Innovative Research Team in University
   [IRT0654]; 973 Program [2008CB617506]; Zhejiang Natural Science
   Foundation [Y407295]
FX We gratefully thank the National Natural Science Foundation of China
   (Grant no. 50903073, 50973096), Changjiang Scholars and Innovative
   Research Team in University (Grant no. IRT0654), 973 Program
   (2008CB617506), and Zhejiang Natural Science Foundation (Grant Y407295)
   for support of this program.
CR Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Jung HY, 2005, J NON-CRYST SOLIDS, V351, P372, DOI 10.1016/j.jnoncrysol.2005.01.044
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371
   Li XK, 2005, J MATER SCI-MATER M, V16, P361, DOI 10.1007/s10856-005-0636-7
   Lin KL, 2005, J INORG MATER, V20, P692
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Lobel KD, 1998, J BIOMED MATER RES, V39, P575, DOI 10.1002/(SICI)1097-4636(19980315)39:4<575::AID-JBM11>3.0.CO;2-6
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   MESSING RA, 1969, J AM CHEM SOC, V91, P2370, DOI 10.1021/ja01037a030
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MINIURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Ni SY, 2006, J BIOMED MATER RES A, V76A, P196, DOI 10.1002/jbm.a.30525
   OTHSUKI C, 1992, J NONCRYST SOLIDS, V143, P84
   Shimoda K, 2005, CHEM GEOL, V222, P83, DOI 10.1016/j.chemgeo.2005.07.003
   TETSUO A, 1985, MACROMOLECULES, V18, P1841
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wu C., 2004, CHIN J CLIN REHABIL, V8, P929
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhang Y, 2001, J NON-CRYST SOLIDS, V282, P159, DOI 10.1016/S0022-3093(01)00345-3
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
NR 44
TC 32
Z9 33
U1 2
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2010
VL 30
IS 1
BP 132
EP 140
DI 10.1016/j.msec.2009.09.009
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 541AR
UT WOS:000273383500019
DA 2018-10-20
ER

PT J
AU Zeugolis, DI
   Paul, RG
   Attenburrow, G
AF Zeugolis, D. I.
   Paul, R. G.
   Attenburrow, G.
TI The influence of a natural cross-linking agent (Myrica rubra) on the
   properties of extruded collagen fibres for tissue engineering
   applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Plant extract; Collagen stabilisation; Mechanical properties; Thermal
   properties; Biomaterial
ID DERMAL SHEEP COLLAGEN; SELF-ASSEMBLY INVITRO; IN-VIVO EVALUATION;
   LONG-TERM CULTURE; MECHANICAL-PROPERTIES; LINKED COLLAGEN;
   FRACTURE-BEHAVIOR; BIOLOGICAL TISSUE; FIBROBLAST MIGRATION; TENSILE
   PROPERTIES
AB Extruded collagen fibres have been shown to be a competitive biomaterial for both soft and hard tissue repair. The natural cross-linking pathway of collagen does not occur in vitro and consequently reconstituted forms of collagen lack sufficient strength. Numerous cross-linking approaches have been investigated through the years, but still there is no ideal method accepted. The use of plant extracts to cross-link collagen scaffolds has been advocated due to superior mechanical properties. As first herein we investigate the stabilisation effect of Myrica rubra on extruded collagen fibres. Fibres treated with M. rubra exhibited higher denaturation temperature (p < 0.005) and lower enthalpy of denaturation (p < 0.034) than formaldehyde of glutaraldehyde. Uniaxial tensile tests of wet tested fibres revealed j-shape curves similar to those of native tissues. Thin fibres exhibited high stress/low strain graphs, whilst thick fibres yielded low stress/high strain graphs. Cross-linking reduced significantly the fibre diameter (p<0.005) and increased significantly the stress (p < 0.004) and force (p < 0.001) at break and the modulus at 2.0% strain (p < 0.003). An inverse relationship between stress at break and fibre diameter was observed for every treatment. Overall, our findings demonstrate the potential of M. rubra in stabilisation of collagen-based materials for tissue engineering applications. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Zeugolis, D. I.] NUIG, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Zeugolis, D. I.] NUIG, Dept Mech & Biomed Engn, Galway, Ireland.
   [Paul, R. G.] Devro Plc, Glasgow G69 0JE, Lanark, Scotland.
   [Attenburrow, G.] Univ Northampton, Sch Appl Sci, Northampton NN2 7AL, England.
RP Zeugolis, DI (reprint author), NUIG, Network Excellence Funct Biomat NFB, NFB Bldg,IDA Business Pk,Newcastle Rd, Galway, Ireland.
EM dimitrios.zeugolis@nuigalway.ie
FU University of Northampton; EPSRC
FX The authors would like to thank Mrs. P. Potter, Ms. S. Lee, Mrs. T.
   Hayes and Mr. L Stathopoulos for excellent technical assistance; Dr. S.
   Jeyapalina and Dr. P. Antunes for their useful discussion; and Prof Tony
   Covington for sample donation. Dimitrios Zeugolis is grateful to The
   University of Northampton and EPSRC for financial support.
CR ANSELME K, 1992, MATRIX, V12, P264, DOI 10.1016/S0934-8832(11)80078-8
   ARUMUGAM V, 1994, J BIOSCIENCE, V19, P307, DOI 10.1007/BF02716820
   ARUMUGAM V, 1992, J MATER SCI, V27, P2649, DOI 10.1007/BF00540684
   ATTENBURROW GE, 1979, J MATER SCI, V14, P2679, DOI 10.1007/BF00610639
   ATTENBURROW GE, 1993, J SOC LEATH TECH CH, V77, P107
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   Bailey AJ, 1989, CONNECTIVE TISSUE ME
   Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009
   BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   BROKAW JL, 1985, INT J BIOL MACROMOL, V7, P135, DOI 10.1016/0141-8130(85)90015-7
   Canty EG, 2002, COMP BIOCHEM PHYS A, V133, P979, DOI 10.1016/S1095-6433(02)00212-X
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Chachra D, 1996, BIOMATERIALS, V17, P1865, DOI 10.1016/0142-9612(95)00305-3
   Chang Y, 2005, J BIOTECHNOL, V120, P207, DOI 10.1016/j.jbiotec.2005.06.029
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Chen CN, 1997, J CHIN INST CHEM ENG, V28, P389
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   CHRISTIANSEN DL, 1993, CELL MATER, V3, P177
   Clyne T. W., 1996, INTRO COMPOSITE MAT
   Collighan RJ, 2004, J AM LEATHER CHEM AS, V99, P293
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Cornwell KG, 2004, J BIOMED MATER RES A, V71A, P55, DOI 10.1002/jbm.a.30132
   COTE MF, 1992, J BIOMAT SCI-POLYM E, V3, P301, DOI 10.1163/156856292X00394
   COTE MF, 1992, BIOMATERIALS, V13, P612, DOI 10.1016/0142-9612(92)90029-N
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   DELORENZI NJ, 1993, MATRIX, V13, P407, DOI 10.1016/S0934-8832(11)80046-6
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.0.CO;2-L
   FINCH A, 1972, BIOCHIM BIOPHYS ACTA, V278, P433, DOI 10.1016/0005-2795(72)90003-7
   Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GROSS J, 1955, P NATL ACAD SCI USA, V41, P1, DOI 10.1073/pnas.41.1.1
   Holmes DF, 1998, J MOL BIOL, V283, P1049, DOI 10.1006/jmbi.1998.2153
   Hong SB, 2000, BIOCHEM BIOPH RES CO, V275, P53, DOI 10.1006/bbrc.2000.3245
   HORMANN H, 1971, BIOCHEMISTRY-US, V10, P932
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   Jarvinen TAH, 2004, J ORTHOP RES, V22, P1303, DOI 10.1016/j.orthres.2004.04.003
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1990, BIOMATERIALS, V11, P169, DOI 10.1016/0142-9612(90)90150-O
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Kitano A, 2006, OPHTHAL RES, V38, P355, DOI 10.1159/000096231
   Knight DP, 1998, J BIOMED MATER RES, V41, P185, DOI 10.1002/(SICI)1097-4636(199808)41:2<185::AID-JBM2>3.3.CO;2-L
   Koob TJ, 2002, COMP BIOCHEM PHYS A, V133, P1171, DOI 10.1016/S1095-6433(02)00247-7
   Koob TJ, 2002, BIOMATERIALS, V23, P203, DOI 10.1016/S0142-9612(01)00096-5
   KOPP J, 1989, Matrix, V9, P443
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Liao XP, 2004, J CHEM TECHNOL BIOT, V79, P335, DOI 10.1002/jctb.974
   Liao XP, 2004, ENVIRON SCI TECHNOL, V38, P324, DOI 10.1021/es034369a
   Liao XP, 2003, IND ENG CHEM RES, V42, P3397, DOI 10.1021/ie0209475
   Madhan B, 2002, BIOMATERIALS, V23, P2841, DOI 10.1016/S0142-9612(01)00410-0
   MEEK KM, 1985, J MOL BIOL, V185, P359, DOI 10.1016/0022-2836(85)90409-7
   Menard C, 2000, BIOMATERIALS, V21, P1867, DOI 10.1016/S0142-9612(00)00062-4
   Mentink CJAL, 2002, CLIN CHIM ACTA, V321, P69, DOI 10.1016/S0009-8981(02)00097-9
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   MILLER A, 1971, NATURE, V230, P437, DOI 10.1038/230437a0
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   Moussy Y, 2007, BIOTECHNOL PROGR, V23, P990, DOI 10.1021/bp0700509
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   NAGARAJ RH, 1995, BBA-PROTEIN STRUCT M, V1253, P75, DOI 10.1016/0167-4838(95)00161-M
   Naidu M, 2007, NEUROSCIENCE, V148, P915, DOI 10.1016/j.neuroscience.2007.07.037
   Nomura Y, 2001, BIOMACROMOLECULES, V2, P105, DOI 10.1021/bm000085w
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Paez JMG, 2003, BIOMATERIALS, V24, P1671, DOI 10.1016/S0142-9612(02)00536-7
   Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113
   Paul R Gordon, 2003, ScientificWorldJournal, V3, P138
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   PIKKARAINEN J, 1968, ACTA PHYSL SCAND S, V309, P5
   Pins GD, 1997, J APPL POLYM SCI, V63, P1429, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1429::AID-APP5>3.3.CO;2-O
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Purslow PP, 1998, J EXP BIOL, V201, P135
   Rajini KH, 2001, J MATER SCI, V36, P5589, DOI 10.1023/A:1012509514714
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Reddy GK, 2003, J ORTHOPAED RES, V21, P738, DOI 10.1016/S0736-0266(03)00006-8
   Rizvi Azam H., 1994, Clinical Materials, V16, P73, DOI 10.1016/0267-6605(94)90100-7
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Saito Y, 2002, J THORAC CARDIOV SUR, V123, P161, DOI 10.1067/mtc.2002.118503
   Silver FH, 2001, J APPL POLYM SCI, V79, P134, DOI 10.1002/1097-4628(20010103)79:1<134::AID-APP160>3.0.CO;2-E
   Silver FH, 2000, CONNECT TISSUE RES, V41, P155, DOI 10.3109/03008200009067667
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   Sionkowska A, 2006, POLYM DEGRAD STABIL, V91, P305, DOI 10.1016/j.polymdegradstab.2005.05.012
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Sionkowska A, 2004, INT J BIOL MACROMOL, V34, P9, DOI 10.1016/j.ijbiomac.2003.10.001
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   Thomason JL, 1999, COMPOS SCI TECHNOL, V59, P2315, DOI 10.1016/S0266-3538(99)00083-4
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Vaissiere G, 2000, MED BIOL ENG COMPUT, V38, P205, DOI 10.1007/BF02344778
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   van Wachem PB, 1999, J BIOMED MATER RES, V47, P270, DOI 10.1002/(SICI)1097-4636(199911)47:2<270::AID-JBM18>3.0.CO;2-D
   VANKLEUNEN J, 2003, 2003 SUMM BIOENG C S
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639
   VERZAR F, 1965, BIOCH PHYSL TISSU CO, P381
   VIIDIK A, 1973, AGING CONNECTIVE TIS, V1, P157
   WANG MC, 1994, BIOMATERIALS, V15, P507
   WARD NP, 1986, J MOL BIOL, V190, P107, DOI 10.1016/0022-2836(86)90079-3
   WASSERMAN AJ, 1989, SCANNING MICROSCOPY, V3, P1183
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yao C, 2008, BIOMATERIALS, V29, P66, DOI 10.1016/j.biomaterials.2007.08.049
   Zahedi S, 1998, J PERIODONTOL, V69, P975, DOI 10.1902/jop.1998.69.9.975
   Zahedi S, 1998, J PERIODONTOL, V69, P1238, DOI 10.1902/jop.1998.69.11.1238
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
   Zeugolis DI, 2008, J APPL POLYM SCI, V108, P2886, DOI 10.1002/app.27208
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zeugolis DI, 2008, ACTA BIOMATER, V4, P1646, DOI 10.1016/j.actbio.2008.05.015
   ZEUGOLIS DI, J BIOMEDI A IN PRESS
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
NR 122
TC 30
Z9 32
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2010
VL 30
IS 1
BP 190
EP 195
DI 10.1016/j.msec.2009.09.017
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 541AR
UT WOS:000273383500027
DA 2018-10-20
ER

PT J
AU Wang, JH
   Gao, C
   Zhang, YS
   Wan, YZ
AF Wang, Jiehua
   Gao, Chuan
   Zhang, Yansen
   Wan, Yizao
TI Preparation and in vitro characterization of BC/PVA hydrogel composite
   for its potential use as artificial cornea biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bacterial cellulose; Poly(vinyl alcohol); Artificial cornea
ID OPTICALLY TRANSPARENT COMPOSITES; BACTERIAL CELLULOSE; BIOMEDICAL
   APPLICATIONS; COLLAGEN; BLENDS; SCAFFOLD; NANOCOMPOSITES; NANOFIBERS;
   MEMBRANES; NETWORKS
AB In order to investigate the potential use for bacterial cellulose (BC) as a novel artificial cornea replacement, BC/poly(vinyl alcohol) (BC/PVA) hydrogel composites were synthesized by freezing-thaw method. The BC/PVA composites were characterized by UV-Vis spectrophotometer (UV-Vis), X-ray diffraction (XRD), thermogravimetric (TG) analysis. mechanical property tests and scanning electron microscope (SEM) analyses. Our results showed that the resultant BC/PVA composites exhibited desirable properties as artificial cornea replacement biomaterial including high water content, high visible light transmittance and suitable UV absorbance, increased mechanical strength and appropriate thermal properties. Results of this work revealed that the BC/PVA composites exhibited some promising characteristics as artificial cornea composite material and may be improved further for its realistic applications. (C) 2009 Elsevier BY. All rights reserved.
C1 [Gao, Chuan; Zhang, Yansen; Wan, Yizao] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
   [Wang, Jiehua] Tianjin Univ, Sch Agr & Bioengn, Tianjin 300072, Peoples R China.
   [Wan, Yizao] Tianjin Univ, Key Lab Adv Ceram & Machining Technol, Minist Educ, Tianjin 300072, Peoples R China.
   [Wan, Yizao] Tianjin Univ, Res Inst Composite Mat, Tianjin 300072, Peoples R China.
RP Wan, YZ (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM yzwantju@yahoo.com
FU National Natural Science Foundation of China [50872088, 50673076];
   Tianjin Municipal Science and Technology Committee [07JCZDJC07200];
   Foundation of Tianjin Key Laboratory of Industrial Microbiology (Tianjin
   University of Science and Technology), China [Wsw-01]; State Key Basic
   Research (973) Program [2007CB936100]; National Hi-Tech Research
   Development (863) Program [2009AA03Z311]
FX This work is supported by the National Natural Science Foundation of
   China (grants 50872088 and 50673076), Tianjin Municipal Science and
   Technology Committee (grant 07JCZDJC07200), the Foundation of Tianjin
   Key Laboratory of Industrial Microbiology (Tianjin University of Science
   and Technology), China (no. Wsw-01), the State Key Basic Research (973)
   Program (grant 2007CB936100) and the National Hi-Tech Research
   Development (863) Program (2009AA03Z311).
CR Barud HS, 2007, J THERM ANAL CALORIM, V87, P815, DOI 10.1007/s10973-006-8170-5
   Bodin A, 2005, ABSTR PAP AM CHEM S, V229, pU297
   Chen CH, 2007, J APPL POLYM SCI, V105, P1086, DOI 10.1002/app.26257
   Chirila TV, 1998, PROG POLYM SCI, V23, P447, DOI 10.1016/S0079-6700(97)00036-1
   Chirila TV, 2001, BIOMATERIALS, V22, P3311, DOI 10.1016/S0142-9612(01)00168-5
   Demming S, 2009, SENSOR ACTUAT B-CHEM, V139, P166, DOI 10.1016/j.snb.2008.10.059
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Favier V, 1997, POLYM ENG SCI, V37, P1732, DOI 10.1002/pen.11821
   Franceschi E, 2008, J THERM ANAL CALORIM, V91, P119, DOI 10.1007/s10973-007-8372-5
   Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b
   Kim DJ, 2005, CERAM INT, V31, P577, DOI 10.1016/j.ceramint.2004.07.006
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   KLEPKO VV, 1994, POLYM SCI, V36, P379
   Kobayashi H, 2004, MAT SCI ENG C-BIO S, V24, P729, DOI 10.1016/j.msec.2004.08.038
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1583, DOI 10.1002/jbm.820261205
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Legeais JM, 1998, BIOMATERIALS, V19, P1517, DOI 10.1016/S0142-9612(98)00069-6
   Legeza VI, 2004, B EXP BIOL MED+, V138, P311
   Liu KM, 2009, MAT SCI ENG C-BIO S, V29, P261, DOI 10.1016/j.msec.2008.06.023
   Liu L, 2005, BIOMATERIALS, V26, P233, DOI 10.1016/j.biomaterials.2004.02.025
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   NISHIO Y, 1988, MACROMOLECULES, V21, P1270, DOI 10.1021/ma00183a016
   Nogi M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2403901
   NOGI N, 2006, APPL PHYS LETT, V88
   Patel S, 2008, J CATARACT REFR SURG, V34, P1077, DOI 10.1016/j.jcrs.2008.03.022
   Saito H, 2003, J APPL POLYM SCI, V90, P3020, DOI 10.1002/app.13015
   Sashina ES, 2007, J THERM ANAL CALORIM, V89, P887, DOI 10.1007/s10973-006-7676-1
   Sunol JJ, 2005, J THERM ANAL CALORIM, V80, P117, DOI 10.1007/s10973-005-0622-9
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Szczesniak L, 2008, CELLULOSE, V15, P445, DOI 10.1007/s10570-007-9192-2
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Yang CC, 2008, J APPL ELECTROCHEM, V38, P1329, DOI 10.1007/s10800-008-9563-x
   Yang SY, 2008, J APPL POLYM SCI, V109, P2452, DOI 10.1002/app.28338
   Yang SY, 2008, MACROMOL SYMP, V272, P150, DOI 10.1002/masy.200851222
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0
   Zhang L, 2007, J MEMBRANE SCI, V306, P93, DOI 10.1016/j.memsci.2007.08.036
NR 42
TC 79
Z9 86
U1 11
U2 86
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2010
VL 30
IS 1
BP 214
EP 218
DI 10.1016/j.msec.2009.10.006
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 541AR
UT WOS:000273383500031
DA 2018-10-20
ER

PT J
AU Patterson, J
   Martino, MM
   Hubbell, JA
AF Patterson, Jennifer
   Martino, Mikael M.
   Hubbell, Jeffrey A.
TI Biomimetic materials in tissue engineering
SO MATERIALS TODAY
LA English
DT Article
ID EXTRACELLULAR-MATRIX PROTEINS; PEPTIDE NANOFIBER SCAFFOLDS; ELASTIN-LIKE
   POLYPEPTIDE; FIBROBLAST-GROWTH-FACTOR; COLLAGEN-BINDING DOMAIN;
   ACID-BASED HYDROGELS; CROSS-LINKING; HYALURONIC-ACID;
   MYOCARDIAL-INFARCTION; REGENERATIVE MEDICINE
AB Biomaterial matrices are being developed that mimic the key characteristics of the extracellular matrix, including presenting adhesion sites and displaying growth factors in the context of a viscoelastic hydrogel. This review focuses on two classes of materials: those that are derived from naturally occurring molecules and those that recapitulate key motifs of biomolecules within biologically active synthetic materials. For biologically derived materials, methods are being sought to gain molecular-level control over biological characteristics and biomechanics. For synthetic, biomimetic materials, chemical schemes are being developed to enable in situ cross-linking and protease-dependent degradation and release of incorporated growth factors. These materials will open new doors to biosurgical therapeutics in tissue engineering and regenerative medicine.
C1 [Patterson, Jennifer; Martino, Mikael M.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland.
   [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Lausanne, Switzerland.
RP Hubbell, JA (reprint author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland.
EM jeffrey.hubbell@epfl.ch
RI Martino, Mikael/N-9345-2013; Patterson, Jennifer/C-4985-2014; Hubbell,
   Jeffrey/A-9266-2008
OI Martino, Mikael/0000-0002-5012-4605; Patterson,
   Jennifer/0000-0001-6927-6548; Hubbell, Jeffrey/0000-0003-0276-5456
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Andrades JA, 1999, EXP CELL RES, V250, P485, DOI 10.1006/excr.1999.4528
   Arrighi I, 2009, BIOMATERIALS, V30, P1763, DOI 10.1016/j.biomaterials.2008.12.023
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chilkoti A, 2006, CURR OPIN CHEM BIOL, V10, P652, DOI 10.1016/j.cbpa.2006.10.010
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   HINZ B, 2009, J BIOMECH, V43, P146
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khire VS, 2006, J POLYM SCI POL CHEM, V44, P7027, DOI 10.1002/pola.21786
   Kim J, 2008, J MATER SCI-MATER M, V19, P3311, DOI 10.1007/s10856-008-3469-3
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   KONG HJ, 2004, BIOMACROMOLECULES, V5, P358
   Lee CA, 2008, HAEMOPHILIA, V14, P11, DOI 10.1111/j.1365-2516.2008.01883.x
   Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007
   Levesque SG, 2007, BIOCONJUGATE CHEM, V18, P874, DOI 10.1021/bc0602127
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Prestwich GD, 2008, CURR PHARM BIOTECHNO, V9, P242, DOI 10.2174/138920108785161523
   Price RD, 2007, J PLAST RECONSTR AES, V60, P1110, DOI 10.1016/j.bjps.2007.03.005
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Rice MA, 2007, TISSUE ENG, V13, P683, DOI 10.1089/ten.2006.0142
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Salinas CN, 2008, MACROMOLECULES, V41, P6019, DOI 10.1021/ma800621h
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Sikorski P, 2007, BIOMACROMOLECULES, V8, P2098, DOI 10.1021/bm0701503
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Soon AS, 2009, BIOMATERIALS
   Sperinde JJ, 1997, MACROMOLECULES, V30, P5255, DOI 10.1021/ma970345a
   Standeven KF, 2007, BLOOD, V110, P902, DOI 10.1182/blood-2007-01-066837
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tognana E, 2007, CELLS TISSUES ORGANS, V186, P97, DOI 10.1159/000102539
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Westhaus E, 2001, BIOMATERIALS, V22, P453, DOI 10.1016/S0142-9612(00)00200-3
   WIJELEATH ES, 2006, CIRC RES, P853
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhao WX, 2009, TISSUE ENG PT A, V15, P991, DOI 10.1089/ten.tea.2008.0240
   Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 97
TC 130
Z9 132
U1 2
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
J9 MATER TODAY
JI Mater. Today
PD JAN-FEB
PY 2010
VL 13
IS 1-2
BP 14
EP 22
DI 10.1016/S1369-7021(10)70013-4
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 556EM
UT WOS:000274572200013
OA Other Gold
DA 2018-10-20
ER

PT S
AU Dangl, A
   Demiroglu, SY
   Gaedcke, J
   Helbing, K
   Jo, P
   Rakebrandt, F
   Rienhoff, O
   Sax, U
AF Dangl, Andrea
   Demiroglu, Sara Y.
   Gaedcke, Jochen
   Helbing, Krister
   Jo, Peter
   Rakebrandt, Fabian
   Rienhoff, Otto
   Sax, Ulrich
BE Safran, C
   Reti, S
   Marin, HF
TI The IT-Infrastructure of a Biobank for an Academic Medical Center
SO MEDINFO 2010, PTS I AND II
SE Studies in Health Technology and Informatics
LA English
DT Proceedings Paper
CT 13th World Congress on Medical and Health Informatics of
   International-Medical-Informatics-Association (Medinfo)
CY SEP 12-15, 2010
CL Cape Town, SOUTH AFRICA
SP Int Med Informat Assoc
DE Biomaterial; Biobank; Biobank software; IT-infrastructure; Repository
ID RECTAL-CANCER; CHEMORADIOTHERAPY
AB For high quality research in biomedicine an operable biobank is essential. In order to make optimal use of the material and the huge amount of data a sustainable IT-infrastructure is indispensable. Therefore, we developed a concept for the IT-infrastructure of a biobank for an academic medical center. The conclusions for this concept are deduced from our experience with the biobank and IT-infrastructure of a clinical research unit. Our results indicate that the IT-infrastructure plays a pivotal role in successfully establishing a biobank. Several aspects of the IT-infrastructure are similarly found in other areas as, e.g. data protection and storage and quality management. Finally, we conclude that although a research database is not required for operating a biobank, the need for it will definitely emerge, especially with regard to personalized medicine and high-throughput gene expression analysis.
C1 [Dangl, Andrea; Gaedcke, Jochen; Jo, Peter; Sax, Ulrich] Univ Med Ctr, Clin Res Unit 179, Gottingen, Germany.
   [Dangl, Andrea; Demiroglu, Sara Y.; Helbing, Krister; Rakebrandt, Fabian; Rienhoff, Otto; Sax, Ulrich] Univ Med Ctr, Dept Med Informat, Gottingen, Germany.
   [Helbing, Krister; Rakebrandt, Fabian; Sax, Ulrich] Competence Network Congenital Heart Defects, Berlin, Germany.
   [Sax, Ulrich] Univ Med Ctr, Dept Informat Technol, Gottingen, Germany.
   [Gaedcke, Jochen; Jo, Peter] Univ Med Ctr, Dept Gen & Visceral Surg, Gottingen, Germany.
RP Demiroglu, SY (reprint author), Univ Med Ctr Goettingen, Dept Med Informat, D-37099 Gottingen, Germany.
EM sara.demiroglu@med.uni-goettingen.de
OI Sax, Ulrich/0000-0002-8188-3495
FU Deutsche Forschungsgemeinschaft [KFO 179]
FX This work was supported by the Deutsche Forschungsgemeinschaft (KFO
   179).
CR Blow N, 2008, NAT METHODS, V5, P109, DOI 10.1038/nmeth0108-109
   Blow N, 2009, NAT METHODS, V6, P173, DOI 10.1038/nmeth0209-173
   Ethikrat, 2004, ETH BIOB FORSCH STEL
   Kiehntopf M, 2008, BIOMATERIALBANKEN CH
   Mendis Michael, 2008, AMIA Annu Symp Proc, P1054
   Mueller O, 2004, RNA INTEGRITY NUMBER
   Murphy SN, 2006, AMIA ANN S P, V2006, P1040
   Riegman PHJ, 2007, PATHOBIOLOGY, V74, P239, DOI 10.1159/000104451
   Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329
   Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
   Shevde Lalita A, 2009, Front Biosci (Schol Ed), V1, P188, DOI 10.2741/s18
   Simon J, 2007, EUR J HUM GENET, V15, P528, DOI 10.1038/sj.ejhg.5201810
   Simon JW, 2006, BIOMATERIALBANKEN RE
   Vysekantsev IP, 2005, CRYOLETTERS, V26, P401
   Waltz E, 2007, NAT MED, V13, P391, DOI 10.1038/nm0407-391
NR 15
TC 5
Z9 5
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
BN 978-1-60750-588-4
J9 STUD HEALTH TECHNOL
PY 2010
VL 160
BP 1334
EP 1338
DI 10.3233/978-1-60750-588-4-1334
PG 5
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA BG8CS
UT WOS:000392215900262
PM 20841901
DA 2018-10-20
ER

PT S
AU Bahena, D
   Uruchurtu, J
   Rosales, I
   Ruiz, JA
AF Bahena, D.
   Uruchurtu, J.
   Rosales, I.
   Ruiz, J. A.
BE PalomarPardave, M
   RomeroRomo, M
   MontielSantillan, T
   Gonzalez, I
   DuronTorres, SM
   EscalanteGarcia, IL
TI Electrochemical Behavior of Ni-Co-Ag Alloy Applied As Biomaterial
SO MES 25: ELECTROCHEMISTRY FOR ALTERNATIVE ENERGY SOURCES AND
   ENVIRONMENTAL IMPROVEMENT
SE ECS Transactions
LA English
DT Proceedings Paper
CT 25th National Meeting of the Mexican-Electrochemical-Society (MES) / 3rd
   Meeting of the Mexican-Section of the Electrochemical-Society (ECS)
CY MAY 31-JUN 04, 2010
CL Autonomous Univ Zacatecas, Zacatecas, MEXICO
SP Mexican Electrochem Soc (MES), Electrochem Soc (ECS), Mexican Sect
HO Autonomous Univ Zacatecas
AB In this work the synthesis of a Ni60-Co35-Ag5 wt% alloy was performed and evaluation of corrosion behavior of the ternary alloy in Hank solution was obtained. The ternary alloys were synthesized by induction heating under vacuum atmosphere. Heat treatments were performed at 500 degrees C and 800 degrees C for 1 hour. The electrochemical corrosion properties were evaluated by open circuit potential technique, polarization curves and electrochemical impedance (EIS) for 30 days. After 10 days, results show that for the three alloys tested, the free potential stabilized. All alloys present corrosion products in agreement with polarization curves, for alloys with a 500 degrees C HT it is observed the lowest corrosion rate. An impedance measurement corroborates the other electrochemical results. The 500 degrees C heat treated alloy shows the best corrosion behavior under the test condition.
C1 [Bahena, D.; Uruchurtu, J.; Rosales, I.; Ruiz, J. A.] UAEM, Ctr Invest Ingn Ciencias Aplicadas, Cuernavaca 62209, Morelos, Mexico.
RP Bahena, D (reprint author), UAEM, Ctr Invest Ingn Ciencias Aplicadas, Av Univ 1001, Cuernavaca 62209, Morelos, Mexico.
CR Buddy J., 2004, BIOMATERIALS SCI, P37
   Bumgardbner Joel D., 2008, ENCY BIOMATERIALS BI, DOI [10.3109/E-EBBE-120007261, DOI 10.3109/E-EBBE-120007261]
   Girault Hubert H., ANAL PHYS ELECTROCHE, P339
   Holler James S., HADBOOK TOXICOLOGY M, V3E, P809
   Lavos-Valetero I.C., 2004, J MATER SCI-MATER M, P55
   Souto M.R., 2003, BIOMATERIALS, V24, P4213
   Venugopalan R, 2000, BIOMATERIALS, V21, P1669, DOI 10.1016/S0142-9612(00)00049-1
   Yaszemsk Michael J., BIOMATERIALS ORTHOPE, P2
   Zamponi C, 2007, SCRIPTA MATER, V56, P1075, DOI 10.1016/j.scriptamat.2007.02.021
NR 9
TC 0
Z9 0
U1 1
U2 4
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 S MAIN ST, PENNINGTON, NJ 08534-2839 USA
SN 1938-5862
BN 978-1-60768-211-0
J9 ECS TRANSACTIONS
PY 2010
VL 29
IS 1
BP 43
EP 49
DI 10.1149/1.3532302
PG 7
WC Electrochemistry; Energy & Fuels; Environmental Sciences
SC Electrochemistry; Energy & Fuels; Environmental Sciences & Ecology
GA BEZ78
UT WOS:000318943900005
DA 2018-10-20
ER

PT J
AU Popescu, SM
   Popescu, FD
   Burlibasa, L
AF Popescu, Sanda Mihaela
   Popescu, Florin-Dan
   Burlibasa, Liliana
TI IN VITRO BIOCOMPATIBILITY OF ZIRCONIA
SO METALURGIA INTERNATIONAL
LA English
DT Article
DE zirconia; in vitro biocompatibility; oral rehabilitation
ID OSTEOBLAST-LIKE CELLS; DIFFERENT SURFACE TOPOGRAPHIES;
   PARTIALLY-STABILIZED ZIRCONIA; POLYETHYLENE PARTICLES;
   ENDOTHELIAL-CELLS; CERAMIC MATERIALS; GENE-EXPRESSION; BIOACTIVITY;
   TITANIUM; COMPOSITE
AB Derived from a transition metal, zirconia is an interesting material, with a lot of biomedical applications. After obtaining yttrium-oxide partially stabilized zirconia (Y-PSZ) ceramics, characterized by high biocompatibility and improved fracture toughness, zirconia was more extensively become a biomaterial of choice in oral rehabilitation and implant dentistry. The quest for finding the best biomaterial remained and compelled researchers to find better zirconia surfaces more resistant and more biocompatible in oral medium. By treating zirconia surface with UV or CO2 laser, or coating with hydroxyapatite or bioglasses, or by combining zirconia with alumina, there were many attempts to obtain the best biomaterial This review is focused on analyzing in vitro biocompatibility studies done on zirconia and its combinations, on different types of cell lines and by different tests.
C1 [Popescu, Florin-Dan] Univ Med & Pharm Carol Davila, Dept Allergol, Bucharest, Romania.
   [Popescu, Sanda Mihaela] Univ Med & Pharm Craiova, Dept Oral Rehabil, Craiova, Romania.
   [Burlibasa, Liliana] Univ Bucharest, Fac Biol, Bucharest, Romania.
RP Popescu, FD (reprint author), Univ Med & Pharm Carol Davila, Dept Allergol, Bucharest, Romania.
EM florindanpopescu@hotmail.com
RI Popescu, Sanda Mihaela/B-9014-2011; Burlibasa, Liliana/S-7557-2017;
   Burlibasa, Liliana/G-2148-2014
OI Popescu, Sanda Mihaela/0000-0003-3011-6322; Burlibasa,
   Liliana/0000-0003-0596-9331
CR Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Basu B, 2004, J EUR CERAM SOC, V24, P2031, DOI 10.1016/S0955-2219(03)00355-8
   Bosetti M, 2001, BIOMATERIALS, V22, P987, DOI 10.1016/S0142-9612(00)00264-7
   BROADLEY C, 1989, AM J PATHOL, V135, P647
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Catelas I, 1999, BIOMATERIALS, V20, P625, DOI 10.1016/S0142-9612(98)00214-2
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   Chen XB, 2008, BIOTECHNOL BIOENG, V101, P378, DOI 10.1002/bit.21900
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   EMSLEY J, 2001, NATURES BUILDING BLO, P506
   Fischer H, 2007, J BIOMED MATER RES A, V81A, P982, DOI 10.1002/jbm.a.31119
   GRECO F, 1993, MINERVA ORTOP TRAUMA, V44, P913
   Han Y, 2009, THIN SOLID FILMS, V517, P1577, DOI 10.1016/j.tsf.2008.09.064
   Han Y, 2009, J BIOMED MATER RES A, V88A, P117, DOI 10.1002/jbm.a.31859
   Hao L, 2005, J MATER SCI-MATER M, V16, P719, DOI 10.1007/s10856-005-2608-3
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Helmer J, 1969, S US CER SURG IMPL S
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Ito A., 1993, Clinical Materials, V12, P203, DOI 10.1016/0267-6605(93)90074-H
   Jelinek A, 2007, BIOMOL ENG, V24, P103, DOI 10.1016/j.bioeng.2006.05.019
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P1265, DOI 10.1111/j.1600-0501.2009.01735.x
   Kong YM, 2005, BIOMATERIALS, V26, P509, DOI 10.1016/j.biomaterials.2004.02.061
   Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G
   Liang H, 2007, APPL SURF SCI, V253, P3326, DOI 10.1016/j.apsusc.2006.07.038
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Lohmann CH, 2002, BIOMATERIALS, V23, P1855, DOI 10.1016/S0142-9612(01)00312-X
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   MEBOUTANKAMGEU E, 2000, J BIOMED MATER RES, V52, P587
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Mustafa K, 2008, CLIN ORAL IMPLAN RES, V19, P1178, DOI 10.1111/j.1600-0501.2008.01560.x
   Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005
   Palmieri A, 2008, J MATER SCI-MATER M, V19, P2471, DOI 10.1007/s10856-008-3386-5
   Pankhurst GJ, 1998, BIOCHEMISTRY-US, V37, P4823, DOI 10.1021/bi972367v
   Pesakova V, 2007, J MATER SCI-MATER M, V18, P465, DOI 10.1007/s10856-007-2006-0
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Quan RF, 2009, MAT SCI ENG C-BIO S, V29, P253, DOI 10.1016/j.msec.2008.06.019
   Raffaelli L, 2008, J BIOMED MATER RES A, V86A, P959, DOI 10.1002/jbm.a.31693
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V7, P669
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Roualdes O, 2010, BIOMATERIALS, V31, P2043, DOI 10.1016/j.biomaterials.2009.11.107
   Sadi AY, 2008, J MATER SCI-MATER M, V19, P2359, DOI 10.1007/s10856-007-3336-7
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Santos C, 2009, CERAM INT, V35, P709, DOI 10.1016/j.ceramint.2008.02.004
   Schmalz G., 2009, BIOCOMPATIBILITY DEN, P1
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Silva VV, 2002, J BIOMED MATER RES, V63, P583, DOI 10.1002/jbm.10308
   Sterner T, 2004, BIOMED TECH, V49, P340, DOI 10.1515/BMT.2004.063
   SWAB JJ, 1991, J MATER SCI, V26, P6706, DOI 10.1007/BF02402664
   Takamori ER, 2008, ARTIF ORGANS, V32, P305, DOI 10.1111/j.1525-1594.2008.00547.x
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
   TUNG PS, 1992, J CELL PHYSIOL, V152, P410, DOI 10.1002/jcp.1041520224
   Uo M, 2003, DENT MATER, V19, P487, DOI 10.1016/S0109-5641(02)00094-5
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Wang GC, 2008, SURF COAT TECH, V202, P5824, DOI 10.1016/j.surfcoat.2008.06.109
   Wang GC, 2010, ACTA BIOMATER, V6, P990, DOI 10.1016/j.actbio.2009.09.021
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
NR 69
TC 6
Z9 6
U1 1
U2 26
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2010
VL 15
SI 4
BP 14
EP 25
PG 12
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 578ZQ
UT WOS:000276336100003
DA 2018-10-20
ER

PT J
AU Vasilescu, M
   Dobrescu, M
AF Vasilescu, Marius
   Dobrescu, Mircea
TI TITANIUM AND TITANIUM ALLOYS AS BIOMATERIALS. PROPERTIES, PROCESSING AND
   DENTAL APPLICATIONS
SO METALURGIA INTERNATIONAL
LA English
DT Article
DE titanium; titanium alloys; biomaterial; properties; casting; surface
   processing; dental applications
AB In the paper are shown the unique properties of titanium and its alloys as biomaterials (from the point of vue biological, chemical and physical characteristics) together with the main properties of unalloyed titanium, alpha, beta and alpha-beta titanium alloys. Basic processing techniques of titanium in dental technology are represented by casting technology and surface processing methods.
C1 [Vasilescu, Marius; Dobrescu, Mircea] Univ Politehn Bucuresti, Fac Sci & Engn Mat, Bucharest, Romania.
RP Vasilescu, M (reprint author), Univ Politehn Bucuresti, Fac Sci & Engn Mat, Bucharest, Romania.
EM marius.vasilescu@upb.ro
RI Vasilescu, Marius/C-9869-2015
CR ARANT WE, 1971, J PROSTHET DENT, V25, P265
   Asmussen E, 1999, J DENT, V27, P275, DOI 10.1016/S0300-5712(98)00066-9
   BLACKMAN R, 1991, J PROSTHET DENT, V65, P309, DOI 10.1016/0022-3913(91)90181-U
   Boyer R, 1994, MAT PROPERTIES HDB T, P3
   DOBRESCU M, 2009, METAL INT, V14, P14
   DOBRESCU M, 2000, TITANIUM TITANIUM AL
NR 6
TC 2
Z9 2
U1 2
U2 9
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2010
VL 15
IS 11
BP 69
EP 73
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 632QJ
UT WOS:000280440800013
DA 2018-10-20
ER

PT S
AU Baudis, S
   Steyrer, B
   Pulka, T
   Wilhelm, H
   Weigel, G
   Bergmeister, H
   Stampfl, J
   Liska, R
AF Baudis, Stefan
   Steyrer, Bernhard
   Pulka, Thomas
   Wilhelm, Harald
   Weigel, Guenter
   Bergmeister, Helga
   Stampfl, Juergen
   Liska, Robert
BE Stelzer, F
   Wiesbrock, E
TI Photopolymerizable Elastomers for Vascular Tissue Regeneration
SO MODERN TRENDS IN POLYMER SCIENCE-EPF 09
SE Macromolecular Symposia
LA English
DT Proceedings Paper
CT 12th European-Polymer-Federation Congress
CY JUL 12-17, 2009
CL Graz, AUSTRIA
SP European Polymer Federat
DE additive manufacturing; biocompatibility; biomaterial; elastomers;
   photopolymerization
ID MECHANICAL-PROPERTIES; REACTIVE DILUENTS
AB The aim of this study was to design new resin formulations for blood vessel substitutes with small inner diameter that can be 3D-printed by Additive Manufacturing (AM). Commercially available urethane oligomer acrylates as cross-linking agents (CAs) with different reactive diluents (RDs) and/or thiol chain transfer agents (CTAs) were examined. It could be shown that the properties of photopolymers of carefully selected CA/RD/CTA combinations can be varied in a wide range, also to fit with those of natural blood vessels. Moreover, these materials showed good biocompatibility in in-vitro cell culture tests with endothelial cells. A new method to assess the tear resistance of the new materials in comparison with natural blood vessels was designed and established. The tear resistance of the developed photopolymers already approaches those of natural material, although there is still need of improvement. The 3D-structuring of optimized resin system succeeded. Hence AM has proven to be an ideal tool to manufacture parts with the complex structure of natural blood vessels.
C1 [Baudis, Stefan; Liska, Robert] Vienna Univ Technol, Inst Appl Synthet Chem, Div Macromol Chem, Getreidemarkt 9-163MC, A-1060 Vienna, Austria.
   [Steyrer, Bernhard; Pulka, Thomas; Wilhelm, Harald] TGM Vienna, A-1200 Vienna, Austria.
   [Weigel, Guenter; Bergmeister, Helga] Vienna Med Univ, Ludwig Boltzmann Cluster ardiovascular Res, A-1090 Vienna, Austria.
   [Stampfl, Juergen] Vienna Univ Technol, Inst Mat Sci & Technol, A-1040 Vienna, Austria.
RP Baudis, S (reprint author), Vienna Univ Technol, Inst Appl Synthet Chem, Div Macromol Chem, Getreidemarkt 9-163MC, A-1060 Vienna, Austria.
EM rliska@otech7.tuwien.ac.at
RI Baudis, Stefan/B-9011-2011; Liska, Robert/C-2814-2008
OI Baudis, Stefan/0000-0002-5390-0761; Liska, Robert/0000-0001-7865-1936
FU Ludwig Boltzmann Cluster for Cardiovascular Research; Sparkling Science
FX This work was supported by the Ludwig Boltzmann Cluster for
   Cardiovascular Research. Samples of monomers from Rahn and Cognis, PIs
   from Ciba SC, and financial support by Sparkling Science are alsokindly
   acknowledged.
CR Baudis S, 2009, J POLYM SCI POL CHEM, V47, P2664, DOI [10.1009/pola.23352, 10.1002/pola.23352]
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366
   Liska R, 2005, J APPL POLYM SCI, V97, P2286, DOI 10.1002/app.22025
   LYMAN DJ, 1978, J BIOMED MATER RES, V12, P337, DOI 10.1002/jbm.820120307
   Schuster M, 2007, J MACROMOL SCI A, V44, P547, DOI 10.1080/10601320701235958
   Schuster M, 2007, APPL SURF SCI, V254, P1131, DOI 10.1016/j.apsusc.2007.07.182
   Schuster M, 2007, MONATSH CHEM, V138, P261, DOI 10.1007/s00706-007-0609-2
   Senyurt AF, 2006, MACROMOLECULES, V39, P6315, DOI 10.1021/ma060507f
   Shalaby SW, 2004, ADV POL BIO, P175
   Stampfl J, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/12/125014
NR 11
TC 7
Z9 7
U1 2
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
PY 2010
VL 296
BP 121
EP +
DI 10.1002/masy.201051018
PG 2
WC Polymer Science
SC Polymer Science
GA BTT87
UT WOS:000288040600018
DA 2018-10-20
ER

PT J
AU Veiga, DFT
   Dutta, B
   Balazsi, G
AF Veiga, Diogo F. T.
   Dutta, Bhaskar
   Balazsi, Gabor
TI Network inference and network response identification: moving
   genome-scale data to the next level of biological discovery
SO MOLECULAR BIOSYSTEMS
LA English
DT Review
ID TRANSCRIPTIONAL-REGULATORY NETWORK; GENE-EXPRESSION DATA;
   ESCHERICHIA-COLI; MUTUAL INFORMATION; SACCHAROMYCES-CEREVISIAE; CELLULAR
   NETWORKS; YEAST-CELLS; PROTEIN; DYNAMICS; NOISE
AB The escalating amount of genome-scale data demands a pragmatic stance from the research community. How can we utilize this deluge of information to better understand biology, cure diseases, or engage cells in bioremediation or biomaterial production for various purposes? A research pipeline moving new sequence, expression and binding data towards practical end goals seems to be necessary. While most individual researchers are not motivated by such well-articulated pragmatic end goals, the scientific community has already self-organized itself to successfully convert genomic data into fundamentally new biological knowledge and practical applications. Here we review two important steps in this workflow: network inference and network response identification, applied to transcriptional regulatory networks. Among network inference methods, we concentrate on relevance networks due to their conceptual simplicity. We classify and discuss network response identification approaches as either data-centric or network-centric. Finally, we conclude with an outlook on what is still missing from these approaches and what may be ahead on the road to biological discovery.
C1 [Veiga, Diogo F. T.; Dutta, Bhaskar; Balazsi, Gabor] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77030 USA.
RP Balazsi, G (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, 1515 Holcombe Blvd, Houston, TX 77030 USA.
EM GBalazsi@mdanderson.org
OI Balazsi, Gabor/0000-0002-6865-5818
FU TB PAN-NET; European Commission's; CAPES/Fulbright Program (Brazil);
   National Institutes of Health [1-DP2-OD006481-01]
FX We thank Boris Hayete, Dmitry Nevozhay, Rhys Adams, James J. Collins,
   Gordon Mills and Marila Gennaro for comments. We acknowledge funding
   support from the TB PAN-NET consortium funded by the European
   Commission's Seventh Framework Programme for Research (FP7) to DFTV and
   GB; from the CAPES/Fulbright Program (Brazil) to DFTV; from the National
   Institutes of Health through the NIH Director's New Innovator Award
   Program, 1-DP2-OD006481-01 to GB and from the NIH-funded UCSF siRNA
   therapeutics consortium to BD.
CR Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714
   Albert R, 2007, J COMPUT BIOL, V14, P927, DOI 10.1089/cmb.2007.0015
   Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101
   Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275
   Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019
   Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029
   Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102
   Balazsi G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.63
   Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120
   Bar-Yam Y, 2009, SCIENCE, V323, P1016, DOI 10.1126/science.1163225
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532
   Baumbach J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-429
   Bayer Travis S, 2009, J Biol Eng, V3, P1, DOI 10.1186/1754-1611-3-1
   BERNARD A, 2005, PAC S BIOCOMPUT, V10, P459
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003
   Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122
   Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053
   Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36
   Brantl S, 2009, FUTURE MICROBIOL, V4, P85, DOI 10.2217/17460913.4.1.85
   Brinkrolf K, 2007, J BIOTECHNOL, V129, P191, DOI 10.1016/j.jbiotec.2006.12.013
   Butte A J, 1999, Proc AMIA Symp, P711
   Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055
   Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234
   Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965
   Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93
   Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180
   Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035
   Cuccato G, 2009, HEREDITY, V102, P527, DOI 10.1038/hdy.2009.18
   D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499
   Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118
   de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445
   Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842
   Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10
   Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125
   Ernst J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000044
   Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008
   Farkas IJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-478
   Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961
   Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994
   Ganter B, 2008, CURR OPIN DRUG DISC, V11, P86
   Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131
   Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900
   Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241
   Perez AG, 2007, NUCLEIC ACIDS RES, V35, pD132, DOI 10.1093/nar/gkl800
   Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108
   Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800
   Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540
   Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117
   Huang W, 2009, NAT PROTOC, V4, P44, DOI DOI 10.1038/NPR0T.2008.211
   Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929
   Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233
   Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166
   Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768
   Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138
   Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488
   Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615
   Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758
   Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102
   Kohane IS, 2000, PACIFIC S BIOCOMPUTI, V5, P418, DOI DOI 10.1142/9789814447331_
   Kyrpides NC, 2009, NAT BIOTECHNOL, V27, P627, DOI 10.1038/nbt.1552
   Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782
   Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Makita Y., 2004, NUCLEIC ACIDS RES, V32, pD75
   Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7
   Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19
   Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49
   Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106
   Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769
   Pe'er D., 2005, SCI STKE, pl4
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060
   Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175
   Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187
   Qian J, 2001, J MOL BIOL, V314, P1053, DOI 10.1006/jmbi.2000.5219
   Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050
   Ramos H, 2008, BIOINFORMATICS, V24, P2110, DOI 10.1093/bioinformatics/btn363
   Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280
   Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+
   Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432
   Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809
   Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804
   Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881
   Smith MCA, 2007, MOL MICROBIOL, V66, P699, DOI 10.1111/j.1365-2958.2007.05951.x
   Sole RV, 2008, J R SOC INTERFACE, V5, P129, DOI 10.1098/rsif.2007.1108
   Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273
   Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231
   Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389
   Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455
   SZENTGYORGYI A, 1977, P NATL ACAD SCI USA, V74, P2844, DOI 10.1073/pnas.74.7.2844
   Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100
   Veiga DFT, 2007, GENET MOL RES, V6, P730
   Veiga DFT, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-101
   WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0
   Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267
   Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043
   Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x
   Wille A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r92
   Yeger-Lotem E, 2003, NUCLEIC ACIDS RES, V31, P6053, DOI 10.1093/nar/gkg787
   Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684
   Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, P203
NR 106
TC 30
Z9 31
U1 1
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2010
VL 6
IS 3
BP 469
EP 480
DI 10.1039/b916989j
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 557FG
UT WOS:000274654400005
PM 20174676
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Demetrescu, I
   Ionita, D
   Pirvu, C
   Portan, D
AF Demetrescu, I.
   Ionita, D.
   Pirvu, C.
   Portan, D.
TI Present and Future Trends in TiO2 Nanotubes Elaboration,
   Characterization and Potential Applications
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Frontiers of Polymers and Advanced
   Materials
CY SEP 28-OCT 02, 2009
CL Santiago, CHILE
DE Electrochemical stability; surface analysis; titania nanotubes
ID TITANIUM; OSTEOBLAST; ADHESION; FILMS
AB The paper is focused on TiO2 nanotubes elaboration, characterization and potential applications, starting from the idea that monitoring anodizing conditions is a way to obtain nanotubes with various dimensions and various potential applications related to the change of hydrophilic - hydrophobic balance, biocompatibility, nano-porosity, stability, etc. Such properties are important for the use of Ti as biomaterial, as self-cleaning, solar energy conversion, controllable wettability, photocatalysis, etc. The electrochemical behaviour of the nanotubes was monitoring by Tafel plots and open circuit potential determinations, and was discussed in connection with surface features evaluated from scanning electron microscopy, atomic force microscopy and contact angle measurements.
C1 [Demetrescu, I.; Ionita, D.; Pirvu, C.; Portan, D.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Demetrescu, I (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Str Polizu 1-7,Sector 6, Bucharest 011061, Romania.
EM ioana_demetrescu@yahoo.com
OI Pirvu, Cristian/0000-0003-0339-6146
CR Albu S. P., 2007, PHYS STATUS SOLIDI-R, V1, P65
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chen YJ, 2008, SURF COAT TECH, V202, P1944, DOI 10.1016/j.surfcoat.2007.08.041
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Ghicov A, 2006, ELECTROCHEM COMMUN, V8, P528, DOI 10.1016/j.elecom.2006.01.015
   Jeon JD, 2006, J POWER SOURCES, V162, P1304, DOI 10.1016/j.jpowsour.2006.08.022
   Kasuga T, 2006, THIN SOLID FILMS, V496, P141, DOI 10.1016/j.tsf.2005.08.341
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P7463, DOI 10.1002/anie.200502781
   Man I, 2008, REV CHIM-BUCHAREST, V59, P615
   Manole CC, 2009, KEY ENG MAT, V415, P5
   MEREDITH DO, 2004, EUROPEAN CELL MAT S, V1, P11
   Nelson K, 2008, J COLLOID INTERF SCI, V319, P130, DOI 10.1016/j.jcis.2007.09.037
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Portan D, 2009, KEY ENG MAT, V415, P9
   Textor M., 2001, TITANIUM MED, V7, P171
   TEXTOR M, 2001, TITANIUM MED, P231
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   ZHANG LY, 1998, CHINESE J SILICON, V17, P22
NR 21
TC 11
Z9 11
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1542-1406
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2010
VL 521
BP 195
EP 203
DI 10.1080/15421401003715918
PG 9
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 602UA
UT WOS:000278163100017
DA 2018-10-20
ER

PT S
AU Cadman, J
   Chen, YH
   Zhou, SW
   Li, Q
AF Cadman, Joseph
   Chen, Yuhang
   Zhou, Shiwei
   Li, Qing
BA Lee, JH
BF Lee, JH
TI Assessing the Effects of Natural Variations in Microstructure for the
   Biomimetic Modeling of Cuttlebone
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES III, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Multi-Functional Materials and
   Structures
CY SEP 14-18, 2010
CL Chonbuk Natl Univ, Jeollabuk do, Jeonju, SOUTH KOREA
SP Minist Knowledge Econ, Korean Soc Mech Engn, Jeonju City, Gunsan City, Wanju Gun, Korean Soc New & Renewable Energy, Mat Res Soc Korea, Jeonbuk Technopark Policy Planning Dept, Jeonju Inst Machinery & Carbon Composites, Jeonbuk Inst Automotive Technol, Korean Soc Composites Mat, Chonbuk Natl Univ, Dept BIN Fusion Tech, BK21 Ctr Future Energy Mat & Devices, Korean Hydrogen & New Energy Soc
HO Chonbuk Natl Univ, Jeollabuk do
DE Biomaterials; Biomimetics; Homogenization; Random Variables; Natural
   Variation
ID CUTTLEFISH; DESIGN; BONE
AB Cuttlebone is a natural material possessing a unique microstructure providing a high compressive strength to weight ratio. It is potentially desirable to use cuttlebone directly in engineering applications or to design new biomimetic materials based on the microstructural features of cuttlebone. A finite element based homogenization method can be used for characterizing the mechanical properties of such a biomaterial and for the design of biomimetic materials. However, this method assumes a periodicity of microstructure, which does not reflect the variation present in natural or fabricated materials. The method can be extended to investigate the effect of natural variation and manufacturing tolerance by enlarging the base cell domain to include a number of representative volume elements (RVEs) and applying a random displacement vector to the nodes at the internal intersections of the RVEs. As the boundary of the base cell domain is not modified, the homogenization method can still be employed to calculate the bulk mechanical properties. It is found that the number of RVEs in the base cell has an impact on the decrease in mean stiffness tensor components, while the length of the introduced variation seems to influence both the mean and the standard deviation of stiffness tensor components.
C1 [Cadman, Joseph; Chen, Yuhang; Zhou, Shiwei; Li, Qing] Univ Sydney, Sch AMME, Sydney, NSW 2006, Australia.
RP Cadman, J (reprint author), Univ Sydney, Sch AMME, Sydney, NSW 2006, Australia.
EM joseph.cadman@sydney.edu.au; yuhang.chen@sydney.edu.au;
   shiwei.zhou@sydney.edu.au; qing.li@sydney.edu.au
RI Chen, Yuhang/B-3532-2010; Chen, Yuhang/C-8602-2014
CR BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2
   Bensoussan A, 1978, ASYMPTOTIC ANAL PERI
   BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001
   Cadman J, 2010, ACTA MECH SINICA-PRC, V26, P27, DOI 10.1007/s10409-009-0310-2
   Gower David, 1996, Biomimetics, V4, P37
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Sherrard KM, 2000, BIOL BULL-US, V198, P404, DOI 10.2307/1542696
NR 8
TC 4
Z9 4
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-246-6
J9 ADV MATER RES-SWITZ
PY 2010
VL 123-125
BP 295
EP 298
DI 10.4028/www.scientific.net/AMR.123-125.295
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BUH15
UT WOS:000289269600071
DA 2018-10-20
ER

PT S
AU Bazaka, K
   Jacob, MV
   Shanks, RA
AF Bazaka, Kateryna
   Jacob, Mohan V.
   Shanks, Robert A.
BA Lee, JH
BF Lee, JH
TI Fabrication and Characterization of RF Plasma Polymerized Thin Films
   from 3,7-Dimethyl-1,6-octadien-3-ol for Electronic and Biomaterial
   Applications
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES III, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Multi-Functional Materials and
   Structures
CY SEP 14-18, 2010
CL Chonbuk Natl Univ, Jeollabuk do, Jeonju, SOUTH KOREA
SP Minist Knowledge Econ (MKE), Korean Soc Mech Engn (KSME), Jeonju City, Gunsan City, Wanju Gun, Korean Soc New & Renewable Energy, Mat Res Soc Korea, Jeonbuk Technopark Policy Planning Dept, Jeonju Inst Machinery & Carbon Composites, Jeonbuk Inst Automotive Technol, Korean Soc Composites Mat, Chonbuk Natl Univ, Dept BIN Fusion Tech, BK21 Ctr Future Energy Mat & Devices, Korean Hydrogen & New Energy Soc
HO Chonbuk Natl Univ, Jeollabuk do
DE Organic polymer; RE plasma polymerisation; Linalool
ID ESSENTIAL OIL
AB Poly(linalool) thin films were fabricated using RF plasma polymerisation. All films were found to be smooth, defect-free surfaces with average roughness of 0.44 nm. The FTIR analysis of the polymer showed a notable reduction in -OH moiety and complete dissociation of C=C unsaturation compared to the monomer, and presence of a ketone band absent from the spectrum of the monomer. Poly(linalool) were characterised by chain branching and a large quantity of short polymer chains. Films were optically transparent, with refractive index and extinction coefficient of 1.55 and 0.001 (at 500 nm) respectively, indicating a potential application as an encapsulating (protective) coating for circuit boards. The optical band gap was calculated to be 2.82 eV, which is in the semiconducting energy gap region.
C1 [Bazaka, Kateryna; Jacob, Mohan V.] James Cook Univ, Sch Engn, Elect Mat Res Lab, Townsville, Qld 4811, Australia.
   [Shanks, Robert A.] RMIT Univ, Appl Sci, Melbourne, Vic 3001, Australia.
RP Bazaka, K (reprint author), James Cook Univ, Sch Engn, Elect Mat Res Lab, Townsville, Qld 4811, Australia.
EM katia.bazaka@jcu.edu.au; mohan.jacob@jcu.edu.au;
   robert.shanks@rmit.edu.au
RI Jacob, Mohan/B-9097-2009; Shanks, Robert/A-1496-2011; Bazaka,
   Kateryna/D-8678-2011
OI Jacob, Mohan/0000-0002-2598-7193; Shanks, Robert/0000-0003-3790-5148;
   Bazaka, Kateryna/0000-0003-2032-6377
FU RIRDC; ARC LIEF; JCU; DAFF as a part of Science and Innovation Award for
   Young People in Agriculture, Fisheries, and Forestry
FX The authors are grateful for support received under RIRDC, ARC LIEF, JCU
   grant schemes. KB is thankful to APA and AINSE scholarships, and funding
   received from DAFF as a part of Science and Innovation Award for Young
   People in Agriculture, Fisheries, and Forestry.
CR Bazaka K, 2009, MATER LETT, V63, P1594, DOI 10.1016/j.matlet.2009.04.025
   Bazaka K., 2010, POLYM DEGRA IN PRESS
   Biederman H., 1992, PLASMA POLYM PROCESS
   Biederman H., 2004, PLASMA POLYM FILMS
   BREDAS JL, 1984, PHYS REV B, V29, P6761, DOI 10.1103/PhysRevB.29.6761
   Easton CD, 2009, THIN SOLID FILMS, V517, P4402, DOI 10.1016/j.tsf.2009.02.023
   Jacob MV, 2008, THIN SOLID FILMS, V516, P3884, DOI 10.1016/j.tsf.2007.07.151
   Pattnaik S, 1997, MICROBIOS, V89, P39
   Shi FF, 1996, SURF COAT TECH, V82, P1, DOI 10.1016/0257-8972(95)02621-5
   Sugawara Y, 1998, ANAL CHIM ACTA, V365, P293, DOI 10.1016/S0003-2670(97)00639-9
   Vardeny Z. V., 2005, Synthetic Metals, V148, P1, DOI 10.1016/j.synthmet.2004.09.001
NR 11
TC 3
Z9 3
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-246-6
J9 ADV MATER RES-SWITZ
PY 2010
VL 123-125
BP 323
EP +
DI 10.4028/www.scientific.net/AMR.123-125.323
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BUH15
UT WOS:000289269600078
DA 2018-10-20
ER

PT S
AU Huang, CC
   Lou, CW
   Lu, CT
   Huang, SH
   Chao, CY
   Lin, JH
AF Huang, Chao-Chiung
   Lou, Ching-Wen
   Lu, Chao-Tsang
   Huang, Sin-Huei
   Chao, Chieh-Yu
   Lin, Jia-Horng
BA Lee, JH
BF Lee, JH
TI Evaluation of the Preparation and Biocompatibility of Poly (vinyl
   alcohol)(PVA)/chitosan Composite Electrospun Membranes
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES III, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Multi-Functional Materials and
   Structures
CY SEP 14-18, 2010
CL Chonbuk Natl Univ, Jeollabuk do, Jeonju, SOUTH KOREA
SP Minist Knowledge Econ (MKE), Korean Soc Mech Engn (KSME), Jeonju City, Gunsan City, Wanju Gun, Korean Soc New & Renewable Energy, Mat Res Soc Korea, Jeonbuk Technopark Policy Planning Dept, Jeonju Inst Machinery & Carbon Composites, Jeonbuk Inst Automotive Technol, Korean Soc Composites Mat, Chonbuk Natl Univ, Dept BIN Fusion Tech, BK21 Ctr Future Energy Mat & Devices, Korean Hydrogen & New Energy Soc
HO Chonbuk Natl Univ, Jeollabuk do
DE electrospinning; scanning electron microscopy; poly (vinyl alcohol);
   chitosan
ID NANO-FIBER
AB Electrospinning has been used in a wide variety of applications, such as tissue engineering, filtration and biomaterial scaffolds for vascular grafts or wound dressings. Recently, wound dressings have become more important in human life. They must have the superior biocompatibility, water absorption, water vapor permeation and antibacterial ability. Chitosan has been employed in clinical applications and exhibits excellent biocompatibility, biodegradation and bacteriostasis. In this investigation OR study, experiments were performed on a series of poly (vinyl alcohol) (PVA)/Chitosan (CS) fiber membranes at various blend ratios and electric fields to evaluate their spinnability. The morphology, diameter and structure of electrospun nanofibers were examined by scanning electron microscopy (SEM). When PVA/Chitosan=80:20 and electric field=0.67 kV/cm, the spinnability of electrospun membrane was good. IR spectra demonstrated strong intermolecular hydrogen bonds between the molecules of Chitosan and PVA. Furthermore, cell cultures demonstrate that both PAV and chitosan have good biocompatibility and are non-toxic.
C1 [Lin, Jia-Horng] Feng Chia Univ, Inst Text Engn, Lab Fiber Applicat & Mfg, Taichung 40724, Taiwan.
   [Huang, Chao-Chiung] Fu Jen Catholic Univ, Dept Text & Clothing, Hsinchuang, Taiwan.
   [Lou, Ching-Wen] Cent Taiwan Univ Sci & Technol, Ctr Gen Educ, Inst Biomed Engn & Mat Sci, Taichung, Taiwan.
   [Lu, Chao-Tsang] Cent Taiwan Univ Sci & Technol, Inst Life Sci, Taichung, Taiwan.
   [Huang, Sin-Huei; Chao, Chieh-Yu] Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung, Taiwan.
   [Lin, Jia-Horng] China Med Univ, Sch Chinese Med, Taichung, Taiwan.
RP Lin, JH (reprint author), Feng Chia Univ, Inst Text Engn, Lab Fiber Applicat & Mfg, Taichung 40724, Taiwan.
EM txc11006@mails.fju.edu.tw; cwlou@.ctust.edu.tw; ctlu@ctust.edu.tw;
   cheyu68@hotmail.com; jhlin@fcu.edu.tw
FU Central Taiwan University of Science and Technology [CTC93-A-2-1]
FX The authors would like to thank the Central Taiwan University of Science
   and Technology for financially supporting this research under Contract
   CTC93-A-2-1.
CR Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Ignatova M, 2006, CARBOHYD RES, V341, P2098, DOI 10.1016/j.carres.2006.05.006
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 5
TC 8
Z9 8
U1 1
U2 14
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-246-6
J9 ADV MATER RES-SWITZ
PY 2010
VL 123-125
BP 975
EP +
DI 10.4028/www.scientific.net/AMR.123-125.975
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BUH15
UT WOS:000289269600238
DA 2018-10-20
ER

PT S
AU Jamsa, T
   Muhonen, V
   Danilov, A
   Tuukkanen, J
AF Jamsa, Timo
   Muhonen, Virpi
   Danilov, Anatoli
   Tuukkanen, Juha
BE Kawasaki, A
   Kumakawa, A
   Niino, M
TI Biocompatibility aspects of NiTi-based medical implants
SO MULTISCALE, MULTIFUNCTIONAL AND FUNCTIONALLY GRADED MATERIALS
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 10th International Symposium on Multiscale, Multifunctional and
   Functionally Graded Materials
CY SEP 22-25, 2008
CL Sendai, JAPAN
SP Functionally Graded Mat Forum
DE Nitinol; shape memory; implant; biocompatibility; surface properties;
   cell behaviour
ID DIRECT TISSUE ATTACHMENT; IN-VITRO; ALLOYS; SOL; COATINGS
AB Nickel-titanium is a functional alloy currently used in various clinical applications, especially in vascular stents. There is an increased interest in the orthopaedic use of NiTi-based implants. The alloy enables the manufacture of applications of constant load, controllable motion, and minimal invasiveness. NiTi is considered biocompatible and it possesses mechanical properties that make it an especially good candidate for bone tissue surroundings. In our studies, we have investigated the effects of surface properties of NiTi on its biocompatibility. The martensitic phase was shown to have lower biocompatibility of material in comparison with austenitic NiTi. Cellular cytotoxicity increased and cell adhesion diminished on martensite phase. This was observed with both osteoblasts and osteoclasts. Our studies showed that the thickness of the oxide layer does not necessarily enhance the biocompatibility. The surface state of NiTi is strongly affected by thermal oxidation. Surface properties affect the initial adsorption of proteins and other macromolecules onto the biomaterial surface; this in turn impacts the following cellular responses, such as proliferation and differentiation, which are dictated by adhesion to the extracellular matrix components. Since adhesive force is connected to the interaction with the adsorbed molecules, it might be an important factor in the biocompatibility. Sol-gel derived titania-silica surface treatment was observed to increase the bone-implant coating of functional intramedullary NiTi nails. Sol-gel treatment together with the bending force increased the fixation of the implant (osseointegration). These studies indicate that the surface properties of NiTi are important for its biocompatibility.
C1 [Jamsa, Timo; Muhonen, Virpi; Danilov, Anatoli] Univ Oulu, Inst Biomed, Dept Med Technol, POB 5000, FI-90014 Oulu, Finland.
   [Muhonen, Virpi; Tuukkanen, Juha] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, FI-90014 Oulu, Finland.
RP Jamsa, T (reprint author), Univ Oulu, Inst Biomed, Dept Med Technol, POB 5000, FI-90014 Oulu, Finland.
EM timo.jamsa@oulu.fi; virpi.muhonen@oulu.fi; juha.tuukkanen@oulu.fi
RI Danilov, Anatoly/I-7654-2013
OI Danilov, Anatoly/0000-0003-3656-1400; Tuukkanen,
   Juha/0000-0002-1723-6461; Jamsa, Timo/0000-0001-8394-9462
FU National Funding Agency for Innovation and Technology (TEKES); Tauno
   Tonning Foundation; National Graduate School of Musculoskeletal
FX The study was financially supported by the National Funding Agency for
   Innovation and Technology (TEKES), Tauno Tonning Foundation, and the
   National Graduate School of Musculoskeletal Disorders and Biomaterials.
CR Aaritalo V, 2007, J MATER SCI-MATER M, V18, P1863, DOI 10.1007/s10856-007-3062-1
   Areva S, 2007, J MATER SCI-MATER M, V18, P1633, DOI 10.1007/s10856-007-3064-z
   Danilov A, 2003, J PHYS IV, V112, P1117, DOI 10.1051/jp4:20031078
   Danilov A., 2004, EUR CELLS MAT S1, V7, P5
   Danilov A, 2007, J BIOMED MATER RES A, V82A, P810, DOI 10.1002/jbm.a.31190
   Jokinen M, 1998, J BIOMED MATER RES, V42, P295, DOI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
   Kapanen A, 2002, BIOMATERIALS, V23, P3733, DOI 10.1016/S0142-9612(02)00107-2
   KAPANEN A, 2002, BIOCOMPATIBILITY ORT
   Kathuria YP, 2006, MAT SCI ENG A-STRUCT, V417, P40, DOI 10.1016/j.msea.2005.11.007
   Kim M, 2005, INT J NETWORK SECURI, V1, P77
   Kujala S, 2002, J MATER SCI-MATER M, V13, P1157, DOI 10.1023/A:1021194005533
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Machado LG, 2003, BRAZ J MED BIOL RES, V36, P683, DOI 10.1590/S0100-879X2003000600001
   Matsui R, 2004, J ENG MATER-T ASME, V126, P384, DOI 10.1115/1.1789952
   Miyazaki S, 1998, SHAPE MEMORY MAT, P267
   Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326
   Muhonen V, 2007, J MATER SCI-MATER M, V18, P959, DOI 10.1007/s10856-006-0082-1
   Muhonen V, 2005, J BIOMED MATER RES A, V75A, P681, DOI 10.1002/jbm.a.30477
   MUHONEN V, 2008, BONE BIOMATERIAL INT
   MUHONEN V, 2008, J BIOMED MAT RES A
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Ryhanen J, 2003, J SHOULDER ELB SURG, V12, P442, DOI 10.1016/S1058-2746(03)00064-8
   Ryhanen J., 1999, BIOCOMPATIBILITY EVA
   Stepan LL, 2005, J BIOMECH ENG-T ASME, V127, P915, DOI 10.1115/1.2049311
   Thompson SA, 2000, INT ENDOD J, V33, P297, DOI 10.1046/j.1365-2591.2000.00339.x
   Xu W, 2005, P I MECH ENG H, V219, P213, DOI 10.1243/095441105X9354
NR 26
TC 0
Z9 0
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 631-632
BP 175
EP +
DI 10.4028/www.scientific.net/MSF.631-632.175
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA BQB62
UT WOS:000280584000028
DA 2018-10-20
ER

PT S
AU Yumoto, A
   Yamamoto, T
   Shiota, I
   Niwa, N
AF Yumoto, Atsushi
   Yamamoto, Takahisa
   Shiota, Ichiro
   Niwa, Naotake
BE Kawasaki, A
   Kumakawa, A
   Niino, M
TI Fabrication of Apatite/Titanium Functionally Graded Coating Using
   Supersonic Free-Jet PVD
SO MULTISCALE, MULTIFUNCTIONAL AND FUNCTIONALLY GRADED MATERIALS
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 10th International Symposium on Multiscale, Multifunctional and
   Functionally Graded Materials
CY SEP 22-25, 2008
CL Sendai, JAPAN
SP Functionally Graded Mat Forum
DE biomaterial; nanoparticle; simulated body fluid; bone-like apatite;
   supersonic gas flow
ID SPRAYED HYDROXYAPATITE COATINGS; CHEMICAL-VAPOR-DEPOSITION; SIMULATED
   BODY-FLUID; COMPOSITE COATINGS; SURFACE-STRUCTURE; AMORPHOUS PHASE;
   POROUS TITANIUM; CATIO3 FILM; PLASMA; ALLOY
AB Hydroxyapatite (HAp) is very attractive in medical field. The objective of this study is to produce HAp/Ti composite coating with Supersonic Free-Jet PVD (SFJ-PVD). The SFJ-PVD is a technique to deposit nanoparticles with supersonic gas flow and to form a thick coating film. In a gas evaporation chamber, a source material is evaporated to form nanoparticles in an inert gas atmosphere. The nanoparticles are then carried to a substrate in a deposition chamber with an inert gas flow through a transfer pipe. The gas flow is generated by the pressure difference between the chambers and accelerated to the supersonic flow of 4.2 Mach through a specially designed supersonic nozzle. With SFJ-PVD, we obtain a uniform high-density HAp/Ti composite coating. XRD analysis reveals that the composite coating is composed of Ti and HAp. An in-vitro study was carried out to investigate the bioactivity of the HAp/Ti composite coating under simulated body fluid.
C1 [Yumoto, Atsushi; Shiota, Ichiro; Niwa, Naotake] Kogakuin Univ, Fac Engn, Tokyo 1920015, Japan.
   [Yamamoto, Takahisa] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138656, Japan.
RP Yumoto, A (reprint author), Kogakuin Univ, Fac Engn, Tokyo 1920015, Japan.
EM yumoto@cc.kogakuin.ac.jp; yamataka@k.u-tokyo.ac.jp;
   i-shiota@cc.kogakuin.ac.jp; niwa@cc.kogakuin.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT)
   [17760586, 19760515]
FX One of the authors (A.Y.) was supported by a Grant-in-Aid for Young
   Scientist B (Grant No. 17760586 and Grant No. 19760515) from the
   Ministry of Education, Culture, Sports, Science and Technology (MEXT).
CR COOK SD, 1988, CLIN ORTHOP RELAT R, P303
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   GROOT KD, 1987, INTERCERAM, V4, P38
   Gross KA, 1998, J BIOMED MATER RES, V39, P407, DOI 10.1002/(SICI)1097-4636(19980305)39:3<407::AID-JBM9>3.0.CO;2-N
   Gu YW, 2003, BIOMATERIALS, V24, P1603, DOI 10.1016/S0142-9612(02)00573-2
   Han Y, 1999, J MATER SCI LETT, V18, P1087, DOI 10.1023/A:1006659907929
   HASEGAWA A, 1992, NIPPON SERAM KYO GAK, V100, P377
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL., 1993, INTRO BIOCERAMICS, P239
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   Inagaki M, 2001, THIN SOLID FILMS, V386, P222, DOI 10.1016/S0040-6090(00)01654-0
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Manso M, 2003, MAT SCI ENG C-BIO S, V23, P447, DOI 10.1016/S0928-4931(02)00319-3
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Ohba Y, 1999, J CERAM SOC JPN, V107, P907, DOI 10.2109/jcersj.107.907
   Sato M, 2007, MATER TRANS, V48, P1505, DOI 10.2320/matertrans.MRA2007016
   Sato M, 2006, MATER TRANS, V47, P1386, DOI 10.2320/matertrans.47.1386
   SUBRAMANIAN MA, 1983, PROG SOLID STATE CH, V15, P55, DOI 10.1016/0079-6786(83)90001-8
   TAKATSUKA K, 1993, J APPL BIOMATER, V4, P317, DOI 10.1002/jab.770040406
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   Weng J, 1997, J MATER SCI LETT, V16, P335, DOI 10.1023/A:1018529924527
   Yumoto A, 2004, MATER TRANS, V45, P1620, DOI 10.2320/matertrans.45.1620
   Yumoto A, 2004, MATER TRANS, V45, P2740, DOI 10.2320/matertrans.45.2740
   Yumoto A, 2003, SURF COAT TECH, V169, P499, DOI 10.1016/S0257-8972(03)00152-X
   Yumoto A, 2002, MATER TRANS, V43, P2932, DOI 10.2320/matertrans.43.2932
   Yumoto A, 2001, J JPN I MET, V65, P635, DOI 10.2320/jinstmet1952.65.7_635
   YUMOTO A, 2004, T MAT RES SOC JPN, V29, P1889
NR 36
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 631-632
BP 187
EP +
DI 10.4028/www.scientific.net/MSF.631-632.187
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA BQB62
UT WOS:000280584000030
DA 2018-10-20
ER

PT S
AU Watanabe, Y
   Iwasa, Y
   Sato, H
   Teramoto, A
   Abe, K
AF Watanabe, Yoshimi
   Iwasa, Yoshimi
   Sato, Hisashi
   Teramoto, Akira
   Abe, Koji
BE Kawasaki, A
   Kumakawa, A
   Niino, M
TI Fabrication of Titanium Biodegradable-polymer FGM for Medical
   Application
SO MULTISCALE, MULTIFUNCTIONAL AND FUNCTIONALLY GRADED MATERIALS
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 10th International Symposium on Multiscale, Multifunctional and
   Functionally Graded Materials
CY SEP 22-25, 2008
CL Sendai, JAPAN
SP Functionally Graded Mat Forum
DE Commercially pure (CP) Ti; poly L-lactic acid (PLLA); spark plasma
   sintering (SPS); biomaterial; wear
ID POROUS TI; COATINGS; DEPOSITION; IMPLANTS; GRADIENT
AB Ti and Ti alloys are widely used as metallic implants, because of their good mechanical properties and nontoxic behavior. However, they have problems as the implant-materials, namely, high Young's modulus comparing that of bone and low bonding ability with bone. There is a need to develop the Ti and Ti alloys with lower Young's modulus and good bonding ability. In previous study, Ti composite containing biodegradable poly-L-lactic-acid (PLLA) fiber has been fabricated to improve these problems. However, this composite has low strength because of the imperfect sintering of Ti matrix. To improve its strength, sintering of Ti matrix should be completed. In this study, Ti-NaCl composite material was fabricated by spark plasma sintering (SPS) method using powder mixture of Ti and NaCl to complete the sintering of Ti matrix. To obtain porous Ti samples, Ti-NaCl composite were put into hot water of 100 degrees C. The porous Ti was dipped into PLLA melt in order to introduce PLLA into the pores of porous Ti. Finally, Ti-PLLA composite was obtained, and PLLA plays a role as reinforcement of Ti matrix. It was found that the Ti-PLLA composite has gradient structure and mechanical properties.
C1 [Watanabe, Yoshimi; Iwasa, Yoshimi; Sato, Hisashi] Nagoya Inst Technol, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
   [Teramoto, Akira; Abe, Koji] Shinshu Univ, Ueda, Nagano 9868567, Japan.
RP Watanabe, Y (reprint author), Nagoya Inst Technol, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM yoshimi@nitech.ac.jp; 18416511@stn.nitech.ac.jp;
   sato.hisashi@nitech.ac.jp; ateramo@shinshu-u.ac.jp;
   kojiabe@shinshu-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
    [19025005]
FX This work is supported by Grant-in-Aid for Scientific Research on
   Priority Areas (19025005) and Tokai Region Nanotechnology Manufacturing
   Cluster in <IT>Knowledge Cluster Initiative</IT> by the Ministry of
   Education, Culture, Sports, Science and Technology of Japan.
CR An YB, 2005, MATER LETT, V59, P2178, DOI 10.1016/j.matlet.2005.02.059
   Choy KL, 2000, J EUR CERAM SOC, V20, P2199, DOI 10.1016/S0955-2219(00)00105-9
   Komotori J, 2001, WEAR, V251, P1239, DOI 10.1016/S0043-1648(01)00753-0
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Lim YM, 2002, CERAM INT, V28, P37, DOI 10.1016/S0272-8842(01)00055-4
   Miyamoto Y, 1999, FUNCTIONALLY GRADED
   Okii N, 2001, NEUROL MED-CHIR, V41, P100, DOI 10.2176/nmc.41.100
   REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5
   Sato H, 2007, MATER SCI FORUM, V539-543, P3201, DOI 10.4028/www.scientific.net/MSF.539-543.3201
   Tsuji H, 2005, POLYMER, V46, P4917, DOI 10.1016/j.polymer.2005.03.069
   Verne E, 2004, J EUR CERAM SOC, V24, P2699, DOI 10.1016/j.jeurceramsoc.2003.09.004
   Watanabe Y, 2004, MATER TRANS, V45, P1005, DOI 10.2320/matertrans.45.1005
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Yin GF, 1999, THIN SOLID FILMS, V345, P67, DOI 10.1016/S0040-6090(99)00076-0
NR 14
TC 2
Z9 3
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 631-632
BP 199
EP +
DI 10.4028/www.scientific.net/MSF.631-632.199
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BQB62
UT WOS:000280584000032
DA 2018-10-20
ER

PT S
AU Estili, M
   Takagi, K
   Kawasaki, A
AF Estili, Mehdi
   Takagi, Kenta
   Kawasaki, Akira
BE Kawasaki, A
   Kumakawa, A
   Niino, M
TI Advanced nanostructure-controlled functionally graded materials
   employing carbon nanotubes
SO MULTISCALE, MULTIFUNCTIONAL AND FUNCTIONALLY GRADED MATERIALS
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 10th International Symposium on Multiscale, Multifunctional and
   Functionally Graded Materials
CY SEP 22-25, 2008
CL Sendai, JAPAN
SP Functionally Graded Mat Forum
DE Alumina; Carbon nanotubes; Functionally graded materials; Powder
   technology; Nanocomposites; Spark plasma sintering
ID ALUMINA CERAMICS
AB Capability of multiwalled carbon nanotubes (CNTs) to create in-depth gradients in properties and functionalities of conventional materials has been investigated for the first time. Functionally graded material (FGM) concept has also been employed for the first time to bridge conventional materials to their advanced nanocomposites containing a high concentration of CNTs, which is promising for unexplored yet novel structural, electronic and biomaterial applications. In this study, a-alumina ceramics considered as the most challenging case has been used as the matrix. Bulk, layered, nanostructure-controlled, CNT-based, functionally graded a-alumina ceramics have been fabricated employing a recently established powder processing technology. In-depth gradients in microstructure, grain size and hardness have been successfully achieved in alumina ceramic without cracking, delamination or warping, after homogeneous and gradual incorporation of the CNTs within the alumina ceramic matrix. The FGM approach showed promise to successfully bridge conventional ceramics to their nanocomposites containing a high concentration of CNTs.
C1 [Estili, Mehdi; Takagi, Kenta; Kawasaki, Akira] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808579, Japan.
RP Estili, M (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808579, Japan.
EM mehdiestili@gmail.com
CR Dresselhaus M. S., 1995, SCI FULLERENE CARBON
   Estili M, 2008, ACTA MATER, V56, P4070, DOI 10.1016/j.actamat.2008.04.029
   Estili M, 2008, SCRIPTA MATER, V59, P703, DOI 10.1016/j.scriptamat.2008.05.042
   Estili M, 2008, SCRIPTA MATER, V58, P906, DOI 10.1016/j.scriptamat.2008.01.016
   Kawasaki A, 2002, ENG FRACT MECH, V69, P1713, DOI 10.1016/S0013-7944(02)00054-1
   KOIZUMI M, 1995, MRS BULL, V20, P19
   Kwon H, 2009, CARBON, V47, P570, DOI 10.1016/j.carbon.2008.10.041
NR 7
TC 7
Z9 7
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 631-632
BP 225
EP 230
DI 10.4028/www.scientific.net/MSF.631-632.225
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BQB62
UT WOS:000280584000036
DA 2018-10-20
ER

PT B
AU Schizas, C
   Karalekas, D
AF Schizas, Ch.
   Karalekas, D.
GP TANGER Ltd
TI MATERIAL INVESTIGATION OF A PHOTOPOLYMERIZED BIOMATERIAL
SO NANOCON 2010, 2ND INTERNATIONAL CONFERENCE
LA English
DT Proceedings Paper
CT 2nd NANOCON International Conference
CY OCT 12-14, 2010
CL Olomouc, CZECH REPUBLIC
DE biopolymer; mechanical properties; UV-curing; exposure time; degree of
   curing
ID 2-PHOTON POLYMERIZATION; COMPLEX; FABRICATION; PHOTONICS; COMPOSITE;
   SENSOR; STRAIN; CURE
AB The objective of this study was to investigate the effects of different UV exposure time on the mechanical properties of a commercially available ORMOCER resin and relate these properties with the level of polymerization within the test samples. Coupons were tested in compression to obtain the mechanical properties as a function of light exposure time. The extent of resin crosslinking (degree of curing), at applied exposure times, was obtained using the recordings of a fiber optic sensor (FBG) embedded in freestanding block specimens.
C1 [Schizas, Ch.; Karalekas, D.] Univ Piraeus, Lab Adv Mfg Technol & Testing, Piraeus 18534, Greece.
RP Schizas, C (reprint author), Univ Piraeus, Lab Adv Mfg Technol & Testing, Karaoli & Dimitriou 80, Piraeus 18534, Greece.
EM dkara@unipi.gr
CR Antonucci V, 2006, COMPOS SCI TECHNOL, V66, P3273, DOI 10.1016/j.compscitech.2005.07.009
   Bachmann D, 2006, SENSOR ACTUAT A-PHYS, V130, P379, DOI 10.1016/j.sna.2005.12.020
   Botsis J, 2005, OPT LASER ENG, V43, P491, DOI 10.1016/j.optlaseng.2004.04.009
   Colpo F, 2007, COMPOS SCI TECHNOL, V67, P1830, DOI 10.1016/j.compscitech.2006.10.024
   Deubel M, 2004, NAT MATER, V3, P444, DOI 10.1038/nmat1155
   Farsari M, 2006, J PHOTOCH PHOTOBIO A, V181, P132, DOI 10.1016/j.jphotochem.2005.11.005
   Farsari M, 2007, APPL SURF SCI, V253, P8115, DOI 10.1016/j.apsusc.2007.02.177
   Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258
   Hill KO, 1997, J LIGHTWAVE TECHNOL, V15, P1263, DOI 10.1109/50.618320
   KWON IK, 2004, J BIOMATER, V6, P1675
   Lu Y, 2006, J BIOMED MATER RES A, V77A, P396, DOI 10.1002/jbm.a.30601
   Measures R.M, 2001, STRUCTURAL MONITORIN
   Montanini R, 2007, SMART MATER STRUCT, V16, P1718, DOI 10.1088/0964-1726/16/5/026
   NGUYEN LH, 2005, J ADV FUNCT MAT, V14, P209
   Ovsianikov A, 2007, APPL SURF SCI, V253, P6599, DOI 10.1016/j.apsusc.2007.01.058
   Serbin J, 2003, OPT LETT, V28, P301, DOI 10.1364/OL.28.000301
   Stampfl J, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/12/125014
   Straub M, 2004, OPT MATER, V27, P359, DOI 10.1016/j.optmat.2004.07.013
   Wu SH, 2006, J PHOTOCH PHOTOBIO A, V181, P1, DOI 10.1016/j.photochem.2006.03.004
NR 19
TC 0
Z9 0
U1 0
U2 5
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-19-2
PY 2010
BP 191
EP 196
PG 6
WC Nanoscience & Nanotechnology; Physics, Atomic, Molecular & Chemical
SC Science & Technology - Other Topics; Physics
GA BTE76
UT WOS:000286656400033
DA 2018-10-20
ER

PT J
AU Aslan, S
   Loebick, CZ
   Kang, S
   Elimelech, M
   Pfefferle, LD
   Van Tassel, PR
AF Aslan, Seyma
   Loebick, Codruta Zoican
   Kang, Seoktae
   Elimelech, Menachem
   Pfefferle, Lisa D.
   Van Tassel, Paul R.
TI Antimicrobial biomaterials based on carbon nanotubes dispersed in
   poly(lactic-co-glycolic acid)
SO NANOSCALE
LA English
DT Article
ID IN-VITRO ACTIVITY; SURFACE; COATINGS; CONTACT; RELEASE; POLYURETHANES;
   PERFORMANCE; INFECTION; PATHOGENS; COMPOSITE
AB Biomaterials that inactivate microbes are needed to eliminate medical device infections. We investigate here the antimicrobial nature of single-walled carbon nanotubes (SWNTs) incorporated within the biomedical polymer poly(lactic-co-glycolic acid) (PLGA). We find Escherichia coli and Staphylococcus epidermidis viability and metabolic activity to be significantly diminished in the presence of SWNT-PLGA, and to correlate with SWNT length and concentration (<2% by weight). Up to 98% of bacteria die within one hour on SWNT-PLGA versus 15-20% on pure PLGA. Shorter SWNTs are more toxic, possibly due to increased density of open tube ends. This study demonstrates the potential usefulness of SWNT-PLGA as an antimicrobial biomaterial.
C1 [Aslan, Seyma; Loebick, Codruta Zoican; Kang, Seoktae; Elimelech, Menachem; Pfefferle, Lisa D.; Van Tassel, Paul R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
RP Van Tassel, PR (reprint author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
EM Paul.VanTassel@yale.edu
RI Elimelech, Menachem/E-7137-2012; Van Tassel, Paul/D-1087-2017; Kang,
   Seoktae/J-2165-2015
OI Elimelech, Menachem/0000-0003-4186-1563; 
FU National Science Foundation [CBET-0756323]
FX We thank Nan Li, Salim Derrouiche, Xiaoming Wang, Dr Sangchoon Jeon,
   Antony Joseph, and Nebi Demirsoy for their assistance in this study. We
   thank the National Science Foundation for financial support through
   CBET-0756323.
CR Balani K, 2008, ACTA MATER, V56, P571, DOI 10.1016/j.actamat.2007.10.038
   Basak P, 2009, J MATER SCI-MATER M, V20, P213, DOI 10.1007/s10856-008-3521-3
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Brady-Estevez AS, 2008, SMALL, V4, P481, DOI 10.1002/smll.200700863
   Chen J, 2001, J AM CHEM SOC, V123, P6201, DOI 10.1021/ja015766t
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s
   Chen Y, 2007, ACS NANO, V1, P327, DOI 10.1021/nn700106c
   Cole N, 2010, INVEST OPHTH VIS SCI, V51, P390, DOI 10.1167/iovs.09-4068
   Dong LF, 2009, NANOSCALE RES LETT, V4, P1517, DOI 10.1007/s11671-009-9429-0
   Fadel TR, 2008, NANO LETT, V8, P2070, DOI 10.1021/nl080332i
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grunzinger SJ, 2007, POLYMER, V48, P4653, DOI 10.1016/j.polymer.2007.06.010
   Gu LR, 2008, BIOMACROMOLECULES, V9, P2408, DOI 10.1021/bm800395e
   Gu LR, 2005, CHEM COMMUN, P874, DOI 10.1039/b415015e
   Guerrero G, 2009, PATHOL BIOL, V57, P36, DOI 10.1016/j.patbio.2008.07.032
   JARVIS WR, 2007, 6 INT C HOSP INF SOC, P3
   Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v
   Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r
   Keshri AK, 2010, CARBON, V48, P431, DOI 10.1016/j.carbon.2009.08.046
   Kim JW, 2007, LASER SURG MED, V39, P622, DOI 10.1002/lsm.20534
   Koyama S, 2009, CARBON, V47, P1365, DOI 10.1016/j.carbon.2009.01.028
   Kugel AJ, 2009, J COAT TECHNOL RES, V6, P107, DOI 10.1007/s11998-008-9124-6
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Leung WK, 2009, J APPL MICROBIOL, V106, P1463, DOI 10.1111/j.1365-2672.2008.04122.x
   Li N, 2009, J PHYS CHEM C, V113, P10070, DOI 10.1021/jp903129h
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lichter JA, 2009, LANGMUIR, V25, P7686, DOI 10.1021/la900349c
   Lim S, 2008, J PHYS CHEM C, V112, P12442, DOI 10.1021/jp710805u
   Liong M, 2009, ADV MATER, V21, P1684, DOI 10.1002/adma.200802646
   Liu SB, 2009, ACS NANO, V3, P3891, DOI 10.1021/nn901252r
   Lobo AO, 2010, CARBON, V48, P245, DOI 10.1016/j.carbon.2009.09.012
   Malcolm RK, 2004, J CONTROL RELEASE, V97, P313, DOI 10.1016/j.jconrel.2004.03.029
   Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966
   McBride MC, 2009, BIOMATERIALS, V30, P6739, DOI 10.1016/j.biomaterials.2009.08.047
   Muthuselvi L, 2006, PRAMANA-J PHYS, V66, P563, DOI 10.1007/BF02704499
   Narayan RJ, 2005, MAT SCI ENG B-SOLID, V123, P123, DOI 10.1016/j.mseb.2005.07.007
   Narayan RJ, 2004, MATER RES SOC SYMP P, V785, P299
   Nepal D, 2008, NANO LETT, V8, P1896, DOI 10.1021/nl080522t
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Pasupuleti S, 2008, MAT SCI ENG A-STRUCT, V491, P224, DOI 10.1016/j.msea.2008.04.058
   Piozzi A, 2004, J CHEMOTHERAPY, V16, P446, DOI 10.1179/joc.2004.16.5.446
   Ruggeri V, 2007, J BIOMED MATER RES A, V81A, P287, DOI 10.1002/jbm.a.30984
   Schneider OD, 2008, J MATER CHEM, V18, P2679, DOI 10.1039/b800522b
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Simmons TJ, 2009, CARBON, V47, P1561, DOI 10.1016/j.carbon.2009.02.005
   Stobie N, 2009, COLLOID SURFACE B, V72, P62, DOI 10.1016/j.colsurfb.2009.03.014
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
   Ye WJ, 2005, POLYMER, V46, P10538, DOI 10.1016/j.polymer.2005.08.019
   Zhang W, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/13/135302
NR 55
TC 62
Z9 63
U1 2
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2010
VL 2
IS 9
BP 1789
EP 1794
DI 10.1039/c0nr00329h
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 647JD
UT WOS:000281613800031
PM 20680202
DA 2018-10-20
ER

PT S
AU Matteini, P
   Ratto, F
   Rossi, F
   Pini, R
AF Matteini, P.
   Ratto, F.
   Rossi, F.
   Pini, R.
BE Cartwright, AN
   Nicolau, DV
TI Biofilms of chitosan-gold nanorods as a novel composite for the laser
   welding of biological tissue
SO NANOSCALE IMAGING, SENSING, AND ACTUATION FOR BIOMEDICAL APPLICATIONS
   VII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nanoscale Imaging, Sensing, and Actuation for Biomedical
   Applications VII
CY JAN 25-28, 2010
CL San Francisco, CA
SP SPIE
DE gold nanorods; laser welding; photothermal effect; chitosan
ID CORNEA
AB Gold nanorods (GNRs) exhibit intense localized plasmon resonances at optical frequencies in the near infrared (NIR), which is the window where the penetration of light into the body is maximal. Upon excitation with a NIR laser, a strong photothermal effect is produced, which can be exploited to develop minimally invasive therapies. Here we prove the use of chitosan-GNRs films as a novel NIR sensitive nanocomposite for the photothermal conversion of NIR laser light during surgical interventions of tissue welding. Chitosan is an attractive biomaterial due to its biodegradability, biocompatibility, hemostatic, antimicrobial and wound healing-promoting activity. Colloidal GNRs were embedded in chitosan based, highly stabilized, flexible and easy-to-handle films, which were stored in water until the time of surgery. The chitosan-GNRs films were first positioned on freshly explanted rabbit tendon samples. Then, by administration of single pulses ranging from 80 to 140 ms duration and 0.5 to 1.5 W power delivered by a 300-mu m optic fiber coupled with a 810 nm diode laser, spots of local thermally-induced adhesion characterized by a tensile strength of similar to 10 kPa were obtained. The present results are encouraging toward the development of a novel minimally-invasive technology based on the application of bioderived nanoplasmonic materials to biomedical optics.
C1 [Matteini, P.; Ratto, F.; Rossi, F.; Pini, R.] CNR, Inst Appl Phys, Sesto Fiorentino, Italy.
RP Matteini, P (reprint author), CNR, Inst Appl Phys, Sesto Fiorentino, Italy.
RI Rossi, Francesca/A-5105-2010; Matteini, Paolo/N-3725-2015
OI Rossi, Francesca/0000-0002-1199-8019; RATTO, FULVIO/0000-0001-6721-9486
CR Matteini P, 2007, LASER SURG MED, V39, P597, DOI 10.1002/lsm.20532
   Matteini P, 2009, LASER MED SCI, V24, P667, DOI 10.1007/s10103-008-0617-4
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   PINI R, 2008, BIOL MED PHYS BIOMED, V15, P275
   Ratto F, 2008, PROC SPIE, V6844, DOI 10.1117/12.763114
   Ratto F, 2010, J NANOPART RES, V12, P2029, DOI 10.1007/s11051-009-9712-0
   Ratto F, 2009, NANOMED-NANOTECHNOL, V5, P143, DOI 10.1016/j.nano.2008.10.002
   Rossi F, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1900703
   Rossi F, 2008, J BIOPHOTONICS, V1, P331, DOI 10.1002/jbio.200810028
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
NR 10
TC 4
Z9 4
U1 0
U2 9
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-7970-9
J9 PROC SPIE
PY 2010
VL 7574
AR 75740U
DI 10.1117/12.840923
PG 4
WC Nanoscience & Nanotechnology; Optics; Imaging Science & Photographic
   Technology
SC Science & Technology - Other Topics; Optics; Imaging Science &
   Photographic Technology
GA BSH15
UT WOS:000284398100016
DA 2018-10-20
ER

PT S
AU Wu, N
   Wang, WH
   Ling, YF
   Farris, L
   Kim, B
   McDonald, MJ
   Wang, XW
AF Wu, Nan
   Wang, Wenhui
   Ling, Yunfeng
   Farris, Leslie
   Kim, Byungki
   McDonald, Melisenda J.
   Wang, Xingwei
BE Cartwright, AN
   Nicolau, DV
TI Label-free Detection of Biomolecules Using LED Technology
SO NANOSCALE IMAGING, SENSING, AND ACTUATION FOR BIOMEDICAL APPLICATIONS
   VII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nanoscale Imaging, Sensing, and Actuation for Biomedical
   Applications VII
CY JAN 25-28, 2010
CL San Francisco, CA
SP SPIE
DE Biosensor; Fabry Perot interferometer; Poly(methyl methacrylate) (PMMA);
   Light Emitting Diode (LED)
ID REFLECTOMETRIC INTERFERENCE SPECTROSCOPY; INTERFEROMETRIC BIOSENSOR;
   POLYMER
AB This paper presents a label-free biosensor using two Light Emitting Diodes (LEDs) as light sources and a photo detector as a receiver. The sensor uses a silica-on-silicon wafer with PMMA [Poly(methyl methacrylate)] as the functional layer. The principle of this biosensor is based on the Fabry Perot (FP) interferometer. A thickness of a 100 nm PMMA layer is spin-coated on the silicon wafer, which has a thin thermal oxide layer of 500 nm. In such a configuration, the PMMA layer and silica layer function as an FP cavity. When a light illuminates the surface of the sensor, the reflections from the PMMA-air and silica-silicon interfaces will interfere with each other. Consequently, the change of the cavity length, which is caused by biomaterial binding on the PMMA layer, will result in a red shift in the reflection spectrum. An intensity change of the reflection light will be observed on an individual wavelength. In order to eliminate environment noise and to enhance the sensitivity of the sensor, two LEDs, whose center wavelength is chosen on either side of the spectrum notch, are introduced in the system. A photo detector will alternatively obtain the intensities of the two individual reflected lights, and collect the signal via a data acquisition system. Long-term tests have shown that the sensor is resistant to environmental fluctuation. Biolinker Protein G' was used for binding tests. The sensor shows great potential in biosensor applications due to its compact size and low cost.
C1 [Wu, Nan; Wang, Wenhui; Wang, Xingwei] UMass Lowell, Dept Elect & Comp Eng, 1 Univ Ave, Lowell, MA 01854 USA.
   [Ling, Yunfeng; Kim, Byungki] UMass Lowell, Dept Mech Engn, Lowell, MA 01854 USA.
   [Farris, Leslie; McDonald, Melisenda J.] UMass Lowell, Dept Chem, Lowell, MA 01854 USA.
RP Wu, N (reprint author), UMass Lowell, Dept Elect & Comp Eng, 1 Univ Ave, Lowell, MA 01854 USA.
EM nan_wu@student.uml.edu
RI Kim, Byungki/N-6143-2017
OI Kim, Byungki/0000-0003-0165-4973
FU Army Research Office [W911NF-07-02-0081]; National Science Foundation
   [EEC-0425826a]
FX This multidisciplinary research endeavor was funded by an Army Research
   Office Grant (#W911NF-07-02-0081) and the National Science Foundation
   Grant (#EEC-0425826a). The authors would like to extend their sincere
   thanks to the Center for High-Rate Nanomanufacturing (CHN) and
   Nanomanufacturing Center of Excellence (NCOE) at UMASS Lowell.
CR CLARIZIA L, 2007, 21 S PROT SOC BOST
   Clarizia LJ, 2009, ANAL BIOANAL CHEM, V393, P1531, DOI 10.1007/s00216-008-2567-x
   Farris LR, 2009, BIOPHYS J, V96, p634A
   Farris LR, 2010, ANAL BIOANAL CHEM, V396, P667, DOI 10.1007/s00216-009-3235-5
   Fixe F, 2004, LAB CHIP, V4, P191, DOI 10.1039/b316616c
   Gauglitz G, 2005, ANAL BIOANAL CHEM, V381, P141, DOI 10.1007/s00216-004-2895-4
   Hanel C, 2002, ANAL BIOANAL CHEM, V372, P91, DOI 10.1007/s00216-001-1197-3
   HUA S, 2005, LAS EL 2005 CLEO C
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   Marquette CA, 2006, BIOSENS BIOELECTRON, V21, P1424, DOI 10.1016/j.bios.2004.09.037
   Mehlmann M, 2005, ANAL BIOANAL CHEM, V382, P1942, DOI 10.1007/s00216-005-3329-7
   Nikitin PI, 2003, SENSOR ACTUAT B-CHEM, V90, P46, DOI 10.1016/S0925-4005(03)00020-0
   RIKLIN A, 1995, NATURE, V376, P672, DOI 10.1038/376672a0
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   STEFANO LD, 2007, SENSORS, V7, P214, DOI DOI 10.3390/S7020214
   Wang XW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364459
   WU N, 2009, AS PAC NETW CTR RES
   Xu JC, 2006, IEEE PHOTONIC TECH L, V18, P1134, DOI 10.1109/LPT.2006.873361
   Zhang Y, 2005, OPT LETT, V30, P1021, DOI 10.1364/OL.30.001021
   Zhang Y, 2007, J LIGHTWAVE TECHNOL, V25, P1797, DOI 10.1109/JLT.2007.899169
NR 20
TC 1
Z9 1
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-7970-9
J9 PROC SPIE
PY 2010
VL 7574
AR UNSP 75740I
DI 10.1117/12.842034
PG 8
WC Nanoscience & Nanotechnology; Optics; Imaging Science & Photographic
   Technology
SC Science & Technology - Other Topics; Optics; Imaging Science &
   Photographic Technology
GA BSH15
UT WOS:000284398100009
DA 2018-10-20
ER

PT B
AU Qiu, WG
   Huang, YD
   Cappello, J
   Wu, XY
AF Qiu, Weiguo
   Huang, Yiding
   Cappello, Joseph
   Wu, Xiaoyi
GP ASME
TI ELECTROSPUN RECOMBINANT PROTEIN POLYMER NANOFIBERS AS A BIOMATERIAL
SO NEMB2010: PROCEEDINGS OF THE ASME FIRST GLOBAL CONGRESS ON
   NANOENGINEERING FOR MEDICINE AND BIOLOGY - 2010
LA English
DT Proceedings Paper
CT ASME 1st Global Congress on Nanoengineering for Medicine and Biology
CY FEB 07-10, 2010
CL Houston, TX
SP ASME Nanotechnol Inst
C1 [Qiu, Weiguo; Huang, Yiding] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.
RP Qiu, WG (reprint author), Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.
CR Alberts B, 2002, MOL BIOL CELL
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4392-5
PY 2010
BP 207
EP 208
PG 2
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Mechanics;
   Medicine, Research & Experimental
SC Engineering; Science & Technology - Other Topics; Mechanics; Research &
   Experimental Medicine
GA BQZ48
UT WOS:000282210100085
DA 2018-10-20
ER

PT B
AU Teng, WB
   Huang, YD
   Cappello, J
   Wu, XY
AF Teng, Weibing
   Huang, Yiding
   Cappello, Joseph
   Wu, Xiaoyi
GP ASME
TI MECHANICAL AND IN-VITRO CELL COMPATIBILITY PROPERTIES OF
   SILK-ELASTINLIKE PROTEIN-BASED BIOMATERIAL
SO NEMB2010: PROCEEDINGS OF THE ASME FIRST GLOBAL CONGRESS ON
   NANOENGINEERING FOR MEDICINE AND BIOLOGY - 2010
LA English
DT Proceedings Paper
CT ASME 1st Global Congress on Nanoengineering for Medicine and Biology
CY FEB 07-10, 2010
CL Houston, TX
SP ASME Nanotechnol Inst
C1 [Teng, Weibing; Wu, Xiaoyi] Univ Arizona, Dept Aerosp & Mech Engn, Biomed Engn Program, Tucson, AZ 85721 USA.
RP Teng, WB (reprint author), Univ Arizona, Dept Aerosp & Mech Engn, Biomed Engn Program, Tucson, AZ 85721 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4392-5
PY 2010
BP 209
EP 210
PG 2
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Mechanics;
   Medicine, Research & Experimental
SC Engineering; Science & Technology - Other Topics; Mechanics; Research &
   Experimental Medicine
GA BQZ48
UT WOS:000282210100086
DA 2018-10-20
ER

PT B
AU Honarmandi, P
AF Honarmandi, Peyman
GP ASME
TI FABRICATION OF SINGLE-CRYSTAL NANOSPHERICAL HYDROXYAPATITE POWDER FOR
   BIOMEDICAL APPLICATIONS
SO NEMB2010: PROCEEDINGS OF THE ASME FIRST GLOBAL CONGRESS ON
   NANOENGINEERING FOR MEDICINE AND BIOLOGY - 2010
LA English
DT Proceedings Paper
CT ASME 1st Global Congress on Nanoengineering for Medicine and Biology
CY FEB 07-10, 2010
CL Houston, TX
SP ASME Nanotechnol Inst
AB The competence and compatibility of biomaterials is always challenging and demanding in biotech industries. Hydroxyapatite (HAp) is a useful biomaterial for biological applications due to its especial properties. In this paper, a dry mechanochemical process is introduced to produce hydroxyapatite nanoparticles. Structural and morphological properties of HAp powder are studied by X-ray diffraction (XRD) and transmission electron microscopy (TEM). The results show that the single-crystal HAp nanospherical particles are successfully produced during milling process. Two different metallic and polymeric vials are applied and the results are compared for both vials. The results verify that the HAp nanoparticles are single crystal and their sizes are in the ranges of 12-24 nm.
C1 MIT, Cambridge, MA 02139 USA.
RP Honarmandi, P (reprint author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
CR Lin KL, 2007, MATER LETT, V61, P1683, DOI 10.1016/j.matlet.2006.07.099
   Pourghahramani P, 2006, INT J MINER PROCESS, V79, P106, DOI 10.1016/j.minpro.2006.02.001
   Rhee SH, 2002, BIOMATERIALS, V23, P1147, DOI 10.1016/S0142-9612(01)00229-0
   Silva CC, 2003, SOLID STATE SCI, V5, P553, DOI 10.1016/S1293-2558(03)00035-9
   Tao JH, 2007, J CRYST GROWTH, V308, P151, DOI 10.1016/j.jcrysgro.2007.08.009
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
NR 7
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4392-5
PY 2010
BP 239
EP 240
PG 2
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Mechanics;
   Medicine, Research & Experimental
SC Engineering; Science & Technology - Other Topics; Mechanics; Research &
   Experimental Medicine
GA BQZ48
UT WOS:000282210100098
DA 2018-10-20
ER

PT J
AU Zhang, ZH
   Liang, Y
   Yan, LJ
   Yan, FF
   Fang, SM
AF Zhang, Zhihong
   Liang, Yan
   Yan, Lijun
   Yan, Fufeng
   Fang, Shaoming
TI Protein adsorption materials of the soluble conducting polymer
   poly(acryloyl chloride)-g-polypyrrole
SO NEW JOURNAL OF CHEMISTRY
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; ELECTROCHEMICAL SYNTHESIS; POLYPYRROLE;
   PYRROLE; FILMS; SENSOR
AB In order to fabricate a soluble conducting polypyrrole matrix, applied as a biomaterial to anchor proteins, the preparation of a poly(acryoyl pyrrole)-g-polypyrrole (PAP-g-PPy) copolymer and the adsorption of bovine serum albumin (BSA) onto this conducting copolymer were studied. Polypyrrole (PPy) was synthesized by electrochemical polymerization on an Au surface, which had been spin-coated with a poly(acryloyl chloride) precursor containing a pyrrole moiety in its side chain. The chemical properties of PPy depend on the polymerization conditions, i.e., the concentration of pyrrole and the polymerization time. Subsequently, the adsorption behavior of BSA on PAP-g-PPy was investigated by surface plasmon resonance spectroscopy, suggesting that the copolymer thickness, the concentration of pyrrole monomer used in the preparation of the polymer, the BSA concentration and the pH value of buffer solutions can affect the adsorption behavior of BSA onto the polymer surface. It is therefore predicted that the conducting copolymer PAP-g-PPy could be used as an adsorbed matrix for protein adsorption.
C1 [Zhang, Zhihong; Liang, Yan; Yan, Lijun; Yan, Fufeng; Fang, Shaoming] Zhengzhou Univ Light Ind, Henan Prov Key Lab Surface & Interface Sci, Zhengzhou 450002, Peoples R China.
   [Zhang, Zhihong] Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju 500712, South Korea.
RP Zhang, ZH (reprint author), Zhengzhou Univ Light Ind, Henan Prov Key Lab Surface & Interface Sci, 5 Dong Feng Rd, Zhengzhou 450002, Peoples R China.
EM mainzhh@yahoo.com.cn
FU National Natural Science Foundation of China (NSFC) [20704039]
FX This work was supported by the Program for the National Natural Science
   Foundation of China (NSFC: Account no. 20704039).
CR Akinyeye R, 2006, ELECTROANAL, V18, P2441, DOI 10.1002/elan.200603699
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Bousalem S, 2005, J MATER CHEM, V15, P3109, DOI 10.1039/b500982k
   De Giglio E, 2005, SURF INTERFACE ANAL, V37, P580, DOI 10.1002/sia.2053
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Grosjean L, 2005, ANAL BIOCHEM, V347, P193, DOI 10.1016/j.ab.2005.09.033
   Kambhampati DK, 1999, CURR OPIN COLLOID IN, V4, P273, DOI 10.1016/S1359-0294(99)90008-0
   KARLSSON R, 1995, ANAL BIOCHEM, V228, P274, DOI 10.1006/abio.1995.1350
   Kharat HJ, 2007, POLYM ADVAN TECHNOL, V18, P397, DOI 10.1002/pat.903
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Lakard B, 2009, BIOELECTROCHEMISTRY, V75, P148, DOI 10.1016/j.bioelechem.2009.03.010
   Li Y, 2008, POLYMER, V49, P225, DOI 10.1016/j.polymer.2007.11.010
   Okner R, 2009, ACS APPL MATER INTER, V1, P758, DOI 10.1021/am800139s
   Pandey PC, 2008, J APPL POLYM SCI, V107, P2594, DOI 10.1002/app.27361
   Park YH, 2002, POLYM ADVAN TECHNOL, V13, P670, DOI 10.1002/pat.331
   Ramanavicius A, 2006, ELECTROCHIM ACTA, V51, P6025, DOI 10.1016/j.electacta.2005.11.052
   Sadki S, 2000, CHEM SOC REV, V29, P283
   Shirsat MD, 2008, ELECTROANAL, V20, P150, DOI 10.1002/elan.200704028
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   Wang Y, 2008, CHEM MATER, V20, P2574, DOI 10.1021/cm800005r
   YU CC, 2004, SYNTHETIC MET, V143, P253
   Zhang XT, 2006, J PHYS CHEM B, V110, P1158, DOI 10.1021/jp054335k
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
   Zhang ZH, 2008, BIOMACROMOLECULES, V9, P1613, DOI 10.1021/bm800111a
NR 24
TC 5
Z9 5
U1 2
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1144-0546
J9 NEW J CHEM
JI New J. Chem.
PY 2010
VL 34
IS 12
BP 2822
EP 2827
DI 10.1039/c0nj00013b
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 684IY
UT WOS:000284544800016
DA 2018-10-20
ER

PT J
AU Gourlay, T
   Shedden, L
   Horne, D
   Stefanou, DM
AF Gourlay, Terence
   Shedden, Laurie
   Horne, David
   Stefanou, Demetrios M.
TI Simple surface sulfonation retards plasticiser migration and impacts
   upon blood/material contact activation processes
SO PERFUSION-UK
LA English
DT Article
ID RAT RECIRCULATION MODEL; POLYVINYL-CHLORIDE; CARDIOPULMONARY BYPASS;
   DI(2-ETHYLHEXYL) PHTHALATE; INFLAMMATORY RESPONSE; POLY(VINYL CHLORIDE);
   BLOOD RESPONSE; EXPRESSION; BIOMATERIAL; NEUTROPHILS
AB Background. The use of Di-2-ethylhexyl phthalate (DEHP) plasticised polyvinyl chloride (DEHPPPVC) in medical devices persists despite evidence suggesting that DEHP migration can be harmful. Researchers have shown that a simple surface sulfonation process can retard the migration of DEHP, which may reduce the associated inflammatory response. The present study is designed to investigate the effects of surface sulfonation on DEHP migration and blood contact activation using in vitro and rodent models.
   Methods. The study was carried out in two phases: phase 1, in which the migration rate of DEHP from DEHPPPVC and sulfonated DEHP plasticised PVC (SDEHPPPVC) was measured; phase 2 of the study, in which the materials were incorporated into a rat recirculation biomaterial test model and blood samples taken to assess CD11b expression on neutrophils, IL-6 and Factor XIIa.
   Results. The initial DEHP concentration washed from the surface after storage was 37.19 +/- 1.17 mg/l in the PPVC group and 5.89 +/- 0.81 mg/l in the SPPVC group (p<0.0001). The post-wash migration rate was 3.07 +/- 0.32 mg/l/hour in the PPVC group compared to 0.46 +/- 0.038 mg/l/hour in the SPPVC group (p<0.0001). In phase 2 of the study, CD11b expression increased by 228.9% +/- 37% over the test period in the PPVC group compared to 118.3% +/- 46% in the SPPVC group (p<'0.01). IL-6 levels rose from 3.1 +/- 1.4 pg/ml to 263 +/- 26 pg/ml in the PPVC group and 2.2 +/- 1.6 pg/ml to 161 +/- 29 pg/ml in the SPPVC group (p<0.01). Factor XIIa levels rose from 0.22 +/- 0.13 g/ml to 3.7 +/- 0.32 mu g/ml and 0.28 +/- 0.09 to 2.71 +/- 0.21 mu g/ml in the PPVC and SPPVC groups, respectively (p<0.05 at 90 minutes).
   Conclusions. The simple sulfonation process significantly retards the migration of DEHP and is associated with the moderation of contact activation processes.
C1 [Gourlay, Terence; Shedden, Laurie; Horne, David] Univ Strathclyde, Bioengn Unit, Glasgow G3 0NW, Lanark, Scotland.
   [Stefanou, Demetrios M.] Univ London Imperial Coll Sci Technol & Med, London, England.
RP Gourlay, T (reprint author), Univ Strathclyde, Bioengn Unit, Wolfson Bldg, Glasgow G3 0NW, Lanark, Scotland.
EM terence.gourlay@strath.ac.uk
CR Asberg AE, 2005, ARTIF ORGANS, V29, P927, DOI 10.1111/j.1525-1594.2005.00162.x
   Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6
   Gourlay T, 2003, PERFUSION-UK, V18, P87, DOI 10.1191/0267659103pf648oa
   Gourlay T, 2003, ARTIF ORGANS, V27, P256, DOI 10.1046/j.1525-1594.2003.07107.x
   Gourlay T, 2002, ARTIF ORGANS, V26, P5, DOI 10.1046/j.1525-1594.2002.06730.x
   Gourlay T, 2001, ARTIF ORGANS, V25, P475, DOI 10.1046/j.1525-1594.2001.025006475.x
   Hanawa T, 2000, INT J PHARM, V210, P109, DOI 10.1016/S0378-5173(00)00578-0
   Hardell L, 1997, INT J CANCER, V73, P828
   Hauser GJ, 1998, INTENS CARE MED, V24, P481, DOI 10.1007/s001340050600
   HILL GE, 1994, ANAESTH ANALG, V79, P1201
   Holmes JH, 2002, INFLAMM RES, V51, P579, DOI 10.1007/PL00012432
   HORNE DC, 2009, J EXTRA-CORP TECHNOL, V41, P204
   Hsiao TJ, 2004, J OCCUP ENVIRON MED, V46, P962, DOI 10.1097/01.jom.0000137722.66767.38
   Ito R, 2008, INT J PHARM, V360, P91, DOI 10.1016/j.ijpharm.2008.04.020
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203
   Jayakrishnan A, 1998, Nature, V396, P638, DOI 10.1038/25275
   Johnell M, 2005, BIOMATERIALS, V26, P1731, DOI 10.1016/j.biomaterials.2004.05.029
   Kambia K, 2004, INT J ARTIF ORGANS, V27, P971
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1
   Lakshmi S, 2003, J BIOMED MATER RES B, V65B, P204, DOI 10.1002/jbm.b.10562
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x
   Lakshmi S, 1998, POLYMER, V39, P151, DOI 10.1016/S0032-3861(97)00244-9
   Matata BM, 1996, J BIOMED MATER RES, V31, P63, DOI 10.1002/(SICI)1097-4636(199605)31:1<63::AID-JBM8>3.0.CO;2-O
   Scientific Committee on Emerging and Newly-Identified Health Risks SCENIHR, 2008, OP SAF MED DEV CONT
   SKAEKKEBAEK NE, 2001, HUMAN REPROD, V16, P972
   SUNDARAM S, 1992, INT J ARTIF ORGANS, V15, P243
   Takahashi Yosuke, 2008, Asian Cardiovasc Thorac Ann, V16, P4
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Zhao XB, 2003, J MATER SCI-MATER M, V14, P905, DOI 10.1023/A:1025690828200
   Zhao X, 2008, J MATER SCI-MATER M, V19, P713, DOI 10.1007/s10856-007-3191-6
NR 34
TC 2
Z9 2
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PD JAN
PY 2010
VL 25
IS 1
BP 31
EP 39
DI 10.1177/0267659110361997
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 567PJ
UT WOS:000275458800007
PM 20159936
DA 2018-10-20
ER

PT J
AU Corno, M
   Rimola, A
   Bolis, V
   Ugliengo, P
AF Corno, Marta
   Rimola, Albert
   Bolis, Vera
   Ugliengo, Piero
TI Hydroxyapatite as a key biomaterial: quantum-mechanical simulation of
   its surfaces in interaction with biomolecules
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID DENSITY-FUNCTIONAL THEORY; HARTREE-FOCK GRADIENTS; MOLECULAR-DYNAMICS
   SIMULATIONS; ATOMIC-FORCE MICROSCOPY; SYNTHETIC CALCIUM HYDROXYAPATITES;
   PHASE-SHIFT INTERFEROMETRY; EFFECTIVE CORE POTENTIALS; AB-INITIO
   SIMULATION; SOLID-STATE NMR; VIBRATIONAL-SPECTRUM
AB Hydroxyapatite is the mineral component of human bones and teeth enamel and is used as synthetic biomaterial. It also grows outside bioglasses as a response of their incorporation in body fluids. The focus is then on understanding the microscopic steps occurring at its surfaces as this allows researchers to understand the key features of biomolecular adhesion. This perspective article deals with in silico simulations of these processes by quantum-mechanical methods based on density functional theory using the hybrid B3LYP functional and Gaussian basis functions.
C1 [Corno, Marta; Rimola, Albert; Ugliengo, Piero] UdR Torino, Dipartimento Chim IFM, NIS Ctr Excellence, Turin, Italy.
   [Corno, Marta; Rimola, Albert; Ugliengo, Piero] UdR Torino, INSTM Mat Sci & Technol Natl Consortium, Turin, Italy.
   [Bolis, Vera] Univ Piemonte Orientale, Dipartimento DiSCAFF, Novara, Italy.
RP Ugliengo, P (reprint author), UdR Torino, Dipartimento Chim IFM, NIS Ctr Excellence, Via P Giuria 7, Turin, Italy.
EM piero.ugliengo@unito.it
RI Corno, Marta/I-4310-2012; ugliengo, piero/H-6373-2015; Rimola,
   Albert/K-1813-2014
OI Corno, Marta/0000-0001-7248-2705; ugliengo, piero/0000-0001-8886-9832;
   Rimola, Albert/0000-0002-9637-4554
FU Barcelona Supercomputing Centre [BCV-2008-2-0013, BCV-2008-3-0006];
   CINECA; Italian Ministry MIUR [COFIN-2006, 2006032335]; Regione
   Piemonte-Italy [CIPE-2004]
FX Some of the largest calculations of this work have been supported by
   generous allowance of computer time from the Barcelona Supercomputing
   Centre (Projects: BCV-2008-2-0013; BCV-2008-3-0006: simulation of
   peptide folding induced by inorganic materials) and the CINECA computing
   centre. Part of this work was supported by the Italian Ministry MIUR
   (Project COFIN-2006, Prot. 2006032335 Interface phenomena in
   silica-based nanostructured biocompatible materials contacted with
   biological systems) and by Regione Piemonte-Italy (Project CIPE-2004,
   Nanotechnologies and Nanosciences Nanostructured materials biocompatible
   for biomedical applications). Colleagues G. Martra, L. Bertinetti, F.
   Chiatti (Dip. Chimica IFM, University of Torino) and C. Busco (Dip.
   DiSCAFF, University of Eastern Piedmont) are acknowledged for fruitful
   discussion and for providing the HA samples, synthesized and kindly
   supplied by ISTEC-CNR (Faenza, Italy), for the electrostatic potential
   maps and for calorimetric measurements. R. Dovesi, C. Roetti, C. Pisani,
   R. Orlando and B. Civalleri (Dip. Chimica IFM, University of Torino), C.
   M. Zicovich-Wilson (Facultad de Ciencias, Universidad Autonoma del
   Estado de Morelos, Mexico) and A. Pedone (Scuola Normale di Pisa, Italy)
   are thanked for discussion on clean surfaces, dispersion forces and
   force field implementations.
CR Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Artacho E, 1999, PHYS STATUS SOLIDI B, V215, P809, DOI 10.1002/(SICI)1521-3951(199909)215:1<809::AID-PSSB809>3.0.CO;2-0
   Astala R, 2006, CHEM MATER, V18, P413, DOI 10.1021/cm051989x
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bertinetti L, 2008, KEY ENG MATER, V361-363, P87, DOI 10.4028/www.scientific.net/KEM.361-363.87
   Bertinetti L, 2007, J PHYS CHEM C, V111, P4027, DOI 10.1021/jp066040s
   Bertinetti L, 2009, LANGMUIR, V25, P5647, DOI 10.1021/la804230j
   Blum RP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226103
   Bolis V, 1997, LANGMUIR, V13, P895, DOI 10.1021/la951006i
   BOLIS V, 1991, J CHEM SOC FARADAY T, V87, P497, DOI 10.1039/ft9918700497
   Bolis V, 2008, J PHYS CHEM C, V112, P16879, DOI 10.1021/jp805206z
   Bolis V, 2006, J PHYS CHEM B, V110, P14849, DOI 10.1021/jp061078q
   Bordiga S, 2002, J PHYS CHEM B, V106, P9892, DOI 10.1021/jp026106t
   BOYS SF, 1970, MOL PHYS, V553, P19
   Bucko T, 2005, J PHYS CHEM B, V109, P7345, DOI 10.1021/jp050151u
   Cabanas MV, 2002, CHEM MATER, V14, P3550, DOI 10.1021/cm021121w
   Calderin L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.224304
   Calderin L, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.134106
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b
   Carter EA, 2008, SCIENCE, V321, P800, DOI 10.1126/science.1158009
   Casassa S, 2005, CHEM PHYS LETT, V409, P110, DOI 10.1016/j.cplett.2005.04.068
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cheatham TE, 2001, BIOPOLYMERS, V56, P232
   Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Civalleri B, 2008, CRYSTENGCOMM, V10, P405, DOI 10.1039/b715018k
   Civalleri B, 2010, PHYS CHEM CHEM PHYS, V12, P6382, DOI 10.1039/c001192d
   Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075
   Cora F, 2004, STRUCT BOND, V113, P171, DOI 10.1007/b97944
   CORNO M, UNPUB
   Corno M, 2008, CHEM MATER, V20, P5610, DOI 10.1021/cm801164u
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Cramer CJ, 2009, PHYS CHEM CHEM PHYS, V11, P10757, DOI 10.1039/b907148b
   Cusco R, 1998, J EUR CERAM SOC, V18, P1301, DOI 10.1016/S0955-2219(98)00057-0
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   de Leeuw NH, 2004, PHYS CHEM CHEM PHYS, V6, P1860, DOI 10.1039/b313242k
   de Leeuw NH, 2004, J PHYS CHEM B, V108, P1809, DOI 10.1021/jp036784v
   de Leeuw NH, 2002, PHYS CHEM CHEM PHYS, V4, P3865, DOI 10.1039/b203114k
   Doll K, 2006, THEOR CHEM ACC, V115, P354, DOI 10.1007/s00214-005-0063-3
   Doll K, 2004, THEOR CHEM ACC, V112, P394, DOI 10.1007/s00214-004-0595-y
   Doll K, 2001, COMPUT PHYS COMMUN, V137, P74, DOI 10.1016/S0010-4655(01)00172-2
   Doll K, 2001, INT J QUANTUM CHEM, V82, P1, DOI 10.1002/1097-461X(2001)82:1<1::AID-QUA1017>3.0.CO;2-W
   Dorozhkin SV, 2009, MATERIALS, V2, P1975, DOI 10.3390/ma2041975
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dovesi R, 2005, REV COMP CH, V21, P1, DOI 10.1002/0471720895.ch1
   Dovesi R, 2005, Z KRISTALLOGR, V220, P571, DOI 10.1524/zkri.220.5.571.65065
   Dovesi R., 2006, CRYSTAL06 USERS MANU
   Elangovan S, 2007, LANGMUIR, V23, P11200, DOI 10.1021/la7013978
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Ertl G., 2003, ENCY CATALYSIS, V1, P329
   ERTL G, 2008, PRIX NOBEL, P116
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   Fleet ME, 2003, J SOLID STATE CHEM, V174, P412, DOI 10.1016/S0022-4596(03)00281-0
   FUBINI B, 1989, SOLID STATE IONICS, V32-3, P258, DOI 10.1016/0167-2738(89)90230-0
   Gale JD, 1997, J CHEM SOC FARADAY T, V93, P629, DOI 10.1039/a606455h
   Gibson JM, 2006, J AM CHEM SOC, V128, P5364, DOI 10.1021/ja056731m
   Gonze X, 2009, COMPUT PHYS COMMUN, V180, P2582, DOI 10.1016/j.cpc.2009.07.007
   Goobes G, 2007, MAGN RESON CHEM, V45, pS32, DOI 10.1002/mrc.2123
   Goobes R, 2006, BIOCHEMISTRY-US, V45, P5576, DOI 10.1021/bi052321z
   Grassian VH, 2008, SURF SCI, V602, P2955, DOI 10.1016/j.susc.2008.07.039
   Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   Guo T, 2009, J PHYS CHEM A, V113, P7112, DOI 10.1021/jp9017234
   Habas MP, 1998, J PHYS-CONDENS MAT, V10, P6897, DOI 10.1088/0953-8984/10/31/008
   Hafner J, 2008, J COMPUT CHEM, V29, P2044, DOI 10.1002/jcc.21057
   Haverty D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.094103
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435
   Huang P, 2008, ANNU REV PHYS CHEM, V59, P261, DOI 10.1146/annurev.physchem.59.032607.093528
   HUGHES JM, 1989, AM MINERAL, V74, P870
   Hutter E, 2005, Z KRISTALLOGR, V220, P549
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Johnson ER, 2006, CHEM PHYS LETT, V419, P333, DOI 10.1016/j.cplett.2005.11.099
   Kandori K, 2000, LANGMUIR, V16, P2301, DOI 10.1021/la9906424
   Kandori K, 2000, PHYS CHEM CHEM PHYS, V2, P2015, DOI 10.1039/a909396f
   Kandori K, 2005, CALCIFIED TISSUE INT, V76, P194, DOI 10.1007/s00223-004-0102-4
   Kanzaki N, 1998, J PHYS CHEM B, V102, P6471, DOI 10.1021/jp981512r
   Kanzaki N, 2001, J PHYS CHEM B, V105, P1991, DOI 10.1021/jp003295b
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kirkham J, 2002, CURR OPIN COLLOID IN, V7, P124, DOI 10.1016/S1359-0294(02)00017-1
   KOCH W, 2000, CHEM GUIDE DENSITY F
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g
   Labeguerie P, 2005, EUR PHYS J B, V43, P453, DOI 10.1140/epjb/e2005-00078-6
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Linder R, 2005, CHEM PHYS LETT, V409, P260, DOI 10.1016/j.cplett.2005.04.109
   Linder R, 2008, CHEM PHYS LETT, V453, P1, DOI 10.1016/j.cplett.2007.12.069
   Lomenech C, 2005, CHEMPHYSCHEM, V6, P1061, DOI 10.1002/cphc.200400608
   Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c
   Magne D, 2001, BONE, V29, P547, DOI 10.1016/S8756-3282(01)00609-3
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   MARX D., 2000, MODERN METHODS ALGOR
   MCCONNELL D, 1973, APATITE
   Meng M, 2004, LANGMUIR, V20, P914, DOI 10.1021/la035336b
   Mizuno S, 1997, SURF SCI, V393, pL69, DOI 10.1016/S0039-6028(97)00646-8
   Mkhonto D, 2002, J MATER CHEM, V12, P2633, DOI 10.1039/b204111a
   Morra M, 2001, WATER BIOMATERIALS S
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Onuma K, 1998, J PHYS CHEM B, V102, P7833, DOI 10.1021/jp981617u
   Pacchioni G, 2008, J AM CHEM SOC, V130, P8690, DOI 10.1021/ja710969t
   PALACHE C, 1951, SYSTEM MINERALOGY JD
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   Pareek A, 2009, LANGMUIR, V25, P1453, DOI 10.1021/la802706y
   Pascale F, 2004, CHEM PHYS LETT, V396, P308, DOI 10.1016/j.cplett.2004.08.047
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Pedone A, 2008, CHEM MATER, V20, P2522, DOI 10.1021/cm703437y
   Pedone A, 2007, J MATER CHEM, V17, P2061, DOI 10.1039/b617858h
   Peroos S, 2006, BIOMATERIALS, V27, P2150, DOI 10.1016/j.biomaterials.2005.09.025
   Pisani C., 1988, LECT NOTES CHEM, V48
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   Prencipe M, 2004, PHYS CHEM MINER, V31, P559, DOI 10.1007/s00269-004-0418-7
   Prencipe M, 2006, PHYS CHEM MINER, V33, P519, DOI 10.1007/s00269-006-0110-1
   Qiu XY, 2005, BIOMACROMOLECULES, V6, P1193, DOI 10.1021/bm0495021
   Rabone JAL, 2007, PHYS CHEM MINER, V34, P495, DOI 10.1007/s00269-007-0165-7
   Ratner B. D., 2004, BIOMATERIAL SCI INTR
   Rautaray D, 2005, LANGMUIR, V21, P5185, DOI 10.1021/la048541f
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   RIMOLA A, 2009, SIMBIOMA WORKSH CHAL
   RIMOLA A, IN PRESS
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015
   Roveri N., 2006, TISSUE CELL ORGAN EN, V9, P283
   Saenger A.T., 2002, Z KRISTALLOGR, V199, P123
   Sato Y, 2002, J AM CERAM SOC, V85, P2142, DOI 10.1111/j.1151-2916.2002.tb00424.x
   SCHLEGEL HB, 1982, J COMPUT CHEM, V3, P214, DOI 10.1002/jcc.540030212
   SCHLOGL R, 2008, HDB HETEROGENEOUS CA, V8
   Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200
   Shaw WJ, 2000, J AM CHEM SOC, V122, P1709, DOI 10.1021/ja9842823
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   Simon GH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.113401
   Somorjai GA, 2009, SURF SCI, V603, P1293, DOI 10.1016/j.susc.2008.08.030
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Takahashi H, 2001, THERMOCHIM ACTA, V371, P53, DOI 10.1016/S0040-6031(01)00431-2
   TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036
   THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X
   Thomas JM, 1996, PRINCIPLES PRACTICE
   Tilocca A, 2010, LANGMUIR, V26, P545, DOI 10.1021/la902548f
   Tilocca A, 2009, ACS APPL MATER INTER, V1, P1324, DOI 10.1021/am900198t
   Tilocca A, 2009, P ROY SOC A-MATH PHY, V465, P1003, DOI 10.1098/rspa.2008.0462
   Tosoni S, 2005, MOL PHYS, V103, P2549, DOI 10.1080/00268970500180808
   Trzesniak D, 2007, CHEMPHYSCHEM, V8, P162, DOI 10.1002/cphc.200600527
   TSUDA H, 1994, J DENT RES, V73, P1703, DOI 10.1177/00220345940730110501
   Ugliengo P, 2004, J PHYS CHEM B, V108, P13632, DOI 10.1021/jp047514v
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Van De Keere I, 2008, LANGMUIR, V24, P1844, DOI [10.1021/la7016566, 10.1021/1a7016566]
   Van Hove MA, 2009, SURF SCI, V603, P1301, DOI 10.1016/j.susc.2008.09.055
   Vanderby R, 2003, J BIOMECH, V36, P1523, DOI 10.1016/S0021-9290(03)00132-5
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   WADT WR, 1985, J CHEM PHYS, V82, P284, DOI 10.1063/1.448800
   Wallwork ML, 2001, LANGMUIR, V17, P2508, DOI 10.1021/la001281r
   Walsh TR, 2005, PHYS CHEM CHEM PHYS, V7, P443, DOI 10.1039/b415563g
   Wander A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.233405
   Wander A, 2001, PHYS REV LETT, V86, P3811, DOI 10.1103/PhysRevLett.86.3811
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wierzbicki A, 2000, J MOL STRUC-THEOCHEM, V529, P73, DOI 10.1016/S0166-1280(00)00534-0
   Williams D.F., 1992, ADV BIOMATER, V10, P525
   Wu X, 2001, J CHEM PHYS, V115, P8748, DOI 10.1063/1.1412004
   Xu X, 2004, P NATL ACAD SCI USA, V101, P2673, DOI 10.1073/pnas.0308730100
   YOUNG RA, 1982, BIOL MINERALIZATION
   Zhao Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2126975
   Zicovich-Wilson CM, 2008, J COMPUT CHEM, V29, P2268, DOI 10.1002/jcc.20993
NR 179
TC 86
Z9 86
U1 5
U2 69
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2010
VL 12
IS 24
BP 6309
EP 6329
DI 10.1039/c002146f
PG 21
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 608MN
UT WOS:000278588500002
PM 20485772
DA 2018-10-20
ER

PT J
AU Koh, LB
   Rodriguez, I
   Venkatraman, SS
AF Koh, Li Buay
   Rodriguez, Isabel
   Venkatraman, Subbu S.
TI Conformational behavior of fibrinogen on topographically modified
   polymer surfaces
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID SECONDARY STRUCTURE CHANGES; ATOMIC-FORCE MICROSCOPY;
   GLYCOPROTEIN-IIB-IIIA; STEEL 316LVM SURFACE; PROTEIN ADSORPTION;
   PLATELET-ADHESION; BIOMATERIAL SURFACES; PM-IRRAS; IN-SITU; ACTIVATION
AB The influence of topographical surface features at the submicron scale on the structural changes in the surface-adsorbed fibrinogen was investigated on poly(lactic-co-glycolic-acid) (PLGA) films. Attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) was employed in this study for the induced conformational change of fibrinogen over various adsorption times, while the adsorption kinetics of fibrinogen was quantified by the enzyme linked immunosorbent assay (ELISA). When a PLGA surface is modified topographically, the adsorbed fibrinogen undergoes less conformational change when compared to adsorption on the pristine PLGA surface. The extent of conformational change is related to platelet adhesion. Reduced thrombogenicity was demonstrated by the higher ratios of alpha-helix to beta-turn and beta-sheet to beta-turn structures on the topographic PLGA film, which suggests that topographical manipulation of surfaces is a viable approach to influence the thrombogenicity of surfaces.
C1 [Koh, Li Buay; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Rodriguez, Isabel] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Venkatraman, SS (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
EM assubbu@ntu.edu.sg
RI KOH, Li Buay/R-8919-2016; Venkatraman, Subramanian/A-2228-2011;
   Rodriguez, Isabel/G-3178-2016; Koh, Li Buay/D-7130-2011
OI Venkatraman, Subramanian/0000-0002-8693-1070; Rodriguez,
   Isabel/0000-0002-7178-8275; 
FU Ministry of Education, Singapore [RG27/05]; Institute of Materials
   Research Engineering, A*STAR (Agency for Science, Technology and
   Research), Singapore
FX This work is supported by the Academic Research Fund RG27/05, Ministry
   of Education, Singapore, and Institute of Materials Research
   Engineering, A*STAR (Agency for Science, Technology and Research),
   Singapore.
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   AZPIAZU I, 1992, BIOCHIM BIOPHYS ACTA, V1119, P268, DOI 10.1016/0167-4838(92)90213-W
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chiumiento A, 2007, BIOMACROMOLECULES, V8, P523, DOI 10.1021/bm060664m
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   Desroches MJ, 2007, BIOMACROMOLECULES, V8, P2836, DOI 10.1021/bm070289d
   Desroches MJ, 2008, PHYS CHEM CHEM PHYS, V10, P2502, DOI 10.1039/b719371h
   DOOLITTLE RF, 1978, J MOL BIOL, V120, P311, DOI 10.1016/0022-2836(78)90070-0
   DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211
   Fujisawa N, 2000, J BIOMED MATER RES, V52, P517, DOI 10.1002/1097-4636(20001205)52:3<517::AID-JBM10>3.0.CO;2-G
   Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2
   HAWIGER J, 1982, P NATL ACAD SCI-BIOL, V79, P2068, DOI 10.1073/pnas.79.6.2068
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145
   Joshi O, 2006, COLLOID SURFACE B, V50, P26, DOI 10.1016/j.colsurfb.2006.03.021
   Kalasin S, 2009, COLLOID SURFACE B, V73, P229, DOI 10.1016/j.colsurfb.2009.05.028
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P37, DOI 10.1111/j.1749-6632.1977.tb41751.x
   Koh LB, 2008, J BIOMED MATER RES A, V86A, P394, DOI 10.1002/jbm.a.31605
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003
   LIEDBERG B, 1986, J COLLOID INTERF SCI, V114, P386, DOI 10.1016/0021-9797(86)90424-8
   LINDON JN, 1986, BLOOD, V68, P355
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   MINELLI C, 2006, INT C NAN NAN GWANGJ, P443
   MOSESSON MW, 2001, STRUCTURE BIOL FEATU
   NIIYA K, 1987, BLOOD, V70, P475
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   PEERSCHKE EI, 1980, BLOOD, V55, P841
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Rooney MM, 1998, BLOOD, V92, P2374
   Salsmann A, 2005, J BIOL CHEM, V280, P33610, DOI 10.1074/jbc.M500146200
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   Spraggon G, 1997, NATURE, V389, P455
   Steiner G, 2007, ANAL CHEM, V79, P1311, DOI 10.1021/ac061341j
   Strehle MA, 2004, PHYS CHEM CHEM PHYS, V6, P5232, DOI 10.1039/b406524g
   Tavares J, 2009, SURF COAT TECH, V203, P2278, DOI 10.1016/j.surfcoat.2009.02.025
   Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004
   Tzoneva R, 2002, J BIOMAT SCI-POLYM E, V13, P1033, DOI 10.1163/156856202760319171
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   Wagner MS, 2003, APPL SURF SCI, V203, P704, DOI 10.1016/S0169-4332(02)00795-X
   Wang J, 2006, J PHYS CHEM B, V110, P5017, DOI 10.1021/jp0534683
   Wang J, 2008, J PHYS CHEM B, V112, P2281, DOI 10.1021/jp077556u
   WEISEL JW, 1992, J BIOL CHEM, V267, P16637
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Ye X, 2009, APPL SURF SCI, V255, P6686, DOI 10.1016/j.apsusc.2009.02.068
NR 55
TC 12
Z9 12
U1 1
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2010
VL 12
IS 35
BP 10301
EP 10308
DI 10.1039/c001747g
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 644DM
UT WOS:000281352300021
PM 20571633
DA 2018-10-20
ER

PT J
AU Paradowska, AE
   Kazmierska, KA
   Ciach, T
AF Paradowska, Anna E.
   Kazmierska, Katarzyna A.
   Ciach, Tomasz
TI Influence of the coating process parameters on the quality of PUR/PVP
   hydrogel coatings for PVC medical devices
SO POLISH JOURNAL OF CHEMICAL TECHNOLOGY
LA English
DT Article
DE Hydrogel coatings; dip-coating; poly(vinyl chloride);
   polyvinylpyrrolidone
ID DRUG-DELIVERY; BIOMATERIAL; RELEASE
AB To decrease friction factor and enhance the biocompatibility of medical devices manufactured from poly(vinyl chloride), PVC, the surface modification with wear resistant polyurethane/polyvinylpyrrolidone (PUR/PVP) hydrogel coating can be applied. In the present work substrates were dip-coated with PVP and PUR solutions and thermally cured. The variable process parameters were: solvent system; concentration of polymers (1, 2 or 3% w/v); coating baths temperature (22, 38 and 55 degrees C); drying temperature (32, 50 and 67 degrees C); length of break between process steps (5, 30 and 90 s); and solutions storage time (up to 72 hrs). The quality of coatings was determined by friction coefficients against porcine aorta, weights of the deposited layer and the swelling capacity. The solvent system and polymers concentration were crucial factors. The increased temperature of coating solutions caused increased deposition but decreased durability. The most lubricious samples were dried in 50 degrees C. Coatings from the solutions prepared 24h prior to use had better properties than those from fresh solutions.
C1 [Paradowska, Anna E.; Kazmierska, Katarzyna A.; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, PL-00645 Warsaw, Poland.
RP Paradowska, AE (reprint author), Med Univ Warsaw, Dept Gen & Nutr Biochem, Ul Banacha 1, PL-02097 Warsaw, Poland.
EM aparadowska@wum.edu.pl; T.Ciach@ichip.pw.edu.pl
RI Ciach, Tomasz/C-2694-2011
OI Ciach, Tomasz/0000-0002-8726-8944
FU Polish Ministry of Science and Higher Education; European Union
FX Presented work was supported by the research grant of Polish Ministry of
   Science and Higher Education.; The work of K. A. Kazmierska was
   supported by the European Union in the framework of European Social Fund
   through the Warsaw University of Technology Development Programme.
CR D'Erricot G, 2008, BIOMACROMOLECULES, V9, P231, DOI 10.1021/bm7008137
   Geever LM, 2008, EUR J PHARM BIOPHARM, V69, P1147, DOI 10.1016/.j.ejpb.2007.12.021
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Karadag E, 2005, MATER DESIGN, V26, P265, DOI 10.1016/j.matdes.2004.07.014
   Kazmierska K, 2008, J MATER SCI-MATER M, V19, P2301, DOI 10.1007/s10856-007-3339-4
   Kazmierska KA, 2008, ACTA POL PHARM, V65, P763
   LaPorte R J, 1997, HYDROPHILIC POLYM CO
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MICKLUS, 1978, Patent No. 4100309
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   SWAMI SN, 2004, RAD SYNTHESIS POLYM
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Yang SH, 2007, J BIOMED MATER RES B, V83B, P304, DOI 10.1002/jbm.b.30796
NR 15
TC 2
Z9 2
U1 2
U2 21
PU VERSITA
PI WARSAW
PA SOLIPSKA 14A-1, 02-482 WARSAW, POLAND
SN 1509-8117
J9 POL J CHEM TECHNOL
JI Pol. J. Chem. Technol.
PY 2010
VL 12
IS 2
BP 38
EP 45
DI 10.2478/v10026-010-0016-z
PG 8
WC Chemistry, Applied; Engineering, Chemical
SC Chemistry; Engineering
GA 622YT
UT WOS:000279704100008
OA Bronze
DA 2018-10-20
ER

PT J
AU Hu, W
   Huang, ZM
AF Hu, Wen
   Huang, Zheng-Ming
TI Biocompatibility of braided poly(L-lactic acid) nanofiber wires applied
   as tissue sutures
SO POLYMER INTERNATIONAL
LA English
DT Article
DE structural biomaterial; electrospinning; suture; poly(L-lactic acid);
   chitosan; histological compatibility
ID IN-VITRO; ABSORBABLE SUTURES; POLYMER NANOFIBERS; DRUG-DELIVERY;
   DEGRADATION; FABRICATION; INFECTION
AB Almost all sutures in current usage only play one role, i.e. to mechanically tie wound tissues together. Drug-loaded composite nanofibers obtained through coaxial electrospinning can initiate the development of a new type of biodegradable sutures with drug release. In this work, electrospun poly(L-lactic acid) (PLLA) nanofibers with uniaxial alignment were made into braided wires and were coated with chitosan and applied as tissue sutures. Toxicity evaluation on cells for the chitosan-coated PLLA braided wires was carried out using the MTT (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) test, and an in vivo study was conducted by implanting the braided wires into muscle tissues of rats. The inflammation responses were examined at 3, 7, 14, 21 and 28 days after implanting. Experimental results indicated that the braided PLLA nanofiber wires coated with chitosan exhibited comparable tensile and knot strengths to those of a commercial suture, could tie wounded tissues for a complete healing without any breakage, had no cellular toxicity and could promote cell growth well. The chitosan-coated PLLA sutures showed better histological compatibility than a silk suture in the in vivo study. Braided PLLA nanofiber wires fabricated using an electrospinning process followed by a braiding technique and coated with chitosan are applicable for uses within the body. (C) 2009 Society of Chemical Industry
C1 [Hu, Wen; Huang, Zheng-Ming] Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
RP Huang, ZM (reprint author), Tongji Univ, Sch Aerosp Engn & Appl Mech, 1239 Siping Rood, Shanghai 200092, Peoples R China.
EM huangzm@mail.tongji.edu.cn
FU National Natural Science Foundations of China [50 773 054]
FX This research as financially supported in part by the National Natural
   Science Foundations of China through grant number 50 773 054. The help
   of staff in the Central Laboratory, Pulmonary Hospital of Tongji
   University is greatly appreciated.
CR [Anonymous], 30NF25 USP
   *ASTM INT, 2000, D225602 ASTM
   BLOMSTEDT B, 1977, ACTA CHIR SCAND, V143, P71
   Chu C, 2002, POLYM BIOMATERIALS, P167
   Edmiston CE, 2006, J AM COLL SURGEONS, V203, P481, DOI 10.1016/j.jamcollsurg.2006.06.026
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Gomez-Alonso A, 2007, J INFECTION, V54, P82, DOI 10.1016/j.jinf.2006.01.008
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221, P163
   Gupta B, 2008, POLYM ADVAN TECHNOL, V19, P1698, DOI 10.1002/pat.1146
   Harnet JC, 2009, J MATER SCI-MATER M, V20, P185, DOI 10.1007/s10856-008-3559-2
   He CL, 2009, J BIOMED MATER RES A, V89A, P80, DOI 10.1002/jbm.a.32004
   Hu W, 2009, J MATER SCI-MATER M, V20, P2275, DOI 10.1007/s10856-009-3797-y
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   HUANG ZM, 2008, Patent No. 2008102033288
   HUANG ZM, 2003, Patent No. 2003101081309
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Lee KH, 2000, J BIOMED MATER RES, V49, P25, DOI 10.1002/(SICI)1097-4636(200001)49:1<25::AID-JBM4>3.0.CO;2-I
   Lu HH, 2003, BIOCHEM BIOPH RES CO, V305, P882, DOI 10.1016/S0006-291X(03)00858-1
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ooi CP, 2002, J BIOMED MATER RES, V63, P280, DOI 10.1002/jbm.10180
   Prokop A, 2004, BIOMATERIALS, V25, P259, DOI 10.1016/S0142-9612(03)00496-4
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   STERBERG B, 1979, ACTA CHIR SCAND, V145, P431
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Togo S, 2008, J GASTROINTEST SURG, V12, P1041, DOI 10.1007/s11605-007-0297-6
   Voges Jurgen, 2002, J Exp Ther Oncol, V2, P70, DOI 10.1046/j.1359-4117.2002.01012.x
NR 32
TC 25
Z9 25
U1 4
U2 45
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JAN
PY 2010
VL 59
IS 1
BP 92
EP 99
DI 10.1002/pi.2695
PG 8
WC Polymer Science
SC Polymer Science
GA 543BZ
UT WOS:000273546200015
DA 2018-10-20
ER

PT S
AU Kanno, K
   Kugimiya, A
   Matsumoto, Y
   Konishi, Y
   Arakawa, T
   Takaki, Y
   Yoshida, Y
   Hanada, K
   Matsumura, K
   Endo, T
AF Kanno, Kenichi
   Kugimiya, Akimitsu
   Matsumoto, Yasumasa
   Konishi, Yuya
   Arakawa, Tsuyoshi
   Takaki, Yuichiro
   Yoshida, Yuya
   Hanada, Keiichiro
   Matsumura, Kotaro
   Endo, Takeshi
BE Skene, W
TI p-Phenylenediamine Epoxy Resin Film for Redox Enzyme Detection
SO POLYMERS AND ORGANIC CHEMISTRY
SE Macromolecular Symposia
LA English
DT Proceedings Paper
CT 13th International Symposium on Polymers and Organic Chemistry
CY JUL 05-08, 2009
CL Mont Royal Ctr, Montreal, CANADA
SP Int Union Pure & Appl Phys (IUPAP)
HO Mont Royal Ctr
DE biomaterial; film; fungi; phenylenediamine; redox enzyme
ID MECHANISM
AB Phenylenediamine derivatives (PDs) are environmentally hazardous, though very useful for chemical analysis. To minimize release into the environment, a PD-containing epoxy resin film was developed that retained redox enzyme activity. p-Phenylenediamine and 2,2-bis(4-glycidyloxyphenyl)-propane were cured to produce a violet film. This film was reactive against peroxidase, a redox enzyme that oxidizes phenylenediamine to afford an imine. Enzymatic oxidation caused the film to change color from violet to deep green. The film exhibited fluorescence at 394 nm under excitation at 350 nm, and the fluorescent intensity decreased with greater oxidation. Thus, the film could be used to detect redox enzyme activity.
C1 [Kanno, Kenichi; Matsumoto, Yasumasa; Konishi, Yuya; Arakawa, Tsuyoshi; Takaki, Yuichiro; Yoshida, Yuya; Hanada, Keiichiro; Matsumura, Kotaro] Kinki Univ, Dept Biol & Environm Chem, Fukuoka 8208555, Japan.
   [Endo, Takeshi] Kinki Univ, Mol Engn Lab, Fukuoka 8208555, Japan.
   [Kugimiya, Akimitsu] Hiroshima City Ind Promot Ctr, Res Ctr Adv Sci & Technol, Hiroshima 7300052, Japan.
RP Kanno, K (reprint author), Kinki Univ, Dept Biol & Environm Chem, Fukuoka 8208555, Japan.
EM kanno@fuk.kindai.ac.jp
CR Abe Y., 2005, DIC TECH REV, V11, P1
   JAFFE RM, 1979, J LAB CLIN MED, V93, P879
   MAJKIC N, 1977, CLIN CHIM ACTA, V80, P121, DOI 10.1016/0009-8981(77)90271-6
   Modestov AD, 2004, J ELECTROANAL CHEM, V565, P7, DOI 10.1016/j.jelechem.2003.09.023
   NICKEL U, 1980, J CHEM SOC PERK T 2, P1601, DOI 10.1039/p29800001601
   Schroder U, 2002, J PHYS CHEM B, V106, P8697, DOI 10.1021/jp0146059
   Tripathi G, 2008, MAT SCI ENG A-STRUCT, V496, P483, DOI 10.1016/j.msea.2008.06.035
   Wlodarska M, 2007, J NON-CRYST SOLIDS, V353, P4371, DOI 10.1016/j.jnoncrysol.2007.04.050
NR 8
TC 0
Z9 0
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
PY 2010
VL 297
BP 108
EP +
DI 10.1002/masy.200900047
PG 2
WC Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA BTT84
UT WOS:000288038900015
DA 2018-10-20
ER

PT S
AU Kume, K
   Furui, M
   Ikeno, S
   Ishisaka, Y
   Yamamoto, M
AF Kume, Kazuhiro
   Furui, Mitsuaki
   Ikeno, Susumu
   Ishisaka, Yusuke
   Yamamoto, Masayuki
BE Nie, JF
   Morton, A
TI Screw Form Rolling of Beta Type Titanium Alloy Preliminary Worked by
   Torsion
SO PRICM 7, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th Pacific Rim International Conference on Advanced Materials and
   Processing
CY AUG 02-06, 2010
CL Cairns, AUSTRALIA
SP Chinese Soc Metals, Japan Inst Metals, Korean Inst Metals & Mat, Mat Australia, Minerals, Met & Mat Soc
DE Beta type titanium alloy; screw; torsion; back-torsion
AB Beta type titanium alloys in a cold processability are light, have high strength, excellent corrosion resistance and the same level as Young's modulus of human bone. Therefore, beta type titanium alloys are used for plant facilities such as nuclear plants, architectural materials, aircraft, car, biomaterial, medical equipment, glasses and golf club head, etc. Microstructure and mechanical properties of beta type titanium alloys processed by rolling and heat treatment have been reported [I]. Additionally, screw form rolling using beta type titanium alloys has also been reported [2]. However, the development in those characteristics after the preliminary working by torsion has been unknown.
C1 [Kume, Kazuhiro; Furui, Mitsuaki; Ikeno, Susumu] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan.
   [Ishisaka, Yusuke; Yamamoto, Masayuki] Tsukiboshi Corp, Kagawa 9228611, Japan.
RP Kume, K (reprint author), Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan.
EM m0971322@ems.u-toyama.ac.jp; furui@eng.u-toyama.ac.jp;
   ikeno@eng.u-toyama.ac.jp; y-ishisaka@tsukiboshi.co.jp;
   m-yamamoto@tsukiboshi.co.jp
CR Gunawarman B, 2005, MAT SCI ENG C-BIO S, V25, P304, DOI 10.1016/j.msec.2004.12.015
   Matsukura N., 2005, Journal of Japan Institute of Light Metals, V55, P599, DOI 10.2464/jilm.55.599
NR 2
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 654-656
BP 906
EP +
DI 10.4028/www.scientific.net/MSF.654-656.906
PN 1-3
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BSQ15
UT WOS:000285374600221
DA 2018-10-20
ER

PT S
AU Miura, H
   Okawachi, K
   Kang, HG
   Tsumori, F
   Kurata, K
   Arimoto, N
AF Miura, Hideshi
   Okawachi, Kenta
   Kang, Hyun-Goo
   Tsumori, Fujio
   Kurata, Kosaku
   Arimoto, Nobuhiro
BE Nie, JF
   Morton, A
TI Laser Forming of Ti-6Al-7Nb Alloy Powder Compacts for Medical Devices
SO PRICM 7, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th Pacific Rim International Conference on Advanced Materials and
   Processing
CY AUG 02-06, 2010
CL Cairns, AUSTRALIA
SP Chinese Soc Metals, Japan Inst Metals, Korean Inst Metals & Mat, Mat Australia, Minerals, Met & Mat Soc
DE Laser forming; Ti-6Al-7Nb; powder material; biomaterial; osteoblast
AB Titanium and its alloys have been widely used for medical and aerospace applications because of their excellent attributes of light metal, high strength, high corrosion resistance and high biocompatibility. Especially, Ti-6Al-7Nb alloy has been developed as a more suitable biomaterial to replace Ti-6Al-4V alloy, because vanadium is toxic element to the biological body. However, it is not easy to fabricate the complex shaped and precise parts by the conventional methods due to their poor castability and machinability. In this study, laser forming technique has been applied to solve the above problems. The precise structure was obtained by optimizing the laser forming parameters. Using this technique, a honeycomb structure was fabricated effective to grow the neighboring tissue and also encourage osseointegration. Finally, mouse osteoblasts were cultured on the formed structures, resulted in the effectiveness of the honeycomb structure for biocompatibility.
C1 [Miura, Hideshi; Okawachi, Kenta; Kang, Hyun-Goo; Tsumori, Fujio] Kyushu Univ, Grad Sch Engn, Dept Intelligent Machinery & Syst, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.
RP Miura, H (reprint author), Kyushu Univ, Grad Sch Engn, Dept Intelligent Machinery & Syst, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.
EM miura@mech.kyushu-u.ac.jp; te208372@s.kyushu-u.ac.jp;
   kanghg@mech.kyushu-u.ac.jp; tsumori@mech.kyushu-u.ac.jp;
   kurata@mech.kyushu-u.ac.jp; narimoto@osaka-ti.co.jp
CR Chita C. K, 2003, RAPID PROTOTYPING PR
   Dewidar MM, 2007, T NONFERR METAL SOC, V17, P468, DOI 10.1016/S1003-6326(07)60117-4
   Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041
   Japan Society of Mechanical Engineering, 1991, BIOM SER BIOM
   Miura H, 2007, MATER SCI FORUM, V534-536, P465, DOI 10.4028/www.scientific.net/MSF.534-536.465
   Miura Hideshi, 2009, P POWD MET PART MAT
NR 6
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 654-656
BP 2057
EP +
DI 10.4028/www.scientific.net/MSF.654-656.2057
PN 1-3
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BSQ15
UT WOS:000285374600505
DA 2018-10-20
ER

PT S
AU Song, HY
   Kim, YH
   Anirban, JM
   Byun, IS
   Kwak, KA
   Lee, BT
AF Song, Ho Yeon
   Kim, Young-Hee
   Anirban, Jyoti M.
   Byun, In-Seon
   Kwak, Kyung-A
   Lee, Byong-Taek
BE Nie, JF
   Morton, A
TI In Vitro And In Vivo Evaluation Of Calcium Phosphate Bone Graft
   Substitutes
SO PRICM 7, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th Pacific Rim International Conference on Advanced Materials and
   Processing
CY AUG 02-06, 2010
CL Cairns, AUSTRALIA
SP Chinese Soc Metals, Japan Inst Metals, Korean Inst Metals & Mat, Mat Australia, Minerals, Met & Mat Soc
DE Calcium phosphate ceramics; biocompatibility; osteoconductive; pore;
   cytotoxicity; bone ingrowths
ID BETA-TCP; CERAMICS; CELLS
AB Calcium phosphate ceramics such as hydroxy apatite (HA), beta-tricalcium phosphate (beta-TCP) and bicalcium phosphate (BCP) have been used as a bone graft biomaterial because of their good biocompatibility and similarity of chemical composition to natural bones. To increase the mechanical and osteoconductive properties, the granules and spongy type porous bone graft substitutes were prepared by fibrous monolithic process and polyurethane foam replica methods, respectively. The pore sizes obtained using these approaches ranged between 100-600 mu m. The cytotoxicity, cellular proliferation, differentiation and ECM deposition on the bone graft substitutes were observed by SEM and confocal microscopy. Moreover, the scaffolds were implanted in the rabbit femur. New bone formation and biodegradation of bone graft were observed through follow-up X-ray, micro-CT analysis and histological findings. After several months (2, 3, 6, 12 and 24 months) of implantation, new bone formation and ingrowths were observed in defect sites of the animal by CaP ceramics and 2 to 3 times higher bone ingrowths were confirmed than that of the normal trabecular bones in terms of total bone volume (BV).
C1 [Song, Ho Yeon; Kim, Young-Hee; Anirban, Jyoti M.; Byun, In-Seon; Kwak, Kyung-A] Soonchunhyang Univ, Sch Med, Dept Immunol, Cheonan 330090, Chungnum, South Korea.
   [Lee, Byong-Taek] Soonchunhyang Univ, Sch Med, Dept Biomed Engn, Chungnum 330090, South Korea.
RP Song, HY (reprint author), Soonchunhyang Univ, Sch Med, Dept Immunol, Cheonan 330090, Chungnum, South Korea.
EM songmic@sch.ac.kr; kim_yh@sch.ac.kr; ani_du_shu@yahoo.com;
   hatecigar@hanmail.com; kka@sch.ac.kr
CR Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Goto K, 2006, J BIOMED MATER RES A, V78A, P629, DOI 10.1002/jbm.a.30793
   Heymann D, 2001, REV CHIR ORTHOP, V87, P8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee BT, 2008, J EUR CERAM SOC, V28, P229, DOI 10.1016/j.jeurceramsoc.2007.05.010
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Mandubalal I, 2005, J BIOMATER APPL, V19, P341
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
NR 11
TC 0
Z9 0
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 654-656
BP 2065
EP +
DI 10.4028/www.scientific.net/MSF.654-656.2065
PN 1-3
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BSQ15
UT WOS:000285374600507
DA 2018-10-20
ER

PT S
AU Kurosu, S
   Li, YP
   Matsumoto, H
   Chiba, A
AF Kurosu, Shingo
   Li, Yunping
   Matsumoto, Hiroaki
   Chiba, Akihiko
BE Nie, JF
   Morton, A
TI Grain Refining Technique and Mechanical Properties of the Biomedical
   Co-Cr-Mo Alloy
SO PRICM 7, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th Pacific Rim International Conference on Advanced Materials and
   Processing
CY AUG 02-06, 2010
CL Cairns, AUSTRALIA
SP Chinese Soc Metals, Japan Inst Metals, Korean Inst Metals & Mat, Mat Australia, Minerals, Metals & Mat Soc
DE Biomaterial; cobalt-chromium-molybdenum alloy; grain refinement;
   microstructure; mechanical properties
AB Thermomechanical processes combined with reverse transformation from (epsilon-hcp and M(2)N) dual-phase to gamma-fcc phase of biomedical Co-Cr-Mo-N alloys were examined. According to XRD analysis, the reverse transformation from epsilon + M(2)N to gamma is completed after heat treating at 1223 to 1373 K without deformation, while after heat treating at 1223 and 1273 K contained residual M(2)N particles in the gamma matrix. After the subsequent hot compression at condition at 1273 K and strain rate less than 1 s(-1), and 1223 K and strain rate less than 10 s(-1), ultra fine grains less than 1 mu m with residual M(2)N were obtained. Therefore, it is suggested that the residual M(2)N suppressed further growing of DRXed grain. The obtained microstructure with ultra fine grain dispersed with residual M(2)N was obtained to demonstrate both grain refining strengthening and precipitation strengthening.
C1 [Kurosu, Shingo; Li, Yunping; Matsumoto, Hiroaki; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi, Japan.
RP Kurosu, S (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi, Japan.
EM kurosu@imr.tohoku.ac.jp; lyping@imr.tohoku.ac.jp;
   matumoto@imr.tohoku.ac.jp; a.chiba@imr.tohoku.ac.jp
RI Li, Yunping/M-2076-2016; Li, Yunping/A-8109-2011
OI Li, Yunping/0000-0002-4657-2923; Li, Yunping/0000-0002-4478-5327
CR CHIBA A, 2005, MAT Sci Forum, V475, P475
   DEVINE TM, 1975, J BIOMED MATER RES, V9, P151, DOI 10.1002/jbm.820090205
   Kurosu S, 2010, MATER LETT, V64, P49, DOI 10.1016/j.matlet.2009.10.001
   Li YP, 2010, METALL MATER TRANS A, V41A, P224, DOI 10.1007/s11661-009-0066-0
   Li YP, 2009, METALL MATER TRANS A, V40A, P982, DOI 10.1007/s11661-009-9783-7
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
NR 7
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 654-656
BP 2184
EP 2187
DI 10.4028/www.scientific.net/MSF.654-656.2184
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BSQ15
UT WOS:000285374600536
DA 2018-10-20
ER

PT S
AU Nakano, T
   Ishimoto, T
   Lee, JW
   Miyabe, S
   Ikeo, N
   Fukuda, H
AF Nakano, Takayoshi
   Ishimoto, Takuya
   Lee, Jee-Wook
   Miyabe, Sayaka
   Ikeo, Naoko
   Fukuda, Hidetsugu
BE Nie, JF
   Morton, A
TI Evaluation and Control of Crystallographic Alignment of Biological
   Apatite Crystallites in Bones
SO PRICM 7, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th Pacific Rim International Conference on Advanced Materials and
   Processing
CY AUG 02-06, 2010
CL Cairns, AUSTRALIA
SP Chinese Soc Metals, Japan Inst Metals, Korean Inst Metals & Mat, Mat Australia, Minerals, Met & Mat Soc
DE Biological apatite; BAp; preferential orientation; bone quality;
   microbeam X-ray diffraction; materials design; porous material; electron
   beam melting; EBM; osteopetrosis; osteoclast
ID X-RAY DIFFRACTOMETER; ORIENTATION
AB Our group focused on the preferential degree of biological apatite (BAp) c-axis, an important bone quality parameter based on the microstructural anisotropy in intact, pathological, and regenerated bones. The preferential degree of the BAp c-axis strongly depends on the bone position, in vivo stress distribution, bone growth, degree of pathology and regeneration, activity of bone cells, gene defect, etc. We attempted to challenge clarification of the BAp preferential alignment formation mechanism and control the degree of BAp orientation by using an anisotropic biomaterial design to develop suitable distribution of the BAp c-axis orientation.
C1 [Nakano, Takayoshi; Ishimoto, Takuya; Lee, Jee-Wook; Miyabe, Sayaka; Ikeo, Naoko] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.
   [Fukuda, Hidetsugu] Nakashima Med Co Ltd, R&D Grp, Okayama 7090625, Japan.
RP Nakano, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.
EM nakano@mat.eng.osaka-u.ac.jp; ishimoto@mat.eng.osaka-u.ac.jp;
   leejw@mat.eng.osaka-u.ac.jp; miyabe@mat.eng.osaka-u.ac.jp;
   naoko.ikeo@mat.eng.osaka-u.ac.jp; h-fukuda@nakashima.co.jp
RI Ikeo, Naoko/P-7896-2016; Kobe Univ, Engineering/D-2028-2017
OI Ikeo, Naoko/0000-0002-9950-449X; 
FU "Priority Assistance of the Formation of Worldwide Renowned Centers of
   ResearchThe Global COE Program; Ministry of Education, Culture, Sports,
   Science and Technology (MEXT),; partly Hosokawa Powder Technology
   Foundation; (Cabinet office, Government of Japan, and Ministry of
   Health, Labor and Welfare, Ministry of Education, Culture, Sports,
   Science and Technology, Ministry of Economy, Trade and Industry).
FX This work was supported by the Priority Assistance of the Formation of
   Worldwide Renowned Centers of ResearchThe Global COE Program (Project:
   Center of Excellence for Advanced Structural and Functional Materials
   Design) a Grant-in-Aid for Scientific Research and Development from the
   Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   and partly Hosokawa Powder Technology Foundation and the Super Special
   Consortia for the supporting development of cutting edge medical care
   (Cabinet office, Government of Japan, and Ministry of Health, Labor and
   Welfare, Ministry of Education, Culture, Sports, Science and Technology,
   Ministry of Economy, Trade and Industry).
CR Abboud SL, 2002, ENDOCRINOLOGY, V143, P1942, DOI 10.1210/en.143.5.1942
   Fratzl P, 2008, NAT MATER, V7, P610, DOI 10.1038/nmat2240
   Ishimoto T, 2010, MATER SCI FORUM, V638-642, P576, DOI 10.4028/www.scientific.net/MSF.638-642.576
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Lee JW, 2007, MATER TRANS, V48, P337, DOI 10.2320/matertrans.48.337
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Nakano T., 2005, ENCY MAT SCI TECHNOL
   Nakano T, 2006, MATER TRANS, V47, P2233, DOI 10.2320/matertrans.47.2233
   NIGHTINGALE JP, 1971, NATURE, V232, P334, DOI 10.1038/232334a0
   NIH and Consensus Development Panel, 2001, JAMA-J AM MED ASSOC, V285, P785, DOI DOI 10.1001/JAMA.285.6.785
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244
NR 12
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 654-656
BP 2212
EP +
DI 10.4028/www.scientific.net/MSF.654-656.2212
PN 1-3
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BSQ15
UT WOS:000285374600543
DA 2018-10-20
ER

PT S
AU Cadman, J
   Chen, YH
   Zhou, SW
   Li, Q
AF Cadman, Joseph
   Chen, Yuhang
   Zhou, Shiwei
   Li, Qing
BE Nie, JF
   Morton, A
TI Creating Biomaterials Inspired by the Microstructure of Cuttlebone
SO PRICM 7, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th Pacific Rim International Conference on Advanced Materials and
   Processing
CY AUG 02-06, 2010
CL Cairns, AUSTRALIA
SP Chinese Soc Metals, Japan Inst Metals, Korean Inst Metals & Mat, Mat Australia, Minerals, Metals & Mat Soc
DE Biomaterial; Graded material; Cuttlebone; Homogenisation; Scanning
   electron microscopy (SEM); Finite element analysis (FEA);
   Stereolithographic apparatus (SLA)
ID DESIGN
AB The microstructure of cuttlebone is investigated using Scanning Electron Microscopy (SEM). A graded aspect ratio of the base cells between layers is evident in some samples. A method for designing graded biomaterials mimicking this cuttlebone microstructure is developed. Simplified 3D biomaterial samples are created using CAD software. These biomaterials are fabricated using a stereolithographic apparatus (SLA). The homogenisation technique is used to evaluate the mechanical properties of the original cuttlebone sample and the fabricated biomaterial sample. Good agreement is found between the Young's moduli of corresponding layers. However, it is inconclusive whether the Young's moduli have a proportional relationship to the aspect ratio of the base cell at this stage of the study.
C1 [Cadman, Joseph; Chen, Yuhang; Zhou, Shiwei; Li, Qing] Univ Sydney, Sch AMME, Sydney, NSW 2006, Australia.
RP Cadman, J (reprint author), Univ Sydney, Sch AMME, Sydney, NSW 2006, Australia.
EM joseph.cadman@sydney.edu.au; yuhang.chen@sydney.edu.au;
   shiwei.zhou@sydney.edu.au; qing.li@sydney.edu.au
RI Chen, Yuhang/B-3532-2010; Chen, Yuhang/C-8602-2014
CR BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2
   Bensoussan A, 1978, ASYMPTOTIC ANAL PERI
   Cadman J, 2010, ACTA MECH SINICA-PRC, V26, P27, DOI 10.1007/s10409-009-0310-2
   Gower David, 1996, Biomimetics, V4, P37
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Kang HW, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/1/015011
   Lee JW, 2009, MICROELECTRON ENG, V86, P1465, DOI 10.1016/j.mee.2008.12.038
   Zhou SW, 2008, J MATER SCI, V43, P5157, DOI 10.1007/s10853-008-2722-y
NR 9
TC 3
Z9 3
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 654-656
BP 2229
EP 2232
DI 10.4028/www.scientific.net/MSF.654-656.2229
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BSQ15
UT WOS:000285374600547
DA 2018-10-20
ER

PT B
AU Li, Y
AF Li Yi
BE Mu, Y
TI Theoretical foundation for engineering design of functional textiles
SO PROCEEDINGS OF 2009 INTERNATIONAL TEXTILE SCIENCE AND TECHNOLOGY FORUM
LA English
DT Proceedings Paper
CT International Textile Science and Technology Forum
CY APR 11-12, 2009
CL Xian, PEOPLES R CHINA
DE functional textiles; engineering design; sensory; biomechanical;
   thermal; biomedical; biomaterial and computational models
ID SYSTEM
AB Functional properties of textiles have become major interests in both military and domestic markets. Design and engineer of textiles for high functional performance involve the integration of the fundamental research in physical, chemical, mathematical, and computational sciences with the development of engineering principles with sound understanding on the relationship between clothing and human biology, medicine, behavior and health. Fundamental concepts need to be advanced together with creating new knowledge from molecules to body-clothing systems, and developing innovative materials, devices, and apparel products for healthy lifestyles with the functions of comfort, protection, prevention, diagnosis, treatment of disease, and healthcare. A systematic, quantitative and integrative way needs being adopted,for approaching the solutions of how clothing and textiles can be engineered to the benefits of biology, physiology, medicine, behavior and health of human populations. This paper reviews the theoretical foundations for engineering design of functional textiles.
C1 Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk
RI LI, YI/G-4421-2012
OI LI, YI/0000-0002-2092-4505; Zhu, Jianguo/0000-0002-9763-4047
CR BISHOP DP, 1994, TEXTILE PROGRESS, V26, P1
   Fanger P.O., 1970, THERMAL COMFORT
   Fourt L., 1970, CLOTHING COMFORT FUN
   HA M, 1996, EUR J APPL PHYSL, V71, P266
   Hollies NRS, 1977, CLOTHING COMFORT INT
   HONGU T, 1999, HIGH TECH FIBERS
   Hongu T, 1997, NEW FIBERS
   KAJIWARA K, 2000, J TEXT I 3, V32
   Li Y, 2006, WOODHEAD TEXT SER, P1, DOI 10.1201/9781439824269
   LI Y, CLOTHING THERM UNPUB
   LI Y, 2002, CLOTHING COMFORT PRO, P1
   LI Y, CLOTHING PHYSL UNPUB
   LI Y, NANOFUNCTIONAL UNPUB
   LI Y, 2000, TEXTILE PROGR, V31, P1
   Li Y, 2006, WOODHEAD TEXT SER, P1, DOI 10.1533/9781845691462.1
   Li Y, 2006, COMPUT AIDED DESIGN, V38, P726, DOI 10.1016/j.cad.2006.03.003
   Mao AH, 2008, COMPUT AIDED DESIGN, V40, P916, DOI 10.1016/j.cad.2008.06.002
   NAGAMACHI M, 1994, SEN-I GAKKAISHI, V50, P468
   SHIMIZU Y, 1996, P 96 SPEC SEM SENS R
   SLATER K, 1986, J TEXT I, V77, P157, DOI 10.1080/00405008608658406
   Slater K, 1985, HUMAN COMFORT
   Slater K, 1977, TEXT PROG, V9, P1
   Sone Yoshiaki, 2000, Journal of Physiological Anthropology and Applied Human Science, V19, P157, DOI 10.2114/jpa.19.157
   Tao X, 2001, SMART FIBRES FABRICS
   TOKURA H, 1989, P INT S CLOTH COMF S
   WOO JL, 2001, P 6 AS TEXT C HONG K
NR 26
TC 92
Z9 112
U1 0
U2 21
PU CHINA TEXTILE & APPAREL PRESS
PI BEIJING
PA NO. 6, DONG ZHI MEN NAN DA JIE,, BEIJING, 100027, PEOPLES R CHINA
BN 978-7-5064-6094-1
PY 2010
BP 1
EP 9
PG 9
WC Materials Science, Textiles
SC Materials Science
GA BNE60
UT WOS:000274278100001
DA 2018-10-20
ER

PT B
AU Demetrescu, I
   Ionita, D
   Iordachescu, D
   Cimpean, A
   Portan, D
AF Demetrescu, Ioana
   Ionita, Daniela
   Iordachescu, Dana
   Cimpean, Anisoara
   Portan, Diana
BE Sandhu, PS
TI Selective behavior of TiO(2) nanotubes covered and uncovered with a Ca-P
   coating for biomedical applications.
SO PROCEEDINGS OF 2010 INTERNATIONAL CONFERENCE ON BIOTECHNOLOGY AND FOOD
   SCIENCE (ICBFS 2010)
LA English
DT Proceedings Paper
CT International Conference on Biotechnology and Food Science
CY FEB 09-10, 2010
CL Bangalore, INDIA
SP IACSIT, Appl Chem Engn Soc, Environ Sci Soc
DE TiO(2) nanotubes; cell culture; calcium phosphate
ID POROUS METAL IMPLANTS; ELABORATION
AB The paper is focused on the relation between the TiO(2) nanotubes dimension as a function of elaboration conditions, electrochemical stability and biocompatibility. As fabrication procedure of nanotubes was chosen anodizing in various fluoride mixture and as testing solution for stability Hank solution was used. Biocompatibility evaluation was realized from ability of biomaterial to built phosphate stratum and from fibroblast cell culture. A relation between electrochemical stability in bioliquids, nanotubes diameter and their biocompatibility was discussed.
C1 [Demetrescu, Ioana; Ionita, Daniela; Portan, Diana] Univ Politehn Bucuresti, Bucharest, Romania.
RP Demetrescu, I (reprint author), Univ Politehn Bucuresti, Bucharest, Romania.
RI Cimpean, Anisoara/C-2101-2011
OI Cimpean, Anisoara/0000-0002-5833-3110
CR Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Bauer S, 2006, ELECTROCHEM COMMUN, V8, P1321, DOI 10.1016/j.elecom.2006.05.030
   BRAMMER KS, 2009, ACTA BIOMATER, DOI DOI 10.1016/ACTBIO.200905.008
   DEMETRESCU DI, MOL CRYSTALS L UNPUB
   Fernández M. E, 2002, Rev. LatinAm. Metal. Mater., V22, P52
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Man I, 2008, REV CHIM-BUCHAREST, V59, P615
   Oliva FY, 2002, J ELECTROANAL CHEM, V534, P19, DOI 10.1016/S0022-0728(02)01099-9
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Portan D, 2009, KEY ENG MAT, V415, P9
   Vitte J, 2004, Eur Cell Mater, V7, P52
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
NR 15
TC 3
Z9 3
U1 0
U2 3
PU WORLD ACAD UNION-WORLD ACAD PRESS
PI LIVERPOOL
PA 113, ACADEMIC HOUSE, MILL LANE, WAVERTREE TECHNOLOGY PARK, LIVERPOOL,
   L13 4 AH, ENGLAND
BN 978-1-84626-036-0
PY 2010
BP 156
EP 160
PG 5
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA BUG46
UT WOS:000289218200031
DA 2018-10-20
ER

PT B
AU Jaresitthikunchai, J
   Phaonakrop, N
   Roytrakul, S
   Veeranondha, S
   San-ngam, R
   Suvannapruk, W
   Panyathanmaporn, T
   Suwanprateeb, J
AF Jaresitthikunchai, J.
   Phaonakrop, N.
   Roytrakul, S.
   Veeranondha, S.
   San-ngam, R.
   Suvannapruk, W.
   Panyathanmaporn, T.
   Suwanprateeb, J.
GP KASETSART UNIV
TI Protein expression of osteoblast as a response to different
   hydroxyapatite bioceramics
SO PROCEEDINGS OF 48TH KASETSART UNIVERSITY ANNUAL CONFERENCE: SCIENCE
LA English
DT Proceedings Paper
CT 48th Kasetsart University Annual Conference
CY FEB 03-05, 2010
CL THAILAND
SP Kasetsart Univ
DE biomaterial; bone-related protein; protein expression; LC-MS;
   mineralization; protein quantitation; protein identification; mass
   spectrometry
ID MASS-SPECTROMETRY; IDENTIFICATION; QUANTITATION
AB Many processes require in bone formation especially involvement of osteoblasts, cells responsible for accumulation and mineralization of the extracellular matrix (ECM). But the mechanisms involved are not yet fully understood. To better understand their function and biogenesis, a label free proteomic analysis of osteoblast response to various type of hydroxyapatite bioceramics was conducted and mass spectrometry was utilized for protein quantification and identification. A total of 10 proteins with MW of 14-20 kDa were identified in all samples using SDS-PAGE combined with nano-LC-MS/MS. Of these, different protein expression levels in the presence of the bioceramics: HA1, HA2 and HA3 were detected. Our findings suggest that different chemical compositions and surface chracteristics affect the protein expression resulting in alteration of cell function.
C1 [Jaresitthikunchai, J.; Phaonakrop, N.; Roytrakul, S.; Veeranondha, S.] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand.
   [San-ngam, R.; Suvannapruk, W.; Panyathanmaporn, T.; Suwanprateeb, J.] Natl Sci & Technol Dev Agcy, Natl Met & Mat Technol Ctr, Bangkok, Thailand.
RP Jaresitthikunchai, J (reprint author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand.
EM janthima.jar@biotec.or.th
FU National Metal and Materials Technology Center, National Science and
   Technology Development Agency, Thailand [P-00-30323]
FX This work was supported by the National Metal and Materials Technology
   Center (grant number P-00-30323), National Science and Technology
   Development Agency, Thailand.
CR BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   CORY AH, 1991, CANCER COMMUN, V3, P207
   Ducheyne P, 1998, HIP SURG NEW MAT DEV, P179
   Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320
   Govorukhina NI, 2003, J CHROMATOGR A, V1009, P171, DOI 10.1016/S0021-9673(03)00921-X
   Jaresitthikunchai J, 2009, 2 BIOCH MOL BIOL C B
   Johansson C, 2006, PROTEOMICS, V6, P4475, DOI 10.1002/pmic.200500921
   Keller JC, 1997, DENT MATER, V13, P62, DOI 10.1016/S0109-5641(97)80010-3
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Ong J.L., 1998, J BIOMED MATER RES, V29, P389
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Thorsell A, 2007, RAPID COMMUN MASS SP, V21, P771, DOI 10.1002/rcm.2898
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 15
TC 0
Z9 0
U1 0
U2 0
PU KASETSART UNIV
PI BANGKOK
PA 50 PHAHONYOTHIN RD, LAT YAO SUBDISTRICT, JATUJAK DISTRICT,, BANGKOK,
   10900, THAILAND
BN 978-616-7262-39-0
PY 2010
BP 183
EP 190
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA BG8XQ
UT WOS:000392778400022
DA 2018-10-20
ER

PT B
AU Haafiz, MKM
   Rosli, WDW
   Azman, SM
   Rohaizu, R
AF Haafiz, M. K. Mohamad
   Rosli, W. D. Wan
   Azman, S. M.
   Rohaizu, R.
BE Baby, S
   Sandhu, PS
TI Cellulose Phosphate as Biomaterial: Preliminary Study
SO PROCEEDINGS OF THE 2010 INTERNATIONAL CONFERENCE ON ENVIRONMENTAL
   SCIENCE AND TECHNOLOGY (ICEST 2010)
LA English
DT Proceedings Paper
CT International Conference on Environmental Science and Technology (ICEST
   2010)
CY APR 23-25, 2010
CL Bangkok, THAILAND
SP IACSIT, Applied Chem Engn Soc, Environm Sci Soc
DE Cellulose phosphate; Biomaterial; Phosphorylation;
   H3PO4/P2O5/Et3PO4/hexanol method
ID CHEMICAL-MODIFICATION
AB Cellulose which is' well known for its, biocompatible, biodegradable and renewability is fast emerging as an upcoming field of interest. This study was conducted to investigate and analyse the biocomatibility of cellulose phosphate and its potential inductivity. Yet to our knowledge, till to date the biocompatibility of cellulose from Empty Fruit Bunch (EFB) still not being investigate. For this purpose, EFB cellulose was chemically modified by phosphorylation using H3PO4 /P2O5 /Et3PO4/hexanol method and immersed in a Simulated Body Fluid (SBF) solution for 5 days in order to investigate it ability to induce the formation of a calcium phosphate layer. Mineralization was assessed by Scanning Electron Microscopy (SEM), Energy Dispersive X-ray (EDX) and Fourier Transform Infrared (FTIR). SEM shown changed in cellulose phosphate morphology in which calcium, magnesium and sodium was formed after immersed in SBF and this conformed by EDX analysis. This preliminary study is attempted to produce cellulose phosphate from Oil Palm lignocellulosic residual as Biomaterial and the analysis still ongoing
C1 [Haafiz, M. K. Mohamad; Rosli, W. D. Wan; Rohaizu, R.] Univ Sains Malaysia, Sch Ind Technol, Bioresources Paper & Coating Div, George Town 11800, Malaysia.
   [Azman, S. M.] Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kelantan 16150, Malaysia.
RP Rosli, WDW (reprint author), Univ Sains Malaysia, Sch Ind Technol, Bioresources Paper & Coating Div, George Town 11800, Malaysia.
EM wanrosli@usm.my
RI M.K, Mohamad Haafiz/J-8883-2015
OI M.K, Mohamad Haafiz/0000-0002-4344-0554
FU Research University (RU) [PTEKIND/1001/8140151]; Universiti Sains
   Malaysia
FX This research was partially supported by a Research University (RU)
   Grant No PTEKIND/1001/8140151 from Universiti Sains Malaysia.
CR Amaral IF, 2005, J BIOMAT SCI-POLYM E, V16, P1575, DOI 10.1163/156856205774576736
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Granja P. L., 2005, EUROPEAN CELL MAT, V10, P3
   Granja PL, 2001, J APPL POLYM SCI, V82, P3354, DOI 10.1002/app.2194
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Law KN, 2007, BIORESOURCES, V2, P351
   Li SH, 1997, BIOMATERIALS, V18, P389, DOI 10.1016/S0142-9612(96)00122-6
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Rosli W. D. Wan, 1998, CELL CHEM TECHNOL, V32, P133
   Salmoria GV, 2009, POLYM TEST, V28, P648, DOI 10.1016/j.polymertesting.2009.05.008
NR 11
TC 0
Z9 0
U1 0
U2 0
PU RESEARCH PUBLISHING SERVICES
PI SINGAPORE
PA NO 83 GENTING LANE, #08-01, GENTING BUILDING, SINGAPORE, 349568,
   SINGAPORE
BN 978-981-08-5716-5
PY 2010
BP 498
EP 502
DI 10.3850/978-981-08-5716-5_T311
PG 5
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA BG9KH
UT WOS:000393361700098
DA 2018-10-20
ER

PT B
AU Dong, LZ
   Guan, J
   Huang, SJ
   Jing, ML
AF Dong, Lizhi
   Guan, Jing
   Huang, Shujie
   Jing, Miaolei
BE Ye, CQ
TI Characterization of Wound Dressing with Microspheres Containing
   Levofloxacin
SO PROCEEDINGS OF THE 2010 INTERNATIONAL CONFERENCE ON INFORMATION
   TECHNOLOGY AND SCIENTIFIC MANAGEMENT, VOLS 1-2
LA English
DT Proceedings Paper
CT International Conference on Information Technology and Scientific
   Management
CY DEC 20-21, 2010
CL Tianjin Polytechn Univ, Tianjin, PEOPLES R CHINA
HO Tianjin Polytechn Univ
DE nonwovens; microspheres; levofloxacin; slow release
ID ACRYLIC-ACID; GRAFT-COPOLYMERIZATION; IN-VITRO; CHITOSAN; BIOMATERIAL;
   ANTIBACTERIAL; DELIVERY; SPONGE; FILM
AB A novel functional material was prepared by composing chitosan-levofloxacin complex microspheres with viscose nonwoven fabrics. The complex microspheres were made by ionic and emulsion crosslinking method. The morphology and formulation of the material were investigated by SEM, FTIR and DSC. The drug release property in vitro was evaluated by UV. The cytotoxicity and its antibacterial property were tested by L929 fibroblast culture and the spread plate method respectively. The results showed that the microspheres were embedded in the fabrics, chitosan microspheres were formed by Schiff base reaction and there are no chemical crosslinking appearance between viscose fibers and chitosan-levofloxacin complex microspheres. Levofloxacin could release slowly and its sustained release property can be controlled by the concentration of chitosan solution effectively. In addition, there were no obvious toxicity role presented and its antibacterial action was excellent. The functional material has the potential to be used as levofloxacin sustained releasing wound dressing.
C1 [Dong, Lizhi; Jing, Miaolei] TianJin Polytech Univ, Acad Text, Tianjin, Peoples R China.
   [Dong, Lizhi; Guan, Jing; Huang, Shujie] Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China.
RP Guan, J (reprint author), Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China.
EM lycheedong@yahoo.cn; janemms@yahoo.com.cn; jingmiaolei@126.com
FU Tianjin Natural Science Foundation [09JCZDJC18800]
FX Tianjin Natural Science Foundation; Contract grant No.09JCZDJC18800
CR Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   dos Santos KSCR, 2006, INT J PHARMACEUT, V310, P37, DOI 10.1016/j.ijpharm.2005.11.019
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Kim IY, 2006, INT J BIOL MACROMOL, V38, P51, DOI 10.1016/j.ijbiomac.2005.12.020
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Liu WG, 2004, J MATER SCI-MATER M, V15, P1199, DOI 10.1007/s10856-004-5672-1
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   MUKHERJEE AK, 1985, J APPL POLYM SCI, V30, P2655, DOI 10.1002/app.1985.070300628
   Ozturk E, 2006, J APPL POLYM SCI, V101, P1602, DOI 10.1002/app.23563
   Phaechamud T, 2008, AAPS PHARMSCITECH, V9, P829, DOI 10.1208/s12249-008-9117-x
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Wang CC, 2005, J APPL POLYM SCI, V98, P391, DOI 10.1002/app.22224
   Wittaya-areekul S, 2006, INT J PHARM, V313, P123, DOI 10.1016/j.ijpharm.2006.01.027
   Xu HT, 2007, POLYM ADVAN TECHNOL, V18, P869, DOI 10.1002/pat.906
   Yang JM, 2008, MAT SCI ENG C-BIO S, V28, P150, DOI 10.1016/j.msec.2007.01.011
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 20
TC 0
Z9 0
U1 0
U2 7
PU SCI RES PUBL, INC-SRP
PI IRVIN
PA 5005 PASEO SEGOVIA, IRVIN, CA 92603-3334 USA
BN 978-1-935068-40-2
PY 2010
BP 344
EP +
PG 3
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Operations Research & Management Science;
   Mathematics, Applied
SC Computer Science; Engineering; Operations Research & Management Science;
   Mathematics
GA BUL02
UT WOS:000289700300101
DA 2018-10-20
ER

PT B
AU Albu, MG
   Ghica, MV
   Lungu, A
   Popa, L
   Stancu, IC
   Dumitrascu, M
   Sima, E
AF Albu, Madalina Georgiana
   Ghica, Mihaela Violeta
   Lungu, Adriana
   Popa, Lacramioara
   Stancu, Izabela-Cristina
   Dumitrascu, Maria
   Sima, Eugen
BE Albu, L
   Deselnicu, V
TI LIDOCAINE RELEASE FROM COLLAGEN DRESSINGS
SO PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS
   AND SYSTEMS
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Materials and Systems
CY SEP 16-18, 2010
CL Bucharest, ROMANIA
SP Minist Educ, Res, Youth and Sport, Natl Author Sci Res, Pielorex SA, Taro Ind, Class Shoe SRL, Nappaconf SRL, Salamandra Design SRL, LAura Fashion SRL, Prodstefano SRL, Hofigal Export Import SA, Muzeul Satului Dimitrie Gusti, A&A Vesa SRL, Picoma SA, Monuments & Tourist Heritage Adm
DE collagen dressings; lidocaine; kinetics release
ID TANNIC-ACID; DELIVERY; MATRICES; SYSTEMS
AB Collagen-based biomaterials represent an ideal support for the release of the drug, on condition that the collagen structure is as close as possible to that of the human body collagen. Collagen, as drug delivery system, offers the advantage of a natural biomaterial with haemostatic and wound healing properties. The GEVICOL is a well known collagen dressing used in treatment of varicous ulcers. Besides collagen, it contains lidocaine and crystal violet. Lidocaine belongs to the local anesthetics class and it is used to relieve the pain by stopping nerves from sending pain signals. The aim of this study is to develop such dressings with improved properties, so, they must degrade in a certain period of time and lidocaine is controlledly released. In this paper collagen dressings were obtained by freeze-drying gels which contain different collagen concentrations, a known amount of lidocaine and different amount of cross-linking agent (glutaraldehyde). Cross-linking degree and degradation ability of the obtained collagen dressings were determined by FT-IR spectroscopy, TGA and DSC analyses and water absorption assays. In vitro lidocaine release from the designed collagen dressings was performed by a sandwich device adapted to USP apparatus in PBS with a 7.4 pH as receiving medium at 370C temperature, simulating in this way the physiological medium. The kinetics mechanism was established from lidocaine release profiles. Results indicate development of dressings with controlled lidocaine release due to both collagen concentrations and cross-linking degrees. These dressings can enhance wound healing and reduce pain at the same time.
C1 [Albu, Madalina Georgiana] Leather & Footwear Res Inst, INCDTP Div, Bucharest 031215, Romania.
RP Albu, MG (reprint author), Leather & Footwear Res Inst, INCDTP Div, 93 Ion Minulescu, Bucharest 031215, Romania.
EM albu_mada@yahoo.com; mihaelaghica@yahoo.corn;
   adriana_lungu2006@yahoo.corn; maria_dumitrascu@yahoo.com
RI Stancu, Izabela-Cristina/D-3788-2014; POPA, LACRAMIOARA/A-8822-2013;
   Demeter, Maria/P-4368-2017
OI Stancu, Izabela-Cristina/0000-0003-0685-3947; POPA,
   LACRAMIOARA/0000-0002-3139-9865; Demeter, Maria/0000-0003-0758-1445;
   Albu, Madalina Georgiana/0000-0001-9960-2244
CR Albu MG, 2010, MOL CRYST LIQ CRYST, V523, P97, DOI 10.1080/15421401003724159
   ALBU MG, 2009, THESIS U BUCHAREST
   Ghica MV, 2009, REV ROUM CHIM, V54, P1103
   Purna S K, 2000, Burns, V26, P54
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
NR 6
TC 0
Z9 0
U1 1
U2 8
PU INCDTP-ICPI
PI BUCHAREST
PA ION MINULESCU 93, 3RD SECTOR, BUCHAREST, 031215, ROMANIA
PY 2010
BP 175
EP 180
PG 6
WC Computer Science, Information Systems; Operations Research & Management
   Science; Materials Science, Multidisciplinary
SC Computer Science; Operations Research & Management Science; Materials
   Science
GA BVJ62
UT WOS:000291667100029
DA 2018-10-20
ER

PT B
AU Ghica, MV
   Albu, MG
   Popa, L
AF Ghica, Mihaela Violeta
   Albu, Madalina Georgiana
   Popa, Lacramioara
BE Albu, L
   Deselnicu, V
TI DESIGN OF SOME TOPICAL DELIVERY SYSTEMS WITH LIDOCAINE BASED ON COLLAGEN
   FOR WOUND TREATMENT
SO PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS
   AND SYSTEMS
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Materials and Systems
CY SEP 16-18, 2010
CL Bucharest, ROMANIA
SP Minist Educ, Res, Youth and Sport, Natl Author Sci Res, Pielorex SA, Taro Ind, Class Shoe SRL, Nappaconf SRL, Salamandra Design SRL, LAura Fashion SRL, Prodstefano SRL, Hofigal Export Import SA, Muzeul Satului Dimitrie Gusti, A&A Vesa SRL, Picoma SA, Monuments & Tourist Heritage Adm
DE collagen hydrogels; lidocaine; quantitative relation rheology-kinetic
ID HYDROGELS; MATRICES; RELEASE; GELS
AB For the acute or chronic wounds, the associated pain is an important aspect that has to be considered in the management of their therapy. Among the local anesthetics, the lidocaine proved its efficiency for topical application, in different aetiology pains. Collagen, a well tolerated biomaterial and biodegradable, represents a favorable matrix for the drugs release. In this study some collagen hydrogels different cross-linked with lidocaine were developed, according to a 32 factorial design. The lidocaine in vitro release from the hydrogels was determined using a modified Franz diffusion cell. For establishing the mechanism of the lidocaine release from hydrogel different kinetic models were used. The formulations were also characterized from their rheological properties. Rheological measurements were performed using a rotational viscometer. The flow behaviour was quantified through different rheological models. The designed topical systems presented a thinning through shearing behaviour. Quantitative relations were built between the rheological parameters with biopharmaceutical implications and the lidocaine release kinetic characteristics.
C1 [Ghica, Mihaela Violeta; Popa, Lacramioara] Carol Davila Univ Med & Pharm, Fac Pharm, Phys Chem & Colloids Dept, Bucharest 020956, Romania.
RP Ghica, MV (reprint author), Carol Davila Univ Med & Pharm, Fac Pharm, Phys Chem & Colloids Dept, 1-6 Traian Vuia, Bucharest 020956, Romania.
EM mihaelaghica@yahoo.com; albu_mada@yahoo.com
RI POPA, LACRAMIOARA/A-8822-2013
OI POPA, LACRAMIOARA/0000-0002-3139-9865; Albu, Madalina
   Georgiana/0000-0001-9960-2244
CR Albu MG, 2009, REV ROUM CHIM, V54, P373
   ALBU MG, 2009, THESIS U BUCHAREST
   Diez-Sales O, 2005, J PHARM SCI-US, V94, P1039, DOI 10.1002/jps.20317
   Ghica MV, 2009, REV ROUM CHIM, V54, P1103
   Lewis G.A., 1997, PHARM EXPT DESIGN
   Pathak P, 2009, AAPS PHARMSCITECH, V10, P985, DOI 10.1208/s12249-009-9287-1
   Ricci EJ, 2005, INT J PHARM, V288, P235, DOI 10.1016/j.ijpharm.2004.09.028
   Shin SC, 2004, INT J PHARM, V287, P73, DOI 10.1016/j.ijpharm.2004.08.012
   Titorencu I, 2010, MOL CRYST LIQ CRYST, V523, P82, DOI 10.1080/15421401003724126
NR 9
TC 0
Z9 0
U1 0
U2 6
PU INCDTP-ICPI
PI BUCHAREST
PA ION MINULESCU 93, 3RD SECTOR, BUCHAREST, 031215, ROMANIA
PY 2010
BP 193
EP 198
PG 6
WC Computer Science, Information Systems; Operations Research & Management
   Science; Materials Science, Multidisciplinary
SC Computer Science; Operations Research & Management Science; Materials
   Science
GA BVJ62
UT WOS:000291667100032
DA 2018-10-20
ER

PT B
AU Vulcan, A
   Cojocaru, D
   Raducanu, D
   Cinca, I
   Dumitrescu, C
AF Vulcan, Andreea
   Cojocaru, Dan
   Raducanu, Doina
   Cinca, Ion
   Dumitrescu, Cristiana
BE Albu, L
   Deselnicu, V
TI MECHANICAL BEHAVIOR OF A THERMO-MECHANICAL PROCESSED TI-25TA-5ZR
   BIOCOMPATIBLE ALLOY
SO PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS
   AND SYSTEMS
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Materials and Systems
CY SEP 16-18, 2010
CL Bucharest, ROMANIA
SP Minist Educ, Res, Youth and Sport, Natl Author Sci Res, Pielorex SA, Taro Ind, Class Shoe SRL, Nappaconf SRL, Salamandra Design SRL, LAura Fashion SRL, Prodstefano SRL, Hofigal Export Import SA, Muzeul Satului Dimitrie Gusti, A&A Vesa SRL, Picoma SA, Monuments & Tourist Heritage Adm
DE titanium alloy; biocompatibility; thermo-mechanical processing
ID TITANIUM
AB The ideal biomaterial for medical implant applications, especially for load-bearing joint replacements, is expected to exhibit excellent biocompatibility with no adverse cytotoxicity, excellent corrosion resistance, and a good combination of mechanical properties such as high strength and fatigue resistance, low modulus, good ductility, and good wear resistance. In comparison with other metallic biomaterials, titanium and titanium alloys are more biocompatible, more corrosion resistant, lighter, more durable, and possess a reasonable balance of high strength and low elastic modulus. For these reasons, titanium and its various alloys are the metals of choice for the manufacture of load-bearing dental and orthopaedic implants. The present study investigated the microstructures and the mechanical properties of Ti-25Ta-5Zr alloy. The experimental results indicated that these alloy possessed a range of different structures and mechanical properties dependent upon the condition (as-cast, cold-rolled, recrystallized). The fractured surfaces were observed by using scanning electron microscopy (SEM).
C1 [Vulcan, Andreea; Cojocaru, Dan; Raducanu, Doina; Cinca, Ion; Dumitrescu, Cristiana] Univ Politehn Bucuresti, Bucharest, Romania.
RP Vulcan, A (reprint author), Univ Politehn Bucuresti, 313 Splaiul Independentei, Bucharest, Romania.
EM vulcan.andreea@mdef.pub.ro
RI Cinca, Ion/F-8979-2010; Cojocaru, Vasile Danut/F-8959-2010; Raducanu,
   Doina/F-8974-2010
OI Cojocaru, Vasile Danut/0000-0001-8563-2952; 
CR Afonso CRM, 2007, MAT SCI ENG C-BIO S, V27, P908, DOI 10.1016/j.msec.2006.11.001
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DAVIDSON JA, 1992, Patent No. 5169597
   FRAUNHOFER HR, 2006, FRACTURE MECH
   HO WF, 1999, STRUCTURE PROPERTIES
   HSU HC, 2010, STRUCTURE MECH PROPE
   LAUTENSCHLAGER EP, 1993, TITANIUM TITANIUM AL
   LONG MJ, 1998, TITANIUM ALLOYS TOTA
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M., 2002, RECENT METALLIC MAT
   SEMIATIN SL, 2003, THERMO MECH PROCESSI
   Semlitsch M., 1986, TITAN, V2, P721
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
NR 13
TC 1
Z9 1
U1 0
U2 3
PU INCDTP-ICPI
PI BUCHAREST
PA ION MINULESCU 93, 3RD SECTOR, BUCHAREST, 031215, ROMANIA
PY 2010
BP 227
EP 232
PG 6
WC Computer Science, Information Systems; Operations Research & Management
   Science; Materials Science, Multidisciplinary
SC Computer Science; Operations Research & Management Science; Materials
   Science
GA BVJ62
UT WOS:000291667100038
DA 2018-10-20
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI SURFACE INTEGRITY OF MAGNESUM-CALCIUM ORTHOPEDIC BIOMATERIAL PROCESSED
   BY DRY HIGH-SPEED FACE MILLING
SO PROCEEDINGS OF THE 5TH FRONTIERS IN BIOMEDICAL DEVICES CONFERENCE AND
   EXPOSITION, 2010
LA English
DT Proceedings Paper
CT 5th Frontiers in Biomedical Devices Conference and Exposition
CY SEP 20-21, 2010
CL Newport Beach, CA
SP ASME, ASME, Emerg Technol
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
NR 0
TC 1
Z9 1
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4945-3
PY 2010
BP 15
EP 16
PG 2
WC Engineering, Biomedical; Engineering, Mechanical
SC Engineering
GA BUY42
UT WOS:000290700400008
DA 2018-10-20
ER

PT J
AU Saikko, V
AF Saikko, V.
TI Performance analysis of an orthopaedic biomaterial 100-station wear test
   system
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART C-JOURNAL OF
   MECHANICAL ENGINEERING SCIENCE
LA English
DT Article
DE biotribology; statistics; wear testing; polyethylene; pin-on-disc
AB Until recently, wear studies of orthopaedic biomaterials have suffered from inadequate testing capacity and high standard deviation (SD) of results. In the present article, the previously validated 100-station hip wear simulator, the SuperCTPOD, is evaluated with regard to its capability of producing statistically significant differences in mean wear rates. SuperCTPOD wear tests were done for 38 different types of polyethylene pins against polished CoCr discs with diluted calf serum lubrication. A total of 200 pins were worn in two consecutive tests of 6 weeks, duration each. The sample size varied from four to six. The mean wear rates of the samples ranged from 0.52 to 77.1 mg per one million cycles. On the average, the SD of the wear rate was 4.2 per cent of the mean value (range 1-8.5 per cent). A difference in the mean wear rates below 5 per cent was large enough to be statistically significant (p < 0.05) in 21 comparisons between two samples, the lowest statistically significant mean difference being 3.2 per cent. In conclusion, the high capacity and the low SD of the wear rate make the SuperCTPOD wear test system unparalleled in efficiency. The observations regarding the effect of crosslinking and molecular weight on polyethylene wear resistance were in agreement with studies published earlier.
C1 Helsinki Univ Technol, Dept Engn Design & Prod, FIN-02015 Helsinki, Finland.
RP Saikko, V (reprint author), Helsinki Univ Technol, Dept Engn Design & Prod, POB 4300, FIN-02015 Helsinki, Finland.
EM vesa.saikko@tkk.fi
RI Saikko, Vesa/I-1675-2016
OI Saikko, Vesa/0000-0002-0196-0033
FU Academy of Finland
FX The polyethylene specimens were supplied by DSM Biomedical Materials B.
   V, The Netherlands. The author thanks Ms Seija Suojakari for the
   grinding and polishing of the test discs. The completion of the
   SuperCTPOD wear test system was made possible by the research project
   'Biotribology of Prosthetic Joints' funded by the Academy of Finland.
CR Chowdhury S, 2008, DIAM RELAT MATER, V17, P419, DOI 10.1016/j.diamond.2007.08.041
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Mazzucco D, 2003, WEAR, V254, P514, DOI 10.1016/S0043-1648(03)00135-2
   Olyslaegers C, 2008, J ARTHROPLASTY, V23, P489, DOI 10.1016/j.arth.2007.02.013
   Saikko V, 2005, P I MECH ENG H, V219, P309, DOI 10.1243/095441105X34301
   Tarasevicius S, 2008, ACTA ORTHOP, V79, P489, DOI 10.1080/17453670710015472
   Turell ME, 2005, WEAR, V259, P984, DOI 10.1016/j.wear.2005.01.050
   Wilkinson JM, 2005, J ORTHOP RES, V23, P520, DOI 10.1016/j.orthres.2004.11.005
NR 8
TC 7
Z9 7
U1 0
U2 7
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4062
J9 P I MECH ENG C-J MEC
JI Proc. Inst. Mech. Eng. Part C-J. Eng. Mech. Eng. Sci.
PY 2010
VL 224
IS C3
BP 697
EP 701
DI 10.1243/09544062JMES1626
PG 5
WC Engineering, Mechanical
SC Engineering
GA 580TF
UT WOS:000276472500018
DA 2018-10-20
ER

PT J
AU Luo, Y
   McCann, L
   Ingham, E
   Jin, ZM
   Ge, S
   Fisher, J
AF Luo, Y.
   McCann, L.
   Ingham, E.
   Jin, Z-M
   Ge, S.
   Fisher, J.
TI Polyurethane as a potential knee hemiarthroplasty biomaterial: an
   in-vitro simulation of its tribological performance
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE hemiarthroplasty; knee; articular cartilage; polyurethane; wear;
   friction; lubrication; contact mechanics
ID MCKEEVER METALLIC HEMIARTHROPLASTY; INNOVATIVE CHONDROPLASTY MATERIALS;
   ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; FRICTION; STRESS;
   COMPRESSION; DEGRADATION; ARTHRITIS; MENISCI
AB Hemiarthroplasty is an attractive alternative to total joint replacement for the young active patient, when only one side of the synovial joint is damaged. In the development of a hemiarthroplasty prosthesis, a comprehensive understanding of the tribology of both the natural joint and the hemireplaced joint is necessary.
   The objectives of this study were to investigate the tribological response of polyurethane (PU) as a potential hemiarthroplasty material. Bovine medial compartmental knees were tested in a Prosim pendulum friction simulator, which applied physiologically relevant loading and motion. The healthy medial compartment was investigated as a negative control; a stainless steel hemiarthroplasty was investigated as a positive control; and three PU hemiarthroplasty plates of different moduli (1.4 MPa, 6.5 MPa, and 22 MPa) were also investigated.
   Using the lower-modulus PU caused reduced levels of contact stress and friction shear stress, which resulted in reduced levels of opposing cartilage wear. The two PU bearings with the lowest moduli demonstrated a similar tribological performance to the negative control. The higher-modulus PU (22 MPa) did demonstrate higher levels of friction shear stress, and wear resulted on the opposing cartilage, although not as severe as the wear from the stainless steel group.
   This study supports the use of compliant PU designs in future tribological experiments and hemiarthroplasty design applications.
C1 [Luo, Y.; McCann, L.; Ingham, E.; Jin, Z-M; Fisher, J.] Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
   [Luo, Y.; Ge, S.] China Univ Min & Technol, Inst Tribol & Reliabil Engn, Xuzhou, Jiangsu, Peoples R China.
RP McCann, L (reprint author), Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.
EM L.McCann@leeds.ac.uk
FU National Nature Science Foundation of China [50535050, 2007CB607605];
   National Basic Research Program of China; China Scholarship Council;
   Engineering and Physical Sciences Research Council (UK); DePuy
   International; NIHR (National Institute for Health Research)
FX The authors wish to thank the National Nature Science Foundation of
   China (Grant 50535050), Project 2007CB607605; this is supported by the
   National Basic Research Program of China (also called the 973 Program),
   the China Scholarship Council, and the Engineering and Physical Sciences
   Research Council (UK).; Funding was also provided by the EPSRC and DePuy
   International. This work is supported by the NIHR (National Institute
   for Health Research) as part of a collaboration with the LMBRU (Leeds
   Musculoskeletal Biomedical Research Unit).
CR AMSTUTZ HC, 1994, J BONE JOINT SURG BR, V76B, P423
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Auger D D, 1993, Proc Inst Mech Eng H, V207, P25, DOI 10.1243/PIME_PROC_1993_207_265_02
   Bailie AG, 2008, J BONE JOINT SURG BR, V90B, P446, DOI 10.1302/0301-620X.90B4.20319
   *BRIT STAND I, 2004, 1424332004 BS BRIT S
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   DARCY J, 1976, J BONE JOINT SURG BR, V58, P279
   Dowson D, 1991, Proc Inst Mech Eng H, V205, P59, DOI 10.1243/PIME_PROC_1991_205_269_02
   Elleuch R, 2007, MATER DESIGN, V28, P824, DOI 10.1016/j.matdes.2005.11.004
   EMERSON RH, 1985, J BONE JOINT SURG AM, V67A, P208, DOI 10.2106/00004623-198567020-00005
   Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02
   Hallock RH, 2003, CLIN ORTHOP RELAT R, P154, DOI 10.1097/01.blo.0000093031.56370.90
   JENNINGS LM, 2002, P IMECHE INT C ENG S
   Katta J, 2007, P I MECH ENG J-J ENG, V221, P175, DOI 10.1243/13506501JET240
   KETTELKAMP DB, 1972, J BONE JOINT SURG AM, VA 54, P349, DOI 10.2106/00004623-197254020-00013
   KURTZ SM, 2008, P 8 WORLD BIOM C AMS
   LINDERGANZ E, 2009, T 55 ANN M ORTH RES
   McCann L, 2008, TRIBOL INT, V41, P1126, DOI 10.1016/j.triboint.2008.03.012
   McCann L, 2009, OSTEOARTHR CARTILAGE, V17, P995, DOI 10.1016/j.joca.2009.02.012
   McCann L, 2009, J BIOMECH, V42, P1326, DOI 10.1016/j.jbiomech.2009.03.028
   MEDLEY JB, 1980, ENG MED, V9, P59
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Northwood E, 2007, P I MECH ENG H, V221, P263, DOI 10.1243/09544119JEIM178
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   Schwartz CJ, 2007, WEAR, V262, P1315, DOI 10.1016/j.wear.2007.01.007
   SCOTT RD, 1985, J BONE JOINT SURG AM, V67A, P203, DOI 10.2106/00004623-198567020-00004
   SEEDHOM BB, 1974, J BONE JOINT SURG BR, VB 56, P381
   SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305
   Sisto DJ, 2005, J BONE JOINT SURG AM, V87A, P1706, DOI 10.2106/JBJS.D.02339
   Springer BD, 2006, J BONE JOINT SURG AM, V88A, P366, DOI 10.2106/JBJS.E.00123
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Unsworth A., 1987, P INT C TRIB FRICT L, P715
   WALKER PS, 1975, CLIN ORTHOP RELAT R, P184
NR 33
TC 5
Z9 8
U1 1
U2 21
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2010
VL 224
IS H3
BP 415
EP 425
DI 10.1243/09544119JEIM657
PG 11
WC Engineering, Biomedical
SC Engineering
GA 575ZS
UT WOS:000276113600002
PM 20408487
DA 2018-10-20
ER

PT J
AU Hughes, FJ
   Ghuman, M
   Talal, A
AF Hughes, F. J.
   Ghuman, M.
   Talal, A.
TI Periodontal regeneration: a challenge for the tissue engineer?
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE periodontal; regeneration; tissue engineering; stem cells; growth
   factors
ID BONE MORPHOGENETIC PROTEINS; CONTROLLED CLINICAL-TRIAL; HUMAN INTRABONY
   DEFECTS; BABOON PAPIO-URSINUS; GROWTH-FACTOR; HISTOLOGIC EVALUATION;
   GENE-THERAPY; STEM-CELLS; GROWTH/DIFFERENTIATION FACTOR-5; OSTEOBLAST
   DIFFERENTIATION
AB Periodontitis affects around 15 per cent of human adult populations. While periodontal treatment aimed at removing the bacterial cause of the disease is generally very successful, the ability predictably to regenerate the damaged tissues remains a major unmet objective for new treatment strategies. Existing treatments include the use of space-maintaining barrier membranes (guided tissue regeneration), use of graft materials, and application of bioactive molecules to induce regeneration, but their overall effects are relatively modest and restricted in application. The periodontal ligament is rich in mesenchymal stem cells, and the understanding of the signalling molecules that may regulate their differentation has increased enormously in recent years. Applying these principles for the development of new tissue engineering strategies for periodontal regeneration will require further work to determine the efficacy of current experimental preclinical treatments, including pharmacological application of growth factors such as bone morphogenetic proteins (BMPs) or Wnts, use of autologous stem cell reimplantation strategies, and development of improved biomaterial scaffolds. This article describes the background to this problem, addresses the current status of periodontal regeneration, including the background biology, and discusses the potential for some of these experimental therapies to achieve the goal of clinically predictable periodontal regeneration.
C1 [Hughes, F. J.; Ghuman, M.] Kings Coll London, Inst Dent, Dept Periodontol, London SE1 9RT, England.
   [Talal, A.] Natl Univ Sci & Technol, Army Med Coll, Dept Dent, Islamabad, Pakistan.
RP Hughes, FJ (reprint author), Kings Coll London, Guys Hosp, Dept Periodontol, Floor 21,Tower Wing, London SE1 9RT, England.
EM francis.hughes@kcl.ac.uk
RI Talal, A/A-4289-2015
OI Talal, A/0000-0003-4965-0955; Ghuman, Mandeep/0000-0001-8927-0741
FU Medical Research Council [G0601408]
CR Aichelmann-Reidy M E, 1998, Dent Clin North Am, V42, P491
   ARCEO N, 1991, J PERIODONTOL, V62, P499, DOI 10.1902/jop.1991.62.8.499
   Aspriello SD, 2011, CLIN ORAL INVEST, V15, P225, DOI 10.1007/s00784-009-0369-y
   Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0
   Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x
   Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023
   Carnes DL, 1997, J PERIODONTOL, V68, P701, DOI 10.1902/jop.1997.68.7.701
   CHEN TL, 1991, J BONE MINER RES, V6, P1387
   Chen YL, 2008, GENE THER, V15, P1469, DOI 10.1038/gt.2008.131
   Cortellini P, 1996, J PERIODONTOL, V67, P217, DOI 10.1902/jop.1996.67.3.217
   Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672
   Cortellini P, 1998, J CLIN PERIODONTOL, V25, P981, DOI 10.1111/j.1600-051X.1998.tb02402.x
   Dori F, 2008, J CLIN PERIODONTOL, V35, P44, DOI 10.1111/j.1600-051X.2007.01161.x
   Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003878.pub4
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Harris RJ, 1999, INT J PERIODONT REST, V19, P225
   Herberg S, 2008, J CLIN PERIODONTOL, V35, P976, DOI 10.1111/j.1600-051X.2008.01323.x
   Hosoya A, 2008, BONE, V42, P350, DOI 10.1016/j.bone.2007.09.054
   Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   Ivanovski S, 2001, J PERIODONTAL RES, V36, P131, DOI 10.1034/j.1600-0765.2001.360301.x
   Jin QM, 2004, MOL THER, V9, P519, DOI 10.1016/j.ymthe.2004.01.016
   Jin QM, 2003, J PERIODONTOL, V74, P202, DOI 10.1902/jop.2003.74.2.202
   Kemoun P, 2007, CELL TISSUE RES, V329, P283, DOI 10.1007/s00441-007-0397-3
   Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802
   Kim JY, 2007, CELL TISSUE RES, V330, P123, DOI 10.1007/s00441-007-0434-2
   Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x
   King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801
   King GN, 1999, J PERIODONTOL, V70, P1125, DOI 10.1902/jop.1999.70.10.1125
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kobayashi M, 1999, J DENT RES, V78, P1624, DOI 10.1177/00220345990780100701
   Leboy PS, 2006, ANN NY ACAD SCI, V1068, P14, DOI 10.1196/annals.1346.003
   Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788
   Lin NH, 2009, PERIODONTOL 2000, V51, P239, DOI 10.1111/j.1600-0757.2009.00303.x
   Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734
   Luan X, 2009, J DENT RES, V88, P781, DOI 10.1177/0022034509340641
   LYNCH SE, 1991, J PERIODONTOL, V62, P458, DOI 10.1902/jop.1991.62.7.458
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   MCCULLOCH CAG, 1987, ANAT RECORD, V219, P233, DOI 10.1002/ar.1092190304
   Moore YR, 2010, J CLIN PERIODONTOL, V37, P288, DOI 10.1111/j.1600-051X.2009.01527.x
   Mouri Y, 2003, CELL BIOL INT, V27, P519, DOI 10.1016/S1065-6995(03)00075-1
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Parkar MH, 1999, ARCH ORAL BIOL, V44, P823, DOI 10.1016/S0003-9969(99)00077-1
   Rai Balwant, 2008, J Oral Sci, V50, P53, DOI 10.2334/josnusd.50.53
   Rawlinson SCF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008358
   Reynolds MA, 1996, J PERIODONTOL, V67, P150, DOI 10.1902/jop.1996.67.2.150
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Ripamonti U, 1996, ARCH ORAL BIOL, V41, P121, DOI 10.1016/0003-9969(95)00110-7
   Ripamonti U, 2005, CYTOKINE GROWTH F R, V16, P357, DOI 10.1016/j.cytogfr.2005.02.006
   RIPAMONTI U, 1994, J PERIODONTAL RES, V29, P439, DOI 10.1111/j.1600-0765.1994.tb01246.x
   RUTHERFORD RB, 1993, J CLIN PERIODONTOL, V20, P537, DOI 10.1111/j.1600-051X.1993.tb00403.x
   Sculean A, 2008, J PERIODONTOL, V79, P1991, DOI 10.1902/jop.2008.080009 
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Stavropoulos Andreas, 2004, Clin Oral Investig, V8, P226, DOI 10.1007/s00784-004-0277-0
   Stavropoulos A, 2010, J PERIODONTOL, V81, P325, DOI 10.1902/jop.2009.090386
   Takayama S, 2001, J DENT RES, V80, P2075, DOI 10.1177/00220345010800121001
   Talal A, 2009, J DENT, V37, P820, DOI 10.1016/j.jdent.2009.06.014
   Talwar R, 2001, J CLIN PERIODONTOL, V28, P340, DOI 10.1034/j.1600-051x.2001.028004340.x
   Tan Z, 2009, CYTOTHERAPY, V11, P317, DOI 10.1080/14653240902824757
   Tashiro T, 2006, J ORTHOP RES, V24, P71, DOI 10.1002/jor.20002
   Tonetti MS, 1998, J PERIODONTOL, V69, P1183, DOI 10.1902/jop.1998.69.11.1183
   Tonetti MS, 1996, J CLIN PERIODONTOL, V23, P548, DOI 10.1111/j.1600-051X.1996.tb01823.x
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582
   WESSELINK PR, 1994, J CLIN PERIODONTOL, V21, P472, DOI 10.1111/j.1600-051X.1994.tb00410.x
   Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044
   Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
NR 77
TC 31
Z9 31
U1 0
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2010
VL 224
IS H12
SI SI
BP 1345
EP 1358
DI 10.1243/09544119JEIM820
PG 14
WC Engineering, Biomedical
SC Engineering
GA 687CS
UT WOS:000284752600003
PM 21287824
DA 2018-10-20
ER

PT B
AU Zhu, HL
   Feng, XX
   Zhang, HP
   Chen, JY
AF Zhu, Hailin
   Feng, Xinxing
   Zhang, Huapeng
   Chen, Jianyong
GP Zhejiang Sci-Tech Univ
TI Fabrication and Characterization of Mesoporous Calcium Silicate/silk
   Fibroin Composite Films
SO PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON ADVANCED TEXTILE
   MATERIALS & MANUFACTURING TECHNOLOGY
LA English
DT Proceedings Paper
CT 2nd International Conference on Advanced Textile Materials &
   Manufacturing Technology
CY OCT 20-24, 2010
CL Zhejiang Sci-Tech Univ, Hangzhou, PEOPLES R CHINA
SP Minist Educ China, Key Lab Adv Textile Mat & Mfg Technol, Zhejiang Provincial Key Lab Fiber Mat & Mfg Technol, Minist Educ China, Engn Res Ctr eco-Dyeing & Finishing Textiles, Textile Engn Inst Zhejiang Province
HO Zhejiang Sci-Tech Univ
DE Silk fibroin; Mesoporous calcium silicate (MCS); Composite film;
   Bioactivity
ID SCAFFOLDS; TISSUE; GLASSES
AB A well-defined mesoporous structure of calcium silicate (MCS) with high specific surface area was synthesized using surfactant P123 (triblock copolymer) as template, and its composite films with silk fibroin (SF) were fabricated by solvent-casting method. Fourier transform infrared (FT-IR) spectroscopy analysis showed that random coil and beta-sheet structure co-existed in the SF films. The bioactivity of the composite film was evaluated by soaking in a simulated body fluid (SBF), and formation of a hydroxycarbonate apatite (HCA) layer was determined by XRD and FESEM. The results showed that the MCS/SF composite film was bioactive as it induced the formation of HCA on the surface of the composite film after soaking in SBF for 7 days. Consequently, the incorporation of MCS into the SF film can enhance the bioactivity of the film, which suggests that the MCS/SF composite film may be a potential biomaterial for bone tissue engineering.
C1 [Zhu, Hailin; Feng, Xinxing; Zhang, Huapeng; Chen, Jianyong] Zhejiang Sci Tech Univ, Minist Educ China, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
RP Chen, JY (reprint author), Zhejiang Sci Tech Univ, Minist Educ China, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
EM cjy@zstu.edu.cn
CR Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Jung HY, 2005, J NON-CRYST SOLIDS, V351, P372, DOI 10.1016/j.jnoncrysol.2005.01.044
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   LV Q, 2007, BIOMATERIALS, V28, P2306
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Shimoda K, 2005, CHEM GEOL, V222, P83, DOI 10.1016/j.chemgeo.2005.07.003
   TETSUO A, 1985, MACROMOLECULES, V18, P1841
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046
   Xia W, 2008, MICROPOR MESOPOR MAT, V108, P345, DOI 10.1016/j.micromeso.2007.04.013
   Zhu HL, 2010, MAT SCI ENG C-MATER, V30, P132, DOI 10.1016/j.msec.2009.09.009
NR 16
TC 1
Z9 1
U1 0
U2 1
PU ZHEJIANG UNIV PRESS
PI HANGZHOU
PA YUGU ROAD 20,, HANGZHOU, ZHEJIANG 310027, PEOPLES R CHINA
BN 978-7-308-07958-7
PY 2010
BP 228
EP 232
PG 5
WC Materials Science, Textiles
SC Materials Science
GA BSL05
UT WOS:000284805300052
DA 2018-10-20
ER

PT J
AU Wiria, FE
   Leong, KF
   Chua, CK
AF Wiria, Florencia Edith
   Leong, Kah Fai
   Chua, Chee Kai
TI Modeling of powder particle heat transfer process in selective laser
   sintering for fabricating tissue engineering scaffolds
SO RAPID PROTOTYPING JOURNAL
LA English
DT Article
DE Rapid prototypes; Biotechnology; Sintering; Heat transfer; Powders
ID POLY(VINYL ALCOHOL); STRUCTURE LIBRARY; DESIGN; BONE; BIOCOMPOSITE;
   CHALLENGES; MATRICES
AB Purpose Tissue engineering (TE) involves biological, medical and engineering expertise and a current engineering challenge is to provide good TE scaffolds. These highly porous 3D scaffolds primarily serve as temporal holding devices for cells that facilitate structural and functional tissue unit formation of the newly transplanted cells. One method used successfully to produce scaffolds is that of rapid prototyping. Selective laser sintering (SLS) is one such versatile method that is able to process many types of polymeric materials and good stability of its products. The purpose of this paper is to present modeling of the heat transfer process, to understand the sintering phenomena that are experienced by powder particles in the SLS powder bed during the sintering process. With the understanding of sintering process obtained through the theoretical modeling, experimental process of biomaterials in SLS could be directed towards the appropriate sintering window, so as not to cause unintentional degradation to the biomaterials.
   Design/methodology/approach SLS uses a laser as a heat source to sinter parts. A theoretical study based on heat transfer phenomena during SLS process was carried out. The study identified the significant biomaterial and laser beam properties that were critical to the sintering result. The material properties were thermal conductivity, thermal diffusivity, surface reflectivity and absorption coefficient.
   Findings The influential laser beam properties were laser power and scan speed, which were machine parameters that can be controlled by users. The identification of the important parameters has ensured that favorable sintering conditions can be achieved.
   Research limitations/implications The selection of biopolymer influences the manner in which energy is absorbed by the powder bed during the SLS process. In this paper, the modeling and investigative work was validated by poly(vinyl alcohol) which is a biomaterial that has been used for many biomedical and pharmaceutical purposes.
   Practical implications The paper can be the foundation for extension to other types of biomaterials including biopolymers, bioceramics and biocomposites.
   Originality/value The formulation of the theory for heat transfer phenomena during the SLS process is of significant value to any studies in using SLS for biomedical applications.
C1 [Wiria, Florencia Edith] Singapore Inst Mfg Technol, Forming Technol Grp, Singapore, Singapore.
   [Leong, Kah Fai; Chua, Chee Kai] Nanyang Technol Univ, Rapid Prototyping Res Lab, Sch Mech & Aerosp Engn, Singapore, Singapore.
RP Wiria, FE (reprint author), Singapore Inst Mfg Technol, Forming Technol Grp, Singapore, Singapore.
EM florencia@SIMTech.a-star.edu.sg
RI Chua, Chee Kai/B-6171-2009; Leong, Kah-Fai/B-6183-2009
CR Aleyamma A. J., 1991, BLOOD COMPATIBLE MAT, P123
   Bartolo PJ, 2009, VIRTUAL PHYS PROTOTY, V4, P203, DOI 10.1080/17452750903476288
   Bourke SL, 2003, AAPS PHARMSCI, V5
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   Cheah CM, 2004, TISSUE ENG, V10, P595, DOI 10.1089/107632704323061951
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Chua CK, 2010, RAPID PROTOTYPING: PRINCIPLES AND APPLICATIONS, 3RD EDITION, P1
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P291
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P302
   Flanagan Thomas C., 2003, European Cells & Materials, V6, P28
   Gibson I, 1997, RAPID PROTOTYPING J, V3, P129, DOI 10.1108/13552549710191836
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Holland BJ, 2001, POLYMER, V42, P6775, DOI 10.1016/S0032-3861(01)00166-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   INCROPERA FP, 1996, FUNDAMENTALS HEAT MA
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Jones SA, 2004, CHROMATOGRAPHIA, V59, P43, DOI 10.1365/s10337-003-0142-3
   Kishida A., 2002, POLYM BIOMATERIALS, P133
   Kruth JP, 2005, RAPID PROTOTYPING J, V11, P26, DOI 10.1108/13552540510573365
   Kruth JP, 2003, ASSEMBLY AUTOM, V23, P357, DOI 10.1108/01445150310698652
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CT, 2005, CARBOHYD POLYM, V61, P348, DOI 10.1016/j.carbpol.2005.06.018
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   Ma L, 2007, INT J ADV MANUF TECH, V34, P898, DOI 10.1007/s00170-006-0665-5
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Meeten G., 1986, OPTICAL PROPERTIES P, P1
   NELSON JC, 1993, IND ENG CHEM RES, V32, P2305, DOI 10.1021/ie00022a014
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Persidis A, 1999, NAT BIOTECHNOL, V17, P508, DOI 10.1038/8700
   ROSENZWEIG N, 1981, POLYM ENG SCI, V21, P582, DOI 10.1002/pen.760211003
   Sun M.M., 1991, P SOL FREEF FABR S, P102
   SUN MM, 1991, THESIS U TEXAS AUSTI
   Tan KH, 2005, BIO-MED MATER ENG, V15, P113
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   THOMSON RC, 2000, PRINCIPLES TISSUE EN
   Tolochko NK, 2000, RAPID PROTOTYPING J, V6, P155, DOI 10.1108/13552540010337029
   Vunjak-Novakovic G, 2006, TISSUE ENG, V12, P3261, DOI 10.1089/ten.2006.12.3261
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zhang YW, 2000, J HEAT TRANS-T ASME, V122, P150, DOI 10.1115/1.521445
NR 46
TC 19
Z9 19
U1 1
U2 36
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1355-2546
EI 1758-7670
J9 RAPID PROTOTYPING J
JI Rapid Prototyping J.
PY 2010
VL 16
IS 6
BP 400
EP 410
DI 10.1108/13552541011083317
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 701IZ
UT WOS:000285812900002
DA 2018-10-20
ER

PT S
AU Lochmuller, H
   Schneiderat, P
AF Lochmuller, Hanns
   Schneiderat, Peter
BE DelaPaz, MP
   Groft, SC
TI Biobanking in Rare Disorders
SO RARE DISEASES EPIDEMIOLOGY
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Biomaterial; Biobanking; Rare disorders; EuroBioBank; Biological
   resources centres
ID DEFICIENCY
AB Biobanks are collections of biomaterials with associated data. Biobanking is an essential tool to provide access to high quality human biomaterial for fundamental and translational research. Research for rare disorders benefits from the provision of human biomaterials through biobanks, and each human sample from a person with a rare disorder has a high value as it may hold the key to answer an important research question. Transnational cooperation in biobanking is an important catalyst to share limited resources and achieve optimal outcomes as in other areas of rare disorder research. Networks of biobanks aim to assure common practices and quality standards, and facilitate access to rare disorder biomaterials for the scientific community.
C1 [Lochmuller, Hanns] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Schneiderat, Peter] Univ Munich, Friedrich Baur Inst, Munich, Germany.
   [Schneiderat, Peter] Univ Munich, Dept Neurol, D-8000 Munich, Germany.
RP Lochmuller, H (reprint author), Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM hanns.lochmuller@ncl.ac.uk; Peter.Schneiderat@med.uni-muenchen.de
OI Lochmuller, Hanns/0000-0003-2324-8001
FU Medical Research Council [G0601943]
CR [Anonymous], 2009, NATURE, V461, P448
   Austin Melissa A, 2003, Community Genet, V6, P37, DOI 10.1159/000069544
   Eurordis, 2005, RAR DIS UND THIS PUB
   Hens K, 2009, EUR J HUM GENET, V17, P979, DOI 10.1038/ejhg.2009.9
   Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025
   Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554
   Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233
   Mayrhofer M. T., 2009, INT J RISK ASSESSMEN, V12, P64, DOI [DOI 10.1504/IJRAM.2009.024130, 10.1504/IJRAM.2009.024130]
   OECD, 2007, BEST PRACT GUID BIOL
   OECD, 2004, GUID OP BIOL RES CTR
   Organization for Economic Co-operation and Development (OECD), 2006, GLOSS STAT TERMS
   Schroers A, 2006, NEUROLOGY, V66, P285, DOI 10.1212/01.wnl.0000194212.31318.fc
   URANGA AM, 2005, LAW HUM GENOME REV, P103
   2008, COUNCIL RECOMMENDATI
NR 14
TC 12
Z9 12
U1 0
U2 4
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-90-481-9484-1
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2010
VL 686
BP 105
EP 113
DI 10.1007/978-90-481-9485-8_7
PG 9
WC Public, Environmental & Occupational Health; Medicine, Research &
   Experimental
SC Public, Environmental & Occupational Health; Research & Experimental
   Medicine
GA BRC95
UT WOS:000282382800007
PM 20824442
DA 2018-10-20
ER

PT J
AU Bullock, AJ
   Pickavance, P
   Haddow, DB
   Rimmer, S
   MacNeil, S
AF Bullock, A. J.
   Pickavance, P.
   Haddow, D. B.
   Rimmer, S.
   MacNeil, S.
TI Development of a calcium-chelating hydrogel for treatment of superficial
   burns and scalds
SO REGENERATIVE MEDICINE
LA English
DT Article
DE calcium; hydrogel; keratinocyte; magnesium; wound healing
ID KERATINOCYTE-DRIVEN CONTRACTION; I COLLAGEN; HUMAN SKIN; MIGRATION;
   INTEGRIN; MODEL; SHIFTS; CELLS; VITRO
AB Aims. Superficial burns and scalds are usually managed conservatively with traditional dressings. Failure to heal within 3 weeks leads to their management by skin grafting. Our aim was to develop a biomaterial to actively promote keratinocyte migration in superficial burns by modulating local cation concentrations to accelerate keratinocyte migration and deter wounds from contracting, thus potentially reducing the number of such wounds requiring grafting. Materials & methods: We investigated polymeric hydrogels for their Ca(2+) chelating properties and enhancement of keratinocyte migration in human tissue-engineered skin models. Results: Dimethylaminoethyl methacrylate:methacrylic acid hydrogel coupled with elevated [Mg(2+)] reduced media [Ca(2+)], potentiating keratinocyte migration in tissue-engineered skin models, it also significantly reduced wound model contraction. Conclusion: Dimethylaminoethyl methacrylate:methacrylic acid hydrogels could promote wound healing and reduce wound contraction, a significant complication in burn wound healing.
C1 [Bullock, A. J.; MacNeil, S.] Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England.
   [Pickavance, P.; Rimmer, S.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.
   [Haddow, D. B.] York Pharma R&D Ltd, Innovat Ctr, Sheffield S1 4DP, S Yorkshire, England.
RP Bullock, AJ (reprint author), Kroto Res Inst, North Campus,Broad Lane, Sheffield S3 7HQ, S Yorkshire, England.
EM a.j.bullock@sheffield.ac.uk
OI Bullock, Anthony/0000-0003-0579-3997
FU Wellcome Trust University
FX This research was supported by a Wellcome Trust University Translation A
   ward to Celltran Ltd. During the period of this work, D Haddow was a
   Director of Celltran Ltd. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.; No writing assistance was utilized in the production of this
   manuscript.
CR Bullock AJ, 2007, BIOELECTROMAGNETICS, V28, P31, DOI 10.1002/bem.20267
   Cabodi M, 2007, J BIOMED MATER RES B, V82B, P210, DOI 10.1002/jbm.b.30723
   Caughman G B, 1999, Clin Oral Investig, V3, P181, DOI 10.1007/s007840050099
   Chakrabarty KH, 2001, WOUND REPAIR REGEN, V9, P95, DOI 10.1046/j.1524-475x.2001.00095.x
   Dallon JC, 2008, WOUND REPAIR REGEN, V16, P472, DOI 10.1111/j.1524-475X.2008.00392.x
   GERONEMUS RG, 1982, J DERMATOL SURG ONC, V8, P850, DOI 10.1111/j.1524-4725.1982.tb03992.x
   Ghosh MM, 1997, ANN PLAS SURG, V39, P390, DOI 10.1097/00000637-199710000-00010
   GILCHRIST T, 1983, BIOMATERIALS, V4, P317, DOI 10.1016/0142-9612(83)90036-4
   GRZESIAK JJ, 1995, J INVEST DERMATOL, V104, P768, DOI 10.1111/1523-1747.ep12606983
   GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644
   GRZESIAK JJ, 1992, J CELL BIOL, V117, P1109, DOI 10.1083/jcb.117.5.1109
   Harrison CA, 2006, WOUND REPAIR REGEN, V14, P203, DOI 10.1111/j.1743-6109.2006.00111.x
   Harrison CA, 2008, BURNS, V34, P153, DOI 10.1016/j.burns.2007.08.011
   Hernon CA, 2007, WOUND REPAIR REGEN, V15, P718, DOI 10.1111/j.1524-475X.2007.00275.x
   Jerome D, 2007, J WOUND OSTOMY CONT, V34, P191, DOI 10.1097/01.WON.0000264834.18732.3b
   Knetsch MLW, 2007, J BIOMED MATER RES A, V82A, P947, DOI 10.1002/ibm.a.31212
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   MOIR GC, 1991, BURNS, V17, P406, DOI 10.1016/S0305-4179(05)80076-2
   PRICE WR, 1966, AM J SURG, V112, P674, DOI 10.1016/0002-9610(66)90103-6
   Ralston DR, 1997, BRIT J PLAST SURG, V50, P408, DOI 10.1016/S0007-1226(97)90327-1
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Rimmer S, 2007, BIOMATERIALS, V28, P5319, DOI 10.1016/j.biomaterials.2007.08.028
   Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663
   Tennenbaum T, 1996, CELL GROWTH DIFFER, V7, P615
   Thornton DJA, 2008, J BURN CARE RES, V29, P369, DOI 10.1097/BCR.0b013e318166da8c
   ZAINUDDIN HDJ, 2007, J MATER SCI-MATER M, V18, P1141
NR 26
TC 10
Z9 10
U1 0
U2 8
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD JAN
PY 2010
VL 5
IS 1
BP 55
EP 64
DI 10.2217/RME.09.67
PG 10
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 544AM
UT WOS:000273623600011
PM 20017694
DA 2018-10-20
ER

PT J
AU Hagenmuller, H
   Hitz, M
   Merkle, HP
   Meinel, L
   Muller, R
AF Hagenmueller, Henri
   Hitz, Marco
   Merkle, Hans P.
   Meinel, Lorenz
   Mueller, Ralph
TI Design and validation of a novel bioreactor principle to combine online
   micro-computed tomography monitoring and mechanical loading in bone
   tissue engineering
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
DE bioreactors; bone; cellular biophysics; computerised tomography;
   nondestructive testing; patient monitoring; tissue engineering
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; SCAFFOLDS IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; NONDESTRUCTIVE EVALUATION; TRABECULAR BONE;
   SILK SCAFFOLDS; STIMULATION; CARTILAGE; COMPRESSION
AB Mechanical loading plays an important role in bone remodeling in vivo and, therefore, has been suggested as a key parameter in stem cell-based engineering of bone-like tissue in vitro. However, the optimization of loading protocols during stem cell differentiation and subsequent bone-like tissue formation is challenged by multiple input factors, which are difficult to control and validate. These include the variable cellular performance of cells harvested from different patients, nonstandardized culture media components, the choice of the biomaterial forming the scaffold, and its morphology, impacting a broader validity of mechanical stimulation regimens. To standardize the cell culture of bone-like tissue constructs, we suggest the involvement of time-lapsed feedback loops. For this purpose we present a prototype bioreactor that combines online, nondestructive monitoring using micro-computed tomography and direct mechanical loading of three-dimensional tissue engineering constructs. Validation of this system showed displacement steps down to 1 mu m and cyclic sinusoidal loadings of up to 10 Hz. Load detection resolution was 0.01 N, and micro-computed tomography data were of high quality. For the first time, the developed bioreactor links time-lapsed, nondestructive, and dynamic imaging with mechanical stimulation, designed for cell culture under sterile conditions. This system is believed to substantially improve today's experimental options to study and optimize osteogenic stem cell culture and differentiation at the interface with mechanical stimulation.
C1 [Hagenmueller, Henri; Hitz, Marco; Mueller, Ralph] ETH, Inst Biomech, CH-8093 Zurich, Switzerland.
   [Hagenmueller, Henri; Merkle, Hans P.; Meinel, Lorenz] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland.
   [Meinel, Lorenz] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Muller, R (reprint author), ETH, Inst Biomech, HCI E 357-2,Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
EM ram@ethz.ch
RI Meinel, Lorenz/D-9997-2015; Merkle, Hans/A-4381-2014; Muller,
   Ralph/A-1198-2008
OI Meinel, Lorenz/0000-0002-7549-7627; Muller, Ralph/0000-0002-5811-7725
FU ETH Zurich [TH 26.04-1]
FX Financial support from ETH Zurich (Grant No. TH 26.04-1) is greatly
   appreciated. We thank Armin Jossi and Alexander Jurgens from Jossi AG
   (Islikon, Switzerland) for the productive collaboration regarding design
   and manufacturing of the apparatus.
CR Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Altman Greg, 2002, FASEB Journal, V16, P270
   Boubriak OA, 2006, J R SOC INTERFACE, V3, P637, DOI 10.1098/rsif.2006.0118
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Demarteau O, 2003, BIORHEOLOGY, V40, P331
   FIELDS RD, 1993, AM BIOTECHNOL LAB, V11, P48
   Frank EH, 2000, J BIOMECH, V33, P1523, DOI 10.1016/S0021-9290(00)00100-7
   Freyria AM, 2005, TISSUE ENG, V11, P674, DOI 10.1089/ten.2005.11.674
   Guldberg RE, 1997, J BONE MINER RES, V12, P1295, DOI 10.1359/jbmr.1997.12.8.1295
   Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hollinger JO, 2000, TISSUE ENG, V6, P341, DOI 10.1089/107632700418065
   Isaksson H, 2008, J THEOR BIOL, V252, P230, DOI 10.1016/j.jtbi.2008.01.030
   Jones D. B., 2003, European Cells & Materials, V5, P48
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Mullender M, 2004, MED BIOL ENG COMPUT, V42, P14, DOI 10.1007/BF02351006
   MULLER R, 1994, PHYS MED BIOL, V39, P145, DOI 10.1088/0031-9155/39/1/009
   Muller R, 1997, ST HEAL T, V40, P61
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094
   Shimko DA, 2003, ANN BIOMED ENG, V31, P1347, DOI 10.1114/1.1626117
   Singh H, 2005, J BIOTECHNOL, V119, P181, DOI 10.1016/j.biotec.2005.03.021
   Tanaka SM, 2003, J BIOMECH, V36, P73, DOI 10.1016/S0021-9290(02)00245-2
   Tanaka SM, 1999, J BIOMECH, V32, P427, DOI 10.1016/S0021-9290(98)00183-3
   Thomas GP, 1996, CALCIFIED TISSUE INT, V58, P101, DOI 10.1007/BF02529731
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Walboomers XF, 2006, J BIOMED MATER RES A, V76A, P16, DOI 10.1002/jbm.a.30304
   Yang Y, 2006, PHYS MED BIOL, V51, P1649, DOI 10.1088/0031-9155/51/7/001
NR 38
TC 19
Z9 19
U1 4
U2 10
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JAN
PY 2010
VL 81
IS 1
AR 014303
DI 10.1063/1.3284787
PG 6
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 551BG
UT WOS:000274179800044
PM 20113118
DA 2018-10-20
ER

PT J
AU Ficai, M
   Andronescu, E
   Voicu, G
   Ficai, D
   Albu, MG
   Ficai, A
AF Ficai, Maria
   Andronescu, Ecaterina
   Voicu, Georgeta
   Ficai, Denisa
   Albu, Madalina Georgiana
   Ficai, Anton
TI MOLLUSC SHELL/COLLAGEN COMPOSITE AS POTENTIAL BIOMATERIAL FOR BONE
   SUBSTITUTES
SO REVISTA ROMANA DE MATERIALE-ROMANIAN JOURNAL OF MATERIALS
LA English
DT Article
DE mollusc shell; calcium carbonate; collagen; composite; bone graft
ID CORTICAL BONE; PHOSPHATE; SURFACE; ULTRASTRUCTURE; REGENERATION;
   ORIENTATION; SCAFFOLDS; ALLOYS; GROWTH; CELLS
AB In this work our attention was focused on the characterization of a corbicula species shell and the synthesis and characterization of collagen/mollusc shell composite materials. The mollusc shell and the composite material were characterized by XRD, SEM, FTIR and DTA-TG. It can be concluded that mollusc shell contain more than 98% of CaCO3 and less than 2% organic phase. The composite material was obtained by mixing fine milled mollusc shell and collagen in 4:1 weight ratio. The recorded SEM images of the obtained composite material exhibit a very good homogeneity; the collagen nanofibrils acting as glue between carbonate particles.
C1 [Ficai, Maria; Ficai, Anton] Univ POLITEHNICA Bucuresti, Bucharest, Romania.
   [Albu, Madalina Georgiana] INCDTP, Bucharest, Romania.
RP Ficai, M (reprint author), Univ POLITEHNICA Bucuresti, Str Gheorghe Polizu 1,Sector 1, Bucharest, Romania.
EM ficaimaria@yahoo.com
OI FICAI, Anton/0000-0002-1777-0525; Albu, Madalina
   Georgiana/0000-0001-9960-2244; Ecaterina,
   Andronescu/0000-0002-7325-9115; Voicu, Georgeta/0000-0001-7155-7138;
   Ficai, Denisa/0000-0003-1243-6904
FU Romanian National Authority for Scientific Research; European Social
   Fund [POSDRU/89/1.5/S/54785]
FX This work was supported by Romanian National Authority for Scientific
   Research. Authors recognise financial support from the European Social
   Fund through POSDRU/89/1.5/S/54785 project: "Postdoctoral Program for
   Advanced Research in the field of nanomaterials
CR Bandyopadhyay-Ghosh S, 2008, TRENDS BIOMATER ARTI, V22, P112
   Bowman SM, 1996, J BIOMECH, V29, P1497, DOI 10.1016/0021-9290(96)84546-5
   Cai YL, 2006, SCRIPTA MATER, V54, P89, DOI 10.1016/j.scriptamat.2005.09.001
   Castro GR, 2007, MOL PHARMACEUT, V4, P33, DOI 10.1021/mp060100x
   Ficai A, 2010, MATER LETT, V64, P541, DOI 10.1016/j.matlet.2009.11.070
   Gallie WE, 1914, J BONE JOINT SURG S, Vs2-12, P201
   Giraud-Guille MM, 2004, CR PALEVOL, V3, P503, DOI 10.1016/j.crpv.2004.07.004
   Hellmich C, 2004, EUR J MECH A-SOLID, V23, P783, DOI 10.1016/j.euromechsol.2004.05.004
   Jacob DE, 2008, GEOCHIM COSMOCHIM AC, V72, P5401, DOI 10.1016/j.gca.2008.08.019
   Liang CY, 2008, MATER LETT, V62, P3783, DOI 10.1016/j.matlet.2008.03.032
   Liu HN, 2008, ACTA BIOMATER, V4, P1472, DOI 10.1016/j.actbio.2008.02.025
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040
   Materna T, 2008, CLIN ORAL IMPLAN RES, V19, P379, DOI 10.1111/j.1600-0501.2007.01483.x
   Medakovic D, 2003, COMP BIOCHEM PHYS A, V134, P123
   Melinescu A, 2008, REV ROM MAT, V38, P233
   Minea AA, 2007, MATER PLAST, V44, P370
   Monsees TK, 2005, CELLS TISSUES ORGANS, V180, P81, DOI 10.1159/000086749
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Popescu M.L., 2008, UPB SCI B B, V70
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Sasaki N, 2002, J MATER SCI-MATER M, V13, P333, DOI 10.1023/A:1014079421895
   Suzuki O, 2008, CURR MED CHEM, V15, P305, DOI 10.2174/092986708783497283
   Tardei C, 2010, REV ROM MATER, V40, P41
   Yao CH, 1996, MATER CHEM PHYS, V45, P6, DOI 10.1016/0254-0584(96)80040-X
NR 25
TC 3
Z9 3
U1 1
U2 10
PU SERBAN SOLACOLU FOUNDATION
PI BUCUREST
PA STR GHEORGHE POLIZU NR 1, COD 011061 SECTOR 1, BUCUREST, 00000, ROMANIA
SN 1583-3186
J9 REV ROM MATER
JI Rev. Rom. Mat.
PY 2010
VL 40
IS 4
BP 359
EP 364
PG 6
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA 704GS
UT WOS:000286039700010
DA 2018-10-20
ER

PT J
AU Ion, R
   Mitran, V
   Ciofrangeanu, CM
   Galateanu, B
   Cimpean, A
   Iordachescu, D
AF Ion, Raluca
   Mitran, Valentina
   Ciofrangeanu, Cristina M.
   Galateanu, Bianca
   Cimpean, Anisoara
   Iordachescu, Dana
TI Comparative study of the in vitro behaviour of osteoblasts on titanium
   and zirconium oxide materials
SO ROMANIAN BIOTECHNOLOGICAL LETTERS
LA English
DT Article
DE osteoblasts; titanium; zirconium oxide; fibronectin; integrins;
   cytoskeleton; proliferation; matrix metaloproteinase
ID GENE-EXPRESSION; INTEGRINS; FIBRONECTIN; BIOMATERIAL; ATTACHMENT;
   INTERFACE; ADHESION; SURFACES; PROTEIN
AB In vitro biocompatibility of zirconium oxide was investigated in comparison with titanium, which is considered the gold standard for medical implants, by using hFOB 1.19 osteoblastic cell line. The viability of osteoblasts was evaluated by MTT and LDH tests that demonstrated the absence of any cytostatic or cytotoxic effect. Immunocytochemical staining of fibronectin, showed the capacity of these cells to elaborate extracellularly large amounts of this important adhesive protein, suggesting a good cell adhesion to both materials. Despite the differences in cell morphology and orientation, fluorescence microscopy studies of beta-integrins and some cytoskeletal proteins revealed almost identical immunolabeling patterns in the cells grown on titanium and zirconia substrates. Cell proliferation, evaluated by bromodeoxyuridine (BrdU) incorporation assay and Proliferating Cell Nuclear Antigen (PCNA) analysis, was similar in both situations. Zymographic analysis of gelatinolytic activities specific to matrix metalloproteinases secreted by cells grown in contact with both materials for different time periods showed no differences in terms of extracellular matrix degradation, suggesting the possibility of equivalent capacities of implant integration into the host tissue. Our in vitro results showed that osteoblast responses to zirconia and titanium are comparable and, therefore, the analyzed zirconia substrate (Biozyr) can be successfully utilized it? bone implantology.
C1 [Ion, Raluca; Mitran, Valentina; Ciofrangeanu, Cristina M.; Galateanu, Bianca; Cimpean, Anisoara; Iordachescu, Dana] Univ Bucharest, Fac Biol, Dept Biochem & Mol Biol, Bucharest, Romania.
RP Cimpean, A (reprint author), Univ Bucharest, Fac Biol, Dept Biochem & Mol Biol, Bucharest, Romania.
EM anisoara.cimpean@bio.unibuc.ro
RI Cimpean, Anisoara/C-2101-2011; Galateanu, Bianca/D-1632-2015
OI Cimpean, Anisoara/0000-0002-5833-3110; Galateanu,
   Bianca/0000-0001-8093-1750; Ion, Raluca/0000-0001-9871-4981; Mitran,
   Valentina/0000-0002-5192-9595
FU National University Research Council, Romania [A 1019/2006]
FX We gratefully acknowledge the National University Research Council,
   Romania for funding of this research through Grant A 1019/2006.
CR Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   CIMPEAN A, 1998, J MED BIOCHEM, V2, P313
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   FISHER JE, 1993, ENDOCRINOLOGY, V132, P1411, DOI 10.1210/en.132.3.1411
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Globus RK, 1998, J CELL SCI, V111, P1385
   Hatori K, 2004, ANAT REC PART A, V277A, P262, DOI 10.1002/ar.a.20007
   HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   TREMBLE P, 1995, J CELL BIOL, V129, P1707, DOI 10.1083/jcb.129.6.1707
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 21
TC 1
Z9 1
U1 0
U2 4
PU ARS DOCENDI
PI BUCHAREST
PA SOS PANDURI 90, SECT 5, BUCHAREST, RO-050663, ROMANIA
SN 1224-5984
J9 ROM BIOTECH LETT
JI Rom. Biotech. Lett.
PD JAN-FEB
PY 2010
VL 15
IS 1
BP 5049
EP 5058
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 565EO
UT WOS:000275272200016
DA 2018-10-20
ER

PT J
AU Aragon, J
   Gonzalez, R
   Fuentes, G
   Palin, L
   Croce, G
   Viterbo, D
AF Aragon, Javier
   Gonzalez, Ramon
   Fuentes, Gaston
   Palin, Luca
   Croce, Gianluca
   Viterbo, Davide
TI Characterization of Novel Controlled Release System of Cephalexin from
   Polyvinyl Acetate/CaCO3/coralline Hydroxyapatite Composite
SO SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS
LA English
DT Article
DE Composite; Drug release; Degradation; Calcium Carbonate
ID CALCIUM-PHOSPHATE CEMENT; BONE CEMENTS; DELIVERY; DRUGS
AB This study explored the potential of polyvinyl acetate/CaCO3/coralline hydroxyapatite composites to act as a controlled drug delivery system. Firstly, a composite biomaterial was prepared and cephalexin was added as a model drug. Physical chemical characterization showed that the incorporation of CaCO3 causes morphological changes in the biomaterial surfaces, due to degradation process of this material after 30 days in contact with phosphate-buffered saline solution. Moreover, the formulations studied behave as a system for controlled release of Cephalexin for 21 days. It was demonstrated that the controlled release of Cephalexin from these composites is carried out through a process of Fickian diffusion, with certain influence of Polymer relaxation which increases CaCO3/HAP-200 ratio. On the other hand, the mathematical model proposed by Peppas and Shalin had the best fit to the data experimental, because this model consider the phenomenon of Fickian diffusion as well as the phenomenon of relaxation or swelling of the polymer.
C1 [Aragon, Javier; Gonzalez, Ramon] Natl Ctr Sci Res, Havana 6880, Cuba.
   [Fuentes, Gaston] Univ Havana, Ctr Biomat, Havana, Cuba.
   [Palin, Luca; Croce, Gianluca; Viterbo, Davide] Univ Piemonte Orientale, Dept Adv Sci & Technol, Alessandria, Italy.
RP Aragon, J (reprint author), Natl Ctr Sci Res, POB 6990, Havana 6880, Cuba.
RI Aragon, Javier/M-9783-2017; Croce, Gianluca/G-2804-2011
OI Aragon, Javier/0000-0003-0505-2435; Palin, Luca/0000-0001-5347-7409
FU FONDAZIONE ISI
FX We thank to FONDAZIONE ISI (LAGRANGE FELLOW 2007) for financial support
   for this scientific project and the Dipartimento di Scienze e Tecnologie
   Avanzate (DISTA) Universita del Piemonte Orientale "A. Avogadro"
CR ARAGON J, 2008, REV CENIC, V39, P94
   Aragon J, 2009, REV IBEROAMERICANA P, V10, P119
   ARAGON J, 2006, REV CENIC, V37, P197
   Armstrong MS, 2002, ACTA ORTHOP SCAND, V73, P688, DOI 10.3109/17453670209178038
   Baker R.W., 1974, CONTROLLED RELEASE B
   Blardoni F, 1998, BIOCERAMICS, V11, P599
   Blom EJ, 2002, J BIOMED MATER RES, V59, P265, DOI 10.1002/jbm.1241
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Gbureck U, 2004, BIOMATERIALS, V25, P2187, DOI 10.1016/j.biomaterials.2003.08.066
   Gbureck U, 2002, BIOMOL ENG, V19, P51, DOI 10.1016/S1389-0344(02)00010-2
   GONZALEZ R, 1993, QUIM NOVA, V16, P513
   Gonzalez R., 2007, United State Patent, Patent No. 0053951
   Green D, 2004, J MATER CHEM, V14, P2206, DOI 10.1039/b400486h
   Green DW, 2009, BIOMATERIALS, V30, P1918, DOI 10.1016/j.biomaterials.2008.12.052
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Iglesias G, 2009, United State Patent No, Patent No. 0306226
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Nelson CL, 2004, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.bio.0000143741.92384.18
   Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571
   PEPPAS NA, 1989, INT J PHARM, V57, P169, DOI 10.1016/0378-5173(89)90306-2
   REGI MV, 2006, LIBERACION FARMACOS
   RUIZ A, 2005, THESIS U SEVILLA SPA
   Serra L, 2006, BIOMATERIALS, V27, P5440, DOI 10.1016/j.biomaterials.2006.06.011
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   Wikesjo UME, 2003, J PERIODONTOL, V74, P957, DOI 10.1902/jop.2003.74.7.957
NR 26
TC 2
Z9 2
U1 1
U2 6
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-181X
J9 SCI ENG COMPOS MATER
JI Sci. Eng. Compos. Mater.
PY 2010
VL 17
IS 3
BP 173
EP 182
PG 10
WC Materials Science, Composites
SC Materials Science
GA 664AN
UT WOS:000282931400003
DA 2018-10-20
ER

PT S
AU Wischke, C
   Neffe, AT
   Lendlein, A
AF Wischke, Christian
   Neffe, Axel T.
   Lendlein, Andreas
BA Lendlein, A
BF Lendlein, A
TI Controlled Drug Release from Biodegradable Shape-Memory Polymers
SO SHAPE-MEMORY POLYMERS
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE Controlled drug release; Shape-memory polymer; Multifunctional material;
   Biodegradable polymer; Biomaterial
ID GLASS-TRANSITION TEMPERATURE; ACTING DELIVERY-SYSTEMS;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; HYDROLYTIC DEGRADATION; ALIPHATIC
   POLYESTERS; NARCOTIC-ANTAGONISTS; NETWORKS; MICROSPHERES; POLYURETHANE;
   BIOMATERIALS
AB Biodegradable shape-memory polymers (SMPs) have attracted significant interest for biomedical applications. Modern concepts for biofunctional implants often comprise the controlled release of bioactive compounds to gain specific biofunctionalities. Therefore, a general strategy has been suggested for polymer systems combining degradability and shape-memory capability with controlled release of drugs. This chapter provides a detailed description of the molecular basis for such multifunctional SMPs including the selection of building blocks, the polymer morphology, and the three dimensional architecture. Moreover, drug loading and release, drug effects on thermomechanical properties of SMPs, and drug release patterns in a physiological environment are described and potential applications in minimally-invasive surgery are discussed.
C1 [Lendlein, Andreas] GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de; andreas.lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013; Wischke, Christian/K-9651-2013; Neffe,
   Axel/H-6997-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Wischke,
   Christian/0000-0001-5531-9033; Neffe, Axel/0000-0002-5056-3990
CR Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   ASO Y, 1994, J CONTROL RELEASE, V31, P33, DOI 10.1016/0168-3659(94)90248-8
   Bajpai AK, 2008, PROG POLYM SCI, V33, P1088, DOI 10.1016/j.progpolymsci.2008.07.005
   Bawa P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/022001
   BECK LR, 1979, AM J OBSTET GYNECOL, V135, P419, DOI 10.1016/0002-9378(79)90717-8
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Behl M, 2010, ADV POLYM SCI, V226, P1, DOI 10.1007/12_2009_26
   Blasi P, 2007, AAPS PHARMSCITECH, V8
   BODMEIER R, 1987, PHARMACEUT RES, V4, P465, DOI 10.1023/A:1016419303727
   Budhian A, 2005, J MICROENCAPSUL, V22, P773, DOI 10.1080/02652040500273753
   CHA Y, 1989, J CONTROL RELEASE, V8, P259, DOI 10.1016/0168-3659(89)90047-3
   CHANG TMS, 1976, J BIOENG, V1, P25
   Chen MC, 2007, BIOMACROMOLECULES, V8, P2774, DOI 10.1021/bm7004615
   Chen MC, 2009, BIOMATERIALS, V30, P79, DOI 10.1016/j.biomaterials.2008.09.006
   CHIANG CN, 1984, CLIN PHARMACOL THER, V36, P704, DOI 10.1038/clpt.1984.243
   Cho JW, 2005, MACROMOL RAPID COMM, V26, P412, DOI 10.1002/marc.200400492
   Cosijns A, 2009, DRUG DEV IND PHARM, V35, P655, DOI 10.1080/03639040802578103
   Desai KGH, 2008, PHARM RES, V25, P586, DOI 10.1007/s11095-007-9430-1
   DESIMON JM, 2005, Patent No. 6932930
   FENG Y, 2007, Patent No. 2007131893
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448
   Jerome C, 2008, ADV DRUG DELIVER REV, V60, P1056, DOI 10.1016/j.addr.2008.02.008
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   LANGER RS, 2000, Patent No. 6160084
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Lendlein A, 2001, MACROMOL CHEM PHYSIC, V202, P2702, DOI 10.1002/1521-3935(20010901)202:13<2702::AID-MACP2702>3.0.CO;2-I
   LENDLEIN A, 2004, Patent No. 2004006885
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   Leng JS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2829388
   Leng JS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2790497
   Leng JS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2936288
   Li L, 2005, J CONTROL RELEASE, V101, P163, DOI 10.1016/j.jconrel.2004.07.029
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Luan XS, 2006, EUR J PHARM SCI, V27, P143, DOI 10.1016/j.ejps.2005.09.002
   Lv HB, 2008, ADV ENG MATER, V10, P592, DOI 10.1002/adem.200800002
   Malucelli G, 1996, POLYMER, V37, P2565, DOI 10.1016/0032-3861(96)85373-0
   MATHER PT, 2009, Patent No. 7524914
   MAULDING H V, 1986, Journal of Controlled Release, V3, P103, DOI 10.1016/0168-3659(86)90071-4
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Nagahama K, 2009, BIOMACROMOLECULES, V10, P1789, DOI 10.1021/bm9002078
   Natu MV, 2008, J SUPERCRIT FLUID, V47, P93, DOI 10.1016/j.supflu.2008.05.006
   Navarro M, 2006, ADV POLYM SCI, V200, P209, DOI 10.1007/12_068
   Neffe AT, 2009, MATER RES SOC SYMP P, V1190, P105
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Niu CH, 1998, J PHARM SCI, V87, P1331, DOI 10.1021/js9800782
   OKADA H, Patent No. 4652441
   Olson DA, 2006, J AM CHEM SOC, V128, P13625, DOI 10.1021/ja063092m
   REMINGTON GJ, 1995, CAN J PSYCHIAT, V40, pS5
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2002, BIOMED TECH, V47, P285, DOI 10.1515/bmte.2002.47.11.285
   Rousseau IA, 2008, POLYM ENG SCI, V48, P2075, DOI 10.1002/pen.21213
   SANDERS LM, 1984, J PHARM SCI, V73, P1294, DOI 10.1002/jps.2600730927
   SHIKINAMI Y, 2004, Patent No. 100958
   STANKUS J, 2009, 20090035350 US, VAPPL
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wang WS, 2006, EUR POLYM J, V42, P1240, DOI 10.1016/j.eurpolymj.2005.11.029
   Weigel T, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/2/025011
   Wischke C, 2009, MATER RES SOC SYMP P, V1190, P131
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
   Wischumerski RS, 2008, J PHARM SCI-US, V97, P4416, DOI 10.1002/jps.21323
   WOODLAND JH, 1973, J MED CHEM, V16, P897, DOI 10.1021/jm00266a007
   Yakacki CM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015010
   Yang B, 2005, SCRIPTA MATER, V53, P105, DOI 10.1016/j.scriptamat.2005.03.009
   Yang B, 2004, SMART MATER STRUCT, V13, P191, DOI 10.1088/0964-1726/13/1/022
   YOLLES S, 1975, J PHARM SCI, V64, P348, DOI 10.1002/jps.2600640239
   YOSHIOKA S, 1991, J CONTROL RELEASE, V16, P341, DOI 10.1016/0168-3659(91)90011-2
   Young J L, 1986, Bull Am Acad Psychiatry Law, V14, P105
   Zotzmann J, 2009, MATER RES SOC SYMP P, V1190, P37
   Zotzmann J, 2009, J MATER SCI-MATER M, V20, P1815, DOI 10.1007/s10856-009-3761-x
NR 81
TC 37
Z9 37
U1 5
U2 73
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 978-3-642-12358-0
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2010
VL 226
BP 177
EP 205
DI 10.1007/12_2009_29
D2 10.1007/978-3-642-12359-7
PG 29
WC Polymer Science
SC Polymer Science
GA BPK60
UT WOS:000279065300005
DA 2018-10-20
ER

PT J
AU Marklein, RA
   Burdick, JA
AF Marklein, Ross A.
   Burdick, Jason A.
TI Spatially controlled hydrogel mechanics to modulate stem cell
   interactions
SO SOFT MATTER
LA English
DT Article
ID SUBSTRATE COMPLIANCE; DIFFERENTIATION; STIFFNESS; NETWORKS; BEHAVIOR;
   PHOTOPOLYMERIZATION; MICROENVIRONMENTS; PROLIFERATION; MIGRATION;
   INTERPLAY
AB Local control of the stem cell microenvironment with biomaterial design is of critical importance for tissue engineering. Matrix mechanics is one aspect of biomaterial design that has received considerable attention recently due to the effect of mechanics on stem cell proliferation, morphology, and differentiation. In order to investigate the effect of locally controlled mechanics on human mesenchymal stem cells (hMSCs), a sequentially crosslinked hyaluronic acid hydrogel system was developed that permits spatial patterning of mechanics ( distinct patterns and gradients). Methacrylated hyaluronic acid was synthesized to allow for crosslinking via both Michael-type addition using a dithiol and radical polymerization using light. By varying the initial methacrylate consumption through addition crosslinking, restricting UV light to specified regions, and varying UV exposure time, a wide range of mechanics (from similar to 3 kPa to similar to 100 kPa) was possible in both uniform and patterned hydrogels. hMSCs exhibited increased spreading and proliferation on stiffer gels compared to cells cultured on softer gels. Furthermore, cells grown on gels with patterned mechanics exhibited spreading and proliferation behavior that correlated with the local mechanics. This method to spatially control matrix mechanics represents a novel hydrogel system to tune the stem cell microenvironment.
C1 [Marklein, Ross A.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
FU David and Lucile Packard Foundation (JAB); National Science Foundation
   CAREER Award (JAB); Graduate Research Fellowship Program (RAM)
FX The authors gratefully acknowledge funding from the David and Lucile
   Packard Foundation (JAB) and the National Science Foundation CAREER
   Award (JAB) and Graduate Research Fellowship Program (RAM).
CR Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   BURDICK JA, 2008, TISSUE ENG PART A, V5, P205
   Byfield FJ, 2009, J BIOMECH, V42, P1114, DOI 10.1016/j.jbiomech.2009.02.012
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chou SY, 2009, BIOMATERIALS, V30, P3136, DOI 10.1016/j.biomaterials.2009.02.037
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Hsiong SX, 2008, J BIOMED MATER RES A, V85A, P145, DOI 10.1002/jbm.a.31521
   Hwang NS, 2006, BIOMATERIALS, V27, P6015, DOI 10.1016/j.biomaterials.2006.06.033
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kutty JK, 2007, BIOMATERIALS, V28, P4928, DOI 10.1016/j.biomaterials.2007.08.007
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Liu YX, 2009, BIOMATERIALS, V30, P196, DOI 10.1016/j.biomaterials.2008.09.041
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863
   Rokstad AM, 2006, BIOMATERIALS, V27, P4726, DOI 10.1016/j.biomaterials.2006.05.011
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zajac AL, 2008, CURR OPIN CELL BIOL, V20, P609, DOI 10.1016/j.ceb.2008.09.006
   Zawko SA, 2009, ACTA BIOMATER, V5, P14, DOI 10.1016/j.actbio.2008.09.012
NR 49
TC 144
Z9 144
U1 6
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 1
BP 136
EP 143
DI 10.1039/b916933d
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 533RV
UT WOS:000272843200012
DA 2018-10-20
ER

PT J
AU Khire, TS
   Kundu, J
   Kundu, SC
   Yadavalli, VK
AF Khire, Tejas S.
   Kundu, Joydip
   Kundu, Subhas C.
   Yadavalli, Vamsi K.
TI The fractal self-assembly of the silk protein sericin
SO SOFT MATTER
LA English
DT Article
ID TROPICAL TASAR SILKWORM; DIFFUSION-LIMITED AGGREGATION; BOMBYX-MORI;
   ANTHERAEA-MYLITTA; FIBROIN; BIOMATERIALS; PURIFICATION; ORGANIZATION;
   FABRICATION; PATTERNS
AB Silk consists primarily of two proteins-a fibrous core protein, fibroin, and a glue protein, sericin, which envelops the fibroin fibers with sticky layers thus helping in the formation of cocoon, achieved by cementing the silk fibers together. Sericin, a water soluble protein, has traditionally been discarded in silk processing, despite great potential for use as a biomaterial. Here we show that this glue protein, sericin, has the ability to form self-assembled nano and microstructures with hierarchical self-similarity across length scales in the form of a diffusion-limited, fractal assembly. Sericin obtained from two silkworms, a domesticated mulberry Bombyx mori and a wild non-mulberry Antheraea mylitta, were studied, with particular insight into its structure and morphology as it dried on a surface. High-resolution atomic force microscopy was used to image the self-assembled protein, with investigations on the various factors that influenced this process. We describe the self-assembly patterns formed by the sericin protein and analyze the images based on the theory of diffusion limited aggregation to explain the fractal nature of these architectures observed. The unique physical behavior and fractal nature of this glue protein may represent a key step in understanding its biological relevance as well as the role it plays in the assembly and formation of silks.
C1 [Khire, Tejas S.; Kundu, Joydip; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in; vyadavalli@vcu.edu
OI Yadavalli, Vamsi/0000-0002-8879-1948; Kundu, Subhas
   C./0000-0002-7170-2291
FU Indo-Australia Biotechnology Fund; Govt. of India; VCU School of
   Engineering
FX The Department of Biotechnology and its bioinformatics facility, the
   Indo-Australia Biotechnology Fund, the Govt. of India and the VCU School
   of Engineering supported this work financially. The short visit by S. C.
   K. to VCU during this work was made possible by the Indo-US Science and
   Technology Forum, New Delhi, India.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aon MA, 2004, MOL CELL BIOCHEM, V256, P169, DOI 10.1023/B:MCBI.0000009867.54552.09
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Halsey TC, 2000, PHYS TODAY, V53, P36, DOI 10.1063/1.1333284
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Huang J, 2007, POLYM REV, V47, P29, DOI 10.1080/15583720601109560
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kaplan D, 1994, SILK POLYM MAT SCI B
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kucheryavski S, 2009, ANAL CHIM ACTA, V642, P135, DOI 10.1016/j.aca.2008.12.016
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   LANGER JS, 1987, PHYS REV A, V36, P3350, DOI 10.1103/PhysRevA.36.3350
   Lomander A, 2005, NANO LETT, V5, P1255, DOI 10.1021/nl050203r
   Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102
   NITTMANN J, 1986, NATURE, V321, P663, DOI 10.1038/321663a0
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Reiter G., 2007, LECT NOTE PHYS, V714, P179
   Sheparovych R, 2009, BIOMACROMOLECULES, V10, P1955, DOI 10.1021/bm900368c
   SINOHARA H, 1971, BIOCHIM BIOPHYS ACTA, V237, P273, DOI 10.1016/0304-4165(71)90317-5
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5
   Sneer R, 2004, CHEMPHYSCHEM, V5, P747, DOI 10.1002/cphc.200301046
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 36
TC 38
Z9 38
U1 4
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 9
BP 2066
EP 2071
DI 10.1039/b924530h
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 587YA
UT WOS:000277031300031
DA 2018-10-20
ER

PT J
AU Tran, RT
   Thevenot, P
   Gyawali, D
   Chiao, JC
   Tang, LP
   Yang, J
AF Tran, Richard T.
   Thevenot, Paul
   Gyawali, Dipendra
   Chiao, Jung-Chih
   Tang, Liping
   Yang, Jian
TI Synthesis and characterization of a biodegradable elastomer featuring a
   dual crosslinking mechanism
SO SOFT MATTER
LA English
DT Article
ID POLYESTER POLY(PROPYLENE FUMARATE); TISSUE ENGINEERING SCAFFOLDS;
   BIOMEDICAL APPLICATIONS; BLOCK-COPOLYMERS; HYDROGELS; BIOMATERIALS;
   NETWORK; ACID; GLYCOL)
AB The need for advanced materials in emerging technologies such as tissue engineering has prompted increased research to produce novel biodegradable polymers elastic in nature and mechanically compliant with the host tissue. We have developed a soft biodegradable elastomeric platform biomaterial created from citric acid, maleic anhydride, and 1,8-octanediol, poly(octamethylene maleate (anhydride) citrate) (POMaC), which is able to closely mimic the mechanical properties of a wide range of soft biological tissues. POMaC features a dual crosslinking mechanism, which allows for the option of the crosslinking POMaC using UV irradiation and/or polycondensation to fit the needs of the intended application. The material properties, degradation profiles, and functionalities of POMaC thermoset networks can all be tuned through the monomer ratios and the dual crosslinking mechanism. POMaC polymers displayed an initial modulus between 0.03 and 1.54 MPa, and elongation at break between 48% and 534% strain. In vitro and in vivo evaluation using cell culture and subcutaneous implantation, respectively, confirmed cell and tissue biocompatibility. POMaC biodegradable polymers can also be combined with MEMS technology to fabricate soft and elastic 3D microchanneled scaffolds for tissue engineering applications. The introduction of POMaC will expand the choices of available biodegradable polymeric elastomers. The dual crosslinking mechanism for biodegradable elastomer design should contribute to biomaterials science.
C1 [Tran, Richard T.; Thevenot, Paul; Gyawali, Dipendra; Tang, Liping; Yang, Jian] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Chiao, Jung-Chih] Univ Texas Arlington, Dept Elect Engn, Arlington, TX 76019 USA.
RP Yang, J (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM jianyang@uta.edu
RI Yang, Jian/N-1291-2014; gyawali, Dipendra/G-2290-2012
OI Yang, Jian/0000-0003-0695-828X; 
FU American Heart Association; National Institute of Biomedical Imaging and
   Bioengineering (NIBIB) [R21EB009795]; NIH [R01 GM074021]
FX This work was supported in part by American Heart Association Beginning
   Grant-in-Aid award (to J.Y.), award R21EB009795 from the National
   Institute of Biomedical Imaging and Bioengineering (NIBIB) (to J.Y.) and
   NIH R01 GM074021 (to L.T).
CR Almeida-Silveira MI, 2000, EUR J APPL PHYSIOL, V81, P252
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bashir R, 2004, ADV DRUG DELIVER REV, V56, P1565, DOI 10.1016/j.addr.2004.03.002
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chen ZF, 2009, BIOMATERIALS, V30, P2219, DOI 10.1016/j.biomaterials.2008.12.078
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guo BL, 2007, COLLOID SURFACE B, V58, P151, DOI 10.1016/j.colsurfb.2007.03.001
   GYAWALI D, 2010, J BIOMAT SCI-POLYM E, V1, DOI DOI 10.1163/092050609X12567178204169
   Harrisson S, 2005, CHEM COMMUN, P3259, DOI 10.1039/b504313a
   Jacinto A., 2001, NAT CELL BIOL, V3, P117
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kim JK, 2008, BIOMACROMOLECULES, V9, P149, DOI 10.1021/bm700924n
   Kim SH, 1999, J BIOMED MATER RES, V46, P160, DOI 10.1002/(SICI)1097-4636(199908)46:2<160::AID-JBM4>3.0.CO;2-P
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lang MD, 2002, J APPL POLYM SCI, V86, P2296, DOI 10.1002/app.11221
   LANGER R, 1993, SCIENCE, V920, P260
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Noga DE, 2008, BIOMACROMOLECULES, V9, P2056, DOI 10.1021/bm800292Z
   Pompe T, 2003, BIOMACROMOLECULES, V4, P1072, DOI 10.1021/bm034071c
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rowley JA, 2002, ADV MATER, V14, P886, DOI 10.1002/1521-4095(20020618)14:12<886::AID-ADMA886>3.0.CO;2-I
   Shi PH, 2004, EUR POLYM J, V40, P1283, DOI 10.1016/j.europolymj.2004.02.024
   Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Tanodekaew S, 2006, J APPL POLYM SCI, V100, P1914, DOI 10.1002/app.22919
   TRAN RT, 2010, RECENT PAT BIOMED EN, V2, P216
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Vert M, 2004, Med J Malaysia, V59 Suppl B, P73
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.2162
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Yang J, 2005, TISSUE ENG, V11, P1876, DOI 10.1089/ten.2005.11.1876
   Yang J, 2003, J BIOMED MATER RES A, V67A, P1139, DOI 10.1002/jbm.a.10034
   Zhao HC, 2009, J APPL POLYM SCI, V114, P1464, DOI 10.1002/app.30735
   Zhu W, 2006, J APPL POLYM SCI, V99, P2375, DOI 10.1002/app.22674
NR 54
TC 45
Z9 45
U1 4
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 11
BP 2449
EP 2461
DI 10.1039/c001605e
PG 13
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 601GM
UT WOS:000278046300014
PM 22162975
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Papenburg, BJ
   Rodrigues, ED
   Wessling, M
   Stamatialis, D
AF Papenburg, Bernke J.
   Rodrigues, Emilie Dooms
   Wessling, Matthias
   Stamatialis, Dimitrios
TI Insights into the role of material surface topography and wettability on
   cell-material interactions
SO SOFT MATTER
LA English
DT Article
ID BLOCK-COPOLYMER FILMS; PROTEIN ADSORPTION; BICINCHONINIC ACID;
   MAMMALIAN-CELLS; MUSCLE CELLS; ADHESION; CULTURE; SCAFFOLDS;
   POLYDIMETHYLSILOXANE; COMPATIBILITY
AB This work investigates the effect of surface topography and biomaterial wettability on protein absorption, cell attachment, proliferation and morphology and reveals important insights in the complexity of cell-material interactions. We use various materials, i.e. poly(dimethyl siloxane) (PDMS), poly(L-lactic acid) (PLLA), a co-polymer of poly(ethylene oxide) and poly(butylene terephtalate) (PEOT/PBT) and tissue culture polystyrene (TCPS) as a reference. These materials are used extensively in biomedical applications and tissue engineering and have differences in hydrophobicity. Patterning of PDMS, PLLA and PEOT/PBT with a micropattern array of pillars with variable pillar spacing and pillar height induces changes in the wettability of their surfaces without changes in their surface chemistry. The cell study is performed using C2C12 pre-myoblasts cells. Our results reveal a clear effect of surface topography, and to a lesser extent of material hydrophobicity, on cell attachment, morphology and proliferation. Generally, surface topography on high hydrophobicity materials improves initial C2C12 cell attachment, whereas less hydrophobic and nonpatterned materials seem to support higher cell proliferation and spreading. With respect to cell morphology, surface topography seems dominant over material wettability; although the transition where cells change from growing on top of the pillars to growing on the underlying surface appears to be determined by the material wettability. These findings are important in the design of biomaterials in various applications including implants, bio-artificial organs and tissue engineering.
C1 [Papenburg, Bernke J.; Rodrigues, Emilie Dooms; Wessling, Matthias; Stamatialis, Dimitrios] Univ Twente, Fac Sci & Technol, Inst Biomed Technol & Tech Med MIRA, NL-7500 AE Enschede, Netherlands.
RP Stamatialis, D (reprint author), Univ Twente, Fac Sci & Technol, Inst Biomed Technol & Tech Med MIRA, POB 217, NL-7500 AE Enschede, Netherlands.
EM d.stamatialis@utwente.nl
RI Zhou, Feng/E-9510-2011; Luong-Van, Emma/A-8685-2012; Wessling,
   Matthias/K-4797-2012
OI Wessling, Matthias/0000-0002-7874-5315
FU University of Twente (MIRA, Institute for Biomedical Technology and
   Technical Medicine)
FX This project is financially supported by the Spearhead program:
   'Advanced Polymeric Microstructures for Tissue Engineering' at the
   University of Twente (MIRA, Institute for Biomedical Technology and
   Technical Medicine).
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Betancourt T, 2006, INT J NANOMED, V1, P483, DOI 10.2147/nano.2006.1.4.483
   Bico J, 1999, EUROPHYS LETT, V47, P220, DOI 10.1209/epl/i1999-00548-y
   Boxshall K, 2006, SURF INTERFACE ANAL, V38, P198, DOI 10.1002/sia.2274
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297
   Claase MB, 2003, BIOMACROMOLECULES, V4, P57, DOI 10.1021/bm0256045
   Dorrer C, 2009, SOFT MATTER, V5, P51, DOI 10.1039/b811945g
   Dusseiller MR, 2005, LAB CHIP, V5, P1387, DOI 10.1039/b509957a
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Gay S, 2009, MAT SCI ENG C-BIO S, V29, P172, DOI 10.1016/j.msec.2008.06.005
   Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w
   Hyun JH, 2006, BIOMATERIALS, V27, P1444, DOI 10.1016/j.biomaterials.2005.08.018
   Kajzar A, 2008, BIOPHYS J, V94, P1854, DOI [10.1529/biophysj.107.115766, 10.1529/biophy.sj.107.115766]
   Kidambi S, 2007, TISSUE ENG, V13, P2105, DOI 10.1089/ten.2006.0151
   KIM HI, 2009, TISSUE ENG
   Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b
   Klee D, 1999, ADV POLYM SCI, V149, P1
   Korin N, 2007, LAB CHIP, V7, P611, DOI 10.1039/b702392h
   Krause B, 2003, CHEM-ING-TECH, V75, P1725, DOI 10.1002/cite.200306149
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lubarsky GV, 2004, SURF SCI, V558, P135, DOI 10.1016/j.susc.2004.03.054
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Mata A., 2007, INT J NANOMED, V2, P1
   Mills CA, 2007, SMALL, V3, P871, DOI 10.1002/smll.200600683
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Nagahama K, 2007, POLYMER, V48, P2649, DOI 10.1016/j.polymer.2007.03.017
   Nisbet DR, 2006, J COLLOID INTERF SCI, V299, P647, DOI 10.1016/j.jcis.2006.02.057
   OKANO T, 1978, POLYM J, V10, P223, DOI 10.1295/polymj.10.223
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Riekerink MBO, 2003, J BIOMED MATER RES A, V65A, P417, DOI 10.1002/jbm.a.10520
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Saltzman W, 2004, TISSUE ENG PRINCIPLE
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50
   Sugiura S, 2008, COLLOID SURFACE B, V63, P301, DOI 10.1016/j.colsurfb.2007.12.013
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Tanaka Y, 2006, LAB CHIP, V6, P362, DOI 10.1039/b515149j
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wang H., 2000, AM J PHYSIOL-CELL PH, V279, P1345
   Wang Y.-Q., 2007, CURR APPL PHYS, V7, pe108
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 58
TC 39
Z9 39
U1 4
U2 52
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 18
BP 4377
EP 4388
DI 10.1039/b927207k
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 647JC
UT WOS:000281613700013
DA 2018-10-20
ER

PT J
AU Willie, BM
   Petersen, A
   Schmidt-Bleek, K
   Cipitria, A
   Mehta, M
   Strube, P
   Lienau, J
   Wildemann, B
   Fratzl, P
   Duda, G
AF Willie, Bettina M.
   Petersen, Ansgar
   Schmidt-Bleek, Katharina
   Cipitria, Amaia
   Mehta, Manav
   Strube, Patrick
   Lienau, Jasmin
   Wildemann, Britt
   Fratzl, Peter
   Duda, Georg
TI Designing biomimetic scaffolds for bone regeneration: why aim for a copy
   of mature tissue properties if nature uses a different approach?
SO SOFT MATTER
LA English
DT Review
ID PEPTIDE-AMPHIPHILE NANOFIBERS; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL
   STEM-CELLS; MARROW STROMAL CELLS; DEGRADABLE HYDROGEL MATRICES;
   SEGMENTAL TIBIAL DEFECTS; POSTERIOR ILIAC CREST; OSTEOBLAST-LIKE CELLS;
   PLATELET-RICH PLASMA; DISTRACTION OSTEOGENESIS
AB This review aims to address the current limitations in biomaterial scaffold-based treatment strategies for bone defect healing and suggests new, alternative approaches that merit further investigation. The question of whether the biomaterial scaffold properties should mimic the natural extracellular matrix of mature tissue or some phase of the dynamic range of tissues observed during the healing process is discussed. Additionally, the authors advocate for a biomimetic approach, which uses the endogenous secondary fracture healing processes to inform the design of scaffold constructs. In particular, the mechanical environment is emphasized as an important factor influencing the clinical success of these constructs. The authors stress the need for a scaffolds design that provides an optimal mechanical environment for cell fate, supplies necessary signals and nutrition to the cells and, thus, more closely mimics the natural healing cascade.
C1 [Willie, Bettina M.; Petersen, Ansgar; Schmidt-Bleek, Katharina; Cipitria, Amaia; Mehta, Manav; Strube, Patrick; Lienau, Jasmin; Wildemann, Britt; Duda, Georg] Charite Univ Med Berlin Campus Virchow Klinkum, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Willie, Bettina M.; Petersen, Ansgar; Schmidt-Bleek, Katharina; Cipitria, Amaia; Mehta, Manav; Strube, Patrick; Lienau, Jasmin; Wildemann, Britt; Duda, Georg] Charite Univ Med Berlin Campus Virchow Klinkum, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
   [Petersen, Ansgar; Lienau, Jasmin; Wildemann, Britt; Fratzl, Peter; Duda, Georg] Charite Univ Med Berlin Campus Virchow Klinkum, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany.
   [Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.
RP Willie, BM (reprint author), Charite Univ Med Berlin Campus Virchow Klinkum, Julius Wolff Inst, D-13353 Berlin, Germany.
EM georg.duda@charite.de
RI Cipitria, Amaia/J-2010-2014; Wildemann, Britt/G-7732-2012; Fratzl,
   Peter/H-9095-2012; Willie, Bettina/G-2397-2014; Duda, Georg/H-2085-2016;
   Petersen, Ansgar/O-1945-2015
OI Cipitria, Amaia/0000-0002-9918-1512; Wildemann,
   Britt/0000-0002-8365-1188; Fratzl, Peter/0000-0003-4437-7830; Willie,
   Bettina/0000-0003-2907-3580; Duda, Georg/0000-0001-7605-3908; 
FU German Research Foundation [DFG SFB 760]; CEIT San Sebastian, Spain
FX The authors would like to acknowledge the financial support of the
   German Research Foundation (DFG SFB 760) and financial support from the
   CEIT (CEIT, Manuel de Lardizabal 15, 20018 San Sebastian, Spain) for A.
   Cipitria.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Arrington E D, 1996, Clin Orthop Relat Res, P300, DOI 10.1097/00003086-199608000-00037
   Aspenberg P, 2000, ACTA ORTHOP SCAND, V71, P558, DOI 10.1080/000164700317362172
   Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002
   Augat P, 2005, OSTEOPOROSIS INT, V16, pS36, DOI 10.1007/s00198-004-1728-9
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   Bhatt KA, 2007, J SURG RES, V143, P329, DOI 10.1016/j.jss.2007.01.023
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Borlongan CV, 2006, CAN MED ASSOC J, V174, P954, DOI 10.1503/cmaj.060199
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Branfoot T, 2005, INJURY, V36, P51, DOI 10.1016/j.injury.2005.07.036
   Braun W, 1996, UNFALLCHIRURG, V99, P59
   Brighton C T, 1984, Instr Course Lect, V33, P60
   Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Calori GM, 2008, INJURY, V39, P1391, DOI 10.1016/j.injury.2008.08.011
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Cetrulo CL, 2005, PLAST RECONSTR SURG, V116, P1053, DOI 10.1097/01.prs.0000178403.79051.70
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chao EYS, 2004, J BONE JOINT SURG AM, V86A, P948, DOI 10.2106/00004623-200405000-00010
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cho TJ, 2007, CALCIFIED TISSUE INT, V80, P192, DOI 10.1007/s00223-006-0240-y
   Cierny 3rd G, 1994, CLIN ORTHOP RELAT R, V301, P118
   Cillo JE, 2000, ORAL SURG ORAL MED O, V90, P147, DOI 10.1067/moe.2000.107531
   Claes L, 2003, LANGENBECK ARCH SURG, V388, P316, DOI 10.1007/s00423-003-0396-0
   Claes L, 2002, J ORTHOP RES, V20, P1099, DOI 10.1016/S0736-0266(02)00044-X
   Clements JR, 2008, J FOOT ANKLE SURG, V47, P350, DOI 10.1053/j.jfas.2008.04.006
   Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37
   CONNOLLY JF, 1995, CLIN ORTHOP RELAT R, P8
   Cornell C.N., 1998, CLIN ORTHOP S, V355, P267
   Cornell Charles N, 2004, Bull Hosp Jt Dis, V62, P13
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DECHALAI, 1999, J BIOMED MATER RES, V44, P280
   DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005
   Desai LP, 2008, AM J PHYSIOL-LUNG C, V295, pL958, DOI 10.1152/ajplung.90218.2008
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Dupoirieux L, 2009, J CRANIO MAXILL SURG, V37, P30, DOI 10.1016/j.jcms.2008.08.004
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Epari DR, 2008, BONE, V43, P734, DOI 10.1016/j.bone.2008.06.007
   FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FROST HM, 1983, CLIN ORTHOP RELAT R, P286
   Fuchs B, 2008, EJSO-EUR J SURG ONC, V34, P1271, DOI 10.1016/j.ejso.2007.11.010
   Gao TJ, 1996, J BIOMED MATER RES, V32, P505, DOI 10.1002/(SICI)1097-4636(199612)32:4<505::AID-JBM2>3.0.CO;2-V
   Garrison KR, 2010, COCHRANE DB SYST REV
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Gerstenfeld LC, 2003, J ORTHOPAED RES, V21, P670, DOI 10.1016/S0736-0266(03)00003-2
   Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014
   Giannoudis PV, 2008, INJURY, V39, pS5, DOI 10.1016/S0020-1383(08)70010-X
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Giannoudis PV, 2005, INJURY, V36, pS2, DOI 10.1016/j.injury.2005.10.006
   Goldhahn J, 2008, OSTEOPOROSIS INT, V19, P761, DOI 10.1007/s00198-007-0515-9
   GOLDSTROHM GL, 1984, J TRAUMA, V24, P50, DOI 10.1097/00005373-198401000-00008
   Griffin XL, 2009, INJURY, V40, P158, DOI 10.1016/j.injury.2008.06.025
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Han DQ, 2008, MED HYPOTHESES, V71, P374, DOI 10.1016/j.mehy.2008.01.035
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   Hecht J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-172
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Hierner R, 1995, MICROSURG, V16, P818, DOI 10.1002/micr.1920161209
   Hierner R, 2009, UNFALLCHIRURG, V112, P419, DOI 10.1007/s00113-009-1614-1
   Hierner R, 2009, UNFALLCHIRURG, V112, P405, DOI 10.1007/s00113-009-1613-2
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ilizarov G A, 1989, Clin Orthop Relat Res, P263
   Iwatsubo T, 2006, BIOMACROMOLECULES, V7, P95, DOI 10.1021/bm0504476
   Jagodzinski M, 2004, Eur Cell Mater, V7, P35
   Jo JH, 2009, J BIOMED MATER RES B, V91B, P213, DOI 10.1002/jbm.b.31392
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Karp JM, 2006, BIOMATERIALS, V27, P4755, DOI 10.1016/j.biomaterials.2006.04.028
   Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432
   Kawaguchi H, 2001, J CLIN ENDOCR METAB, V86, P875, DOI 10.1210/jc.86.2.875
   Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4
   Khan Safdar N, 2008, HSS J, V4, P149, DOI 10.1007/s11420-008-9087-2
   Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507
   KO FC, 2010, T 56 ANN M ORTH RES, P391
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI [10.1089/ten.teb.2009.0687, 10.1089/ten.TEB.2009.0687]
   Koyama Y, 2008, ARCH ORAL BIOL, V53, P488, DOI 10.1016/j.archoralbio.2007.12.004
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LAM CXF, 2008, BIOMED MATER, V3
   LANE JM, 1999, CLIN ORTHOP S, V367, P107
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Le AX, 2001, J ORTHOPAED RES, V19, P78, DOI 10.1016/S0736-0266(00)00006-1
   LE Z, 2007, COMPUT MATH APPL, V53, P232
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lienau J, 2005, J ORTHOP RES, V23, P639, DOI 10.1016/j.orthres.2004.09.006
   Lienau J, 2010, TISSUE ENG PT A, V16, P191, DOI [10.1089/ten.tea.2009.0187, 10.1089/ten.TEA.2009.0187]
   Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Liu YF, 2010, J BONE MINER RES, V25, P2029, DOI 10.1002/jbmr.84
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MALANIN TI, 1992, ACQUISITION BANKING
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Manjubala I, 2009, BONE, V45, P185, DOI 10.1016/j.bone.2009.04.249
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Issa JPM, 2008, MICRON, V39, P17, DOI 10.1016/j.micron.2007.08.008
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   MATHOULIN C, 1993, REV CHIR ORTHOP, V79, P492
   Mehta M, 2009, BONE, V44, pS264, DOI 10.1016/j.bone.2009.03.457
   MEHTA M, 2009, ORTHOPAEDIC RES SOC, V34
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MICLAU T, 2000, ORTH TRAUM ASS ANN M
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369
   MIYAMOTO S, 1993, ANN CHIR GYNAECOL FE, V82, P69
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   OPDENBUIJS J, 2010, TISSUE ENG C
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   OrtizCruz E, 1997, J BONE JOINT SURG AM, V79A, P97, DOI 10.2106/00004623-199701000-00010
   Pacicca DM, 2003, BONE, V33, P889, DOI 10.1016/j.bone.2003.06.002
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   PARFITT AM, 1979, CALCIFIED TISSUE INT, V28, P1, DOI 10.1007/BF02441211
   PELKER RR, 1987, ORTHOP CLIN N AM, V18, P235
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Peters A, 2009, TISSUE ENG PT A, V15, P2947, DOI [10.1089/ten.tea.2009.0058, 10.1089/ten.TEA.2009.0058]
   Peters A, 2010, HISTOL HISTOPATHOL, V25, P1149, DOI 10.14670/HH-25.1149
   Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102
   Putzier M, 2009, EUR SPINE J, V18, P687, DOI 10.1007/s00586-008-0875-7
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Reed AAC, 2002, J ORTHOP RES, V20, P593, DOI 10.1016/S0736-0266(01)00142-5
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Sarkar MR, 2006, BIOMATERIALS, V27, P1817, DOI 10.1016/j.biomaterials.2005.10.039
   SCHENK RK, 1977, UNFALLHEILKUNDE, V80, P155
   Schirmer CM, 2008, J VASC INTERV RADIOL, V19, P459, DOI 10.1016/j.jvir.2007.11.017
   Schmidmaier G, 2002, BONE, V30, P816, DOI 10.1016/S8756-3282(02)00740-8
   Schmidmaier G, 2004, J ORTHOPAED RES, V22, P514, DOI 10.1016/j.orthres.2003.09.009
   Schmidt-Bleek K, 2009, J ORTHOP RES, V27, P1147, DOI 10.1002/jor.20901
   SCHMIDTBLEEK K, 2010, 56 ANN M ORTH RES SO
   SCHWARZ C, 2010, INT SOC FRACTURE REP
   SCHWEIBERER L, 1977, UNFALLHEILKUNDE, V80, P275
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Sethuraman S, 2010, ACTA BIOMATER, V6, P1931, DOI 10.1016/j.actbio.2009.12.012
   Shang QX, 2001, J CRANIOFAC SURG, V12, P586, DOI 10.1097/00001665-200111000-00017
   Simons M, 2000, CIRCULATION, V102, pE73, DOI 10.1161/01.CIR.102.11.e73
   Stangenberg L, 2005, TISSUE ENG, V11, P855, DOI 10.1089/ten.2005.11.855
   STEVENSON S, 1987, J BONE JOINT SURG AM, V69A, P573, DOI 10.2106/00004623-198769040-00015
   Street J, 2000, CLIN ORTHOP RELAT R, P224
   STROBEL C, 2010, T 56 ANN M ORTH RES
   Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annure/bioeng.9.060906.151850
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003
   Theos C, 2008, ARCH ORTHOP TRAUM SU, V128, P179, DOI 10.1007/s00402-007-0301-3
   TOBEN D, 2010, 56 ANN M ORTH RES SO, P446
   TOBEN D, 2010, T 56 ANN M ORTH RES
   Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006
   Tsuchiya H, 2005, J BONE JOINT SURG BR, V87B, P218, DOI 10.1302/0301-620X.87B2.15325
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Urciuolo F, 2008, AICHE J, V54, P824, DOI 10.1002/aic.11394
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002
   WALLACE AL, 1994, CLIN ORTHOP RELAT R, P281
   Wang Y, 2007, ANN NY ACAD SCI, V1117, P1, DOI 10.1196/annals.1402.049
   Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JC131581
   WENDEBERG B., 1961, ACTA ORTHOPAED SCAND SUPPL, V52, P1
   WILLIE B, 2010, T 56 ANN M ORTH RES, P678
   WOOD MB, 1987, J HAND SURG-AM, V12A, P422, DOI 10.1016/S0363-5023(87)80017-5
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022
   Yonamine Y, 2010, ORAL SURG ORAL MED O, V109, P225, DOI 10.1016/j.tripleo.2009.09.010
   Yoshimoto T, 2006, J PERIODONTAL RES, V41, P140, DOI 10.1111/j.1600-0765.2005.00847.x
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6
   Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681
   Zhao J, 2008, MACROMOL BIOSCI, V8, P836, DOI 10.1002/mabi.200700334
   Zhong RK, 2004, EXP HEMATOL, V32, P470, DOI 10.1016/j.exphem.2004.01.011
   Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200
NR 214
TC 44
Z9 44
U1 5
U2 52
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 20
BP 4976
EP 4987
DI 10.1039/c0sm00262c
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 658WF
UT WOS:000282522700004
DA 2018-10-20
ER

PT J
AU Cooke, MJ
   Vulic, K
   Shoichet, MS
AF Cooke, M. J.
   Vulic, K.
   Shoichet, M. S.
TI Design of biomaterials to enhance stem cell survival when transplanted
   into the damaged central nervous system
SO SOFT MATTER
LA English
DT Review
ID SPINAL-CORD-INJURY; NEURAL STEM/PROGENITOR CELLS; MARROW STROMAL CELLS;
   BONE-MARROW; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; PROGENITOR CELLS;
   IN-VITRO; PRECURSOR CELLS; SCHWANN-CELLS
AB Following injury to the central nervous system (CNS) there is a cascade of events that leads to cell death, tissue loss and consequently functional deficit. In response to injury, the CNS stimulates endogenous stem cell populations. However, this host repair mechanism is insufficient to restore function to the damaged tissue. Stem cells can be transplanted into damaged tissues to replace the lost cells. Although stem cell transplantation is promising, this technique is currently suboptimal. Following transplantation, significant death of the transplanted cells impedes the effectiveness of this technique. In an attempt to improve cell transplantation, groups have used scaffolds to deliver cells. In effect, biomaterials are used to create a niche that provides the appropriate microenvironment to promote survival of transplanted cells. As shown in Fig. 1, this niche includes a biomaterial with the appropriate biochemical and mechanical factors for the cells and tissues studied. In this review, we examine the mechanisms that contribute to the death of transplanted cells. We review both the in vitro data, where biomaterial scaffolds are designed to enhance cell survival, and the in vivo data, where scaffolds are shown to improve cell survival following transplantation into the damaged brain and spinal cord.
C1 [Shoichet, M. S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Vulic, K.; Shoichet, M. S.] Univ Toronto, Dept Chem, Toronto, ON M5S 3E6, Canada.
   [Shoichet, M. S.] Donnelley Ctr, Toronto, ON M5S 3E1, Canada.
   [Cooke, M. J.; Shoichet, M. S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Shoichet, MS (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.
EM molly.shoichet@utoronto.ca
CR Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174
   Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   BALAZS EA, 1991, COSMETIC AND PHARMACEUTICAL APPLICATIONS OF POLYMERS, P293
   Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Bhang SH, 2009, BIOMATERIALS, V30, P126, DOI 10.1016/j.biomaterials.2008.09.021
   Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Cooke MJ, 2008, CYTOTECHNOLOGY, V56, P71, DOI 10.1007/s10616-007-9119-7
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   FORET A, 2009, J NEUROCHEM, V112, P762
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71
   Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x
   Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287
   Hiraoka M, 2009, BIOCONJUGATE CHEM, V20, P976, DOI 10.1021/bc9000068
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hu JG, 2009, J NEUROSCI RES, V87, P2854, DOI 10.1002/jnr.22111
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.184
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Johann V, 2007, EXP BRAIN RES, V177, P458, DOI 10.1007/s00221-006-0689-y
   Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096
   Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066
   Karoubi G, 2009, BIOMATERIALS, V30, P5445, DOI 10.1016/j.biomaterials.2009.06.035
   Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   Koda M, 2008, NEUROSCI LETT, V444, P143, DOI 10.1016/j.neulet.2008.07.055
   Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   Le Belle JE, 2004, J NEUROSCI RES, V76, P174, DOI 10.1002/jnr.20035
   Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Lu D., 2007, NEUROSURGERY, V61, P602
   Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.000028004/.85651.4F
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Nakagomi T, 2009, EUR J NEUROSCI, V29, P1842, DOI 10.1111/j.1460-9568.2009.06732.x
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771
   Parr AM, 2008, SURG NEUROL, V70, P600, DOI 10.1016/j.surneu.2007.09.043
   Parr AM, 2007, NEUROSURGERY, V61, P208, DOI 10.1227/01.neu.0000279920.57751.d6
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   Peretz H, 2007, TISSUE ENG, V13, P461, DOI 10.1089/ten.2005.0522
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Stabenfeldt SE, 2006, J BIOMED MATER RES A, V77A, P718, DOI 10.1002/jbm.a.30638
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032
   Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
NR 71
TC 52
Z9 53
U1 3
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 20
BP 4988
EP 4998
DI 10.1039/c0sm00448k
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 658WF
UT WOS:000282522700005
DA 2018-10-20
ER

PT J
AU Bettinger, CJ
   Borenstein, JT
AF Bettinger, Christopher J.
   Borenstein, Jeffrey T.
TI Biomaterials-based microfluidics for engineered tissue constructs
SO SOFT MATTER
LA English
DT Review
ID EMBRYONIC STEM-CELLS; ON-A-CHIP; MECHANICAL-PROPERTIES; IN-VITRO;
   BIOMEDICAL APPLICATIONS; CULTURE SYSTEM; CROSS-LINKING; REAL-TIME;
   BIODEGRADABLE ELASTOMER; SCAFFOLD DESIGN
AB The utility of microfluidics in biotechnology has dramatically increased in recent years as these systems have expanded to supplement efforts in lab-on-a-chip technology. The driving force for the widespread implementation of these systems for biological discovery is based on (1) miniaturization to increase sensitivity and reduce the scale of experimentation and (2) the ability to design high throughput systems. These two advantages have also motivated the integration of biomaterials with microfluidic structures and cell culture techniques. Micron scale systems enable precise control over cellular microenvironment while high throughput strategies are able to rapidly screen complex interactions such as cell-biomaterial responses. This review presents recent progress in the integration of biomaterials microfabrication and microfluidics-based cell culture systems towards tissue development. Materials considerations are of great importance in order to develop microfluidic biomaterials that are mechanically robust, compatible with established fabrication techniques, and able to accommodate the integration of viable cell populations. The use of biopolymers for these systems requires materials-specific microfabrication techniques for applications in microfluidic biomaterials. Pertinent examples that integrate aspects of biomaterials, microfabrication techniques, and cell culture for in vitro tissue morphogenesis are also discussed. These include systems designed to study basic mechanisms of tissue development, potential clinically relevant tissue engineered constructs, and in vitro model tissue systems for drug discovery and safety evaluation. The confluence of biomaterials-based microfluidics and controlled cellular integration portends the realization of far-reaching applications that span the spectrum between basic science and technologies for advancing human health.
C1 [Borenstein, Jeffrey T.] Draper Lab, Ctr Biomed Engn, Cambridge, MA USA.
   [Bettinger, Christopher J.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA.
   [Bettinger, Christopher J.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
RP Borenstein, JT (reprint author), Draper Lab, Ctr Biomed Engn, Cambridge, MA USA.
EM jborenstein@draper.com
RI Bettinger, Christopher/A-3895-2009
FU NIH [1F32NS064771-01]
FX CJB was funded by an NIH Ruth Kirschstein Fellowship (#
   1F32NS064771-01). The authors would also like to acknowledge the work of
   authors whose work was not able to be featured due to formatting
   constraints. The content of this paper does not necessarily reflect the
   position or the policy of the government, and no official endorsement
   should be inferred.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Armani DK, 2000, J MICROMECH MICROENG, V10, P80, DOI 10.1088/0960-1317/10/1/311
   Beamish JA, 2009, BIOMATERIALS, V30, P6286, DOI 10.1016/j.biomaterials.2009.08.004
   Becker H, 2008, ANAL BIOANAL CHEM, V390, P89, DOI 10.1007/s00216-007-1692-2
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bettinger CJ, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P341, DOI 10.1016/B978-012370615-7/50028-7
   Bettinger CJ, 2009, J BIOMED MATER RES A, V91A, P1077, DOI 10.1002/jbm.a.32306
   Bettinger CJ, 2009, TISSUE ENG PT A, V15, P1321, DOI 10.1089/ten.tea.2008.0134
   Bettinger Christopher J., 2008, P87
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Bruzewicz DA, 2008, LAB CHIP, V8, P663, DOI 10.1039/b719806j
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031
   Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/1076327042500256
   Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Erickson D, 2003, LAB CHIP, V3, P141, DOI 10.1039/b306158b
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747
   Haber C, 2006, LAB CHIP, V6, P1118, DOI 10.1039/b610250f
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hermann S., 2005, J BIOMED MATER RES B, V74, P782
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HOLGER B, 2000, ELECTROPHORESIS, V21, P12
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hsiao AY, 2009, BIOMATERIALS, V30, P3020, DOI 10.1016/j.biomaterials.2009.02.047
   Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jen-Huang H, 2009, ADV MATER, V21, P3567
   Khademhosseini A, 2004, LAB CHIP, V4, P425, DOI 10.1039/b404842c
   Khademhosseini A, 2005, LAB CHIP, V5, P1380, DOI 10.1039/b508096g
   Khademhosseini A, 2004, ANAL CHEM, V76, P3675, DOI 10.1021/ac035415s
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khademhosseini A, 2006, J BIOMAT SCI-POLYM E, V17, P1221, DOI 10.1163/156856206778667488
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   KIERSTAN M, 1977, BIOTECHNOL BIOENG, V19, P387, DOI 10.1002/bit.260190309
   Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f
   Kim MS, 2007, BIOMED MICRODEVICES, V9, P25, DOI 10.1007/s10544-006-9016-4
   Kim SH, 2000, J BIOMATER APPL, V15, P23, DOI 10.1106/ML30-FMLG-1HRU-7C4B
   Kim SM, 2008, LAB CHIP, V8, P1015, DOI 10.1039/b800835c
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kumar G, 2000, POLYMER, V41, P2157, DOI 10.1016/S0032-3861(99)00360-2
   Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lan P, 2004, J APPL POLYM SCI, V92, P2163, DOI 10.1002/app.20197
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Lee W, 2010, BIOTECHNOL BIOENG, V105, P1178, DOI 10.1002/bit.22613
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509
   Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   McGuigan AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002258
   Meyvantsson I, 2008, LAB CHIP, V8, P717, DOI 10.1039/b715375a
   Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1
   Myers FB, 2008, LAB CHIP, V8, P2015, DOI 10.1039/b812343h
   Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Normand V, 2000, MACROMOLECULES, V33, P1063, DOI 10.1021/ma9909455
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Ong SM, 2008, BIOMATERIALS, V29, P3237, DOI 10.1016/j.biomaterials.2008.04.022
   Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k
   Pearce TM, 2005, LAB CHIP, V5, P97, DOI 10.1039/b407871c
   Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060
   Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e
   Rivron NC, 2009, BIOMATERIALS, V30, P4851, DOI 10.1016/j.biomaterials.2009.06.037
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   ROTMAN D, 2010, TECHNOLOGY REV, V113
   Rowat AC, 2009, P NATL ACAD SCI USA, V106, P18149, DOI 10.1073/pnas.0903163106
   Ryu W, 2007, BIOMATERIALS, V28, P1174, DOI 10.1016/j.biomaterials.2006.11.002
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SEOK C, 2009, ADV MATER, V21, P4863
   Sershen SR, 2005, ADV MATER, V17, P1366, DOI 10.1002/adma.200401239
   Simms HA, 2008, BIOMATERIALS, V29, P2228, DOI 10.1016/j.biomaterials.2008.02.001
   Simms HM, 2005, LAB CHIP, V5, P151, DOI 10.1039/b412589d
   Sodunke TR, 2007, BIOMATERIALS, V28, P4006, DOI 10.1016/j.biomaterials.2007.05.021
   Someya T, 2002, LANGMUIR, V18, P5299, DOI 10.1021/la020026z
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001
   Studer V, 2002, APPL PHYS LETT, V80, P3614, DOI 10.1063/1.1479202
   Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820
   Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043
   Swiston AJ, 2008, NANO LETT, V8, P4446, DOI 10.1021/nl802404h
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   Tan WH, 2007, ADV MATER, V19, P2696, DOI 10.1002/adma.200700433
   Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Toh YC, 2007, LAB CHIP, V7, P302, DOI 10.1039/b614872g
   Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h
   Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f
   Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d
   Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e
   Wang XH, 2010, J BIOACT COMPAT POL, V25, P229, DOI 10.1177/0883911510365661
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Weigl BH, 1999, SCIENCE, V283, P346, DOI 10.1126/science.283.5400.346
   Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wong AP, 2008, BIOMATERIALS, V29, P1853, DOI 10.1016/j.biomaterials.2007.12.044
   Xie YB, 2009, BIOTECHNOL PROGR, V25, P535, DOI [10.1021/bp.151, 10.1002/btpr.151]
   Xu QB, 2009, SMALL, V5, P1575, DOI 10.1002/smll.200801855
   YANG H, 1994, BIOMATERIALS, V15, P113, DOI 10.1016/0142-9612(94)90259-3
   Yang ST, 2008, CURR OPIN DRUG DISC, V11, P111
   Yang Y, 2006, J AM CHEM SOC, V128, P14040, DOI 10.1021/ja066157u
   YOON Y, 2006, J BIOMED MATER RES A, V78, P668
   Yu Q, 2001, APPL PHYS LETT, V78, P2589, DOI 10.1063/1.1367010
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang C, 2009, BIOMATERIALS, V30, P3847, DOI 10.1016/j.biomaterials.2009.03.052
   Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d
NR 160
TC 27
Z9 27
U1 6
U2 53
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 20
BP 4999
EP 5015
DI 10.1039/c0sm00247j
PG 17
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 658WF
UT WOS:000282522700006
DA 2018-10-20
ER

PT J
AU Sung, HJ
   Luk, A
   Murthy, NS
   Liu, E
   Jois, M
   Joy, A
   Bushman, J
   Moghe, PV
   Kohn, J
AF Sung, Hak-Joon
   Luk, Arnold
   Murthy, N. Sanjeeva
   Liu, Er
   Jois, Malasa
   Joy, Abraham
   Bushman, Jared
   Moghe, Prabhas V.
   Kohn, Joachim
TI Poly(ethylene glycol) as a sensitive regulator of cell survival fate on
   polymeric biomaterials: the interplay of cell adhesion and pro-oxidant
   signaling mechanisms
SO SOFT MATTER
LA English
DT Article
ID POLYETHYLENE-GLYCOL; IN-VITRO; NUCLEAR TRANSLOCATION; PROTEIN
   ADSORPTION; OXIDATIVE STRESS; PRECURSOR CELL; APOPTOSIS; PEG;
   COPOLYMERS; SURFACES
AB Poly(ethylene glycol) (PEG) is one of the most widely used compounds across a variety of platforms and is increasingly found in medical applications. Polycarbonates containing varying mol% of PEG (M-w 1000) were used to probe the effects of PEG on cell adhesion, proliferation, spreading, and survival. Two contrasting PEG-mediated cell signaling elements affected these cellular behaviors: (i) integrin alpha 5 receptor mediated cellular focal adhesions to the biomaterial surface and (ii) modulation of cellular redox and apoptosis through generation of reactive oxygen species (ROS). At lower PEG(1k) mol% (5% and 8%) cell attachment and spreading decreased concomitantly due to ROS, whereas at the higher PEG(1k) mol% studied (10% and 20%) an unusual super-adhesive behavior was observed. At higher PEG(1k) mol% cells exhibited greatly enhanced spreading, which was confirmed through immunolocalization of integrin alpha 5 receptors and enhanced mRNA expression of the integrin alpha 5 gene. These cellular responses on higher PEG(1k) mol% co-polymers were sufficient to overcome the ROS-driven effects on caspase activation and cell shrinkage, which dominated at lower PEG(1k) mol%. These studies elucidate PEG-mediated cellular signaling with the implication that the adhesion and apoptotic activity of PEG-rich materials can be sensitively controlled by anti-oxidant addition. Moreover, this study shows that biomaterials can drive the cell fate in opposing directions through concurrent property changes.
C1 [Sung, Hak-Joon; Luk, Arnold; Murthy, N. Sanjeeva; Jois, Malasa; Joy, Abraham; Bushman, Jared; Kohn, Joachim] New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
   [Luk, Arnold; Liu, Er; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
RP Kohn, J (reprint author), New Jersey Ctr Biomat, 145 Bevier Rd,Rm 101, Piscataway, NJ 08854 USA.
EM kohn@biology.rutgers.edu
RI Liu, Er/H-8441-2012
OI Liu, Er/0000-0001-7858-1333
FU DOE [W-31-109-ENG-38]; National Institutes of Health [P41 EB001046]
FX The X-ray scattering work was carried out at DND-CAT at the Advanced
   Photon Source, and the neutron scattering work was carried out at IPNS,
   both at the Argonne National Laboratory supported by DOE contract no.
   W-31-109-ENG-38. We thank Drs. S. Weigand and P. Thiyagarajan for
   enabling X-ray and neutron data, respectively, to be collected. This
   work was supported by RESBIO (Integrated Technology Resource for
   Polymeric Biomaterials) funded by National Institutes of Health (NIBIB
   and NCMHD) under grant P41 EB001046. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the NIH, NIBIB or NCMHD.
CR BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   Bertuglia S, 2006, AM J PHYSIOL-HEART C, V291, pH1536, DOI 10.1152/ajpheart.01114.2005
   Briggs T, 2009, J BIOMED MATER RES A, V91A, P975, DOI 10.1002/jbm.a.32310
   Dastoor Z, 2001, J CELL SCI, V114, P1643
   DENG XM, 1995, J APPL POLYM SCI, V55, P1193, DOI 10.1002/app.1995.070550806
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   Ellis G, 2006, CLIN BIOCHEM, V39, P1035, DOI 10.1016/j.clinbiochem.2006.05.014
   Fernando MR, 2006, FASEB J, V20, P2645, DOI 10.1096/fj.06-5919fje
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   HAMBURGER R, 1975, PHARM ACTA HELV, V50, P10
   Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Hsu SH, 2007, MACROMOL BIOSCI, V7, P482, DOI 10.1002/mabi.200600248
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Johnson PA, 2010, J BIOMED MATER RES A, V93A, P505, DOI 10.1002/jbm.a.32544
   Kim JW, 2009, LANGMUIR, V25, P5304, DOI 10.1021/la804057e
   Kumar V, 2006, AAPS PHARMSCITECH, V7
   Laity PR, 2004, POLYMER, V45, P7273, DOI 10.1016/j.polymer.2004.08.033
   Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427
   Liu-Snyder P, 2007, J EXP BIOL, V210, P1455, DOI 10.1242/jeb.02756
   Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x
   Luo WJ, 2002, J APPL POLYM SCI, V84, P1729, DOI 10.1002/app.10580
   Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762
   Marks Jeremy D., 2001, FASEB Journal, V15, P1107
   MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Noble M, 2005, ANTIOXID REDOX SIGN, V7, P1456, DOI 10.1089/ars.2005.7.1456
   Okatchi K, 2008, ANTICANCER RES, V28, P2687
   Pasello M, 2008, CANCER RES, V68, P6661, DOI 10.1158/0008-5472.CAN-07-5840
   Patel T, 1996, FASEB J, V10, P587
   PESNELL A, 2006, THESIS STATE U NEW J
   Schut J, 2007, POLYMER, V48, P6115, DOI 10.1016/j.polymer.2007.07.048
   Shashidharan P, 1999, NEUROREPORT, V10, P1149, DOI 10.1097/00001756-199904060-00045
   Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797
   Smith SS, 2009, TOXICOL IN VITRO, V23, P60, DOI 10.1016/j.tiv.2008.10.011
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   Sun G, 2008, J MATER SCI-MATER M, V19, P2865, DOI 10.1007/s10856-008-3410-9
   Sung HJ, 2009, J CELL PHYSIOL, V218, P549, DOI 10.1002/jcp.21629
   Thomas CH, 1999, J BIOMECH ENG-T ASME, V121, P40, DOI 10.1115/1.2798041
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
NR 44
TC 20
Z9 20
U1 1
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 20
BP 5196
EP 5205
DI 10.1039/c0sm00172d
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 658WF
UT WOS:000282522700026
DA 2018-10-20
ER

PT J
AU Ibele, A
   Garren, M
   Gould, J
AF Ibele, Anna
   Garren, Michael
   Gould, Jon
TI Effect of circular staple line buttressing material on gastrojejunostomy
   failure in laparoscopic Roux-en-Y gastric bypass
SO SURGERY FOR OBESITY AND RELATED DISEASES
LA English
DT Article
DE Gastrojejunostomy leak; Bovine pericardium; Staple line buttressing
AB Background: To determine the effect of bovine pericardium strip (BPS) reinforcement of the circular stapler on the gastrojejunostomy leak rates and staple line failure after laparoscopic Roux-en-Y gastric bypass (LRYGB) at a university hospital in the United States. Gastrojejunostomy leak after LRYGB is a devastating complication. Various techniques, including buttressing the gastrojejunostomy staple line with biomaterial, have been used in an effort to minimize leaks.
   Methods: A total of 350 consecutive patients underwent LRYGB without staple line buttressing. After this initial experience, BPS reinforcement of the gastrojejunostomy was conducted in 81 consecutive patients. BPS reinforcement was not used for the final 69 consecutive patients in this 500 patient series. Circular staple line failures (intraoperative immediate and complete failure of the anastomosis) and leaks were evaluated retrospectively.
   Results: Three leaks (and no intraoperative staple line failures) occurred in 419 patients without BPS buttressing, all in the first 100 cases of our experience, and 3 leaks and an anastomotic staple line failure occurred in the 81 patients with BPS buttressing (.7% versus 4.9%, P = .02). The body mass index and other potential leak risk factors did not differ between the 2 groups.
   Conclusion: In our experience, buttressing of the circular staple line with BPS during LRYGB was associated with an increased staple line adverse event rate. BPS buttressing of the gastrointestinal circular staple lines should be used with caution. (Surg Obes Relat Dis 2010;6:64-67.) (C) 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
C1 Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.
RP Gould, J (reprint author), Univ Wisconsin, Ctr Clin Sci, 600 Highland Ave,H4-726, Madison, WI 53792 USA.
EM gould@surgery.wisc.edu
CR Angrisani L, 2004, OBES SURG, V14, P1198, DOI 10.1381/0960892042387075
   Arnold W, 2005, OBES SURG, V15, P164, DOI 10.1381/0960892053268309
   Brolin RE, 2001, SURG CLIN N AM, V81, P1077, DOI 10.1016/S0039-6109(05)70185-7
   de la Torre RA, 1999, OBES SURG, V9, P492, DOI 10.1381/096089299765552800
   DeMaria Eric J, 2002, Ann Surg, V235, P640, DOI 10.1097/00000658-200205000-00005
   Downey DM, 2005, OBES SURG, V15, P1379, DOI 10.1381/096089205774859254
   Fernandez AZ, 2004, SURG ENDOSC, V18, P193, DOI 10.1007/s00464-003-8926-y
   Flancbaum L, 2007, J GASTROINTEST SURG, V11, P500, DOI 10.1007/s11605-007-0117-z
   Fobi MAL, 1998, OBES SURG, V8, P283, DOI 10.1381/096089298765554485
   Gonzalez R, 2004, OBES SURG, V14, P1299, DOI 10.1381/0960892042583978
   Gould JC, 2004, OBES SURG, V14, P618, DOI 10.1381/096089204323093381
   Jones WB, 2008, AM SURGEON, V74, P462
   Livingston EH, 2005, SURG CLIN N AM, V85, P853, DOI 10.1016/j.suc.2005.04.007
   Maher JW, 2008, J AM COLL SURGEONS, V206, P940, DOI 10.1016/j.jamcollsurg.2007.12.043
   Marshall JS, 2003, ARCH SURG-CHICAGO, V138, P520, DOI 10.1001/archsurg.138.5.520
   Mery CM, 2008, SURG OBES RELAT DIS, V4, P416, DOI 10.1016/j.soard.2007.11.008
   Nguyen NT, 2005, ARCH SURG-CHICAGO, V140, P773, DOI 10.1001/archsurg.140.8.773
   Saber AA, 2008, OBES SURG, V18, P525, DOI 10.1007/s11695-008-9465-3
   Sapala JA, 2004, OBES SURG, V14, P35, DOI 10.1381/096089204772787266
   Schauer P, 2003, SURG ENDOSC, V17, P212, DOI 10.1007/s00464-002-8857-z
   Schauer PR, 2000, ANN SURG, V232, P515, DOI 10.1097/00000658-200010000-00007
   Shikora SA, 2003, OBES SURG, V13, P37, DOI 10.1381/096089203321136566
   Shikora SA, 2008, SURG OBES RELAT DIS, V4, P729, DOI 10.1016/j.soard.2008.02.00l
NR 23
TC 9
Z9 9
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1550-7289
EI 1878-7533
J9 SURG OBES RELAT DIS
JI Surg. Obes. Relat. Dis.
PD JAN-FEB
PY 2010
VL 6
IS 1
BP 64
EP 67
DI 10.1016/j.soard.2009.05.006
PG 4
WC Surgery
SC Surgery
GA V30LF
UT WOS:000208816800014
PM 19640800
DA 2018-10-20
ER

PT B
AU Yan, SQ
   Zhang, QA
   Wang, JN
   Li, MZ
AF Yan, Shu-Qin
   Zhang, Qiang
   Wang, Jian-Nan
   Li, Ming-Zhong
BE Li, Y
   Qui, YP
   Luo, XN
   Li, JS
TI Characterization of Silk Fibroin/Hyaluronic Acid Blend Film Cross-linked
   by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
LA English
DT Proceedings Paper
CT 3rd International Symposium of Textile Bioengineering and Informatics
CY MAY 28-30, 2010
CL Coll Textiles, Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers, Key Lab Textile Sci & Technol, Key Lab Sci & Technol Eco Textiles, Res Ctr Ind Textiles, Minist Educ, Donghua Univ, Textile Bioengineering & Info Soc
HO Coll Textiles
DE silk fibroin; hyaluronic acid; films; blends; crosslinking; structure;
   cyotocompatibility
ID PHYSICAL-PROPERTIES; HYALURONIC-ACID; DRUG-DELIVERY; BOMBYX-MORI;
   FIBROIN; BIOMATERIAL; CHITOSAN; STATE
AB Silk fibroin (SF) / hyaluronic acid (HA) blend films were prepared using 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) as crosslinking agent and N-hydroxysuccinimide (NHS), 2-morpholinoethanesulfonic acid (MES) as assistant agent. The physico-chemical properties of the blend films were examined and analyzed. The FTIR showed that HA interfere with SF to form crystal structure, whereas EDC induced SF to form Silk I. Comparing with uncross-linked blend films, the EDC cross-linked blend films showed an obvious increase of elongation at break, a decrease of tensile strength and Young's modulus, the flexibleness of the films improved significantly. L929 cells grow well on SF/HA blend films, demonstrating that the blend films cross-linked by EDC have no significant toxicity.
C1 [Yan, Shu-Qin; Zhang, Qiang; Wang, Jian-Nan; Li, Ming-Zhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Li, MZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM mzli@suda.edu.cn
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arvanitoyannis I, 1999, CARBOHYD POLYM, V38, P47, DOI 10.1016/S0144-8617(98)00087-3
   Arvanitoyannis IS, 1998, CARBOHYD POLYM, V37, P371, DOI 10.1016/S0144-8617(98)00083-6
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Campbell J, 2007, OSTEOARTHR CARTILAGE, V15, P1424, DOI 10.1016/j.joca.2007.01.022
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   GILLI R, 1994, CARBOHYD RES, V263, P315, DOI 10.1016/0008-6215(94)00147-2
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Kazuaki K., 2003, J CHROMATOGR B, V797, P347
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu YC, 1996, J APPL POLYM SCI, V61, P641, DOI 10.1002/(SICI)1097-4628(19960725)61:4<641::AID-APP7>3.0.CO;2-L
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Mayo L, 2008, EUR J PHARM BIOPHARM, V70, P199, DOI 10.1016/j.ejpb.2008.04.025
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   RAPPORT MM, 1951, NATURE, V168, P996, DOI 10.1038/168996b0
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
NR 24
TC 0
Z9 0
U1 2
U2 10
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
PY 2010
BP 248
EP 253
DI 10.3993/tbis2010043
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BRN79
UT WOS:000283206000043
DA 2018-10-20
ER

PT B
AU Zhang, QA
   Yan, SQ
   Li, MZ
AF Zhang, Qiang
   Yan, Shu-Qin
   Li, Ming-Zhong
BE Li, Y
   Qui, YP
   Luo, XN
   Li, JS
TI Porous Materials Based on Bombyx mori Silk Fibroin
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
LA English
DT Proceedings Paper
CT 3rd International Symposium of Textile Bioengineering and Informatics
CY MAY 28-30, 2010
CL Coll Textiles, Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers, Key Lab Textile Sci & Technol, Key Lab Sci & Technol Eco Textiles, Res Ctr Ind Textiles, Minist Educ & Ciencia, Donghua Univ, Textile Bioengineering & Info Soc
HO Coll Textiles
DE bombyx mori silk fibroin; porous materials; processing; biomaterial;
   application; biocompatibility; biodegradation
ID BIOMIMETIC NANOFIBROUS SCAFFOLDS; CONTROLLED DRUG-RELEASE; MESENCHYMAL
   STEM-CELLS; IN-VITRO EVALUATION; PHYSICAL-PROPERTIES; VASCULAR GRAFTS;
   GLUCOSE-OXIDASE; BONE-FORMATION; TISSUE; BIOMATERIALS
AB Silk from the Bombyx mori silkworm is a protein-based fiber. Bombyx mori silk fibroin (SF) is one of the most important candidates for biomedical porous material based on its superior machinability, biocompatibility, biodegradation, bioresorbability, and so on. In this paper, we have reviewed the key features of SF. Moreover we have focused on the morphous, technical processing, and biocompatibility of SF porous materials, followed by the application research. Finally, perspective potential and problems of SF porous materials were provided.
C1 [Zhang, Qiang; Yan, Shu-Qin; Li, Ming-Zhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Li, MZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM mzli@suda.edu.cn
CR Ajisawa A, 1998, J SERIC SCI JPN, V67, P91
   ARMATO U, 2001, Patent No. 10398252
   AYUB ZH, 1994, POLYMER, V35, P2197, DOI 10.1016/0032-3861(94)90250-X
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Beris A, 2007, J NEUROTRAUM, V24, P909, DOI 10.1089/neu.2006.0165
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kumar R, 2008, J BIOBASED MATER BIO, V2, P1, DOI 10.1166/jbmb.2008.204
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee SY, 2007, J CELL PHYSIOL, V210, P561, DOI 10.1002/jcp.20890
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu LP, 2005, CURR TOP DEV BIOL, V68, P149, DOI 10.1016/S0070-2153(05)68006-4
   LIU YC, 1995, ANAL CHIM ACTA, V316, P65, DOI 10.1016/0003-2670(95)00340-6
   Liu YC, 1996, J BIOTECHNOL, V46, P131, DOI 10.1016/0168-1656(95)00182-4
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Mandal BB, 2009, EUR J PHARM SCI, V37, P160, DOI 10.1016/j.ejps.2009.02.005
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Migliaresi C, 2004, ABSTR PAP AM CHEM S, V228, pU384
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Morita Y, 2002, BIO-MED MATER ENG, V12, P291
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Ni Y, 2008, OTOLARYNG HEAD NECK, V139, P256, DOI 10.1016/j.otohns.2008.03.028
   Nishlbe T, 2007, VASCULAR, V15, P356, DOI 10.2310/6670.2007.00053
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Piotrowicz A, 2006, BIOMATERIALS, V27, P2018, DOI 10.1016/j.biomaterials.2005.09.042
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rice MA, 2005, OTOLARYNG CLIN N AM, V38, P199, DOI 10.1016/j.otc.2004.10.010
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Ripamonti U, 2006, BIOMATERIALS, V27, P807, DOI 10.1016/j.biomaterials.2005.09.021
   Ripamonti U, 1996, MRS BULL, V21, P36
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VEITH F J, 1986, Journal of Vascular Surgery, V3, P104, DOI 10.1067/mva.1986.avs0030104
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2005, CURR BIOL, V15, pR364, DOI 10.1016/j.cub.2005.05.014
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Wu XM, 2008, MICROVASC RES, V75, P119, DOI 10.1016/j.mvr.2007.04.012
   YANG YM, 2009, POLYM DEGRA IN PRESS
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoo CR, 2008, INT J BIOL MACROMOL, V42, P324, DOI 10.1016/j.ijbiomac.2007.12.004
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhaoming W, 1996, J INV ALLERGY CLIN I, V6, P237
NR 74
TC 2
Z9 2
U1 0
U2 7
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
PY 2010
BP 254
EP 261
DI 10.3993/tbis2010044
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BRN79
UT WOS:000283206000044
DA 2018-10-20
ER

PT B
AU Zhou, DX
   Li, Y
   Zhang, J
AF Zhou, Dang-Xia
   Li, Yi
   Zhang, Jing
BE Li, Y
   Qui, YP
   Luo, XN
   Li, JS
TI Haemostatic Effect of Neutral Wool Hydrolyzed Polypeptides
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
LA English
DT Proceedings Paper
CT 3rd International Symposium of Textile Bioengineering and Informatics
CY MAY 28-30, 2010
CL Coll Textiles, Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers, Key Lab Textile Sci & Technol, Key Lab Sci & Technol Eco Textiles, Res Ctr Ind Textiles, Minist Educ, Donghua Univ, Textile Bioengineering & Info Soc
HO Coll Textiles
DE neutral wool hydrolyzed polypeptide; haemostatic effect; bleeding model
ID KERATIN
AB Neutral Wool hydrolyzed polypeptide (NWHP) is a new biomaterial derived from natural wool. This study was designed to explore the haemostatic effect of NWHP by using different animal bleeding models. The results indicated that wool hydrolyzed polypeptide obviously shortens bleeding time. The NWHP is capable of producing haemostatic effect.
C1 [Zhou, Dang-Xia; Zhang, Jing] Xi An Jiao Tong Univ, Dept Pathol, Xian 710061, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk; tcliyi@polyu.edu.hk
RI LI, YI/G-4421-2012
OI LI, YI/0000-0002-2092-4505
CR Barba C, 2008, SKIN RES TECHNOL, V14, P243, DOI 10.1111/j.1600-0846.2007.00280.x
   Barba C, 2007, J COSMET SCI, V58, P99
   Cardamnone JM, 2007, TEXT RES J, V77, P277, DOI 10.1177/004517507078788
   Chen AZ.ZhaoZ, 2009, TEXTILE BIOENGINEERI, V1-2, P122
   Chen LP, 2009, WOOL TEXTILE J, V37, P20
   Hui Yu-Hua, 2007, Journal of Pharmacological and Toxicological Methods, V56, P256, DOI 10.1016/j.vascn.2007.05.006
   Marder V.J., 2009, THROMB RES, V123, P56
   Qin YM, 2008, POLYM ADVAN TECHNOL, V19, P6, DOI 10.1002/pat.960
   RYAN KL, 2006, RESUSCITATION, V70, P1
   SEVEBRYAKOVA TN, 2007, J THROMB HAEMOST, V5, P402
   Tung WS, 2009, ACTA BIOMATER, V5, P50, DOI 10.1016/j.actbio.2008.08.009
   Yang X, 2009, J COLLOID INTERF SCI, V336, P756, DOI 10.1016/j.jcis.2009.04.050
NR 12
TC 0
Z9 0
U1 0
U2 0
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
PY 2010
BP 576
EP 579
DI 10.3993/tbis2010101
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BRN79
UT WOS:000283206000098
DA 2018-10-20
ER

PT B
AU Kan, CW
   Yuen, CWM
   Tsoi, WYI
AF Kan, C. W.
   Yuen, C. W. M.
   Tsoi, W. Y. I.
BE Li, Y
   Qui, YP
   Luo, XN
   Li, JS
TI Plasma Pretreatment for Digital Ink-jet Printing for Cotton Fabric
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
LA English
DT Proceedings Paper
CT 3rd International Symposium of Textile Bioengineering and Informatics
CY MAY 28-30, 2010
CL Coll Textiles, Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers, Key Lab Textile Sci & Technol, Key Lab Sci & Technol Eco Textiles, Res Ctr Ind Textiles, Minist Educ, Donghua Univ, Textile Bioengineering & Info Soc
HO Coll Textiles
DE cotton; plasma; digital ink-jet printing; chitosan; sodium; alginate;
   reactive dye
AB In this paper, plasma was used as a pretreatment for improving the coating process of printing medium for digital ink-jet printing process with reactive dye. Currently, sodium alginate is commonly used for preparing the printing medium for digital ink-jet printing due to its ready solubility and excellent stability even at high-temperature fixation treatments. However, chitosan is also widely used as novel biomaterial. As a natural polymer, sodium alginate and chitosan are biocompatible, biodegradable and non-toxic, chitosan may be used as a chemical for preparing the printing medium for digital ink-jet printing for cotton fabric. Recently, plasma treatment has proved to be an effective pretreatment method for the improving coating process by altering the surface properties of the material. Thus, the aim of this study was to investigate the application of plasma as a pretreatment process to enhance the coating of printing medium, i.e. sodium alginate and sodium alginate/chitosan mixture, so as to improve the colour properties of the digital ink-jet printed cotton fabric.
C1 [Kan, C. W.; Yuen, C. W. M.; Tsoi, W. Y. I.] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
RP Kan, CW (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
EM tccwk@inet.polyu.edu.hk
RI Report, TBIS/G-5407-2012
CR ASTON SO, 1993, J SOC DYERS COLOUR, V109, P147
   Choi PSR, 2005, FIBER POLYM, V6, P229, DOI 10.1007/BF02875647
   CHOI PSR, 2005, TEXT ASIA, V35, P50
   Gupta S, 2001, INDIAN J FIBRE TEXT, V26, P156
   LUO S, 2002, J AD SCI TECHN, V16, P715
   Shishoo R., 1996, J COATED FABRICS, V26, P26
   Van Parys M., 2002, MELLIAND TEXTILBERIC, V83, pE96
NR 7
TC 0
Z9 0
U1 0
U2 2
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
PY 2010
BP 835
EP 839
DI 10.3993/tbis2010147
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BRN79
UT WOS:000283206000144
DA 2018-10-20
ER

PT S
AU Santos, E
   Zarate, J
   Orive, G
   Hernandez, RM
   Pedraz, JL
AF Santos, Edorta
   Zarate, Jon
   Orive, Gorka
   Ma Hernandez, Rosa
   Luis Pedraz, Jose
BE Pedraz, JL
   Orive, G
TI Biomaterials in Cell Microencapsulation
SO THERAPEUTIC APPLICATIONS OF CELL MICROENCAPSULATION
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID ALGINATE-BASED MICROCAPSULES; POLY(ETHYLENE GLYCOL) DIACRYLATE;
   MESENCHYMAL STEM-CELLS; L-LYSINE MICROCAPSULES; TERM IMMUNOISOLATED
   TRANSPLANTATION; MOLECULAR-WEIGHT DISTRIBUTION; ACUTE INFLAMMATORY
   RESPONSES; POLYMER-ENCAPSULATED CELLS; FOREIGN-BODY REACTION; IN-VITRO
AB The field of cell encapsulation is advancing rapidly. This cell-based technology permits the local and long-term delivery of a desired therapeutic product reducing or even avoiding the need of immunosuppressant drugs. The choice of a suitable material preserving the viability and functionality of enclosed cells becomes fundamental if a therapeutic aim is intended. Alginate, which is by far the most frequently used biomaterial in the field of cell microencapsulation, has been demonstrated to be probably the best polymer for this purpose due to its biocompatibility, easy manipulation, gel forming capacity and in vivo performance.
C1 [Luis Pedraz, Jose] Univ Basque Country, Lab Pharm & Pharmaceut Technol, Vitoria, Spain.
RP Pedraz, JL (reprint author), Univ Basque Country, Lab Pharm & Pharmaceut Technol, Vitoria, Spain.
EM joseluis.pedraz@ehu.es; joseluis.pedraz@ehu.es
RI Hernandez, Rosa Maria/S-6332-2017; SANTOS VIZCAINO, EDORTA/L-2796-2017
OI SANTOS VIZCAINO, EDORTA/0000-0001-7064-4563; Hernandez, Rosa
   Maria/0000-0002-3947-409X
CR Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bae KH, 2006, BIOTECHNOL PROGR, V22, P297, DOI 10.1021/bp050312b
   Baroli B, 2006, J CHEM TECHNOL BIOT, V81, P491, DOI 10.1002/jctb.1468
   Baruch L, 2006, BIOPOLYMERS, V82, P570, DOI 10.1002/bip.20509
   Bellin I, 2006, P NATL ACAD SCI USA, V103, P18043, DOI 10.1073/pnas.0608586103
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Benzoni E, 2005, INT J IMMUNOPATH PH, V18, P677, DOI 10.1177/039463200501800409
   Bikram M, 2007, ANN BIOMED ENG, V35, P796, DOI 10.1007/s10439-007-9263-4
   Blasi P, 2006, INT J PHARM, V324, P27, DOI 10.1016/j.ijpharm.2006.07.049
   Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Boontheekul T, 2008, FARADAY DISCUSS, V139, P105
   Boontheekul T, 2008, FARADAY DISCUSS, V139, P419
   Boontheekul T, 2008, FARADAY DISCUSS, V139, P53, DOI 10.1039/b719928g
   Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151
   Chae SY, 2004, BIOMATERIALS, V25, P843, DOI 10.1016/S0142-9612(03)00605-7
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   DARQUY S, 1994, ARTIF ORGANS, V18, P898, DOI 10.1111/j.1525-1594.1994.tb03341.x
   Darrabie MD, 2006, J MICROENCAPSUL, V23, P613, DOI 10.1080/0265204060087621
   Darrabie MD, 2005, BIOMATERIALS, V26, P6846, DOI 10.1016/j.biomaterials.2005.05.009
   de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060
   de Vos P, 2007, J BIOMED MATER RES A, V80A, P813, DOI 10.1002/jbm.a.30979
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   DECASTRO M, 2009, J BIOMED A IN PRESS
   Desai TA, 2002, EXPERT OPIN BIOL TH, V2, P633, DOI 10.1517/14712598.2.6.633
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e
   Donati I, 2007, BIOMACROMOLECULES, V8, P957, DOI 10.1021/bm060856h
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Dusseault J, 2005, BIOMATERIALS, V26, P1515, DOI 10.1016/j.biomaterials.2004.05.013
   Dusseault J, 2008, BIOMATERIALS, V29, P917, DOI 10.1016/j.biomaterials.2007.10.045
   Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Figliuzzi M, 2006, ACTA BIOMATER, V2, P221, DOI 10.1016/j.actbio.2005.12.002
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207
   Goto Y, 2008, BIOMACROMOLECULES, V9, P828, DOI 10.1021/bm701161d
   Grosskinsky U, 2006, DESALINATION, V199, P265, DOI 10.1016/j.desal.2006.03.172
   Holland NB, 1998, NATURE, V392, P799
   HORCHER A, 1994, TRANSPLANT P, V26, P784
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Huebsch ND, 2007, BIOMATERIALS, V28, P2424, DOI 10.1016/j.biomaterials.2007.01.023
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Inaki Y, 1997, Nucleic Acids Symp Ser, P25
   Juste S, 2005, J BIOMED MATER RES A, V72A, P389, DOI 10.1002/jbm.a.30254
   Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008
   Keegan AD, 2001, CYTOKINE REFERENCE
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   KESSLER L, 1991, HORM METAB RES, V23, P312, DOI 10.1055/s-2007-1003685
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   King A, 2000, TRANSPLANTATION, V70, P380, DOI 10.1097/00007890-200007270-00025
   King A, 2003, TRANSPLANTATION, V76, P275, DOI 10.1097/01.TP.0000078625.29988.0A
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Kizilel Seda, 2005, Diabetes Technol Ther, V7, P968, DOI 10.1089/dia.2005.7.968
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Leinfelder U, 2003, BIOMATERIALS, V24, P4161, DOI 10.1016/S0142-9612(03)00299-0
   LI HR, 1998, ADV DRUG DEL REV, V33, P87
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307
   MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Mokry J, 2000, BIOTECHNOL PROGR, V16, P897, DOI 10.1021/bp000113m
   Morch YA, 2008, BIOMACROMOLECULES, V9, P2360, DOI 10.1021/bm8003572
   Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Orive G, 2005, MOL THER, V12, P283, DOI 10.1016/j.ymthe.2005.04.002
   Orive G, 2005, J BIOMED MATER RES B, V74B, P429, DOI 10.1002/jbm.b.30146
   Orive G, 2005, BIOMACROMOLECULES, V6, P927, DOI 10.1021/bm049380x
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   ORIVE G, 2009, J CONTROL R IN PRESS
   PEDERSEN SS, 1989, J CLIN MICROBIOL, V27, P691
   Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Prokop A, 1997, ANN NY ACAD SCI, V831, P223
   PUEYO ME, 1993, J BIOMAT SCI-POLYM E, V5, P197
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rice MA, 2006, BIOMACROMOLECULES, V7, P1968, DOI 10.1021/bm060086+
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Rokstad AM, 2006, BIOMATERIALS, V27, P4726, DOI 10.1016/j.biomaterials.2006.05.011
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043
   Sakai S, 2008, J BIOMED MATER RES A, V85A, P345, DOI 10.1002/jbm.a.31299
   Sakai S, 2007, BIOMACROMOLECULES, V8, P2622, DOI 10.1021/bm070300+
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   SAWHNEY AS, 1994, BIOTECHNOL BIOENG, V44, P383, DOI 10.1002/bit.260440317
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   SHEN F, 2008, J BIOMED B IN PRESS
   Sikorski P, 2007, BIOMACROMOLECULES, V8, P2098, DOI 10.1021/bm0701503
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   SMIDSROD O, 1974, FARADAY DISCUSS, V57, P263
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Strand BL, 2003, J BIOMED MATER RES A, V64A, P540, DOI 10.1002/jbm.a.10337
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Tam SK, 2006, BIOMATERIALS, V27, P1296, DOI 10.1016/j.biomaterials.2005.08.027
   Tam SK, 2005, BIOMATERIALS, V26, P6950, DOI 10.1016/j.biomaterials.2005.05.007
   TAM SK, 2008, J BIOMED A IN PRESS
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thanos CG, 2007, J BIOMED MATER RES A, V83A, P216, DOI 10.1002/jbm.a.31472
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Thu B, 2000, BIOPOLYMERS, V53, P60, DOI 10.1002/(SICI)1097-0282(200001)53:1<60::AID-BIP6>3.0.CO;2-F
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   van Hoogmoed CG, 2003, J BIOMED MATER RES A, V67A, P172, DOI 10.1002/jbm.a.10086
   Wang XL, 2006, BIOTECHNOL PROGR, V22, P791, DOI 10.1021/bp050386n
   Weber LM, 2006, ACTA BIOMATER, V2, P1, DOI 10.1016/j.actbio.2005.10.005
   WEBER LM, 2007, BIOMATERIALS, V28, P3304
   WIEGAND F, 1993, TRANSPLANTATION, V56, P1206, DOI 10.1097/00007890-199311000-00030
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, P66
   Wu JX, 1997, TRANSPLANT P, V29, P2146, DOI 10.1016/S0041-1345(97)00267-4
   Xu Y, 2009, BIOMACROMOLECULES, V10, P267, DOI 10.1021/bm801279y
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
   Zimmermann H, 2003, BIOMATERIALS, V24, P2083, DOI 10.1016/S0142-9612(02)00639-7
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
   Zimmermann H, 2007, BIOMATERIALS, V28, P1327, DOI 10.1016/j.biomaterials.2006.11.032
   Zimmermann U, 2000, BIOTECHNIQUES, V29, P564, DOI 10.2144/00293rv01
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 151
TC 45
Z9 47
U1 1
U2 15
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-1-4419-5785-6
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2010
VL 670
BP 5
EP 21
D2 10.1007/978-1-4419-5786-3
PG 17
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BMW42
UT WOS:000273740200002
PM 20384214
OA Bronze
DA 2018-10-20
ER

PT S
AU Bergemann, C
   Klinkenberg, ED
   Luthen, F
   Weidmann, A
   Lange, R
   Beck, U
   Bader, R
   Schroder, K
   Nebe, B
AF Bergemann, Claudia
   Klinkenberg, Ernst-Dieter
   Luethen, Frank
   Weidmann, Arne
   Lange, Regina
   Beck, Ulrich
   Bader, Rainer
   Schroeder, Karsten
   Nebe, Barbara
BE Chandra, T
   Wanderka, N
   Reimers, W
   Ionescu, M
TI PROLIFERATION AND MIGRATION OF HUMAN OSTEOBLASTS ON POROUS THREE
   DIMENSIONAL SCAFFOLDS
SO THERMEC 2009, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Conference on Processing and Manufacturing of Advanced
   Materials (THERMEC)/2nd Symposium Session on Multiscale Mechanical
   Modelling of Complex Materials and Engineering Applications
CY AUG 25-29, 2009
CL Berlin, GERMANY
SP Minerals, Met & Mat Soc (TMS)
DE Bone tissue engineering; Human osteoblast; 3D scaffold; Tantalum; Cell
   morphology; Cell migration; Gene expression; In vitro model
ID TRABECULAR METAL; TANTALUM; DIFFERENTIATION; ARTHROPLASTY; EXPRESSION;
   TITANIUM; HYPOXIA; CELLS
AB Porous tantalum (Ta) biomaterial is designed to function as a scaffold for osseous ingrowths and has found applications in orthopedics. Integration of this Ta foam into the neighboring bone requires that osteoprogenitor cells attach to the implant, grow into the scaffold, proliferate and differentiate to osteoblasts The aim of the present study was to create an in vitro 3D model system to investigate the interaction of human osteoblasts with porous Ta in the depth of the corpus To explore active migration of osteoblasts into the Ta scaffold two porous Ta discs (Zimmer. Poland) were horizontally fixed within a clamping ring. Thereby a 3D Ta module with 4 levels is generated, which is placed into a cell culture well with the appropriate medium Osteoblast-like cells were seeded apical onto the Ta module and cultured for 7 days in humidified atmosphere. Active migration of cells into the scaffold was monitored by field emission scanning electron microscopy (FESEM) imaging of the apical, medial and basal layers. A problem in 3D cell culture is the nutrition of cells inside of the scaffold Therefore morphological changes and differentiation of the cells in distinct layers were analyzed
C1 [Bergemann, Claudia; Luethen, Frank; Weidmann, Arne; Nebe, Barbara] Univ Rostock, Fac Med, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
   [Klinkenberg, Ernst-Dieter] DOT GmbH, D-18059 Rostock, Germany.
   [Lange, Regina; Beck, Ulrich] Univ Rostock, Dept Elect Engn & Informat Technol, D-18119 Rostock, Germany.
   [Bader, Rainer] Univ Rostock, Fac Med, Dept Orthoped, D-18055 Rostock, Germany.
   [Schroeder, Karsten] Leibniz Inst Plasma Sci & Technol, D-17489 Greifswald, Germany.
RP Bergemann, C (reprint author), Univ Rostock, Fac Med, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
EM klinkenberg@dot-coating.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
CR Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Chalkin B, 2005, J ARTHROPLASTY, V20, P127, DOI 10.1016/j.arth.2004.09.029
   Christie Michael J, 2002, Am J Orthop (Belle Mead NJ), V31, P219
   Frosch KH, 2002, CELLS TISSUES ORGANS, V170, P214, DOI 10.1159/000047925
   Fukuoka H, 2005, BIOCHEM BIOPH RES CO, V328, P885, DOI 10.1016/j.bbrc.2005.01.042
   Gross AE, 2005, J ARTHROPLASTY, V20, P91, DOI 10.1016/j.arth.2005.03.020
   Hui PW, 1996, J BIOMECH, V29, P123, DOI 10.1016/0021-9290(95)00010-0
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Steinbrech DS, 2000, AM J PHYSIOL-CELL PH, V278, pC853
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 17
TC 5
Z9 6
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 638-642
BP 506
EP +
DI 10.4028/www.scientific.net/MSF.638-642.506
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BQH93
UT WOS:000281043800083
DA 2018-10-20
ER

PT S
AU Maruyama, N
AF Maruyama, Norio
BE Chandra, T
   Wanderka, N
   Reimers, W
   Ionescu, M
TI FATIGUE AND FRETTING FATIGUE BEHAVIOR OF METALLIC BIOMATERIALS
SO THERMEC 2009, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Conference on Processing and Manufacturing of Advanced
   Materials
CY AUG 25-29, 2009
CL Berlin, GERMANY
SP Minerals, Met & Mat Soc
DE fatigue; fretting fatigue; metallic biomaterial; simulated body fluid;
   fatigue strength; tensile strength; Ti alloy; Co-Cr alloy; stainless
   steel
ID PSEUDO-BODY FLUID
AB A fretting fatigue test method in a simulated body fluid is shown to evaluate fatigue properties of metallic materials which are used in the orthopaedics field Next, fatigue/fretting fatigue behavior in a simulated body fluid is given for 316L stainless steel, Ti-6% Al-4% V alloy, pure Ti for industrial use and Co-Cr-Mo alloy. Finally, we discuss the relationship between the tensile strength and the fatigue strength/fretting fatigue strength of metallic biomaterials at 10(7) cycles in air and in a simulated body fluid For all of the biomaterials tested, the fatigue strength at 10(7) cycles is similar in air and in a simulated body fluid The fatigue strength is closely correlated to the tensile strength. The fatigue strength increases with increasing tensile strength However, a correlation is not observed between the fretting fatigue strength at 10(7) cycles and the fatigue strength or the tensile strength
C1 Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
RP Maruyama, N (reprint author), Natl Inst Mat Sci, Ctr Biomat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
CR *ASTM, 1984, F89784 ASTM
   *ASTM, 1997, F180197 ASTM
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   MARUYAMA N, 1995, J JAPANESE SOC BIOMA, V13, P14
   MARUYAMA N, 2000, J JAPANESE SOC BIOMA, V18, P17
   MARUYAMA N, 1999, J JPN SOC BIOMATER, V17, P172
   NAKAZAWA K, 1992, AM SOC TEST MATER, V1159, P115, DOI 10.1520/STP25824S
   Nakazawa K, 1999, J JPN I MET, V63, P1600, DOI 10.2320/jinstmet1952.63.12_1600
   NISHIOKA I, 1969, B JSME, V52, P692
   SASADA T, 1988, BIOTRIBOLOGY FRICTIO, P123
   WATERHOUSE RB, 1984, FRETTING CORROSION, P191
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
NR 12
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 638-642
BP 618
EP 623
DI 10.4028/www.scientific.net/MSF.638-642.618
PN 1-4
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BQH93
UT WOS:000281043800102
DA 2018-10-20
ER

PT S
AU Asaoka, T
   Kajihata, Y
   Furukawa, K
   Ushida, T
   Tateishi, T
AF Asaoka, Teruo
   Kajihata, Yuji
   Furukawa, Katsuko
   Ushida, Takashi
   Tateishi, Tetsuya
BE Chandra, T
   Wanderka, N
   Reimers, W
   Ionescu, M
TI Solubility Control of alpha TCP-HAp Functionally Graded Porous Beads in
   SBF for Biomaterial Use
SO THERMEC 2009, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Conference on Processing and Manufacturing of Advanced
   Materials (THERMEC)/2nd Symposium Session on Multiscale Mechanical
   Modelling of Complex Materials and Engineering Applications
CY AUG 25-29, 2009
CL Berlin, GERMANY
SP Minerals, Met & Mat Soc (TMS)
DE biomaterial; alpha TCP; HAp; functionally graded material
ID BONE-MARROW-CELLS; PHOSPHATE BEADS
AB As excellent scaffolds for cultivating bone cells, porous beads of bioactive ceramics such as HAp, TCP are considered to be promising. HAp and alpha-TCP are well known as non-toxic bioceramics to human cells, but their behavior in living body fluid are different. HAp is bioactive material which has both high strength and better tissue-adhesive properties, but that is not readily absorbed by the human body. On the contrary, alpha-TCP is highly bioabsorbable; it is quickly absorbed by the body, and, therefore, disappears before bone is completely replaced. To realize a composite which has suitable solubility in living body fluid, alpha-TCP/HAp functionally graded porous beads were fabricated by the method of spheroidization in liquid nitrogen. This type of composite maintains the function of scaffold with sufficient strength up to growth of new bone, and after the growth, it is expected to absorbed completely in the body
   In the present study, ceramic beads with alpha-TCP at the center were fabricated and coated with a functionally graded layer of HAp By controlling the thickness of HAp layer, which could be realized by changing time of hydrolytic reaction, the absorption rate into the body would be easily controlled. In addition, to accelerate the formation of porous structure, some acid solutions were used to dissolve the beads surface and to penetrate pores toward inside of the beads. Observed surface and inner structure by SEM, also the measured change in absorption rate will be presented
C1 [Asaoka, Teruo; Kajihata, Yuji] Tokyo Denki Univ, Hatoyama, Saitama 35003, Japan.
   [Furukawa, Katsuko; Ushida, Takashi] Univ Tokyo, Bunkyo Ku, Tokyo, Japan.
   [Tateishi, Tetsuya] NIMS, Umezono, Tsuhuba, Japan.
RP Asaoka, T (reprint author), Tokyo Denki Univ, Hatoyama, Saitama 35003, Japan.
EM asaoka@mail.dendai.ac.jp
CR Furukawa KS, 2004, MAT SCI ENG C-BIO S, V24, P437, DOI 10.1016/j.msec.2003.11.010
   Miyauchi S, 2004, MAT SCI ENG C-BIO S, V24, P875, DOI 10.1016/j.msec.2004.08.031
   MONMA H, 1984, GYPSUM LIME
   Nakahira A, 1999, J CERAM SOC JPN, V107, P89, DOI 10.2109/jcersj.107.89
NR 4
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 638-642
BP 2021
EP +
DI 10.4028/www.scientific.net/MSF638-642.2021
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BQH93
UT WOS:000281043801001
DA 2018-10-20
ER

PT S
AU Hatanaka, S
   Ueda, M
   Ikeda, M
   Ogawa, M
AF Hatanaka, Shota
   Ueda, Masato
   Ikeda, Masahiko
   Ogawa, Michiharu
BE Chandra, T
   Wanderka, N
   Reimers, W
   Ionescu, M
TI Isothermal aging behavior in Ti-10 Cr-Al alloys for medical applications
SO THERMEC 2009 SUPPLEMENT: 6TH INTERNATIONAL CONFERENCE ON PROCESSING &
   MANUFACTURING OF ADVANCED MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th International Conference on Processing and Manufacturing of Advanced
   Materials (THERMEC)/2nd Symposium Session on Multiscale Mechanical
   Modelling of Complex Materials and Engineering Applications
CY AUG 25-29, 2009
CL Berlin, GERMANY
SP Minerals, Met & Mat Soc (TMS)
DE Biomaterial; Beta Titanium Alloy; Aging; Elastic Modulus; TTT Diagram
ID PHASE
AB The effect of Al addition on the elastic modulus and aging behavior in Ti-10 Cr alloys was investigated by means of electrical resistivity, X-ray diffractometry and Vickers hardness measurements. All of the alloys used were formed from solutions treated at 1173 K for 3.6 ks and then quenched into ice water (STQ). Following STQ, all Al-containing specimens exhibited a beta phase, with the athermal omega appearing only for alloys with zero Al addition. The elastic modulus was found to decrease with addition of Al from approximately 80 to 70 GPa, due to the suppression of the athermal omega. The specimens following STQ were isothermally aged at 573 K, 673 K and 773 K. The addition of Al was found to retard the onset of precipitation of the isothermal omega phase and decrease the upper limit temperature for precipitation of this phase. On the other hand, as the Al content was increased, precipitation of the alpha phase was accelerated in the presence of an existing isothermal omega phase. By contrast, this precipitation was suppressed under single beta phase conditions. Surface modification for osteointegration was also performed. When the modified specimens were immersed in simulated body fluid, the surface modification was found to promote the deposition of HAp.
C1 [Hatanaka, Shota] Kansai Univ, Grad Stud, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.
   [Ueda, Masato; Ikeda, Masahiko] Kansai Univ, Fac Chem, Mat Bioengn, Kansas City, KS USA.
   [Ogawa, Michiharu] R & D Lab, Boston 1987, MA USA.
RP Hatanaka, S (reprint author), Kansai Univ, Grad Stud, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.
EM m-ueda@ipcku.kansai-u.ac.jp; hikoik@ipcku.kansai-u.ac.jp
CR BOYER R, 1994, MAT PROPERTIES HDB T
   Doi S., 2007, P 11 WOULD C TIT, V2, P399
   Gloriant T, 2008, SCRIPTA MATER, V58, P271, DOI 10.1016/j.scriptamat.2007.10.007
   Ikeda M., 2007, P 11 WORLD C TIT, V2, P1433
   Ogawa M., 2007, P 11 WORLD C TIT, V2, P591
   Sugano D, 2005, MAT SCI ENG C-BIO S, V25, P377, DOI 10.1016/j.msec.2005.01.021
   Ueda M., 2008, MAT SCI E C IN PRESS
   Ueda M, 2008, MATER TRANS, V49, P1706, DOI 10.2320/matertrans.MRP2008132
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   WILLIAMS JC, 1973, METALL TRANS, V4, P2701, DOI 10.1007/BF02644570
NR 10
TC 3
Z9 3
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-293-0
J9 ADV MATER RES-SWITZ
PY 2010
VL 89-91
BP 232
EP +
DI 10.4028/www.scientific.net/AMR.89-91.232
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBQ62
UT WOS:000307888500040
DA 2018-10-20
ER

PT S
AU Lee, S
   Obata, A
   Kasuga, T
AF Lee, Sungho
   Obata, Akiko
   Kasuga, Toshihiro
BE Chandra, T
   Wanderka, N
   Reimers, W
   Ionescu, M
TI Structure of CaO-SrO-TiO2-P2O5 Glasses and Their Ion-releasing Abilities
   in Tris Buffer Solution
SO THERMEC 2009 SUPPLEMENT: 6TH INTERNATIONAL CONFERENCE ON PROCESSING &
   MANUFACTURING OF ADVANCED MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th International Conference on Processing and Manufacturing of Advanced
   Materials (THERMEC)/2nd Symposium Session on Multiscale Mechanical
   Modelling of Complex Materials and Engineering Applications
CY AUG 25-29, 2009
CL Berlin, GERMANY
SP Minerals, Met & Mat Soc (TMS)
DE Calcium phosphate glass; Strontium; Structure; Ion release; Biomaterial
ID PHOSPHATE INVERT GLASSES; STRONTIUM RANELATE; CERAMICS
AB SrO-containing calcium phosphate invert glasses, (60-x) CaO center dot xSrO center dot 30P(2)O(5)center dot 7Na(2)O center dot 3TiO(2) (mol%, x = 0 similar to 60), which are expected to inhibit bone resorption by osteoclast and enhance bone formation, were prepared and estimated in their ion release behavior in Tris buffer solution. The glasses gradually released ions and the dissolved amounts of ions were the smallest when the glass contained 20 mol% of SrO. Laser Raman spectra showed that the peaks of phosphate groups and TiOy polyhedral groups red-shifted with increasing the SrO content in the glasses. The red-shift is suggested to be due to decrease in bonding strength between cations and phosphate groups or TiOy polyhedral groups in the glasses. In the case of the glasses containing SrO over 20 mol%, no Raman peaks of TiOy polyhedral shifted. TiOy (y=4 or 6) polyhedral in the glasses can coordinate with cation up to 18 mol% since they contain 3 mol% of TiO2. Sr2+ ions are supposed to preferentially coordinate with TiOy polyhedral, the formation of this structure would induce the decrease in the ion amounts released from the glasses containing 0 similar to 20 mol% of SrO.
C1 [Lee, Sungho; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Lee, S (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp
CR Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8
   Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020
   Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   KISHIOKA A, 1974, B CHEM SOC JPN, V47, P2493, DOI 10.1246/bcsj.47.2493
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   NELSON BN, 1979, J CHEM PHYS, V71, P2739, DOI 10.1063/1.438679
   OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22
   ROUSE GB, 1978, J NON-CRYST SOLIDS, V28, P193, DOI 10.1016/0022-3093(78)90006-6
   SAKKA S, 1989, J NON-CRYST SOLIDS, V112, P64, DOI 10.1016/0022-3093(89)90494-8
   Takahashi T., 2003, J BONE MINER RES, V18, P1082, DOI DOI 10.1359/JBMR.2003.18.6.1082
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   XYONS ID, 2000, J BIOMED MATER RES, V276, P461
NR 16
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-293-0
J9 ADV MATER RES-SWITZ
PY 2010
VL 89-91
BP 342
EP +
DI 10.4028/www.scientific.net/AMR.89-91.342
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBQ62
UT WOS:000307888500059
DA 2018-10-20
ER

PT S
AU Narita, K
   Niinomi, M
   Nakai, M
   Akahori, T
   Tsutsumi, H
   Oribe, K
AF Narita, Kengo
   Niinomi, Mitsuo
   Nakai, Masaaki
   Akahori, Toshikazu
   Tsutsumi, Harumi
   Oribe, Kazuya
BE Chandra, T
   Wanderka, N
   Reimers, W
   Ionescu, M
TI Bending fatigue and spring back properties of implant rods made of
   beta-type titanium alloy for spinal fixture
SO THERMEC 2009 SUPPLEMENT: 6TH INTERNATIONAL CONFERENCE ON PROCESSING &
   MANUFACTURING OF ADVANCED MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th International Conference on Processing and Manufacturing of Advanced
   Materials (THERMEC)/2nd Symposium Session on Multiscale Mechanical
   Modelling of Complex Materials and Engineering Applications
CY AUG 25-29, 2009
CL Berlin, GERMANY
SP Minerals, Met & Mat Soc (TMS)
DE Biomaterial; Titanium alloy; Bending property; Spring back; Four-point
   bending fatigue strength
ID MECHANICAL-PROPERTIES; TI-29NB-13TA-4.6ZR
AB Implanting a spinal fixture using metallic rods is one of the effective treatments for spinal diseases. Because cyclic bending stress is loaded on the implant rods when patients move their upper bodies in daily life, bending fatigue properties are important for the implant rod. Further, the implant rods are bended plastically into a curved shape of spine by hand in a surgical operation. In that case, keeping shape is important, namely bending spring back properties are important factors. On the other hand, a biomedical beta-type titanium alloy, Ti-29Nb-13Ta-4.6Zr (mass %) alloy (TNTZ), has been developed by the authors. Currently, this alloy are investigated to be applied to the above mentioned implant rod practically. Therefore, four-point bending fatigue and three point-bending spring back properties of TNTZ subjected various heat treatments were examined in this study.
   TNTZ rods were subjected to solution treatment, and then some of them were subjected to aging treatment at 673 K or 723 K for 259.2 ks, followed by water quenching. Then, four-point bending fatigue and three-point bending spring back tests were carried out on TNTZ rods subjected to the various heat treatments mentioned above.
   The bending fatigue strength at 2.5 million cycles in the high cycle fatigue region are not much different among any TNTZ rod. However, the bending fatigue strength of the Ti-6Al-4V ELI (Ti64) rod exceeds the fatigue strengths of every TNTZ rods in both low and high cycle fatigue regions. On the other hand, the lower spring back, which is a favorable property, was obtained for some TNTZ rod than Ti64 rod.
C1 [Narita, Kengo] Tohoku Univ, Sendai, Miyagi 9808579, Japan.
   [Niinomi, Mitsuo; Nakai, Masaaki; Akahori, Toshikazu; Tsutsumi, Harumi] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Sendai, Miyagi 9808579, Japan.
   [Oribe, Kazuya] Showa Ika Kogyo Co LTD, Toyohashi, Aichi 441, Japan.
RP Narita, K (reprint author), Tohoku Univ, Sendai, Miyagi 9808579, Japan.
EM narita@imr.tohoku.ac.jp; niinomi@imr.tohoku.ac.jo;
   nakai@imr.tohoku.ac.jp; akahori@imr.tohoku.ac.jp;
   tsutsumi@imr.tohoku.ac.jp; oribe@showaika.co.jp
CR Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   [Anonymous], 2002, F13202 ASTM INT
   *ASTM INT, 2002, F219302 ASTM INT
   HARRINGTON PR, 1962, J BONE JOINT SURG AM, V44, P591, DOI 10.2106/00004623-196244040-00001
   HARRINGTON PR, 1962, S AFR J SURG, V5, P7
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   NAKAHARA S, 2006, 41 JAPAN MED SOC SPI, P76
   Narita K, 2008, J JPN I MET, V72, P674, DOI 10.2320/jinstmet.72.674
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   WNEK GE, 2004, ENCY BIOMATERIALS BI, V1, P809
   YOUNG RJ, 1997, BIOMATER, V18, P1325, DOI DOI 10.1016/S0142-9612(97)00073-2
NR 11
TC 5
Z9 5
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-293-0
J9 ADV MATER RES-SWITZ
PY 2010
VL 89-91
BP 400
EP +
DI 10.4028/www.scientific.net/AMR.89-91.400
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBQ62
UT WOS:000307888500069
DA 2018-10-20
ER

PT S
AU Sarra-Bournet, C
   Vallieres, K
   Gherardi, N
   Turgeon, S
   Massines, F
   Laroche, G
AF Sarra-Bournet, C.
   Vallieres, K.
   Gherardi, N.
   Turgeon, S.
   Massines, F.
   Laroche, G.
BE Chandra, T
   Wanderka, N
   Reimers, W
   Ionescu, M
TI Deposition of Functional Polymer Thin Films Using Atmospheric Pressure
   Plasma for Biomedical Applications - Endothelialization of Vascular
   Prostheses
SO THERMEC 2009 SUPPLEMENT: 6TH INTERNATIONAL CONFERENCE ON PROCESSING &
   MANUFACTURING OF ADVANCED MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th International Conference on Processing and Manufacturing of Advanced
   Materials (THERMEC)/2nd Symposium Session on Multiscale Mechanical
   Modelling of Complex Materials and Engineering Applications
CY AUG 25-29, 2009
CL Berlin, GERMANY
SP Minerals, Met & Mat Soc (TMS)
DE Plasma deposition; Thin films; Atmospheric Pressure; Biomedical;
   Biomaterial
ID CHEMICAL-CHARACTERIZATION; SURFACES; ADHESION; CELL
AB Functionalized plasma polymer thin films were obtained in a dielectric barrier discharge at atmospheric pressure in an atmosphere of N-2 and C2H4. The coatings were hydrophilic, adherent, chemically stable and presented a surface concentration of NH2 suitable for further biomolecule conjugation. Covalent grafting of a linking arm (glutaric anhydride) and subsequent conjugation of fibronectin, a protein of the extracellular matrix, were successful. Finally, endothelial cell adhesion experiments were performed directly on the functionalized thin films as well as on the conjugated coatings. Effects on cell adhesion were observed as a function of the plasma thin film deposition parameters.
C1 [Sarra-Bournet, C.; Vallieres, K.; Turgeon, S.; Laroche, G.] St Francis Assisi Hosp, CHUQ, Univ Hosp Res Ctr, 10 Rue Espinay, Quebec City, PQ G1L 3L5, Canada.
RP Sarra-Bournet, C (reprint author), St Francis Assisi Hosp, CHUQ, Univ Hosp Res Ctr, 10 Rue Espinay, Quebec City, PQ G1L 3L5, Canada.
EM christian.sarra-bournet.1@ulaval.ca; karine.vallieres.1@ulaval.ca;
   nicolas.gherardi@laplace.univ-tlse.fr; stephane.Turgeon@crsfa.ulaval.ca;
   francoise.massines@univ-perp.fr; gaetan.Laroche@gmn.ulaval.ca
CR Chevallier P, 2001, J PHYS CHEM B, V105, P12490, DOI 10.1021/jp011607k
   Gauvreau V, 2005, BIOCONJUGATE CHEM, V16, P1088, DOI 10.1021/bc049717s
   Gauvreau V, 2004, BIOCONJUGATE CHEM, V15, P1146, DOI 10.1021/bc049858u
   Girard-Lauriault PL, 2008, PLASMA PROCESS POLYM, V5, P631, DOI 10.1002/ppap.200800054
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Kidd KR, 2005, TISSUE ENG, V11, P1379, DOI 10.1089/ten.2005.11.1379
   Majumdar A, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990054
   Massines F., 2000, Plasmas and Polymers, V5, P151, DOI 10.1023/A:1011310319171
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Sarra-Bournet C., 2008, 11 INT S HIGH PRESS, P483
   Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   Zarge JI, 1997, J SURG RES, V67, P4, DOI 10.1006/jsre.1996.4903
NR 14
TC 2
Z9 2
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-293-0
J9 ADV MATER RES-SWITZ
PY 2010
VL 89-91
BP 479
EP +
DI 10.4028/www.scientific.net/AMR.89-91.479
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBQ62
UT WOS:000307888500082
DA 2018-10-20
ER

PT J
AU Zivkovic, P
   Petrovic, V
   Najman, S
   Stefanovic, V
AF Zivkovic, Petar
   Petrovic, Vladimir
   Najman, Stevo
   Stefanovic, Vladisav
TI Stem Cell-Based Dental Tissue Engineering
SO THESCIENTIFICWORLDJOURNAL
LA English
DT Review
DE tooth development; stem cells; tooth engineering; dentin-pulp complex;
   periodontium
ID HUMAN PERIODONTAL-LIGAMENT; GROWTH-FACTOR-BETA; BONE MORPHOGENETIC
   PROTEINS; ENAMEL MATRIX PROTEINS; TOOTH ROOT DEVELOPMENT; MARROW STROMAL
   CELLS; IN-VITRO; REGENERATIVE DENTISTRY; EXTRACELLULAR-MATRIX;
   REPARATIVE DENTIN
AB The development of biological and biomaterial sciences profiled tissue engineering as a new and powerful tool for biological replacement of organs. The combination of stem cells and suitable scaffolds is widely used in experiments today, in order to achieve partial or whole organ regeneration. This review focuses on the use of tissue engineering strategies in tooth regeneration, using stem cells and stem cells/scaffold constructs. Although whole tooth regeneration is still not possible, there are promising results. However, to achieve this goal, it is important to understand and further explore the mechanisms underlying tooth development. Only then will we be able to mimic the natural processes with the use of stem cells and tissue engineering techniques.
C1 [Zivkovic, Petar; Petrovic, Vladimir; Najman, Stevo; Stefanovic, Vladisav] Univ Sch Med, Nish 18000, Serbia.
RP Stefanovic, V (reprint author), Univ Sch Med, Nish 18000, Serbia.
EM petarz83@yahoo.com; vlada@medfak.ni.ac.rs; stevo@medfak.ni.ac.rs;
   stefan@ni.ac.rs
OI Najman, Stevo/0000-0002-2411-9802
FU Ministry of Science and Technological Development of Serbia [145004]
FX This work was supported by a grant, No 145004, from the Ministry of
   Science and Technological Development of Serbia. The authors declare no
   conflict of interests.
CR Ando Y, 2009, NAGOYA J MED SCI, V71, P51
   Arany S, 2009, BIOCHEM BIOPH RES CO, V381, P84, DOI 10.1016/j.bbrc.2009.02.025
   Bartold PM, 2006, PERIODONTOL 2000, V41, P123, DOI 10.1111/j.1600-0757.2006.00156.x
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Beertsen W, 1999, J DENT RES, V78, P1221, DOI 10.1177/00220345990780060501
   Benatti BB, 2007, J BIOSCI BIOENG, V103, P1, DOI 10.1263/jbb.103.1
   BHATT A, 2009, CDA J, V37, P799
   Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x
   Camelo M, 2003, INT J PERIODONT REST, V23, P213
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Cassidy N, 1997, ARCH ORAL BIOL, V42, P219, DOI 10.1016/S0003-9969(96)00115-X
   Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chen HF, 2005, J COLLOID INTERF SCI, V288, P97, DOI 10.1016/j.jcis.2005.02.064
   Chen R, 2009, J DENT RES, V88, P1008, DOI 10.1177/0022034509346119
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Cho MI, 1996, ANAT RECORD, V245, P342
   Chung IH, 2007, J ORAL MAXIL SURG, V65, P501, DOI 10.1016/j.joms.200607.004
   Coppe C, 2009, PEDIATR DENT, V31, P467
   Du C, 2006, BIOMED MATER, V1, pR10, DOI 10.1088/1748-6041/1/1/R02
   Duailibi SE, 2008, J DENT RES, V87, P745, DOI 10.1177/154405910808700811
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   El-Backly RM, 2008, AUST ENDOD J, V34, P52, DOI 10.1111/j.1747-4477.2008.00139.x
   FINKELMAN RD, 1990, J BONE MINER RES, V5, P717
   Foster BL, 2006, CALCIFIED TISSUE INT, V78, P103, DOI 10.1007/s00223-005-0184-7
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x
   Goldberg M, 2009, J DENT RES, V88, P396, DOI 10.1177/0022034509337101
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034
   Hacking SA, 2009, J DENT RES, V88, P409, DOI 10.1177/0022034509334774
   Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469
   Hatakeyama J, 2006, J DENT RES, V85, P144, DOI 10.1177/154405910608500206
   Haze A, 2009, J CELL MOL MED, V13, P1110, DOI 10.1111/j.1582-4934.2009.00700.x
   Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039
   Honda MJ, 2008, MED MOL MORPHOL, V41, P183, DOI 10.1007/s00795-008-0416-9
   Honda MJ, 2006, BONE, V39, P125, DOI 10.1016/j.bone.2005.12.005
   Honda MJ, 2005, ARCH HISTOL CYTOL, V68, P89, DOI 10.1679/aohc.68.89
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Hu B, 2006, J DENT RES, V85, P416, DOI 10.1177/154405910608500504
   Hu B, 2006, TISSUE ENG, V12, P2069, DOI 10.1089/ten.2006.12.2069
   Hu CC, 1998, J ENDODONT, V24, P744, DOI 10.1016/S0099-2399(98)80166-0
   Iohara K, 2009, REGEN MED, V4, P377, DOI 10.2217/RME.09.5
   Ishimatsu H, 2009, J ENDODONT, V35, P858, DOI 10.1016/j.joen.2009.03.049
   Ivanovski S, 2006, ORAL DIS, V12, P358, DOI 10.1111/j.1601-0825.2006.01253.x
   Ivanovski S, 2009, AUST DENT J, V54, pS118, DOI 10.1111/j.1834-7819.2009.01150.x
   Jaasma MJ, 2008, J BIOTECHNOL, V133, P490, DOI 10.1016/j.jbiotec.2007.11.010
   Jin QM, 2004, MOL THER, V9, P519, DOI 10.1016/j.ymthe.2004.01.016
   Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281
   Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016
   Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142
   Kitamura C, 2003, J DENT RES, V82, P91, DOI 10.1177/154405910308200203
   Kitamura C, 2001, J DENT RES, V80, P1530, DOI 10.1177/00220345010800061001
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kline LW, 2009, J ENDODONT, V35, P866, DOI 10.1016/j.joen.2009.03.045
   Kruzynska-Frejtag A, 2004, DEV DYNAM, V229, P857, DOI 10.1002/dvdy.10453
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   LESOT H, 1993, CELL MATER, V3, P201
   Leung L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025006
   Lezot F, 2000, J HISTOCHEM CYTOCHEM, V48, P277, DOI 10.1177/002215540004800213
   Lin NH, 2008, AUST DENT J, V53, P108, DOI 10.1111/j.1834-7819.2008.00019.x
   Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101
   Maria OM, 2007, ORAL DIS, V13, P11, DOI 10.1111/j.1601-0825.2006.01324.x
   MCCULLOCH CA, 2000, PERIODONTOL, V40, P173
   Mitsiadis TA, 2003, DEVELOPMENT, V130, P4451, DOI 10.1242/dev.00631
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Morsczeck C, 2006, CALCIFIED TISSUE INT, V78, P98, DOI 10.1007/s00223-005-0146-0
   Morsczeck C, 2005, CELL BIOL INT, V29, P567, DOI 10.1016/j.cellbi.2005.03.020
   Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004
   Morsczeck C, 2008, CLIN ORAL INVEST, V12, P113, DOI 10.1007/s00784-007-0170-8
   Murakami Shinya, 2007, Clin Calcium, V17, P249
   Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013
   Nakahara T, 2007, HUM CELL, V20, P63, DOI 10.1111/j.1749-0774.2007.00031.x
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601
   Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x
   Ning F, 2010, BIOCHEM BIOPH RES CO, V394, P342, DOI 10.1016/j.bbrc.2010.03.007
   Nociti FH, 2002, J DENT RES, V81, P817, DOI 10.1177/154405910208101204
   Ohazama A, 2004, J DENT RES, V83, P518, DOI 10.1177/154405910408300702
   Okuda K, 2003, J PERIODONTOL, V74, P849, DOI 10.1902/jop.2003.74.6.849
   Ol Y, 2009, DENT MATER J, V28, P162
   Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6
   Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667
   Parker GC, 2004, STEM CELLS DEV, V13, P579, DOI 10.1089/scd.2004.13.579
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Raja S, 2009, INT J DENT HYG, V7, P82, DOI 10.1111/j.1601-5037.2009.00380.x
   Ramseier Christoph A, 2006, Dent Clin North Am, V50, P245, DOI 10.1016/j.cden.2005.12.001
   Ripamonti U, 2007, TISSUE ENG, V13, P51, DOI 10.1089/ten.2006.0167
   Ripamonti U, 2009, J PERIODONTAL RES, V44, P141, DOI 10.1111/j.1600-0765.2008.01158.x
   RUTHERFORD RB, 1993, ARCH ORAL BIOL, V38, P571, DOI 10.1016/0003-9969(93)90121-2
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Seo BM, 2005, J DENT RES, V84, P907, DOI 10.1177/154405910508401007
   Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   SLAVKIN HC, 1989, BIOCHIM BIOPHYS ACTA, V991, P12, DOI 10.1016/0304-4165(89)90021-4
   Slavkin HC, 2006, PERIODONTOL 2000, V41, P9, DOI 10.1111/j.1600-0757.2006.00172.x
   Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x
   Sloan AJ, 2000, HISTOCHEM J, V32, P247, DOI 10.1023/A:1004007202404
   Smith AJ, 2008, CLIN ORAL INVEST, V12, P103, DOI 10.1007/s00784-008-0189-5
   Smith AJ, 1998, EUR J ORAL SCI, V106, P179, DOI 10.1111/j.1600-0722.1998.tb02173.x
   SMITH AJ, 1995, INT J DEV BIOL, V39, P273
   Song AM, 2007, CELL PROLIFERAT, V40, P381, DOI 10.1111/j.1365-2184.2007.00441.x
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547
   Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410
   Thesleff I, 2001, Adv Dent Res, V15, P14
   Thesleff I, 2002, INT REV CYTOL, V217, P93
   THESLEFF I, 1998, MOL BASIS EPITHELIAL, P157
   Timmins NE, 2007, TISSUE ENG, V13, P2021, DOI 10.1089/ten.2006.0158
   TISSIERSETA JP, 1995, MECH DEVELOP, V51, P3, DOI 10.1016/0925-4773(94)00343-L
   Tziafas D, 1998, ARCH ORAL BIOL, V43, P431, DOI 10.1016/S0003-9969(98)00026-0
   Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9
   VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Wang XK, 2009, J NANOSCI NANOTECHNO, V9, P1361, DOI 10.1166/jnn.2009.C157
   Xu WP, 2008, TISSUE ENG PT A, V14, P549, DOI 10.1089/tea.2007.0227
   Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200
   Yamamoto H, 2003, J ELECTRON MICROSC, V52, P559, DOI 10.1093/jmicro/52.6.559
   Yang ZH, 2009, J PERIODONTAL RES, V44, P199, DOI 10.1111/j.1600-0765.2008.01106.x
   Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200
   Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6
   Young CS, 2005, TISSUE ENG, V11, P1599, DOI 10.1089/ten.2005.11.1599
   Young CS, 2005, ARCH ORAL BIOL, V50, P259, DOI 10.1016/j.archoralbio.2004.11.020
   Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008
   Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926
   Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404
   Zhang YD, 2000, DEVELOPMENT, V127, P1431
   ZWAKA TP, 2006, REGENERATIVE MED 200, P45
NR 135
TC 5
Z9 5
U1 2
U2 20
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 THESCIENTIFICWORLDJO
JI TheScientificWorldJOURNAL
PY 2010
VL 10
BP 901
EP 916
DI 10.1100/tsw.2010.81
PG 16
WC Environmental Sciences; Multidisciplinary Sciences
SC Environmental Sciences & Ecology; Science & Technology - Other Topics
GA 600GD
UT WOS:000277972000004
PM 20495769
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Gargiulo, C
   Thao, HD
   Tuan, HM
   Filgueira, L
   Tran, CT
   Strong, DM
AF Gargiulo, C.
   Thao, H. D.
   Tuan, H. M.
   Filgueira, L.
   Tran, Cong Toai
   Strong, D. Michael
BE Toi, VV
   Khoa, TQD
TI In Vitro Culture and Differentiation of Osteoblasts on Coral Scaffold
   from Human Bone Marrow Mesenchymal Stem Cells
SO THIRD INTERNATIONAL CONFERENCE ON THE DEVELOPMENT OF BIOMEDICAL
   ENGINEERING IN VIETNAM
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 3rd International Conference on the Development of Biomedical
   Engineering in Vietnam
CY JAN 11-14, 2010
CL Ho Chi Minh City, VIETNAM
DE osteoblast; mesenchymal stem cell; human bone marrow; coral;
   transplantation
ID BLOOD
AB Biomaterial such as corals is an excellent osteoconductive material to be used to bone human derived stem cells for clinical regenerative intent. Bone regeneration is often needed for multiple clinical purposes for instance in aesthetic reconstruction and regenerative procedures. In this paper we describe an approach that aim to provide fundamental information allowing a scientific biomechanical basis for use of natural coral scaffold to initiate mesenchymal stem cells into osteogenic differentiation process for transplant purposes. Isolated MSCs from human bone marrow were induced into osteoblasts by using an osteogenic medium enriched with two specific growth factors FGF9 and vitamin D2. Eventually, part of cultured MSCs were directly transferred and seeded onto coral scaffolds and induced to differentiate into osteoblasts and part were cultured in apposite flask for mesenchymal stem cell medium. Finally, our data indicated that hBM is a very reliable source of MSCs and that these cells may be easily differentiated into osteoblast and seeded into coral as optimal device for clinical application.
C1 [Gargiulo, C.; Thao, H. D.; Tuan, H. M.; Tran, Cong Toai] Pham Ngoc Thach Med Univ, Dept Histopathol Embryol Genet & Biotechnol Tissu, Ho Chi Minh City, Vietnam.
   [Filgueira, L.] Univ Western Australia, Sch Anat & Human Biol, Noongar, WA, Australia.
   [Strong, D. Michael] Univ Washington, Sch Med, Dept Orthoped & Sports Med, Seattle, WA 98195 USA.
RP Gargiulo, C (reprint author), Pham Ngoc Thach Med Univ, Dept Histopathol Embryol Genet & Biotechnol Tissu, Ho Chi Minh City, Vietnam.
OI Filgueira, Luis/0000-0002-2266-6650
CR Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chang YJ, 2006, STEM CELLS, V24, P679, DOI 10.1634/stemcells.2004-0308
   Chao NJ, 2004, J HEMATOLOGY, V1, P354
   CHEN FL, 2004, J ORAL MAXILLOFACIAL, V42, P532, DOI DOI 10.1016/J.BJOMS.2004.08.007
   Chun Y, 2009, J MATER SCI-MATER M, V20, P1273
   De Bari C, 2007, CLIN SCI, V113, P339, DOI 10.1042/CS20070126
   de Wynter EA, 2003, CYTOTECHNOLOGY, V41, P133, DOI 10.1023/A:1024874706356
   Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716
   Holick MF, 2008, J CLIN ENDOCR METAB, V93, P677, DOI 10.1210/jc.2007-2308
   Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249
   JONO S, 1998, J AM HEART ASS CIRCU, V98, P1302
   Lee HS, 2003, STEM CELLS, V21, P190, DOI 10.1634/stemcells.21-2-190
   Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122
   Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje
   TOAI TC, 2009, CELL TISSUE BANK
   Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023
   Waese EYL, 2008, SKELETAL RADIOL, V37, P601, DOI 10.1007/s00256-007-0438-8
   Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279
NR 19
TC 0
Z9 0
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-12019-0
J9 IFMBE PROC
PY 2010
VL 27
BP 211
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BBO19
UT WOS:000307677500053
DA 2018-10-20
ER

PT J
AU Nettles, DL
   Haider, MA
   Chilkoti, A
   Setton, LA
AF Nettles, Dana L.
   Haider, Mansoor A.
   Chilkoti, Ashutosh
   Setton, Lori A.
TI Neural Network Analysis Identifies Scaffold Properties Necessary for In
   Vitro Chondrogenesis in Elastin-like Polypeptide Biopolymer Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; POLY(ETHYLENE GLYCOL) HYDROGELS;
   TISSUE-ENGINEERED CARTILAGE; MESENCHYMAL STEM-CELLS; SELF-ORGANIZING
   MAPS; CROSS-LINKING; FIBRINOGEN ADSORPTION; OSTEOCHONDRAL DEFECT;
   TENSILE PROPERTIES; CHONDROCYTES
AB The successful design of biomaterial scaffolds for articular cartilage tissue engineering requires an understanding of the impact of combinations of material formulation parameters on diverse and competing functional outcomes of biomaterial performance. This study sought to explore the use of a type of unsupervised artificial network, a self-organizing map, to identify relationships between scaffold formulation parameters (crosslink density, molecular weight, and concentration) and 11 such outcomes (including mechanical properties, matrix accumulation, metabolite usage and production, and histological appearance) for scaffolds formed from crosslinked elastin-like polypeptide (ELP) hydrogels. The artificial neural network recognized patterns in functional outcomes and provided a set of relationships between ELP formulation parameters and measured outcomes. Mapping resulted in the best mean separation amongst neurons for mechanical properties and pointed to crosslink density as the strongest predictor of most outcomes, followed by ELP concentration. The map also grouped formulations together that simultaneously resulted in the highest values for matrix production, greatest changes in metabolite consumption or production, and highest histological scores, indicating that the network was able to recognize patterns amongst diverse measurement outcomes. These results demonstrated the utility of artificial neural network tools for recognizing relationships in systems with competing parameters, toward the goal of optimizing and accelerating the design of biomaterial scaffolds for articular cartilage tissue engineering.
C1 [Nettles, Dana L.; Chilkoti, Ashutosh; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
   [Haider, Mansoor A.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA.
   [Setton, Lori A.] Duke Univ, Dept Surg, Div Orthopaed Surg, Durham, NC USA.
RP Setton, LA (reprint author), 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.
EM setton@duke.edu
FU NIH [EB002263, AG15768]; NSF [DMS-0616597]
FX This work was funded by NIH Grant EB002263 (to L. A. S.), NIH Grant
   AG15768 (to M. A. H.), and NSF Grant DMS-0616597 (to M. A. H.). The
   authors thank Dr. Bruce Klitzman for support in metabolite analysis.
CR Abramson SD, 2005, J BIOMED MATER RES A, V73A, P116, DOI 10.1002/jbm.a.30266
   AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   ATESHIAN GA, 2005, CLIN ORTHOP RELAT RE, V81
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Bhadeshia HKDH, 1999, ISIJ INT, V39, P966, DOI 10.2355/isijinternational.39.966
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   BUCKWALTER JA, 1983, INSTR COURSE LECT, V32, P349
   Chen YL, 2006, BIOMATERIALS, V27, P2222, DOI 10.1016/j.biomaterials.2005.10.029
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Darling EM, 2008, TISSUE ENG PT A, V14, P1507, DOI 10.1089/ten.tea.2008.0180
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Guilak F, 2003, FUNCTIONAL TISSUE ENGINEERING, P277, DOI 10.1007/0-387-21547-6_21
   Guilak F, 2002, ANN NY ACAD SCI, V961, P193, DOI 10.1111/j.1749-6632.2002.tb03080.x
   HAIDER MA, 2005, P SUMM BIOENG C VAIL
   HAYES WC, 1978, J BIOMECH, V11, P407, DOI 10.1016/0021-9290(78)90075-1
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   JACKSON JE, 1991, USERS GUIDE PRINICPA
   Kang SW, 2005, TISSUE ENG, V11, P438, DOI 10.1089/ten.2005.11.438
   KEMPSON GE, 1968, NATURE, V220, P1127, DOI 10.1038/2201127b0
   Kohonen T, 1988, SELF ORG ASSOCIATIVE
   Lee J, 2001, MACROMOLECULES, V34, P5968, DOI 10.1021/ma0017844
   Lee J, 2001, MACROMOLECULES, V34, P4114, DOI 10.1021/ma0015673
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1417, DOI 10.1021/bm060849t
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Nettles DL, 2008, TISSUE ENG PT A, V14, P1133, DOI [10.1089/ten.tea.2007.0245, 10.1089/tea.2007.0245]
   Nettles DL, 2009, TISSUE ENG PT A, V15, P2113, DOI 10.1089/ten.tea.2008.0448
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Nikkila J, 2002, NEURAL NETWORKS, V15, P953, DOI 10.1016/S0893-6080(02)00070-9
   Obradovic B, 2000, AICHE J, V46, P1860, DOI 10.1002/aic.690460914
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   Schneider G, 1998, PROG BIOPHYS MOL BIO, V70, P175, DOI 10.1016/S0079-6107(98)00026-1
   Sengers BG, 2005, J BIOMECH ENG-T ASME, V127, P758, DOI 10.1115/1.1993664
   Setton L.A., 1995, J ORTHOP RES, V12, P437
   Setton LA, 1999, OSTEOARTHR CARTILAGE, V7, P2, DOI 10.1053/joca.1998.0170
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   Smith JR, 2005, POLYMER, V46, P4296, DOI 10.1016/j.polymer.2005.03.012
   Smith JR, 2004, J CHEM INF COMP SCI, V44, P1088, DOI 10.1021/ci0499774
   Sontjens SHM, 2006, BIOMACROMOLECULES, V7, P310, DOI 10.1021/bm050663e
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 74
TC 21
Z9 22
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2010
VL 16
IS 1
BP 11
EP 20
DI 10.1089/ten.tea.2009.0134
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 541QD
UT WOS:000273432300002
PM 19754250
OA Green Published
DA 2018-10-20
ER

PT J
AU Kim, JH
   Choi, SJ
   Park, JS
   Lim, KT
   Choung, PH
   Kim, SW
   Lee, JB
   Chung, JH
   Choung, YH
AF Kim, Jang Ho
   Choi, Seong Jun
   Park, Jung-Sub
   Lim, Ki Taek
   Choung, Pill-Hoon
   Kim, Seung Won
   Lee, Jong Bin
   Chung, Jong Hoon
   Choung, Yun-Hoon
TI Tympanic Membrane Regeneration Using a Water-Soluble Chitosan Patch
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PERFORATIONS; REPAIR; COLLAGEN; SCAFFOLD
AB Chronic otitis media or tympanic membrane (TM) perforation is one of the most common otologic diseases. Surgical tympanoplasty remains the best treatment option despite the fact that paper patches are frequently used. Although paper patches are not biocompatible or effective, tympanoplasty is an expensive, complex surgery. Tissue engineering techniques offer a new treatment strategy for TM regeneration. In this study, novel tissue-engineered artificial eardrums were fabricated from water-soluble chitosan, which is known to be a good wound-healing biomaterial. The characteristics, cytotoxicity, and healing effects of several water-soluble chitosan patches (WSCPs) made using various concentrations of water-soluble chitosan and glycerol were investigated. The optimal WSCP was fabricated with 3% water-soluble chitosan and 3% glycerol, and it had a thickness of about 35 mm, a tensile strength of 7 MPa, a percent elongation of 101%, a hydrophilic surface, and no cytotoxicity. In vivo studies showed that the WSCPs were more effective than spontaneous healing for the repair of traumatic TM perforations. The healed TMs to which WSCPs were applied had a much higher density of collagen fibers and a better lamina propria layer structure than spontaneously healed TMs.
C1 [Kim, Jang Ho; Lim, Ki Taek; Chung, Jong Hoon] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 151742, South Korea.
   [Choi, Seong Jun] Konyang Univ, Coll Med, Dept Otorhinolaryngol, Taejon, South Korea.
   [Park, Jung-Sub; Kim, Seung Won; Lee, Jong Bin; Choung, Yun-Hoon] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea.
   [Choung, Pill-Hoon] Seoul Natl Univ, Dept Oral & Maxillofacial Surg, Tooth Bioengn Natl Res Lab, Sch Dent, Seoul 151742, South Korea.
   [Chung, Jong Hoon] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151742, South Korea.
RP Chung, JH (reprint author), Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, San 56-1 Sillim Dong, Seoul 151742, South Korea.
EM jchung@snu.ac.kr; yhc@ajou.ac.kr
OI Park, Jung-sub/0000-0002-7887-1557
FU Korea Health Technology R&D Project, Ministry for Health, Welfare &
   Family Affairs, Republic of Korea [A090869]
FX This study was supported by a grant of the Korea Health Technology R&D
   Project, Ministry for Health, Welfare & Family Affairs, Republic of
   Korea (A090869).
CR Blake C.J., 1887, T 1 C INT OT SOC, P125
   BUCHELER M, 2003, DNA CELL BIOL, V22, P579
   Cheng T, 2007, ANN BIOMED ENG, V35, P305, DOI 10.1007/s10439-006-9227-0
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   CHOLE RA, 1989, ANN OTO RHINOL LARYN, V98, P761, DOI 10.1177/000348948909801002
   Chun S. H., 1999, KOREAN J OTOLARYNGOL, V23, P437
   Debry C, 2003, J LARYNGOL OTOL, V117, P113
   DECRAEMER WF, 1980, J BIOMECH, V13, P463, DOI 10.1016/0021-9290(80)90338-3
   Fay J, 2005, J BIOMECH, V38, P1807, DOI 10.1016/j.jbiomech.2004.08.022
   Golz A, 2003, OTOLARYNG HEAD NECK, V128, P565, DOI 10.1016/mhn.2003.132
   Kim JH, 2009, J BIOMED MATER RES A, V90A, P446, DOI 10.1002/jbm.a.32119
   KIRIKAE I, 1960, STRUCTURE FUNCTION M, P157
   Laidlaw DW, 2001, LARYNGOSCOPE, V111, P702, DOI 10.1097/00005537-200104000-00025
   LIM DJ, 1970, ACTA OTO-LARYNGOL, V70, P176, DOI 10.3109/00016487009181875
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   McFeely WJ, 2000, OTOLARYNG HEAD NECK, V123, P17, DOI 10.1067/mhn.2000.105920
   MORGAN EH, 2006, LARYNGOSCOPE, V114, P1290
   Nicole R, 2005, EUR ARCH OTO-RHINO-L, V262, P539, DOI 10.1007/s00405-004-0866-1
   PAKAKRONG S, 2007, BIOMACROMOLECULES, V8, P1587
   QURAISHI MS, 1995, CLIN OTOLARYNGOL, V20, P12, DOI 10.1111/j.1365-2273.1995.tb00004.x
   SCHMIDT SH, 1991, ORL J OTO-RHINO-LARY, V53, P32, DOI 10.1159/000276181
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   VONBEKESY G, 1960, EXPT HEARING, P745
   Wang WQ, 2004, ACTA OTO-LARYNGOL, V124, P1141, DOI 10.1080/00016480410022921
   Weber DE, 2006, LARYNGOSCOPE, V116, P700, DOI 10.1097/01.mlg.0000208549.44462.fa
NR 26
TC 29
Z9 29
U1 3
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2010
VL 16
IS 1
BP 225
EP 232
DI 10.1089/ten.tea.2009.0476
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 541QD
UT WOS:000273432300020
PM 19691425
DA 2018-10-20
ER

PT B
AU Kurosu, S
   Matsumoto, H
   Chiba, A
AF Kurosu, Shingo
   Matsumoto, Hiroaki
   Chiba, Akihiko
GP TMS
TI Effect of Nitrogen Addition on Isothermal Phase Transformation and
   Mechanical Properties in Biomedical Co-Cr-Mo Alloys
SO TMS 2010 139TH ANNUAL MEETING & EXHIBITION - SUPPLEMENTAL PROCEEDINGS,
   VOL 3: GENERAL PAPER SELECTIONS
LA English
DT Proceedings Paper
CT TMS 2010 Annual Meeting Supplemental Proceedings on Materials Processing
   and Properties
CY FEB 14-18, 2010
CL Seattle, WA
DE Cobalt-chromium-molybdenum alloy; Biomaterial; Phase transformation;
   Mechanical Properties
ID STAINLESS-STEEL; IMPLANT ALLOY
AB Effect of nitrogen addition on isothermal phase transformation behavior in a biomedical Co-Cr-Mo alloy without addition of carbon was investigated during aging at temperature between 973 K and 1273 K for up to 90 ks. In the Co-Cr-Mo alloy, phase transformation from fcc to hcp(1) with super-saturation of Cr occurred by massive transformation. With prolonged aging treatment, a lamellar structure consisting of hcp(2) with equilibrium of Cr and sigma phases was formed at hcp(1)/hcp(1) boundaries by a discontinuous/cellular reaction, expressed by the reaction equation hcp(1)-> hcp(2)+sigma. The phase transformation is remarkably changed by addition of nitrogen. In the Co-Cr-Mo-N alloy, the phase transformation from fcc to hcp occurs with a significant long incubation period compared with that in Co-Cr-Mo alloy. Besides, lamellar M(2)N(M=Cr, Mo, Co) precipitates during phase transformation, suggesting that phase transformation of Co-Cr-Mo-N alloy may be dominant by the eutectoid transformation (fcc -> hcp+M(2)N).
C1 [Kurosu, Shingo; Matsumoto, Hiroaki; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Kurosu, S (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
CR DEMPSEY AJ, 1987, J MATER SCI, V22, P575, DOI 10.1007/BF01160771
   Escobedo J, 1996, MATER DESIGN, V17, P79, DOI 10.1016/S0261-3069(96)00036-2
   Ha H, 2007, ELECTROCHIM ACTA, V52, P2175, DOI 10.1016/j.electacta.2006.08.034
   Hsu HC, 2003, J MATER PROCESS TECH, V138, P231, DOI 10.1016/S0924-0136(03)00077-3
   Lee SH, 2008, MATER TRANS, V49, P260, DOI 10.2320/matertrans.MRA2007220
   RAJAN K, 1982, METALL TRANS A, V13, P1161, DOI 10.1007/BF02645497
   Sande J. B. V., 1976, METALL T A, V7, P389
   SIMMONS JW, 1995, METALL MATER TRANS A, V26, P2085, DOI 10.1007/BF02670680
   TAYLOR RNJ, 1983, J MATER SCI, V18, P3265, DOI 10.1007/BF00544151
   Vanderschaeve F, 1995, J MATER SCI, V30, P6035, DOI 10.1007/BF01151525
   WEENTON JW, 1995, T ASM, V47, P815
NR 11
TC 0
Z9 0
U1 0
U2 0
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 978-0-87339-753-7
PY 2010
BP 707
EP 714
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BUB38
UT WOS:000288718800083
DA 2018-10-20
ER

PT J
AU Nilsson, B
   Korsgren, O
   Lambris, JD
   Ekdahl, KN
AF Nilsson, Bo
   Korsgren, Olle
   Lambris, John D.
   Ekdahl, Kristina Nilsson
TI Can cells and biomaterials in therapeutic medicine be shielded from
   innate immune recognition?
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID CLINICAL ISLET TRANSPLANTATION; MEDIATED INFLAMMATORY REACTION; HUMAN
   PANCREATIC-ISLETS; WEIGHT DEXTRAN SULFATE; COMPLEMENT ACTIVATION; TISSUE
   FACTOR; IN-VITRO; ALTERNATIVE PATHWAY; INSULIN-SECRETION; WHOLE-BLOOD
AB Biomaterials (e.g. polymers, metals, or ceramics), cell and cell cluster (e.g. pancreatic islets) transplantation are beginning to offer novel treatment modalities for some otherwise intractable diseases. The innate immune system is involved in incompatibility reactions that occur when biomaterials or cells are introduced into the blood circulation. In particular, the complement, coagulation and contact systems are involved in the recognition of biomaterials and cells, eliciting activation of platelets and leukocytes. Such treatments are associated with anaphylactoid and thrombotic reactions, inflammation, and rejection of biomaterials and cells, leading to treatment failures and adverse reactions. We discuss here the new technologies that are being developed to shield the biomaterial and cell surfaces from recognition by the innate immune system.
C1 [Nilsson, Bo; Korsgren, Olle; Ekdahl, Kristina Nilsson] Uppsala Univ, Rudbeck Lab, Div Clin Immunol, Uppsala, Sweden.
   [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Ekdahl, Kristina Nilsson] Univ Kalmar, Dept Pure & Appl Nat Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Uppsala Univ, Rudbeck Lab, Div Clin Immunol, Uppsala, Sweden.
EM bo.nilsson@klinimm.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730; Lambris, John/0000-0002-9370-5776
FU National Institute of Health [AI068730, EB003968, GM62134, GM069736];
   Swedish Research Council [2006-5595, 15244]; Swedish Research
   Council/Vinnova/Swedish Foundation [6076170]; Natural Sciences Faculty,
   University of Kalmar, Sweden
FX We thank Mr Hans Nilsson for preparing the artwork in Figure 2. This
   work was supported by National Institute of Health grants AI068730,
   EB003968, GM62134, and GM069736, Swedish Research Council grants
   2006-5595 and 15244, a combined grant from Swedish Research
   Council/Vinnova/Swedish Foundation Strategic Research 6076170, and
   grants from the Natural Sciences Faculty, University of Kalmar, Sweden.
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Beck J, 2007, TISSUE ENG, V13, P589, DOI 10.1089/ten.2006.0183
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Bennet W, 2001, TRANSPLANTATION, V72, P312, DOI 10.1097/00007890-200107270-00026
   Berman DM, 2007, TRANSPLANTATION, V84, P308, DOI 10.1097/01.tp.0000275401.80187.le
   Cabric S, 2008, TISSUE ENG PT C-METH, V14, P141, DOI 10.1089/ten.tec.2007.0312
   Cabric S, 2007, DIABETES, V56, P2008, DOI 10.2337/db07-0358
   Contreras JL, 2004, SURGERY, V136, P537, DOI 10.1016/j.surg.2004.05.031
   Contreras JL, 2004, DIABETES, V53, P2804, DOI 10.2337/diabetes.53.11.2804
   Contreras JL, 2003, DIABETES, V52, P2935, DOI 10.2337/diabetes.52.12.2935
   Dufrane D, 2008, TRANSPLANTATION, V86, P753, DOI 10.1097/TP.0b013e3181840f55
   Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068
   Inverardi L, 2006, TRANSPLANTATION, V82, P312, DOI 10.1097/01.tp.0000228879.22020.0f
   Johansson H, 2006, AM J TRANSPLANT, V6, P305, DOI 10.1111/j.1600-6143.2005.01186.x
   Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755
   Kirchhof N, 2004, XENOTRANSPLANTATION, V11, P396, DOI 10.1111/j.1399-3089.2004.00157.x
   Larsson R., 2004, ENCY BIOMATERIALS BI, P753
   MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8
   Miura S, 2006, BIOMATERIALS, V27, P5828, DOI 10.1016/j.biomaterials.2006.07.039
   Moberg L, 2005, CLIN EXP IMMUNOL, V142, P125, DOI 10.1111/j.1365-2249.2005.02883.x
   Moberg L, 2003, TRANSPLANTATION, V76, P1285, DOI 10.1097/01.TP.0000098905.86445.0F
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Molne J, 2008, TRANSPLANTATION, V86, P1407, DOI 10.1097/TP.0b013e31818a6805
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   Patel H, 2006, J AM SOC NEPHROL, V17, P1102, DOI 10.1681/ASN.200610116
   Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55
   Pratschke J, 2005, TRANSPLANT INT, V18, P15, DOI 10.1111/j.1432-2277.2004.00018.x
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Schmidt P, 2008, TRANSPLANTATION, V86, P1523, DOI 10.1097/TP.0b013e3181890593
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Song HB, 2003, J CLIN INVEST, V111, P1875, DOI 10.1172/JCI200317348
   Stephenne X, 2007, LIVER TRANSPLANT, V13, P599, DOI 10.1002/lt.21128
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Teramura Y, 2008, BIOCONJUGATE CHEM, V19, P1389, DOI 10.1021/bc800064t
   Tjernberg J, 2008, TRANSPLANTATION, V85, P1193, DOI 10.1097/TP.0b013e31810226
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   Weber LM, 2006, ACTA BIOMATER, V2, P1, DOI 10.1016/j.actbio.2005.10.005
NR 51
TC 73
Z9 74
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD JAN
PY 2010
VL 31
IS 1
BP 32
EP 38
DI 10.1016/j.it.2009.09.005
PG 7
WC Immunology
SC Immunology
GA 555ZI
UT WOS:000274555200005
PM 19836998
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lim, DH
   Lee, JY
   Lastoskie, CM
AF Lim, Dong-Hee
   Lee, Jai-Young
   Lastoskie, Christian M.
TI Ability of Beijerinckia indica to degrade phenanthrene and reduce
   hydraulic conductivity
SO WATER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Beijerinckia indica; biofilm barriers; hydraulic conductivity; intrinsic
   permeability; rigid wall soil column; two-phase partitioning bioreactor
ID 2-PHASE PARTITIONING BIOREACTOR; BIODEGRADATION; BIOFILM; SOLVENT
AB This study evaluates the ability of Beijerinckia indica (B. indica) as a biomaterial for aerobic biofilm barriers. B. indica's ability to remove phenanthrene was measured using a two-phase partitioning bioreactor. Approximately 500 mg/L of phenanthrene was gradually removed over a two week period under aerobic conditions of the bioreactor. B. indica's ability to reduce hydraulic conductivity was evaluated using rigid wall soil columns inoculated with the bacteria. B. indica formed a large quantity of strongly adhesive biofilm among soil particles, reducing the hydraulic conductivity in the soil columns by 2 or 3 orders of magnitude. To assess recovery of the biofilm, the formed biofilm was purposely destroyed by introducing landfill leachate into the soil columns. The biofilm recovery test showed that the hydraulic conductivity increased after leachate introduction. However, re-permeation of nutrient solution restored the permeability to its original lower value, which suggests a full recovery of the damaged biofilm. This study suggests that B. indica may be used as a possible biomaterial for aerobic biofilm barriers for the removal of phenanthrene from groundwater, provided that sufficient substrate and electron acceptor are provided to the treatment system.
C1 [Lee, Jai-Young] Univ Seoul, Dept Environm Engn, Seoul 130743, South Korea.
   [Lim, Dong-Hee; Lastoskie, Christian M.] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA.
RP Lee, JY (reprint author), Univ Seoul, Dept Environm Engn, 13 Siripdae Gil, Seoul 130743, South Korea.
EM limkr@umich.edu; leejy@uos.ac.kr; cmlasto@umich.edu
CR Collins LD, 1999, APPL MICROBIOL BIOT, V52, P354, DOI 10.1007/s002530051531
   Collins LD, 1997, BIOTECHNOL BIOENG, V55, P155
   Daugulis AJ, 2001, TRENDS BIOTECHNOL, V19, P457, DOI 10.1016/S0167-7799(01)01789-9
   Dennis ML, 1998, J GEOTECH GEOENVIRON, V124, P120, DOI 10.1061/(ASCE)1090-0241(1998)124:2(120)
   Han YS, 2009, WASTE MANAGE RES, V27, P233, DOI 10.1177/0734242X08095230
   Kim DS, 2000, BIOTECHNOL BIOENG, V69, P47, DOI 10.1002/(SICI)1097-0290(20000705)69:1<47::AID-BIT6>3.0.CO;2-N
   Kim G, 2006, J BIOSCI BIOENG, V101, P142, DOI 10.1263/jbb.101.142
   Komlos J, 2004, ENVIRON PROG, V23, P69, DOI 10.1002/ep.10003
   MacLeod CT, 2003, APPL MICROBIOL BIOT, V62, P291, DOI 10.1007/s00253-003-1297-4
   Prabhu Y, 2003, APPL MICROBIOL BIOT, V61, P342, DOI 10.1007/s00253-002-1218-y
   STRANDBERG GW, 1986, BIOTECHNOL BIOENG, V28, P142, DOI 10.1002/bit.260280125
   Todd D.K, 1959, GROUND WATER HYDROLO
   Traczewska TM, 2000, WATER SCI TECHNOL, V41, P31
   Warith M, 1999, WASTE MANAGE, V19, P9, DOI 10.1016/S0956-053X(98)00080-4
   Wicke D, 2008, ENVIRON SCI TECHNOL, V42, P1990, DOI 10.1021/es702267s
   Yeom SH, 1999, BIOTECHNOL TECH, V13, P549, DOI 10.1023/A:1008939515431
NR 16
TC 0
Z9 0
U1 0
U2 9
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0273-1223
J9 WATER SCI TECHNOL
JI Water Sci. Technol.
PY 2010
VL 62
IS 12
BP 2953
EP 2960
DI 10.2166/wst.2010.345
PG 8
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA 693QC
UT WOS:000285237600028
PM 21123927
DA 2018-10-20
ER

PT S
AU Loprang, RR
   Fleck, C
AF Loprang, R. R.
   Fleck, C.
GP IAENG
TI Geometrical and Loading Influence on Compression Strength of Macadamia
   Nut
SO WORLD CONGRESS ON ENGINEERING, WCE 2010, VOL II
SE Lecture Notes in Engineering and Computer Science
LA English
DT Proceedings Paper
CT World Congress on Engineering (WCE 2010)
CY JUN 30-JUL 02, 2010
CL Imperial Coll London, London, UNITED KINGDOM
SP Int Assoc Engineers, IAENG, Soc Artificial Intelligence, IAENG, Soc of Bioinformat, IAENG, Soc Comp Sci, IAENG, Soc Data Min, IAENG, Soc Elect Engn, IAENG, Soc Imag Engn, IAENG, Soc Ind Engn, IAENG, Soc Informat Syst Engn, IAENG, Soc Internet Comp & Web Serv, IAENG, Soc Mech Engn, IAENG, Soc Operat Res, IAENG, Soc Sci Comp, IAENG, Soc Software Engn, IAENG, Soc Wireless Networks
HO Imperial Coll London
DE biomaterial; compression; fracture; macadamia nut
AB In comparison with other nuts, macadamia nutshell is observed to have a high strength. A quite large amount of force is, therefore, required to crack macadamia. The present paper presents a study of geometrical effects on the compression strength of macadamia nutshell. Geometrical parameters such as wall thickness, diameter and height are evaluated. Compression tests were performed on 80 Macadamia integrifolia nuts with moisture contents of 4 - 5 %. The test data were analysed using two methods: clustering and multi linear regression. The effect of loading axes on the compression fracture force was studied by performing the test in two different loading directions, parallel and perpendicular to the suture. Our results show that wall thickness and loading direction are the most important parameters, while nut size only has a small influence on compression fracture force.
C1 [Loprang, R. R.; Fleck, C.] Tech Univ Berlin, Dept Mat Engn, Berlin, Germany.
RP Loprang, RR (reprint author), Tech Univ Berlin, Dept Mat Engn, Berlin, Germany.
EM ruth.r.loprang@tu-berlin.de; claudia.fleck@tu-berlin.de
FU German Research Foundation (DFG) [SPP 1420]
FX This work was supported by the German Research Foundation (DFG) as part
   of the project "Impact resistant hierarchically structured materials
   based on fruit walls and nut shells" within priority programme SPP 1420.
CR [Anonymous], 1982, S410T ASAE, P346
   Barrett DM, 2004, PROCESSING FRUITS SC
   Braga GC, 1999, J AGR ENG RES, V72, P239, DOI 10.1006/jaer.1998.0369
   JENNINGS JS, 1986, J MATER SCI, V21, P1517, DOI 10.1007/BF01114704
   Loprang R. R., UNPUB
   Romesburg HC, 2004, CLUSTER ANAL RES
   Tussy A. S., 2009, INTERMEDIATE ALGEBRA
   VINCENT JFV, 1993, MATER RES SOC SYMP P, V292, P35
   Xavier J. A., 1992, THESIS
NR 9
TC 0
Z9 0
U1 0
U2 0
PU INT ASSOC ENGINEERS-IAENG
PI HONG KONG
PA UNIT 1, 1-F, 37-39 HUNG TO ROAD, KWUN TONG, HONG KONG, 00000, PEOPLES R
   CHINA
SN 2078-0958
BN 978-988-18210-7-2
J9 LECT NOTES ENG COMP
PY 2010
BP 1586
EP 1591
PG 6
WC Engineering, Electrical & Electronic; Engineering, Mechanical
SC Engineering
GA BG9WR
UT WOS:000394059900148
DA 2018-10-20
ER

PT S
AU Denkena, B
   de Leon, L
   Lucas, A
AF Denkena, B.
   de Leon, L.
   Lucas, A.
BE Dossel, O
   Schlegel, WC
TI Machining Processes of Degradable Implant Materials to adjust Surface
   and Subsurface Properties
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT
   4: IMAGE PROCESSING, BIOSIGNAL PROCESSING, MODELLING AND SIMULATION,
   BIOMECHANICS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT World Congress on Medical Physics and Biomedical Engineering
CY SEP 07-12, 2009
CL Munich, GERMANY
SP IUPESM, IOMP
DE Magnesium; Biomaterial; Rolling; Cutting; Degradation; Corrosion
ID BIODEGRADABLE IMPLANTS; MAGNESIUM ALLOYS
AB This interdisciplinary project between medical and engineering sciences focuses on the development of degradable magnesium implants for osteosynthesis. The removal of those implants after convalescence of the fractured bone is no longer necessary, resulting in a considerable benefit for patients and the public health care system. Different magnesium bone screw designs are investigated and show comparable biomechanical properties to conventional surgical steel implants. The influence of the mechanical processing on surface and subsurface layers of the selected biocompatible magnesium alloys is analyzed. Different operations of processing and postprocessing magnesium workpieces enable the adjustment of distinct surface and subsurface properties. These properties are then utilized to adjust the corrosion resistance and therefore the degradation kinetics of the implant in the organism. Results of in-vitro an in-vivo experiments validate the strong relation between workpiece properties and corrosion behavior respectively degradation kinetics.
C1 [Denkena, B.; de Leon, L.; Lucas, A.] Univ Leipzig, IFW Inst Prod Engn & Machine Tools, D-30823 Hannover, Germany.
RP Lucas, A (reprint author), Univ Leipzig, IFW Inst Prod Engn & Machine Tools, Univ 2, D-30823 Hannover, Germany.
EM lucas@ifw.uni-hannover.de
CR Claes L, 2002, CHIRURG, V73, P990, DOI 10.1007/s00104-002-0543-0
   Denkena B., 2006, WGP ANN PRODUCTION E, VXIII, P13
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385
   Von der Hoeh N, 2006, DEUT TIERARZTL WOCH, V113, P439
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
NR 5
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-03881-5
J9 IFMBE PROC
PY 2010
VL 25
BP 977
EP 979
PN 4
PG 3
WC Engineering, Biomedical
SC Engineering
GA BZB27
UT WOS:000300975300260
DA 2018-10-20
ER

PT S
AU Schliessmann, SJ
   Zissel, G
   Guttmann, J
AF Schliessmann, S. J.
   Zissel, G.
   Guttmann, J.
BE Dossel, O
   Schlegel, WC
TI Analyzing of Cladosporium as a Biomaterial Sample by Semi-dynamic Video
   Microscopy under Biaxial Stretch
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT
   4: IMAGE PROCESSING, BIOSIGNAL PROCESSING, MODELLING AND SIMULATION,
   BIOMECHANICS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 11th International Congress of the IUPESM/World Congress on Medical
   Physics and Biomedical Engineering
CY SEP 07-12, 2009
CL Munich, GERMANY
SP IUPESM, Int Org Med Phys (IOMP)
DE Cladosporium spp.; hyphae; biaxial stretch; mechanostimulator;
   semi-dynamic video microscopy
ID PHEOHYPHOMYCOSIS; OXYSPORUM; PHAEOHYPHOMYCOSIS
AB Cladosporiunt is the fungal genus most frequently encountered in both outdoor and indoor air. However it is also one of the most common pathogens of phaeolophotnycosis. Phaeohyphomycosis has become increasingly recognized in a wide variety of clinical syndromes.
   In this study, we observed the influence of biaxial stretch on form stability of Cladosporium hyphae's meshwork.
   As mechanostimulator we used a modified pressure operated strain applicator, which was connected to a syringe. The additional pressure of insuftlated air results in a deflection of the carrier membrane, on which the Cladosporiunt colony was attached.
   We observed the influence of the membrane deflection with an area increase of up to 100% on the colonies.
   After every single step of deflection a picture was recorded. For analyzing pictures were composed to a movie sequence.
   Our study demonstrates that hyphae of Cladosporium spp. build a solid and inductile meshwork, which shows no viscoelastic property.
   The used semi-dynamic video microscopy allows visualization of dynamic processes under static biaxial stretch.
   The instrumental setting allows monitoring of the sample thus an appropriate observation of morphological changes in different levels of biaxial stretch. This could improve the understanding of macroscopic mechanical characteristics of the investigated biomaterials.
C1 [Schliessmann, S. J.; Guttmann, J.] Univ Freiburg Klinikum, Sekt Exp Anaesthesiol, AG Klin Atemphysiol, Hugstetter Str 55, D-79106 Freiburg, Germany.
   [Zissel, G.] Univ Med Ctr, Dept Pheumol, Freiburg, Germany.
RP Schliessmann, SJ (reprint author), Univ Freiburg Klinikum, Sekt Exp Anaesthesiol, AG Klin Atemphysiol, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM St.Schliessmann@yahoo.de
CR BOUDGHENESTAMBOULI O, 1994, ANN DERMATOL VENER, V121, P37
   Chen QX, 2008, MYCOSES, V51, P79, DOI 10.1111/j.1439-0507.2007.01417.x
   GONZALEZ MS, 1984, SABOURAUDIA, V22, P427
   Gugnani HC, 2006, MED MYCOL, V44, P285, DOI 10.1080/13693780500294824
   Kantarcioglu AS, 2002, MYCOSES, V45, P500, DOI 10.1046/j.1439-0507.2002.00811.x
   MCGINNIS MR, 1983, J AM ACAD DERMATOL, V8, P1, DOI 10.1016/S0190-9622(83)70001-0
   Revankar SG, 2006, INFECT DIS CLIN N AM, V20, P609, DOI 10.1016/i.idc.2006.06.004
   Romano C, 1999, MYCOSES, V42, P111, DOI 10.1046/j.1439-0507.1999.00263.x
   Schliessmann S J, 2008, 4th European Conference of the International Federation for Medical and Biological Engineering - ECIFMBE 2008, P2027
   Schumann S, 2008, J BIOMED MATER RES B, V86B, P483, DOI 10.1002/jbm.b.31045
   SINGH SM, 1992, MYCOPATHOLOGIA, V117, P145, DOI 10.1007/BF00442775
   Yano S, 2003, MYCOSES, V46, P348
NR 12
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-03881-5
J9 IFMBE PROC
PY 2010
VL 25
BP 1596
EP 1599
PN 4
PG 4
WC Engineering, Biomedical
SC Engineering
GA BZB27
UT WOS:000300975300423
DA 2018-10-20
ER

PT S
AU Birkholz, H
   Matschegewski, C
   Nebe, JB
   Engel, K
AF Birkholz, H.
   Matschegewski, C.
   Nebe, J. B.
   Engel, K.
BE Dossel, O
   Schlegel, WC
TI Quantification of Actin Filament Organization by Estimating Graph
   Structures in Confocal Microscopic Images
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT
   4: IMAGE PROCESSING, BIOSIGNAL PROCESSING, MODELLING AND SIMULATION,
   BIOMECHANICS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 11th International Congress of the IUPESM/World Congress on Medical
   Physics and Biomedical Engineering
CY SEP 07-12, 2009
CL Munich, GERMANY
SP IUPESM, Int Org Med Phys (IOMP)
DE Texture Analysis; Ridge Detection; Image Processing; Confocal Laser
   Microscopy; Actin Cytoskeleton; Osteoblast
ID TITANIUM SURFACES; OSTEOBLASTS; PARAMETERS; ADHESION
AB With the progress in implant technology, the understanding of the interaction between implants and living cells and tissue raised in relevance. To get insight into the biocomplexity of the underlying cellular mechanisms in the cell-biomaterial dialogue, an automatic quantification of cell parameters is required as a first step. An ad hoc designed texture analysis procedure is implemented to assess the development of actin filaments in human osteoblasts grown on titanium surfaces from confocal microscopic images.
   The main tool for the assessment of filaments is a graph, embedded into the plane. To automatically detect this feature from given image data, one has to consider a variety of random disturbances and variability. The solution is a specially adapted Ridge Method for the feature estimation.
C1 [Birkholz, H.; Engel, K.] Univ Rostock, Inst Math, Univ Pl 1, D-18055 Rostock, Germany.
   [Matschegewski, C.; Nebe, J. B.] Univ Rostock, Dept Cell Biol, Biomed Res Ctr, Rostock 18057, Germany.
RP Birkholz, H (reprint author), Univ Rostock, Inst Math, Univ Pl 1, D-18055 Rostock, Germany.
EM harald.birkholz@uni-rostock.de
FU Deutsche Forschungsgemeinschaft DFG [1505/1]
FX This work was supported by the Deutsche Forschungsgemeinschaft DFG GRK
   1505/1 Welisa
CR Beil M, 2005, J MICROSC-OXFORD, V220, P84, DOI 10.1111/j.1365-2818.2005.01505.x
   Birkholz H, J COMPUT AP IN PRESS
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Lange R, 2007, BIOMOL ENG, V24, P526, DOI 10.1016/j.bioeng.2007.08.002
   Matschegewski C, 2009, EUR J CELL BIOL, V88, P32
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Nebe J. G. B., 2008, METALLIC BIOMATERIAL, P215
   Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293
   Russ J. C., 1999, IMAGE PROCESSING HDB
NR 10
TC 4
Z9 4
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-03881-5
J9 IFMBE PROC
PY 2010
VL 25
BP 1932
EP 1935
PN 4
PG 4
WC Engineering, Biomedical
SC Engineering
GA BZB27
UT WOS:000300975300513
DA 2018-10-20
ER

PT J
AU Goyal, P
   Srivastava, S
AF Goyal, Pritee
   Srivastava, Shalini
TI Characterization of novel Zea mays based biomaterial designed for toxic
   metals biosorption
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Novel biomaterial; Graft co-polymerization; Regeneration cycle;
   Structural modification
ID RELIGIOSA LEAF POWDER; WASTE-WATER; HEXAVALENT CHROMIUM; HEAVY-METALS;
   REMOVAL; DECONTAMINATION; BIOSORBENT; ADSORBENT; CADMIUM
AB Structural modifications onto Zea mays Cob powder, ZMCP lead to the formation of novel biomaterial with increased sorption efficiency and environmental stability for the abatement of Pb (II), Cd (II), Ni (II) and Cr (III) in single as well as multi-metal ion solutions. Synthetic strategy for strengthening the functional groups, COO(-) responsible for binding of metal species has been applied using acetylation, succination and graft co-polymerization processes. The resultant novel biomaterial exhibits enhancement in sorption efficiency from 2 to 15% and stability in terms of regeneration cycles from 3 to 5, evidence to support biomaterial designed has been provided on the basis of SEM, FTIR and TGA. The findings open up new avenues in the modern Green Technology of water treatment using biosorbent-possessing potential for commercialization. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Goyal, Pritee; Srivastava, Shalini] Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
RP Srivastava, S (reprint author), Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
EM smohanm@rediffmail.com
FU UGC
FX The authors gratefully acknowledge Prof. V.G. Dass, Director, Prof. L.D.
   Khemani, Head, Department of Chemistry, Dayalbagh Educational Institute,
   Dayalbagh, Agra, for providing necessary research facilities. Pritee
   Goyal, one of the authors gratefully acknowledges UGC for providing
   Research Assistant Fellowship.
CR Costa G, 1997, J PLANT NUTR, V20, P883, DOI 10.1080/01904169709365303
   Goyal P, 2008, INT J ENVIRON SCI TE, V5, P27, DOI 10.1007/BF03325994
   Goyal P., 2007, J NUCL AGR BIOL, V36, P16
   Goyal P, 2008, NATL ACAD SCI LETT, V31, P347
   Goyal P, 2007, ARCH ENVIRON PROT, V33, P35
   Goyal P, 2008, ARCH ENVIRON PROT, V34, P35
   Iqbal M, 2002, BIORESOURCE TECHNOL, V81, P151, DOI 10.1016/S0960-8524(01)00126-2
   Kardam A, 2009, NATL ACAD SCI LETT, V32, P179
   Kelleher B., 2001, THESIS U LIMERICK IR, P194
   Kumar U, 2006, SCI RES ESSAYS, V1, P33
   Kurniawan TA, 2006, CHEM ENG J, V118, P83, DOI 10.1016/j.cej.2006.01.015
   Nakano Y, 2001, WATER RES, V35, P496, DOI 10.1016/S0043-1354(00)00279-7
   Sharma P, 2007, CHEM SPEC BIOAVAILAB, V19, P175, DOI 10.3184/095422907X255938
   Ugwuanyi JO, 2008, BIORESOURCE TECHNOL, V99, P6974, DOI 10.1016/j.biortech.2008.01.025
   Wang YH, 2003, J HAZARD MATER, V102, P291, DOI 10.1016/S0304-3894(03)00218-8
NR 15
TC 25
Z9 28
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD DEC 30
PY 2009
VL 172
IS 2-3
BP 1206
EP 1211
DI 10.1016/j.jhazmat.2009.07.125
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 522EO
UT WOS:000271980800092
PM 19709812
DA 2018-10-20
ER

PT J
AU Foo, CTSWP
   Lee, JS
   Mulyasasmita, W
   Parisi-Amon, A
   Heilshorn, SC
AF Foo, Cheryl T. S. Wong Po
   Lee, Ji Seok
   Mulyasasmita, Widya
   Parisi-Amon, Andreina
   Heilshorn, Sarah C.
TI Two-component protein-engineered physical hydrogels for cell
   encapsulation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; cell transplantation; protein engineering
ID MOLECULAR-SIZE DISTRIBUTION; PARKINSONS-DISEASE; STEREOCOMPLEX
   FORMATION; REVERSIBLE HYDROGELS; HNT NEURONS; WW DOMAINS; STEM-CELLS;
   IN-VITRO; SURVIVAL; PEPTIDE
AB Current protocols to encapsulate cells within physical hydrogels require substantial changes in environmental conditions (pH, temperature, or ionic strength) to initiate gelation. These conditions can be detrimental to cells and are often difficult to reproduce, therefore complicating their use in clinical settings. We report the development of a two-component, molecular-recognition gelation strategy that enables cell encapsulation without environmental triggers. Instead, the two components, which contain multiple repeats of WW and proline-rich peptide domains, undergo a sol-gel phase transition upon simple mixing and hetero-assembly of the peptide domains. We term these materials mixing-induced, two-component hydrogels. Our results demonstrate use of the WW and proline-rich domains in protein-engineered materials and expand the library of peptides successfully designed into engineered proteins. Because both of these association domains are normally found intracellularly, their molecular recognition is not disrupted by the presence of additional biomolecules in the extracellular milieu, thereby enabling reproducible encapsulation of multiple cell types, including PC-12 neuronal-like cells, human umbilical vein endothelial cells, and murine adult neural stem cells. Precise variations in the molecular-level design of the two components including (i) the frequency of repeated association domains per chain and (ii) the association energy between domains enable tailoring of the hydrogel viscoelasticity to achieve plateau shear moduli ranging from approximate to 9 to 50 Pa. Because of the transient physical crosslinks that form between association domains, these hydrogels are shear-thinning, injectable, and self-healing. Neural stem cells encapsulated in the hydrogels form stable three-dimensional cultures that continue to self-renew, differentiate, and sprout extended neurites.
C1 [Foo, Cheryl T. S. Wong Po; Lee, Ji Seok; Mulyasasmita, Widya; Parisi-Amon, Andreina; Heilshorn, Sarah C.] Stanford Univ, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, 476 Lomita Mall, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
FU National Heart Foundation [H2007-024]; John and Ulla de Larios Fund;
   Stanford Bio-X Interdisciplinary Initiative; National Science Foundation
FX We thank Nick Melosh, Megan Valentine, and Ian Wong for expertise and
   equipment for microrheology and Theo Palmer and Katrin Schrenk-Siemens
   for expertise in NSC culture. Work was supported by the National Heart
   Foundation (American Health Assistance Foundation H2007-024), John and
   Ulla de Larios Fund, and Stanford Bio-X Interdisciplinary Initiative. W.
   M. acknowledges a Stanford Graduate Fellowship; A. P.-A. acknowledges a
   National Science Foundation Graduate Fellowship.
CR Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388
   BEATY CE, 1993, J CONTROL RELEASE, V24, P15, DOI 10.1016/0168-3659(93)90165-2
   Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2
   Bliss TM, 2006, J NEUROSCI RES, V83, P1004, DOI 10.1002/jnr.20800
   Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Byfield FJ, 2009, J BIOMECH, V42, P1114, DOI 10.1016/j.jbiomech.2009.02.012
   Cao F, 2007, J TISSUE ENG REGEN M, V1, P465, DOI 10.1002/term.55
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Chen DT, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108301
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562
   Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Koopmans C, 2008, MACROMOLECULES, V41, P7418, DOI 10.1021/ma801202f
   KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702
   Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lim DW, 2000, J APPL POLYM SCI, V75, P1615, DOI 10.1002/(SICI)1097-4628(20000328)75:13<1615::AID-APP7>3.0.CO;2-L
   Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144
   Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Niece KL, 2008, BIOMATERIALS, V29, P4501, DOI 10.1016/j.biomaterials.2008.07.049
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1
   Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032
   Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h
   SHAPIRO AM, 2000, NEW ENGL J MED, V343, P320
   Shen W, 2005, MACROMOLECULES, V38, P3909, DOI 10.1021/ma048348s
   Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991
   Stockmayer WH, 1943, J CHEM PHYS, V11, P45, DOI 10.1063/1.1723803
   Straley Karin S, 2009, Front Neuroeng, V2, P9, DOI 10.3389/neuro.16.009.2009
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   STRALEY KS, 2009, J NEUROTRAUM, DOI DOI 10.1089/NEU.2009/0948
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Topp S, 2006, J AM CHEM SOC, V128, P13994, DOI 10.1021/ja064546i
   van de Manakker F, 2008, MACROMOLECULES, V41, P1766, DOI 10.1021/ma702607r
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103
NR 61
TC 180
Z9 181
U1 6
U2 131
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 29
PY 2009
VL 106
IS 52
BP 22067
EP 22072
DI 10.1073/pnas.0904851106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 538IV
UT WOS:000273178700008
PM 20007785
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Aguilar-Frutis, M
   Kumar, S
   Falcony, C
AF Aguilar-Frutis, M.
   Kumar, S.
   Falcony, C.
TI Spray-pyrolyzed hydroxyapatite thin-film coatings
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 36th International Conference on Metallurgical Coatings and Thin Films
CY APR 27-MAY 01, 2009
CL San Diego, CA
SP Amer Vacuum Soc, Adv Surface Engn Div
DE Spray pyrolysis; Hydroxyapatite; XPS; XRD
ID COMPOSITE COATINGS; STAINLESS-STEEL; ELECTRODEPOSITION; DEPOSITION;
   TITANIUM
AB Hydroxyapatite (HA) thin-film coatings have been deposited on sheet substrates of a commonly used biomaterial (Ti6Al4V) using the spray pyrolysis technique. For this, a 0.042 M calcium spraying solution was prepared by dissolving calcium acetylacetonate hydrate in N,N-dimethylformamide, and phosphoric acid (H3PO4) was used as the source of phosphorous with different volume concentrations in deionized water. Both the solutions were supplied simultaneously and in parallel during the deposition of the coatings. The coatings were deposited at substrate temperatures of 425 and 525 degrees C. The use of 0.27% (volume) solution of H3PO4 resulted in coatings with stoichiometry close to that of the HA. The chemical composition, surface morphology and structure of the HA coatings were investigated by X-ray photoelectrom spectroscopy (XPS), scanning electron microscopy (SEM) and X-ray diffraction (XRD). The characteristics of the coatings thus observed are presented and discussed. The high purity of the coatings was revealed by XPS, confirming the presence of Ca, P and O as the main constituents, with a Ca/P ratio of about 1.3. Some carbon, inherent to the precursors used, was also detected by XPS. The XRD patterns obtained suggested preferred (113) and (321) crystal orientations in the coatings. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Aguilar-Frutis, M.] CICATA IPN, Mexico City 11500, DF, Mexico.
   [Kumar, S.] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5095, Australia.
   [Falcony, C.] Inst Politecn Nacl, CINVESTAV, Mexico City 07000, DF, Mexico.
RP Aguilar-Frutis, M (reprint author), CICATA IPN, Mexico City 11500, DF, Mexico.
EM mafrutis@yahoo.es
OI Falcony, Ciro/0000-0001-9986-0809
CR Aguilar-Frutis M, 1998, APPL PHYS LETT, V72, P1700, DOI 10.1063/1.121156
   Aguilar-Frutis M, 2001, THIN SOLID FILMS, V389, P200, DOI 10.1016/S0040-6090(01)00854-9
   An GH, 2007, MAT SCI ENG A-STRUCT, V449, P821, DOI 10.1016/j.msea.2006.02.436
   Balamurugan A, 2006, MATER LETT, V60, P2288, DOI 10.1016/j.matlet.2005.12.126
   BLANDENET G, 1981, THIN SOLID FILMS, V77, P81, DOI 10.1016/0040-6090(81)90362-X
   Dasarathy H, 1996, J BIOMED MATER RES, V31, P81, DOI 10.1002/(SICI)1097-4636(199605)31:1<81::AID-JBM10>3.0.CO;2-P
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kim BH, 2007, CERAM INT, V33, P119, DOI 10.1016/j.ceramint.2005.08.002
   Kumar S, 2007, SURF COAT TECH, V202, P1242, DOI 10.1016/j.surfcoat.2007.07.075
   Langlet M., 1993, CHEM ADV MAT, P55
   Leeuwenburgh SCG, 2006, BIOMATERIALS, V27, P3368, DOI 10.1016/j.biomaterials.2006.01.052
   Pang X, 2008, SURF COAT TECH, V202, P3815, DOI 10.1016/j.surfcoat.2008.01.022
   Redepenning J, 2003, J BIOMED MATER RES A, V66A, P411, DOI 10.1002/jbm.a.10571
   Szili EJ, 2008, SURF SCI, V602, P2402, DOI 10.1016/j.susc.2008.05.027
   Tucker BE, 1996, BIOMATERIALS, V17, P631, DOI 10.1016/0142-9612(96)88714-X
   Van Dijk K., 1995, Journal of Biomedical Materials Research, V29, P269
   Ye G, 2008, CERAM INT, V34, P511, DOI 10.1016/j.ceramint.2006.11.014
NR 17
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 25
PY 2009
VL 204
IS 6-7
BP 1116
EP 1120
DI 10.1016/j.surfcoat.2009.07.021
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 533XO
UT WOS:000272859500073
DA 2018-10-20
ER

PT J
AU Doshi, N
   Zahr, AS
   Bhaskar, S
   Lahann, J
   Mitragotri, S
AF Doshi, Nishit
   Zahr, Alisar S.
   Bhaskar, Srijanani
   Lahann, Joerg
   Mitragotri, Samir
TI Red blood cell-mimicking synthetic biomaterial particles
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomimetic; drug delivery; erythrocyte; imaging; nanotechnology
ID DRUG-DELIVERY; POLYMERIC NANOPARTICLES; DESIGN; SHAPE; ELASTICITY;
   MEDICINE; CARRIERS
AB Biomaterials form the basis of current and future biomedical technologies. They are routinely used to design therapeutic carriers, such as nanoparticles, for applications in drug delivery. Current strategies for synthesizing drug delivery carriers are based either on discovery of materials or development of fabrication methods. While synthetic carriers have brought upon numerous advances in drug delivery, they fail to match the sophistication exhibited by ;innate biological entities. In particular, red blood cells (RBCs), the most ubiquitous cell type in the human blood, constitute highly specialized entities with unique shape, size, mechanical flexibility, and material composition, all of which are optimized for extraordinary biological performance. Inspired by this natural example, we synthesized particles that mimic the key structural and functional features of RBCs. Similar to their natural counterparts, RBC-mimicking particles described here possess the ability to carry oxygen and flow through capillaries smaller than their own diameter. Further, they can also encapsulate drugs and imaging agents. These particles provide a paradigm for the design of drug delivery and imaging carriers, because they combine the functionality of natural RBCs with the broad applicability and versatility of synthetic drug delivery particles.
C1 [Bhaskar, Srijanani; Lahann, Joerg] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
   [Doshi, Nishit; Zahr, Alisar S.; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.
   [Lahann, Joerg] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Lahann, Joerg] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
RP Lahann, J (reprint author), Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
EM lahann@umich.edu; samir@engineering.ucsb.edu
RI Lahann, Joerg/J-7663-2013
FU National Heart Lung and Blood Institute's Program of Excellence in
   Nanotechnology [1UO1 HL080718]; The National Center for Research
   Resources [1S10RR017753-01]; American Cancer Society [08-1556]
FX We thank Dr. Alejandro Bonilla for assistance with atomic force
   microscopy and Mansi Seth and Prof. Gary Leal for providing capillaries
   and assistance with capillary flow experiments. This work was supported
   by the National Heart Lung and Blood Institute's Program of Excellence
   in Nanotechnology Grant 1UO1 HL080718, The National Center for Research
   Resources shared instrumentation Grant 1S10RR017753-01 was used for
   confocal laser-scanning microscopy, and the American Cancer Society
   Grant 08-1556 (to J.L.).
CR Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Bhaskar S, 2008, MACROMOL RAPID COMM, V29, P1655, DOI 10.1002/marc.200800459
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   DISCHER DE, 1994, SCIENCE, V266, P1032, DOI 10.1126/science.7973655
   Duan L, 2007, BIOCHEM BIOPH RES CO, V354, P357, DOI 10.1016/j.bbrc.2006.12.223
   Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550
   Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   GUTOWSKA A, 1992, J CONTROL RELEASE, V22, P95, DOI 10.1016/0168-3659(92)90194-V
   Haghgooie R, 2010, MACROMOL RAPID COMM, V31, P128, DOI 10.1002/marc.200900302
   Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 1998, NATURE, V392, P5
   Lulevich VV, 2004, J CHEM PHYS, V120, P3822, DOI 10.1063/1.1644104
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171
   Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064
   Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445
   PALEK J, 1987, Blood Reviews, V1, P147, DOI 10.1016/0268-960X(87)90031-2
   Picart C, 2007, COLLOID SURFACE A, V303, P30, DOI 10.1016/j.colsurfa.2007.02.015
   POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F
   Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9
   Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Stadler AM, 2008, BIOPHYS J, V95, P5449, DOI 10.1529/biophysj.108.138040
   Stupp SI, 2005, MRS BULL, V30, P546, DOI 10.1557/mrs2005.148
   SURGENOR D, 1974, RED BLOOD CELL, P13
   Walenga JM, 1998, MED CLIN N AM, V82, P635, DOI 10.1016/S0025-7125(05)70015-8
   Waugh RE, 2001, BLOOD, V97, P1869, DOI 10.1182/blood.V97.6.1869
NR 34
TC 173
Z9 175
U1 3
U2 116
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 22
PY 2009
VL 106
IS 51
BP 21495
EP 21499
DI 10.1073/pnas.0907127106
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 535TM
UT WOS:000272994200008
PM 20018694
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Caldorera-Moore, M
   Peppas, NA
AF Caldorera-Moore, Mary
   Peppas, Nicholas A.
TI Micro- and nanotechnologies for intelligent and responsive
   biomaterial-based medical systems
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Responsive hydrogels; Intelligent therapeutics; Micro- and
   nano-electromechanical systems; Biosensors; Controlled drug delivery;
   Tissue engineering
ID PH-SENSITIVE HYDROGELS; TISSUE-ENGINEERING SCAFFOLDS; DRUG-DELIVERY
   SYSTEMS; POLY(ETHYLENE GLYCOL); COMPLEXATION HYDROGELS; CELL-ADHESION;
   IN-VITRO; RECOGNITIVE HYDROGELS; MECHANICAL-PROPERTIES; MICROFLUIDIC
   SYSTEMS
AB Advances in medical treatments of a wide variety of pathophysiological conditions require the development of better therapeutic agents, as well as a combination of the required therapeutic agents with device-integrated biomaterials that can serve as sensors and carriers. Combination of micro- and nano-fabricated systems with intelligent biomaterials that have the ability to sense and respond is a promising avenue for the development of better diagnostic and therapeutic medical systems. Micro- and nano-electromechanical systems (MEMs and NEMs) are now becoming a family of potentially powerful new technologies for drug delivery, diagnostic tools, and tissue engineering. Improvements in micro- and nano-fabrication technologies have enhanced the ability to create better performing therapeutic systems for numerous pathophysiological applications. More importantly, MEMS- and NEMS-based tissue regeneration scaffolds, biosensors, and drug delivery devices provide new opportunities to mimic the natural intelligence and response of biological systems. Published by Elsevier B.V.
C1 [Peppas, Nicholas A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
   [Caldorera-Moore, Mary; Peppas, Nicholas A.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP Peppas, NA (reprint author), Univ Texas Austin, Dept Chem Engn, CPE 3-466,C0400,1 Univ Stn, Austin, TX 78712 USA.
EM peppas@che.utexas.edu
FU National Science Foundation; National Institutes of Health [EB-000246]
FX Work discussed here was supported in part by grants from the National
   Science Foundation and the National Institutes of Health (grant
   EB-000246). MCM is a National Science Foundation Fellow.
CR Ahmed A, 2002, J CONTROL RELEASE, V81, P291, DOI 10.1016/S0168-3659(02)00074-3
   Akala EO, 1998, BIOMATERIALS, V19, P1037, DOI 10.1016/S0142-9612(98)00023-4
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Bacher W, 1998, MICROSYST TECHNOL, V4, P117, DOI 10.1007/s005420050110
   Bashir R, 2002, APPL PHYS LETT, V81, P3091, DOI 10.1063/1.1514825
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Bender M, 2000, MICROELECTRON ENG, V53, P233, DOI 10.1016/S0167-9317(00)00304-X
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bergmann NM, 2008, PROG POLYM SCI, V33, P271, DOI 10.1016/j.progpolymsci.2007.09.004
   Bergmann NM, 2008, IND ENG CHEM RES, V47, P9099, DOI 10.1021/ie071270u
   Besheer A, 2006, J CONTROL RELEASE, V111, P73, DOI 10.1016/j.jconrel.2005.12.008
   BETANCOURT JPT, 2009, J BIOMED MATER RES, DOI DOI 10.1002/JBM.A.32510:P
   Betancourt T, 2007, NANOMEDICINE-UK, V2, P219, DOI 10.2217/17435889.2.2.219
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bikram M, 2007, J CONTROL RELEASE, V123, P219, DOI 10.1016/j.jconrel.2007.08.013
   Borenstein JT, 2002, BIOMED MICRODEVICES, V4, P167, DOI 10.1023/A:1016040212127
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   BRANNONPEPPAS L, 1997, BIOMATERIAL POLYM CO
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Byrne ME, 2008, J BIOMED MATER RES A, V84A, P137, DOI 10.1002/jbm.a.31443
   Byrne ME, 2002, POLYM ADVAN TECHNOL, V13, P798, DOI 10.1002/pat.272
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Carr DA, 2009, MACROMOL BIOSCI, V9, P497, DOI 10.1002/mabi.200800235
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   DANIEL AC, 2009, J BIOMED MATER RES A, DOI DOI 10.1002/JBM.A.32395:P
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Dickert FL, 2003, SYNTHETIC MET, V138, P65, DOI 10.1016/S0379-6779(03)00026-2
   Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Farmer TG, 2008, IND ENG CHEM RES, V47, P10053, DOI 10.1021/ie070957b
   Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550
   Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Gale MT, 1997, MICROELECTRON ENG, V34, P321, DOI 10.1016/S0167-9317(97)00189-5
   Gaubert HE, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/13/135101
   Gershon D, 2002, NATURE, V416, P885, DOI 10.1038/416885a
   Glangchai LC, 2008, J CONTROL RELEASE, V125, P263, DOI 10.1016/j.jconrel.2007.10.021
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hilt JZ, 2006, CHEM MATER, V18, P5869, DOI 10.1021/cm061343k
   Hilt JZ, 2004, ADV DRUG DELIVER REV, V56, P1599, DOI 10.1016/j.addr.2004.04.002
   Hilt JZ, 2003, BIOMED MICRODEVICES, V5, P177, DOI 10.1023/A:1025786023595
   James L W, 1996, NANOTECHNOLOGY, V7, P452
   JAN H, 1996, MOLD ASSISTED NANOLI
   JENNIFER HW, 2001, J BIOMED MATER RES, V56, P351
   Johnson BD, 2004, MAT SCI ENG C-BIO S, V24, P575, DOI 10.1016/j.msec.2003.11.002
   Jun HW, 2005, J BIOMED MATER RES B, V72B, P131, DOI 10.1002/jbm.b.30135
   Kamei N, 2009, J CONTROL RELEASE, V134, P98, DOI 10.1016/j.jconrel.2008.11.014
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Koh WG, 2002, LANGMUIR, V18, P2459, DOI 10.1021/la0115740
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LAUTEN EH, J DRUG DELI IN PRESS
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Leoni L, 2002, BIOMED MICRODEVICES, V4, P131, DOI 10.1023/A:1014639332543
   Liang HF, 2004, BIOMACROMOLECULES, V5, P1917, DOI 10.1021/bm049831
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lu Y, 2004, ADV DRUG DELIVER REV, V56, P1621, DOI 10.1016/j.addr.2004.05.002
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MANZ A, 1999, MICROSYSTEM TECHNOLO
   Mao JS, 2006, ADV MATER, V18, P2289, DOI 10.1002/adma.200600040
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   MARK S, 2006, PHARM RES V, V23, P847
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   MATTHEW C, 2001, J VAC SCI TECHNOL B, V19, P2162
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   NA P, 2006, MRS BULL, V31, P888
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Oral E, 2004, J BIOMED MATER RES A, V68A, P439, DOI 10.1002/jbm.a.20076
   Owens DE, 2007, J BIOMED MATER RES A, V83A, P692, DOI 10.1002/jbm.a.31284
   Park TG, 1999, BIOMATERIALS, V20, P517, DOI 10.1016/S0142-9612(98)00197-5
   PARK TG, 1992, J APPL POLYM SCI, V46, P659, DOI 10.1002/app.1992.070460413
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 2006, EUR J PHARM SCI, V29, P183, DOI 10.1016/j.ejps.2006.04.014
   Podual K, 2000, J CONTROL RELEASE, V67, P9, DOI 10.1016/S0168-3659(00)00195-4
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Ramanan RMK, 2006, BIOTECHNOL PROGR, V22, P118, DOI 10.1021/bp0501367
   Reed ML, 1998, J PHARM SCI-US, V87, P1387, DOI 10.1021/js980085q
   Resnick DJ, 2005, MATER TODAY, V8, P34, DOI 10.1016/S1369-7021(05)00700-5
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Santini Jr J. T., 2000, ANGEW CHEM INT EDIT, V39, P2396
   Santini JT, 1999, NATURE, V397, P335
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Serra L, 2006, BIOMATERIALS, V27, P5440, DOI 10.1016/j.biomaterials.2006.06.011
   Serra L, 2009, EUR J PHARM BIOPHARM, V71, P519, DOI 10.1016/j.ejpb.2008.09.022
   SHVARTSMAN FP, 1991, P SOC PHOTO-OPT INS, V1461, P313, DOI 10.1117/12.44742
   Spizzirri UG, 2005, CHEM MATER, V17, P6719, DOI 10.1021/cm0478531
   STEPHEN Y, 1995, APPL PHYS LETT, V67, P3114
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Tao SL, 2003, ADV DRUG DELIVER REV, V55, P315, DOI 10.1016/S0169-409X(02)00227-2
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   WEBER RE, 2003, EUROPEAN CELLS MAT, V5, P33
   WOOD K, ACTA BIOMATER
   Wood KM, 2006, J CONTROL RELEASE, V116, pE66, DOI 10.1016/j.jconrel.2006.09.053
   WOOD KM, ACTA BIOMAT IN PRESS
   Wood KM, 2008, BIOMACROMOLECULES, V9, P1293, DOI 10.1021/bm701274p
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Ye L, 2001, REACT FUNCT POLYM, V48, P149, DOI 10.1016/S1381-5148(01)00050-5
   Zawko SA, 2009, ACTA BIOMATER, V5, P14, DOI 10.1016/j.actbio.2008.09.012
   Zawko Scott A., 2008, J BIOMED MATER RES A, V87A, P1044
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
NR 132
TC 119
Z9 122
U1 3
U2 100
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 17
PY 2009
VL 61
IS 15
BP 1391
EP 1401
DI 10.1016/j.addr.2009.09.002
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 530BK
UT WOS:000272563700002
PM 19758574
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Johnson, PJ
   Parker, SR
   Sakiyama-Elbert, SE
AF Johnson, Philip J.
   Parker, Stanley R.
   Sakiyama-Elbert, Shelly E.
TI Controlled Release of Neurotrophin-3 From Fibrin-Based Tissue
   Engineering Scaffolds Enhances Neural Fiber Sprouting Following Subacute
   Spinal Cord Injury
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE nerve regeneration; growth factors; biomaterial; delivery system
ID ADULT RATS; AXONAL GROWTH; CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY;
   REGENERATION; DELIVERY; BDNF; FIBROBLASTS; TRANSPLANTS; NT-3
AB This study investigated whether delayed treatment of spinal cord injury with controlled release of neurotrophin-3 (NT-3) from fibrin scaffolds can stimulate enhanced neural fiber sprouting. Long Evans rats received a T9 dorsal hemisection spinal cord injury. Two weeks later, the injury site was re-exposed, and either a fibrin scaffold alone, a fibrin scaffold containing a heparin-based delivery system with different concentrations of NT-3 (500 and 1,000 ng/mL), or a fibrin scaffold containing 1,000 ng/mL of NT-3 (no delivery system) was implanted into the injury site. The injured spinal cords were evaluated for morphological differences using markers for neurons, astrocytes, and chondroitin sulfate proteoglycans 2 weeks after treatment. The addition of 500 ng/mL of NT-3 with the delivery system resulted in an increase in neural fiber density compared to fibrin alone. These results demonstrate that the controlled release of NT-3 from fibrin scaffolds can enhance neural fiber sprouting even when treatment is delayed 2 weeks following injury. Biotechnol. Bioeng. 2009; 104: 1207-1214. (C) 2009 Wiley Periodicals, Inc.
C1 [Johnson, Philip J.; Parker, Stanley R.; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Sakiyama-Elbert, Shelly E.] Washington Univ, Sch Med, Div Plast & Reconstruct Surg, Dept Surg, St Louis, MO 63130 USA.
   [Sakiyama-Elbert, Shelly E.] Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA.
RP Sakiyama-Elbert, SE (reprint author), Washington Univ, Dept Biomed Engn, Campus Box 1097,1 Brookings Dr, St Louis, MO 63130 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NIH-NINDS [R01 NS051454]
FX Contract grant sponsor: NIH-NINDS; Contract grant number: R01 NS051454
CR Blits Bas, 2000, Experimental Neurology, V164, P25, DOI 10.1006/exnr.2000.7413
   Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Grill R, 1997, J NEUROSCI, V17, P5560
   Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704
   Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263
   Hsu JYC, 2005, J NEUROSCI RES, V82, P472, DOI 10.1002/jnr.20662
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980
   JOHNSON PJ, 2009, J BIOMED MATER RES A, DOI DOI 10.1002/JBM.A32343
   KNOOPS B, 1991, BRAIN RES, V540, P183, DOI 10.1016/0006-8993(91)90506-Q
   Lu P, 2007, EXP NEUROL, V203, P8, DOI 10.1016/j.expneurol.2006.07.030
   Lynskey JV, 2006, J NEUROTRAUM, V23, P617, DOI 10.1089/neu.2006.23.617
   McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1
   Novikova LN, 2002, J COMP NEUROL, V452, P255, DOI 10.1002/cne.10381
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Shumsky JS, 2003, EXP NEUROL, V184, P114, DOI 10.1016/S0014-4886(03)00398-4
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7
   von Meyenburg J, 1998, EXP NEUROL, V154, P583, DOI 10.1006/exnr.1998.6912
   Xu B, 2002, NEUROSCIENCE, V115, P1295, DOI 10.1016/S0306-4522(02)00384-6
NR 27
TC 64
Z9 67
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD DEC 15
PY 2009
VL 104
IS 6
BP 1207
EP 1214
DI 10.1002/bit.22476
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 546LX
UT WOS:000273813400017
PM 19603426
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akar, ST
   Ozcan, AS
   Akar, T
   Ozcan, A
   Kaynak, Z
AF Akar, Sibel Tunali
   Oezcan, A. Safa
   Akar, Tamer
   Oezcan, Adnan
   Kaynak, Zerrin
TI Biosorption of a reactive textile dye from aqueous solutions utilizing
   an agro-waste
SO DESALINATION
LA English
DT Article
DE Biosorption; Reactive dye; Agro-waste; Isotherm; Kinetics;
   Thermodynamics
ID METHYLENE-BLUE; BASIC DYE; REMOVAL; ADSORPTION; EQUILIBRIUM; BIOMASS;
   PARAMETERS; KINETICS; ACID-RED-57; BIOSORBENT
AB In the present study a low-cost waste biomass derived from canned food plant, was tested for its ability to remove reactive textile dye from aqueous solutions. The batch biosorption experiments were carried out at various pH, biosorbent dosage. contact time and temperature. Optimum decolorization was observed at pH 2.0 and 1.6 g dm(-3) of biomass dosage within 20 min. The first-order and the pseudo-second-order kinetics were investigated for the biosorption system. The applicability of the Langmuir and Freundlich isotherm models was examined. The thermodynamic parameters for the biosorption were also calculated. The experimental results in this study indicated that this low-cost biomaterial was an attractive candidate for the removal of textile dye Reactive Red 198 (RR198) from aqueous solutions. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Akar, Sibel Tunali; Akar, Tamer] Eskisehir Osmangazi Univ, Dept Chem, Fac Arts & Sci, TR-26480 Eskisehir, Turkey.
   [Oezcan, A. Safa; Oezcan, Adnan] Anadolu Univ, Dept Chem, Fac Sci, TR-26470 Eskisehir, Turkey.
   [Kaynak, Zerrin] Bilecik Univ, Program Chem, Vocat Sch Higher Educ, TR-11210 Bilecik, Turkey.
RP Akar, ST (reprint author), Eskisehir Osmangazi Univ, Dept Chem, Fac Arts & Sci, Campus Meselik, TR-26480 Eskisehir, Turkey.
EM stunali@ogu.edu.tr
RI Tunali Akar, Sibel/D-8927-2011
OI Tunali Akar, Sibel/0000-0003-4312-3601
CR Akar T, 2008, BIORESOURCE TECHNOL, V99, P3057, DOI 10.1016/j.biortech.2007.06.029
   Akkaya G, 2005, PROCESS BIOCHEM, V40, P3559, DOI 10.1016/j.procbio.2005.03.048
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2000, PROCESS BIOCHEM, V36, P431, DOI 10.1016/S0032-9592(00)00233-8
   Amini M, 2008, J HAZARD MATER, V154, P694, DOI 10.1016/j.jhazmat.2007.10.114
   Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Arica MY, 2007, J HAZARD MATER, V149, P499, DOI 10.1016/j.jhazmat.2007.04.021
   Ashraf SS, 2006, DYES PIGMENTS, V69, P74, DOI 10.1016/j.dyepig.2005.02.009
   Bai R.S., 2001, BIORESOURCE TECHNOL, V79, P73, DOI DOI 10.1016/S0960-8524(00)00107-3
   Bayramoglu G, 2007, J HAZARD MATER, V143, P135, DOI 10.1016/j.jhazmat.2006.09.002
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   Dapinder K, 1999, WORLD J MICROB BIOT, V15, P507
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gong RM, 2005, DYES PIGMENTS, V64, P187, DOI 10.1016/j.dyepig.2004.05.05
   Gupta VK, 2009, J HAZARD MATER, V163, P396, DOI 10.1016/j.jhazmat.2008.06.104
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Ho Y.S., 1998, J ENV SCI HLTH B, V76, P183
   Ho YS, 2005, BIORESOURCE TECHNOL, V96, P1285, DOI 10.1016/j.biortech.2004.10.021
   Ho YS, 2005, PROCESS BIOCHEM, V40, P119, DOI 10.1016/j.procbio.2003.11.035
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   Kargi F, 2004, ENZYME MICROB TECH, V35, P267, DOI 10.1016/j.enzmictec.2004.05.002
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Liversidge RM, 1997, PROCESS BIOCHEM, V32, P473, DOI 10.1016/S0032-9592(96)00107-0
   Matheickal JT, 1997, MINER ENG, V10, P947, DOI 10.1016/S0892-6875(97)00076-9
   McKay G, 1999, WATER AIR SOIL POLL, V114, P423, DOI 10.1023/A:1005197308228
   Namasivayam C, 2001, WASTE MANAGE, V21, P381, DOI 10.1016/S0956-053X(00)00081-7
   NAWAR SS, 1989, SCI TOTAL ENVIRON, V79, P271, DOI 10.1016/0048-9697(89)90342-2
   Ofomaja AE, 2007, DYES PIGMENTS, V74, P60, DOI 10.1016/j.dyepig.2006.01.014
   Ozacar M, 2005, PROCESS BIOCHEM, V40, P565, DOI 10.1016/j.procbio.2004.01.032
   Ozcan A, 2005, J HAZARD MATER, V125, P252, DOI 10.1016/j.jhazmat.2005.05.039
   Ozcan AS, 2005, COLLOID SURFACE A, V266, P73, DOI 10.1016/j.colsurfa.2005.06.001
   Pagnanelli F, 2001, PROCESS BIOCHEM, V37, P115, DOI 10.1016/S0032-9592(01)00180-7
   Patel R, 2008, BIORESOURCE TECHNOL, V99, P51, DOI 10.1016/j.biortech.2006.12.003
   Raghuvanshi S.P., 2005, INT J ENVIRON STUD, V62, P329
   Robinson T, 2002, WATER RES, V36, P2824, DOI 10.1016/S0043-1354(01)00521-8
   Tunali S, 2006, CHEM ENG J, V115, P203, DOI 10.1016/j.cej.2005.09.023
   Tunali S, 2007, J ENVIRON SCI HEAL A, V42, P591, DOI 10.1080/10934520701244359
   Wang BE, 2008, BIORESOURCE TECHNOL, V99, P794, DOI 10.1016/j.biortech.2007.01.043
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204
   YUZHU F., 2001, BIORESOURCE TECHNOL, V79, P251
NR 42
TC 83
Z9 88
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
J9 DESALINATION
JI Desalination
PD DEC 15
PY 2009
VL 249
IS 2
BP 757
EP 761
DI 10.1016/j.desal.2008.09.012
PG 5
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 522RK
UT WOS:000272015800048
DA 2018-10-20
ER

PT J
AU Valentin, JE
   Freytes, DO
   Grasman, JM
   Pesyna, C
   Freund, J
   Gilbert, TW
   Badylak, SF
AF Valentin, Jolene E.
   Freytes, Donald O.
   Grasman, Jonathan M.
   Pesyna, Colin
   Freund, John
   Gilbert, Thomas W.
   Badylak, Stephen F.
TI Oxygen diffusivity of biologic and synthetic scaffold materials for
   tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biologic scaffold material; extracellular matrix; tissue engineering;
   oxygen diffusivity; ultrastructure
ID SMALL-INTESTINAL SUBMUCOSA; ENDOTHELIAL GROWTH-FACTOR;
   EXTRACELLULAR-MATRIX; URINARY-BLADDER; CELL SHEETS; MODEL; BIOREACTOR;
   POROSITY; DEGRADATION; GRADIENTS
AB Scaffolds for tissue engineering and regenerative medicine applications are commonly manufactured from synthetic materials, intact or isolated components of extracellular matrix (ECM), or a combination of such materials. After Surgical implantation, the metabolic requirements of cells that populate the scaffold depend upon adequate gas and nutrient exchange with the surrounding microenvironment. The present study measured the oxygen transfer through three biologic scaffold materials composed of ECM including small intestinal submucosa (SIS), Urinary bladder submucosa (UBS), and Urinary bladder matrix (UBM), and one synthetic biomaterial, Dacron (TM). The oxygen diffusivity was calculated from Fick's first law of diffusion. Each material permitted measurable oxygen diffusion. The diffusivity of SIS was found to be dependent on the direction of oxygen transfer; the oxygen transfer in the abluminal-to-luminal direction was significantly greater than the luminal-to-abluminal direction. The oxygen diffusivity of UBM and UBS were similar despite the presence of an intact basement membrane on the luminal surface of UBM. Dacron showed oxygen diffusivity values seven times greater than the ELM biomaterials. The Current study showed that each material has unique oxygen diffusivity values, and these values may be dependent on the scaffold's Ultrastructure. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 1010-1017, 2009
C1 [Valentin, Jolene E.; Freytes, Donald O.; Pesyna, Colin; Freund, John; Gilbert, Thomas W.; Badylak, Stephen F.] McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Valentin, Jolene E.; Freytes, Donald O.; Grasman, Jonathan M.; Gilbert, Thomas W.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Gilbert, Thomas W.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), McGowan Inst Regenerat Med, 100 Technol Dr,Suite 200, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Grasman, Jonathan/0000-0001-8289-9627; Badylak,
   Stephen/0000-0003-3555-0689
CR Ambrosino G, 2002, INT J ARTIF ORGANS, V25, P960
   Androjna C, 2008, TISSUE ENG PT A, V14, P559, DOI 10.1089/tea.2006.0361
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Cartwright LM, 2006, J BIOMED MATER RES A, V77A, P180, DOI 10.1002/jbm.a.30652
   Cheema U, 2008, CELL MOL LIFE SCI, V65, P177, DOI 10.1007/s00018-007-7356-8
   Cussler E. L., 1997, DIFFUSION MASS TRANS
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   De Bartolo L, 2006, BIOMATERIALS, V27, P4794, DOI 10.1016/j.biomaterials.2006.05.015
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Dusseault J, 2005, BIOMATERIALS, V26, P1515, DOI 10.1016/j.biomaterials.2004.05.013
   El Ghalbzouri A, 2004, BIOMATERIALS, V25, P2987, DOI 10.1016/j.biomaterials.2003.09.098
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Isayeva IS, 2003, BIOMATERIALS, V24, P3483, DOI 10.1016/S0142-9612(03)00172-8
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Ng KW, 2005, J BIOMED MATER RES A, V75A, P425, DOI 10.1002/jbm.a.30454
   Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518
   Pittman RN, 2005, MICROCIRCULATION, V12, P59, DOI 10.1080/10739680590895064
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   ROBINSON KA, 2005, CIRCULATION, V112, P1135
   Sieminski AL, 2000, BIOMATERIALS, V21, P2232
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wallis MC, 2008, TISSUE ENG PT A, V14, P339, DOI 10.1089/tea.2006.0398
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Weind KL, 2001, AM J PHYSIOL-HEART C, V281, pH2604
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 39
TC 21
Z9 22
U1 2
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2009
VL 91A
IS 4
BP 1010
EP 1017
DI 10.1002/jbm.a.32328
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 525EN
UT WOS:000272196900007
PM 19097154
DA 2018-10-20
ER

PT J
AU Jegoux, F
   Goyenvalle, E
   Cognet, R
   Malard, O
   Moreau, F
   Daculsi, G
   Aguado, E
AF Jegoux, Franck
   Goyenvalle, Eric
   Cognet, Ronan
   Malard, Olivier
   Moreau, Francoise
   Daculsi, Guy
   Aguado, Eric
TI Reconstruction of irradiated bone segmental defects with a biomaterial
   associating MBCP plus (R), microstructured collagen membrane and total
   bone marrow grafting: An experimental study in rabbits
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate ceramic; bone marrow graft; radiotherapy; segmental
   bone defect; rabbit and dog experimental model; tissue engineering
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE SCAFFOLD; MANDIBULAR
   RECONSTRUCTION; CORALLINE HYDROXYAPATITE; POROUS HYDROXYAPATITE;
   MORPHOGENETIC PROTEIN; RADIATION-THERAPY; STROMAL DAMAGE; SPINE FUSION;
   REPAIR
AB The bone tissue engineering models used today are still a long way from any oncologic application as immediate postimplantation irradiation would decrease their osteoinductive potential. The aim of this study was to reconstruct a segmental critical size defect in a weight-bearing bone irradiated after implantation. Six white New Zealand rabbits were immediately implanted with a biomaterial associating resorbable collagen membrane EZ (R) filled and micro-macroporous biphasic calcium phosphate granules (MBCP+(R)). After a daily schedule of radiation delivery, and within 4 weeks, a total autologous bone marrow (BM) graft was injected percutaneously into the center of the implant. All the animals were sacrificed at 16 weeks. Successful osseous colonization was found to have bridged the entire length of the defects. Identical distribution of bone ingrowth and residual ceramics at the different levels of the implant suggests that the BM graft plays an osteoinductive role in the center of the defect. Periosteum-like formation was observed at the periphery, with the collagen membrane most likely playing a role. This model succeeded in bridging a large segmental defect in weight-bearing bone with immediate postimplantation fractionated radiation delivery. This has significant implications for the bone tissue engineering approach to patients with cancer-related bone defects. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 1160-1169, 2009
C1 [Jegoux, Franck; Malard, Olivier; Daculsi, Guy] INSERM, U791, Nantes, France.
   [Goyenvalle, Eric; Cognet, Ronan; Aguado, Eric] Nantcs Vet Sch, BBTOCEx, Nantes, France.
   [Goyenvalle, Eric; Aguado, Eric] INSERM, U922, Angers, France.
   [Moreau, Francoise] Biomatlante, Vigneux De Bretagne, France.
   [Daculsi, Guy] CHGU, CIC, CIT, Bordeaux, France.
RP Jegoux, F (reprint author), CHU Pontchaillou, Serv ORL & Chirurg Maxillofaciale, Rue Henri Le Guillou, F-35033 Rennes 9, France.
EM franck.jegoux@chu-rennes.fr
RI Daculsi, Guy/P-1320-2014; Malard, Olivier/A-4742-2012; jegoux,
   franck/P-6231-2014
OI Daculsi, Guy/0000-0003-1030-3446; 
FU The French government (the Agence Nationale de la Recherche ANR 2005);
   Bio-Rimp Project
FX Contract grant sponsors: The French government (the Agence Nationale de
   la Recherche ANR 2005) and the Bio-Rimp Project
CR Andrades JA, 1999, EXP CELL RES, V250, P485, DOI 10.1006/excr.1999.4528
   ARORA V, 1992, OPHTHALMOLOGY, V99, P380
   Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Banfi A, 2001, LEUKEMIA LYMPHOMA, V42, P863, DOI 10.3109/10428190109097705
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Breen SL, 1995, PHYS MED BIOL, V40, P2065, DOI 10.1088/0031-9155/40/12/005
   Brogniez W, 2002, CLIN ORAL IMPLAN RES, V13, P234
   BURWELL RG, 1985, CLIN ORTHOP RELAT R, P125
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Cinotti G, 2004, J BONE JOINT SURG BR, V86B, P135, DOI 10.1302/0301-620X.86B1.14308
   Connolly J F, 1986, Nebr Med J, V71, P105
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   CONNOLLY JF, 1995, CLIN ORTHOP RELAT R, P8
   Crigel MH, 2002, VET COMP ORTHOPAED, V15, P158
   Curylo LJ, 1999, SPINE, V24, P434, DOI 10.1097/00007632-199903010-00004
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Deutsch M, 1999, ANN PLAS SURG, V42, P662, DOI 10.1097/00000637-199906000-00014
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Dudziak ME, 2000, PLAST RECONSTR SURG, V106, P1049, DOI 10.1097/00006534-200010000-00015
   Dupraz A, 1999, BIOMATERIALS, V20, P663, DOI 10.1016/S0142-9612(98)00222-1
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   Goujon E., 1869, J ANAT PHYSL, V6, P399
   Granstrom G, 2005, J ORAL MAXIL SURG, V63, P579, DOI 10.1016/j.joms.2005.01.008
   Granstrom G, 2003, PERIODONTOL 2000, V33, P145, DOI 10.1046/j.0906-6713.2002.03312.x
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   Guicheux J, 1998, J BONE MINER RES, V13, P739, DOI 10.1359/jbmr.1998.13.4.739
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Jiang B, 2006, BIOMATERIALS, V27, P15, DOI 10.1016/j.biomaterials.2005.05.091
   Jisander S, 1997, INT J ORAL MAX IMPL, V12, P643
   Kudo M, 2001, J ORAL MAXIL SURG, V59, P293, DOI 10.1053/joms.2001.20998
   KUDO M, 2001, J ORAL MAXILLOFAC SU, V59, P301
   Lerouxel E, 2006, BIOMATERIALS, V27, P4566, DOI 10.1016/j.biomaterials.2006.04.027
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018
   Matsumura S, 1996, CALCIFIED TISSUE INT, V59, P307, DOI 10.1007/s002239900129
   Miura M, 2006, ORAL DIS, V12, P514, DOI 10.1111/j.1601-0825.2006.01300.x
   NATHANSON A, 1978, SCAND J PLAST RECONS, V12, P139, DOI 10.3109/02844317809012985
   Nussenbaum B, 2005, LARYNGOSCOPE, V115, P1170, DOI 10.1097/01.MLG.0000166513.74247.CC
   Ohgushi H, 2004, YONSEI MED J, V45, P61
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   Ohgushi H., 2003, NOVART FDN SYMP, V249, P239
   Ohgushi H., 2003, NOVART FDN SYMP, V249, P127
   Ohgushi H., 2003, NOVART FDN SYMP, V249, P170
   Ohgushi Hajime, 2003, Novartis Found Symp, V249, P118
   Olmsted-Davis EA, 2003, P NATL ACAD SCI USA, V100, P15877, DOI 10.1073/pnas.2632959100
   Peled M, 2005, J ORAL MAXIL SURG, V63, P220, DOI 10.1016/j.joms.2004.06.052
   Sabo D, 2000, J BONE JOINT SURG BR, V82B, P276, DOI 10.1302/0301-620X.82B2 .9447
   Schiodt M, 2002, SUPPORT CARE CANCER, V10, P40, DOI 10.1007/s005200100284
   Schliephake H, 1999, INT J ORAL MAX SURG, V28, P260, DOI 10.1016/S0901-5027(99)80155-6
   Schultze-Mosgau S, 2000, INT J ORAL MAX SURG, V29, P112, DOI 10.1016/S0901-5027(00)80007-7
   TAKAGI K, 1982, CLIN ORTHOP RELAT R, P224
   Tshamala M, 2006, VET COMP ORTHOPAED, V19, P133
   VANOS R, 1993, RADIAT RES, V136, P118, DOI 10.2307/3578648
   von Arx T, 2005, INT J ORAL MAX IMPL, V20, P843
   Werntz JR, 1996, J ORTHOP RES, V14, P85, DOI 10.1002/jor.1100140115
NR 62
TC 13
Z9 13
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2009
VL 91A
IS 4
BP 1160
EP 1169
DI 10.1002/jbm.a.32274
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 525EN
UT WOS:000272196900022
PM 19148925
DA 2018-10-20
ER

PT J
AU Chang, DT
   Colton, E
   Matsuda, T
   Anderson, JM
AF Chang, David T.
   Colton, Erica
   Matsuda, Takehisa
   Anderson, James M.
TI Lymphocyte adhesion and interactions with biomaterial adherent
   macrophages and foreign body giant cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; lymphocyte activation; adhesion; macrophages and foreign
   body giant cells; cytokines
ID T-CELL; ALVEOLAR MACROPHAGES; BREAST IMPLANTS; HUMAN MONOCYTES; B-CELL;
   SURFACE; ACTIVATION; PROLIFERATION; EXPRESSION; CYTOKINE
AB To characterize the effects of adherent macrophages and biomaterial surface chemistries on lymphocyte adhesion and activation, lymphocytes were co-cultured with monocytes alone and together, directly and separated by a porous membrane transwell on hydrophobic, hydrophilic/neutral, hydrophilic/anionic, and hydrophilic/cationic biomaterial surfaces. Surface adherent cells were quantitatively analyzed after 3 clays utilizing immunofluorescence and phase contrast imaging. After periods of 3, 7, and 10 days, secreted interferon-gamma (IFN-gamma) was quantified by ELISA. Limited direct biomaterial-adherent lymphocytes were identified regardless of the presence of macrophages or foreign body giant cells (FBGC). The majority of adherent lymphocytes, which were T cells (>95%) rather than natural killer cells, predominantly interacted with adherent macrophages and FBGCs; greater than 90% were interacting on surfaces with higher levels of adherent macrophages and FBGCs and greater than 55%, were interacting on surfaces with lower levels of macrophages and FBGCs. The hydrophilic/anionic surface promoted higher levels of macrophage- and FBGC-adherent lymphocytes but was nonselective for lymphocyte subtype interactions. The hydrophilic/neutral surface was selective for CD4+ T lymphocyte interactions while the hydrophobic surface was selective for CD8+ T lymphocyte interactions. IFN-gamma was produced in direct and indirect CO-cultures but not in lymphocyte- and monocyte-only cultures suggesting that lymphocytes are activated via macrophage-derived cytokines rather than direct biomaterial contact. Direct lymphocyte interactions with adherent macrophages/FBGCs enhanced IFN-gamma production relative to indirect co-cultures. These results suggest that lymphocytes prefer interactions with adherent macrophages and FBGCs, resulting in lymphocyte activation, and these interactions can be influenced by biomaterial Surface chemistries. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 1210-1220,2009
C1 [Chang, David T.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Colton, Erica; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   [Matsuda, Takehisa] Kanazawa Inst Technol, Genome Biotechnol Lab, Kanazawa, Ishikawa 9218501, Japan.
RP Anderson, JM (reprint author), Wolstein Res Bldg Room 5105,2103 Cornell Rd, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIH [T32 GM007250]; NIBIB [EB-000275, EB-000282]
FX Contract grant sponsor: NIBIB; contract grant numbers: EB-000275,
   EB-000282
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ATHANASOU NA, 1990, J CLIN PATHOL, V43, P997, DOI 10.1136/jcp.43.12.997
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   CANTRELL DA, 1988, IMMUNOLOGY, V65, P343
   CASTIGLIONE A, 1991, NEPHROL DIAL TRANSPL, V2, P31
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   ENELOW RI, 1992, AM J RESP CELL MOL, V6, P57
   Grooteman MPC, 1996, NEPHROL DIAL TRANSPL, V11, P1073
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   Hallett WHD, 2006, SEMIN CANCER BIOL, V16, P367, DOI 10.1016/j.semcancer.2006.07.003
   Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P352, DOI 10.1046/j.1365-2567.2000.00025.x
   Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876
   ITESCU S, 2003, ANN THORAC SURG S, V75, pS65
   Ito T, 2003, SCI TECHNOL ADV MAT, V4, P99, DOI 10.1016/S1468-6996(03)00014-7
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Katzin WE, 1996, CLIN DIAGN LAB IMMUN, V3, P156
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MAEDA M, 1986, J BIOMED MATER RES, V20, P25, DOI 10.1002/jbm.820200104
   MAHER SG, 2007, CURR MED CHEM, V14, P1271
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Miyamoto YJ, 2003, IMMUNOL RES, V27, P71, DOI 10.1385/IR:27:1:71
   Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   Prantl L, 2008, PLAST RECONSTR SURG, V121, P25, DOI 10.1097/01.prs.0000293758.61624.68
   Santana MA, 2003, J CELL PHYSIOL, V195, P392, DOI 10.1002/jcp.10258
   Schuster M, 2002, HUM IMMUNOL, V63, P211, DOI 10.1016/S0198-8859(01)00380-9
   STRICKLAND DH, 1994, EUR RESPIR J, V7, P2124, DOI 10.1183/09031936.94.07122124
   Upham JW, 1997, THORAX, V52, P786, DOI 10.1136/thx.52.9.786
   UPHAM JW, 1995, IMMUNOLOGY, V84, P142
   von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 39
TC 15
Z9 16
U1 0
U2 20
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2009
VL 91A
IS 4
BP 1210
EP 1220
DI 10.1002/jbm.a.32218
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 525EN
UT WOS:000272196900027
PM 19148923
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Themistos, C
   Rajarajan, M
   Rahman, BMA
   Grattan, KTV
AF Themistos, Christos
   Rajarajan, Muttukrishnan
   Rahman, B. M. Azizur
   Grattan, Kenneth T. V.
TI Characterization of Silica Nanowires for Optical Sensing
SO JOURNAL OF LIGHTWAVE TECHNOLOGY
LA English
DT Article
DE Biomedical transducers; finite element methods; optical fiber
   applications
ID WAVE-GUIDES; BIOSENSOR
AB In this paper, the optical properties of silica nanowires in a Mach-Zehnder-based optical sensor for detecting biomaterial specimens have been studied using the full vectorial H-field formulation of the finite element method. The variation of the propagation constant, the power fraction in the composite nanowires with the variation of the nanowire size and the specimen refractive index, temperature, and wavelength are also presented.
C1 [Themistos, Christos] Frederick Univ, CY-1036 Nicosia, Cyprus.
   [Rajarajan, Muttukrishnan; Rahman, B. M. Azizur; Grattan, Kenneth T. V.] City Univ London, London EC1V 0HB, England.
RP Themistos, C (reprint author), Frederick Univ, CY-1036 Nicosia, Cyprus.
EM c.themistos@cytanet.com.cy; R.Muttukr-ishnan@city.ac.uk;
   B.M.A.Rahman@city.ac.uk; K.T.V.Grattan@city.ac.uk
CR Barrelet CJ, 2004, NANO LETT, V4, P1981, DOI 10.1021/nl048739k
   Debackere P, 2006, OPT EXPRESS, V14, P7063, DOI 10.1364/OE.14.007063
   Foster MA, 2008, OPT EXPRESS, V16, P1300, DOI 10.1364/OE.16.001300
   Klocek P., 1991, HDB INFRARED OPTICAL
   Law M, 2004, SCIENCE, V305, P1269, DOI 10.1126/science.1100999
   Lou JY, 2005, OPT EXPRESS, V13, P2135, DOI 10.1364/OPEX.13.002135
   Luff BJ, 1998, J LIGHTWAVE TECHNOL, V16, P583, DOI 10.1109/50.664067
   Malitson H., 1965, J OPT SOC AM, V55, P1205, DOI DOI 10.1364/JOSA.55.001205
   Poulton CG, 2007, OPT LETT, V32, P1647, DOI 10.1364/OL.32.001647
   RAHMAN BMA, 1984, J LIGHTWAVE TECHNOL, V2, P682, DOI 10.1109/JLT.1984.1073669
   SCHIEBENER P, 1990, J PHYS CHEM REF DATA, V19, P677
   TONG L, 2006, OPT EXP, V12, P82
   Tong LM, 2003, NATURE, V426, P816, DOI 10.1038/nature02193
NR 13
TC 17
Z9 17
U1 0
U2 13
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0733-8724
J9 J LIGHTWAVE TECHNOL
JI J. Lightwave Technol.
PD DEC 15
PY 2009
VL 27
IS 24
BP 5537
EP 5542
DI 10.1109/JLT.2009.2026655
PG 6
WC Engineering, Electrical & Electronic; Optics; Telecommunications
SC Engineering; Optics; Telecommunications
GA 511FJ
UT WOS:000271149000001
DA 2018-10-20
ER

PT J
AU Balkundi, SS
   Veerabadran, NG
   Eby, DM
   Johnson, GR
   Lvov, YM
AF Balkundi, Shantanu S.
   Veerabadran, Nalinkanth G.
   Eby, D. Matthew
   Johnson, Glenn R.
   Lvov, Yuri M.
TI Encapsulation of Bacterial Spores in Nanoorganized Polyelectrolyte
   Shells
SO LANGMUIR
LA English
DT Article
ID LIVING CELLS; MICROCAPSULES; FILMS
AB Layer-by-layer assembly uses alternating charged layers of polyionic polymers to coat materials sequentially in a sheath of functionalized nanofilms. Bacterial spores were encapsulated in organized ultrathin shells using layer-by-layer assembly in order to assess the biomaterial as a suitable core and determine the physiological effects of the coating. The shells were constructed on Bacillus subtilis spores using biocompatible polymers polyglutamic acid, polylysine, albumin, lysozyme, gelatin A, prolamine sulfate, and chondroitin sulfate, The assembly process was monitored by measuring the electrical surface potential (zeta-potential) of the particles at each stage of assembly. Fluorescent laser confocal microscopy and scanning electron microscopy confirmed the formation of uniform coatings on the spores. The coating surface charge and thickness (20-100 nm) could be selectively tuned by using appropriate polymers and the number of bilayers assembled. The effect of each coating type oil germination was assessed and compared to native spores. The coated spores were viable, but the kinetics and extent of germination were changed from control spores in all instances. The results and insight gained from the experiments may be used to design various bioinspired systems. The spores call be made dormant for a desired amount of time using the LbL encapsulation technique and call be made active when appropriate.
C1 [Balkundi, Shantanu S.; Veerabadran, Nalinkanth G.; Lvov, Yuri M.] Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA.
   [Balkundi, Shantanu S.; Veerabadran, Nalinkanth G.; Lvov, Yuri M.] Louisiana Tech Univ, Biomed Engn Program, Ruston, LA 71270 USA.
   [Eby, D. Matthew; Johnson, Glenn R.] USAF, Res Lab RXQL, Tyndall AFB, FL USA.
RP Lvov, YM (reprint author), Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA.
EM ylov@latech.edu
RI Lvov, Yuri/E-7633-2012
FU Air Force Office of Scientific Research; Air Force Research Laboratory
   Materials Science Directorate; NSF-EPSCoR [34768]
FX S.S.B. was supported through a predoctoral fellowship administered by
   the Oak Ridge Institute of Science and Engineering. Work at Tyndall AFB
   was supported by funding from the Air Force Office of Scientific
   Research (J. Gresham, Program Manager) and the Air Force Research
   Laboratory Materials Science Directorate. This work was also supported
   by NSF-EPSCoR no. 34768. Any opinions, findings, and conclusions or
   recommendations expressed in this material are those of the authors and
   do not necessarily reflect the view of the National Science Foundation.
CR Ai H, 2003, J CONTROL RELEASE, V86, P59, DOI 10.1016/S0168-3659(02)00322-X
   Baca HK, 2006, SCIENCE, V313, P337, DOI 10.1126/science.1126590
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   DECHER G, 1997, SCIENCE, V277, P1237
   Diaspro A, 2002, LANGMUIR, V18, P5047, DOI 10.1021/la025646e
   DONATH E, 1998, ANGEW CHEM INT EDIT, V6, P413
   Estrela-Lopis I, 2007, LANGMUIR, V23, P7209, DOI 10.1021/la700496c
   Hillberg AL, 2006, BIOMACROMOLECULES, V7, P2742, DOI 10.1021/bm060266j
   Hindle AA, 1999, ANALYST, V124, P1599, DOI 10.1039/a906846e
   Hua A, 2002, BIOMACROMOLECULES, V3, P560
   Li ZF, 2005, MACROMOLECULES, V38, P7876, DOI 10.1021/ma0513012
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   Neu B, 2001, J MICROENCAPSUL, V18, P385
   PELEGRINO PM, 2002, ANAL CHIM ACTA, V455, P167
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194
   SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704
   Shenoy DB, 2003, BIOMACROMOLECULES, V4, P265, DOI 10.1021/bm025661y
   Shutava TG, 2006, J AM CHEM SOC, V128, P9926, DOI 10.1021/ja062318i
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Swiston AJ, 2008, NANO LETT, V8, P4446, DOI 10.1021/nl802404h
   Veerabadran N., 2007, MACROMOL BIOSCI, V37, P877
   Yang SY, 2004, LANGMUIR, V20, P5978, DOI 10.1021/la0490442
   Yu M, 2004, BIOMATERIALS, V25, P3655, DOI [10.1016/j.biomaterials.2003.10.061, 10.1010/j.biomaterials.2003.10.061]
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
NR 25
TC 51
Z9 51
U1 1
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 15
PY 2009
VL 25
IS 24
BP 14011
EP 14016
DI 10.1021/la900971h
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 527UW
UT WOS:000272394400042
PM 19469562
DA 2018-10-20
ER

PT J
AU Wang, YC
   Yuan, YY
   Du, JZ
   Yang, XZ
   Wang, J
AF Wang, Yu-Cai
   Yuan, You-Yong
   Du, Jin-Zhi
   Yang, Xian-Zhu
   Wang, Jun
TI Recent Progress in Polyphosphoesters: From Controlled Synthesis to
   Biomedical Applications
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE biodegradable; drug delivery; gene delivery; polyphosphoesters; tissue
   engineering
ID RING-OPENING POLYMERIZATION; POTENTIAL BIOMATERIAL APPLICATIONS;
   POLY(ETHYL ETHYLENE PHOSPHATE); BLOCK-COPOLYMER MICELLES; HYDROPHILIC
   GRAFT CHAINS; DRUG-RELEASE PROPERTIES; EPSILON-CAPROLACTONE; CYCLIC
   ESTERS; PLASMID DNA; POLY(ALKYLENE PHOSPHATE)S
AB Polyphosphoesters (PPEs) with repeating phosphoester bonds in the backbone are structurally versatile, biocompatible, and biodegradable through hydrolysis as well as enzymatic digestion under physiological conditions. They are appealing for biological applications because of their potential functionality, biocompatibility, and similarity to biomacromolecules such as nucleic acids. The expanding scope of PPEs in materials science, especially as biomaterials, is described in this review. We mainly focus on controlled synthetic methods of PPEs, which provide access to novel and complex polymer structures, especially for block copolymers. The hydrolytic and enzymatic degradation of PPEs, thermoresponsive PPEs, and biomedical applications have also been discussed.
C1 [Yuan, You-Yong; Yang, Xian-Zhu; Wang, Jun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.
   [Yuan, You-Yong; Yang, Xian-Zhu; Wang, Jun] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.
   [Wang, Yu-Cai; Du, Jin-Zhi] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei 230026, Anhui, Peoples R China.
   [Wang, Yu-Cai; Du, Jin-Zhi] Univ Sci & Technol China, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
RP Wang, J (reprint author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.
EM jwang699@ustc.edu.cn
RI wang, yucai/B-5388-2012; Yang, Xian-Zhu/G-7980-2012; Wang,
   Jun/F-9033-2011; Wang, Yucai/A-1098-2017; Soft Matter, CAS Key
   Lab/A-9757-2011; Yuan, Youyong/L-4466-2017; Wang, Yucai/G-9298-2011; Du,
   Jinzhi/F-8453-2010
OI wang, yucai/0000-0001-6046-2934; Yang, Xian-Zhu/0000-0002-1006-0950;
   Wang, Jun/0000-0001-9957-9208; Wang, Yucai/0000-0001-6046-2934; Yuan,
   Youyong/0000-0003-2784-3780; Du, Jinzhi/0000-0003-4037-1212
FU National Natural Science Foundation of China [50733003, 20774089];
   Ministry of Sciences and Technology of the People's Republic of China
   [2006CB933300, 2009CB930300]
FX This work was supported by grants from the National Natural Science
   Foundation of China (50733003, 20774089) and the Ministry of Sciences
   and Technology of the People's Republic of China (2006CB933300,
   2009CB930300).
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   BARAN J, 1989, MAKROMOL CHEM, V190, P1903
   BARAN J, 1995, MACROMOLECULES, V28, P5167, DOI 10.1021/ma00119a002
   Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Chen DP, 2006, MACROMOLECULES, V39, P473, DOI 10.1021/ma0517852
   Cheng J, 2008, POLYMER, V49, P4784, DOI 10.1016/j.polymer.2008.08.052
   DAHIYAT BI, 1995, J CONTROL RELEASE, V33, P13, DOI 10.1016/0168-3659(94)00039-W
   Ditto AJ, 2009, INT J PHARM, V368, P199, DOI 10.1016/j.ijpharm.2008.10.019
   Du JZ, 2007, BIOMACROMOLECULES, V8, P3375, DOI 10.1021/bm700474b
   Du JZ, 2006, BIOMACROMOLECULES, V7, P1898, DOI 10.1021/bm051003c
   DUBOIS P, 1991, MACROMOLECULES, V24, P2266, DOI 10.1021/ma00009a022
   DUDA A, 1995, MACROMOL RAPID COMM, V16, P67, DOI 10.1002/marc.1995.030160112
   DUDA A, 1995, MACROMOLECULES, V28, P5981, DOI 10.1021/ma00122a001
   Fan CL, 1996, CHEM J CHINESE U, V17, P1788
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fu J, 1997, CHEM J CHINESE U, V18, P813
   Fu J, 1997, CHEM J CHINESE U, V18, P1706
   Hacchou Y, 2007, J DENT RES, V86, P893, DOI 10.1177/154405910708600917
   Harper E, 1999, CLIN CANCER RES, V5, P4242
   Huang SW, 2008, PHOSPHORUS SULFUR, V183, P340, DOI 10.1080/10426500701734620
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwu JR, 2009, J AM CHEM SOC, V131, P66, DOI 10.1021/ja804947u
   Iwasaki Y, 2006, BIOMACROMOLECULES, V7, P1433, DOI 10.1021/bm050917w
   Iwasaki Y, 2004, MACROMOLECULES, V37, P7637, DOI 10.1021/ma049043g
   Iwasaki Y, 2007, MACROMOLECULES, V40, P8136, DOI 10.1021/ma0715573
   Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0
   Koseva N, 2008, REACT FUNCT POLYM, V68, P954, DOI 10.1016/j.reactfunctpolym.2008.02.001
   Kowalski A, 2000, MACROMOLECULES, V33, P7359, DOI 10.1021/ma000125o
   Kowalski A, 2005, MACROMOLECULES, V38, P8170, DOI 10.1021/ma050752j
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lechardeur D, 2005, ADV DRUG DELIVER REV, V57, P755, DOI 10.1016/j.addr.2004.12.008
   Leong KW, 1995, CHINESE J POLYM SCI, V13, P289
   Li F, 2006, J APPL POLYM SCI, V102, P5507, DOI 10.1002/app.23966
   Li KW, 2003, CLIN CANCER RES, V9, P3441
   Li Q, 2006, BIOMATERIALS, V27, P1027, DOI 10.1016/j.biomaterials.2005.07.019
   Li Y, 2004, GENE THER, V11, P109, DOI 10.1038/sj.gt.3302135
   Liaw DJ, 1997, J POLYM SCI POL CHEM, V35, P2365
   LIBISZOWSKI J, 1978, J POLYM SCI POL CHEM, V16, P1275, DOI 10.1002/pol.1978.170160610
   Liu JY, 2009, MACROMOLECULES, V42, P4394, DOI 10.1021/ma900798h
   Lu ZZ, 2008, BIOMATERIALS, V29, P733, DOI 10.1016/j.biomaterials.2007.10.033
   Luo Y, 1995, CHEM J CHINESE U, V16, P1633
   Luo Y, 1995, CHINESE CHEM LETT, V6, P333
   Luten J, 2008, J CONTROL RELEASE, V126, P97, DOI 10.1016/j.jconrel.2007.10.028
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Mao HQ, 2005, ADV GENET, V53, P275, DOI 10.1016/S0065-2660(05)53011-6
   Mao HQ, 2005, J BIOMAT SCI-POLYM E, V16, P135, DOI 10.1163/1568562053115426
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Penczek S, 2003, MACROMOL SYMP, V201, P261, DOI 10.1002/masy.200351129
   PENCZEK S, 1994, POL J CHEM, V68, P2129
   PENCZEK S, 1993, MAKROMOL CHEM-M SYMP, V73, P91, DOI 10.1002/masy.19930730110
   PENCZEK S, 1993, MACROMOLECULES, V26, P2228, DOI 10.1021/ma00061a014
   Penczek S, 2005, J POLYM SCI POL CHEM, V43, P650, DOI 10.1002/pola.20525
   Penczek S, 2007, PROG POLYM SCI, V32, P247, DOI 10.1016/j.progpolymsci.2007.01.002
   Pretula J, 1997, MACROMOLECULES, V30, P8172, DOI 10.1021/ma970390i
   PRETULA J, 1990, MAKROMOL CHEM, V191, P671
   Pretula J, 2008, J POLYM SCI POL CHEM, V46, P830, DOI 10.1002/pola.22427
   Qiu JJ, 2008, PHOSPHORUS SULFUR, V183, P815, DOI 10.1080/10426500701808309
   Qiu JJ, 2006, J APPL POLYM SCI, V102, P3095, DOI 10.1002/app.23720
   QIU JJ, 2008, BIOMED MATER, P3
   Rapoport N, 2007, PROG POLYM SCI, V32, P962, DOI 10.1016/j.progpolymsci.2007.05.009
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Sheiko SS, 2008, PROG POLYM SCI, V33, P759, DOI 10.1016/j.progpolymsci.2008.05.001
   SHI FY, 1991, ACS SYM SER, V469, P141
   Song WJ, 2008, MACROMOLECULES, V41, P6935, DOI 10.1021/ma801043m
   Sun TM, 2008, BIOMATERIALS, V29, P4348, DOI 10.1016/j.biomaterials.2008.07.036
   Torchilin VP, 2002, ADV DRUG DELIVER REV, V54, P235, DOI 10.1016/S0169-409X(02)00019-4
   Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Wang J, 2001, J AM CHEM SOC, V123, P9480, DOI 10.1021/ja016062m
   Wang J, 2002, GENE THER, V9, P1254, DOI 10.1038/sj.gt.3301794
   Wang J, 2004, MACROMOLECULES, V37, P670, DOI 10.1021/ma035453d
   Wang J, 2003, INT J PHARM, V265, P75, DOI 10.1016/j.ijpharm.2003.07.006
   Wang J, 1999, EUR POLYM J, V35, P491, DOI 10.1016/S0014-3057(98)00139-6
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Wang XL, 2001, POLYM INT, V50, P1175, DOI 10.1002/pi.711
   Wang YC, 2006, MACROMOLECULES, V39, P8992, DOI 10.1021/ma061821c
   Wang YC, 2008, J CONTROL RELEASE, V128, P32, DOI 10.1016/j.jconrel.2008.01.021
   Wang YC, 2008, BIOMACROMOLECULES, V9, P388, DOI 10.1021/bm700732g
   Wang YC, 2009, MACROMOLECULES, V42, P3026, DOI 10.1021/ma900288t
   Wang YC, 2009, BIOMACROMOLECULES, V10, P66, DOI 10.1021/bm800808q
   Wen J, 1998, POLYM INT, V47, P503, DOI 10.1002/(SICI)1097-0126(199812)47:4<503::AID-PI90>3.3.CO;2-E
   Wen J, 2003, J CONTROL RELEASE, V92, P39, DOI 10.1016/S0168-3659(03)00294-3
   Wen J, 1998, MACROMOL RAPID COMM, V19, P641, DOI 10.1002/marc.1998.030191209
   Xiao CS, 2006, MACROMOLECULES, V39, P6825, DOI 10.1021/ma0615396
   Xiong MH, 2009, MACROMOLECULES, V42, P893, DOI 10.1021/ma802688y
   Yang XZ, 2008, J POLYM SCI POL CHEM, V46, P6425, DOI 10.1002/pola.22951
   Yang XZ, 2009, BIOMACROMOLECULES, V10, P2213, DOI 10.1021/bm900390k
   Yuan YY, 2008, MACROMOLECULES, V41, P8620, DOI 10.1021/ma801452n
   Zhang MF, 2005, J POLYM SCI POL CHEM, V43, P3461, DOI 10.1002/pola.20900
   Zhang ZX, 2009, BIOCHEM BIOPH RES CO, V379, P557, DOI 10.1016/j.bbrc.2008.12.084
   Zhao Z, 2003, ADV DRUG DELIVER REV, V55, P483, DOI 10.1016/S0169-409X(03)00040-1
NR 100
TC 131
Z9 133
U1 6
U2 122
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 8
PY 2009
VL 9
IS 12
BP 1154
EP 1164
DI 10.1002/mabi.200900253
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 539QK
UT WOS:000273272100002
PM 19924681
DA 2018-10-20
ER

PT J
AU Wu, ZQ
   Chen, H
   Huang, H
   Zhao, TL
   Liu, XL
   Li, D
   Yu, Q
AF Wu, Zhaoqiang
   Chen, Hong
   Huang, He
   Zhao, Tieliang
   Liu, Xiaoli
   Li, Dan
   Yu, Qian
TI A Facile Approach to Modify Polyurethane Surfaces for Biomaterial
   Applications
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; 2-hydroxyethyl methacrylate (HEMA); N-isopropyl
   acrylamide (NIPAAm); polyurethanes; proteins
ID POLY(ETHYLENE OXIDE); PROTEIN ADSORPTION; PLASMA; LIMITATIONS;
   SCAFFOLDS; CARRIERS
AB In this communication, we introduce a facile and highly efficient approach for surface modification of polyurethane (PU). Double bonds were incorporated onto the PU surface using a unique monomer, methacryloyl isothiocyanate (MI). Several monomers, such as N-isopropyl acrylamide (NIPAAm) and 2-hydroxyethyl methacrylate (HEMA), were used to prove that the polymerization process can be carried out on a vinyl-functionalized surface. The protein-adsorption property of the grafted surfaces shows that protein adsorption was significantly reduced after grafting each polymer onto the PU surface. Moreover, this method can be applied to polyurethane materials with any shape, including tubes and scaffolds, for which plasma treatment and photoinitiation at the inner surface are difficult to perform.
C1 [Wu, Zhaoqiang; Chen, Hong; Huang, He; Zhao, Tieliang; Liu, Xiaoli; Li, Dan; Yu, Qian] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China.
   [Wu, Zhaoqiang; Chen, Hong; Huang, He; Zhao, Tieliang; Liu, Xiaoli; Li, Dan; Yu, Qian] Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China.
   [Wu, Zhaoqiang] S Cent Univ Nationalities, Key Lab Catalysis & Mat Sci Hubei Prov, Coll Chem & Mat Sci, Wuhan 430074, Peoples R China.
RP Chen, H (reprint author), Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China.
EM hongchen@whut.edu.cn
RI Liu, Xiaoli/M-5410-2013; Yu, Qian/F-5992-2011; chen, Hong/L-6932-2013;
   Li, Dan/R-8422-2016
OI Li, Dan/0000-0002-1141-8838; Liu, Xiaoli/0000-0003-1686-3292
FU National Natural Science Foundation of China [20634030]; Ministry of
   Science and Technology of China [2008CB617510]; Hubei Province Natural
   Science Foundation of China [2008CDB270]; Program for New Century
   Excellent Talents in University [NCET0606055]
FX The work was supported by the National Natural Science Foundation of
   China (20634030), the Ministry of Science and Technology of China
   (2008CB617510), the Hubei Province Natural Science Foundation of China
   (2008CDB270) and the Program for New Century Excellent Talents in
   University (NCET0606055).
CR Alferiev IS, 2006, BIOMACROMOLECULES, V7, P317, DOI 10.1021/bm0506694
   Alferiev IS, 2002, BIOMATERIALS, V23, P4753, DOI 10.1016/S0142-9612(02)00224-7
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Cheng XH, 2006, BIOINTERPHASES, V1, P61, DOI 10.1116/1.2187980
   Chia SL, 2006, TISSUE ENG, V12, P1945, DOI 10.1089/ten.2006.12.1945
   Cho EC, 2004, POLYMER, V45, P3195, DOI 10.1016/j.polymer.2004.02.052
   Du YJ, 2007, J BIOMED MATER RES A, V80A, P216, DOI 10.1002/jbm.a.30977
   Eyrich D, 2007, TISSUE ENG, V13, P2207, DOI 10.1089/ten.2006.0358
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Heinz P, 2008, LANGMUIR, V24, P6166, DOI 10.1021/la800575f
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Kuo JS, 2009, LAB CHIP, V9, P870, DOI 10.1039/b818873d
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   LIN WC, 2004, BIOINTERFACES, V44, P82
   Liu YC, 2004, TISSUE ENG, V10, P1084, DOI 10.1089/1076327041887817
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   MORRA M, 1995, J BIOMED MATER RES, V29, P39, DOI 10.1002/jbm.820290107
   Poelaert J, 2008, J THORAC CARDIOV SUR, V135, P771, DOI 10.1016/j.jtcvs.2007.08.052
   Simmons A, 2008, BIOMATERIALS, V29, P2987, DOI 10.1016/j.biomaterials.2008.04.007
   Tan KT, 2007, J MEMBRANE SCI, V289, P199, DOI 10.1016/j.memsci.2006.11.054
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Wu ZQ, 2007, POLYM ADVAN TECHNOL, V18, P853, DOI 10.1002/pat.979
   Yuan J, 2008, COLLOID SURFACE B, V66, P90, DOI 10.1016/j.colsurfb.2008.05.020
NR 27
TC 41
Z9 45
U1 2
U2 34
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 8
PY 2009
VL 9
IS 12
BP 1165
EP 1168
DI 10.1002/mabi.200900221
PG 4
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 539QK
UT WOS:000273272100003
PM 19821452
DA 2018-10-20
ER

PT J
AU Sen, G
   Pal, S
AF Sen, Gautam
   Pal, Sagar
TI A Novel Polymeric Biomaterial Based on Carboxymethylstarch and its
   Application in Controlled Drug Release
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biopolymers; control drug release; light scattering; polysaccharides
ID THERMALLY MODIFIED STARCHES; CONTROLLED ORAL DELIVERY; HYDROPHILIC
   MATRICES; POLYSACCHARIDES; THEOPHYLLINE; SYSTEMS
AB This study reports investigation of the sustained release behavior of a model drug (acetylsalicylic acid) from carboxymethylstarch (CMS) based matrix. CMS was prepared by incorporation of carboxymethyl groups in the starch moiety; by reacting starch with sodium salt of monochloro acetic acid in presence of sodium hydroxide. The in vitro drug release study was performed by United States Pharmacopeia rotating paddle method, at various pH. The rate of drug release from the above matrix was found to increase with increase in pH. Further, the release behavior of the drug from the CMS based matrix was found to be non-Fickian, n value being between 0.80 and 0.85, suggesting that the release was controlled by a combination of tablet erosion and diffusion of the drug from the swollen matrix. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 114: 2798-2805, 2009
C1 [Sen, Gautam; Pal, Sagar] Mesra, Birla Inst Technol, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
RP Pal, S (reprint author), Mesra, Birla Inst Technol, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
EM sagarpal@bitmesra.ac.in
RI Pal, Sagar/F-4214-2010; Sen, Gautam/F-2930-2010
OI Pal, Sagar/0000-0002-3425-7010; Sen, Gautam/0000-0003-0395-2878
FU Birla Institute of Technology, Mesra, Ranchi, India
FX Contract grant sponsor: Birla Institute of Technology, Mesra, Ranchi,
   India.
CR Bajpai AK, 2003, CARBOHYD POLYM, V53, P271, DOI 10.1016/S0144-8617(03)00071-7
   BONFERONI MC, 1994, J CONTROL RELEASE, V30, P175, DOI 10.1016/0168-3659(94)90264-X
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   BROWN RL, 1974, GUT, V15, P999
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   Cheng Y, 2002, INT J BIOL MACROMOL, V31, P29, DOI 10.1016/S0141-8130(02)00046-6
   Chourasia MK, 2003, J PHARM PHARM SCI, V6, P33
   Collins E. A., 1973, EXPT POLYM SCI, P394
   EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035
   FALAMARZIAN M, 1988, BIOACT MAT, V5, P23
   FRIEND DR, 1991, ADV DRUG DELIVER REV, V7, P149, DOI 10.1016/0169-409X(91)90051-D
   Geresh S, 2004, J CONTROL RELEASE, V94, P391, DOI 10.1016/j.jconrel.2003.10.019
   HERMAN J, 1989, INT J PHARM, V56, P65, DOI 10.1016/0378-5173(89)90061-6
   HERMAN J, 1989, INT J PHARM, V56, P51, DOI 10.1016/0378-5173(89)90060-4
   Lancer R., 1993, ACCOUNTS CHEM RES, V26, P537
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LENAERTS V, 1991, J CONTROL RELEASE, V15, P39, DOI 10.1016/0168-3659(91)90101-I
   MELDRUM SJ, 1972, BRIT MED J, V2, P104
   PATEL VM, 2007, AAPS PHARMSCITECH, V8, pA22
   PEPPAS NA, 2002, PHARM ACTA HELV, V60, P10
   Picout DR, 2001, BIOMACROMOLECULES, V2, P1301, DOI 10.1021/bm010118n
   RAIMUNDO A H, 1992, Gastroenterology, V102, pA681
   ROBINSON G, 1982, CARBOHYD RES, V107, P17, DOI 10.1016/S0008-6215(00)80772-7
   Song CX, 1997, J CONTROL RELEASE, V45, P177, DOI 10.1016/S0168-3659(96)01551-9
   TOMLIN J, 1988, BRIT J NUTR, V60, P467, DOI 10.1079/BJN19880119
   WHISTLER RL, 1983, ENCY CHEM TECHNOLOGY, V21, P492
   Wilson C, 1989, PHYSL PHARM
NR 27
TC 15
Z9 16
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 5
PY 2009
VL 114
IS 5
BP 2798
EP 2805
DI 10.1002/app.30762
PG 8
WC Polymer Science
SC Polymer Science
GA 502YO
UT WOS:000270497200028
DA 2018-10-20
ER

PT J
AU Radhakumary, C
   Nair, PD
   Nair, CPR
   Mathew, S
AF Radhakumary, C.
   Nair, Prabha D.
   Nair, C. P. Reghunadhan
   Mathew, Suresh
TI Chitosan-Comb-graft-Polyethylene Glycol Monomethacrylate-Synthesis,
   Characterization, and Evaluation as a Biomaterial for Hemodialysis
   Applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE grafting; hydrophilicity; glass transition; hemolysis; cytotoxicity
ID INVITRO; PEG
AB Chitosan was reacted with "Polyethylene glycol monomethacrylate" (PEGm) using a redox initiation method. Different compositions were prepared by varying the relative amount of PEGm in the feed. A maximum of 88% yield with 320% grafting could be achieved. The graft copolymerization was confirmed by FTIR, thermal, and XRD studies. Higher graft % could be achieved as the monomer used is a macro monomer of PEG and the resultant graft is a comb-like polymer. Grafting with PEGm did not affect the thermal stability of chitosan film significantly, however, it resulted in a marginal increase in the tensile strength of the films in the dry state. The products showed much improved swelling at pH 7.4 and pH 1.98 compared to the virgin chitosan. The preliminary biocompatibility evaluation showed that the materials are blood compatible and non-cytotoxic. Though the permeability to low molecular weight solutes like creatinine and glucose was equal to or better than commercial cellulose membranes, the copolymer films expressed comparatively less permeability to these solutes initially, due to the crystalline domains of PEO grafts that impede the transport. On exposure in the medium, this effect is nullified culminating in better permeability. The crystallization of PEG grafts was very helpful in preventing the permeation of the high molecular weight solute albumin, the leakage of which above a certain limit is dangerous to the patient. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 114: 2873-2886, 2009
C1 [Radhakumary, C.; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thiruvananthapuram 695012, Kerala, India.
   [Nair, C. P. Reghunadhan] Vikram Sarabhai Space Ctr, PSC Div, Thiruvananthapuram 695022, Kerala, India.
   [Mathew, Suresh] Mahatma Gandhi Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
RP Radhakumary, C (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thiruvananthapuram 695012, Kerala, India.
EM gopinath_radha@yahoo.com
FU "Kerala State Council for Science, Technology Environment"
FX The authors are grateful to the Director, SCTIMST and the Head,
   B.MT.Wing for providing the facilities, and to "Kerala State Council for
   Science, Technology & Environment," for the funding.
CR AMIJI MM, 1995, BIOMATERIALS, V8, P93
   *ASTM INT, 2000, ANN BOOK ASTM STAND, P309
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Claudio R., 2006, HEMODIAL INT, V10, pS48
   DON TM, 2006, CARBOHYD POLYM, V63, P33
   DUTTA R, 2002, JMS POLYM REV, V42, P3
   Enescu D, 2008, CHEM ENG COMMUN, V195, P1269, DOI 10.1080/00986440801958808
   GANJI F, 2008, CARBOHYD POLYM, V74, P3
   HAUNG M, 2006, BIOPOLYMERS, V81, P160
   HUANG M, 2006, INT J BIOL MACROMOL, V38, P3
   ISO 10993-5, 1999, 109935 ISO
   JIANG H, 2004, J BIOMAT SCI-POLYM E, V15, P3
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   KUMARY CR, 2005, TRENDS BIOMATER ART, V8, P2
   KUMARY CR, 2003, J MACROMOL SCI, V40, P7
   Lee JY, 1998, J IND ENG CHEM, V4, P1
   LI Y, 2003, POLYM INT, V52, P2
   LIU L, 2006, MACROMOL BIOSCI, V6, P10
   MALINAUSKAS RA, 1997, ARTIF ORGANS, V21, P12
   MATTHEW HWT, 2006, BIOMIMETIC MAT DESIG
   NASIR NFM, 2005, AM J APPL SCI, V2, P12
   PANEVA D, 2005, J BIOACT COMPAT POLY, V20, P2
   Radhakumary C, 2007, J APPL POLYM SCI, V104, P1852, DOI 10.1002/app.25841
   SINGH DK, 2000, J MACROMOL SCI R M C, V40, P1
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   Vento R, 1998, MOL CELL BIOCHEM, V185, P7, DOI 10.1023/A:1006836428202
   YANG JM, 2004, J MEMB SCI, V236, P1
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   ZOHURIAANMEHR MJ, 2005, IRAN POLYM J, V4, P3
NR 29
TC 14
Z9 14
U1 2
U2 14
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 5
PY 2009
VL 114
IS 5
BP 2873
EP 2886
DI 10.1002/app.30862
PG 14
WC Polymer Science
SC Polymer Science
GA 502YO
UT WOS:000270497200036
DA 2018-10-20
ER

PT J
AU Shah, PN
   Lopina, ST
   Yun, YH
AF Shah, Parth N.
   Lopina, Stephanie T.
   Yun, Yang H.
TI Blends of Novel L-Tyrosine-Based Polyurethanes and Polyphosphate for
   Potential Biomedical Applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polyurethane; blends; hydrolytic degradation
ID STRUCTURE-PROPERTY RELATIONSHIPS; BIOMATERIAL APPLICATIONS; SEGMENTED
   POLYURETHANES; POLY(L-LACTIC ACID); BLOCK-COPOLYMERS; L-LACTIDE;
   DEGRADATION; DELIVERY; MORPHOLOGY; POLYMERS
AB Elastomeric biodegradable polyurethanes and polyphosphate have been developed using an L-tyrosine-based diphenolic monomer desaminotyrosine-tyrosine hexyl ester (DTH). Soft segments, which are polycaproloctone diol (PCL) and polyethylene glycol (PEG) have been used for the synthesis of two biodegradable L-tyrosine polyurethanes (LTUs), which are PEG-C-DTH and PCL-C-DTH. An investigation of the physico-chemical properties shows that these polymers have dramatically different properties. By blending LTUs with L-tyrosine polyphosphate (LTP), we hope to produce a family of materials with a wide range of thermal, morphological, surface, and degradative properties. Examination of the blends shows a smooth surface morphology with a partially phase-separated structure. These findings are consistent with the results obtained from thermal analysis of the blends. Hydrophilic nature of PEG imparts the PEG-based blends (PEG-C-DTH/LTP) with a significantly higher surface and bulk hydrophilicity compared with the PCL-based blends (PCL-C-DTH/LTP). Finally, the blends demonstrate a rapid initial hydrolytic degradation in phosphate buffered saline (PBS) followed by a significantly slower, prolonged degradation. The observed trend may occur due to the rapid hydrolytic degradation rate of the polyphosphate polymer followed by the degradation of the polyurethane component. Thus, tuning the physical properties by blending LTUs with LTP may be useful for drug delivery device and soft tissue engineering scaffold applications. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 114: 3235-3247, 2009
C1 [Lopina, Stephanie T.; Yun, Yang H.] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Shah, Parth N.; Lopina, Stephanie T.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Yun, YH (reprint author), Univ Akron, Dept Biomed Engn, 301 Sidney Olson Res Ctr, Akron, OH 44325 USA.
EM yy@uakron.edu
RI Yun, Yang/C-1937-2009
OI Yun, Yang/0000-0001-5447-8833
CR Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Bikiaris D, 2004, J APPL POLYM SCI, V93, P726, DOI 10.1002/app.20531
   BUCHANAN CM, 1992, MACROMOLECULES, V25, P7373, DOI 10.1021/ma00052a046
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   DELGUERRA RS, 1994, J MATER SCI-MATER M, V5, P891, DOI 10.1007/BF01172032
   Dunn AS, 2001, J MATER SCI-MATER M, V12, P673, DOI 10.1023/A:1011204106373
   Friend DR, 2005, ADV DRUG DELIVER REV, V57, P247, DOI 10.1016/j.addr.2004.08.011
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   HELLER J, 1993, ADV DRUG DELIVER REV, V10, P163, DOI 10.1016/0169-409X(93)90047-8
   Hepburn C., 1993, POLYURETHANE ELASTOM
   Hollinger J.O., 1995, BIOMEDICAL APPL SYNT
   IANNACE S, 1994, J APPL POLYM SCI, V54, P1525, DOI 10.1002/app.1994.070541017
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   JAMES K, 1997, CONTROLLED DRUG DELI, P389
   KOHN J, 1990, DRUGS PHARM SCI, V45, P195
   KOHN J, 1988, CHEM BIOL P AM PEPT, V10, P658
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   LI YJ, 1993, MACROMOLECULES, V26, P612, DOI 10.1021/ma00056a010
   Maurer J., 1981, THERMAL CHARACTERIZA
   McCormickThomson LA, 1989, J BIOACT COMPAT POLY, V4, P242
   Park ES, 1997, J CONTROL RELEASE, V48, P67, DOI 10.1016/S0168-3659(97)00034-5
   PARK TG, 1992, MACROMOLECULES, V25, P116, DOI 10.1021/ma00027a019
   Paul DR, 1978, POLYM BLENDS
   PEPPAS NA, 1993, BIOPOLYMERS, V1
   Sarkar D, 2007, EXPRESS POLYM LETT, V1, P724, DOI 10.3144/expresspolymlett.2007.100
   SARKAR D, 2007, J BIOMED MA IN PRESS
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   SCHMITT EE, 1968, Patent No. 3371069
   SENGUPTA A, 2003, THESIS U AKRON
   SENGUPTA A, 2004, J POLYM SCI A, V42, P1906
   SENGUPTA A, 2004, POLYMER, V45, P4563
   SHIMAMURA E, 1994, MACROMOLECULES, V27, P878, DOI 10.1021/ma00081a041
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Slomkowski S, 2007, MACROMOL SYMP, V253, P47, DOI 10.1002/masy.200750706
   SPIRA M, 1969, Journal of Biomedical Materials Research, V3, P213, DOI 10.1002/jbm.820030203
   VANBOGART JWC, 1983, J POLYM SCI POL PHYS, V21, P65, DOI 10.1002/pol.1983.180210106
   VASQUEZTORRES H, 1994, J APPL POLYM SCI, V54, P1141
   Yang XQ, 2004, J APPL POLYM SCI, V94, P1670, DOI 10.1002/app.21056
NR 44
TC 6
Z9 6
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 5
PY 2009
VL 114
IS 5
BP 3235
EP 3247
DI 10.1002/app.30509
PG 13
WC Polymer Science
SC Polymer Science
GA 502YO
UT WOS:000270497200081
DA 2018-10-20
ER

PT J
AU Hutchens, SA
   Benson, RS
   Evans, BR
   O'Neill, H
AF Hutchens, Stacy A.
   Benson, Roberto S.
   Evans, Barbara R.
   O'Neill, Hugh
TI An Exopolysaccharide Nanofiber Composite for Biomedical Applications
SO AATCC REVIEW
LA English
DT Article
DE Bacterial Cellulose; Biomaterial; Bone Growth; Nanofiber; Osteoblast;
   Scaffold
ID CALCIUM-DEFICIENT HYDROXYAPATITE; BACTERIAL CELLULOSE; IN-VIVO;
   SCAFFOLDS; HYDROGEL; APATITE
AB Bacterial cellulose (BC) is a highly-versatile nanostructured biomaterial with diverse applications including paper products, and in electronic, acoustic, and biomedical devices. This work describes the properties of a novel composite material consisting of calcium-deficient hydroxyapatite (CdHAP) that is biomimetically deposited in a BC hydrogel by sequential incubation in calcium chloride followed by sodium phosphate. The ability of native BC and BC-CdHAP composite to act as a scaffold for growth of osteoblasts, the cells responsible for bone formation in the body, was tested. Results show the cells grow well on both materials, but adhere more strongly to BC-CdHAP compared to the native material. This composite material holds great promise as a biomaterial for bone substitution and regeneration.
C1 [O'Neill, Hugh] Oak Ridge Natl Lab, Struct Biol Ctr, Div Chem Sci, Oak Ridge, TN 37831 USA.
   [Hutchens, Stacy A.; Benson, Roberto S.; O'Neill, Hugh] Univ Tennessee, Knoxville, TN USA.
RP O'Neill, H (reprint author), Oak Ridge Natl Lab, Struct Biol Ctr, Div Chem Sci, POB 2008, Oak Ridge, TN 37831 USA.
EM oneillhm@ornl.gov
FU National Science Foundation; P.E.O. International; Southern Regional
   Education Board; Oak Ridge National Laboratorys (ORNL); US Department of
   Energy [DE-AC05-00OR22725]
FX S. A. Hutchens would like to acknowledge The National Science Foundation
   Graduate Research Fellowship, P.E.O. International, and the Southern
   Regional Education Board for support. This research was supported by
   funding from the Oak Ridge National Laboratorys (ORNL) Technology
   Transfer and Economic Development Maturation Funding Program. ORNL is
   managed by UT-Battelle LLC for the US Department of Energy under
   contract number DE-AC05-00OR22725. Accordingly, the US government
   retains a nonexclusive, royalty-free license to publish or reproduce
   this document, or to allow others to do so, for US government purposes.
CR BELLAMY LJ, 1974, INFRARED SPECTRA COM
   Bielecki S., 2002, BIOPOLYMERS, V5, P37, DOI 10.1002/3527600035.bpol5003
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   Danilchenko SN, 2004, CRYST RES TECHNOL, V39, P71, DOI 10.1002/crat.200310151
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hutchens SA, 2007, LETT APPL MICROBIOL, V44, P175, DOI 10.1111/j.1472-765X.2006.02055.x
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Hutchens SA, 2009, CELLULOSE, V16, P887, DOI 10.1007/s10570-009-9300-6
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   NOVAES AB, 1991, BRAZ DENT J, V4, P65
   Park JB, 1984, BIOMATERIALS SCI ENG
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   SAUER GR, 1988, J BIOL CHEM, V263, P13718
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   Sutherland IW, 2001, INT DAIRY J, V11, P663, DOI 10.1016/S0958-6946(01)00112-1
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Thomas V, 2006, CURR NANOSCI, V2, P155
   White D. G, 1989, CELLULOSE WOOD CHEM
NR 23
TC 1
Z9 1
U1 0
U2 6
PU AMER ASSOC TEXTILE CHEMISTS COLORISTS
PI RES TRIANGLE PK
PA PO BOX 12215, RES TRIANGLE PK, NC 27709 USA
SN 1532-8813
J9 AATCC REV
JI AATCC Rev.
PD DEC
PY 2009
VL 9
IS 12
BP 40
EP 45
PG 6
WC Chemistry, Applied; Engineering, Chemical; Materials Science, Textiles
SC Chemistry; Engineering; Materials Science
GA 530NR
UT WOS:000272600100007
DA 2018-10-20
ER

PT J
AU South, AB
   Whitmire, RE
   Garcia, AJ
   Lyon, LA
AF South, Antoinette B.
   Whitmire, Rachel E.
   Garcia, Andres J.
   Lyon, L. Andrew
TI Centrifugal Deposition of Microgels for the Rapid Assembly of Nonfouling
   Thin Films
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hydrogel particles; centrifugation; film interfaces; layer by layer;
   cellular adhesion
ID CORE-SHELL MICROGELS; PROTEIN ADSORPTION; PHASE-TRANSITION; HYDROGEL
   FILMS; PARTICLES; SURFACES; MONOLAYERS; BEHAVIOR; POLYMER; RESPONSES
AB Thin films assembled from microgel building blocks have been constructed using a simple, high-throughput, and reproducible centrifugation (or "active") deposition technique. When compared to a common passive adsorption method (e.g., dip coating), microgels that are actively deposited onto a surface have smaller footprints and are more closely packed. Under both active and passive deposition conditions, the microgel footprint areas decrease during deposition. However, under active deposition, the microgel footprint appears to decrease continually and to a greater degree over the course of the deposition, forming a tightly packed, homogeneous him. Taking advantage of the rapid and uniform assembly of these films, we demonstrate the use of active deposition toward the fabrication of polyelectrolyte multilayers containing anionic microgels and a cationic linear polymer. Microgel multilayers successfully demonstrated effective blocking of the underlying substrate toward macrophage adhesion, which is a highly sought-after property for modulating the inflammatory response to an implanted biomaterial.
C1 [South, Antoinette B.; Lyon, L. Andrew] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   [South, Antoinette B.; Whitmire, Rachel E.; Garcia, Andres J.; Lyon, L. Andrew] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Whitmire, Rachel E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Whitmire, Rachel E.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Lyon, LA (reprint author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
EM lyon@chemistry.gatech.edu
RI Lyon, Andrew/A-4082-2009
OI Lyon, Andrew/0000-0001-7828-7345
FU Georgia Institute of Technology
FX We thank the Nils Kroger group for the use of their Zetasizer
   instrument. We also thank Prof. K. C. Chan (Albany State University,
   Physics) for discussions about radial distribution functions and Jae Kyu
   Cho (Georgia Institute of Technology, ChBE) for help using the IDL
   program for calculating radial distribution functions. Furthermore, we
   thank the Georgia Institute of Technology for providing GTEC II funding
   for this research.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barrett DG, 2007, ANGEW CHEM INT EDIT, V46, P7437, DOI 10.1002/anie.200701841
   Bridges AW, 2008, BIOMATERIALS, V29, P4605, DOI 10.1016/j.biomaterials.2008.08.015
   Cho SH, 2009, ADV MATER, V21, P645, DOI 10.1002/adma.200802008
   Debord JD, 2000, J PHYS CHEM B, V104, P6327, DOI 10.1021/jp001238c
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   DOUGLAS JF, 1993, SCIENCE, V262, P2010, DOI 10.1126/science.262.5142.2010
   FitzGerald PA, 2007, SOFT MATTER, V3, P580, DOI 10.1039/b613981g
   Gan DJ, 2001, J AM CHEM SOC, V123, P7511, DOI 10.1021/ja010609f
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Hellweg T, 2004, LANGMUIR, V20, P4330, DOI 10.1021/la0354786
   Hendrickson GR, 2009, SOFT MATTER, V5, P29, DOI 10.1039/b811620b
   Hoefl S., 2007, POLYMER, V48, P245
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JOHN ANS, 2008, J PHYS CHEM B, V112, P11258
   Jones CD, 2000, MACROMOLECULES, V33, P8301, DOI 10.1021/ma001398m
   KAELLROT N, 2007, MACROMOLECULES, V40, P4669
   Kim J, 2004, J AM CHEM SOC, V126, P9512, DOI 10.1021/ja047274x
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Lee SK, 2006, LAB CHIP, V6, P1171, DOI 10.1039/b606448e
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Lynch I, 2006, J PHYS CHEM B, V110, P14581, DOI 10.1021/jp06L166a
   Lyon LA, 2009, CHEM SOC REV, V38, P865, DOI 10.1039/b715522k
   McGrath JG, 2007, CHEM MATER, V19, P1584, DOI 10.1021/cm061931y
   Meng Z, 2009, J PHYS CHEM B, V113, P4590, DOI 10.1021/jp8104979
   Motornov M, 2007, LANGMUIR, V23, P13, DOI 10.1021/la061737q
   Nayak S, 2005, ANGEW CHEM INT EDIT, V44, P7686, DOI 10.1002/anie.200501321
   Nerapusri V, 2006, LANGMUIR, V22, P5036, DOI 10.1021/la060252z
   Nerapusri V, 2007, LANGMUIR, V23, P9572, DOI 10.1021/1a700877n
   Nolan CM, 2005, BIOMACROMOLECULES, V6, P2032, DOI 10.1021/bm0500087
   Nolan CM, 2004, BIOMACROMOLECULES, V5, P1940, DOI 10.1021/bm049750h
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   Saunders BR, 1997, MACROMOLECULES, V30, P482, DOI 10.1021/ma961277f
   Schmaljohann D, 2003, BIOMACROMOLECULES, V4, P1733, DOI 10.1021/bm034160p
   Schmidt S, 2008, LANGMUIR, V24, P12595, DOI 10.1021/la801770n
   Schmidt S, 2008, POLYMER, V49, P749, DOI 10.1016/j.polymer.2007.12.025
   Serpe MJ, 2005, BIOMACROMOLECULES, V6, P408, DOI 10.1021/bm049455x
   Serpe MJ, 2004, ADV MATER, V16, P184, DOI 10.1002/adma.200305675
   Serpe MJ, 2003, LANGMUIR, V19, P8759, DOI 10.1021/la034391h
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Singh N, 2007, BIOMACROMOLECULES, V8, P3271, DOI 10.1021/bm700516v
   Sorrell CD, 2008, LANGMUIR, V24, P7216, DOI 10.1021/la800092q
   Sorrell CD, 2007, J PHYS CHEM B, V111, P4060, DOI 10.1021/jp069057j
   St John AN, 2007, J PHYS CHEM B, V111, P7796, DOI 10.1021/jp071630r
   Ugur S, 2007, COLLOID POLYM SCI, V285, P423, DOI 10.1007/s00396-006-1584-6
   VANDERMARK MB, 1994, J LIGHTWAVE TECHNOL, V12, P1, DOI 10.1109/50.265727
   Wei YY, 2006, COLLOID POLYM SCI, V284, P1171, DOI 10.1007/s00396-006-1500-0
   WU X, 1994, COLLOID POLYM SCI, V272, P467, DOI 10.1007/BF00659460
   Yi YD, 1998, J APPL POLYM SCI, V67, P2087, DOI 10.1002/(SICI)1097-4628(19980321)67:12<2087::AID-APP15>3.0.CO;2-Z
   Yoshida M, 2006, POLYM REV, V46, P347, DOI 10.1080/15583720600945394
   Zhang LG, 1997, J COLLOID INTERF SCI, V190, P76, DOI 10.1006/jcis.1997.4820
NR 53
TC 44
Z9 44
U1 3
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD DEC
PY 2009
VL 1
IS 12
BP 2747
EP 2754
DI 10.1021/am9005435
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 535XO
UT WOS:000273005500008
PM 20356152
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Elhachi, Y
   Atmani, F
   Daimellah, A
   Hellal, F
AF Elhachi, Younes
   Atmani, Fouad
   Daimellah, Abderrahmane
   Hellal, Fatah
TI A MORPHOLOGICAL AND AN ELECTROCHEMICAL CHARACTERIZATION OF A PVD
   TITANIUM FILM DEPOSITED UPON AN AISI 316L STAINLESS STEEL
SO ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING
LA English
DT Article
DE titanium thin film; surface characterization; roughness; AFM; PVD;
   electrochemistry
ID THIN-FILMS; COATINGS; GROWTH; TIN
AB In order to improve the biocompatibility of austenitic stainless steel (AISI 316L), titanium has been deposited upon it by a physical vapour process. Depositions have been carried out by varying experiment parameters.
   The new biomaterial surface has been investigated by AFM, EDX, and SEM. Further, mechanical and electrochemical tests were performed, because these are the required properties for such biomaterial implants.
   In this work, we focused on the relationship between shape surface factors (roughness, porosity occurrence, crystalline lattice) and surface properties. The film seems to be homogeneous, but its RMS parameter is affected by the duration of the PVD process. Crystallization of titanium is probably linked to the stainless steel surface roughness and its microstructure. The better corrosion resistance is due to the good adhesion of the columnar deposited film.
C1 [Elhachi, Younes; Atmani, Fouad; Daimellah, Abderrahmane; Hellal, Fatah] Natl Polytech Sch, Lab Sci & Engn Mat, Dept Met, Algiers 16200, Algeria.
RP Hellal, F (reprint author), Natl Polytech Sch, Lab Sci & Engn Mat, Dept Met, 16 Rue Freres Ouadek Hassen Badi,BP182, Algiers 16200, Algeria.
EM fatah.hellal@enp.edu.dz
FU French-Algerian CMEP [03MDU586]
FX The authors would like to acknowledge the financial support of the
   French-Algerian CMEP Project 03MDU586.
CR AUDISIO S, 1999, REVETEMENTS TRAITEME
   Barshilia HC, 2004, B MATER SCI, V27, P35, DOI 10.1007/BF02708482
   Bearinger JP, 2003, BIOMATERIALS, V24, P1837, DOI 10.1016/S0142-9612(02)00547-1
   BHUSHAN B, 1995, HDB MICRONANOTRIBOLO
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Cai KY, 2005, APPL SURF SCI, V250, P252, DOI 10.1016/j.apsusc.2005.01.013
   FONTANA LC, 2002, THIN SOLID FILMS, V408, P79
   GALERIE A, 2002, TRAITEMENTS SURFACES
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Kiuchi M, 2000, COLLOID SURFACE B, V19, P269, DOI 10.1016/S0927-7765(00)00165-X
   LEVEQUE R, 1998, DIFFERENTS PROCEDES
   Mardare D, 2002, SURF SCI, V507, P468, DOI 10.1016/S0039-6028(02)01287-6
   Movchan B. A., 1969, Fizika Metallov i Metallovedenie, V28, P653
   Pawlowski L., 2003, DEPOTS PHYS TECHNIQU
   Poppeller M, 1997, THIN SOLID FILMS, V295, P60, DOI 10.1016/S0040-6090(96)09142-0
   Robyr C, 1997, THIN SOLID FILMS, V310, P87, DOI 10.1016/S0040-6090(97)00350-7
   SEDJAL H, 2004, THESIS U ABDERRAHMAN
   Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010
   TEXIER G, 2005, THESIS I NATL SCI AP
   VICK D, 1998, SURFACE COATINGS TEC, V107, P24
   Zhang J, 2004, COMP MATER SCI, V31, P317, DOI 10.1016/j.commatsci.2004.03.021
NR 21
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1319-8025
J9 ARAB J SCI ENG
JI Arab. J. Sci. Eng.
PD DEC
PY 2009
VL 34
IS 2C
BP 7
EP 17
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 578BX
UT WOS:000276269500001
DA 2018-10-20
ER

PT J
AU Vinas-Castells, R
   Holladay, C
   di Luca, A
   Diaz, VM
   Pandit, A
AF Vinas-Castells, Rosa
   Holladay, Carolyn
   di Luca, Andrea
   Manuel Diaz, Victor
   Pandit, Abhay
TI Snail1 Down-Regulation using Small Interfering RNA Complexes Delivered
   through Collagen Scaffolds
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID NONVIRAL GENE DELIVERY; POLYAMIDOAMINE DENDRIMERS; IN-VIVO; EFFICIENT
   TRANSFER; PROTEIN ABUNDANCE; DNA DELIVERY; EXPRESSION; CELLS;
   TRANSFECTION; CANCER
AB Control of gene expression via small interfering RNA has enormous potential for the treatment of it variety of diseases, including cancer and Huntington's disease. However, before any therapies can be developed, effective techniques for controlled delivery of these molecules must be devised. In this proof-of-concept study, small interfering RNA was complexed with it polymer and loaded into a biomaterial scaffold, The scaffold was introduced primarily to control the release of the complexes, and the polymer was introduced to improve the transfection efficiency. An optimal dose and complexation ratio were selected, at which more (ban 50% down-regulation of the target gene Snail1was observed in two-dimensional culture. Delayed release of the complexes was observed, and significant sustained down-regulation of Snail1 was seen in a three-dimensional scaffold system after 7 days. Thus, the use of the scaffold altered the transfection profile significantly, demonstrating the feasibility of a collagen scaffold as it controlled release system for delivery of small interfering RNA-dendrimer complexes.
C1 [Vinas-Castells, Rosa; Holladay, Carolyn; di Luca, Andrea; Pandit, Abhay] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Vinas-Castells, Rosa; Manuel Diaz, Victor] Hosp del Mar, IMIM, Programa Recerca Canc, Barcelona, Spain.
   [Manuel Diaz, Victor] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Vinas-Castells, Rosa/J-7722-2017; Diaz, Victor Manuel/F-5013-2016;
   Pandit, Abhay/B-6187-2008
OI Vinas-Castells, Rosa/0000-0003-0610-4495; Diaz, Victor
   Manuel/0000-0001-8561-7576; Pandit, Abhay/0000-0002-6292-4933
FU Irish Research Council for Science Engineering and Technology (IRCSET);
   National Development Plan; Ministerio de Ciencia y Tecnologia
   [SAF2006-00339]; Instituto Carlos III [RD06/0020/0040]
FX This project was supported by the Irish Research Council for Science
   Engineering and Technology (IRCSET) funded by the National Development
   Plan and a grant awarded by the Ministerio de Ciencia y Tecnologia
   (SAF2006-00339) to Antonio Garcia de Herreros. Partial support from
   Instituto Carlos III (RD06/0020/0040) and from the Generalitat de
   Catalunya (2005SGR00970) is also appreciated. V.M.D. was a recipient of
   a Juan de la Cierva contract. Thanks to Dr. Antonio Garcht de Herreros
   for his input in this project. Additional acknowledgement is due to Dr.
   Oliver Carroll for editorial assistance.
CR Aguilar S, 2004, AM J PATHOL, V165, P1129, DOI 10.1016/S0002-9440(10)63374-3
   Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494
   Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034
   Bielinska AU, 1999, BIOCONJUGATE CHEM, V10, P843, DOI 10.1021/bc990036k
   Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9
   DENNIG J, 2003, DENDRIMERS, V5, P227
   DENNIG J, 2002, REV MOL BIOTECHNOL, V90, P339, DOI DOI 10.1016/S1389-0352(01)00066-6
   Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017
   Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1
   Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519
   Georgiou TK, 2005, BIOMACROMOLECULES, V6, P2990, DOI 10.1021/bm050307w
   Greenbaum D, 2001, GENOME RES, V11, P1463, DOI 10.1101/gr.207401
   Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117
   Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585
   Gupta U, 2006, NANOMED-NANOTECHNOL, V2, P66, DOI 10.1016/j.nano.2006.04.002
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hanai K, 2006, ANN NY ACAD SCI, V1082, P9, DOI 10.1196/annals.1348.010
   Holladay C, 2009, J CONTROL RELEASE, V136, P220, DOI 10.1016/j.jconrel.2009.02.006
   Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389
   Kiefer K, 2004, PHARM RES, V21, P1009, DOI 10.1023/B:PHAM.0000029291.62615.ec
   Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24
   Kodama K, 2006, CURR MED CHEM, V13, P2155, DOI 10.2174/092986706777935276
   Kukowska-Latallo JF, 2000, HUM GENE THER, V11, P1385, DOI 10.1089/10430340050057468
   KUKOWSKALATALLO J, 1995, FASEB J, V9, pA409
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Lechardeur D, 2005, ADV DRUG DELIVER REV, V57, P755, DOI 10.1016/j.addr.2004.12.008
   Lechardeur Delphine, 2002, Current Gene Therapy, V2, P183, DOI 10.2174/1566523024605609
   Manunta M, 2004, NUCLEIC ACIDS RES, V32, P2730, DOI 10.1093/nar/gkh595
   Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Roth CM, 2004, ANNU REV BIOMED ENG, V6, P397, DOI 10.1146/annurev.bioeng.6.040803.140203
   Ruponen M, 2003, J CONTROL RELEASE, V93, P213, DOI 10.1016/j.jconrel.2003.08.004
   Shcharbin D, 2009, J CONTROL RELEASE, V135, P186, DOI 10.1016/j.jconrel.2009.01.015
   Smith DK, 2008, CURR TOP MED CHEM, V8, P1187, DOI 10.2174/156802608785849030
   Su CJ, 2007, LANGMUIR, V23, P975, DOI 10.1021/la0624642
   Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   TOMALIA DA, 1995, SCI AM, V272, P62, DOI 10.1038/scientificamerican0595-62
   Uchida E, 2002, BIOL PHARM BULL, V25, P891, DOI 10.1248/bpb.25.891
NR 40
TC 17
Z9 18
U1 2
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD DEC
PY 2009
VL 20
IS 12
BP 2262
EP 2269
DI 10.1021/bc900241w
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 531SX
UT WOS:000272690100008
PM 19916547
DA 2018-10-20
ER

PT J
AU Tian, XY
   Li, MG
   Cao, N
   Li, JW
   Chen, XB
AF Tian, X. Y.
   Li, M. G.
   Cao, N.
   Li, J. W.
   Chen, X. B.
TI Characterization of the flow behavior of alginate/hydroxyapatite
   mixtures for tissue scaffold fabrication
SO BIOFABRICATION
LA English
DT Article
ID OF-THE-ART; ALGINATE
AB Mixtures of alginate and hydroxyapatite (HA) are promising materials for biomedical applications such as the fabrication of tissue scaffolds. In this paper, the flow behavior of alginate/HA mixtures was investigated and determined to be dependent on the concentration of both alginate and HA, and temperature. The relationships were mathematically established and verified with experimental results. As applied to the tissue scaffold fabrication, the flow rate of the biomaterial solution was predicted from the established flow behavior and verified by experiments. On this basis, the moving speed of the needle was determined and used in the tissue scaffold fabrication. The results obtained show that the knowledge of the flow behavior is essential to the fabrication of tissue scaffolds with an interconnected microstructure.
C1 [Tian, X. Y.; Cao, N.; Li, J. W.; Chen, X. B.] Univ Saskatchewan, Div Biomed Engn, Saskatoon, SK S7N 5A9, Canada.
   [Li, M. G.; Chen, X. B.] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada.
RP Tian, XY (reprint author), Univ Saskatchewan, Div Biomed Engn, Saskatoon, SK S7N 5A9, Canada.
EM xit602@mail.usask.ca
FU Natural Sciences and Engineering Research Council (NSERC) of Canada;
   Saskatchewan Health Research Foundation (SHRF)
FX The authors would acknowledge the financial support from the Natural
   Sciences and Engineering Research Council (NSERC) of Canada and the
   Saskatchewan Health Research Foundation (SHRF) to the present study.
CR BOUHADIR KH, 2002, METHODS TISSUE ENG
   Chen XB, 2000, IEEE T ELECTRON PA M, V23, P300, DOI 10.1109/6104.895075
   CHEN XB, 2008, T ASME, V130
   DeGroot K., 1981, SCI CERAM, V11, P433
   Dietmar W.H., 2000, BIOMATERIALS, V21, P2529
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Holdsworth S. D., 1993, Food and Bioproducts Processing, V71, P139
   Khalid MS, 2005, SURG-J R COLL SURG E, V3, P11, DOI 10.1016/S1479-666X(05)80004-6
   KHALIL S, 2005, THESIS DREXEL U LIB
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   LAURENCIN CT, 2008, NANOTECHNOLOGY TISSU
   LI MG, 2009, T ASME, V131
   Li MGTianXY, 2009, BIOFABRICATION, V1, P1
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Mikolajczyk T, 2004, FIBRES TEXT EAST EUR, V12, P19
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Parhi P, 2006, J APPL POLYM SCI, V102, P5162, DOI 10.1002/app.24706
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
NR 20
TC 12
Z9 12
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
J9 BIOFABRICATION
JI Biofabrication
PD DEC
PY 2009
VL 1
IS 4
AR 045005
DI 10.1088/1758-5082/1/4/045005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 602DI
UT WOS:000278118300006
PM 20811114
DA 2018-10-20
ER

PT J
AU Back, J
   Lang, MH
   Elgue, G
   Kalbitz, M
   Sanchez, J
   Ekdahl, KN
   Nilsson, B
AF Back, Jennie
   Lang, Markus Huber
   Elgue, Graciela
   Kalbitz, Miriam
   Sanchez, Javier
   Ekdahl, Kristina Nilsson
   Nilsson, Bo
TI Distinctive regulation of contact activation by antithrombin and
   C1-inhibitor on activated platelets and material surfaces
SO BIOMATERIALS
LA English
DT Article
DE Antithrombin; Blood clotting; C1-inhibitor; Contact activation; Factor
   XII; Platelet
ID HUMAN-PLASMA KALLIKREIN; FACTOR-XII; IMMOBILIZED HEPARIN; COAGULATION;
   INACTIVATION; INHIBITION; MICE; POLYPHOSPHATE; THROMBOSIS; COMPLEXES
AB Activated human plate lets trigger FXII-mediated contact activation, which leads to the generation of FXIla-antithrombin (AT) and FXIa-AT complexes. This suggests that contact activation takes place at different sites, on activated platelets and material surfaces, during therapeutic procedures involving biomaterials in contact with blood and is differentially regulated. Here we show that activation in platelet-poor plasma, platelet-rich plasma (PRP), and whole blood induced by glass, kaolin, and polyphosphate elicited high levels of FXIIa-C1-inhibitor (C1INH), low levels of FXIa-C1INH and KK-C1INH, and almost no AT complexes. Platelet activation, in both PRP and blood, led to the formation of FXIIa-AT, FXIa-AT, and kallikrein (KK)-AT but almost no C1INH complexes. In severe trauma patients, FXIIa-AT and FXIa-AT were correlated with the release of thrombospondin-1 (TSP-1) from activated platelets. In contrast, FXIIa-C1INH complexes were detected when the FXIIa-AT levels were low. No correlations were found between FXIIa-C1INH and FXIIa-AT or TSP-1. Inhibition of FXIIa on material surfaces was also shown to affect the function of aggregating platelets. In conclusion, formation of FXIIa-AT and FXIIa-C1INH complexes can help to distinguish between contact activation triggered by biomaterial surfaces and by activated platelets. Platelet aggregation studies also demonstrated that platelet function is influenced by material surface-mediated contact activation and that generation of FXIIa-AT complexes may serve as a new biomarker for thrombotic reactions during therapeutic procedures employing biomaterial devices. (C) 2009 Published by Elsevier Ltd.
C1 [Back, Jennie; Elgue, Graciela; Sanchez, Javier; Ekdahl, Kristina Nilsson; Nilsson, Bo] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Div Clin Immunol, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
   [Lang, Markus Huber; Kalbitz, Miriam] Univ Hosp Ulm, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany.
   [Ekdahl, Kristina Nilsson] Univ Kalmar, Dept Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden.
RP Nilsson, B (reprint author), Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Div Clin Immunol, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
EM bo.nilsson@klinimm.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU National Institute of Health [EB003968]; Swedish Research Council
   [2006-5595, 15244]; Natural Sciences Faculty, University of Kalmar,
   Sweden
FX This work was supported by National Institute of Health Grant EB003968,
   Swedish Research Council Grants 2006-5595 and 15244, and grants from the
   Natural Sciences Faculty, University of Kalmar, Sweden.
CR Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Brown SA, 2000, CLIN APPL THROMB-HEM, V6, P181, DOI 10.1177/107602960000600312
   CHOWDHURY V, 1994, THROMB HAEMOSTASIS, V72, P198
   Cornelius RM, 2003, J BIOMED MATER RES A, V67A, P475, DOI 10.1002/jbm.a.10118
   de Agostini A, 1984, J Clin Invest, V73, P1542
   ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393
   FORBES CD, 1970, J LAB CLIN MED, V76, P809
   Gozzo AJ, 2003, BRAZ J MED BIOL RES, V36, P1055, DOI 10.1590/S0100-879X2003000800011
   HARPEL PC, 1985, J BIOL CHEM, V260, P4257
   Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230
   MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005
   Renne T, 2006, BLOOD CELL MOL DIS, V36, P148, DOI 10.1016/j.bcmd.2005.12.014
   Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664
   Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Sanchez J, 1997, J BIOMED MATER RES, V37, P37, DOI 10.1002/(SICI)1097-4636(199710)37:1<37::AID-JBM5>3.3.CO;2-O
   Shworak NW, 2002, GLYCOCONJUGATE J, V19, P355, DOI 10.1023/A:1025377206600
   Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103
   TANKERSLEY DL, 1983, BLOOD, V62, P448
   VANDERKAMP KWHJ, 1994, J BIOMED MATER RES, V28, P349, DOI 10.1002/jbm.820280309
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   WUILLEMIN WA, 1995, BLOOD, V85, P1517
NR 23
TC 27
Z9 28
U1 2
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2009
VL 30
IS 34
BP 6573
EP 6580
DI 10.1016/j.biomaterials.2009.07.052
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 513TY
UT WOS:000271347900002
PM 19783299
DA 2018-10-20
ER

PT J
AU McBride, MC
   Malcolm, RK
   Woolfson, AD
   Gorman, SP
AF McBride, Marcella C.
   Malcolm, R. Karl
   Woolfson, A. David
   Gorman, Sean P.
TI Persistence of antimicrobial activity through sustained release of
   triclosan from pegylated silicone elastomers
SO BIOMATERIALS
LA English
DT Article
DE Antimicrobial; Bacterial adhesion; Drug release; Polyethylene glycol;
   Silicone elastomer; Triclosan
ID URINARY-TRACT-INFECTION; POLY(ETHYLENE GLYCOL); BACTERIAL BIOFILMS;
   PROTEIN ADSORPTION; URETERAL STENTS; CATHETER; SURFACES; IMMOBILIZATION;
   COLONIZATION; BIOMATERIALS
AB Microbial adhesion to silicone elastomer biomaterials is a major problem often resulting in infection and medical device failure. Several strategies have been employed to modulate eukaryotic cell adhesion and to hamper bacterial adherence to polymeric biomaterials. Chemical modification of the surface by grafting of polyethylene glycol (PEG) chains or the incorporation of non-antibiotic antimicrobial agents such as riclosan into the biomaterial matrix may reduce bacterial adhesion. Here, such strategies are simultaneously applied to the preparation of both condensation-cure and addition-cure silicone elastomer systems, seeking a sustained release antimicrobial device biomaterial. The influence of triclosan incorporation and degree of pegylation on antimicrobial release, surface microbial adherence and persistence (Escherichia coli and Staphylococcus epidermidis) were evaluated in vitro. Non-pegylated silicone elastomers provided an increased percentage release of triclosan extending over a relatively short duration (99% release by day 64) compared with their pegylated (4% w/w) counterparts (65% and 72% release by day 64, for condensation and addition-cure systems respectively). Viable E. coli adherence to a non-pegylated silicone elastomer containing 1% w/w triclosan was reduced by over 99% after 24 h compared to the non-pegylated silicone elastomer containing no triclosan. No viable S. epidermidis adhered to any of the triclosan-loaded (>0.1% w/w) formulations other than the control. Persistence of the antimicrobial activity of the triclosan-loaded pegylated silicone elastomers continued for at least 70 days compared to the triclosan-loaded non-pegylated elastomers (at least 49 days). Understanding how PEG affects the release of triclosan from silicone elastomers may prove useful in the development of a biomaterial providing prolonged, effective antimicrobial activity. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [McBride, Marcella C.; Malcolm, R. Karl; Woolfson, A. David; Gorman, Sean P.] Queens Univ Belfast, Sch Pharm, McClay Res Ctr, Belfast BT9 7BL, Antrim, North Ireland.
RP Malcolm, RK (reprint author), Queens Univ Belfast, Sch Pharm, McClay Res Ctr, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM k.malcolm@qub.ac.uk
FU European Social Fund
FX This work was funded by the European Social Fund. The authors thank Stef
   McGrath, Gerard McGrillen and Richard Murphy for technical asistance.
CR Bayston R, 2009, BIOMATERIALS, V30, P3167, DOI 10.1016/j.biomaterials.2009.02.028
   Bozukova D, 2007, BIOMACROMOLECULES, V8, P2379, DOI 10.1021/bm0701649
   Cadieux PA, 2006, J UROLOGY, V175, P2331, DOI 10.1016/S0022-5347(06)00252-7
   Cadieux PA, 2009, J ENDOUROL, V23, P1187, DOI 10.1089/end.2008.0437
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8
   Dautle MP, 2003, J PEDIATR SURG, V38, P216, DOI 10.1053/jpsu.2003.50046
   Dayan AD, 2007, FOOD CHEM TOXICOL, V45, P125, DOI 10.1016/j.fct.2006.08.009
   DICOLO G, 1992, BIOMATERIALS, V13, P850
   Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023
   Gaonkar TA, 2007, INFECT CONT HOSP EP, V28, P596, DOI 10.1086/513449
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Hamill TM, 2007, EXPERT REV MED DEVIC, V4, P215, DOI 10.1586/17434440.4.2.215
   Heiner J, 2003, POLYM TEST, V22, P253, DOI 10.1016/S0142-9418(02)00081-8
   JERCHOW F, 2001, RAPRA REV REP, P12
   Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009
   Jones DS, 2002, PHARMACEUT RES, V19, P818, DOI 10.1023/A:1016104516034
   Jones GL, 2006, J ANTIMICROB CHEMOTH, V57, P266, DOI 10.1093/jac/dki447
   Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   LEE HB, 2003, BIOMATERIALS PRINCIP, P55
   Lin LY, 2001, J CARDIOVASC ELECTR, V12, P26, DOI 10.1046/j.1540-8167.2001.00026.x
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   Malcolm K, 2003, J CONTROL RELEASE, V90, P217, DOI 10.1016/S0168-3659(03)00178-0
   Malcolm R.K., 2003, MODIFIED RELEASE DRU, P775
   McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001
   Michniak B. B., 2002, POLYM BIOMATERIALS, P1007
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   PORTOLES M, 1994, J BIOMED MATER RES, V28, P303, DOI 10.1002/jbm.820280304
   Schwartz JL, 2008, CONTRACEPTION, V78, P237, DOI 10.1016/j.contraception.2008.04.118
   Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1016/S0378-1097(01)00273-7
   Stickler DJ, 2008, J HOSP INFECT, V69, P350, DOI 10.1016/j.jhin.2008.04.031
   STICKLER DJ, 1995, CELL MATER, V5, P167
   Tenke P, 2004, EUA UPDATE SERIES, P106
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Warren JW, 2001, INT J ANTIMICROB AG, V17, P299, DOI 10.1016/S0924-8579(00)00359-9
   Woolfson AD, 2006, INT J PHARM, V325, P82, DOI 10.1016/j.ijpharm.2006.06.026
   Woolfson AD, 2003, J MATER CHEM, V13, P2465, DOI 10.1039/b306578b
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Zalipsky S, 1997, ACS SYM SER, V680, P1
NR 41
TC 26
Z9 26
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2009
VL 30
IS 35
BP 6739
EP 6747
DI 10.1016/j.biomaterials.2009.08.047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518BP
UT WOS:000271665300007
PM 19765822
DA 2018-10-20
ER

PT J
AU Leipzig, ND
   Shoichet, MS
AF Leipzig, Nic D.
   Shoichet, Molly S.
TI The effect of substrate stiffness on adult neural stem cell behavior
SO BIOMATERIALS
LA English
DT Article
DE Neural stem cells; Substrate stiffness; Hydrogel scaffolds; Chitosan;
   Neurons; Oligodendrocytes
ID MYELIN OLIGODENDROCYTE GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM;
   SPINAL-CORD-INJURY; MECHANICAL-PROPERTIES; SUBVENTRICULAR ZONE;
   IN-VITRO; ENDOTHELIAL-CELLS; BRAIN; TISSUE; NEURONS
AB Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal and differentiation. In order to better understand the contribution of substrate stiffness to neural stem/progenitor cell (NSPC) differentiation and proliferation, a photopolymerizable methacrylamide chitosan (MAC)biomaterial was developed. Photopolymerizable MAC is particularly compelling for the study of the central nervous system stem cell niche because Young's elastic modulus (E(Y)) can be tuned from less than 1 kPa to greater than 30 kPa. Additionally, the numerous free amine functional groups enable inclusion of biochemical signaling molecules that, together with the mechanical environment, influence cell behavior. Herein, NSPCs proliferated on MAC substrates with Young's elastic moduli below 10 kPa and exhibited maximal proliferation on 3.5 kPa surfaces. Neuronal differentiation was favored on the softest surfaces with E(Y) < 1 kPa as confirmed by both immunohistochemistry and qRT-PCR. Oligodendrocyte differentiation was favored on stiffer scaffolds (>7 kPa); however, myelin oligodendrocyte glycoprotein (MOG) gene expression suggested that oligodendrocyte maturation and myelination was best on <1 kPa scaffolds where more mature neurons were present. Astrocyte differentiation was only observed on < 1 and 3.5 kPa surfaces and represented less than 2% of the total cell population. This work demonstrates the importance of substrate stiffness to the proliferation and differentiation of adult NSPCs and highlights the importance of mechanical properties to the success of scaffolds designed to engineer central nervous system tissue. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Leipzig, Nic D.; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada.
RP Shoichet, MS (reprint author), Donelly CCBR Room 514,160 Coll St, Toronto, ON M5S 3E1, Canada.
EM molly.shoichet@utoronto.ca
FU Natural Sciences and Engineering Research Council of Canada; Ontario
   Ministry of Research and Innovation postdoctoral fellowship (NDL);
   Advanced Food and Materials Network
FX We are grateful to partial funding from the Natural Sciences and
   Engineering Research Council of Canada (NSERC Discovery grant to MSS),
   Ontario Ministry of Research and Innovation postdoctoral fellowship
   (NDL) and the Advanced Food and Materials Network (AFM-Net to MSS). The
   authors thank Dr. Tasneern Zahir for stimulating discussions and
   assistance with neural stem cell assays, Dr. Ying Fang Chen for
   assistance with cell culture, Dr. Laura Yu for help with the synthesis
   of MAC, Ryan Wylie for assistance creating and purifying FAM-laminin and
   Xiao Yang for his assistance with SEM. We also would like to thank Dr.
   Derek van der Kooy for allowing us to perform qRT-PCR analysis in his
   laboratory.
CR Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Ayuso-Sacido A, 2008, NEUROSURGERY, V62, p[223, 229]
   Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI [10.1227/01.NEU.0000280154.19237.36, 10.1227/01.NEU.0000311081.50648.4C]
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Benoit BO, 2001, J NEUROBIOL, V46, P265, DOI 10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.0.CO;2-B
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256
   Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017
   Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, P1219
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4
   HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069
   KATSAMANIS F, 1990, J BIOMECH, V23, P1173, DOI 10.1016/0021-9290(90)90010-Z
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160
   Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005
   Leipzig ND, 2005, J BIOMECH, V38, P77, DOI 10.1016/j.jbiomech.2004.03.013
   LEIPZIG ND, J BIOMED A IN PRESS
   Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007
   Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978
   Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006
   Milner R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-3
   Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X
   Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884
   Pagany M, 2003, NEUROSCI LETT, V350, P165, DOI 10.1016/S0304-3940(03)00899-1
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   PHAMDINH D, 1993, P NATL ACAD SCI USA, V90, P7990, DOI 10.1073/pnas.90.17.7990
   Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127
   Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Shetty AK, 1998, J NEUROBIOL, V35, P395, DOI 10.1002/(SICI)1097-4695(19980615)35:4<395::AID-NEU7>3.0.CO;2-U
   Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174
   Toma JS, 2007, BRAIN RES, V1137, P1, DOI 10.1016/j.brainres.2006.12.053
   Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950
   Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   YU QL, 1993, AM J PHYSIOL, V265, pH52
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
NR 56
TC 270
Z9 275
U1 20
U2 176
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2009
VL 30
IS 36
BP 6867
EP 6878
DI 10.1016/j.biomaterials.2009.09.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 523KG
UT WOS:000272071400007
PM 19775749
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Kikkawa, Y
   Takahashi, N
   Matsuda, Y
   Miwa, T
   Akizuki, T
   Kataoka, A
   Nomizu, M
AF Kikkawa, Yamato
   Takahashi, Naoya
   Matsuda, Yuji
   Miwa, Takahiro
   Akizuki, Taneyasu
   Kataoka, Akira
   Nomizu, Motoyoshi
TI The influence of synthetic peptides derived from the laminin alpha 1
   chain on hepatocyte adhesion and gene expression
SO BIOMATERIALS
LA English
DT Article
DE Cell adhesion; Cell culture; Hepatocyte; Laminin; ECM; Bioartificial
   liver
ID CONJUGATED CHITOSAN MEMBRANES; HEPATIC EXTRACELLULAR-MATRIX; CULTURED
   RAT HEPATOCYTES; CELL-BINDING SEQUENCES; NONPARENCHYMAL CELLS; BETA-1
   CHAIN; LIVER; IDENTIFICATION; INTEGRINS; ATTACHMENT
AB Laminin-111, a heterotrimer composed of the laminin alpha 1, beta 1, and gamma 1 chains, has been used as a biomaterial for primary cell culture to maintain cellular functions. Our previous studies have reported that synthetic peptides derived from laminin alpha 1 exhibit biological functions such as influencing cell adhesion, migration, angiogenesis, and tumor metastasis. In this study we screened hepatocyte attachment peptides using twenty-five biologically active peptides from laminin ad and examined the maintenance of hepatic function on the peptides using primary rat hepatocytes. Peptide A13 (RQVFQVAYIIIKA), mouse laminin alpha 1 chain residues 121-133, exhibited the strongest activity. Furthermore, primary hepatocytes on A13 peptide maintained expression of hepatic differentiation markers such as tyrosine aminotransferase, tryptophan-2,3-dioxygenase, and cytochrome P450. We also determined the active core sequence of A13 using systematically truncated N- and C-terminal peptides. The results indicated that the nine-amino acid sequence RQVFQVAYI was critical for A13's hepatocyte adhesion activity. However, the truncated peptides could not interact with beta 1-intgerin and maintain expression of hepatic differentiation markers. The amino acid sequence of A13 peptide was required for regulating hepatocyte behavior. The hepatocyte adhesive peptides can be utilized in tailoring synthetic biomaterials in order to achieve a specific cellular response. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Kikkawa, Yamato; Takahashi, Naoya; Matsuda, Yuji; Miwa, Takahiro; Akizuki, Taneyasu; Kataoka, Akira; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, Tokyo 1920392, Japan.
RP Kikkawa, Y (reprint author), Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, 1432-1 Hachioji, Tokyo 1920392, Japan.
EM kikkawa@toyaku.ac.jp
RI Kikkawa, Yamato/D-1503-2010
FU Ministry of Education, Sciences Sports and Culture, Japan [20200412,
   17390024]
FX We thank Dr. Toshihiro Mitaka and Dr. Jeffrey H. Miner for comments on
   the manuscript. This work was supported in part by grants to Y. Kikkawa
   (20200412) and M. Nomizu (17390024) from the Ministry of Education,
   Sciences Sports and Culture, Japan.
CR Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753
   Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x
   Bhatia SN, 1999, FASEB J, V13, P1883
   BODANSZKY M, 1983, SIDE REACTIONS PEPTI
   CLEMENT B, 1990, J CELL BIOL, V110, P185, DOI 10.1083/jcb.110.1.185
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5
   GUGUENGUILLOUZO C, 1983, MOL CELL BIOCHEM, V53-4, P35
   HANSEN LK, 1994, MOL BIOL CELL, V5, P967
   Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Kamiya A, 2002, HEPATOLOGY, V35, P1351, DOI 10.1053/jhep.2002.33331
   Kikkawa Y, 2005, EXP CELL RES, V305, P99, DOI 10.1016/j.yexcr.2005.01.005
   Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kuratomi Y, 1999, EXP CELL RES, V249, P386, DOI 10.1006/excr.1999.4497
   Malinda KM, 1999, FASEB J, V13, P53
   Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8
   MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P77, DOI 10.1007/BF01606580
   MICHALOPOULOS G, 1978, CANCER RES, V38, P1550
   Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   NAGAKI M, 1995, BIOCHEM BIOPH RES CO, V210, P38, DOI 10.1006/bbrc.1995.1624
   Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   PIERSCHBACHER MD, 1994, J CELL BIOCHEM, V56, P150, DOI 10.1002/jcb.240560205
   Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x
   Ponce ML, 2001, FASEB J, V15, P1389, DOI 10.1096/fj.00-0736com
   SAWADA N, 1987, IN VITRO CELL DEV B, V23, P267
   STAMATOGLOU SC, 1994, FASEB J, V8, P420
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Weiner OH, 1996, CELL TISSUE RES, V285, P11, DOI 10.1007/s004410050615
NR 38
TC 11
Z9 11
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2009
VL 30
IS 36
BP 6888
EP 6895
DI 10.1016/j.biomaterials.2009.09.011
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 523KG
UT WOS:000272071400009
PM 19775747
DA 2018-10-20
ER

PT J
AU Wang, CM
   Adrianus, GN
   Sheng, N
   Toh, S
   Gong, YH
   Wang, DA
AF Wang, Chunming
   Adrianus, Gerard N.
   Sheng, Nan
   Toh, Shikai
   Gong, Yihong
   Wang, Dong-An
TI In vitro performance of an injectable hydrogel/microsphere based
   immunocyte delivery system for localised anti-tumour activity
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Microsphere; Macrophage; Cytokine; Apoptosis; Cancer
   immunotherapy
ID COLONY-STIMULATING FACTOR; T-CELL THERAPY; CANCER-IMMUNOTHERAPY;
   METASTATIC MELANOMA; BASIC RESEARCH; PHASE-I; POTENT; VACCINATION;
   APOPTOSIS; RESPONSES
AB The current practice of cell immunotherapy against cancer has encountered a substantial challenge, that is, targeted delivery of therapeutic cells to tumour sites is not favourably managed. In this study, we aimed to provide an engineering solution to govern the cell targeting and actions, for which a biomaterial model is developed to mediate the conveyance and accommodation of activated immunocytes with anticancer potentials. We fabricated a dual-layered hydrogel/microsphere (GS) composite, which preserves all advantageous features of hydrogel such as injectability and favourable permeability, to achieve genuine localisation and physical immobilisation of the executing immunocytes-macrophages. According to our presented in vitro investigations, the GS immunoconstruct exhibited effective elimination of carcinoma cells as well as high safety free of gene alteration or cell leakage. Notably, unwanted long-term proliferation of the delivered cells was restrained by physical encapsulation in the bio-inert 3D hydrogel frameworks. By these efforts, we have provided an immunocyte delivery platform with which cell-based immunotherapy can be initiated at a desired location and implemented in a controlled manner. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Wang, Chunming; Adrianus, Gerard N.; Sheng, Nan; Toh, Shikai; Gong, Yihong; Wang, Dong-An] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore.
RP Wang, DA (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, 70 Nanyang Dr,N1-3-B2-13, Singapore 637457, Singapore.
EM dawang@ntu.edu.sg
RI Wang, Dong-an/G-6195-2010; Wang, Chunming/I-3392-2013
OI Wang, Chunming/0000-0001-9185-9678
FU AcRF Tier 1 [RG64/08]; Ministry of Education, Singapore
FX This research was financially supported by AcRF Tier 1 Grant RG64/08,
   Ministry of Education, Singapore. The authors are grateful to Mr Rohan
   R. Varshney for his valuable suggestions.
CR Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4
   Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369
   CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666
   Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072
   Caspi RR, 2008, NAT REV IMMUNOL, V8, P970, DOI 10.1038/nri2438
   COUKOS G, 2006, IMMUNOTHERAPY CANC, P285
   Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252
   DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539
   Gong YH, 2009, J MATER CHEM, V19, P1968, DOI 10.1039/b818090c
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Jakubowski AA, 1996, CLIN CANCER RES, V2, P295
   Karanikas V, 2003, J IMMUNOL, V171, P4898, DOI 10.4049/jimmunol.171.9.4898
   Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527
   Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100
   Okamoto N, 2007, J CLIN INVEST, V117, P997, DOI 10.1172/JCI30379
   Panza JL, 2000, BIOMATERIALS, V21, P1155, DOI 10.1016/S0142-9612(99)00283-5
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   Sentman CL, 2006, ADV CANCER RES, V95, P249, DOI 10.1016/S0065-230X(06)95007-6
   Silk Ann Willman, 2007, Future Oncol, V3, P299, DOI 10.2217/14796694.3.3.299
   Stoeckle C, 2009, CANCER IMMUNOL IMMUN, V58, P1129, DOI 10.1007/s00262-008-0544-z
   Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039
   URBAN JL, 1986, P NATL ACAD SCI USA, V83, P5233, DOI 10.1073/pnas.83.14.5233
   van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397
   VIRCA GD, 1989, J BIOL CHEM, V264, P21951
   Wang CM, 2008, BIOTECHNOL PROGR, V24, P1142, DOI 10.1021/bp.52
   Wang CM, 2008, ANAL BIOCHEM, V380, P333, DOI 10.1016/j.ab.2008.06.005
   Wang CM, 2009, BIOMATERIALS, V30, P2259, DOI 10.1016/j.biomaterials.2008.12.072
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yoshida J, 2004, CANCER SCI, V95, P858, DOI 10.1111/j.1349-7006.2004.tb02194.x
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 32
TC 20
Z9 20
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2009
VL 30
IS 36
BP 6986
EP 6995
DI 10.1016/j.biomaterials.2009.09.006
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 523KG
UT WOS:000272071400020
PM 19783044
DA 2018-10-20
ER

PT J
AU Xu, LL
   Liu, HC
   Wang, DS
   E, LL
   Xu, L
   Jin, ZL
   Duan, YZ
AF Xu, Lu-Lu
   Liu, Hong-Chen
   Wang, Dong-Sheng
   E, Ling-Ling
   Xu, Lin
   Jin, Zuo-Lin
   Duan, Yin-Zhong
TI Effects of BMP-2 and dexamethasone on osteogenic differentiation of rat
   dental follicle progenitor cells seeded on three-dimensional beta-TCP
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; IN-VITRO; TRICALCIUM
   PHOSPHATE; VIVO; HYDROXYAPATITE; CARRIER; REGENERATION; OSTEOBLASTS;
   INSULIN
AB The aim of this study was to investigate the effects of BMP-2 and dexamethasone (Dex) on osteogenic differentiation of rat dental follicle progenitor cells (RDFCs) seeded on three-dimensional beta-TCP. The alkaline phosphatase (ALP), the calcium and phosphonium, the osteocalcin in media of the third passage RDFCs on biomaterial beta-TCP after 1-3, 3-7, 7-14 days of culture were examined respectively. The growth of cells on the scaffolds was observed by scanning electron microscope (SEM) after 3, 7 days of culture and by implanting in the backs of severe combined immunodeficient (SCID) mice for bone regeneration. The third passage RDFCs could be seen adhered, extended and proliferated on the beta-TCP by scanning electron microscopy. The ALP activity, the calcium and phosphoniums and the osteocalcin content of dexamethasone (10(-8) M) or/and BMP-2 (100 ng ml(-1)) were significantly higher than their existence in the control group. They were the significantly highest among four groups after joint application of BMP-2 and dexamethasone. After 8 weeks of implantation, the percentage of the new bones formed area in the RDFCs+beta-TCP+BMP-2+Dex group was significantly higher than that in the RDFCs+beta-TCP+BMP-2 group. In contrast, beta-TCP, RDFCs+beta-TCP+Dex and control constructs lacked new bone formation by histological staining and histomorphometric analysis. The BMP-2+Dex could significantly promote osteogenic differentiation of RDFCs on beta-TCP. beta-TCP supported fast cellular adhesion, proliferation and differentiation of RDFCs. The feasibility of its application in periodontal tissue engineering was also proved.
C1 [Xu, Lu-Lu; Jin, Zuo-Lin; Duan, Yin-Zhong] Fourth Mil Med Univ, Stomatol Coll, Dept Orthodont, Xian 710032, Peoples R China.
   [Xu, Lu-Lu; Liu, Hong-Chen; Wang, Dong-Sheng; E, Ling-Ling] China PLA Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.
   [Xu, Lin] First Hosp PLA, Dept Stomatol, Lanzhou 730000, Peoples R China.
RP Jin, ZL (reprint author), Fourth Mil Med Univ, Stomatol Coll, Dept Orthodont, Xian 710032, Peoples R China.
EM jinzuolin88@yahoo.com.cn; duanyinzhong@yahoo.com.cn
FU Nature Science Foundation of China [30400510]
FX This study was supported by grants from the Nature Science Foundation of
   China (Project no. 30400510).
CR BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   BOO JS, 2002, J CRANIOFAC SURG, V13, P240
   Cheng SL, 1998, J CELL BIOCHEM, V71, P449, DOI 10.1002/(SICI)1097-4644(19981201)71:3<449::AID-JCB13>3.0.CO;2-D
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331
   Grimm B, 2001, J MATER SCI-MATER M, V12, P929, DOI 10.1023/A:1012840527774
   Hakki SS, 2001, J PERIODONTOL, V72, P679, DOI 10.1902/jop.2001.72.5.679
   Handa K, 2002, BONE, V31, P606, DOI 10.1016/S8756-3282(02)00868-2
   Handa K, 2002, CONNECT TISSUE RES, V43, P406, DOI 10.1080/03008200290001023
   Jin QM, 2003, J BIOMED MATER RES A, V67A, P54, DOI 10.1002/jbm.a.10058
   Kawakatsu N, 2008, J ORAL REHABIL, V35, P647, DOI 10.1111/j.1365-2842.2008.01850.x
   Kemoun P, 2007, CELL TISSUE RES, V329, P283, DOI 10.1007/s00441-007-0397-3
   King GN, 2001, J CLIN PERIODONTOL, V28, P465, DOI 10.1034/j.1600-051x.2001.028005465.x
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Li XM, 2009, J BIOMED MATER RES A, V91A, P132, DOI 10.1002/jbm.a.32203
   Li XM, 2009, J BIOMED MATER RES B, V90B, P503, DOI 10.1002/jbm.b.31311
   Li XM, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015005
   Luan XG, 2006, STEM CELLS DEV, V15, P595, DOI 10.1089/scd.2006.15.595
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Matsumura K, 2004, BIOMATERIALS, V25, P4817, DOI 10.1016/j.biomaterials.2003.11.055
   Morsczeck C, 2006, CALCIFIED TISSUE INT, V78, P98, DOI 10.1007/s00223-005-0146-0
   Morsczeck C, 2005, CELL BIOL INT, V29, P567, DOI 10.1016/j.cellbi.2005.03.020
   Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Rangavittal N, 2000, J BIOMED MATER RES, V51, P660, DOI 10.1002/1097-4636(20000915)51:4<660::AID-JBM14>3.0.CO;2-B
   Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x
   Saito M, 2005, J BONE MINER RES, V20, P50, DOI 10.1359/jbmr.041006
   Sous M, 1998, BIOMATERIALS, V19, P2147, DOI 10.1016/S0142-9612(98)00118-5
   Talwar R, 2001, J CLIN PERIODONTOL, V28, P340, DOI 10.1034/j.1600-051x.2001.028004340.x
   Thesleff I, 1996, ANAT REC, V245, P151
   VAKEVA L, 1990, ANAT REC, V228, P69, DOI 10.1002/ar.1092280111
   WISE GE, 1992, CELL TISSUE RES, V267, P483, DOI 10.1007/BF00319370
   Zambonin G, 2000, J BIOMED MATER RES, V49, P120, DOI 10.1002/(SICI)1097-4636(200001)49:1<120::AID-JBM15>3.0.CO;2-Q
   Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441
NR 36
TC 8
Z9 10
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2009
VL 4
IS 6
AR 065010
DI 10.1088/1748-6041/4/6/065010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 530KT
UT WOS:000272591000010
PM 19966384
DA 2018-10-20
ER

PT J
AU Dutta, S
   Karak, N
   Saikia, JP
   Konwar, BK
AF Dutta, Suvangshu
   Karak, Niranjan
   Saikia, Jyoti Prasad
   Konwar, Bolin Kumar
TI Biocompatible epoxy modified bio-based polyurethane nanocomposites:
   Mechanical property, cytotoxicity and biodegradation
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Biomaterial; Polyurethane nanocomposite; Biodegradation; Cytotoxicity
ID SEED OIL; LAYERED SILICATES; MONTMORILLONITE; MORPHOLOGY; BLENDS; RESINS
AB Epoxy modified Mesua ferrea L. seed oil (MFLSO) based polyurethane nanocomposites with different weight % of clay loadings (1%, 2.5% and 5%) have been evaluated as biocompatible materials. The nanocomposites were prepared by ex situ solution technique under high mechanical shearing and ultrasonication at room temperature. The partially exfoliated nanocomposites were characterized by Fourier transform infra-red (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM) techniques. The mechanical properties such as tensile strength and scratch hardness were improved 2 and 5 times, respectively by nanocomposites formation. Even the impact resistance improved a little. The thermostability of the nanocomposites was enhanced by about 40 degrees C. Biodegradation study confirmed 5-10 fold increase in biodegradation rate for the nanocomposites compared to the pristine polymers. All the nanocomposites showed non-cytotoxicity as evident from RBC hemolysis inhibition observed in anti-hemolytic assay carried over the sterilized films. The study reveals that the epoxy modified MFLSO based polyurethane nanocomposites deserve the potential to be applicable as biomaterials. (c) 2009 Published by Elsevier Ltd.
C1 [Dutta, Suvangshu; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Tezpur 784028, Assam, India.
   [Saikia, Jyoti Prasad; Konwar, Bolin Kumar] Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur 784028, Assam, India.
RP Karak, N (reprint author), Tezpur Univ, Dept Chem Sci, Tezpur 784028, Assam, India.
EM karakniranja@yahoo.com
RI Karak, Niranjan/F-2954-2011; Karak, Niranjan/A-1030-2014
OI Karak, Niranjan/0000-0002-3402-9536; Saikia, Jyoti/0000-0003-3973-3220
FU DST, India [SR/S3/ME/13/2005-SERC-Engg]
FX The authors express their gratitude and thanks to the major research
   project assistance given by DST, India through the grant No.
   SR/S3/ME/13/2005-SERC-Engg, dated 9th April, 2007. Authors are also
   grateful to the Department of Physics, Tezpur University and CIF, IIT
   Guwahati for helping in XRD and TEM analyses, respectively.
CR Ash RJ, 2002, EMERG INFECT DIS, V8, P713, DOI 10.3201/eid0807.010264
   Ayres E, 2006, MACROMOL SYMP, V245, P330, DOI 10.1002/masy.200651345
   Chen W, 2006, COMPOS SCI TECHNOL, V66, P3029, DOI 10.1016/j.compscitech.2006.01.024
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Ding QJ, 2006, POLYM INT, V55, P500, DOI 10.1002/pi.1990
   Dutta S, 2007, PIGM RESIN TECHNOL, V36, P74, DOI 10.1108/03699420710733501
   Dutta S, 2006, POLYM INT, V55, P49, DOI 10.1002/pi.1914
   Dutta S, 2005, PROG ORG COAT, V53, P147, DOI 10.1016/j.porgcoat.2005.02.003
   DUTTA S, 2008, PROG ORG COAT, DOI DOI 10.1016/JPORGCOAT.2008.10.008
   DUTTA S, J APPL POLY IN PRESS
   Finnigan B, 2004, POLYMER, V45, P2249, DOI 10.1016/j.polymer.2004.01.049
   Giannelis EP, 1998, APPL ORGANOMET CHEM, V12, P675, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<675::AID-AOC779>3.0.CO;2-V
   Gultekin G, 2009, J MATER SCI-MATER M, V20, P421, DOI 10.1007/s10856-008-3572-5
   Jeong EH, 2008, J APPL POLYM SCI, V107, P803, DOI 10.1002/app.27179
   Jin J, 2006, MACROMOL MATER ENG, V291, P1414, DOI 10.1002/mame.200600273
   KLUGMAN KP, 1995, ANTIMICROB AGENTS CH, V39, P1988, DOI 10.1128/AAC.39.9.1988
   Lee SR, 2002, POLYMER, V43, P2495, DOI 10.1016/S0032-3861(02)00012-5
   Ma XY, 2004, J APPL POLYM SCI, V93, P608, DOI 10.1002/app.20423
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ni P, 2006, J APPL POLYM SCI, V99, P6, DOI 10.1002/app.21306
   Osman MA, 2003, MACROMOLECULES, V36, P9851, DOI 10.1021/ma035077x
   Petrovic ZS, 2000, J APPL POLYM SCI, V76, P133, DOI 10.1002/(SICI)1097-4628(20000411)76:2<133::AID-APP3>3.0.CO;2-K
   RANA S, 2008, NANOTECHNOLOGY, V19
   Rehab A, 2005, MAT SCI ENG A-STRUCT, V399, P368, DOI 10.1016/j.msea.2005.04.019
   Seo WJ, 2006, J APPL POLYM SCI, V102, P3764, DOI 10.1002/app.24735
   Sinha R. S., 2003, PROG POLYM SCI, V28, P1539, DOI DOI 10.1016/J.PR0GP0LYMSCI.2003.08.002
   USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179
   Wang JC, 2007, J POLYM SCI POL PHYS, V45, P519, DOI [10.1002/polb.21029, 10.1002/polb21029]
   Wang Z, 1998, CHEM MATER, V10, P3769, DOI 10.1021/cm980448n
   Yurekli K, 2003, MACROMOLECULES, V36, P7256, DOI 10.1021/ma0207551
   Zhou SX, 2003, J APPL POLYM SCI, V88, P189, DOI 10.1002/app.11624
   Zhu QY, 2002, EXP BIOL MED, V227, P321
   Zou H, 2008, POLYM COMPOSITE, V29, P385, DOI 10.1002/pc.20406
NR 33
TC 47
Z9 47
U1 1
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD DEC
PY 2009
VL 100
IS 24
BP 6391
EP 6397
DI 10.1016/j.biortech.2009.06.029
PG 7
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 498NK
UT WOS:000270147700036
PM 19683433
DA 2018-10-20
ER

PT J
AU Bartlett, L
   Ho, YH
AF Bartlett, L.
   Ho, Y. -H.
TI PTQ (TM) anal implants for the treatment of faecal incontinence
SO BRITISH JOURNAL OF SURGERY
LA English
DT Article
ID INJECTABLE SILICONE BIOMATERIAL; 1-YEAR FOLLOW-UP; SPHINCTER
   DYSFUNCTION; URINARY-INCONTINENCE; INJECTION; THERAPY; HEMORRHOIDECTOMY;
   ADULTS
AB Background: In North Queensland demand for conservative faecal incontinence treatments outweighs supply. Injectable bulking agents offer a safe and effective treatment for patients with internal anal sphincter (IAS) dysfunction.
   Methods-Information, including age and sex, baseline incontinence score, quality of life, resting and squeeze pressures, was collected for 74 patients (37 men) who received intersphincteric PTQ (TM) injections. Postimplant satisfaction was assessed at 6-week review. Incontinence scores and satisfaction ratings were determined annually.
   Results: At a median follow-up of 28 months, 52 patients (70 per cent) with IAS dysfunction who received PTQ (TM) anal implants as a treatment for faecal incontinence were continent and extremely satisfied with the result. The incontinence score in participants who remained incontinent was reduced significantly from 12 of 20 before implant to 3.5 of 20 at follow-up (P < 0.001). Migration rates improved with experience. The poorest results occurred in women with pudendal neuropathy, or patients who had previously received biofeedback treatment.
   Conclusion: Implanted PTQ (TM) provides an effective solution to faecal incontinence in the short and mid term for patients with IAS dysfunction.
C1 [Bartlett, L.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
   [Ho, Y. -H.] James Cook Univ, Sch Med, Townsville, Qld 4811, Australia.
   [Ho, Y. -H.] James Cook Univ, Australian Inst Trop Med, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
RP Bartlett, L (reprint author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
EM lynne.bartlett@jcu.edu.au
FU Cancer Council, Queensland
FX L.B. is supported by a scholarship from the Cancer Council, Queensland.
   The authors declare no conflict of interest.
CR Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Bartlett L, 2007, Tech Coloproctol, V11, P251, DOI 10.1007/s10151-007-0360-z
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Chatoor DR, 2007, BRIT J SURG, V94, P134, DOI 10.1002/bjs.5676
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   *DEP HLTH AG MED S, 2006, INT INJ SIL BIOM SEV
   Felt-Bersma RJ, 2007, EUR J GASTROEN HEPAT, V19, P575, DOI 10.1097/MEG.0b013e32811ec010
   Garcia-Olmo D, 2008, EXPERT OPIN BIOL TH, V8, P1417, DOI [10.1517/14712590802321613, 10.1517/14712598.8.9.1417 ]
   HO YH, 1995, BRIT J SURG, V82, P596, DOI 10.1002/bjs.1800820507
   Ho Yik-Hong, 2005, Aust J Rural Health, V13, P28, DOI 10.1111/j.1440-1854.2004.00642.x
   LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870
   Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Mitterberger M, 2008, J UROLOGY, V179, P226, DOI 10.1016/j.juro.2007.08.154
   Mitterberger M, 2007, BJU INT, V100, P1081, DOI 10.1111/j.1464-410X.2007.07119.x
   Mowatt G, 2008, NEUROUROL URODYNAM, V27, P155, DOI 10.1002/nau.20565
   Nijhuis PH, 1998, DIS COLON RECTUM, V41, P624, DOI 10.1007/BF02235272
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Strasser H, 2004, UROLOGE A, V43, P1237, DOI 10.1007/s00120-004-0700-9
   Takahashi-Monroy T, 2008, DIS COLON RECTUM, V51, P355, DOI 10.1007/s10350-007-9169-0
   Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   Whitehead W E, 2001, Dis Colon Rectum, V44, P131, DOI 10.1007/BF02234835
NR 27
TC 21
Z9 23
U1 0
U2 2
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0007-1323
J9 BRIT J SURG
JI Br. J. Surg.
PD DEC
PY 2009
VL 96
IS 12
BP 1468
EP 1475
DI 10.1002/bjs.6745
PG 8
WC Surgery
SC Surgery
GA 531FX
UT WOS:000272650300014
PM 19918861
DA 2018-10-20
ER

PT J
AU Chang, DT
   Saidel, GM
   Anderson, JM
AF Chang, David T.
   Saidel, Gerald M.
   Anderson, James M.
TI Dynamic Systems Model for Lymphocyte Interactions with Macrophages at
   Biomaterial Surfaces
SO CELLULAR AND MOLECULAR BIOENGINEERING
LA English
DT Article
DE Mathematical model; Computer simulation; Lymphocyte; Monocyte;
   Macrophage; Foreign body giant cell; Biomaterial; Foreign body reaction;
   Adhesion; Fusion
ID GIANT-CELL FORMATION; FOREIGN-BODY RESPONSE; THEORETICAL-ANALYSIS;
   IN-VIVO; T-CELL; ADHERENT MACROPHAGES; PROTEIN ADHESION; FUSION;
   INTERLEUKIN-4; INTEGRINS
AB A mechanistic mathematical model of cell population dynamics was developed to describe lymphocyte interactions with macrophages at biomaterial surfaces. The chemical properties of a biomaterial surface are expected to modulate its interaction with cells. Quantitative aspects of the relationship of surface characteristics to cellular adhesion were studied. Surfaces with hydrophobic, hydrophilic/neutral, hydrophilic/anionic, and hydrophilic/cationic characteristics were used in an in vitro co-culture system. The mathematical model represents monocyte adherence onto the surface, differentiation into macrophages, and fusion into foreign body giant cells (FBGCs) as well as concurrent lymphocyte adherence onto the surface and interaction with monocytes, macrophages, and FBGCs. Also, the model describes apoptosis and detachment of adherent monocytes, macrophages, and lymphocytes from the surface as well as proliferation of adherent lymphocytes. Based on this mechanistic model, computer simulations simulate the dynamic responses of these cell populations in the presence of different biomaterial surfaces. This computational model provides a major advance toward quantitative predictability of biomaterial-dependent cellular adhesion processes.
C1 [Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Chang, David T.; Saidel, Gerald M.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Wolstein Res Bldg,Room 5105,2103 Cornell Rd, Cleveland, OH 44106 USA.
EM jma6@case.edu
OI Saidel, Gerald/0000-0003-2159-2343
FU NIH [T32 GM007250]; NIBIB [EB-000275, EB000282]
FX This work was supported by NIH, Grant T32 GM007250, and NIBIB, Grants
   EB-000275 and EB000282.
CR Abramson SD, 2005, J BIOMED MATER RES A, V73A, P116, DOI 10.1002/jbm.a.30266
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ASHANY D, 1995, P NATL ACAD SCI USA, V92, P11225, DOI 10.1073/pnas.92.24.11225
   Bajzer Z, 2005, BIOSYSTEMS, V80, P1, DOI 10.1016/j.biosystems.2004.09.025
   BALE MD, 1989, BLOOD, V74, P2698
   Bigerelle M, 2005, J BIOMED MATER RES A, V75A, P530, DOI 10.1002/jbm.a.30473
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Ludewig B, 2004, EUR J IMMUNOL, V34, P2407, DOI 10.1002/eji.200425085
   Macallan DC, 2003, EUR J IMMUNOL, V33, P2316, DOI 10.1002/eji.200323763
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Miyamoto YJ, 2003, IMMUNOL RES, V27, P71, DOI 10.1385/IR:27:1:71
   N'Dri NA, 2003, BIOPHYS J, V85, P2273, DOI 10.1016/S0006-3495(03)74652-9
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   Santana MA, 2003, J CELL PHYSIOL, V195, P392, DOI 10.1002/jcp.10258
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   SIMON SI, 1990, J CELL BIOL, V111, P2747, DOI 10.1083/jcb.111.6.2747
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
   Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4
NR 42
TC 4
Z9 4
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1865-5025
J9 CELL MOL BIOENG
JI Cell. Mol. Bioeng.
PD DEC
PY 2009
VL 2
IS 4
BP 573
EP 590
DI 10.1007/s12195-009-0088-0
PG 18
WC Cell & Tissue Engineering; Biophysics; Cell Biology
SC Cell Biology; Biophysics
GA 531MW
UT WOS:000272671600011
DA 2018-10-20
ER

PT J
AU Ernstberger, T
   Buchhorn, G
   Heidrich, G
AF Ernstberger, Thorsten
   Buchhorn, Gottfried
   Heidrich, Gabert
TI Intervertebral test spacers and postfusion MRI artifacting: A
   comparative in vitro study of magnesium versus titanium and carbon fiber
   reinforced polymers as biomaterials
SO CENTRAL EUROPEAN JOURNAL OF MEDICINE
LA English
DT Article
DE Magnesium alloys; Innovative biomaterials; Interbody test implants; MRI
   artifacting
ID PEDICLE SCREWS; LUMBAR SPINE; IMPLANTS; PARAMETERS; ALLOYS; FUSION
AB Intervertebral spacers are made of different materials, which can effect the postfusion magnetic imaging (MRI) scans. Susceptibility artifacts specially for metallic implants can decrease the image quality. This study aimed to determine whether magnesium as a lightweight and biocompatible metal is suitable as a biomaterial for spinal implants based on its MRI artifacting behavior. To compare artifacting behaviors, we implanted into one porcine cadaveric spine different test spacers made of magnesium, titanium and CFRP. All test spacers were scanned using 2 T1-TSE MRI sequences. The artifact dimensions were traced on all scans and statistically analyzed. The total artifact volume and median artifact area of the titanium spacers were statistically significantly larger than magnesium spacers (p < 0.001), while magnesium and CFRP spacers produced almost identical artifacting behaviors (p > 0.05). Our results suggest that spinal implants made with magnesium alloys will behave more like CFRP devices in MRI scans.
C1 [Ernstberger, Thorsten] Klinikum Bad Bramstedt, Ctr Spinal Surg, D-24576 Bad Bramstedt, Germany.
   [Buchhorn, Gottfried] Univ Gottingen, Dept Orthopaed Surg, Biomat Lab, D-37075 Gottingen, Germany.
   [Heidrich, Gabert] Univ Gottingen, Dept Diagnost Radiol, D-37075 Gottingen, Germany.
RP Ernstberger, T (reprint author), Klinikum Bad Bramstedt, Ctr Spinal Surg, D-24576 Bad Bramstedt, Germany.
EM ernstberger@r-on-klinik.de
FU Peter Brehm Company, Weisendorf, Germany; Material Science at the
   Technical University of Hannover, Germany
FX The authors thank Dr. Mark Riner of MedTech Composites GmbH,
   Switzerland, the Peter Brehm Company, Weisendorf, Germany, and the
   Material Science at the Technical University of Hannover, Germany for
   producing the respective test implants.
CR BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030
   DEBATIN JF, 1992, INVEST RADIOL, V27, P198, DOI 10.1097/00004424-199203000-00003
   ERNSTBERGER T, 2006, EUR SPINE J, V7, P1
   Ernstberger T, 2007, SPINE J, V7, P353, DOI 10.1016/j.spinee.2006.03.016
   HENK CB, 1999, TOP MAGN RESON IMAG, V10, P47
   Herold T, 2004, ROFO-FORTSCHR RONTG, V176, P1296, DOI 10.1055/s-2004-813404
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Malik AS, 2001, ACTA RADIOL, V42, P291, DOI 10.1034/j.1600-0455.2001.042002291.x
   Ortiz O, 1996, NEUROSURGERY, V38, P741, DOI 10.1227/00006123-199604000-00022
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   Rudisch A, 1998, SPINE, V23, P692, DOI 10.1097/00007632-199803150-00009
   RUPP R, 1993, SPINE, V18, P379
   Schreiner U, 2000, Z ORTHOP GRENZGEB, V138, P540, DOI 10.1055/s-2000-9598
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomsen M, 2001, ORTHOPADE, V30, P540, DOI 10.1007/s001320170063
   Troitskii VV, 1944, KHIRURGIIA, V8, P41
   VACCARO AR, 1994, SPINE, V19, P237
   Van Goethem JWM, 2002, NEURORADIOLOGY, V44, P723, DOI 10.1007/s00234-002-0790-2
   Walde TA, 2005, CLIN ORTHOP RELAT R, P138, DOI 10.1097/01.blo.0000164028.14504.46
   Wang JC, 1997, J SPINAL DISORD, V10, P27
   Znamenskii MS, 1945, KHIRURGIIA, V12, P60
NR 21
TC 0
Z9 0
U1 0
U2 5
PU VERSITA
PI WARSAW 41
PA 9 DRUGA POPRZECNA ST, 04-604 WARSAW 41, POLAND
SN 1895-1058
J9 CENT EUR J MED
JI Cent. Eur. J. Med.
PD DEC
PY 2009
VL 4
IS 4
BP 496
EP 500
DI 10.2478/s11536-009-0027-4
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 502HP
UT WOS:000270448700015
OA Other Gold
DA 2018-10-20
ER

PT J
AU Nanno, K
   Sugiyasu, K
   Daimon, T
   Yoshikawa, H
   Myoui, A
AF Nanno, Katsuhiko
   Sugiyasu, Kenjiro
   Daimon, Takashi
   Yoshikawa, Hideki
   Myoui, Akira
TI Synthetic Alginate is a Carrier of OP-1 for Bone Induction
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID GLYCOL BLOCK-COPOLYMERS; MORPHOGENETIC PROTEIN; IN-VIVO; BIODEGRADABLE
   POLYMERS; TISSUE REGENERATION; BMP CARRIERS; DELIVERY; COLLAGEN;
   TRANSPLANTATION; ALLOGRAFTS
AB Bone morphogenetic proteins (BMPs) can induce bone formation in vivo when combined with appropriate carriers. Several materials, including animal collagens and synthetic polymers, have been evaluated as carriers for BMPs. We examined alginate, an approved biomaterial for human use, as a carrier for BMP-7. In a mouse model of ectopic bone formation, the following four carriers for recombinant human OP-1 (BMP-7) were tested: alginate crosslinked by divalent cations (DC alginate), alginate crosslinked by covalent bonds (CB alginate), Type I atelocollagen, and poly-D,L-lactic acid-polyethyleneglycol block copolymer (PLA-PEG). Discs of carrier materials (5-mm diameter) containing OP-1 (3-30 mu g) were implanted beneath the fascia of the back muscles in six mice per group. These discs were recovered 3 weeks after implantation and subjected to radiographic and histologic studies. Ectopic bone formation occurred in a dose-dependent manner after the implantation of DC alginate, atelocollagen, and PLA-PEG, but occurred only at the highest dose implanted with CB alginate. Bone formation with DC alginate/OP-1 composites was equivalent to that with atelocollagen/OP-1 composites. Our data suggest DC alginate, a material free of animal products that is already approved by the FDA and other authorities, is a safe and potent carrier for OP-1. This carrier may also be applicable to various other situations in the orthopaedic field.
C1 [Nanno, Katsuhiko; Sugiyasu, Kenjiro; Yoshikawa, Hideki; Myoui, Akira] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan.
   [Daimon, Takashi; Myoui, Akira] Osaka Univ Hosp, Med Ctr Translat Res, Osaka 553, Japan.
RP Yoshikawa, H (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM yhideki@ort.med.osaka-u.ac.jp
RI Myoui, Akira/E-8296-2010
FU Stryker Biotech K. K. (Tokyo, Japan); Japan Science and Technology
   Agency
FX One or more of the authors have received funding from Stryker Biotech K.
   K. (Tokyo, Japan) (AM) and from the Japan Science and Technology Agency
   (AM).
CR Bach FH, 1998, NAT MED, V4, P141, DOI 10.1038/nm0298-141
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012
   Butler D, 1998, NATURE, V391, P320
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Gensheimer D, 1993, Ostomy Wound Manage, V39, P34
   Gensheimer D, 1993, OSTOMY WOUND MANAG, V39, P42
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, P7
   GREESINK RG, 1999, J BONE JOINT SURG BR, V81, P710
   JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5
   Johnsson R, 2002, SPINE, V27, P2654, DOI 10.1097/00007632-200212010-00004
   Kato M, 2006, BIOMATERIALS, V27, P3927, DOI 10.1016/j.biomaterials.2006.03.013
   Kato M, 2006, BIOMATERIALS, V27, P2035, DOI 10.1016/j.biomaterials.2005.10.007
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Lee DD, 1999, CLIN ORTHOP RELAT R, pS396
   Matsumine A, 2004, J BONE JOINT SURG BR, V86B, P719, DOI 10.1302/0301-620X.86B5.14242
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   NEMZEK JA, 1994, J BONE JOINT SURG AM, V76A, P1036, DOI 10.2106/00004623-199407000-00012
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Saito N, 2001, J BONE JOINT SURG AM, V83A, pS92
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
   Schmidmaier G, 2008, INJURY, V39, pS37, DOI 10.1016/S0020-1383(08)70014-7
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tamura S, 2001, BONE, V29, P169, DOI 10.1016/S8756-3282(01)00498-7
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VANSTRAELEN P, 1992, BURNS, V18, P145, DOI 10.1016/0305-4179(92)90014-L
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
NR 39
TC 8
Z9 8
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD DEC
PY 2009
VL 467
IS 12
BP 3149
EP 3155
DI 10.1007/s11999-009-0899-2
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 515CR
UT WOS:000271444700015
PM 19475466
OA Green Published
DA 2018-10-20
ER

PT J
AU Korsgren, O
   Nilsson, B
AF Korsgren, Olle
   Nilsson, Bo
TI Improving islet transplantation: a road map for a widespread application
   for the cure of persons with type I diabetes
SO CURRENT OPINION IN ORGAN TRANSPLANTATION
LA English
DT Review
DE bone marrow; encapsulation; islet transplantation; solid tissues;
   titanium; Young's modulus
ID PORCINE ISLETS; ARTIFICIAL PANCREAS; CELL-DIFFERENTIATION; THROMBIN
   GENERATION; NONHUMAN-PRIMATES; BONE-FORMATION; WHOLE-BLOOD; STEM-CELLS;
   XENOTRANSPLANTATION; GROWTH
AB Purpose of review
   The widespread application of replacement therapies for type I diabetes is at present limited by the side-effects of systemic immunosuppression. Results obtained in several animal models show that islet encapsulation can control the rejection process without systemic side-effects. However, results have, in general, been disappointing when transferred to large animal models or to humans.
   Recent findings
   Growing insights into how cells respond to mechanical forces and surrounding extracellular matrixes indicate that differences in the Young's modulus (the resistance to deformation) between the implanted biomaterial and surrounding tissues induce inflammation and fibrosis. A valid approach would be to select for implantation a tissue having a higher value of the Young's modulus, for example, bone, allowing direct contact with the highly vascularized bone marrow providing nutrient and oxygen support as well as a rapid distribution of released insulin to the systemic circulation.
   Summary
   Development of a biochamber with bone-integrating properties will allow initiation of clinical trials with allogeneic human islets, xenogeneic pig islets or insulin-producing cells generated from human embryonic stem cell (hESC)/inducible pluripotent stem cell (iPSC).
C1 [Korsgren, Olle; Nilsson, Bo] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden.
RP Korsgren, O (reprint author), Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, S-75185 Uppsala, Sweden.
EM Olle.Korsgren@klinimm.uu.se
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Brauker J, 1996, TRANSPLANTATION, V61, P1671, DOI 10.1097/00007890-199606270-00002
   BURNGARDNER GL, 1999, TRANSPLANTATION, V68, P555
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649
   CHICK WL, 1975, T AM SOC ART INT ORG, V21, P8
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381
   DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   GATES RJ, 1972, LANCET, V300, P567
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Gray DWR, 1997, BRIT MED BULL, V53, P777
   Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   KORSGREN O, 1988, TRANSPLANTATION, V45, P509, DOI 10.1097/00007890-198803000-00001
   Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Leu Fur-Jiang, 1992, Journal of the Formosan Medical Association, V91, P849
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   RICORDI C, 1986, DIABETES, V35, P649, DOI 10.2337/diabetes.35.6.649
   Ryan EA, 2006, DIABETES OBES METAB, V8, P1, DOI 10.1111/j.1463-1326.2004.00460.x
   Salazar-Banuelos A, 2008, AM J SURG, V195, P674, DOI 10.1016/j.amjsurg.2007.12.040
   Soderlund J, 1999, TRANSPLANTATION, V67, P784
   Sorenby AK, 2008, TRANSPLANTATION, V86, P364, DOI 10.1097/TP.0b013e31817efc78
   Sorenby AK, 2006, TRANSPLANTATION, V82, P393, DOI 10.1097/01.tp.0000228912.62374.44
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   Tibell A, 2001, CELL TRANSPLANT, V10, P591
   TUCH BE, 2009, DIABETES CARE
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   Zajac AL, 2008, CURR OPIN CELL BIOL, V20, P609, DOI 10.1016/j.ceb.2008.09.006
   Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267
NR 41
TC 20
Z9 23
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1087-2418
J9 CURR OPIN ORGAN TRAN
JI Curr. Opin. Organ Transpl.
PD DEC
PY 2009
VL 14
IS 6
BP 683
EP 687
DI 10.1097/MOT.0b013e328332c44c
PG 5
WC Transplantation
SC Transplantation
GA 526WK
UT WOS:000272326300015
PM 19779341
DA 2018-10-20
ER

PT J
AU Vinatier, C
   Bouffi, C
   Merceron, C
   Gordeladze, J
   Brondello, JM
   Jorgensen, C
   Weiss, P
   Guicheux, J
   Noel, D
AF Vinatier, Claire
   Bouffi, Carine
   Merceron, Christophe
   Gordeladze, Jan
   Brondello, Jean-Marc
   Jorgensen, Christian
   Weiss, Pierre
   Guicheux, Jerome
   Noel, Daniele
TI Cartilage Tissue Engineering: Towards a Biomaterial-Assisted Mesenchymal
   Stem Cell Therapy
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Review
AB Injuries to articular cartilage are one of the most challenging issues of musculoskeletal medicine due to the poor intrinsic ability of this tissue for repair. Despite progress in orthopaedic surgery, the lack of efficient modalities of treatment for large chondral defects has prompted research on tissue engineering combining chondrogenic cells, scaffold materials and environmental factors. The aim of this review is to focus on the recent advances made in exploiting the potentials of cell therapy for cartilage engineering. These include: 1) defining the best cell candidates between chondrocytes or multipotent progenitor cells, such as multipotent mesenchymal stromal cells (MSC), in terms of readily available sources for isolation, expansion and repair potential; 2) engineering biocompatible and biodegradable natural or artificial matrix scaffolds as cell carriers, chondrogenic factors releasing factories and supports for defect filling, 3) identifying more specific growth factors and the appropriate scheme of application that will promote both chondrogenic differentiation and then maintain the differentiated phenotype overtime and 4) evaluating the optimal combinations that will answer to the functional demand placed upon cartilage tissue replacement in animal models and in clinics. Finally, some of the major obstacles generally encountered in cartilage engineering are discussed as well as future trends to overcome these limiting issues for clinical applications.
C1 [Vinatier, Claire; Merceron, Christophe; Weiss, Pierre; Guicheux, Jerome] LIOAD, INSERM, U 791, F-44042 Nantes, France.
   [Vinatier, Claire; Merceron, Christophe; Guicheux, Jerome] Univ Nantes, UFR Odontol, F-44042 Nantes, France.
   [Bouffi, Carine; Gordeladze, Jan; Brondello, Jean-Marc; Jorgensen, Christian; Noel, Daniele] INSERM, U 844, F-34091 Montpellier, France.
   [Bouffi, Carine; Gordeladze, Jan; Brondello, Jean-Marc; Jorgensen, Christian; Noel, Daniele] Univ Montpellier I, UFR Med, F-34000 Montpellier, France.
   [Jorgensen, Christian] Hop Lapeyronie, Serv Immuno Rhumatol, F-34295 Montpellier, France.
   [Vinatier, Claire] Graftys SARL, F-13854 Aix En Provence, France.
RP Noel, D (reprint author), Hop St Eloi, INSERM, U844, Bat INM,80 Ave Augustin Fliche, F-34295 Montpellier 5, France.
EM daniele.noel@inserm.fr
RI merceron, christophe/P-1306-2014; Weiss, Pierre/P-1372-2014; Vinatier,
   Claire/P-1686-2014; guicheux, Jerome/F-7767-2013; Noel,
   Daniele/E-5719-2016
OI Weiss, Pierre/0000-0002-6159-8590; Vinatier, Claire/0000-0002-6063-9901;
   guicheux, Jerome/0000-0003-2754-3024; 
FU Fondation de l'Avenir pour la Recherche Medicale Appliquee; Fondation
   pour la Recherche Medicale; Arthritis-Fondation Courtin; Societe
   Francaise de Rhumatologie; Graftys SARL and ANR "Scartifold"; ANR
   "Chondrograft"
FX This work was supported by grants from the "Fondation de l'Avenir pour
   la Recherche Medicale Appliquee", the "Fondation pour la Recherche
   Medicale", the "Arthritis-Fondation Courtin", the "Societe Francaise de
   Rhumatologie", Graftys SARL and ANR "Scartifold" and ANR "Chondrograft".
CR Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781
   Alsalameh S, 2004, ARTHRITIS RHEUM, V50, P1522, DOI 10.1002/art.20269
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Andrade AC, 2007, BONE, V40, P1361, DOI 10.1016/j.bone.2007.01.005
   Andrews GP, 2005, BIOMATERIALS, V26, P571, DOI 10.1016/j.biomaterials.2004.02.062
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   Bhatia R, 2005, CONGEST HEART FAIL, V11, P92
   Bhatia Rinky, 2005, Congest Heart Fail, V11, P87, DOI 10.1111/j.1527-5299.2005.03618.x
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   BRADHAM DM, 1995, MATRIX BIOL, V14, P561, DOI 10.1016/S0945-053X(05)80005-8
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bulic Kresimir, 1996, Acta Medica Croatica, V50, P69
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Carossino AM, 2007, BIOGERONTOLOGY
   Carranza-Bencano A, 2000, BIOMATERIALS, V21, P2171, DOI 10.1016/S0142-9612(00)00144-7
   Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200
   Chen Y, 2008, INT J BIOCHEM CELL B, V40, P815, DOI 10.1016/j.biocel.2008.01.007
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152
   D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200
   Davidson ENB, 2007, ARTHRITIS RHEUM, V56, P4065, DOI 10.1002/art.23034
   Davies LC, 2008, TISSUE ENG A
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   DEFRERE J, 1992, ACTA CHIR BELG, P217
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Dounchis JS, 2000, CLIN ORTHOP RELAT R, P248
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022
   Edwards PC, 2005, GENE THER, V12, P75, DOI 10.1038/sj.gt.3302386
   Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Estrada LE, 2001, OSTEOARTHR CARTILAGE, V9, P169, DOI 10.1053/joca.2000.0373
   Facchini A, 2006, BIORHEOLOGY, V43, P471
   Fan H, 2006, INT J ARTIF ORGANS, V29, P602
   Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Fukui N, 2001, Curr Rheumatol Rep, V3, P496, DOI 10.1007/s11926-001-0064-8
   Fussenegger M, 2003, ANN PLAS SURG, V51, P493, DOI 10.1097/01.sap.0000067726.32731.E1
   Galois L, 2005, PATHOL BIOL, V53, P590, DOI 10.1016/j.patbio.2004.12.019
   Gelse K, 2008, ARTHRITIS RHEUM-US, V58, P475, DOI 10.1002/art.23124
   Glansbeek HL, 1998, LAB INVEST, V78, P133
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7
   Gronthos S, 1996, J Hematother, V5, P15, DOI 10.1089/scd.1.1996.5.15
   Gruber R, 2001, ENDOCRINOLOGY, V142, P2087, DOI 10.1210/en.142.5.2087
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   Hangody L, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P262, DOI 10.1007/s001670050061
   Hannallah D, 2004, J BONE JOINT SURG AM, V86A, P80, DOI 10.2106/00004623-200401000-00013
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hoffmann A, 2002, J CELL SCI, V115, P769
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   INSALL J, 1974, CLIN ORTHOP RELAT R, P61
   Ishii I, 2007, J BONE JOINT SURG BR, V89B, P693, DOI 10.1302/0301-620X.89B5.18450
   Isogai N, 2006, TISSUE ENG, V12, P691, DOI 10.1089/ten.2006.12.691
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jorgensen C, 2004, CURR OPIN BIOTECH, V15, P406, DOI 10.1016/j.copbio.2004.08.003
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Knudson W, 2000, ARTHRITIS RHEUM, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H
   Kose GT, 2005, BIOMATERIALS, V26, P5187, DOI 10.1016/j.biomaterials.2005.01.037
   Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   Liao E, 2007, TISSUE ENG, V13, P537, DOI 10.1089/ten.2006.0117
   Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602
   Long FX, 2001, DEVELOPMENT, V128, P5099
   Lubiatowski P, 2006, TRANSPLANT P, V38, P320, DOI 10.1016/j.transproceed.2005.12.012
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342
   Magnussen RA, 2008, CLIN ORTHOP RELAT R, V466, P952, DOI 10.1007/s11999-007-0097-z
   Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Malda J, 2003, TISSUE ENG, V9, P939, DOI 10.1089/107632703322495583
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Martson M, 1998, EUR SURG RES, V30, P419, DOI 10.1159/000008608
   MCCOY JP, 1985, ARCH DERMATOL, V121, P990, DOI 10.1001/archderm.121.8.990
   Mercier NR, 2005, BIOMATERIALS, V26, P1945, DOI 10.1016/j.biomaterials.2004.06.030
   Mercier NR, 2004, ANN BIOMED ENG, V32, P418, DOI 10.1023/B:ABME.0000017547.84146.fd
   MESSNER K, 1994, BIOMATERIALS, V15, P657, DOI 10.1016/0142-9612(94)90163-5
   MESSNER K, 1993, J BIOMED MATER RES, V27, P1527, DOI 10.1002/jbm.820271209
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002
   Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Noel D, 2003, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74
   Noel D, 2007, LEUKEMIA LYMPHOMA, V48, P1283, DOI 10.1080/10428190701361869
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Ornitz DM, 2001, GENOME BIOL, V2
   Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Park JS, 2008, TRANSPLANTATION, V85, P589, DOI 10.1097/TP.0b013e3181639b3a
   Peng HR, 2005, MOL THER, V12, P239, DOI 10.1016/j.ymthe.2005.02.027
   Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206
   Peterson L, 2002, AM J SPORT MED, V30, P2, DOI 10.1177/03635465020300011601
   Phinney DG, 2005, CURR PHARM DESIGN, V11, P1255, DOI 10.2174/1381612053507495
   Pittenger M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P309
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Pulkkinen H, 2006, BIO-MED MATER ENG, V16, pS29
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615
   Rudnicki JA, 1997, DEV BIOL, V185, P104, DOI 10.1006/dbio.1997.8536
   Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148
   Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Schneider U, 2003, Z Orthop Ihre Grenzgeb, V141, P496
   Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Sontjens SHM, 2006, BIOMACROMOLECULES, V7, P310, DOI 10.1021/bm050663e
   Spain TL, 1998, TISSUE ENG, V4, P343, DOI 10.1089/ten.1998.4.343
   Steadman JR, 1999, ORTHOPADE, V28, P26, DOI 10.1007/PL00003545
   Stewart AA, 2007, AM J VET RES, V68, P941, DOI 10.2460/ajvr.68.9.941
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Taguchi T, 2005, BIOMATERIALS, V26, P1247, DOI 10.1016/j.biomaterials.2004.04.029
   Takafuji H, 2007, INT J ORAL MAX SURG, V36, P934, DOI 10.1016/j.ijom.2007.06.007
   Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P896, DOI 10.1016/j.joca.2005.05.003
   Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   van Susante JLC, 1999, BIOMATERIALS, V20, P1167, DOI 10.1016/S0142-9612(97)00190-7
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279
   Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867
   Vinatier C, 2009, J BIOMED MATER RES A, V89A, P176, DOI 10.1002/jbm.a.31988
   Vinatier C, 2009, BIOTECHNOL BIOENG, V102, P1259, DOI 10.1002/bit.22137
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wakitani S, 2008, J BONE MINER METAB, V26, P115, DOI 10.1007/s00774-007-0802-8
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
   Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1
   Weizmann S, 2005, MATRIX BIOL, V24, P520, DOI 10.1016/j.matbio.2005.07.003
   Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382
   Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103
   Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805
   Yan JH, 2007, ARTIF CELL BLOOD SUB, V35, P333, DOI 10.1080/10731190701460200
   Yoon DM, 2008, TISSUE ENG PT A, V14, P1263, DOI 10.1089/ten.tea.2007.0172
NR 171
TC 113
Z9 116
U1 1
U2 41
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
EI 2212-3946
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD DEC
PY 2009
VL 4
IS 4
BP 318
EP 329
DI 10.2174/157488809789649205
PG 12
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA V22BB
UT WOS:000208249600009
PM 19804369
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Forriol, F
   Longo, UG
   Concejo, C
   Ripalda, P
   Maffulli, N
   Denaro, V
AF Forriol, Francisco
   Longo, Umile Giuseppe
   Concejo, Carlos
   Ripalda, Purificacion
   Maffulli, Nicola
   Denaro, Vincenzo
TI Platelet-rich plasma, rhOP-1 (R) (rhBMP-7) and frozen rib allograft for
   the reconstruction of bony mandibular defects in sheep. A pilot
   experimental study
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Bone defect;rhOP-1 (R) (rhBMP-7); Allograft; Bone induction;
   Platelet-rich plasma
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; GROWTH-FACTORS;
   REGENERATION; DIFFERENTIATION; PROLIFERATION; BIOMATERIAL; CONCENTRATE;
   COMBINATION; OSTEOTOMY
AB A 6cm bony defect in the mandible of 15 sheep, 8 years old, was reconstructed using variously allograft of frozen rib, rhOP-1 (rh BMP-7), platelet-rich plasma (PRP), and a combination of frozen rib allograft and rhOP-1. The histological, histomorphometric, immunohistochemical and radiographic features of reconstruction were analysed. The animals were euthanised at 2 months postoperatively. In the control and PRP groups, no bone formation was detected. The sheep receiving rhOP-1 showed some and those receiving both rhOP-1 and allograft showed most new bone formation; in both groups this was through endochondral and also fibrous ossification. The combination of bone allograft with growth factors demonstrated osteoconductive as well as osteoinductive properties, and is appealing in the management of problem fractures. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Forriol, Francisco] FREMAP Hosp, Res Unit, Madrid 28220, Spain.
   [Longo, Umile Giuseppe; Denaro, Vincenzo] Campus Biomedico Univ, Dept Orthopaed & Trauma Surg, Rome, Italy.
   [Concejo, Carlos; Ripalda, Purificacion] Univ Navarra Pamplona, Orthopaed Res Lab, Navarra, Spain.
   [Maffulli, Nicola] Univ Hosp N Staffordshire, Dept Trauma & Orthopaed Surg, Stoke On Trent, Staffs, England.
RP Forriol, F (reprint author), FREMAP Hosp, Res Unit, Ctra Pozuelo 61, Madrid 28220, Spain.
EM fforiol@gmail.com
RI Denaro, Vincenzo/K-9567-2016
OI Denaro, Vincenzo/0000-0003-4739-9795
FU Mapfre Foundation; Stryker Biotech, Hopkinton, MA
FX This work was supported by a grant from the Mapfre Foundation. The OP-1
   (R) (Osigraft (R)) was kindly donated by Stryker Biotech, Hopkinton, MA.
CR Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3
   Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010
   Fennis JPM, 2002, INT J ORAL MAX SURG, V31, P281, DOI 10.1054/ijom.2002.0151
   Gerard D, 2007, J ORAL MAXIL SURG, V65, P721, DOI 10.1016/j.joms.2006.09.025
   Gruber R, 2003, J ORTHOPAED RES, V21, P941, DOI 10.1016/S0736-0266(03)00053-6
   HARRIS SE, 1994, J BONE MINER RES, V9, P855
   Hokugo A, 2007, ORAL SURG ORAL MED O, V104, P44, DOI 10.1016/j.tripleo.2006.11.032
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Ito K, 2006, CLIN ORAL IMPLAN RES, V17, P579, DOI 10.1111/j.1600-0501.2005.01246.X
   Jensen SS, 2005, INT J ORAL MAX IMPL, V20, P703
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P362, DOI 10.1016/j.joms.2004.07.016
   Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5
   MARDEN LJ, 1993, J CLIN INVEST, V92, P2897, DOI 10.1172/JCI116912
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Mizumoto Y, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300003-00019
   Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x
   Pountos I, 2006, J BONE JOINT SURG BR, V88B, P421, DOI 10.1302/0301-620x.88B4.17060
   Roldan JC, 2004, BONE, V34, P80, DOI 10.1016/j.bone.2003.09.011
   Sandhu HS, 2003, SPINE, V28, pS64, DOI 10.1097/00007632-200308011-00012
   Schmidmaier G, 2004, J ORTHOPAED RES, V22, P514, DOI 10.1016/j.orthres.2003.09.009
   Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015
   Siebrecht MAN, 2002, ORTHOPEDICS, V25, P169
   Toriumi DM, 1999, LARYNGOSCOPE, V109, P1481, DOI 10.1097/00005537-199909000-00023
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Van Den Dolder J, 2006, TISSUE ENG, V12, P3067, DOI 10.1089/ten.2006.12.3067
   Wang HM, 2004, J BIOMED MATER RES A, V68A, P219, DOI 10.1002/jbm.a.10129
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
   Yu Y, 2002, J BIOMED MATER RES, V60, P392, DOI 10.1002/jbm.1289
NR 28
TC 30
Z9 30
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
J9 INJURY
JI Injury-Int. J. Care Inj.
PD DEC
PY 2009
VL 40
SU 3
BP 44
EP 49
PG 6
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 558EV
UT WOS:000274724600010
DA 2018-10-20
ER

PT J
AU Ni, M
   Tong, WH
   Choudhury, D
   Rahim, NAA
   Iliescu, C
   Yu, H
AF Ni, Ming
   Tong, Wen Hao
   Choudhury, Deepak
   Rahim, Nur Aida Abdul
   Iliescu, Ciprian
   Yu, Hanry
TI Cell Culture on MEMS Platforms: A Review
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE cell culture; MEMS platforms; biocompatibility; biomaterials
ID MESENCHYMAL STEM-CELLS; ION MASS-SPECTROMETRY; ON-A-CHIP; SELF-ASSEMBLED
   MONOLAYERS; ADSORBED PROTEIN FILMS; OSTEOBLAST-LIKE CELLS; SINGLE-CELL;
   IN-VITRO; POROUS SILICON; EXTRACELLULAR-MATRIX
AB Microfabricated systems provide an excellent platform for the culture of cells, and are an extremely useful tool for the investigation of cellular responses to various stimuli. Advantages offered over traditional methods include cost-effectiveness, controllability, low volume, high resolution, and sensitivity. Both biocompatible and bio-incompatible materials have been developed for use in these applications. Biocompatible materials such as PMMA or PLGA can be used directly for cell culture. However, for bio-incompatible materials such as silicon or PDMS, additional steps need to be taken to render these materials more suitable for cell adhesion and maintenance. This review describes multiple surface modification strategies to improve the biocompatibility of MEMS materials. Basic concepts of cell-biomaterial interactions, such as protein adsorption and cell adhesion are covered. Finally, the applications of these MEMS materials in Tissue Engineering are presented.
C1 [Ni, Ming; Tong, Wen Hao; Choudhury, Deepak; Iliescu, Ciprian; Yu, Hanry] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
   [Tong, Wen Hao; Choudhury, Deepak; Yu, Hanry] NUS Grad Sch Integrat Sci & Engn, CeLS, Singapore 117456, Singapore.
   [Rahim, Nur Aida Abdul; Yu, Hanry] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.
   [Yu, Hanry] Natl Univ Singapore, DSO Labs, NUS Tissue Engn Programme, Singapore 117597, Singapore.
   [Yu, Hanry] MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
RP Iliescu, C (reprint author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,Nanos 04-01, Singapore 138669, Singapore.
EM mni@ibn.a-star.edu.sg; whtong@ibn.a-star.edu.sg;
   deepakc@ibn.a-star.edu.sg; ciliescu@ibn.a-star.edu.sg;
   hyu@ibn.a-star.edu.sg
RI Iliescu, Ciprian/B-8035-2008; Yu, Hanry/C-1031-2013
OI Iliescu, Ciprian/0000-0001-7042-5248; Yu, Hanry/0000-0002-0339-3685
FU Biomedical Research Council, Agency for Science, Technology and Research
   (A*STAR) [R-185-001-045-305]; Ministry of Education [R-185000- 135-112];
   National Medical Research Council [R-185-000-099-213]; Jassen Cilag
   [R-185-000-182-592]; Singapore-MIT Alliance Computational and Systems
   Biology Flagship Project; Global Enterprise for Micro- Mechanics and
   Molecular Medicine (GEM4)
FX This work is supported in part by intramural funding from the Institute
   of Bioengineering and Nanotechnology, and grants from the Biomedical
   Research Council, Agency for Science, Technology and Research (A*STAR)
   of Singapore (R-185-001-045-305); Ministry of Education Grant (R-185000-
   135-112); National Medical Research Council Grant (R-185-000-099-213);
   Jassen Cilag Grant (R-185-000-182-592); Singapore-MIT Alliance
   Computational and Systems Biology Flagship Project funding and
   postdoctoral fellowship support from the Global Enterprise for Micro-
   Mechanics and Molecular Medicine (GEM4).
CR Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h
   Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753
   ANDERSON SHC, 2002, 3 INT C POR SEM SCI
   Andersson H, 2004, CURR OPIN BIOTECH, V15, P44, DOI 10.1016/j.copbio.2004.01.004
   Andersson H, 2003, SENSOR ACTUAT B-CHEM, V92, P315, DOI 10.1016/S0925-4005(03)00266-1
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Antia M, 2006, BIOMATERIALS, V27, P679, DOI 10.1016/j.biomaterials.2005.06.014
   Aravamudhan S, 2007, BIOSENS BIOELECTRON, V22, P2289, DOI 10.1016/j.bios.2006.11.027
   Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173
   Bayliss SC, 2000, J POROUS MAT, V7, P191, DOI 10.1023/A:1009686704506
   Bayliss SC, 1999, ADV MATER, V11, P318, DOI 10.1002/(SICI)1521-4095(199903)11:4<318::AID-ADMA318>3.0.CO;2-Z
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Beebe D, 2002, THERIOGENOLOGY, V57, P125, DOI 10.1016/S0093-691X(01)00662-8
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Berry M. N., 2000, HEPATOCYTE REV
   Berthiaume F, 1996, FASEB J, V10, P1471
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, pC171, DOI 10.1152/ajpcell.00013.2003
   Boccazzi P, 2005, APPL MICROBIOL BIOT, V68, P518, DOI 10.1007/s00253-005-1966-6
   Bowditch AP, 1999, MATER RES SOC SYMP P, V536, P149
   BRETT CMA, 1998, 7 EUR C ELECTROANALY
   Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   CANHAM LT, 2000, 2 INT C POR SEM SCI
   Cao L, 2007, J BIOMED MATER RES A, V81A, P827, DOI 10.1002/jbm.a.31091
   Carlson RH, 1997, PHYS REV LETT, V79, P2149, DOI 10.1103/PhysRevLett.79.2149
   Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   CHEN B, 2007, S DES TEST INT PACK
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen JC, 2005, SENSOR ACTUAT B-CHEM, V110, P364, DOI 10.1016/j.snb.2005.02.026
   Chen SF, 2003, LANGMUIR, V19, P2859, DOI 10.1021/la026498v
   CHENG SS, 1994, J COLLOID INTERF SCI, V126, P508
   Cheng XH, 2005, LANGMUIR, V21, P7833, DOI 10.1021/la050417o
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Collins BE, 2002, ADV FUNCT MATER, V12, P187, DOI 10.1002/1616-3028(200203)12:3<187::AID-ADFM187>3.0.CO;2-E
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Cui XQ, 2007, BIOSENS BIOELECTRON, V22, P3288, DOI 10.1016/j.bios.2007.03.004
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Das SK, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2988313
   Degenaar P, 2001, J BIOCHEM-TOKYO, V130, P367, DOI 10.1093/oxfordjournals.jbchem.a002995
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Desai TA, 1999, BIOMED MICRODEVICES, V2, P123, DOI 10.1023/A:1009997620679
   Desai TA, 1999, BIOMED MICRODEVICES, V1, P131, DOI 10.1023/A:1009948524686
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Dittami GM, 2008, J MICROELECTROMECH S, V17, P850, DOI 10.1109/JMEMS.2008,921726
   Drouvalakis KA, 2008, BIOSENS BIOELECTRON, V23, P1413, DOI 10.1016/j.bios.2007.11.022
   Du YN, 2006, BIOMATERIALS, V27, P5669, DOI 10.1016/j.biomaterials.2006.07.018
   Duan HG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/13/135306
   DUNN JCY, 1989, FASEB J, V3, P174
   Ebara M, 2006, LAB CHIP, V6, P843, DOI 10.1039/b515128g
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Fan CH, 2000, ELECTROANAL, V12, P205
   Fan YW, 2002, APPL SURF SCI, V187, P313, DOI 10.1016/S0169-4332(01)01046-7
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Fissell WH, 2007, BLOOD PURIFICAT, V25, P12, DOI 10.1159/000096391
   Fissell WH, 2006, ASAIO J, V52, P221, DOI 10.1097/01.mat.0000205228.30516.9c
   Fissell WH, 2007, TRANSL RES, V150, P327, DOI 10.1016/j.trsl.2007.06.001
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FORSEN E, 2003, 29 INT C MICR NAN EN
   Fu AY, 1999, NAT BIOTECHNOL, V17, P1109
   FUH CB, 2003, 26 INT S CAP CHRMT E
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Gao J, 2004, LAB CHIP, V4, P47, DOI 10.1039/b310552k
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Glasgow IK, 2001, IEEE T BIO-MED ENG, V48, P570, DOI 10.1109/10.918596
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784
   Gu W, 2004, P NATL ACAD SCI USA, V101, P15861, DOI 10.1073/pnas.0404353101
   Hayes DL, 1999, AM J CARDIOL, V83, p161D
   Holmstrom N, 1998, BIOSENS BIOELECTRON, V13, P1287, DOI 10.1016/S0956-5663(98)00091-8
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992
   Huang CJ, 2007, SENSOR ACTUAT B-CHEM, V122, P461, DOI 10.1016/j.snb.2006.06.015
   Huang HH, 2008, J ANAL CHEM+, V63, P492, DOI 10.1134/S1061934808050158
   Huang Y, 2001, SENSOR ACTUAT A-PHYS, V89, P242, DOI 10.1016/S0924-4247(00)00557-4
   Huang Y, 2002, ANAL CHEM, V74, P3362, DOI 10.1021/ac011273v
   Humes HD, 2006, KIDNEY INT, V69, P1115, DOI 10.1038/sj.ki.5000204
   Ibrahim S, 2007, LANGMUIR, V23, P12406, DOI 10.1021/la7020066
   ILIESCU C, 2007, INT SEM C SIN ROM 15
   Iliescu C, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2747187
   Iliescu C, 2008, SENSOR ACTUAT B-CHEM, V129, P491, DOI 10.1016/j.snb.2007.11.023
   Iliescu C, 2008, SENSOR ACTUAT B-CHEM, V129, P404, DOI 10.1016/j.snb.2007.08.043
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Ivanov D, 2006, BIODRUGS, V20, P351, DOI 10.2165/00063030-200620060-00005
   Ji J, 2006, J MICROMECH MICROENG, V16, P958, DOI 10.1088/0960-1317/16/5/012
   Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Kang IK, 2004, BIOMATERIALS, V25, P4225, DOI 10.1016/j.biomaterials.2003.11.004
   Karlsson LM, 2003, J COLLOID INTERF SCI, V266, P40, DOI 10.1016/S0021-9797(03)00595-2
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khine M, 2005, LAB CHIP, V5, P38, DOI 10.1039/b408352k
   Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f
   Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b
   Kim YC, 2007, SENSOR ACTUAT B-CHEM, V128, P108, DOI 10.1016/j.snb.2007.05.050
   Kitching KJ, 2003, REV SCI INSTRUM, V74, P4832, DOI 10.1063/1.1618013
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kohler J.M., 1999, MICROSYSTEM TECHNOLO
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kouoh F, 2000, APMIS, V108, P417, DOI 10.1034/j.1600-0463.2000.d01-77.x
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K
   L'Heureux N, 1998, FASEB J, V12, P47
   Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p
   Lam YZ, 2007, MED ENG PHYS, V29, P291, DOI 10.1016/j.medengphy.2006.03.010
   Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002
   Leclerc E, 2004, BIOCHEM ENG J, V20, P143, DOI 10.1016/j.bej.2003.09.010
   Leclerc E, 2006, BIOMATERIALS, V27, P4109, DOI 10.1016/j.biomaterials.2006.03.031
   Lee PJ, 2006, BIOTECHNOL BIOENG, V94, P5, DOI 10.1002/bit.20745
   Leong K, 2009, LANGMUIR, V25, P4615, DOI 10.1021/la8037318
   LI JN, 2002, NAT BIOTECHNOL, V20, P826
   Li MW, 2005, ELECTROANAL, V17, P1171, DOI 10.1002/elan.200403231
   Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Lima RR, 2009, SENSOR ACTUAT B-CHEM, V137, P170, DOI 10.1016/j.snb.2008.11.040
   LIMA RR, 2009, SENSOR ACTUAT B-CHEM, V130, P110
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509
   Mahmood TA, 2000, J MATER SCI-MATER M, V11, P19, DOI 10.1023/A:1008929500904
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   MANZ A, 1999, MICROSYSTEM TECHNOLO
   Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460
   MARKX GH, 1994, MICROBIOL-SGM, V140, P585, DOI 10.1099/00221287-140-3-585
   Marquette CA, 2006, BIOSENS BIOELECTRON, V21, P1424, DOI 10.1016/j.bios.2004.09.037
   Martin SM, 2003, J BIOMED MATER RES A, V67A, P334, DOI 10.1002/jbm.a.10060
   Mirzadeh H, 2003, J BIOMED MATER RES A, V67A, P727, DOI 10.1002/jbm.a.10107
   Morgan J., 1997, SCI MED, V4, P6
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Munson MS, 2005, LAB CHIP, V5, P856, DOI 10.1039/b501035g
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Olofsson J, 2003, CURR OPIN BIOTECH, V14, P29, DOI 10.1016/S0958-1669(02)00003-4
   Ostrovidov S, 2004, BIOMED MICRODEVICES, V6, P279, DOI 10.1023/B:BMMD.0000048560.96140.ca
   Pal R, 2005, LAB CHIP, V5, P1024, DOI 10.1039/b505994a
   Palkova Z, 2004, CYTOM PART A, V59A, P246, DOI 10.1002/cyto.a.20049
   Park JY, 2007, LAB CHIP, V7, P1673, DOI 10.1039/b710777c
   Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Prestidge CA, 2008, PHYS STATUS SOLIDI A, V205, P311, DOI 10.1002/pssa.200723113
   Qin TW, 2005, BIOMATERIALS, V26, P6635, DOI 10.1016/j.biomaterials.2005.04.023
   Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Raty S, 2004, LAB CHIP, V4, P186, DOI 10.1039/b316437c
   Ronco C, 2001, BLOOD PURIFICAT, V19, P347, DOI 10.1159/000046964
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   ROSENGREN A, 2000, 2 INT C POR SEM SCI
   Rowe L, 2007, LAB CHIP, V7, P475, DOI 10.1039/b700795g
   Ryu W, 2007, BIOMATERIALS, V28, P1174, DOI 10.1016/j.biomaterials.2006.11.002
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   Santini JT, 1999, NATURE, V397, P335
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   SATAKE D, 2001, TRANSD 2001 C EUR 15
   Scavetta E, 2007, ELECTROCHEM COMMUN, V9, P2838, DOI 10.1016/j.elecom.2007.10.007
   Scuor N, 2006, BIOMED MICRODEVICES, V8, P239, DOI 10.1007/s10544-006-8268-3
   Service RF, 2002, SCIENCE, V297, P962, DOI 10.1126/science.297.5583.962
   Sethu P, 2004, ANAL CHEM, V76, P6247, DOI 10.1021/ac049429p
   SILVA CCG, 2003, 2 M BRAZ SOC FOR MAT
   Sim WY, 2007, LAB CHIP, V7, P1775, DOI 10.1039/b712361m
   Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/nmeth.1290, 10.1038/NMETH.1290]
   SOPER SA, 2001, 28 ANN C FED OF AN C
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820
   Sun Y, 2006, J CHROMATOGR A, V1117, P228, DOI 10.1016/j.chroma.2006.03.088
   SUZUKI H, 2000, 8 INT M CHEM SENS IM
   Szita N, 2005, LAB CHIP, V5, P819, DOI 10.1039/b504243g
   Takubo T, 2007, POINT CARE, V6, P174, DOI 10.1097/poc.0b013e318124fd3b
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Toh YC, 2007, LAB CHIP, V7, P302, DOI 10.1039/b614872g
   Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108
   Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Troyk PR, 1999, ANNU REV BIOMED ENG, V1, P177, DOI 10.1146/annurev.bioeng.1.1.177
   Tsai HKA, 2009, ADV MATER, V21, P656, DOI 10.1002/adma.200801770
   TSAI HH, 2009, SENS ACTU B IN PRESS
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Veiseh M, 2007, BIOSENS BIOELECTRON, V23, P253, DOI 10.1016/j.bios.2007.04.010
   Vernon RB, 2005, BIOMATERIALS, V26, P3131, DOI 10.1016/j.biomateriasl.2004.08.011
   Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d
   Walters EM, 2004, METH MOL B, V254, P375
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang P, 2007, TALANTA, V73, P431, DOI 10.1016/j.talanta.200.7.04.022
   Weber J, 2006, SENSOR ACTUAT B-CHEM, V117, P308, DOI 10.1016/j.snb.2005.12.025
   Wei JS, 2008, THIN SOLID FILMS, V516, P5181, DOI 10.1016/j.tsf.2007.07.051
   West J, 2008, ANAL CHEM, V80, P4403, DOI 10.1021/ac800680j
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wilding P, 1998, ANAL BIOCHEM, V257, P95, DOI 10.1006/abio.1997.2530
   Wirthlin DJ, 2002, J SURG RES, V108, P14, DOI 10.1006/jsre.2002.6509
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wu HK, 2004, P NATL ACAD SCI USA, V101, P12809, DOI 10.1073/pnas.0405299101
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   YALCINKAYA F, 1997, ANN INT C IEEE ENG M, V6, P2350
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zborowski M, 2003, BIOPHYS J, V84, P2638, DOI 10.1016/S0006-3495(03)75069-3
   Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h
   Zhang SF, 2008, BIOMATERIALS, V29, P3993, DOI 10.1016/j.biomaterials.2008.06.024
   Zhao YJ, 2007, J MICROMECH MICROENG, V17, P2528, DOI 10.1088/0960-1317/17/12/020
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zhu XY, 2004, ANALYST, V129, P1026, DOI 10.1039/b407623k
   Ziaie B, 2004, ADV DRUG DELIVER REV, V56, P145, DOI 10.1016/j.addr.2003.09.001
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
   Zou H, 2006, BIOMED MICRODEVICES, V8, P353, DOI 10.1007/s10544-006-9818-4
NR 231
TC 86
Z9 90
U1 2
U2 78
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2009
VL 10
IS 12
BP 5411
EP 5441
DI 10.3390/ijms10125411
PG 31
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 536KE
UT WOS:000273042500015
PM 20054478
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zwetyenga, N
   Catros, S
   Emparanza, A
   Deminiere, C
   Siberchicot, F
   Fricain, JC
AF Zwetyenga, N.
   Catros, S.
   Emparanza, A.
   Deminiere, C.
   Siberchicot, F.
   Fricain, J. -C.
TI Mandibular reconstruction using induced membranes with autologous
   cancellous bone graft and HA-beta TCP: animal model study and
   preliminary results in patients
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE induced membrane; mandibular reconstruction; bone substitute;
   biomaterial
ID DYNAMIC BRIDGING PLATES; FREE FLAPS; DEFECTS; DISTRACTION; EXPERIENCE;
   CERAMICS
AB Providing an acceptable quality of life for patients after reconstruction of mandibular segmental defects is challenging because the surgical techniques available have limitations. The authors evaluated two-stage mandibular reconstruction in rabbits and provide preliminary results in humans. 21 rabbits underwent bilateral segmental manibulectomy and the defect was filled with methylmethacrylate. The methylmethacrylate was removed after 4 weeks and an iliac autograft performed on the right-hand side and an autogenous graft with hydroxyapatite and triphasic calcium phosphate (HA-PTCP) oil the left-hand side. Four patients with severe mandibular osteoradionecrosis Underwent a two-stage reconstruction. No clinical or paraclinical complications were noted. Hematoxylineosin-saffron staining revealed an induced membrane lining the cavity of all samples with dense vascularity. Decalcified, undecalcified and histomorphometric analysis showed new bone formation in the biomaterial and the autograft. Calcium uptake was higher inside the new cortical bone, notably at sites with HA-PTCP. CT scans at 6 months showed that two patients had a favorable outcome with cortico-cancellous bone. Microscopic and immunochemical analysis confirmed the experimental data. This study demonstrates the feasibility of mandibular reconstruction using the induced membranes technique. This technique is efficient, and the results would be better in non-irradiated patients with good general health.
C1 [Zwetyenga, N.] Ctr Hosp Univ Bordeaux, Dept Maxillofacial & Plast Surg, F-33076 Bordeaux, France.
   [Catros, S.] Dept Odontol, Bordeaux, France.
   [Deminiere, C.; Fricain, J. -C.] Ctr Hosp Univ Bordeaux, Dept Pathol, F-33076 Bordeaux, France.
   [Zwetyenga, N.; Fricain, J. -C.] Univ Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
RP Zwetyenga, N (reprint author), Ctr Hosp Univ Bordeaux, Dept Maxillofacial & Plast Surg, F-33076 Bordeaux, France.
EM narcisse.zwetyenga@chu-bordeaux.fr
CR Al-Sebaei MO, 2005, J ORAL MAXIL SURG, V63, P664, DOI 10.1016/j.joms.2004.12.015
   AN YH, 1999, ANIMAL MODELS ORTHOP, P251
   Barthe N, 2004, NUCL INSTRUM METH A, V527, P41, DOI 10.1016/j.nima.2004.03.014
   BENOIST M, 1978, J MAXILLOFAC SURG, V6, P40, DOI 10.1016/S0301-0503(78)80067-8
   Catros S, 2009, J ORTHOP RES, V27, P155, DOI 10.1002/jor.20738
   Cordeiro PG, 1999, PLAST RECONSTR SURG, V104, P1314, DOI 10.1097/00006534-199910000-00011
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Duan YR, 2005, J MATER SCI-MATER M, V16, P795, DOI 10.1007/s10856-005-3577-2
   Fennis JPM, 2004, INT J ORAL MAX SURG, V33, P48, DOI 10.1054/ijom.2003.0452
   GLEUR CC, 1995, OSTEOPOROSIS INT, V5, P262
   Goodger NM, 2005, J ORAL MAXIL SURG, V63, P1048, DOI 10.1016/j.joms.2005.03.024
   GULLANE PJ, 1986, ARCH OTOLARYNGOL, V112, P714
   HIDALGO DA, 1994, CLIN PLAST SURG, V21, P25
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Huh JY, 2005, ORAL SURG ORAL MED O, V100, P296, DOI 10.1016/j.tripleo.2004.12.015
   ILIZAROV GA, 1988, B HOSP JOINT DIS ORT, V48, P1
   Labbe D, 2005, PLAST RECONSTR SURG, V116, P1596, DOI 10.1097/01.prs.0000187170.48370.76
   Lu M, 2003, BRIT J ORAL MAX SURG, V41, P385, DOI 10.1016/S0266-4356(03)00169-4
   Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346
   Pelissier P, 2004, J ORTHOPAED RES, V22, P73, DOI 10.1016/S0736-0266(03)00165-7
   Pelissier P, 2002, BRIT J PLAST SURG, V55, P596, DOI 10.1054/bjps.2002.3936
   Pogrel MA, 1997, J ORAL MAXIL SURG, V55, P1200, DOI 10.1016/S0278-2391(97)90165-8
   Pothuaud L, 2005, BIOMATERIALS, V26, P6788, DOI 10.1016/j.biomaterials.2005.04.002
   Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017
   URKEN ML, 1991, ARCH OTOLARYNGOL, V117, P724
   WOLF E, 1992, VIRCHOWS ARCH A, V420, P17, DOI 10.1007/BF01605979
   Yoshimoto M, 2004, J ORAL MAXIL SURG, V62, P131, DOI 10.1016/j.joms.2004.03.011
   Zwetyenga N, 2002, BRIT J ORAL MAX SURG, V40, P307, DOI 10.1016/S0266-4356(02)00133-X
   Zwetyenga N, 2005, HORIZ CANC RES, V22, P139
   ZWETYENGA N, 2006, MAXILLOFACIAL CRANIO
NR 30
TC 24
Z9 33
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD DEC
PY 2009
VL 38
IS 12
BP 1289
EP 1297
DI 10.1016/j.ijom.2009.07.018
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 537HL
UT WOS:000273103800011
PM 19699612
DA 2018-10-20
ER

PT J
AU Gyorgy, E
   del Pino, AP
   Sauthier, G
   Figueras, A
AF Gyorgy, E.
   Perez del Pino, A.
   Sauthier, G.
   Figueras, A.
TI Biomolecular papain thin films grown by matrix assisted and conventional
   pulsed laser deposition: A comparative study
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
DE atomic force microscopy; biomedical materials; composite materials;
   enzymes; Fourier transform spectra; infrared spectra; molecular
   biophysics; powders; pulsed laser deposition; surface morphology; thin
   films
ID SECONDARY STRUCTURE; MOLECULAR-DYNAMICS; INFRARED-SPECTRA;
   DRUG-DELIVERY; EVAPORATION; PROTEIN; ABLATION; WATER; BIOMATERIALS;
   EMISSION
AB Biomolecular papain thin films were grown both by matrix assisted pulsed laser evaporation (MAPLE) and conventional pulsed laser deposition (PLD) techniques with the aid of an UV KrF* (lambda=248 nm, tau(FWHM)congruent to 20 ns) excimer laser source. For the MAPLE experiments the targets submitted to laser radiation consisted on frozen composites obtained by dissolving the biomaterial powder in distilled water at 10 wt % concentration. Conventional pressed biomaterial powder targets were used in the PLD experiments. The surface morphology of the obtained thin films was studied by atomic force microscopy and their structure and composition were investigated by Fourier transform infrared spectroscopy. The possible physical mechanisms implied in the ablation processes of the two techniques, under comparable experimental conditions were identified. The results showed that the growth mode, surface morphology as well as structure of the deposited biomaterial thin films are determined both by the incident laser fluence value as well as target preparation procedure.
C1 [Gyorgy, E.; Sauthier, G.; Figueras, A.] CSIC CIN2, Bellaterra 08193, Spain.
   [Gyorgy, E.] Natl Inst Lasers Plasma & Radiat Phys, Bucharest 76900 V, Romania.
   [Perez del Pino, A.] CSIC, ICMAB, Bellaterra 08193, Spain.
RP Gyorgy, E (reprint author), CSIC CIN2, Campus UAB, Bellaterra 08193, Spain.
EM egyorgy@cin2.es
RI Sauthier, Guillaume/A-5350-2011; Perez del Pino, Angel/G-3758-2011;
   Gyorgy, Eniko/C-4620-2012
OI Perez del Pino, Angel/0000-0002-1405-6027; 
FU Spanish Ministry for Science and Innovation [MAT2006-26534-E]; Romanian
   National University Research Council [652]
FX The authors acknowledge with thanks the financial support from the
   Spanish Ministry for Science and Innovation under the Contract No.
   MAT2006-26534-E and the Romanian National University Research Council
   under the Contract IDEAS No. 652.
CR Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Bauerle D., 1996, LASER PROCESSING CHE
   Bergeld J, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2360258
   Berthe L, 1999, J APPL PHYS, V85, P7552, DOI 10.1063/1.370553
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Caricato AP, 2008, APPL PHYS A-MATER, V93, P651, DOI 10.1007/s00339-008-4724-7
   DELAHAY P, 1981, CHEM PHYS LETT, V83, P250, DOI 10.1016/0009-2614(81)85456-5
   Dong SJ, 2002, ELECTROANAL, V14, P7, DOI 10.1002/1521-4109(200201)14:1<7::AID-ELAN7>3.0.CO;2-V
   Ellegaard O, 1998, J APPL PHYS, V83, P1078, DOI 10.1063/1.366797
   ESENALIEV RO, 1994, APPL PHYS B-LASERS O, V59, P73, DOI 10.1007/BF01081730
   Fitz-Gerald JM, 2005, APPL PHYS A-MATER, V80, P1109, DOI 10.1007/s00339-003-2392-1
   Gutierrez-Llorente A, 2004, ORG ELECTRON, V5, P29, DOI 10.1016/j.orgel.2003.11.003
   Gyorgy E, 2007, J MATER SCI-MATER M, V18, P1643, DOI 10.1007/s10856-007-3055-0
   Hernandez-Perez MA, 2003, APPL SURF SCI, V208, P658, DOI 10.1016/S0169-4332(02)01419-8
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Kecskemeti G, 2005, APPL SURF SCI, V247, P83, DOI 10.1016/j.apsusc.2005.01.144
   Leipner J, 2000, DRUGS, V59, P769, DOI 10.2165/00003495-200059040-00004
   Leveugle E, 2004, APPL PHYS A-MATER, V79, P1643, DOI 10.1007/s00339-004-2682-2
   Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Mercado AL, 2005, APPL PHYS A-MATER, V81, P591, DOI 10.1007/s00339-004-2994-2
   Mihailescu IN, 1999, TRENDS OPTICS PHOTON, P201
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   NISHI N, 1984, J CHEM PHYS, V80, P3898, DOI 10.1063/1.447172
   Patz T, 2005, APPL SURF SCI, V248, P416, DOI 10.1016/j.apsusc.2005.03.056
   PETROVICH DK, 2002, UV RAD ARCTIC ECOSYS, P73
   Pique A, 2003, SURF COAT TECH, V163, P293, DOI 10.1016/S0257-8972(02)00606-0
   Pique A, 2002, APPL SURF SCI, V186, P408, DOI 10.1016/S0169-4332(01)00704-8
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Rodrigo K, 2005, J LOW TEMP PHYS, V139, P683, DOI 10.1007/s10909-005-5480-0
   Rodrigo K, 2004, CHEM PHYS LETT, V399, P368, DOI 10.1016/j.cplett.2004.10.052
   Rodriguez-Mozaz S, 2004, PURE APPL CHEM, V76, P723, DOI 10.1351/pac200476040723
   Sankalia MG, 2006, J PHARM SCI-US, V95, P1994, DOI 10.1002/jps.20665
   Smausz T, 2009, THIN SOLID FILMS, V517, P4299, DOI 10.1016/j.tsf.2008.11.141
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Taketani I, 2005, APPL SURF SCI, V244, P623, DOI 10.1016/j.apsusc.2004.09.167
   Thrower JD, 2008, J VAC SCI TECHNOL A, V26, P919, DOI 10.1116/1.2834687
   Toftmann B, 2004, THIN SOLID FILMS, V453, P177, DOI 10.1016/j.tsf.2003.11.099
   Tsuboi Y, 2001, J APPL PHYS, V89, P7917, DOI 10.1063/1.1371266
   Vedantham G, 2000, ANAL BIOCHEM, V285, P33, DOI 10.1006/abio.2000.4744
   von Allmen M. B., 1995, LASER BEAM INTERACTI
   XING XL, 2003, BIOCHIPS TECHNOLOGY
   Zhigilei LV, 1999, APPL PHYS A-MATER, V69, pS75, DOI 10.1007/s003390051358
NR 44
TC 20
Z9 20
U1 2
U2 10
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD DEC 1
PY 2009
VL 106
IS 11
AR 114702
DI 10.1063/1.3266670
PG 6
WC Physics, Applied
SC Physics
GA 533QF
UT WOS:000272838600148
DA 2018-10-20
ER

PT J
AU Ainslie, KM
   Tao, SL
   Popat, KC
   Daniels, H
   Hardev, V
   Grimes, CA
   Desai, TA
AF Ainslie, Kristy M.
   Tao, Sarah L.
   Popat, Ketul C.
   Daniels, Hugh
   Hardev, Veeral
   Grimes, Craig A.
   Desai, Tejal A.
TI In vitro inflammatory response of nanostructured titania, silicon oxide,
   and polycaprolactone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silicon oxide; titanium; titania nanotubes; nanowires; inflammation;
   polycaprolactone
ID BIOMATERIAL SURFACE-CHEMISTRY; SMOOTH-MUSCLE-CELLS;
   POLY(EPSILON-CAPROLACTONE) FILMS; MAGNETOSTRICTIVE NANOWIRES;
   NANOPARTICLES; IL-1-BETA; MONOCYTES; TOXICITY; BIOCOMPATIBILITY;
   DEGRADATION
AB Nanostructured materials are ubiquitous in tissue engineering, drug delivery, and biosensing applications. Nonetheless, little is known about the inflammatory response of materials differing in surface nanoarchitecture. Here we report human monocyte viability and morphology, in addition to inflammatory cytokines (IL-1 alpha and B, IL-6, IL-10, IFN-alpha and gamma, TNF-alpha, IL-12, MIP-1 alpha and beta), and reactive oxygen species production on several nanostructured surfaces, compared to flat surfaces of the same material. The surfaces studied were titiania nanotubes, short and long silicon oxide, and polycaprolactone nanowires. The results indicate that inflammation on titanium, polycaprolactone, and silicon oxide materials can be reduced by restructuring the surface with nanoarchitecture. Nanostructured surfaces display a reduced inflammation response compared to a respective flat control, with significant differences between titanium and nanotubular titanium. Little difference is observed in the inflammatory response between short and long nanowires of PCL and silicon oxide. All Surfaces are significantly less inflammatory than the positive control, lipopolysaccharide. Additionally, we show that flat titanium is more inflammatory than silicon oxide and polycaprolactone. This study shows that nanoarchitecture can be used to reduce the inflammatory response of human monocytes in vitro. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 647-655, 2009
C1 [Ainslie, Kristy M.; Tao, Sarah L.; Popat, Ketul C.; Desai, Tejal A.] Univ Calif San Francisco, Dept Physiol, Div Bioengn, Lab Therapeut Micro & Nanotechnol, San Francisco, CA 94158 USA.
   [Tao, Sarah L.] Charles Stark Draper Lab Inc, Cambridge, MA 02139 USA.
   [Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Daniels, Hugh; Hardev, Veeral] Nanosys Inc, Palo Alto, CA 94040 USA.
   [Grimes, Craig A.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   [Grimes, Craig A.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP Desai, TA (reprint author), Univ Calif San Francisco, Dept Physiol, Div Bioengn, Lab Therapeut Micro & Nanotechnol, San Francisco, CA 94158 USA.
EM tejal.desai@ucsf.edu
OI Popat, Ketul C./0000-0002-2417-7789; Ainslie, Kristy/0000-0002-1820-8382
FU NSF; UC Discovery Grant; Sandler Family Foundation; Knights Templar Eye
   Foundation; Nanosys, Inc.; UCSF REAC AWARD
FX Contract grant sponsors: NSF, UC Discovery Grant, Sandler Family
   Foundation, Knights Templar Eye Foundation, Nanosys, Inc., UCSF REAC
   AWARD
CR Ainslie KM, 2005, NANO LETT, V5, P1852, DOI 10.1021/nl051117u
   Ainslie KM, 2007, NANOTOXICOLOGY, V1, P279, DOI 10.1080/17435390701781142
   Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   Bosetti M, 2002, J BIOMED MATER RES, V60, P79, DOI 10.1002/jbm.1282
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chang S, 2003, J VASC SURG, V37, P1082, DOI 10.1067/mva.2003.160
   Coligan JE, 2005, CURRENT PROTOCOLS IM
   Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Fukumori Y, 2006, ADV POWDER TECHNOL, V17, P1, DOI 10.1163/156855206775123494
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Gorrieri O, 2006, INT J ARTIF ORGANS, V29, P1012
   Gough JE, 2004, J BIOMED MATER RES A, V69A, P17, DOI 10.1002/jbm.a.20072
   HARRINGTON PC, 2007, DEV COMP IMMUNOL, V31, P817
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Inoue K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-106
   Janeway C., 2001, IMMUNOBIOLOGY
   Kim DH, 2005, P ANN INT IEEE EMBS, P4091
   Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233
   Lin H, 2006, NATL MED J INDIA, V19, P27
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MANGAN DF, 1991, J IMMUNOL, V146, P1541
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   NEWTON RC, 1990, PROG CLIN BIOL RES, V349, P217
   Paul W. E., 1994, FUNDAMENTAL IMMUNOLO
   Peters K, 2004, J MATER SCI-MATER M, V15, P321, DOI 10.1023/B:JMSM.0000021095.36878.1b
   Popat KC, 2006, J ORTHOP RES, V24, P619, DOI 10.1002/jor.20105
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197
   Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215
   Serrano MC, 2006, BIOMATERIALS, V27, P4706, DOI 10.1016/j.biomaterials.2006.05.007
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Sirenko O, 2002, IMMUNOL CELL BIOL, V80, P328, DOI 10.1046/j.1440-1711.2002.01085.x
   Suska F, 2003, BIOMATERIALS, V24, P461, DOI 10.1016/S0142-9612(02)00359-9
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Tao SL, 2007, NANO LETT, V7, P1463, DOI 10.1021/nl0700346
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   THORNAS MV, 2005, J LONG-TERM EFF MED, V15, P585
   Tsuji JS, 2006, TOXICOL SCI, V89, P42, DOI 10.1093/toxsci/kfi339
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhang H, 2005, MACROMOL BIOSCI, V5, P477, DOI 10.1002/mabi.200400202
   Zuruzi AS, 2006, NANOTECHNOLOGY, V17, P531, DOI 10.1088/0957-4484/17/2/032
NR 48
TC 52
Z9 56
U1 0
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2009
VL 91A
IS 3
BP 647
EP 655
DI 10.1002/jbm.a.32262
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 517BW
UT WOS:000271588800002
PM 18988278
DA 2018-10-20
ER

PT J
AU Faghihi, S
   Azari, F
   Szpunar, JA
   Vali, H
   Tabrizian, M
AF Faghihi, Shahab
   Azari, Fereshteh
   Szpunar, Jerzy A.
   Vali, Hojatollah
   Tabrizian, Maryam
TI Titanium crystal orientation as a tool for the improved and regulated
   cell attachment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium single crystals; preosteoblasts; fibroblasts; coculture system;
   immunofluorescence
ID OSTEOBLAST-LIKE CELLS; PLASMA FIBRONECTIN; SURFACE-ROUGHNESS; BOUND
   WATER; HUMAN BONE; ADHESION; FIBROBLASTS; MECHANISM; CULTURE;
   WETTABILITY
AB Cell adhesion is a fundamental process that controls cell proliferation, migration, and differentiation and is crucial for biomaterial-tissue integration. Osteoblast attachment on the surfaces of implant materials is, therefore, essential for the proper function of any implant in which osseointegration is required. Although many reports are available on osteoblast attachment using different surface modification, there is no specific report, so far, that investigates the effect of atomic order of specific crystallographic orientation of substrates on cell behavior. A novel coculture system is proposed to show the differential response of preosteoblast and fibroblast cell lines to the titanium single-crystal substrates. Our investigation has shown that surface recognition by the cell is influenced by the atomic structure of the surface leading to cell-type-specific adhesion. The degree of preosteoblast attachment is significantly higher on the Ti-(11 (2) over bar0), whereas the fibroblast adhesion is increased on the Ti-(10 (1) over bar0). This demonstrates that the three distinct faces of titanium substrates differ greatly in their capacity to serve as cell adhesive substrates. It also provides clear evidence for the role of crystal structure in regulating and improving cell-substrate interactions relevant for the optimal function of bone implant materials. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 656-662, 2009
C1 [Faghihi, Shahab; Azari, Fereshteh; Tabrizian, Maryam] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   [Faghihi, Shahab; Vali, Hojatollah; Tabrizian, Maryam] McGill Univ, Ctr Biorecognit & Biosensors, Montreal, PQ H3A 2B2, Canada.
   [Azari, Fereshteh; Vali, Hojatollah] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.
   [Szpunar, Jerzy A.] McGill Univ, Dept Min Met & Mat Engn, Montreal, PQ H3A 2B2, Canada.
   [Vali, Hojatollah] McGill Univ, Facil Elect Microscopy Res, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.
   [Tabrizian, Maryam] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Tabrizian, Maryam] McGill Univ, McGill Inst Adv Mat, Montreal, PQ H3A 2B2, Canada.
RP Tabrizian, M (reprint author), McGill Univ, Dept Biomed Engn, Duff Med Sci Bldg,Room 313,3775 Univ St, Montreal, PQ H3A 2B4, Canada.
EM maryam.tabrizian@mcgill.ca
RI Vali, Hojatollah/F-3511-2012
OI Vali, Hojatollah/0000-0003-3464-9943
FU Natural Science and Engineering Research Council (NSERC) of Canada;
   Canadian Institutes for Health Research-Regenerative Medicine; Fonds
   Quebecois de la recherche sur la nature et les technologies
   (FQRNT-Regroupement strategique); NanoQuebec
FX Contract grant sponsors: Natural Science and Engineering Research
   Council (NSERC) of Canada, Canadian Institutes for Health
   Research-Regenerative Medicine, Fonds Quebecois de la recherche sur la
   nature et les technologies (FQRNT-Regroupement strategique) and
   NanoQuebec
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BOSS JH, 1994, MED PROG TECHNOL, V20, P119
   Boyan BD, 1999, J ORTHOP RES, V17, P446, DOI 10.1002/jor.1100170322
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gregory CA, 2005, J BIOL CHEM, V280, P2309, DOI 10.1074/jbc.M406275200
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1981, J CELL SCI, V48, P19
   Gronowicz G, 1996, J BONE MINER RES, V11, pS323
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   HANEIN D, 1993, J CELL SCI, V104, P275
   Hanein D, 1996, CELL ADHES COMMUN, V4, P341, DOI 10.3109/15419069609010777
   HANEIN D, 1995, CELL MATER, V5, P197
   HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221
   HANEIN D, 1993, LANGMUIR, V9, P1058, DOI 10.1021/la00028a030
   Harris LG, 2005, J BIOMED MATER RES A, V73A, P12, DOI 10.1002/jbm.a.30276
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Lallier TE, 2005, J PERIODONTOL, V76, P1044, DOI 10.1902/jop.2005.76.7.1044
   Lohmann CH, 1999, J BIOMED MATER RES, V47, P139, DOI 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Misch Carl E, 2003, Clin Implant Dent Relat Res, V5, P17, DOI 10.1111/j.1708-8208.2003.tb00178.x
   Palaiologou AA, 2001, J PERIODONTOL, V72, P798, DOI 10.1902/jop.2001.72.6.798
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Traskine V, 2000, COLLOID SURFACE A, V166, P261, DOI 10.1016/S0927-7757(99)00491-4
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Zimmerman E, 1999, J STRUCT BIOL, V125, P25, DOI 10.1006/jsbi.1998.4061
NR 33
TC 10
Z9 10
U1 3
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2009
VL 91A
IS 3
BP 656
EP 662
DI 10.1002/jbm.a.32275
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 517BW
UT WOS:000271588800003
PM 18988281
DA 2018-10-20
ER

PT J
AU Sandberg, T
   Blom, H
   Caldwell, KD
AF Sandberg, Tomas
   Blom, Hans
   Caldwell, Karin D.
TI Potential use of mucins as biomaterial coatings. I. Fractionation,
   characterization, and model adsorption of bovine, porcine, and human
   mucins
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mucin fractionation; mucin-associated components; size-exclusion
   chromatograpliy-multiangle light scattering-refractometry (SEC-MALS-RI);
   biomaterial coating; MUC5B
ID LIGHT-SCATTERING; GASTRIC MUCIN; HYDROPHOBIC SURFACES; SUBMAXILLARY
   MUCINS; MUCUS GLYCOPROTEINS; ELLIPSOMETRY; SALIVA; LUBRICATION;
   POLYSTYRENE; TRANSITION
AB Previously, we presented evidence that mucins have potential as biomaterial coatings. Here, we reveal substantial batch-to-batch variations for a frequently used commercial bovine salivary mucin preparation (BSM) and stress the importance of standardizing mucins intended for comparative purposes. "Mild" fractionation strategies, aiming at preserving natural mucin functions, were used to prepare two more defined BSM fractions as well as three mucin fractions from porcine gastric (PGM) and human salivary (MG1) sources. While the BSM and PGM were highly purified and mainly adopted random coil conformations in solution, the MG1 contained mucin-bound components (1.6 wt% albumin) and appeared compact. Average molar masses and root-mean-square radii for the predominant BSM, PGM, and MG1 species spanned 0.8-4.2 MDa and 46-86 nm, respectively. An ellipsometric evaluation, using hydrophilic and hydrophobic silica, showed the mucin adsorption to be slow and related to mucin charge, size, conformation, and compositional complexity. The mass uptakes on hydrophobic silica averaged 2.6, 2.6, and 5.0 mg/m(2), for BSM, PGM, and MG1, respectively. Finally, we find that stable mucin coatings can be formed on polymers of different wettability. The reported mucin preparations serve as platforms for a series of studies on the biocompatibility of mucin coatings. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 762-772, 2009
C1 [Sandberg, Tomas; Blom, Hans; Caldwell, Karin D.] Uppsala Univ, BMC, Dept Phys & Analyt Chem, Div Surface Biotechnol, SE-75123 Uppsala, Sweden.
RP Caldwell, KD (reprint author), Uppsala Univ, BMC, Dept Phys & Analyt Chem, Div Surface Biotechnol, SE-75123 Uppsala, Sweden.
EM karin.caldwell@ytbioteknik.uu.se
CR Andersson M, 2003, ANAL CHEM, V75, P4279, DOI 10.1021/ac030128+
   BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223
   Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001
   Bastardo L, 2002, LANGMUIR, V18, P3848, DOI 10.1021/la015717u
   Benesch J, 2000, COLLOID SURFACE B, V18, P71, DOI 10.1016/S0927-7765(99)00136-8
   Berg CH, 2004, BIOFOULING, V20, P65, DOI 10.1080/08927010310001639082
   BERRY GC, 1966, J CHEM PHYS, V44, P4550, DOI 10.1063/1.1726673
   BETTELHEIM FA, 1965, ARCH BIOCHEM BIOPHYS, V109, P259, DOI 10.1016/0003-9861(65)90360-7
   Cao XX, 1999, BIOPHYS J, V76, P1250, DOI 10.1016/S0006-3495(99)77288-7
   CUYPERS PA, 1983, J BIOL CHEM, V258, P2426
   Davies Jr, 2000, METH MOL B, V125, P3
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DURRER C, 1995, J COLLOID INTERF SCI, V170, P555, DOI 10.1006/jcis.1995.1134
   GONG DH, 1990, AM J PHYSIOL, V259, pG681
   Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501
   Jumel K, 1996, INT J BIOL MACROMOL, V18, P133, DOI 10.1016/0141-8130(95)01071-8
   Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169
   Lee S, 2005, LANGMUIR, V21, P8344, DOI 10.1021/la050779w
   LEVINE MJ, 1993, CRIT REV ORAL BIOL M, V4, P279, DOI 10.1177/10454411930040030401
   Lindh L, 2002, COLLOID SURFACE B, V25, P139, DOI 10.1016/S0927-7765(01)00300-9
   Liu B, 2002, J HISTOCHEM CYTOCHEM, V50, P811, DOI 10.1177/002215540205000607
   LOOMIS RE, 1987, ARCH BIOCHEM BIOPHYS, V258, P452, DOI 10.1016/0003-9861(87)90366-3
   MALMSTEN M, 1992, J COLLOID INTERF SCI, V151, P579, DOI 10.1016/0021-9797(92)90506-H
   O'Boyle KP, 2000, SCAND J IMMUNOL, V52, P46
   Perez-Vilar J, 2004, ENCY BIOL CHEM, P758
   Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2
   PROUST JE, 1983, J COLLOID INTERF SCI, V94, P421, DOI 10.1016/0021-9797(83)90282-5
   Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/bj3620289
   SANDBERG T, 2008, POTENTIAL USE UNPUB, V2
   SCAWEN M, 1977, BIOCHEM J, V163, P363, DOI 10.1042/bj1630363
   SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501
   SCHILLEN K, 1994, MACROMOLECULES, V27, P4825, DOI 10.1021/ma00095a025
   SHEEHAN JK, 1984, BIOCHEM J, V221, P499, DOI 10.1042/bj2210499
   Shi L, 2000, J COLLOID INTERF SCI, V224, P372, DOI 10.1006/jcis.2000.6724
   Shi L, 2000, TRENDS GLYCOSCI GLYC, V12, P229, DOI 10.4052/tigg.12.229
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   SHI L, 1999, THESIS U UTAH, P190
   SHOGREN RL, 1987, CARBOHYD RES, V160, P317
   Sigurdsson HH, 2006, INT J PHARM, V325, P75, DOI 10.1016/j.ijpharm.2006.06.027
   Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x
   VANKLINKEN BJW, 1995, AM J PHYSIOL-GASTR L, V269, pG613
   Woodward R.P., 1999, CONTACT ANGLE MEASUR
   Zhang J, 2005, J CELL PHYSIOL, V204, P166, DOI 10.1002/jcp.20277
   SWISS PROT TREMBL PR
NR 44
TC 41
Z9 41
U1 0
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2009
VL 91A
IS 3
BP 762
EP 772
DI 10.1002/jbm.a.32266
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 517BW
UT WOS:000271588800014
PM 19051309
DA 2018-10-20
ER

PT J
AU Sandberg, T
   Ott, MK
   Carlsson, J
   Feiler, A
   Caldwell, KD
AF Sandberg, Tomas
   Ott, Marjam Karlsson
   Carlsson, Jan
   Feiler, Adam
   Caldwell, Karin D.
TI Potential use of mucins as biomaterial coatings. II. Mucin coatings
   affect the conformation and neutrophil-activating properties of adsorbed
   host proteins-Toward a mucosal mimic
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mucin-based surface coatings; human neutrophil lipocalin (HNL);
   surface-exposed protein; protein stabilization; quartz crystal
   microbalance with dissipation monitoring (QCM-D)
ID QUARTZ-CRYSTAL MICROBALANCE; VISCOELASTIC PROPERTIES; RESPIRATORY BURST;
   MATERIAL-SURFACES; IN-VIVO; QCM-D; ADSORPTION; COMPLEXES; SERUM;
   LEUKOCYTES
AB In continuation of our recent fractionation and characterization study on mucins of bovine salivary (BSM), porcine gastric (PGM), and human salivary (MG1) origin, this study evaluates the effect of mucin precoating on the conformation and neutrophil-activating properties of host proteins adsorbed to a polyethylene terephthalate-based model biomaterial. Microscopy combined with assays for the neutrophil releases of reactive oxygen species and human neutrophil lipocalin showed that mucin precoating greatly reduced the strong immune-response normally induced by adsorbed immunoglobulin G (IgG) and secretory immunoglobulin A (sIgA), respectively. A similar finding was made for the proinflammatory fibrinogen. Although the total uptakes of these proteins depended on the mucin surface concentration, a detailed composite analysis suggested the fraction Of surface-exposed protein to be a stronger determinant of coating performance. The unexpectedly low neutrophil activation showed by composites containing near-monolayer concentrations of exposed IgG and sIgA, respectively, suggested that these act synergistically with mucin on the surface. In support of this hypothesis, quartz crystal microbalance with dissipation monitoring measurements revealed that a preadsorbed BSM layer stabilizes IgG through complexation on a polymeric model surface. Our findings link well to the complex in vivo situation and suggest that functional mucosal mimics can be created in situ for improved biomaterials performance. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 773-785, 2009
C1 [Sandberg, Tomas; Ott, Marjam Karlsson; Carlsson, Jan; Feiler, Adam; Caldwell, Karin D.] Uppsala Univ, BMC, Dept Phys & Analyt Chem, Div Surface Biotechnol, SE-75123 Uppsala, Sweden.
RP Caldwell, KD (reprint author), Uppsala Univ, BMC, Dept Phys & Analyt Chem, Div Surface Biotechnol, SE-75123 Uppsala, Sweden.
EM karin.caldwell@ytbioteknik.uu.se
CR Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001
   BUIJS J, 1995, COLLOID SURFACE B, V5, P11, DOI 10.1016/0927-7765(95)98205-2
   Cooper S. L., 2004, BIOMATERIALS SCI, P67
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Dedinaite A, 2005, LANGMUIR, V21, P9502, DOI 10.1021/la0511844
   Feiler AA, 2007, J COLLOID INTERF SCI, V315, P475, DOI 10.1016/j.jcis.2007.07.029
   GONG DH, 1990, AM J PHYSIOL, V259, pG681
   HAKANSSON L, 1980, SCAND J IMMUNOL, V11, P271, DOI 10.1111/j.1365-3083.1980.tb00235.x
   Hanson S., 2004, BIOMATERIALS SCI INT, P332
   HOFFMAN AS, 2004, BIOMATERIALS SCI INT, P225
   Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Horbett TA, 2004, BIOMATERIALS SCI INT, P237
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501
   JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3
   Johnson R.J., 2004, BIOMATERIALS SCI INT, P318
   Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169
   Lindh L, 2007, J COLLOID INTERF SCI, V310, P74, DOI 10.1016/j.jcis.2007.01.086
   Mitchell R.N., 2004, BIOMATERIALS SCI, P304
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   Nygren H, 2001, COLLOID SURFACE B, V22, P87, DOI 10.1016/S0927-7765(00)00216-2
   Otto M, 2003, J MATER SCI-MATER M, V14, P263, DOI 10.1023/A:1022840909038
   Park WK, 2006, ARCH ORAL BIOL, V51, P861, DOI 10.1016/j.archoralbio.2006.04.002
   Peppas NA, 2004, BIOMATERIALS SCI INT, P100
   PEREZ E, 1987, J COLLOID INTERF SCI, V118, P182, DOI 10.1016/0021-9797(87)90447-4
   Perez-Vilar J, 2004, ENCY BIOL CHEM, P758
   Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2
   RATNER BD, 2004, BIOMATERIALS SCI, P197
   SANDBERG T, 2008, J COLLOID INTE UNPUB
   Sandberg T, 2007, MICROSC RES TECHNIQ, V70, P864, DOI 10.1002/jemt.20489
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P762, DOI 10.1002/jbm.a.32266
   Sandberg T, 2009, J MATER SCI-MATER M, V20, P621, DOI 10.1007/s10856-008-3595-y
   Shi L, 2000, J COLLOID INTERF SCI, V224, P372, DOI 10.1006/jcis.2000.6724
   Shi L, 2000, TRENDS GLYCOSCI GLYC, V12, P229, DOI 10.4052/tigg.12.229
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   SHI L, 1999, THESIS U UTAH, P190
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Soares RV, 2004, ARCH ORAL BIOL, V49, P337, DOI 10.1016/j.archoralbio.2003.11.007
   STEWART WW, 1990, IMMUNOLOGY, V71, P328
   Svensson O, 2006, J COLLOID INTERF SCI, V299, P608, DOI 10.1016/j.jcis.2006.02.027
   Tammelin T, 2004, LANGMUIR, V20, P10900, DOI 10.1021/la0487693
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016
   Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Woodley J, 2001, CLIN PHARMACOKINET, V40, P77, DOI 10.2165/00003088-200140020-00001
   XU SY, 1994, J IMMUNOL METHODS, V171, P245, DOI 10.1016/0022-1759(94)90044-2
NR 52
TC 24
Z9 24
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2009
VL 91A
IS 3
BP 773
EP 785
DI 10.1002/jbm.a.32315
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 517BW
UT WOS:000271588800015
PM 19051307
DA 2018-10-20
ER

PT J
AU Wu, CKA
   Pettit, AR
   Toulson, S
   Grondahl, L
   Mackie, EJ
   Cassady, AI
AF Wu, C. K. A.
   Pettit, A. R.
   Toulson, S.
   Grondahl, L.
   Mackie, E. J.
   Cassady, A. I.
TI Responses in vivo to purified
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate) implanted in a murine
   tibial defect model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE murine model; fracture repair; bone tissue engineering; PHBV;
   inflammatory response; biocompatibility
ID FOREIGN-BODY REACTION; TISSUE-RESPONSE; BONE; VITRO;
   POLYHYDROXYALKANOATES; POLYHYDROXYBUTYRATE; HYDROXYAPATITE; DEGRADATION;
   MACROPHAGES; COMPOSITE
AB Effective bone biomaterials provide structural support for bone regeneration and elicit minimal inflammatory or toxic effects in vivo. Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) is a bacterially derived biodegradable polymer that possesses suitable mechanical strength for use as a bone biomaterial and has a slow rate of degradation in biological environments. Our previous in vitro study showed that many PHBV preparations are contaminated with bacterial lipopolysaccharide, and we developed a purification procedure to substantially remove it. Here, we have evaluated the in vivo biocompatibility of PHBV purified by H(2)O(2) treatment and solvent extraction. We utilized a murine tibial defect model consisting of a hole drilled through the diameter of the tibial diaphysis into which nonporous cylindrical plugs of purified PHBV were implanted. The animals were sacrificed at 1 week and 4 weeks postsurgery, and tibiae were examined using histological staining. The PHBV implant induced a mild inflammatory response I week after injury, which persisted for 4 weeks. Granuloma type tissues formed only when the implant protruded into the overlaying tissue. Woven bone formation occurred adjacent to the implant, which gave rise to lamellar bone and stabilized the implant indicating that the PHBV did not affect this process. Our data validated the murine defect model and indicate that solid PHBV induces a mild tissue reaction with bone deposition adjacent to the implant with no fibrous tissue present at 4 weeks post surgery. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 845-854, 2009
C1 [Wu, C. K. A.; Pettit, A. R.; Cassady, A. I.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.
   [Wu, C. K. A.; Pettit, A. R.; Cassady, A. I.] Univ Queensland, Cooperat Res Ctr Chron Inflammatory Dis, St Lucia, Qld 4072, Australia.
   [Toulson, S.; Mackie, E. J.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3010, Australia.
   [Grondahl, L.] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia.
RP Cassady, AI (reprint author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.
EM i.cassady@imb.uq.edu.au
RI Mackie, Eleanor/B-2045-2008; Pettit, Allison/G-2591-2010
OI Pettit, Allison/0000-0003-4707-7892; Grondahl,
   Lisbeth/0000-0001-6012-9808; Cassady, Alan/0000-0001-8585-5427; Mackie,
   Eleanor/0000-0002-8057-5407
FU Cooperative Research Centre for Chronic Inflammatory Diseases
FX Contract grant sponsor: Cooperative Research Centre for Chronic
   Inflammatory Diseases
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bostman OM, 1998, J BONE JOINT SURG AM, V80A, P1791, DOI 10.2106/00004623-199812000-00010
   Campbell TM, 2003, CALCIFIED TISSUE INT, V73, P49, DOI 10.1007/s00223-002-2120-4
   Cool SM, 2007, J BIOMED MATER RES A, V82A, P599, DOI 10.1002/jbm.a.31174
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Einhorn TA, 2005, J ORTHOP TRAUMA, V19, pS4, DOI 10.1097/00005131-200511101-00002
   Emery SE, 1996, SPINE, V21, P2713, DOI 10.1097/00007632-199612010-00003
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Honma T, 1996, VIRCHOWS ARCH, V428, P165
   HUME DA, 1984, J CELL SCI, V66, P189
   Jackson RA, 2006, J ORTHOP RES, V24, P636, DOI 10.1002/jor.20103
   Keen I, 2007, J BIOMAT SCI-POLYM E, V18, P1101, DOI 10.1163/156856207781554046
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   MAURIN N, 1995, J BIOMED MATER RES, V29, P1493, DOI 10.1002/jbm.820291205
   Reddy CSK, 2003, BIORESOURCE TECHNOL, V87, P137, DOI 10.1016/S0960-8524(02)00212-2
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   Shishatskaya EI, 2006, J BIOMAT SCI-POLYM E, V17, P481, DOI 10.1163/156856206776986242
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Unverdorben M, 2002, CARDIOVASC INTER RAD, V25, P127, DOI 10.1007/s00270-001-0118-3
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
NR 29
TC 13
Z9 16
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2009
VL 91A
IS 3
BP 845
EP 854
DI 10.1002/jbm.a.32238
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 517BW
UT WOS:000271588800022
PM 19065568
DA 2018-10-20
ER

PT J
AU Bernstein, P
   Dong, M
   Graupher, S
   Corbeil, D
   Gelinsky, M
   Gunther, KP
   Fickert, S
AF Bernstein, Peter
   Dong, Meng
   Graupher, Sylvi
   Corbeil, Denis
   Gelinsky, Michael
   Guenther, Klaus-Peter
   Fickert, Stefan
TI Sox9 expression of alginate-encapsulated chondrocytes is stimulated by
   low cell density
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Sox9; alginate; chondrocyte differentiation; cell density
ID HUMAN ARTICULAR CHONDROCYTES; TISSUE-ENGINEERED CARTILAGE;
   GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SULFATED
   GLYCOSAMINOGLYCANS; TRANSCRIPTION FACTOR; MATRIX SYNTHESIS; SEEDING
   DENSITY; OXYGEN-TENSION; IN-VITRO
AB Recent research in tissue engineering for the treatment of cartilage defects have demonstrated that matrix-biomaterial, cell culture conditions, and cytokine-related factors influence the chondrogenic differentiation pattern, especially for the expression of matrix genes. However, little is known about the impact of cell seeding density in a three-dimensional environment on the key chondrogenic transcription factor Sox9. Here we investigated, whether the cell concentration of alginate encapsulated chondrocytes influences the Sox9 expression. Dedifferentiated passage-4 porcine chondrocytes were encapsulated in alginate beads at two different concentrations (4 X 10(6) versus 7 X 10(7) cells/mL) and cultivated for up to 4 weeks under TGF-beta Stimulation. The expression of Sox9, Collagen I, II, and X was assessed via quantitative RT-PCR and compared to those observed in the initial monolayer culture. Cellular viability, cell morphology, and the sulphated glycosaminoglycan-production were monitored. Interestingly Sox9 expression was significantly upregulated in the low-cell-density group, whereas no difference between high-cell-density and monolayer culture group could be observed. Furthermore, the cellular survival and the sulphated glycosaminoglycan production were higher in the low-cell-density group. Collagen I expression was downregulated in the low-cell-density group whereas it was upregulated in the high-cell-density one. Surprisingly, only the high-cell-density group showed the expression of Collagen II, although it appeared not significant. Collagen X expression was upregulated in the low-cell-density group. Taken together our data indicate that a low concentration of cell seeding in a three-dimensional environment is beneficial for the overall chondrogenic development. However, this article reveals discrepancies between Sox9 and the chondrogenic pathway in redifferentiating chondrocytes that should be addressed in further work. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 910-918, 2009
C1 [Bernstein, Peter; Dong, Meng; Graupher, Sylvi; Guenther, Klaus-Peter] Tech Univ Dresden, Fac Med, Univ Hosp Carl Gustav Carus Dresden, Dept Orthopaed Surg, Dresden, Germany.
   [Dong, Meng; Graupher, Sylvi; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, Dresden, Germany.
   [Gelinsky, Michael] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, Dresden, Germany.
   [Fickert, Stefan] Univ Heidelberg, Dept Orthopaed Surg, Fac Clin Med Mannheim, D-6800 Mannheim, Germany.
RP Bernstein, P (reprint author), Tech Univ Dresden, Fac Med, Univ Hosp Carl Gustav Carus Dresden, Dept Orthopaed Surg, Dresden, Germany.
EM peter.bernstein@uniklinikum-dresden.de
RI Corbeil, Denis/A-6519-2010; Gelinsky, Michael/A-9680-2012
OI Gelinsky, Michael/0000-0001-9075-5121; Corbeil,
   Denis/0000-0003-1181-3659
FU Saxonian Ministry for Science and Arts (SMWK), Germany
FX Contract grant sponsor: The Saxonian Ministry for Science and Arts
   (SMWK), Germany
CR Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0
   Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bi WM, 1999, NAT GENET, V22, P85
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bradham DM, 1998, CLIN ORTHOP RELAT R, P239
   Chaipinyo K, 2002, J ORTHOPAED RES, V20, P1070, DOI 10.1016/S0736-0266(02)00025-6
   Cucchiarini M, 2007, ARTHRITIS RHEUM, V56, P158, DOI 10.1002/art.22299
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   de Haart M, 1999, ACTA ORTHOP SCAND, V70, P55, DOI 10.3109/17453679909000959
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fortier LA, 1997, AM J VET RES, V58, P66
   Fraser SA, 2006, TISSUE ENG, V12, P569, DOI 10.1089/ten.2006.12.569
   Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606
   GALERA P, 1992, EXP CELL RES, V200, P379, DOI 10.1016/0014-4827(92)90186-C
   Goldberg AJ, 2005, J BONE JOINT SURG BR, V87B, P128, DOI 10.1302/0301-620X.87B1.14154
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   GUERNE PA, 1994, J CELL PHYSIOL, V158, P476, DOI 10.1002/jcp.1041580312
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Heywood HK, 2004, TISSUE ENG, V10, P1467, DOI 10.1089/ten.2004.10.1467
   Hoemann CD, 2002, ANAL BIOCHEM, V300, P1, DOI 10.1006/abio.2001.5436
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kolettas E, 2001, RHEUMATOLOGY, V40, P1146, DOI 10.1093/rheumatology/40.10.1146
   Kypriotou M, 2003, DNA CELL BIOL, V22, P119, DOI 10.1089/104454903321515922
   Lefebvre V., 2001, OSTEOARTHR CARTILAGE, V9, P69
   LI Y, 2004, TISSUE ENG, V10, P576
   Mandl EW, 2004, TISSUE ENG, V10, P109, DOI 10.1089/107632704322791754
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Moller HD, 2000, ORTHOPADE, V29, P75
   Moretti M, 2005, TISSUE ENG, V11, P1421, DOI 10.1089/ten.2005.11.1421
   Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481
   PUJOL JP, 1994, ANN ENDOCRINOL-PARIS, V55, P109
   Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738
   Shum Lillian, 2003, Birth Defects Research, V69, P102, DOI 10.1002/bdrc.10012
   Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004
   Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200
   Van Osch GJVM, 1998, MATRIX BIOL, V17, P413, DOI 10.1016/S0945-053X(98)90101-9
   WATT FM, 1988, J CELL SCI, V89, P373
   Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35
NR 42
TC 13
Z9 13
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2009
VL 91A
IS 3
BP 910
EP 918
DI 10.1002/jbm.a.32308
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 517BW
UT WOS:000271588800029
PM 19097150
DA 2018-10-20
ER

PT J
AU Wang, DZ
   Lott, P
   Sarver, DB
   Livada, R
   Kaur, M
   Reddy, M
   Lemons, J
AF Wang, Dezhi
   Lott, Patty
   Sarver, David B.
   Livada, Rania
   Kaur, Manender
   Reddy, Michael
   Lemons, Jack
TI A Novel Technique for the Quantification of Demineralized Bone Matrix
   Versus New Bone in Dental Extraction Sockets
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 35th Annual Symposium/Convention of the
   National-Society-for-Histotechnology
CY OCT 03-08, 2009
CL Birmingham, AL
SP Natl Soc Histotechnol
AB Demineralized bone matrix (DBM) is a well-established osteoinductive bone material derived from pulverized cortical bone specimens. To develop an implantable product, acellular particles are added to a substrate such as glycerol or a biodegradable polymer, resulting in an osteoinductive bone graft material. DBM has been used successfully as bone-graft substitute material in the treatment of many periodontal procedures, in craniofacial defect repairs, and also in orthopedic and other types of surgery. In this clinical study, DBM was used as the graft material to help complete the alveolar bone healing before placement of a dental implant. To further analyze the amount of new bone growth versus the residual DBM in the site, histological serial sections were prepared of each bone core removed from patients. and histomorphometry was performed on the sections stained using Methylene Blue/Basic Fuchsin (hematoxylin and eosin-like stain) and von Kossa stains. We found that von Kossa staining offered opportunities for the identification of specimen components when compared with the hematoxylin and eosin-like stain for identifying the DBM versus new bone. The von Kossa stains the DBM biomaterial light brown, whereas it stains the phosphate ion of mineralized bone black. This staining creates an excellent contrast to a transparent background, facilitating quantification with the use of image analysis software on the basis of color. Furthermore, the combined use of von Kossa staining and polarized light created much more consistent results for the histomorphometric analysis through considerably lower intraobserver variability. (The J Histotechnol 32(4):204-206, 2009)
C1 [Wang, Dezhi; Lott, Patty; Sarver, David B.] Univ Alabama, Ctr Metab Bone Dis Lab, Orthopaed Res Lab, Birmingham, AL 35294 USA.
   [Livada, Rania; Kaur, Manender; Reddy, Michael] Univ Alabama, Sch Dent, Dept Periodont, Birmingham, AL 35294 USA.
   [Lemons, Jack] Univ Alabama, Sch Dent, Dept Prosthodont, Birmingham, AL 35294 USA.
   [Lemons, Jack] Univ Alabama, Sch Engn, Dept Biomat, Birmingham, AL 35294 USA.
RP Lott, P (reprint author), Univ Alabama, Ctr Metab Bone Dis Lab, Orthopaed Res Lab, 509 Lyons Harrison Res Bldg,701 19th St S, Birmingham, AL 35294 USA.
EM plott@uab.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073 USA
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD DEC
PY 2009
VL 32
IS 4
BP 204
EP 206
DI 10.1179/his.2009.32.4.204
PG 3
WC Cell Biology
SC Cell Biology
GA 564UM
UT WOS:000275243200020
DA 2018-10-20
ER

PT J
AU Sun, YQ
   Zhou, YM
   Wang, ZQ
AF Sun, Yanqing
   Zhou, Yuming
   Wang, Zhiqiang
TI Novel Hybrid Materials Obtained During the Crystalline Growth of Layered
   Double Hydroxides Using Grafted Chitosan as a Template
SO JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS
LA English
DT Article
DE CTS; Layered double hydroxides; Acrylic acid; Graft copolymerization;
   Biomineralization; Infrared emissivity
ID INFRARED EMISSIVITY; FILMS; NANOCOMPOSITE; MATRICES; SIZE
AB To overcome some limitations of layered double hydroxides (LDH)-type materials in efficient development of composites with biopolymers, a templating method was employed based on graft copolymerization of acrylic acid onto CTS and successive impregnation of the LDH into the interstices of the grafted CTS matrix. The results indicated that, with gradual increase in the stirring speed, grafted CTS experienced evolutions from formless bulky agglomerations to well-dispersed spheroids and then to a well-ordered matrix of a copolymer network. In the subsequent templating synthesis, an LDH-type phase was formed and an LDH replica was obtained either by dissolution of the grafted CTS or by a calcination-reconstruction process. It was found that the copolymer network showed superiority over spheroids on adsorption of metal ions and efficient combination with the LDH that was generated in situ. The growth of LDH crystallites was templated and inhibited by the grafted copolymer, thereby filling the template voids of the matrix network in the form of a club at the nanometer scale with a load content up to 38.7 wt%. This type of novel hybrid biomaterial exhibited potential use in infrared camouflage by achieving a minimum emissivity value of 0.351 due to regular and ordered inorganic-organic combinations with large synergistic interfaces at molecular level.
C1 [Sun, Yanqing; Zhou, Yuming; Wang, Zhiqiang] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China.
RP Zhou, YM (reprint author), Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China.
EM fchem@seu.edu.cn
OI Zhou, Yuming/0000-0001-9958-455X
FU Jiangsu Province of China [06-A-033]; University of China [NCET-040482];
   National Natural Science Foundation of China [50377005]; Excellent
   Doctoral Thesis Foundation of Southeast University
FX This work was financially supported by "The Six Top Talents' of Jiangsu
   Province of China (06-A-033), Program for New Century Excellent Talents
   in University of China (NCET-040482), the National Natural Science
   Foundation of China (50377005) and Excellent Doctoral Thesis Foundation
   of Southeast University.
CR Aimoli CG, 2006, COLLOID SURFACE B, V53, P15, DOI 10.1016/j.colsurfb.2006.07.012
   bin Hussein MZ, 2002, MAT SCI ENG B-SOLID, V88, P98, DOI 10.1016/S0921-5107(01)00918-7
   Biswas PK, 2003, MATER LETT, V57, P2326, DOI 10.1016/S0167-577X(02)01220-X
   Boulova M, 2002, J SOLID STATE CHEM, V167, P425, DOI 10.1006/jssc.2002.9649
   Choi SW, 2003, SEP PURIF TECHNOL, V30, P69, DOI 10.1016/S1383-5866(02)00121-1
   Chou KS, 2007, THIN SOLID FILMS, V515, P7217, DOI 10.1016/j.tsf.2007.03.047
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Coradin T, 2004, COLLOID SURFACE B, V35, P53, DOI 10.1016/j.colsurfb.2004.02.008
   El-Tahlawy KF, 2006, CARBOHYD POLYM, V66, P176, DOI 10.1016/j.carbpol.2006.03.001
   Falini G, 2000, INT J INORG MATER, V2, P455, DOI 10.1016/S1466-6049(00)00040-4
   Geraud E, 2006, J PHYS CHEM SOLIDS, V67, P903, DOI 10.1016/j.jpcs.2006.01.002
   He J, 2004, COLLOID SURFACE A, V251, P191, DOI 10.1016/j.colsurfa.2004.09.032
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Leftheriotis G, 1999, SOL ENERG MAT SOL C, V58, P185, DOI 10.1016/S0927-0248(98)00202-5
   Leroux F, 2001, CHEM MATER, V13, P3507, DOI 10.1021/cm0110268
   Leroux F, 2004, J SOLID STATE CHEM, V177, P245, DOI 10.1016/j.jssc.2003.08.013
   Li BG, 2003, COLLOID POLYM SCI, V281, P998, DOI 10.1007/s00396-003-0874-5
   Li B, 2006, J PHYS CHEM SOLIDS, V67, P1067, DOI 10.1016/j.jpcs.2006.01.027
   Lin BP, 2005, J SOLID STATE CHEM, V178, P650, DOI 10.1016/j.jssc.2004.12.010
   Lin BP, 2004, J SOLID STATE CHEM, V177, P3849, DOI 10.1016/j.jssc.2004.07.022
   Mahulikar SP, 2007, PROG AEROSP SCI, V43, P218, DOI 10.1016/j.paerosci.2007.06.002
   Morni NM, 1997, MAT SCI ENG B-SOLID, V45, P140, DOI 10.1016/S0921-5107(96)02023-5
   Okamoto K, 2007, APPL CLAY SCI, V37, P23, DOI 10.1016/j.clay.2006.10.008
   Tao YG, 2007, MAT SCI ENG B-SOLID, V138, P84, DOI 10.1016/j.mseb.2006.12.013
   Volkmer D, 2005, MAT SCI ENG C-BIO S, V25, P161, DOI 10.1016/j.msec.2005.01.006
   Yi J, 2007, APPL SURF SCI, V253, P7100, DOI 10.1016/j.apsusc.2007.02.051
   Zhang HT, 2004, REACT FUNCT POLYM, V59, P23, DOI 10.1016/j.reactfunctpolym.2003.11.001
NR 27
TC 1
Z9 1
U1 1
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1574-1443
J9 J INORG ORGANOMET P
JI J. Inorg. Organomet. Polym. Mater.
PD DEC
PY 2009
VL 19
IS 4
BP 436
EP 442
DI 10.1007/s10904-009-9292-6
PG 7
WC Polymer Science
SC Polymer Science
GA 522YG
UT WOS:000272035600002
DA 2018-10-20
ER

PT J
AU Joseph, L
   Velayudhan, A
   Charuvila, MV
   Vayalappil, MC
AF Joseph, Leena
   Velayudhan, Arumugham
   Charuvila, Muraleedharan V.
   Vayalappil, Muraleedharan C.
TI Reference biomaterials for biological evaluation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT Symposium on Materials for Biomedical Applications
CY 2007
CL Bangalore, INDIA
ID STANDARD REFERENCE MATERIALS; BIOCOMPATIBILITY; TITANIUM; IMPLANT;
   INVITRO; TI
AB The variability associated with most of the biological evaluation studies is relatively large and hence experimental controls are frequently employed to ensure that the results are reliable. These experimental controls, either positive or negative controls, could be considered as reference materials in the context of biological evaluation. Currently, reference biomaterial needs across the world are not addressed satisfactorily. Affordability and lack of availability of certified reference materials necessitates the development and the use of laboratory developed RMs. A well defined characterization strategy is essential for the successful development of in house reference materials. This article provides an overview of the current international status in the area of reference biomaterials and enumerates the steps involved in the development of an in house reference material. The production and characterization of commercially pure titanium pins for use as negative controls during muscle implantation studies is presented as a case study.
C1 [Joseph, Leena; Velayudhan, Arumugham; Charuvila, Muraleedharan V.; Vayalappil, Muraleedharan C.] Sree Chitra Tirunal Inst Med Sci & Technol, Thiruvananthapuram, Kerala, India.
RP Joseph, L (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Thiruvananthapuram, Kerala, India.
EM leenaj@sctimst.ac.in
RI CV, Muraleedharan/B-7060-2009
OI CV, Muraleedharan/0000-0002-8398-0379
CR [Anonymous], 1999, 109935 ISO
   [Anonymous], 2006, F67 ASTM
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Certification of Reference Materials, 1989, 35 ISO, V35
   Hsu SH, 2007, BIO-MED MATER ENG, V17, P53
   *INT ORG STAND, 2000, 109938 ISO
   *INT ORG STAND, 2002, 109934 ISO
   *INT ORG STAND, 2000, 34 ISO
   *INT ORG STAND, 1992, 30 ISO
   *INT ORG STAND, 2004, ISO VIM INT IN PRESS
   International Organisation for Standardisation, 2006, 35 ISO
   International Organization for Standardization, 2007, 109936 ISO
   International Organization for Standardization, 2007, 1099312 ISO
   International Organization for Standardization, 1999, 58322 ISO
   IP WF, 1991, J BIOMED MATER RES, V25, P1321, DOI 10.1002/jbm.820251012
   Krishnan LK, 2002, BIOMOL ENG, V19, P251, DOI 10.1016/S1389-0344(02)00029-1
   MAYER AE, 1999, HDB BIOMATERIALS EVA, P195
   Muller BP, 2002, J BIOMED MATER RES, V61, P83, DOI 10.1002/jbm.10158
   MURALEEDHARAN CV, 2006, METALS MAT PROCESS, V18, P441
   *NAT HEART LUNG BL, 1980, NIH PUBL
   Olin C, 2001, TITANIUM CARDIAC CAR, P890
   PELZER H, 1986, J BIOMED MATER RES, V20, P1401, DOI 10.1002/jbm.820200913
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   RATNER BD, 2001, PERSPECTIVE TITANIUM, P1
   Tesk J A, 2000, J Biomed Mater Res, V51, P155, DOI 10.1002/(SICI)1097-4636(200008)51:2<155::AID-JBM2>3.0.CO;2-#
   TESK JA, 2001, J BIOMED MATER RES B, V58, P466
   THERIN M, 1991, J MATER SCI-MATER M, V2, P1, DOI 10.1007/BF00701681
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   TSUCHIYA T, 1993, J BIOMED MATER RES, V27, P885, DOI 10.1002/jbm.820270707
   *UKAS, 2007, M3003 UKAS
   von Recum AF, 1999, HDB BIOMATERIALS EVA, P1
NR 31
TC 1
Z9 1
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2009
VL 20
BP 9
EP 17
DI 10.1007/s10856-008-3522-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 534QI
UT WOS:000272911800003
PM 18648911
DA 2018-10-20
ER

PT J
AU Mitha, MK
   Jayabalan, M
AF Mitha, M. K.
   Jayabalan, M.
TI Studies on biodegradable and crosslinkable poly(castor oil
   fumarate)/poly(propylene fumarate) composite adhesive as a potential
   injectable biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT Symposium on Materials for Biomedical Applications
CY 2007
CL Bangalore, INDIA
ID BONE-CEMENT; RESPONSES
AB Biodegradable hydroxyl terminated-poly(castor oil fumarate) (HT-PCF) and poly(propylene fumarate) (HT-PPF) resins were synthesized as an injectable and in situ-cross linkable polyester resins for orthopedic applications. An injectable adhesive formulation containing this resin blend, N-vinyl pyrrolidone (NVP), hydroxy apatite, free radical initiator and accelerator was developed. The Composite adhesives containing the ratio of resin blend and NVP, 2.1:1.5, 2.1:1.2 and 2.1:1.0 set fast with tolerable exothermic temperature as a three dimensionally cross linked toughened material. Crosslink density and mechanical properties of the crosslinked composite increase with increase of NVP. The present crosslinked composite has hydrophilic character and cytocompatibility with L929 fibroblast cells.
C1 [Mitha, M. K.; Jayabalan, M.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Polymer, Thiruvananthapuram 695012, Kerala, India.
RP Jayabalan, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Polymer, Thiruvananthapuram 695012, Kerala, India.
EM muthujayabalan@rediffmail.com
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Gough JE, 2003, BIOMATERIALS, V24, P4905, DOI 10.1016/S0142-9612(03)00409-5
   GUNATILLAKE PA, 2003, SCIENCE, V295, P1009
   Hasirci V, 2001, J BIOTECHNOL, V86, P135, DOI 10.1016/S0168-1656(00)00409-0
   Ignjatovic N, 2003, BIO-MED MATER ENG, V13, P401
   Jayabalan M, 2001, BIOMATERIALS, V22, P2749, DOI 10.1016/S0142-9612(01)00018-7
   Jayabalan M, 2000, BIO-MED MATER ENG, V10, P57
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P293, DOI 10.1016/S0142-9612(99)00180-5
   NI GX, 2007, J BIOMED MATER RES A, V82, P570
   Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028
   Rong MZ, 2007, MATER SCI FORUM, V539-543, P2311, DOI 10.4028/www.scientific.net/MSF.539-543.2311
   Shafranska O, 2007, J BIOMAT SCI-POLYM E, V18, P439, DOI 10.1163/156856207780425040
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   THOMAS V, J BIOMED MAT RES A
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
NR 15
TC 17
Z9 17
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2009
VL 20
BP 203
EP 211
DI 10.1007/s10856-008-3518-y
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 534QI
UT WOS:000272911800028
PM 18592346
DA 2018-10-20
ER

PT J
AU Rohanizadeh, R
   Kokabi, N
AF Rohanizadeh, Ramin
   Kokabi, Nima
TI Heat denatured/aggregated albumin-based biomaterial: effects of
   preparation parameters on biodegradability and mechanical properties
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; GELS
AB Albumin-based biomaterials prepared using heat-aggregation or cross-linking agents have been used in various biomedical applications such as solder materials for laser-assisted tissue welding, anti-bacterial coatings and drug carriers. In this study, solid albumin-based materials were prepared via heat aggregation of albumin solution. The study aimed to determine the influences of the preparation parameters such as albumin concentration in solution, solution pH and temperature, on the mechanical properties as well as the biodegradation rate of heat-aggregated albumin-based materials. The results demonstrated that the materials prepared from the albumin solution with the pH of 8.5 had the highest mechanical strength. Augmenting the albumin concentration in solution led to an increase in mechanical strength, and the materials prepared from the solution with isoelectric albumin pH (pH 4.8) possessed the lowest biodegradation rate and those prepared at pH 12 showed the highest biodegradation rate.
C1 [Rohanizadeh, Ramin] Univ Sydney, Adv Drug Delivery Grp, Fac Pharm, Sydney, NSW 2006, Australia.
   [Kokabi, Nima] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia.
RP Rohanizadeh, R (reprint author), Univ Sydney, Adv Drug Delivery Grp, Fac Pharm, Sydney, NSW 2006, Australia.
EM raminr@pharm.usyd.edu.au
RI Rohanizadeh, Ramin/J-5719-2016
OI Rohanizadeh, Ramin/0000-0002-7967-5515
FU Avastra Ltd (Brisbane, Australia)
FX The study was fully supported by Avastra Ltd (Brisbane, Australia).
CR An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   CLARK AH, 1981, INT J PEPT PROT RES, V17, P353
   CLARKE RC, 1977, CHEM REACTIVITY GELA
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Kinnari TJ, 2004, LARYNGOSCOPE, V114, P2038, DOI 10.1097/01.mlg.0000147944.20676.17
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Maitz PKM, 1999, PLAST RECONSTR SURG, V104, P1726, DOI 10.1097/00006534-199911000-00017
   NAKAMURA R, 1978, AGR BIOL CHEM TOKYO, V42, P819, DOI 10.1080/00021369.1978.10863067
   Park HY, 1998, INT J PHARM, V175, P231, DOI 10.1016/S0378-5173(98)00289-0
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RATNER RD, 1996, BIOMATERIALS SCI
   Santhi K, 2002, DRUG DEV IND PHARM, V28, P1171, DOI 10.1081/DDC-120014584
   SHIMADA K, 1981, AGR BIOL CHEM TOKYO, V45, P1945, DOI 10.1080/00021369.1981.10864826
   Trickett RI, 1998, MICROSURG, V18, P414, DOI 10.1002/(SICI)1098-2752(1998)18:7<414::AID-MICR5>3.0.CO;2-W
   WETZEL R, 1980, EUR J BIOCHEM, V104, P469, DOI 10.1111/j.1432-1033.1980.tb04449.x
   WOODWARD SA, 1986, J FOOD SCI, V51, P333, DOI 10.1111/j.1365-2621.1986.tb11123.x
   Wright B, 2007, LASER SURG MED, V39, P667, DOI 10.1002/lsm.20541
   YAPEL A, 1979, ALBUMIN MEDICAMENT C
   Yu ZS, 2004, EUR J PHARM BIOPHARM, V58, P529, DOI 10.1016/j.ejpb.2004.04.018
NR 20
TC 11
Z9 11
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2009
VL 20
IS 12
BP 2413
EP 2418
DI 10.1007/s10856-009-3819-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 530UC
UT WOS:000272616800006
PM 19847625
DA 2018-10-20
ER

PT J
AU Mishra, R
   Basu, B
   Kumar, A
AF Mishra, Ruchi
   Basu, Bikramjit
   Kumar, Ashok
TI Physical and cytocompatibility properties of bioactive glass-polyvinyl
   alcohol-sodium alginate biocomposite foams prepared via sol-gel
   processing for trabecular bone regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HYDROXYAPATITE; OSTEOBLASTS; COMPOSITES; SCAFFOLDS; POWDERS
AB In the present work, biocomposite foams of bioactive glass along with polyvinyl alcohol and sodium alginate are designed and developed as a potential biomaterial for bone regeneration. These biocomposite foams have a low density of 0.92 g/cm(3), providing desired property for bone tissue engineering applications. Biocomposite foams were prepared via surfactant foaming. Scanning electron microscopic characterization revealed pore size of 200-500 mu m of the biocomposite foams. When these materials were incubated in simulated body fluid, hydroxyapatite layer formation was observed on the material surface. To confirm the cell viability and proliferation on these materials, MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was performed with NIH 3T3 fibroblast cells and the results revealed good biocompatibility with the biocomposite foams. Cell adhesion studies further confirmed the biocompatibility of the scaffolds via cell attachment and ECM production. The optimally synthesized biocomposite foams had a good combination of physical properties with compressive strength of 1.64 MPa and elastic modulus of 18 MPa. In view of the favorable combination of physical and biological properties, the newly developed materials are considered to be suitable for regeneration of trabecular bone.
C1 [Mishra, Ruchi; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
   [Basu, Bikramjit] Indian Inst Technol, Dept Mat & Met Engn, Kanpur 208016, Uttar Pradesh, India.
RP Kumar, A (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
RI Kumar, Ashok/G-8515-2015; BASU, BIKRAMJIT/A-9967-2013
FU Indian Institute of Technology, Kanpur, India; Department of
   Biotechnology (DBT), Ministry of Science and Technology, Govt. of India;
   Indian Institute of Technology Kanpur, India
FX The work was financially supported by the grants from Indian Institute
   of Technology, Kanpur, India and Department of Biotechnology (DBT),
   Ministry of Science and Technology, Govt. of India. Ruchi Mishra
   gratefully acknowledges the fellowship received from Indian Institute of
   Technology Kanpur, India for her Ph. D. program.
CR Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   Blom A, 2007, CURR ORTHOPAED, V21, P280, DOI 10.1016/j.cuor.2007.06.005
   Clupper DC, 2004, J MATER SCI-MATER M, V15, P803, DOI 10.1023/B:JMSM.0000032821.32577.fc
   Costa Vilma Conceição, 2007, Mat. Res., V10, P21, DOI 10.1590/S1516-14392007000100006
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lobel KD, 1996, J SOL-GEL SCI TECHN, V7, P69, DOI 10.1007/BF00401885
   Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X
   Morgan Elise F., 2005, European Journal of Morphology, V42, P13, DOI 10.1080/09243860500095273
   Nath S, 2009, MAT SCI ENG C-BIO S, V29, P97, DOI 10.1016/j.msec.2008.05.019
   Nath S, 2009, J BIOMED MATER RES B, V88B, P1, DOI 10.1002/jbm.b.31050
   Oki A, 2006, MATER LETT, V60, P2751, DOI 10.1016/j.matlet.2006.01.084
   Pereira MM, 2005, J MATER SCI-MATER M, V16, P1045, DOI 10.1007/s10856-005-4758-8
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Roy S., 2008, J MATER SCI-MATER M, V20, P51
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Tripathi A, 2009, J BIOMED MATER RES A, V90A, P680, DOI 10.1002/jbm.a.32127
   Valerio P, 2005, J MATER SCI-MATER M, V16, P851, DOI 10.1007/s10856-005-3582-5
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
   Zhou Z, 2008, MATER SCI-POLAND, V26, P505
NR 22
TC 12
Z9 13
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2009
VL 20
IS 12
BP 2493
EP 2500
DI 10.1007/s10856-009-3814-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 530UC
UT WOS:000272616800015
PM 19588233
DA 2018-10-20
ER

PT J
AU Xu, FM
   Hart, K
   Flanagan, CE
   Nacker, JC
   Moftakhar, R
   Aagaard-Kienitz, B
   Consigny, DW
   Grinde, JR
   Crone, WC
   Masters, KS
AF Xu, Fangmin
   Hart, Kevin
   Flanagan, Claire E.
   Nacker, John C.
   Moftakhar, Roham
   Aagaard-Kienitz, Beverly
   Consigny, Daniel W.
   Grinde, Julie R.
   Crone, Wendy C.
   Masters, Kristyn S.
TI A Hybrid Coil/Polymer Device for Occlusion of Cerebral Aneurysms
SO JOURNAL OF MEDICAL DEVICES-TRANSACTIONS OF THE ASME
LA English
DT Article
DE aneurysm; shape memory; biomaterial
ID GUGLIELMI DETACHABLE COILS; INTRACRANIAL ANEURYSMS; ENDOVASCULAR
   TREATMENT; PLATINUM COILS; SINGLE-CENTER; MATRIX COILS; BLOOD-FLOW;
   FOLLOW-UP; EXPERIENCE; NITINOL
AB The treatment of cerebral aneurysms is frequently accomplished via endovascular delivery of metal coils in order to occlude the aneurysm and prevent rupture This procedure involves unprecise packing of large lengths of wire into the aneurysm and often results in high rates of aneurysm recanalization Over time this mcomplete aneurysm occlusion can lead to aneurysm enlargement which may have fatal consequences This report describes the fabrication and preliminary testing of a novel aneurysm occlusion device composed of a singlc metal coil surrounded by a biocompatible polymer shell These coil in shell devices were tested under flow conditions in synthetic in vitro models of saccular aneurysms and deployed m vivo in a short-term porcine aneurysm model to study occlusion efficacy A single nickel titanium shape memory wire was used to deploy a biocompatible elastic polymeric shell leading to aneurysmal sac filling in both in vitro and in vivo aneurysm models The deployment of this coil in shell device in synthetic aneurysm models in vitro resulted in varying dcgrees of aneurysm occlusion with less than 2% of trials resulting in significant leakage of fluid into the aneurysm Meanwhile in vivo coil in shell device implantation in a porcine aneurysm model provided proof of concept for successful occlusion as both ancurysm were completely occluded by the devices Both in vitro and in vivo studies demonstrated that this coil in shell device may be attractive as an alternative to traditional coil embolization methods in some cases allowing for a more precise and controlled aneurysm occlusion
C1 [Xu, Fangmin; Flanagan, Claire E.; Crone, Wendy C.; Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Hart, Kevin; Nacker, John C.; Crone, Wendy C.] Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA.
   [Moftakhar, Roham; Aagaard-Kienitz, Beverly] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA.
   [Aagaard-Kienitz, Beverly; Consigny, Daniel W.; Grinde, Julie R.] Univ Wisconsin, Dept Radiol, Madison, WI 53792 USA.
RP Masters, KS (reprint author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
FU W H Coulter Foundation
FX This work was funded by a Translational Research Partnership grant from
   the W H Coulter Foundation
CR Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   Bourekas EC, 2006, AM J NEURORADIOL, V27, P297
   D'Agostino SJ, 2009, SURG NEUROL, V72, P41, DOI 10.1016/j.surneu.2009.02.014
   Dai DY, 2007, STROKE, V38, P170, DOI 10.1161/01.STR.0000252128.83405.71
   Hendrikse J, 2005, RADIOLOGY, V235, P184, DOI 10.1148/radiol.2351031799
   Kang HS, 2005, AM J NEURORADIOL, V26, P1921
   Katsaridis V, 2006, AM J NEURORADIOL, V27, P1841
   KIM C, 1988, STROKE, V19, P507, DOI 10.1161/01.STR.19.4.507
   Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399
   Lamba N, 1997, POLYURETHANES BIOMED
   LEACH JB, 2004, ENCY BIOMATERIALS BI
   Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6
   Murayama Y, 1999, AM J NEURORADIOL, V20, P1992
   Murayama Y, 2002, STROKE, V33, P1120, DOI 10.1161/01.STR.0000014423.20476.EE
   Niimi Y, 2006, STROKE, V37, P1028, DOI 10.1161/01.STR.0000206459.73897.a3
   Parlea L, 1999, AM J NEURORADIOL, V20, P1079
   RODE TS, 1999, INVEST RADIOL, V34, P317
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   STEHBENS WE, 1989, J NEUROSURG, V70, P823, DOI 10.3171/jns.1989.70.6.0823
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
   Tanaka H, 2006, AM J NEURORADIOL, V27, P1770
   Taschner CA, 2005, STROKE, V36, P2176, DOI 10.1161/01.STR.0000181770.14869.ce
   Thornton J, 2002, NEUROSURGERY, V50, P239, DOI 10.1097/00006123-200202000-00003
   Turk AS, 2007, AM J NEURORADIOL, V28, P531
   Turk AS, 2008, NEURORADIOLOGY, V50, P57, DOI 10.1007/s00234-007-0302-5
   van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6
   Vespa PM, 1999, CRIT CARE CLIN, V15, P667, DOI 10.1016/S0749-0704(05)70081-6
   Xu F, 2008, BIOMATERIALS, V29, P150, DOI 10.1016/j.biomaterials.2007.09.028
   Yuki I, 2005, EXPERT REV MED DEVIC, V2, P539, DOI 10.1586/17434440.2.5.539
NR 29
TC 1
Z9 1
U1 0
U2 7
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1932-6181
J9 J MED DEVICES
JI J. Med. Devices
PD DEC
PY 2009
VL 3
IS 4
AR 045001
DI 10.1115/1.4000203
PG 7
WC Engineering, Biomedical
SC Engineering
GA 674RB
UT WOS:000283763900011
DA 2018-10-20
ER

PT J
AU Vavken, P
   Joshi, S
   Murray, MM
AF Vavken, Patrick
   Joshi, Shilpa
   Murray, Martha M.
TI TRITON-X Is Most Effective among Three Decellularization Agents for ACL
   Tissue Engineering
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE ACL repair; decellularization; tissue engineering
ID ANTERIOR CRUCIATE LIGAMENT; PATELLAR TENDON; HEART-VALVES;
   EXTRACELLULAR-MATRIX; PLASMA SCAFFOLD; RECONSTRUCTION; COLLAGEN;
   CARTILAGE; PORCINE; REPAIR
AB Ruptures of the anterior cruciate ligament (ACL) are still associated with high rates of long-term complications, even in patients undergoing modern, state-of-the-art replacement. Tissue-engineering approaches have been shown to be of value in improving treatment of ACL ruptures. However, the success of tissue-engineering procedures depends on the choice of an appropriate biomaterial. Decellularized ACL tissue potentially combines the structural composition of the targeted tissue with a reduced risk of graft rejection or disease transmission. In this study, we tested the effectiveness of currently available decellularization methods based on TRITON-X, sodium dodecyl sulfate (SDS), and trypsin. After identifying the most effective decellularization method, the capacity for reseeding with ACL fibroblasts was studied. All decellularization protocols reduced DNA content, with TRITON-X treatment having the greatest effect. Concurrently, decellularization did not affect tissue collagen or total protein content, but did decrease glycosaminoglycan content. TRITON-X also resulted the least glycosaminoglycan depletion. Porcine ACL tissue after decellularization with TRITON-X could be successfully reseeded with human ACL fibroblasts as demonstrated by steady DNA content and increasing pro-collagen expression. (C) Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:1612-1618, 2009
C1 [Vavken, Patrick; Joshi, Shilpa; Murray, Martha M.] Harvard Univ, Childrens Hosp, Dept Orthoped Surg, Sports Med Res Lab,Sch Med, Boston, MA 02115 USA.
RP Vavken, P (reprint author), Harvard Univ, Childrens Hosp, Dept Orthoped Surg, Sports Med Res Lab,Sch Med, 300 Longwood Ave,Enders 1016, Boston, MA 02115 USA.
EM patrick.vavken@childrens.harvard.edu
FU NIH-NIAMS [R01 AR052772]
FX This study was supported by the NIH-NIAMS grant R01 AR052772.
CR ARNOCZKY SP, 1982, J BONE JOINT SURG AM, V64, P217, DOI 10.2106/00004623-198264020-00011
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Bell E., 2000, PRINCIPLES TISSUE EN, pxxxv
   Cartmell JS, 2004, TISSUE ENG, V10, P1065, DOI 10.1089/ten.2004.10.1065
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   DAHL S, 2003, CELL TRANSPLANT, V21, P659
   Delay BS, 2002, J BONE JOINT SURG AM, V84A, P1433, DOI 10.2106/00004623-200208000-00021
   Dumont CE, 1997, TRANSPLANTATION, V63, P1210, DOI 10.1097/00007890-199705150-00004
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FLEMING BC, 2009, AM J SPORTS IN PRESS
   Forslund C, 2003, AM J SPORT MED, V31, P555, DOI 10.1177/03635465030310041301
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Fufa D, 2008, J ORAL MAXIL SURG, V66, P684, DOI 10.1016/j.joms.2007.06.635
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Hoemann C. D., 2004, CARTILAGE OSTEOARTHR, P127
   Hoemann CD, 2002, ANAL BIOCHEM, V300, P1, DOI 10.1006/abio.2001.5436
   HUBBELL JA, 2007, MATRIX EFFECTS, P297
   Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346
   INGRAM J, 2005, EUR CELLS MATER, V10, P14
   Jones Alex P, 2007, J Long Term Eff Med Implants, V17, P59
   Kessler MA, 2008, KNEE SURG SPORT TR A, V16, P442, DOI 10.1007/s00167-008-0498-x
   Liden M, 2008, ARTHROSCOPY, V24, P899, DOI 10.1016/j.arthro.2008.04.066
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Murray MM, 2001, BIOMATERIALS, V22, P2393
   Murray MM, 2000, J BONE JOINT SURG AM, V82A, P1387, DOI 10.2106/00004623-200010000-00004
   Neuman P, 2008, AM J SPORT MED, V36, P1717, DOI 10.1177/0363546508316770
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SMITH J, 1997, PROTEIN SEQUENCING P
   Spindler KP, 2003, J ORTHOPAED RES, V21, P245, DOI 10.1016/S0736-0266(02)00145-6
   Spindler KP, 2009, J ORTHOP RES, V27, P631, DOI 10.1002/jor.20785
   Stone KR, 2007, TRANSPLANTATION, V83, P211, DOI 10.1097/01.tp.0000250598.29377.13
   Tohyama H, 2000, J BIOMECH ENG-T ASME, V122, P594, DOI 10.1115/1.1319659
   TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017
   Vavken P, 2008, CLIN ORTHOP RELAT R, V466, P985, DOI 10.1007/s11999-007-0098-y
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
NR 45
TC 51
Z9 57
U1 1
U2 25
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD DEC
PY 2009
VL 27
IS 12
BP 1612
EP 1618
DI 10.1002/jor.20932
PG 7
WC Orthopedics
SC Orthopedics
GA 523UV
UT WOS:000272101000011
PM 19504590
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mazor, Z
   Horowitz, RA
   Del Corso, M
   Prasad, HS
   Rohrer, MD
   Ehrenfest, DAD
AF Mazor, Ziv
   Horowitz, Robert A.
   Del Corso, Marco
   Prasad, Hari S.
   Rohrer, Michael D.
   Ehrenfest, David A. Dohan
TI Sinus Floor Augmentation With Simultaneous Implant Placement Using
   Choukroun's Platelet-Rich Fibrin as the Sole Grafting Material: A
   Radiologic and Histologic Study at 6 Months
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Blood platelets; bone regeneration; dental implants; fibrin; maxillary
   sinus; wound healing
ID ATROPHIC POSTERIOR MAXILLA; ASTRA TECH IMPLANTS; MEMBRANE ELEVATION;
   CONSENSUS CONFERENCE; BONE-FORMATION; SIMULTANEOUS INSERTION; GRINDING
   TECHNIQUE; DENTAL IMPLANTS; PART 1; PRF
AB Background: Sinus augmentation with simultaneous implant placement without bone graft material is a hotly debated technique. This technique could be improved and secured by the use of an autologous leukocyte- and platelet-rich fibrin (PRF) (Choukroun's technique) concentrate. The objectives of this study were to assess the relevance of PRF clots and membranes as the sole filling material during a lateral sinus lift with immediate implantation using radiologic and histologic analyses in a case series.
   Methods: Twenty-flue sinus elevations with simultaneous implantation were performed on 20 patients with Choukroun's PRF as the sole filling biomaterial. For each patient, a presurgical exam and a 6-month post-surgical radiologic exam were performed with a panoramic x-ray and three-dimensional volumetric computed radiography (VCR) to evaluate the subsinus residual bone height and the final bone gain around the implants. In nine patients, 6 months after the sinus lift, bone biopsies were collected on the buccal wall of the alveolar ridge at the level of the osteotomy window, and evaluated by histomorphometry.
   Results: In this study, 41 implants from three different systems with different screw designs (Biomet 31 Nanotite, MIS Seven, Intra-Lock Ossean) were placed. All implants were inserted in residual bone height between 7.5 and 6 mm (mean +/- SD: 2.9 +/- 0.9 mm). The final bone gain was always very significant (between 7 and 13 mm [mean +/- SD: 10. +/- 0.9 mm]). No implant was lost. After radiologic analyses, the position of the final sinus floor was always in the continuation of the end of the implant. All biopsies showed well organized and vital bone.
   Conclusions: From a radiologic and histologic point of view at 6 months after surgery, the use of PRF as the sole filling material during a simultaneous sinus lift and implantation stabilized a high volume of natural regenerated bone in the subsinus cavity up to the tip of the implants. Choukroun's PRF is a simple and inexpensive biomaterial, and its systematic use during a sinus lift seems a relevant option, particularly for the protection of the Schneiderian membrane. J Periodontol 2009;80:2056-2064.
C1 [Horowitz, Robert A.; Del Corso, Marco] NYU, Coll Dent, Dept Periodontol, New York, NY USA.
   [Horowitz, Robert A.; Del Corso, Marco] NYU, Coll Dent, Dept Implant Dent, New York, NY USA.
   [Prasad, Hari S.; Rohrer, Michael D.] Univ Minnesota, Sch Dent, Div Oral & Maxillofacial Pathol, Hard Tissue Res Lab, Minneapolis, MN 55455 USA.
   [Ehrenfest, David A. Dohan] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, S-41390 Gothenburg, Sweden.
RP Ehrenfest, DAD (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Med Aregatan 8B, S-41390 Gothenburg, Sweden.
EM LoB5@mac.com
RI Dohan Ehrenfest, David/C-8866-2012
OI Del Corso, Marco/0000-0002-2882-8139
FU LoB5 Foundation for Research, Paris, France
FX This work was partially supported by a grant from the LoB5 Foundation
   for Research, Paris, France. The authors thank Dr. Joseph Choukroun,
   Pain Clinic Center, Nice, France, inventor of the PRF technique and
   initiator of its use as sole filling material during a simultaneous
   sinus lift and implantation. The authors report no conflicts of interest
   related to this case series.
CR Braccini F, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P255
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Charrier J B, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P313
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J, 2001, IMPLANTODONTIE, V42, P55
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P305, DOI 10.1016/j.tripleo.2006.10.009
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.016
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Fermergard R, 2008, CLIN IMPLANT DENT R, V10, P62, DOI 10.1111/j.1708-8208.2007.00062.x
   Geurs NC, 2001, INT J PERIODONT REST, V21, P517
   Hatano N, 2007, CLIN IMPLANT DENT R, V9, P150, DOI 10.1111/j.1708-8208.2007.00043.x
   Horowitz R A, 1997, Compend Contin Educ Dent, V18, P441
   HOROWITZ RA, 1997, COMPENDIUM CONTINUIN, V18, P454
   HOROWITZ RA, 1997, COMPEND CONTIN ED DE, V18, P450
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jeong SM, 2009, ORAL SURG ORAL MED O, V107, P364, DOI 10.1016/j.tripleo.2008.05.032
   Leclercq P, 2008, J ORAL MAXIL SURG, V66, P183, DOI 10.1016/j.joms.2005.12.050
   Leclercq P, 2008, J ORAL MAXIL SURG, V66, P177, DOI 10.1016/j.joms.2005.12.054
   Lundgren S, 2008, PERIODONTOL 2000, V47, P193, DOI 10.1111/j.1600-0757.2008.00264.x
   Misch CE, 2008, IMPLANT DENT, V17, P5, DOI 10.1097/ID.0b013e3181676059
   Nedir R, 2006, CLIN ORAL IMPLAN RES, V17, P679, DOI 10.1111/j.1600-0501.2006.01264.x
   Peleg M, 1999, INT J ORAL MAX IMPL, V14, P549
   Peleg M, 2006, INT J ORAL MAX IMPL, V21, P94
   Peleg M, 1998, J PERIODONTOL, V69, P1397, DOI 10.1902/jop.1998.69.12.1397
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   SCHARF DR, 1993, J PERIODONTOL, V64, P954, DOI 10.1902/jop.1993.64.10.954
   Shulman LB, 1998, INT J ORAL MAX IMPL, V13, P5
   Simonpieri A., 2005, IMPLANT, V11, P33
   Simonpieri A, 2009, IMPLANT DENT, V18, P220, DOI 10.1097/ID.0b013e31819b5e3f
   Simonpieri A, 2009, IMPLANT DENT, V18, P102, DOI 10.1097/ID.0b013e318198cf00
   Soadoun Andre P, 2007, Pract Proced Aesthet Dent, V19, P81
   SOADOUN AP, 2007, PRACT PROCED AESTHET, V19, P88
   Sul SH, 2008, ORAL SURG ORAL MED O, V105, P684, DOI 10.1016/j.tripleo.2007.09.024
   Sul SH, 2008, ORAL SURG ORAL MED O, V105, pE1, DOI 10.1016/j.tripleo.2007.11.019
   Summers R B, 1994, Compendium, V15, P154
   Summers R. B., 1994, COMPENDIUM, V15, P162
   Summers RB, 1994, COMPENDIUM, V15, P158
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
NR 49
TC 110
Z9 117
U1 1
U2 23
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD DEC
PY 2009
VL 80
IS 12
BP 2056
EP 2064
DI 10.1902/jop.2009.090252
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 534EL
UT WOS:000272878900018
PM 19961389
DA 2018-10-20
ER

PT J
AU Hargreaves, MD
   Macleod, NA
   Brewster, VL
   Munshi, T
   Edwards, HGM
   Matousek, P
AF Hargreaves, Michael D.
   Macleod, Neil A.
   Brewster, Victoria L.
   Munshi, Tasnim
   Edwards, Howell G. M.
   Matousek, Pavel
TI Application of portable Raman spectroscopy and benchtop spatially offset
   Raman spectroscopy to interrogate concealed biomaterials
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE Raman spectroscopy; spatially offset Raman spectroscopy (SORS); ivory;
   biomaterials detection
ID CHEMOMETRIC METHODS; PHOTON MIGRATION; TURBID MEDIA; IVORY;
   DIFFERENTIATION; FLUORESCENCE; ELEPHANT; TISSUE
AB In this paper, we demonstrate the ability of portable Raman spectroscopy and benchtop spatially offset Raman spectroscopy (SORS) techniques to rapidly identify real and fake ivory samples. Both techniques were able to identify exposed genuine from fake ivory samples. In contrast to conventional Raman spectroscopy, SORS was, in addition, able to identify ivory concealed by plastics, paints, varnishes and cloth. Application of the SORS technique allows the interrogation of biomaterial samples through materials in which conventional Raman spectroscopic instrumentation cannot penetrate. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Hargreaves, Michael D.; Brewster, Victoria L.; Munshi, Tasnim; Edwards, Howell G. M.] Univ Bradford, Raman Spect Grp, Div Chem & Forens Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.
   [Macleod, Neil A.; Matousek, Pavel] Rutherford Appleton Lab, Sci & Technol Facil Council, Cent Laser Facil, Didcot OX11 0QX, Oxon, England.
RP Hargreaves, MD (reprint author), Univ Bradford, Raman Spect Grp, Div Chem & Forens Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.
EM mhargrea@gmail.com
RI Matousek, Pavel/D-5750-2011
OI Matousek, Pavel/0000-0003-0912-5339
FU CLIK Knowledge Transfer; EPSRC [EP/D037662/1, GR/S63052/01]; HM CITES;
   Renishaw Plc; HM Revenue and Customs; HM Government Communication Centre
   (HMGCC); Defence Science and Technology Laboratory (DSTL); Home Office
   Scientific Development Branch (HOSDB)
FX The authors wish to thank Dr Darren Andrews, Dr Tim Bestwick, Professor
   Anthony Parker and Professor Mike Dunne of the Science and Technology
   Facilities Council for their support of this work. The financial
   contribution of CLIK Knowledge Transfer and the EPSRC (grants
   EP/D037662/1 and GR/S63052/01), HM CITES, Renishaw Plc, HM Revenue and
   Customs, HM Government Communication Centre (HMGCC), the Defence Science
   and Technology Laboratory (DSTL) and the Home Office Scientific
   Development Branch (HOSDB).
CR Brody RH, 2001, ANAL CHIM ACTA, V427, P223, DOI 10.1016/S0003-2670(00)01206-X
   Draper ERC, 2005, J BONE MINER RES, V20, P1968, DOI 10.1359/JBMR.050710
   Edwards HGM, 1998, STUD CONSERV, V43, P9, DOI 10.2307/1506632
   Edwards HGM, 2006, ANAL CHIM ACTA, V559, P64, DOI 10.1016/j.aca.2005.11.067
   Edwards HGM, 2006, J RAMAN SPECTROSC, V37, P353, DOI 10.1002/jrs.1458
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   Eliasson C, 2007, ANAL CHEM, V79, P8185, DOI 10.1021/ac071383n
   Eliasson C, 2007, ANAL CHEM, V79, P1696, DOI 10.1021/ac062223z
   Everall N, 2004, APPL SPECTROSC, V58, P591, DOI 10.1366/000370204774103426
   Everall N, 2001, APPL SPECTROSC, V55, P1701, DOI 10.1366/0003702011954053
   Hargreaves MD, 2008, J RAMAN SPECTROSC, V39, P873, DOI 10.1002/jrs.1926
   Macleod NA, 2008, PHARM RES-DORDR, V25, P2205, DOI 10.1007/s11095-008-9587-2
   Matousek P, 2005, APPL SPECTROSC, V59, P1485, DOI 10.1366/000370205775142548
   Matousek P, 2005, APPL SPECTROSC, V59, P393, DOI 10.1366/0003702053641450
   Matousek P, 2005, APPL SPECTROSC, V59, P200, DOI 10.1366/0003702053085115
   Matousek P, 2007, CHEM SOC REV, V36, P1292, DOI 10.1039/b614777c
   Matousek P, 2006, APPL SPECTROSC, V60, P758, DOI 10.1366/000370206777886955
   Matousek P, 2006, APPL SPECTROSC, V60, P1341, DOI 10.1366/000370206778999102
   Morris MD, 2005, LECT NOTES COMPUT SC, V5693, P344, DOI 10.1117/12.585457
   Schulmerich MV, 2006, APPL SPECTROSC, V60, P109, DOI 10.1366/000370206776023340
   SCHULMERICH MV, 2006, BIOMED VIB SPECTROSC, V6093, pO930
   Vandenabeele P, 2007, ANAL CHIM ACTA, V588, P108, DOI 10.1016/j.aca.2007.01.082
   WU J, 1995, APPL OPTICS, V34, P3425, DOI 10.1364/AO.34.003425
NR 23
TC 14
Z9 14
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
EI 1097-4555
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD DEC
PY 2009
VL 40
IS 12
BP 1875
EP 1880
DI 10.1002/jrs.2335
PG 6
WC Spectroscopy
SC Spectroscopy
GA 544AD
UT WOS:000273622500021
DA 2018-10-20
ER

PT J
AU Sanpo, N
   Ang, SM
   Cheang, P
   Khor, KA
AF Sanpo, Noppakun
   Ang, Siao Ming
   Cheang, Philip
   Khor, Khiam Aik
TI Antibacterial Property of Cold Sprayed Chitosan-Cu/Al Coating
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article
DE aluminum composites; biomaterial; biomaterials of TS coatings; cold gas
   dynamic spraying; composite materials; nanostructured coatings;
   nanostructured materials
ID IN-VITRO; ION-IMPLANTATION; MEDICAL METALS; COPPER; BIOCOMPATIBILITY;
   DELIVERY; CHITIN; SILVER; NANOPARTICLES; POLYETHYLENE
AB The antibacterial behavior of CS-Cu (chitosan-copper complex) powder and their composite coatings were investigated against Escherichia coli (DH5 alpha). CS-Cu powder and Al (aluminum) based CS-Cu composite powders were synthesized using in-house powder processing techniques. The results indicated that the antibacterial effect of all the powders increased with the proportion of CS-Cu powder. These composite powders were subsequently used as feedstock to generate antibacterial coatings via cold spray technology. The ratios of CS-Cu to Al in their composite powders were 25:75, 50:50, and 75:25 (wt.%). Microstructural characterization and phase analysis of feedstock powders and as-deposited coatings were carried out using FESEM/EDX and FTIR. Antibacterial composite CS-Cu/Al coatings were successfully deposited using cold spraying parameters of 6-8 bars at preheated helium gas, temperature between 140 and 150 A degrees C. The coatings retained the antibacterial properties of the original feedstock powders.
C1 [Sanpo, Noppakun] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.
   [Ang, Siao Ming] Swinburne Univ Technol, Ind Res Inst, Melbourne, Vic, Australia.
   [Cheang, Philip] SIM Univ, Sch Sci & Technol, Singapore, Singapore.
   [Khor, Khiam Aik] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RP Sanpo, N (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.
EM Noppakuns@hotmail.com; AANG@groupwise.swin.edu.au;
   Philipcheanghn@unisim.edu.sg; Mkakhor@ntu.edu.sg
RI Khor, Khiam Aik (Michael)/B-6929-2009; Khor, Khiam Aik/G-2827-2010
OI KHOR, Khiam/0000-0003-1954-8423; Ang, Andrew SM/0000-0001-7664-9971
FU Nanyang Technological University [RG1/04]; ST Kinetics (Singapore)
FX We wish to acknowledge the funding support for this project (RG1/04)
   from Nanyang Technological University, and the joint research
   collaboration with ST Kinetics (Singapore).
CR Bhagat R. B., 1997, THERMAL SPRAY UNITED, P361
   Bittelli M, 2001, AGR FOREST METEOROL, V107, P167, DOI 10.1016/S0168-1923(00)00242-2
   BODMEIER R, 1989, PHARMACEUT RES, V6, P413, DOI 10.1023/A:1015987516796
   BRINE C, 1992, ADV CHITIN CHITOSAN, P543
   CHANDY T, 1992, BIOMATERIALS, V13, P949, DOI 10.1016/0142-9612(92)90119-9
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Choi WB, 2007, ACTA MATER, V55, P857, DOI 10.1016/j.actamat.2006.09.006
   Cuero RG, 1999, EXS, V87, P315
   DUMITRIU S, 1989, COLLOID POLYM SCI, V267, P595, DOI 10.1007/BF01410436
   ENTSAR IR, 2003, BIOMACROMOLECULES, V4, P1457
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Huang CP, 2000, WATER RES, V34, P1057, DOI 10.1016/S0043-1354(99)00211-0
   Kalyon BD, 2001, AM J INFECT CONTROL, V29, P124, DOI 10.1067/mic.2001.113229
   Karthikeyan J, 2001, THERMAL SPRAY 2001: NEW SURFACES FOR A NEW MILLENNIUM, P383
   Karthikeyan J., 2000, THERMAL SPRAY SURFAC, P255
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Matsuhashi S, 1997, J SCI FOOD AGR, V73, P237, DOI 10.1002/(SICI)1097-0010(199702)73:2<237::AID-JSFA711>3.0.CO;2-4
   McCune RC, 1996, THERMAL SPRAY: PRACTICAL SOLUTIONS FOR ENGINEERING PROBLEMS, P397
   MUZZARELLI RAA, 1983, CARBOHYD POLYM, V3, P53
   ODUNOLA OA, 1993, SYN REACT INORG MET, V23, P1241, DOI 10.1080/15533179308016683
   Qi LF, 2005, BIOORG MED CHEM LETT, V15, P1397, DOI 10.1016/j.bmcl.2005.01.010
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Risbud MV, 2000, DRUG DELIV, V7, P69
   SANPO N, 2008, BMEI, V1, P488
   Stoltenhoff T, 2001, THERMAL SPRAY 2001: NEW SURFACES FOR A NEW MILLENNIUM, P409
   Suntornsuk W, 2002, PROCESS BIOCHEM, V37, P727, DOI 10.1016/S0032-9592(01)00265-5
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1
   Wan YZ, 2007, APPL SURF SCI, V253, P9426, DOI 10.1016/j.apsusc.2007.06.031
   Wan YZ, 2007, VACUUM, V81, P1114, DOI 10.1016/j.vacuum.2006.12.011
   Wang XH, 2005, POLYM BULL, V55, P105, DOI 10.1007/s00289-005-0414-1
   Yamamoto H, 1997, MACROMOLECULES, V30, P3936, DOI 10.1021/ma961766f
   Yuan YL, 2004, COLLOID SURFACE B, V35, P1, DOI 10.1016/j.colsurfb.2004.01.005
   Zhang W, 2006, POLYMER, V47, P7441, DOI 10.1016/j.polymer.2006.08.057
   Zhang W, 2009, SURF COAT TECH, V203, P2550, DOI 10.1016/j.surfcoat.2009.02.073
   Zheng Y, 2006, BIOORG MED CHEM LETT, V16, P4127, DOI 10.1016/j.bmcl.2006.04.077
NR 36
TC 13
Z9 14
U1 3
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9630
EI 1544-1016
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD DEC
PY 2009
VL 18
IS 4
BP 600
EP 608
DI 10.1007/s11666-009-9391-5
PG 9
WC Materials Science, Coatings & Films
SC Materials Science
GA 521RT
UT WOS:000271942400017
DA 2018-10-20
ER

PT J
AU Wu, B
   Zheng, QX
   Guo, XD
   Wu, YC
   Wang, Y
   Cui, FZ
AF Wu Bin
   Zheng Qixin
   Guo Xiaodong
   Wu Yongchao
   Wang Yu
   Cui Fuzai
TI The enhancement of osteogenesis by scaffold based on mineralized
   recombinant human-like collagen loading with rhBMP-2
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE rhBMP-2; bone tissue engineering; osteogenesis; biomaterial
ID BONE REGENERATION; COMPOSITE; DELIVERY
AB A biomimetic scaffold based on mineralized recombinant collagen, nano-hydroxyapatite/recombinant human-like collagen/poly(lactic acid) (nHA/RHLC/PLA), was prepared with recombinant human bone morphogenic protein-2 (rhBMP-2) for improving the osteoinductive property of the scaffold. The nHA/RHLC/PLA scaffolds loaded with 10 A mu g rhBMP-2 and the unloaded scaffolds were implanted subcutaneously in the rat model. The osteogenetic capacity of these composites was evaluated by CT scan, ALP activity test and histological observation at 4 and 8 weeks after implantation. The experimental results indicated that the osteogenic capability of the scaffolds loaded with rhBMP-2 was superior to the unloaded scaffold. It was concluded that rhBMP-2 can enhance the osteoinductive property of the nHA/RHLC/PLA scaffold and the nHA/RHLC/PLA scaffold loaded with rhBMP-2 have the good potential of being used in bone tissue engineering.
C1 [Wu Bin; Zheng Qixin; Guo Xiaodong; Wu Yongchao] Huazhong Univ Sci & Technol, Dept Orthopaed, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
   [Wang Yu; Cui Fuzai] Tsinghua Univ, Biomat Lab, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Zheng, QX (reprint author), Huazhong Univ Sci & Technol, Dept Orthopaed, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
EM wubin1980@gmail.com; zheng-qx@163.com
RI guo, xiaodong/K-2600-2013
FU National Natural Science Foundation of China [30170270]; National
   High-tech Research Program (863) [2006AA320605]
FX Funded by the National Natural Science Foundation of China(No.
   30170270), and the National High-tech Research Program (863)(No.
   2006AA320605)
CR Boden SD, 2005, ORTHOP NURS, V24, P49
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   GUO XD, 2005, J WUHAN UNIV TECHNOL, V20, P234
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   HENRIETTE C, 2005, BIOMATERIALS, V26, P1131
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Kato M, 2006, BIOMATERIALS, V27, P3927, DOI 10.1016/j.biomaterials.2006.03.013
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Li Y, 2005, J WUHAN U TECHNOL S, V20, P173
   Liao S, 2005, J BIOMED MATER RES B, V74B, P817, DOI 10.1002/jbm.b.30315
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Rose FRAJ, 2004, J PHARM PHARMACOL, V56, P415, DOI 10.1211/0022357023312
   WANG Y, 2007, J BIOMED MATER RES B, V86, P29
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   ZHAI Y, 2005, J WUHAN U TECHNOL S, V20, P41
NR 19
TC 2
Z9 2
U1 1
U2 9
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD DEC
PY 2009
VL 24
IS 6
BP 956
EP 960
DI 10.1007/s11595-009-6956-6
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 534RW
UT WOS:000272916000024
DA 2018-10-20
ER

PT J
AU Zhang, ZX
   Zheng, QX
   Wu, YC
   Liu, YD
AF Zhang Zhenxing
   Zheng Qixin
   Wu Yongchao
   Liu Yudong
TI Biocompatibility of FGL peptide self-assembly nanofibers with neural
   stem cells in vitro
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE peptide; nanofiber; biomaterial; neural stem cell; biocompatibility
ID ADHESION MOLECULE; ACTIVATION; OUTGROWTH; SCAFFOLDS; SURVIVAL
AB In order to study the biocompatibility of self-assembled FGL peptide nanofibers scaffold with neural stem cells (NSCs), FGL pepitide-amphiphile (FGL-PA) was synthesized by solid-phase peptide synthesis technique. The diluted hydrochloric acid was added into FGL-PA solution to reduce the PH value and accordingly induce self-assembly. The morphological features of the assembled material were studied by transmission electron microscope. NSCs were cultured and added with self-assembled FGL-PA. CCK-8 kit was used to test its effect on the proliferation of NSCs. The differentiation of NSCs was also tested after FGL-PA assembled material added. The experimental results showed that FGL-PA could be self-assembled to form a hydrogel. TEM analysis showed the self-assembled hydrogel was nanofibers with diameter of 10-20 nm and length of hundreds nanometers. FGL-PA with concentrations of 50,100, or 200 mg/L could promote the proliferation of NSCs, and absorbance of them was increased (P < 0.05). The rate of neurons differentiated from NSCs was improved greatly by FGL-PA assembled material compared with control (P < 0.05). The findings suggested that FGL-PA could self-assemble to nanofiber hydrogel, which had good biocompatibility with NSCs.
C1 [Zhang Zhenxing; Zheng Qixin; Wu Yongchao; Liu Yudong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthoped, Wuhan 430022, Peoples R China.
RP Zheng, QX (reprint author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthoped, Wuhan 430022, Peoples R China.
EM zheng-qx@21cn.com
FU National Natural Science Foundation of China [30500511]
FX Funded by the National Natural Science Foundation of China (No.
   30500511)
CR Anderson AA, 2005, J NEUROCHEM, V95, P570, DOI 10.1111/j.1471-4159.2005.03417.x
   GALLI R, 2003, CIRC RES, V92, P596
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x
   Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297
   Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060
   Welzl H, 2003, NEWS PHYSIOL SCI, V18, P147, DOI 10.1152/nips.01422.2002
NR 9
TC 1
Z9 1
U1 0
U2 3
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD DEC
PY 2009
VL 24
IS 6
BP 992
EP 996
DI 10.1007/s11595-009-6992-2
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 534RW
UT WOS:000272916000032
DA 2018-10-20
ER

PT J
AU Hoogenboom, R
   Popescu, D
   Steinhauer, W
   Keul, H
   Moller, M
AF Hoogenboom, Richard
   Popescu, Dragos
   Steinhauer, Wiktor
   Keul, Helmut
   Moeller, Martin
TI Nitroxide-Mediated Copolymerization of 2-Hydroxyethyl Acrylate and
   2-Hydroxypropyl Acrylate: Copolymerization Kinetics and Thermoresponsive
   Properties
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE copolymerization; kinetics (polym.); nitroxide-mediated polymerization;
   reactivity ratios; thermoresponsive polymer
ID FREE-RADICAL POLYMERIZATION; STIMULI-RESPONSIVE POLYMERS; WATER-SOLUBLE
   ALKOXYAMINE; N-BUTYL ACRYLATE; BIOMEDICAL APPLICATIONS;
   AQUEOUS-SOLUTIONS; BLOCK-COPOLYMERS; DRUG-DELIVERY; TEMPERATURE;
   HYDROGELS
AB Poly(2-hydroxyethyl acrylate) (PHEA) is an interesting biomaterial with similar biocompatibility as the widespread used poly(2-hydroxyethyl methacrylate). Poly(2-hydroxypropyl acrylate) (PHPA) is a less frequently studied polymer that exhibits thermoresponsive behavior in water. Therefore, copolymers of HEA and HPA are interesting thermoresponsive polymers to evaluate as potential biomaterials. Here, we report the copolymerization kinetics of HEA and HPA by nitroxide-mediated polymerization, employing Bloc-builder(R) initiator and SG-1 free nitroxide, revealing an ideal random copolymerization. Furthermore, the thermoresponsive properties of the resulting copolymers are discussed, whereby the cloud points are related to both polymer composition as well as polymer concentration.
C1 [Hoogenboom, Richard] Rhein Westfal TH Aachen, Inst Tech & Makromol Chem, D-52056 Aachen, Germany.
   DWI RWTH Aachen eV, D-52056 Aachen, Germany.
RP Hoogenboom, R (reprint author), Rhein Westfal TH Aachen, Inst Tech & Makromol Chem, Pauwelsstr 8, D-52056 Aachen, Germany.
EM hoogenboom@dwi.rwth-aachen.de
RI Moller, Martin/F-7860-2015; Hoogenboom, Richard/B-8977-2008
OI Moller, Martin/0000-0002-5955-4185; Hoogenboom,
   Richard/0000-0001-7398-2058
FU Alexander von Humboldt Foundation; Netherlands Scientific Organization
   (NWO)
FX RH is grateful to the Alexander von Humboldt Foundation and the
   Netherlands Scientific Organization (NWO) for financial support. Arkema
   is thanked for providing BlocBuilder(R) initiator and SG-1.
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Aoshima S, 2008, ADV POLYM SCI, V210, P169, DOI 10.1007/12_2007_120
   Arun A, 2005, BIOMATERIALS, V26, P1185, DOI 10.1016/j.biomaterials.2004.04.023
   Becer CR, 2006, J POLYM SCI POL CHEM, V44, P6202, DOI 10.1002/pola.21694
   Bian K, 2005, MACROMOLECULES, V38, P695, DOI 10.1021/ma0485383
   Chan Y, 2008, BIOMACROMOLECULES, V9, P1826, DOI 10.1021/bm800043n
   Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951
   Christova D, 2003, POLYMER, V44, P2255, DOI 10.1016/S0032-3861(03)00139-3
   Clement B, 2009, BIOMACROMOLECULES, V10, P1436, DOI 10.1021/bm900003f
   Costioli MD, 2003, BIOTECHNOL BIOENG, V81, P535, DOI 10.1002/bit.10497
   DEARFIELD KL, 1989, MUTAGENESIS, V4, P381, DOI 10.1093/mutage/4.5.381
   Deng KL, 2009, EXPRESS POLYM LETT, V3, P97, DOI 10.3144/expresspolymlett.2009.13
   Desmazes P. L., 2001, MACROMOLECULES, V34, P8866
   Diab C, 2004, MACROMOLECULES, V37, P2556, DOI 10.1021/ma0358733
   Eggenhuisen TM, 2008, MACROMOLECULES, V41, P5132, DOI 10.1021/ma800469p
   Fischer H, 1997, MACROMOLECULES, V30, P5666, DOI 10.1021/ma970535l
   Fukuda T, 1996, MACROMOLECULES, V29, P6393, DOI 10.1021/ma960552v
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Grimaldi S, 2000, MACROMOLECULES, V33, P1141, DOI 10.1021/ma9913414
   Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u
   Hoogenboom R, 2008, CHEM COMMUN, P5758, DOI 10.1039/b813140f
   Hoogenboom R, 2009, ANGEW CHEM INT EDIT, V48, P7978, DOI 10.1002/anie.200901607
   Kamigaito M, 2001, CHEM REV, V101, P3689, DOI 10.1021/cr9901182
   Khutoryanskaya OV, 2008, BIOMACROMOLECULES, V9, P3353, DOI 10.1021/bm8006242
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   KOWOLLIK CB, 2003, J POLYM SCI A, V41, P365
   Lai JT, 2002, MACROMOLECULES, V35, P6754, DOI 10.1021/ma020362m
   Lizotte JR, 2004, MACROMOL CHEM PHYSIC, V205, P692, DOI 10.1002/macp.200300110
   Lluch AV, 2009, J BIOMED MATER RES B, V90B, P182, DOI 10.1002/jbm.b.31272
   Luck M, 1998, J BIOMED MATER RES, V39, P478
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n
   Lutz JF, 2001, MACROMOL RAPID COMM, V22, P189, DOI 10.1002/1521-3927(200102)22:3<189::AID-MARC189>3.0.CO;2-X
   McAllister K, 2002, J AM CHEM SOC, V124, P15198, DOI 10.1021/ja027759q
   Mercier C. L., 2002, MACROMOL S, V182, P225
   Mun GA, 2006, J POLYM SCI POL PHYS, V44, P195, DOI 10.1002/polb.20695
   Mun GA, 2007, MACROMOL CHEM PHYSIC, V208, P979, DOI 10.1002/macp.200600555
   Nicolas J, 2004, ANGEW CHEM INT EDIT, V43, P6186, DOI 10.1002/anie.200460704
   Nicolas J, 2004, MACROMOLECULES, V37, P4453, DOI 10.1021/ma049800a
   Nicolas J, 2006, MACROMOLECULES, V39, P8274, DOI 10.1021/ma061380x
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   PERERA DI, 1995, POLYM INT, V37, P133, DOI 10.1002/pi.1995.210370208
   Pietsch C, 2009, ANGEW CHEM INT EDIT, V48, P5653, DOI 10.1002/anie.200901071
   Ramos CM, 2008, TISSUE ENG PART A, V14, P1365
   RUSSOM CL, 1988, B ENVIRON CONTAM TOX, V41, P589, DOI 10.1007/BF02021005
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   VEREGIN RPN, 1995, MACROMOLECULES, V28, P4391, DOI 10.1021/ma00117a006
   Vertommen MAME, 2008, J MEMBRANE SCI, V322, P243, DOI 10.1016/j.memsci.2008.05.044
   WANG JS, 1995, MACROMOLECULES, V28, P7901, DOI 10.1021/ma00127a042
   Wang Y, 2005, MACROMOLECULES, V38, P5846, DOI 10.1021/ma050604t
   Wischerhoff E, 2008, ANGEW CHEM INT EDIT, V47, P5666, DOI 10.1002/anie.200801202
   YOSHIDA R, 1993, ADV DRUG DELIVER REV, V11, P85, DOI 10.1016/0169-409X(93)90028-3
NR 55
TC 37
Z9 37
U1 1
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD DEC 1
PY 2009
VL 30
IS 23
BP 2042
EP 2048
DI 10.1002/marc.200900507
PG 7
WC Polymer Science
SC Polymer Science
GA 532ML
UT WOS:000272752700012
PM 21638493
DA 2018-10-20
ER

PT J
AU Ki, CS
   Park, YH
   Jin, HJ
AF Ki, Chang Seok
   Park, Young Hwan
   Jin, Hyoung-Joon
TI Silk Protein as a Fascinating Biomedical Polymer: Structural
   Fundamentals and Applications
SO MACROMOLECULAR RESEARCH
LA English
DT Review
DE silk protein; silk fibroin; structure; biomaterial
ID HUMAN BONE-MARROW; SOLID-STATE NMR; MESENCHYMAL STEM-CELLS; BOMBYX-MORI
   SILKWORM; AMINO-ACID-SEQUENCE; IN-VITRO EVALUATION; X-RAY-SCATTERING;
   STROMAL CELLS; PHYSICAL-PROPERTIES; FIBROIN NANOFIBERS
AB Silk is a textile material, as well as one of the oldest biomaterials. However, the recent progress of biomedical science and technology has led to the replacement of silk by various biomaterials based oil synthetic polymers. Despite the wide variety of biomaterials available, these materials suffer certain limitations that prevent them from meeting the various demands of the medical field. Therefore, silk continues to attract considerable interest as a promising biomaterial. This paper explains the fundamentals of silk protein, and reviews the many applications of silk biomedical polymers.
C1 [Ki, Chang Seok; Park, Young Hwan] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 151921, South Korea.
   [Ki, Chang Seok; Park, Young Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea.
   [Jin, Hyoung-Joon] Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RP Park, YH (reprint author), Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 151921, South Korea.
EM nfchempf@snu.ac.kr
FU Rural Development Administration, Republic of Korea [200810FTH010102001]
FX This study was supported by a grant (200810FTH010102001) from the
   BioGreen21 Program, Rural Development Administration, Republic of Korea.
CR ALTMAN CH, 2003, BIOMATERIALS, V24, P401
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Asakura T, 2006, BIOMACROMOLECULES, V7, P627, DOI 10.1021/bm050863q
   Asakura T, 2005, MACROMOLECULES, V38, P3356, DOI 10.1021/ma047660z
   Asakura T, 2004, MAGN RESON CHEM, V42, P258, DOI 10.1002/mrc.1337
   Asakura T, 2001, BIOPOLYMERS, V58, P521, DOI 10.1002/1097-0282(20010415)58:5<521::AID-BIP1027>3.0.CO;2-T
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Drummy LF, 2007, SOFT MATTER, V3, P877, DOI 10.1039/b701220a
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Huang T, 2007, J APPL POLYM SCI, V106, P4054, DOI 10.1002/app.26591
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kang GD, 2004, MACROMOL RES, V12, P534, DOI 10.1007/BF03218439
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Ki CS, 2007, J APPL POLYM SCI, V106, P3922, DOI 10.1002/app.26914
   Ki CS, 2007, J MEMBRANE SCI, V302, P20, DOI 10.1016/j.memsci.2007.06.003
   Ki CS, 2007, INT J BIOL MACROMOL, V41, P346, DOI 10.1016/j.ijbiomac.2007.05.005
   Ki CS, 2009, POLYMER, V50, P4618, DOI 10.1016/j.polymer.2009.02.017
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee KH, 2004, MACROMOL RAPID COMM, V25, P1792, DOI 10.1002/marc.200400333
   LI CM, 2003, PAPERS ACS, V226, pU498
   Li GY, 2001, EUR J BIOCHEM, V268, P6600, DOI 10.1046/j.0014-2956.2001.02614.x
   Li XG, 2008, BIOPOLYMERS, V89, P497, DOI 10.1002/bip.20905
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Magoshi J, 1996, ABSTR PAP AM CHEM S, V212, P53
   MAGOSHI J, 1985, POLYM COMMUN, V26, P60
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   MAGOSHI J, 1999, PAPERS ACS, V217, pU469
   MAGOSHI J, 2001, PAPERS ACS, V221, pU575
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Min SJ, 1998, SEN-I GAKKAISHI, V54, P270, DOI 10.2115/fiber.54.5_270
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Moreau JE, 2005, J ORTHOP RES, V23, P164, DOI 10.1016/j.orthres.2004.05.004
   Moreau J, 2006, TISSUE ENG, V12, P2905, DOI 10.1089/ten.2006.12.2905
   Moreau JE, 2008, TISSUE ENG PT A, V14, P1161, DOI [10.1089/ten.tea.2007.0147, 10.1089/tea.2007.0147]
   Nakazawa Y, 2002, MACROMOLECULES, V35, P2393, DOI 10.1021/ma011999t
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ochi A, 2002, BIOMACROMOLECULES, V3, P1187, DOI 10.1021/bm020056g
   Oh H, 2007, FIBER POLYM, V8, P470, DOI 10.1007/BF02875867
   Ohgo K, 2008, J AM CHEM SOC, V130, P4182, DOI 10.1021/ja710011d
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Raghu A, 2007, J POLYM SCI POL PHYS, V45, P2555, DOI 10.1002/polb.21252
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Rossle M, 2004, BIOPOLYMERS, V74, P316, DOI 10.1002/bip.20083
   SAITO H, 1984, MACROMOLECULES, V17, P1405, DOI 10.1021/ma00137a018
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Simonet M, 2007, POLYM ENG SCI, V47, P2020, DOI 10.1002/pen.20914
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   TANAKA T, 2001, PAPERS ACS, V222, pU251
   TSUKADA M, 1990, Journal of Sericultural Science of Japan, V59, P325
   TSUKADA M, 1983, SEN-I GAKKAISHI, V39, P265
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 84
TC 25
Z9 25
U1 2
U2 48
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD DEC
PY 2009
VL 17
IS 12
BP 935
EP 942
DI 10.1007/BF03218639
PG 8
WC Polymer Science
SC Polymer Science
GA 539FN
UT WOS:000273239200001
DA 2018-10-20
ER

PT J
AU Nita, LE
   Nistor, MT
   Chiriac, AP
AF Nita, Loredana Elena
   Nistor (Pintilie), Manuela Tatiana
   Chiriac, Aurica P.
TI Tailoring a Biomaterial Structure Based on Poly(aspartic acid) and
   Poly(ethylene glycol)
SO MATERIALE PLASTICE
LA English
DT Article
DE biomaterial; poly(aspartic acid); poly(ethylene glycol); NIR-CI
ID INTERPOLYMER COMPLEX; POLY(ACRYLIC ACID)
AB Polymer complexation is one of the convenient routes for the development of new polymeric materials. Polymeric complex based on poly(aspartic acid) and poly(ethylene glycol) is an interesting compound due to its attractive properties brought by the both components. Poly(aspartic acid) belongs to the family of synthetic polypeptides and it is a biocompatible and biodegradable water-soluble polymer, and owing in part to the carboxylic groups has some similar chemical properties to that of poly(acrylic acid). Poly(ethylene glycol) is also an interesting nonionic polymer because it is soluble in water and several organic solvents, due to the presence of both hydrophobic and hydrophilic segments. The near-infrared chemical imaging (NIR-CI) method is the fusion between near-infrared spectroscopy and image analysis with the unique capability to provide both qualitative and quantitative data of localized and space-averaged chemical compositions. The NIR-CI technique is successfully used in pharmaceutical applications to reveal the extent of ingredient blending, particle size distribution, the presence of polymorphs, and trace contaminants. In the present study the homogeneity of the polymeric complex based on poly(aspartic acid) and poly(ethylene glycol) it was evaluated, using NIR-CI technique which was also sustained by zeta potential and FT-IR analyses, the methods being employed in order to characterize the compound as future potential biomaterial structure.
C1 [Nita, Loredana Elena; Nistor (Pintilie), Manuela Tatiana; Chiriac, Aurica P.] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
RP Nita, LE (reprint author), Petru Poni Inst Macromol Chem, 41 Grigore Ghica Voda Alley, Iasi 700487, Romania.
EM emapintilie@yahoo.com
RI Chiriac, Aurica/B-9627-2012; Nita, Loredana Elena/B-3612-2012
OI Chiriac, Aurica/0000-0002-8452-1780; Nita, Loredana
   Elena/0000-0002-5788-3882
FU CNCSIS-Idea [995]
FX This work was supported by a CNCSIS-Idea Project, No 995: RESEARCHES IN
   THE FIELD OF POLYMERIC MATRICES DESIGN FOR SENSITIVE STRUCTURES Romania,
   Ministry of Education Research, 2009-2011.
CR BEKTUROV EA, 1980, ADV POLYM SCI, V43, P99
   Beliz K, 2009, REV CHIM-BUCHAREST, V60, P544
   Carceanu I, 2007, MATER PLAST, V44, P321
   Carelli V, 2000, INT J PHARM, V202, P103, DOI 10.1016/S0378-5173(00)00429-4
   CHIRIAC AP, 2009, COLLOID SURF A, V348, P254
   Chun MK, 2002, J CONTROL RELEASE, V81, P327, DOI 10.1016/S0168-3659(02)00078-0
   Craciunescu O, 2008, MATER PLAST, V45, P163
   Dinc E, 2009, REV CHIM-BUCHAREST, V60, P216
   Greenwald RB, 2001, J CONTROL RELEASE, V74, P159, DOI 10.1016/S0168-3659(01)00331-5
   HILTON CL, 1959, ANAL CHEM, V31, P1610, DOI 10.1021/ac60154a015
   Mathur AM, 1998, NATURE, V392, P367, DOI 10.1038/32856
   Nakato T, 1998, MACROMOLECULES, V31, P2107, DOI 10.1021/ma971629y
   Neamtu I, 2007, J OPTOELECTRON ADV M, V9, P3459
   Ozeki T, 2000, J CONTROL RELEASE, V63, P287, DOI 10.1016/S0168-3659(99)00202-3
   Panaitescu DM, 2007, MATER PLAST, V44, P195
   Reich G, 2005, ADV DRUG DELIVER REV, V57, P1109, DOI 10.1016/j.addr.2005.01.020
   Roweton S, 1997, J ENVIRON POLYM DEGR, V5, P175
   SIVADASAN K, 1991, COLLOID POLYM SCI, V269, P131, DOI 10.1007/BF00660302
   Snavely DL, 1996, J POLYM SCI POL CHEM, V34, P2575, DOI 10.1002/(SICI)1099-0518(19960930)34:13<2575::AID-POLA3>3.0.CO;2-R
   Sulca NM, 2009, MATER PLAST, V46, P1
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P111
   Umana E, 1999, J MEMBRANE SCI, V157, P85, DOI 10.1016/S0376-7388(98)00362-7
   Vorob'eva GA, 1998, RUSS CHEM B+, V47, P2155, DOI 10.1007/BF02494271
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 24
TC 2
Z9 2
U1 0
U2 3
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0025-5289
J9 MATER PLAST
JI Mater. Plast.
PD DEC
PY 2009
VL 46
IS 4
BP 345
EP 349
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 552IG
UT WOS:000274282300001
DA 2018-10-20
ER

PT J
AU Vroman, L
AF Vroman, Leo
TI When Blood Is Touched
SO MATERIALS
LA English
DT Review
DE blood; surface; interface; biomaterial
ID MOLECULAR-WEIGHT KININOGEN; PROTEIN ADSORPTION; PLATELET-ADHESION;
   VASCULAR GRAFTS; FIBRINOGEN; SURFACES; HEPARIN; PLASMA; MODEL; GLASS
AB The development of blood-compatible materials is reviewed. It grew from originally simplistic views of physical requirements such as surface charge and wettability, to endothelial cells seeded onto a biodegradable cast, and tissue engineering. In vitro findings grew from the discovery of one specific protein being adsorbed, to that of sequential protein adsorption with complex implications of platelet and white cell adhesion. The main challenge is still the production of small blood vessels (capillaries).
RP Vroman, L (reprint author), 1600 Texas St,Apt 1005, Ft Worth, TX 76102 USA.
EM lvroman@flash.net
CR ADAMS AL, 1978, J COLLOID INTERF SCI, V65, P468, DOI 10.1016/0021-9797(78)90098-X
   ADAMS AL, 1984, J BIOMED MATER RES, V18, P6643
   BAIER RE, 1972, B NY ACAD MED, V48, P2257
   BELDEN TA, 1982, T AM SOC ART INT ORG, V28, P173
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   CHAN BMC, 1981, J COLLOID INTERF SCI, V82, P217, DOI 10.1016/0021-9797(81)90141-7
   CRADDOCK PR, 1977, NEW ENGL J MED, V296, P769, DOI 10.1056/NEJM197704072961401
   DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310
   ELWING H, 1992, VROMAN EFFECT, P85
   Fedel M, 2009, J BIOMED MATER RES B, V90B, P338, DOI 10.1002/jbm.b.31291
   GARTNER TK, 1990, THROMB RES, V60, P291, DOI 10.1016/0049-3848(90)90108-O
   Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011
   GAYLORD MS, 1991, PEDIATRICS, V87, P631
   Gott VL, 1999, ANN THORAC SURG, V68, pS19, DOI 10.1016/S0003-4975(99)00817-6
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   HERRING M, 1978, SURGERY, V84, P498
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   LEDUC C, 1994, J BIOMAT SCI-POLYM E, V6, P7599
   LEDUC CA, 1995, IND ENG CHEM RES, V34, P3488, DOI 10.1021/ie00037a037
   Liu Y, 2009, J BIOMED MATER RES B, V90B, P492, DOI 10.1002/jbm.b.31310
   LU CF, 1994, J COLLOID INTERF SCI, V168, P152, DOI 10.1006/jcis.1994.1404
   Maalej N, 1999, J AM COLL CARDIOL, V33, P1408, DOI 10.1016/S0735-1097(98)00687-1
   Mangoush O, 2007, EUR J CARDIO-THORAC, V31, P1058, DOI 10.1016/j.ejcts.2007.01.029
   Moza AK, 2001, J THORAC CARDIOV SUR, V121, P697, DOI 10.1067/mtc.2001.112530
   Niimi Y, 1999, ANESTH ANALG, V89, P573, DOI 10.1097/00000539-199909000-00006
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Numata S, 2004, J HEART VALVE DIS, V13, P984
   Qiu YZ, 2009, J BIOMED MATER RES B, V90B, P668, DOI 10.1002/jbm.b.31333
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   ROTHEN A, 1951, ANN NY ACAD SCI, V53, P1054, DOI 10.1111/j.1749-6632.1951.tb48881.x
   SAWYER PN, 1972, B NY ACAD MED, V48, P2235
   SCHMAIER AH, 1984, THROMB RES, V33, P51, DOI 10.1016/0049-3848(84)90154-3
   STANFORD MF, 1983, ANN NY ACAD SCI, V416, P504, DOI 10.1111/j.1749-6632.1983.tb35208.x
   VROMAN L, 1958, J Mt Sinai Hosp N Y, V25, P261
   VROMAN L, 1964, NATURE, V204, P701, DOI 10.1038/204701b0
   VROMAN L, 1964, THROMB DIATH HAEMOST, V10, P455, DOI 10.1055/s-0038-1654798
   VROMAN L, 1980, BLOOD, V55, P156
   VROMAN L, 1958, THESIS UTRECHT U UTR
   Vroman L., 1982, ADV CHEM SER, V199, P265
   VROMAN L, 1975, ADV CHEM SER, V145, P255
   VROMAN L, 1991, BIOFOULING, V4, P81
   WILLEMS GM, 1992, VROMAN EFFECT, P21
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 45
TC 7
Z9 8
U1 0
U2 18
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD DEC
PY 2009
VL 2
IS 4
BP 1547
EP 1557
DI 10.3390/ma2041547
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA V20KZ
UT WOS:000208140200005
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Fredriksson, C
   Hedhammar, M
   Feinstein, R
   Nordling, K
   Kratz, G
   Johansson, J
   Huss, F
   Rising, A
AF Fredriksson, Camilla
   Hedhammar, My
   Feinstein, Ricardo
   Nordling, Kerstin
   Kratz, Gunnar
   Johansson, Jan
   Huss, Fredrik
   Rising, Anna
TI Tissue Response to Subcutaneously Implanted Recombinant Spider Silk: An
   in Vivo Study
SO MATERIALS
LA English
DT Article
DE spider silk; recombinant; biocompatibility; in vivo
AB Spider silk is an interesting biomaterial for medical applications. Recently, a method for production of recombinant spider silk protein (4RepCT) that forms macroscopic fibres in physiological solution was developed. Herein, 4RepCT and Mersilk(TM) (control) fibres were implanted subcutaneously in rats for seven days, without any negative systemic or local reactions. The tissue response, characterised by infiltration of macrophages and multinucleated cells, was similar with both fibres, while only the 4RepCT-fibres supported ingrowth of fibroblasts and newly formed capillaries. This in vivo study indicates that 4RepCT-fibres are well tolerated and could be used for medical applications, e. g., tissue engineering.
C1 [Hedhammar, My; Nordling, Kerstin; Johansson, Jan; Rising, Anna] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, S-75123 Uppsala, Sweden.
   [Fredriksson, Camilla] Linkopings Univ, Inst Clin & Expt Med, Fac Hlth Sci, Lab Expt Plast Surg, S-58183 Linkoping, Sweden.
   [Fredriksson, Camilla] Berzelius Clin Res Ctr, S-58225 Linkoping, Sweden.
   [Feinstein, Ricardo] Natl Vet Inst, S-75189 Uppsala, Sweden.
   [Kratz, Gunnar; Huss, Fredrik] Linkoping Univ Hosp, Dept Plast Hand & Burn Surg, S-58185 Linkoping, Sweden.
RP Rising, A (reprint author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, Box 575, S-75123 Uppsala, Sweden.
EM camilla.fredriksson@liu.se; my.hedhammar@afb.slu.se;
   ricardo.feinstein@sva.se; kerstin.nordling@afb.slu.se;
   gunnar.kratz@liu.se; jan.johansson@afb.slu.se; fredrik.huss@lio.se;
   anna.rising@afb.slu.se
RI Huss, Fredrik/G-6951-2018
OI Huss, Fredrik/0000-0002-9735-1434; Rising, Anna/0000-0002-1872-1207
FU European Commission [G5RD-CT-2002-00738]; Swedish Research Council;
   Swedish Agency for Innovation Systems; Formas
FX This study was supported by a European Commission grant ("Spiderman"
   contract no G5RD-CT-2002-00738), The Swedish Research Council, The
   Swedish Agency for Innovation Systems and Formas. The authors whish to
   thank Sonja von Aulock for help with the IPT-test and Eva Westergren for
   preparing the tissue samples.
CR Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fernandez-Cossio S, 2006, PLAST RECONSTR SURG, V117, P1789, DOI 10.1097/01.prs.0000214656.07273.b0
   Foschi D, 2001, EUR SURG RES, V33, P16, DOI 10.1159/000049687
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Grip S, 2009, PROTEIN SCI, V18, P1012, DOI 10.1002/pro.111
   Hartung Thomas, 1996, In Vitro Toxicology, V9, P353
   Hasiwa M, 2007, BIOMATERIALS, V28, P1367, DOI 10.1016/j.biomaterials.2006.11.016
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Huss FRM, 2010, J PLAST RECONSTR AES, V63, P848, DOI 10.1016/j.bjps.2009.01.068
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.3.CO;2-K
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2002, IN VIVO, V16, P229
   Williams K L, 2007, ENDOTOXINS PYROGENS, V167
NR 38
TC 31
Z9 32
U1 0
U2 15
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD DEC
PY 2009
VL 2
IS 4
BP 1908
EP 1922
DI 10.3390/ma2041908
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA V20KZ
UT WOS:000208140200019
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sadrnezhaad, SK
   Hosseini, SA
AF Sadrnezhaad, S. K.
   Hosseini, S. A.
TI Fabrication of porous NiTi-shape memory alloy objects by partially
   hydrided titanium powder for biomedical applications
SO MATERIALS & DESIGN
LA English
DT Article
ID SUPERELASTIC PROPERTIES; HYDROGEN
AB Porous NiTi-shape memory alloy (SMA) is a promising biomaterial with desirable mechanical property and appropriate biocompatibility for human implant manufacturing. In this research, porous NiTi-SMAs have been successfully produced by using thermohydrogen process (THP). This process has capability of production of homogenous structures, appropriate pore-size distributions and short sintering times. The THP-SMA samples produced in this research have a low Young's modulus (19.8 GPa) and a high tensile strength of 255 MPa. These properties are close to those of the natural bone and can meet the mechanical property demands of the hard-tissue implants for heavy load-bearing applications. The samples produced exhibit sufficient thermoelastic effect distinguished by a 1.2% mean recoverable strain. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Sadrnezhaad, S. K.] Mat & Energy Res Ctr, Karaj, Iran.
   Sharif Univ Technol, Dept Mat Sci & Engn, Tehran, Iran.
RP Sadrnezhaad, SK (reprint author), Mat & Energy Res Ctr, Karaj, Iran.
EM sadrnezh@sharif.edu
CR Bram M, 2002, MAT SCI ENG A-STRUCT, V337, P254, DOI 10.1016/S0921-5093(02)00028-X
   Bronzino J.D, 2000, BIOMEDICAL ENG HDB, V1
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Eliaz N, 2000, MAT SCI ENG A-STRUCT, V289, P41, DOI 10.1016/S0921-5093(00)00906-0
   Eliezer D, 2000, MAT SCI ENG A-STRUCT, V280, P220, DOI 10.1016/S0921-5093(99)00670-X
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Li BY, 1998, J MATER RES, V13, P2847, DOI 10.1557/JMR.1998.0389
   Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326
   Moxson VS, 2000, JOM-J MIN MET MAT S, V52, P24, DOI 10.1007/s11837-000-0027-y
   Panigrahi BB, 2006, INTERMETALLICS, V14, P130, DOI [10.1016/j.intermet.2005.04.020, 10.1016/j.internet.2005.04.020]
   Sadrnezhaad K, 1997, MATER MANUF PROCESS, V12, P107, DOI 10.1080/10426919708935124
   Sadrnezhaad SK, 2006, MATER MANUF PROCESS, V21, P87, DOI 10.1081/AMP-200060636
   SAULI K, 2003, BIOCOMPATIBILITY BIO
   Senkov ON, 1999, INT J HYDROGEN ENERG, V24, P565, DOI 10.1016/S0360-3199(98)00112-8
   Yuan B, 2006, MAT SCI ENG A-STRUCT, V438, P657, DOI 10.1016/j.msea.2005.12.077
   Yuan B, 2005, SMART MATER STRUCT, V14, pS201, DOI 10.1088/0964-1726/14/5/005
   YUAN B, 2004, MAT SCI ENG A-STRUCT, V382
   Zarandi FMH, 1997, MATER MANUF PROCESS, V12, P1093, DOI 10.1080/10426919708935206
   Zhu SL, 2005, MAT SCI ENG A-STRUCT, V408, P264, DOI 10.1016/j.msea.2005.08.012
NR 19
TC 34
Z9 35
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD DEC
PY 2009
VL 30
IS 10
BP 4483
EP 4487
DI 10.1016/j.matdes.2009.05.034
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 476PC
UT WOS:000268453500066
DA 2018-10-20
ER

PT J
AU Nakai, M
   Niinomi, M
   Akahori, T
   Tsutsumi, H
   Ogawa, M
AF Nakai, Masaaki
   Niinomi, Mitsuo
   Akahori, Toshikazu
   Tsutsumi, Harumi
   Ogawa, Michiharu
TI Effect of Oxygen Content on Microstructure and Mechanical Properties of
   Biomedical Ti-29Nb-13Ta-4.6Zr Alloy under Solutionized and Aged
   Conditions
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; titanium alloy; interstitial element; oxygen; Young's
   modulus; tensile properties
ID TEMPERATURE STEAM OXIDATION; CHROMIUM FERRITIC STEELS; TITANIUM-ALLOY;
   IMPROVEMENT; RESISTANCE; SULFUR
AB The effect of oxygen content on the microstructure and mechanical properties of the Ti-29 mass%Nb-13 mass%Ta-4.6 mass%Zr (TNTZ) alloy was investigated in this study. The microstructural observation of TNTZ alloys, containing 0.1-0.4 mass% oxygen, subjected to solution treatment shows the presence of a single phase. With an increase in oxygen content, the hardness, tensile strength, and Young's modulus of TNTZ alloy increase, but its elongation decreases. Further, the a phase precipitates in TNTZ alloys subjected to aging treatment at 723 K for 259.2 ks. The results of transmission electron microscopy and X-ray diffraction analysis indicate that the size and volume fraction of the a phase increase with oxygen content. Corresponding to the changes in the microstructure. the mechanical properties of TNTZ alloy subjected to aging treatment at 723 K change with oxygen content. The increase in oxygen content leads to enhancement of the age hardening of TNTZ alloy, thereby increasing both tensile strength and Young's modulus of TNTZ alloy, but its elongation decreases due to the a-phase precipitation. The mechanical properties of TNTZ alloy (Young's modulus: around 60-100 GPa, tensile strength: around 600-1400 MPa, and elongation: around 5-25%) vary significantly depending on oxygen content and heat treatment. [doi: 10.2320/matertrans.MA200904]
C1 [Nakai, Masaaki; Niinomi, Mitsuo; Akahori, Toshikazu; Tsutsumi, Harumi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Ogawa, Michiharu] Daido Steel Co Ltd, Nagoya, Aichi 4578545, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009
FU Global COE Program; Ministry of Education, Culture, Sports, Science and
   Technology (MEXT) of Japan; Inter-university Cooperative Research
   Program; New Energy and Industrial Technology Development Organization
   (NEDO) of Japan; Advanced Research Center of Metallic Glasses, Institute
   for Materials Research, Tohoku University, Japan
FX This work was supported in part by the Global COE Program "Materials
   Integration International Center of Education and Research, Tohoku
   University", Ministry of Education, Culture, Sports, Science and
   Technology (MEXT) of Japan, the Inter-university Cooperative Research
   Program "Highly-functional Interface Science: Innovation of Biomaterials
   with Highly-functional Interface to Host and Parasite, Tohoku University
   and Kyushu University", MEXT of Japan, the Industrial Technology
   Research Grant Program in 2009 from the New Energy and Industrial
   Technology Development Organization (NEDO) of Japan, and the cooperative
   research program of the Advanced Research Center of Metallic Glasses,
   Institute for Materials Research, Tohoku University, Japan.
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Boyer R., 1994, MAT PROPERTIES HDB T, p[10, 490]
   Fujii H., 2003, TITANIUM JPN, V51, P33
   FUJII H, 1996, TITANIUM 95, P2309
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Morinaga M, 2001, ISIJ INT, V41, P314, DOI 10.2355/isijinternational.41.314
   Nakai M, 2005, MATER TRANS, V46, P69, DOI 10.2320/matertrans.46.69
   Nakai M, 2004, MATER TRANS, V45, P865, DOI 10.2320/matertrans.45.865
   Nakai M, 2009, MATER TRANS, V50, P423, DOI 10.2320/matertrans.MRP2008380
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OUCHI C, 1994, METALLURGY AND TECHNOLOGY OF PRACTICAL TITANIUM ALLOYS, P37
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
NR 16
TC 32
Z9 32
U1 0
U2 24
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2009
VL 50
IS 12
SI SI
BP 2716
EP 2720
DI 10.2320/matertrans.MA200904
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 549WA
UT WOS:000274083800004
OA Bronze
DA 2018-10-20
ER

PT J
AU Kardashev, BK
   Orlova, TS
   Smirnov, BI
   Wilkes, TE
   Faber, KT
AF Kardashev, B. K.
   Orlova, T. S.
   Smirnov, B. I.
   Wilkes, T. E.
   Faber, K. T.
TI Young's modulus and internal friction in porous biocarbon white pine
   wood precursors
SO PHYSICS OF THE SOLID STATE
LA English
DT Article
ID SILICON-CARBIDE CERAMICS; ANELASTIC PROPERTIES; MATRIX
AB This paper reports on a study performed in the temperature range 100-293 K, in air and in vacuum, for the amplitude and time dependences of the Young's modulus and the internal friction (ultrasound damping) of biocarbon precursors prepared from white pine wood at two pyrolysis (carbonization) temperatures of 1000 and 2400A degrees C. The measurements have been conducted by the resonance technique with a composite vibrator on samples cut along and across the tree growth direction. The desorption of molecules of the external medium at low amplitudes of ultrasonic vibrations has been found to produce the pronounced influence on the effective elastic modulus and elastic vibration decrement. The data obtained from acoustic measurements of the amplitude dependences of the elastic modulus have been used to estimate the microplastic properties of the samples. It has been shown that increasing the carbonization temperature gives rise to noticeable changes in the Young's modulus and internal friction, as well as to reduction of the microplastic stress sigma (y) of the biomaterial studied. The stress sigma (y) of the samples cut across the growth direction has been found to be substantially smaller than that of the "longitudinal" samples. The elastic and microplastic properties of precursors prepared from white pine wood have been compared with those of the white eucalyptus wood.
C1 [Kardashev, B. K.; Orlova, T. S.; Smirnov, B. I.] Russian Acad Sci, AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia.
   [Wilkes, T. E.; Faber, K. T.] Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Dept Mat & Engn, Evanston, IL 60208 USA.
RP Kardashev, BK (reprint author), Russian Acad Sci, AF Ioffe Phys Tech Inst, Politekhnicheskaya Ul 26, St Petersburg 194021, Russia.
EM b.kardashev@mail.ioffe.ru; smir.bi@mail.ioffe.ru
RI Kardashev, Boris/D-2118-2014; Orlova, Tatiana/E-5877-2014; Faber,
   Katherine/B-6741-2009
FU Russian Foundation for Basic Research [07-03-91353NNF_a]; Presidium of
   the Russian Academy of Sciences [P-03]; US National Science Foundation
   [DMR-0710630]
FX This study was supported by the Russian Foundation for Basic Research
   (project no. 07-03-91353NNF_a) and the Presidium of the Russian Academy
   of Sciences (program P-03). The financial support for T. E. W. and K. T.
   F. from the US National Science Foundation under grant DMR-0710630 is
   gratefully acknowledged.
CR Chernov VM, 1998, J NUCL MATER, V257, P263, DOI 10.1016/S0022-3115(98)00457-7
   de Arellano-Lopez A. R., 2004, INT J APPL CERAM TEC, V1, P95
   Greil P, 1998, J EUR CERAM SOC, V18, P1961, DOI 10.1016/S0955-2219(98)00156-3
   Kardashev BK, 2006, MAT SCI ENG A-STRUCT, V442, P444, DOI 10.1016/j.msea.2006.02.221
   Kardashev BK, 2005, PHYS SOLID STATE+, V47, P886, DOI 10.1134/1.1924850
   Kaul VS, 2006, MAT SCI ENG A-STRUCT, V428, P225, DOI 10.1016/j.msea.2006.05.033
   Nikanorov SP, 1985, ELASTICITY DISLOCATI
   Parfen'eva L, 2008, PHYS SOLID STATE+, V50, P2245, DOI 10.1134/S1063783408120032
   Sebo P, 2003, INT J MATER PROD TEC, V18, P141, DOI 10.1504/IJMPT.2003.003589
   Smirnov BI, 2001, PHYS SOLID STATE+, V43, P2094, DOI 10.1134/1.1417186
   VARELAFERIA FM, 2004, THESIS U SEVILLA SEV
NR 11
TC 6
Z9 6
U1 0
U2 9
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1063-7834
J9 PHYS SOLID STATE+
JI Phys. Solid State
PD DEC
PY 2009
VL 51
IS 12
BP 2463
EP 2468
DI 10.1134/S1063783409120063
PG 6
WC Physics, Condensed Matter
SC Physics
GA 531KQ
UT WOS:000272665400006
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tomic, SL
   Dimitrijevic, SI
   Marinkovic, AD
   Najman, S
   Filipovic, JM
AF Tomic, Simonida Ljubisa
   Dimitrijevic, Suzana I.
   Marinkovic, Aleksandar D.
   Najman, Stevo
   Filipovic, Jovanka M.
TI Synthesis and characterization of poly(2-hydroxyethyl
   methacrylate/itaconic acid) copolymeric hydrogels
SO POLYMER BULLETIN
LA English
DT Article
DE Hydrogels; 2-Hydroxyethyl methacrylate; Itaconic acid; Morphology;
   Hemocompatibility; Controlled drug release; Antibacterial activity
ID DRUG-DELIVERY; IN-VITRO; PENETRANT DIFFUSION; SWELLABLE POLYMERS;
   RELEASE; NETWORKS; SOLUTE; MECHANISMS
AB In the present study poly(2-hydroxyethyl methacrylate-co-itaconic acid) (P(HEMA/IA)) hydrogels were synthesized by free-radical copolymerization of 2-hydroxyethyl methacrylate and itaconic acid in order to evaluate as controlled release drug delivery system. All polymerizations were performed in a mixture of water/ethanol with ethylene glycol dimethacrylate, as crosslinking agent, potassium persulfate, as initiator, and N, N, N', N'-tetramethylethylene diamine, as activator. The samples were characterized by FTIR and SEM. Swelling kinetics and antibiotic release studies were performed using gravimetry and UV spectrophotometry, respectively. The antibacterial activity studies were performed bearing in mind that infections are the most common cause of biomaterial implant failure and represent a constant menace to the application of medical implants. The hemocompatibility testing was performed as imperative for medical devices intended for direct or indirect blood exposure. In accordance with the results of antibacterial assessment on gels loaded with antibiotics and hemolytic activity testing these gels exerted good bacterial growth inhibition and favorable hemolytic activity. The release profiles of antibiotics, evaluated in vitro conditions, were correspondent for antibacterial therapeutics. Therefore, it was concluded that (P(HEMA/IA)) gels could be propound for the potential application as drug delivery systems for the controlled release of antibiotics.
C1 [Tomic, Simonida Ljubisa; Dimitrijevic, Suzana I.; Marinkovic, Aleksandar D.; Filipovic, Jovanka M.] Fac Technol & Met Belgrade, Belgrade 11000, Serbia.
   [Najman, Stevo] Univ Med Sch, Inst Biol, Nish, Serbia.
RP Tomic, SL (reprint author), Fac Technol & Met Belgrade, Karnegijeva 4-V, Belgrade 11000, Serbia.
EM simonida@tmf.bg.ac.rs
OI Dimitrijevic-Brankovic, Suzana/0000-0001-6849-6936; Tomic,
   Simonida/0000-0002-9013-682X; Najman, Stevo/0000-0002-2411-9802
FU Ministry for Science and Technological Development of the Republic of
   Serbia [145072]
FX This work has been supported by the Ministry for Science and
   Technological Development of the Republic of Serbia ( grant no. 145072).
CR ALFREY T, 1966, J POLYM SCI        C, V12, P249, DOI DOI 10.1002/P0LC.5070120119
   Bajpai AK, 2008, PROG POLYM SCI, V33, P1088, DOI 10.1016/j.progpolymsci.2008.07.005
   BAMBA M, 1979, INT J PHARM, V3, P87, DOI 10.1016/0378-5173(79)90069-3
   Bell CL, 1995, J CONTROL RELEASE, V37, P277, DOI 10.1016/0168-3659(95)00085-2
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   DUMITRIU S, 2002, POLYMERIC BIOMATERIA
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Houghton PJ, 2005, J ETHNOPHARMACOL, V100, P100, DOI 10.1016/j.jep.2005.07.001
   Hughes PM, 2005, ADV DRUG DELIVER REV, V57, P2010, DOI 10.1016/j.addr.2005.09.004
   *ISO, 1992, 109935 ISO 4
   KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P409, DOI 10.1002/polb.1986.090240215
   Martineau L, 2006, BURNS, V32, P172, DOI 10.1016/j.burns.2005.08.012
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Peppas N.A., 1987, HYDROGELS MED PHARM, P118
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 1998, EUR J PHARM BIOPHARM, V46, P15, DOI 10.1016/S0939-6411(97)00113-6
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Tomic SL, 2006, POLYM BULL, V57, P691, DOI 10.1007/s00289-006-0606-3
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
NR 28
TC 22
Z9 22
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
J9 POLYM BULL
JI Polym. Bull.
PD DEC
PY 2009
VL 63
IS 6
BP 837
EP 851
DI 10.1007/s00289-009-0123-2
PG 15
WC Polymer Science
SC Polymer Science
GA 524CS
UT WOS:000272122000006
DA 2018-10-20
ER

PT J
AU Foster, LJR
   Tighe, BJ
AF Foster, L. John R.
   Tighe, Brian J.
TI In vitro hydrolytic degradation of centrifugally spun
   polyhydroxybutyrate-pectin composite fibres
SO POLYMER INTERNATIONAL
LA English
DT Article
DE centrifugal spinning; polyhydroxybutyrate; PHB; biomaterial;
   degradation; blending
ID INTRACELLULAR DEPOLYMERASE; PSEUDOMONAS-OLEOVORANS;
   POLYHYDROXYOCTANOATE; HYDROXYBUTYRATE
AB BACKGROUND: Centrifugal spinning is a novel fibre-forming process that readily permits the incorporation of additives while avoiding the thermal damage often associated with conventional melt spinning. Centrifugal spinning of a viscous solution of poly(3-hydroxybutyrate) (PHB) mixed with pectin was used to fabricate a range of fibres containing different concentrations of this biologically active agent. The influence of this blending on fibre morphology and in vitro degradation in an accelerated hydrolytic model at 70 degrees C and pH of 10.6 is reported.
   RESULTS: Blending influenced the physiochemical properties of the fibres, and this significantly affected the degradation profile of both the fibre and its PHB constituent. A greater influence on degradation was exerted by the type of pectin and its degree of esterification than by variations in its loading.
   CONCLUSION: Centrifugal spinning permits the fabrication of composite fibrous matrices from PHB and pectin. Incorporation of the polysaccharide into the fibres can be used to manipulate degradation behaviour and demonstrates a model for doping of matrices with active biological constituents. The unique features of the centrifugal spinning process, as illustrated by the structure of the fibres and the degradation profiles, suggest possible applications of centrifugally spun biopolymers as wound scaffolding devices and in tissue engineering. (C) 2009 Society of Chemical Industry
C1 [Tighe, Brian J.] Aston Univ, Sch Engn & Appl Sci, Biomat Res Unit, Birmingham B4 7ET, W Midlands, England.
   [Foster, L. John R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Biopolymer Res Grp, Sydney, NSW 2052, Australia.
RP Tighe, BJ (reprint author), Aston Univ, Sch Engn & Appl Sci, Biomat Res Unit, Birmingham B4 7ET, W Midlands, England.
EM B.J.Tighe@oston.ac.uk
CR BONFIELD W, 1986, BIOL BIOMECHANICAL P, P153
   Cros S, 1996, BIOPOLYMERS, V39, P339, DOI 10.1002/(SICI)1097-0282(199609)39:3<339::AID-BIP6>3.0.CO;2-P
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Foster LJR, 2005, POLYM DEGRAD STABIL, V87, P1, DOI 10.1016/j.polymdegradstab.2003.11.012
   Foster LJR, 1996, INT J BIOL MACROMOL, V19, P177, DOI 10.1016/0141-8130(96)01125-7
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   Foster LJR, 2001, J BIOMAT SCI-POLYM E, V12, P317, DOI 10.1163/156856201750180843
   FREDERICKS RJ, 1984, J POLYM SCI POL PHYS, V22, P57, DOI 10.1002/pol.1984.180220106
   GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P127, DOI 10.1016/0141-3910(84)90032-6
   Li XT, 2008, BIOMATERIALS, V29, P3720, DOI 10.1016/j.biomaterials.2008.06.004
   Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8
   REUSCH RN, 1992, BIOCHIM BIOPHYS ACTA, V1123, P33, DOI 10.1016/0005-2760(92)90168-U
   Schmack G, 2000, J POLYM SCI POL PHYS, V38, P2841, DOI 10.1002/1099-0488(20001101)38:21<2841::AID-POLB130>3.0.CO;2-#
   STEEL ML, 1981, Patent No. 21606
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Stuart ES, 1996, INT J BIOL MACROMOL, V19, P171, DOI 10.1016/0141-8130(96)01124-5
   Williams SF, 2002, BIOPOLYMERS, P91
   YASIN M, 1992, BIOMATERIALS, V13, P9, DOI 10.1016/0142-9612(92)90087-5
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 19
TC 7
Z9 7
U1 1
U2 20
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD DEC
PY 2009
VL 58
IS 12
BP 1442
EP 1451
DI 10.1002/pi.2682
PG 10
WC Polymer Science
SC Polymer Science
GA 526RK
UT WOS:000272310300013
DA 2018-10-20
ER

PT J
AU Bettinger, CJ
AF Bettinger, Christopher J.
TI Synthesis and microfabrication of biomaterials for soft-tissue
   engineering
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE biomaterials; microfabrication; nanostructures; polymers; tissue
   engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO; NANOSCALE TOPOGRAPHY;
   MECHANICAL-PROPERTIES; CONTACT GUIDANCE; BIODEGRADABLE ELASTOMER;
   DIRECTIONAL MIGRATION; HEPATOCYTE CULTURE; BASEMENT-MEMBRANE; SCAFFOLD
   DESIGN
AB Biomaterials synthesis and scaffold fabrication will play an increasingly important role in the design of systems for regenerative medicine and tissue engineering. These rapidly growing fields are converging as scaffold design must begin to incorporate multidisciplinary aspects in order to effectively organize cell-seeded constructs into functional tissue. This review article examines the use of synthetic biomaterials and fabrication strategies across length scales with the ultimate goal of guiding cell function and directing tissue formation. This discussion is parsed into three subsections: (1) biomaterials synthesis, including elastomers and gels; (2) synthetic micro- and nanostructures for engineering the cell-biomaterial interface; and (3) complex biomaterials systems design for controlling aspects of the cellular microenvironment.
C1 Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
RP Bettinger, CJ (reprint author), Stanford Univ, Dept Chem Engn, 381 North South Axis,Room 113, Stanford, CA 94305 USA.
RI Bettinger, Christopher/A-3895-2009
FU Charles Stark Draper Graduate Fellowship; Ruth L. Kirschstein National
   Institutes of Health Fellowship [1F32NS064771-01]
FX C.J.B. was funded in part by a Charles Stark Draper Graduate Fellowship
   and a Ruth L. Kirschstein National Institutes of Health Fellowship
   (Grant #1F32NS064771-01). C.J.B. would like to thank the following
   people: Robert Langer, Jeffrey Borenstein, Zhenan Bao, Krystyn Van Vhet,
   and Michael Cima for their ongoing mentorship and support; Joost
   Bruggeman, Jason Fuller, Kerry Mahon, Jordan Green, David Nguyen, and
   Emmanuel Simons for extensive collaboration, scientific discussions, and
   aencral interest in scholarly pursuits and Asish Misra and Zhitong Zhang
   for their enthusiasm and interest in academic research.
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402
   Amsden BG, 2004, BIOMACROMOLECULES, V5, P2479, DOI 10.1021/bm049578h
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bettinger CJ, 2009, J BIOMED MATER RES A, V91A, P1077, DOI 10.1002/jbm.a.32306
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bettinger CJ, 2009, TISSUE ENG PT A, V15, P1321, DOI 10.1089/ten.tea.2008.0134
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228
   Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704
   Brinkman WT, 2003, BIOMACROMOLECULES, V4, P890, DOI 10.1021/bm0257412
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001
   Friedl P, 2000, Dev Immunol, V7, P249, DOI 10.1155/2000/56473
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747
   Heckele M, 2004, J MICROMECH MICROENG, V14, pR1, DOI 10.1088/0960-1317/14/3/R01
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hsu SH, 2005, BIOTECHNOL BIOENG, V92, P579, DOI 10.1002/bit.20634
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hubbell JA, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P297, DOI 10.1016/B978-012370615-7/50025-1
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kim SH, 2000, J BIOMATER APPL, V15, P23, DOI 10.1106/ML30-FMLG-1HRU-7C4B
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   MOTTA PM, 1984, ARCH HISTOL JAPON, V47, P1, DOI 10.1679/aohc.47.1
   Nagata M, 2004, POLYMER, V45, P87, DOI 10.1016/j.polymer.2003.11.003
   Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.3.CO;2-6
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   Park J, 2005, BIOTECHNOL BIOENG, V90, P632, DOI 10.1002/bit.20463
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Rajnicek AM, 2007, DEV BIOL, V312, P448, DOI 10.1016/j.ydbio.2007.09.051
   Rivron NC, 2009, BIOMATERIALS, V30, P4851, DOI 10.1016/j.biomaterials.2009.06.037
   ROBERT AB, 2009, ADV MATER, V21, P2407
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   Seunarine K, 2008, MICROELECTRON ENG, V85, P1350, DOI 10.1016/j.mee.2008.02.002
   Shito M, 2001, ARTIF ORGANS, V25, P571, DOI 10.1046/j.1525-1594.2001.025007571.x
   Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Wang XF, 2008, BIOMATERIALS, V29, P2049, DOI 10.1016/j.biomaterials.2007.12.047
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791
   Wu HK, 2003, J AM CHEM SOC, V125, P554, DOI 10.1021/ja021045y
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   YOON Y, 2006, J BIOMED MATER RES A, V78, P668
   Zhao XM, 1996, ADV MATER, V8, P837, DOI 10.1002/adma.19960081016
NR 87
TC 14
Z9 14
U1 1
U2 16
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD DEC
PY 2009
VL 81
IS 12
BP 2183
EP 2201
DI 10.1351/PAC-CON-09-07-10
PG 19
WC Chemistry, Multidisciplinary
SC Chemistry
GA 538TF
UT WOS:000273206200003
DA 2018-10-20
ER

PT J
AU Nagahama, K
   Shimizu, K
   Ouchi, T
   Ohya, Y
AF Nagahama, Koji
   Shimizu, Keiko
   Ouchi, Tatsuro
   Ohya, Yuichi
TI Biodegradable poly(L-lactide)-grafted alpha-cyclodextrin copolymer
   displaying specific dye absorption by host-guest interactions
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Graft copolymer; Biodegradable polymer; Amphiphilic; alpha-Cyclodextrin;
   Poly(L-lactide)
ID POLYLACTIDE-GRAFTED DEXTRAN; GLYCOL)-POLY(L-LACTIDE) BLOCK-COPOLYMER;
   SOLUTION-CAST FILM; L-LACTIDE; POLYMERIZATION; DEGRADATION; BIOMATERIAL;
   SUPPRESSION; HYDROGEL; GLYCOL)
AB A biodegradable graft copolymer (CD-g-PLLA) composed of alpha-cyclodextrin (alpha-CD) and poly(L-lactide) (PLLA) was synthesized by the ring-opening polymerization of L-LA using mostly trimethylsilylated (alpha-CD (TMS-alpha-CD) as an initiator. TEM measurements of the CD-g-PLLA film showed a nanoscale lamellar-type microphase-separated structure in the most of the film. In contrast, an irregular phase-separated structure was observed in the TMS-CD-g-PLLA film, suggesting that the hydroxyl groups in CD-g-PLLA governed the formation of the lamellar structure, likely because of their important roles in intra- and/or intermolecular hydrogen bonding. The CD-g-PLLA film was mechanically tenacious but soft, and it showed reduced PLLA crystallinity, high transparency, and accelerated hydrolytic degradation. The CD-g-PLLA film served as a host for various dye compounds based on specific host-guest interactions of the alpha-CDs. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Shimizu, Keiko; Ouchi, Tatsuro; Ohya, Yuichi] Kansai Univ, High Technol Res Ctr, Dept Chem & Mat Engn, Osaka 5648680, Japan.
   [Nagahama, Koji] Konan Univ, Frontiers Innovat Res Sci & Technol, Dept Nanobiochem, Chuo Ku, Kobe, Hyogo 6500047, Japan.
RP Ohya, Y (reprint author), Kansai Univ, High Technol Res Ctr, Dept Chem & Mat Engn, Osaka 5648680, Japan.
EM yohya@kansai-u.ac.jp
FU MEXT (Ministry of Education, Culture, Sports, Science and Technology),
   Japan [20034055]; Kansai University
FX This work was supported by a "High-Tech Research Center" Project for
   Private Universities: Matching Fund Subsidy from MEXT (Ministry of
   Education, Culture, Sports, Science and Technology), Japan. A portion of
   this study was financially supported by a Grant-in-Aid for Scientific
   Research on Priority Areas (20034055) from MEXT, Japan and by the Kansai
   University Grant-in-Aid for progress of research in graduate courses,
   2008.
CR BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   Choi HS, 2006, PROG POLYM SCI, V31, P121, DOI 10.1016/j.progpolymsci.2005.09.002
   Deng W, 2007, ANGEW CHEM INT EDIT, V46, P5144, DOI 10.1002/anie.200701272
   DORGAN JR, 2006, ACS S SERIES, V939
   Finne A, 2002, BIOMACROMOLECULES, V3, P684, DOI 10.1021/bm020009o
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Huang MH, 2004, POLYMER, V45, P8675, DOI 10.1016/j.polymer.2004.10.054
   Ikkala O, 2002, SCIENCE, V295, P2407, DOI 10.1126/science.1067794
   Jacobsen S, 1999, POLYM ENG SCI, V39, P1311, DOI 10.1002/pen.11518
   Joziasse CAP, 2000, MACROMOL CHEM PHYSIC, V201, P107, DOI 10.1002/(SICI)1521-3935(20000101)201:1<107::AID-MACP107>3.0.CO;2-W
   Kricheldorf HR, 2005, MACROMOLECULES, V38, P7018, DOI 10.1021/ma047836x
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lemmouchi Y, 2007, J POLYM SCI POL CHEM, V45, P2235, DOI 10.1002/pola.21991
   Li YX, 1998, POLYMER, V39, P4421, DOI 10.1016/S0032-3861(97)10362-7
   MATSUSUE Y, 1992, J BIOMED MATER RES, V26, P1553, DOI 10.1002/jbm.820261203
   Muthukumar M, 1997, SCIENCE, V277, P1225, DOI 10.1126/science.277.5330.1225
   Nagahama K, 2006, MACROMOL BIOSCI, V6, P412, DOI 10.1002/mabi.200500249
   Nagahama K, 2006, POLYM J, V38, P852, DOI 10.1295/polymj.PJ2005240
   Nelson A, 2004, J AM CHEM SOC, V126, P11914, DOI 10.1021/ja0491073
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Ouchi T, 2006, POLYMER, V47, P429, DOI 10.1016/j.polymer.2005.11.039
   Ouchi T, 2005, J BIOMAT SCI-POLYM E, V16, P1035, DOI 10.1163/1568562054414649
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Ouchi T, 2006, J POLYM SCI POL CHEM, V44, P6402, DOI 10.1002/pola.21750
   Pitet LM, 2007, MACROMOLECULES, V40, P2327, DOI 10.1021/ma0618068
   Sanabria-DeLong N, 2006, MACROMOLECULES, V39, P1308, DOI 10.1021/ma052243n
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   Takashima Y, 2004, J AM CHEM SOC, V126, P13588, DOI 10.1021/ja047171e
   Tasaka F, 2001, MACROMOLECULES, V34, P5494, DOI 10.1021/ma010067m
   TAWARAH KM, 1993, J CHEM SOC FARADAY T, V89, P1729, DOI 10.1039/ft9938901729
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Zheng XT, 2006, BIOMATERIALS, V27, P4288, DOI 10.1016/j.biomaterials.2006.03.043
NR 36
TC 8
Z9 8
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD DEC
PY 2009
VL 69
IS 12
BP 891
EP 897
DI 10.1016/j.reactfunctpolym.2009.09.004
PG 7
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 524HN
UT WOS:000272134500006
DA 2018-10-20
ER

PT J
AU Ebara, M
   Yuki, I
   Murayama, Y
   Saguchi, T
   Nien, YL
   Vinters, HV
   Vinuela, F
   Abe, T
AF Ebara, Masaki
   Yuki, Ichiro
   Murayama, Yuichi
   Saguchi, Takayuki
   Nien, Yih-Lin
   Vinters, Harry V.
   Vinuela, Fernando
   Abe, Toshiaki
TI A rabbit model for efficacy evaluation of endovascular coil materials
SO SURGICAL NEUROLOGY
LA English
DT Article
DE Experimental animal models; Material screening; Intracranial aneurysm;
   Biomaterial; Therapeutic embolization
ID GUGLIELMI DETACHABLE COIL; INTRACRANIAL ANEURYSMS; NATURAL-HISTORY;
   EMBOLIZATION
AB Background: To investigate biomaterials seeking for their possible use for aneurysm treatment, in vivo screening tests using a number of potential materials are required. However, there is no established animal model that is suitable for such purpose. Some models require special preparation of tested materials for transcatheter delivery and others are inappropriate in view of their cost-effectiveness. The purpose of this study is to establish an animal model that overcomes these limitations and help us select potential materials before the preclinical evaluation.
   Methods: Bilateral CCAs in a rabbit were surgically ligated, and a 2-cm segment of either a bare platinum coil or a polymeric coil (a platinum coil coated with PLGA 10/90) was implanted into each blind-ended arterial segment (n = 26). They were harvested at day 1, 7, 10, 14, or 30, respectively. Angiographic and histologic evaluations as well as quantitative analysis on the development of the organized thrombus were performed.
   Results: One day after the implantation, both platinum and PLGA coils were surrounded by immature thrombus that was induced by blood flow stagnation in the arterial segment. At day 7, minimal thrombus organization was observed around both types of materials. At postimplantation days 10 and 14, fibrocellular responses, the early findings of the thrombus organization process, were observed in both material groups. Such histologic findings were more prominent in the PLGA coil group as compared to the platinum coil group (day 10, P = .051; day 14, P = .011). Well-organized thrombus was observed in both material groups at day 30 without showing statistical difference (P = .12).
   Conclusion: Given the cost-effectiveness, the simple material preparation process, and its feasible histologic evaluation methods, this new animal model can be useful in screening other potential biomaterials for the development of new coil devices. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Yuki, Ichiro; Murayama, Yuichi] Jikei Univ, Sch Med, Div Endovasc Neurosurg, Tokyo 1058471, Japan.
   [Ebara, Masaki; Saguchi, Takayuki; Abe, Toshiaki] Jikei Univ, Sch Med, Dept Neurosurg, Tokyo 1058471, Japan.
   [Yuki, Ichiro; Murayama, Yuichi; Nien, Yih-Lin; Vinuela, Fernando] Univ Calif Los Angeles, Div Intervent Neuroradiol, UCLA Med Ctr, Los Angeles, CA 90095 USA.
   [Yuki, Ichiro; Murayama, Yuichi; Nien, Yih-Lin; Vinuela, Fernando] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med & Neurol, Los Angeles, CA 90024 USA.
RP Yuki, I (reprint author), Jikei Univ, Sch Med, Div Endovasc Neurosurg, Tokyo 1058471, Japan.
EM iyuki@mednet.ucla.edu
FU UCLA SPOTRIAS [NS 44378]; Daljit S. and Elaine Sarkaria Chair in
   Diagnostic Medicine
FX We gratefully acknowledge the technical assistance of Fernando A.
   Vinuela and Shawn McGill of the Leo G. Rigler Radiological Research
   Center at the University of California, Los Angeles. Dr Harry V.
   Vinters, who is one of our co-investigators, was supported in part by
   UCLA SPOTRIAS grant (NS 44378) and the Daljit S. and Elaine Sarkaria
   Chair in Diagnostic Medicine.
CR Bavinzski G, 1999, J NEUROSURG, V91, P284, DOI 10.3171/jns.1999.91.2.0284
   Burger C, 2006, ARCH ORTHOP TRAUM SU, V126, P695, DOI 10.1007/s00402-006-0207-5
   Chu CC, 1997, WOUND CLOSURE BIOMAT
   Hayakawa M, 2000, J NEUROSURG, V93, P561, DOI 10.3171/jns.2000.93.4.0561
   Kallmes DF, 2003, AM J NEURORADIOL, V24, P591
   Kallmes DF, 2002, AM J NEURORADIOL, V23, P1580
   KWAN ESK, 1993, AM J NEURORADIOL, V14, P323
   LEE DWY, 2007, J NEUROSURG
   Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6
   MOLYNEUX AJ, 1995, J NEUROSURG, V83, P129, DOI 10.3171/jns.1995.83.1.0129
   Murayama Y, 2003, J NEUROSURG, V98, P959, DOI 10.3171/jns.2003.98.5.0959
   Murayama Y, 2002, STROKE, V33, P1120, DOI 10.1161/01.STR.0000014423.20476.EE
   Outlaw KK, 1998, AM SURGEON, V64, P348
   Raymond J, 2002, STROKE, V33, P850, DOI 10.1161/hs0302.104090
   Raymond J, 2006, STROKE, V37, P2147, DOI 10.1161/01.STR.0000231724.18357.68
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
   YUKI LD, 2007, J NEUROSURG
NR 18
TC 1
Z9 2
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-3019
J9 SURG NEUROL
JI Surg. Neurol.
PD DEC
PY 2009
VL 72
IS 6
BP 620
EP 627
DI 10.1016/j.surneu.2009.04.017
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 616TY
UT WOS:000279233900014
PM 20082832
DA 2018-10-20
ER

PT J
AU Kim, KH
   Kim, MH
   Lim, YH
   Park, SR
   Choi, BH
   Park, HC
   Yoon, SH
   Min, BH
   Park, H
AF Kim, Kil Hwan
   Kim, Moon Hang
   Lim, Yoon Hee
   Park, So Ra
   Choi, Byung Hyune
   Park, Hyung Chun
   Yoon, Seung Hwan
   Min, Byoung-Hyun
   Park, Hyeonseon
TI A Comparative Biocompatibility Study of Chondrocyte-derived ECM and Silk
   Fibroin Scaffolds In Vitro and in Rat Acute Traumatic Brain Injury
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biocompatibility; chondrocyte derived ECM scaffold; silk fibroin
   scaffold; traumatic brain injury
ID MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; TISSUE; MARROW; LESION;
   TRANSPLANTATION; BIOMATERIALS; MEMBRANE; GROWTH; REPAIR
AB Traumatic brain injury (TBI) often leads to critical tissue damage and loss. Brain tissue engineering is a promising technique for cellular replacement and neurological functional recovery in animals. However, useful biomaterial scaffolds have not been found so far. In order to explore the feasibility of stem cell based brain tissue engineering, it is first necessary to evaluate the biocompatibility of biomaterials with stem cells and brain tissues. In the present study, two biomaterials, chondrocyte derived ECM (ECM) and silk fibroin (SF) scaffolds, were investigated for their biocompatibility in vitro and in acute TBI. We found that when the ECM scaffold was cultured with rat mesenchymal stem cells (rMSCs) or implanted directly into brain injury, had a good biocompatibility. rMSCs, seeded on the ECM scaffold, were evenly distributed with a spindle shape and attached well, while on SF scaffold attached with a round shape relatively weakly. In the TBI model, the SF scaffold resulted in a significant increase in the cavity volume at 6 weeks postimplantation, but not the ECM scaffold. In addition, the ECM scaffold induced a lower inflammatory response, with active microglia/macrophages at 1 week, than the SF scaffold and control. Interestingly, both scaffolds reduced glial fibrillary acidic protein (GFAP) and neurocan expression in the cavity boundary throughout the experimental periods. These results indicate that the scaffolds tested inhibit the glial scar fort-nation in injured brain tissue. Moreover, there were no significant differences in the neurological outcome and weight body gain, when compared with the brain injury alone. Taken together, these findings reveal that the ECM scaffold showed good biocompatibility to the donor rMSCs and host brain tissue. Thus, the ECM scaffold seems to be beneficial as a biomaterial for brain tissue engineering.
C1 [Park, Hyung Chun; Yoon, Seung Hwan; Park, Hyeonseon] Inha Univ, Coll Med, Dept Neurosurg, Inchon 400712, South Korea.
   [Min, Byoung-Hyun] Ajou Univ, Cell Therapy Ctr, Sch Med, Suwon 443270, South Korea.
   [Kim, Kil Hwan; Kim, Moon Hang; Lim, Yoon Hee; Park, So Ra] Inha Univ, Coll Med, Dept Physiol, Inchon 400712, South Korea.
   [Choi, Byung Hyune] Inha Univ, Coll Med, Div Biomed & Bioengn Sci, Inchon 400712, South Korea.
RP Park, H (reprint author), Inha Univ, Coll Med, Dept Neurosurg, 7-241,3 Ga Shinheung Dong, Inchon 400712, South Korea.
EM hspark@inha.ac.kr
FU Ministry for Health, Welfare & Family Affairs, Republic of Korea
   [A084615]; Ministry of Education, Science and Technology, Republic of
   Korea [SC-4181]
FX This study Was Supported by a grant of the Korea Healthcare technology
   R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of
   Korea (A084615) and Stem Cell Research Center of the 21st Century
   Frontier Research Program funded by the Ministry of Education, Science
   and Technology (Grant No. SC-4181), Republic of Korea. We thank Dr.
   David L. Kaplan and Dr. Sang-Hyug Park (Tufts University) for generously
   providing us with the silk fibroin scaffold.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701
   Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006
   Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071
   HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.000028004/.85651.4F
   Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935
   Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Min B.H., 1998, J KOREAN ORTHOP RES, V1, P23
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005
   SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 30
TC 4
Z9 4
U1 0
U2 8
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JEONJU
PA CHONBUK NATIONAL UNIV, DEPT POLYMER-NANO SCIENCE & TECH, 664-14,
   DUCKJIN, JEONJU, 561-756, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD DEC
PY 2009
VL 6
IS 14
BP 1420
EP 1428
PG 9
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 544IG
UT WOS:000273647500011
DA 2018-10-20
ER

PT J
AU Tang, PF
   Yao, Q
   Zhang, W
   Liang, YH
   Zhang, LH
   Wang, Y
AF Tang, Peifu
   Yao, Qi
   Zhang, Wei
   Liang, Yonghui
   Zhang, Lihai
   Wang, Yan
TI A Study of Femoral Neck Fracture Repair Using a Recombinant Human Bone
   Morphogenetic Protein-2 Directional Release System
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TOTAL HIP-REPLACEMENT; RAT ECTOPIC MODEL; INTERNAL-FIXATION;
   GROWTH-FACTOR; BIOMATERIAL CARRIERS; SUSTAINED-RELEASE;
   PHARMACOKINETICS; RHBMP-2; MATRIX
AB Objective: Significant difficulties are caused by the delayed union of femoral neck fractures. To address this issue, we designed a new device that applies recombinant human bone morphogenetic protein-2 (rhBMP-2) to promote fracture union.
   Methods: A cannulated screw with holes was used to deliver rhBMP-2 to the fracture site. Fibrin glue was used as an adhesive agent to hold rhBMP-2 in the vicinity of fracture. RhBMP-2 was protected with polylactide-glycolide acid microspheres. RhBMP-2 release was evaluated to determine the effect of the improved screws.
   Result: When polylactide-glycolide acid microspheres were used, 3.65% of the rhBMP-2 was released in the first 2 h, 5.17% was released within 8 h, and 8.95% was released within 24 h. In the microsphere + fibrin glue group, 1.15% of the rhBMP-2 was released in the first 2 h, 1.75% was released within 8 h, and 6.68% was released within 24 h. Over 42 days, about 76.75% of the rhBMP-2 was released when using fibrin glue, which was lower than the amount released using microspheres alone (91.75%). In dog, a faster repair rate was observed on the side with the improved screw than on the side with traditional screw.
   Conclusion: The directional release system described here can improve the process of fracture healing and is a promising technique for repairing femoral neck fracture.
C1 [Tang, Peifu; Yao, Qi; Zhang, Wei; Liang, Yonghui; Zhang, Lihai; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China.
RP Zhang, LH (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, 28 Fuxing Rd, Beijing 100853, Peoples R China.
EM zhanglihai@gmail.com; wyan301@gmail.com
OI Tang, Peifu/0000-0003-4279-1704
FU National Natural Science Foundation of China [30700848, 30672135];
   Natural Science Foundation of Beijing, China [7072072]
FX This study was suppoted by the National Natural Science Foundation of
   China (30700848 and 30672135) and the Natural Science Foundation of
   Beijing, China (7072072).
CR Aharonoff GB, 1997, J ORTHOP TRAUMA, V11, P162, DOI 10.1097/00005131-199704000-00004
   ALLEN HL, 1980, ACTA ORTHOP SCAND, V51, P595, DOI 10.3109/17453678008990848
   BARNES ROLAND, 1967, J BONE JOINT SURG B BRIT, V49, P607
   Bartonicek J, 2007, J ORTHOP TRAUMA, V21, P229, DOI 10.1097/BOT.0b013e31804afb0b
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P2122, DOI 10.2106/JBJS.E.00535
   Bhandari M, 1999, Int J Surg Investig, V1, P319
   Blomfeldt R, 2005, J BONE JOINT SURG AM, V87A, P1680, DOI 10.2106/JBJS.D.02655
   Estrada LS, 2002, CLIN ORTHOP RELAT R, P110
   HICKEY MJ, 1994, BIOCHEM BIOPH RES CO, V201, P1066, DOI 10.1006/bbrc.1994.1813
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Jackson M, 2002, CLIN ORTHOP RELAT R, P119
   Johansson T, 2006, INT ORTHOP, V30, P1, DOI 10.1007/s00264-005-0037-z
   Kim TH, 2002, BIOMATERIALS, V23, P2311, DOI 10.1016/S0142-9612(01)00365-9
   Lam XM, 2000, J CONTROL RELEASE, V67, P281, DOI 10.1016/S0168-3659(00)00224-8
   MOON MS, 1980, INT ORTHOP, V3, P265
   Ohnishi I, 2003, J BIOMECH, V36, P431, DOI 10.1016/S0021-9290902)00363-9
   Old Andrew, 2006, J Surg Orthop Adv, V15, P86
   Rogmark C, 2006, ACTA ORTHOP, V77, P359, DOI 10.1080/17453670610046262
   TEASDALL RD, 2003, ORTHOPAEDICS, V26, P843
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 2001, J BONE JOINT SURG AM, V83, P128
   Wang Y, 2008, J BIOMED MATER RES A, V86A, P244, DOI 10.1002/jbm.a.31758
   WINN SR, 1999, CLIN ORTHOP S, V367, P95
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yan Hongyin, 2002, Chin J Traumatol, V5, P121
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 28
TC 6
Z9 11
U1 0
U2 6
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2009
VL 15
IS 12
BP 3971
EP 3978
DI 10.1089/ten.tea.2009.0052
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 529OZ
UT WOS:000272528400028
PM 19995304
DA 2018-10-20
ER

PT J
AU Kasoju, N
   Bhonde, RR
   Bora, U
AF Kasoju, Naresh
   Bhonde, Ramesh R.
   Bora, Utpal
TI Fabrication of a novel micro-nano fibrous nonwoven scaffold with
   Antheraea assama silk fibroin for use in tissue engineering
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Polymers; Silk fibroin; Antheraea assama; Micro-nano
   scaffold; Tissue engineering
ID REGENERATIVE MEDICINE; GROWTH; FIBERS; CELLS
AB The success of developing artificial organs by tissue engineering depends on scaffold properties and architecture. Here, we describe the fabrication of an Antheraea assama fibroin based novel micro-nano fibrous nonwoven scaffold. The morphological and chemical characterization was done by scanning electron microscope (SEM) and Fourier transform infrared spectroscopy (FTIR) respectively, which demonstrated the formation of scaffold with micro-nano architecture. The biocompatibility was assessed in vitro by haemolysis and cytotoxicity assays, whereby the scaffold was found to be nontoxic and efficient in supporting cell adhesion and growth. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kasoju, Naresh; Bora, Utpal] Indian Inst Technol, Biomat & Tissue Engn Lab, Dept Biotechnol, Gauhati 781039, Assam, India.
   [Bhonde, Ramesh R.] Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune 411007, Maharashtra, India.
RP Bora, U (reprint author), Indian Inst Technol, Biomat & Tissue Engn Lab, Dept Biotechnol, Gauhati 781039, Assam, India.
EM ubora@iitg.ernet.in
RI Kasoju, Naresh/A-5295-2009
OI Kasoju, Naresh/0000-0002-8700-0729
FU DBT, Government of India [BT/ PR7984/MED/14/1214/2006]; IITG; MHRD
FX We thank DBT, Government of India, for financial support (BT/
   PR7984/MED/14/1214/2006), NCCS for cell lines and MSSO for silk cocoons.
   NX thanks IITG and MHRD for fellowship.
CR Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Daar AS, 2007, J TISSUE ENG REGEN M, V1, P179, DOI 10.1002/term.20
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Gandhi M, 2009, POLYMER, V50, P1918, DOI 10.1016/j.polymer.2009.02.022
   Hazarika LK, 1998, BIORESOURCE TECHNOL, V64, P67, DOI 10.1016/S0960-8524(97)00158-2
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Rajkhowa R, 2000, J APPL POLYM SCI, V77, P2418, DOI 10.1002/1097-4628(20000912)77:11<2418::AID-APP10>3.3.CO;2-H
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   SINGH J, 1990, BIOMATERIALS, V11, P473, DOI 10.1016/0142-9612(90)90060-4
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 22
TC 25
Z9 25
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD NOV 30
PY 2009
VL 63
IS 28
BP 2466
EP 2469
DI 10.1016/j.matlet.2009.08.037
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 514CF
UT WOS:000271370600021
DA 2018-10-20
ER

PT J
AU Madigan, NN
   McMahon, S
   O'Brien, T
   Yaszemski, MJ
   Windebank, AJ
AF Madigan, Nicolas N.
   McMahon, Siobhan
   O'Brien, Timothy
   Yaszemski, Michael J.
   Windebank, Anthony J.
TI Current tissue engineering and novel therapeutic approaches to axonal
   regeneration following spinal cord injury using polymer scaffolds
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Review
DE Spinal cord injury; Axonal regeneration; Polymer scaffold; Tissue
   engineering; Neurotrophins
ID OLFACTORY-ENSHEATHING GLIA; PERIPHERAL-NERVE REGENERATION; NEURAL
   STEM-CELLS; PARTIAL FUNCTIONAL RECOVERY; IMPROVES HINDLIMB FUNCTION; RAT
   OPTIC TRACT; ADULT-RAT; SCHWANN-CELLS; GUIDANCE CHANNELS; DRUG-DELIVERY
AB This review highlights current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury. The concept of developing 3-dimensional polymer scaffolds for placement into a spinal cord transection model has recently been more extensively explored as a solution for restoring neurologic function after injury. Given the patient morbidity associated with respiratory compromise, the discrete tracts in the spinal cord conveying innervation for breathing represent an important and achievable therapeutic target. The aim is to derive new neuronal tissue from the surrounding, healthy cord that will be guided by the polymer implant through the injured area to make functional reconnections. A variety of naturally derived and synthetic biomaterial polymers have been developed for placement in the injured spinal cord. Axonal growth is supported by inherent properties of the selected polymer, the architecture of the scaffold, permissive microstructures such as pores, grooves or polymer fibres, and surface modifications to provide improved adherence and growth directionality. Structural support of axonal regeneration is combined with integrated polymeric and cellular delivery systems for therapeutic drugs and for neurotrophic molecules to regionalize growth of specific nerve populations. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Madigan, Nicolas N.; Windebank, Anthony J.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA.
RP Windebank, AJ (reprint author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.
EM windebank.anthony@mayo.edu
RI O'Brien, Timothy/N-7112-2014
OI O'Brien, Timothy/0000-0001-9028-5481
FU NIBIB NIH HHS [R01 EB002390, R01 EB002390-04]
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711
   Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008
   Blitts B, 2003, NEUROSCIENCE, V118, P271, DOI 10.1016/S0306-4522(02)00970-3
   Bodley R, 2002, EUR J RADIOL, V42, P135, DOI 10.1016/S0720-048X(02)00046-3
   Borgens RB, 2002, J EXP BIOL, V205, P1
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Carone TW, 2006, J BIOMED MATER RES B, V78B, P274, DOI 10.1002/jbm.b.30483
   Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013
   Chen AQ, 1996, EXP NEUROL, V138, P261, DOI 10.1006/exnr.1996.0065
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4
   Chuah MI, 2004, EXP NEUROL, V185, P15, DOI 10.1016/j.expneurol.2003.09.008
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   CLARK P, 1991, J CELL SCI, V99, P73
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Dadsetan M, 2008, BIOMATERIALS, V29, P2193, DOI 10.1016/j.biomaterials.2008.01.006
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   DEWITT DG, 2009, TISSUE ENG A
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   Duerstock BS, 2002, J EXP BIOL, V205, P13
   Enzmann GU, 2006, J NEUROTRAUM, V23, P479, DOI 10.1089/neu.2006.23.479
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Giannetti S, 2001, NEUROL RES, V23, P405, DOI 10.1179/016164101101198622
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   Grill R, 1997, J NEUROSCI, V17, P5560
   Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   HAN Q, 2009, TISSUE ENG A, V16
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   JENG CB, 1985, BRAIN RES, V408, P239
   JOHNSON P, 2009, J BIOMED MAT RES, V22
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.0.CO;2-Q
   KATZ JS, 2009, REV NANOMED NANOBIOT, V1, P128
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021
   Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI [10.1021/bp070352a, 10.1021/bp.070352a]
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   KRYCH AJ, 2009, ACTA BIOMATER
   KWON BK, 2009, J NEUROTRAUMA, V24
   LALI HS, 2001, SPINE, V26, pS2
   Lane MA, 2008, TRENDS NEUROSCI, V31, P538, DOI 10.1016/j.tins.2008.07.002
   Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/0897715042664867
   Lesny P, 2006, J MATER SCI-MATER M, V17, P829, DOI 10.1007/s10856-006-9842-1
   Liu W, 2007, BIOMATERIALS, V28, P5078, DOI 10.1016/j.biomaterials.2007.07.028
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   Lowry NA, 2007, PLOS MED, V4, P236, DOI 10.1371/jourmal.pmed.0040048
   Lu K, 2002, SPINE, V27, P887, DOI 10.1097/00007632-200204150-00021
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Mahoney MJ, 2006, TISSUE ENG, V12, P1915, DOI 10.1089/ten.2006.12.1915
   MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E
   Maysinger D, 1996, EXP NEUROL, V138, P177, DOI 10.1006/exnr.1996.0056
   Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006
   Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036
   Nash HH, 2002, J NEUROSCI, V22, P7111
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Nogues MA, 2008, NEUROLOGIST, V14, P273, DOI 10.1097/NRL.0b013e318173e830
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   *NSCIA, 2009, NAT SPIN CORD INJ DA
   OH J, 2008, J BIOMED MAT RES A, V4
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2005, BRAZ J MED BIOL RES, V38, P825, DOI 10.1590/S0100-879X2005000600003
   Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6
   Oudega M, 1996, EXP NEUROL, V140, P218, DOI 10.1006/exnr.1996.0131
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056
   Pfister BJ, 2006, J NEUROSCI METH, V153, P95, DOI 10.1016/j.jneumeth.2005.10.012
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pinzon A, 2001, J NEUROSCI RES, V64, P533, DOI 10.1002/jnr.1105
   Piotrowicz A, 2006, BIOMATERIALS, V27, P2018, DOI 10.1016/j.biomaterials.2005.09.042
   Plant GW, 1998, CELL TRANSPLANT, V7, P381, DOI 10.1016/S0963-6897(98)00016-5
   PLANT GW, 1995, BRAIN RES, V671, P119, DOI 10.1016/0006-8993(94)01312-6
   Quencer RM, 1996, SPINE, V21, P2064, DOI 10.1097/00007632-199609150-00002
   Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Reynolds LF, 2008, SPINAL CORD, V46, P58, DOI 10.1038/sj.sc.3102063
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131
   Rooney GE, 2008, SPINE, V33, pE914, DOI 10.1097/BRS.0b013e318186b2b1
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SODERQUIST RG, 2008, J BIOMED MAT RES A
   Stichel CC, 1999, GLIA, V28, P156, DOI 10.1002/(SICI)1098-1136(199911)28:2<156::AID-GLIA7>3.3.CO;2-Q
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Tadie M, 2002, J NEUROTRAUM, V19, P909, DOI 10.1089/089771502320317069
   Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9212(03)00497-6
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Vleggeert-Lankamp CLAM, 2007, J BIOMED MATER RES A, V80A, P965, DOI 10.1002/jbm.a.30941
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wang SF, 2009, ACTA BIOMATER, V5, P1531, DOI 10.1016/j.actbio.2008.12.015
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   YAO L, 2009, J BIOMED MAT RES A, V11
   Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yoshil S, 2009, J TISSUE ENG REGEN M, V3, P19, DOI 10.1002/term.130
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zimmer MB, 2008, EXP NEUROL, V209, P399, DOI 10.1016/j.expneurol.2007.05.015
NR 166
TC 104
Z9 116
U1 1
U2 69
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9048
EI 1878-1519
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD NOV 30
PY 2009
VL 169
IS 2
SI SI
BP 183
EP 199
DI 10.1016/j.resp.2009.08.015
PG 17
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA 525OJ
UT WOS:000272225400013
PM 19737633
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cui, LY
   Liu, F
   Ou-Yang, ZC
AF Cui, Lin-ying
   Liu, Fei
   Ou-Yang, Zhong-can
TI The study of the elasticity of spider dragline silk with liquid crystal
   model
SO THIN SOLID FILMS
LA English
DT Article
DE Spider dragline silk; Liquid crystal material; Elasticity; Nematics
ID MECHANICAL-PROPERTIES; FIBERS; ORIENTATION; BEHAVIOR; PHASE;
   SUPERCONTRACTION; ELONGATION; ELASTOMERS; ARANEAE; STRAIN
AB Spider dragline silk is an optimal biomaterial with a combination of high tensile strength and high elasticity, and it has long been suggested to belong to liquid crystalline materials. However, a satisfactory liquid crystal description for the mechanical properties of the dragline is still missing.
   To solve the long existing problem, we generalized the Maier-Saupe theory of nematics to construct a liquid crystal model of the deformation mechanism of the dragline silk.
   We show that the remarkable elasticity of the dragline can be understood as the isotropic-nematic phase transition of the chain network with the beginning of the transition corresponding to the yield point. The calculated curve fits well with the measurements and the yield point is obtained self-consistently within our framework. The present theory can also qualitatively account for the drop of stress in supercontracted spider silk. All these comprehensive agreements between theory and experiments strongly indicate the dragline to belong to liquid crystal materials. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Ou-Yang, Zhong-can] Chinese Acad Sci, Inst Theoret Phys, Beijing 100190, Peoples R China.
   [Cui, Lin-ying] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China.
   [Liu, Fei; Ou-Yang, Zhong-can] Tsinghua Univ, Ctr Adv Study, Beijing 100084, Peoples R China.
RP Ou-Yang, ZC (reprint author), Chinese Acad Sci, Inst Theoret Phys, POB 2735, Beijing 100190, Peoples R China.
EM cly05@mails.tsinghua.edu.cn; oy@itp.ac.cn
RI Liu, Fei/E-9777-2013
CR Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a
   CHANDRASEKARAN B, 1992, IEEE EXPERT, V7, P2
   DEGENNES PG, 1993, PHYS LIQUID CRYSTALS
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   Eles PT, 2004, BIOMACROMOLECULES, V5, P661, DOI 10.1021/bm0342685
   Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a
   Emile O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167402
   Glisovic A, 2008, MACROMOLECULES, V41, P390, DOI 10.1021/ma070528p
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   KERKAM K, 1991, NATURE, V349, P596, DOI 10.1038/349596a0
   Knight DP, 2002, PHILOS T R SOC B, V357, P155, DOI 10.1098/rstb.2001.1030
   Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667
   Krasnov I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048104
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   LEWIS RV, 2002, BIOL CHEM BIOTECHNOL, V8
   Li XG, 2008, BIOPOLYMERS, V89, P497, DOI 10.1002/bip.20905
   LUCAS FRED, 1964, DISCOVERY, V25, P20
   MAIER W, 1959, Z NATURFORSCH PT A, V14, P882
   Papadopoulos P, 2007, EUR PHYS J E, V24, P193, DOI 10.1140/epje/i2007-10229-9
   PINCUS P, 1978, J POLYM SCI POLYM S, V65, P85
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   WARNER M, 1991, MACROMOLECULES, V24, P4932, DOI 10.1021/ma00017a033
   Warner M, 2003, LIQUID CRYSTAL ELAST
   Willcox PJ, 1996, MACROMOLECULES, V29, P5106, DOI 10.1021/ma960588n
   WORK RW, 1985, J EXP BIOL, V118, P379
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
   WORK RW, 1981, J ARACHNOL, V9, P299
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zhou HJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028104
NR 37
TC 1
Z9 1
U1 0
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 30
PY 2009
VL 518
IS 2
BP 735
EP 738
DI 10.1016/j.tsf.2009.07.080
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 519OK
UT WOS:000271776300074
DA 2018-10-20
ER

PT J
AU Fratzl, P
   Barth, FG
AF Fratzl, Peter
   Barth, Friedrich G.
TI Biomaterial systems for mechanosensing and actuation
SO NATURE
LA English
DT Review
ID ARTHROPOD FILIFORM HAIRS; CUPIENNIUS-SALEI KEYS; ARACHNID SLIT SENSILLA;
   MECHANICAL-PROPERTIES; SPIDER TRICHOBOTHRIA; STRUCTURAL-MATERIALS; TOUCH
   RECEPTION; FLOW-SENSORS; WHEAT AWNS; PINE-CONES
AB Living organisms use composite materials for various functions, such as mechanical support, protection, motility and the sensing of signals. Although the individual components of these materials may have poor mechanical qualities, they form composites of polymers and minerals with a remarkable variety of functional properties. Researchers are now using these natural systems as models for artificial mechanosensors and actuators, through studying both natural structures and their interactions with the environment. In addition to inspiring the design of new materials, analysis of natural structures on this basis can provide insight into evolutionary constraints on structure-function relationships in living organisms and the variety of structural solutions that emerged from these constraints.
C1 [Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.
   [Barth, Friedrich G.] Univ Vienna, Dept Neurobiol & Cognit Res, A-1090 Vienna, Austria.
RP Fratzl, P (reprint author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Res Campus Golm, D-14424 Potsdam, Germany.
EM fratzl@mpikg.mpg.de; friedrich.g.barth@univie.ac.at
RI Fratzl, Peter/H-9095-2012
OI Fratzl, Peter/0000-0003-4437-7830
FU Austrian Science Fund; US Defense Advanced Research Projects Agency;
   Alexander von Humboldt Foundation
FX The work of F. G. B. was generously supported by the Austrian Science
   Fund and the BioSenSE programme of the US Defense Advanced Research
   Projects Agency. The productive collaboration with engineers, in
   particular J.A.C. Humphrey, F. G. Rammerstorfer and V. V. Tsukruk and
   their research groups, is gratefully acknowledged. P. F. was supported
   by the Alexander von Humboldt Foundation in the framework of the Max
   Planck Research Prize. He is grateful for discussions with, and advice
   from, co-workers and colleagues, in particular I. Burgert, R. Elbaum, O.
   Paris, J. Dunlop and L. Mahadevan.
CR AIZENBERG J, 2009, ADV MAT, V21
   Albert JT, 2001, J COMP PHYSIOL A, V187, P303, DOI 10.1007/s003590100202
   BARBOSA CAS, 2007, 20 NOVEMBRO 1910 REV, P1
   Barth F. G, 2002, SPIDERS WORLD SENSES
   BARTH FG, 1993, PHILOS T ROY SOC B, V340, P445, DOI 10.1098/rstb.1993.0084
   BARTH FG, 1973, Z ZELLFORSCH MIK ANA, V144, P409, DOI 10.1007/BF00307585
   BARTH FG, 1988, OECOLOGIA, V77, P194, DOI 10.1007/BF00379186
   Barth FG, 1999, PHILOS T ROY SOC B, V354, P183, DOI 10.1098/rstb.1999.0370
   Barth FG, 1998, SPR HDB AUD, V10, P228
   BARTH FG, 1995, PHILOS T ROY SOC B, V347, P397, DOI 10.1098/rstb.1995.0032
   BARTH FG, 1997, ORIENTATION COMMUNIC, P247
   Beckwith T. G., 1993, MECH MEASUREMENTS
   BLECKMANN H, 2006, SENSORY SYSTEMS NEUR, P411
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Burgert I, 2007, PLANTA, V226, P981, DOI 10.1007/s00425-007-0544-9
   Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003
   Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307
   Chen NN, 2007, J MICROELECTROMECH S, V16, P999, DOI 10.1109/JMEMS.2007.902436
   Dawson J, 1997, NATURE, V390, P668
   Dechant HE, 2001, J COMP PHYSIOL A, V187, P313, DOI 10.1007/s003590100203
   DECHANT HE, 2001, THESIS VIENNA TU
   den Toonder J, 2008, LAB CHIP, V8, P533, DOI 10.1039/b717681c
   Dijkstra M, 2005, J MICROMECH MICROENG, V15, pS132, DOI 10.1088/0960-1317/15/7/019
   Dong LX, 2007, NANO TODAY, V2, P12, DOI 10.1016/S1748-0132(07)70169-X
   Elbaum R, 2008, J STRUCT BIOL, V164, P101, DOI 10.1016/j.jsb.2008.06.008
   Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097
   Evans BA, 2007, NANO LETT, V7, P1428, DOI 10.1021/nl070190c
   Fan ZF, 2002, J MICROMECH MICROENG, V12, P655, DOI 10.1088/0960-1317/12/5/322
   Farber J, 2001, J MATER SCI, V36, P5087, DOI 10.1023/A:1012465005607
   Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185
   Fratzl P, 2008, FARADAY DISCUSS, V139, P275, DOI 10.1039/b716663j
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Friedel T, 1997, J COMP PHYSIOL A, V180, P223, DOI 10.1007/s003590050043
   FRIEDRICH OC, 2001, THESIS U VIENNA
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Goswami L, 2008, PLANT J, V56, P531, DOI 10.1111/j.1365-313X.2008.03617.x
   GULCH RW, 1994, INT J SPORTS MED, V15, pS2, DOI 10.1055/s-2007-1021103
   Haupt W, 1977, BEWEGUNGSPHYSIOLOGIE
   HILL AV, 1953, PROC R SOC SER B-BIO, V141, P104, DOI 10.1098/rspb.1953.0027
   Hossl B, 2006, J BIOMECH, V39, P1761, DOI 10.1016/j.jbiomech.2005.05.031
   Hossl B, 2007, J COMP PHYSIOL A, V193, P445, DOI 10.1007/s00359-006-0201-y
   Humphrey JAC, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P129
   Humphrey JAC, 2007, ADV INSECT PHYSIOL, V34, P1, DOI 10.1016/S0065-2806(07)34001-0
   Johnson EAC, 2009, PHILOS T R SOC A, V367, P1559, DOI 10.1098/rsta.2009.0005
   KLOPSCH C, 2007, P 5 INT S TURB SHEAR, P1023
   Krijnen GJM, 2006, NANOTECHNOLOGY, V17, pS84, DOI 10.1088/0957-4484/17/4/013
   Kulic IM, 2009, P ROY SOC B-BIOL SCI, V276, P2243, DOI 10.1098/rspb.2008.1685
   Li DB, 2009, MRS BULL, V34, P671, DOI 10.1557/mrs2009.179
   McConney ME, 2007, J R SOC INTERFACE, V4, P1135, DOI 10.1098/rsif.2007.1000
   McConney ME, 2009, ADV FUNCT MATER, V19, P2527, DOI 10.1002/adfm.200900606
   McConney ME, 2009, J R SOC INTERFACE, V6, P681, DOI 10.1098/rsif.2008.0463
   Messersmith PB, 2008, SCIENCE, V319, P1767, DOI 10.1126/science.1155122
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Neville A. C., 1975, BIOL ARTHROPOD CUTIC
   Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295
   Pennycuick CJ, 1992, NEWTON RULES BIOL PH, P30
   Pokroy B, 2009, SCIENCE, V323, P237, DOI 10.1126/science.1165607
   Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184
   SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339
   Schwille P, 2009, CRIT REV BIOCHEM MOL, V44, P223, DOI 10.1080/10409230903074549
   Seidel R, 2008, MICRON, V39, P198, DOI 10.1016/j.micron.2007.02.004
   Shimozawa T, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P145
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976
   Sperling L.H., 1997, POLYM MULTICOMPONENT
   Suh JW, 1999, J MICROELECTROMECH S, V8, P483, DOI 10.1109/84.809064
   Thurm U., 1982, BIOPHYSIK, P691
   Vaia R, 2008, SCIENCE, V319, P420, DOI 10.1126/science.1152931
   van der Zwaag S., 2007, SELF HEALING MAT ALT
   VOGEL E, 2009, THESIS U VIENNA
   Wheeler TD, 2008, NATURE, V455, P208, DOI 10.1038/nature07226
   Whitesides GM, 2009, FARADAY DISCUSS, V143, P373, DOI 10.1039/b917540g
NR 73
TC 232
Z9 234
U1 20
U2 254
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 26
PY 2009
VL 462
IS 7272
BP 442
EP 448
DI 10.1038/nature08603
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 524LG
UT WOS:000272144200032
PM 19940914
DA 2018-10-20
ER

PT J
AU Subramanian, A
   Krishnan, UM
   Sethuraman, S
AF Subramanian, Anuradha
   Krishnan, Uma Maheswari
   Sethuraman, Swaminathan
TI Development of biomaterial scaffold for nerve tissue engineering:
   Biomaterial mediated neural regeneration
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Review
ID EMBRYONIC STEM-CELLS; BIODEGRADABLE POLYMER CONDUITS; OLFACTORY
   ENSHEATHING CELLS; INJURED SPINAL-CORD; PERIPHERAL-NERVE; NEURITE
   OUTGROWTH; SCHWANN-CELLS; AXONAL REGENERATION; GROWTH-FACTOR;
   ELECTROSPUN NANOFIBERS
AB Neural tissue repair and regeneration strategies have received a great deal of attention because it directly affects the quality of the patient's life. There are many scientific challenges to regenerate nerve while using conventional autologous nerve grafts and from the newly developed therapeutic strategies for the reconstruction of damaged nerves. Recent advancements in nerve regeneration have involved the application of tissue engineering principles and this has evolved a new perspective to neural therapy. The success of neural tissue engineering is mainly based on the regulation of cell behavior and tissue progression through the development of a synthetic scaffold that is analogous to the natural extracellular matrix and can support three-dimensional cell cultures. As the natural extracellular matrix provides an ideal environment for topographical, electrical and chemical cues to the adhesion and proliferation of neural cells, there exists a need to develop a synthetic scaffold that would be biocompatible, immunologically inert, conducting, biodegradable, and infection-resistant biomaterial to support neurite outgrowth. This review outlines the rationale for effective neural tissue engineering through the use of suitable biomaterials and scaffolding techniques for fabrication of a construct that would allow the neurons to adhere, proliferate and eventually form nerves.
C1 [Subramanian, Anuradha; Krishnan, Uma Maheswari; Sethuraman, Swaminathan] SASTRA Univ, Ctr Nanotechnol & Adv Biomat, Sch Chem & Biotechnol, Thanjavur, India.
RP Sethuraman, S (reprint author), SASTRA Univ, Ctr Nanotechnol & Adv Biomat, Sch Chem & Biotechnol, Thanjavur, India.
EM anuradha@bioengg.sastra.edu; umakrishnan@biotech.sastra.edu;
   swami@sastra.edu
CR AIJUN W, 2006, J BIOMED MATER RES A, V79, P36
   Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Amillo S, 1995, MICROSURG, V16, P621, DOI 10.1002/micr.1920160908
   An YH, 2006, BIOMED MATER, V1, pR38, DOI 10.1088/1748-6041/1/2/R02
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Barker RA, 2003, J NEUROL NEUROSUR PS, V74, P553, DOI 10.1136/jnnp.74.5.553
   Barnett SC, 2004, J NEUROTRAUM, V21, P375, DOI 10.1089/089771504323004520
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Bender MD, 2004, BIOMATERIALS, V25, P1269, DOI 10.1016/j.biomaterials.2003.08.046
   BERGETHON PR, 1989, J CELL SCI, V92, P111
   BERTELLI JA, 1994, BRAIN RES, V644, P150, DOI 10.1016/0006-8993(94)90358-1
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bini TB, 2006, J MATER SCI, V41, P6453, DOI 10.1007/s10853-006-0714-3
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Blacher S, 2003, BIOMATERIALS, V24, P1033, DOI 10.1016/S0142-9612(02)00423-4
   BOLAND ED, 2008, TISSUE ENG SCAFFOLDS, V1, P2828
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   CAO H, ADV DRUG DELIVERY RE, V61, P1055
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   Chen PR, 2005, BIOMATERIALS, V26, P6579, DOI 10.1016/j.biomaterials.2005.03.037
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   DAVID RN, 2009, BIOMATERIALS, V30, P4573
   Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   FRANK C, 2006, REGEN MED, V1, P469
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Girard C, 2005, J NEUROSCI, V25, P7924, DOI 10.1523/JNEUROSCI.4890-09.2005
   Gizdavic-Nikolaidis M, 2004, CURR APPL PHYS, V4, P347, DOI 10.1016/j.cap.2003.11.045
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   Haile Y, 2008, BIOMATERIALS, V29, P1880, DOI 10.1016/j.biomaterials.2007.12.030
   HAOQING C, 2009, ADV DRUG DELIVERY RE, V61, P1055
   Hasan NAKES, 1996, J ANAT, V189, P293
   He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021
   Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405
   Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38
   JAE YL, 2009, BIOMATERIALS, V30, P4325
   Jain KK, 2006, NANOMEDICINE-UK, V1, P9, DOI 10.2217/17435889.1.1.9
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Johansson S, 2005, BRAIN, V128, P2961, DOI 10.1093/brain/awh644
   Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883
   Katayama Y, 2006, BIOMATERIALS, V27, P505, DOI 10.1016/j.biomaterials.2005.07.016
   Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9
   Kilmartin PA, 2005, SYNTHETIC MET, V153, P153, DOI 10.1016/j.synthmet.2005.07.170
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   KIMBERLEY DN, 2004, BIOMATERIALS, V25, P5763
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Krekoski CA, 2002, J NEUROSCI, V22, P10408
   LAURA FG, 2009, FAWCETT EXP IN PRESS
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li Y., 2001, BIOTECHNOL BIOPROC E, V6, P311
   Liao S, 2006, BIOMED MATER, V1, pR45, DOI 10.1088/1748-6041/1/3/R01
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Musoke-Zawedde P, 2006, BIOMED MATER, V1, P162, DOI 10.1088/1748-6041/1/3/011
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nikkhah G, 1997, ORTHOPADE, V26, P612, DOI 10.1007/PL00003419
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   PATEL N, 1982, J NEUROSCI, V2, P483
   RAVI VB, 2006, BIOMATERIALS, V27, P3515
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Richmond AT, 2004, CYTOTECHNOLOGY, V46, P173, DOI 10.1007/s10616-005-3099-2
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rowlands AS, 2007, BIOMATERIALS, V28, P2109, DOI 10.1016/j.biomaterials.2006.12.032
   Salvay DM, 2006, MOL BIOSYST, V2, P36, DOI 10.1039/b514174p
   Samadikuchaksaraei A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-15
   SARAH ES, 2006, J BIOMED MATER RES A, V77, P718
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   Song SH, 2002, NATURE, V417, P39
   Spilker MH, 1997, TISSUE ENG, V3, P309, DOI 10.1089/ten.1997.3.309
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   TRUMBLE TE, 1992, J NEURAL TRANSP PLAS, V3, P39, DOI 10.1155/NP.1992.39
   UWE F, 2009, BIOMATERIALS, V30, P5049
   VALLE LJ, 2007, EUR POLYM J, V43, P2342
   Verreck G, 2005, BIOMATERIALS, V26, P1307, DOI 10.1016/j.biomaterials.2004.04.040
   VICTOR TR, 2009, BIOMATERIALS, V30, P5251
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   Whittlesey KJ, 2006, BIOMATERIALS, V27, P2477, DOI 10.1016/j.biomaterials.2005.11.016
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   Woerly S, 2000, NEUROSURG REV, V23, P59
   XIAODONG YU, 2007, CHIN MED J, V120, P1438
   XIAOYUN X, 2002, BIOMATERIALS, V23, P3765
   Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
NR 133
TC 213
Z9 223
U1 3
U2 134
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD NOV 25
PY 2009
VL 16
AR 108
DI 10.1186/1423-0127-16-108
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 528YM
UT WOS:000272482900002
PM 19939265
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tung, WS
   Daoud, WA
   Leung, SK
AF Tung, Wing Sze
   Daoud, Walid A.
   Leung, Sze Kar
TI Understanding photocatalytic behavior on biomaterials: Insights from
   TiO2 concentration
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Titanium dioxide; Photocatalysis; Self-cleaning; Nanocoating; Biopolymer
ID MODIFIED COTTON TEXTILES; SELF-CLEANING KERATINS; TITANIUM-DIOXIDE;
   DAYLIGHT IRRADIATION; CELLULOSE FIBERS; LOW-TEMPERATURES; WASTE-WATER;
   FABRICS; FILMS; DECOMPOSITION
AB We report the details of our success in conferring photocatalytic self-cleaning properties on keratin fibers using modified sol-gel colloids. To the best of our knowledge, we studied for the first time the crucial effect of the concentration of titanium dioxide precursor on colloid composition, properties, and biocompatibility in an attempt to enhance the properties and application of anatase titanium dioxide colloid to keratins. The transparency, the particle size distribution, and the crystallinity of synthesized colloids were systematically investigated. The compatibility of the colloids and keratin substrates is thoroughly compared and discussed. The insights presented contribute to the further understanding of the structure-property-use relationship of titanium dioxide in biomaterial applications. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Tung, Wing Sze; Daoud, Walid A.; Leung, Sze Kar] Monash Univ, Sch Engn & Appl Sci, Churchill, Vic 3842, Australia.
RP Daoud, WA (reprint author), Monash Univ, Sch Engn & Appl Sci, Churchill, Vic 3842, Australia.
EM Walid.Daoud@sci.monash.edu.au
FU Monash Research Graduate School; School of Applied Sciences and
   Engineering at Monash University
FX This work was financially supported by Monash Research Graduate School
   and School of Applied Sciences and Engineering at Monash University. The
   authors gratefully acknowledge Dr. jormy Tang and Miss Shuk Yan Cheng
   for their help with the cytotoxicity study. Thanks are also due to the
   Hong Kong Polytechnic University for providing their instrumentation.
CR Alhakimi G, 2003, J PHOTOCH PHOTOBIO A, V154, P219, DOI 10.1016/S1010-6030(02)00329-5
   ANPO M, 1987, J PHYS CHEM-US, V91, P4305, DOI 10.1021/j100300a021
   Bozzi A, 2005, J PHOTOCH PHOTOBIO A, V174, P156, DOI 10.1016/j.jphotochem.2005.03.019
   Bozzi A, 2005, J PHOTOCH PHOTOBIO A, V172, P27, DOI 10.1016/j.jphotochem.2004.11.010
   Chen DW, 1998, WATER RES, V32, P3223, DOI 10.1016/S0043-1354(98)00118-3
   Daoud WA, 2005, SURF SCI, V599, P69, DOI 10.1016/j.susc.2005.09.038
   Daoud WA, 2004, J AM CERAM SOC, V87, P953, DOI 10.1111/j.1551-2916.2004.00953.x
   Daoud WA, 2004, J SOL-GEL SCI TECHN, V29, P25, DOI 10.1023/B:JSST.0000016134.19752.b4
   Daoud WA, 2005, CHEM COMMUN, P2110, DOI 10.1039/b418821g
   Daoud WA, 2008, CHEM MATER, V20, P1242, DOI 10.1021/cm702661k
   DAVIS RJ, 1994, WATER ENVIRON RES, V66, P50, DOI 10.2175/WER.66.1.8
   Dong YC, 2006, J APPL POLYM SCI, V99, P286, DOI 10.1002/app.22476
   Fujishima A, 2006, CR CHIM, V9, P750, DOI 10.1016/j.crci.2005.02.055
   Fujishima A., 1972, NATURE, V238, P38
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Grzechulska J, 2002, APPL CATAL B-ENVIRON, V36, P45, DOI 10.1016/S0926-3373(01)00275-2
   Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269
   Ichiura H, 2003, CHEMOSPHERE, V50, P79, DOI 10.1016/S0045-6535(02)00604-5
   Jia BY, 2007, CHINESE J CHEM, V25, P553, DOI 10.1002/cjoc.200790103
   Kaneco S, 2004, J PHOTOCH PHOTOBIO A, V163, P419, DOI 10.1016/j.jphotochem.2004.01.012
   Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5
   Lewin M., 1998, HDB FIBER CHEM
   McMurray TA, 2004, APPL CATAL A-GEN, V262, P105, DOI 10.1016/j.apcata.2003.11.013
   Meilert KT, 2005, J MOL CATAL A-CHEM, V237, P101, DOI 10.1016/j.molcata.2005.03.040
   Mills A, 2002, J PHOTOCH PHOTOBIO A, V152, P233, DOI 10.1016/S1010-6030(02)00243-5
   Parkin IP, 2005, J MATER CHEM, V15, P1689, DOI 10.1039/b412803f
   Qi KH, 2007, J MATER CHEM, V17, P3504, DOI 10.1039/b702887c
   Qi KH, 2006, J MATER CHEM, V16, P4567, DOI 10.1039/b610861j
   Sopyan I, 1996, J ELECTROANAL CHEM, V415, P183, DOI 10.1016/S0022-0728(96)01007-8
   STEINBUCHEL A, 2003, BIOPOLYMERS, V8
   Tung WS, 2008, J COLLOID INTERF SCI, V326, P283, DOI 10.1016/j.jcis.2008.07.037
   Tung WS, 2009, J APPL POLYM SCI, V112, P235, DOI 10.1002/app.29396
   Tung WS, 2009, ACTA BIOMATER, V5, P50, DOI 10.1016/j.actbio.2008.08.009
   Uddin MJ, 2007, J PHOTOCH PHOTOBIO A, V189, P286, DOI 10.1016/j.jphotochem.2007.02.015
   Wang SH, 2007, SURF COAT TECH, V202, P460, DOI 10.1016/j.surfcoat.2007.06.012
   Wang W, 2004, J PHYS CHEM B, V108, P14789, DOI 10.1021/jp0470952
   Wu RJ, 2009, J HAZARD MATER, V162, P945, DOI 10.1016/j.jhazmat.2008.05.121
   Xin JH, 2004, TEXT RES J, V74, P97, DOI 10.1177/004051750407400202
   Yang HY, 2004, J APPL POLYM SCI, V92, P3201, DOI 10.1002/app.20327
   Yip J, 2002, J MATER PROCESS TECH, V123, P5, DOI 10.1016/S0924-0136(02)00024-9
   Yu HG, 2006, J MOL CATAL A-CHEM, V246, P206, DOI 10.1016/j.molcata.2005.11.007
   Yuranova T, 2007, CATAL TODAY, V122, P109, DOI 10.1016/j.cattod.2007.01.040
   Yuranova T, 2006, J MOL CATAL A-CHEM, V244, P160, DOI 10.1016/j.molcata.2005.08.059
   Zang YJ, 2005, APPL CATAL B-ENVIRON, V57, P275, DOI 10.1016/j.apcatb.2004.11.005
   Zhang HZ, 2000, J PHYS CHEM B, V104, P3481, DOI 10.1021/jp000499j
   Zhang LX, 2007, SURF COAT TECH, V201, P7607, DOI 10.1016/j.surfcoat.2007.02.004
   Zhang TY, 2006, DYES PIGMENTS, V68, P95, DOI 10.1016/j.dyepig.2005.01.003
NR 47
TC 25
Z9 25
U1 1
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD NOV 15
PY 2009
VL 339
IS 2
BP 424
EP 433
DI 10.1016/j.jcis.2009.07.043
PG 10
WC Chemistry, Physical
SC Chemistry
GA 506BR
UT WOS:000270748500019
PM 19716565
DA 2018-10-20
ER

PT J
AU Sathishkumar, M
   Sneha, K
   Kwak, IS
   Mao, J
   Tripathy, SJ
   Yun, YS
AF Sathishkumar, M.
   Sneha, K.
   Kwak, In Seob
   Mao, Juan
   Tripathy, S. J.
   Yun, Y. -S.
TI Phyto-crystallization of palladium through reduction process using
   Cinnamom zeylanicum bark extract
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Palladium; Nanoparticles; Cinnamon zeylanicum; Reduction
ID SILVER NANOPARTICLES; PLATINUM; BIOSORPTION; METALS
AB In this paper we studied the potential of nanocrystalline palladium particle production using Cinnamom zeylanicum bark extract (CBE) as the biomaterial for the first time. We studied the effects of biomaterial dosage, pH and temperature on nanoparticle formation: none of these factors had a major effect on the size and shape of the nanoparticles formed. Transmission electron microscopy (TEM) observations confirmed the synthesis of nano-sized palladium particles. More or less uniformly sized palladium nanoparticles were synthesized with an average size ranging from 15 to 20 nm. It was found that the zeta potential of these formed palladium nanoparticles was negative. and that it increased with an increase in pH. Energy dispersive X-ray (EDX) analysis results confirmed the significant presence of palladium. Of the palladium ions, 60% were reduced to a zero valent form by CBE. Terpenoids are believed to play an important role in palladium nanoparticle biosynthesis through the reduction of palladium ions. Currently, however, the exact mechanism for the synthesis of palladium nanoparticles is unclear. Our protocol for the phyto-synthesis of palladium nanoparticles under moderate pH and room temperature offers a new means to develop environmentally benign nanoparticles. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sathishkumar, M.; Sneha, K.; Kwak, In Seob; Mao, Juan; Yun, Y. -S.] Chonbuk Natl Univ, Environm Biotechnol Natl Res Lab, Sch Chem Engn, Res Inst Ind Technol, Jeonju 561756, South Korea.
   [Tripathy, S. J.] Chonbuk Natl Univ, Div Adv Mat Engn, Nanoparticulate Mat Lab, Jeonju 561756, South Korea.
RP Yun, YS (reprint author), Chonbuk Natl Univ, Environm Biotechnol Natl Res Lab, Sch Chem Engn, Res Inst Ind Technol, Jeonju 561756, South Korea.
EM ysyun@chonbuk.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011; Krishnamurthy, Sneha/B-1938-2012
OI Yun, Yeoung-Sang/0000-0002-2583-8278; 
FU Korea government (MEST) [R0A-2008-000-20117-0]; AEBRC
FX This work was supported by the Korea Science and Engineering Foundation
   (KOSEF) NRL Program grant funded by the Korea government (MEST) (No.
   R0A-2008-000-20117-0) and in part by AEBRC at POSTECH. We would like to
   thank Mr. J.-G. Kang, Center for University-wide research facilities.
CR Andreescu D, 2007, J MATER RES, V22, P2488, DOI 10.1557/JMR.2007.0308
   BASAVARAJA S, 2008, MAT RES B, V43, P164
   Cioffi N, 2006, MICROELECTRON J, V37, P1620, DOI 10.1016/j.mejo.2006.04.017
   de Vargas I, 2004, J CHEM TECHNOL BIOT, V79, P49, DOI 10.1002/jctb.928
   DEMOPOULOS GP, 1989, CIM BULL, V82, P165
   Gole A, 2001, LANGMUIR, V17, P1674, DOI 10.1021/la001164w
   GUIBAL E, BIOHYDROMETALLURGY B, P265
   HOFFMAN JE, 1988, J MET, P40
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Jham G. N., 2005, Fitopatologia Brasileira, V30, P404, DOI 10.1590/S0100-41582005000400011
   Konishi Y, 2007, J BIOTECHNOL, V128, P648, DOI 10.1016/j.jbiotec.2006.11.014
   Muthuswamy S, 2008, J FOOD SAFETY, V28, P534, DOI 10.1111/j.1745-4565.2008.00129.x
   Paranagama P. A., 2001, Journal of the National Science Foundation of Sri Lanka, V29, P147
   Park YJ, 2009, J HAZARD MATER, V164, P1152, DOI 10.1016/j.jhazmat.2008.09.043
   Sari A, 2009, J HAZARD MATER, V162, P874, DOI 10.1016/j.jhazmat.2008.05.112
   Schoene NW, 2005, CANCER LETT, V230, P134, DOI 10.1016/j.canlet.2004.12.039
   Shan B, 2005, J AGR FOOD CHEM, V53, P7749, DOI 10.1021/jf051513y
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Singaravelu G, 2007, COLLOID SURFACE B, V57, P97, DOI 10.1016/j.colsurfb.2007.01.010
   XU L, 2008, NANOTECHNOLOGY, V19, DOI DOI 10.1088/0957-4484/19/30/305603
   Yong P, 2002, BIOTECHNOL BIOENG, V80, P369, DOI 10.1002/bit.10369
NR 22
TC 79
Z9 81
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD NOV 15
PY 2009
VL 171
IS 1-3
BP 400
EP 404
DI 10.1016/j.jhazmat.2009.06.014
PG 5
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 511KZ
UT WOS:000271165100050
PM 19576689
DA 2018-10-20
ER

PT J
AU Hsu, NH
   Wang, SL
   Liao, YH
   Huang, ST
   Tzou, YM
   Huang, YM
AF Hsu, Nai-Hua
   Wang, Shan-Li
   Liao, Yi-Huei
   Huang, Shiuh-Tsuen
   Tzou, Yu-Min
   Huang, Yuh-Ming
TI Removal of hexavalent chromium from acidic aqueous solutions using rice
   straw-derived carbon
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Hexavalent chromium; Reduction; Rice straw; Activated carbon;
   Adsorption; Surface functional group
ID 2P PHOTOELECTRON-SPECTRA; LOW-COST ADSORBENTS; CROP RESIDUE BURNS;
   ACTIVATED CARBONS; PARTICULATE MATTER; ADSORPTION; WATER; CR(VI);
   SPECTROSCOPY; BIOMATERIAL
AB This study evaluates the removal of Cr(VI) from water by carbon derived from the burning of rice straw. Rice straw was burned in the air to obtain rice carbon (RC), and then the removal of Cr(VI) by RC was investigated under various pHs and ionic strengths. After the experiments, the oxidation state of Cr bound to RC was analyzed using X-ray photoelectron spectroscopy, which revealed that Cr bound to RC was predominately in the trivalent form. The results showed that upon reacting with RC, Cr(VI) was reduced to Cr(III), which was either adsorbed on RC or released back into solution. The extent and rate of Cr(VI) removal increased with decreasing solution pH because the Cr(VI) adsorption and the subsequent reduction of adsorbed Cr(VI) to Cr(III) both occur preferentially at low pH. The minimal effect of ionic strength on the rates of Cr(VI) removal and Cr(III) adsorption indicated specific interactions between Cr(VI)/Cr(III) and their surface binding sites on RC. These results suggest that rice straw-based carbon may be effectively used at low pH as a substitute for activated carbon for the treatment of Cr(VI) contaminated water. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Hsu, Nai-Hua; Wang, Shan-Li; Liao, Yi-Huei; Tzou, Yu-Min; Huang, Yuh-Ming] Natl Chung Hsing Univ, Dept Soil & Environm Sci, Taichung 40227, Taiwan.
   [Huang, Shiuh-Tsuen] Natl Taichung Univ, Dept Sci Applicat & Disseminat, Taichung 40306, Taiwan.
RP Wang, SL (reprint author), Natl Chung Hsing Univ, Dept Soil & Environm Sci, 250 Kuo Kuang Rd, Taichung 40227, Taiwan.
EM slwang@dragon.nchu.edu.tw
RI tzou, yu-min/C-6585-2008; Wang, Shan-Li/C-6016-2008
OI tzou, yu-min/0000-0002-3680-7303; Wang, Shan-Li/0000-0003-3156-5365
FU National Science Council [NSC 97-2313-B-005-024-MY3]; Ministry of
   Education of Taiwan ROC
FX This work was financially supported by the National Science Council
   (under Project No. NSC 97-2313-B-005-024-MY3) and the Ministry of
   Education (under the ATU plan) of Taiwan ROC.
CR Aggarwal D, 1999, CARBON, V37, P1989, DOI 10.1016/S0008-6223(99)00072-X
   Alfarra A, 2004, APPL SURF SCI, V228, P84, DOI 10.1016/j.apsusc.2003.12.033
   Babel S, 2004, CHEMOSPHERE, V54, P951, DOI 10.1016/j.chemosphere.2003.10.001
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Barraclough D, 2005, ENVIRON POLLUT, V133, P85, DOI 10.1016/j.envpol.2004.04.016
   BARTLETT RJ, 1991, ENVIRON HEALTH PERSP, V92, P17, DOI 10.2307/3431133
   CHOI HD, 2008, J HAZARD MATER, V166, P642
   Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w
   Demirbas E, 2004, WATER SA, V30, P533
   DESIMONI E, 1988, SURF INTERFACE ANAL, V13, P173, DOI 10.1002/sia.740130210
   Di Natale F, 2007, J HAZARD MATER, V145, P381, DOI 10.1016/j.jhazmat.2006.11.028
   FANNING PE, 1993, CARBON, V31, P721, DOI 10.1016/0008-6223(93)90009-Y
   Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056
   Gonzalez-Perez JA, 2004, ENVIRON INT, V30, P855, DOI 10.1016/j.envint.2004.02.003
   Grohmann I, 1995, SURF INTERFACE ANAL, V23, P887, DOI 10.1002/sia.740231306
   HUANG CP, 1975, J WATER POLLUT CON F, V47, P2437
   Khezami L, 2005, J HAZARD MATER, V123, P223, DOI 10.1016/j.jhazmat.2005.04.012
   Kimbrough DE, 1999, CRIT REV ENV SCI TEC, V29, P1, DOI 10.1080/10643389991259164
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Liu SX, 2007, J HAZARD MATER, V141, P315, DOI 10.1016/j.jhazmat.2006.07.006
   Mandal K.G., 2004, FOOD AGR ENV, V2, P224
   MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599
   Mohan D, 2005, IND ENG CHEM RES, V44, P1027, DOI 10.1021/ie0400898
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   OREILLY JM, 1983, CARBON, V21, P47, DOI 10.1016/0008-6223(83)90155-0
   PALMER CD, 1991, ENVIRON HEALTH PERSP, V92, P25, DOI 10.1289/ehp.919225
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Park D, 2006, J HAZARD MATER, V137, P1254, DOI 10.1016/j.jhazmat.2006.04.007
   Park SJ, 2002, J COLLOID INTERF SCI, V249, P458, DOI 10.1006/jcis.2002.8269
   Park SJ, 2001, J COLLOID INTERF SCI, V239, P380, DOI 10.1006/jcis.2001.7582
   Pratt AR, 1996, SURF INTERFACE ANAL, V24, P529, DOI 10.1002/(SICI)1096-9918(199608)24:8<529::AID-SIA153>3.0.CO;2-H
   RADOVIC LR, 1999, SURFACES NANOPARTICL, P529
   RAMOS RL, 1994, WATER SCI TECHNOL, V30, P191
   Rivera-Utrilla J, 2003, WATER RES, V37, P3335, DOI 10.1016/S0043-1354(03)00177-5
   SELLITTI C, 1990, CARBON, V28, P221, DOI 10.1016/0008-6223(90)90116-G
   Sun CH, 2003, ADV COLLOID INTERFAC, V105, P151, DOI 10.1016/S0001-8686(03)00066-6
   Wang SL, 2007, J HAZARD MATER, V147, P313, DOI 10.1016/j.jhazmat.2007.01.031
   Yang YN, 2003, ENVIRON SCI TECHNOL, V37, P3635, DOI 10.1021/es034006a
   Yang YN, 2004, LANGMUIR, V20, P6736, DOI 10.1021/la049363t
   Yang YN, 2003, J AGR FOOD CHEM, V51, P5047, DOI 10.1021/jf0345301
NR 41
TC 44
Z9 44
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD NOV 15
PY 2009
VL 171
IS 1-3
BP 1066
EP 1070
DI 10.1016/j.jhazmat.2009.06.112
PG 5
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 511KZ
UT WOS:000271165100144
PM 19619940
DA 2018-10-20
ER

PT J
AU Guerin, G
   Ambard, D
   Swider, P
AF Guerin, G.
   Ambard, D.
   Swider, P.
TI Cells, growth factors and bioactive surface properties in a
   mechanobiological model of implant healing
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Implant fixation; Mechanobiology; Growth factor; Osteoblast; Transport
   in porous media; Biomaterial
ID OSTEOBLAST-LIKE CELLS; FINITE-ELEMENT-ANALYSIS; TITANIUM IMPLANTS;
   IN-VITRO; BONE-FORMATION; MECHANICAL CONDITIONS; INTERFACE; ROUGHNESS;
   PROLIFERATION; INTEGRATION
AB Interface conditions are of prime importance for implant fixation in the early post-operative period and modelling of specific biochemical interactions at implant surface is still missing. We hypothesized that updating osteoblast adhesion properties and growth factor source in an active zone located at the implant surface was relevant to model biochemical interactions of implant with its environment. We proposed an innovative set of diffusive-convective-reactive equations which relevant parameters were the cell decay factor, the cell motility and the growth factor balance.
   Initial comparison with histomorphometic results from a stable PMMA canine implant model provided an encouraging base to implement a numerical sensitivity analysis to evaluate the role of three types of bioactive Surfaces: acid-etched titanium, coarse grit-blasted acid-etched titanium and coarse grit-blasted acid-etched titanium with RGDS peptide. We found that cell diffusion decrease (acid-etched+RGDS peptide vs. PMMA), and increase of local growth factor fraction (PMMA vs. acid-etched+RGDS peptide), significantly improved the amount of mineralized tissue on the implant surface. When the variation of structural fraction to cell motility and growth factor synthesis was investigated, an envelope pattern with an optimum was obtained but this could be exceeded for strong surface modifications and/or for high growth factor concentrations. The model also confirmed that implant bioactive properties should play a limited role to reduce heterogeneity of new-formed tissue. In conclusion, we suggested that our innovative theoretical approach was relevant to investigate implant fixation and could potentially help in reduction of implant revision. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Guerin, G.; Ambard, D.; Swider, P.] Univ Toulouse, Biomech Grp, IMFT UMR CNRS 5502, Toulouse, France.
   [Ambard, D.] LMGC UMR CNRS 5508, Montpellier, France.
RP Swider, P (reprint author), Univ Toulouse, Biomech Grp, IMFT UMR CNRS 5502, Toulouse, France.
EM swider@cict.fr
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Alliston Tamara N., 2000, P233
   AMBARD D, 2007, 53 ANN M ORTH RES SO
   AMBARD D, 2004, 50 ANN M ORTH RES SO
   Ambard D., 2005, ITBM RBM, V26, P117
   AMBARD D, 2005, THESIS U TOULOUSE 3
   AMBARD D, 2004, 6 INT S COMP METH BI
   Ambard D, 2006, EUR J MECH A-SOLID, V25, P927, DOI 10.1016/j.euromechsol.2006.02.006
   Ambard D, 2009, EUR J COMPUT MECH, V18, P131, DOI 10.3166/EJCM.18.131-143
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Broderick E, 2005, CALCIFIED TISSUE INT, V76, P379, DOI 10.1007/s00223-004-0150-9
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27
   Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9
   Colnot C, 2007, J DENT RES, V86, P862, DOI 10.1177/154405910708600911
   Cowin S., 2001, BONE MECH HDB
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Duyck J, 2007, J CLIN PERIODONTOL, V34, P998, DOI 10.1111/j.1600-051X.2007.01135.x
   Fermor B, 1998, BONE, V22, P637, DOI 10.1016/S8756-3282(98)00047-7
   Fernandes PR, 2002, J BIOMECH, V35, P167, DOI 10.1016/S0021-9290(01)00204-4
   Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008
   Geris L, 2008, J BIOMECH, V41, P145, DOI 10.1016/j.jbiomech.2007.07.008
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   HAHN M, 1988, CHIRURG, V59, P782
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim MJ, 2006, J BIOMED MATER RES A, V79A, P1023, DOI 10.1002/jbm.a.31040
   LAUFFENBURGER D, 1983, J IMMUNOL, V131, P940
   Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D
   MARINUCCI L, 2007, INT J ORAL MAXILLOF, V22, P19
   Marinucci L, 2006, INT J ORAL MAX IMPL, V21, P719
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Maxwell J. C., 1881, TREATISE ELECT MAGNE
   Meinel L, 2003, BONE, V33, P660, DOI 10.1016/S8756-3282(03)00207-2
   Meirelles L, 2007, CLIN ORAL IMPLAN RES, V18, P326, DOI 10.1111/j.1600-0501.2006.01308.x
   Mesfar W, 2003, BIO-MED MATER ENG, V13, P91
   Morshed S, 2007, ACTA ORTHOP, V78, P315, DOI 10.1080/17453670710013861
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   NEALE GH, 1973, AICHE J, V19, P112, DOI 10.1002/aic.690190116
   NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109
   OVERGAARD S, 2000, ACTA ORTHOPAEDI S297, V71
   Pesskova V, 2007, J MATER SCI-MATER M, V18, P465
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Prendergast PJ, 1997, CLIN BIOMECH, V12, P343, DOI 10.1016/S0268-0033(97)00018-1
   Puthumanapully Pramod, 2008, Journal of Biomechanics, DOI 10.1016/S0021-9290(08)70289-6
   Qu Z, 2007, J BIOMED MATER RES A, V82A, P658, DOI 10.1002/bjm.a.31023
   Ramamurti BS, 1997, J BIOMED MATER RES, V36, P274, DOI 10.1002/(SICI)1097-4636(199708)36:2<274::AID-JBM17>3.3.CO;2-U
   Rausch-fan XH, 2008, DENT MATER, V24, P102, DOI 10.1016/j.dental.2007.03.001
   Roberts Anita B., 2000, P221
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Simon U, 2003, J BIOMECH, V36, P1079, DOI 10.1016/S0021-9290(03)00114-3
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   Stein Gary S., 2000, P51
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   TRACQUI P, 1999, MODELES CONTINUS POP, P195
   Tranqui L, 2000, CR ACAD SCI III-VIE, V323, P31, DOI 10.1016/S0764-4469(00)00110-4
   Vestermark MT, 2004, J ORTHOPAED RES, V22, P647, DOI 10.1016/j.orthres.2003.1.012
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   WAKEFIELD LM, 1990, J CLIN INVEST, V86, P1976, DOI 10.1172/JCI114932
   Wang JY, 1997, CLIN ORTHOP RELAT R, P216
   WU CY, 1995, J CELL SCI, V108, P821
NR 68
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PD NOV 13
PY 2009
VL 42
IS 15
BP 2555
EP 2561
DI 10.1016/j.jbiomech.2009.07.012
PG 7
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 526UT
UT WOS:000272320800020
PM 19665713
DA 2018-10-20
ER

PT J
AU Toita, S
   Soma, Y
   Morimoto, N
   Akiyoshi, K
AF Toita, Sayaka
   Soma, Yuki
   Morimoto, Nobuyuki
   Akiyoshi, Kazunari
TI Cycloamylose-based Biomaterial: Nanogel of Cholesterol-bearing Cationic
   Cycloamylose for siRNA Delivery
SO CHEMISTRY LETTERS
LA English
DT Article
ID SELF-ASSEMBLED NANOGELS; PROTEIN DELIVERY; POLYSACCHARIDES; CHAPERONE;
   DNA
AB A new siRNA delivery system made of a functional cycloamylose nanogel is reported. Cholesterol-bearing cationic cycloamylose formed nanogels by self-assembly in water. The nanogels formed 20-40 nm nanoparticles that bound to 21 bp siRNA. The complexes exerted an RNAi effect on SCC7-GL3 cells that stably express the luciferase gene.
C1 [Toita, Sayaka; Soma, Yuki; Morimoto, Nobuyuki; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Morimoto, Nobuyuki] Tohoku Univ, Dept Mat Proc, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan.
RP Akiyoshi, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
EM akiyoshi.org@tmd.ac.jp
FU JST; Ministry of Education, Culture, Sports, Science and Technology
   [20240047, 18GS0421]; JSPS [20-4657]
FX The authors are grateful to Prof. Osamu Mazda for providing SCC7-GL3
   cells. They also thank Prof. Shinichi Kitamura, Dr. Yoshinobu Terada,
   and Dr. Takeshi Takaha for helpful discussion about cycloamylose. This
   work was supported by the "Research Program on development of innovative
   technology" of JST and a Grant-in-Aid for Scientific Research from the
   Ministry of Education, Culture, Sports, Science and Technology (Nos.
   20240047 and 18GS0421), JSPS fellows (No. 20-4657) and CREST, JST.
CR Akiyama E, 2007, BIOMACROMOLECULES, V8, P2366, DOI 10.1021/bm070136q
   AKIYOSHI K, 1993, MACROMOLECULES, V26, P3062, DOI 10.1021/ma00064a011
   Ayame H, 2008, BIOCONJUGATE CHEM, V19, P882, DOI 10.1021/bc700422s
   Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y
   Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021
   Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441
   Morimoto N, 2009, CHEM LETT, V38, P496, DOI 10.1246/cl.2009.496
   Nomura Y, 2003, FEBS LETT, V553, P271, DOI 10.1016/S0014-5793(03)01028-7
   Ozawa Y, 2009, MACROMOL BIOSCI, V9, P694, DOI 10.1002/mabi.200800288
   Saenger WR, 1998, CHEM REV, V98, P1787, DOI 10.1021/cr9700181
   Takaha T, 1996, J BIOL CHEM, V271, P2902, DOI 10.1074/jbc.271.6.2902
   Xiong XB, 2009, BIOMATERIALS, V30, P242, DOI 10.1016/j.biomaterials.2008.09.025
NR 12
TC 15
Z9 17
U1 0
U2 23
PU CHEMICAL SOC JAPAN
PI TOKYO
PA 1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN
SN 0366-7022
EI 1348-0715
J9 CHEM LETT
JI Chem. Lett.
PD NOV 5
PY 2009
VL 38
IS 11
BP 1114
EP 1115
DI 10.1246/cl.2009.1114
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 533VT
UT WOS:000272854200051
DA 2018-10-20
ER

PT J
AU Peramo, A
   Bahng, JH
   Marcelo, CL
   Kotov, N
   Martin, DC
AF Peramo, Antonio
   Bahng, Joong Hwan
   Marcelo, Cynthia L.
   Kotov, Nicholas
   Martin, David C.
TI In vitro integration of human skin dermis with porous cationic hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Wound healing; Skin biomaterial; Cationic hydrogel; Dermal integration;
   Porous scaffolds
ID HIGH-DENSITY POLYETHYLENE; ORGAN-CULTURE; PERCUTANEOUS DEVICES;
   SCAFFOLDS; ATTACHMENT; IMPLANTS; GROWTH; MODEL; BONE; INFECTIONS
AB Porous poly(DMAA-co-AMTAC) hydrogels, fabricated using the inverted colloid crystal method, were used to observe their integration with human skin. Full thickness human breast skin explants discarded from surgeries were cultured for up to 10 days at the air-liquid interface using a Transwell culture system. Cylindrical, disk- or other shaped hydrogels were placed inside the skin explants fitting punctures produced by punch biopsies or scalpels and full section histological analysis of the skin explants with the inserted hydrogel was then performed. In addition, separated hydrogels were cultured up to 7 days with human fibroblasts. The results indicate that poly(DMAA-co-AMTAC) hydrogels induce substantial extracellular matrix material deposition, maintain dermal integrity in the contact areas with the skin and permit dermal fibers to integrate into the hydrogel pores. Different types of cells remaining in the explants migrated into the hydrogels pores, including red blood cells. Fibroblasts adhered to and colonized separately cultured hydrogels. We plan to use this type of soft material as an interface to permit skin integration with percutaneous devices in contact with skin. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Peramo, Antonio; Martin, David C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Bahng, Joong Hwan; Kotov, Nicholas] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Peramo, Antonio; Marcelo, Cynthia L.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Martin, DC (reprint author), Univ Michigan, Dept Mat Sci & Engn, 2644 CSE Bldg, Ann Arbor, MI 48109 USA.
EM milty@umich.edu
RI Martin, David/B-1838-2008
OI Martin, David/0000-0003-1195-3838; Kotov, Nicholas/0000-0002-6864-5804
FU Army Research Office Multidisciplinary University Research Initiative
FX We thank the Microscopy & Image-Analysis Laboratory of the University of
   Michigan School of Medicine for their work on specimen preparation; Ming
   Qin, from the Department of Chemical Engineering, University of
   Michigan, Ann Arbor, for his help with the spin coater; and Meghan
   Cuddihy, Department of Chemical Engineering, University of Michigan for
   the SEM hydrogel imaging of Fig. 1A and B. This report is presented as
   part of the research efforts within the Army Research Office
   Multidisciplinary University Research Initiative award on
   Bio-Integrating Structural and Neural Prosthetic Materials, and we
   gratefully acknowledge the funding provided.
CR ALBREKTSSON T, 1987, PLAST RECONSTR SURG, V79, P721, DOI 10.1097/00006534-198705000-00007
   AUMAILLEY M, 1986, J CELL BIOL, V103, P1569, DOI 10.1083/jcb.103.4.1569
   BRANEMARK PI, 1982, SCAND J PLAST RECONS, V16, P17, DOI 10.3109/02844318209006565
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Deveci M, 2005, BRIT J DERMATOL, V152, P217, DOI 10.1111/J.1365-2133.2004.06329.X
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DRUMHELLER PD, 1994, BIOTECHNOL BIOENG, V43, P772, DOI 10.1002/bit.260430812
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Hong H, 2007, COMPOS PART B-ENG, V38, P311, DOI 10.1016/j.compositesb.2006.05.005
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kang HS, 2007, J APPL POLYM SCI, V103, P386, DOI 10.1002/app.24623
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   LEE JJ, 2007, CURR APPL PHYS, V7, pE37
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee J, 2006, J MATER CHEM, V16, P3558, DOI 10.1039/b605797g
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   LEPOOLE IC, 1994, PIGM CELL RES, V7, P33
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   Mermel LA, 2000, ANN INTERN MED, V133, P395
   Mullarney MP, 2006, POLYMER, V47, P3845, DOI 10.1016/j.polymer.2006.03.096
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P1897, DOI 10.1016/j.bios.2004.08.016
   RESAU JH, 1991, CYTOTECHNOLOGY, V7, P137, DOI 10.1007/BF00365924
   Rosso F, 2003, MAT SCI ENG C-BIO S, V23, P371, DOI 10.1016/S0928-4931(02)00290-4
   Sclafani AP, 1997, PLAST RECONSTR SURG, V99, P41, DOI 10.1097/00006534-199701000-00007
   Solomon S, 2003, AM J INFECT CONTROL, V31, P481
   SPECTOR M, 1976, J BIOMED MATER RES, V10, P595, DOI 10.1002/jbm.820100416
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   TAMMI R, 1979, J INVEST DERMATOL, V73, P138, DOI 10.1111/1523-1747.ep12581579
   Tavakkol A, 1999, ARCH DERMATOL RES, V291, P643, DOI 10.1007/s004030050469
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   WINTER GD, 1974, J BIOMED MAT RES S 1, V13, P99
   Yamada N, 1999, SCAND J PLAST RECONS, V33, P147
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang YJ, 2005, ADV FUNCT MATER, V15, P725, DOI 10.1002/adfm.200400325
NR 41
TC 5
Z9 5
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2009
VL 5
IS 9
BP 3337
EP 3345
DI 10.1016/j.actbio.2009.05.031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 520NX
UT WOS:000271853300006
PM 19481182
DA 2018-10-20
ER

PT J
AU Tsai, WB
   Chen, RPY
   Wei, KL
   Chen, YR
   Liao, TY
   Liu, HL
   Lai, JY
AF Tsai, Wei-Bor
   Chen, Rita Pei-Yeh
   Wei, Kuang-Ling
   Chen, Yi-Ru
   Liao, Tai-Yan
   Liu, Hsuan-Liang
   Lai, Juin-Yih
TI Polyelectrolyte multilayer films functionalized with peptides for
   promoting osteoblast functions
SO ACTA BIOMATERIALIA
LA English
DT Article
DE RGD; Polyelectrolyte multilayer; Osteoblasts; Calcium deposition; Cell
   adhesion
ID QUARTZ-CRYSTAL MICROBALANCE; ENDOTHELIAL-CELLS; CYTOSKELETAL
   ORGANIZATION; WEAK POLYELECTROLYTES; REGULATE ADHESION; SURFACE SCIENCE;
   FIBRONECTIN; RGD; ADSORPTION; MATRIX
AB Layer-by-layer deposition of polyelectrolyte multilayer (PEM) thin films has recently been applied to biomaterial applications. This simple and versatile technique provides a wide variety of potential utilization by insertion of biomolecules such as cell adhesion peptides. In this work dual peptides containing RGD (a cell-binding domain) and LHRRVKI (a heparin-binding domain) were immobilized onto polystyrene by the PEM technique and the effects on osteoblast cell culture were investigated. These peptides were conjugated to the amino groups of poly(allylamine hydrochloride) and then adsorbed onto the top of a 10 layer poly(allylamine hydrochloride)/poly (acrylic acid) film assembled at either pH 2.0 or pH 6.5. Osteoblasts, isolated from neonatal rat calvariae, were then seeded and cultured on the peptide-conjugated surfaces. We found that the cells adhered and grew better on the RGD-conjugated PEM films. The osteoblasts exhibited a better differentiated phenotype on the pH 2.0 films than the pH 6.5 films with respect to calcium deposition. The incorporation of LHRRVKI did not support cell adhesion, growth and matrix mineral deposition. Our results showed that the efficacy of RGD conjugation on osteoblast behavior was affected by the base PEM film. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tsai, Wei-Bor; Wei, Kuang-Ling] Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
   [Chen, Rita Pei-Yeh; Liao, Tai-Yan] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.
   [Chen, Yi-Ru; Liu, Hsuan-Liang] Natl Taipei Inst Technol, Grad Inst Biotechnol, Taipei, Taiwan.
   [Chen, Yi-Ru; Liu, Hsuan-Liang] Natl Taipei Inst Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan.
   [Lai, Juin-Yih] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Tao Yuan, Taiwan.
   [Lai, Juin-Yih] Chung Yuan Christian Univ, Dept Chem Engn, Tao Yuan, Taiwan.
RP Tsai, WB (reprint author), Natl Taiwan Univ, Dept Chem Engn, 1 Roosevelt Rd,Sect 4, Taipei 106, Taiwan.
EM weibortsai@ntu.edu.tw
RI Chen, Rita/M-8397-2013; Tsai, Wei-Bor/B-7953-2011
OI Chen, Rita/0000-0003-3987-033X; Tsai, Wei-Bor/0000-0002-2316-5751
FU National Science Council, Taiwan [97-2628-E-002-028-MY2]
FX The authors gratefully acknowledge the financial support of the National
   Science Council, Taiwan (Grant No. 97-2628-E-002-028-MY2).
CR Baba A, 2000, COLLOID SURFACE A, V173, P39, DOI 10.1016/S0927-7757(00)00579-3
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Bretaudiere J. P., 1984, METHOD ENZYMAT AN, P75
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen PY, 2001, PROTEIN SCI, V10, P1794, DOI 10.1110/ps.49001
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DWORETZKY SI, 1990, P NATL ACAD SCI USA, V87, P4605, DOI 10.1073/pnas.87.12.4605
   Hentschel J, 2008, MACROMOLECULES, V41, P1073, DOI 10.1021/ma8000934
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kikuchi A, 1996, J BIOMAT SCI-POLYM E, V8, P77, DOI 10.1163/156856296X00165
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   LATERRA J, 1983, J CELL BIOL, V96, P112, DOI 10.1083/jcb.96.1.112
   LEBARON RG, 1988, J CELL BIOL, V106, P945, DOI 10.1083/jcb.106.3.945
   Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y
   Loschonsky S, 2008, BIOMACROMOLECULES, V9, P543, DOI 10.1021/bm7010714
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   PECK WA, 1964, SCIENCE, V146, P1476, DOI 10.1126/science.146.3650.1476
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Plunkett MA, 2003, LANGMUIR, V19, P4673, DOI 10.1021/la026569q
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rojas OJ, 2002, LANGMUIR, V18, P1604, DOI 10.1021/la0155698
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cellbio.4.1.229
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Tsai WB, 2004, J BIOMAT SCI-POLYM E, V15, P817, DOI 10.1163/1568562041271093
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
NR 41
TC 41
Z9 42
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2009
VL 5
IS 9
BP 3467
EP 3477
DI 10.1016/j.actbio.2009.05.034
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 520NX
UT WOS:000271853300018
PM 19497392
DA 2018-10-20
ER

PT J
AU Liu, YY
   Tung, TH
   Liu, KH
   Chen, SY
   Liu, DM
AF Liu, Yen-Yu
   Tung, Tsan-Hua
   Liu, Kun-Ho
   Chen, San-Yuan
   Liu, Dean-Mo
TI Structural Evolution and Copper-Ion Release Behavior of Cu-pHEMA Hybrids
   Synthesized In Situ
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID NITRIC-OXIDE; NANOCOMPOSITE; CHITOSAN; VITRO
AB A novel Cu-pHEMA hybrid was successfully prepared by in situ photopolymerization of 2-hydroxyethyl methacrylate (HEMA) monomer in the presence of COP copper ions, following an in situ chemical reduction. Experimental observations indicate that intermolecular interactions such as the coupling force and hydrogen bonding between the Cu and the hydroxyl groups further stabilize the hybrid structure to a considerable extent. Localization of the metallic copper particles within the pHEMA network structure as a result of those intermolecular interactions gives rise to the formation of discretely distributed nanocrystallites with particle sizes ranging from 5 to 25 nm in diameter, A crystallographic change of the Cu nanophase from an amorphous-like to a crystalline structure is observed as the H(2)O:HEMA molar ratio increases, upon synthesis, accompanied with an increase in the particle size, A relatively slow and sustained release of the Cu (in the form of cupric ions) from the hybrids was measured for a time period of about 10 days, which also illustrates a Cu(II)-induced proliferation of the endothelial cells over a relatively small range of release rate of the Cu from the hybrids. Such a new type of Cu-loaded hybrid hydrogel is expected to be compatible and may be considered as a candidate biomaterial for biomedical/therapeutic uses.
C1 [Liu, Yen-Yu; Tung, Tsan-Hua; Liu, Kun-Ho; Chen, San-Yuan; Liu, Dean-Mo] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30049, Taiwan.
RP Liu, YY (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Ta Hsueh Rd, Hsinchu 30049, Taiwan.
EM deanmo_liu@yahoo.ca
FU National Science Council of the Republic of China [NSC
   98-2113-M-009-004]
FX The authors would like to thank the National Science Council of the
   Republic of China for its financial support through Contract No. NSC
   98-2113-M-009-004.
CR Ahn JS, 2002, BIOMATERIALS, V23, P1411, DOI 10.1016/S0142-9612(01)00261-7
   Bastidas JM, 2000, CONTRACEPTION, V61, P395, DOI 10.1016/S0010-7824(00)00124-4
   Bastidas JM, 1997, BIOMATERIALS, V18, P247, DOI 10.1016/S0142-9612(96)00136-6
   Belfer S, 2005, J APPL POLYM SCI, V98, P509, DOI 10.1002/app.22142
   Cai SZ, 2007, J BIOMED MATER RES B, V80B, P220, DOI 10.1002/jbm.b.30587
   Deki S, 1998, J MATER CHEM, V8, P1865, DOI 10.1039/a801506f
   Giavaresi G, 2005, BIOMATERIALS, V26, P3001, DOI 10.1016/j.biomaterials.2004.08.027
   HOFFMAN H, 1976, EXP CELL RES, V102, P269, DOI 10.1016/0014-4827(76)90042-2
   Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
   Hu Y, 2007, INT J MOL SCI, V8, P1, DOI 10.3390/i8010001
   LI YY, 2008, COLLOID SURFACE B, V61, P43
   Liu YY, 2008, ACTA BIOMATER, V4, P2052, DOI 10.1016/j.actbio.2008.05.022
   Oh BK, 2004, BIOMATERIALS, V25, P283, DOI 10.1016/S0142-9612(03)00530-1
   Perkowska A, 1999, J MOL STRUCT, V508, P111, DOI 10.1016/S0022-2860(99)00007-1
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Sen C. K., 2002, AM J PHYSIOL-HEART C, V282, P1821
   Vlugt-Wensink KDF, 2006, BIOMACROMOLECULES, V7, P2983, DOI 10.1021/bm060385z
   Wu YD, 2007, SENSOR ACTUAT B-CHEM, V121, P36, DOI 10.1016/j.snb.2006.09.025
NR 18
TC 1
Z9 1
U1 1
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD NOV
PY 2009
VL 11
IS 11
BP B219
EP B226
DI 10.1002/adem.200900142
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 529BU
UT WOS:000272491500021
DA 2018-10-20
ER

PT J
AU Lagoa, R
   Rodrigues, JR
AF Lagoa, R.
   Rodrigues, J. R.
TI Kinetic analysis of metal uptake by dry and gel alginate particles
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Biosorption; Biopolymer; Heavy metals; Biomaterial; Effluent; Water
   treatment
ID ION-EXCHANGE-RESIN; HEAVY-METALS; CA-ALGINATE; HUMIC-ACID; MODELING
   SIMULATION; TRIVALENT CHROMIUM; AQUEOUS-SOLUTIONS; BEADS; BIOSORPTION;
   REMOVAL
AB The kinetics of metal uptake by gel and dry calcium alginate beads was analysed using solutions of copper or lead ions. Gel beads sorbed metal ions faster than the dry ones and larger diffusivities of metal ions were calculated for gel beads: approximately 10(-4) cm(2)/min vs. 10(-6) cm(2)/min for dry beads. In accordance, scanning electron microscopy and nitrogen adsorption data revealed a low porosity of dry alginate particles. However, dry beads showed higher sorption capacities and a mechanical stability more suitable for large-scale use. Two sorption models were. fitted to the kinetic results: the Lagergren pseudo. first order and the Ho and McKay pseudo-second order equations. The former was found to be the most adequate to model metal uptake by dry alginate beads and kinetic constants in the orders of 10(-3) and 10(-2) min(-1) were obtained for lead solutions with concentrations up to 100 g/m(3). The pseudo-first order model was also found to be valid to describe biosorbent operation with a real wastewater indicating that it can be used to design processes of metal sorption with alginate-based materials. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Lagoa, R.; Rodrigues, J. R.] Polytech Inst Leiria, Sch Technol & Management, P-2401951 Alto Do Vieiro, Leiria, Portugal.
RP Lagoa, R (reprint author), Polytech Inst Leiria, Sch Technol & Management, P-2401951 Alto Do Vieiro, Leiria, Portugal.
EM rlagoa@estg.ipleiria.pt
RI Rodrigues, Joaquim Rui/L-4137-2014
OI Rodrigues, Joaquim Rui/0000-0002-9756-1124; Lagoa,
   Ricardo/0000-0003-2375-6612
FU University of Extremadura, Spain
FX We are grateful to Prof. Virginio Garcia-Martinez (University of
   Extremadura, Spain) for kindly making available the scanning electron
   microscope at his laboratory, and to Carlos Ganan-Serrano for helpful
   assistance in the microscopy studies.
CR Araujo MM, 1997, INT BIODETER BIODEGR, V40, P63, DOI 10.1016/S0964-8305(97)00064-4
   Arica MY, 2001, BIORESOURCE TECHNOL, V80, P121, DOI 10.1016/S0960-8524(01)00084-0
   Bai YX, 2006, CARBOHYD POLYM, V64, P402, DOI 10.1016/j.carbpol.2005.12.009
   Banerjee A, 2007, BIOCHEM ENG J, V33, P260, DOI 10.1016/j.bej.2006.11.005
   Bayramoglu G, 2006, INT J MINER PROCESS, V81, P35, DOI 10.1016/j.minpro.2006.06.002
   Bayramoglu G, 2009, BIORESOURCE TECHNOL, V100, P186, DOI 10.1016/j.biortech.2008.05.050
   BOYD GE, 1947, J AM CHEM SOC, V69, P2836, DOI 10.1021/ja01203a066
   Chan LW, 2006, CARBOHYD POLYM, V63, P176, DOI 10.1016/j.carbpol.2005.07.033
   CHEN D, 1993, BIOTECHNOL BIOENG, V41, P755, DOI 10.1002/bit.260410710
   Chen JP, 2007, CHEM ENG J, V131, P209, DOI 10.1016/j.cej.2006.11.012
   Chen JP, 2002, LANGMUIR, V18, P9413, DOI 10.1021/la026060v
   Davis TA, 2008, ENVIRON SCI TECHNOL, V42, P1673, DOI 10.1021/es702350w
   Dhakal RP, 2005, SEP PURIF TECHNOL, V42, P219, DOI 10.1016/j.seppur.2004.07.016
   HAUG A, 1961, ACTA CHEM SCAND, V15, P1794, DOI 10.3891/acta.chem.scand.15-1794
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ibanez JP, 2002, HYDROMETALLURGY, V64, P89, DOI 10.1016/S0304-386X(02)00012-9
   Ibanez JP, 2004, HYDROMETALLURGY, V72, P327, DOI 10.1016/j.hydromet.2003.10.009
   JANG LK, 1991, BIOTECHNOL BIOENG, V37, P266, DOI 10.1002/bit.260370309
   Jeon C, 2002, BIOCHEM ENG J, V11, P159, DOI 10.1016/S1369-703X(02)00020-7
   Kacar Y, 2002, PROCESS BIOCHEM, V37, P601, DOI 10.1016/S0032-9592(01)00248-5
   Lagoa R, 2007, APPL BIOCHEM BIOTECH, V143, P115, DOI 10.1007/s12010-007-0041-4
   Lai YL, 2008, BIORESOURCE TECHNOL, V99, P6480, DOI 10.1016/j.biortech.2007.11.041
   Lamelas C, 2005, BIOMACROMOLECULES, V6, P2756, DOI 10.1021/bm050252y
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Ocio A, 2006, J CHEM TECHNOL BIOT, V81, P1409, DOI 10.1002/jctb.1578
   Ouwerx C, 1998, POLYM GELS NETW, V6, P393, DOI 10.1016/S0966-7822(98)00035-5
   Pandey AK, 2003, J HAZARD MATER, V98, P177, DOI 10.1016/S0304-3894(02)00316-3
   Pandey AK, 2003, CHEMOSPHERE, V51, P329, DOI 10.1016/S0045-6535(02)00824-X
   Pandey AK, 2002, ECOTOX ENVIRON SAFE, V52, P92, DOI 10.1006/eesa.2002.2144
   Papageorgiou SK, 2006, J HAZARD MATER, V137, P1765, DOI 10.1016/j.jhazmat.2006.05.017
   Park HG, 2007, PROCESS BIOCHEM, V42, P1371, DOI 10.1016/j.procbio.2007.06.016
   REICHENBERG D, 1953, J AM CHEM SOC, V75, P589, DOI 10.1021/ja01099a022
   Robitzer M, 2008, LANGMUIR, V24, P12547, DOI 10.1021/la802103t
   Rodrigues JR, 2006, J CARBOHYD CHEM, V25, P219, DOI 10.1080/07328300600732956
   Serp D, 2002, BIOTECHNOL BIOENG, V79, P253, DOI 10.1002/bit.10287
   Silva RMP, 2008, J ENVIRON SCI HEAL A, V43, P1311, DOI 10.1080/10934520802177953
   Vijaya Y, 2008, CARBOHYD POLYM, V72, P261, DOI 10.1016/j.carbpol.2007.08.010
   Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2
   Vreeker R, 2008, FOOD BIOPHYS, V3, P361, DOI 10.1007/s11483-008-9087-2
NR 41
TC 49
Z9 52
U1 4
U2 42
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD NOV 1
PY 2009
VL 46
IS 3
BP 320
EP 326
DI 10.1016/j.bej.2009.06.007
PG 7
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 559CL
UT WOS:000274797800012
DA 2018-10-20
ER

PT J
AU Potta, T
   Chun, C
   Song, SC
AF Potta, Thrimoorthy
   Chun, ChangJu
   Song, Soo-Chang
TI Chemically crosslinkable thermosensitive polyphosphazene gels as
   injectable materials for biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE Injectable; Thermosensitive; Chemically crosslinkable; Biodegradable;
   Hydrogels; Degree of substitution
ID PPO-PEO TRIBLOCKS; AMINO-ACID ESTERS; POLY(ETHYLENE GLYCOL);
   DRUG-DELIVERY; SIDE-GROUPS; HYALURONAN HYDROGELS; AQUEOUS-SOLUTIONS;
   DEXTRAN; TISSUE; COPOLYMERS
AB Chemically crosslinkable and thermosensitive poly(organophosphazenes) containing multiple thiol (-SH) groups along with hydrophobic isoleucine ethyl ester and hydrophilic alpha-amino-omega-methoxypoly(ethylene glycol) of the molecular weight 550 have been synthesized and characterized as an injectable biomaterial. The aqueous solutions of these polymers were transformed into hydrogel with desired gel strength at body temperature via hydrophobic interactions, and the gel strength was further improved by the cross-linking of thiol groups with crosslinkers, divinyl sulfone (VS) and PEG divinyl sulfone (PEGVS) under physiological conditions. The kinetics of cross-linking behavior of polymer thiol groups with crosslinkers was studied in both in vitro and in vivo conditions. Field Emission-Scanning Electron Microscopy (FE-SEM), swelling experiments, and rheology study of present polymers revealed that the inner three-dimensional hydrogel networks depended on the degree of thiol units in the polymer network. From the in vivo (in mice) degradation studies, the dual cross-linked gels showed to have a controlled degradation. These results demonstrate that the inner network of the hydrogels can be tuned, gel strength and degradation rate can be controlled, and the chemically crosslinkable and thermosensitive poly(organophosphazenes) hold promises for uses as injectable systems for biomedical applications including tissue engineering and protein delivery. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Potta, Thrimoorthy; Chun, ChangJu; Song, Soo-Chang] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea.
   [Potta, Thrimoorthy] Univ Sci & Technol, Dept Biomol Sci, Taejon 305333, South Korea.
RP Song, SC (reprint author), Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea.
EM scsong@kist.re.kr
RI Tarsitano, Elisa/D-6611-2015; Potta, Thrimoorthy/H-6687-2012
OI CHUN, CHANGJU/0000-0002-2452-6184; Song, Soo-Chang/0000-0001-9344-0686
FU Ministry of Education, Science and Technology in Korea
FX This research was financially supported by the Ministry of Education,
   Science and Technology in Korea.
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 2003, CHEM APPL POLYPHOSPH, P223
   ALLCOCK HR, 2003, CHEM APPL POLYPHOSPH, P40
   ALLCOCK HR, 2003, CHEM APPL POLYPHOSPH, P531
   Bilicic MB, 2005, INT J PHARM, V291, P211, DOI 10.1016/j.ijpharm.2004.07.058
   Bromberg L, 1999, LANGMUIR, V15, P8633, DOI 10.1021/la990946q
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Chun C, 2009, BIOMATERIALS, V30, P2349, DOI 10.1016/j.biomaterials.2008.12.083
   Crescenzi V, 2002, BIOMACROMOLECULES, V3, P1384, DOI 10.1021/bm025657m
   de Jong SJ, 2001, J CONTROL RELEASE, V72, P47, DOI 10.1016/S0168-3659(01)00261-9
   Greenstein J.D., 1961, CHEM AMINO ACIDS, P925
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Kang GD, 2006, EUR J PHARM BIOPHARM, V63, P340, DOI 10.1016/j.ejpb.2006.01.001
   Kim SH, 2000, J BIOMED MATER RES, V53, P258, DOI 10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   Lee B. H., 2003, BIOMATER RES, V7, P182
   Lee BH, 2006, BIOMACROMOLECULES, V7, P2059, DOI 10.1021/bm060211h
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee SB, 1999, MACROMOLECULES, V32, P7820, DOI 10.1021/ma990645n
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Lukaszczyk J, 2005, MACROMOL BIOSCI, V5, P64, DOI 10.1002/mabi.200400135
   Luten J, 2003, J CONTROL RELEASE, V89, P483, DOI 10.1016/S0168-3659(03)00127-5
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Mo XM, 2000, J BIOMAT SCI-POLYM E, V11, P341, DOI 10.1163/156856200743742
   Niu GG, 2008, BIOMACROMOLECULES, V9, P2621, DOI 10.1021/bm800573e
   Oh EJ, 2008, BIOCONJUGATE CHEM, V19, P2401, DOI 10.1021/bc800255y
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Robb SA, 2007, BIOMACROMOLECULES, V8, P2294, DOI 10.1021/bm070267r
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   SOHN YS, 1995, MACROMOLECULES, V28, P7566, DOI 10.1021/ma00126a039
   Song R, 2005, J CONTROL RELEASE, V105, P142, DOI 10.1016/j.jconrel.2005.03.016
   Song SC, 1999, MACROMOLECULES, V32, P2188, DOI 10.1021/ma981190p
   Sosnik A, 2004, BIOMATERIALS, V25, P2851, DOI 10.1016/j.biomaterials.2003.09.057
   Sosnik A, 2003, J BIOMAT SCI-POLYM E, V14, P227, DOI 10.1163/156856203763572680
   Van Tomme SR, 2005, BIOMATERIALS, V26, P2129, DOI 10.1016/j.biomaterials.2004.05.035
   Vandorpe J, 1996, POLYMER, V37, P3141, DOI 10.1016/0032-3861(96)89416-X
   VERNON BL, 2002, J BIOMED MATER RES, V64, P447
   Weng LH, 2008, BIOMATERIALS, V29, P2153, DOI 10.1016/j.biomaterials.2008.01.012
NR 50
TC 49
Z9 50
U1 2
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2009
VL 30
IS 31
BP 6178
EP 6192
DI 10.1016/j.biomaterials.2009.08.015
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 506IA
UT WOS:000270767300004
PM 19709738
DA 2018-10-20
ER

PT J
AU Tamimi, F
   Torres, J
   Gbureck, U
   Lopez-Cabarcos, E
   Bassett, DC
   Alkhraisat, MH
   Barralet, JE
AF Tamimi, Faleh
   Torres, Jesus
   Gbureck, Uwe
   Lopez-Cabarcos, Enrique
   Bassett, David C.
   Alkhraisat, Mohammad H.
   Barralet, Jake E.
TI Craniofacial vertical bone augmentation: A comparison between 3D printed
   monolithic monetite blocks and autologous onlay grafts in the rabbit
SO BIOMATERIALS
LA English
DT Article
DE Monetite; Bone; Autograft; Onlay; Monolithic; Histomorphometry
ID ALVEOLAR DISTRACTION OSTEOGENESIS; DEFICIENT EDENTULOUS RIDGES; IMPLANT
   PLACEMENT; AUTOGENOUS BONE; BIO-OSS; REGENERATION; MEMBRANE; HUMANS;
   HYDROXYAPATITE; RECONSTRUCTION
AB Onlay autografting is amongst the most predictable techniques for craniofacial vertical bone augmentation, however, complications related to donor site surgery are common and synthetic alternatives to onlay autografts are desirable. Recent studies have shown that the acidic calcium phosphates, brushite and monetite, are osteoconductive, osteoinductive and resorb faster in vivo than hydroxyapatite. Moreover, they can be 3D printed allowing precise host bone-implant conformation. The objectives of this study were to confirm that craniofacial screw fixation of 3D printed monetite blocks was possible and to compare the resulting vertical bone augmentation with autograft. 3D printed monolithic monetite onlay implants were fixed with osteosynthesis screws on the calvarial bone surface of New Zealand rabbits. After 8 weeks, integration between the implant and the calvarial bone surface was observed in all cases. Histomorphometry revealed that 42% of the monetite was resorbed and that the new bone formed within the implant occupied 43% of its volume, sufficient for immediate dental implant placement. Bone tissue within the autologous onlay occupied 60% of the volume. We observed that patterns of regeneration within the implants differed throughout the material and propose that this was due to the anatomy and blood supply pattern in the region. Rapid prototyped monetite being resorbable osteoconductive and osteoinductive would appear to be a promising biomaterial for many bone regeneration strategies. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Tamimi, Faleh; Bassett, David C.; Barralet, Jake E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Torres, Jesus] Rey Juan Carlos Univ, Madrid, Spain.
   [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, Wurzburg, Germany.
   [Lopez-Cabarcos, Enrique; Alkhraisat, Mohammad H.] Univ Complutense Madrid, Dept Phys Chem 2, E-28040 Madrid, Spain.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
EM faleh.taminimarino@mail.mcgill.ca
RI barralet, jake/A-5820-2008; Bassett, David/B-2489-2009; Lopez Cabarcos,
   Enrique/L-5802-2014; Gbureck, Uwe/G-1430-2012
OI barralet, jake/0000-0003-3543-6042; Bassett, David/0000-0001-7167-2566;
   Lopez Cabarcos, Enrique/0000-0003-2939-4130; Alkhraisat,
   Mohammad/0000-0003-4422-4527; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209
FU Fundacion Espanola para la Ciencia y Tecnologia (FECYT); Spanish Science
   and Education Ministry [MAT2006-13646-C03-01]; UCM Program for Research
   Groups; Canada Research Chair program; NSERC; Quebec Ministere des
   Relations Internationales [PSR-SIIRI-029 1131]
FX The authors acknowledge financial support from "Fundacion Espanola para
   la Ciencia y Tecnologia" (FECYT); The Spanish Science and Education
   Ministry (MAT2006-13646-C03-01); the UCM Program for Research Groups:
   The Canada Research Chair program and NSERC Discovery Grant O.E.B.), and
   the Quebec Ministere des Relations Internationales (Quebec-Bavaria
   Exchange Program) PSR-SIIRI-029 1131.
CR Bahat O, 2001, INT J PERIODONT REST, V21, P357
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   Bohner M, 2008, J BIOMED MATER RES B, V84B, P375, DOI 10.1002/jbm.b.30881
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Canullo L, 2006, INT J PERIODONT REST, V26, P355
   Chiapasco M, 2004, INT J ORAL MAX IMPL, V19, P399
   Chiapasco M, 2004, CLIN ORAL IMPLAN RES, V15, P82, DOI 10.1111/j.1600-0501.2004.00999.x
   Chiapasco M, 2007, CLIN ORAL IMPLAN RES, V18, P432, DOI 10.1111/j.1600-0501.2007.01351.x
   Cordaro L, 2002, CLIN ORAL IMPLAN RES, V13, P103, DOI 10.1034/j.1600-0501.2002.130113.x
   Cottrell DA, 1998, J ORAL MAXIL SURG, V56, P935, DOI 10.1016/S0278-2391(98)90654-1
   Cottrell DA, 1998, J ORAL MAXILLOFAC SU, V56, P941
   CUTTING CB, 1984, PLAST RECONSTR SURG, V74, P603, DOI 10.1097/00006534-198411000-00003
   De Santis R, 2002, INTEGRATED BIOMATERIALS SCIENCE, P589
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Enislidis G, 2005, ORAL SURG ORAL MED O, V100, P25, DOI 10.1016/j.tripleo.2004.11.021
   Eski M, 2007, J CRANIOFAC SURG, V18, P520, DOI 10.1097/scs.0b013e318053432c
   FREIHOFER HPM, 1989, J CRANIO MAXILL SURG, V17, P306, DOI 10.1016/S1010-5182(89)80058-7
   Galea LG, 2008, BIOMATERIALS, V29, P3400, DOI 10.1016/j.biomaterials.2008.04.041
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gbureck U, 2007, J CONTROL RELEASE, V122, P173, DOI 10.1016/j.jconrel.2007.06.022
   Gielkens PFM, 2008, J DENT RES, V87, P1048, DOI 10.1177/154405910808701107
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Iizuka T, 2005, CLIN ORAL IMPLAN RES, V16, P700, DOI 10.1111/j.1600-0501.2005.01185.x
   ISAKSSON S, 1992, J CRANIO MAXILL SURG, V20, P2, DOI 10.1016/S1010-5182(05)80187-8
   Jensen OT, 2002, INT J ORAL MAX IMPL, V17, P52
   Klug CN, 2001, J ORAL MAXIL SURG, V59, P1302, DOI 10.1053/joms.2001.27520
   Kunkel M, 2005, CLIN ORAL IMPLAN RES, V16, P89, DOI 10.1111/j.1600-0501.2004.01073.x
   McAllister BS, 2001, J PERIODONTOL, V72, P1767, DOI 10.1902/jop.2001.72.12.1767
   MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1
   Parma-Benfenati S, 1999, Int J Periodontics Restorative Dent, V19, P424
   Piattelli M, 1996, J PERIODONTOL, V67, P158, DOI 10.1902/jop.1996.67.2.158
   Rachmiel A, 2001, INT J ORAL MAX SURG, V30, P510, DOI 10.1054/ijom.2001.0134
   Raghoebar GM, 2002, CLIN ORAL IMPLAN RES, V13, P558, DOI 10.1034/j.1600-0501.2002.130517.x
   RENKA RJ, 1984, ROCKY MT J MATH, V14, P223, DOI 10.1216/RMJ-1984-14-1-223
   Rocchietta I, 2008, J CLIN PERIODONTOL, V35, P203, DOI 10.1111/j.1600-051X.2008.01271.x
   Schleier P, 2007, INT J ORAL MAX IMPL, V22, P408
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P496
   Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8
   Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P620, DOI 10.1111/j.1600-0501.2007.01389.x
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   Tamimi F, 2009, BIOMATERIALS, V30, P208, DOI 10.1016/j.biomaterials.2008.09.032
   Marinno FT, 2007, J BIOMED MATER RES A, V81A, P93, DOI 10.1002/jbm.a.31014
   Tinti C, 1997, Int J Periodontics Restorative Dent, V17, P53
   Tinti C, 1998, Int J Periodontics Restorative Dent, V18, P434
   Tinti C, 1996, Int J Periodontics Restorative Dent, V16, P220
   Turker N, 2007, J ORAL MAXIL SURG, V65, P608, DOI 10.1016/j.joms.2006.05.057
NR 47
TC 59
Z9 60
U1 6
U2 77
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2009
VL 30
IS 31
BP 6318
EP 6326
DI 10.1016/j.biomaterials.2009.07.049
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 506IA
UT WOS:000270767300018
PM 19695698
OA Green Published
DA 2018-10-20
ER

PT J
AU Daubine, F
   Cortial, D
   Ladam, G
   Atmani, H
   Haikel, Y
   Voegel, JC
   Clezardin, P
   Benkirane-Jessel, N
AF Daubine, Florence
   Cortial, Delphine
   Ladam, Guy
   Atmani, Hassan
   Haikel, Youssef
   Voegel, Jean-Claude
   Clezardin, Philippe
   Benkirane-Jessel, Nadia
TI Nanostructured polyelectrolyte multilayer drug delivery systems for bone
   metastasis prevention
SO BIOMATERIALS
LA English
DT Article
DE Bioactive coatings; Polyelectrolyte multilayers; Bone metastasis;
   Bisphosphonates; Cyclodextrins
ID CYCLODEXTRIN COMPLEXES; BISPHOSPHONATES; COATINGS; CELLS; ARCHITECTURE;
   PROSTATE; BUILDUP; BREAST
AB Polyelectrolyte multilayers (PEM) are well established nanoarchitectures with numerous potential applications, in particular as biomaterial coatings. They may exhibit specific biological properties in terms of controlled cell activation or local drug delivery. Here, in a new approach for bone metastasis prevention, we employed poly-L-lysine covalently grafted with beta-cyclodextrin as a polycationic vector (PLL-CD) for the antitumor bisphosphonate drug risedronate (RIS). Molar ratio for maximum loading of the PLL-CD vector with RIS was determined by Raman microspectroscopy. The efficacy of RIS at inhibiting cancer cell invasion in vitro was strongly enhanced upon complexation, whatever PLL-CD:RIS complexes were in solution or embedded into PEM nanoarchitectures. Complexes in solution also clearly prevented cancer-induced bone metastasis in animals. Incorporation of the complexes into PEM nanoarchitectures covering bone implants appears of interest for in situ prevention of bone metastasis after ablation. (C) 2009 Elsevier Ltd. All rights reserved
C1 [Cortial, Delphine; Haikel, Youssef; Voegel, Jean-Claude; Benkirane-Jessel, Nadia] Fac Med Strasbourg, INSERM, U977, F-67085 Strasbourg, France.
   [Cortial, Delphine; Haikel, Youssef; Voegel, Jean-Claude; Benkirane-Jessel, Nadia] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France.
   [Daubine, Florence; Clezardin, Philippe] INSERM, U664, F-69372 Lyon, France.
   [Daubine, Florence; Clezardin, Philippe] Univ Lyon 1, Fac Med Laennec, F-69372 Lyon, France.
   [Ladam, Guy; Atmani, Hassan] Univ Rouen, Ctr Univ Evreux, EA3233, SMS La2B, F-27002 Evreux, France.
   [Benkirane-Jessel, Nadia] Hop Cent, Serv Chirurg Orthoped, Nancy, France.
RP Benkirane-Jessel, N (reprint author), Fac Med Strasbourg, INSERM, U977, 11 Rue Humann, F-67085 Strasbourg, France.
EM philippe.clezardin@inserm.fr; nadia.jessel@medecine.u-strasbg.fr
RI Benkirane-Jessel, Nadia/H-6438-2016; Clezardin, Philippe/M-8071-2014;
   Ladam, Guy/C-4362-2011
OI Clezardin, Philippe/0000-0003-0149-4463; Benkirane-Jessel,
   Nadia/0000-0003-3059-3559
FU Agence Nationale de la Recherche [ANR06-BLAN-0197-01/CartilSpray];
   Fondation Avenir; Ligue contre le Cancer, Region Alsace; Canceropele du
   Grand Est
FX This work was supported by the project ANR06-BLAN-0197-01/CartilSpray,
   from the "Agence Nationale de la Recherche", the "Fondation Avenir", the
   "Ligue contre le Cancer, Region Alsace" and "Canceropele du Grand Est".
   Delphine Cortial thanks the "Facullte de Chirurgie Dentaire" of
   Strasbourg for financial support. Nadia Benkirane-Jessel is indebted to
   CHU de Nancy ("Contrat d'Interface vers I'Hopital"). The authors thank
   Florian Bombard ("Facullte de Chirurgie Dentaire") for the in vivo
   experiments, Dr. Valerie Dupray (SMS-La2B) for technical support, and
   Dr. Philippe Lavalle for his participation to QCM experiments.
CR Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Benkirane-Jessel N, 2004, ADV FUNCT MATER, V14, P174, DOI 10.1002/adfm.200304413
   BENKIRANEJESSEL N, 2006, P NATL ACAD SCI USA, V103, P8618
   BENKIRANEJESSEL N, 2004, ADV FUNCT MATER, V14, P963
   Berth G, 2002, BIOMACROMOLECULES, V3, P579, DOI 10.1021/bm0200130
   Boissier S, 2000, CANCER RES, V60, P2949
   Boissier S, 1997, CANCER RES, V57, P3890
   Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8
   Coleman RE, 2008, BRIT J CANCER, V98, P1736, DOI 10.1038/sj.bjc.6604382
   Connors KA, 1997, CHEM REV, V97, P1325, DOI 10.1021/cr960371r
   CONNORS KA, 1995, J PHARM SCI, V84, P843, DOI 10.1002/jps.2600840712
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271
   Gangloff SC, 2006, BIOMATERIALS, V27, P1771, DOI 10.1016/j.biomaterials.2005.10.001
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Kempf M, 2003, J DRUG TARGET, V11, P11, DOI 10.1080/1061186031000072978
   LOFTSSON T, 2007, INT J PHARMACEUT, V32, P1
   Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Schuster KC, 2000, J MICROBIOL METH, V42, P29, DOI 10.1016/S0167-7012(00)00169-X
   Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007
   Wang DY, 2002, NANO LETT, V2, P857, DOI 10.1021/nl025624c
   Zhang X, 2008, NANO LETT, V8, P2432, DOI 10.1021/nl801379y
NR 26
TC 28
Z9 28
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2009
VL 30
IS 31
BP 6367
EP 6373
DI 10.1016/j.biomaterials.2009.08.002
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 506IA
UT WOS:000270767300024
PM 19692117
DA 2018-10-20
ER

PT J
AU Broekhuizen, CAN
   de Boer, L
   Schipper, K
   Jones, CD
   Quadir, S
   Feldman, RG
   Vandenbroucke-Grauls, CMJE
   Zaat, SAJ
AF Broekhuizen, Corine A. N.
   de Boer, Leonie
   Schipper, Kim
   Jones, Christopher D.
   Quadir, Shan
   Feldman, Robert G.
   Vandenbroucke-Grauls, Christina M. J. E.
   Zaat, Sebastian A. J.
TI The influence of antibodies on Staphylococcus epidermidis adherence to
   polyvinylpyrrolidone-coated silicone elastomer in experimental
   biomaterial-associated infection in mice
SO BIOMATERIALS
LA English
DT Article
DE Staphylococcus epidermidis; Biomaterial-associated infection; Monoclonal
   antibodies; Accumulation-associated protein (Aap); Lipoteichoic acid
   (LTA)
ID ACCUMULATION-ASSOCIATED PROTEIN; SUBCUTANEOUS ABSCESS FORMATION;
   FIBRONECTIN-BINDING PROTEIN; CATHETER-RELATED INFECTIONS; PERI-IMPLANT
   TISSUE; CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; BIOFILM
   FORMATION; PROTECTIVE EFFICACY; CONJUGATE VACCINES
AB Biomaterial-associated infection (BAI) is a major problem in modern medicine, and is often caused by Staphylococcus epidermidis. We aimed to raise monoclonal antibodies (mAbs) against major surface protein antigens of S. epidermidis, and to assess their possible protective activity in experimental BAI. Mice were vaccinated with a cell wall protein preparation of S. epidermidis. A highly immunodominant antigen was identified as Accumulation-associated protein (Aap). mAbs against Aap and against surface-exposed lipoteichoic acid (LTA) were used for passive immunization of mice in experimental biomaterial-associated infection. Neither anti-Aap nor anti-LTA mAbs showed protection. Either with or without antibodies, tissue surrounding the implants was more often culture positive than the implants themselves, but bacterial adherence to the implants was significantly increased in mice injected with anti-LTA. In vitro, anti-Aap and anti-LTA did show binding to S. epidermidis, but no opsonic activity was observed. We conclude that antibodies against S. epidermidis LTA or Aap showed no opsonic activity and did not protect mice against BAI. Moreover, the increase in binding to implanted biomaterial suggests that passive immunization may increase the risk for BAI. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Broekhuizen, Corine A. N.; de Boer, Leonie; Schipper, Kim; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   [Jones, Christopher D.; Quadir, Shan; Feldman, Robert G.] Emergent Prod Dev UK Ltd, Wokingham RG41 5TU, Berks, England.
   [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Dis, Med Ctr, Amsterdam, Netherlands.
RP Zaat, SAJ (reprint author), Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07
   Cerca N, 2006, INFECT IMMUN, V74, P4849, DOI 10.1128/IAI.00230-06
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   Domanski PJ, 2005, INFECT IMMUN, V73, P5229, DOI 10.1128/IAI.73.8.5229-5232.2005
   Fattom AI, 1996, INFECT IMMUN, V64, P1659
   Fleck RA, 2005, CLIN DIAGN LAB IMMUN, V12, P19, DOI 10.1128/CDLI.12.1.19-27.2005
   Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Guttormsen HK, 2008, HUM VACCINES, V4, P370, DOI 10.4161/hv.4.5.5988
   HEBERT GA, 1985, J CLIN MICROBIOL, V22, P409
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   Hussain M, 1997, INFECT IMMUN, V65, P519
   JONG EC, 2004, TRAVELLERS VACCINES
   Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006
   KOJIMA Y, 1990, J INFECT DIS, V162, P435, DOI 10.1093/infdis/162.2.435
   Lee JC, 1997, INFECT IMMUN, V65, P4146
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005
   MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Monk AB, 2007, J CLIN MICROBIOL, V45, P730, DOI 10.1128/JCM.02317-06
   MUKHERJEE J, 1995, INFECT IMMUN, V63, P3353
   Niemann S, 2004, CIRCULATION, V110, P193, DOI 10.1161/01.CIR.0000134486.93030.E7
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Rice K, 2001, INFECT IMMUN, V69, P3791, DOI 10.1128/IAI.69.6.3791-3799.2001
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Romero-Steiner S, 2006, CLIN VACCINE IMMUNOL, V13, P165, DOI 10.1128/CVI.13.2.165-169.2006
   RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415
   Sellman BR, 2005, INFECT IMMUN, V73, P6591, DOI 10.1128/IAI.73.10.6591-6600.2005
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   TAMURA Y, 1992, J GEN MICROBIOL, V138, P537, DOI 10.1099/00221287-138-3-537
   Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x
   Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006
   Weisman LE, 2007, ARCH PEDIATRIE, V14, pS31, DOI 10.1016/S0929-693X(07)80008-X
   Weisman LE, 2009, INT IMMUNOPHARMACOL, V9, P639, DOI 10.1016/j.intimp.2009.02.008
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
NR 50
TC 10
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2009
VL 30
IS 32
BP 6444
EP 6450
DI 10.1016/j.biomaterials.2009.08.018
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509WD
UT WOS:000271049000006
PM 19716173
DA 2018-10-20
ER

PT J
AU Borgognoni, CF
   Tattini, V
   Ayrosa, AMIB
   Polakiewicz, B
   Leirner, AA
   Maizato, MJS
   Higa, OZ
   Beppu, MM
   Pitombo, RND
AF Borgognoni, Camila Figueiredo
   Tattini Junior, Virgilio
   Irene Bartolomeu Ayrosa, Ana Maria
   Polakiewicz, Bronislaw
   Leirner, Adolfo Alberto
   Shiotsu Maizato, Marina Junko
   Higa, Olga Zazuco
   Beppu, Marisa Masumi
   de Moraes Pitombo, Ronaldo Nogueira
TI The Influence of Freezing Rates on Bovine Pericardium Tissue
   Freeze-Drying
SO BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY
LA English
DT Article
DE Freeze-drying; freezing; bovine pericardium
ID SECONDARY STRUCTURE; RAMAN-SPECTROSCOPY; PORE STRUCTURE; COLLAGEN;
   LYOPHILIZATION; SCAFFOLDS; WATER; HYDRATION; PROTEINS; OPTIMIZE
AB The bovine pericardium has been used as biomaterial in developing bioprostheses. Freeze-drying is a drying process that could be used for heart valve's preservation. The maintenance of the characteristics of the biomaterial is important for a good heart valve performance. This paper describes the initial step in the development of a bovine pericardium tissue freeze-drying to be used in heart valves. Freeze-drying involves three steps: freezing, primary drying and secondary drying. The freezing step influences the ice crystal size and, consequently, the primary and secondary drying stages. The aim of this work was to investigate the influence of freezing rates on the bovine pericardium tissue freeze-drying parameters. The glass transition temperature and the structural behavior of the lyophilized tissues were determined as also primary and secondary drying time. The slow freezing with thermal treatment presented better results than the other freeze-drying protocols.
C1 [Borgognoni, Camila Figueiredo; Tattini Junior, Virgilio; Irene Bartolomeu Ayrosa, Ana Maria; Polakiewicz, Bronislaw; de Moraes Pitombo, Ronaldo Nogueira] Univ Sao Paulo, Fac Ciencias Farmaceut, BR-05315970 Sao Paulo, Brazil.
   [Leirner, Adolfo Alberto; Shiotsu Maizato, Marina Junko] Fac Med Sao Paulo, Inst Coracao, Sao Paulo, Brazil.
   [Higa, Olga Zazuco] IPEN CNEN SP, Sao Paulo, Brazil.
   [Beppu, Marisa Masumi] Univ Estadual Campinas, Fac Engn Quim, Campinas, SP, Brazil.
RP Pitombo, RND (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut, BR-05315970 Sao Paulo, Brazil.
EM pitombo@usp.br
RI BEPPU, MARISA/E-1057-2012; Borgognoni, Camila/E-4468-2012
FU FAPESP (The State of Sao Paulo Research Foundation); CNPq (The National
   Council for Scientific and Technological Development)
FX The authors are grateful to FAPESP (The State of Sao Paulo Research
   Foundation) and to CNPq (The National Council for Scientific and
   Technological Development) for the financial support.
CR Abdelwahed W, 2006, INT J PHARM, V324, P74, DOI 10.1016/j.ijpharm.2006.06.047
   Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Biazus JPM, 2005, BRAZ ARCH BIOL TECHN, V48, P185, DOI 10.1590/S1516-89132005000400023
   BUSSIAN BM, 1989, BIOCHEMISTRY-US, V28, P4271, DOI 10.1021/bi00436a023
   Buttafoco L, 2006, J BIOMED MATER RES B, V77B, P357, DOI 10.1002/jbm.b.30444
   Chaikof EL, 2007, NEW ENGL J MED, V357, P1368, DOI 10.1056/NEJMp078175
   CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C
   Costantino HR, 1996, J PHARM SCI, V85, P1290, DOI 10.1021/js960148+
   Curtil A, 1997, CRYOBIOLOGY, V34, P13, DOI 10.1006/cryo.1996.1982
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Faraj KA, 2007, TISSUE ENG, V13, P2387, DOI 10.1089/ten.2006.0320
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   Gniadecka M, 1998, J INVEST DERMATOL, V111, P1129, DOI 10.1046/j.1523-1747.1998.00430.x
   GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969
   Hawe A, 2006, EUR J PHARM BIOPHARM, V64, P316, DOI 10.1016/j.ejpb.2006.06.002
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   Jastrzebska M, 2003, J RAMAN SPECTROSC, V34, P424, DOI 10.1002/jrs.1016
   Jennings T.A., 1999, LYOPHILIZATION INTRO
   Leikin S, 1997, P NATL ACAD SCI USA, V94, P11312, DOI 10.1073/pnas.94.21.11312
   LEVINE H, 1988, CRYO-LETT, V9, P21
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Mellemkjaer L, 2006, EPIDEMIOLOGY, V17, P668, DOI 10.1097/01.ede.0000239651.06579.a4
   Nail SL, 2002, DEV MANUFACTURE PROT, P281
   NAIMARK WA, 1992, AM J PHYSIOL-HEART C, V262, pH1095
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   PATAPOFF TW, 2002, BIOPHARM, V3, P16
   PIKAL MJ, 1990, INT J PHARM, V62, P165, DOI 10.1016/0378-5173(90)90231-R
   PRESTRELSKI SJ, 1993, BIOPHYS J, V65, P661, DOI 10.1016/S0006-3495(93)81120-2
   Searles JA, 2001, J PHARM SCI, V90, P872, DOI 10.1002/jps.1040
   SPIRO TG, 1988, BIOL APPL RAMAN SPEC, V2
   WALTON AG, 1970, CALC TISS RES, V6, P162, DOI 10.1007/BF02196195
   WEBSTER DA, 1983, CLIN ORTHOP RELAT R, P301
NR 32
TC 9
Z9 9
U1 0
U2 13
PU INST TECNOLOGIA PARANA
PI CURITIBA-PARANA
PA RUA PROF ALGACYR MUNHOZ MADER 3775-CIC, 81350-010 CURITIBA-PARANA,
   BRAZIL
SN 1516-8913
J9 BRAZ ARCH BIOL TECHN
JI Braz. Arch. Biol. Technol.
PD NOV-DEC
PY 2009
VL 52
IS 6
BP 1493
EP 1504
DI 10.1590/S1516-89132009000600021
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 542YR
UT WOS:000273535800021
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Bansiwal, A
   Thakre, D
   Labhshetwar, N
   Meshram, S
   Rayalu, S
AF Bansiwal, Amit
   Thakre, Dilip
   Labhshetwar, Nitin
   Meshram, Siddharth
   Rayalu, Sadhana
TI Fluoride removal using lanthanum incorporated chitosan beads
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Fluoride removal; Chitosan beads; Thermodynamic parameter; Mechanism;
   Adsorption isotherm; Kinetic
ID DRINKING-WATER; AQUEOUS-SOLUTION; ADSORPTION; DEFLUORIDATION; KINETICS;
   EQUILIBRIUM; ADSORBENT; FLUOROSIS; SORPTION; ALUMINA
AB Highly selective material based on naturally occurring biomaterial namely chitosan has been designed for the defluoridation of water. Lanthanum incorporated chitosan beads (LCB) were prepared using precipitation method. The synthesis was optimized by varying different synthesis parameters namely lanthanum loading, complexation and precipitation time, strength of ammonia solution used for precipitation, drying time. etc. Lanthanum incorporated chitosan beads were characterized using SEM, FTIR, XRD and EDX. Surface area of LCB was observed to be 2.76 m(2) g(-1). The equilibrium adsorption data fitted well to Langmuir adsorption isotherm and showing maximum fluoride adsorption capacity of 4.7 mg g(-1) with negligible lanthanum release. Kinetic study reveals that adsorption of fluoride is fast and follows pseudo-first-order kinetics. The effect of pH was also studied and the best efficiency was observed at pH 5. Presence of sulphate, nitrate and chloride marginally affected the removal efficiency, however drastic reduction in fluoride uptake was observed in the presence of carbonate and bicarbonate. Negative value of change in free energy (Delta G degrees) and positive value of change in entropy (Delta S degrees) suggest the adsorption of fluoride by LCB is feasible and spontaneous process. Positive value of change in enthalpy (Delta H degrees) suggests the process of fluoride adsorption is endothermic in nature. Regeneration study reveals that I M ammonium chloride solution appears to be the promising regeneration media showing 81.22% regeneration. The adsorption capacity of LCB was similar in fluoride-contaminated ground water collected from Dhar district of Madhya Pradesh, India, as compared to simulated water. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Rayalu, Sadhana] Natl Environm Engn Res Inst, Environm Mat Unit, Nagpur 440020, Maharashtra, India.
   [Meshram, Siddharth] RTM Nagpur Univ, Laxminarayan Inst Technol, Dept Chem, Nagpur, Maharashtra, India.
RP Rayalu, S (reprint author), Natl Environm Engn Res Inst, Environm Mat Unit, Nehru Marg, Nagpur 440020, Maharashtra, India.
EM s_rayalu@neeri.res.in
FU CSIR, New Delhi; UNIECF Bhopal, India
FX Authors thankfully acknowledge CSIR, New Delhi for granting SRF to carry
   out the research work and constant support and guidance of Dr. T.
   Chakrabarty, Director NEERI. Financial assistance from UNIECF Bhopal,
   India for this work is gratefully acknowledged.
CR Annouar S, 2004, DESALINATION, V165, P437, DOI 10.1016/j.desal.2004.06.049
   Ayoob S, 2008, CHEM ENG J, V140, P6, DOI 10.1016/j.cej.2007.08.029
   Ayoob S, 2006, CRIT REV ENV SCI TEC, V36, P433, DOI 10.1080/10643380600678112
   Berger D, 2003, J OPTOELECTRON ADV M, V5, P719
   Chidambaram S, 2003, WATER SA, V29, P339
   Chubar NI, 2005, J COLLOID INTERF SCI, V291, P67, DOI 10.1016/j.jcis.2005.04.086
   Coetzee PP, 2003, WATER SA, V29, P331
   Fan X, 2003, WATER RES, V37, P4929, DOI 10.1016/j.watres.2003.08.014
   Ghorai S, 2005, SEP PURIF TECHNOL, V42, P265, DOI 10.1016/j.seppur.2004.09.001
   IS Drinking Water, 1991, 10500 IS
   Jagtap S, 2009, J COLLOID INTERF SCI, V332, P280, DOI 10.1016/j.jcis.2008.11.080
   Kamble SP, 2007, CHEM ENG J, V129, P173, DOI 10.1016/j.cej.2006.10.032
   KHAN AA, 1987, COLLOID SURFACE, V24, P33, DOI 10.1016/0166-6622(87)80259-7
   Lhassani A, 2001, WATER RES, V35, P3260, DOI 10.1016/S0043-1354(01)00020-3
   Ma W, 2007, J HAZARD MATER, V143, P296, DOI 10.1016/j.jhazmat.2006.09.032
   Meenakshi S, 2008, J HAZARD MATER, V153, P164, DOI 10.1016/j.jhazmat.2007.08.031
   Meenakshi S, 2007, J COLLOID INTERF SCI, V308, P438, DOI 10.1016/j.jcis.2006.12.032
   Mjengera H, 2003, PHYS CHEM EARTH, V28, P1097, DOI 10.1016/j.pce.2003.08.030
   Mohapatra D, 2004, J COLLOID INTERF SCI, V275, P355, DOI 10.1016/j.jcis.2004.02.051
   NAN L, 2005, SEP PURIF TECHNOL, V42, P235
   Nawlakhe W.G., 1975, INDIAN J ENV HLTH, V17, P26
   Onyango MS, 2004, J COLLOID INTERF SCI, V279, P341, DOI 10.1016/j.jcis.2004.06.038
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Ramos RL, 1999, CARBON, V37, P609, DOI 10.1016/S0008-6223(98)00231-0
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Sarkar M, 2006, J COLLOID INTERF SCI, V302, P432, DOI 10.1016/j.jcis.2006.07.001
   Shen F, 2003, CHEM ENG SCI, V58, P987, DOI 10.1016/S0009-2509(02)00639-5
   Susheela AK, 1999, CURR SCI INDIA, V77, P1250
   TEOTIA SPS, 1981, FLUORIDE, V14, P69
   Tor A, 2006, DESALINATION, V201, P267, DOI 10.1016/j.desal.2006.06.003
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   WHO, 1993, GUID DRINK WAT QUAL
   Yadav AK, 2006, J HAZARD MATER, V128, P289, DOI 10.1016/j.jhazmat.2005.08.006
NR 33
TC 78
Z9 87
U1 3
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2009
VL 74
IS 1
BP 216
EP 224
DI 10.1016/j.colsurfb.2009.07.021
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 514CM
UT WOS:000271371300032
PM 19699619
DA 2018-10-20
ER

PT J
AU Coutinho, E
   Jarmar, T
   Svahn, F
   Neves, AA
   Verlinden, B
   Van Meerbeek, B
   Engqvist, H
AF Coutinho, E.
   Jarmar, T.
   Svahn, F.
   Neves, A. A.
   Verlinden, B.
   Van Meerbeek, B.
   Engqvist, H.
TI Ultrastructural characterization of tooth-biomaterial interfaces
   prepared with broad and focused ion beams
SO DENTAL MATERIALS
LA English
DT Article
DE FIB; BIB; Adhesion; Dental; Dentin; Enamel; TEM; Glass-ionomer; 3-Step
   etch-and-rinse; 2-Step self-etch
ID TRANSMISSION ELECTRON-MICROSCOPY; RESIN-DENTIN INTERFACES; GLASS-IONOMER
   CEMENTS; SELF-ETCH ADHESIVE; BOND STRENGTH; MOIST DENTIN; TEM; IMPLANTS;
   SYSTEMS
AB Current available techniques for transmission electron microscopy (TEM) of tooth biomaterial interfaces are mostly ineffective for brittle phases and impair integrated chemical and morphological characterization.
   Objectives. The aims of this study were (1) to determine the applicability of new focused ion beam (FIB) and broad ion beam (BIB) techniques for TEM preparation of tooth-biomaterial interfaces; (2) to characterize the interfacial interaction with enamel and dentin of a conventional glass-ionomer (Chem. l Superior, DeTrey Dentsply, Germany), a 2-step self-etch (Clear. l SE, Kuraray, Japan) and a 3-step etch-and-rinse (OptiBond FL, Kerr, USA) adhesives; and (3) to characterize clinically relevant interfaces obtained from actual Class-I cavities.
   Methods. After bonding to freshly extracted human third molars, non-demineralized and non-stained sections were obtained using the FIB/BIB techniques and examined under TEM.
   Results. The main structures generally disclosed in conventional ultramicrotomy samples were recognized in FIB/BIB-based ones. There were not any major differences between FIB and BIB concerning the resulting ultrastructural morphology. FIB/BIB-sections enabled to clearly resolve sub-micron hydroxyapatite crystals on top of hard tissues and the interface between matrix and filler in all materials, even at nano-scale. Some investigated interfaces disclosed areas with a distinct "fog" or "melted look", which is probably an artifact due to surface damage caused by the high-energy beam. Interfaces with enamel clearly disclosed the distinct "keyhole" shape of enamel rods sectioned at 90 degrees, delimited by a thin electron-lucent layer of inter-rod enamel. At regions where enamel crystals ran parallel with the interface, we observed a lack of interaction and some de-bonding along with interfacial void formation.
   Significance. The FIB/BIB methods are viable and reliable alternatives to conventional ultramicrotomy for preparation of thin sections of brittle and thus difficult to cut biomaterial-hard tissue interfaces. They disclose additional ultrastructural information about both substrates and are more suitable for advanced analytic procedures. (C) 2009 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Coutinho, E.; Neves, A. A.; Van Meerbeek, B.] Catholic Univ Louvain, Sch Dent Oral Pathol & Maxillofacial Surg, Dept Conservat Dent, Leuven BIOMAT Res Cluster, B-3000 Louvain, Belgium.
   [Jarmar, T.; Svahn, F.; Engqvist, H.] Uppsala Univ, Dept Mat Sci & Engn, Uppsala, Sweden.
   [Verlinden, B.] Catholic Univ Louvain, Dept Mat Sci & Engn, B-3000 Louvain, Belgium.
RP Van Meerbeek, B (reprint author), Catholic Univ Louvain, Sch Dent Oral Pathol & Maxillofacial Surg, Dept Conservat Dent, Leuven BIOMAT Res Cluster, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
EM bart.vanmeerbeek@med.kuleuven.be
RI Neves, Aline/A-2593-2009; Coutinho, Eduardo/E-6765-2013
OI Neves, Aline/0000-0002-6049-0588; Engqvist, Hakan/0000-0001-9529-650X
FU KULeuven [OT/06/55]; Research Foundation-Flanders (FWO) [G.0206.07];
   Toshio Nakao Chair for Adhesive Dentistry; Goran Gustafsson Foundation
   for Academic Research (Uppsala University); CAPES Foundation
FX This study was supported by the KULeuven (OT/06/55), the Research
   Foundation-Flanders (FWO G.0206.07), the Toshio Nakao Chair for Adhesive
   Dentistry, the Goran Gustafsson Foundation for Academic Research
   (Uppsala University), and CAPES Foundation. We would also like to thank
   Dominique Crombez and Luk Boon for extensive technical support, as well
   as, Dentsply and Kerr for the generous donation of materials.
CR Botton GA, 1999, MICRON, V30, P109, DOI 10.1016/S0968-4328(99)00014-1
   Carvalho R M, 2000, J Adhes Dent, V2, P251
   Coutinho E, 2007, J DENT RES, V86, P656, DOI 10.1177/154405910708600714
   Coutinho E, 2006, J DENT RES, V85, P349, DOI 10.1177/154405910608500413
   Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Engqvist H, 2008, J MATER SCI-MATER M, V19, P467, DOI 10.1007/s10856-006-0042-9
   Giannuzzi L. A., 2004, INTRO FOCUSED ION BE
   Giannuzzi LA, 2007, J ORAL MAXIL SURG, V65, P737, DOI 10.1016/j.joms.2006.10.025
   HAYASHI Y, 1998, P SCANNING, V20, P234
   Hoshi K, 2001, J MICROSC-OXFORD, V201, P44, DOI 10.1046/j.1365-2818.2001.00784.x
   Jarmar T, 2008, CLIN IMPLANT DENT R, V10, P11, DOI 10.1111/j.1708-8208.2007.00056.x
   Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856
   JESIOR JC, 1989, SCANNING MICROSCOPY, P147
   JESIOR JC, 1989, SCANNING MICROSCOPY, V3, P152
   Koshiro K, 2006, J BIOMED MATER RES B, V77B, P401, DOI 10.1002/jbm.b.30450
   McCaffrey JP, 2001, ULTRAMICROSCOPY, V87, P97, DOI 10.1016/S0304-3991(00)00096-6
   Mjor IA, 2002, OPER DENT, V27, P528
   Nakabayashi N, 1992, Quintessence Int, V23, P135
   Nakabayashi N, 1998, HYBRIDIZATION DENT H
   Ogata M, 2001, OPER DENT, V26, P27
   Pashley DH, 2004, J ADHES DENT, V6, P263
   PERDIGAO J, 1995, J BIOMED MATER RES, V29, P1111, DOI 10.1002/jbm.820290911
   Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003
   Phaneuf MW, 1999, MICRON, V30, P277, DOI 10.1016/S0968-4328(99)00012-8
   POCIUS AV, 1996, ADHESION ADHESIVES T
   Reis AF, 2007, DENT MATER, V23, P1164, DOI 10.1016/j.dental.2006.10.006
   Shirai K, 2005, DENT MATER, V21, P110, DOI 10.1016/j.dental.2004.01.003
   Tay F R, 2001, J Adhes Dent, V3, P153
   Tay FR, 2003, J ADHES DENT, V5, P91
   Ten Cate AR, 1998, ORAL HISTOLOGY DEV S
   van Dijken JWV, 2008, DENT MATER, V24, P915, DOI 10.1016/j.dental.2007.11.008
   Van Landuyt KL, 2006, J DENT, V34, P77, DOI 10.1016/j.jdent.2005.04.001
   Van Meerbeek B, 2003, OPER DENT, V28, P215
   Van Meerbeek B, 2000, AM J DENT, V13, p3D
   Van Meerbeek B, 1998, J DENT RES, V77, P50, DOI 10.1177/00220345980770010501
   VanMeerbeek B, 1997, J BIOMED MATER RES, V35, P191, DOI 10.1002/(SICI)1097-4636(199705)35:2<191::AID-JBM7>3.0.CO;2-I
   VANMEERBEEK B, 1995, DENT MATER, V11, P87, DOI 10.1016/0109-5641(95)80039-5
   VanMeerbeek B, 1996, J DENT RES, V75, P879, DOI 10.1177/00220345960750030401
   Williams D. B., 1996, TRANSMISSION ELECT M
   Yasuhara A., 2005, JEOL NEWS, V40, P46
   Yiu CKY, 2004, J DENT RES, V83, P283, DOI 10.1177/154405910408300403
   Yiu CKY, 2004, J DENT, V32, P521, DOI 10.1016/j.jdent.2004.04.005
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
NR 45
TC 15
Z9 15
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD NOV
PY 2009
VL 25
IS 11
BP 1325
EP 1337
DI 10.1016/j.dental.2009.06.002
PG 13
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 515LI
UT WOS:000271471600004
PM 19596422
DA 2018-10-20
ER

PT J
AU Wang, YB
   Li, HF
   Cheng, Y
   Wei, SC
   Zheng, YF
AF Wang, Y. B.
   Li, H. F.
   Cheng, Y.
   Wei, S. C.
   Zheng, Y. F.
TI Corrosion performances of a Nickel-free Fe-based bulk metallic glass in
   simulated body fluids
SO ELECTROCHEMISTRY COMMUNICATIONS
LA English
DT Article
DE Bulk metallic glass; Fe(41)Co(7)Cr(15)Mo(14)C(15)B(6)Y(2) BMG;
   Corrosion; Electrochemical characterization
ID STAINLESS-STEEL; TITANIUM; ALLOYS; BEHAVIOR; RESISTANCE; RELEASE; CR
AB The corrosion performance of a Nickel-free Fe-based bulk metallic glass (BMG). Fe(41)Co(7)Cr(15)Mo(14)C(15)B(6)Y(2) alloy, in Hank's solution with pH value 7.4 and artificial saliva solution with pH value 6.3, was investigated by electrochemical techniques, aiming to assess the feasibility of Fe-based BMG as potential biomaterial. It was found that Fe(41)Co(7)Cr(15)Mo(14)C(15)B(6)Y(2) BMG shows superior corrosion resistance in both simulated body fluids (SBF). The EIS analysis and cyclic polarization measurements indicated that the Fe(41)Co(7)Cr(15)Mo(14)C(15)B(6)Y(2) BMG has larger polarization resistance value than that of 316L SS. The pitting corrosion potentials of Fe(41)Co(7)Cr(15)Mo(14)C(15)B(6)Y(2) BMG are much higher than that of the 316L SS, resulting in very few ions releasing into the SBFs while a significant amount of Ni and Fe ions release was found for 316L SS under the same condition. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Wang, Y. B.; Li, H. F.; Zheng, Y. F.] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Wang, Y. B.; Li, H. F.; Zheng, Y. F.] Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
   [Cheng, Y.; Wei, S. C.; Zheng, Y. F.] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Wang, Yanbo/E-8046-2010; BAI,
   JIE/D-7448-2016; Li, Huafang/D-5486-2013
OI Zheng, Yufeng/0000-0002-7402-9979; Wang, Yanbo/0000-0002-3184-4201; 
FU National Natural Science Foundation of China [30770580]; National Key
   Scientific Program - Nanoscience and Nanotechnology [2007C13936103];
   Program for New Century Excellent Talents in University [NCET-07-0033]
FX This work was supported by the National Natural Science Foundation of
   China (No. 30770580), the National Key Scientific Program - Nanoscience
   and Nanotechnology (No. 2007C13936103) and Program for New Century
   Excellent Talents in University (NCET-07-0033).
CR Assis SL, 2005, J BIOMED MATER RES B, V73B, P109, DOI 10.1002/jbm.b.30205
   Chang E, 2002, BIOMATERIALS, V23, P2917, DOI 10.1016/S0142-9612(01)00420-3
   Fathi MH, 2003, DENT MATER, V19, P188, DOI 10.1016/S0109-5641(02)00029-5
   Gioka C, 2004, DENT MATER, V20, P693, DOI 10.1016/j.dental.2004.02.008
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Hodgson AWE, 2002, ELECTROCHIM ACTA, V47, P1913, DOI 10.1016/S0013-4686(02)00029-4
   Huang YZ, 2005, ELECTROCHIM ACTA, V51, P1099, DOI 10.1016/j.electacta.2005.05.051
   Lekatou A, 2009, J ALLOY COMPD, V483, P514, DOI 10.1016/j.jallcom.2008.07.217
   Long ZL, 2008, J ALLOY COMPD, V462, P52, DOI 10.1016/j.jallcom.2007.07.117
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   Reclaru L, 2008, ACTA BIOMATER, V4, P680, DOI 10.1016/j.actbio.2007.10.008
   Schroers J, 2009, JOM-US, V61, P21, DOI 10.1007/s11837-009-0128-1
   Shen J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1897426
   Shim HM, 2005, J BIOMED MATER RES B, V73B, P252, DOI 10.1002/jbm.b.30206
   Shukla AK, 2005, INTERMETALLICS, V13, P631, DOI 10.1016/j.intermet.2004.10.001
   Wang SL, 2009, MATER CHEM PHYS, V113, P878, DOI 10.1016/j.matchemphys.2008.08.057
NR 16
TC 27
Z9 28
U1 1
U2 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1388-2481
J9 ELECTROCHEM COMMUN
JI Electrochem. Commun.
PD NOV
PY 2009
VL 11
IS 11
BP 2187
EP 2190
DI 10.1016/j.elecom.2009.09.027
PG 4
WC Electrochemistry
SC Electrochemistry
GA 524AG
UT WOS:000272115600029
DA 2018-10-20
ER

PT J
AU Sergent, F
   Desilles, N
   Lacoume, Y
   Bunel, C
   Marie, JP
   Marpeau, L
AF Sergent, Fabrice
   Desilles, Nicolas
   Lacoume, Yann
   Bunel, Claude
   Marie, Jean-Paul
   Marpeau, Loic
TI Mechanical evaluation of synthetic biomaterials used in the correction
   of pelvic floor disorders-Experimental study in rabbits
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE Biomechanical properties; Pelvic organ prolapse; Polyester prosthesis;
   Polypropylene prosthesis; Rabbit model
ID POLYPROPYLENE-MESH; HERNIA MODEL; IN-VIVO; REPAIR; PROLAPSE; TRIAL; RATS
AB Objective: To evaluate the biomechanical properties of the principal prosthetic materials currently used in genital prolapse surgery.
   Study design: Based on an animal model of incisional abdominal hernia, 40 adult rabbits were implanted. Four 2.5 cm x 2.5cm parietal defects, were created in the abdominal fascia and muscles while respecting the peritoneum. For each rabbit, the defect was repaired by four different large pore size prostheses which varied according to the material used: two with monofilament of heavy (75 g/m(2)) or low (38 g/m(2)) weight polypropylene (PP), and two with multifilament of heavy (115 g/m(2)) or low (59 g/m(2)) weight polyethylene-terephthalate (PET). Animals were sacrificed in groups of 10 after 14, 30, 90 and 180 days to evaluate contraction, solidity and elasticity of the prostheses.
   Results: PP and PET retracted, independently of their weight, in 81.25% and 20% respectively. Intensity of contraction was not predictable but median value of retracted surface was 14% with PP, none with PET. Contraction settled quickly after tissue integration and did not subsequently occur. Heavyweight PET was considered the most solid material (70 N cm(-1)), low-weight PP the most fragile (20 N cm(-1)). Heavy forms of PP or PET resisted better to the rupture than the light forms which were sometimes insufficient to resist the extreme values of the human abdominal pressure (16 N cm(-1)). PP was more flexible than PET, but PET was the only form which was able to support extreme values of the abdominal pressure and remain in the elastic range. Duration of implantation did not modify solidity or elasticity of the prostheses.
   Conclusion: In our abdominal rabbit model, as regards mechanical properties, heavyweight PET seems to be the optimal biomaterial. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Sergent, Fabrice; Marpeau, Loic] CHU Hop Rouen, Clin Gynecol & Obstet, F-76031 Rouen, France.
   [Sergent, Fabrice; Desilles, Nicolas; Bunel, Claude] CNRS, FRE 3101, INSA ROUEN, F-76131 Mont St Aignan, France.
   [Sergent, Fabrice; Lacoume, Yann; Marie, Jean-Paul] Fac Med Pharm Rouen, UPRES EA GRHV 3830, Chirurg Expt Lab, F-76183 Rouen, France.
RP Sergent, F (reprint author), Rouen Univ Hosp, Dept Obstet & Gynecol, Pavillon Femme Mere Enfant,1 Rue Germont, F-76031 Rouen, France.
EM Fabrice.Sergent@chu-rouen.fr
CR Alponat A, 1997, AM SURGEON, V63, P818
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   CLAERHOUT F, 2003, NEUROUROL URODYNAM, V5, P516
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   De Ridder D, 2008, CURR OPIN UROL, V18, P377, DOI 10.1097/MOU.0b013e3282fceaae
   Debodinance P, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P527
   DEPREST J, 2006, INT UROGYNECOL J PEL, V17, P16
   Gauruder-Burmester A, 2007, INT UROGYNECOL J, V18, P1059, DOI 10.1007/s00192-006-0291-7
   Gonzalez R, 2005, WORLD J SURG, V29, P1038, DOI 10.1007/s00268-005-7786-0
   Klinge U, 1998, EUR J SURG, V164, P965
   Klosterhalfen B, 1998, BIOMATERIALS, V19, P2235, DOI 10.1016/S0142-9612(98)00115-X
   Konstantinovic ML, 2007, INT UROGYNECOL J, V18, P619, DOI 10.1007/s00192-006-0202-y
   Mathe ML, 2007, GYNECOL OBSTET FERTI, V35, P398, DOI 10.1016/j.gyobfe.2007.02.024
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Sand PK, 2001, AM J OBSTET GYNECOL, V184, P1357, DOI 10.1067/mob.2001.115118
NR 15
TC 8
Z9 9
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0301-2115
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD NOV
PY 2009
VL 147
IS 1
BP 106
EP 110
DI 10.1016/j.ejogrb.2009.07.019
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 520OE
UT WOS:000271854000024
PM 19709796
DA 2018-10-20
ER

PT J
AU Yang, XL
   Li, XD
AF Yang, Xinlin
   Li, Xudong
TI Nucleus pulposus tissue engineering: a brief review
SO EUROPEAN SPINE JOURNAL
LA English
DT Review
DE Nucleus pulposus; Intervertebral disc degeneration; Tissue engineering;
   Review
ID INTERVERTEBRAL DISC CELLS; MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC
   PROTEIN-2; FIBROBLAST GROWTH FACTOR-2; IN-VITRO; DIFFERENTIATION
   FACTOR-5; DEGENERATION MODEL; CONTROLLED-RELEASE; FACTOR-BETA; BACK-PAIN
AB Symptomatic intervertebral disc degeneration is associated with several spinal diseases, which cause losses of life quality and money. Tissue engineering provides a promising approach to recover the functionality of the degenerative intervertebral disc. Most studies are directed toward nucleus pulposus (NP) tissue engineering because disc degeneration is believed to originate in NP region, and considerable progress has been made in the past decade. Before this important technique is utilized for clinical treatment of disc degeneration, many challenges need to address including in all three principal components of tissue engineering, i.e., seed cells, signals and biomaterial scaffolds. This article briefly gives certain aspects of state of the art in this field, as well as pays a little more attention to our work published in the past 5 years, on growth and differentiation factor-5 (GDF-5), adipose-derived stem cells (ADSCs) and heparin functionalization of scaffold. We suggest that combinatorial application of ADSCs, GDF-5, heparin functionalization and injectable hydrogels will be advantageous in NP tissue engineering.
C1 [Yang, Xinlin; Li, Xudong] Univ Virginia, Sch Med, Dept Orthopaed Surg, Charlottesville, VA 22908 USA.
   [Yang, Xinlin] Beijing Inst Technol, Sch Life Sci & Technol, Beijing 100081, Peoples R China.
RP Yang, XL (reprint author), Univ Virginia, Sch Med, Dept Orthopaed Surg, Charlottesville, VA 22908 USA.
EM xy3c@virginia.edu
CR Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005
   Bader RA, 2008, J BIOMED MATER RES A, V86A, P494, DOI 10.1002/jbm.a.31637
   Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012
   Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x
   Boyd LM, 2006, EUR SPINE J, V15, pS414, DOI 10.1007/s00586-006-0172-2
   Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   CHOU AI, 2008, J BIOMED MAT RES A
   Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86
   Cui M, 2008, SPINE J, V8, P287, DOI 10.1016/j.spinee.2007.05.012
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u
   Feng G, 2008, GROWTH FACTORS, V26, P132, DOI 10.1080/08977190802105917
   Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166
   Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105
   Gaetani P, 2008, TISSUE ENG PT A, V14, P1415, DOI 10.1089/ten.tea.2007.0330
   Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006
   Gruber HE, 2000, SPINE, V25, P2153, DOI 10.1097/00007632-200009010-00002
   Haefeli M, 2006, SPINE, V31, P1522, DOI 10.1097/01.brs.0000222032.52336.8e
   Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584
   Huang KY, 2007, SPINE, V32, P1174, DOI 10.1097/01.brs.0000263369.95182.19
   Jandial Rahul, 2008, Neurosurg Focus, V24, pE21, DOI 10.3171/FOC/2008/24/3-4/E20
   Joung YK, 2008, EXPERT OPIN DRUG DEL, V5, P1173, DOI 10.1517/17425240802431811 
   Kandel R, 2008, EUR SPINE J, V17, pS480, DOI 10.1007/s00586-008-0746-2
   KAWAKITA K, 2005, JAM, V1, P1
   Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y
   Li J, 2009, COLLOID SURFACE B, V70, P15, DOI 10.1016/j.colsurfb.2008.12.001
   Li XD, 2005, CONNECT TISSUE RES, V46, P75, DOI 10.1080/03008200590954104
   Li XD, 2004, SPINE, V29, P2229, DOI 10.1097/01.brs.0000142427.82605.fb
   Lu ZF, 2007, BIOCHEM BIOPH RES CO, V359, P991, DOI 10.1016/j.bbrc.2007.06.002
   Lu ZF, 2008, J CELL MOL MED, V12, P2812, DOI 10.1111/j.1582-4934.2008.00278.x
   Luo XL, 2006, MACROMOL BIOSCI, V6, P373, DOI 10.1002/mabi.200500236
   Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b
   Matsunaga S, 2003, J NEUROSURG, V98, P63, DOI 10.3171/spi.2003.98.1.0063
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Nair LS, 2007, BIOMACROMOLECULES, V8, P3779, DOI 10.1021/bm7006967
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   Nomura T, 2001, CLIN ORTHOP RELAT R, P94
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Okuda S, 2001, SPINE, V26, P2421, DOI 10.1097/00007632-200111150-00005
   Paesold G, 2007, EUR SPINE J, V16, P447, DOI 10.1007/s00586-006-0220-y
   Phillips FM, 2003, SPINE, V28, pS99, DOI 10.1097/00007632-200308011-00017
   Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Sive J. I., 2002, Molecular Pathology, V55, P91, DOI 10.1136/mp.55.2.91
   Slade SC, 2007, J MANIP PHYSIOL THER, V30, P301, DOI 10.1016/j.jmpt.2007.03.010
   Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011
   Specchia N, 2002, EUR SPINE J, V11, P145, DOI 10.1007/s00586-001-0361-y
   Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107
   Takada T, 2002, SPINE, V27, P1526, DOI 10.1097/01.BRS.0000018955.10564.3B
   Tapp H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2473
   Tapp H, 2009, EXP BIOL MED, V234, P1, DOI [10.3181/0805-MR-170, 10.3181/0805/MR-170]
   Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1
   Vadala G, 2008, SPINE J, V8, P804, DOI 10.1016/j.spinee.2007.07.394
   Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F
   Wei AQ, 2008, SPINE J, V8, P466, DOI 10.1016/j.spinee.2007.04.021
   Yamamoto Y, 2004, SPINE, V29, P1508, DOI 10.1097/01.BRS.0000131416.90906.20
NR 64
TC 70
Z9 78
U1 1
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD NOV
PY 2009
VL 18
IS 11
BP 1564
EP 1572
DI 10.1007/s00586-009-1092-8
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 515VW
UT WOS:000271502000003
PM 19603198
OA Green Published
DA 2018-10-20
ER

PT J
AU Levin, B
   Rajkhowa, R
   Redmond, SL
   Atlas, MD
AF Levin, Brett
   Rajkhowa, Rangam
   Redmond, Sharon Leanne
   Atlas, Marcus David
TI Grafts in myringoplasty: utilizing a silk fibroin scaffold as a novel
   device
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; fibroin; graft; myringoplasty; perforation; silk; tissue
   engineering; tympanic membrane
ID TYMPANIC MEMBRANE PERFORATIONS; SUPPURATIVE OTITIS-MEDIA; CEREBRAL
   ARTERIOVENOUS-MALFORMATIONS; NORMAL HUMAN KERATINOCYTES; MESENCHYMAL
   STEM-CELLS; IN-VITRO; CARTILAGE TYMPANOPLASTY; INLAY TYMPANOPLASTY;
   INDUCED ASTHMA; PARS FLACCIDA
AB Chronic perforations of the eardrum or tympanic membrane represent a significant source of morbidity worldwide. Myringoplasty is the operative repair of a perforated tympanic membrane and is a procedure commonly performed by otolaryngologists. Its purpose is to close the tympanic membrane, improve hearing and limit patient susceptibility to middle ear infections. The success rates of the different surgical techniques used to perform a myringoplasty, and the optimal graft materials to achieve complete closure and restore hearing, vary significantly in the literature. A number of autologous tissues, homografts and synthetic materials are described as graft options. With the advent and development of tissue engineering in the last decade, a number of biomaterials have been studied and attempts have been made to mimic biological functions with these materials. Fibroin, a core structural protein in silk from silkworms, has been widely studied with biomedical applications in mind. Several cell types, including keratinocytes, have grown on silk biomaterials, and scaffolds manufactured from silk have successfully been used in wound healing and for tissue engineering purposes. This review focuses on the current available grafts for myringoplasty and their limitations, and examines the biomechanical properties of silk, assessing the potential benefits of a silk fibroin scaffold as a novel device for use as a graft in myringoplasty surgery.
C1 [Levin, Brett] Univ Western Australia, Sir Charles Gairdner Hosp, Ear Sci Inst Australia, Ear Sci Ctr,Sch Surg, Perth, WA 6009, Australia.
   [Rajkhowa, Rangam] Deakin Univ, CMFI, Geelong, Vic 3217, Australia.
   [Redmond, Sharon Leanne; Atlas, Marcus David] Univ Western Australia, Ear Sci Inst Australia, Ear Sci Ctr, Sch Surg, Perth, WA 6009, Australia.
   [Atlas, Marcus David] St John God Hosp, Perth, WA, Australia.
RP Levin, B (reprint author), Univ Western Australia, Queen Elizabeth II Med Ctr, Ear Sci Ctr, Sch Surg, 2nd Floor M Block, Nedlands, WA 6009, Australia.
EM blevin@med.usyd.edu.au
RI Redmond, Sharon/B-8701-2009
OI Eikelboom, Robert/0000-0003-2911-5381
FU Garnett Passe and Rodney Williams Memorial Foundation Surgeon Scientist
   Scholarship
FX Brett Levin is supported by a Garnett Passe and Rodney Williams Memorial
   Foundation Surgeon Scientist Scholarship. The authors have no other
   relevant affiliations or financial involvement with any organization or
   entity with a financial interest in or financial conflict with the
   subject matter or materials discussed in the manuscript apart from those
   disclosed.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Aggarwal R, 2006, J LARYNGOL OTOL, V120, P429, DOI 10.1017/S0022215106000697
   AJULO SO, 1993, CLIN OTOLARYNGOL, V18, P433, DOI 10.1111/j.1365-2273.1993.tb00609.x
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bluestone CD, 1998, INT J PEDIATR OTORHI, V42, P207, DOI 10.1016/S0165-5876(97)00147-X
   Chanvimalueng W, 2000, Ear Nose Throat J, V79, P113
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Chu EA, 2003, OTOL NEUROTOL, V24, P507, DOI 10.1097/00129492-200305000-00026
   Cirillo B, 2004, INT J ARTIF ORGANS, V27, P60
   CORNISH CB, 1968, ARCH OTOLARYNGOL, V88, P350
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Darrow David H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P416, DOI 10.1097/00020840-200312000-00002
   Dehdashti A R, 2001, Neurosurg Focus, V11, pe6
   DELATORRE MC, 2000, ACTA OTORRINOLARINGO, V51, P101
   Dirckx JJJ, 1998, HEARING RES, V118, P35, DOI 10.1016/S0378-5955(98)00025-2
   Dornhoffer J, 2003, LARYNGOSCOPE, V113, P1844, DOI 10.1097/00005537-200311000-00002
   Dornhoffer JL, 2006, OTOLARYNG CLIN N AM, V39, P1161, DOI 10.1016/j.otc.2006.08.006
   Dursun E, 2008, OTOLARYNG HEAD NECK, V138, P353, DOI 10.1016/j.otohns.2008.01.003
   Eavey RD, 1998, LARYNGOSCOPE, V108, P657, DOI 10.1097/00005537-199805000-00006
   Effat KG, 2005, J LARYNGOL OTOL, V119, P611
   El-Hennawi DM, 2001, INT J PEDIATR OTORHI, V59, P1, DOI 10.1016/S0165-5876(01)00414-1
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   FARRIOR JB, 1983, LARYNGOSCOPE, V93, P75
   Fiorino F, 2007, EUR ARCH OTO-RHINO-L, V264, P1125, DOI 10.1007/s00405-007-0323-z
   Freid VM, 1998, VITAL HLTH STAT, V13, P1
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0
   Gerard JM, 2006, B-ENT, V2, P177
   Gerber MJ, 2000, LARYNGOSCOPE, V110, P1994, DOI 10.1097/00005537-200012000-00002
   Ghanem MA, 2006, LARYNGOSCOPE, V116, P1813, DOI 10.1097/01.mlg.0000231742.11048.ed
   Ghassemifar R, 2010, J BIOMATER APPL, V24, P591, DOI 10.1177/0885328209104289
   Gierek Tatiana, 2004, Otolaryngol Pol, V58, P529
   Golz A, 2003, OTOLARYNG HEAD NECK, V128, P565, DOI 10.1016/mhn.2003.132
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   HECK W E, 1961, Laryngoscope, V71, P847
   HENEIN RR, 1980, J LARYNGOL OTOL, V94, P1005, DOI 10.1017/S0022215100089775
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   HUTTENBRINK K, 2004, CURRENT TOPICS OTOLA
   Inwood JL, 2003, CLIN OTOLARYNGOL, V28, P396, DOI 10.1046/j.1365-2273.2003.00716.x
   Jelinek R, 1967, Cesk Otolaryngol, V16, P362
   Jiang Ying, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P560
   KANGSANARAK J, 1993, J LARYNGOL OTOL, V107, P999
   Karela M, 2008, EUR ARCH OTO-RHINO-L, V265, P1039, DOI 10.1007/s00405-007-0570-z
   Kartush JM, 2002, LARYNGOSCOPE, V112, P802, DOI 10.1097/00005537-200205000-00007
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon H, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034115
   Landsberg R, 2006, J OTOLARYNGOL, V35, P44, DOI 10.2310/7070.2005.4124
   Levin B, 2010, OTOLARYNG HEAD NECK, V142, pS33, DOI 10.1016/j.otohns.2009.06.746
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu HF, 2007, J BIOMED MATER RES B, V82B, P129, DOI 10.1002/jbm.b.30714
   LYONS GD, 1977, LARYNGOSCOPE, V87, P1705
   Ma XL, 2006, J BIOMED MATER RES B, V78B, P89, DOI 10.1002/jbm.b.30466
   Mansour MH, 2006, J LARYNGOL OTOL, V120, P952
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Mei N, 2006, J MATER SCI-MATER M, V17, P749, DOI 10.1007/s10856-006-9686-8
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Meinel L, 2008, BONE, V43, P1123, DOI 10.1016/j.bone.2008.08.114
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Mitchell J F, 1967, J Laryngol Otol, V81, P339, DOI 10.1017/S0022215100067141
   Miyoshi T, 1971, Jibiinkoka, V43, P25
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   NAGAI T, 1989, ARCH OTO-RHINO-LARYN, V246, P169, DOI 10.1007/BF00456661
   Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114
   Ni Y, 2008, OTOLARYNG HEAD NECK, V139, P256, DOI 10.1016/j.otohns.2008.03.028
   Nittrouer S, 2005, J COMMUN DISORD, V38, P29, DOI 10.1016/j.jcomdis.2004.03.006
   Osma U, 2000, J LARYNGOL OTOL, V114, P97
   Ozgursoy OB, 2005, J LARYNGOL OTOL, V119, P277
   PACKER P, 1982, J LARYNGOL OTOL, V96, P25, DOI 10.1017/S0022215100092203
   Panda NK, 1996, AM J OTOLARYNG, V17, P391, DOI 10.1016/S0196-0709(96)90072-1
   Park AH, 2006, OTOLARYNG HEAD NECK, V135, P877, DOI 10.1016/j.otohns.2006.02.040
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Puls T, 2003, Acta Otorhinolaryngol Belg, V57, P187
   Raghavan U, 2000, J LARYNGOL OTOL, V114, P174
   Richards S H, 1965, J Laryngol Otol, V79, P952, DOI 10.1017/S0022215100064641
   RINGENBERG JC, 1978, LARYNGOSCOPE, V88, P982, DOI 10.1288/00005537-197806000-00010
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Saadat D, 2001, LARYNGOSCOPE, V111, P181, DOI 10.1097/00005537-200101000-00033
   SALTHOUSE TN, 1980, OTOLARYNG HEAD NECK, V88, P658, DOI 10.1177/019459988008800606
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schmutz F, 1997, AM J NEURORADIOL, V18, P1233
   Schulte DL, 1998, AM J OTOL, V19, P141
   Singh M, 2003, J LARYNGOL OTOL, V117, P444
   Song JK, 2000, J NEUROSURG, V92, P955, DOI 10.3171/jns.2000.92.6.0955
   Spiegel JH, 2005, OTOL NEUROTOL, V26, P563, DOI 10.1097/01.mao.0000169636.63440.4e
   Strasser GM, 2008, LARYNGO RHINO OTOL, V87, P93, DOI 10.1055/s-2007-966890
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Teoh SW, 1997, HEARING RES, V106, P39, DOI 10.1016/S0378-5955(97)00002-6
   Tos M, 2008, OTOLARYNG HEAD NECK, V139, P747, DOI 10.1016/j.otohns.2008.09.021
   Trimis G, 2003, J PAEDIATR CHILD H, V39, P635, DOI 10.1046/j.1440-1754.2003.00251.x
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   URAGODA CG, 1991, J SOC OCCUP MED, V41, P140
   Valenzuela C, 1967, Int Surg, V47, P87
   VARTIAINEN E, 1993, AM J OTOL, V14, P301
   Verhoeff M, 2006, INT J PEDIATR OTORHI, V70, P1, DOI 10.1016/j.ijporl.2005.08.021
   Vorwerk U, 1998, ORL J OTO-RHINO-LARY, V60, P138, DOI 10.1159/000027582
   Vos JD, 2005, LARYNGOSCOPE, V115, P1599, DOI 10.1097/01.mlg.0000172042.73024.ad
   Vovolis V, 1999, ALLERGY ASTHMA PROC, V20, P107, DOI 10.2500/108854199778612626
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   WEN CM, 1990, ANN ALLERGY, V65, P375
   *WHO, GLOB BURD HEAR LOSS
   Williamson PA, 1999, CLIN OTOLARYNGOL, V24, P252, DOI 10.1046/j.1365-2273.1999.00246.x
   World Health Organization, 2004, CHRON SUPP OT MED BU
   Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yetiser S, 2001, OTOLARYNG HEAD NECK, V124, P518, DOI 10.1067/mhn.2001.115058
   Youssef AM, 1999, LARYNGOSCOPE, V109, P1832, DOI 10.1097/00005537-199911000-00020
   Yung M, 2008, J LARYNGOL OTOL, V122, P663, DOI 10.1017/S0022215108001813
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
NR 121
TC 26
Z9 26
U1 1
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2009
VL 6
IS 6
BP 653
EP 664
DI 10.1586/ERD.09.47
PG 12
WC Engineering, Biomedical
SC Engineering
GA 528HC
UT WOS:000272432600013
PM 19911876
DA 2018-10-20
ER

PT J
AU Balzer, BL
   Weiss, SW
AF Balzer, Bonnie L.
   Weiss, Sharon W.
TI Do biomaterials cause implant-associated mesenchymal tumors of the
   breast? Analysis of 8 new cases and review of the literature
SO HUMAN PATHOLOGY
LA English
DT Article
DE Breast implant; Fibromatosis; Biomaterial sarcoma; Silicone
ID DESMOID TUMOR; AGGRESSIVE FIBROMATOSIS; APC GENE; UNITED-STATES;
   BETA-CATENIN; MUTATIONS; CARCINOMA; SARCOMAS; CANCER; RECONSTRUCTION
AB Implant-associated mesenchymal tumors (IAMT) of the breast are rare, and most are fibromatoses. There has been no systematic analysis of IAMT to determine their full histologic spectrum, whether there is an association with implant type or rupture, and if evidence supports a causal or fortuitous relationship between tumor and implant. We, therefore, analyzed all mesenchymal tumors associated with breast implants from our soft tissue consultation database spanning a period from 1989 to 2005. Information regarding location, type, and integrity of implant and its temporal relationship to tumor was recorded. Eight IAMT were identified exclusively in female patients (ages 28-64 years; median, 38 years), all of whom presented with a palpable mass. Tumors developed after placement of either a silicone (n = 7) or saline (n = 1) implant (median, 2 years; range, 1.8-10 years), which was usually inserted for cosmetic purposes (n = 7). All tumors arose in or around the capsule of a grossly intact implant, and in one case, the tumor was confined exclusively to the implant capsule. In patients with silicone implants, silicone granulomas were identified within the capsule and associated neoplasm despite the integrity of the implant. Six cases were fibromatoses; one was a pleomorphic undifferentiated sarcoma; and one was a fibrosarcoma. None of the patients with fibromatosis was known to have familial adenomatous polyposis (FAP) or Gardner syndrome, although one had Poland syndrome (aplasia of the thorax). One patient with a sarcoma had received radiation 10 years previously for breast carcinoma. Six patients were treated with local excision, one with a wide excision, and one patient with fibromatosis was treated with medical therapy. Median follow-up was 3.2 years (range, 1692 months). One of the 5 patients with fibromatosis developed 2 recurrences. Neither of the 2 patients with sarcomas has developed metastasis. No patient has died of disease. We conclude that IAMT comprise 2 distinct groups-fibromatosis and sarcoma. Surgical trauma, perhaps occurring in patients with a predisposition to develop desmoid tumors, could account for fibromatosis in this setting. The causal relationship between implants and sarcomas is difficult to assess given the rarity of these tumors and that some may be radiation induced. However, at present, there is insufficient evidence to claim that they are biomaterial related. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Weiss, Sharon W.] Emory Univ Hosp, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Balzer, Bonnie L.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
RP Weiss, SW (reprint author), Emory Univ Hosp, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
EM sharon.weiss@emoryhealthcare.org
CR Abraham SC, 2002, HUM PATHOL, V33, P39, DOI 10.1053/hupa.2002.30196
   Aharon-Maor Anabel, 1998, Harefuah, V134, P339
   ARON AD, 1996, SURG ONCOL, V5, P93
   BARKER DE, 1978, PLAST RECONSTR SURG, V61, P836, DOI 10.1097/00006534-197861060-00002
   BOGOMOLETZ WV, 1981, J CLIN PATHOL, V34, P30, DOI 10.1136/jcp.34.1.30
   Brinton LA, 1997, J NATL CANCER I, V89, P1341, DOI 10.1093/jnci/89.18.1341
   Brueckl WM, 2005, DIS COLON RECTUM, V48, P1275, DOI 10.1007/s10350-004-0949-5
   CEDERLUND CG, 1984, BRIT J RADIOL, V57, P98, DOI 10.1259/0007-1285-57-673-98
   COOK RR, 1995, J CLIN EPIDEMIOL, V48, P519, DOI 10.1016/0895-4356(94)00208-8
   Couture J, 2000, CLIN GENET, V57, P205, DOI 10.1034/j.1399-0004.2000.570306.x
   CRESTINU JM, 1995, PLAST RECONSTR SURG, V95, P421, DOI 10.1097/00006534-199502000-00040
   Cuesta-Mejias Teresa, 2002, Ginecol Obstet Mex, V70, P76
   DALE PS, 1995, ANN PLAS SURG, V35, P515, DOI 10.1097/00000637-199511000-00012
   Devouassoux-Shisheboran M, 2000, ARCH PATHOL LAB MED, V124, P276
   Eccles DM, 1996, AM J HUM GENET, V59, P1193
   ENGEL A, 1995, J CLIN EPIDEMIOL, V48, P539, DOI 10.1016/0895-4356(94)00210-H
   ENZINGER FM, 1967, CANCER-AM CANCER SOC, V20, P1131, DOI 10.1002/1097-0142(196707)20:7<1131::AID-CNCR2820200716>3.0.CO;2-8
   Fokin AA, 2002, ANN THORAC SURG, V74, P2218, DOI 10.1016/S0003-4975(02)04161-9
   Folpe AL, 2004, AM J SURG PATHOL, V28, P1, DOI 10.1097/00000478-200401000-00001
   Fujita K, 2003, INT J UROL, V10, P274, DOI 10.1046/j.1442-2042.2003.00618.x
   Jandali A R, 2004, Handchir Mikrochir Plast Chir, V36, P343, DOI 10.1055/s-2004-830487
   JENNINGS TA, 1988, CANCER-AM CANCER SOC, V62, P2436, DOI 10.1002/1097-0142(19881201)62:11<2436::AID-CNCR2820621132>3.0.CO;2-J
   JEWITT ST, 1979, PLAST RECONSTR SURG, V63, P577
   Kaplan DB, 1998, AM SURGEON, V64, P388
   Khanfir K, 2003, J CLIN ONCOL, V21, P2216, DOI 10.1200/JCO.2003.04.189
   Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6
   Knudsen A L, 2001, Fam Cancer, V1, P111
   Kobayashi S, 1988, Gan No Rinsho, V34, P467
   Marks M W, 2000, Chest Surg Clin N Am, V10, P341
   MAY DS, 1991, PLAST RECONSTR SURG, V87, P193, DOI 10.1097/00006534-199101000-00045
   NORRIS HJ, 1968, CANCER, V22, P22, DOI 10.1002/1097-0142(196807)22:1<22::AID-CNCR2820220105>3.0.CO;2-R
   OBERMAN HA, 1965, CANCER, V18, P1233, DOI 10.1002/1097-0142(196510)18:10<1233::AID-CNCR2820181004>3.0.CO;2-M
   Pandey M, 2004, J SURG ONCOL, V87, P121, DOI 10.1002/jso.20110
   REITAMO JJ, 1986, AM J SURG, V151, P230, DOI 10.1016/0002-9610(86)90076-0
   RODRIGUEZBIGAS MA, 1994, CANCER, V74, P1270, DOI 10.1002/1097-0142(19940815)74:4<1270::AID-CNCR2820740415>3.0.CO;2-7
   Roncadin M, 1998, ACTA ONCOL, V37, P209, DOI 10.1080/028418698429801
   ROSEN PP, 1989, CANCER-AM CANCER SOC, V63, P1363, DOI 10.1002/1097-0142(19890401)63:7<1363::AID-CNCR2820630722>3.0.CO;2-B
   SCHILLER VL, 1995, CHEST, V108, P1466, DOI 10.1378/chest.108.5.1466
   SCHUH ME, 1994, PLAST RECONSTR SURG, V93, P603, DOI 10.1097/00006534-199493030-00028
   SHARP N, 1984, AM J OBSTET GYNECOL, V149, P83, DOI 10.1016/0002-9378(84)90296-5
   Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041
   Vandeweyer E, 2000, PLAST RECONSTR SURG, V105, P2627, DOI 10.1097/00006534-200006000-00065
   Wada H, 1988, Gan No Rinsho, V34, P67
NR 43
TC 20
Z9 22
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0046-8177
J9 HUM PATHOL
JI Hum. Pathol.
PD NOV
PY 2009
VL 40
IS 11
BP 1564
EP 1570
DI 10.1016/j.humpath.2009.03.020
PG 7
WC Pathology
SC Pathology
GA 513EU
UT WOS:000271306000006
PM 19540553
DA 2018-10-20
ER

PT J
AU Gunaydin, S
   McCusker, K
   Vijay, V
AF Gunaydin, Serdar
   McCusker, Kevin
   Vijay, Venkataramana
TI Clinical and biomaterial evaluation of a new condensed dual-function
   extracorporeal circuit in reoperation for coronary artery bypass surgery
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Cardiopulmonary bypass; Coronary artery bypass grafting; Oxygenator;
   Cardioplegia; Coated Materials-Biocompatible
ID CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; BIOCOMPATIBILITY
AB Purpose: This prospective, randomized study compared the clinical performance of three types of circuits: a newly introduced, fully-coated, interchangeable open-closed circuit with a dual configuration (hard shell with a bypass shunt), reduced length, and reduced prime of less than 800 cc (CondEC); a completely coated circuit (EC); and a similar uncoated, open circuit with standard length and prime (CONT).
   Methods: 75 patients undergoing reoperation for coronary revascularization were randomly allocated into three groups (N=25): Group 1: CondEC with shortened tubing, components and an open-closed configuration of low priming volume with a centrifugal pump and a shunt which bypassed the reservoir for closed configuration; Group 2: EC with a roller pump and hard-shell reservoir; Group 3: CONT. Blood samples for CBC, inflammatory mediators [Interleukin-2 (IL-2), Complement-3a (C3a)] and flow cytometry (CD11b/CD18) were collected after induction (T1) and heparin administration (T2), 15 min after cardiopulmonary bypass (CPB) (T3), before cessation of CPB (T4), 15 min after reversal (T5), and the first postoperative day (T6).
   Results: Leukocyte counts demonstrated significant increases at T4, T5 in CONT but remained stable in EC and CondEC (p<0.05). Platelets were preserved better at T4, T5 in both EC and CondEC study groups (p<0.05). IL-2 and C3a levels were significantly lower at T3, T4, T5 in CondEC and T4, T5 in EC (p<0.05). Blood protein adsorption analysis demonstrated increased amount of microalbumin on CONT fibers (p<0.05).
   Conclusions: The CondEC is a flexible, dual-function, open/closed configuration system that was easy to use, safe and achieved better biocompatibility when compared to coated and uncoated conventional circuits. (Int J Artif Organs 2009; 32: 802-10)
C1 [Gunaydin, Serdar] Kirikkale Univ, Dept Cardiovasc Surg, Kirikkale, Turkey.
   [McCusker, Kevin] Portsmouth Reg Hosp, Portsmouth, NH USA.
   [Vijay, Venkataramana] SUNY, New York, NY USA.
RP Gunaydin, S (reprint author), Univ K Kale, Dept CV Surg, Angora Evleri G-8,Bl 1, TR-06800 Beysukent Ankara, Turkey.
EM sgunaydin@isnet.net.tr
CR Fransen EJ, 2005, PERFUSION-UK, V20, P91, DOI 10.1191/0267659105pf795oa
   Gorman R. C., 1996, J THORAC CARDIOVASC, V111, P11
   Groom RC, 2005, SEMIN CARDIOTHORAC V, V9, P159, DOI 10.1177/108925320500900210
   Gunaydin S, 2004, PERFUSION-UK, V19, pS33, DOI 10.1191/0267659104pf718oa
   Gunaydin S, 2002, ANN THORAC SURG, V74, P819, DOI 10.1016/S0003-4975(02)03796-7
   GUNAYDIN S, 2005, FILTRATION, V1, P95
   Gunaydin Serdar, 2004, Curr Med Chem Cardiovasc Hematol Agents, V2, P295, DOI 10.2174/1568016043356237
   McCusker K, 2001, PERFUSION-UK, V16, P447, DOI 10.1177/026765910101600603
   Moen O, 1996, ANN THORAC SURG, V62, P1134, DOI 10.1016/0003-4975(96)00492-4
   Nishida H, 1999, ARTIF ORGANS, V23, P547, DOI 10.1046/j.1525-1594.1999.06401.x
   NOLLERT G, 2005, ANN THORAC SURG, V80, P2332
   Norman Matthew J, 2004, J Extra Corpor Technol, V36, P336
   Perthel M, 2005, PERFUSION-UK, V20, P329, DOI 10.1191/0267659105pf828oa
   REPO H, 1993, J IMMUNOL METHODS, V164, P193, DOI 10.1016/0022-1759(93)90312-U
   Rizzi G, 2004, INT J ARTIF ORGANS, V27, P649
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   von Segesser LK, 2003, PERFUSION-UK, V18, P219, DOI 10.1191/0267659103pf676oa
NR 17
TC 4
Z9 4
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD NOV
PY 2009
VL 32
IS 11
BP 802
EP 810
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 548VA
UT WOS:000273995400006
PM 20020412
DA 2018-10-20
ER

PT J
AU Matsumoto, G
   Omi, Y
   Kubota, E
   Ozono, S
   Tsuzuki, H
   Kinoshita, Y
   Yamamoto, M
   Tabata, Y
AF Matsumoto, Goichi
   Omi, Yasushi
   Kubota, Eiro
   Ozono, Satoru
   Tsuzuki, Hideko
   Kinoshita, Yukihiko
   Yamamoto, Masaya
   Tabata, Yasuhiko
TI Enhanced Regeneration of Critical Bone Defects Using a Biodegradable
   Gelatin Sponge and beta-Tricalcium Phosphate with Bone Morphogenetic
   Protein-2
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE bone morphogenetic protein; gelatin-beta-tricalcium phosphate (beta TCP)
   sponge; controlled release
ID MESENCHYMAL STEM-CELLS; CONTROLLED-RELEASE; OSTEOGENIC DIFFERENTIATION;
   SYNTHETIC-POLYMER; DELIVERY-SYSTEM; GROWTH-FACTOR; VITAMIN-K; TISSUE;
   RHBMP-2; COLLAGEN
AB We examine the osteogenicity of a sponge biomaterial consisting of a biodegradable mixture of gelatin and b-tricalcium phosphate (beta TCP) that bound bone morphogenetic protein 2 (BMP-2) in critical-sized bone defects in rats. Gelatin-beta TCP sponges containing either phosphate buffered saline or incorporating BMP-2 are implanted into 5 mm diameter bone defects created in rat mandibles. We assess the defects biweekly for 8 weeks following implantation. There is significantly higher osteoinductive activity and significantly more Gla-osteocalcin content at bone-defect healing sites treated with gelatin-beta TCP sponges incorporating BMP-2 than there is in those treated with sponges that did not contain BMP-2. Histologically, new bone that contains bone marrow and that is connected to the original bone almost entirely replaces the regenerated bone. These results show that biodegradable gelatin-beta TCP incorporating BMP-2 is osteogenic enough to promote healing in large bone defects.
C1 [Matsumoto, Goichi; Omi, Yasushi; Kubota, Eiro] Kanagawa Dent Coll, Dept Oral & Maxillofacial Surg, Kanagawa 2388580, Japan.
   [Ozono, Satoru; Tsuzuki, Hideko; Kinoshita, Yukihiko] Kanagawa Dent Coll, Inst Frontier Oral Sci, Dept Tissue Engn, Kanagawa 2388580, Japan.
   [Yamamoto, Masaya; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Sakyo Ku, Kyoto 6068507, Japan.
RP Matsumoto, G (reprint author), Kanagawa Dent Coll, Dept Oral & Maxillofacial Surg, 82 Inaoka, Kanagawa 2388580, Japan.
EM oslab@kdcnet.ac.jp
CR Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Erbe EM, 2001, EUR SPINE J, V10, pS141, DOI 10.1007/s005860100287
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   GALLOP PM, 1980, NEW ENGL J MED, V302, P1460, DOI 10.1056/NEJM198006263022608
   Gittens SA, 2001, J DRUG TARGET, V9, P407, DOI 10.3109/10611860108998776
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hu Yun-Yu, 2003, Chin J Traumatol, V6, P67
   Hu YY, 2003, J BIOMED MATER RES A, V67A, P591, DOI 10.1002/jbm.a.10070
   Jeppsson C, 1999, ACTA ORTHOP SCAND, V70, P77, DOI 10.3109/17453679909000963
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kinoshita Y, 2008, INT J ORAL MAX SURG, V37, P275, DOI 10.1016/j.ijom.2007.11.010
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41, DOI 10.2106/00004623-200412002-00008
   Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3
   Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   PRICE PA, 1985, VITAM HORM, V42, P65
   REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213
   Reddi AH, 1997, NAT MED, V3, P837, DOI 10.1038/nm0897-837
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Shimaoka H, 2004, J BIOMED MATER RES A, V68A, P168, DOI 10.1002/jbm.a.20059
   Tabar L, 2003, CANCER J, V9, P15, DOI 10.1097/00130404-200301000-00004
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Zabka AG, 2001, J ORTHOP RES, V19, P318, DOI 10.1016/S0736-0266(00)90003-2
   ZEKORN D, 1969, BIBL HAEMATOL, P131
   Zhao M, 2003, J DENT RES, V82, P23, DOI 10.1177/154405910308200106
NR 38
TC 17
Z9 20
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD NOV
PY 2009
VL 24
IS 4
BP 327
EP 342
DI 10.1177/0885328208096523
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509TC
UT WOS:000271040300003
PM 18987021
DA 2018-10-20
ER

PT J
AU Beckstead, BL
   Tung, JC
   Liang, KJ
   Tavakkol, Z
   Usui, ML
   Olerud, JE
   Giachelli, CM
AF Beckstead, Benjamin L.
   Tung, Jason C.
   Liang, Katharine J.
   Tavakkol, Zarry
   Usui, Marcia L.
   Olerud, John E.
   Giachelli, Cecilia M.
TI Methods to promote Notch signaling at the biomaterial interface and
   evaluation in a rafted organ culture model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Notch; biomaterials; Jagged-1; organ culture; stem cells
ID CELL-FATE; DIFFERENTIATION; JAGGED1; KERATINOCYTES; LIGAND; ACTIVATION;
   MATURATION; INDUCE; FORM; SKIN
AB The Notch signaling pathway is a promising target for controlling cell fate choices at the biomaterial-tissue interface. Building on our previous work in developing Notch-signaling biomaterials, we evaluated various immobilization schemes for Notch ligands, and their effect on human foreskin keratinocytes. A peptide sequence derived from the Jagged-1 DSL-region and immobilized to poly(2-hydroxyethyl methacrylate) (polyHEMA) showed no bioactivity in relation to the Notch-CSL pathway. The full-length Jagged-1 protein immobilized directly to the polyHEMA surface showed activity in signaling the Notch-CSL pathway. However, an indirect affinity immobilization approach yielded a stronger signal. Human keratinocytes plated on bound Jagged-1 showed upregulated involucrin, keratin 10, and loricrin protein expression, with this expression being cell density-dependent. Utilizing a human foreskin rafted organ culture model as a bridge between in vitro and in vivo studies, Jagged-l-modified or control polyHEMA rods were implanted in human foreskin and cultured at the air-medium interface. Keratinocyte proliferation was suppressed and intermediate-stage differentiation promoted in Jagged-1-modified rods compared with control rods. Thus, Notch-signaling biomaterials provide a robust approach to control keratinocyte differentiation and may find application to other progenitor and stem cells. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 436-446, 2009
C1 [Beckstead, Benjamin L.; Tung, Jason C.; Giachelli, Cecilia M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Liang, Katharine J.] Univ Washington, Neurobiol Undergrad Program, Seattle, WA 98195 USA.
   [Tavakkol, Zarry; Usui, Marcia L.; Olerud, John E.] Univ Washington, Dept Med, Div Dermatol, Seattle, WA 98195 USA.
RP Giachelli, CM (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM ceci@u.washington.edu
FU Singapore-University of Washington Alliance (SUWA, A*Star of Singapore);
   University of Washington Engineered Biomaterials [EEC-9529161]
FX Contract grant sponsor: University of Washington Engineered
   Biomaterials, contract grant number: EEC-9529161
CR Aho S, 2004, J CELL BIOCHEM, V92, P1271, DOI 10.1002/jcb.20125
   Anderson J., 2004, BIOMATERIALS SCI INT
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217
   Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920
   Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074
   Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182
   Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4
   LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5
   Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   Martin SM, 2003, J BIOMED MATER RES A, V67A, P334, DOI 10.1002/jbm.a.10060
   Nehring LC, 2005, J BIOL CHEM, V280, P20349, DOI 10.1074/jbc.M500273200
   Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036
   Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9
   Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X
   Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI [10.1016/S0960-9822(04)00038-7, 10.1016/j.cub.2004.01.023]
   Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200
   SMITH SA, 1986, J INVEST DERMATOL, V86, P168, DOI 10.1111/1523-1747.ep12284213
   Varnum-Finney B, 2000, J CELL SCI, V113, P4313
   Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273
NR 32
TC 23
Z9 24
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2009
VL 91A
IS 2
BP 436
EP 446
DI 10.1002/jbm.a.32214
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 506BA
UT WOS:000270746200015
PM 18985776
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Abshagen, K
   Schrodi, I
   Gerber, T
   Vollmar, B
AF Abshagen, K.
   Schrodi, I.
   Gerber, T.
   Vollmar, B.
TI In vivo analysis of biocompatibility and vascularization of the
   synthetic bone grafting substitute NanoBone (R)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE angiogenesis; biocompatibility; dorsal skinfold chamber; hydroxyapatite;
   NanoBone (R)
ID ANGIOGENESIS; MICROCIRCULATION; CHAMBER
AB One of the major challenges in the application of bone substitutes is adequate vascularization and biocompatibility of the implant. Thus, the temporal course of neovascularization and the microvascular inflammatory response of implants of NanoBone (R) (fully synthetic nano-crystalline bone grafting material) were studied in vivo by using the mouse dorsal skinfold chamber model. Angiogenesis, microhemodynamics, and leukocyte-endothelial cell interaction were analyzed repetitively after implantation in the center and in the border zone of the implant up to 15 days. Both NanoBone (R) granules and plates exhibited high biocompatibility comparable to that of cancellous bone, as indicated by a lack of venular leukocyte activation after implantation. In both synthetic NanoBone (R) groups, signs of angiogenesis could be observed even at day 5 after implantation, whereas granules showed higher functional vessel density compared with NanoBone (R) plates. The angiogenic response of the cancellous bone was markedly accelerated in the center of the implant tissue. Histologically, implant tissue showed an ingrowth of vascularized fibrous tissue into the material combined with an increased number of foreign-body giant cells. In conclusion, NanoBone (R), particularly in granular form, showed high biocompatibility and high angiogenic response, thus improving the healing of bone defects. Our results underline that, beside the composition and nanostructure, the macrostructure is also of importance for the incorporation of the biomaterial by the host tissue. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 557-566, 2009
C1 [Abshagen, K.; Schrodi, I.; Vollmar, B.] Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany.
   [Gerber, T.] Univ Rostock, Inst Phys, D-18055 Rostock, Germany.
RP Abshagen, K (reprint author), Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany.
EM kerstin.abshagen@uni-rostock.de
CR BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   Bayerlein T., 2006, Folia Morphologica, V65, P89
   Betz RR, 2002, ORTHOPEDICS, V25, P561
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Gerike W., 2006, Folia Morphologica, V65, P54
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Hoffmann JN, 2002, ANESTHESIOLOGY, V97, P460, DOI 10.1097/00000542-200208000-00025
   Klyscz T, 1997, BIOMED TECH, V42, P168, DOI 10.1515/bmte.1997.42.6.168
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   POSNER AS, 1969, PHYSIOL REV, V49, P760
   RUBANYI GM, 1994, PHARMACOL REV, V46, P325
   Rumpel E., 2006, Folia Morphologica, V65, P43
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070
   Sommer B, 2005, J BIOMED MATER RES A, V72A, P67, DOI 10.1002/jbm.a.30202
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   Yamauchi J, 1998, ADV EXP MED BIOL, V454, P355
NR 27
TC 45
Z9 46
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2009
VL 91A
IS 2
BP 557
EP 566
DI 10.1002/jbm.a.32237
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 506BA
UT WOS:000270746200026
PM 18985779
DA 2018-10-20
ER

PT J
AU Xu, WG
   Holzhuter, G
   Sorg, H
   Wolter, D
   Lenz, S
   Gerber, T
   Vollmar, B
AF Xu, Weiguo
   Holzhueter, Gerd
   Sorg, Heiko
   Wolter, Daniel
   Lenz, Solvig
   Gerber, Thomas
   Vollmar, Brigitte
TI Early Matrix Change of a Nanostructured Bone Grafting Substitute in the
   Rat
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tissue engineering; electron microscopy; histomorphometry;
   hydroxyapatite; matrix
ID ANIMAL-MODELS; TISSUE; OSTEOGENESIS
AB A nanocrystalline bone substitute embedded in a highly porous silica gel matrix (Nanolioneo (R)) has previously been shown to bridge bone defects by an organic matrix. As the initial host response on the bone graft substitute might be a determinant for subsequent bone formation, our present purpose was to characterize the early tissue reaction on this biomaterial. After implantation of 80 mg of NanoBone into the adipose neck tissue of a total of 35 rats, grafts were harvested for subsequent analysis at days 3, 6, 9, 12, and 21. The biomaterial was found encapsulated by granulation tissue which partly penetrated the implant at day 3 and completely pervaded the graft at day 12 on implantation. Histology revealed tartrate-resista n t acid phosphatase (TRAP)-positive giant cells covering the biomaterial. ED1 (CD68) immunopositivity of these cells further indicated their osteoclast-like phenotype. Scanning electron microscopy revealed organic tissue components within the periphery of the graft already at day 9, whereas the central hematoma region still presented the silica-surface of the biomaterial. Energy dispersive X-ray spectroscopy further demonstrated that the silica gel was degraded faster in the peripheral granulation tissue than in the central hematoma and was replaced by organic host components by day 12. In conclusion, the silica gel matrix is rapidly replaced by carbohydrate macromolecules. This might represent a key step in the process of graft degradation on its way toward induction of bone formation. The unique composition and structure of this nanoscaled biomaterial seem to support its degradation by host osteoclast-like giant cells. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 9113: 692-699, 2009
C1 [Xu, Weiguo; Sorg, Heiko; Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18057 Rostock, Germany.
   [Holzhueter, Gerd; Lenz, Solvig; Gerber, Thomas] Univ Rostock, Dept Mat Res, Inst Phys, D-18055 Rostock, Germany.
   [Wolter, Daniel] Univ Rostock, Dept Oral Maxillofacial & Plast Surg, D-18055 Rostock, Germany.
RP Vollmar, B (reprint author), Univ Rostock, Inst Expt Surg, D-18057 Rostock, Germany.
EM brigitte.vollmar@med.uni-rostock.de
FU German Federal Ministry of Education and Research [01EZ0729]
FX Contract grant sponsor: German Federal Ministry of Education and
   Research; Contract grant number: BMBF 01EZ0729
CR ABSHAGEN K, J BIOMED A IN PRESS
   Barrere F, 2006, INT J NANOMED, V1, P317
   Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Christopher CL, 2003, INT J CARDIOL, V88, P183, DOI 10.1016/S1067-5273(02)00393-5
   Davies John E, 2003, J Dent Educ, V67, P932
   Eid K, 2001, J ORTHOPAED RES, V19, P962, DOI 10.1016/S0736-0266(00)00080-2
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Gerber T., 2006, EUR J TRAUMA, V2, P132
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Henkel KO, 2006, ORAL SURG ORAL MED O, V102, P606, DOI 10.1016/j.tripleo.2005.10.034
   Holzhuter G, 2005, ANAL BIOANAL CHEM, V382, P1121, DOI 10.1007/s00216-005-3220-6
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   ILERT RK, 1979, CHEM SILICA
   Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Klein M, 2009, CLIN ORAL IMPLAN RES, V20, P67, DOI 10.1111/j.1600-0501.2008.01605.x
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   O'Loughlin PF, 2008, J BONE JOINT SURG AM, V90A, P79, DOI 10.2106/JBJS.G.01585
   Pareek A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035418
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
NR 25
TC 18
Z9 18
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2009
VL 91B
IS 2
BP 692
EP 699
DI 10.1002/jbm.b.31445
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 507QE
UT WOS:000270868600024
PM 19572294
DA 2018-10-20
ER

PT J
AU Zenz, P
   Stiehl, JB
   Knechtel, H
   Titzer-Hochmaier, G
   Schwagerl, W
AF Zenz, P.
   Stiehl, J. B.
   Knechtel, H.
   Titzer-Hochmaier, G.
   Schwagerl, W.
TI Ten-year follow-up of the non-porous Allofit cementless acetabular
   component
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; POROUS TANTALUM BIOMATERIAL; PRESS-FIT
   STABILITY; PRIMARY OSTEOARTHRITIS; SCREW FIXATION; CUP FIXATION;
   THREADED CUP; OSTEOLYSIS; METAL; SOCKETS
AB Cementless acetabular fixation has demonstrated superior long-term durability in total hip replacement, but most series have studied implants with porous metal surfaces. We retrospectively evaluated the results of 100 consecutive patients undergoing total hip replacement where a non-porous Allofit component was used for primary press-fit fixation.
   This implant is titanium alloy, grit-blasted, with a macrostructure of forged teeth and has a biradial shape. A total of 81 patients (82 hips) were evaluated at final follow-up at a mean of 10.1 years (8.9 to 11.9). The Harris Hip Score improved from a mean 53 points ( 23 to 73) pre-operatively to a mean of 96 points (78 to 100) at final review. The osseointegration of all acetabular components was radiologically evaluated with no evidence of loosening. The survival rate with revision of the component as the endpoint was 97.5% (95% confidence interval 94 to 100) after 11.9 years. Radiolucency was found in one DeLee-Charnley zone in four acetabular components. None of the implants required revision for aseptic loosening. Two patients were treated for infection, one requiring a two-stage revision of the implant. One femoral stem was revised for osteolysis due to the production of metal wear debris, but the acetabular shell did not require revision.
   This study demonstrates that a non-porous titanium acetabular component with adjunct surface fixation offers an alternative to standard porous-coated implants.
C1 [Zenz, P.; Stiehl, J. B.; Knechtel, H.; Titzer-Hochmaier, G.; Schwagerl, W.] OttoWagnerSpital, A-1140 Vienna, Austria.
RP Stiehl, JB (reprint author), St Marys Hosp, 4573 CJ Heck Rd, Salem, IL 62881 USA.
EM jbstiehl@me.com
CR Adler E, 1992, J Arthroplasty, V7, P295, DOI 10.1016/0883-5403(92)90052-R
   BAUER R, 1979, ARCH ORTHOP TRAUM SU, V95, P47, DOI 10.1007/BF00379169
   BEAULE PE, 2001, CLIN ORTHOP RELAT R, V386, P159
   Berli BJ, 2007, CLIN ORTHOP RELAT R, P114, DOI 10.1097/BLO.0b013e3180592a79
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bruijn JD, 1996, ACTA ORTHOP SCAND, V67, P133, DOI 10.3109/17453679608994657
   Carr AM, 2008, ANZ J SURG, V78, P144, DOI 10.1111/j.1445-2197.2007.04390.x
   Civinini R, 2008, J BONE JOINT SURG BR, V90B, P570, DOI 10.1302/0301-620X.90B5.20116
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Della Valle AG, 2004, J BONE JOINT SURG AM, V86A, P1998, DOI 10.2106/00004623-200409000-00019
   Epinette JA, 2003, J ARTHROPLASTY, V18, P140, DOI 10.1054/arth.2003.50039
   Eskelinen A, 2006, ACTA ORTHOP, V77, P57, DOI 10.1080/17453670610045704
   Fernandez-Gonzalez J, 1997, INT ORTHOP, V21, P327, DOI 10.1007/s002640050178
   Fisher J, 2006, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000238871.07604.49
   Gaffey JL, 2004, J BONE JOINT SURG AM, V86A, P257, DOI 10.2106/00004623-200402000-00007
   Garcia-Cimbrelo E, 2003, J BONE JOINT SURG AM, V85A, P296, DOI 10.2106/00004623-200302000-00017
   GarciaCimbrelo E, 1996, J ARTHROPLASTY, V11, P773, DOI 10.1016/S0883-5403(96)80176-8
   GREENWALD A S, 1972, Journal of Bone and Joint Surgery British Volume, V54, P157
   Grubl A, 2002, J BONE JOINT SURG AM, V84A, P425
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Illgen Richard 2nd, 2002, J Am Acad Orthop Surg, V10, P43
   Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903
   Klapperich C, 1999, J ARTHROPLASTY, V14, P877, DOI 10.1016/S0883-5403(99)90042-6
   Kwong L M, 1994, J Arthroplasty, V9, P163, DOI 10.1016/0883-5403(94)90065-5
   Makela KT, 2008, J BONE JOINT SURG AM, V90A, P2160, DOI 10.2106/JBJS.G.00870
   Markel DC, 2002, INT ORTHOP, V26, P72, DOI 10.1007/s00264-001-0314-4
   Olory Bruno, 2004, Acta Orthop Belg, V70, P31
   Ries MD, 1997, J ARTHROPLASTY, V12, P207, DOI 10.1016/S0883-5403(97)90068-1
   Rohrl SM, 2004, J ARTHROPLASTY, V19, P962, DOI 10.1016/j.arth.2004.06.024
   Roth A, 2006, ARCH ORTHOP TRAUM SU, V126, P77, DOI 10.1007/s00402-005-0001-9
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Stiehl J B, 1991, J Arthroplasty, V6, P295, DOI 10.1016/S0883-5403(06)80179-8
   Stiehl JB, 2005, ORTHOPEDICS, V28, P662
   SUMNER DR, 1993, ACTA ORTHOP SCAND, V64, P619, DOI 10.3109/17453679308994584
   Tonino A, 2001, J BONE JOINT SURG AM, V83A, P817, DOI 10.2106/00004623-200106000-00002
   Udomkiat P, 2002, J BONE JOINT SURG AM, V84A, P1195, DOI 10.2106/00004623-200207000-00016
   Watson-Jones R, 1936, BRIT J SURG, V23, P787, DOI 10.1002/bjs.1800239213
   Widmer KH, 2002, J ARTHROPLASTY, V17, P926, DOI 10.1054/arth.2002.34526
   Witzleb WC, 2007, ACTA ORTHOP, V78, P211, DOI 10.1080/17453670710013708
   WON CH, 1995, J BONE JOINT SURG BR, V77B, P484
   YAHIRO MA, 1995, J ARTHROPLASTY, V10, P339, DOI 10.1016/S0883-5403(05)80183-4
   Zweymuller KA, 2007, CLIN ORTHOP RELAT R, P128, DOI 10.1097/BLO.0b013e318155978b
NR 44
TC 15
Z9 15
U1 0
U2 3
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
EI 2044-5377
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD NOV
PY 2009
VL 91B
IS 11
BP 1443
EP 1447
DI 10.1302/0301-620X.91B11.22368
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 513ZK
UT WOS:000271362600008
PM 19880887
OA Bronze
DA 2018-10-20
ER

PT J
AU Ypsilantis, E
   Key, T
   Bradley, JA
   Morgan, CH
   Tsui, S
   Parameshwar, J
   Taylor, CJ
AF Ypsilantis, Efthymios
   Key, Timothy
   Bradley, J. Andrew
   Morgan, C. Helen
   Tsui, Stephen
   Parameshwar, Jayan
   Taylor, Craig J.
TI Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do
   Not Predict Post-transplant Outcome
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
ID BRONCHIOLITIS OBLITERANS SYNDROME; RENAL-ALLOGRAFT REJECTION;
   KIDNEY-TRANSPLANTATION; LUNG TRANSPLANTATION; GRAFT FUNCTION; T-CELLS;
   PRETRANSPLANT; MARKER; SCD30; IDENTIFICATION
AB Background: The pre-transplant serum level of soluble CD30 (sCD30), a proteolytic derivative of the lymphocyte surface receptor CD30, has been suggested as a biomarker for immunologic risk after organ transplantation.
   Methods: Pre-transplant serum sCD30 levels were determined in 200 consecutive adult heart transplant recipients undertaken at a single center. Transplant outcome (acute rejection in the first 12 months and patient survival up to 5 years post-transplant) was determined.
   Results: Patients treated with a left ventricular assist device (LVAD) prior to transplantation (n = 28) had higher levels of sCD30 (median 64 U/ml, range 12 to 112 U/ml) than those (n = 172) with no LVAD (median 36 U/ml, range 1 to 158 U/ml, p < 0.0001). Recipients were categorized according to whether sCD30 levels were "low" (lower quartile, <24 U/ml, n = 50), "intermediate" (24 to 58 U/ml, n = 100) or "high" (tipper quartile, >58 U/ml, n = 50). Neither acute rejection nor recipient survival differed according to sCD30 level, with values (mean +/- SEM) of 0.30 +/- 0.04, 0.23 0.03 and 0.30 +/- 0.05 acute rejection episodes per 100 days in the low, intermediate and high groups, respectively, with recipient survival rates at 1 year of 77.7%, 84.9% and 86% and at 5 years of 73.6%, 67.9% and 75.8%, respectively.
   Conclusions: Pre-transplant serum sCD30 level does not predict acute allograft rejection or recipient survival after heart transplantation, although sCD30 levels are increased by LVAD, possibly as a result of biomaterial-host immune interaction. J Heart Lung Transplant 2009;28:1206-10. Copyright (C) 2009 by the International Society for Heart and Lung Transplantation.
C1 [Key, Timothy; Morgan, C. Helen; Taylor, Craig J.] Univ Cambridge, Hosp NHS Fdn Trust, Tissue Typing Lab, Addenbrookes Hosp, Cambridge CB2 0QQ, England.
   [Ypsilantis, Efthymios; Bradley, J. Andrew] Univ Cambridge, Dept Surg, Addenbrookes Hosp, Cambridge CB2 0QQ, England.
   [Tsui, Stephen; Parameshwar, Jayan] Papworth Hosp, NHS Fdn Trust, Cambridge CB3 8RE, England.
RP Taylor, CJ (reprint author), Univ Cambridge, Hosp NHS Fdn Trust, Tissue Typing Lab, Addenbrookes Hosp, Box 209,Hills Rd, Cambridge CB2 0QQ, England.
EM craig.taylor@addenbrookes.nhs.uk
FU NIHR Cambridge Biomedical Research Centre
FX Supported by the NIHR Cambridge Biomedical Research Centre.
CR Altermann W, 2007, NEPHROL DIAL TRANSPL, V22, P2795, DOI 10.1093/ndt/gfm397
   Cinti P, 2005, TRANSPLANTATION, V79, P1154, DOI 10.1097/01.TP.0000152660.56055.53
   Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727
   Frisaldi E, 2006, TRANSPLANTATION, V81, P1153, DOI 10.1097/01.tp.0000205181.31604.09
   Golocheikine AS, 2008, TRANSPL IMMUNOL, V18, P260, DOI 10.1016/j.trim.2007.07.007
   Heinemann FM, 2007, TRANSPLANTATION, V83, P706, DOI 10.1097/01.tp.0000255326.27474.a4
   Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156
   Itescu S, 2003, ANN THORAC SURG, V75, pS58, DOI 10.1016/S0003-4975(03)00480-6
   Iv R, 2008, TRANSPL P, V40, P3375, DOI 10.1016/j.transproceed.2008.03.173
   Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x
   Kim MS, 2006, TRANSPLANTATION, V82, P1602, DOI 10.1097/01.tp.0000248779.17754.5e
   Kovac J, 2008, TRANSPL P, V40, P1357, DOI 10.1016/j.transproceed.2008.03.092
   Kwakkel-van Erp JM, 2008, J HEART LUNG TRANSPL, V27, P1172, DOI 10.1016/j.healun.2008.06.007
   Langan LL, 2007, AM J TRANSPLANT, V7, P847, DOI 10.1111/j.1600-6143.2006.01691.x
   Lopez-Hoyos M, 2008, TRANSPL P, V40, P2903, DOI 10.1016/j.transproceed.2008.08.087
   Nikaein A, 2007, CLIN TRANSPLANT, V21, P744, DOI 10.1111/j.1399-0012.2007.00732.x
   Pelzl S, 2002, TRANSPLANTATION, V73, P3, DOI 10.1097/00007890-200201150-00002
   Pelzl S, 2003, TRANSPLANTATION, V75, P421, DOI 10.1097/01.TP.0000044702.18327.66
   Rajakariar R, 2005, AM J TRANSPLANT, V5, P1922, DOI 10.1111/j.1600-6143.2005.00966.x
   Rossi FM, 2001, FEBS LETT, V508, P418, DOI 10.1016/S0014-5793(01)03076-9
   Sengul S, 2006, TRANSPLANTATION, V81, P1216, DOI 10.1097/01.tp.0000203324.49969.30
   Slavcev A, 2007, TRANSPL IMMUNOL, V18, P22, DOI 10.1016/j.trim.2007.04.001
   Spiridon C, 2006, TRANSPLANT P, V38, P3689, DOI 10.1016/j.transproceed.2006.10.088
   Susal C, 2004, TRANSPLANT P, V36, P29, DOI 10.1016/j.transproceed.2003.11.019
   Susal C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014256.75920.5B
   Wang D, 2006, TRANSPL IMMUNOL, V16, P41, DOI 10.1016/j.trim.2006.02.005
   Wang D, 2007, TRANSPL IMMUNOL, V17, P278, DOI 10.1016/j.trim.2007.02.001
   Weimer R, 2006, AM J TRANSPLANT, V6, P1865, DOI 10.1111/j.1600-6143.2006.01407.x
NR 28
TC 14
Z9 14
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
EI 1557-3117
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD NOV
PY 2009
VL 28
IS 11
BP 1206
EP 1210
DI 10.1016/j.healun.2009.05.041
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA 519VA
UT WOS:000271795900014
PM 19782609
DA 2018-10-20
ER

PT J
AU Sabir, MI
   Xu, XX
   Li, L
AF Sabir, Muhammad Iqbal
   Xu, Xiaoxue
   Li, Li
TI A review on biodegradable polymeric materials for bone tissue
   engineering applications
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID IN-VITRO DEGRADATION; COMPOSITE SCAFFOLDS; PHASE-SEPARATION;
   DRUG-DELIVERY; HYDROLYTIC DEGRADATION; MECHANICAL-PROPERTIES; LEACHING
   METHOD; MATRICES; BIOMATERIALS; FABRICATION
AB Biodegradable polymer scaffolds have played a significant role in wide range of tissue engineering application such as bone scaffolds since the last decade. The aim of this article is to provide the comprehensive overview of biocompatible and biodegradable polymer materials and composite materials with their advantages and drawbacks in the application of biomaterial scaffolds, furthermore the properties and degradation criteria of the biomaterials are discussed in this review.
C1 [Sabir, Muhammad Iqbal; Xu, Xiaoxue; Li, Li] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Harbin 150001, Peoples R China.
RP Li, L (reprint author), Harbin Engn Univ, Coll Mat Sci & Chem Engn, Harbin 150001, Peoples R China.
EM iqbalsabir@hotmail.com; xuxiaoxue99731@163.com; lili_heu@hrbeu.edu.cn
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Allcock HR, 2006, CURR OPIN SOLID ST M, V10, P231, DOI 10.1016/j.cossms.2007.06.001
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cai Q, 2002, BIOMATERIALS, V23, P4483, DOI 10.1016/S0142-9612(02)00168-0
   Callaghan JJ, 1997, J BONE JOINT SURG AM, V79A, P1416, DOI 10.2106/00004623-199709000-00019
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   CONCONI MT, 2006, TISSUE ENG, V12, P4
   Dimar JR, 2007, CURR OPIN ORTHOP, V18, P226, DOI DOI 10.1097/BC0.1090B1013E328112F328135D
   DOMB AJ, 1998, HDB BIODEGRADABLE PO, P87
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Duda A, 2002, BIOPOLYMERS B, V3B, P371
   EINHORN TA, 2004, J BONE JOINT SURG AM, V86, P1350
   Gopferich A, 2002, ADV DRUG DELIVER REV, V54, P911, DOI 10.1016/S0169-409X(02)00051-0
   Gravel M, 2006, BIOMATERIALS, V27, P1899, DOI 10.1016/j.biomaterials.2005.10.020
   GREEN D, 2002, BONE, V30, pPG810
   Hedberg EL, 2005, BIOMATERIALS, V26, P3215, DOI 10.1016/j.biomaterials.2004.09.012
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Hollinger JO, 1997, ANN NY ACAD SCI, V831, P427
   Ibim SEM, 1998, J BIOMED MATER RES, V43, P374, DOI 10.1002/(SICI)1097-4636(199824)43:4<374::AID-JBM5>3.0.CO;2-5
   Ibim SM, 1996, J CONTROL RELEASE, V40, P31, DOI 10.1016/0168-3659(95)00136-0
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Kai Z, 2003, BIOCH ENG J, V16, P115
   KALFAS LH, 2001, NEUROSURG FOCUS, V10
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kim HD, 2004, BIOMATERIALS, V25, P2319, DOI 10.1016/j.biomaterials.2003.09.011
   Kim JY, 2009, MICROELECTRON ENG, V86, P1447, DOI 10.1016/j.mee.2008.11.026
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Kuo YC, 2006, BIOTECHNOL PROGR, V22, P1664, DOI 10.1021/bp0602303
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Lin CY, 2005, TISSUE ENG, V11, P1589, DOI 10.1089/ten.2005.11.1589
   Ma P. X., 2003, ENCY POLYM SCI TECHN
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Muggli DS, 1999, J BIOMED MATER RES, V46, P271, DOI 10.1002/(SICI)1097-4636(199908)46:2<271::AID-JBM17>3.0.CO;2-X
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Nukavarapu SP, 2008, BIOMACROMOLECULES, V9, P1818, DOI 10.1021/bm800031t
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   PARSONS JR, 1998, HDB BIOMATERIALS PRO
   Peter SJ, 1997, TISSUE ENG, V3, P207, DOI 10.1089/ten.1997.3.207
   Pouton CW, 1996, ADV DRUG DELIVER REV, V18, P133, DOI 10.1016/0169-409X(95)00092-L
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Reignier J, 2006, POLYMER, V47, P4703, DOI 10.1016/j.polymer.2006.04.029
   Rhim JW, 2006, J APPL POLYM SCI, V101, P3736, DOI 10.1002/app.23403
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   SAMBROOK P, 2001, MUSCULOSKELETAL SYST, P67
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Seunarine K, 2006, NANOMEDICINE-UK, V1, P281, DOI 10.2217/17435889.1.3.281
   SHALABY SW, 1994, BIOMEDICAL POLYM
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Shin KC, 2005, POLYMER, V46, P3801, DOI 10.1016/j.polymer.2005.02.114
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vert M, 1997, ANGEW MAKROMOL CHEM, V247, P239, DOI 10.1002/apmc.1997.052470116
   Vin F, 2002, J Wound Care, V11, P335
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   YAO D, 2005, J BIOMED MAT B, V77, P287
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   YOUNG Y, 2005, POLYM DEGRAD STABIL, V90, P441
   YOUNG Y, 2004, J APPL POLYM SCI, V95, P193
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 81
TC 243
Z9 246
U1 17
U2 117
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD NOV
PY 2009
VL 44
IS 21
BP 5713
EP 5724
DI 10.1007/s10853-009-3770-7
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 496GB
UT WOS:000269956600002
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Sima, LE
   Filimon, A
   Piticescu, RM
   Chitanu, GC
   Suflet, DM
   Miroiu, M
   Socol, G
   Mihailescu, IN
   Neamtu, J
   Negroiu, G
AF Sima, L. E.
   Filimon, A.
   Piticescu, R. M.
   Chitanu, G. C.
   Suflet, D. M.
   Miroiu, M.
   Socol, G.
   Mihailescu, I. N.
   Neamtu, J.
   Negroiu, G.
TI Specific biofunctional performances of the hydroxyapatite-sodium maleate
   copolymer hybrid coating nanostructures evaluated by in vitro studies
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MINERAL TRIOXIDE AGGREGATE; PULSED-LASER EVAPORATION; CELL-ADHESION;
   THIN-FILMS; FOCAL ADHESION; SIGNAL-TRANSDUCTION; PORTLAND CEMENTS;
   INTEGRIN BINDING; BONE-FORMATION; STEM-CELLS
AB The nanohybrid structures consisting of hydroxyapatite (HA) and sodium maleate-vinyl acetate copolymer (MP) deposited by Matrix Assisted Pulsed Laser Evaporation (MAPLE) technique on Ti surfaces were investigated for specific biological qualities required in bone implantology. The data from in vitro studies demonstrated that human primary osteoblasts (OBs) firmly adhered to Ti coated with HA-MP as indicated by cytoskeleton and vinculin dynamics. OBs spread onto biomaterial surface and formed groups of cells which during their biosynthetic activity expressed OB phenotype specific markers (collagen and non-collagenous proteins) and underwent controlled proliferation.
C1 [Sima, L. E.; Filimon, A.; Negroiu, G.] Acad Romana, Inst Biochem, Bucharest 060031, Romania.
   [Piticescu, R. M.] Natl R&D Inst Nonferrous & Rare Met, Pantelimon Ilfov, Romania.
   [Chitanu, G. C.; Suflet, D. M.] Inst Macromol Chem, Iasi 700487, Romania.
   [Miroiu, M.; Socol, G.; Mihailescu, I. N.] Natl R&D Inst Lasers Plasma & Radiat Phys, Magurele Ilfov, Romania.
   [Neamtu, J.] Univ Med & Pharm, Craiova, Romania.
RP Negroiu, G (reprint author), Acad Romana, Inst Biochem, Splaiul Independentei 296, Bucharest 060031, Romania.
EM gnegroiu@biochim.ro
RI MIROIU, Floralice Marimona/C-5044-2011; Mihailescu, Ion/A-5403-2011;
   Socol, Gabriel/A-5405-2011; Negroiu, Gabriela/G-4649-2016; Sima,
   Livia/C-2882-2011; Suflet, Dana/B-5681-2011
OI Socol, Gabriel/0000-0002-1992-7346; Sima, Livia/0000-0002-3404-4162;
   Filimon, Anca/0000-0001-8859-5237
FU National Program Research for Excellence [46/2005-2008]
FX This work was supported by National Program Research for Excellence
   Grant no. 46/2005-2008. The authors thank to Dr. Roxana Mustata for
   contribution to the preparation of fluorescence microscopy figures and
   to Emilia Ardelean for technical assistance.
CR Allen M. J., 1994, PROMEGA NOTES, V45, P7
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bishop A, 2006, POLYM ADVAN TECHNOL, V17, P902, DOI 10.1002/pat.787
   Black J, 2006, BIOL PERFORMANCE MAT
   Bouropoulos K, 1998, J UROLOGY, V159, P1755, DOI 10.1097/00005392-199805000-00107
   Braz MG, 2006, J ORAL REHABIL, V33, P234, DOI 10.1111/j.1365-2842.2005.01559.x
   *BUS COMM CO INC, 2000, IMPL MED DEV BIOC MA
   Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323
   Chitanu C.C., 2006, REV ROUM CHIM, V51, P915
   Chitanu GC, 2005, REV ROUM CHIM, V50, P589
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Cristescu R, 2009, APPL SURF SCI, V255, P5496, DOI 10.1016/j.apsusc.2008.11.012
   Cristescu R, 2006, NATO SCI SER II-MATH, V223, P211
   Cui ZD, 2008, MAT SCI ENG C-BIO S, V28, P1117, DOI 10.1016/j.msec.2007.05.006
   Frycek R, 2006, THIN SOLID FILMS, V495, P308, DOI 10.1016/j.tsf.2005.08.178
   Gonzalez-McQuire R, 2004, J MATER CHEM, V14, P2277, DOI 10.1039/b400317a
   Gyorgy E, 2008, J MATER SCI-MATER M, V19, P1335, DOI 10.1007/s10856-007-3254-8
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jager M, 2006, J BIOMED MATER RES A, V76A, P310, DOI 10.1002/jbm.a.30515
   Jelinek M, 2007, APPL SURF SCI, V253, P7755, DOI 10.1016/j.apsusc.2007.02.085
   Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim HW, 2006, J BIOMED MATER RES B, V77B, P323, DOI 10.1002/jbm.b.30376
   Kirkpatrick C. J., 2005, ITBM RBM, V26, P192
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KLEPETSANIS KP, 1998, ACS SYM SER, P117
   KOOTEN TG, 1997, J MATER SCI-MATER M, V8, P835
   Kumar R, 2008, J R SOC INTERFACE, V5, P427, DOI 10.1098/rsif.2007.1141
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Le M K, 2001, Biomaterials, V22, P641
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Locci P, 2000, J BIOMED MATER RES, V51, P561, DOI 10.1002/1097-4636(20000915)51:4<561::AID-JBM3>3.0.CO;2-H
   Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s
   Negroiu G, 2008, J MATER SCI-MATER M, V19, P1537, DOI 10.1007/s10856-007-3300-6
   Pique A., 2007, PULSED LASER DEPOSIT
   Piticescu R.M., 2004, ANN TRANSPL, V9, P20
   Piticescu RM, 2005, SOL ST PHEN, V106, P47, DOI 10.4028/www.scientific.net/SSP.106.47
   Ribeiro DA, 2005, J ENDODONT, V31, P605, DOI 10.1097/01.don.0000153842.06657.e2
   Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014
   Schmalz G, 1997, Clin Oral Investig, V1, P154
   Schneiders W, 2009, J ORTHOP RES, V27, P15, DOI 10.1002/jor.20719
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Shida J, 2000, CALCIFIED TISSUE INT, V67, P151, DOI 10.1007/s00223001125
   Staffolani N, 1999, J DENT, V27, P449, DOI 10.1016/S0300-5712(98)00073-6
   Suh H, 2001, ARTIF ORGANS, V25, P14, DOI 10.1046/j.1525-1594.2001.025001014.x
   Suratwala SJ, 2008, J BONE JOINT SURG AM, V90A, P2189, DOI 10.2106/JBJS.G.00409
   Trindade MCD, 2001, BIOMATERIALS, V22, P2067, DOI 10.1016/S0142-9612(00)00376-8
   Vahey J W, 1995, Am J Orthop (Belle Mead NJ), V24, P319
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 55
TC 6
Z9 6
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2009
VL 20
IS 11
BP 2305
EP 2316
DI 10.1007/s10856-009-3800-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 521QQ
UT WOS:000271938100015
PM 19543854
DA 2018-10-20
ER

PT J
AU Kajiyama, S
   Tsurumoto, T
   Osaki, M
   Yanagihara, K
   Shindo, H
AF Kajiyama, Shiro
   Tsurumoto, Toshiyuki
   Osaki, Makoto
   Yanagihara, Katsunori
   Shindo, Hiroyuki
TI Quantitative analysis of Staphylococcus epidermidis biofilm on the
   surface of biomaterial
SO JOURNAL OF ORTHOPAEDIC SCIENCE
LA English
DT Article
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; IN-VITRO; AUREUS; EXPRESSION;
   INFECTIONS; SUSCEPTIBILITY; ADHERENCE; GENES; ICA; BACTERIA
AB Staphylococcus epidermidis biofilm is considered to be an important cause of device-related infection. Polysaccharide intercellular adhesin (PIA), encoded by the icaADBC locus, has been found to be a functional component of S. epidermidis biofilm, but the sequential change of the ica gene expression during biofilm development is still unclear. We have established a quantitative experiment of biofilm formation on nontranslucent biomaterial surfaces using the biofilm coverage rate (BCR). In this study, we quantified the time course of biofilm formation on a biomaterial (stainless steel) surface by means of BCR, viable cell count (VCC) with colony-forming units, and ATP-bioluminescence (ATP) as relative light units, and investigated the time-course relationship between biofilm development process and ica gene expression using reverse transcription-polymerase chain reaction (RT-PCR).
   S. epidermidis RP62A was inoculated on stainless steel washers and incubated for 0-8, 24, and 48 h. Biofilms attached to the washers were quantified by means of BCR, VCC, and ATP. RT-PCR of the ica gene was performed using total RNA isolated from biofilms at each incubation period. Results of these methods were compared.
   The amount of biofilms measured by BCR increased over time and particularly grew at 5-6 h into the incubation period. On the other hand, the results of VCC and ATP increased gradually, and at 24 h or 48 h the measurement values were very much greater than previously. Up to 8 h, there were significant correlations between BCR and VCC or ATP. The growth of BCR until 6 h is supported by RT-PCR of the ica gene.
   Compared with each result, two-dimensional biofilm occupation on a biomaterial surface is proposed to be rapidly completed within 6-8 h after bacterial attachment. Our data indicate that bacterial biofilms first grow two dimensionally with a producing matrix, and subsequently grow vertically and become mature.
C1 [Kajiyama, Shiro; Tsurumoto, Toshiyuki; Osaki, Makoto; Shindo, Hiroyuki] Nagasaki Univ, Dept Orthopaed Surg, Grad Sch Biomed Sci, Nagasaki 8528501, Japan.
   [Yanagihara, Katsunori] Nagasaki Univ Hosp, Div Lab Med, Nagasaki, Japan.
RP Kajiyama, S (reprint author), Nagasaki Univ, Dept Orthopaed Surg, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
CR Adachi K, 2007, J ORTHOP SCI, V12, P178, DOI 10.1007/s00776-006-1102-1
   Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   BOWERS WH, 1973, J BONE JOINT SURG AM, VA 55, P795, DOI 10.2106/00004623-197355040-00014
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   Donlan RM, 2005, CLIN ORTHOP RELAT R, P12, DOI 10.1097/01.blo.0000175120.66051.29
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Handke LD, 2004, J MED MICROBIOL, V53, P367, DOI 10.1099/jmm.0.05372-0
   Hudetz D, 2008, CLIN MICROBIOL INFEC, V14, P1135, DOI 10.1111/j.1469-0691.2008.02096.x
   Jaeger Martin, 2006, Injury, V37 Suppl 2, pS74, DOI 10.1016/j.injury.2006.04.012
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   Kobayashi N, 2007, CLIN ORTHOP RELAT R, P210, DOI 10.1097/BLO.0b013e3180312042
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Nishimura S, 2006, J ORTHOP SCI, V11, P46, DOI 10.1007/s00776-005-0968-7
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Rupp ME, 1994, CLIN INFECT DIS, V19, P244
   Sheehan E, 2004, J ORTHOPAED RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Vandecasteele SJ, 2004, J BACTERIOL, V186, P2236, DOI 10.1128/JB.186.8.2236-2239.2004
   Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452
   Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001
   WORLOCK P, 1988, J BONE JOINT SURG AM, V70A, P1341, DOI 10.2106/00004623-198870090-00011
NR 31
TC 21
Z9 24
U1 1
U2 8
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 0949-2658
J9 J ORTHOP SCI
JI J. Orthop. Sci.
PD NOV
PY 2009
VL 14
IS 6
BP 769
EP 775
DI 10.1007/s00776-009-1405-0
PG 7
WC Orthopedics
SC Orthopedics
GA 529QI
UT WOS:000272531900013
PM 19997825
DA 2018-10-20
ER

PT J
AU Stein, JM
   Fickl, S
   Yekta, SS
   Hoischen, U
   Ocklenburg, C
   Smeets, R
AF Stein, Jamal M.
   Fickl, Stefan
   Yekta, Sareh Said
   Hoischen, Ulrich
   Ocklenburg, Christina
   Smeets, Ralf
TI Clinical Evaluation of a Biphasic Calcium Composite Grafting Material in
   the Treatment of Human Periodontal Intrabony Defects: A 12-Month
   Randomized Controlled Clinical Trial
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Bone graft; calcium phosphates; clinical trials; debridement;
   periodontitis; regeneration
ID GUIDED TISSUE REGENERATION; ELECTRICALLY POLARIZED HYDROXYAPATITE; ACID
   ROOT TREATMENT; OSSEOUS DEFECTS; TRICALCIUM PHOSPHATE; HISTOLOGIC
   EVALUATION; HEALING RESPONSES; INTRAOSSEOUS DEFECTS; SURGICAL APPROACH;
   BONE-FORMATION
AB Background: The aim of this study was to compare the clinical outcome of a novel biphasic calcium composite (BCC) biomaterial versus autogenous bone spongiosa (ABS) or open flap debridement (OFD) for the treatment of intrabony periodontal defects.
   Methods: Forty-five subjects with at least one intrabony defect with a probing depth (PD) >= 7 mm and a vertical radiographic bone loss 3 mm were enrolled in the study. Subjects were randomly assigned to treatment with BCC (n = 15), ABS (n = 15), or OFD (n = 15). Clinical parameters were recorded at baseline and 12 months after surgery and included the plaque index, gingival index, PD, clinical attachment level (CAL), and gingival recession.
   Results: In all treatment groups, significant PD reductions and CAL gains occurred during the study period (P<0.0001). At 12 months, patients treated with BCC exhibited a mean PD reduction of 3.6 +/- 0.7 mm and a mean CAL gain of 3.0 +/- 0.8 mm compared to baseline. Corresponding values for patients treated with ABS were 3.4 +/- 0.8 mm and 2.9 +/- 0.9 mm, whereas OFD sites produced values of 2.8 +/- 0.8 mm and 1.6 +/- 0.7 mm. Compared to OFD, the additional CAL gain was significantly greater in patients treated with BCC (P=0.002) and ABS (P=0.001). The additional PD reduction was significant for the BCC group (P=0.011) and borderline significant for the ABS group (P=0.059). There were no significant differences of PD and CAL changes between BCC and ABS groups.
   Conclusions: The clinical benefits of BCC were equivalent to ABS and superior to OFD alone. BCC may be an appropriate alternative to conventional graft materials. J Periodontol 2009;80:1774-1782.
C1 [Stein, Jamal M.; Yekta, Sareh Said; Hoischen, Ulrich] Univ Hosp Aachen, Dept Operat Dent Periodontol & Prevent Dent, D-52074 Aachen, Germany.
   [Fickl, Stefan] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA.
   [Ocklenburg, Christina] Univ Hosp Aachen, Inst Med Stat, D-52074 Aachen, Germany.
   [Smeets, Ralf] Univ Hosp Aachen, Dept Oral & Maxillofacial Surg, D-52074 Aachen, Germany.
RP Stein, JM (reprint author), Univ Hosp Aachen, Dept Operat Dent Periodontol & Prevent Dent, Pauwelsstr 30, D-52074 Aachen, Germany.
EM jstein@ukaachen.de
OI Said Yekta-Michael, Sareh/0000-0003-1186-9417
FU Biocomposites, Keele, United Kingdom
FX The study was supported, in part, by Biocomposites, Keele, United
   Kingdom. The authors report no conflicts of interest related to this
   study.
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Bhatavadekar NB, 2008, J PERIODONTOL, V79, P1802, DOI [10.1902/jop.2008.070636, 10.1902/jop.2008.070636 ]
   BOWEN JA, 1989, J PERIODONTOL, V60, P647, DOI 10.1902/jop.1989.60.12.647
   BOWERS GM, 1989, J PERIODONTOL, V60, P675, DOI 10.1902/jop.1989.60.12.675
   Camargo PM, 2000, J CLIN PERIODONTOL, V27, P889, DOI 10.1034/j.1600-051x.2000.027012889.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Caplanis N, 1998, J CLIN PERIODONTOL, V25, P801, DOI 10.1111/j.1600-051X.1998.tb02373.x
   Cooper JJ, 2006, T 31 ANN M BIOM PITT, P592
   Cortellini P, 1999, INT J PERIODONT REST, V19, P589
   CORTELLINI P, 1995, J PERIODONTOL, V66, P261, DOI 10.1902/jop.1995.66.4.261
   Dybvik T, 2007, J PERIODONTOL, V78, P403, DOI 10.1902/jop.2007.060263
   Francetti L, 2005, INT J PERIODONT REST, V25, P461
   FROUM SJ, 1983, J PERIODONTOL, V54, P67, DOI 10.1902/jop.1983.54.2.67
   FROUM SJ, 1976, J PERIODONTOL, V47, P287, DOI 10.1902/jop.1976.47.5.287
   Froum SJ, 1998, J PERIODONTOL, V69, P698, DOI 10.1902/jop.1998.69.6.698
   GALGUT PN, 1992, J CLIN PERIODONTOL, V19, P570, DOI 10.1111/j.1600-051X.1992.tb00685.x
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x
   Hanes Philip J, 2007, Oral Maxillofac Surg Clin North Am, V19, P499, DOI 10.1016/j.coms.2007.06.001
   Kasaj A, 2008, J PERIODONTOL, V79, P394, DOI [10.1902/jop.2008.070378, 10.1902/jop.2008.070378 ]
   Kim CK, 1998, J PERIODONTOL, V69, P982, DOI 10.1902/jop.1998.69.9.982
   LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610
   Machtei EE, 2001, J PERIODONTOL, V72, P512, DOI 10.1902/jop.2001.72.4.512
   Mellonig JT, 2000, INT J PERIODONT REST, V20, P19
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   Needleman I, 2002, J PERIODONTAL RES, V37, P380, DOI 10.1034/j.1600-0765.2002.01369.x
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Nevins ML, 2000, INT J PERIODONT REST, V20, P459
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Orsini M, 2001, J PERIODONTOL, V72, P296, DOI 10.1902/jop.2001.72.3.296
   RENVERT S, 1985, J CLIN PERIODONTOL, V12, P707, DOI 10.1111/j.1600-051X.1985.tb01396.x
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   Ricci JL, 2000, BONE ENG, P332
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Shirakata Y, 2008, J PERIODONTOL, V79, P25, DOI 10.1902/jop.2008.070141 
   Smeets Ralf, 2009, Head Face Med, V5, P13, DOI 10.1186/1746-160X-5-13
   Smith IO, 2004, J BIOMED MATER RES A, V70A, P436, DOI 10.1002/jbm.a.30098
   SNYDER AJ, 1984, J PERIODONTOL, V55, P273, DOI 10.1902/jop.1984.55.5.273
   STAHL SS, 1986, J PERIODONTOL, V57, P211, DOI 10.1902/jop.1986.57.4.211
   STAHL SS, 1983, J PERIODONTOL, V54, P325, DOI 10.1902/jop.1983.54.6.325
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Teng NC, 2001, J DENT RES, V80, P1925, DOI 10.1177/00220345010800101201
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Tonetti MS, 1996, J CLIN PERIODONTOL, V23, P548, DOI 10.1111/j.1600-051X.1996.tb01823.x
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
NR 54
TC 18
Z9 21
U1 1
U2 6
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD NOV
PY 2009
VL 80
IS 11
BP 1774
EP 1782
DI 10.1902/jop.2009.090229
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 520IC
UT WOS:000271836200012
PM 19905932
DA 2018-10-20
ER

PT J
AU Etienne, O
   Schneider, A
   Kluge, JA
   Bellemin-Laponnaz, C
   Polidori, C
   Leisk, GG
   Kaplan, DL
   Garlick, JA
   Egles, C
AF Etienne, Olivier
   Schneider, Aurore
   Kluge, Jonathan A.
   Bellemin-Laponnaz, Claire
   Polidori, Camille
   Leisk, Gary G.
   Kaplan, David L.
   Garlick, Jonathan A.
   Egles, Christophe
TI Soft Tissue Augmentation Using Silk Gels: An In Vitro and In Vivo Study
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Biocompatible materials; fibroblasts; grafts; regeneration; silk
ID BOMBYX-MORI SILK; POLY(ETHYLENE OXIDE); FIBROIN; BIOMATERIALS;
   SCAFFOLDS; MATRIX; DEGRADATION; INSECTS; SPIDERS; CELLS
AB Background: Restoration of a three-dimensional shape with soft tissue augmentation is a challenge for surgical reconstruction and esthetic improvement of intraoral mucosa and perioral skin tissues. A connective tissue graft or free gingival graft, classically used for such indications, requires a donor site, which may lead to various clinical complications.
   Methods: In this article, a new three-dimensional scaffold made of silk fibroin that could be of great interest for these indications was studied. Mechanical tests were conducted to characterize the physical properties of the materials. The biocompatibility of such scaffolds was positively assessed in vitro using a combination of immunostaining, 5-bromo-2'-deoxyuridine proliferation assays, and histologic staining. Finally, the shaped material was grafted subcutaneously in nude mice for a long-time implantation study.
   Results: Human fibroblasts embedded in this material had a survival rate up to 68.4% and were able to proliferate and synthesize proteins. One month after subcutaneous implantation, the three-dimensional soft tissue augmentation was stable, and histologic analysis revealed revascularization of the area through the biomaterial. A mild inflammatory reaction disappeared after 12 weeks.
   Conclusion: The results indicate that silk-gel material was able to create a lasting three-dimensional soft tissue augmentation and is a promising biomaterial for periodontal and maxillofacial therapies, either as a scaffold for cells or alone as a biomaterial. J Periodontol 2009;80:1852-1858.
C1 [Etienne, Olivier; Schneider, Aurore; Bellemin-Laponnaz, Claire; Polidori, Camille; Garlick, Jonathan A.; Egles, Christophe] Tufts Univ, Sch Dent Med, Div Canc Biol & Tissue Engn, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA.
   [Etienne, Olivier] Univ Strasbourg, Dept Prosthodont, Sch Dent Med, Strasbourg, France.
   [Schneider, Aurore] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   [Kluge, Jonathan A.; Leisk, Gary G.; Kaplan, David L.; Garlick, Jonathan A.; Egles, Christophe] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Leisk, Gary G.] Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
RP Egles, C (reprint author), Tufts Univ, Sch Dent Med, Div Canc Biol & Tissue Engn, Dept Oral & Maxillofacial Pathol, 136 Harrison Ave,Room SC116, Boston, MA 02111 USA.
EM christophe.egles@tufts.edu
RI etienne, olivier/D-9542-2011; ETIENNE, olivier/D-1601-2013
OI ETIENNE, olivier/0000-0001-8870-4659; EGLES,
   Christophe/0000-0003-0982-7752
FU NIDCR NIH HHS [R01 DE017413, R01 DE017413-01A1, R01 DE017413-02]
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   al-Maseeh J, 2003, COMPEND CONTIN ED DE, V24
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Ashinoff R, 2000, CLIN PLAST SURG, V27, P479
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Cohen Alan S., 1994, Current Opinion in Rheumatology, V6, P55, DOI 10.1097/00002281-199401000-00010
   Dadzie OE, 2008, J CUTAN PATHOL, V35, P536, DOI 10.1111/j.1600-0560.2007.00853.x
   ELSON ML, 1995, DERMATOL SURG, V21, P491, DOI 10.1111/j.1524-4725.1995.tb00252.x
   ELSON ML, 1995, DERMATOL SURG, V21, P501
   Evian CI, 2003, COMPEND CONTIN ED DE, V24, P200
   Evian CI, 2003, COMPEND CONTIN ED DE, V24, P204
   Evian Cyril I, 2003, Compend Contin Educ Dent, V24, P195
   Fowler E B, 2001, J Contemp Dent Pract, V2, P31
   Frodel JL, 1998, ARCH OTOLARYNGOL, V124, P1219, DOI 10.1001/archotol.124.11.1219
   Gapski R, 2005, J PERIODONTOL, V76, P1814, DOI 10.1902/jop.2005.76.11.1814
   Griffin TJ, 2006, J PERIODONTOL, V77, P2070, DOI 10.1092/jop.2006.050296
   Hanke CW, 1997, COSMETIC SURG SKIN, P217
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Inoue K, 1985, Dent Mater J, V4, P47
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Masuda T, 2004, TISSUE ENG, V10, P1672, DOI 10.1089/ten.2004.10.1672
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   NGUYEN A, 1990, PLAST RECONSTR SURG, V85, P378, DOI 10.1097/00006534-199003000-00007
   Oates Thomas W, 2003, Ann Periodontol, V8, P303, DOI 10.1902/annals.2003.8.1.303
   Pascal P, 2000, MED BIOL ENG COMPUT, V38, P241, DOI 10.1007/BF02344783
   Perenack J, 2002, J ORAL MAXIL SURG, V60, P415, DOI 10.1053/joms.2002.31229
   Seibert J S, 1993, Dent Clin North Am, V37, P265
   Seibert J S, 1983, Compend Contin Educ Dent, V4, P437
   Seibert JS, 1996, PERIODONTOL 2000, V11, P69, DOI 10.1111/j.1600-0757.1996.tb00185.x
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   STRIETZEL FP, 2001, ORAL MAXILLOFACIAL S, V5, P28
   Studer S, 1997, Quintessence Int, V28, P785
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Winter GD, 1972, EPIDERMAL WOUND HEAL, P71
NR 43
TC 34
Z9 38
U1 1
U2 29
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD NOV
PY 2009
VL 80
IS 11
BP 1852
EP 1858
DI 10.1902/jop.2009.090231
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 520IC
UT WOS:000271836200021
PM 19905955
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kon, E
   Delcogliano, M
   Filardo, G
   Altadonna, G
   Marcacci, M
AF Kon, Elizaveta
   Delcogliano, M.
   Filardo, G.
   Altadonna, G.
   Marcacci, M.
TI Novel nano-composite multi-layered biomaterial for the treatment of
   multifocal degenerative cartilage lesions
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE Osteochondral defect; Degenerative lesions; Biomimetic scaffold;
   Cartilage regeneration
AB We report on a 46-year-old athletic patient, previously treated with anterior cruciate ligament reconstruction, with large degenerative chondral lesions of the medial femoral condyle, trochlea and patella, which was successfully treated with a closing-wedge high tibial osteotomy and the implant of a newly developed biomimetic nanostructured osteochondral bioactive scaffold. After 1 year of follow-up the patient was pain-free, had full knee range of motion, and had returned to his pre-operation level of athletic activity. MRI evaluation at 6 months showed that the implant gave a hyaline-like signal as well as a good restoration of the articular surface, with minimal subchondral bone oedema. Subchondral oedema was almost non-visible at 12 months.
C1 [Kon, Elizaveta; Delcogliano, M.; Filardo, G.; Altadonna, G.; Marcacci, M.] Rizzoli Orthopaed Inst, Dept Orthopaed & Sports Trauma, Biomech Lab, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Dept Orthopaed & Sports Trauma, Biomech Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
CR Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Kon E., 2007, OSTEOARTHR CARTIL S2, V15, pB76
   Kramer J, 2006, CELL MOL LIFE SCI, V63, P616, DOI 10.1007/s00018-005-5527-z
   Marcacci M, 2007, OSTEOARTHR CARTILAGE, V15, pB11
   Marcacci M, 2007, KNEE SURG SPORT TR A, V15, P610, DOI 10.1007/s00167-006-0265-9
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
NR 8
TC 49
Z9 52
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD NOV
PY 2009
VL 17
IS 11
BP 1312
EP 1315
DI 10.1007/s00167-009-0819-8
PG 4
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 514TG
UT WOS:000271417900006
PM 19468711
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Miljkovic, ND
   Lin, YC
   Cherubino, M
   Minteer, D
   Marra, KG
AF Miljkovic, Natasa D.
   Lin, Yen-Chih
   Cherubino, Mario
   Minteer, Danielle
   Marra, Kacey G.
TI A novel injectable hydrogel in combination with a surgical sealant in a
   rat knee osteochondral defect model
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE Osteochondral defect; Hydrogel; Surgical sealant
ID MESENCHYMAL STEM-CELLS; FIBROBLAST GROWTH FACTOR-2; POLY(ETHYLENE
   GLYCOL); ARTICULAR-CARTILAGE; IN-VITRO; EXTRACELLULAR-MATRIX; RABBIT
   MODEL; REPAIR; DEGRADATION; SCAFFOLDS
AB Osteochondral defects are frequent, painful, debilitating and expensive to treat, often resulting in poor results. The goal of the present study was to synthesize and characterize a novel biocompatible and biodegradable hydrogel comprised of poly(ethylene glycol), gelatin, and genipin, and examine the hydrogel as an injectable biomaterial in combination with a cyanoacrylate-based surgical sealant for cartilage repair. An osteochondral knee defect was generated in 24 rats, then the hydrogel, with or without a surgical sealant, was injected into the defect and followed for 14 days. The results demonstrated that the hydrogel is biocompatible and biodegradable, and that the cyanoacrylate-based surgical sealant is a relatively safe option for maintaining the hydrogel in the defect. This is the first study describing a cyanoacrylate-based surgical sealant in combination with a polymer hydrogel for cartilage repair.
C1 [Miljkovic, Natasa D.; Lin, Yen-Chih; Cherubino, Mario; Marra, Kacey G.] Univ Pittsburgh, Dept Surg, Div Plast Surg, Pittsburgh, PA 15261 USA.
   [Minteer, Danielle; Marra, Kacey G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Marra, Kacey G.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA.
RP Marra, KG (reprint author), Univ Pittsburgh, Dept Surg, Div Plast Surg, 1655E Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.
EM marrak@upmc.edu
RI Cherubino, Mario/C-2806-2017
OI Cherubino, Mario/0000-0003-1196-3075; Marra, Kacey/0000-0002-8437-4864
CR Aaron RK, 2006, ANN NY ACAD SCI, V1068, P513, DOI 10.1196/annals.1346.045
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Centers for Disease Control and Prevention (CDC), ARTHR
   Charlton DC, 2008, TISSUE ENG PT A, V14, P207, DOI 10.1089/ten.a.2006.0344
   COLE JE, 1964, J NEUROSURG, V21, P884
   Dickhut A, 2008, FRONT BIOSCI, V13, P4517, DOI 10.2741/3020
   Ferretti M, 2006, TISSUE ENG, V12, P2657, DOI 10.1089/ten.2006.12.2657
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   Ishii I, 2007, J BONE JOINT SURG BR, V89B, P693, DOI 10.1302/0301-620X.89B5.18450
   Issa JPM, 2008, ANAT HISTOL EMBRYOL, V37, P181, DOI 10.1111/j.1439-0264.2007.00824.x
   Ito Y, 2005, ARTHROSCOPY, V21, P1155, DOI 10.1016/j.arthro.2005.06.016
   Kim JK, 2008, BIOMACROMOLECULES, V9, P149, DOI 10.1021/bm700924n
   Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031
   Kushibiki T, 2004, BIOMACROMOLECULES, V5, P202, DOI 10.1021/bm0343139
   LENAERTS V, 1984, BIOMATERIALS, V5, P65, DOI 10.1016/0142-9612(84)90002-4
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Lu LC, 2001, CLIN ORTHOP RELAT R, pS251
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Moffat KL, 2004, J BIOMED MATER RES B, V71B, P181, DOI 10.1002/jbm.b.30070
   Nakayama J, 2009, INT ORTHOP, V33, P275, DOI 10.1007/s00264-007-0459-x
   Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322
   PAPATHEOFANIS FJ, 1989, ARCH ORTHOP TRAUM SU, V108, P236, DOI 10.1007/BF00936207
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   PASSL R, 1989, Beitraege zur Orthopaedie und Traumatologie, V36, P503
   Perez M, 2000, ARTIF ORGANS, V24, P241, DOI 10.1046/j.1525-1594.2000.06519.x
   Schagemann JC, 2009, TISSUE ENG PT A, V15, P75, DOI 10.1089/ten.tea.2008.0087
   Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1
   Setlik DE, 2005, AM J OPHTHALMOL, V140, P920, DOI 10.1016/j.ajo.2005.04.062
   Sun G, 2008, J MATER SCI-MATER M, V19, P2865, DOI 10.1007/s10856-008-3410-9
   Tam HK, 2007, J ORTHOP RES, V25, P1136, DOI 10.1002/jor.20428
   TORIUMI DM, 1990, ARCH OTOLARYNGOL, V116, P546
   TORIUMI DM, 1991, LARYNGOSCOPE, V101, P339
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Wilson DJ, 2005, J BIOMAT SCI-POLYM E, V16, P449, DOI 10.1163/1568562053700200
   Xian Cory J, 2006, Curr Stem Cell Res Ther, V1, P213, DOI 10.2174/157488806776956904
NR 39
TC 6
Z9 6
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD NOV
PY 2009
VL 17
IS 11
BP 1326
EP 1331
DI 10.1007/s00167-009-0881-2
PG 6
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 514TG
UT WOS:000271417900008
PM 19633829
DA 2018-10-20
ER

PT J
AU Herrera, VLM
   Viereck, JC
   Lopez-Guerra, G
   Kumai, Y
   Kobler, J
   Karajanagi, S
   Park, H
   Hillman, R
   Zeitels, SM
AF Herrera, Victoria L. M.
   Viereck, Jason C.
   Lopez-Guerra, Gerardo
   Kumai, Yoshihiko
   Kobler, James
   Karajanagi, Sandeep
   Park, Hyoungshin
   Hillman, Robert
   Zeitels, Steven M.
TI 11.7 Tesla Magnetic Resonance Microimaging of Laryngeal Tissue
   Architecture
SO LARYNGOSCOPE
LA English
DT Article
DE 11.7 T MRI; microimaging; VF implants; vocal fold scar
ID MRI
AB Objectives/Hypothesis: High-resolution imaging of vocal folds that distinguishes vocal fold (VF) layered microstructure and VF implants would provide a key experimental tool for translational research investigating biomaterial-based interventions to treat vocal fold scar. To establish proof of concept, we studied whether 11.7 Tesla (T) magnetic resonance (MR) microimaging provides the needed resolution to resolve vocal fold tissue architecture.
   Study Design: We performed ex vivo MR microimaging of fixed ferret and canine larynges to determine whether changes in the layered architecture can be detected in the presence of scar and subsequent to biomaterial injections into the vocal folds. Serial section histological analyses were done to corroborate MR microimaging findings.
   Methods: Multiple axial and transverse/coronal 300-mu m slices were obtained using an 11.7 T MR speetrometer/500 MHz for proton with gradient-recalled echo and rapid acquisition with relaxation enhancement imaging sequences.
   Results: High-resolution (39 mu m/pixel) MR microimages distinguished VF epithelium, lamina propria, muscle, and cartilage in ferret and canine larynges. In ferret scarred VFs (n = 25), collagen-rich dense scar tissue was distinguishable from contralateral nonscarred VFs and from normal ferret VFs (n = 25), as confirmed on histology. MR microimaging accurately detected injected autologous fat, hyaluronic acid-based and polyethylene glycol (PEG)based implants injected into both ferret and canine VFs. Importantly, MRI accurately showed resorption of PEG implants in ferrets and canines, as confirmed on histology. Additionally, ex vivo MR spectroscopy distinguished fat from PEG-based implants.
   Conclusions: Ex vivo 11.7 T MR microimaging provided high-resolution images of ferret and canine laryngeal tissue microstructure, although the superficial lamina propria could not be distinguished. Histology confirmed MR microimaging findings, indicating utility of MR microimaging of modeled scar, implant residence time, and tissue responses, thus providing integrative insight relevant to translational research.
C1 [Herrera, Victoria L. M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   [Viereck, Jason C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.
   [Lopez-Guerra, Gerardo; Kumai, Yoshihiko; Kobler, James; Karajanagi, Sandeep; Park, Hyoungshin; Hillman, Robert; Zeitels, Steven M.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA.
RP Herrera, VLM (reprint author), Boston Univ, Sch Med, Dept Med, 700 Albany St,Room W-609, Boston, MA 02118 USA.
EM vherrera@bu.edu
OI Lopez-Guerra, Gerardo/0000-0003-0305-4680
FU Institute of Laryngeal and Voice Restoration; Eugene B. Casey Foundation
FX This work was supported by the Institute of Laryngeal and Voice
   Restoration and the Eugene B. Casey Foundation.
CR Ahmad M, 2009, J VOICE, V23, P235, DOI 10.1016/j.jvoice.2007.08.008
   Berkiten Guler, 2002, Kulak Burun Bogaz Ihtis Derg, V9, P203
   Brandenburg JH, 1996, LARYNGOSCOPE, V106, P174, DOI 10.1097/00005537-199602000-00013
   Bryant NJ, 1996, LARYNGOSCOPE, V106, P1386, DOI 10.1097/00005537-199611000-00015
   Decano JL, 2009, CIRCULATION, V119, P1501, DOI 10.1161/CIRCULATIONAHA.108.833327
   FORD CN, 1995, LARYNGOSCOPE, V105, P498, DOI 10.1288/00005537-199505000-00010
   Hirano S, 2004, LARYNGOSCOPE, V114, P2161, DOI 10.1097/01.mlg.0000149450.37640.db
   Kumai Y, 2009, LARYNGOSCOPE, V119, P799, DOI 10.1002/lary.20149
   Moonis G, 2005, ANN OTO RHINOL LARYN, V114, P593, DOI 10.1177/000348940511400803
   Oysu Cagatay, 2004, Kulak Burun Bogaz Ihtis Derg, V13, P67
   Pirko Istvan, 2005, NeuroRx, V2, P250, DOI 10.1602/neurorx.2.2.250
   Shenkar R, 2008, NEUROSURGERY, V63, P790, DOI 10.1227/01.NEU.0000315862.24920.49
   Sosnovik DE, 2008, BASIC RES CARDIOL, V103, P122, DOI 10.1007/s00395-008-0710-7
   Sosnovik David E, 2008, Top Magn Reson Imaging, V19, P59, DOI 10.1097/RMR.0b013e318176c57b
   TUCKER GF, 1971, HUMAN LARYNX CORONAL
   ZABREN P, 1996, CANCER, V77, P1263
NR 16
TC 11
Z9 12
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0023-852X
J9 LARYNGOSCOPE
JI Laryngoscope
PD NOV
PY 2009
VL 119
IS 11
BP 2187
EP 2194
DI 10.1002/lary.20643
PG 8
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA 518LG
UT WOS:000271692900019
PM 19824052
DA 2018-10-20
ER

PT J
AU Park, DH
   Eve, DJ
AF Park, Dong-Hyuk
   Eve, David J.
TI Regenerative medicine: Advances in new methods and technologies
SO MEDICAL SCIENCE MONITOR
LA English
DT Review
DE biomaterial; cell transplantation; pre-treatment; regenerative medicine;
   stem cell; tissue engineering
ID MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; NEURAL PROGENITOR CELLS;
   LONG-TERM SURVIVAL; RAT SPINAL-CORD; MARROW-DERIVED STEM; TRANSGENIC
   MOUSE MODEL; MUSCLE PRECURSOR CELLS; SPINOCEREBELLAR ATAXIA TYPE-1;
   CONVECTION-ENHANCED DELIVERY
AB The articles published in the journal Cell Transplantation - The Regenerative Medicine Journal over the last two years reveal the recent and future cutting-edge research in the fields of regenerative and transplantation medicine. 437 articles were published from 2007 to 2008, a 17% increase compared to the 373 articles in 2006-2007. Neuroscience was still the most common section in both the number of articles and the percentage of all manuscripts published. The increasing interest and rapid advance in bioengineering technology is highlighted by tissue engineering and bioartificial organs being ranked second again. For a similar reason, the methods and new technologies section increased significantly compared to the last period. Articles focusing on the transplantation of stem cell lineages encompassed almost 20% of all articles published. By contrast, the non-stem cell transplantation group which is made up primarily of islet cells, followed by biomaterials and fetal neural tissue, etc. comprised less than 15%. Transplantation of cells pre-treated with medicine or gene transfection to prolong graft survival or promote differentiation into the needed phenotype, was prevalent in the transplantation articles regardless of the kind of cells used. Meanwhile, the majority of non-transplantation-based articles were related to new devices for various purposes, characterization of unknown cells, medicines, cell preparation and/or optimization for transplantation (e.g. isolation and culture), and disease pathology.
C1 [Park, Dong-Hyuk; Eve, David J.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.
   [Park, Dong-Hyuk] Korea Univ, Coll Med, Korea Univ Med Ctr, Dept Neurosurg, Seoul 136705, South Korea.
RP Eve, DJ (reprint author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, MDC-78,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.
EM deve@health.usf.edu
CR Abbah SA, 2008, CELL TRANSPLANT, V17, P1181, DOI 10.3727/096368908787236648
   Ablamunits V, 2007, CELL TRANSPLANT, V16, P375, DOI 10.3727/000000007783464830
   Acosta SA, 2008, CELL TRANSPLANT, V17, P457
   af Bjerken S, 2007, CELL TRANSPLANT, V16, P315
   Agrawal A, 2008, CELL TRANSPLANT, V17, P1315, DOI 10.3727/096368908787648065
   AIRAVAARA M, 2008, CELL TRANSPLANT, V17, P457
   Akesson E, 2008, CELL TRANSPLANT, V17, P1115, DOI 10.3727/096368908787236585
   Alberti E, 2009, MED SCI MONITOR, V15, pBR47
   Ali MM, 2008, CELL TRANSPLANT, V17, P458
   Alvarez-Mercado AI, 2008, CELL TRANSPLANT, V17, P845, DOI 10.3727/096368908786516837
   Amable R, 2007, CELL TRANSPLANT, V16, P313
   Amable RJ, 2008, CELL TRANSPLANT, V17, P458
   Andres RH, 2008, CELL TRANSPLANT, V17, P458
   Arefanian H, 2007, CELL TRANSPLANT, V16, P787, DOI 10.3727/000000007783465244
   Asiedu C, 2008, CELL TRANSPLANT, V17, P713, DOI 10.3727/096368908786092748
   Astradsson A, 2008, CELL TRANSPLANT, V17, P459
   Azari H, 2008, CELL TRANSPLANT, V17, P459
   Aziz MTA, 2008, MED SCI MONITOR, V14, pBR249
   Bachstetter AD, 2008, CELL TRANSPLANT, V17, P459
   Bachstetter AD, 2007, CELL TRANSPLANT, V16, P313
   Badri VK, 2008, CELL TRANSPLANT, V17, P460
   Bagga V, 2008, CELL TRANSPLANT, V17, P763, DOI 10.3727/096368908786516774
   Bakay RAE, 2008, CELL TRANSPLANT, V17, P460
   Bankiewicz K, 2008, CELL TRANSPLANT, V17, P460
   Barone TA, 2008, CELL TRANSPLANT, V17, P461
   Behrstock S, 2008, CELL TRANSPLANT, V17, P753, DOI 10.3727/096368908786516819
   Benabdallah BF, 2008, CELL TRANSPLANT, V17, P337, DOI 10.3727/096368908784153913
   Berglof E, 2007, CELL TRANSPLANT, V16, P314
   Bespalov MM, 2007, CELL TRANSPLANT, V16, P314
   Bidzan L, 2008, MED SCI MONITOR, V14, pCR473
   Bierinx AS, 2008, CELL TRANSPLANT, V17, P1193, DOI 10.3727/096368908787236530
   Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507
   Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409
   Bjugstad KB, 2007, CELL TRANSPLANT, V16, P315
   Block A, 2008, MED SCI MONITOR, V14, pBR88
   Bobek V, 2008, CELL TRANSPLANT, V17, P461
   Boger HA, 2008, CELL TRANSPLANT, V17, P461
   Bohman S, 2007, CELL TRANSPLANT, V16, P15, DOI 10.3727/000000007783464452
   Boldrin L, 2008, CELL TRANSPLANT, V17, P577, DOI 10.3727/096368908785095980
   Bombard MC, 2008, CELL TRANSPLANT, V17, P462
   Borlongan CV, 2008, CELL TRANSPLANT, V17, P462
   Borlongan CV, 2007, CELL TRANSPLANT, V16, P987, DOI 10.3727/000000007783472426
   Bosio E, 2008, CELL TRANSPLANT, V17, P587, DOI 10.3727/096368908786092784
   Braithwaite J, 2007, REGUL GOV, V1, P1, DOI 10.1111/j.1748-5991.2007.00006.x
   Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800
   Brock JH, 2007, CELL TRANSPLANT, V16, P315
   Bruder JM, 2007, CELL TRANSPLANT, V16, P316
   Buzzeo MP, 2008, CELL TRANSPLANT, V17, P489, DOI 10.3727/096368908785096042
   Cabrera O, 2007, CELL TRANSPLANT, V16, P1039, DOI 10.3727/000000007783472408
   Callewaert H, 2007, CELL TRANSPLANT, V16, P527, DOI 10.3727/000000007783464948
   Carty N, 2008, CELL TRANSPLANT, V17, P462
   Carty N, 2007, CELL TRANSPLANT, V16, P316
   Carvey PM, 2008, CELL TRANSPLANT, V17, P463
   Carvey PM, 2007, CELL TRANSPLANT, V16, P316
   Casella GTB, 2007, CELL TRANSPLANT, V16, P317
   Cass WA, 2007, CELL TRANSPLANT, V16, P317
   Chachques JC, 2007, CELL TRANSPLANT, V16, P927, DOI 10.3727/096368907783338217
   Chadashvili T, 2007, CELL TRANSPLANT, V16, P317
   Chang YC, 2007, CELL TRANSPLANT, V16, P171
   Chao KC, 2008, CELL TRANSPLANT, V17, P657, DOI 10.3727/096368908786092801
   Chen JC, 2008, CELL TRANSPLANT, V17, P495, DOI 10.3727/096368908785095971
   Chen K, 2007, CELL TRANSPLANT, V16, P799, DOI 10.3727/000000007783465253
   Chen N, 2007, CELL TRANSPLANT, V16, P318
   Cheng YH, 2007, CELL TRANSPLANT, V16, P318
   Cho SW, 2007, CELL TRANSPLANT, V16, P421, DOI 10.3727/000000007783464795
   Choi CYU, 2007, CELL TRANSPLANT, V16, P663, DOI 10.3727/000000007783465037
   Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471
   Cobianchi L, 2008, CELL TRANSPLANT, V17, P559, DOI 10.3727/096368908785096060
   Collier TJ, 2007, CELL TRANSPLANT, V16, P318
   COLLIER TJ, 2008, CELL TRANSPLANT, V17, P457
   Coolen NA, 2007, CELL TRANSPLANT, V16, P649, DOI 10.3727/000000007783465046
   Davalli AM, 2008, CELL TRANSPLANT, V17, P1323, DOI 10.3727/096368908787648137
   Denovan-Wright E, 2007, CELL TRANSPLANT, V16, P319
   Desai BS, 2007, CELL TRANSPLANT, V16, P319
   Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731
   Dey ND, 2007, CELL TRANSPLANT, V16, P319
   Diaz-Ruiz O, 2008, CELL TRANSPLANT, V17, P463
   Ding DC, 2007, CELL TRANSPLANT, V16, P273, DOI 10.3727/000000007783464777
   Dobrossy MD, 2008, CELL TRANSPLANT, V17, P1125
   Donato MT, 2008, CELL TRANSPLANT, V17, P1211, DOI 10.3727/096368908787236620
   Ducray A, 2008, CELL TRANSPLANT, V17, P463
   Ducray AD, 2007, CELL TRANSPLANT, V16, P320
   Dufour JM, 2008, CELL TRANSPLANT, V17, P525, DOI 10.3727/096368908785096033
   Dufour JM, 2007, CELL TRANSPLANT, V16, P1029, DOI 10.3727/000000007783472417
   Ei-Badri N, 2008, CELL TRANSPLANT, V17, P464
   Eidelberg D, 2008, CELL TRANSPLANT, V17, P464
   Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461
   Emborg EM, 2007, CELL TRANSPLANT, V16, P320
   Emborg ME, 2008, CELL TRANSPLANT, V17, P383
   Emborg ME, 2007, CELL TRANSPLANT, V16, P185, DOI 10.3727/000000007783464722
   Emerich DF, 2007, CELL TRANSPLANT, V16, P697, DOI 10.3727/000000007783465145
   Emerich DF, 2007, CELL TRANSPLANT, V16, P435, DOI 10.3727/000000007783464867
   Engelsberg K, 2007, CELL TRANSPLANT, V16, P31, DOI 10.3727/000000007783464506
   Estrada EJ, 2008, CELL TRANSPLANT, V17, P1295, DOI 10.3727/096368908787648119
   Eve DJ, 2008, CELL TRANSPLANT, V17, P464
   Eve DJ, 2007, CELL TRANSPLANT, V16, P867, DOI 10.3727/000000007783465190
   Eve DJ, 2007, CELL TRANSPLANT, V16, P751, DOI 10.3727/000000007783465136
   Fan HB, 2007, CELL TRANSPLANT, V16, P823, DOI 10.3727/000000007783465181
   Fan HB, 2008, CELL TRANSPLANT, V17, P1389, DOI 10.3727/096368908787648047
   Fenjves ES, 2008, CELL TRANSPLANT, V17, P793, DOI 10.3727/096368908786516828
   Ferrari A, 2007, CELL TRANSPLANT, V16, P320
   Ferrero I, 2008, CELL TRANSPLANT, V17, P255, DOI 10.3727/096368908784153940
   Formisano R, 2009, MED SCI MONITOR, V15, pCR101
   Fort A, 2008, CELL TRANSPLANT, V17, P997, DOI 10.3727/096368908786991498
   Foust KD, 2007, CELL TRANSPLANT, V16, P321
   Freed WJ, 2008, CELL TRANSPLANT, V17, P465
   Freeman L, 2008, CELL TRANSPLANT, V17, P465
   Freeman L, 2007, CELL TRANSPLANT, V16, P321
   Freeman TB, 2008, CELL TRANSPLANT, V17, P465
   French KL, 2007, CELL TRANSPLANT, V16, P197, DOI 10.3727/000000007783464759
   Friberg AS, 2008, CELL TRANSPLANT, V17, P1305, DOI 10.3727/096368908787648100
   Fujita S, 2008, CELL TRANSPLANT, V17, P1169, DOI 10.3727/096368908787236611
   Furmanski O, 2008, CELL TRANSPLANT, V17, P466
   Furmanski O, 2007, CELL TRANSPLANT, V16, P321
   Gajavelli S, 2008, CELL TRANSPLANT, V17, P466
   Gajavelli S, 2007, CELL TRANSPLANT, V16, P322
   Gajavelli S, 2008, CELL TRANSPLANT, V17, P445
   Galoyan AA, 2008, CELL TRANSPLANT, V17, P1061, DOI 10.3727/096368908786991579
   Gao Y, 2007, CELL TRANSPLANT, V16, P322
   Gao YX, 2008, CELL TRANSPLANT, V17, P723, DOI 10.3727/096368908786516729
   Garbuzova-Davis S, 2008, CELL TRANSPLANT, V17, P466
   GARBUZOVADAVIS SN, 2007, CELL TRANSPLANT, V16, P323
   Garkavenko O, 2008, CELL TRANSPLANT, V17, P1381, DOI 10.3727/096368908787648056
   Gastens MH, 2007, CELL TRANSPLANT, V16, P685, DOI 10.3727/000000007783465172
   Gazda LS, 2007, CELL TRANSPLANT, V16, P609, DOI 10.3727/000000007783465028
   Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074
   Gemma C, 2008, CELL TRANSPLANT, V17, P467
   Ghosh D, 2008, CELL TRANSPLANT, V17, P351, DOI 10.3727/096368908784153869
   Gimi B, 2007, CELL TRANSPLANT, V16, P403, DOI 10.3727/000000007783464803
   Golat BT, 2008, CELL TRANSPLANT, V17, P1135, DOI 10.3727/096368908787236512
   Granholm AC, 2008, CELL TRANSPLANT, V17, P467
   Granholm AC, 2007, CELL TRANSPLANT, V16, P324
   Grondin R, 2008, CELL TRANSPLANT, V17, P373
   Grondin R, 2007, CELL TRANSPLANT, V16, P324
   Gross RE, 2008, CELL TRANSPLANT, V17, P467
   Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740
   Grumbles RM, 2007, CELL TRANSPLANT, V16, P324
   Gunji T, 2008, CELL TRANSPLANT, V17, P619, DOI 10.3727/096368908786092720
   Guo W, 2007, CELL TRANSPLANT, V16, P325
   Hanson MS, 2008, CELL TRANSPLANT, V17, P1337, DOI 10.3727/096368908787648038
   Harvey BK, 2007, CELL TRANSPLANT, V16, P483, DOI 10.3727/000000007783464984
   Hattiangady B, 2007, CELL TRANSPLANT, V16, P325
   Helbig G, 2008, MED SCI MONITOR, V14, pCR584
   Henning RJ, 2007, CELL TRANSPLANT, V16, P907, DOI 10.3727/096368907783338299
   Hentall ID, 2007, CELL TRANSPLANT, V16, P326
   Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363
   Hirose N, 2008, CELL TRANSPLANT, V17, P211, DOI 10.3727/000000008783906919
   Hodges H, 2007, CELL TRANSPLANT, V16, P101
   Honda MJ, 2007, CELL TRANSPLANT, V16, P833, DOI 10.3727/000000007783465208
   Horne PH, 2008, CELL TRANSPLANT, V17, P829, DOI 10.3727/096368908786516792
   Howland DR, 2007, CELL TRANSPLANT, V16, P326
   Hsu YC, 2007, CELL TRANSPLANT, V16, P133
   Hu CJ, 2008, CELL TRANSPLANT, V17, P1067, DOI 10.3727/096368908786991506
   Huang GP, 2007, CELL TRANSPLANT, V16, P579, DOI 10.3727/000000007783465073
   Huang L, 2007, CELL TRANSPLANT, V16, P887, DOI 10.3727/096368907783338181
   Huettl P, 2007, CELL TRANSPLANT, V16, P326
   Hunt DPJ, 2008, CELL TRANSPLANT, V17, P865, DOI 10.3727/096368908786516738
   Hwang P, 2007, CELL TRANSPLANT, V16, P327
   Imamura R, 2008, CELL TRANSPLANT, V17, P135, DOI 10.3727/000000008783907044
   Imamura T, 2008, CELL TRANSPLANT, V17, P267, DOI 10.3727/096368908784153850
   Iop L, 2008, CELL TRANSPLANT, V17, P679, DOI 10.3727/096368908786092739
   Irons HR, 2007, CELL TRANSPLANT, V16, P327
   Isacson O, 2008, CELL TRANSPLANT, V17, P468
   Ito D, 2007, CELL TRANSPLANT, V16, P1021, DOI 10.3727/000000007783472345
   Ito M, 2008, CELL TRANSPLANT, V17, P165, DOI 10.3727/000000008783906883
   Ito M, 2007, CELL TRANSPLANT, V16, P547, DOI 10.3727/000000007783464894
   Jha RK, 2008, MED SCI MONITOR, V14, pBR14
   Jiang Z, 2008, CELL TRANSPLANT, V17, P969, DOI 10.3727/096368908786576525
   Jones GL, 2007, CELL TRANSPLANT, V16, P505, DOI 10.3727/000000007783464993
   Gomez-Lechon MJ, 2008, CELL TRANSPLANT, V17, P887, DOI 10.3727/096368908786576534
   Juang JH, 2008, CELL TRANSPLANT, V17, P641, DOI 10.3727/096368908786092766
   JUNHUA Z, 2008, MED SCI MONITOR, V14, pRA1
   Kabatas S, 2008, CELL TRANSPLANT, V17, P468
   Kakinohana O, 2007, CELL TRANSPLANT, V16, P327
   Kamath SG, 2007, CELL TRANSPLANT, V16, P328
   Kanaan NM, 2007, CELL TRANSPLANT, V16, P328
   Karakostas T, 2008, CELL TRANSPLANT, V17, P468
   Kawazoe T, 2008, CELL TRANSPLANT, V17, P203, DOI 10.3727/000000008783906964
   Keene CD, 2008, CELL TRANSPLANT, V17, P469
   Kelly CM, 2007, CELL TRANSPLANT, V16, P328
   Kenmochi T, 2008, CELL TRANSPLANT, V17, P61, DOI 10.3727/000000008783907026
   KERN DS, 2007, CELL TRANSPLANT, V16, P329
   Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939
   Kim BG, 2007, CELL TRANSPLANT, V16, P355, DOI 10.3727/000000007783464885
   Kim DS, 2007, CELL TRANSPLANT, V16, P329
   Kim DS, 2007, CELL TRANSPLANT, V16, P117
   Kim DH, 2007, CELL TRANSPLANT, V16, P1007, DOI 10.3727/000000007783472381
   Kim JY, 2007, CELL TRANSPLANT, V16, P75, DOI 10.3727/000000007783464515
   Kim SM, 2007, CELL TRANSPLANT, V16, P330
   Kim YH, 2008, CELL TRANSPLANT, V17, P609, DOI 10.3727/096368908786092694
   Kin T, 2007, CELL TRANSPLANT, V16, P9, DOI 10.3727/000000007783464498
   Kinomura M, 2008, CELL TRANSPLANT, V17, P143, DOI 10.3727/000000008783907008
   Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560
   Klaffschenkel RA, 2007, CELL TRANSPLANT, V16, P587, DOI 10.3727/000000007783465091
   Kleim JA, 2007, CELL TRANSPLANT, V16, P330
   Klein JA, 2008, CELL TRANSPLANT, V17, P585, DOI 10.3727/096368908785096015
   Kleitman N, 2007, CELL TRANSPLANT, V16, P330
   Kobayashi M, 2008, CELL TRANSPLANT, V17, P291, DOI 10.3727/096368908784153904
   Kobayashi N, 2008, CELL TRANSPLANT, V17, P19, DOI 10.3727/000000008783906982
   Kobayashi N, 2008, CELL TRANSPLANT, V17, P11, DOI 10.3727/000000008783907107
   Kobayashi N, 2008, CELL TRANSPLANT, V17, P1, DOI 10.3727/000000008783906946
   Kobayashi N, 2008, CELL TRANSPLANT, V17, P3, DOI 10.3727/000000008783907099
   Kobayashi T, 2008, CELL TRANSPLANT, V17, P1243, DOI 10.3727/096368908787236602
   Koizumi T, 2007, CELL TRANSPLANT, V16, P67, DOI 10.3727/000000007783464489
   Kordower JH, 2008, CELL TRANSPLANT, V17, P469
   Kordower JH, 2008, CELL TRANSPLANT, V17, P361
   Koren J, 2007, CELL TRANSPLANT, V16, P330
   Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793
   Krynska B, 2008, CELL TRANSPLANT, V17, P469
   Kucukatay V, 2009, MED SCI MONITOR, V15, pBR88
   Kumaraswamy GK, 2008, CELL TRANSPLANT, V17, P469
   Kusaka M, 2008, CELL TRANSPLANT, V17, P129, DOI 10.3727/000000008783907116
   La Flamme KE, 2007, CELL TRANSPLANT, V16, P765, DOI 10.3727/000000007783465262
   Laconi S, 2008, CELL TRANSPLANT, V17, P1415, DOI 10.3727/096368908787648128
   Lakey JRT, 2007, CELL TRANSPLANT, V16, P441, DOI 10.3727/000000007783464849
   Lane MA, 2008, CELL TRANSPLANT, V17, P470
   Lane MA, 2007, CELL TRANSPLANT, V16, P331
   Lebson LA, 2008, CELL TRANSPLANT, V17, P470
   Lebson LA, 2007, CELL TRANSPLANT, V16, P331
   Lee DC, 2008, CELL TRANSPLANT, V17, P471
   Lee DC, 2007, CELL TRANSPLANT, V16, P331
   Lee IW, 2007, CELL TRANSPLANT, V16, P332
   Lee JK, 2007, CELL TRANSPLANT, V16, P849, DOI 10.3727/000000007783465271
   Lee JI, 2008, CELL TRANSPLANT, V17, P51, DOI 10.3727/000000008783907035
   Lee KW, 2007, CELL TRANSPLANT, V16, P629, DOI 10.3727/000000007783465019
   Leichtle SW, 2007, CELL TRANSPLANT, V16, P332
   Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444
   Li H, 2007, CELL TRANSPLANT, V16, P85, DOI 10.3727/000000007783464470
   Li Q, 2008, CELL TRANSPLANT, V17, P471
   Li Q, 2007, CELL TRANSPLANT, V16, P332
   Li QY, 2008, CELL TRANSPLANT, V17, P397
   Li S, 2007, CELL TRANSPLANT, V16, P539, DOI 10.3727/000000007783464957
   Li TS, 2008, CELL TRANSPLANT, V17, P695, DOI 10.3727/096368908786092702
   Li TS, 2007, CELL TRANSPLANT, V16, P365, DOI 10.3727/000000007783464858
   Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551
   Licznerski P, 2008, CELL TRANSPLANT, V17, P471
   Lieu CA, 2008, CELL TRANSPLANT, V17, P471
   Lieu CA, 2007, CELL TRANSPLANT, V16, P333
   Lim JY, 2008, CELL TRANSPLANT, V17, P472
   Lim JY, 2007, CELL TRANSPLANT, V16, P333
   Lin SZ, 2008, CELL TRANSPLANT, V17, P472
   Lin SZ, 2007, CELL TRANSPLANT, V16, P99, DOI 10.3727/000000007783464641
   LIN X, 2008, CELL TRANSPLANT, V17, P649
   Lindquist J, 2008, CELL TRANSPLANT, V17, P473
   Liu DD, 2008, CELL TRANSPLANT, V17, P473
   Liu Y, 2007, CELL TRANSPLANT, V16, P333
   Lockrow JP, 2007, CELL TRANSPLANT, V16, P334
   Lopez C, 2008, CELL TRANSPLANT, V17, P859, DOI 10.3727/096368908786516783
   Lu XM, 2008, CELL TRANSPLANT, V17, P1423, DOI 10.3727/096368908787648155
   Luan LM, 2008, CELL TRANSPLANT, V17, P417
   Lubansu A, 2007, CELL TRANSPLANT, V16, P1013, DOI 10.3727/000000007783472372
   Luo Y, 2008, CELL TRANSPLANT, V17, P473
   Macri R, 2008, CELL TRANSPLANT, V17, P473
   Madhavan L, 2008, CELL TRANSPLANT, V17, P474
   Magalhaes R, 2008, CELL TRANSPLANT, V17, P813, DOI 10.3727/096368908786516765
   Magnasco A, 2008, CELL TRANSPLANT, V17, P1157, DOI 10.3727/096368908787236567
   Mancarella R, 2008, CELL TRANSPLANT, V17, P1271, DOI 10.3727/096368908787236639
   Mandel RJ, 2007, CELL TRANSPLANT, V16, P334
   MANFREDSSON FP, 2007, CELL TRANSPLANT, V16, P335
   Marsala S, 2007, CELL TRANSPLANT, V16, P336
   Marschinke F, 2007, CELL TRANSPLANT, V16, P336
   Martinez I, 2008, CELL TRANSPLANT, V17, P987, DOI 10.3727/096368908786576499
   Marupudi NI, 2008, CELL TRANSPLANT, V17, P474
   Marupudi NI, 2007, CELL TRANSPLANT, V16, P337
   McGregor L, 2008, CELL TRANSPLANT, V17, P475
   Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190
   Melzi R, 2008, CELL TRANSPLANT, V17, P1361, DOI 10.3727/096368908787648146
   Mervis RF, 2008, CELL TRANSPLANT, V17, P475
   Michell AW, 2007, CELL TRANSPLANT, V16, P461, DOI 10.3727/000000007783464911
   Miyagi S, 2008, CELL TRANSPLANT, V17, P173, DOI 10.3727/000000008783906874
   Monahan AJ, 2007, CELL TRANSPLANT, V16, P337
   Monahan AJ, 2008, CELL TRANSPLANT, V17, P363
   Montolio M, 2007, CELL TRANSPLANT, V16, P517, DOI 10.3727/000000007783464920
   Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756
   Mufson EJ, 2007, CELL TRANSPLANT, V16, P337
   Munoz JR, 2007, CELL TRANSPLANT, V16, P338
   Najimi M, 2007, CELL TRANSPLANT, V16, P717, DOI 10.3727/000000007783465154
   Nasseri BA, 2007, CELL TRANSPLANT, V16, P941, DOI 10.3727/096368907783338235
   Naujok O, 2008, CELL TRANSPLANT, V17, P1231, DOI 10.3727/096368908787236549
   Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P111, DOI 10.3727/000000008783907125
   Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P27, DOI 10.3727/000000008783906900
   Naylor MC, 2007, CELL TRANSPLANT, V16, P187, DOI 10.3727/000000007783464786
   Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462
   Newcomb JD, 2007, CELL TRANSPLANT, V16, P151
   Newman MB, 2008, CELL TRANSPLANT, V17, P475
   Newman MB, 2007, CELL TRANSPLANT, V16, P338
   NIKKHAH G, 2008, CELL TRANSPLANT, V17, P476
   Nikolic WV, 2008, CELL TRANSPLANT, V17, P477
   NIKOLIC WV, 2007, CELL TRANSPLANT, V16, P339
   Noguchi H, 2008, CELL TRANSPLANT, V17, P69, DOI 10.3727/000000008783907062
   Noguchi H, 2008, CELL TRANSPLANT, V17, P121, DOI 10.3727/000000008783906991
   Nolan K, 2008, CELL TRANSPLANT, V17, P241, DOI 10.3727/096368908784153931
   O'Malley JA, 2008, CELL TRANSPLANT, V17, P477
   O'Malley JA, 2007, CELL TRANSPLANT, V16, P339
   Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516
   Oishi K, 2008, CELL TRANSPLANT, V17, P35, DOI 10.3727/000000008783906937
   Olson L, 2008, CELL TRANSPLANT, V17, P477
   Ono M, 2008, CELL TRANSPLANT, V17, P231, DOI 10.3727/000000008783907143
   Ourednik V, 2007, CELL TRANSPLANT, V16, P263, DOI 10.3727/000000007783464696
   Park DH, 2008, MED SCI MONITOR, V14, pRA206
   Park DH, 2009, MED SCI MONITOR, V15, pRA23
   Patel AN, 2008, CELL TRANSPLANT, V17, P303, DOI 10.3727/096368908784153922
   Patel AN, 2007, CELL TRANSPLANT, V16, P875, DOI 10.3727/096368907783338262
   Patel AN, 2007, CELL TRANSPLANT, V16, P899, DOI 10.3727/096368907783338253
   Paumier KL, 2008, CELL TRANSPLANT, V17, P478
   Paumier KL, 2007, CELL TRANSPLANT, V16, P340
   Pernaute RS, 2007, CELL TRANSPLANT, V16, P340
   Piao CS, 2008, CELL TRANSPLANT, V17, P478
   Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443
   Ponte GM, 2007, CELL TRANSPLANT, V16, P595, DOI 10.3727/000000007783465082
   Ponte GM, 2007, CELL TRANSPLANT, V16, P23, DOI 10.3727/000000007783464524
   Praud C, 2008, CELL TRANSPLANT, V17, P1035, DOI 10.3727/096368908786991588
   Praud C, 2007, CELL TRANSPLANT, V16, P741, DOI 10.3727/000000007783465118
   Price C, 2007, CELL TRANSPLANT, V16, P340
   Quaglia A, 2008, CELL TRANSPLANT, V17, P1403, DOI 10.3727/096368908787648083
   Quarta M, 2008, MED SCI MONITOR, V14, pBR286
   Quintanilha LF, 2008, CELL TRANSPLANT, V17, P943, DOI 10.3727/096368908786576453
   Quintero JE, 2007, CELL TRANSPLANT, V16, P341
   Quintin A, 2007, CELL TRANSPLANT, V16, P675, DOI 10.3727/000000007783465127
   Rafael H, 2008, MED SCI MONITOR, V14, pLE15
   Rafael H, 2009, MED SCI MONITOR, V15, pLE5
   Rajab A, 2008, CELL TRANSPLANT, V17, P1015, DOI 10.3727/096368908786991533
   Rajakumar B, 2007, CELL TRANSPLANT, V16, P449, DOI 10.3727/000000007783464975
   Ramachandra R, 2008, CELL TRANSPLANT, V17, P479
   Ramaswamy S, 2008, CELL TRANSPLANT, V17, P479
   Ramaswamy S, 2007, CELL TRANSPLANT, V16, P341
   Ramaswamy S, 2007, CELL TRANSPLANT, V16, P301, DOI 10.3727/000000007783464687
   Ramos GA, 2007, CELL TRANSPLANT, V16, P951, DOI 10.3727/096368907783338208
   Rehnmark A, 2007, CELL TRANSPLANT, V16, P341
   Reier PJ, 2007, CELL TRANSPLANT, V16, P313
   Reimsnider SK, 2007, CELL TRANSPLANT, V16, P342
   Revoltella RP, 2008, CELL TRANSPLANT, V17, P665, DOI 10.3727/096368908786092685
   Rezai-Zadeh K, 2007, CELL TRANSPLANT, V16, P342
   Riley J, 2007, CELL TRANSPLANT, V16, P342
   Rising A, 2008, CELL TRANSPLANT, V17, P479
   Rising A, 2007, CELL TRANSPLANT, V16, P343
   Rodriguez-Mulero S, 2008, CELL TRANSPLANT, V17, P1025, DOI 10.3727/096368908786991524
   Sabek OM, 2007, CELL TRANSPLANT, V16, P775, DOI 10.3727/000000007783465217
   Sabek OM, 2008, CELL TRANSPLANT, V17, P785, DOI 10.3727/096368908786516747
   SANCHEZRAMOS J, 2007, CELL TRANSPLANT, V16, P447
   Sandhu MS, 2007, CELL TRANSPLANT, V16, P343
   Sasaki K, 2008, CELL TRANSPLANT, V17, P1221, DOI 10.3727/096368908787236666
   Schaal SM, 2007, CELL TRANSPLANT, V16, P207, DOI 10.3727/000000007783464768
   Schafer R, 2008, CELL TRANSPLANT, V17, P923, DOI 10.3727/096368908786576480
   Selenica MB, 2008, CELL TRANSPLANT, V17, P479
   Shamekh R, 2007, CELL TRANSPLANT, V16, P344
   Sharma AD, 2008, CELL TRANSPLANT, V17, P313, DOI 10.3727/096368908784153896
   Sherman W, 2007, CELL TRANSPLANT, V16, P971, DOI 10.3727/096368907783338226
   Shi G, 2007, CELL TRANSPLANT, V16, P344
   Shytle RD, 2008, CELL TRANSPLANT, V17, P480
   Shytle RD, 2007, CELL TRANSPLANT, V16, P344
   Singh RP, 2008, CELL TRANSPLANT, V17, P480
   Singh RP, 2007, CELL TRANSPLANT, V16, P345
   Sladek JR, 2008, CELL TRANSPLANT, V17, P480
   Sladek JR, 2008, CELL TRANSPLANT, V17, P427
   Soderstrom K, 2007, CELL TRANSPLANT, V16, P345
   Soderstrom KE, 2008, CELL TRANSPLANT, V17, P585
   Sortwell CE, 2008, CELL TRANSPLANT, V17, P481
   Sortwell CE, 2007, CELL TRANSPLANT, V16, P345
   Spieles-Engemann AL, 2008, CELL TRANSPLANT, V17, P481
   Spieles-Engemann AL, 2007, CELL TRANSPLANT, V16, P346
   Stabenfeldt SE, 2007, CELL TRANSPLANT, V16, P346
   Stancati JA, 2008, CELL TRANSPLANT, V17, P482
   Steece-Collier K, 2008, CELL TRANSPLANT, V17, P482
   Stephan L, 2007, CELL TRANSPLANT, V16, P391, DOI 10.3727/000000007783464876
   Stephenne X, 2007, CELL TRANSPLANT, V16, P409, DOI 10.3727/000000007783464821
   Stephens ML, 2007, CELL TRANSPLANT, V16, P346
   Stephenson DT, 2007, CELL TRANSPLANT, V16, P229, DOI 10.3727/000000007783464704
   Storn V, 2008, CELL TRANSPLANT, V17, P543, DOI 10.3727/096368908785095999
   Stromberg I, 2008, CELL TRANSPLANT, V17, P482
   Suarez-Pinzon WL, 2008, CELL TRANSPLANT, V17, P631, DOI 10.3727/096368908786092775
   Sun JH, 2008, CELL TRANSPLANT, V17, P279, DOI 10.3727/096368908784153878
   Suryanarayana P, 2007, MED SCI MONITOR, V13, pBR286
   Suzuki C, 2008, CELL TRANSPLANT, V17, P223, DOI 10.3727/000000008783907053
   Suzuki M, 2008, CELL TRANSPLANT, V17, P482
   Suzuki T, 2007, CELL TRANSPLANT, V16, P493, DOI 10.3727/000000007783464966
   Taglialatela G, 2007, CELL TRANSPLANT, V16, P347
   Tai JH, 2008, CELL TRANSPLANT, V17, P1349, DOI 10.3727/096368908787648092
   Takenaga M, 2007, CELL TRANSPLANT, V16, P57, DOI 10.3727/000000007783464434
   Tang YM, 2007, CELL TRANSPLANT, V16, P159
   Tate CC, 2008, CELL TRANSPLANT, V17, P483
   Tateishi K, 2008, CELL TRANSPLANT, V17, P549, DOI 10.3727/096368908785096024
   Taupin P, 2008, MED SCI MONITOR, V14, pLE6
   Taupin P, 2009, MED SCI MONITOR, V15, pLE1
   Teng YD, 2007, CELL TRANSPLANT, V16, P347
   Terpstra BT, 2008, CELL TRANSPLANT, V17, P483
   Terpstra BT, 2007, CELL TRANSPLANT, V16, P347
   Terry C, 2007, CELL TRANSPLANT, V16, P639, DOI 10.3727/000000007783465000
   Thompson CK, 2007, AM J SPEECH-LANG PAT, V16, P3, DOI 10.1044/1058-0360(2007/002)
   Tian C, 2008, CELL TRANSPLANT, V17, P325, DOI 10.3727/096368908784153841
   Timmer M, 2007, CELL TRANSPLANT, V16, P348
   Tokiwa T, 2008, CELL TRANSPLANT, V17, P179, DOI 10.3727/000000008783907080
   Torigoe I, 2007, CELL TRANSPLANT, V16, P729, DOI 10.3727/000000007783465109
   Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064
   Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576
   Torres EM, 2008, CELL TRANSPLANT, V17, P535, DOI 10.3727/096368908785096006
   Tredget EB, 2008, CELL TRANSPLANT, V17, P599, DOI 10.3727/096368908786092757
   Truong W, 2007, CELL TRANSPLANT, V16, P977, DOI 10.3727/000000007783472390
   Tsuruga Y, 2008, CELL TRANSPLANT, V17, P1083, DOI 10.3727/096368908786991542
   TURNER N, 2007, CELL TRANSPLANT, V16, P349
   Ueda M, 2008, CELL TRANSPLANT, V17, P91, DOI 10.3727/000000008783906892
   Unzek S, 2007, CELL TRANSPLANT, V16, P879, DOI 10.3727/096368907783338271
   Valeikiene V, 2008, MED SCI MONITOR, V14, pCR221
   van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515
   Vanderheyden M, 2007, CELL TRANSPLANT, V16, P919, DOI 10.3727/096368907783338244
   Vaysse L, 2008, CELL TRANSPLANT, V17, P484
   VAZEY EM, 2008, CELL TRANSPLANT, V17, P484
   Vazin T, 2008, CELL TRANSPLANT, V17, P485
   Vazin T, 2007, CELL TRANSPLANT, V16, P349
   Vidal I, 2008, CELL TRANSPLANT, V17, P507, DOI 10.3727/096368908785096051
   Vinerean HV, 2008, CELL TRANSPLANT, V17, P567, DOI 10.3727/096368908785095962
   VLASTARAKOS PV, 2008, CELL TRANSPLANT, V14, pRA114
   von Seth E, 2007, CELL TRANSPLANT, V16, P621, DOI 10.3727/000000007783465055
   Vriens AP, 2008, CELL TRANSPLANT, V17, P1199, DOI 10.3727/096368908787236521
   Walczak P, 2007, CELL TRANSPLANT, V16, P349
   Wang Y, 2007, CELL TRANSPLANT, V16, P350
   Weber LM, 2007, CELL TRANSPLANT, V16, P1049, DOI 10.3727/000000007783472336
   Wee YM, 2008, CELL TRANSPLANT, V17, P1257, DOI 10.3727/096368908787236657
   Weeks BS, 2007, MED SCI MONITOR, V13, pBR51
   Wei YD, 2008, MED SCI MONITOR, V14, pBR198
   White TE, 2008, CELL TRANSPLANT, V17, P485
   White TE, 2007, CELL TRANSPLANT, V16, P350
   Wiersma JJ, 2008, MED SCI MONITOR, V14, pCR406
   Womble TA, 2008, CELL TRANSPLANT, V17, P485
   Xu L, 2007, CELL TRANSPLANT, V16, P350
   Xue YQ, 2008, CELL TRANSPLANT, V17, P486
   Xue YQ, 2007, CELL TRANSPLANT, V16, P351
   Yamakawa T, 2007, CELL TRANSPLANT, V16, P811, DOI 10.3727/000000007783465226
   Yamasaki T, 2008, MED SCI MONITOR, V14, pCS23
   Yasuhara T, 2007, CELL TRANSPLANT, V16, P351
   Yasuhara T, 2007, CELL TRANSPLANT, V16, P125
   Yerebakan C, 2007, CELL TRANSPLANT, V16, P935, DOI 10.3727/096368907783338280
   Yin ZH, 2007, CELL TRANSPLANT, V16, P859, DOI 10.3727/000000007783465235
   Yokokawa M, 2008, CELL TRANSPLANT, V17, P1145, DOI 10.3727/096368908787236594
   Yoshida Y, 2008, CELL TRANSPLANT, V17, P83, DOI 10.3727/000000008783907017
   Yu DH, 2008, CELL TRANSPLANT, V17, P1371, DOI 10.3727/096368908787648029
   Yu GL, 2008, MED SCI MONITOR, V14, pRA163
   Yuasa T, 2008, CELL TRANSPLANT, V17, P187, DOI 10.3727/000000008783906973
   Yue F, 2007, CELL TRANSPLANT, V16, P352
   Yukawa H, 2008, CELL TRANSPLANT, V17, P43, DOI 10.3727/000000008783907071
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zayko O, 2008, CELL TRANSPLANT, V17, P486
   Zhang D, 2008, CELL TRANSPLANT, V17, P159, DOI 10.3727/000000008783907134
   Zhang HQ, 2008, CELL TRANSPLANT, V17, P195, DOI 10.3727/000000008783906955
   Zhang LY, 2007, CELL TRANSPLANT, V16, P475, DOI 10.3727/000000007783464902
   Zhang SC, 2007, CELL TRANSPLANT, V16, P352
   Zhang Z, 2007, CELL TRANSPLANT, V16, P352
   Zhao LR, 2008, CELL TRANSPLANT, V17, P487
   Zhao LR, 2007, CELL TRANSPLANT, V16, P353
   Zhao XD, 2008, CELL TRANSPLANT, V17, P99, DOI 10.3727/000000008783906928
   Zhao YM, 2008, CELL TRANSPLANT, V17, P775, DOI 10.3727/096368908786516846
   Zhou J, 2008, MED SCI MONITOR, V14, pCR552
   Zinnanti WJ, 2008, CELL TRANSPLANT, V17, P487
NR 453
TC 13
Z9 13
U1 0
U2 23
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD NOV
PY 2009
VL 15
IS 11
BP RA233
EP RA251
PG 19
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 530EZ
UT WOS:000272573100021
PM 19865067
DA 2018-10-20
ER

PT J
AU Cerbasi, LLC
AF Cossi Cerbasi, Laura L.
TI Spontaneous tissue regeneration of the Stensen duct in dogs
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
ID SALIVARY-GLAND DUCTS; PAROTID DUCT; DIAGNOSIS; STRICTURES; EXPERIENCE;
   MANAGEMENT; SIALOCELES; DISEASES; FISTULAS; KINKS
AB Objective. There is a high incidence of wounds in the excretion duct of the salivary parotid gland owing to facial trauma that causes a loss of duct tissue. The aim of this study is to evaluate the ability of the salivary tissue to spontaneously self-regenerate, which is here widely demonstrated.
   Study design. This work was carried out on 20 adult dogs. A biomaterial catheter was inserted using microsurgical procedures to regenerate the lost duct tissue. This catheter served as an indicator for regenerating tissue growth. The results were assessed through clinical and radiographic exams by means of salivary charts and a histologic study.
   Results. The results obtained demonstrate the complete regeneration of the Stensen duct in all cases. The self-expulsion of the intraductal guide was satisfactory, albeit unexpected, such that subsequent management of the patient was unnecessary.
   Conclusion. Spontaneous tissue regeneration of salivary ducts is possible using a biomaterial guide. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:e11-e14)
C1 [Cossi Cerbasi, Laura L.] Cent Def Hosp, Dept Expt Surg, Madrid, Spain.
   [Cossi Cerbasi, Laura L.] Univ Granada, Fac Odontol, Dept Oral Med, Granada, Spain.
RP Cerbasi, LLC (reprint author), C Ibiza 52-1 D, Madrid 28009, Spain.
EM lcossi@fisica.edu.uy
CR Baurmash HD, 1997, J ORAL MAXIL SURG, V55, P919, DOI 10.1016/S0278-2391(97)90057-4
   CANT PJ, 1991, AUST NZ J SURG, V61, P742, DOI 10.1111/j.1445-2197.1991.tb01676.x
   Chauvel-Lebret DJ, 2002, POLYM BIOMATERIALS, P311
   DAVIS PKB, 1985, MAXILLOFACIAL INJURI, V1, P170
   Dumpis J, 2001, J CRANIO MAXILL SURG, V29, P56, DOI 10.1054/jcms.2000.0190
   ELLEMPORT CR, 1975, ANATOMY DOMESTIC ANI, V2, P1538
   Gear KJ, 2002, ORAL SURG ORAL MED O, V94, P632, DOI 10.1067/moe.2002.127718
   Gehrking E, 1999, HNO, V47, P283, DOI 10.1007/s001060050397
   HALLOCK GG, 1992, MICROSURG, V13, P243, DOI 10.1002/micr.1920130509
   KANNEGIETER NJ, 1992, AUST VET J, V69, P62, DOI 10.1111/j.1751-0813.1992.tb07451.x
   Karas N D, 1998, Atlas Oral Maxillofac Surg Clin North Am, V6, P99
   KASSEM MA, 1982, INT J PHARMACEUT, V12, P1, DOI 10.1016/0378-5173(82)90128-4
   LANDAU R, 1985, BRIT J SURG, V72, P42, DOI 10.1002/bjs.1800720117
   LANDENBACH P, 1987, REV STOMATOL CHIR MA, V88, P228
   Lazaridis N, 1990, Dtsch Z Mund Kiefer Gesichtschir, V14, P90
   Lewkowicz AA, 2002, J ORAL MAXIL SURG, V60, P676, DOI 10.1053/joms.2002.33118
   MACHTENS E, 1996, CIRUGIA ORAL MAXILOF, V2, P234
   Mandel L, 2001, J ORAL MAXIL SURG, V59, P490, DOI 10.1053/joms.2001.22670
   Medbery R, 2000, RADIOTHER ONCOL, V54, P87, DOI 10.1016/S0167-8140(99)00150-4
   Mehall J R, 2001, Surg Infect (Larchmt), V2, P225, DOI 10.1089/109629601317202704
   Nahlieli O, 2001, J ORAL MAXIL SURG, V59, P484, DOI 10.1053/joms.2001.22667
   Nahlieli O, 1999, J ORAL MAXIL SURG, V57, P1394, DOI 10.1016/S0278-2391(99)90716-4
   Nahlieli O, 2000, LARYNGOSCOPE, V110, P988, DOI 10.1097/00005537-200006000-00020
   Ozgenel GY, 2000, BRIT J PLAST SURG, V53, P106, DOI 10.1054/bjps.1999.3221
   Pogrel MA, 1996, J ORAL MAXIL SURG, V54, P71, DOI 10.1016/S0278-2391(96)90309-2
   Schroeder H, 1998, J SMALL ANIM PRACT, V39, P121, DOI 10.1111/j.1748-5827.1998.tb03615.x
   SCHULTZ RC, 1987, ESSENTIALS PLASTIC M, P121
   Scott J, 1999, J DENT RES, V78, P1711, DOI 10.1177/00220345990780110801
   Shojaku H, 2000, Radiat Med, V18, P143
   TIFFANY JS, 1995, ENCY HDB BIOMATERI A, V2, P1675
   TRAPPE M, 1991, ANN RADIOL, V34, P98
   Zenk J, 1998, HNO, V46, P980, DOI 10.1007/s001060050345
NR 32
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD NOV
PY 2009
VL 108
IS 5
BP E11
EP E14
DI 10.1016/j.tripleo.2009.06.043
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 508BY
UT WOS:000270903000029
PM 19716726
DA 2018-10-20
ER

PT J
AU Saju, KK
   Reshmi, R
   Jayadas, NH
   James, J
   Jayaraj, MK
AF Saju, K. K.
   Reshmi, R.
   Jayadas, N. H.
   James, J.
   Jayaraj, M. K.
TI Polycrystalline coating of hydroxyapatite on TiAl6V4 implant material
   grown at lower substrate temperatures by hydrothermal annealing after
   pulsed laser deposition
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE hydrothermal; MTT assay; cell viability; bioactive; hydroxyapatite (HA)
ID CALCIUM-PHOSPHATE COATINGS; WATER-VAPOR PRESSURES; THIN-FILMS;
   MECHANICAL-PROPERTIES; IN-VITRO; TITANIUM; ABLATION; THICKNESS; STRENGTH
AB Hydroxyapatite (HA) is a bioactive ceramic material that mimics the mineral composition of natural bone. This material does not possess acceptable mechanical properties for use as a bulk biomaterial; however, it does demonstrate significant potential for use as a coating on metallic orthopaedic and dental prostheses. Pulsed laser deposition (PLD) of thin films of HA on TiAl6V4 have shown crystalline coatings to be obtained at temperatures of the order of 350-500 degrees C. This condition of high substrate temperature promoted the oxidation of the substrate surface prior to the growth of the HA layer and the oxidation layer degraded the adhesion of the coating to the substrate. In this study, thin films of HA were deposited on TiAl6V4 alloy at a lower temperature of 200 degrees C by PLD and crystallized by a hydrothermal treatment at 100 degrees C. The film was subjected to mechanical as well as cell viability tests in vitro. The thickness, roughness, crystallanity, composition ratio, adhesive strength, and cell adhesion of the film suggest the application of this technique for producing bioactive implants.
C1 [Saju, K. K.] Cochin Univ Sci & Technol, Dept Mech Engn, Div Mech Engn, Kochi 682025, Kerala, India.
   [Reshmi, R.; Jayaraj, M. K.] Coshin Univ Sci & Technol, Dept Phys, Kochi, Kerala, India.
   [James, J.] Rajiv Gandhi Ctr Biotechnol, Div Neurobiol, Neurostem Cell Biol Lab, Thiruvananthapuram, Kerala, India.
RP Saju, KK (reprint author), Cochin Univ Sci & Technol, Dept Mech Engn, Div Mech Engn, Kochi 682025, Kerala, India.
EM kksaju@cusat.ac.in
OI James, Jackson/0000-0002-7038-2687; N H, Jayadas/0000-0003-3990-6072
CR AOKI H, 1994, MED APPL HAP, P179
   Arias JL, 2003, BIOMATERIALS, V24, P3403, DOI 10.1016/S0142-9612(03)00202-3
   Arias JL, 1998, BIOMATERIALS, V19, P883, DOI 10.1016/S0142-9612(97)00168-3
   Bao QH, 2005, APPL SURF SCI, V252, P1538, DOI 10.1016/j.apsusc.2005.02.127
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Byrappa K., 2001, HDB HYDROTHERMAL TEC
   Cao Y, 1996, BIOMATERIALS, V17, P419, DOI 10.1016/0142-9612(96)89658-X
   Cleries L, 1998, BIOMATERIALS, V19, P1483, DOI 10.1016/S0142-9612(98)00063-5
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Feng B, 2002, J BIOMED MATER RES, V59, P12, DOI 10.1002/jbm.1211
   Fernandez-Pradas JM, 2001, BIOMATERIALS, V22, P2171, DOI 10.1016/S0142-9612(00)00408-7
   Grigorescu S, 2005, ROM REP PHYS, V57, P1003
   Gu YW, 2002, BIOMATERIALS, V23, P37, DOI 10.1016/S0142-9612(01)00076-X
   Heimann RB, 2006, BIOMATERIALS, V27, P823, DOI 10.1016/j.biomaterials.2005.06.029
   Katto M, 2007, J PHYS CONF SER, V59, P75, DOI 10.1088/1742-6596/59/1/016
   Kim HL, 2006, J KOREAN PHYS SOC, V49, P2418
   Koch CF, 2007, MAT SCI ENG C-BIO S, V27, P484, DOI 10.1016/j.msec.2006.05.025
   Lee WJ, 2005, J KOREAN PHYS SOC, V47, P152
   Li H, 2002, BIOMATERIALS, V23, P85, DOI 10.1016/S0142-9612(01)00082-5
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Mroz W, 2007, J PHYS CONF SER, V59, P720, DOI 10.1088/1742-6596/59/1/153
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   REVANKAR G, 2000, ASM METALS HDB, V8
   Sousa SR, 1996, BIOMATERIALS, V17, P397, DOI 10.1016/0142-9612(96)89655-4
   Suda Y, 2006, THIN SOLID FILMS, V506, P115, DOI 10.1016/j.tsf.2005.08.125
   Thian ES, 2005, BIOMATERIALS, V26, P2947, DOI 10.1016/j.biomaterials.2004.07.058
   Thian ES, 2002, BIOMATERIALS, V23, P2927, DOI 10.1016/S0142-9612(01)00422-7
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Zeng HT, 2000, BIOMATERIALS, V21, P23, DOI 10.1016/S0142-9612(99)00128-3
NR 30
TC 9
Z9 10
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD NOV
PY 2009
VL 223
IS H8
BP 1049
EP 1057
DI 10.1243/09544119JEIM568
PG 9
WC Engineering, Biomedical
SC Engineering
GA 528WR
UT WOS:000272478200011
PM 20092101
DA 2018-10-20
ER

PT J
AU Platt, MO
   Wilder, CL
   Wells, A
   Griffith, LG
   Lauffenburger, DA
AF Platt, Manu O.
   Wilder, Catera L.
   Wells, Alan
   Griffith, Linda G.
   Lauffenburger, Douglas A.
TI Multipathway Kinase Signatures of Multipotent Stromal Cells are
   Predictive for Osteogenic Differentiation
SO STEM CELLS
LA English
DT Article
DE Biomathematical modeling; Bone marrow stromal cells; Cell signaling;
   Mesenchymal stem cells; Stem cell-microenvironment interactions
ID MESENCHYMAL STEM-CELLS; EPIDERMAL-GROWTH-FACTOR; SIGNAL-REGULATED
   KINASE; ALKALINE-PHOSPHATASE ACTIVITY; ACTIVATED PROTEIN-KINASE;
   OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION;
   TRANSCRIPTIONAL REGULATION; RUNX2 ACTIVATION
AB Bone marrow-derived multipotent stromal cells (MSCs) offer great promise for regenerating tissue. Although certain transcription factors have been identified in association with tendency toward particular MSC differentiation phenotypes, the regulatory network of key receptor-mediated signaling pathways activated by extracellular ligands that induce various differentiation responses remains poorly understood. Attempts to predict differentiation fate tendencies from individual pathways in isolation are problematic due to the complex pathway interactions inherent in signaling networks. Accordingly, we have undertaken a multivariate systems approach integrating experimental measurement of multiple kinase pathway activities and osteogenic differentiation in MSCs, together with computational analysis to elucidate quantitative combinations of kinase signals predictive of cell behavior across diverse contexts. In particular, for culture on polymeric biomaterial surfaces presenting tethered epidermal growth factor, type I collagen, neither, or both, we have found that a partial least-squares regression model yields successful prediction of phenotypic behavior on the basis of two principal components comprising the weighted sums of eight intracellular phosphoproteins: phospho-epidermal growth factor receptor, phospho-Akt, phospho-extracellular signal-related kinase 1/2, phospho-heat shock protein 27, phospho-c-Jun, phospho-glycogen synthase kinase 3 alpha/beta, phospho-p38, and phospho-signal transducer and activator of transcription 3. This combination provides the strongest predictive capability for 21-day differentiated phenotype status when calculated from day-7 signal measurements; day-4 and day-14 signal measurements are also significantly predictive, indicating a broad time frame during MSC osteogenesis wherein multiple pathways and states of the kinase signaling network are quantitatively integrated to regulate gene expression, cell processes, and ultimately, cell fate. STEM CELLS 2009; 27: 2804-2814
C1 [Platt, Manu O.; Wilder, Catera L.; Griffith, Linda G.; Lauffenburger, Douglas A.] MIT, Dept Biomol Engn, Cambridge, MA 02139 USA.
   [Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.
   [Wells, Alan] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA USA.
RP Lauffenburger, DA (reprint author), 16-343 MIT,77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM lauffen@mit.edu
OI Platt, Manu/0000-0001-6390-4320; Wells, Alan/0000-0002-1637-8150
FU NIH [R01-GM059870-07, R01 DE019523-10, NIH R01-GM69668]; United Negro
   College Fund (UNCF)/Merck Postdoctoral Fellowship; Georgia Tech
   Facilitating Academic Careers in Engineering and Sciences (FACES);
   Tulane Center for Gene Therapy through National Center for Research
   Resources (NCRR) [P40RR017447]
FX The authors are grateful to Linda Stockdale, Arthur Goldsipe, and
   Benjamin Cosgrove for technical assistance, for funding provided by NIH
   R01-GM059870-07 (LGG), R01 DE019523-10 (L.G.G. and A.W.), NIH
   R01-GM69668 (A.W. and D.A.L.), United Negro College Fund (UNCF)/Merck
   Postdoctoral Fellowship (M.O.P.), and Georgia Tech Facilitating Academic
   Careers in Engineering and Sciences (FACES) Fellowship (M.O.P.). Some of
   the materials used were provided by the Tulane Center for Gene Therapy
   through National Center for Research Resources (NCRR) Grant P40RR017447.
   M.O.P. is currently affiliated with Wallace H. Coulter Department of
   Biomedical Engineering at Georgia Tech and Emory University, Atlanta,
   GA.
CR ANDRIANARIVO AG, 1992, J CELL PHYSIOL, V153, P256, DOI 10.1002/jcp.1041530205
   Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21907
   Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080
   Benayahu D, 2009, ANN ANAT, V191, P2, DOI 10.1016/j.aanat.2008.07.008
   Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284
   Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0
   Caplan MR, 2009, CELL BIOCHEM BIOPHYS, V54, P1, DOI 10.1007/s12013-009-9048-5
   Caverzasio J, 2007, ENDOCRINOLOGY, V148, P5323, DOI 10.1210/en.2007-0520
   Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200
   Chen YJ, 2004, BONE, V34, P466, DOI 10.1016/j.bone.2003.11.013
   Cheng XW, 2004, AM J PATHOL, V164, P243, DOI 10.1016/S0002-9440(10)63114-8
   Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5
   Cool SM, 2005, STEM CELLS DEV, V14, P632, DOI 10.1089/scd.2005.14.632
   Cosgrove BD, 2008, CELL MOL BIOENG, V1, P33, DOI 10.1007/s12195-008-0007-9
   Ding S, 2005, CURR TOP MED CHEM, V5, P383, DOI 10.2174/1568026053828402
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   GRONTHOS S, 1995, BLOOD, V85, P929
   Harrington M, 2007, OBESITY, V15, P563, DOI 10.1038/oby.2007.562
   Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785
   Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955
   Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249
   Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058
   Kemp ML, 2007, J IMMUNOL, V178, P4984, DOI 10.4049/jimmunol.178.8.4984
   Klees RF, 2005, MOL BIOL CELL, V16, P881
   Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645
   Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627
   Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004
   KUMEGAWA M, 1983, CALCIFIED TISSUE INT, V35, P542, DOI 10.1007/BF02405091
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   Lee HW, 2008, J BONE MINER RES, V23, P1227, DOI 10.1359/JBMR.080325
   Leonardi R, 2004, CALCIFIED TISSUE INT, V75, P509, DOI 10.1007/s00223-004-0077-1
   Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5
   McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398
   McMahon LA, 2008, BIOCHEM BIOPH RES CO, V368, P990, DOI 10.1016/j.bbrc.2008.01.160
   Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001
   Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2
   Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/em.2005-0303
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Sato H, 2005, CANCER GENE THER, V12, P757, DOI 10.1038/sj.cgt.7700827
   Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530
   Sibilia M, 2003, DEVELOPMENT, V130, P4515, DOI 10.1242/dev.00664
   Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6
   Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200
   Stein GS, 1996, PHYSIOL REV, V76, P593
   Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176
   Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010
   Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4
   Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8
   Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200
   Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748
   Yarden Y, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.013
   Zayzafoon M, 2000, J CELL BIOCHEM, V79, P301, DOI 10.1002/1097-4644(20001101)79:2<301::AID-JCB130>3.0.CO;2-0
   Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200
NR 72
TC 32
Z9 32
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD NOV
PY 2009
VL 27
IS 11
BP 2804
EP 2814
DI 10.1002/stem.215
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 520GS
UT WOS:000271830700018
PM 19750537
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Yoon, DM
   Curtiss, S
   Reddi, AH
   Fisher, JP
AF Yoon, Diana M.
   Curtiss, Shane
   Reddi, A. Hari
   Fisher, John P.
TI Addition of Hyaluronic Acid to Alginate Embedded Chondrocytes Interferes
   with Insulin-like Growth Factor-1 Signaling In Vitro and In Vivo
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TISSUE-ENGINEERED CARTILAGE; HUMAN ARTICULAR-CARTILAGE; HUMAN
   SYNOVIAL-FLUID; EXTRACELLULAR-MATRIX; CULTURE-CONDITIONS;
   BINDING-PROTEINS; SEEDING DENSITY; PROTEOGLYCAN; EXPRESSION; DIFFUSION
AB The development of an engineered tissue requires a clear understanding of the interactions between the individual components. In this study, we investigated how the addition of hyaluronic acid (HA) to a cartilage tissue engineered scaffold alters chondrocytic expression, and specifically the expression of insulin-like growth factor-1 (IGF-1) signaling molecules. Bovine chondrocytes were embedded (7 million cells/mL) in 2.0% w/v alginate hydrogels containing varying HA concentrations (0, 0.05, 0.50, and 5.00 mg/mL). In vitro constructs were cultured with exogenous IGF-1, and gene expression was monitored at days 1, 4, and 8 for IGF-1, IGF-1 receptor (IGF-1R), IGF binding protein 3 (IGFBP-3), type II collagen and type I collagen. In vivo constructs were precultured for 24 h with exogenous IGF-1 before being implanted subcutaneously in severe combined immunodeficient mice; samples were analyzed using histology at days 7, 14, and 21. Results indicate that, with the addition of high levels (5.00 mg/mL) of HA, IGF-1 can become entrapped within the matrix and therefore interfere with the delivery of IGF-1 to chondrocytes. In vitro and in vivo data showed that increasing the concentration of HA in an alginate hydrogel can decrease chondrocyte IGF-1 expression. IGF-1R expression did not change with HA concentration, and the addition of any HA did not significantly alter IGFBP-3 expression. Chondrocytes continuously expressed phenotypic type II collagen in vitro and in vivo throughout the study for all the groups. However, for all the HA concentrations investigated, chondrocytes showed more of a fibroblastic phenotype, as indicated by greater expression of type I collagen than with no HA, in vitro and in vivo. In conclusion, these results indicate that HA interferes with the delivery of IGF-1 to chondrocytes, affecting the endogenous expression of IGF-1 signaling molecules and the resulting chondrocyte phenotype, and therefore demonstrating the critical effect of biomaterial scaffolds on encapsulated cell function.
C1 [Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Yoon, Diana M.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Curtiss, Shane; Reddi, A. Hari] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
FU National Science Foundation [0448684]; Arthritis Foundation; University
   of Maryland Fischell Fellowship in Biomedical Engineering (DMY);
   Lawrence J Ellison Endowed Chair in Musculoskeletal Molecular Biology
   and Tissue Regeneration
FX This study was supported by the National Science Foundation (CAREER
   Award to JPF, # 0448684), the Arthritis Foundation (Arthritis
   Investigator Award to JPF), and the University of Maryland Fischell
   Fellowship in Biomedical Engineering (DMY). In addition, AHR is
   supported by the Lawrence J Ellison Endowed Chair in Musculoskeletal
   Molecular Biology and Tissue Regeneration.
CR Akmal M, 2005, J BONE JOINT SURG BR, V87B, P1143, DOI 10.1302/0301-620X.87B8
   Bryant S J, 1999, Biomed Sci Instrum, V35, P309
   Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3
   Chevalier X, 1996, BRIT J RHEUMATOL, V35, P515
   Chubinskaya S, 2007, OSTEOARTHR CARTILAGE, V15, P421, DOI 10.1016/j.joca.2006.10.004
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Davies LC, 2008, TISSUE ENG PT A, V14, P1251, DOI [10.1089/ten.tea.2007.0211, 10.1089/tea.2007.0211]
   Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022
   Eviatar T, 2003, ARTHRITIS RHEUM, V48, P410, DOI 10.1002/art.10761
   Favre E, 2001, COLLOID SURFACE A, V194, P197, DOI 10.1016/S0927-7757(01)00789-0
   Gerard C, 2005, J MATER SCI-MATER M, V16, P541, DOI 10.1007/s10856-005-0530-3
   Hickey Derrick G, 2003, Am J Orthop (Belle Mead NJ), V32, P70
   HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435
   Homandberg GA, 2004, INFLAMM RES, V53, P396, DOI 10.1007/s00011-004-1276-y
   HONEGGER A, 1986, J BIOL CHEM, V261, P569
   HUA Q, 1993, J CELL SCI, V106, P365
   Kamada H, 2002, ARCH BIOCHEM BIOPHYS, V408, P192, DOI 10.1016/S0003-9861(02)00543-X
   Karna E, 2008, MOL CELL BIOCHEM, V308, P57, DOI 10.1007/s11010-007-9612-5
   Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   Kuo YC, 2007, BIOTECHNOL PROGR, V23, P238, DOI 10.1021/bp060253h
   Leddy HA, 2004, J BIOMED MATER RES B, V70B, P397, DOI 10.1002/jbm.b.30053
   LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143
   Lindenhayn K, 1999, J BIOMED MATER RES, V44, P149, DOI 10.1002/(SICI)1097-4636(199902)44:2<149::AID-JBM4>3.0.CO;2-C
   LUYTEN FP, 1988, ARCH BIOCHEM BIOPHYS, V267, P416, DOI 10.1016/0003-9861(88)90047-1
   Mahmoudifar N, 2006, TISSUE ENG, V12, P1675, DOI 10.1089/ten.2006.12.1675
   Martin JA, 2000, BIORHEOLOGY, V37, P129
   Matsumoto T, 1996, J CLIN ENDOCR METAB, V81, P150, DOI 10.1210/jc.81.1.150
   MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423
   Nauman JV, 2007, BIOPHYS J, V92, P4444, DOI 10.1529/biophysj.106.102699
   Nishimoto S, 2005, J BIOSCI BIOENG, V100, P123, DOI 10.1263/jbb.100.123
   O'Connor WJ, 2000, ORTHOP CLIN N AM, V31, P399, DOI 10.1016/S0030-5898(05)70159-0
   Porter RM, 2007, TISSUE ENG, V13, P1333, DOI 10.1089/ten.2006.0345
   ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007
   Saini S, 2003, BIOTECHNOL PROGR, V19, P510, DOI 10.1021/bp0256519
   SCHALKWIJK J, 1989, ARTHRITIS RHEUM, V32, P66, DOI 10.1002/anr.1780320111
   Schneiderman R, 1995, ARCH BIOCHEM BIOPHYS, V324, P173, DOI 10.1006/abbi.1995.9913
   Trippel S B, 1995, J Rheumatol Suppl, V43, P129
   TYLER JA, 1989, BIOCHEM J, V260, P543, DOI 10.1042/bj2600543
   Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   Yen CN, 2008, BIOTECHNOL PROGR, V24, P452, DOI 10.1021/bp0702828
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoon DM, 2008, TISSUE ENG PT A, V14, P1263, DOI 10.1089/ten.tea.2007.0172
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
NR 46
TC 28
Z9 29
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2009
VL 15
IS 11
BP 3449
EP 3459
DI 10.1089/ten.tea.2009.0069
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 519EC
UT WOS:000271746800022
PM 19426107
DA 2018-10-20
ER

PT J
AU Yang, YF
   Zhao, YN
   Chen, B
   Han, QQ
   Sun, WJ
   Xiao, ZF
   Dai, JW
AF Yang, Yifan
   Zhao, Yannan
   Chen, Bing
   Han, Qianqian
   Sun, Wenjie
   Xiao, Zhifeng
   Dai, Jianwu
TI Collagen-Binding Human Epidermal Growth Factor Promotes Cellularization
   of Collagen Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID FACTOR FUSION PROTEIN; DOMAIN; REPAIR; EXPRESSION; TISSUES; EGF
AB Previous studies have demonstrated that epidermal growth factor (EGF) can promote tissue regeneration effectively. The aim of the present study was to combine a collagen-binding domain (CBD) with native EGF (NAT-EGF) to form a fusion protein, aiming at that it could bind to collagen scaffolds specifically. This approach could restrict the diffusion of EGF despite of extracellular fluids and limit the release of EGF to surrounding tissues. Thus, the retained CBD-EGF would render a continual function during the tissue regeneration. In our study, in vitro bioactivity assay showed that there was no significant difference between CBD-EGF and NAT-EGF to stimulate human fibroblasts to proliferate. In the collagen-binding assay, CBD-EGF exhibited a specific binding ability to collagen compared to NAT-EGF. Finally, in vivo experiment demonstrated that CBD-EGF loaded collagen membranes uniformly possess a high capability to promote cellularization of scaffolds as compared with that of NAT-EGF. All results aforementioned suggested that collagen loaded with CBD-EGF is a functional biomaterial with potential clinical applications.
C1 [Yang, Yifan; Zhao, Yannan; Chen, Bing; Han, Qianqian; Sun, Wenjie; Xiao, Zhifeng; Dai, Jianwu] Chinese Acad Sci, Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100080, Peoples R China.
   [Yang, Yifan; Zhao, Yannan] Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Key Lab Mol Dev Biol, Inst Genet & Dev Biol, 3 Nanyitiao, Beijing 100080, Peoples R China.
EM jwdai@genetics.ac.cn
FU NSFC [30688002]; Ministry of Science and Technology of China
   [2006CB943601]; Chinese Academy of Sciences [KSCX2-YW-R-133,
   KSCX2-YW-G-047, KJCX2YW-L08]; K.C. Wong Education Foundation
FX The authors thank members of Dai Lab for their invaluable comments and
   technical assistance. This work was supported by grants from NSFC
   (30688002), the Ministry of Science and Technology of China
   (2006CB943601), Chinese Academy of Sciences (KSCX2-YW-R-133,
   KSCX2-YW-G-047, and KJCX2YW-L08), and K.C. Wong Education Foundation.
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340
   Chen B, 2007, J BIOMED MATER RES A, V80A, P428, DOI 10.1002/jbm.a.30900
   COHEN S, 1986, BIOSCIENCE REP, V6, P1017, DOI 10.1007/BF01141022
   DESOUZA SJ, 1992, J BIOL CHEM, V267, P13763
   Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817
   Frew SE, 2007, NAT BIOTECHNOL, V25, P403, DOI 10.1038/nbt0407-403
   Hall FL, 2000, INT J MOL MED, V6, P635
   Hardwicke J, 2008, SURG-J R COLL SURG E, V6, P172, DOI 10.1016/S1479-666X(08)80114-X
   Ishikawa T, 2003, ARTIF ORGANS, V27, P147, DOI 10.1046/j.1525-1594.2003.07009.x
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   Kim DG, 2009, BIOTECHNOL LETT, V31, P259, DOI 10.1007/s10529-008-9863-6
   Kumar RK, 1998, CELL BIOL TOXICOL, V14, P293, DOI 10.1023/A:1007439109686
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JH, 2005, FEBS LETT, V579, P2507, DOI 10.1016/j.febslet.2005.03.062
   LEMBACH KJ, 1976, P NATL ACAD SCI USA, V73, P183, DOI 10.1073/pnas.73.1.183
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643
   Mola E, 2003, J COMM BIOTECHNO, V9, P147
   NIMNI ME, 1980, BIORHEOLOGY, V17, P51
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7
   Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184
   PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P92, DOI 10.1016/0016-5085(95)90012-8
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407
   Soler LF, 2003, J CHROMATOGR B, V788, P113, DOI 10.1016/S1570-0232(02)01035-8
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Tanaka A, 2005, J VET MED SCI, V67, P909, DOI 10.1292/jvms.67.909
   TRIPATHI RC, 1990, SURV OPHTHALMOL, V34, P457, DOI 10.1016/0039-6257(90)90127-H
NR 31
TC 21
Z9 22
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2009
VL 15
IS 11
BP 3589
EP 3596
DI 10.1089/ten.tea.2008.0648
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 519EC
UT WOS:000271746800033
PM 19480569
DA 2018-10-20
ER

PT J
AU Ribeiro, MP
   Espiga, A
   Silva, D
   Baptista, P
   Henriques, J
   Ferreira, C
   Silva, JC
   Borges, JP
   Pires, E
   Chaves, P
   Correia, IJ
AF Ribeiro, Maximiano P.
   Espiga, Ana
   Silva, Daniela
   Baptista, Patricia
   Henriques, Joaquim
   Ferreira, Catarina
   Silva, Jorge C.
   Borges, Joao P.
   Pires, Eduardo
   Chaves, Paula
   Correia, Ilidio J.
TI Development of a new chitosan hydrogel for wound dressing
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; HYDROALCOHOLIC MEDIUM; PROLIFERATION;
   DERIVATIVES; MEMBRANE; GELATION; FIBROBLASTS; SCAFFOLDS; ADHESIVE;
   REPAIR
AB Wound healing is a complex process involving an integrated response by many different cell types and growth factors in order to achieve rapid restoration of skin architecture and function. The present study evaluated the applicability of a chitosan hydrogel (CH) as a wound dressing. Scanning electron microscopy analysis was used to characterize CH morphology. Fibroblast cells isolated from rat skin were used to assess the cytotoxicity of the hydrogel. CH was able to promote cell adhesion and proliferation. Cell viability studies showed that the hydrogel and its degradation by-products are noncytotoxic. The evaluation of the applicability of CH in the treatment of dermal burns in Wistar rats was performed by induction of full-thickness transcutaneous dermal wounds. Wound healing was monitored through macroscopic and histological analysis. From macroscopic analysis, the wound beds of the animals treated with CH were considerably smaller than those of the controls. Histological analysis revealed lack of a reactive or a granulomatous inflammatory reaction in skin lesions with CH and the absence of pathological abnormalities in the organs obtained by necropsy, which supported the local and systemic histocompatibility of the biomaterial. The present results suggest that this biomaterial may aid the re-establishment of skin architecture.
C1 [Ribeiro, Maximiano P.; Silva, Daniela; Baptista, Patricia; Henriques, Joaquim; Ferreira, Catarina; Chaves, Paula; Correia, Ilidio J.] Univ Beira Interior, Fac Ciencias Saude, Ctr Invest Ciencias Saude, Covilha, Portugal.
   [Espiga, Ana; Borges, Joao P.; Pires, Eduardo] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Mat, P-2825 Monte De Caparica, Portugal.
   [Espiga, Ana; Borges, Joao P.; Pires, Eduardo] Univ Nova Lisboa, Fac Ciencias & Tecnol, CENIMAT 13N, P-2825 Monte De Caparica, Portugal.
   [Espiga, Ana; Pires, Eduardo] Ceramed, Lisbon, Portugal.
   [Silva, Jorge C.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Fis, P-2825 Monte De Caparica, Portugal.
RP Correia, IJ (reprint author), Univ Beira Interior, Fac Ciencias Saude, Ctr Invest Ciencias Saude, Av Infante D Henrique, Covilha, Portugal.
EM icorreia@ubi.pt
RI Correia, ilidio/S-8295-2016; Silva, Jorge/A-3979-2012; Borges,
   Joao/C-9078-2009
OI Correia, ilidio/0000-0003-1613-9675; Silva, Jorge/0000-0001-9959-4272;
   Borges, Joao/0000-0002-3996-6545; Chaves, Paula/0000-0002-0732-2059;
   Batista, Patricia/0000-0003-3007-7263; Pires,
   Eduardo/0000-0002-8088-0444; Ribeiro, Maximiano/0000-0001-6357-8115
FU Portuguese Foundation for Science and Technology
   [AE-SFRH/BDE/15653/2007, IJC-SFRH/BPD/19776/2004]
FX The authors would like to thank Ana Paula Gomes for acquiring SEM images
   and Ricardo Relvas for his technical support in the preparation of the
   final images for publication. Funding was provided by the Portuguese
   Foundation for Science and Technology (in the form of a fellowship to
   AE-SFRH/BDE/15653/2007 and IJC-SFRH/BPD/19776/2004).
CR Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Attia J, 2008, TISSUE ENG PT A, V14, P1687, DOI 10.1089/ten.tea.2007.0057
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Blasinska A, 2008, BIOMACROMOLECULES, V9, P776, DOI 10.1021/bm7006373
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Chen YM, 2005, BIOMATERIALS, V26, P4588, DOI [10.1016/j.biomaterials.2004.11.025, 10.1016/j.bomaterials.2004.11.025]
   Dai TH, 2009, ANTIMICROB AGENTS CH, V53, P393, DOI 10.1128/AAC.00760-08
   Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x
   Garcia Y, 2008, BIOMATERIALS, V29, P857, DOI 10.1016/j.biomaterials.2007.10.053
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Hong HJ, 2008, BIOMATERIALS, V29, P4831, DOI 10.1016/j.biomaterials.2008.08.023
   Hong JP, 2008, ANN PLAS SURG, V61, P457, DOI 10.1097/SAP.0b013e31815b1feac
   Ignatova M, 2009, MACROMOL BIOSCI, V9, P102, DOI 10.1002/mabi.200800189
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kimura Y, 2008, EUR J PHARMACOL, V584, P415, DOI 10.1016/j.ejphar.2008.02.036
   Kiyozumi T, 2006, J BIOMED MATER RES B, V79B, P129, DOI 10.1002/jbm.b.30522
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Montembault A, 2005, BIOMACROMOLECULES, V6, P653, DOI 10.1021/bm049593m
   Montembault A, 2005, BIOMATERIALS, V26, P1633, DOI 10.1016/j.biomaterials.2004.06.029
   Montembault A, 2005, BIOMATERIALS, V26, P933, DOI 10.1016/j.biomaterials.2004.03.033
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 34
TC 113
Z9 116
U1 8
U2 71
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD NOV-DEC
PY 2009
VL 17
IS 6
BP 817
EP 824
DI 10.1111/j.1524-475X.2009.00538.x
PG 8
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 513IC
UT WOS:000271314900007
PM 19903303
DA 2018-10-20
ER

PT J
AU Preoteasa, EA
   Preoteasa, E
   Ciortea, C
   Marin, DD
   Gurban, D
   Gugiu, M
   Scafes, A
AF Preoteasa, Eugen A.
   Preoteasa, Elena
   Ciortea, Constantin
   Marin, Daniel D.
   Gurban, Dan
   Gugiu, Marius
   Scafes, Adela
TI PIXE and PIGE assessment of in vivo elemental and physical changes of a
   composite from a dental filling
SO X-RAY SPECTROMETRY
LA English
DT Article
ID FLUORINE UPTAKE; TOOTH ENAMEL; MICROANALYSIS; TEETH
AB Simultaneous particle-induced x-ray emission (PIXE) and particle-induced gamma-ray emission (PIGE) measurements in the 0-270 keV range with a low-energy hyperpure Ge detector have been performed on the outer surface and on an inner section of a dental composite filling extracted from a patient. The biomaterial has been identified as the fluorine-releasing Tetric Ceram dental composite. Compared to the native material, the dental filling evidenced changes occurring during the in vivo oral use. These included mainly Cl and K accumulation and loss of Zr, Ba, Yb (by PIXE), and F (in the PIGE region). The changes were similar at the surface and inside of the dental filling for most of the above elements, indicating an unexpectedly high permeability of the material, maybe due to microscopic bulk fracture of the dental composite filling throughout its use. The PIGE spectra detected also Al and traces of Hf and Sm possibly associated with Zr and Yb. Changes in the ratio of the L lines of Yb and in the ratio of the 110- and 197-keV lines of F evidenced alterations in the matrix physical properties of the composite, associated with factors such as surface roughening by wear, grain size decrease by slow dissolution, and compositional variations. Further studies are needed to gain a deeper insight into the complex changes taking place in a dental composite filling. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Preoteasa, Eugen A.] Horia Hulubei Natl Inst Phys & Nucl Engn, Dept Environm & Life Phys, Bucharest 077125, Romania.
   [Preoteasa, Elena] Helident Dent Surg Ltd, Bucharest 021575, Romania.
RP Preoteasa, EA (reprint author), Horia Hulubei Natl Inst Phys & Nucl Engn, Dept Environm & Life Phys, 407 Aromistilor,POB MG-6, Bucharest 077125, Romania.
EM eugen_preoteasa@yohoo.com
FU Romanian Ministry of Education and Research
FX one of the authors (EAP) is indebted to Cristina Bordeianu and Bogdan
   Constantinescu (Bucharest) and Dieter Grambole (Dresden) for valuable
   discussions. This study was supported by a grant from Romanian Ministry
   of Education and Research.
CR Albers HF, 2002, TOOTH COLORED RESTOR
   CAMPBELL JL, 1993, NUCL INSTRUM METH B, V77, P95, DOI 10.1016/0168-583X(93)95530-I
   Chaudhri MA, 1995, NUTRITION, V11, P538
   Coote GE, 1997, NUCL INSTRUM METH B, V130, P571, DOI 10.1016/S0168-583X(97)00250-4
   COOTE GE, 1992, NUCL INSTRUM METH B, V66, P191, DOI 10.1016/0168-583X(92)96150-W
   Dahl JE, 1999, SCAND J WORK ENV HEA, V25, P285, DOI 10.5271/sjweh.436
   Demortier G, 2008, NUCL INSTRUM METH B, V266, P2408, DOI 10.1016/j.nimb.2008.03.053
   Grambole D, 2000, NUCL INSTRUM METH B, V161, P269, DOI 10.1016/S0168-583X(99)00827-7
   HANSON AL, 1984, NUCL INSTRUM METH B, V4, P401, DOI 10.1016/0168-583X(84)90587-1
   Heintze SD, 1999, AM J DENT, V12, pS4
   JOHANSSON SA, 1995, PARTICLE INDUCED XRA
   Komatsu H, 2007, NUCL INSTRUM METH B, V260, P201, DOI 10.1016/j.nimb.2007.02.068
   Lill JO, 1999, ANAL CHIM ACTA, V378, P273, DOI 10.1016/S0003-2670(98)00630-8
   LINDH U, 1980, J RADIOANAL CHEM, V59, P167, DOI 10.1007/BF02516846
   MAXWELL JA, 1995, NUCL INSTRUM METH B, V95, P407, DOI 10.1016/0168-583X(94)00540-0
   NENITESCU C. D., 1979, GEN CHEM
   Pineda-Vargas CA, 2007, NUCL INSTRUM METH B, V260, P190, DOI 10.1016/j.nimb.2007.02.023
   POPESCU A, 1981, SPECIAL BIOCH DENT
   Preoteasa EA, 2004, ANAL BIOANAL CHEM, V379, P825, DOI 10.1007/s00216-004-2656-4
   Preoteasa EA, 2002, NUCL INSTRUM METH B, V189, P426, DOI 10.1016/S0168-583X(01)01119-3
   Preoteasa EA, 2004, 10 INT C PART IND XR
   RAISANEN J, 1984, NUCL INSTRUM METH B, V4, P404, DOI 10.1016/0168-583X(84)90588-3
   Schiffner U, 1999, AM J DENT, V12, pS10
   SHIOI R, 2007, ADV XRAY CHEM ANAL J, V38, P205
   Sletten GBG, 1999, ACTA ODONTOL SCAND, V57, P316, DOI 10.1080/000163599428544
   Tesmer J R, 1995, HDB MODERN ION BEAM
   Vecchi R, 2004, 10 INT C PART IND XR
   VIVADENT E, 1999, TETRIC CERAM PRODUCT
   Yamamoto H, 2007, NUCL INSTRUM METH B, V260, P194, DOI 10.1016/j.nimb.2007.02.024
   Yamamoto H, 2003, NUCL INSTRUM METH B, V210, P388, DOI 10.1016/S0168-583X(03)01039-5
   Yasuda K, 2007, NUCL INSTRUM METH B, V260, P207, DOI 10.1016/j.nimb.2007.02.109
NR 31
TC 11
Z9 11
U1 1
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0049-8246
J9 X-RAY SPECTROM
JI X-Ray Spectrom.
PD NOV-DEC
PY 2009
VL 38
IS 6
BP 548
EP 556
DI 10.1002/xrs.1175
PG 9
WC Spectroscopy
SC Spectroscopy
GA 516CS
UT WOS:000271519900013
DA 2018-10-20
ER

PT J
AU Kalasin, S
   Santore, MM
AF Kalasin, Surachate
   Santore, Maria M.
TI Non-specific adhesion on biomaterial surfaces driven by small amounts of
   protein adsorption
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Bioadhesion; Bacterial adhesion; Flow; Biofouling; Electrostatic; Salt
   effects; Screening; Heterogeneity; Hydration effects; Charge patchiness
ID POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL) LAYERS; STAPHYLOCOCCUS-AUREUS
   ADHESION; SELF-ASSEMBLED MONOLAYERS; METAL-OXIDE SURFACES; FIBRINOGEN
   ADSORPTION; INTERACTION FORCES; CLUMPING FACTOR; HYDROPHOBIC SURFACES;
   COMPETITIVE BEHAVIOR; RELAXATION KINETICS
AB This work explores how long-range non-specific interactions, resulting from small amounts of adsorbed fibrinogen, potentially influence bioadhesion. Such non-specific interactions between protein adsorbed on a biomaterial and approaching cells or bacteria may complement or even dominate ligand-receptor mating. This work considers situations where the biomaterial surface and the approaching model cells (micron-scale silica particles) exhibit strong electrostatic repulsion, as may be the case in diagnostics and lab-on-chip applications. We report that adsorbed fibrinogen levels near 0.5 mg/m(2) produce non-specific fouling. For underlying surfaces that are less fundamentally repulsive, smaller amounts of adsorbed fibrinogen would have a similar effect. Additionally, it was observed that particle adhesion engages sharply and only above a threshold loading of fibrinogen on the collector. Also, in the range of ionic strength. 1, below about 0.05 M, increases in 1 reduce the fibrinogen needed for microparticle capture, due to screening of electrostatic repulsions. Surprisingly, however, ionic strengths of 0.15 M reduce fibrinogen adsorption altogether. This observation opposes expectations based on DLVO arguments, pointing to localized electrostatic attractions and hydration effects to drive silica-fibrinogen adhesion. These behaviors are benchmarked against microparticle binding on silica surfaces carrying small amounts of a polycation, to provide insight into the role of electrostatics in fibrinogen-driven non-specific adhesion. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Santore, Maria M.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
   [Kalasin, Surachate] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA.
RP Santore, MM (reprint author), Univ Massachusetts, Dept Polymer Sci & Engn, 120 Governors Dr, Amherst, MA 01003 USA.
EM santore@mail.pse.umass.edu
OI Kalasin, Surachate/0000-0001-6413-6642
FU NSF [CBET-0428455, BMAT-0805061]; UMass-Baystate initiative
FX This work was made possible by NSF grants CBET-0428455 and BMAT-0805061,
   and aid from the UMass-Baystate initiative.
CR Andruzzi L, 2005, LANGMUIR, V21, P2495, DOI 10.1021/la047574s
   Bruinsma GM, 2001, J MICROBIOL METH, V45, P95, DOI 10.1016/S0167-7012(01)00238-X
   Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   Dickinson RB, 1997, J COLLOID INTERF SCI, V190, P142, DOI 10.1006/jcis.1997.4882
   Duffadar R, 2009, J COLLOID INTERF SCI, V337, P396, DOI 10.1016/j.jcis.2009.05.046
   Duval JFL, 2005, LANGMUIR, V21, P11268, DOI 10.1021/la051735q
   Evans E, 1998, FARADAY DISCUSS, V111, P1
   FENG L, 1994, FUNDAMENTALS APPL, V602, P66
   FLEER GJ, 1993, POLYM INTERFACES
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   Francois P, 1997, MED MALADIES INFECT, V27, P143, DOI 10.1016/S0399-077X(97)80013-3
   Hansupalak N, 2004, MACROMOLECULES, V37, P1621, DOI 10.1021/ma0343636
   Hansupalak N, 2003, LANGMUIR, V19, P7423, DOI 10.1021/la0302145
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   Herrmann M, 1997, J INFECT DIS, V176, P984, DOI 10.1086/516502
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Kalasin S, 2008, LANGMUIR, V24, P4435, DOI 10.1021/la8000202
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kim DH, 2000, LANGMUIR, V16, P2808, DOI 10.1021/la990749r
   Kim HJ, 1999, COLLOID SURFACE A, V149, P561, DOI 10.1016/S0927-7757(98)00765-1
   Kozlova N, 2006, LANGMUIR, V22, P1135, DOI 10.1021/la0515221
   Leveque M, 1928, ANN MINES, V13, P284
   LIANG OD, 1993, BIOCHIM BIOPHYS ACTA, V1225, P57, DOI 10.1016/0925-4439(93)90122-H
   Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.3.CO;2-4
   NopplSimson DA, 1996, BIOPHYS J, V70, P1391, DOI 10.1016/S0006-3495(96)79697-2
   PASHLEY RM, 1981, J COLLOID INTERF SCI, V83, P531, DOI 10.1016/0021-9797(81)90348-9
   Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125
   Rebar VA, 1996, J COLLOID INTERF SCI, V178, P29, DOI 10.1006/jcis.1996.0089
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s
   Santore MM, 2005, CURR OPIN COLLOID IN, V10, P176, DOI 10.1016/j.cocis.2005.05.005
   SHIBATA CT, 1992, J COLLOID INTERF SCI, V148, P485, DOI 10.1016/0021-9797(92)90185-O
   Shin Y, 2002, MACROMOLECULES, V35, P4090, DOI 10.1021/ma0115390
   Shin YW, 2002, J COLLOID INTERF SCI, V247, P220, DOI 10.1006/jcis.2001.8100
   Toscano A, 2006, LANGMUIR, V22, P2588, DOI 10.1021/la051641g
   TOY PTCY, 1985, INFECT IMMUN, V48, P83
   Tsapikouni TS, 2008, BIOINTERPHASES, V3, P1, DOI 10.1116/1.2840052
   Tsapikouni TS, 2007, COLLOID SURFACE B, V57, P89, DOI 10.1016/j.colsurfb.2007.01.011
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   Walker SL, 2005, ENVIRON SCI TECHNOL, V39, P6405, DOI 10.1021/es050077t
   Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Xu CP, 2007, LANGMUIR, V23, P9423, DOI 10.1021/la701477w
   Zdyrko B, 2008, J COLLOID INTERF SCI, V322, P365, DOI 10.1016/j.jcis.2008.03.047
NR 58
TC 54
Z9 54
U1 6
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 15
PY 2009
VL 73
IS 2
BP 229
EP 236
DI 10.1016/j.colsurfb.2009.05.028
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 491SE
UT WOS:000269598900011
PM 19556113
DA 2018-10-20
ER

PT J
AU Sathishkumar, M
   Sneha, K
   Won, SW
   Cho, CW
   Kim, S
   Yun, YS
AF Sathishkumar, M.
   Sneha, K.
   Won, S. W.
   Cho, C. -W.
   Kim, S.
   Yun, Y. -S.
TI Cinnamon zeylanicum bark extract and powder mediated green synthesis of
   nano-crystalline silver particles and its bactericidal activity
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Silver; Nanoparticles; Cinnamon zeylanicum; Reduction; Antimicrobial
   activity
ID ANTIMICROBIAL ACTIVITY; NANOPARTICLES; BIOSYNTHESIS; MICROORGANISMS;
   COPPER; FUNGUS; WATER; IONS
AB The exploitation of various plant materials for the biosynthesis of nanoparticles is considered a green technology as it does not involve any harmful chemicals. The present study reports the synthesis of silver (Ag) nanoparticles from silver precursor using the bark extract and powder of novel Cinnamon zeylanicum. Water-soluble organics present in the plant materials were mainly responsible for the reduction of silver ions to nano-sized Ag particles. TEM and XRD results confirmed the presence of nano-crystalline Ag particles. The pH played a major role in size control of the particles. Bark extract produced more Ag nanoparticles than the powder did. which was attributed to the large availability of the reducing agents in the extract. Zeta potential studies showed that the surface charge of the formed nanoparticles was highly negative. The EC(50) value of the synthesized nanoparticles against Escherichia coli BL-21 strain was 11 +/- 1.72 mg/L Thus C. zeylanicum bark extract and powder are a good bio-resource/biomaterial for the synthesis of Ag nanoparticles with antimicrobial activity. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sathishkumar, M.; Sneha, K.; Won, S. W.; Cho, C. -W.; Kim, S.; Yun, Y. -S.] Chonbuk Natl Univ, Environm Biotechnol Natl Res Lab, Sch Chem Engn, Res Inst Ind Technol, Jeonju 561756, South Korea.
RP Yun, YS (reprint author), Chonbuk Natl Univ, Environm Biotechnol Natl Res Lab, Sch Chem Engn, Res Inst Ind Technol, Jeonju 561756, South Korea.
EM ysyun@chonbuk.ac.kr
RI Won, Sung Wook/B-3125-2012; Yun, Yeoung-Sang/F-8340-2011; Krishnamurthy,
   Sneha/B-1938-2012
OI Yun, Yeoung-Sang/0000-0002-2583-8278; 
FU Korea government (MEST) [R0A-2008-000-20117-0]; KOSEF through AEBRC at
   POSTECH
FX The authors thank Mr. Jong-Gyun Kang, EM lab, center for University-wide
   research facilities, Chonbuk National University, Korea for TEM
   analysis. This work was supported by the Korea Science and Engineering
   Foundation (KOSEF) NRL Program grant funded by the Korea government
   (MEST) (No. R0A-2008-000-20117-0) and in part by KOSEF through AEBRC at
   POSTECH.
CR Ahmad A, 2002, J AM CHEM SOC, V124, P12108, DOI 10.1021/ja0272960o
   Andreescu D, 2007, J MATER RES, V22, P2488, DOI 10.1557/JMR.2007.0308
   BASAVARAJA S, 2008, MAT RES B, V43, P164
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Gardea-Torresdey JL, 2003, LANGMUIR, V19, P1357, DOI 10.1021/la020835i
   Gardea-Torresdey JL, 2002, NANO LETT, V2, P397, DOI 10.1021/nl015673+
   Gole A, 2001, LANGMUIR, V17, P1674, DOI 10.1021/la001164w
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Jayaprakasha GK, 2002, Z NATURFORSCH C, V57, P990
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Kumar VS, 2004, J MOL CATAL A-CHEM, V223, P313, DOI 10.1016/j.molcata.2003.09.047
   Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082
   Lin YSE, 1998, WATER RES, V32, P1997, DOI 10.1016/S0043-1354(97)00460-0
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Mukherjee P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075103
   Mukherjee P, 2001, NANO LETT, V1, P515, DOI 10.1021/nl0155274
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Rai A, 2006, LANGMUIR, V22, P736, DOI 10.1021/la052055q
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Sadowski Z, 2008, MATER SCI-POLAND, V26, P419
   Sarkar S, 2007, POLYHEDRON, V26, P4419, DOI 10.1016/j.poly.2007.05.056
   Sastry M, 2003, CURR SCI INDIA, V85, P162
   Schoene NW, 2005, CANCER LETT, V230, P134, DOI 10.1016/j.canlet.2004.12.039
   Shan B, 2005, J AGR FOOD CHEM, V53, P7749, DOI 10.1021/jf051513y
   Shan B, 2007, J AGR FOOD CHEM, V55, P5484, DOI 10.1021/jf070424d
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Verspohl EJ, 2005, PHYTOTHER RES, V19, P203, DOI 10.1002/ptr.1643
NR 30
TC 383
Z9 390
U1 5
U2 95
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 15
PY 2009
VL 73
IS 2
BP 332
EP 338
DI 10.1016/j.colsurfb.2009.06.005
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 491SE
UT WOS:000269598900025
PM 19576733
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Coutu, DL
   Yousefi, AM
   Galipeau, J
AF Coutu, Daniel L.
   Yousefi, Azizeh-Mitra
   Galipeau, Jacques
TI Three-Dimensional Porous Scaffolds at the Crossroads of Tissue
   Engineering and Cell-Based Gene Therapy
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE GENE THERAPY; CELL THERAPY; 3D POROUS SCAFFOLDS; BIOMATERIALS; TISSUE
   ENGINEERING; ADULT STEM CELLS
ID HEMOPHILIA-A; BONE REPAIR; FACTOR-VIII; STEM-CELLS; FACTOR-IX; IN-VIVO;
   CLINICAL-TRIALS; DESIGN; DELIVERY; LIVER
AB In the last 20 years, more than 1,500 gene therapy clinical trials have been approved worldwide targeting a variety of indications, From inherited monogenic diseases to acquired conditions such as cancer, cardiovascular and infectious diseases. However, concerns about the safety and efficacy of gene therapy pharmaceuticals justify the development of alternative strategies to ensure the clinical translation of this still promising field. In particular, ex vivo gene therapy strategies using autologous adult stern cells coupled to three-dimensional (3D) porous scaffolds show great promises in preclinical studies. Developments in the fields of biomaterial sciences and tissue engineering have already helped understanding how we can harness to regenerative potential of many cell types to create artificial tissues and organs and vastly improve the engraftment of ex vivo manipulated adult stem cells. In this article, we will review the current state of the art in tissue engineering by exploring the various types of clinically available biomaterials and the methods used to process them into complex 3D scaffolds. We will then review how these technologies are applied in cell-based gene therapy and identify novel avenues of research that may benefit patients in the near Future. J. Cell. Biochem. 108: 537-546, 2009. (C) 2009 Wiley-Liss, Inc.
C1 [Galipeau, Jacques] McGill Univ, Jewish Gen Hosp, Div Hematol, Montreal, PQ H3T 1E2, Canada.
   [Coutu, Daniel L.] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.
   [Yousefi, Azizeh-Mitra] Natl Res Council Canada, Inst Ind Mat, Boucherville, PQ J4B 6Y4, Canada.
RP Galipeau, J (reprint author), McGill Univ, Jewish Gen Hosp, Div Hematol, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.
EM jacques.galipeau@mcgill.ca
RI Yousefi, Azizeh-Mitra/G-6566-2014
OI Coutu, Daniel/0000-0002-4641-0115
CR Arumuganathar S, 2008, BIOMACROMOLECULES, V9, P759, DOI 10.1021/bm701322k
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Brunetti-Pierri N, 2005, MOL GENET METAB, V86, P13, DOI 10.1016/j.ymgme.2005.07.015
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Chang PL, 1999, ANN NY ACAD SCI, V875, P146, DOI 10.1111/j.1749-6632.1999.tb08500.x
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963
   DUNCAN AW, 2009, GASTROENTER IN PRESS
   Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fiegel HC, 2008, J CELL MOL MED, V12, P56, DOI 10.1111/j.1582-4934.2007.00162.x
   Gamradt SC, 2004, ANN BIOMED ENG, V32, P136, DOI 10.1023/B:ABME.0000007798.78548.b8
   Garcia-Martin C, 2002, J GENE MED, V4, P215, DOI 10.1002/jgm.248
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hoganson DM, 2008, PEDIATR RES, V63, P520, DOI 10.1203/01.pdr.0000305879.38476.0c
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hortelano G, 2001, HAEMOPHILIA, V7, P207, DOI 10.1046/j.1365-2516.2001.00492.x
   Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Krebsbach PH, 2003, J GENE MED, V5, P11, DOI 10.1002/jgm.292
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Lillicrap D, 2006, HAEMOPHILIA, V12, P36, DOI 10.1111/j.1365-2516.2006.01259.x
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Matsui H, 2007, STEM CELLS, V25, P2660, DOI 10.1634/stemcells.2006-0699
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Murphy SL, 2008, BRIT J HAEMATOL, V140, P479, DOI 10.1111/j.1365-2141.2007.06942.x
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nathwani AC, 2005, BRIT J HAEMATOL, V128, P3, DOI 10.1111/j.1365-2141.05231.x
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Porteus MH, 2006, PLOS GENET, V2, P1285, DOI 10.1371/journal.pgen.0020133
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.2007.6100313
   Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433
   Pryor HI, 2008, FRONT BIOSCI-LANDMRK, V13, P2140, DOI 10.2741/2830
   Roth DA, 2001, NEW ENGL J MED, V344, P1735, DOI 10.1056/NEJM200106073442301
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sands MS, 2006, MOL THER, V13, P839, DOI 10.1016/j.ymthe.2006.01.006
   Scime A, 2009, FRONT BIOSCI-LANDMRK, V14, P3012, DOI 10.2741/3431
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Srouji S, 2006, REGEN MED, V1, P519, DOI 10.2217/17460751.1.4.519
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Thorrez L, 2008, BIOMATERIALS, V29, P75, DOI 10.1016/j.biomaterials.2007.09.014
   Thorrez L, 2006, MOL THER, V14, P442, DOI 10.1016/j.ymthe.2006.03.019
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
NR 49
TC 40
Z9 42
U1 1
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD OCT 15
PY 2009
VL 108
IS 3
BP 537
EP 546
DI 10.1002/jcb.22296
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 503UU
UT WOS:000270567100001
PM 19681040
DA 2018-10-20
ER

PT J
AU Narayanan, R
   Kwon, TY
   Kim, KH
AF Narayanan, R.
   Kwon, Tae-Yub
   Kim, Kyo-Han
TI TiO2 nanotubes from stirred glycerol/NH4F electrolyte: Roughness,
   wetting behavior and adhesion for implant applications
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Oxide; Coating; Nanostructure
ID TITANIUM-OXIDE NANOTUBES; HYDROXYAPATITE COATINGS; GROWTH; SURFACES;
   ELECTRODEPOSITION; BIOMATERIALS; WETTABILITY; ALLOY; CELLS
AB Titanium oxide (TiO2) was anodically formed on titanium from non-aqueous electrolyte containing glycerol and 0.5 wt% ammonium fluoride (NH4F). Oxidation was carried out for 30, 60, 120 and 240 min at potentiostatic 30 V with the bath being stirred using magnetic pellet. All the conditions produced amorphous nanotubes. They had an average diameter of 50-130 nm and length in the range of 1.2-1.9 mu m. The porosity was in the range of 70-80%. Stirring of the glycerol-based electrolyte has proved to be advantageous in retaining the tubular structure and providing smooth tubes even at 30V condition.
   The coatings had surface roughness Ra lower than 0.5 mu m, water wetting angles in the range of 58-84 degrees. Increasing pore diameters increased the water wetting angles. All the coatings invariably showed poor tensile pull-off adhesion strengths. This poor adhesion is attributed to the stirring of the electrolyte. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Narayanan, R.; Kwon, Tae-Yub; Kim, Kyo-Han] Kyungpook Natl Univ, Sch Dent, Dept Dent Biomat, Taegu, South Korea.
   [Narayanan, R.; Kwon, Tae-Yub; Kim, Kyo-Han] Kyungpook Natl Univ, Sch Dent BK21, Taegu, South Korea.
   [Kwon, Tae-Yub; Kim, Kyo-Han] Kyungpook Natl Univ, Inst Biomat Res & Dev, Taegu, South Korea.
RP Kim, KH (reprint author), Kyungpook Natl Univ, Sch Dent, Dept Dent Biomat, Taegu, South Korea.
EM kyohan@mail.knu.ac.kr
FU Brain Korea 21 (BK21) project
FX The authors acknowledge the assistance provided by Brain Korea 21 (BK21)
   project.
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   [Anonymous], 1980, C63379 ASTM
   Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Ghicov A, 2005, ELECTROCHEM COMMUN, V7, P505, DOI 10.1016/j.elecom.2005.03.007
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Han Y, 2001, J BIOMED MATER RES, V54, P96, DOI 10.1002/1097-4636(200101)54:1<96::AID-JBM11>3.0.CO;2-U
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kim HJ, 2005, J BIOMED MATER RES A, V74A, P366, DOI 10.1002/jbm.a.30327
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Macak JM, 2008, J ELECTROANAL CHEM, V621, P254, DOI 10.1016/j.jelechem.2008.01.005
   Macak JM, 2006, ELECTROCHIM ACTA, V52, P1258, DOI 10.1016/j.electacta.2006.07.021
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P7463, DOI 10.1002/anie.200502781
   Macak JM, 2005, ELECTROCHIM ACTA, V50, P3679, DOI 10.1016/j.electacta.2005.01.014
   Mohammadi Z, 2007, APPL SURF SCI, V253, P4960, DOI 10.1016/j.apsusc.2006.11.002
   Mohapatra SK, 2007, ELECTROCHIM ACTA, V53, P590, DOI 10.1016/j.electacta.2007.04.123
   Narayanan R, 2008, METALL MATER TRANS B, V39, P493, DOI 10.1007/s11663-008-9153-7
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P231, DOI 10.1002/jbm.b.30941
   Narayanan R, 2009, MATER LETT, V63, P2003, DOI 10.1016/j.matlet.2009.06.036
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Taveira LV, 2005, J ELECTROCHEM SOC, V152, pB405, DOI 10.1149/1.2008980
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
NR 28
TC 35
Z9 35
U1 0
U2 20
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD OCT 15
PY 2009
VL 117
IS 2-3
BP 460
EP 464
DI 10.1016/j.matchemphys.2009.06.023
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 506JK
UT WOS:000270770900025
DA 2018-10-20
ER

PT J
AU Jiang, LL
   Lu, X
   Leng, Y
   Qu, SX
   Feng, B
   Weng, J
AF Jiang, Lili
   Lu, Xiong
   Leng, Yang
   Qu, Shuxin
   Feng, Bo
   Weng, Jie
TI Micropatterned TiO2 effects on calcium phosphate mineralization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE TiO2; Calcium phosphate; Microgrooves; Biomineralization
ID IN-VITRO; TITANIUM; HYDROXYAPATITE; DESIGN; COATINGS; SURFACES; VIVO
AB The effects of implant surface topography and chemistry on biomineralization have been a research focus because of their potential importance in orthopedic and bone replacement applications. While avast amount of research is focusing on chemical modified surfaces and rough surfaces, little attention has been paid to the well-defined micropatterned surface effects on calcium phosphate mineralization process due to the difficulties in preparing microfabricated biomaterial surfaces. This work focuses on the effects of microgrooved TiO2 surfaces on the calcium phosphate mineralization process. Firstly, we developed a new process that can prepare microgrooved TiO2 coatings on glass substrates using soft-lithography and sol-gel technology. Then microgrooved TiO2 surfaces were used to induce Ca-P mineralization under biomimetic conditions. The results revealed that topography dominated the growth and distribution of mineralization at the initial days and then the effects of topography become weak with the extended immersion days. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Jiang, Lili; Lu, Xiong; Qu, Shuxin; Feng, Bo; Weng, Jie] SW Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu, Peoples R China.
   [Lu, Xiong; Leng, Yang] Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
RP Lu, X (reprint author), SW Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu, Peoples R China.
EM luxiong_2004@163.com
RI QU, SHU XIN/H-3036-2011; LU, xiong/B-3092-2010; Weng, Jie/B-3005-2010;
   Feng, Bo/B-3498-2010; Leng, Yang/B-3187-2010
OI LU, xiong/0000-0001-6367-430X; 
FU National Natural Science Foundation of China [30700172]; NSFC/RGC
   [N_HKUST601/08, 30831160509]; Specialized Research Fund for the Doctoral
   Program of Higher Education for Young Teacher [20070613019]; MSTC
   [2006BA116B01]
FX This project was financially supported by the National Natural Science
   Foundation of China (No. 30700172), NSFC/RGC joint Research Funding
   (N_HKUST601/08, 30831160509), Specialized Research Fund for the Doctoral
   Program of Higher Education for Young Teacher (20070613019) and National
   Key Project of Scientific and Technical Supporting Programs Fund from
   MSTC (2006BA116B01).
CR ANDREAS T, 2007, MACROMOL BIOSCI, V7, P1085
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Cagin T, 1999, NANOTECHNOLOGY, V10, P278, DOI 10.1088/0957-4484/10/3/310
   Cheng YT, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2130392
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835
   Habibovic P., 2003, LEARNING NATURE DESI, P105
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Jarn M, 2006, LANGMUIR, V22, P8209, DOI 10.1021/la060966+
   Jiang HD, 2005, J BIOL CHEM, V280, P42061, DOI 10.1074/jbc.M412280200
   Kokubo T, 2005, MAT SCI ENG C-BIO S, V25, P97, DOI 10.1016/j.msec.2005.01.002
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P46
   Lu X, 2005, BIOMATERIALS, V26, P1793, DOI 10.1016/j.biomaterials.2004.06.009
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   Lu X, 2008, J BIOMED MATER RES A, V84A, P523, DOI 10.1002/jbm.a.31471
   Lu X, 2007, MAT SCI ENG C-BIO S, V27, P700, DOI 10.1016/j.msec.2006.06.030
   MARKOV IV, 1995, CRYSTAL GROWTH BEGIN, P69
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   PERIZZOLO D, 2001, BIOMED MATER, V65, P494
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Sato K, 2007, TOP CURR CHEM, V270, P127, DOI 10.1007/128_075
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m
   Zhang QY, 2005, BIOMATERIALS, V26, P2857, DOI 10.1016/j.biomaterials.2004.08.016
NR 25
TC 12
Z9 13
U1 2
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 15
PY 2009
VL 29
IS 8
BP 2355
EP 2359
DI 10.1016/j.msec.2009.06.005
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 512NP
UT WOS:000271256700007
DA 2018-10-20
ER

PT J
AU Liu, WN
   Chang, J
AF Liu, Weining
   Chang, Jiang
TI In vitro evaluation of gentamicin release from a bioactive tricalcium
   silicate bone cement
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tricalcium silicate; Gentamicin sulfate; Prolonged release; Apatite;
   Drug delivery
ID SELF-SETTING PROPERTIES; CALCIUM-SULFATE; DRUG-DELIVERY;
   NEUTRON-SCATTERING; CARRIER MATERIAL; PORTLAND-CEMENT; VIVO EVALUATION;
   COMPOSITE; OSTEOMYELITIS; HYDROXYAPATITE
AB Tricalcium silicate (Ca(3)SiO(5)) cement, a novel self-setting biomaterial. has been shown to exhibit good hydraulic properties and excellent bioactivity. In this study, gentamicin sulfate (GS) was integrated into cement pastes and in vitro release of GS from the Ca(3)SiO(5) cement was performed in deionized water, phosphate buffer saline (PBS) and HCI solutions with different pH at 37 degrees C, respectively. The results showed that the initial fast release of GS was restricted to a low level and prolonged release of drugs was achieved in water and PBS. The prolonged GS release is attributed to the interaction of GS with the calcium silicate hydrate network and the formation of unique nano-to-micro porous structure after hydration. Furthermore, GS release from milled powders of the hydrated cement suggested that the constrained GS could be released at low pH environment or during the degradation of the cement. When the samples were soaked in PBS, a nano-structured apatite layer was formed on the surface of the cement, which resulted in a relatively lower GS release rate as compared to that in water. The results suggest that Ca(3)SiO(5) cement might be used as bioactive bone implant materials with drug loading and prolonged release properties. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Liu, Weining; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Liu, Weining] Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
FU National Basic Science Research Program of China (973 Program)
   [2005CB522704]; Science and Technology Commission of Shanghai
   Municipality [08JC1420800]; Natural Science Foundation of China
   [30730034]; National High Technology Research and Development Program of
   China (863 Program) [2007AA03Z317]
FX This work is supported by the National Basic Science Research Program of
   China (973 Program) (Grant No.: 2005CB522704), Science and Technology
   Commission of Shanghai Municipality (Grant No. 08JC1420800) and the
   Natural Science Foundation of China (Grant 30730034) as well as the
   National High Technology Research and Development Program of China (863
   Program) (Grant No. 2007AA03Z317).
CR Allen AJ, 2007, NAT MATER, V6, P311, DOI 10.1038/nmat1871
   Baro M, 2002, J CONTROL RELEASE, V83, P353, DOI 10.1016/S0168-3659(02)00179-7
   Cabanas MV, 2002, CHEM MATER, V14, P3550, DOI 10.1021/cm021121w
   Chopra R, 2002, INT J PHARM, V239, P171, DOI 10.1016/S0378-5173(02)00104-7
   Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Doadrio AL, 2004, J CONTROL RELEASE, V97, P125, DOI 10.1016/j.jcornel.2004.03.005
   Doadrio JC, 2004, BIOMATERIALS, V25, P2629, DOI 10.1016/j.biomaterials.2003.09.037
   FitzGerald SA, 2002, CEMENT CONCRETE RES, V32, P409, DOI 10.1016/S0008-8846(01)00685-8
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   GREENBERG SA, 1960, J PHYS CHEM-US, V64, P1151, DOI 10.1021/j100838a012
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Huan Z, 2007, ACTA BIOMATER, V3, P952, DOI 10.1016/j.actbio.2007.05.003
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Kobayashi M, 1998, J BIOMED MATER RES, V42, P223, DOI 10.1002/(SICI)1097-4636(199811)42:2<223::AID-JBM7>3.0.CO;2-R
   Kobayashi M, 1999, J BIOMED MATER RES, V46, P447, DOI 10.1002/(SICI)1097-4636(19990915)46:4<447::AID-JBM2>3.3.CO;2-G
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Li HY, 2005, J CONTROL RELEASE, V107, P463, DOI 10.1016/j.jconrel.2005.05.019
   MCCURDY KG, 1973, CEMENT CONCRETE RES, V3, P509
   Mojumdar SC, 2005, J THERM ANAL CALORIM, V82, P89, DOI 10.1007/s10973-005-0846-8
   Mori K, 2006, PHYSICA B, V385, P517, DOI 10.1016/j.physb.2006.05.260
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   PECORA G, 2004, INT ENDOD J, V34, P184
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   RAMACHANDRAN AR, 1993, J AM CERAM SOC, V76, P72, DOI 10.1111/j.1151-2916.1993.tb03691.x
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Siepmann J, 2000, INT J PHARM, V201, P151, DOI 10.1016/S0378-5173(00)00390-2
   Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014
   Suominen E, 1996, J BIOMED MATER RES, V32, P543, DOI 10.1002/(SICI)1097-4636(199612)32:4<543::AID-JBM7>3.0.CO;2-R
   Taylor HF, 1997, CEMENT CHEM
   Thomas JJ, 2001, J AM CERAM SOC, V84, P1811
   Vogt S, 2007, ADV ENG MATER, V9, P1135, DOI 10.1002/adem.200700223
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xue WC, 2005, BIOMATERIALS, V26, P3455, DOI 10.1016/j.biomaterials.2004.09.027
   ZHANG XC, 1994, J PHARM PHARMACOL, V46, P718, DOI 10.1111/j.2042-7158.1994.tb03890.x
   Zhao WY, 2008, J BIOMED MATER RES A, V85A, P336, DOI 10.1002/jbm.a.31523
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
   Zhao WY, 2004, MATER LETT, V58, P2350, DOI 10.1016/j.matlet.2004.02.045
NR 39
TC 19
Z9 21
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 15
PY 2009
VL 29
IS 8
BP 2486
EP 2492
DI 10.1016/j.msec.2009.07.015
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 512NP
UT WOS:000271256700027
DA 2018-10-20
ER

PT J
AU Gigout, A
   Levasseur, S
   Girard-Lauriault, PL
   Buschmann, MD
   Wertheimer, MR
   Jolicoeur, M
AF Gigout, Anne
   Levasseur, Sophie
   Girard-Lauriault, Pierre-Luc
   Buschmann, Michael D.
   Wertheimer, Michael R.
   Jolicoeur, Mario
TI CHO Cells Adhering to Nitrogen-Rich Plasma-Polymerised Ethylene Exhibit
   High Production of a Specific Recombinant Protein
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adhesion; biomaterial; biotechnology; mammalian cells; plasma
   polymerisation
ID ATMOSPHERIC-PRESSURE; MICROCARRIER CULTURE; FUNCTIONAL-GROUPS; INTEGRIN
   BINDING; SERUM-PROTEINS; ANIMAL-CELLS; ADHESION; SURFACE; GROWTH;
   ATTACHMENT
AB In many industrial applications, inadequate cell attachment can be a limitation, especially when serum-free media are used. Nitrogen-rich plasma-polymerised ethylene (PPE:N) exhibits high concentrations of polar groups that can help to promote the attachment of weakly adherent cell types. Tissue plasminogen activatorproducing Chinese hamster ovary (CHO) cells adapted to suspension, were grown in the presence PPE:N flakes and were found to adhere to them. The growth rate was reduced, but cell viability was enhanced and their metabolism was more efficient, with generally higher recombinant protein productivity. Finally, cell adhesion on PPE:N surfaces was found to be independent of integrins, and was probably mediated by certain non-specific interactions with the PPE:N surface.
C1 [Gigout, Anne; Levasseur, Sophie; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Canada Res Chair Appl Metab Engn, Montreal, PQ H3C 3A7, Canada.
   [Girard-Lauriault, Pierre-Luc; Wertheimer, Michael R.] Ecole Polytech, Dept Engn Phys, Montreal, PQ H3C 3A7, Canada.
   [Buschmann, Michael D.] Ecole Polytech, Canada Res Chair Cartilage Tissue Engn, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada.
RP Jolicoeur, M (reprint author), Ecole Polytech, Dept Chem Engn, Canada Res Chair Appl Metab Engn, POB 6079 Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.
EM mario.jolicoeur@polymtl.ca
OI Buschmann, Michael/0000-0002-2242-6198
CR Arima Y, 2007, J MATER CHEM, V17, P4079, DOI 10.1039/b708099a
   BENTCHAVTCHAVAD.M, 2007, PHARM ENG, V27
   Chiarugi P, 2008, IUBMB LIFE, V60, P301, DOI 10.1002/jub.45
   Clark J M, 1981, Ann N Y Acad Sci, V369, P33, DOI 10.1111/j.1749-6632.1981.tb14175.x
   Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G
   Durrschmid M, 2003, BIOTECHNOL BIOENG, V83, P681, DOI 10.1002/bit.10700
   Even MS, 2006, TRENDS BIOTECHNOL, V24, P105, DOI 10.1016/j.tibtech.2006.01.001
   Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019
   Girard-Lauriault PL, 2008, PLASMA PROCESS POLYM, V5, P631, DOI 10.1002/ppap.200800054
   Girard-Lauriault PL, 2009, MACROMOL BIOSCI, V9, P911, DOI 10.1002/mabi.200800359
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20085
   Gramer MJ, 1998, BIOTECHNOL PROGR, V14, P203, DOI 10.1021/bp9800081
   HEIFETZ AH, 1989, BIOTECHNIQUES, V7, P192
   HONN KV, 1975, P SOC EXP BIOL MED, V149, P344
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   KOLLER MR, 1995, BIOPROCESS TECHNOL, V20, P31
   Kong D, 1999, CYTOTECHNOLOGY, V29, P149
   Kumar S, 2004, BIOTECHNOL LETT, V26, P1, DOI 10.1023/B:BILE.0000009469.69116.03
   KURKELA R, 1993, BIOTECHNIQUES, V15, P674
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lerouge S, 2007, BIOMATERIALS, V28, P1209, DOI 10.1016/j.biomaterials.2006.10.033
   MUKHOPADHYAY A, 1993, J CHEM TECHNOL BIOT, V56, P369
   Mwale F, 2006, TISSUE ENG, V12, P2639, DOI 10.1089/ten.2006.12.2639
   Ng YC, 1996, BIOTECHNOL BIOENG, V50, P627, DOI 10.1002/(SICI)1097-0290(19960620)50:6<627::AID-BIT3>3.0.CO;2-M
   Nishijima K, 2000, CYTOTECHNOLOGY, V33, P147, DOI 10.1023/A:1008189802014
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   RENNER WA, 1993, BIOTECHNOL BIOENG, V41, P188, DOI 10.1002/bit.260410204
   Reuveny S, 1990, Bioprocess Technol, V10, P271
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200
   Schulz R, 1987, Dev Biol Stand, V66, P489
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   Thissen H, 2006, J BIOMED MATER RES A, V77A, P590, DOI 10.1002/jbm.a.30612
   Truica-Marasescu F, 2008, THIN SOLID FILMS, V516, P7406, DOI 10.1016/j.tsf.2008.02.033
   Varani J, 1998, CYTOTECHNOLOGY, V28, P101, DOI 10.1023/A:1008029715765
   VARANI J, 1993, CYTOTECHNOLOGY, V13, P89, DOI 10.1007/BF00749935
NR 44
TC 7
Z9 7
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD OCT 8
PY 2009
VL 9
IS 10
BP 979
EP 988
DI 10.1002/mabi.200900079
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 511OC
UT WOS:000271174100005
PM 19623580
OA Bronze
DA 2018-10-20
ER

PT J
AU Zaliz, CLR
   Varela, O
AF Romero Zaliz, C. Lorena
   Varela, Oscar
TI Cyclic oligomers (macroaldonolactones) from a protected D-galactonic
   acid monomer
SO TETRAHEDRON LETTERS
LA English
DT Article
DE Macrocycle; Macrolactone; Cyclodextrin; Aldonic acid; Biomaterial
ID STRUCTURE ASSIGNMENT; DERIVATIVES; CHROMATOGRAPHY; CYCLODEXTRINS;
   CYCLOVIRACIN; GLUCOLIPSIN; NYLON-6; LACTIDE; CORE; DRUG
AB Dicyclohexylcarbodiimide-promoted self-condensation of 2,3:4,5-di-O-isopropylidene-D-galactonic acid (3) led to the macrocyclic oligomeric cyclo[(2,3:4,5-di-O-isopropylidene-(1 -> 6)-D-galactonate)(2)] (4) and cyclo[(2,3:4,5-di-O-isopropylidene-(1 -> 6)-D-galactonate)(3)] (5), having, respectively, 14- and 21-membered rings. The macrocycles 4 and 5 were also synthesized by cyclization of the respective linear dinner 11 and trimer 14 omega-hydroxy acids precursors prepared by stepwise additions of 3. Compounds 4 and 5 are biomaterials that may be described as macrolactone-cyclodextrins. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Romero Zaliz, C. Lorena; Varela, Oscar] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR CONICET, RA-1428 Buenos Aires, DF, Argentina.
RP Varela, O (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR CONICET, Pabellon 2,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.
EM varela@qo.fcen.uba.ar
FU University of Buenos Aires [X059]; National Research Council of
   Argentina [5011]; National Agency for Promotion of Science and
   Technology [PICT-13922]
FX Support of this work by the University of Buenos Aires (project X059),
   the National Research Council of Argentina (CONICET, project PIP 5011),
   and the National Agency for Promotion of Science and Technology
   (ANPCyT-FCNCyT, project PICT-13922) is gratefully acknowledged. O.V. is
   a Research Member of CONICET.
CR Appelt HR, 2008, TETRAHEDRON LETT, V49, P4956, DOI 10.1016/j.tetlet.2008.05.109
   Bailliez V, 2003, TETRAHEDRON LETT, V44, P9151, DOI 10.1016/j.tetlet.2003.10.047
   BODEN EP, 1985, J ORG CHEM, V50, P2394, DOI 10.1021/jo00213a044
   Chisholm MH, 2006, P NATL ACAD SCI USA, V103, P15315, DOI 10.1073/pnas.0602662103
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Culkin DA, 2007, ANGEW CHEM INT EDIT, V46, P2627, DOI 10.1002/anie.200604740
   Fukuda M, 2008, INT J PHARM, V350, P188, DOI 10.1016/j.ijpharm.2007.08.038
   Furstner A, 2004, J ORG CHEM, V69, P459, DOI 10.1021/jo035079f
   Furstner A, 2003, J AM CHEM SOC, V125, P13132, DOI 10.1021/ja036521e
   Gattuso G, 1998, CHEM REV, V98, P1919, DOI 10.1021/cr960133w
   Gotsch A, 2005, J CHROMATOGR A, V1063, P193, DOI 10.1016/j.chroma.2004.11.059
   Hebeish A, 2008, CARBOHYD POLYM, V74, P268, DOI 10.1016/j.carbpol.2008.02.013
   Higashi T, 2008, BIOMATERIALS, V29, P3866, DOI 10.1016/j.biomaterials.2008.06.019
   Kricheldorf HR, 2003, J POLYM SCI POL CHEM, V41, P3414, DOI 10.1002/pola.10933
   Li J, 2008, ADV DRUG DELIVER REV, V60, P1000, DOI 10.1016/j.addr.2008.02.011
   Liberto E, 2008, J CHROMATOGR A, V1195, P117, DOI 10.1016/j.chroma.2008.04.045
   LONG DD, 1999, J CHEM SOC P1, V8, P901
   Mayes BA, 2004, TETRAHEDRON-ASYMMETR, V15, P627, DOI 10.1016/j.tetasy.2003.12.031
   Nagashima I, 2008, TETRAHEDRON LETT, V49, P3413, DOI 10.1016/j.tetlet.2008.03.103
   Nakagawa Y, 2001, BIOORG MED CHEM LETT, V11, P723, DOI 10.1016/S0960-894X(01)00047-6
   Parenty A, 2006, CHEM REV, V106, P911, DOI 10.1021/cr0301402
   ROMEROZALIZ CL, 2005, ARKIVOC 12, P76
   STORK G, 1987, J AM CHEM SOC, V109, P1565, DOI 10.1021/ja00239a045
   Takahashi S, 2004, J ORG CHEM, V69, P4509, DOI 10.1021/jo0496392
   Tang M, 2009, CHEM COMMUN, P941, DOI 10.1039/b817658b
   Wang RQ, 2008, J CHROMATOGR A, V1203, P185, DOI 10.1016/j.chroma.2008.07.046
   Zaliz CLR, 2005, TETRAHEDRON-ASYMMETR, V16, P97, DOI 10.1016/j.tetasy.2004.11.061
   Zaliz CLR, 2003, TETRAHEDRON-ASYMMETR, V14, P2579, DOI 10.1016/S0957-4166(03)00588-3
   Zaliz CLR, 2001, J CARBOHYD CHEM, V20, P689, DOI 10.1081/CAR-100108283
   Zhang YZ, 2000, BIOORG MED CHEM LETT, V10, P775, DOI 10.1016/S0960-894X(00)00096-2
NR 30
TC 2
Z9 2
U1 2
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4039
J9 TETRAHEDRON LETT
JI Tetrahedron Lett.
PD OCT 7
PY 2009
VL 50
IS 40
BP 5677
EP 5680
DI 10.1016/j.tetlet.2009.07.123
PG 4
WC Chemistry, Organic
SC Chemistry
GA 493EE
UT WOS:000269715600036
DA 2018-10-20
ER

PT J
AU Zhang, XH
   Reagan, MR
   Kaplan, DL
AF Zhang, Xiaohui
   Reagan, Michaela R.
   Kaplan, David L.
TI Electrospun silk biomaterial scaffolds for regenerative medicine
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Silk; Biomaterials; Electrospinning; Nanofiber; Tissue engineering;
   Matrices; Scaffolds
ID BOMBYX-MORI SILK; TISSUE-ENGINEERING SCAFFOLDS; NORMAL HUMAN
   KERATINOCYTES; BIOMIMETIC NANOFIBROUS SCAFFOLDS; FIBROIN
   AQUEOUS-SOLUTIONS; ELECTRICALLY FORCED JETS; MESENCHYMAL STEM-CELLS;
   HUMAN BONE-MARROW; IN-VITRO; MOLECULAR-WEIGHT
AB Electrospinning is a versatile technique that enables the development of nanofiber-based biomaterial scaffolds. Scaffolds can be generated that are useful for tissue engineering and regenerative medicine since they mimic the nanoscale properties of certain fibrous components of the native extracellular matrix in tissues. Silk is a natural protein with excellent biocompatibility, remarkable mechanical properties as well as tailorable degradability. Integrating these protein polymer advantages with electrospinning results in scaffolds with combined biochemical, topographical and mechanical cues with versatility for a range of biomaterial, cell and tissue studies and applications. This review covers research related to electrospinning of silk, including process parameters, post treatment of the spun fibers, functionalization of nanofibers, and the potential applications for these material systems in regenerative medicine. Research challenges and future trends are also discussed. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Reagan, Michaela R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhang, Xiaohui; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Zhang, Xiaohui/C-4569-2013; Reagan, Michaela/E-3549-2017
OI Reagan, Michaela/0000-0003-2884-6481
FU NIH; NSF; AFOSR
FX This work was supported by the NIH P41 Tissue Engineering Resource
   Center, the NSF and the AFOSR. The authors would like to gratefully
   thank Cassandra B Baughma, Evangelia Bellas and Vinny Keshav for their
   assistance in preparation of this review.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Annis D, 1978, Trans Am Soc Artif Intern Organs, V24, P209
   ASAKURA T, 1992, J POLYM SCI POL PHYS, V30, P693, DOI 10.1002/polb.1992.090300706
   Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   BRAU RR, 2004, ENCY BIOMATERIALS BI, P1652
   Choi JS, 2004, INT J BIOL MACROMOL, V34, P249, DOI 10.1016/j.ijbiomac.2004.06.001
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039
   Fang X, 1997, J MACROMOL SCI PHYS, VB36, P169, DOI 10.1080/00222349708220422
   FISHER AC, 1985, LIFE SUPPORT SYST S, V1, P462
   Fong H, 2001, STRUCTURE FORMATION, P225
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   FORMHALS A, 1940, Patent No. 187306
   FORMHALS A, 1939, Patent No. 160962
   FORMHALS A, 1944, Patent No. 349950
   FORMHALS A, 1934, Patent No. 975504
   FORMHALS A, 1943, Patent No. 323025
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Gupta P, 2003, POLYMER, V44, P6353, DOI 10.1016/S0032-3861(03)00616-5
   HAYATI I, 1987, J COLLOID INTERF SCI, V117, P205, DOI 10.1016/0021-9797(87)90185-8
   HOERSTRUP SP, 2004, BIOMATERIAL SCI INTR, P712
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Hohman MM, 2001, PHYS FLUIDS, V13, P2221, DOI 10.1063/1.1384013
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jarusuwannapoom T, 2005, EUR POLYM J, V41, P409, DOI 10.1016/j.eurpolymj.2004.10.010
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Jeong L, 2006, INT J BIOL MACROMOL, V38, P140, DOI 10.1016/j.ijbiomac.2006.02.009
   Jeong L, 2007, KEY ENG MATER, V342-343, P813, DOI 10.4028/www.scientific.net/KEM.342-343.813
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kameoka J, 2003, NANOTECHNOLOGY, V14, P1124, DOI 10.1088/0957-4484/14/10/310
   Kang M, 2007, J NANOSCI NANOTECHNO, V7, P3888, DOI 10.1166/jnn.2007.056
   Kang M, 2007, COLLOID POLYM SCI, V285, P1163, DOI 10.1007/s00396-007-1668-y
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kim HS, 2005, MACROMOL SYMP, V224, P145, DOI 10.1002/masy.200550613
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0
   Koski A, 2004, MATER LETT, V58, P493, DOI 10.1016/S0167-577X(03)00532-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   Lee KH, 2005, FIBER POLYM, V6, P181, DOI 10.1007/BF02875641
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liao S, 2006, BIOMED MATER, V1, pR45, DOI 10.1088/1748-6041/1/3/R01
   Lu C, 2006, POLYMER, V47, P915, DOI 10.1016/j.polymer.2005.11.090
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MAGOSHI J, 1977, J POLYM SCI POL PHYS, V15, P1675, DOI 10.1002/pol.1977.180150915
   MAGOSHI J, 1996, POLYM MAT ENCY, P667
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   McManus MC, 2007, J BIOMED MATER RES A, V81A, P299, DOI 10.1002/jbm.a.30989
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Megelski S, 2002, MACROMOLECULES, V35, P8456, DOI 10.1021/ma020444a
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MORRIS NP, 2003, CONNECTIVE TISSUE IT, P41
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   NAKAMURA S, 1994, S SERIES AM CHEM SOC, V544, P211
   Nishlbe T, 2007, VASCULAR, V15, P356, DOI 10.2310/6670.2007.00053
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   PENEKER DH, 1996, NANOTECHNOLOGY, V7, P216
   Peng XN, 2004, ACTA CHIM SINICA, V62, P2127
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   ROUABHIA M, 1997, LANDES BIOSCIENCE
   SAPSFORD RN, 1981, J THORAC CARDIOV SUR, V81, P860
   SAW SH, 2007, NANOTECHNOLOGIES LIF, V9, P66
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Schreuder-Gibson H, 2002, J ADV MATER-COVINA, V34, P44
   Shin YM, 2001, APPL PHYS LETT, V78, P1149, DOI 10.1063/1.1345798
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   SIMONS HL, 1966, Patent No. 280229
   SKALAK R, TISSUE ENG
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   Song JH, 2008, J MATER SCI-MATER M, V19, P95, DOI 10.1007/s10856-007-3169-4
   Steinthorsson G, 1999, ACTA CHIR BELG, V99, P282
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Sukigara S, 2004, POLYMER, V45, P3701, DOI 10.1016/j.polymer.2004.03.059
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Tsai PP, 2002, J ELECTROSTAT, V54, P333, DOI 10.1016/S0304-3886(01)00160-7
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   VACANTI JP, 1997, PRINCIPLES TISSUE EN, P1
   VEITH FJ, 1986, J VASC SURG, V3, P104
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wang H, 2006, J APPL POLYM SCI, V101, P961, DOI 10.1002/app.24024
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Wang M, 2006, MACROMOLECULES, V39, P1102, DOI 10.1021/ma0517749
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   WARNER SB, 1998, NATL TEXTILE CTR ANN, P83
   Wen X, 2005, HDB NANOSTRUCTURED B, P1
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   YOKOYAMA T, 1978, J THORAC CARDIOV SUR, V76, P552
   Yoo CR, 2008, INT J BIOL MACROMOL, V42, P324, DOI 10.1016/j.ijbiomac.2007.12.004
   Zarkoob S, 2004, POLYMER, V45, P3973, DOI 10.1016/j.polymer.2003.10.102
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 150
TC 219
Z9 232
U1 22
U2 193
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD OCT 5
PY 2009
VL 61
IS 12
BP 988
EP 1006
DI 10.1016/j.addr.2009.07.005
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 514LH
UT WOS:000271395700002
PM 19643154
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Nogueira, GM
   Weska, RF
   Vieira, WC
   Polakiewicz, B
   Rodas, ACD
   Higa, OZ
   Beppu, MM
AF Nogueira, Grinia M.
   Weska, Raquel F.
   Vieira, Wellington C., Jr.
   Polakiewicz, Bronislaw
   Rodas, Andrea C. D.
   Higa, Olga Z.
   Beppu, Marisa M.
TI A New Method to Prepare Porous Silk Fibroin Membranes Suitable for
   Tissue Scaffolding Applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE silk fibroin; porous membrane; biopolymer; biomaterial
ID BOMBYX-MORI SILK; BONE REGENERATION
AB A new method to prepare porous silk fibroin (SF) membranes without dialysis proposed. Silk fibers were degummed to remove sericin and the resultant fibroin was dissolved in a CaCl(2)-CH(3)CH(2)OH-H(2)O ternary solvent. Rather than undergoing dialysis, a fibroin salty solution was diluted in water and then submitted to a mechanical agitation that led to a phase separation through foam formation on the solution surface. This foam was continually collected and then compacted between plates to remove the excess of water. The membranes presented large pores with diameters of greater than 100 pm (as shown by scanning electron microscopy - SEM), porosity of 68% and water content of 91% w/w. X-ray diffraction (XRD) and infrared spectroscopy (FTIR-ATR) indicated that the membranes present SF in a beta-sheet structure even before the ethanol treatment. A typical elastic deformation profile and degradation under temperature were observed using calorimetric analysis (DSC), thermal gravimetric analysis (TGA) and mechanical tests. As indicated by the in vitro cytotoxicity tests, these membranes present potential for use as scaffolds. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 114: 617-623, 2009
C1 [Nogueira, Grinia M.; Weska, Raquel F.; Vieira, Wellington C., Jr.; Beppu, Marisa M.] Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
   [Polakiewicz, Bronislaw] Univ Sao Paulo, Sch Pharmaceut Sci, BR-09500900 Sao Paulo, Brazil.
   [Rodas, Andrea C. D.; Higa, Olga Z.] IPEN CNEN SP, Energy & Nucl Res Inst, Ctr Biotechnol, Sao Paulo, Brazil.
RP Beppu, MM (reprint author), Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
EM beppu@feq.unicamp.br
RI BEPPU, MARISA/E-1057-2012; Biofabris, Inct/I-2418-2013; Rodas,
   Andrea/E-1130-2012
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   [Anonymous], 2002, D88202 ASTM
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   BEPPU M, 2006, Patent No. 06019757
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   International Organization for Standardization, 1992, 10993 ISO
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   MAGNANI A, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P81
   Magoshi J, 2000, THERMOCHIM ACTA, V352, P165, DOI 10.1016/S0040-6031(99)00462-1
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Um C., 2001, INT J BIOL MACROMOL, V29, P91
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Weska RF, 2009, KEY ENG MAT, V396-398, P187, DOI 10.4028/www.scientific.net/KEM.396-398.187
NR 29
TC 11
Z9 11
U1 3
U2 26
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 5
PY 2009
VL 114
IS 1
BP 617
EP 623
DI 10.1002/app.30627
PG 7
WC Polymer Science
SC Polymer Science
GA 480MH
UT WOS:000268738500073
DA 2018-10-20
ER

PT J
AU Krebs, MD
   Sutter, KA
   Lin, ASP
   Guldberg, RE
   Alsberg, E
AF Krebs, Melissa D.
   Sutter, Kathleen A.
   Lin, Angela S. P.
   Guldberg, Robert E.
   Alsberg, Eben
TI Injectable poly(lactic-co-glycolic) acid scaffolds with in situ pore
   formation for tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterial; Injectable; In situ pore formation; Poly(lactic-co-glycolic
   acid); Scaffold
ID 3-DIMENSIONAL SCAFFOLDS; BIODEGRADABLE POLYMERS; MOLECULAR-WEIGHT;
   DELIVERY-SYSTEM; DRUG-DELIVERY; DEGRADATION; FABRICATION; HYDROGELS;
   IMPLANTS; DESIGN
AB Appropriate porosity is an important biomaterial design criterion for scaffolds used in tissue engineering applications as it can permit increased cell adhesion, migration, proliferation and extracellular matrix production within the scaffold at a tissue defect site. Tissue engineering scaffolds can either be injected in a minimally invasive manner or implanted through surgical procedures. Many injectable scaffolds are hydrogel-based; these materials often possess nanoscale porosity, which is suboptimal for cell migration and proliferation. Solid scaffolds with engineered micron-scale porosity are widely used, but these scaffolds are usually pre-formed and then must be implanted. Here we report on the development of a solid, injectable, biomaterial scaffold that solidifies in situ via phase inversion with microporous, interconnected architecture on the surface and within the bulk. This injectable system utilizes the biodegradable polymer poly(lactic-co-glycolic acid), a nontoxic FDA-approved solvent, and biocompatible porogens. Various scaffold formulations are examined in terms of morphology, porosity, degradation, elastic modulus, and ability to support cellular adhesion and growth. Furthermore, the ability to form a microporous architecture upon injection in vivo is verified. This technology is a promising noninvasive approach for in vivo formation of porous biodegradable scaffolds. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Krebs, Melissa D.; Sutter, Kathleen A.; Alsberg, Eben] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Lin, Angela S. P.; Guldberg, Robert E.] Georgia Inst Technol, Atlanta, GA 30332 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, 309 Wickenden,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Krebs, Melissa/L-4878-2015
OI Krebs, Melissa/0000-0002-5170-7116; Alsberg, Eben/0000-0002-3487-4625
FU Ohio Department of Development [05-065]; The Ellison Medical Foundation;
   National Science Foundation Graduate Research Fellowship
FX We thank Eric Chen and Andrew Fu for technical assistance. The authors
   gratefully acknowledge funding support for this work from Biomedical
   Research and Technology Transfer Grant 05-065 from the Ohio Department
   of Development (E.A.), a New Scholar in Aging Award from The Ellison
   Medical Foundation (E.A.), and a National Science Foundation Graduate
   Research Fellowship (M. D. K.).
CR Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   BUDDEN R, 1979, PHARMACOL THERAPEUT, V5, P467, DOI 10.1016/0163-7258(79)90119-0
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
   Eliaz RE, 2002, GENE THER, V9, P1230, DOI 10.1038/sj.gt.3301786
   Eliaz RE, 2000, PHARMACEUT RES, V17, P1546, DOI 10.1023/A:1007621512647
   Frazza E.J., 1971, J BIOMED MATER RES, V5, P43, DOI DOI 10.1002/JBM.820050207
   GE ZG, 2008, BIOMED MATER, V3, P22001
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   Hile DD, 2005, BIO-MED MATER ENG, V15, P219
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2007, J CELL MOL MED, V11, P654, DOI 10.1111/j.1582-4934.2007.00078.x
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim CW, 2008, J BIOMED MATER RES A, V85A, P1114, DOI 10.1002/jbm.a.31633
   Kim SH, 2000, J BIOMED MATER RES, V53, P258, DOI 10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F
   Koegler WS, 2002, J BIOMED MATER RES, V63, P567, DOI 10.1002/jbm.10209
   Kong HJ, 2003, CELL TRANSPLANT, V12, P779, DOI 10.3727/000000003108747253
   Kranz H, 2008, EUR J PHARM SCI, V34, P164, DOI 10.1016/j.ejps.2008.03.004
   Kranz H, 2008, PHARM RES, V25, P1347, DOI 10.1007/s11095-007-9478-y
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   McGlohorn JB, 2004, TISSUE ENG, V10, P505, DOI 10.1089/107632704323061861
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Oh SH, 2006, BIOMATERIALS, V27, P1936, DOI 10.1016/j.biomaterials.2005.09.030
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
NR 37
TC 39
Z9 39
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2009
VL 5
IS 8
BP 2847
EP 2859
DI 10.1016/j.actbio.2009.04.035
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 514JF
UT WOS:000271389700003
PM 19446056
DA 2018-10-20
ER

PT J
AU Azevedo, HS
   Reis, RL
AF Azevedo, Helena S.
   Reis, Rui L.
TI Encapsulation of alpha-amylase into starch-based biomaterials: An
   enzymatic approach to tailor their degradation rate
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Starch-based biomaterials; Controlled degradation rate; Thermostable
   alpha-amylase; Encapsulation; Enzyme activity
ID DRUG-DELIVERY SYSTEMS; IN-VITRO; THERMOPLASTIC STARCH; BIODEGRADABLE
   POLYMERS; MECHANICAL-PROPERTIES; BEHAVIOR; RELEASE; BLENDS; SCAFFOLDS;
   POLYCAPROLACTONE
AB This paper reports the effect of alpha-amylase encapsulation on the degradation rate of a starch-based biomaterial. The encapsulation method consisted in mixing a thermostable alpha-amylase with a blend of corn starch and polycaprolactone (SPCL), which were processed by compression moulding to produce circular disks. The presence of water was avoided to keep the water activity low and consequently to minimize the enzyme activity during the encapsulation process. No degradation of the starch matrix occurred during processing and storage (the encapsulated enzyme remained inactive due to the absence of water), since no significant amount of reducing sugars was detected in solution. After the encapsulation process, the released enzyme activity from the SPCL disks after 28 days was found to be 40% comparatively to the free enzyme (unprocessed). Degradation studies on SPCL disks, with alpha-amylase encapsulated or free in solution, showed no significant differences on the degradation behaviour between both conditions. This indicates that alpha-amylase enzyme was successfully encapsulated with almost full retention of its enzymatic activity and the encapsulation of alpha-amylase clearly accelerates the degradation rate of the SPCL disks, when compared with the enzyme-free disks. The results obtained in this work show that degradation kinetics of the starch polymer can be controlled by the amount of encapsulated alpha-amylase into the matrix. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Azevedo, Helena S.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4806909 Taipas, Guimaraes, Portugal.
   IBB, PT Govt Associated Lab, Guimaraes, Portugal.
RP Azevedo, HS (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Ave Pk, P-4806909 Taipas, Guimaraes, Portugal.
EM hazevedo@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Azevedo, Helena/A-8298-2011; Group,
   3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Azevedo, Helena/0000-0002-5470-1844;
   Group, 3Bs/0000-0002-5195-3456
FU Portuguese Foundation for Science and Technology (FCT) through funds
   from the POCTI and/or FEDER Programmes
FX This work was partially supported by Portuguese Foundation for Science
   and Technology (FCT) through funds from the POCTI and/or FEDER
   Programmes. This work was carried out under the scope of the European
   NoE EXPERTISSUES (NMP3-CT-2004-500283).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   BASTIOLI C, 1995, J ENVIRON POLYM DEGR, V3, P81, DOI 10.1007/BF02067484
   Bastioli C, 1998, POLYM DEGRAD STABIL, V59, P263, DOI 10.1016/S0141-3910(97)00156-0
   BASTIOLI C, 1997, Patent No. 0539541
   Bastioli C, 2002, U. S. Patent, Patent No. [6,348,524 B2, 6348524]
   Bastioli C., 1992, [No title captured], Patent No. [WO 9219680, 9219680]
   Bell G, 1995, TRENDS BIOTECHNOL, V13, P468, DOI 10.1016/S0167-7799(00)89004-6
   Birnbaum DT, 2003, J BIOMAT SCI-POLYM E, V14, P87, DOI 10.1163/15685620360511155
   Boesel LF, 2004, J BIOMED MATER RES B, V70B, P368, DOI 10.1002/jbm.b.30055
   Boesel LF, 2006, BIOMACROMOLECULES, V7, P2600, DOI 10.1021/bm060387j
   Dumoulin Y, 1999, J CONTROL RELEASE, V60, P161, DOI 10.1016/S0168-3659(99)00065-6
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257
   Goldbart R, 2002, POLYM ADVAN TECHNOL, V13, P1006, DOI 10.1002/pat.275
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hanes J, 1998, BIOMATERIALS, V19, P163, DOI 10.1016/S0142-9612(97)00221-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   Ishiaku US, 2002, EUR POLYM J, V38, P393, DOI 10.1016/S0014-3057(01)00125-2
   Kamimura W, 2001, J BIOMAT SCI-POLYM E, V12, P1109, DOI 10.1163/15685620152691887
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170
   Mi FL, 2001, J BIOMAT SCI-POLYM E, V12, P835, DOI 10.1163/156856201753113051
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Ongen G, 2002, CARBOHYD POLYM, V50, P1, DOI 10.1016/S0144-8617(01)00366-6
   Pashkuleva I, 2008, MACROMOL BIOSCI, V8, P210, DOI 10.1002/mabi.200700076
   Rahmouni M, 2001, EUR J PHARM BIOPHARM, V51, P191, DOI 10.1016/S0939-6411(01)00127-8
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   RESLOW M, 2002, DRUG DELIVERY SYSTEM, V2, P103
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Schwach E, 2004, POLYM INT, V53, P2115, DOI 10.1002/pi.1636
   Shalaby W, 1994, BIOMEDICAL POLYM DES, P213
   SHEPPARD NF, 1992, J APPL POLYM SCI, V46, P19, DOI 10.1002/app.1992.070460103
   Shin BY, 2004, POLYM ENG SCI, V44, P1429, DOI 10.1002/pen.20139
   Silva GA, 2005, J BIOMED MATER RES A, V73A, P234, DOI 10.1002/jbm.a.30287
   Suzuki M, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P3
   Tang YW, 1997, BIOMATERIALS, V18, P37, DOI 10.1016/S0142-9612(96)00101-9
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   Tracy MA, 1999, BIOMATERIALS, V20, P1057, DOI 10.1016/S0142-9612(99)00002-2
   Tuovinen L, 2004, BIOMATERIALS, V25, P4355, DOI 10.1016/j.biomaterials.2003.11.026
   Vikman M, 1999, J APPL POLYM SCI, V74, P2594, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2594::AID-APP5>3.0.CO;2-R
   VILLAR MA, 1995, POLYMER, V36, P1869, DOI 10.1016/0032-3861(95)90933-S
   VOET D, 1999, FUNDAMENTALS BIOCH
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   YASIN M, 1993, PLAST RUB COMPOS PRO, V19, P15
   Yilmaz G, 2002, BIOMACROMOLECULES, V3, P305, DOI 10.1021/bm015600k
NR 50
TC 16
Z9 16
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2009
VL 5
IS 8
BP 3021
EP 3030
DI 10.1016/j.actbio.2009.04.039
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 514JF
UT WOS:000271389700020
PM 19427418
DA 2018-10-20
ER

PT J
AU Han, B
   Ma, PW
   Zhang, LL
   Yin, YJ
   Yao, KD
   Zhang, FJ
   Zhang, YD
   Li, XL
   Nie, W
AF Han, Bing
   Ma, Peng-Wei
   Zhang, Li-Li
   Yin, Yu-Ji
   Yao, Kang-De
   Zhang, Fu-Jiang
   Zhang, Yong-Dong
   Li, Xiu-Lan
   Nie, Wei
TI beta-TCP/MCPM-based premixed calcium phosphate cements
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Premixed calcium phosphate cement; beta-Tricalcium phosphate;
   Monocalcium phosphate monohydrate; Washout resistance; Biocompatibility
ID TRICALCIUM PHOSPHATE; IN-VITRO; MECHANICAL-PROPERTIES; BRUSHITE CEMENT;
   SODIUM ALGINATE; CHITOSAN; HYDROXYAPATITE; DIHYDRATE; BIOCOMPATIBILITY;
   BIOMATERIAL
AB Novel premixed calcium phosphate cements (CPCs) were prepared by combining cement liquids comprised of glycerol or polyethylene glycol with CPC powders that consisted of beta-tricalcium phosphate (beta-TCP) and monocalcium phosphate monohydrate (MCPM). Changing the powder to liquid mass ratio enabled the setting time to be regulated, and improved the compressive strength of the CPCs. Although some ratios of the new premixed CPCs had long setting times, these ranged from 12.4 to 27.8 min which is much shorter than the hour or more reported previously for a premixed CPC. The premixed CPCs had tolerable washout resistance before final setting, and the cements had strengths matching that of cancellous bone (5-10 MPa); their maximum compressive strength was up to 12 M Pa. The inflammatory response around the premixed CPCs implanted in the subcutaneous tissue in rabbits was more prominent than that of apatite cement. These differences might be due to the much faster resorption rate of the premixed CPCs. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Han, Bing; Ma, Peng-Wei; Zhang, Li-Li; Yin, Yu-Ji; Yao, Kang-De] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
   [Zhang, Fu-Jiang; Zhang, Yong-Dong; Li, Xiu-Lan] Tianjin Hosp, Tianjin 300211, Peoples R China.
   [Nie, Wei] Tianjin Inst Med & Pharmaceut Sci, Tianjin 300020, Peoples R China.
RP Yin, YJ (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM yinyuji@tju.edu.cn
FU Tianjin Key Technologies RD Program [06YFSZSF01000]; National Natural
   Science Foundation of China [50203007, 30670572]
FX This work was supported by the Tianjin Key Technologies R&D Program via
   Grant 06YFSZSF01000 and the National Natural Science Foundation of China
   via Grants of 50203007 and 30670572.
CR Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bodde EWH, 2007, J BIOMED MATER RES B, V83B, P161, DOI 10.1002/jbm.b.30780
   Brown PW, 1986, CEMENTS RES PROGR, P352
   Burguera EF, 2006, J BIOMED MATER RES B, V77B, P126, DOI 10.1002/jbm.b.30403
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   Chai F, 2006, J BIOMED MATER RES B, V77B, P104, DOI 10.1002/jbm.b.30438
   Fernandez E, 2005, BIOMATERIALS, V26, P3395, DOI 10.1016/j.biomaterials.2004.09.023
   Ferreira A, 2003, J CRYST GROWTH, V252, P599, DOI 10.1016/S0022-0248(03)00899-6
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gbureck U, 2005, BIOMATERIALS, V26, P3691, DOI 10.1016/j.biomaterials.2004.09.036
   Gbureck U, 2003, BIOMATERIALS, V24, P4123, DOI 10.1016/S0142-9612(03)00283-7
   Greenwald RB, 2001, J CONTROL RELEASE, V74, P159, DOI 10.1016/S0168-3659(01)00331-5
   Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X
   Ishikawa K, 1997, J BIOMED MATER RES, V36, P393, DOI 10.1002/(SICI)1097-4636(19970905)36:3<393::AID-JBM14>3.0.CO;2-F
   ISHIKAWA K, 1995, BIOMATERIALS, V16, P527, DOI 10.1016/0142-9612(95)91125-I
   Ishikawa K, 1999, J BIOMED MATER RES, V46, P504, DOI 10.1002/(SICI)1097-4636(19990915)46:4<504::AID-JBM8>3.0.CO;2-H
   Leroux L, 1999, BONE, V25, P31
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P634, DOI 10.1016/0142-9612(89)90120-8
   MIYAMOTO Y, 1995, BIOMATERIALS, V16, P855, DOI 10.1016/0142-9612(95)94147-D
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   Rau JV, 2008, ACTA BIOMATER, V4, P1089, DOI 10.1016/j.actbio.2008.01.006
   Sun LM, 2007, J BIOMATER APPL, V21, P299, DOI 10.1177/0885328206063687
   Takagi S, 2003, J BIOMED MATER RES B, V67B, P689, DOI 10.1002/jbm.b.10065
   Takagi S, 1998, BIOMATERIALS, V19, P1593, DOI 10.1016/S0142-9612(97)00119-1
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   Xia ZD, 2006, BIOMATERIALS, V27, P4557, DOI 10.1016/j.biomaterials.2006.04.030
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Yin YJ, 2003, J MATER SCI-MATER M, V14, P255, DOI 10.1023/A:1022836824968
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 36
TC 38
Z9 42
U1 3
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2009
VL 5
IS 8
BP 3165
EP 3177
DI 10.1016/j.actbio.2009.04.024
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 514JF
UT WOS:000271389700035
PM 19427931
DA 2018-10-20
ER

PT J
AU Bedi, RS
   Beving, DE
   Zanello, LP
   Yan, YS
AF Bedi, Rajwant S.
   Beving, Derek E.
   Zanello, Laura P.
   Yan, Yushan
TI Biocompatibility of corrosion-resistant zeolite coatings for titanium
   alloy biomedical implants
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Corrosion resistant; Biocompatible; Zeolite; Biomaterial; Stem cells
ID Y-TYPE ZEOLITES; IN-VITRO; BIOMATERIALS; SILICATES; COMPLEXES; ALUMINUM;
   RELEASE
AB Titanium alloy, Ti6Al4V, is widely used in dental and orthopedic implants. Despite its excellent biocompatibility, Ti6Al4V releases toxic Al and V ions into the surrounding tissue after implantation. In addition, the elastic modulus of Ti6Al4V (similar to 110 GPa) is significantly higher than that of bone (10-40 GPa), leading to a modulus mismatch and consequently implant loosening and deosteointegration. Zeolite coatings are proposed to prevent the release of the toxic ions into human tissue and enhance osteointegration by matching the mechanical properties of bone. Zeolite MFI coatings are successfully synthesized on commercially pure titanium and Ti6Al4V for the first time. The coating shows excellent adhesion by incorporating titanium from the substrate within the zeolite framework. Higher corrosion resistance than the bare titanium alloy is observed in 0.856 M NaCl solution at pHs of 7.0 and 1.0. Zeolite coatings eliminate the release of cytotoxic Al and V ions over a 7 day period. Pluripotent mouse embryonic stem cells show higher adhesion and cell proliferation on the three-dimensional zeolite microstructure surface compared with a two-dimensional glass surface, indicating that the zeolite coatings are highly biocompatible. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bedi, Rajwant S.; Beving, Derek E.; Yan, Yushan] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.
   [Zanello, Laura P.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
RP Yan, YS (reprint author), Univ Calif Riverside, Dept Chem & Environm Engn, 900 Univ Ave, Riverside, CA 92521 USA.
EM yushan.yan@ucr.edu
CR BALKUS KJ, 1995, J INCLUS PHENOM MOL, V21, P159
   Balkus KJ, 1997, MICROPOROUS MATER, V11, P325, DOI 10.1016/S0927-6513(97)00054-0
   Beving DE, 2006, J ELECTROCHEM SOC, V153, pB325, DOI 10.1149/1.2207845
   BRESINSKA I, 1994, J PHYS CHEM-US, V98, P12989, DOI 10.1021/j100100a029
   Cachinho SCP, 2008, J MATER SCI-MATER M, V19, P451, DOI 10.1007/s10856-006-0052-7
   Cheng XL, 2001, ELECTROCHEM SOLID ST, V4, pB23, DOI 10.1149/1.1359396
   Corma A., 1994, J CHEM SOC CHEM COMM, V147
   Cortizo AM, 1997, BIOMETALS, V10, P127, DOI 10.1023/A:1018335324447
   Domingo C, 2002, ANAL CHIM ACTA, V452, P311, DOI 10.1016/S0003-2670(01)01469-6
   Dyer A, 2000, J HELMINTHOL, V74, P137, DOI 10.1017/S0022149X00000184
   Gunawarman B, 2005, MAT SCI ENG C-BIO S, V25, P304, DOI 10.1016/j.msec.2004.12.015
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   Lacefield W R, 1999, Adv Dent Res, V13, P21
   Li ZJ, 2006, ANGEW CHEM INT EDIT, V45, P6329, DOI 10.1002/anie.200602036
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mihailova B, 1997, J MATER SCI LETT, V16, P1303, DOI 10.1023/A:1018591312000
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Pavelic K, 2001, J MOL MED-JMM, V78, P708, DOI 10.1007/s001090000176
   Piveteau LD, 1999, J MATER SCI-MATER M, V10, P161, DOI 10.1023/A:1008985423644
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Saxton RJ, 1999, TOP CATAL, V9, P43, DOI 10.1023/A:1019102320274
   Shi XL, 1996, TOXICOLOGY, V106, P27, DOI 10.1016/0300-483X(95)03151-5
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Szostak R., 1992, HDB MOL SIEVES
   Williams DF, 2003, SADHANA-ACAD P ENG S, V28, P563, DOI 10.1007/BF02706447
   YORUC ABH, 2007, J OPTOELECTRON ADV M, V9, P2627
   Zhang SC, 1996, J MOL CATAL A-CHEM, V106, P119, DOI 10.1016/1381-1169(95)00263-4
NR 27
TC 57
Z9 59
U1 0
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2009
VL 5
IS 8
BP 3265
EP 3271
DI 10.1016/j.actbio.2009.04.019
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 514JF
UT WOS:000271389700045
PM 19433139
DA 2018-10-20
ER

PT J
AU Tchemtchoua, VT
   Atanasova, G
   Aqil, A
   Maquet, V
   Jerome, C
   Poumay, Y
   Colige, A
AF Tchemtchoua, Victor T.
   Atanasova, Ganka
   Aqil, Abdelhafid
   Maquet, Veronique
   Jerome, Christine
   Poumay, Yves
   Colige, Alain
TI Development of a procedure to simultaneously isolate RNA, DNA, and
   proteins from characterizing cells invading or cultured on chitosan
   scaffolds
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Editorial Material
ID FIBROBLASTS; FILMS
AB For many years, chitosan and its derivatives have been considered to be promising biomaterials for tissue engineering and repair. However, information regarding their biological effect on cell phenotype is usually limited to evaluation of cell proliferation and survival, overlooking proteomic and transcriptomic analysis. This is largely related to the lack of efficient and quantitative procedures for protein and nucleic acid purification from cells cultured on, or inside, chitosan scaffold. Here we describe an ultracentrifugation procedure enabling the Simultaneous and quantitative recovery of high quality RNA, DNA and proteins from cells growing in close contact of biomaterial matrices containing chitosan. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Tchemtchoua, Victor T.; Colige, Alain] Univ Liege, GIGA Res Ctr, Lab Connect Tissues Biol, B-4000 Sart Tilman Par Liege, Belgium.
   [Atanasova, Ganka; Poumay, Yves] Univ Namur FUNDP, Cell & Tissue Lab, B-5000 Namur, Belgium.
   [Aqil, Abdelhafid; Jerome, Christine] Univ Liege, Inst Chim, Ctr Macromol Study & Res, B-4000 Liege, Belgium.
   [Maquet, Veronique] KitoZyme SA, B-4040 Herstal, Belgium.
RP Colige, A (reprint author), Univ Liege, GIGA Res Ctr, Lab Connect Tissues Biol, B-4000 Sart Tilman Par Liege, Belgium.
EM acolige@ulg.ac.be
RI Poumay, Yves/G-4525-2016
OI Poumay, Yves/0000-0001-5200-3367
CR Cardenas G, 2008, J MATER SCI-MATER M, V19, P2397, DOI 10.1007/s10856-007-3275-3
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   DAVINREGLI A, 1995, RES MICROBIOL, V146, P561, DOI 10.1016/0923-2508(96)80562-6
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lambert CA, 2001, MATRIX BIOL, V20, P397, DOI 10.1016/S0945-053X(01)00156-1
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Wang CM, 2008, ANAL BIOCHEM, V380, P333, DOI 10.1016/j.ab.2008.06.005
NR 8
TC 6
Z9 8
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD OCT 1
PY 2009
VL 393
IS 1
BP 145
EP 147
DI 10.1016/j.ab.2009.06.013
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 480JS
UT WOS:000268731300023
PM 19538933
DA 2018-10-20
ER

PT J
AU Ahmad, Z
   Nangrejo, M
   Edirisinghe, M
   Stride, E
   Colombo, P
   Zhang, HB
AF Ahmad, Z.
   Nangrejo, M.
   Edirisinghe, M.
   Stride, E.
   Colombo, P.
   Zhang, H. B.
TI Engineering a material for biomedical applications with electric field
   assisted processing
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID POLYMER PARTICLES; DRUG-DELIVERY; ENCAPSULATION; FORMULATION;
   FABRICATION; NANOFIBERS; MEMBRANES; DESIGN; DROPS; SHAPE
AB In this work, using multiple co-flows we demonstrate in-situ encapsulation of nano-particles, liquids and/or gases in different structural morphologies, which can also be deposited in a designated pattern by a direct write method and surface modification can be controlled to release encapsulated material. The range of possibilities offered by exposing a material solution to an applied electric field can result in a plethora of structures which can accommodate a whole host of biomedical applications from microfluidic devices (microchannels, loaded with various materials), printed 3D structures and patterns, lab-on-a-chip devices to encapsulated materials (capsules, tubes, fibres, dense multi-layered fibrous networks) for drug delivery and tissue engineering. The structures obtained in this way can vary in size from micrometer to the nanometer range and the processing is viable for all states of matter. The work shown demonstrates some novel structures and methodologies for processing a biomaterial.
C1 [Ahmad, Z.; Nangrejo, M.; Edirisinghe, M.; Stride, E.; Colombo, P.] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Colombo, P.] Univ Padua, Dept Mech Engn & Mat Sci, I-35122 Padua, Italy.
   [Colombo, P.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   [Zhang, H. B.] E China Univ Sci & Technol, Sch Mech & Power Engn, Shanghai 200237, Peoples R China.
RP Edirisinghe, M (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk
OI Ahmad, Zeeshan/0000-0001-8863-6211; Stride, Eleanor/0000-0003-3371-5929
FU EPSRC [EP/E045839]; Royal Academy of Engineering; Leverhulme Trust
   [F/07134/BL]; Engineering and Physical Sciences Research Council
   [EP/E045839/1]
FX The authors are grateful to the Archaeology Department at University
   College London for use of their SEM equipment. We also acknowledge the
   EPSRC grant EP/E045839, Royal Academy of Engineering and the Leverhulme
   Trust (F/07134/BL) for supporting this work. Collaboration between UCL
   and the University of Padua was funded by the Royal Society and we wish
   to acknowledge the exchange visits made possible by this grant.
CR Ahmad Z, 2008, J R SOC INTERFACE, V5, P1255, DOI 10.1098/rsif.2008.0247
   Ahmad Z, 2008, J BIOMED NANOTECHNOL, V4, P185, DOI 10.1166/jbn.2008.017
   Ahmad Z, 2006, J BIOMED NANOTECHNOL, V2, P201, DOI 10.1166/jbn.2006.032
   BENFIELD RE, 1991, NATURE, V353, P340, DOI 10.1038/353340a0
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   Chen HY, 2008, J AM CHEM SOC, V130, P7800, DOI 10.1021/ja801803x
   Cheng CJ, 2006, J COLLOID INTERF SCI, V300, P375, DOI 10.1016/j.jcis.2006.03.056
   Cross SE, 2007, SKIN PHARMACOL PHYS, V20, P148, DOI 10.1159/000098701
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Goldenstedt C, 2008, ULTRASON SONOCHEM, V15, P808, DOI 10.1016/j.ultsonch.2007.10.005
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Jaworek A, 1999, EXP FLUIDS, V27, P43, DOI 10.1007/s003480050327
   Kapsi SG, 2001, INT J PHARM, V229, P193, DOI 10.1016/S0378-5173(01)00867-5
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595
   McCann JT, 2005, J MATER CHEM, V15, P735, DOI 10.1039/b415094e
   Park JU, 2007, NAT MATER, V6, P782, DOI 10.1038/nmat1974
   Patton JS, 2006, NAT BIOTECHNOL, V24, P280, DOI 10.1038/nbt0306-280
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Samarasinghe SR, 2008, APPL PHYS A-MATER, V91, P141, DOI 10.1007/s00339-007-4387-9
   Setton L, 2008, NAT MATER, V7, P172, DOI 10.1038/nmat2130
   Wang DZ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942531
   Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872
   Wu YQ, 2007, J COLLOID INTERF SCI, V310, P529, DOI 10.1016/j.jcis.2007.02.023
   Yarin AL, 2007, J MATER CHEM, V17, P2585, DOI 10.1039/b618508h
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 27
TC 25
Z9 25
U1 0
U2 31
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD OCT
PY 2009
VL 97
IS 1
BP 31
EP 37
DI 10.1007/s00339-009-5359-z
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 486OM
UT WOS:000269206600005
DA 2018-10-20
ER

PT J
AU Cho, HJ
   Yoo, DC
   Kim, HJ
   Khang, KW
   Jeong, HS
   Yang, SA
   Lee, IS
   Jhee, KH
AF Cho, Hyun-Jung
   Yoo, Dong-Chan
   Kim, Hee-Joon
   Khang, Kong-Won
   Jeong, Ho-Soon
   Yang, Seun-Ah
   Lee, In-Seon
   Jhee, Kwang-Hwan
TI Efficient, High-Yield Purification of Pulegone from the Oriental Herb,
   Schizonepeta tenuifolia Briquet and Demonstration of Supramolecule
   Formation by Cyclodextrins
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Pulegone; Schizonepeta tenuifolia Briquet; Purification; Cyclodextrins;
   Supramolecules
ID BETA-CYCLODEXTRIN; ESSENTIAL OILS; TERPENES; PENETRATION; PENNYROYAL;
   SKIN
AB Pulegone is an organic compound obtained from the essential oils of a variety of plants. Biomaterial screening of various herbs has demonstrated that large amounts of pulegone are present in Schizonepeta tenuifolia Briquet. To purify this useful volatile compound for nano-biomaterials, we prepared extracts from 220 g of Schizonepeta tenuifolia Briquet with chloroform at 55 degrees C for 12 h and concentrated the extracts under reduced pressure. We obtained a total of 9.48 g, which was then solubilized with hexane and subjected to silica gel column chromatography and eluted with hexane/chloroform solvents. The resulting pulegone was more than 99 % pure, based on estimates using multiple spectroscopic analyses, including APCI-MS, gas chromatography, GC-MS and UV-visible absorbance. Supramolecule encapsulation of purified pulegone with cyclodextrins was shown by the fluorescence spectrum. These supramolecules have the ability to permeate hydrophilic biological membranes and might offer important advantages in various applications for cosmetic, pharmaceutical and food-flavour industries.
C1 [Cho, Hyun-Jung; Yoo, Dong-Chan; Kim, Hee-Joon; Khang, Kong-Won; Jeong, Ho-Soon; Yang, Seun-Ah; Lee, In-Seon; Jhee, Kwang-Hwan] Kumoh Natl Inst Technol, Dept Appl Chem, Gumi 730701, South Korea.
EM khjhee@kumoh.ac.kr
FU Ministry of Education, Science Technology (MEST); Korea Industrial
   Technology Foundation (KOTEF) through the Human Resource Training
   Project for Regional Innovation; Korea government (MEST)
   [R01-2006-000-10232-0]
FX This research was financially supported by the Ministry of Education,
   Science Technology (MEST) and Korea Industrial Technology Foundation
   (KOTEF) through the Human Resource Training Project for Regional
   Innovation. It is also supported by the Korea Science and Engineering
   Foundation (KOSEF) grant funded by the Korea government (MEST)
   (R01-2006-000-10232-0).
CR Bartoli G, 2002, J ORG CHEM, V67, P9111, DOI 10.1021/jo026418s
   Botella SM, 1996, J PHARMACEUT BIOMED, V14, P909, DOI 10.1016/0731-7085(95)01672-4
   Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012
   CHANG HM, 1986, PHARM APPL CHINESE M, P855
   de Sousa DP, 2007, Z NATURFORSCH C, V62, P39
   Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9
   Fung D, 2002, J CLIN PHARMACOL, V42, P30, DOI 10.1177/0091270002042001003
   GILDEMEISTER E, 1928, ATHERISCHEN OLE, V1, P560
   GRUNDSCHOBER F, 1979, PERFUMER, V4, P415
   Hall R. L., 1965, FOOD TECH, V19, P253
   Horvath G, 2008, MOL PHARM, V5, P358, DOI 10.1021/mp700144t
   Kang L, 2007, J CONTROL RELEASE, V120, P211, DOI 10.1016/j.jconrel.2007.05.006
   Li ZhuQiang, 1996, Acta Botanica Yunnanica, V18, P115
   Moon TW, 2008, B KOREAN CHEM SOC, V29, P1579
   Narishetty STK, 2004, J CONTROL RELEASE, V95, P367, DOI 10.1016/j.jconrel.2003.11.022
   Park IK, 2006, J ECON ENTOMOL, V99, P1717
   Rim In-Sook, 2006, Korean Journal of Parasitology, V44, P133
   SULLIVAN JB, 1979, JAMA-J AM MED ASSOC, V242, P2873
   WILLIAMS AC, 1991, PHARMACEUT RES, V8, P17, DOI 10.1023/A:1015813803205
   ZHU YP, 1998, CHINESE MAT MED CHEM, P60
NR 20
TC 1
Z9 1
U1 1
U2 7
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
EI 0975-427X
J9 ASIAN J CHEM
JI Asian J. Chem.
PD OCT-NOV
PY 2009
VL 21
IS 8
BP 6536
EP 6546
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 484BO
UT WOS:000269018300107
DA 2018-10-20
ER

PT J
AU Schulte, VA
   Diez, M
   Moller, M
   Lensen, MC
AF Schulte, Vera A.
   Diez, Mar
   Moeller, Martin
   Lensen, Marga C.
TI Surface Topography Induces Fibroblast Adhesion on Intrinsically
   Nonadhesive Poly(ethylene glycol) Substrates
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; INDUCED CONFORMATIONAL-CHANGES; PROTEIN
   ADSORPTION; CELL-ADHESION; SIGNAL-TRANSDUCTION; INTEGRIN BINDING;
   FIBRONECTIN; WETTABILITY; BIOCOMPATIBILITY; POLYSTYRENE
AB Important in developing new biomaterials is the prevention of unspecific protein adsorption and cell interactions that in vivo can lead to a foreign body reaction. On the other hand, the material should support the growth of a specific cell type in a defined way. We investigate the possibility of manipulating cellular behavior on an intrinsically nonadhesive material by topographic patterning without additional Surface chemistry modifications. The biomaterial applied is a hydrogel cross-linked from star-shaped poly(ethylene glycol) macromonomers (starPEG). Cell biological studies with a mouse fibroblast cell line (L929) showed that, while substrates with a smooth surface are nonadhesive, as expected, imprinted topography enabled cell adhesion and spreading. The fibroblasts aligned to micrometer groove patterns and were, depending on the respective dimensions, able to span or enter the grooves. Especially substrates with topography dimensions in the cell size range or smaller (<10 mu m) lead to an establishment of stable cell-surface contacts (vinculin and actin accumulation). On micrometer post patterns the cells spread on top of the pillars and wrapped around the structures. The strong influence of the topography shows that nonadhesive materials do not necessarily have to be specifically biofunctionalized to enable cell adhesion. Possible explanations for the peculiar cell behavior are discussed in terms of (initial) protein adsorption and geometry-dependent cytoskeletal arrangements.
C1 Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52056 Aachen, Germany.
   DWI eV, D-52056 Aachen, Germany.
RP Lensen, MC (reprint author), Tech Univ Berlin, Inst Chem, Sekr OE 1,Franklinstr 29, D-10587 Berlin, Germany.
EM lensen@mailbox.tu-berlin.de
RI Zhou, Feng/E-9510-2011; Moller, Martin/F-7860-2015
OI Moller, Martin/0000-0002-5955-4185
FU Alexander von Humboldt Foundation; BMBF
FX This work was supported by a Sofia Kovalevskaja Award granted to M.C.L.
   by the Alexander von Humboldt Foundation and funded by the federal
   ministry of research and education (BMBF). Also, the DFG Graduate School
   1035 "Biointerface" is thanked (V.A.S.).
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Brown E, 1996, IMMUNOL LETT, V54, P189, DOI 10.1016/S0165-2478(96)02671-5
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   DALBY MJ, 2002, BIOMATERIALS, V23, P2045
   Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   DIEZ M, 2009, SMALL IN PRESS
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Harris J. M., 1997, POLYETHYLENE GLYCOL
   Harrison RG, 1912, ANAT REC, V6, P181, DOI 10.1002/ar.1090060404
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kidambi S, 2007, TISSUE ENG, V13, P2105, DOI 10.1089/ten.2006.0151
   Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072
   LATOUR RA, 2005, ENCY BIOMATERIALS BI, P270, DOI DOI 10.3109/9781420078039.026
   Lensen MC, 2007, LANGMUIR, V23, P7841, DOI 10.1021/la7007683
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Pelham RJ, 1998, P NATL ACAD SCI USA, V95, P12070
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tzoneva R, 2007, BBA-GEN SUBJECTS, V1770, P1538, DOI 10.1016/j.bbagen.2007.07.008
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Weiss P., 1941, GROWTH             S, V5, P163
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 62
TC 62
Z9 62
U1 3
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2009
VL 10
IS 10
BP 2795
EP 2801
DI 10.1021/bm900631s
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 503PA
UT WOS:000270548700011
PM 19785405
DA 2018-10-20
ER

PT J
AU Muller, R
   Eidt, A
   Hiller, KA
   Katzur, V
   Subat, M
   Schweikl, H
   Imazato, S
   Ruhl, S
   Schmalz, G
AF Mueller, Rainer
   Eidt, Andreas
   Hiller, Karl-Anton
   Katzur, Verena
   Subat, Michael
   Schweikl, Helmut
   Imazato, Satoshi
   Ruhl, Stefan
   Schmalz, Gottfried
TI Influences of protein films on antibacterial or bacteria-repellent
   surface coatings in a model system using silicon wafers
SO BIOMATERIALS
LA English
DT Article
DE Antibacterial activity; Cationic charges; MDPB; Silicon wafers; Saliva;
   Oral streptococci
ID MICROBIAL ADHESION; BIOFILM FORMATION; SOLID-SURFACES; ADSORPTION;
   BIOMATERIALS; BIOADHESION; MECHANISMS; MONOLAYERS; INFECTION; BRUSHES
AB Immobilization of defined chemical functionalities to biomaterial surfaces is employed to optimize them not only for tissue compatibility but also for prevention of bacterial infection. Grafting surfaces with chains of poly(ethylene glycol) (PEG) results in bacterial repellence whereas modification with cationic groups conveys them with bactericidal properties. Since biomaterials in situ will become exposed to a protein-rich environment, it is necessary to investigate the influence of prior protein adsorption on the antibacterial activity of this type of chemical surface modification. In the present study, we immobilized short-chain PEG and two pyridinium group-containing methacrylate monomers, 12-methacryloyloxy-dodecylpyridinium bromide (MDPB) and 6-methacryloyloxyhexylpyridinium chloride (MHPC), to silicon wafer model surfaces to investigate the influence of prior protein adsorption on the bactericidal activity of the surface coating towards subsequently attached bacteria. Adsorbed amounts of human serum albumin and salivary proteins were found to be two times higher on cationic compared to PEG-modified surfaces. An analogous tendency was found for attachment of Streptococcus gordonii and Streptococcus mutans to the same surfaces without prior protein exposure. However, most bacteria attached to cationic surfaces were found to be dead. Prior exposure of cationic surfaces to protein solutions drastically altered bacterial attachment dependent on the type of protein solution and bacterial species employed. Significantly, the original bactericidal activity of pyridinium-coated surfaces was found greatly reduced upon adsorption of a protein film. As a conclusion we propose that future approaches should combine the protein- and bacteria-repellent properties of PEG-coatings with the bactericidal function of charged cationic groups. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Mueller, Rainer; Katzur, Verena; Subat, Michael] Univ Regensburg, Inst Phys & Theoret Chem, D-93053 Regensburg, Germany.
   [Mueller, Rainer; Eidt, Andreas; Hiller, Karl-Anton; Subat, Michael; Schweikl, Helmut; Schmalz, Gottfried] Univ Regensburg, Dept Operat Dent & Periodontol, D-93053 Regensburg, Germany.
   [Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka 5650871, Japan.
   [Ruhl, Stefan] SUNY Buffalo, Dept Oral Biol, Sch Dent Med, Buffalo, NY 14214 USA.
RP Muller, R (reprint author), Univ Regensburg, Inst Phys & Theoret Chem, Univ Str 31, D-93053 Regensburg, Germany.
EM rainer.mueller@chemie.uni-regensburg.de
RI Mueller, Rainer/D-3326-2009; Schweikl, Helmut/C-2998-2013
OI Mueller, Rainer/0000-0001-9641-7780; Ruhl, Stefan/0000-0003-3888-4908
FU Dental Material Division (Tokyo, Japan)
FX The authors would like to thank Kuraray Medical Inc., Dental Material
   Division (Tokyo, Japan) for technical and financial support. We further
   thank E. Deigele for excellent technical assistance.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Azizi N, 2004, TETRAHEDRON, V60, P383, DOI 10.1016/j.tet.2003.11.012
   BOS MA, 1994, COLLOID SURFACE B, V3, P91
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   CLARK WB, 1978, INFECT IMMUN, V19, P846
   Delgado AV, 2005, PURE APPL CHEM, V77, P1753, DOI 10.1351/pac200577101753
   Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j
   Denyer SP, 1995, INT BIODETER BIODEGR, V36, P227, DOI 10.1016/0964-8305(96)00015-7
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   IMAZATO S, 1994, J DENT RES, V73, P1437, DOI 10.1177/00220345940730080701
   Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5
   Imazato S, 1998, J DENT, V26, P267, DOI 10.1016/S0300-5712(97)00013-4
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Knerr R, 2006, MACROMOL BIOSCI, V6, P827, DOI 10.1002/mabi.200600106
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Muller R, 2008, J BIOMED MATER RES A, V84A, P817, DOI 10.1002/jbm.a.31495
   Muller R, 2007, APPL ENVIRON MICROB, V73, P2653, DOI 10.1128/AEM.02884-06
   Muller R, 2006, ANAL BIOCHEM, V359, P194, DOI 10.1016/j.ab.2006.09.032
   Norde W, 2003, BIOPOLYMERS INTERFAC, V110, P21
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Puranik DB, 1997, ENERG FUEL, V11, P1311, DOI 10.1021/ef970128a
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Rosentritt M, 2008, J BIOMED MATER RES B, V86B, P36, DOI 10.1002/jbm.b.30985
   Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614
   Schroder K, 2002, PLASMAS POLYM, V7, P103, DOI 10.1023/A:1016239302194
   Schwender N, 2005, APPL SURF SCI, V252, P117, DOI 10.1016/j.apsusc.2005.02.042
   Thome J, 2003, SURF COAT TECH, V174, P584, DOI 10.1016/S0257-8972(03)00703-5
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Walz A, 2006, PROTEOMICS, V6, P1631, DOI 10.1002/pmic.200500125
NR 40
TC 46
Z9 46
U1 4
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 28
BP 4921
EP 4929
DI 10.1016/j.biomaterials.2009.05.079
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 489XP
UT WOS:000269459900009
PM 19545893
DA 2018-10-20
ER

PT J
AU Niepel, MS
   Peschel, D
   Sisquella, X
   Planell, JA
   Groth, T
AF Niepel, Marcus S.
   Peschel, Dieter
   Sisquella, Xavier
   Planell, Josep A.
   Groth, Thomas
TI pH-dependent modulation of fibroblast adhesion on multilayers composed
   of poly(ethylene imine) and heparin
SO BIOMATERIALS
LA English
DT Article
DE Surface modification; Layer-by-layer; Poly(ethylene imine); Heparin;
   Serum; Fibronectin
ID SELF-ASSEMBLED MONOLAYERS; POLYELECTROLYTE MULTILAYERS; CELL-ADHESION;
   IN-SITU; FILMS; ADSORPTION; SURFACE; LAYER; WETTABILITY; MICROSCOPY
AB Adhesion of tissue cells is a prerequisite for their growth and differentiation but prevents also apoptosis. Here the layer-by-layer technique (LbL) was used to design multilayer structures of poly(ethylene imine) (PEI) and heparin (HEP) on glass as model biomaterial to control the adhesion of primary human dermal fibroblasts. Distinct surface features like wettability, charge and lateral structures were controlled by changing the pH value of the HEP solution during multilayer assembly to acidic neutral or alkaline, values. While plain terminal layers were rather cytophobic, the pre-adsorption of serum or fibronectin (FN) caused a distinct change in cell morphology in dependence on the pH setup. The effect of serum was more prominent on PEI layers probably due to their positive surface charge, whereas the effect of FN was more pronounced on HEP terminated multilayers possibly due to its ability to bind FN specifically. Those layers which hampered cell adhesion also inhibited growth of human fibroblasts under serum conditions. Conversely, on layers where cell adhesion was increased also an elevated growth and, thus, metabolic activity was observed. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Niepel, Marcus S.; Peschel, Dieter; Groth, Thomas] Univ Halle Wittenberg, Biomed Mat Grp, Dept Pharmaceut Technol & Biopharm, Inst Pharm, D-06099 Halle, Saale, Germany.
   [Planell, Josep A.] Univ Barcelona, Inst Bioengn Catalonia IBEC, E-08028 Barcelona, Spain.
RP Groth, T (reprint author), Univ Halle Wittenberg, Biomed Mat Grp, Dept Pharmaceut Technol & Biopharm, Inst Pharm, D-06099 Halle, Saale, Germany.
EM thomas.groth@pharmazie.uni-halle.de
RI Niepel, Marcus/G-2340-2011
OI Niepel, Marcus/0000-0002-4479-1225; Groth, Thomas/0000-0001-6647-9657
FU German Academic Exchange Service (DAAD)
FX This work was partly supported by the German Academic Exchange Service
   (DAAD) in the frame of a short-term stipend for Ph.D. students to MSN.
   Dr. J.Vogel is acknowledged for scientific support and discussion.
CR Boese G, 2007, TISSUE ENG, V13, P2995, DOI 10.1089/ten.2006.0442
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Czeslik C, 2006, CHEM UNSERER ZEIT, V40, P238, DOI 10.1002/ciuz.200600352
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DECHER G, 2003, MULTILAYER THIN FILM
   Dukhin SS, 2008, J COLLOID INTERF SCI, V328, P217, DOI 10.1016/j.jcis.2008.08.035
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   FOLKERS JP, 1992, LANGMUIR, V8, P1330, DOI 10.1021/la00041a015
   FOLKERS JP, 1994, J PHYS CHEM-US, V98, P563, DOI 10.1021/j100053a035
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   GROTH T, NATO SCI SERIE UNPUB
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   HORCAS I, 2007, REV SCI INSTRUM
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Kirchhof K, 2009, J MATER SCI-MATER M, V20, P897, DOI 10.1007/s10856-008-3639-3
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   McAloney RA, 2001, LANGMUIR, V17, P6655, DOI 10.1021/la010136q
   Muller M, 2001, MACROMOL RAPID COMM, V22, P390, DOI 10.1002/1521-3927(20010301)22:6<390::AID-MARC390>3.0.CO;2-B
   Ngankam AP, 2004, LANGMUIR, V20, P3362, DOI 10.1021/la035479y
   Notley SM, 2005, J COLLOID INTERF SCI, V292, P29, DOI 10.1016/j.jcis.2005.05.057
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   Schonhoff M., 2003, J PHYS-CONDENS MAT, V15, P1781
   Tan QG, 2003, BIOMATERIALS, V24, P4699, DOI 10.1016/S0142-9612(03)00363-6
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Tjipto E, 2005, LANGMUIR, V21, P8785, DOI 10.1021/la051197h
   Trimpert C, 2006, MACROMOL BIOSCI, V6, P274, DOI 10.1002/mabi.200500238
   TROMMLER A, 1985, BIOPHYS J, V48, P835, DOI 10.1016/S0006-3495(85)83842-X
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
NR 34
TC 33
Z9 33
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 28
BP 4939
EP 4947
DI 10.1016/j.biomaterials.2009.06.014
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 489XP
UT WOS:000269459900011
PM 19573910
DA 2018-10-20
ER

PT J
AU Vilalta, M
   Jorgensen, C
   Degano, IR
   Chernajovsky, Y
   Gould, D
   Noel, D
   Andrades, JA
   Becerra, J
   Rubio, N
   Blanco, J
AF Vilalta, Marta
   Jorgensen, Christian
   Degano, Irene R.
   Chernajovsky, Yuti
   Gould, David
   Noel, Daniele
   Andrades, Jose A.
   Becerra, Jose
   Rubio, Nuria
   Blanco, Jeronimo
TI Dual luciferase labelling for non-invasive bioluminescence imaging of
   mesenchymal stromal cell chondrogenic differentiation in demineralized
   bone matrix scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Bioluminescence imaging (BLI); Collagen type II (COL2A1); Demineralized
   bone matrix (DBM); Human adipose tissue derived mesenchymal stromal
   cells (hAMSCs); Murine cell line (CL1)
ID HUMAN ADIPOSE-TISSUE; REPORTER GENE-EXPRESSION; STEM-CELLS; IN-VIVO;
   MORPHOGENETIC PROTEIN-2; CHONDROCYTE DIFFERENTIATION; CARTILAGE
   FORMATION; COLLAGEN GENE; MARROW; INDUCTION
AB Non-invasive bioluminescence imaging (BLI) to monitor changes in gene expression of cells implanted in live animals should facilitate the development of biomaterial scaffolds for tissue regeneration. We show that, in vitro, induction of chondrogenic differentiation in mouse bone marrow stromal cell line (CL1) and human adipose tissue derived mesenchymal stromal cells (hAMSCs), permanently transduced with a procollagen II (COL2A1) promoter driving a firefly luciferase gene reporter (PLuc) (COL2A1p.PLuc), induces PLuc expression in correlation with increases in COL2A1 and Sox9 mRNA expression and acquisition of chondrocytic phenotype. To be able to simultaneously monitor in vivo cell differentiation and proliferation, COL2A1p.PLuc labelled cells were also genetically labelled with a renilla luciferase (RLuc) gene driven by a constitutively active cytomegalovirus promoter, and then seeded in demineralized bone matrix (DBM) subcutaneously implanted in SCID mice. Non-invasive BLI monitoring of the implanted mice showed that the PLuc/RLuc ratio reports on gene expression changes indicative of cell differentiation. Large (CL1) and moderated (hAMSCs) changes in the PLuc/RLuc ratio over a 6 week period, revealed different patterns of in vivo chondrogenic differentiation for the CL1 cell line and primary MSCs, in agreement with in vitro published data and our results from histological analysis of DBM sections. This double bioluminescence labelling strategy together with BLI imaging to analyze behaviour of cells implanted in live animals should facilitate the development of progenitor cell/scaffold combinations for tissue repair. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Vilalta, Marta; Degano, Irene R.; Rubio, Nuria; Blanco, Jeronimo] CSIC ICCC, Cardiovasc Res Ctr, CIBER BBN, Barcelona 08025, Spain.
   [Jorgensen, Christian; Noel, Daniele] INSERM, U844, F-34091 Montpellier, France.
   [Jorgensen, Christian; Noel, Daniele] Univ Montpellier 1, UFR Med, F-34000 Montpellier, France.
   [Chernajovsky, Yuti; Gould, David] Barts & London Queen Marys Sch Med & Dent, Bone & Joint Res Unit, London EC1M 6BQ, England.
   [Andrades, Jose A.; Becerra, Jose] Univ Malaga, Dept Cell Biol Genet & Physiol, Lab Bioengn & Tissue Regenerat, Fac Sci,CIBER BBN, E-29071 Malaga, Spain.
RP Blanco, J (reprint author), CSIC ICCC, Cardiovasc Res Ctr, CIBER BBN, C St Atnoni MaClaret 167, Barcelona 08025, Spain.
EM jblancof@csic-iccc.org
RI Blanco, Jeronimo/H-2764-2015; Rubio, Nuria/H-3156-2015; Roman Degano,
   Irene/C-1826-2012; Noel, Daniele/E-5719-2016
OI Blanco, Jeronimo/0000-0003-3765-0640; Rubio, Nuria/0000-0003-2471-4684;
   Degano, Irene R./0000-0003-1914-6934
FU EU-FP7 Integrated Project Angioscaff [CP-IP 214402-2]; EU-FP6 Integrated
   Project GENOSTEM [LSHB-CT-503161]; Arthritis Research Campaign (UK);
   Fundacio Marato TV3 [050210]; Fondo de Investigacion Sanitaria [PI
   060208, PI 061855]; Ministerio de Educacion y Ciencia [2007-62472,
   2006-03599]; Ministerio de Salud [P07-CVI-2781]; Red Tematica de
   Investigacion Cooperativa TERCEL
FX The authors would like to thank Javier F. Alcudia for his essential help
   with real-time PCR methodology and results interpretation and to Silvia
   Claros for his essential help in histological procedures. We would also
   like to acknowledge Dr. P. Galera and Dr. S.S. Gambhir for the gift of
   plasmids pGL2-0.387kbE715(+) and hrl-mrfp-ttk, respectively. This study
   was funded in part by grants from: EU-FP7 Integrated Project Angioscaff
   (CP-IP 214402-2), EU-FP6 Integrated Project GENOSTEM (LSHB-CT-503161),
   Arthritis Research Campaign (UK), Fundacio Marato TV3 (Ref # 050210),
   Fondo de Investigacion Sanitaria (FIS, PI 060208 and PI 061855),
   Ministerio de Educacion y Ciencia (SAF 2007-62472 and BIO 2006-03599);
   Ministerio de Salud (P07-CVI-2781) and Red Tematica de Investigacion
   Cooperativa TERCEL.
CR Andrades JA, 2001, INT J DEV BIOL, V45, P689
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Becerra J, 1996, J BONE MINER RES, V11, P1703
   Becerra J, 2006, REGEN MED, V1, P267, DOI 10.2217/17460751.1.2.267
   Bi WM, 1999, NAT GENET, V22, P85
   Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONHA.105.588954
   Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778
   CHEAH KSE, 1985, P NATL ACAD SCI USA, V82, P2555, DOI 10.1073/pnas.82.9.2555
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024
   Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x
   de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Ghayor C, 2000, J BIOL CHEM, V275, P27421
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, P239
   Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kitamura H, 2004, OSTEOARTHR CARTILAGE, V12, P25, DOI 10.1016/j.joca.2003.09.002
   Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336
   Lin H, 2008, BIOMATERIALS, V29, P1189, DOI 10.1016/j.biomaterials.2007.11.032
   Lin YF, 2005, J CELL MOL MED, V9, P929, DOI 10.1111/j.1582-4934.2005.tb00389.x
   MONTES GS, 1988, COLLAGEN, V2, P41
   Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77
   Naujoks Christian, 2008, Head Face Med, V4, P3, DOI 10.1186/1746-160X-4-3
   NIMNI ME, 1988, CLIN ORTHOP RELAT R, P255
   OKAZAKI K, 2004, CLIN ORTHOP RELAT R, V427, pS123, DOI DOI 10.1097/01.BLO.0000144478.51284.F3
   Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702
   Pacaccio Douglas J, 2005, Clin Podiatr Med Surg, V22, P599, DOI 10.1016/j.cpm.2005.07.001
   Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816
   Roman I, 2007, BIOMATERIALS, V28, P2718, DOI 10.1016/j.biomaterials.2007.02.011
   Rome C, 2007, EUR RADIOL, V17, P305, DOI 10.1007/s00330-006-0378-z
   Sandhu HS, 2001, EUR SPINE J, V10, pS122, DOI 10.1007/s005860100303
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   THOROGOOD P, 1986, DEV BIOL, V116, P497, DOI 10.1016/0012-1606(86)90150-8
   Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201
   Xian Cory J, 2006, Curr Stem Cell Res Ther, V1, P213, DOI 10.2174/157488806776956904
   Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 45
TC 34
Z9 39
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 28
BP 4986
EP 4995
DI 10.1016/j.biomaterials.2009.05.056
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 489XP
UT WOS:000269459900016
PM 19539363
DA 2018-10-20
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, Subhas C.
TI Osteogenic and adipogenic differentiation of rat bone marrow cells on
   non-mulberry and mulberry silk gland fibroin 3D scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Osteogenesis; Adipogenesis; Biomaterial; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS; IN-VIVO;
   STROMAL CELLS; 3-D SCAFFOLDS; ADIPOSE; PROTEIN; BIOMATERIALS; VITRO;
   REGENERATION
AB This study investigates the potential of 3D silk scaffolds fabricated using tropical tasar non-mulberry, Antheraea mylitta and mulberry, Bombyx man silk gland fibroin proteins as substrate for osteogenic and adipogenic differentiation of rat bone marrow cells (BMCs). The scaffolds are mechanically robust and show homogenous pore distribution with high porosity and interconnected pore walls. Low immunogenicity of fabricated silk scaffolds as estimated through TNF alpha release indicates its potential as future biopolymeric graft material. Rat bone marrow cells cultured on scaffolds for 28 days under static conditions in osteogenic and adipogenic media respectively led to induction of differentiation. Proliferation and spreading of fibroblasts and bone marrow cells on silk scaffolds were observed to be dependent on scaffold porosity as revealed through confocal microscopic observations. Histological analysis shows osteogenic differentiation within silk scaffolds resulting in extensive mineralization in the form of deposited nodules as observed through intense Alizarin Red S staining. Similarly, adipogenesis was marked by the presence of lipid droplets within scaffolds on staining with Oil Red O. Real-time PCR studies reveal higher transcript levels for osteopontin (Spp1), osteocalcin (Bglap2) and osteonectin (Sparc) genes under osteogenic conditions. Similarly, upregulated adipogenic gene expression was observed within A. mylitta and B. man scaffolds under adipogenic conditions for Peroxisome proliferator activated receptor gamma (PPAR gamma 2), lipoprotein lipase (LPL) and adipocyte binding protein (aP2) genes. The results suggest suitability of silk fibroin protein 3D scaffolds as natural biopolymer for potential bone and adipose tissue engineering applications. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Mandal, Biman B.; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology [BT/PR6035/MED/14/733/2005]; Indo-Australia
   Biotechnology Fund [BT/PR9552/ICD/16/755/2006]; Council of Scientific
   Industrial Research; Govt. of India, Indo-US Science and Technology
   Forum, New Delhi
FX Department of Biotechnology and its bioinformatics facility
   (BT/PR6035/MED/14/733/2005), Indo-Australia Biotechnology Fund
   (BT/PR9552/ICD/16/755/2006), Council of Scientific Industrial Research
   (for fellowship to BBM), Govt. of India, Indo-US Science and Technology
   Forum, New Delhi, are acknowledged for financially supporting this work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BENNETT JH, 1991, J CELL SCI, V99, P131
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Borzacchiello A, 2007, BIOMATERIALS, V28, P4399, DOI 10.1016/j.biomaterials.2007.06.007
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chen ZX, 2007, REGUL PEPTIDES, V142, P16, DOI 10.1016/j.regpep.2007.01.003
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Choi YS, 2006, BIOCHEM BIOPH RES CO, V345, P631, DOI 10.1016/j.bbrc.2006.04.128
   DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   FRIEDENSTEIN AJ, 1990, BONE MINERAL RES, V7, P243
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee K., 2000, PRINCIPLES TISSUE EN, P409
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liechty KW, 2000, NAT MED, V6, P1282
   Makowski L, 2004, J NUTR, V134, p2464S
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2009, BIOMED MICRODEVICES, V11, P467, DOI 10.1007/s10544-008-9252-x
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab
   OWEN M, 1988, CIBA F SYMP, V136, P42
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Powers MP, 1996, J ORAL MAXIL SURG, V54, P934, DOI 10.1016/S0278-2391(96)90386-9
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   Rooney DP, 2006, DIABETIC MED, V23, P436, DOI 10.1111/j.1464-5491.2006.01855.x
   Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7
   SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x
   Schoderbock P, 1996, APPL SURF SCI, V93, P109, DOI 10.1016/0169-4332(95)00327-4
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Tzikas Thomas L, 2004, Facial Plast Surg, V20, P135, DOI 10.1055/s-2004-861754
   Vacanti JP, 1999, LANCET, V354, pSI32
   Valarmathi MT, 2008, BIOMATERIALS, V29, P2203, DOI 10.1016/j.biomaterials.2008.01.025
   Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
NR 57
TC 61
Z9 65
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 28
BP 5019
EP 5030
DI 10.1016/j.biomaterials.2009.05.064
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 489XP
UT WOS:000269459900019
PM 19577292
DA 2018-10-20
ER

PT J
AU Zhang, SF
   Doschak, MR
   Uludag, H
AF Zhang, Sulfeng
   Doschak, Michael R.
   Uludag, Hasan
TI Pharmacokinetics and bone formation by BMP-2 entrapped in
   polyethylenimine-coated albumin nanoparticles
SO BIOMATERIALS
LA English
DT Article
DE Bone morphogenetic protein-2; Polyethylenimine; Bovine serum albumin;
   Nanoparticle; Pharmacokinetics; Ectopic bone formation
ID RAT ECTOPIC MODEL; MORPHOGENETIC PROTEIN-2; CONTROLLED-RELEASE; DELIVERY
   SYSTEMS; BIOMATERIAL CARRIERS; CEMENT COMPOSITES; SPINAL-FUSION;
   IN-VITRO; COLLAGEN; RHBMP-2
AB The osteoinductive growth factor, bone morphogenetic protein-2 (BMP-2), is capable of inducing de novo bone formation after implantation. A nanoparticulate (NP) system was developed for BMP-2 delivery based on NPs fabricated from bovine serum albumin (BSA) and stabilized by polyethylenimine (PEI) coating. In this study, the pharmacokinetics and osteoinductivity of BMP-2 delivered with different BSA NP formulations were determined by subcutaneous implantation in rats. A 7-day pharmacokinetics study showed that PEI coating on NPs effectively reduced the initial burst release of BMP-2 and prolonged the BMP-2 retention at implantation site. However, the uncoated BMP-2 NPs (BMP-2 loading of 1.44% w/w) were able to induce a robust ectopic bone formation, while no bone formation was found by the BMP-2 NPs coated with PEI. The toxicity of the PEI used for NP coating was determined to be the reason for lack of osteoinduction. Increasing BMP-2 loading (up to 5.76% w/w) was then employed to formulate NPs; with lower PEI content: the higher BMP-2 loading was found to better promote induction of de novo bone. Our findings indicated that PEI coating on BSA NPs was effective for controlling BMP-2 release from NPs, but the toxicity of cationic PEI was a concern for the osteoinductive activity, which should be alleviated by further optimization of NP formulations. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Zhang, Sulfeng; Uludag, Hasan] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
   [Doschak, Michael R.; Uludag, Hasan] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2G6, Canada.
   [Uludag, Hasan] Univ Alberta, Fac Med, Dept Biomed Engn, Edmonton, AB T6G 2G6, Canada.
RP Uludag, H (reprint author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, 830 Chem & Mat Engn Bldg, Edmonton, AB T6G 2G6, Canada.
EM hasan.uludag@ualberta.ca
OI Doschak, Michael/0000-0002-0293-6596
FU Canadian Foundation for Innovation (CFI); Alberta Heritage Foundation
   for Medical Research (AHFMR)
FX The authors thank the technicians, Mr. Charles Tran and Ms. Jillian
   Chapman in the Pharmacy Micro-CT (PMCT) imaging laboratory (Faculty of
   Pharmacy and Pharmaceutical Sciences, University of Alberta), for their
   assistance with the micro-CT study. Mr. Cezary Kucharski is acknowledged
   for his help with implantation procedures. This project was financially
   supported by an operating grant from the Canadian Institutes of Health
   Research (CIHR). Infrastructure support was provided by Canadian
   Foundation for Innovation (CFI) and Alberta Heritage Foundation for
   Medical Research (AHFMR).
CR Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   Boyne PJ, 2001, J BONE JOINT SURG AM, V83A, pS146
   Chakravarthi S. S., 2007, NANOPARTICULATE DRUG, P51
   Chatzinikolaidou M, 2003, MATERIALWISS WERKST, V34, P1106, DOI 10.1002/mawe.200300714
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Ebara S, 2002, SPINE, V27, pS10, DOI 10.1097/01.BRS.0000020727.98493.20
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Gadeau AP, 2001, J HISTOCHEM CYTOCHEM, V49, P79, DOI 10.1177/002215540104900108
   Gittens SA, 2005, MOL PHARMACEUT, V2, P392, DOI 10.1021/mp050017u
   Helm GA, 1997, J NEUROSURG, V86, P93, DOI 10.3171/jns.1997.86.1.0093
   Hillaireau H, 2006, POLYM DRUG DELIVERY, P101
   HORISAKA Y, 1994, J BIOMED MATER RES, V28, P97, DOI 10.1002/jbm.820280113
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Huang M, 2007, BIOMACROMOLECULES, V8, P1607, DOI 10.1021/bm061211k
   Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008
   Isobe M, 1996, J BIOMED MATER RES, V32, P433
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Levine JP, 1997, ANN PLAS SURG, V39, P158, DOI 10.1097/00000637-199708000-00008
   Lin W, 1993, J DRUG TARGET, V1, P237, DOI 10.3109/10611869308996081
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   Maeda H, 2004, INT J PHARM, V275, P109, DOI 10.1016/j.ijpharm.2004.01.040
   McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/01.BRS.0000020738.16636.B3
   Messai I, 2003, COLLOID SURFACE B, V32, P293, DOI 10.1016/S0927-7765(03)00182-6
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2002, BRIT J ORAL MAX SURG, V40, P131, DOI 10.1054/bjom.2001.0743
   OKAMOTO Y, 1991, CLIN ORTHOP RELAT R, P242
   PARK TG, 1992, PHARMACEUT RES, V9, P37, DOI 10.1023/A:1018971525301
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153
   RENGACHARY SS, 2002, NEUROSURG FOCUS, V13, P1
   Riedel GE, 1999, ORTHOPEDICS, V22, P663
   Ripamonti U, 2001, J BONE JOINT SURG AM, V83A, pS116
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2001, J BONE JOINT SURG AM, V83, P92
   SANDS A, 2002, FOOD ENG INGREDIENTS, V27, P8
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Seeherman H, 2001, J BONE JOINT SURG AM, V83A, pS79
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Szpalski Marek, 2005, Acta Orthop Belg, V71, P133
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Takita H, 2004, J BIOMED MATER RES A, V71A, P181, DOI 10.1002/jbm.a.30152
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDENBOS T, 1994, J BIOMED MATER RES, V28, P1295, DOI 10.1002/jbm.820281107
   Varkey M, 2006, CLIN ORTHOP RELAT R, P113, DOI 10.1097/01.blo.0000200236.84189.87
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yoshida K, 1999, J DENT RES, V78, P1505, DOI 10.1177/00220345990780090401
   Zhang SF, 2008, BIOTECHNOL PROGR, V24, P945, DOI 10.1002/btpr.12
NR 60
TC 35
Z9 36
U1 3
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 28
BP 5143
EP 5155
DI 10.1016/j.biomaterials.2009.05.060
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 489XP
UT WOS:000269459900032
PM 19540582
DA 2018-10-20
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, Subhas C.
TI Calcium alginate beads embedded in silk fibroin as 3D dual drug
   releasing scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Scaffolds; Drug delivery; Controlled release; Tissue
   engineering
ID TISSUE ENGINEERING APPLICATIONS; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO;
   BIOMATERIAL COATINGS; 3-D SCAFFOLDS; DELIVERY; MICROSPHERES; PROTEIN;
   REGENERATION; MATRICES
AB 3D scaffolds based on embedding drug loaded calcium alginate beads within silk fibroin protein were fabricated for investigating controlled dual drug release. The 3D matrices were evaluated for in vitro release using two different molecular weight model compounds, bovine serum albumin (66 kDa) and FITC-Inulin (3.9 kDa). The model compound release profiles revealed dependence on molecular weight of encapsulated model drugs for sustained release. Further, silk fibroin protein blended calcium alginate beads resulted in prolonged drug release without initial bursts for 35 days as compared to calcium alginate beads without silk fibroin as control. The release kinetics were further tested as a function of wt% silk content for scaffold fabrication suggesting their possible role in restricting initial burst and leading to sustainable release of compounds for prolong time. Silk coatings on calcium alginate beads provided mechanically stable shells as well as a diffusion barrier to the encapsulated protein drugs thus controlling their release. Scanning electron microscopic observations were carried out to assess cellular viability and biocompatibility of bead embedded-silk 3D scaffolds using fibroblast cells. The results highlight the versatile and tunable properties of calcium alginate embedded fibroin 3D scaffolds making them exciting candidate for the controlled release of a wide spectrum of bioactive molecules from a single delivery vehicle. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Mandal, Biman B.; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology [BT/PR6035/MED/14/733/2005]; Indo-Australia
   Biotechnology Fund [BT/PR9552/ICD/16/755/2006]; Council of Scientific
   Industrial Research, Govt. of India; Indo-US Science and Technology
   Forum, New Delhi
FX Department of Biotechnology (BT/PR6035/MED/14/733/2005) and its
   bioinformatics facility, Indo-Australia Biotechnology Fund
   (BT/PR9552/ICD/16/755/2006), Council of Scientific Industrial Research
   (for fellowship to BBM), Govt. of India, Indo-US Science and Technology
   Forum, New Delhi are acknowledged for supporting our program
   financially.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BOURQUE WT, 1993, INT J DEV BIOL, V37, P573
   Deng TZ, 2007, J MICROENCAPSUL, V24, P163, DOI 10.1080/02652040701233523
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Ikada Y., 1998, ADV DRUG DELIV REV, V31, P287
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim HD, 1997, BIOMATERIALS, V18, P1175
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee KY, 2003, J CONTROL RELEASE, V87, P49, DOI 10.1016/S0168-3659(02)00349-8
   Lee KY, 2000, NATURE, V408, P998
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu LS, 1997, J CONTROL RELEASE, V43, P65, DOI 10.1016/S0168-3659(96)01471-X
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Raiche AT, 2004, BIOMATERIALS, V25, P677, DOI 10.1016/S0142-9612(03)00564-7
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sakano S, 2002, BIOCHEM BIOPH RES CO, V293, P680, DOI 10.1016/S0006-291X(02)00273-5
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yu Y, 2002, J BIOMED MATER RES, V60, P392, DOI 10.1002/jbm.1289
NR 43
TC 52
Z9 54
U1 2
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 28
BP 5170
EP 5177
DI 10.1016/j.biomaterials.2009.05.072
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 489XP
UT WOS:000269459900035
PM 19552952
DA 2018-10-20
ER

PT J
AU Moraes, C
   Kagoma, YK
   Beca, BM
   Tonelli-Zasarsky, RLM
   Sun, Y
   Simmons, CA
AF Moraes, Christopher
   Kagoma, Yban K.
   Beca, Bogdan M.
   Tonelli-Zasarsky, Rachel L. M.
   Sun, Yu
   Simmons, Craig A.
TI Integrating polyurethane culture substrates into poly(dimethylsiloxane)
   microdevices
SO BIOMATERIALS
LA English
DT Article
DE Polyurethane; Polydimethylsiloxane; Cell culture; Microfabrication;
   Protein patterning
ID CELL-CULTURE; MICROFLUIDIC DEVICES; PDMS POLYDIMETHYLSILOXANE;
   REGENERATIVE MEDICINE; EXTRACELLULAR-MATRIX; ADHESION; FABRICATION;
   MEMBRANES; SURFACES; COLLAGEN
AB Poly(dimethylsiloxane) (PDMS)-based microdevices have enabled rapid, high-throughput assessment of cellular response to precisely controlled microenvironmental stimuli, including chemical, matrix and mechanical factors. However, the use of PDMS as a culture substrate precludes long-term culture and may significantly impact cell response. Here we describe a method to integrate polyurethane (PU), a well-studied and clinically relevant biomaterial, into the PDMS multilayer microfabrication process, enabling the exploration of long-term cellular response on alternative substrates in microdevices. To demonstrate the utility of these hybrid microdevices for cell culture, we compared initial cell adhesion, cell spreading, and maintenance of protein patterns on PU and PDMS substrates. initial cell adhesion and cell spreading after three days were comparable between collagen-coated PDMS and PU substrates (with or without collagen coating), but significantly lower on native PDMS substrates. However, for longer culture durations (>= 6 days), cell spreading and protein adhesion on PU substrates was significantly better than that on PDMS substrates, and comparable to that on tissue culture-treated polystyrene. Thus. the use of a generic polyurethane substrate in microdevices enables longer-term cell culture than is possible with PDMS substrates. More generally, this technique can improve the impact and applicability of microdevice-based research by facilitating the use of alternate, relevant biomaterials while maintaining the advantages of using PDMS for microdevice fabrication. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Moraes, Christopher; Kagoma, Yban K.; Beca, Bogdan M.; Tonelli-Zasarsky, Rachel L. M.; Sun, Yu; Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Moraes, Christopher; Sun, Yu; Simmons, Craig A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada.
EM simmons@mie.utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772; Moraes,
   Christopher/0000-0002-8950-2212; Sun, Yu/0000-0001-7895-0741
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3
   Dennes TJ, 2008, SOFT MATTER, V4, P86, DOI 10.1039/b714947f
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H
   Frevert CW, 2006, LAB CHIP, V6, P849, DOI 10.1039/b515560f
   Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gunatillake PA, 2003, AUST J CHEM, V56, P545, DOI 10.1071/CH02168
   Heijkants RGJC, 2004, J MATER SCI-MATER M, V15, P423, DOI 10.1023/B:JMSM.0000021114.39595.1e
   Huang B, 2006, LAB CHIP, V6, P369, DOI 10.1039/b515840k
   Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780
   Kamotani Y, 2008, BIOMATERIALS, V29, P2646, DOI 10.1016/j.biomaterials.2008.02.019
   Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b
   Keranov I, 2008, J APPL POLYM SCI, V110, P321, DOI 10.1002/app.28630
   Kim JY, 2008, BIOMED MICRODEVICES, V10, P11, DOI 10.1007/s10544-007-9105-z
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Langowski BA, 2005, LANGMUIR, V21, P10509, DOI 10.1021/la052222m
   Leclerc E, 2004, BIOTECHNOL PROGR, V20, P750, DOI 10.1021/bp0300568
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Leclerc E, 2008, BIOMED MICRODEVICES, V10, P169, DOI 10.1007/s10544-007-9122-y
   Lee HLT, 2006, LAB CHIP, V6, P1229, DOI 10.1039/b608014f
   Li YH, 2006, J APPL POLYM SCI, V99, P1832, DOI 10.1002/app.22150
   Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g
   Mai JY, 2007, BIOMED MICRODEVICES, V9, P523, DOI 10.1007/s10544-007-9060-8
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Mehta G, 2007, BIOMED MICRODEVICES, V9, P123, DOI 10.1007/s10544-006-9005-7
   Mehta G, 2009, ANAL CHEM, V81, P3714, DOI 10.1021/ac802178u
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m
   Ozdemir Y, 2002, J MATER SCI-MATER M, V13, P1147, DOI 10.1023/A:1021185803716
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Piccin E, 2007, J CHROMATOGR A, V1173, P151, DOI 10.1016/j.chroma.2007.09.081
   Ramrattan NN, 2005, TISSUE ENG, V11, P1212, DOI 10.1089/ten.2005.11.1212
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Satyanarayana S, 2005, J MICROELECTROMECH S, V14, P392, DOI 10.1109/JMEMS.2004.839334
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tan W, 2008, BIOMED MICRODEVICES, V10, P869, DOI 10.1007/s10544-008-9201-8
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Wipff PJ, 2009, BIOMATERIALS, V30, P1781, DOI 10.1016/j.biomaterials.2008.12.022
   Ying PQ, 2004, COLLOID SURFACE B, V33, P259, DOI 10.1016/j.colsurfb.2003.10.015
   Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394
   Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d
NR 52
TC 12
Z9 12
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 28
BP 5241
EP 5250
DI 10.1016/j.biomaterials.2009.05.066
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 489XP
UT WOS:000269459900043
PM 19545891
DA 2018-10-20
ER

PT J
AU Ribeiro-Resende, VT
   Koenig, B
   Nichterwitz, S
   Oberhoffner, S
   Schlosshauer, B
AF Ribeiro-Resende, Victor T.
   Koenig, Brigitte
   Nichterwitz, Susanne
   Oberhoffner, Sven
   Schlosshauer, Burkhard
TI Strategies for inducing the formation of bands of Bungner in peripheral
   nerve regeneration
SO BIOMATERIALS
LA English
DT Editorial Material
DE Bands of Bungner; Collagen; Growth factor; Nerve regeneration;
   Poly-caprolactone; Rat Schwann cell
ID SCHWANN-CELL DIFFERENTIATION; GROWTH-FACTOR-BETA; SCIATIC-NERVE;
   N-CADHERIN; IN-VITRO; ADHESION MOLECULES; RETINAL AXONS; COLLAGEN;
   EXPRESSION; GUIDANCE
AB Peripheral human nerves fail to regenerate across longer tube implants (>2 cm), most likely because implants lack the microarchitecture of native nerves, including bands of Bungner. Bands of Bungner comprise longitudinally aligned Schwann cell strands that guide selectively regrowing axons. We aim to optimize tubular implants by integrating artificial bands of Bungner. Three principle strategies for inducing the formation of bands of Bungner were investigated: (a) an aligned extracellular matrix, (b) polarizing differentiation factors, and (c) microstructured biomaterial filaments. In vitro oriented collagen and a combination of differentiation factors (NGF, neuregulin-1, TGF-beta) induced Schwann cell alignment to some extent. The most pronounced Schwann cell alignment was evident on ultrathin, endless poly-epsilon-caprolactone (PCL) filaments with longitudinal microgrooves. Precoated PCL filaments proved to be non-cytotoxic, displayed good cell attachment, and supported Schwann cell proliferation as well as guided axonal outgrowth. In vitro on PCL filaments Schwann cells displayed a polarized expression of the cell adhesion molecule L1 similar to that seen in vivo in bands of Bungner after sciatic nerve crush in adult rats. In summary, the integration of bioengineered bands of Bungner based on microstructured polymer filaments in nerve conduits promises to be the most valuable approach to initiating a more efficient regeneration across longer nerve lesions. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Ribeiro-Resende, Victor T.; Koenig, Brigitte; Nichterwitz, Susanne; Schlosshauer, Burkhard] Univ Tubingen, NMI, D-72770 Reutlingen, Germany.
   [Ribeiro-Resende, Victor T.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, BR-21949900 Rio De Janeiro, Brazil.
   [Oberhoffner, Sven] ITV, D-73770 Denkendorf, Germany.
RP Schlosshauer, B (reprint author), Univ Tubingen, NMI, Markwiesenstr 55, D-72770 Reutlingen, Germany.
EM schlosshauer@nmi.de
CR ANDERSON PN, 1991, ACTA NEUROPATHOL, V82, P193, DOI 10.1007/BF00294445
   BASTMEYER M, 1989, SOC NEUR ABSTR, P574
   BIGNAMI A, 1984, J NEUROPATH EXP NEUR, V43, P94, DOI 10.1097/00005072-198401000-00008
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T
   Bungner OV, 1891, BEITR PATHOL ANAT, V10, P321
   Bunting S, 2005, J HAND SURG-BRIT EUR, V30B, P242, DOI 10.1016/j.jhsh.2004.11.003
   D'Antonio M, 2006, J NEUROSCI, V26, P8417, DOI 10.1523/JNEUROSCI.1578-06.2006
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0
   Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G
   Fairless R, 2005, MOL CELL NEUROSCI, V28, P253, DOI 10.1016/j.mcn.2004.09.009
   Funk D, 2007, EUR J CELL BIOL, V86, P207, DOI 10.1016/j.ejcb.2006.12.006
   Gess B, 2008, J NEUROSCI RES, V86, P797, DOI 10.1002/jnr.21528
   Hasegawa M, 1996, J NEUROPATH EXP NEUR, V55, P424, DOI 10.1097/00005072-199604000-00005
   Ide C, 1996, NEUROSCI RES, V25, P101
   Kandenwein JA, 2005, J NEUROSURG, V103, P614, DOI 10.3171/jns.2005.103.4.0614
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   LIETZ M, 2006, J BIOTECH BIOENG, V5, P99
   Lohmeyer JA, 2007, INT J ARTIF ORGANS, V30, P64
   MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735
   Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038
   MOLLERS S, 2008, TISSUE ENG PART A, V15, P461
   Parkinson DB, 2001, J NEUROSCI, V21, P8572
   Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   PORTER S, 1986, J NEUROSCI, V6, P3070
   Previtali SC, 2003, J NEUROSCI, V23, P5520
   ROGISTER B, 1993, J NEUROSCI RES, V34, P32, DOI 10.1002/jnr.490340105
   Rosenbaum C, 1997, EXP NEUROL, V148, P604, DOI 10.1006/exnr.1997.6696
   Samardzic MM, 1998, ACTA NEUROCHIR, V140, P1177, DOI 10.1007/s007010050234
   SCHLOSSHAUER B, 1984, NATURE, V310, P141, DOI 10.1038/310141a0
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Sethi KK, 2002, WOUND REPAIR REGEN, V10, P397, DOI 10.1046/j.1524-475X.2002.10609.x
   Sinis N, 2005, J NEUROSURG, V103, P1067, DOI 10.3171/jns.2005.103.6.1067
   Sinis N, 2007, RESTOR NEUROL NEUROS, V25, P131
   Soares S, 2005, EUR J NEUROSCI, V21, P1169, DOI 10.1111/j.1460-9568.2005.03961.x
   Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060
   Steinbach K, 2002, EXP CELL RES, V279, P52, DOI 10.1006/excr.2002.5595
   Stewart HJS, 1997, J NEUROBIOL, V33, P914, DOI 10.1002/(SICI)1097-4695(199712)33:7<914::AID-NEU4>3.0.CO;2-B
   Verdu E, 2002, RESTOR NEUROL NEUROS, V20, P169
   Waller A., 1850, PHILOS T R SOC LOND, V140, P423, DOI [10.1098/rstl.1850.0021, DOI 10.1098/RSTL.1850.0021]
   WALTER J, 1987, DEVELOPMENT, V101, P685
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002
   Wu J, 1999, ANN PLAS SURG, V43, P661, DOI 10.1097/00000637-199912000-00016
   Yoshii S, 2004, NEUROL RES, V26, P145, DOI 10.1179/016164104225013770
   ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202
NR 50
TC 95
Z9 100
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 29
BP 5251
EP 5259
DI 10.1016/j.biomaterials.2009.07.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498CW
UT WOS:000270115200001
PM 19632717
DA 2018-10-20
ER

PT J
AU Seo, JH
   Matsuno, R
   Takai, M
   Ishihara, K
AF Seo, Ji-Hun
   Matsuno, Ryosuke
   Takai, Madoka
   Ishihara, Kazuhiko
TI Cell adhesion on phase-separated surface of block copolymer composed of
   poly(2-methacryloyloxyethyl phosphorylcholine) and
   poly(dimethylsiloxane)
SO BIOMATERIALS
LA English
DT Article
DE Phosphorylcholine; Polydimethylsiloxane; Block copolymer; Protein
   adsorption; Cell adhesion
ID SELECTIVE PROTEIN ADSORPTION; PHOSPHOLIPID POLYMERS; BLOOD
   COMPATIBILITY; SEGMENTED POLYURETHANE; DIBLOCK COPOLYMERS;
   PLATELET-ADHESION; PLASMA; BEHAVIOR; MOIETY
AB We investigated the morphological effect of phase-separated block copolymer surfaces composed of poly(2-methacryloyloxyethyl phosphorylcholine (MPC)) (PMPC) and poly(dimethylsiloxane) (PDMS) on protein adsorption and cell adhesion behavior. We observed three different types of phase-separated surface morphologies by TEM and AFM. The elemental composition of phosphorus on the surface increases with the PMPC composition. Furthermore, the polymer surface formed by a block copolymer-containing a higher MPC unit composition shows a slightly lower static water contact angle. This result indicates that the elemental surface ratio of the surface depends on the MPC composition in the block copolymer. Protein adsorption tests revealed that only hydrophobic PDMS domains showed selective protein adsorption. Cell adhesion tests revealed that the number of adhered cells increased with increasing hydrophobic PDMS domain size of block copolymers in serum-containing media. In contrast, no cells adhered onto block copolymer surfaces in serum-free media, whereas a large amount of adhered cells were observed on the hydrophobic PDMS surface. This result indicates that segregated hydrophobic domains on a biocompatible PMPC surface strongly affect serum protein adsorption, thereby promoting considerable cell adhesion, although the surface is hydrophilic. Thus, both the composition of MPC units and the segregated hydrophobic surface morphology are important considerations in biomaterial surface design. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Seo, Ji-Hun; Matsuno, Ryosuke; Takai, Madoka; Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Ishihara, Kazuhiko] Univ Tokyo, Dept Bioengn, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Seo, Ji-Hun; Matsuno, Ryosuke; Takai, Madoka; Ishihara, Kazuhiko] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@mpc.t.u-tokyo.ac.jp
FU Core Research for Evolution Science and Technology (CREST), Japan
   Science and Technology Agency
FX This research was partially supported by the Core Research for Evolution
   Science and Technology (CREST), Japan Science and Technology Agency.
CR Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Cooke DM, 2006, MACROMOLECULES, V39, P6661, DOI 10.1021/ma060717s
   Fasolka MJ, 2001, ANN REV MATER RES, V31, P323, DOI 10.1146/annurev.matsci.31.1.323
   Futamura K, 2008, LANGMUIR, V24, P10340, DOI 10.1021/la801017h
   Horbett TA, 1995, ACS SYM SER, V602, P2
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   Ishihara K, 2000, J BIOMAT SCI-POLYM E, V11, P1183, DOI 10.1163/156856200744264
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 2003, BIOMATERIALS, V24, P3599, DOI 10.1016/S0142-9612(03)00212-6
   Jang K, 2009, BIOMATERIALS, V30, P1413, DOI 10.1016/j.biomaterials.2008.11.013
   KIM HI, 2009, TISSUE ENG, DOI DOI 10.1089/TEN.TEA.2008.0307
   Kimura M, 2007, J BIOMAT SCI-POLYM E, V18, P623, DOI 10.1163/156856207780852541
   KOHR HL, 2007, BIOMACROMOLECULES, V8, P1530
   Konno T, 2007, BIOMATERIALS, V28, P1770, DOI 10.1016/j.biomaterials.2006.12.017
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Kumar N, 2008, LANGMUIR, V24, P2688, DOI 10.1021/la7022456
   Kwak D, 2005, J BIOMED MATER RES A, V74A, P69, DOI 10.1002/jbm.a.30365
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   Seo JH, 2008, BIOMATERIALS, V29, P1367, DOI 10.1016/j.biomaterials.2007.11.039
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Sousa A, 2006, LANGMUIR, V22, P6286, DOI 10.1021/la053081r
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Yamane T, 2008, ARTIF ORGANS, V32, P484, DOI 10.1111/j.1525-1594.2008.00570.x
   Ye SH, 2005, J MEMBRANE SCI, V249, P133, DOI 10.1016/j.memsci.2004.10.006
NR 32
TC 42
Z9 43
U1 6
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 29
BP 5330
EP 5340
DI 10.1016/j.biomaterials.2009.06.031
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498CW
UT WOS:000270115200010
PM 19592090
DA 2018-10-20
ER

PT J
AU Goncalves, IC
   Martins, MCL
   Barbosa, MA
   Ratner, BD
AF Goncalves, Ines C.
   Martins, M. Cristina L.
   Barbosa, Mario A.
   Ratner, Buddy D.
TI Protein adsorption and clotting time of pHEMA hydrogels modified with
   C18 ligands to adsorb albumin selectively and reversibly
SO BIOMATERIALS
LA English
DT Article
DE polyHEMA; Surface modification; Protein adsorption; Human serum albumin;
   Clotting time
ID SELF-ASSEMBLED MONOLAYERS; PLATELET-ADHESION; BINDING SURFACES;
   POLY(2-HYDROXYETHYL METHACRYLATE); FIBRINOGEN ADSORPTION; PROCOAGULANT
   ACTIVITY; BLOOD COMPATIBILITY; CONTACT ACTIVATION; POLYMERS; PLASMA
AB This work intended to create a nanostructured biomaterial that would bind albumin in a selective and reversible way in order to inhibit the adsorption of other blood proteins and therefore minimize activation of coagulation. Different levels of C18 ligand have been immobilized on poly(2-hydroxyethyl methacrylate) (pHEMA). We hypothesize that samples with intermediate amounts of C18 ligand would allow albumin to recognize them and bind through its hydrophobic pockets specific for long chain fatty acids. Surface characterization has confirmed increasing amounts of C18 ligand on pHEMA as the percentage of C18 in solution increases, with maximum coverage achieved in 10% C18 samples. Adsorption from pure albumin solution revealed a small decrease in albumin adsorption from pHEMA to 1% C18 and 2.5% C18 samples, but on surfaces with 5% or higher C18 the amount of adsorbed albumin increased as the percentage of C18 increased. Competitive adsorption studies in the presence of both albumin and fibrinogen, and in the presence of all plasma proteins showed that 1% C18 and 2.5% C18 were the only surfaces selective for albumin, and that the presence of all plasma proteins may even potentiate albumin adsorption. Reversibility studies demonstrated that both 2.5% C18 and 5% C18 samples exchange (125)I-albumin selectively in the presence of both unlabeled albumin and plasma, but 2.5% C18 samples presented higher exchangeability rates (58%). Clotting times using recalcified plasma revealed that samples with none or small amounts of C18 (pHEMA to 5% C18) did not shorten the clotting time compared to the negative control (polystyrene), indicating low activation of the intrinsic coagulation cascade. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Goncalves, Ines C.; Martins, M. Cristina L.; Barbosa, Mario A.] Univ Porto, Inst Biomed Engn, Div Biomat, P-4150180 Oporto, Portugal.
   [Goncalves, Ines C.; Barbosa, Mario A.] Univ Porto, Fac Engn, Dept Mat & Met Engn, P-4150180 Oporto, Portugal.
   [Ratner, Buddy D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Ratner, Buddy D.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Goncalves, IC (reprint author), Univ Porto, Inst Biomed Engn, Div Biomat, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM icastro@ineb.up.pt
RI Barbosa, Mario/F-5964-2011; Goncalves, Ines/K-4147-2012; Martins, M.
   Cristina/J-8284-2013
OI Barbosa, Mario/0000-0003-3568-7482; Goncalves, Ines/0000-0001-9759-4965;
   Martins, M. Cristina/0000-0002-6574-4794
FU Portuguese Foundation for Science and Technology - FCT
   [POCI/CTM/55644/2004, SFRH/BD/188337/2004]; University of Washington
   Engineered Biomaterials - UWEB (NSF) [EEC-9529161]
FX The authors acknowledge the support from the Portuguese Foundation for
   Science and Technology - FCT (project POCI/CTM/55644/2004) and
   University of Washington Engineered Biomaterials - UWEB (NSF Grant
   EEC-9529161). We thank the Portuguese Blood Institute (IPS) for donating
   the human plasma. Ines Goncalves is grateful to FCT for awarding her the
   grant SFRH/BD/188337/2004 and to Misty Noble and Jeanette Stein for
   their support in the preparation of pHEMA and protein radiolabeling,
   respectively.
CR BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Cao L, 2007, J BIOMED MATER RES A, V81A, P827, DOI 10.1002/jbm.a.31091
   Castner D. G., 1996, SURF SCI SPECTRA, V4, P14
   FENG L, 1994, BIOMATERIALS, V15, P323
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, P183
   Ji J, 2001, BIOMATERIALS, V22, P3015, DOI 10.1016/S0142-9612(01)00048-5
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Kwok CS, 2000, BIOMACROMOLECULES, V1, P139, DOI 10.1021/bm000292w
   LOPEZ GP, 1993, MACROMOLECULES, V26, P3247, DOI 10.1021/ma00065a001
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Martins MCL, 2003, J BIOMAT SCI-POLYM E, V14, P439, DOI 10.1163/156856203766652057
   McFarland CD, 1998, J BIOMAT SCI-POLYM E, V9, P1227, DOI 10.1163/156856298X00749
   Mequanint K, 2005, J BIOMAT SCI-POLYM E, V16, P1303, DOI 10.1163/156856205774269548
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   RATNER BD, 1981, BIOCOMPATIBILITY CLI
   Stovbun E., 1996, POLYM SCI SER A+, V38, P691
   STRYER L, 1998, BIOCHEMISTRY
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tsai C. C., 1990, ASAIO T, V36, P307
   Tsukagoshi T, 2007, COLLOID SURFACE B, V54, P101, DOI 10.1016/j.colsurfb.2006.10.004
   Wang DA, 2002, BIOCONJUGATE CHEM, V13, P792, DOI 10.1021/bc0255079
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
NR 35
TC 16
Z9 16
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 29
BP 5541
EP 5551
DI 10.1016/j.biomaterials.2009.06.025
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498CW
UT WOS:000270115200032
PM 19595453
DA 2018-10-20
ER

PT J
AU Kayamuro, H
   Abe, Y
   Yoshioka, Y
   Katayama, K
   Nomura, T
   Yoshida, T
   Yamashita, K
   Yoshikawa, T
   Kawai, Y
   Mayumi, T
   Hiroi, T
   Itoh, N
   Nagano, K
   Kamada, H
   Tsunoda, S
   Tsutsumi, Y
AF Kayamuro, Hiroyuki
   Abe, Yasuhiro
   Yoshioka, Yasuo
   Katayama, Kazufumi
   Nomura, Tetsuya
   Yoshida, Tokuyuki
   Yamashita, Kohei
   Yoshikawa, Tomoaki
   Kawai, Yuichi
   Mayumi, Tadanori
   Hiroi, Takachika
   Itoh, Norio
   Nagano, Kazuya
   Kamada, Haruhiko
   Tsunoda, Shin-ichi
   Tsutsumi, Yasuo
TI The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of
   mucosal immune responses
SO BIOMATERIALS
LA English
DT Article
DE Bioactivity; Cytokine; Mucosa; Immunomodulation
ID TUMOR-NECROSIS-FACTOR; DENDRITIC CELL MATURATION; SITE-SPECIFIC
   PEGYLATION; ALZHEIMERS-DISEASE; PHAGE DISPLAY; ANTITUMOR; BETA;
   IMMUNIZATION; MOUSE; PROTEINS
AB Safe and potent adjuvants are required in order to establish effective mucosal vaccines. Cytokines are promising adjuvants because they are human-derived safe biomaterial and display immune-modulating functions. We have created a mutant tumor necrosis factor-alpha (TNF-alpha), mTNF-K90R, that exhibits high bioactivity and resistance to proteases. Here, we examined the potential of mTNF-K90R as a mucosal adjuvant. Initially, we showed that intranasal co-administration of mTNF-K90R with ovalbumin (OVA) potently produced OVA-specific Immunoglobulin (Ig) G antibodies (Abs) in serum and IgA Abs both at local and distal mucosal sites compared to co-administration with wild-type TNF-alpha. The OVA-specific immune response was characterized by high levels of serum IgG1 and increased production of interleukin-4 (IL-4), IL-5 and IL-10 from splenocytes of immunized mice, suggesting a Th2 response. Furthermore, intranasal immunization with an antigen from influenza virus plus mTNF-K90R exhibited mucosal adjuvant activity for induction of both systemic and mucosal immune responses. Importantly, histopathological examination of the nasal tissue of mTNF-K90R treated mice detected no signs of toxicity. These findings suggest that mTNF-K90R is safe and effective mucosal adjuvant and this system may have potential application as a universal mucosal adjuvant system for mucosal vaccines improving the immune response to a variety of viral antigens. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Kayamuro, Hiroyuki; Abe, Yasuhiro; Yoshioka, Yasuo; Nomura, Tetsuya; Yoshida, Tokuyuki; Yamashita, Kohei; Yoshikawa, Tomoaki; Nagano, Kazuya; Kamada, Haruhiko; Tsunoda, Shin-ichi; Tsutsumi, Yasuo] Natl Inst Biomed Innovat NiBio, Lab Pharmaceut Prote, Osaka 5670085, Japan.
   [Kayamuro, Hiroyuki; Katayama, Kazufumi; Nomura, Tetsuya; Yoshida, Tokuyuki; Yamashita, Kohei; Yoshikawa, Tomoaki; Itoh, Norio; Tsutsumi, Yasuo] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan.
   [Yoshioka, Yasuo; Kamada, Haruhiko; Tsunoda, Shin-ichi; Tsutsumi, Yasuo] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan.
   [Katayama, Kazufumi; Hiroi, Takachika] Tokyo Metropolitan Inst Med Sci, Dept Allergy & Immunol, Bunkyo Ku, Tokyo 1138613, Japan.
   [Kawai, Yuichi; Mayumi, Tadanori] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan.
RP Tsunoda, S (reprint author), Natl Inst Biomed Innovat NiBio, Lab Pharmaceut Prote, 7-6-8 Saito Asagi, Osaka 5670085, Japan.
EM tsunoda@nibio.go.jp
RI Abe, Yasuhiro/F-5206-2016
OI Abe, Yasuhiro/0000-0002-5931-6590; Kamada, Haruhiko/0000-0002-2478-3818;
   Tsunoda, Shin-ichi/0000-0003-3299-2182
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   (MEXT); Japan Society for the Promotion of Science (JSPS); Ministry of
   Health, Labor, and Welfare in Japan; Japan Health Sciences Foundation;
   Takeda Science Foundation
FX This study was supported in part by Grants-in-Aid for Scientific
   Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan (MEXT) and Japan Society for the Promotion of
   Science (JSPS), some Health Labour Sciences Research Grants from the
   Ministry of Health, Labor, and Welfare in Japan by the Research on
   Health Sciences focusing on Drug Innovation from the Japan Health
   Sciences Foundation and by the Takeda Science Foundation.
CR Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223
   Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67
   Boyaka PN, 1999, J IMMUNOL, V162, P122
   Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001
   Brunner C, 2000, J IMMUNOL, V165, P6278, DOI 10.4049/jimmunol.165.11.6278
   Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567
   Chen Z, 2002, CANCER GENE THER, V9, P778, DOI 10.1038/sj.cgt.7700498
   Eggermont AMM, 2000, J IMMUNOTHER, V23, P505, DOI 10.1097/00002371-200007000-00015
   Eriksson K, 2002, CURR OPIN IMMUNOL, V14, P666, DOI 10.1016/S0952-7915(02)00384-9
   Gitter AH, 2000, ANN NY ACAD SCI, V915, P193
   GORBACH SL, 1971, J LAB CLIN MED, V78, P981
   Hasegawa H, 2007, EXPERT REV VACCINES, V6, P193, DOI 10.1586/14760584.6.2.193
   Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036
   Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Lee LF, 2005, P NATL ACAD SCI USA, V102, P15995, DOI 10.1073/pnas.0508122102
   Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4
   MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0
   Monsonego A, 2006, P NATL ACAD SCI USA, V103, P5048, DOI 10.1073/pnas.0506209103
   Mukai Y, 2005, COMB CHEM HIGH T SCR, V8, P145, DOI 10.2174/1386207053258578
   Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840
   Nikolic WV, 2007, P NATL ACAD SCI USA, V104, P2507, DOI 10.1073/pnas.0609377104
   Nimal S, 2006, VACCINE, V24, P3298, DOI 10.1016/j.vaccine.2006.01.020
   Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124
   Shibata H, 2004, CLIN CANCER RES, V10, P8293, DOI 10.1158/1078-0432.CCR-04-0770
   Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200
   Staats HF, 2001, J IMMUNOL, V167, P5386, DOI 10.4049/jimmunol.167.9.5386
   Takenouchi-Ohkubo N, 2008, IMMUNOLOGY, V123, P500, DOI 10.1111/j.1365-2567.2007.02716.x
   Toka FN, 2004, IMMUNOL REV, V199, P100, DOI 10.1111/j.0105-2896.2004.0147.x
   Trevejo JM, 2001, P NATL ACAD SCI USA, V98, P12162, DOI 10.1073/pnas.211423598
   van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778
   Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812
   Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540
   Yoshioka Y, 2004, BIOCHEM BIOPH RES CO, V315, P808, DOI 10.1016/j.bbrc.2004.01.125
   Yoshioka Yasuo, 2004, Current Vascular Pharmacology, V2, P259, DOI 10.2174/1570161043385682
NR 39
TC 20
Z9 20
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 29
BP 5869
EP 5876
DI 10.1016/j.biomaterials.2009.07.009
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498CW
UT WOS:000270115200068
PM 19646748
DA 2018-10-20
ER

PT J
AU Williams, DF
AF Williams, David F.
TI On the nature of biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Medical devices; Scaffolds; Gene vectors; Drug delivery; Engineered
   tissues; Nanostructured materials
ID ELUTING CORONARY STENTS; DRUG-DELIVERY; GENE DELIVERY; QUANTUM DOTS;
   BIODEGRADABLE POLYMERS; CELL SHEETS; NANOPARTICLES; ANGIOPLASTY;
   VECTORS; BIOCOMPATIBILITY
AB The situations in which biomaterials are currently used are vastly different to those of just a decade ago. Although implantable medical devices are still immensely important, medical technologies now encompass a range of drug and gene delivery systems, tissue engineering and cell therapies, organ printing and cell patterning, nanotechnology based imaging and diagnostic systems and microelectronic devices. These technologies still encompass metals, ceramics and synthetic polymers, but also biopolymers, self assembled systems, nanoparticles, carbon nanotubes and quantum dots. These changes imply that our original concepts of biomaterials and our expectations of their performance also have to change. This Leading Opinion Paper addresses these issues. It concludes that many substances which hitherto we may not have thought of as biomaterials should now be considered as such so that, alongside the traditional structural biomaterials, we have substances that have been engineered to perform functions within health care where their performance is directly controlled by interactions with tissues and tissue components. These include engineered tissues, cells, organs and even viruses. This essay develops the arguments for a radically different definition of a biomaterial. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Williams, David F.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Williams, David F.] Univ Cape Town, Christiaan Barnard Dept Cardiothorac Surg, ZA-7700 Rondebosch, South Africa.
   [Williams, David F.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   [Williams, David F.] Tsinghua Univ, Beijing 100084, Peoples R China.
   [Williams, David F.] Shanghai Jiao Tong Univ, Shanghai, Peoples R China.
   [Williams, David F.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
RP Williams, DF (reprint author), Ave Foret 103, B-1000 Brussels, Belgium.
EM dfwillia@wfubmc.edu
CR Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Chang CC, 2007, BIOMATERIALS, V28, P1941, DOI 10.1016/j.biomaterials.2006.11.048
   Chatteriee DK, 2008, BIOMATERIALS, V29, P937, DOI 10.1016/j.biomaterials.2007.10.051
   Chen C, 2009, BIOMATERIALS, V30, P2912, DOI 10.1016/j.biomaterials.2009.02.010
   Chen LD, 2008, BIOMATERIALS, V29, P4170, DOI 10.1016/j.biomaterials.2008.07.025
   De Laporte L, 2006, BIOMATERIALS, V27, P947, DOI 10.1016/j.biomaterials.2005.09.036
   DOHERTY P, 1992, BIOMATERIALS TISSUE
   *EUR COMM, 2001, OP STAT ART TISS ENG
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Heldman AW, 2001, CIRCULATION, V103, P2289
   Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012
   Hsiao AY, 2009, BIOMATERIALS, V30, P3020, DOI 10.1016/j.biomaterials.2009.02.047
   Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032
   Jamieson T, 2007, BIOMATERIALS, V28, P4717, DOI 10.1016/j.biomaterials.2007.07.014
   Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002
   Kato K, 2007, BIOMATERIALS, V28, P1289, DOI 10.1016/j.biomaterials.2006.11.007
   Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a
   Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010
   Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321
   Kubo H, 2007, BIOMATERIALS, V28, P3508, DOI 10.1016/j.biomaterials.2007.04.016
   Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021
   Langer R, 1998, NATURE, V392, P5
   Luten J, 2008, J CONTROL RELEASE, V126, P97, DOI 10.1016/j.jconrel.2007.10.028
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   MYLER RK, 1992, J AM COLL CARDIOL, V19, P1641, DOI 10.1016/0735-1097(92)90631-V
   *N CAR STAT U, 2009, FOR BIOM
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Pan J, 2009, BIOMATERIALS, V30, P1176, DOI 10.1016/j.biomaterials.2008.10.039
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Peng H, 2009, BIOMATERIALS, V30, P2132, DOI 10.1016/j.biomaterials.2008.12.065
   Rihn JA, 2008, J BONE JOINT SURG AM, V90A, P2014
   Schaffer DV, 2008, ANNU REV BIOMED ENG, V10, P169, DOI 10.1146/annurev.bioeng.10.061807.160514
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   Smith David, 2009, Biophysical Reviews and Letters, V4, P179
   Sokolova VV, 2006, BIOMATERIALS, V27, P3147, DOI 10.1016/j.biomaterials.2005.12.030
   Stamenovic D, 2008, CELL MOL LIFE SCI, V65, P3592, DOI 10.1007/s00018-008-8292-y
   Staples M, 2006, PHARM RES, V23, P847, DOI 10.1007/s11095-006-9906-4
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Sun TM, 2008, BIOMATERIALS, V29, P4348, DOI 10.1016/j.biomaterials.2008.07.036
   Trepat X, 2008, SOFT MATTER, V4, P1750, DOI 10.1039/b804866e
   US Food and Drug Administration, 2008, REC HUM BON MORPH PR
   Vemula PK, 2009, BIOMATERIALS, V30, P383, DOI 10.1016/j.biomaterials.2008.09.045
   Wagner E, 2006, ADV POLYM SCI, V192, P135, DOI 10.1007/12_023
   Walker PMB, 2006, LAROUSSE DICT SCI TE
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Williams D, 2008, BIOMATERIALS, V29, P1737, DOI 10.1016/j.biomaterials.2008.01.003
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Wolff JA, 2007, MOL THER, V16, P8
   Wu ZS, 2009, BIOMATERIALS, V30, P2950, DOI 10.1016/j.biomaterials.2009.02.017
   Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yang Y, 2009, BIOMATERIALS, V30, P5767, DOI 10.1016/j.biomaterials.2009.06.020
   Zhang SB, 2007, J CONTROL RELEASE, V123, P1, DOI 10.1016/j.jconrel.2007.07.016
   2008, FORD DEV BIOMATERIAL
NR 61
TC 380
Z9 389
U1 33
U2 381
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2009
VL 30
IS 30
BP 5897
EP 5909
DI 10.1016/j.biomaterials.2009.07.027
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 499FY
UT WOS:000270204500001
PM 19651435
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Kuo, SM
   Chang, SJ
   Yao, CH
   Manousakas, I
AF Kuo, Shyh Ming
   Chang, Shwu Jen
   Yao, Chun-Hsu
   Manousakas, Ioannis
TI A PERSPECTIVE VIEW ON THE PREPARATION OF MICRO- AND NANOPARTICULATES OF
   BIOMATERIALS FROM ELECTROSTATIC AND ULTRASONIC METHODS
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE Microspheres; Collagen; Chitosan; Alginate; Tissue regeneration
ID HIGH-INTENSITY ULTRASOUND; CHITOSAN MICROSPHERES; FIELD SYSTEM;
   PARTICLES; RELEASE; CEMENT
AB Developments on tissue engineering, especially on tissue regeneration and drug delivery, demand also developments on biomaterials. Research on the preparation methods of biomaterials has exhibited remarkable advances in the recent years. Natural biomaterials, such as chitosan and collagen, or synthetic materials like poly( lactic acid) can be shaped in various forms. The parameters involved in the fabrication processes provide methodologies for control of the materials' properties, such as morphology, biodegradability, mechanical strength, and adhesion. As new applications develop for these materials, the preparation methods have to be optimized to achieve the desired material properties. These properties mostly not only mimic the conditions in the human body, but also may divert the microenvironment of cells in the diseased area in order to promote faster or guided healing and tissue regeneration. This review pays attention on some of the fabrication methods for biomaterial particulates of sizes in the micro- and nanoscale. The views expressed here focus on the many years of experience of the authors with electrostatic and ultrasonic fabrication methods. These methods are still under development and up to now can produce particulates of various sizes down to the nanometer scale with narrow size distributions. Such biomaterials that have extraordinary properties may provide ways for the development of remarkable biomedical applications.
C1 [Yao, Chun-Hsu; Manousakas, Ioannis] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.
   [Kuo, Shyh Ming; Chang, Shwu Jen; Manousakas, Ioannis] I Shou Univ, Dept Biomed Engn, Kaohsiung Cty, Taiwan.
RP Manousakas, I (reprint author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.
EM i.manousakas@ieee.org
CR Amsden BG, 1997, J CONTROL RELEASE, V43, P183, DOI 10.1016/S0168-3659(96)01483-6
   Chang SJ, 2007, J BIOMED MATER RES A, V81A, P554, DOI 10.1002/jbm.a.31084
   Chang SJ, 2009, ACTA BIOMATER, V5, P101, DOI 10.1016/j.actbio.2008.08.002
   Chang SJ, 2006, IEE PROC-NANOBIOTECH, V153, P1, DOI 10.1049/ip-nbt:20050037
   Cravotto G, 2005, ULTRASON SONOCHEM, V12, P95, DOI 10.1016/j.ultsonch.2004.03.005
   Freitas S, 2006, ULTRASON SONOCHEM, V13, P76, DOI 10.1016/j.ultsonch.2004.10.004
   Gedanken A, 2008, CHEM-EUR J, V14, P3840, DOI 10.1002/chem.200701541
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Ko JA, 2002, INT J PHARM, V249, P165, DOI 10.1016/S0378-5173(02)00487-8
   Kuo SM, 2008, BIOMED ENG-APP BAS C, V20, P239, DOI 10.4015/S1016237208000830
   Kuo SM, 2006, J BIOMED MATER RES A, V76A, P408, DOI 10.1002/jbm.a.30534
   Kuo SM, 2004, J APPL POLYM SCI, V94, P2150, DOI 10.1002/app.21131
   Kuo SM, 2003, J APPL POLYM SCI, V89, P3897, DOI 10.1002/app.12590
   Learoyd TP, 2008, POWDER TECHNOL, V187, P231, DOI 10.1016/j.powtec.2008.02.015
   LEE KW, 2009, 3 INT C BIOINF BIOM
   Liao S, 2008, MAT SCI ENG C-BIO S, V28, P1189, DOI 10.1016/j.msec.2008.08.015
   Lin LC, 2005, J MATER SCI-MATER M, V16, P567, DOI 10.1007/s10856-005-0533-0
   LIN LC, 2006, BIOMED ENG-APP BAS C, V18, P10
   Lin LC, 2008, J APPL POLYM SCI, V108, P3210, DOI 10.1002/app.27309
   Liu GG, 2007, CHINA PART, V5, P384, DOI 10.1016/j.cpart.2007.08.002
   MANOUSAKAS I, 2007, 2007 INT C BION SCI
   Reich G, 1998, EUR J PHARM BIOPHARM, V45, P165, DOI 10.1016/S0939-6411(97)00152-5
   Wu T, 2008, J AGR FOOD CHEM, V56, P5112, DOI 10.1021/jf073136q
NR 23
TC 2
Z9 2
U1 0
U2 6
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD OCT
PY 2009
VL 21
IS 5
BP 343
EP 353
DI 10.4015/S101623720900143X
PG 11
WC Engineering, Biomedical
SC Engineering
GA 508RZ
UT WOS:000270953300007
DA 2018-10-20
ER

PT J
AU Chen, MR
   Kao, VYY
   Liu, SW
   Wu, TC
   Yu, HC
   Hsu, CH
   Chen, CT
   Lin, KM
AF Chen, Mei-Ru
   Kao, Vivia Yu-Ying
   Liu, Shan-Wen
   Wu, Tzu-Chin
   Yu, Hsiao-Chi
   Hsu, Chin-Han
   Chen, Chin-Tu
   Lin, Kurt M.
TI NONINVASIVE OPTICAL IMAGING FOR TRACKING GENE DELIVERY AND RECOMBINATION
   IN TUMOR
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE Green fluorescence protein; Bioluminescence; Firefly luciferase; Cre
   recombinase; loxP site; Gene therapy
ID TYPE-1 THYMIDINE KINASE; REPORTER GENE; CRE-LOXP; CELLS; LIPOSOMES;
   MEDICINE; THERAPY; BIOLOGY; SYSTEMS; FUTURE
AB Here, we report the generation of optical imaging reporter breast tumor cells that allow the longitudinal, in vivo, noninvasive imaging of gene recombination in tumor. Tumor-gene targeting is a promising approach of treating cancers, and a suitable gene delivery method is the criteria for success. By using the cre lox genetic engineering tool, we targeted stable green fluorescent protein expression in metastatic-prone human breast cancer MDA-MB231 cells that switch to express firefly luciferase upon the exogenous delivery and expression of cre DNA recombinase. We tested this model in vivo by intratumor injection of cre adenovirus and demonstrated the usefulness of this model to achieve longitudinal bioluminescence imaging of DNA recombination in tumor. This optical imaging vector and tumor model will facilitate the research for biomaterial solutions for carriers in gene therapy, and in studies on tumor targeting, tracking for tumor metastasis and migration of tumor stem cells, and for determining the anticancer drug efficacy.
C1 [Chen, Mei-Ru; Liu, Shan-Wen; Wu, Tzu-Chin; Yu, Hsiao-Chi; Lin, Kurt M.] Natl Hlth Res Inst, Div Med Engn Res, Miaoli 350, Taiwan.
   [Kao, Vivia Yu-Ying] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan.
   [Liu, Shan-Wen; Hsu, Chin-Han] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.
   [Chen, Chin-Tu] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.
   [Chen, Chin-Tu] Univ Chicago, Comm Med Phys, Chicago, IL 60637 USA.
RP Lin, KM (reprint author), Natl Hlth Res Inst, Div Med Engn Res, 35 Keyan Rd, Miaoli 350, Taiwan.
EM klin@nhri.org.tw
RI Lin, Kurt Ming-Chao/E-3975-2010; Chen, Chin-Tu/K-3393-2014
FU NHRI [ME097-PP02,NM097-PP06]; Taiwan National Science Council
   [NSC-96-2627-B-400-001]
FX The authors gratefully acknowledge technical assistance provided by Ms
   Yi-Hua Chen. This research was supported by NHRI intramural research
   grants ME097-PP02,NM097-PP06, and Taiwan National Science Council Grant
   NSC-96-2627-B-400-001.
CR ALSHAWI R, 1991, MOL CELL BIOL, V11, P4207, DOI 10.1128/MCB.11.8.4207
   Brandwijk RJMGE, 2007, TRENDS MOL MED, V13, P200, DOI 10.1016/j.molmed.2007.03.001
   Brault V, 2007, Handb Exp Pharmacol, P29
   Bucholtz Frank, 2008, J Vis Exp, DOI 10.3791/718
   Cai LY, 2009, REPROD TOXICOL, V27, P14, DOI 10.1016/j.reprotox.2008.11.052
   Conti PS, 2008, J NUCL MED, V49, p16N
   Dass CR, 2008, J MICROENCAPSUL, V25, P275, DOI [10.1080/02652040801970461, 10.1080/02652040801970461 ]
   Dass Crispin R., 2008, V437, P177, DOI 10.1007/978-1-59745-210-6_9
   De Gasperi R, 2008, GENESIS, V46, P308, DOI 10.1002/dvg.20400
   Ellison AR, 1998, BBA-GENE STRUCT EXPR, V1442, P28, DOI 10.1016/S0167-4781(98)00112-2
   Henriquez NV, 2007, CLIN EXP METASTAS, V24, P699, DOI 10.1007/s10585-007-9115-5
   Kiessling Fabian, 2008, V185, P305, DOI 10.1007/978-3-540-77496-9_13
   Kim YJ, 2004, MOL IMAGING BIOL, V6, P331, DOI 10.1016/j.mibio.2004.06.009
   Lecchi M, 2007, Q J NUCL MED MOL IM, V51, P111
   Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787
   Lin KM, 2008, MOL IMAGING BIOL, V10, P253, DOI 10.1007/s11307-008-0147-2
   Liu YZ, 2006, BLOOD, V107, P3027, DOI 10.1182/blood-2005-10-4114
   Love Z, 2007, J NUCL MED, V48, P2011, DOI 10.2967/jnumed.107.043166
   Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799
   Modo M, 2008, CURR OPIN ORGAN TRAN, V13, P654, DOI 10.1097/MOT.0b013e328317a43c
   Mouchess ML, 2006, J COMPUT ASSIST TOMO, V30, P525, DOI 10.1097/00004728-200605000-00030
   Mullassery D, 2008, ESSAYS BIOCHEM, V45, P121, DOI 10.1042/BSE0450121
   Schwendener RA, 2007, ADV EXP MED BIOL, V620, P117
   Sundaresan G, 2004, GENE THER, V11, P609, DOI 10.1038/sj.gt.3302194
   Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044
   Winnard PT, 2008, J NUCL MED, V49, p96S, DOI 10.2967/jnumed.107.045948
   Yan L, 2007, STEM CELL REV, V3, P265, DOI 10.1007/s12015-007-9004-y
   Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000
NR 28
TC 1
Z9 1
U1 1
U2 6
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD OCT
PY 2009
VL 21
IS 5
BP 355
EP 360
DI 10.4015/S1016237209001441
PG 6
WC Engineering, Biomedical
SC Engineering
GA 508RZ
UT WOS:000270953300008
DA 2018-10-20
ER

PT J
AU Schumann, DA
   Wippermann, J
   Klemm, DO
   Kramer, F
   Koth, D
   Kosmehl, H
   Wahlers, T
   Salehi-Gelani, S
AF Schumann, Dieter A.
   Wippermann, Jens
   Klemm, Dieter O.
   Kramer, Friederike
   Koth, Daniel
   Kosmehl, Hartwig
   Wahlers, Thorsten
   Salehi-Gelani, Schariar
TI Artificial vascular implants from bacterial cellulose: preliminary
   results of small arterial substitutes
SO CELLULOSE
LA English
DT Article
DE Animal experiments; Bacterial cellulose; Biomaterials; Long term study;
   Small vessel substitute; Vascular implant
ID WEB-LIKE NETWORK; MECHANICAL-PROPERTIES; MICROBIAL CELLULOSE;
   POLYTETRAFLUOROETHYLENE; POLYURETHANE; GRAFTS; CELLS
AB The biomaterial bacterial cellulose (BC) represents an innovative approach for overcoming reconstructive problems associated with extended vascular diseases by providing small caliber vascular grafts (diameter 1.0-3.7, length 5.0-10.0, and wall-thickness 0.7 mm). In a first microsurgical study, the BC implants were attached in an artificial defect of the carotid artery of rats for 1 year. These long term results show the incorporation of the BC under formation of neointima and ingrowth of active fibroblasts. In a second study, the grafts were used to replace the carotid arteries of pigs. After 3 months, these grafts were removed and analyzed both macro- and microscopically. Seven grafts (87.5%) were patent whereas one graft was found occluded. These data indicate that the innovative BC engineering technique results in the production of stable vascular conduits and confirm a highly attractive approach to in vivo tissue engineered blood vessels as part of programs in cardiovascular surgery.
C1 [Schumann, Dieter A.; Klemm, Dieter O.; Kramer, Friederike; Koth, Daniel] Univ Jena, Polymet Jena eV Transfergrp, Jena, Germany.
   [Wippermann, Jens; Wahlers, Thorsten; Salehi-Gelani, Schariar] Univ Hosp Cologne, Dept Cardiothorac Surg, Cologne, Germany.
   [Kosmehl, Hartwig] Helios Clin Erfurt, Inst Pathol, Erfurt, Germany.
RP Schumann, DA (reprint author), Univ Jena, Polymet Jena eV Transfergrp, Jena, Germany.
EM Dieter.Schumann@polymet-jena.de
CR *AM HEART ASS, 1999, 2000 HEART STROK STA
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   BROTHERS TE, 1990, J BIOMED MATER RES, V24, P761, DOI 10.1002/jbm.820240610
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Ciechanska D, 1998, FIBRES TEXT EAST EUR, V6, P59
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Eberhart A, 1999, J BIOMED MATER RES, V48, P546, DOI 10.1002/(SICI)1097-4636(1999)48:4<546::AID-JBM22>3.0.CO;2-V
   FREISCHLAG J, 1990, ANN VASC SURG, V3, P895
   Greisler H P, 1990, Ann Vasc Surg, V4, P98, DOI 10.1007/BF02042699
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   HONGU T, 1987, WOOD CELLULOSICS IND
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 2001, Patent No. [WO 2001061026 (A1), 2001061026]
   Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097
   MERTENS RA, 1995, J VASC SURG, V21, P782, DOI 10.1016/S0741-5214(05)80009-6
   Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P155, DOI 10.1007/s00339-003-2225-2
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   PASIC M, 1995, CIRCULATION, V92, P2605, DOI 10.1161/01.CIR.92.9.2605
   Salmon S, 1997, J MACROMOL SCI R M C, VC37, P199
   Sayers RD, 1998, BRIT J SURG, V85, P934
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Sjostrom E., 1993, WOOD CHEM FUNDAMENTA
   SZILAGYI DE, 1986, J VASC SURG, V3, P421
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   White D. G, 1989, CELLULOSE WOOD CHEM
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   YAMANAKA S, 1994, CELLULOSIC POLYM BLE
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Yano H, 2004, J MATER SCI, V39, P1635, DOI 10.1023/B:JMSC.0000016162.43897.0a
NR 33
TC 81
Z9 85
U1 2
U2 47
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD OCT
PY 2009
VL 16
IS 5
BP 877
EP 885
DI 10.1007/s10570-008-9264-y
PG 9
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 495RB
UT WOS:000269911600013
DA 2018-10-20
ER

PT J
AU Busenlechner, D
   Huber, CD
   Vasak, C
   Dobsak, A
   Gruber, R
   Watzek, G
AF Busenlechner, Dieter
   Huber, Christian D.
   Vasak, Christoph
   Dobsak, Antonia
   Gruber, Reinhard
   Watzek, Georg
TI Sinus augmentation analysis revised: the gradient of graft consolidation
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal model; bone graft; bone regeneration; degradation; hydroxyapatite
   osteoconduction; sinus augmentation
ID FLOOR AUGMENTATION; DENTAL IMPLANTS; ANIMAL-MODELS; BONE; CELLS;
   SUBSTITUTES
AB Objective
   Graft consolidation follows a gradient that reflects the properties of bone substitutes at sites of sinus augmentation. Here we present an analytical method to investigate the process of graft consolidation taking the distance from the maxillary host bone into account.
   Material and methods
   We therefore evaluated histological specimens, 6 and 12 weeks after the sinus of minipigs was augmented with Bio-Oss((R)), a deproteinized bovine bone mineral, and Ostim((R)), an aqueous paste of synthetic nanoparticular hydroxyapatite. A curve was drawn that represents the changes in histomorphometric parameters within a given distance from the maxillary host bone.
   Results
   Based on this curve, three regions of interest were defined: R1 (0-1 mm) the bridging distance where new bone is laid onto the host bone, R2 (2-3 mm) a region of osteoconduction where new bone exclusively grows on the biomaterial, R3 (4-5 mm) and a region of osteoconduction where bone formation has reached its maximal extension. Qualitative and quantitative analysis of the three regions can reveal differences in graft consolidation, depending on the bone substitutes and the observation period [Bone volume (BV) per tissue volume after 6 weeks: R1: 19 +/- 8.4% for Bio-Oss((R)) and 42.9 +/- 13.2% for Ostim((R)) (P=0.03), R2: 3 +/- 2.4% for Bio-Oss((R)) and 14.7 +/- 9.5% for Ostim((R)) (P=0.03), R3: 5 +/- 4.1% for Bio-Oss((R)) and 5.3 +/- 5.3% for Ostim((R)) (P=0.86). BV per tissue volume after 12 weeks: R1: 38.0 +/- 13.3% for Bio-Oss((R)) and 53.3 +/- 6.6 for Ostim((R)) (P=0.04), R2: 14 +/- 12.2 for Bio-Oss((R)) and 26.4 +/- 11 for Ostim((R)) (P=0.18), R3: 6.6 +/- 7 for Bio-Oss((R)) and 10.7 +/- 5.8 for Ostim((R)) (P=0.32) after 12 weeks].
   Conclusion
   Based on the graft consolidation gradient, the impact of bone substitutes to modulate the process of bone formation and the kinetic of degradation within a distinct region of the augmented sinus can be investigated.
   To cite this article:Busenlechner D, Huber CD, Vasak C, Dobsak A, Gruber R, Watzek G. Sinus augmentation analysis revised: the gradient of graft consolidation.Clin. Oral Impl. Res. 20, 2009; 1078-1083.
C1 [Busenlechner, Dieter; Huber, Christian D.; Vasak, Christoph; Gruber, Reinhard; Watzek, Georg] Med Univ Vienna, Dept Oral Surg, A-1090 Vienna, Austria.
   [Busenlechner, Dieter; Huber, Christian D.; Vasak, Christoph; Dobsak, Antonia; Gruber, Reinhard; Watzek, Georg] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Dobsak, Antonia] Ludwig Boltzmann Inst Clin & Expt Traumatol, Vienna, Austria.
RP Gruber, R (reprint author), Med Univ Vienna, Dept Oral Surg, Wahringerstr 25A, A-1090 Vienna, Austria.
EM reinhard.gruber@meduniwien.ac.at
RI Watzek, Georg/G-7565-2012; Gruber, Reinhard/A-8053-2012
OI Gruber, Reinhard/0000-0001-5400-9009; Dobsak, Toni/0000-0003-0152-9419
FU Heraeus Kulzer Germany
FX The authors are grateful to Prof. Dr h.c. mult. Karl Donath for
   histological evaluation, to Prof. DDr Gabor Furst for sharing his
   surgical experience, to Dr Birgit Mair for her support during surgical
   procedures. This study was generously supported by Heraeus Kulzer
   Germany.
CR Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P35, DOI 10.1034/j.1600-0501.2003.140105.x
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Busenlechner D, 2008, BIOMATERIALS, V29, P3195, DOI 10.1016/j.biomaterials.2008.04.021
   Donath K., 1988, PRAPARATOR, V34, P197
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Fuerst G, 2004, CLIN ORAL IMPLAN RES, V15, P733, DOI 10.1111/j.1600-0501.2004.01077.x
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Gruber R, 2004, CLIN ORAL IMPLAN RES, V15, P575, DOI 10.1111/j.1600-0501.2004.01062.x
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Huber FX, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-50
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kim C, 1999, COMMUN STAT-THEOR M, V28, P1577, DOI 10.1080/03610929908832374
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Liu YM, 2008, CLIN ORAL IMPLAN RES, V19, P497, DOI 10.1111/j.1600-0501.2007.01504.x
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roldan JC, 2004, CLIN ORAL IMPLAN RES, V15, P716, DOI 10.1111/j.1600-0501.2004.01070.x
   Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021
   Schenk RK, 1998, PERIODONTOL 2000, V17, P22, DOI 10.1111/j.1600-0757.1998.tb00120.x
   Spray J R, 2000, Ann Periodontol, V5, P119, DOI 10.1902/annals.2000.5.1.119
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
NR 25
TC 46
Z9 47
U1 0
U2 5
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2009
VL 20
IS 10
BP 1078
EP 1083
DI 10.1111/j.1600-0501.2009.01733.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 492QO
UT WOS:000269674300003
PM 19519790
DA 2018-10-20
ER

PT J
AU Zhang, SZ
   Fan, JL
   Xu, XG
   Chen, GM
   Zhu, FM
   Yan, LX
AF Zhang, ShaoZhi
   Fan, JuLi
   Xu, XianGuo
   Chen, GuangMing
   Zhu, FaMing
   Yan, LiXing
TI An experimental study of the use of ultrasound to facilitate the loading
   of trehalose into platelets
SO CRYOBIOLOGY
LA English
DT Article
DE Platelets; Ultrasound; Trehalose; Fluid-phase endocytosis
ID MAMMALIAN-CELLS; MEMBRANES; VITRIFICATION
AB Trehalose is widely used as a freeze-drying protectant in biomaterial preservation. For this purpose, trehalose has to be loaded into the cells but this is difficult and many methods have been tried. The application of ultrasound can temporarily permeabilize cell membranes, which offers a non-chemical, nonviral, and non-invasive method of cellular drug delivery. Ultrasound is employed here to enhance the loading of trehalose into human platelets. Two frequencies were used, 25 kHz and 800 kHz. The estimated intensity of ultrasound in the sample was varied from 0 to 1.5 W/cm(2). The trehalose concentration in the platelets was 11.27 +/- 2.53 mmol/L when Wolkers et aL's method was used without ultrasound. The application of 0.8 W/cm(2), 800 kHz ultrasound for 1 h increased the concentration of trehalose loaded by 54%. The application of 0.8 W/cm(2), 25 kHz ultrasound for 30 min increased the trehalose concentration that was loaded by 172%. The number and mean volume of the platelets following ultrasonic radiation in these two cases remained normal as compared with fresh untreated platelets. Morphological examination of the radiated platelets showed slight changes. Although further work is needed, ultrasound has been shown to be efficient for the loading of trehalose into platelets. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Zhang, ShaoZhi; Fan, JuLi; Chen, GuangMing] Zhejiang Univ, Inst Refrigerat & Cryogen Engn, Cryobiol Lab, Hangzhou 310027, Peoples R China.
   [Xu, XianGuo; Zhu, FaMing; Yan, LiXing] Blood Ctr Zhejiang Prov, Hangzhou 310006, Zhejiang, Peoples R China.
   [Xu, XianGuo; Zhu, FaMing; Yan, LiXing] Minist Hlth, Key Lab Blood Safety Res, Hangzhou 310006, Zhejiang, Peoples R China.
RP Chen, GM (reprint author), Zhejiang Univ, Inst Refrigerat & Cryogen Engn, Cryobiol Lab, Hangzhou 310027, Peoples R China.
EM gmchen@zju.edu.cn
FU National Natural Science Foundation of China [50606032]; Science
   Foundation of Health Office of China [WKJ2005-2-037]
FX This work supported by the National Natural Science Foundation of China
   (No. 50606032) and Science Foundation of Health Office of China
   (WKJ2005-2-037).
CR Beattie GM, 1997, DIABETES, V46, P519, DOI 10.2337/diabetes.46.3.519
   Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353
   Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580
   deAraujo PS, 1996, BRAZ J MED BIOL RES, V29, P873
   Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608
   Eroglu A, 2002, FERTIL STERIL, V77, P152, DOI 10.1016/S0015-0282(01)02959-4
   FLOROS JD, 1994, FOOD TECHNOL-CHICAGO, V48, P79
   FULLER BJ, 2004, STABILIZATION CELLS, P581
   HE ZY, 1981, THEORETICAL FUNDAMEN, P353
   KENNETH SS, 1988, ULTRASOUND ITS CHEM, P287
   Lawrie A, 2003, ULTRASOUND MED BIOL, V29, P1453, DOI 10.1016/S0301-5629(03)01032-9
   LOTA M J, 1955, Arch Phys Med Rehabil, V36, P282
   Oliver A.E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745
   Oliver AE, 1998, SEED SCI RES, V8, P211
   Paiva C L, 1996, Biotechnol Annu Rev, V2, P293, DOI 10.1016/S1387-2656(08)70015-2
   Paliwal Sumit, 2006, Expert Opin Drug Deliv, V3, P713, DOI 10.1517/17425247.3.6.713
   Shirakashi R, 2002, J MEMBRANE BIOL, V189, P45, DOI 10.1007/s00232-1003-y
   Sundaram J, 2003, BIOPHYS J, V84, P3087, DOI 10.1016/S0006-3495(03)70034-4
   UMBREIT WW, 1972, MANOMETRIC BIOCH TEC, P262
   Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195
   Wolkers W. F., 2003, CELL PRESERV TECHNOL, V1, P175, DOI DOI 10.1089/153834402765035617
   Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306
NR 22
TC 3
Z9 8
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD OCT
PY 2009
VL 59
IS 2
BP 135
EP 140
DI 10.1016/j.cryobiol.2009.06.003
PG 6
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 495BL
UT WOS:000269864100003
PM 19538954
DA 2018-10-20
ER

PT J
AU Krause, HG
   Goh, JTW
AF Krause, Hannah G.
   Goh, Judith T. W.
TI Biomechanical properties of graft materials employed for pelvic floor
   reconstructive surgeries
SO CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
DE biomaterials; biomechanics; pelvic organ prolapse; polypropylene mesh;
   viscoelasticity
ID SURGICAL MESH; MECHANICAL-PROPERTIES; SUPPORTIVE TISSUES; MODEL;
   PROTEIN; REPAIR; VAGINA
AB Purpose of review
   Numerous biomaterials are currently used to augment pelvic organ prolapse reconstructive surgeries. Understanding the biomechanical properties of the raw and implanted graft materials may lead to improvements in biomaterial design and development. This summary aims to review recent assessments and advances in the understanding of vaginal tissues and synthetic graft materials profiles.
   Recent findings
   Numerous meshes have been assessed and compared for various biomechanical properties. There is now an emphasis on more relevant mechanical tests rather than only comparing loads at failure. Development of tests at physiological loads is important in achieving relevance of biomechanical data. Comparisons of partly absorbable with nonabsorbable meshes both preimplantation and postimplantation, have shown no difference in biomechanical properties, thus promoting the use of less permanent components in meshes. Potential factors contributing to mesh exposure are presented.
   Summary
   Biomechanical testing of synthetic graft materials is moving towards achieving data relevant to physiological loads and clinical conditions. Modeling research is required to understand these physiological loads, and create relevant measurements which can then be used when biomechanically assessing both raw and implanted grafts.
C1 [Krause, Hannah G.] Greenslopes Private Hosp, Ramsay Specialist Ctr, Greenslopes, Australia.
   [Krause, Hannah G.; Goh, Judith T. W.] Griffith Univ Gold Coast, Greenslopes Private Hosp, Brisbane, Qld 4120, Australia.
RP Krause, HG (reprint author), Griffith Univ Gold Coast, Greenslopes Private Hosp, Suite 209 Ramsay Specialist Ctr, Brisbane, Qld 4120, Australia.
EM hannahkrause@hotmail.com
CR Afonso JS, 2008, INT UROGYNECOL J, V19, P375, DOI 10.1007/s00192-007-0446-1
   Alperin M, 2008, INT UROGYNECOL J, V19, P977, DOI 10.1007/s00192-008-0561-7
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   Bellon JM, 2007, AM J SURG, V194, P68, DOI 10.1016/j.amjsurg.2006.11.016
   Binnebosel M, 2007, SURGERY, V142, P365, DOI 10.1016/j.surg.2007.04.024
   CUMBERLAND V H, 1952, Med J Aust, V1, P143
   Dietz HP, 2003, INT UROGYNECOL J PEL, V14, P239, DOI 10.1007/s00192-003-1041-8
   Elmer C, 2009, J UROLOGY, V181, P1189, DOI 10.1016/j.juro.2008.11.030
   Ettema GJC, 1998, MED ENG PHYS, V20, P308, DOI 10.1016/S1350-4533(98)00026-5
   Fenner DE, 2000, CLIN OBSTET GYNECOL, V43, P650, DOI 10.1097/00003081-200009000-00024
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Krause H, 2008, INT UROGYNECOL J, V19, P1677, DOI 10.1007/s00192-008-0711-y
   Krause H, 2009, J OBSTET GYNAECOL RE, V35, P219, DOI 10.1111/j.1447-0756.2008.00930.x
   Krause HG, 2006, AUST NZ J OBSTET GYN, V46, P42, DOI 10.1111/j.1479-828X.2006.00513.x
   Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297
   Moalli PA, 2005, AM J OBSTET GYNECOL, V192, P80, DOI 10.1016/j.ajog.2004.07.008
   Moalli PA, 2008, AM J OBSTET GYNECOL, V199
   Moalli PA, 2008, INT UROGYNECOL J, V19, P655, DOI 10.1007/s00192-007-0499-1
   Rubod C, 2008, INT UROGYNECOL J, V19, P811, DOI 10.1007/s00192-007-0533-3
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   Yamamoto K, 1997, CELL BIOL INT, V21, P605, DOI 10.1006/cbir.1997.0192
NR 21
TC 3
Z9 3
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1040-872X
J9 CURR OPIN OBSTET GYN
JI Curr. Opin. Obstet. Gynecol.
PD OCT
PY 2009
VL 21
IS 5
BP 419
EP 423
DI 10.1097/GCO.0b013e32832fd27c
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 497LX
UT WOS:000270062100010
PM 19593132
DA 2018-10-20
ER

PT J
AU Bjarnsholt, T
   Tolker-Nielsen, T
   Givskov, M
   Janssen, M
   Christensen, LH
AF Bjarnsholt, Thomas
   Tolker-Nielsen, Tim
   Givskov, Michael
   Janssen, Martin
   Christensen, Lise Hanne
TI Detection of Bacteria by Fluorescence in Situ Hybridization in
   Culture-Negative Soft Tissue Filler Lesions
SO DERMATOLOGIC SURGERY
LA English
DT Article
ID MICROBIAL ADHESION; BIOFILM FORMATION; BIOMATERIAL; INTEGRATION;
   PERMANENT
AB BACKGROUND Adverse reactions to polyacrylamide gel occur as swellings or nodules, and controversy exists whether these are due to bacterial infection or an autoimmune reaction to the filler.
   OBJECTIVES Biopsies from culture-negative long-lasting nodules after injection with different types of polyacrylamide gel were examined with a combination of Gram stain and fluorescence in situ hybridization.
   RESULTS Bacteria were detected in biopsies from seven of eight patients. They inhabited gel and intervening tissue and tended to lie in aggregates.
   CONCLUSION This study supports the assumption that infection with bacteria in aggregates causes culture-negative late adverse reactions to polyacrylamide gel, suggesting a biofilm environment.
C1 [Christensen, Lise Hanne] Bispebjerg Hosp, Dept Pathol, DK-2400 Copenhagen NV, Denmark.
   [Bjarnsholt, Thomas; Tolker-Nielsen, Tim; Givskov, Michael] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.
   [Janssen, Martin] Janssen Klin, Oisterwijk, Netherlands.
RP Christensen, LH (reprint author), Bispebjerg Hosp, Dept Pathol, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.
EM LC24@bbh.regionh.dk
OI Tolker-Nielsen, Tim/0000-0002-9751-474X; Bjarnsholt,
   Thomas/0000-0002-8003-7414; Givskov, Michael/0000-0001-5004-8609
FU Carlsberg Foundation; Lundbeck Foundation
FX The authors would like to thank AdvanDx Inc., Woburn, Massachusetts, for
   supplying the PNA probes for the FISH experiments. TB has received
   financial support from The Carlsberg Foundation and Lundbeck Foundation.
CR Broder KW, 2006, PLAST RECONSTR SURG, V118, p7S, DOI 10.1097/01.prs.0000234900.26676.0b
   Christensen L, 2005, AESTHET PLAST SURG, V29, P34, DOI 10.1007/s00266-004-0113-6
   CHRISTENSEN L, 2006, EUR J PLAST SURG, V287, P464
   CHRISTENSEN L, 2007, DERMATOL SURG S, V2, pS168
   Christensen LH, 2008, DERMATOL SURG, V34, pS68, DOI 10.1111/j.1524-4725.2008.34246.x
   Del Pozo JL, 2006, INT J ARTIF ORGANS, V29, P379
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536
   Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08
   Pamp SJ, 2007, BIOFILM MODE LIFE ME, P37
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54
   Verkerke GJ, 1997, ARTIF ORGANS, V21, P413
NR 16
TC 77
Z9 79
U1 0
U2 6
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1076-0512
J9 DERMATOL SURG
JI Dermatol. Surg.
PD OCT
PY 2009
VL 35
IS 2
BP 1620
EP 1624
DI 10.1111/j.1524-4725.2009.01313.x
PG 5
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 503PM
UT WOS:000270550200005
PM 19709133
DA 2018-10-20
ER

PT J
AU Santhi, T
   Manonmani, S
AF Santhi, T.
   Manonmani, S.
TI Uptake of Cationic Dyes from Aqueous Solution by Biosorption Using
   Granulized Annona squmosa Seed
SO E-JOURNAL OF CHEMISTRY
LA English
DT Article
DE Annona squmosa; Biosorption; Methylene blue; Methylene red; Malachite
   green
ID ORANGE PEEL; METAL-IONS; ADSORPTION; REMOVAL; EQUILIBRIUM; ADSORBENT;
   SORPTION
AB A new, low cost, locally available biomaterial was tested for its ability to remove cationic dyes from aqueous solution. A sample of granulized Annona squmosa seeds had been utilized as a sorbent for uptake of three cationic dyes, methylene blue (MB), methylene red (MR) and malachite green (MG). The effects of various experimental parameters (e.g., contact time, dye concentration, adsorbent dose and pH) were investigated and optimal experimental conditions were ascertained. Above the value of initial pH 5, three dyes studied could be removed effectively. The isothermal data fitted the Langmuir model in the case of MB sorption and the Freundlich model for all three dyes sorption. The biosorption processes followed the pseudo first order rate kinetics. The results in this study indicated that granulized Annona squmosa seed was an attractive candidate for removing cationic dyes from the dye wastewater.
C1 [Santhi, T.] Karpagam Univ, Dept Chem, Coimbatore 641021, Tamil Nadu, India.
   [Manonmani, S.] PSG Coll Arts & Sci, Dept Chem, Coimbatore 641014, Tamil Nadu, India.
RP Santhi, T (reprint author), Karpagam Univ, Dept Chem, Coimbatore 641021, Tamil Nadu, India.
EM ssnilasri@yahoo.co.in
CR Arami M, 2005, J COLLOID INTERF SCI, V288, P371, DOI 10.1016/j.jcis.2005.03.020
   Brown P, 2000, ADV ENVIRON RES, V4, P19, DOI 10.1016/S1093-0191(00)00004-6
   Dhakal RP, 2005, SEP PURIF TECHNOL, V42, P219, DOI 10.1016/j.seppur.2004.07.016
   Ghimire K. N., 2001, CHITIN CHITOSAN RES, V7, P61
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Husseien M, 2007, J APPL SCI RES, V3, P1352
   Kumar KV, 2007, DYES PIGMENTS, V74, P595, DOI 10.1016/j.dyepig.2006.03.026
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Kweon DK, 2001, CARBOHYD POLYM, V46, P171, DOI 10.1016/S0144-8617(00)00300-3
   Maheswari P, 2008, E-J CHEM, V5, P233, DOI 10.1155/2008/376839
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Senthilkumaar S, 2005, J COLLOID INTERF SCI, V284, P78, DOI 10.1016/j.jcis.2004.09.027
   Singh KK, 2006, BIORESOURCE TECHNOL, V97, P2124, DOI 10.1016/j.biortech.2005.09.016
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
NR 16
TC 5
Z9 5
U1 0
U2 1
PU WWW PUBL PTE
PI TAMIL NADU
PA KHADAR BLDG, NEAR SHIFA HOSP, ADIRAMPATTINAM, TAMIL NADU, 614 701, INDIA
SN 0973-4945
J9 E-J CHEM
JI E-J. Chem.
PD OCT-DEC
PY 2009
VL 6
IS 4
BP 1260
EP 1266
DI 10.1155/2009/472703
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 520RV
UT WOS:000271864800046
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Hanif, A
   Bhatti, HN
   Hanif, MA
AF Hanif, Asma
   Bhatti, Haq Nawaz
   Hanif, Muhammad Asif
TI Removal and recovery of Cu(II) and Zn(II) using immobilized Mentha
   arvensis distillation waste biomass
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Mentha arvensis; Immobilization; Biosorption; Cu(II); Zn(II)
ID GOLDEN SHOWER BIOMASS; AQUEOUS-SOLUTIONS; NI(II) BIOSORPTION;
   CHLORRELA-VULGARIS; HEAVY-METALS; EQUILIBRIUM; SORPTION; CR(VI); PB(II);
   COPPER
AB The potential use of the immobilized Mentha arvensis distillation waste (IMADW) biomass for removal and recovery of Cu(II)and Zn(II) from aqueous was evaluated in the present study. Biosorption capacity of Cu(II) and Zn(II) on IMADW increased with increase in pH reaching a maximum at 5 for Cu(II) and 6 for Zn(II). The equilibrium sorption data agreed well with Langmuir isotherm model and pseudo-second-order kinetic model in batch mode. Cu(II) and Zn(II) uptake by IMADW was best described by pseudo-first-order kinetic model in continuous mode. Maximum Cu(II) and Zn(II) uptake by IMADW was 104.48 and 107.75 mg/g, respectively. Fourier Transform Infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) were also carried out to investigate functional groups and surface changes of biomass. The results showed that IMADW biomass is a potential biomaterial to remove Cu(II) and Zn(II) ions with a high biosorption capacity from aqueous solutions. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Hanif, Asma; Bhatti, Haq Nawaz; Hanif, Muhammad Asif] Univ Agr Faisalabad, Dept Chem & Biochem, Faisalabad 38040, Pakistan.
RP Bhatti, HN (reprint author), Univ Agr Faisalabad, Dept Chem & Biochem, Faisalabad 38040, Pakistan.
EM hnbhatti2005@yahoo.com
RI Hanif, Muhammad Asif/G-7242-2015; Bhatti, Haq Nawaz/I-2069-2015
OI Bhatti, Haq Nawaz/0000-0002-5445-8338
CR Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4
   Aksu Z., 1991, J CHEM TECHNOL BIOT, V52, P108
   Antunes WM, 2003, ELECTRON J BIOTECHN, V6, P174, DOI 10.4067/S0717-34582003000300003
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Bhatti HN, 2007, PROCESS BIOCHEM, V42, P547, DOI 10.1016/j.procbio.2006.11.009
   Bhatti HN, 2009, CHEM ENG J, V148, P434, DOI 10.1016/j.cej.2008.09.028
   Celis R, 2000, ENVIRON SCI TECHNOL, V34, P4593, DOI 10.1021/es000013c
   Ertugrul S, 2009, ECOL ENG, V35, P128, DOI 10.1016/j.ecoleng.2008.09.015
   Hanif MA, 2007, J HAZARD MATER, V145, P501, DOI 10.1016/j.jhazmat.2007.01.022
   Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040
   HELLAWELL JM, 1989, POLLUTION MONITORING, P546
   Javed MA, 2007, SEPAR SCI TECHNOL, V42, P3641, DOI 10.1080/01496390701710794
   Jnr M.H., 2005, ELECTRON J BIOTECHN, V8, P162
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Lazaro N, 2003, WATER RES, V37, P2118, DOI 10.1016/S0043-1354(02)00575-4
   LESAGE E, 2007, ECOL ENG, V30, P303
   Loukidou MX, 2004, COLLOID SURFACE A, V242, P93, DOI 10.1016/j.colsurfa.2004.03.030
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   Mehta SK, 2001, ECOL ENG, V18, P1, DOI 10.1016/S0925-8574(00)00174-9
   Mohapatra H, 2005, BIORESOURCE TECHNOL, V96, P1387, DOI 10.1016/j.biortech.2004.11.004
   Nadeem R, 2008, J HAZARD MATER, V150, P335, DOI 10.1016/j.jhazmat.2007.04.110
   Nomanbhay S. M., 2005, ELE J BIOTECHNOL, V8, P44
   Nuhoglu Y, 2002, BIORESOURCE TECHNOL, V85, P331, DOI 10.1016/S0960-8524(02)00098-6
   Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2
   PAZIRANDCH M, 1998, APPL ENVIRON MICROB, V64, P1068
   Quek SY, 1998, WATER SA, V24, P251
   Razmouski R, 2008, ECOL ENG, V34, P179, DOI 10.1016/j.ecoleng.2008.07.020
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   SHAFQAT F, 2008, J CHIL CHEM SOC, V54, P1
   Tsezos M, 1997, COMP BIOCHEM PHYS A, V118, P481, DOI 10.1016/S0300-9629(97)00009-1
   Vijayaraghavan K, 2004, ELECTRON J BIOTECHN, V7, P61
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Wong JPK, 2000, BIORESOURCE TECHNOL, V73, P133, DOI 10.1016/S0960-8524(99)00175-3
   Yu J, 2006, J HAZARD MATER, V132, P126
   Zhou JL, 1998, ENVIRON POLLUT, V101, P67, DOI 10.1016/S0269-7491(98)00034-7
   Zubair A, 2008, WATER AIR SOIL POLL, V191, P305, DOI 10.1007/s11270-008-9626-y
NR 36
TC 47
Z9 49
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
J9 ECOL ENG
JI Ecol. Eng.
PD OCT
PY 2009
VL 35
IS 10
BP 1427
EP 1434
DI 10.1016/j.ecoleng.2009.05.013
PG 8
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA 504VH
UT WOS:000270645400007
DA 2018-10-20
ER

PT J
AU Al-Jawad, M
   Fragneto, G
   Liu, J
   Chang, SR
   Clarkson, B
AF Al-Jawad, M.
   Fragneto, G.
   Liu, J.
   Chang, S. R.
   Clarkson, B.
TI Fibronectin adsorption studied using neutron reflectometry and
   complementary techniques
SO EUROPEAN PHYSICAL JOURNAL E
LA English
DT Article
ID FORCE MICROSCOPY; SPECULAR REFLECTION; SURFACES; HYDROXYAPATITE;
   INTERFACES; ATTACHMENT; ADHESION
AB In implantology it is known that fibronectin affects cell-substrate adhesion, consequently, the structure and composition of the initially adsorbed fibronectin layer to a large extent determines the biological response to a biomaterial implanted into the body. In this study we have used neutron reflectometry and quartz-crystal microbalance with dissipation to investigate the amount of fibronectin adsorbed, the layer density, thickness and structure of films adsorbed to polished silicon oxide surfaces. We have cultured MG63 osteoblast-like cells on surfaces coated and uncoated with fibronectin and monitored the cellular response to these surfaces. The results show that at fibronectin concentrations in the range 0.01 to 0.1mg/ml a single highly hydrated layer of fibronectin approximately 40-50 in thickness adsorbs to a polished silicon oxide surface and is likely to correspond to one diffuse monolayer of fibronectin arranged side-on. Cells cultured on this fibronectin layer have dramatically different morphology and growth to those grown on bare surfaces. Using a model silicon oxide surface has enabled us to study the substrate/protein interface, together with the impact of a fibronectin layer on the cellular response using consistent experimental conditions across a unique set of experimental techniques.
C1 [Al-Jawad, M.] Univ Leeds, Leeds Dent Inst, Leeds LS2 9LU, W Yorkshire, England.
   [Fragneto, G.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France.
   [Liu, J.; Chang, S. R.; Clarkson, B.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA.
RP Al-Jawad, M (reprint author), Univ Leeds, Leeds Dent Inst, Leeds LS2 9LU, W Yorkshire, England.
EM m.al-jawad@leeds.ac.uk
FU UK Engineering and Physical Sciences Research Council; Engineering and
   Physical Sciences Research Council [EP/D066298/1]
FX The authors are grateful to the Intitut Laue Langevin, Grenoble for the
   allocation of neutron beam time and to A. Rennie, Upsala University,
   Sweden for the use of the computer program drydoc. In addition we thank
   C. Dodd for help with QCM-D measurements, and the UK Engineering and
   Physical Sciences Research Council for funding.
CR Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Cubitt R, 2002, APPL PHYS A-MATER, V74, pS329, DOI 10.1007/s003390201611
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Fragneto-Cusani G, 2001, J PHYS-CONDENS MAT, V13, P4973, DOI 10.1088/0953-8984/13/21/322
   Galtayries A, 2006, SURF INTERFACE ANAL, V38, P186, DOI 10.1002/sia.2295
   Lu JR, 1996, ACTA CRYSTALLOGR A, V52, P11, DOI 10.1107/S0108767395011202
   Meadows PY, 2005, LANGMUIR, V21, P4096, DOI 10.1021/la047241v
   Norde W, 1999, MACROMOL SYMP, V145, P125, DOI 10.1002/masy.19991450114
   PENFOLD J, 1990, J PHYS-CONDENS MAT, V2, P1369, DOI 10.1088/0953-8984/2/6/001
   Rouahi M, 2006, J BIOMED MATER RES A, V78A, P222, DOI 10.1002/jbm.a.30682
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   VIG JR, 1985, J VAC SCI TECHNOL A, V3, P1027, DOI 10.1116/1.573115
   Yang YZ, 2003, COLLOID SURFACE B, V30, P291, DOI 10.1016/S0927-7765(03)00116-4
   ZENHAUSERN F, 1993, J ELECTRON MICROSC, V42, P378
NR 14
TC 14
Z9 14
U1 2
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1292-8941
J9 EUR PHYS J E
JI Eur. Phys. J. E
PD OCT
PY 2009
VL 30
IS 2
BP 175
EP 179
DI 10.1140/epje/i2009-10472-0
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 521RC
UT WOS:000271939600011
PM 19551415
DA 2018-10-20
ER

PT J
AU Fathima, NN
   Dhathathreyan, A
AF Fathima, N. Nishad
   Dhathathreyan, Aruna
TI Effect of surfactants on the thermal, conformational and rheological
   properties of collagen
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Collagen; Surfactants; Circular dichroism (CD); Differential scanning
   calorimetry (DSC); Viscosity
ID SODIUM DODECYL-SULFATE; ANIONIC SURFACTANTS; ACETATE BUFFER;
   TRIPLE-HELIX; GELATIN; TEMPERATURE; STABILITY; MICELLES
AB Collagen is an important biomaterial and its interaction with surfactant is important in light of its use in various cosmetics and dermatological applications. Presently, the effect of surfactants on the physico-chemical properties of collagen has been studied. The thermal stability of collagen is reduced by sodium dodecyl sulfate and hexadecyltrimethylammmonium bromide, whereas Triton X-100 does not. The viscosity of collagen is influenced greatly depending on the surfactant concentrations. The secondary structure of collagen shows changes only in the molar ellipticity. The role of charge and concentration of surfactants in influencing the various physico-chemical properties of collagen has been elucidated. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Fathima, N. Nishad; Dhathathreyan, Aruna] Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Madras 60002, Tamil Nadu, India.
RP Fathima, NN (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Sardar Patel Rd, Madras 60002, Tamil Nadu, India.
EM nishad.naveed@gmail.com
RI Fathima, Nishad/B-7919-2009
CR Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   Buron C, 2004, COLLOID POLYM SCI, V282, P446, DOI 10.1007/s00396-003-0967-1
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   CROSS J, 1994, SURF SCI SER, V53, P3
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Fathima NN, 2006, J INORG BIOCHEM, V100, P1774, DOI 10.1016/j.jinorgbio.2006.06.014
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   GUIDOTTI G, 1972, ANNU REV BIOCHEM, V41, P731, DOI 10.1146/annurev.bi.41.070172.003503
   HAYASHI K, 1974, P NATL ACAD SCI USA, V71, P2419, DOI 10.1073/pnas.71.6.2419
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Krejci J., 2007, International Journal of Cosmetic Science, V29, P121, DOI 10.1111/j.1467-2494.2007.00368.x
   Kronick PL, 1998, J POLYM SCI POL PHYS, V36, P805, DOI 10.1002/(SICI)1099-0488(19980415)36:5<805::AID-POLB8>3.0.CO;2-J
   Lai GL, 2008, INT J BIOL MACROMOL, V42, P285, DOI 10.1016/j.ijbiomac.2007.12.010
   Li Y, 2008, THERMOCHIM ACTA, V469, P71, DOI 10.1016/j.tca.2008.01.006
   MANDAL AB, 1987, EUR J BIOCHEM, V169, P617, DOI 10.1111/j.1432-1033.1987.tb13653.x
   MANDAL AB, 1988, LANGMUIR, V4, P736, DOI 10.1021/la00081a041
   MANDAL AB, 1980, J PHYS CHEM-US, V84, P856, DOI 10.1021/j100445a012
   Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r
   Rose C, 1996, INT J BIOL MACROMOL, V18, P41, DOI 10.1016/0141-8130(95)01054-8
   SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9
   Sovilj V, 1998, COLLOID POLYM SCI, V276, P328, DOI 10.1007/s003960050247
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 22
TC 25
Z9 25
U1 2
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD OCT 1
PY 2009
VL 45
IS 3
BP 274
EP 278
DI 10.1016/j.ijbiomac.2009.06.003
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 489BC
UT WOS:000269393500011
PM 19540261
DA 2018-10-20
ER

PT J
AU Malkani, AL
   Price, MR
   Crawford, CH
   Baker, DL
AF Malkani, Arthur L.
   Price, Matthew R.
   Crawford, Charles H., III
   Baker, Dale L.
TI Acetabular Component Revision Using a Porous Tantalum Biomaterial A Case
   Series
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE acetabular; component; revision; porous; tantalum
ID TOTAL HIP-ARTHROPLASTY; 6-YEAR FOLLOW-UP; BONE LOSS; RECONSTRUCTION;
   CEMENT; CLASSIFICATION; REPLACEMENT; PROSTHESIS; DEFICIENCY; MANAGEMENT
AB Biologic ingrowth can be difficult to achieve in acetabular component revision, especially in cases with significant bone loss. The purpose of this study was to review our clinical results of acetabular component revisions in patients with significant bone loss using a porous tantalum biomaterial. This is a retrospective review of 25 patients. There were 16 females and 9 males with a mean age of 71.7 +/- 10.54 years. The mean follow up was 39 +/- 11.09 months (range, 28-55 months). All patients in this series had combined segmental and cavitary bone loss, Paprosky type 2 or type 3. Of 22 patients in this series, 21 had a well-fixed and functioning implant at latest follow up. All 21 patients developed ingrowth along the tantalum surface despite compromised host bone. There were no cases of dislocation or aseptic loosening. Porous tantalum appears to be a promising material for use in revision hip arthroplasty to facilitate biologic ingrowth in patients with acetabular bone loss.
C1 [Malkani, Arthur L.; Price, Matthew R.; Crawford, Charles H., III; Baker, Dale L.] Univ Louisville, Dept Orthopaed Surg, Sch Med, Louisville, KY 40202 USA.
RP Malkani, AL (reprint author), Univ Louisville, Dept Orthopaed Surg, Sch Med, 210 E Gray St,Suite 1003, Louisville, KY 40202 USA.
CR AMSTUTZ HC, 1982, CLIN ORTHOP RELAT R, P21
   AYERZA M, 1988, ORTHOP T, V12, P662
   BERRY DJ, 1992, J BONE JOINT SURG BR, V74, P711
   Berry DJ, 1999, J BONE JOINT SURG AM, V81A, P1692, DOI 10.2106/00004623-199912000-00006
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   CALLAGHAN JJ, 1985, J BONE JOINT SURG AM, V67A, P1074, DOI 10.2106/00004623-198567070-00011
   CHANDLER HP, 1989, BONE STOCK DEFICIENC
   DANTONIO JA, 1989, CLIN ORTHOP RELAT R, P126
   DANTONIO JA, 1992, ORTHOP CLIN N AM, V23, P279
   DeBoer DK, 1998, J ARTHROPLASTY, V13, P674, DOI 10.1016/S0883-5403(98)80012-0
   Della Valle CJ, 2004, CLIN ORTHOP RELAT R, P96, DOI 10.1097/00003086-200403000-00013
   FUCHS MD, 1988, ORTHOP CLIN N AM, V19, P649
   Garbuz D, 1996, CLIN ORTHOP RELAT R, P98
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Harris WH, 1998, ORTHOPEDICS, V21, P991
   HEDLEY AK, 1988, CLIN ORTHOP RELAT R, P75
   Jasty M, 1998, ORTHOP CLIN N AM, V29, P249, DOI 10.1016/S0030-5898(05)70323-0
   KAVANAGH BF, 1985, J BONE JOINT SURG AM, V67A, P517, DOI 10.2106/00004623-198567040-00003
   KAVANAGH BF, 1987, J BONE JOINT SURG AM, V69A, P1144, DOI 10.2106/00004623-198769080-00006
   Lachiewicz PF, 1998, J BONE JOINT SURG AM, V80A, P980, DOI 10.2106/00004623-199807000-00006
   Maloney WJ, 1997, J BONE JOINT SURG AM, V79A, P1628, DOI 10.2106/00004623-199711000-00003
   Masri B A, 1996, Instr Course Lect, V45, P199
   Moore MS, 2006, CLIN ORTHOP RELAT R, P176, DOI 10.1097/01.blo.0000201149.14078.50
   Mulroy WF, 1995, J BONE JOINT SURG AM, V77A, P1845, DOI 10.2106/00004623-199512000-00008
   MURRAY WR, 1990, CLIN ORTHOP RELAT R, P92
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   PADGETT DE, 1993, J BONE JOINT SURG AM, V75A, P663, DOI 10.2106/00004623-199305000-00005
   Paprosky W G, 1994, J Arthroplasty, V9, P33, DOI 10.1016/0883-5403(94)90135-X
   PELLICCI PM, 1982, CLIN ORTHOP RELAT R, V170, P34
   Rorabeck C H, 1997, Acta Orthop Belg, V63 Suppl 1, P83
   ROSSON J, 1992, J BONE JOINT SURG BR, V74, P716
   SCOTT RD, 1984, CONT ORTHOP, V9, P35
   Silverton CD, 1996, J BONE JOINT SURG AM, V78A, P1366, DOI 10.2106/00004623-199609000-00011
   SLOOFF TJJH, 1984, ACTA ORTHOP SCAND, V55, P593, DOI 10.3109/17453678408992402
   Sutherland CJ, 1996, J ARTHROPLASTY, V11, P91, DOI 10.1016/S0883-5403(96)80166-5
   TANZER M, 1992, J BONE JOINT SURG AM, V74A, P987, DOI 10.2106/00004623-199274070-00005
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
NR 39
TC 19
Z9 23
U1 0
U2 1
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD OCT
PY 2009
VL 24
IS 7
BP 1068
EP 1073
DI 10.1016/j.arth.2008.07.008
PG 6
WC Orthopedics
SC Orthopedics
GA 506HB
UT WOS:000270764600010
PM 18823745
DA 2018-10-20
ER

PT J
AU Long, WJ
   Scuderi, GR
AF Long, William J.
   Scuderi, Giles R.
TI Porous Tantalum Cones for Large Metaphyseal Tibial Defects in Revision
   Total Knee Arthroplasty A Minimum 2-Year Follow-up
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE porous tantalum cones; tibial bone loss; revision total knee
   arthroplasty
ID BONE LOSS; STRUCTURAL ALLOGRAFT; HUMAN OSTEOBLASTS; TOTAL HIP;
   COMPONENTS; STEMS; RECONSTRUCTION; REPLACEMENT; BIOMATERIAL; MANAGEMENT
AB Sixteen cases of revision total knee arthroplasty requiring the Use of porous tantalum tibial cones for 2 T2A, 3 T2B, 4 T3A, and 7 T3B tibial bone defects (Anderson Orthopaedic Research Institute classification) after 13 cases of aseptic loosening and 3 cases of staged reimplantation for infection were reviewed. At an average 31 months (24-38), no patients were lost to follow-up. There were 2 cases of recurrent sepsis requiring removal of a well-fixed cone. In the remaining 14 cases, the reconstructions were functioning well with no reoperations. Radiographs demonstrated reestablishment of the joint line, neutral mechanical axis (average, 5.4 degrees of valgus), and signs of stable osteointegration into the cones. Good short-term results were achieved in complex revisions, with these new reconstructive tools.
C1 [Long, William J.; Scuderi, Giles R.] Insall Scott Kelly Inst Orthopaed & Sports Med, New York, NY 10065 USA.
RP Long, WJ (reprint author), Insall Scott Kelly Inst Orthopaed & Sports Med, 210 E 64th St, New York, NY 10065 USA.
CR Backstein D, 2006, CLIN ORTHOP RELAT R, P104, DOI 10.1097/01.blo.0000214426.52206.2c
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BRADLEY GW, 2000, CLIN ORTHOP RELAT RE, V113
   Burnett R Stephen J, 2005, J Bone Joint Surg Am, V87 Suppl 1, P175, DOI 10.2106/JBJS.E.00442
   Clatworthy MG, 2001, J BONE JOINT SURG AM, V83A, P404, DOI 10.2106/00004623-200103000-00013
   Dennis DA, 2002, J ARTHROPLASTY, V17, P90, DOI 10.1054/arth.2002.32456
   Engh GA, 1997, J BONE JOINT SURG AM, V79A, P1030, DOI 10.2106/00004623-199707000-00009
   Engh GA, 1998, ORTHOP CLIN N AM, V29, P205, DOI 10.1016/S0030-5898(05)70319-9
   Engh GA, 2007, J BONE JOINT SURG AM, V89A, P2640, DOI 10.2106/JBJS.F00865
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Ghazavi MT, 1997, J BONE JOINT SURG AM, V79A, P17, DOI 10.2106/00004623-199701000-00002
   HAAS SB, 1995, J BONE JOINT SURG AM, V77A, P1700, DOI 10.2106/00004623-199511000-00009
   HARRIS AI, 1995, J BONE JOINT SURG AM, V77A, P373, DOI 10.2106/00004623-199503000-00007
   Iorio R, 2008, J BONE JOINT SURG AM, V90A, P1598, DOI 10.2106/JBJS.H.00067
   Itala A, 2007, CLIN ORTHOP RELAT R, P202, DOI 10.1097/BLO.0b013e318142b3f0
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kress K J, 1993, J Arthroplasty, V8, P49, DOI 10.1016/S0883-5403(06)80107-5
   LONG WJ, 2007, UNCEMENTED POROUS TA
   Lotke PA, 2006, CLIN ORTHOP RELAT R, P99, DOI 10.1097/01.blo.0000214414.06464.00
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   NEHME A, 2004, CLIN ORTHOP RELAT RE, V201
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Rose PS, 2006, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000238854.16121.a3
   SCHILDHAUER TA, 2008, J BIOMED MAT RES A
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Sporer SM, 2006, J ARTHROPLASTY, V21, P83, DOI 10.1016/j.arth.2006.05.008
   SPRINGER BD, 2001, CLIN ORTHOP RELAT RE, V283
   TSAHAKIS PJ, 1994, CLIN ORTHOP RELAT RE, V86
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
NR 31
TC 58
Z9 62
U1 0
U2 2
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD OCT
PY 2009
VL 24
IS 7
BP 1086
EP 1092
DI 10.1016/j.arth.2008.08.011
PG 7
WC Orthopedics
SC Orthopedics
GA 506HB
UT WOS:000270764600013
PM 18823749
DA 2018-10-20
ER

PT J
AU Tang, X
   Ding, F
   Yang, YM
   Hu, N
   Wu, H
   Gu, XS
AF Tang, Xin
   Ding, Fei
   Yang, Yumin
   Hu, Nan
   Wu, Hong
   Gu, Xiaosong
TI Evaluation on in vitro biocompatibility of silk fibroin-based
   biomaterials with primarily cultured hippocampal neurons
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silk fibroin; hippocampal neurons; biocompatibility; cytotoxic effects;
   growth-associated molecules
ID NERVE GROWTH-FACTOR; CONTROLLED-RELEASE; CELLS; DELIVERY; PROTEIN;
   DEGRADATION; DETERMINANT; EXPRESSION; SCAFFOLDS; BEHAVIOR
AB Silk fibroin-based biomaterials have recently found increasing applications in the tissue-engineering field including the generation of artificial nerve guides for peripheral nerve repair. The aim of this study was to investigate the suitability of silk fibroin as a candidate biomaterial for central nervous system (CNS) therapy. We found that substrates made up of silk fibroin fibers supported the survival and growth of the attached hippocampal neurons by using morphological observation. We also cultured the hippocampal neurons in silk fibroin extract for different times, and observed no significant difference occurring in their morphology, cell viability for these cultured hippocampal neurons as compared to those cultured in plain neuronal culture medium. Moreover, immunocytochemistry, RT-PCR and Western blot analysis revealed that no significant difference was found in mRNA or protein levels of the growth-associated molecules, such as brain-derived neurotrophic factor, growth-associated protein-43, neurofilament, nerve growth factor, and nerve growth factor-receptor P75, between the hippocampal neurons cultured in the silk fibroin extract and in plain neuronal culture medium. Taken together, all the results demonstrate that silk fibroin has good biocompatibility with primarily cultured hippocampal neurons without any significant cytotoxic effects on their cell phenotype and functions, suggesting a potential possible use of silk fibroin for preparing the tissue-engineered nerve guides or drug delivery vehicles to treat CNS injuries or diseases. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 166-174, 2009
C1 [Tang, Xin; Ding, Fei; Yang, Yumin; Hu, Nan; Wu, Hong; Gu, Xiaosong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu Prov, Peoples R China.
RP Gu, XS (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu Prov, Peoples R China.
EM neurongu@public.nt.js.cn
FU Hi-Tech Research and Development Program of China (863 Program)
   [2006AA02A128]; National Natural Science Foundation of China [30770585];
   Jiangsu Province Natural Science Foundation of China [BK 2005202]; Basic
   Research Program of Jiangsu Education Department [07KJA31025]
FX Contract grant sponsor: Basic Research Program of Jiangsu Education
   Department; contract grant number: 07KJA31025
CR Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2
   Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655
   Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965
   CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   COBIN AS, 2006, TISSUE ENG, V12, P3383
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0
   LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   MOHAMMED AK, 1990, BRAIN RES, V528, P62, DOI 10.1016/0006-8993(90)90195-H
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Popovic N, 2006, INT J PHARM, V314, P120, DOI 10.1016/j.ijpharm.2005.09.040
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Rigato F., 2005, V1, P82
   Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yagyu K, 2001, J NEUROCHEM, V78, P569, DOI 10.1046/j.1471-4159.2001.00446.x
   Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 45
TC 46
Z9 60
U1 1
U2 29
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2009
VL 91A
IS 1
BP 166
EP 174
DI 10.1002/jbm.a.32212
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 492BA
UT WOS:000269627700019
PM 18780373
DA 2018-10-20
ER

PT J
AU Chou, AI
   Nicoll, SB
AF Chou, Alice I.
   Nicoll, Steven B.
TI Characterization of photocrosslinked alginate hydrogels for nucleus
   pulposus cell encapsulation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE alginate; photopolymerization; cell encapsulation; intervertebral disc
   cells; mechanical properties
ID INTERVERTEBRAL DISC CELLS; HYALURONIC-ACID NETWORKS; IN-VITRO;
   MECHANICAL-PROPERTIES; HYDROSTATIC-PRESSURE; NEOCARTILAGE FORMATION;
   ANULUS FIBROSUS; GENE-EXPRESSION; STEM-CELLS; CHONDROCYTES
AB Intervertebral disc (IVD) degeneration is a significant health concern in the USA. Tissue engineering strategies have the potential to provide a viable alternative to current treatments. Nevertheless, such approaches require a suitable biomaterial scaffold for IVD tissue regeneration. Calcium crosslinked alginate has traditionally been used for in vitro culture of nucleus pulposus (NP) cells of the IVD. However, such ionically crosslinked hydrogels lose structural integrity over time. Recently, various polymers have been modified with photopolymerizable functional groups to create covalently crosslinked hydrogels. This technology may be employed to maintain the structural and mechanical integrity of three-dimensional alginate hydrogels. In this study, photocrosslinkable alginate was synthesized and evaluated for material properties and the ability to maintain the viability of encapsulated NP cells. Photocrosslinked alginate at varying percent modifications and weight/volume percentages displayed equilibrium swelling ratios and Young's moduli of 30.52 +/- 1.782 to 43.50 +/- 1.345 and 0.5850 +/- 0.1701 to 8.824 +/- 0.6014 kPa, respectively. The viability of encapsulated NP cells was highest in hydrogels at lower percent modifications, and decreased with time in culture. Taken together, this study is the first to demonstrate that photocrosslinked alginate can be used for cellular encapsulation and synthesized with tunable material properties that may be tailored for specific applications. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91 A: 187-194, 2009
C1 [Chou, Alice I.; Nicoll, Steven B.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Nicoll, Steven B.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Nicoll, SB (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM nicoll@seas.upenn.edu
FU NIH [DE014228, EB002425]
FX Contract grant sponsor: NIH; contract grant numbers: DE014228, EB002425
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0
   Baer AE, 2001, J ORTHOPAED RES, V19, P2, DOI 10.1016/S0736-0266(00)00003-6
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Fernandez-Nieves A, 2000, MACROMOLECULES, V33, P2114, DOI 10.1021/ma991520l
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Gruber HE, 1997, MATRIX BIOL, V16, P285, DOI 10.1016/S0945-053X(97)90016-0
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   HOMER HA, 2002, SPINE, V27, P1018
   Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F
   Maguire T, 2007, BIOTECHNOL BIOENG, V98, P631, DOI 10.1002/bit.21435
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011
   Masuda Koichi, 2004, Spine J, V4, p330S, DOI 10.1016/j.spinee.2004.07.028
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   OEGEMA TR, 1993, CLIN SPORT MED, V12, P419
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   URBAN JPG, 1981, CONNECT TISSUE RES, V9, P1, DOI 10.3109/03008208109160234
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Yoon ST, 2003, SPINE, V28, P1773, DOI 10.1097/01.BRS.0000083204.44190.34
NR 48
TC 51
Z9 58
U1 2
U2 36
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2009
VL 91A
IS 1
BP 187
EP 194
DI 10.1002/jbm.a.32191
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 492BA
UT WOS:000269627700021
PM 18785646
DA 2018-10-20
ER

PT J
AU Chen, YP
   Webster, TJ
AF Chen, Yupeng
   Webster, Thomas J.
TI Increased osteoblast functions in the presence of BMP-7 short peptides
   for nanostructured biomaterial applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone morphogenetic protein-7; peptides; osteoblasts; orthopedics;
   nanotechnology
ID HELICAL ROSETTE NANOTUBES; BONE MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY
   SYSTEMS; TITANIUM IMPLANTS; GROWTH-FACTORS; DIFFERENTIATION;
   NANOPARTICLES; COLLAGEN
AB To improve bone regeneration around orthopedic biomaterials, researchers have attempted to combine growth factors on and in implants. Equally as exciting, greater bone growth has been demonstrated around nanoscaled materials (like helical rosette nanotubes or nanocrystalline hydroxyapatite) that mimic the geometry of the natural components of bone. To combine these two approaches, in this in vitro study, the ability of three short peptides [labeled for convenience: a or SNVILKKYRN, b or KPSSAPTQLN, and c or KAISVLYFDDS chosen from the larger bone morphogenetic protein-7 (BM-P-7)] to promote osteoblast (bone-forming cells) functions were determined. Shorter peptides of BMP-7 are required for growth factor incorporation into nanoscale biomaterials because their sizes are in the nanometer regime. Results showed that of all the peptides, peptide b and the peptide combination a,b, enhanced osteoblast density the most after 5 days when compared with the controls (no growth factors). Furthermore, osteoblasts cultured with peptide b had a larger and more spread morphology than did controls. In addition, peptide c and its combinations (a, c; b, c; and a, b, c) increased osteoblast calcium deposition after 14 and 21 days compared with the controls. Since these peptides are much smaller than BMP-7, the results of this study provided information that peptides can be easily chemically functionalized onto nanoscaled biomaterials to improve bone growth. Thus, the present study elucidated that shorter peptides in BMP-7 was found to be more appropriate for inclusion in and on nanomaterials to promote osteoblast proliferation (peptide b and the peptide combination a b) and osteoblast deposition of calcium-containing mineral (peptide c and the peptide combinations a,c; b,c; and a, b, c). (C). 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 296-304, 2009
C1 [Chen, Yupeng; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
   [Chen, Yupeng] Brown Univ, Dept Chem, Providence, RI 02912 USA.
   [Webster, Thomas J.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA.
RP Webster, TJ (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
EM thomas_webster@brown.edu
FU National Institutes of Health [1R21AG027521]
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: 1R21AG027521
CR Anderson James M., 1996, P165
   ARTHUR HW, 1972, BIOCH PHYSL BONE, P337
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b
   BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565
   Chun AL, 2005, BIOMATERIALS, V26, P7304, DOI 10.1016/j.biomaterials.2005.05.080
   Chun AL, 2004, NANOTECHNOLOGY, V15, pS234, DOI 10.1088/0957-4484/15/4/022
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Fenniri H, 2002, J AM CHEM SOC, V124, P11064, DOI 10.1021/ja026164s
   Fenniri H, 2001, J AM CHEM SOC, V123, P3854, DOI 10.1021/ja0058861
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gavenis K, 2007, J BIOMED MATER RES B, V82B, P275, DOI 10.1002/jbm.b.30731
   Giannobile WV, 1996, BONE, V19, pS23, DOI 10.1016/S8756-3282(96)00127-5
   KIRKWOOD K, 2000, J ORAL IMPLANTOL, V29, P57
   Lee SH, 2007, BIOMATERIALS, V28, P2041, DOI 10.1016/j.biomaterials.2007.01.003
   LIND M, 1995, APMIS, V103, P140, DOI 10.1111/j.1699-0463.1995.tb01089.x
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   REDDI AH, 1993, J BONE MINER RES, V8, pS499
   SAILER HF, 1994, J CRANIO MAXILL SURG, V22, P2, DOI 10.1016/S1010-5182(05)80289-6
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Simank HG, 2006, BIOMATERIALS, V27, P3988, DOI 10.1016/j.biomaterials.2006.02.041
   SLONE RM, 1991, RADIOGRAPHICS, V11, P823, DOI 10.1148/radiographics.11.5.1947319
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Wang JS, 1996, ACTA ORTHOP SCAND, V67, P1
   Yin H, 2005, BIOMATERIALS, V26, P5818, DOI 10.1016/j.biomaterials.2005.02.036
NR 28
TC 37
Z9 39
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2009
VL 91A
IS 1
BP 296
EP 304
DI 10.1002/jbm.a.32246
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 492BA
UT WOS:000269627700031
PM 18980196
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yang, M
   Chen, CZ
   Wang, XN
   Zhu, YB
   Gu, YJ
AF Yang, Min
   Chen, Chang-Zhi
   Wang, Xue-Ning
   Zhu, Ya-Bin
   Gu, Y. John
TI Favorable Effects of the Detergent and Enzyme Extraction Method for
   Preparing Decellularized Bovine Pericardium Scaffold for Tissue
   Engineered Heart Valves
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE decellularization methods; bovine pericardium; tissue engineering; heart
   valve
ID EXTRACELLULAR-MATRIX; CELLS; RECELLULARIZATION; BIOMATERIALS; SURVIVAL;
   DISEASE
AB Bovine pericardium has been extensively applied as the biomaterial for artificial heart valves and may potentially be used as a scaffold for tissue-engineered heart valves after decellularization. Although various methods of decellularization are currently available, it is unknown which method is the most ideal one for the decellularization for bovine pericardium. We compared three decellularization methods, namely, the detergent and enzyme extraction (DEE), the trypsin (TS), and the Triton X-100 and sodium-deoxycholate (TSD) method, to examine their efficacy on cell removal and their preservation of the mechanical function and the tissue matrix structure. Results indicated that decellularization was achieved by all the three methods as confirmed by hematoxylin-eosin staining, scanning electron microscopy, as well as quantitative DNA measurement. However, TS and TSD methods resulted in severe structural destruction of the bovine pericardium as shown by von Gieson staining and Gomori staining. Furthermore, both TS and TSD methods changed the mechanical property of the bovine pericardium, as evidenced by a lower elastic modulus, maximal-stress, maximal-disfiguration, maximal-load, and maximal-strain. In conclusion, the DEE method achieved both a complete decellularization and preservation of the mechanical function and tissue structure of the bovine pericardium. Thus, this method is superior to either the TS or the TSD method for preparing decellularized bovine pericardium scaffold for constructing tissue-engineered heart valves. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 91B: 354-361,2009
C1 [Yang, Min; Chen, Chang-Zhi; Wang, Xue-Ning] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cardiothorac Surg, Shanghai 200030, Peoples R China.
   [Yang, Min; Zhu, Ya-Bin] Yangzhou Univ, Subei Hosp, Dept Cardiothorac Surg, Yangzhou, Jiangsu Prov, Peoples R China.
   [Wang, Xue-Ning] Teda Int Cardiovasc Hosp, Dept Cardiothorac Surg, Tianjin, Peoples R China.
   [Gu, Y. John] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Chen, CZ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cardiothorac Surg, Shanghai 200030, Peoples R China.
EM changzhi6@hotmail.com
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   Durbin AD, 2002, CARDIOVASC PATHOL, V11, P69, DOI 10.1016/S1054-8807(01)00109-0
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hafeez Y. M., 2005, Cell and Tissue Banking, V6, P85, DOI 10.1007/s10561-004-1888-z
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   Khan S, 2002, J HEART VALVE DIS, V11, pS8
   Lund O, 2006, J THORAC CARDIOV SUR, V132, P20, DOI 10.1016/j.jtcvs.2006.01.043
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Neidert MR, 2006, TISSUE ENG, V12, P891, DOI 10.1089/ten.2006.12.891
   Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I
   Oei FBS, 2002, J HEART VALVE DIS, V11, P315
   Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Sacks MS, 2006, EXPERT REV MED DEVIC, V3, P817, DOI 10.1586/17434440.3.6.817
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378
   Takagi K, 2006, ARTIF ORGANS, V30, P233, DOI 10.1111/j.1525-1594.2006.00210.x
NR 22
TC 45
Z9 52
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2009
VL 91B
IS 1
BP 354
EP 361
DI 10.1002/jbm.b.31409
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 495MM
UT WOS:000269897100040
PM 19507136
DA 2018-10-20
ER

PT J
AU Shirai, T
   Tsuchiya, H
   Shimizu, T
   Ohtani, K
   Zen, Y
   Tomita, K
AF Shirai, Toshiharu
   Tsuchiya, Hiroyuki
   Shimizu, Tohru
   Ohtani, Kaori
   Zen, Yo
   Tomita, Katsuro
TI Prevention of Pin Tract Infection with Titanium-Copper Alloys
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE titanium-copper alloy; antibacterial; biocompatibility; pin tract
   infection; cytotoxicity
ID STAPHYLOCOCCUS-AUREUS ADHESION; IN-VITRO; EXTERNAL FIXATION; BACTERIAL
   ADHERENCE; ANTIBACTERIAL ACTIVITY; STAINLESS-STEEL; SILVER; SURFACES;
   COLONIZATION; BIOMATERIALS
AB The most frequent complication in external fixation is pin tract infection. To reduce the incidence of implant-associated infection, many published reports have looked at preventing bacterial adhesion by treating the pin surface. This study aimed to evaluate the antibacterial activity of a Titanium-Copper (Ti-Cu) alloy on implant infection, and to determine the potential use of the Ti-Cu alloy as a biomaterial. Two forms of Ti-Cu alloys were synthesized: one with 1% Cu and the other with 5% Cu. For analyzing infectious behavior, the implants were exposed to Staphylococcus aureus and Escherichia coli. The reaction of pathogens to the Ti-Cu alloys was compared with their reaction to stainless steel and pure titanium as controls. Both Ti-Cu alloys evidently inhibited colonization by both bacteria. Conversely, cytocompatibility studies were performed using fibroblasts and colony formation on the metals was assessed by counting the number of colonies. Ti-1% Cu alloy showed no difference in the number of colonies compared with the control. External fixator pins made of Ti-Cu alloys were evaluated in a rabbit model. The tissue-implant interactions were analyzed for the presence of infection, inflammatory changes and osteoid-formation. Ti-1% Cu alloy significantly inhibited inflammation and infection, and had excellent osteoid-formation. Copper blood levels were measured before surgery and at 14 days postoperatively. Preoperative and postoperative blood copper values were not statistically different. Overall, it was concluded that Ti-Cu alloys have antimicrobial activity and substantially reduce the incidence of pin tract infection. Ti-1% Cu alloy shows particular promise as a biomaterial. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 91B: 373-380, 2009
C1 [Shirai, Toshiharu; Tsuchiya, Hiroyuki; Tomita, Katsuro] Kanazawa Univ, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan.
   [Shimizu, Tohru; Ohtani, Kaori] Kanazawa Univ, Dept Bacteriol, Kanazawa, Ishikawa 9208641, Japan.
   [Zen, Yo] Kanazawa Univ, Dept Pathol, Kanazawa, Ishikawa 9208641, Japan.
RP Tsuchiya, H (reprint author), Kanazawa Univ, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan.
EM tsuchi@med.kanazawa-u.ac.jp
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   ALBREKTSSON T, 1995, DENT MAXILLOFACIAL I, P9
   An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Bremner I, 1987, Experientia Suppl, V52, P81
   Buczynski BW, 2003, COLLOID SURFACE B, V30, P167, DOI 10.1016/S0927-7765(03)00068-7
   Cen L, 2004, J BIOMED MATER RES A, V71A, P70, DOI 10.1002/jbm.a.30125
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   COLLINGE CA, 1994, ORTHOPEDICS, V17, P445
   COX JL, 1983, BIOCHEM BIOPH RES CO, V115, P106, DOI 10.1016/0006-291X(83)90975-0
   DEBASTIANI G, 1984, J BONE JOINT SURG BR, V66, P538
   DRAKE DR, 1993, J DENT RES, V72, P524, DOI 10.1177/00220345930720020901
   Eichhorn G L, 1973, Adv Exp Med Biol, V40, P43
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Fitzgerald RH, 1995, J AM ACAD ORTHOP SUR, V3, P249
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Harris LG, 2005, J BIOMED MATER RES A, V73A, P12, DOI 10.1002/jbm.a.30276
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   KEATING J F, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P272
   KELLER JC, 1984, FUND APPL TOXICOL, V4, P778, DOI 10.1016/0272-0590(84)90099-X
   Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87
   KISHIMOTO T, 1992, JPN J HYG, V47, P965
   KOTOURA Y, 1985, ARCH ORTHOP TRAUM SU, V104, P15, DOI 10.1007/BF00449950
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   KUMADA M, 2001, J JCBRA, V40, P122
   LEONHARDT A, 1995, EUR J ORAL SCI, V103, P382, DOI 10.1111/j.1600-0722.1995.tb01861.x
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   NOHR RS, 1994, J BIOMAT SCI-POLYM E, V5, P607, DOI 10.1163/156856294X00239
   OLOFFS A, 1994, BIOMATERIALS, V15, P753, DOI 10.1016/0142-9612(94)90028-0
   READ RR, 1989, KIDNEY INT, V35, P614, DOI 10.1038/ki.1989.30
   RESPET PJ, 1987, J ORTHOPAED RES, V5, P600, DOI 10.1002/jor.1100050416
   ROMMENS P, 1989, J TRAUMA, V29, P630, DOI 10.1097/00005373-198905000-00018
   ROMMENS PM, 1988, INJURY, V19, P432, DOI 10.1016/0020-1383(88)90141-6
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   STERNLIEB I, 1980, GASTROENTEROLOGY, V78, P1615
   Tyagi M, 1997, Biomed Sci Instrum, V33, P240
   Uauy R, 1998, AM J CLIN NUTR, V67, p952S, DOI 10.1093/ajcn/67.5.952S
   von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   Watanabe K, 2003, BIOMATERIALS, V24, P1737, DOI 10.1016/S0142-9612(02)00583-5
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yorganci K, 2002, EUR J CLIN MICROBIOL, V21, P379, DOI 10.1007/s10096-002-0719-z
   Zhai QW, 2000, J CELL PHYSIOL, V184, P161, DOI 10.1002/1097-4652(200008)184:2<161::AID-JCP3>3.3.CO;2-E
NR 51
TC 88
Z9 90
U1 1
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2009
VL 91B
IS 1
BP 373
EP 380
DI 10.1002/jbm.b.31412
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 495MM
UT WOS:000269897100043
PM 19507137
DA 2018-10-20
ER

PT J
AU Choi, JS
   Yang, HJ
   Kim, BS
   Kim, JD
   Kim, JY
   Yoo, B
   Park, K
   Lee, HY
   Cho, YW
AF Choi, Ji Suk
   Yang, Hyrun-Jin
   Kim, Beob Soo
   Kim, Jae Dong
   Kim, Jun Young
   Yoo, Bongyoung
   Park, Kinam
   Lee, Hee Young
   Cho, Yong Woo
TI Human extracellular matrix (ECM) powders for injectable cell delivery
   and adipose tissue engineering
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Injectable cell delivery; Tissue engineering; Extracellular matrix
   (ECM); Powders; Adipose-derived stem cell (ASC)
ID SMALL-INTESTINE SUBMUCOSA; STEM-CELLS; AXONAL REGENERATION; SCAFFOLD
   MATERIAL; STRATEGIES; SURFACE; GRAFTS; REPAIR; HEART
AB Here, we present extracellular matrix (ECM) powders derived from human adipose tissue as injectable cell delivery carriers for adipose tissue engineering. We postulate that human adipose tissue may provide an ideal biomaterial because it contains large amounts of ECM components including collagen. Fresh human adipose tissue was obtained by a simple surgical operation (liposuction). After removing blood and oil components, the tissue was homogenized, centrifuged, freeze-dried, and ground to powders by milling. In an in vitro study, the human ECM powders were highly effective for promotion of cell attachment and proliferation for three-dimensional (3D) cell culture. In in vivo studies, suspensions of human ECM powders containing human adipose-derived stem cells (hASCs) were subcutaneously injected into nude mice. At eight weeks post-injection, numerous blood vessels were observed and the newly formed tissue exhibited adipogenesis with accumulated intracellular small lipid droplets. Overall, the grafts showed well-organized adipose tissue constructs without any signs of tissue necrosis, cystic spaces, or fibrosis. We believe that human ECM powders could act as efficient injectable biomaterials for tissue engineering and have great potential for meeting clinical challenges in regenerative medicine, particularly in relation to adipose tissue engineering. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Yang, Hyrun-Jin; Kim, Jun Young; Lee, Hee Young] Kangnam Plast Surg Clin, Seoul 135120, South Korea.
   [Choi, Ji Suk; Kim, Beob Soo; Kim, Jae Dong; Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
   [Choi, Ji Suk; Kim, Beob Soo; Kim, Jae Dong; Cho, Yong Woo] Hanyang Univ, Dept Bionanotechnol, Ansan 426791, Gyeonggi Do, South Korea.
   [Yoo, Bongyoung] Hanyang Univ, Dept Mat Engn, Ansan 426791, Gyeonggi Do, South Korea.
   [Park, Kinam] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   [Park, Kinam] Purdue Univ, Dept Pharmaceut, W Lafayette, IN 47907 USA.
   [Lee, Hee Young] Medikan Inc, Seoul 135120, South Korea.
RP Lee, HY (reprint author), Kangnam Plast Surg Clin, Seoul 135120, South Korea.
EM pslhy@medimail.co.kr; ywcho7@hanyang.ac.kr
FU Korea Science and Engineering Foundation (KOSEF), Korean government
   (MEST) [R11-2008-044-02001-0]; Ministry of Knowledge Economy (MKE)
   [10030042]
FX This work was supported by a Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korean government (MEST) (Grant No.
   R11-2008-044-02001-0) and a grant funded by the Ministry of Knowledge
   Economy (MKE) (Grant No. 10030042).
CR Altman AM, 2008, AESTHET PLAST SURG, V32, P698, DOI 10.1007/s00266-008-9159-1
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bae YH, 1998, J CONTROL RELEASE, V53, P249, DOI 10.1016/S0168-3659(97)00258-7
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Chaput C., 1996, CURR OPIN ORTHOP, V7, P62
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Evans MDM, 1998, J BIOMED MATER RES, V40, P621, DOI 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Hall S, 1997, J ANAT, V190, P57, DOI 10.1046/j.1469-7580.1997.19010057.x
   HEBDERG EL, 2002, J CONTROL RELEASE, V84, P137
   Hopper RA, 2003, ANN PLAS SURG, V51, P598, DOI 10.1097/01.sap.0000095658.46675.76
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021
   Khang G, 2002, MACROMOL RES, V10, P158, DOI 10.1007/BF03218266
   Krekoski CA, 2001, J NEUROSCI, V21, P6206
   Kurita M, 2008, PLAST RECONSTR SURG, V121, P1033, DOI 10.1097/01.prs.0000299384.53131.87
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Lee SH, 2007, SOL ST PHEN, V119, P319, DOI 10.4028/www.scientific.net/SSP.119.319
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Nelson CM, 2006, CURR OPIN BIOTECH, V17, P518, DOI 10.1016/j.copbio.2006.08.011
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Spiegel JH, 2004, DERMATOL SURG, V30, P1486, DOI 10.1111/j.1524-4725.2004.30507.x
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI 10.1042/BST0331078
   Trujillo ME, 2006, ENDOCR REV, V27, P762, DOI 10.1210/er.2006-0033
   Urs S, 2004, J NUTR, V134, P762
   VAN RLR, 1976, J CLIN INVEST, V58, P699, DOI 10.1172/JCI108516
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005
NR 38
TC 79
Z9 84
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD OCT 1
PY 2009
VL 139
IS 1
BP 2
EP 7
DI 10.1016/j.jconrel.2009.05.034
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 498DB
UT WOS:000270115800002
PM 19481576
DA 2018-10-20
ER

PT J
AU Li, CW
   Zheng, QX
   Guo, XD
   Quan, DP
   Zhao, J
AF Li, Changwen
   Zheng, Qixin
   Guo, Xiaodong
   Quan, Daping
   Zhao, Jie
TI Combined Use of RGD-peptide Modified PLGA and TGF-beta 1 Gene
   Transfected MSCs to Improve Cell Biobehaviors in vitro
SO JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL
   SCIENCES
LA English
DT Article
DE tissue engineering; biomaterial; PLGA; RGD; transforming growth factor
   beta; bone marrow stromal cells
ID MESENCHYMAL STEM-CELLS; SURFACE MODIFICATION; OSTEOGENIC
   DIFFERENTIATION; TGF-BETA; MATRIX; HYDROGELS; PROLIFERATION;
   BIOMATERIALS; ADHESION; CULTURE
AB In order to improve the surface properties of PLGA polymer for a better material/cell interface to modulate the cells behaviors, we prepared a novel three-block copolymer, PLGA-[ASP-PEG], and immobilized an RGD-containing peptide, Gly-Arg-Gly-Asp-Ser-Pro-Cys (GRGDSPC) on the surface of it. Transforming growth factor-beta 1 (TGF-beta 1) was transfected into bone marrow stromal cells (MSCs) employed as seeded cells. Cell adhesion, spreading, proliferation and differentiation on this material were investigated. The results showed that the cell adhesive ratio on RGD-modified materials was higher than on un-modified materials (P < 0.05). The extent of cell spreading was also wider on RGD-modified materials than on un-modified materials. Cell proliferation indices of transfected MSCs were increased as compared with the un-transfected MSCs (P < 0.05). The ALP activities in the MSCs cultured with RGD-modified materials were higher than on un-modified materials after 14 days (P < 0.05), and those in transfected MSCs were higher than in un-transfected MSCs (P < 0.05). It was suggested that the combined use of RGD-modification and TGF-beta gene transfection could improve the interaction of biomaterial and cells.
C1 [Li, Changwen; Zheng, Qixin; Guo, Xiaodong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
   [Quan, Daping; Zhao, Jie] Sun Yat Sen Univ, Inst Polymer Sci, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China.
RP Zheng, QX (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
EM ortho@163.com
RI guo, xiaodong/K-2600-2013
CR Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202
   Chin D, 2004, BRIT J PLAST SURG, V57, P215, DOI 10.1016/j.bjps.2003.12.012
   Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606
   Guo XD, 2006, J WUHAN UNIV TECHNOL, V21, P41
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 2008, J AM ACAD ORTHOP SUR, V16, P4, DOI 10.5435/00124635-200801000-00002
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Macdonald KK, 2007, J TISSUE ENG REGEN M, V1, P314, DOI 10.1002/term.31
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Roelen Bernard A J, 2003, J Orthop Sci, V8, P740, DOI 10.1007/s00776-003-0702-2
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Zhao J, 2005, MACROMOL BIOSCI, V5, P636, DOI 10.1002/mabi.200500043
NR 24
TC 2
Z9 3
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1672-0733
J9 J HUAZHONG U SCI-MED
JI J. Huazhong Univ. Sci. Tech.-Med.
PD OCT
PY 2009
VL 29
IS 5
BP 592
EP 598
DI 10.1007/s11596-009-0512-7
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 505HA
UT WOS:000270681700012
PM 19821092
DA 2018-10-20
ER

PT J
AU Kim, JY
   Park, JK
   Hahn, SK
   Kwon, TH
   Cho, DW
AF Kim, Jong Young
   Park, Jung Kyu
   Hahn, Sei Kwang
   Kwon, Tai Hun
   Cho, Dong-Woo
TI Development of the flow behavior model for 3D scaffold fabrication in
   the polymer deposition process by a heating method
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID TISSUE; DESIGN; FLUID
AB The flow behavior model for 3D scaffold fabrication in the polymer deposition process by the heating method was developed for enhanced efficiency of the deposition process. The analysis of the polymer flow property is very important in the fabrication process of precise micro-structures such as scaffolds. In this study, a deposition model considering fluid mechanics and heat transfer phenomena was built up and introduced for the estimation of the fluid behavior of molten polymer. The effectiveness of the simulation model was verified through comparison with the experimental result in the case of PCL biomaterial. In addition, the effects of various parameters, such as pressure, temperature and nozzle size, were predicted through simulation before experimental approaches. Through the fabrication of 3D scaffold, it is concluded that this model is useful in predicting the flow behavior characteristics in the micro-structure fabrication process, which is based on the heating method.
C1 [Kim, Jong Young; Kwon, Tai Hun; Cho, Dong-Woo] POSTECH, Dept Mech Engn, Pohang 790784, Gyungbuk, South Korea.
   [Park, Jung Kyu; Hahn, Sei Kwang] POSTECH, Dept Mat Sci & Engn, Pohang 790784, Gyungbuk, South Korea.
   [Kwon, Tai Hun; Cho, Dong-Woo] POSTECH, Dept Integrat Biosci & Bioengn, Pohang 790784, Gyungbuk, South Korea.
RP Cho, DW (reprint author), POSTECH, Dept Mech Engn, San 31 Hyoja Dong, Pohang 790784, Gyungbuk, South Korea.
EM dwcho@postech.ac.kr
FU Korea government (MEST) [R0A-2005-000-10042-0,
   M10646020003-08N4602-00310]
FX This work was supported by the Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korea government (MEST) ( nos:
   R0A-2005-000-10042-0 and M10646020003-08N4602-00310).
CR Brandrup J., 1989, POLYM HDB
   Cao T., 2003, TISSUE ENG, V9, P103
   Chen XB, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2789725
   Chen XB, 2006, IEEE T ELECTRON PACK, V29, P75, DOI 10.1109/TEPM.2006.874964
   CHHABRA RP, 1999, NONNEWTONIAN FLOW PR
   CHU WS, 2007, INT J PRECIS ENG MAN, V8, P63
   DOMININGHANS H, 1993, PLASTICS ENG MAT PRO
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Kim JY, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055027
   Kim JY, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015002
   LOULOU T, 1992, INT J HEAT MASS TRAN, V35, P2557, DOI 10.1016/0017-9310(92)90097-C
   LYCHE BC, 1956, CHEM ENG SCI, V6, P35, DOI 10.1016/0009-2509(56)80008-0
   Minakov AA, 1999, THERMOCHIM ACTA, V330, P109, DOI 10.1016/S0040-6031(99)00025-8
   Peter S., 1996, J APPL POLYM SCI, V61, P2455
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525
   Yamada A, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/2/025035
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 19
TC 2
Z9 2
U1 1
U2 5
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD OCT
PY 2009
VL 19
IS 10
AR 105003
DI 10.1088/0960-1317/19/10/105003
PG 8
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 498IZ
UT WOS:000270133900003
DA 2018-10-20
ER

PT J
AU Zharov, VV
   Lyalin, AN
   Karban, OV
   Perevozchikov, PA
   Samartseva, NN
   Konygin, GN
   Leesment, SI
AF Zharov, V. V.
   Lyalin, A. N.
   Karban, O. V.
   Perevozchikov, P. A.
   Samartseva, N. N.
   Konygin, G. N.
   Leesment, S. I.
TI Atomic Force Microscopy in Studying Regeneration of Tissues in Sclera
   Plasty in Ophthalmology
SO JOURNAL OF SURFACE INVESTIGATION-X-RAY SYNCHROTRON AND NEUTRON
   TECHNIQUES
LA English
DT Article
ID COLLAGEN FIBRILS
AB The atomic force method (AFM) was used to study the processes of repair in the sclera tissue within the grafting zone of a nanostructured biomaterial in a rabbit. The use of the nanostructured placenta has been shown to speed up the penetration of a graft into the sclera and to induce the formation of new connective-tissue structures. Differences have been revealed in the structure of mature and newly-formed collagen fibrils.
C1 [Zharov, V. V.] Izhevsk State Med Acad, Izhevsk, Russia.
   [Zharov, V. V.; Lyalin, A. N.; Perevozchikov, P. A.; Samartseva, N. N.] Republican Ophthalmol Clin Hosp, Izhevsk, Russia.
   [Karban, O. V.; Konygin, G. N.] Ur D RAS, Phys Tech Inst, Izhevsk, Russia.
   [Leesment, S. I.] Nanotechnol MDT, Zelenograd, Russia.
RP Zharov, VV (reprint author), Izhevsk State Med Acad, Izhevsk, Russia.
CR Bozec L, 2006, J MATER SCI-MATER M, V17, P1043, DOI 10.1007/s10856-006-0442-x
   Gutsmann T, 2003, BIOPHYS J, V84, P2593, DOI 10.1016/S0006-3495(03)75064-4
   HABBELITZ S, 2002, J STRUCT BIOL, V138, P227
   Kato K, 2001, EUR PHYS J E, V6, P7, DOI 10.1007/s101890170022
   Mallick SB, 2006, ANAL BIOANAL CHEM, V386, P652, DOI 10.1007/s00216-006-0538-7
   Marshall GW, 2001, SURF SCI, V491, P444, DOI 10.1016/S0039-6028(01)01310-3
   Meller D, 1997, CELL TISSUE RES, V288, P111, DOI 10.1007/s004410050798
   Muller DJ, 2002, TRENDS BIOTECHNOL, V20, pS45, DOI 10.1016/S0167-7799(02)02000-0
   Muslimov S. A., 2000, MORPHOLOGICAL ASPECT
   OHNOS, 1991, OPHTHAL RES, V23, P320
   SELLHEYER K, 1998, GRAEFES ARCH CLIN EX, V226, P885
   SPITZNAS M, 1971, Z ZELLFORSCH MIK ANA, V118, P439, DOI 10.1007/BF00331196
   ZHAROV VV, 2008, IZHEVSKS ORIGINS 200, P264
   ZHAROV VV, 2008, Patent No. 200810121615
   Zyryanov V. V., 1991, MEKHANOKHIMICHESKII, P102
NR 15
TC 1
Z9 1
U1 0
U2 2
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1027-4510
J9 J SURF INVESTIG-X-RA
JI J. Surf. Ingestig.-X-Ray Synchro.
PD OCT
PY 2009
VL 3
IS 5
BP 804
EP 808
DI 10.1134/S1027451009050243
PG 5
WC Physics, Condensed Matter
SC Physics
GA 506AP
UT WOS:000270744900024
DA 2018-10-20
ER

PT J
AU Dubey, DK
   Tomar, V
AF Dubey, Devendra K.
   Tomar, Vikas
TI Understanding the influence of structural hierarchy and its coupling
   with chemical environment on the strength of idealized
   tropocollagen-hydroxyapatite biomaterials
SO JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS
LA English
DT Article
DE Chemo-mechanical processes; Strengthening and mechanisms; Biological
   material; Constitutive behavior; Molecular simulations
ID COLLAGEN-LIKE PEPTIDE; MOLECULAR-DYNAMICS SIMULATIONS; HUMAN TRABECULAR
   BONE; MECHANICAL-PROPERTIES; BIOLOGICAL-MATERIALS; ELASTIC PROPERTIES;
   YOUNGS MODULUS; TRIPLE-HELIX; FIBRILS; FRACTURE
AB Hard biomaterials such as bone, dentin, and nacre have primarily an organic phase (e.g. tropocollagen (TC)) and a mineral phase (e.g. hydroxypatitie (HAP) or aragonite) arranged in a staggered arrangement at the nanoscopic length scale, Interfacial interactions between the organic phase and the mineral phase as well as the structural effects arising due to the staggered arrangement significantly affect the strength of such biomaterials. The effect of such factors is intricately intertwined with the chemical environment of such materials. In the present investigation, an idealized TC-HAP composite system under tensile loading is analyzed using explicit three-dimensional (3-D) molecular dynamics (MD) simulations to develop an understanding of these factors. The material system is analyzed in three different environments: (1) in the absence of water molecules (non-hydrated), (2) in the presence of water molecules (hydrated), and (3) in the presence of water molecules with calcium ions (ionized water). The analyses focus on understanding the correlations among factors such as the structural arrangement, the peak stress during deformation, Young's modulus, the peak interfacial strength, and the length scale of the localization of peak stress during deformation. Analyses show that maximizing the contact are between the TC and HAP phases results in higher interfacial strength as well as higher fracture strength. Due to the staggered arrangement, the orientation of HAP crystals has insignificant effect on the biomaterial strength. Analyses based on strength scaling as a function of structural hierarchy level reveal that while peak strength follows a multiscaling relation, the fracture strength does not. The peak strain for failure was found to be independent of the changes in levels of structural hierarchy. Overall, the analyses, being limited in size due to the computational time constraint, point out important correlations between the mechanical strength and chemically influenced structural hierarchy of biomaterials (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Dubey, Devendra K.; Tomar, Vikas] Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
RP Tomar, V (reprint author), Purdue Univ, Sch Aeronaut & Astronaut, Neil Armstrong Hall Engn, W Lafayette, IN 47907 USA.
EM tomar@purdue.edu
CR Anderson D, 2005, THESIS U TORONTO
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bembey AK, 2006, J MATER RES, V21, P1962, DOI 10.1557/JMR.2006.0237
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Berryman JG, 2005, J MECH PHYS SOLIDS, V53, P2141, DOI 10.1016/j.jmps.2005.05.004
   BHOWMIK R, 2007, MAT RES SOC S P, V975
   Bhowmik R, 2007, MAT SCI ENG C-BIO S, V27, P352, DOI 10.1016/j.msec.2006.05.048
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Broedling NC, 2008, J MECH PHYS SOLIDS, V56, P1086, DOI 10.1016/j.jmps.2007.06.006
   Buehler M. J., 2007, NANOTECHNOLOGY, V18
   Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Chen JH, 2006, J PHYS-CONDENS MAT, V18, pS1049, DOI 10.1088/0953-8984/18/25/S11
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   CUSACK S, 1979, J MOL BIOL, V135, P39, DOI 10.1016/0022-2836(79)90339-5
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Ghosh P, 2007, BIOMACROMOLECULES, V8, P851, DOI 10.1021/bm060942h
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Handgraaf JW, 2006, PROTEINS, V64, P711, DOI 10.1002/prot.21019
   HARLEY R, 1977, NATURE, V267, P285, DOI 10.1038/267285a0
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hein JI, 2005, PHILOS T ROY SOC A, V363, P1987, DOI 10.1098/rsta.2005.1624
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Huang C C, 1998, Pac Symp Biocomput, P349
   Israelowitz M, 2005, PROTEIN ENG DES SEL, V18, P329, DOI 10.1093/protein/gzi037
   Jager I, 2000, BIOPHYS J, V79, P1737
   Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   Klein TE, 1999, BIOPOLYMERS, V49, P167
   Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Lorenzo AC, 2005, J BIOMECH, V38, P1527, DOI 10.1016/j.jbiomech.2004.07.011
   Lucksanasombool P, 2001, BIOMATERIALS, V22, P3127, DOI 10.1016/S0142-9612(01)00062-X
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Makarov V, 2002, ACCOUNTS CHEM RES, V35, P376, DOI 10.1021/ar0100273
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Radmer RJ, 2006, BIOPHYS J, V90, P578, DOI 10.1529/biophysj.105.065276
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Simone A. D., 2008, BIOCHEM BIOPH RES CO, V372, P121
   Sun YL, 2004, J BIOMECH, V37, P1665, DOI 10.1016/j.jbiomech.2004.02.028
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024
   Tomar V, 2007, J MECH PHYS SOLIDS, V55, P1053, DOI 10.1016/j.jmps.2006.10.005
   Vesentini S, 2005, BIOMECH MODEL MECHAN, V3, P224, DOI 10.1007/s10237-004-0064-5
   Voth GA, 2006, ACCOUNTS CHEM RES, V39, P143, DOI 10.1021/ar0402098
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
NR 66
TC 28
Z9 29
U1 5
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-5096
J9 J MECH PHYS SOLIDS
JI J. Mech. Phys. Solids
PD OCT
PY 2009
VL 57
IS 10
BP 1702
EP 1717
DI 10.1016/j.jmps.2009.07.002
PG 16
WC Materials Science, Multidisciplinary; Mechanics; Physics, Condensed
   Matter
SC Materials Science; Mechanics; Physics
GA 536RR
UT WOS:000273062000002
DA 2018-10-20
ER

PT J
AU Oliveira, JT
   Santos, TC
   Martins, L
   Silva, MA
   Marques, AP
   Castro, AG
   Neves, NM
   Reis, RL
AF Oliveira, J. T.
   Santos, T. C.
   Martins, L.
   Silva, M. A.
   Marques, A. P.
   Castro, A. G.
   Neves, N. M.
   Reis, R. L.
TI Performance of new gellan gum hydrogels combined with human articular
   chondrocytes for cartilage regeneration when subcutaneously implanted in
   nude mice
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE cartilage; tissue engineering; hydrogel; adipose stem cells; in vivo;
   natural biomaterial
ID TISSUE-ENGINEERING APPLICATIONS; X COLLAGEN; OSTEOARTHRITIC CARTILAGE;
   MECHANICAL-PROPERTIES; SCAFFOLDS; FIBER; BONE; DIFFERENTIATION;
   ARCHITECTURE; DEFECTS
AB Gellan gum is a polysaccharide that has been recently proposed by our group for cartilage tissue-engineering applications. It is commonly used in the food and pharmaceutical industry and has the ability to form stable gels without the use of harsh reagents. Gellan gum can function as a minimally invasive injectable system, gelling inside the body in situ under physiological conditions and efficiently adapting to the defect site. In this work, gellan gum hydrogels were combined with human articular chondrocytes (hACs) and were subcutaneously implanted in nude mice for 4 weeks. The implants were collected for histological (haematoxylin and eosin and Alcian blue staining), biochemical [dimethylmethylene blue (GAG) assay], molecular (real-time PCR analyses for collagen types I, II and X, aggrecan) and immunological analyses (immunolocalization of collagen types I and II). The results showed a homogeneous cell distribution and the typical round-shaped morphology of the chondrocytes within the matrix upon implantation. Proteoglycans synthesis was detected by Alcian blue staining and a statistically significant increase of proteoglycans content was measured with the GAG assay quantified from I to 4 weeks of implantation. Real-time PCR analyses showed a statistically significant upregulation of collagen type II and aggrecan levels in the same periods. The immunological assays suggest deposition of collagen type II along with some collagen type I. The overall data shows that gellan gum hydrogels adequately support the growth and ECM deposition of human articular chondrocytes when implanted subcutaneously in nude mice. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Oliveira, J. T.; Santos, T. C.; Silva, M. A.; Marques, A. P.; Neves, N. M.; Reis, R. L.] Univ Minho, Res Grp 3Bs, European Inst Excellence Tissue Engn & Regenerat, P-4806909 Taipas, Guimaraes, Portugal.
   [Oliveira, J. T.; Santos, T. C.; Silva, M. A.; Marques, A. P.; Neves, N. M.; Reis, R. L.] IBB, PT Associated Lab, Guimaraes, Portugal.
   [Martins, L.; Castro, A. G.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.
RP Oliveira, JT (reprint author), Univ Minho, Res Grp 3Bs, Dept Polymer Engn, European Inst Excellence Tissue Engn & Regenerat, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM joao.oliveira@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Marques, Alexandra/B-1238-2012; Santos,
   Tircia/I-5595-2013; Group, 3Bs/E-4374-2012; Neves, Nuno/B-4685-2008;
   Castro, Antonio/F-5863-2011; Alves da Silva, Marta/O-2545-2013
OI Reis, Rui L./0000-0002-4295-6129; Marques,
   Alexandra/0000-0002-3222-0310; Santos, Tircia/0000-0002-5365-4863;
   Group, 3Bs/0000-0002-5195-3456; Neves, Nuno/0000-0003-3041-0687; Castro,
   Antonio/0000-0002-4684-4183; Alves da Silva, Marta/0000-0002-5146-9728
FU Portuguese Foundation for Science and Technology (FCT)
   [SFP,H/BD17135/2004]; European NoE EXPERTISSUES [NMP3-CT-2004-500283];
   European Project HIPPOCRATES [STRP 505758-1]
FX J. T. Oliveira would like to acknowledge the Portuguese Foundation for
   Science and Technology (FCT) for his grant (SFP,H/BD17135/2004). The
   authors would like to thank the patients at Hospital de S. Marcos,
   Braga, Portugal, for the donation of the biological samples and the
   medical staff for their help and support. The authors would also like to
   thank the Institute for Health and Life Sciences (ICVS), University of
   Minho, Braga, Portugal, for allowing the use of their research
   facilities. This work was carried out under the scope of European NoE
   EXPERTISSUES (Project No. NMP3-CT-2004-500283) and partially supported
   by the European Project HIPPOCRATES (No. STRP 505758-1).
CR Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   Crawford A, 2004, METHODS MOL BIOL BIO
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Ge ZG, 2006, ARTHRIT RHEUM-ARTHR, V55, P493, DOI 10.1002/art.21994
   Girkontaite I, 1996, MATRIX BIOL, V15, P231, DOI 10.1016/S0945-053X(96)90114-6
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   GRASDALEN H, 1987, CARBOHYD POLYM, V7, P371, DOI 10.1016/0144-8617(87)90004-X
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Hunt Stephen A, 2002, J Am Acad Orthop Surg, V10, P356
   Jackson RW, 2003, ARTHROSCOPY, V19, P13, DOI 10.1053/jars.2003.50022
   Jakob RP, 2002, CLIN ORTHOP RELAT R, P170
   Kafienah W, 2004, METHODS MOL BIOL BIO
   KANG KS, 1982, APPL ENVIRON MICROB, V43, P1086
   KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x
   Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Malafaya PB, 2008, BIOMATERIALS, V29, P3914, DOI 10.1016/j.biomaterials.2008.06.023
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mao R, 2000, CARBOHYD POLYM, V41, P331, DOI 10.1016/S0144-8617(99)00108-3
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Oliveira JT, 2008, TISSUE ENG PT A, V14, P1651, DOI 10.1089/ten.tea.2007.0307
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OLIVEIRA JT, 2008, VIVO EVAL UNPUB
   OLIVEIRA JT, 2009, J BIOMED A IN PRESS
   OLIVEIRA JT, 2008, GELLAN GUM BASED HYD
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   Videki B, 2005, EUR POLYM J, V41, P1699, DOI 10.1016/j.europolymj.2005.03.002
   VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715
   Vunjak-Novakovic G., 1998, ADV DRUG DELIV REV, V33, P15
NR 41
TC 41
Z9 44
U1 1
U2 32
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD OCT
PY 2009
VL 3
IS 7
BP 493
EP 500
DI 10.1002/term.184
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 506ZT
UT WOS:000270819400001
PM 19598145
DA 2018-10-20
ER

PT J
AU Kasoju, N
   Bhonde, RR
   Bora, U
AF Kasoju, Naresh
   Bhonde, Ramesh R.
   Bora, Utpal
TI Preparation and characterization of Antheraea assama silk fibroin based
   novel non-woven scaffold for tissue engineering applications
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Antheraea assama; silk fibroin; biocompatible; biodegradable; tissue
   engineering and regenerative medicine; angiogenesis
ID EMBRYO CHORIOALLANTOIC MEMBRANE; IN-VITRO; REGENERATIVE MEDICINE;
   PHYSICAL-PROPERTIES; CHICK-EMBRYO; BIOMATERIALS; MODEL; GROWTH; ACID;
   VIVO
AB The quest for novel materials as scaffolds with suitable micro-architecture for supporting tissue neogenesis in tissue engineering and regenerative medicine (TERM) is continuing. In this paper we report an Antheraea assama silk-based non-woven fibroin scaffold for applications in TERM. The novel three-dimensional scaffold is highly interconnected and porous, with a pore size of 150 mu m, porosity of 90% and water uptake capacity of 85%. FTIR revealed a typical beta-sheet structure of fibroin. The scaffold has thermal and mechanical properties superior to those of Bombyx mori, as revealed by DSC, TGA and tensile tests. The scaffold exhibited satisfactory blood compatibility, as determined by thrombogenicity, haemolysis, platelet/leukocyte count, platelet adhesion and protein adsorption studies. The scaffold was found to be cytocompatible with human cell lines A549, KB, HepG2 and HeLa for a period of up to 4 weeks. SEM analysis revealed excellent attachment, spreading and migration of cells in the scaffold. MTT assay was performed to estimate the viability and growth of cells in the matrix. Quantification of collagen in cell-scaffold constructs was done by picro-Sirius red assay. Ex ovo chorioallantoic membrane assay and nitric oxide estimations in spent culture medium showed the scaffold's ability to promote angiogenesis. Finally, the biodegradability of the scaffold was determined by the weight loss observed upon treatment with trypsin over a period of 4 weeks. The results reveal that the fibroin from A. assama is a promising candidate as a biocompatible, biomimetic and biodegradable biomaterial of natural origin for applications in TERM. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Kasoju, Naresh; Bora, Utpal] Indian Inst Technol Guwahati, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
   [Bhonde, Ramesh R.] Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune 411007, Maharashtra, India.
RP Bora, U (reprint author), Indian Inst Technol Guwahati, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
EM ubora@iitg.ernet.in
RI Kasoju, Naresh/A-5295-2009
OI Kasoju, Naresh/0000-0002-8700-0729
FU Department of Biotechnology; Ministry of Science and Technology,
   Government of India [BT/PR7984/MED/14/1214/2006]; IITG; MHRD; NCCS,
   Pune, India,; MSSO, Guwahati, India; State Forensic Science Laboratory,
   Guwahati, Assam, India [JSM 6380 LA, JEOL]; Life Care Diagnostics,
   Guwahati, India; Central Instrumentation Facility
FX We thank the Department of Biotechnology, Ministry of Science and
   Technology, Government of India, for supporting this work through
   Project No. BT/PR7984/MED/14/1214/2006. N.K. thanks IITG and MHRD for
   financial support in the form of a fellowship. We thank NCCS, Pune,
   India, for providing cell lines; MSSO, Guwahati, India, for providing
   silk cocoons; the State Forensic Science Laboratory, Guwahati, Assam,
   India, for SEM analysis (JSM 6380 LA, JEOL); and Life Care Diagnostics,
   Guwahati, India, Central Instrumentation Facility, IITG, Mr Abhishek
   Sahu and Mr Ratul K. Das for their suggestions and technical support.
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ARMATO U, 2002, Patent No. 200100501
   Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Azzarello J, 2007, BIOMED MATER, V2, P55, DOI 10.1088/1748-6041/2/2/001
   Binyamin Gary, 2006, Semin Pediatr Surg, V15, P276, DOI 10.1053/j.sempedsurg.2006.07.007
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Cooke JP, 2003, ATHEROSCLEROSIS SUPP, V4, P53, DOI 10.1016/S1567-5688(03)00034-5
   Daar AS, 2007, J TISSUE ENG REGEN M, V1, P179, DOI 10.1002/term.20
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   DAUNER M, NONWOVEN TECHNOLOGIE
   EDWARDS SL, 2004, AUTEX RES J, V4
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hazarika LK, 1998, BIORESOURCE TECHNOL, V64, P67, DOI 10.1016/S0960-8524(97)00158-2
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Khattak SF, 2006, BIOTECHNOL LETT, V28, P1361, DOI 10.1007/s10529-006-9104-9
   Klueh U, 2003, J BIOMED MATER RES A, V67A, P838, DOI 10.1002/jbm.a.10059
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LI M, 2007, POLYM ADVAN TECHNOL, V19, P207
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Miller WJ, 2004, J TRANSL MED, V2, P4, DOI DOI 10.1186/1479-5876-2-4
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Pabbruwe MB, 2005, BIOTECHNOL LETT, V27, P1451, DOI 10.1007/s10529-005-1308-x
   Rajkhowa R, 2000, J APPL POLYM SCI, V77, P2418, DOI 10.1002/1097-4628(20000912)77:11<2418::AID-APP10>3.3.CO;2-H
   Ribatti D, 1996, INT J DEV BIOL, V40, P1189
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SINGH J, 1990, BIOMATERIALS, V11, P473, DOI 10.1016/0142-9612(90)90060-4
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Taddei P, 2007, BIOMACROMOLECULES, V8, P1200, DOI 10.1021/bm061017y
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447
   Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   WILTING J, 1991, ANAT EMBRYOL, V183, P259
   Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6
   Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001
NR 51
TC 32
Z9 33
U1 0
U2 27
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD OCT
PY 2009
VL 3
IS 7
BP 539
EP 552
DI 10.1002/term.196
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 506ZT
UT WOS:000270819400006
PM 19670334
DA 2018-10-20
ER

PT J
AU Rouvillain, JL
   Lavalle, F
   Pascal-Mousselard, H
   Catonne, Y
   Daculsi, G
AF Rouvillain, J. L.
   Lavalle, F.
   Pascal-Mousselard, H.
   Catonne, Y.
   Daculsi, G.
TI Clinical, radiological and histological evaluation of biphasic calcium
   phosphate bioceramic wedges filling medial high tibial valgisation
   osteotomies
SO KNEE
LA English
DT Article
DE High tibial valgisation osteotomy (HTVO); Biomaterial; Plate and locking
   screw; Biphasic calcium phosphate bioceramic; Varus knee; Arthritis
ID FOLLOW-UP; VARUS DEFORMITY; DEGENERATIVE ARTHRITIS; OSTEO-ARTHRITIS;
   BONE; KNEE; GONARTHROSIS; CERAMICS; OSTEOARTHRITIS; IMPLANTATION
AB We report clinical, radiological and histological findings following high tibial valgisation osteotomy (HTVO) using micro-macroporous biphasic calcium phosphate wedges fixed with a plate and locking screws. From 1999 to 2002, 43 knees were operated on and studied prospectively. All underwent clinical and radiological follow-up at days 1, 90, and 365 to evaluate consolidation and bone substitute interfaces. Additionally, biopsies were taken for histology at least 1 year after implantation from 10 patients who requested plate removal.
   Radiologically, consolidation was observed in 98% of cases. At 1 year, correction was unchanged in 95% of cases. Histological analysis revealed considerable MBCP (R) resorption and bone ingrowth, both into the pores and replacing the bioceramic material. Polarised light microscopy confirmed normal bony architecture with trabecular and/or dense lamellar bone growth at the expense of the wedge implants. X-ray and micro-CT scan revealed a well organised and mineralised structure in the newly-formed bone.
   This study shows that using MBCP (R) wedges in combination with orientable locking screws and a plate is a simple, safe and fast surgical technique for HTVO. The is the first study to examine the results by histological analysis, which confirmed good outcomes. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Rouvillain, J. L.; Lavalle, F.; Pascal-Mousselard, H.; Catonne, Y.] Univ Meynard Hosp, Dept Orthopaed, F-97261 Fort De France, Martinique, France.
   [Daculsi, G.] Univ Nantes, Nantes Hosp Dent Fac, ERT Clin Fesearch 1051, F-44042 Nantes, France.
RP Rouvillain, JL (reprint author), Univ Meynard Hosp, Dept Orthopaed, F-97261 Fort De France, Martinique, France.
EM jlrouvillain@sasi.fr
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446; ROUVILLAIN, JEAN
   LOUIS/0000-0002-9076-9096
FU INSERM; Bordeaux Hospital (Interface INSERM Contract); SC3M department
FX We thank Francoise Moreau for technical assistance in histology and
   Jacques Demotes Mainard and Marlene Durand from CIC Bordeaux for their
   assistance in the clinical research.r This study was supported by INSERM
   and the Bordeaux Hospital (Interface INSERM Contract), and the SC3M
   department, which performed the X-rays, microtomography, SEM and TEM
   analyses.
CR Ahlback S., 1968, ACTA RADIOL STOCKH S, V277, P7
   BLANCHARD JP, 1979, REV CHIR ORTHOP, V65, P209
   Bonnevialle P, 2002, REV CHIR ORTHOP, V88, P486
   Bove JC, 2002, REV CHIR ORTHOP, V88, P480
   Cauchoix J, 1968, Rev Chir Orthop Reparatrice Appar Mot, V54, P343
   COVENTRY MB, 1985, J BONE JOINT SURG AM, V67A, P1136, DOI 10.2106/00004623-198567070-00025
   DACULSI G, 1989, REV CHIR ORTHOP, V75, P65
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEBEYRE J, 1972, REV CHIR ORTHOP, V58, P335
   Delecrin J, 2000, SPINE, V25, P563, DOI 10.1097/00007632-200003010-00006
   GOUIN F, 1995, REV CHIR ORTHOP, V81, P59
   GOUTALLIER D, 1986, REV CHIR ORTHOP, V72, P101
   GOUTALLIER D, 1992, REV CHIR ORTHOP, V78, P138
   GUIGUI P, 1994, SPINE, V19, P2798, DOI 10.1097/00007632-199412150-00012
   HERNIGOU P, 1987, J BONE JOINT SURG AM, V69A, P332
   Hernigou P, 1996, REV CHIR ORTHOP, V82, P241
   INSALL JN, 1984, J BONE JOINT SURG AM, V66A, P1040, DOI 10.2106/00004623-198466070-00010
   Jenny JY, 1998, REV CHIR ORTHOP, V84, P350
   Koshino T, 2003, J BONE JOINT SURG AM, V85A, P78, DOI 10.2106/00004623-200301000-00013
   LOOTVOET L, 1993, REV CHIR ORTHOP, V79, P375
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   PASSUTI N, 1992, IMPLANTS ORTHOPAEDIC, pCHA12
   Rohanizadeh R, 1999, CALCIFIED TISSUE INT, V64, P430, DOI 10.1007/PL00005825
   TRECANT M, 1994, CLIN MATER, V15, P233, DOI 10.1016/0267-6605(94)90051-5
   VAINIONPAA S, 1981, Journal of Bone and Joint Surgery American Volume, V63, P938
NR 26
TC 22
Z9 23
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0968-0160
EI 1873-5800
J9 KNEE
JI Knee
PD OCT
PY 2009
VL 16
IS 5
BP 392
EP 397
DI 10.1016/j.knee.2008.12.015
PG 6
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 498SI
UT WOS:000270163000019
PM 19185500
DA 2018-10-20
ER

PT J
AU Patel, MR
   Shukla, JM
   Patel, NK
   Patel, KH
AF Patel, Mitesh Ramanlal
   Shukla, Jignesh Markandray
   Patel, Natvarbhai Khodidas
   Patel, Ketan Haribhai
TI Biomaterial Based Novel Polyurethane Adhesives for Wood to Wood and
   Metal to Metal Bonding
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE adhesive; castor oil; polyurethanes
ID INTERPENETRATING POLYMER NETWORKS; CASTOR-OIL; POLYOL
AB Polyurethane adhesives made from synthetic chemicals are non-biodegradable, costly and difficult to find raw materials from local market. To avoid solid pollution problem, cost effectiveness and easy availability of raw materials, biomaterials based polyurethane adhesives are used in current industrial interest. Direct use of castor oil in polyurethane adhesive gives limited hardness. Modification on active sites of castor oil to utilize double bond of unsaturated fatty acid and carboxyl group yields new modified or activated polyols, which can be utilized for polyurethane adhesive formulation. In view of this, we have synthesized polyurethane adhesives from polyester polyols, castor oil based polyols and epoxy based polyols with Isocyanate adducts based on castor oil and trimethylolpropane. To study the effects of polyurethane adhesive strength (i.e. lap shear strength) on wood-to-wood and metal-to-metal bonding through various types of polyols, cross-linking density, isocyanate adducts and also to compare adhesive strength between wood to wood and metal to metal surface. These polyols and polyurethanes were characterized through GPC, NMR and IR-spectroscopy, gel and surface drying time. Thermal stability of PU adhesives was determined under the effect of cross-linking density (NCO/OH ratio). The NCO/OH ratio (1.5) was optimized for adhesives as the higher NCO/OH ratio (2.0) increasing cross-linking density and decreases adhesion. Lower NCO/OH ratio (1.0) provideslow cross-linking density and low strength of adhesives.
C1 [Patel, Mitesh Ramanlal] Univ Sheffield, Dept Chem, Ctr Polymer, Sheffield S3 7HF, S Yorkshire, England.
   [Shukla, Jignesh Markandray; Patel, Natvarbhai Khodidas; Patel, Ketan Haribhai] Sardar Patel Univ, Dept Chem, Vallabh Vidyanagar 388120, Gujarat, India.
RP Patel, MR (reprint author), Univ Sheffield, Dept Chem, Ctr Polymer, Brook Hill, Sheffield S3 7HF, S Yorkshire, England.
EM drmrp56@hotmail.com; jignesh.m.shukla@gmail.com
CR ALTAFIM RAC, 1999, P IEEE C EL INS DIEL, P305
   Athawale V, 1998, J MACROMOL SCI PURE, VA35, P1929, DOI 10.1080/10601329808000988
   Badri KH, 2006, J APPL POLYM SCI, V100, P1759, DOI 10.1002/app.23015
   Benli S, 1998, J APPL POLYM SCI, V68, P1057, DOI 10.1002/(SICI)1097-4628(19980516)68:7<1057::AID-APP3>3.0.CO;2-E
   BROIDO A, 1969, J POLYM SCI A2, V7, P1761, DOI 10.1002/pol.1969.160071012
   Cocks I. V., 1976, LAB HDB OIL FAT ANAL
   DAVID DJ, 1974, ANAL CHEM POLYURETHA, P365
   Desai SD, 2003, J POLYM RES-TAIWAN, V10, P275, DOI 10.1023/B:JPOL.0000004630.77120.bb
   Desai SD, 2003, INT J ADHES ADHES, V23, P393, DOI 10.1016/S0143-7496(03)00070-8
   DEVIA N, 1979, MACROMOLECULES, V12, P360, DOI 10.1021/ma60069a002
   Dias Fabricio Moura, 2004, Mat. Res., V7, P413, DOI 10.1590/S1516-14392004000300007
   DINWOODIE JM, 1978, J I WOOD SCI, V8, P59
   Dunky M., 2003, HDB ADHESIVE TECHNOL, P887
   EBEWELE RO, 1994, EUROPEAN J WOOD WOOD, V52, P179
   Eling B., 2003, POLYURETHANE ADHESIV
   FREEMAN H. G., 1968, FOREST PROD J, V18, P39
   Jellinek H. H. G., 1983, DEGRADATION STABILIT, P91
   JIA D, 1994, J POLYM SCI POL LETT, P817
   JIA D, J POLYM SCI B, V32, P817
   KIMBALL ME, 1981, ADHESIVES AGE    JUN, P21
   KRENCESKI MA, 1986, POLYM REV, V26, P143
   LIANG F, 1984, J APPL POLYM SCI, V29, P3147, DOI 10.1002/app.1984.070291017
   LIU DH, 2005, SYNTHETIC FIBER CHIN, V9, P11
   Myers G. E., 1988, ADHES AGE, V31, P31
   OERTEL G, 1985, POLYURETHANE HDB, P54
   PATEL N, 2003, EUROPEAN COATING J, V11, P34
   PATEL P, 1990, J APPL POLYM SCI, V40, P1037, DOI 10.1002/app.1990.070400535
   Petrovic Z. S., 2002, US Patent, Patent No. 6399698
   Sanmathi CS, 2004, J APPL POLYM SCI, V94, P1029, DOI 10.1002/app.20930
   Saunders JH, 1963, POLYURETHANE CHEM TE, P51
   Somani KP, 2003, INT J ADHES ADHES, V23, P269, DOI 10.1016/S0143-7496(03)00044-7
   STROBECH C, 1990, INT J ADHES ADHES, V10, P225, DOI 10.1016/0143-7496(90)90108-A
   TAKEMURA A, 1991, ADV INTERPENETRATING, P25
   TRANGHTON GE, 1968, J I WOOD SCI, V21, P29
   Vallat MF, 2000, J APPL POLYM SCI, V76, P665, DOI 10.1002/(SICI)1097-4628(20000502)76:5<665::AID-APP8>3.0.CO;2-A
   WHITE JT, 1981, ADHES AGE, V7, P19
   YENWO GM, 1977, J APPL POLYM SCI, V21, P1531, DOI 10.1002/app.1977.070210609
NR 37
TC 17
Z9 18
U1 2
U2 41
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD OCT-DEC
PY 2009
VL 12
IS 4
BP 385
EP 393
DI 10.1590/S1516-14392009000400003
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 548PC
UT WOS:000273976800002
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Mitzner, E
   Pelt, PAHM
   Mueller, C
   Strohwig, A
   Mueller, WD
AF Mitzner, Elke
   Pelt, Paco Albertus Hubert Maria
   Mueller, Christian
   Strohwig, Angela
   Mueller, Wolf-Dieter
TI Material Properties and In Vitro Biocompatibility of a Newly Developed
   Bone Cement
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE bone cement; biomaterial; vertebroplasty; biocompatibility
ID ZINC ION RELEASE; CALCIUM PHOSPHATES; TISSUE-CULTURE; HIP-JOINT;
   POLYMETHYLMETHACRYLATE; POLYMERIZATION; BIOMATERIALS; ARTHROPLASTY;
   OSTEOBLASTS; EXPRESSION
AB In this study mechanical properties and biocompatibility (In Vitro) of a new bone cement were investigated. A new platform technology named COOL is a variable composite of dissolved, chemically modified PMMA and different bioceramics. COOL cures at body temperature via a classical cementation reaction. Compressive strengths ranging from 3.6 +/- 0.8 to 62.8 +/- 1.3 MPa and bending strengths ranging from 9.9 +/- 2.4 to 26.4 +/- 3.0 MPa were achieved with different COOL formulations. Porosity varied between 31 and 43%. Varying the components of each formulation mechanical properties and porosity could be adjusted. In Vitro biocompatibility studies with primary human osteoblasts (pHOB) in direct contact with different COOL formulations, did not reveal any signs of toxicity. In contrast to Refobacin (R) R, cells incubated with COOL showed similar density, viability and ALP activity compared to control, if specimen were added immediately to the cell monolayer after preparation. In conclusion, COOL has promising mechanical properties in combination with high biocompatibility In Vitro and combines different advantages of both CPCs and PMMA cements by avoiding some of the respective shortcomings.
C1 [Mitzner, Elke; Pelt, Paco Albertus Hubert Maria; Mueller, Christian; Strohwig, Angela] Bond GmbH, D-10117 Berlin, Germany.
   [Mueller, Wolf-Dieter] Charite, Sch Dent, Dept Dent Mat & Biomat Res, D-14197 Berlin, Germany.
RP Mitzner, E (reprint author), Bond GmbH, D-10117 Berlin, Germany.
EM wolf-dieter.mueller@charite.de
CR Abdel-Kader KFM, 2001, J ARTHROPLASTY, V16, P811, DOI 10.1054/arth.2001.25561
   Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Arola D, 2006, J BIOMED MATER RES B, V76B, P287, DOI 10.1002/jbm.b.30364
   BERGER G, 1995, BIOMATERIALS, V16, P1241, DOI 10.1016/0142-9612(95)98131-W
   Bernstein A, 2008, J BIOMED MATER RES B, V86B, P422, DOI 10.1002/jbm.b.31037
   Blattert TR, 2003, EUR SPINE J, V12, P216, DOI 10.1007/s00586-002-0471-1
   Brook IM, 1998, BIOMATERIALS, V19, P565, DOI 10.1016/S0142-9612(98)00138-0
   CHARNLEY J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P340
   CHARNLEY J, 1975, J BONE JOINT SURG BR, V57, P245
   CHARNLEY J, 1960, BRIT MED J, V1, P821, DOI 10.1136/bmj.1.5176.821
   Chavali R, 2003, AM J NEURORADIOL, V24, P545
   Ciapetti G, 2000, J BIOMAT SCI-POLYM E, V11, P481, DOI 10.1163/156856200743823
   Currey J.D., 2002, BONES STRUCTURE MECH
   Deramond H, 1999, BONE S, V25, P17
   Dimai HP, 1998, CALCIFIED TISSUE INT, V62, P309, DOI 10.1007/s002239900437
   EGGERT A, 1974, CHIRURG, V45, P236
   Feith R, 1975, Acta Orthop Scand Suppl, V161, P3
   Glant TT1, 1996, AM J THER, V3, P27, DOI [DOI 10.1097/00045391-199601000-00006, 10.1097/00045391-199601000-00006]
   Gough JE, 2001, J BIOMED MATER RES, V57, P497, DOI 10.1002/1097-4636(20011215)57:4<497::AID-JBM1195>3.0.CO;2-U
   GRANCHI D, 1995, ORAL SURG ORAL MED O, V79, P359, DOI 10.1016/S1079-2104(05)80230-6
   Gravius S, 2007, Z ORTHOP UNFALLCHIR, V145, P579, DOI 10.1055/s-2007-965666
   Gross AE, 2005, ORTHOP CLIN N AM, V36, P49, DOI 10.1016/j.ocl.2004.06.009
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Knabe C, 2004, BIOMATERIALS, V25, P4911, DOI 10.1016/j.biomaterials.2004.01.059
   Knabe C, 2004, J BIOMED MATER RES A, V69A, P145, DOI 10.1002/jbm.a.20131
   Knabe C, 2004, BIOMATERIALS, V25, P335, DOI 10.1016/S0142-9612(03)00525-8
   Knabe C, 1998, J MATER SCI-MATER M, V9, P337, DOI 10.1023/A:1008854930676
   Kuhn K. D., 2000, BONE CEMENTS UP TO D
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Liso PA, 1997, BIOMATERIALS, V18, P15, DOI 10.1016/S0142-9612(96)00082-8
   MattioliBelmonte M, 1997, J MATER SCI-MATER M, V8, P85, DOI 10.1023/A:1018554715962
   MJOBERG B, 1984, ACTA ORTHOP SCAND, V55, P597, DOI 10.3109/17453678408992403
   MUELLER WD, 2005, Patent No. 1395261
   Ohtsuki C, 2007, J TISSUE ENG REGEN M, V1, P33, DOI 10.1002/term.3
   Ploska U, 1997, BIOMATERIALS, V18, P1671, DOI 10.1016/S0142-9612(97)00142-7
   Puska MA, 2003, BIOMATERIALS, V24, P417, DOI 10.1016/S0142-9612(02)00354-X
   Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.3.CO;2-Y
   Towler MR, 2006, J MATER SCI-MATER M, V17, P835, DOI 10.1007/s10856-006-9843-0
   Towler MR, 2004, BIO-MED MATER ENG, V14, P565
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   YAMAGUCHI M, 1988, BIOCHEM PHARMACOL, V37, P4075, DOI 10.1016/0006-2952(88)90098-6
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   Yang JM, 1998, J BIOMED MATER RES, V43, P54, DOI 10.1002/(SICI)1097-4636(199821)43:1<54::AID-JBM6>3.0.CO;2-L
NR 43
TC 6
Z9 6
U1 0
U2 2
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD OCT-DEC
PY 2009
VL 12
IS 4
BP 447
EP 454
DI 10.1590/S1516-14392009000400013
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 548PC
UT WOS:000273976800012
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Nomura, N
   Tanaka, Y
   Suyalatu
   Kondo, R
   Doi, H
   Tsutsumi, Y
   Hanawa, T
AF Nomura, Naoyuki
   Tanaka, Yuko
   Suyalatu
   Kondo, Ryota
   Doi, Hisashi
   Tsutsumi, Yusuke
   Hanawa, Takao
TI Effects of Phase Constitution of Zr-Nb Alloys on Their Magnetic
   Susceptibilities
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE zirconium-niobium alloy; magnetic susceptibility; omega phase; phase
   constitution; magnetic resonance imaging (MRI)
ID BIOMATERIALS; BEHAVIOR
AB The magnetic susceptibilities and microstructures of Zr-Nb binary alloys were investigated to develop a new metallic biomaterial with a low magnetic susceptibility for magnetic resonance imaging (MRI). The magnetic susceptibility was measured with a magnetic susceptibility balance, and the microstructure was evaluated with an X-ray diffractometer (XRD), an optical microscope (OM), and a transmission electron microscope (TEM). Zr-Nb alloys as-cast showed a minimum value of magnetic susceptibility between 3 and 9 mass% Nb, and the value abruptly increased up to 20 mass% Nb, followed by a gradual increase with the increase of the Nb content. XRD, OM, and TEM revealed that the minimum value of the susceptibility was closely related to the appearance of the athermal omega phase in the beta phase. Since the magnetic susceptibility of Zr-3Nb alloy consisting of an alpha' phase was as low as that of Zr-9Nb alloy consisting of the beta and omega phases, that of the omega phase was lower than that of the alpha' and beta phases. When Zr-16Nb alloy was heat-treated, the isothermal omega phase appeared, and, simultaneously, the magnetic susceptibility decreased. Therefore, the omega phase contributes to the decrease of the magnetic susceptibility, independently of the formation process of the omega phase. The magnetic susceptibility of the Zr-3Nb alloy as-cast was almost one-third that of Ti-6Al-4V alloy, which is commonly used for medical implant devices. Zr-Nb alloys are useful for medical devices used under MRI. [doi:10.2320/matertrans.M2009187]
C1 [Nomura, Naoyuki; Tanaka, Yuko; Suyalatu; Kondo, Ryota; Doi, Hisashi; Tsutsumi, Yusuke; Hanawa, Takao] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RP Nomura, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RI NOMURA, Naoyuki/L-7149-2017
OI Doi, Hisashi/0000-0003-0833-4809
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [18300160]; Iketani Science and Technology Foundation
FX The authors would like to thank Dr. S. Ichinose for the TEM
   observations. This work was partially supported by a Grant-in-Aid for
   Fundamental Scientific Research (Kiban B: No. 18300160) from the
   Ministry of Education, Culture, Sports, Science, and Technology of Japan
   as well as by a Grant-in-Aid from Iketani Science and Technology
   Foundation.
CR COLLINGS EW, 1974, PHYS REV B, V9, P3989, DOI 10.1103/PhysRevB.9.3989
   COLLINGS EW, 1979, METALL TRANS A, V10, P463, DOI 10.1007/BF02697074
   DOI H, 2005, J DENT MAT, V24, P184
   Ernstberger T, 2007, EUR SPINE J, V16, P179, DOI 10.1007/s00586-006-0064-5
   Ikeda M, 2007, MATER SCI FORUM, V561-565, P1435, DOI 10.4028/www.scientific.net/MSF.561-565.1435
   Massalski TB, 1986, BINARY ALLOY PHASE D, P171
   Matsuura H, 2005, NEUROL MED-CHIR, V45, P395, DOI 10.2176/nmc.45.395
   Matsuura H, 2002, J NEUROSURG, V97, P1472, DOI 10.3171/jns.2002.97.6.1472
   MOFFAT DL, 1988, METALL TRANS A, V19, P1687, DOI 10.1007/BF02645136
   NARASIMHAN SL, 1976, J MATER SCI, V11, P134, DOI 10.1007/BF00541085
   Ride D.R., 2006, CRC HDB CHEM PHYS
   SASS SL, 1972, J LESS-COMMON MET, V28, P157, DOI 10.1016/0022-5088(72)90177-4
   VOHRA YK, 1980, P 4 INT C TIT AM I M, P2999
   YAMAMOTO A, 2002, KINZOKU, V72, P20
NR 14
TC 33
Z9 33
U1 1
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD OCT
PY 2009
VL 50
IS 10
BP 2466
EP 2472
DI 10.2320/matertrans.M2009187
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 523JY
UT WOS:000272070600021
OA Bronze
DA 2018-10-20
ER

PT J
AU Chou, AI
   Akintoye, SO
   Nicoll, SB
AF Chou, A. I.
   Akintoye, S. O.
   Nicoll, S. B.
TI Photo-crosslinked alginate hydrogels support enhanced matrix
   accumulation by nucleus pulposus cells in vivo
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE Nucleus pulposus; Alginate; Hydrogel; Proteoglycan; Type II collagen;
   Young's modulus
ID INTERVERTEBRAL DISC CELLS; TISSUE ENGINEERING SCAFFOLDS; HYALURONIC-ACID
   HYDROGELS; EXTRACELLULAR-MATRIX; STEM-CELLS; PHOTOCROSSLINKABLE
   POLYSACCHARIDES; SULFATED GLYCOSAMINOGLYCANS; 3-DIMENSIONAL CULTURE;
   MECHANICAL-PROPERTIES; ANULUS FIBROSUS
AB Objective: Intervertebral disc (IVD) degeneration is a major health concern in the United States. Replacement of the nucleus pulposus (NP) with injectable biomaterials represents a potential treatment strategy for IVD degeneration. The objective of this study was to characterize the extracellular matrix (ECM) assembly and functional properties of NP cell-encapsulated, photo-crosslinked alginate hydrogels in comparison to ionically crosslinked alginate constructs.
   Methods: Methacrylated alginate was synthesized by esterification of hydroxyl groups with methacrylic anhydride. Bovine NP cells were encapsulated in alginate hydrogels by ionic crosslinking using CaCl(2) or through photo-crosslinking upon exposure to long-wave UV light in the presence of a photoinitiator. The hydrogels were evaluated in vitro by gross and histological analysis and in vivo using a murine subcutaneous pouch model. In vivo samples were analyzed for gene expression, ECM localization and accumulation, and equilibrium mechanical properties.
   Results: Ionically crosslinked hydrogels exhibited inferior proteoglycan accumulation in vitro and were unable to maintain structural integrity in vivo. In further studies, photo-crosslinked alginate hydrogels were implanted for up to 8 weeks to examine NP tissue formation. Photo-crosslinked hydrogels displayed temporal increases in gene expression and assembly of type II collagen and proteoglycans. Additionally, hydrogels remained intact over the duration of the study and the equilibrium Young's modulus increased from 1.24 +/- 0.09 kPa to 4.31 +/- 1.39 kPa, indicating the formation of functional matrix with properties comparable to those of the native NP.
   Conclusions: These findings support the use of photo-crosslinked alginate hydrogels as biomaterial scaffolds for NP replacement. (c) 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Chou, A. I.; Nicoll, S. B.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Akintoye, S. O.] Univ Penn, Dept Oral Med, Philadelphia, PA 19104 USA.
   [Nicoll, S. B.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Nicoll, SB (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM aic@seas.upenn.edu; akintoye@dental.upenn.edu; nicoll@seas.upenn.edu
FU NIH [EB002425]; Wallace H. Coulter Foundation
FX Funding sources: National Institutes of Health and the Wallace H.
   Coulter Foundation.
CR Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Baer AE, 2001, J ORTHOPAED RES, V19, P2, DOI 10.1016/S0736-0266(00)00003-6
   BAYLISS MT, 1988, SPINE, V13, P972, DOI 10.1097/00007632-198809000-00003
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Chou AI, 2008, TISSUE ENG PT A, V14, P2079, DOI 10.1089/ten.tea.2007.0337
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Gruber HE, 1997, MATRIX BIOL, V16, P285, DOI 10.1016/S0945-053X(97)90016-0
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   JENSEN MC, 1994, MAGN RESON QUART, V10, P173
   Johannessen W, 2004, T ORTHOP RES SOC, V29, P1150
   KESTLE JRW, 1989, J NEUROSURG, V71, P938, DOI 10.3171/jns.1989.71.6.0938
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   LEE CK, 1988, SPINE, V13, P375, DOI 10.1097/00007632-198803000-00029
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   Maguire T, 2007, BIOTECHNOL BIOENG, V98, P631, DOI 10.1002/bit.21435
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Melrose J, 2003, EUR SPINE J, V12, P57, DOI 10.1007/s00586-002-0434-6
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Mizuno H, 2004, SPINE, V29, P1297
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   OEGEMA TR, 1993, CLIN SPORT MED, V12, P419
   Perka C, 2001, TISSUE ENG, V7, P359, DOI 10.1089/10763270152044215
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2006, BIOMATERIALS, V27, P346, DOI 10.1016/j.biomaterials.205.06.040
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   Umehara S, 1996, SPINE, V21, P811, DOI 10.1097/00007632-199604010-00007
   URBAN JPG, 1993, MUSCULOSKELETAL SOFT-TISSUE AGING: IMPACT ON MOBILITY, P391
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003
   Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4
NR 63
TC 63
Z9 65
U1 1
U2 56
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD OCT
PY 2009
VL 17
IS 10
BP 1377
EP 1384
DI 10.1016/j.joca.2009.04.012
PG 8
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 513OR
UT WOS:000271332900019
PM 19427928
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Black, B
AF Black, Bruce
TI Use of Titanium in Repair of External Auditory Canal Defects
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE Canal; Cholesteatoma; Reconstruction; Titanium
ID WALL RECONSTRUCTION; MESH; SURGERY
AB Introduction: Canal wall defect repairs commonly result from cholesteatoma, surgery for chronic ear disease, or exostosis and also from congenital deformities. Reconstructions of these defects are often difficult and unstable. This article reports the use of titanium sheeting to repair external auditory canal wall defects.
   Methods: Titanium sheeting was used to repair a variety of wall defects. The sheeting was used as a support material, lying deep to the wall defect, which was sealed with an autograft cartilage layer that was fitted to fill the defect. Middle temporal or temporalis fascia vascular flaps were used to cover large-defect repairs to promote rapid healing. The sheeting was used in 56 external auditory canal defect cases, including 35 deep canal defects, 4 lateral bony wall repairs, 12 open-cavity reconstructions, and 5 anterior wall repairs.
   Results: There were no evident biomaterial complications, and infection was absent from the series. The sheeting was simpler touse than ceramics, being easily shaped and bent to fit the individual case. Second-look cavity reinspections were simpler than when ceramics or autografts had been used for reconstructions.
   Discussion & Conclusion: Titanium sheeting has been proven an effective method of canal wall repair when combined with the supplementary techniques used with biomaterials in this role (cartilage cover and vascular flaps). Its ease of use, versatility, and reliability are superior to previous organic or ceramic methods.
C1 [Black, Bruce] Royal Childrens Hosp, Dept Otolaryngol, Brisbane, Qld, Australia.
   [Black, Bruce] Univ Queensland, Brisbane, Qld, Australia.
RP Black, B (reprint author), 6-101 Wickham Terr,Spring Hill, Brisbane, Qld 4000, Australia.
EM bruceblackmd@bigpond.com
RI BLACK, BRUCE/G-4636-2012
CR Black B, 1998, AM J OTOL, V19, P420
   BLACK B, 1994, AM J OTOL, V15, P91
   Black B, 1995, LARYNGOSCOPE, V105, P1, DOI 10.1288/00005537-199512000-00023
   BLACK B, 1992, AM J OTOL, V13, P273
   BLACK B, 1991, J OTOLARYNGOL SOC AU, V6, P435
   BLACK B, 2001, P 6 INT C CHOL EAR S, P813
   Black Bruce, 1998, American Journal of Otology, V19, P551
   Jung TTK, 2004, ACTA OTO-LARYNGOL, V124, P440, DOI 10.1080/00016480410016450
   Magnan J, 1995, Rev Laryngol Otol Rhinol (Bord), V116, P19
   MEYER JM, 2001, P 6 INT C CHOL EAR S, P833
   SADE J, 1982, CHOLESTEATOMA MASTOI, P511
   SANNA M, 1986, AM J OTOL, V1, P74
   Sudhoff H, 2006, J LARYNGOL OTOL, V120, P832, DOI 10.1017/S0022215106001927
   Zini C, 2002, LARYNGOSCOPE, V112, P753, DOI 10.1097/00005537-200204000-00029
NR 14
TC 8
Z9 8
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD OCT
PY 2009
VL 30
IS 7
BP 930
EP 935
DI 10.1097/MAO.0b013e3181b4eee0
PG 6
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 586QN
UT WOS:000276926500010
PM 19730144
DA 2018-10-20
ER

PT J
AU Bajpai, AK
   Bundela, H
AF Bajpai, A. K.
   Bundela, H.
TI Development of Poly(acrylamide)-Hydroxyapatite Composites as Bone
   Substitutes: Study of Mechanical and Blood Compatible Behavior
SO POLYMER COMPOSITES
LA English
DT Article
ID X-RAY-DIFFRACTION; WATER SORPTION; POLYMER NETWORKS; POLY(2-HYDROXYETHYL
   METHACRYLATE); STATISTICAL-MECHANICS; SPONGY CRYOGELS; HYDROXYAPATITE;
   POLYACRYLAMIDE; ACRYLAMIDE; HYDROGEL
AB The Hydroxyapatite (HAp) serves as potential biomaterial in various biomedical applications. This study is a continuing attempt to design the biomimetic bone-like composite materials. The authors have tried to develop HAp/Polyacrylamide (PAm) composites with different weight ratios through a suspension polymerization method. The prepared composite materials were characterized by Fourier transform infrared spectroscopy, X-ray diffraction analysis, thermogravimetric analysis, scanning electron microscopy, optical microscopy techniques, and compressive strength tests. The composites were also studied for water sorption capacity and the water sorption data were used to evaluate network parameters revealing the internal chemical architecture of the composite. In vitro tests were carried out to study water uptake and dissolution profiles of HAp/PAm composites. Furthermore, in vitro blood compatibility of the composites was also judged using protein adsorption, percentage haemolysis, blood clot formation, and platelet adhesion tests. The results obtained fairly support the objectives of the study to meet physiochemical and biological concerns for a bone-like material. POLYM. COMPOS., 30:1532-1543,2009. (C) 2009 Society of Plastics Engineers
C1 [Bajpai, A. K.; Bundela, H.] Govt Model Sci Coll, Bose Mem Res Lab, Dept Chem, Jabalpur, Madhya Pradesh, India.
RP Bajpai, AK (reprint author), Govt Model Sci Coll, Bose Mem Res Lab, Dept Chem, Jabalpur, Madhya Pradesh, India.
EM akbmrl@yahoo.co.in
FU BRNS (Board of Research in Nuclear Sciences Bhabha Atomic Research
   Center, Mumbai, India) [2005/35/26-BRNS/RTAC]
FX BRNS (Board of Research in Nuclear Sciences Bhabha Atomic Research
   Center, Mumbai, India); contract grant number: 2005/35/26-BRNS/RTAC.
CR AKOI H, 1994, SCI MED APPL HYDROXY
   ALMEDIA CC, 2005, BRAZ DENT J, V16, P75
   Bajpai A, 2005, POLYM INT, V54, P796, DOI 10.1002/pi.1773
   Bajpai AK, 2007, J APPL POLYM SCI, V104, P1559, DOI 10.1002/app.25580
   Bajpai AK, 2007, POLYM INT, V56, P557, DOI 10.1002/pi.2171
   Bajpai AK, 2006, J MATER SCI-MATER M, V17, P49, DOI 10.1007/s10856-006-6329-z
   Bajpai AK, 2005, POLYM INT, V54, P1347, DOI 10.1002/pi.1839
   Bajpai AK, 2005, POLYM INT, V54, P1233, DOI 10.1002/pi.1813
   Bajpai AK, 2004, J MATER SCI-MATER M, V15, P583, DOI 10.1023/B:JMSM.0000026380.40151.28
   Bajpai AK, 2001, J APPL POLYM SCI, V81, P1238, DOI 10.1002/app.1546
   Bajpai AK, 2007, POLYM INT, V56, P231, DOI 10.1002/pi.2137
   BARRALET J, 1998, J BIOMED MATER RES, V41, P77
   Bera P, 1998, POLYMER, V39, P1461, DOI 10.1016/S0032-3861(97)00359-5
   BLAKESLEE KC, 1971, J AM CERAM SOC, V54, P559, DOI 10.1111/j.1151-2916.1971.tb12207.x
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Flory PJ, 1943, J CHEM PHYS, V11, P512, DOI 10.1063/1.1723791
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Huang M, 2003, J MATER SCI-MATER M, V14, P655, DOI 10.1023/A:1024087410890
   ILMAIN F, 1991, NATURE, V349, P400, DOI 10.1038/349400a0
   ISHIKAWA T, 1989, LANGMUIR, V5, P140, DOI 10.1021/la00085a025
   Jalota S, 2007, J BIOMED MATER RES B, V80B, P304, DOI 10.1002/jbm.b.30598
   Jha SK, 2005, J BIOCHEM BIOPH METH, V62, P215, DOI 10.1016/j.jbbm.2004.11.006
   Jiang YB, 2007, CRYST RES TECHNOL, V42, P673, DOI 10.1002/crat.200610887
   JUANZHANG, 2004, MATER LETT, V58, P719
   Koumoulidis GC, 2001, J AM CERAM SOC, V84, P1203
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   LEGEROS RZ, 1965, NATURE, V206, P403, DOI DOI 10.1038/206403A0
   LI Z, 2004, J MATER SCI-MATER M, V15, P1
   Magnussen RA, 2005, J ORTHOP RES, V23, P576, DOI 10.1016/j.orthres.2004.12.006
   Mahadaviniya G. R., 2004, POLYM AVD TECH, V15, P173
   Maria V. R., 2004, PROG SOLID STATE CHE, V32, P1
   Mayer I, 2000, J CRYST GROWTH, V219, P98, DOI 10.1016/S0022-0248(00)00608-4
   Murugan R, 2006, MATER LETT, V60, P2844, DOI 10.1016/j.matlet.2006.01.104
   Murugan R, 2006, ACTA BIOMATER, V2, P201, DOI 10.1016/j.actbio.2005.09.005
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Murugan R, 1998, J KOREAN PHYS SOC, V32, P505
   Murugan R, 2004, ENCY NANOSCIENCE NAN, P595
   Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2
   Pourjavadi A, 2006, TURK J CHEM, V30, P595
   Prabakaran K., 2006, TRENDS BIOMATERIALS, V19, P84
   RAHAMAN MN, 1995, CERAMICS PROCESSING
   Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7
   SANG Y, 2002, MAT RES SOC S P, V724
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   Song J, 2003, J AM CHEM SOC, V125, P1236, DOI 10.1021/ja028559h
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Takata S, 1999, MACROMOLECULES, V32, P3989, DOI 10.1021/ma990188a
   Takeda M, 2000, MACROMOLECULES, V33, P2909, DOI 10.1021/ma9921044
   Tas AC, 2004, KEY ENG MATER, V264-268, P2079, DOI 10.4028/www.scientific.net/KEM.264-268.2079
   TAS AC, 2000, BIOMATERIALS, V2, P11429
   Victoria E. Caroline, 2002, TRENDS BIOMATER ARTI, V16, P12
   Vijayalakshmi U, 2006, TRENDS BIOMATER ARTI, V19, P57
   Wang YJ, 2007, MATER LETT, V61, P1071, DOI 10.1016/j.matlet.2006.06.042
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 58
TC 8
Z9 8
U1 1
U2 12
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0272-8397
J9 POLYM COMPOSITE
JI Polym. Compos.
PD OCT
PY 2009
VL 30
IS 10
BP 1532
EP 1543
DI 10.1002/pc.20726
PG 12
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 500VJ
UT WOS:000270333400022
DA 2018-10-20
ER

PT J
AU Moldovan, S
AF Moldovan, Sebastian
TI ORGAN TRANSPLANTATION AND THE ORTHODOX CHRISTIAN ARGUMENT FOR LOVE
SO REVISTA ROMANA DE BIOETICA
LA English
DT Article
DE transplantation; altruism; anonymity; kinship; Christian Orthodox
AB The current clinical and ideological situation of human organs transplantations (OT) is characterized by a chronic "organ shortage" and by the increasing dispute between the promoters of legally regulated organ markets and those who oppose them in the name of socially mobilized altruistic donation. After identifying the causes that makes altruism the only motivation globally admitted, I will proceed to the analysis of the role this virtue plays as a Christian argument, in three bioethical documents issued by local Orthodox Churches (the Greek, Russian and Romanian), and in the bioethical stances adopted by Nikolaos Hatzinikolaou (chairman of the Committee for Bioethics in the Greek Orthodox Church). In Orthodox Christian spirituality, self-offering represents the utmost act of love, yet this does not per se warrant OT as the humankind's novel strategy to deal with death. Unlike both individualism and communitarianism, for which OT transfers a biomaterial anonymously, Christian love bestows privilege on human personal relationships and identifies an eternal kinship in the bio-transfer.
C1 Lucian Blaga Univ Sibiu, Andrei Saguna Fac Orthodox Theol, Sibiu, Romania.
RP Moldovan, S (reprint author), Lucian Blaga Univ Sibiu, Andrei Saguna Fac Orthodox Theol, Sibiu, Romania.
EM smoldova@yahoo.com
CR Abouna GM, 2001, TRANSPLANT INT, V14, P117, DOI 10.1007/s001470050859
   ANDRONIKOF M, 1993, TRANSPLANTATION ORGA
   [Anonymous], 2008, CLIN J AM SOC NEPHRO, V3, P1227, DOI 10.2215/CJN.03320708
   Bruzzone P, 2008, TRANSPL P, V40, P1064, DOI 10.1016/j.transproceed.2008.03.049
   BUTA MG, 2008, REV ROM BIOETICA, V6
   deSilva David A, 2000, HONOR PATRONAGE KINS
   Frunza M, 2009, J STUDY RELIG IDEOL, V8, P3
   HATZINIKOLAOU N, 2007, REV BIOETICA TEOLOGI, V1, P55
   KUCZEWSKI GM, 2002, AM J BIOETHICS, V2, P53
   Lock M, 2002, QUAL HEALTH RES, V12, P1406, DOI 10.1177/1049732302238751
   Lock Margaret, 2008, Transplant Rev (Orlando), V22, P154, DOI 10.1016/j.trre.2008.04.007
   MATOKA MC, 2006, MORTALITY, V11, P166
   MOLDOVAN S, 2004, PROBLEMATICA ANTROPO, P250
   MOLDOVAN S, 2009, MED SI BISERICA, V7, P108
   RADUCA V, 2004, ORTODOXIA, V55, P116
   Sanner MA, 2006, MORTALITY, V11, P133, DOI DOI 10.1080/13576270600615351
   Scheper-Hughes N, 2007, AM J TRANSPLANT, V7, P507, DOI 10.1111/j.1600-6143.2006.01679.x
   SHARP LA, 2006, STANGE HARVEST ORGAN
   2008, CONTROVERSIES DETERM
   2002, EKKLESIA KAI METAMOS
   2002, GANDIREA SOCIALA BIS, P246
NR 21
TC 3
Z9 3
U1 0
U2 3
PU COLEGIUL MEDICILOR IASI
PI IASI
PA STR CAROL I, NR. 3-5, IASI, 00000, ROMANIA
SN 1583-5170
J9 REV ROM BIOET
JI Rev. Rom. Bioet.
PD OCT-DEC
PY 2009
VL 7
IS 4
BP 185
EP 197
PG 13
WC Ethics; Medical Ethics; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Biomedical Social
   Sciences
GA 550CT
UT WOS:000274106600011
DA 2018-10-20
ER

PT J
AU Cacchioli, A
   Ravanetti, F
   Bagno, A
   Dettin, M
   Gabbi, C
AF Cacchioli, Antonio
   Ravanetti, Francesca
   Bagno, Andrea
   Dettin, Monica
   Gabbi, Carlo
TI Human Vitronectin-Derived Peptide Covalently Grafted onto Titanium
   Surface Improves Osteogenic Activity: A Pilot In Vivo Study on Rabbits
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID OSTEOBLAST-ADHESIVE PEPTIDES; BONE-FORMATION; CHEMICAL-MODIFICATION;
   ENDOSSEOUS IMPLANTS; SYNTHETIC PEPTIDES; RGD PEPTIDE; BIOMATERIALS;
   ORGANIZATION; HISTOMORPHOMETRY; MINERALIZATION
AB Peptide and protein exploitation for the biochemical functionalization of biomaterial surfaces allowed fabricating biomimetic devices able to evoke and promote specific and advantageous cell functions in vitro and in vivo. In particular, cell adhesion improvement to support the osseointegration of implantable devices has been thoroughly investigated. This study was aimed at checking the biological activity of the (351-359) human vitronectin precursor (HVP) sequence, mapped on the human vitronectin protein; the peptide was covalently linked to the surface of titanium cylinders, surgically inserted in the femurs of New Zealand white rabbits and analyzed at short experimental time points (4, 9, and 16 days after surgery). To assess the osteogenic activity of the peptide, three vital fluorochromic bone markers were used (calcein green, xylenol orange, and calcein blue) to stain the areas of newly grown bone. Static and dynamic histomorphometric parameters were measured at the bone-implant interface and at different distances from the surface. The biological role of the (351-359) HVP sequence was checked by comparing peptide-grafted samples and controls, analyzing how and how much its effects change with time across the bone regions surrounding the implant surface. The results obtained reveal a major activity of the investigated peptide 4 days after surgery, within the bone region closest to the implant surface, and larger bone to implant contact 9 and 16 days after surgery. Thus, improved primary fixation of endosseous devices can be foreseen, resulting in an increased osteointegration.
C1 [Bagno, Andrea; Dettin, Monica] Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
   [Cacchioli, Antonio; Ravanetti, Francesca; Gabbi, Carlo] Univ Parma, Dept Anim Hlth, I-43100 Parma, Italy.
RP Bagno, A (reprint author), Univ Padua, Dept Chem Proc Engn, Via Marzolo 9, I-35131 Padua, Italy.
EM andrea.bagno@unipd.it
OI Bagno, Andrea/0000-0002-4296-3601
FU University of Padova [60A10-1194]
FX This work has been in part supported by a grant from the University of
   Padova (Progetto ex 60% 60A10-1194). The authors wish to thank Prof.
   Ezio Bottarelli (Full Professor of Infectious Diseases of Domestic
   Animals, Department of Animal Heath, University of Parma) for his
   assistance in the statistical analysis.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BAGNO A, 2003, BIOCERAMIC SURFACES, P113
   Bagno A, 2007, BONE, V41, P704, DOI 10.1016/j.bone.2007.06.008
   Bagno A, 2007, BONE, V40, P693, DOI 10.1016/j.bone.2006.10.007
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Bigi A, 1998, J BIOMED MATER RES, V41, P289, DOI 10.1002/(SICI)1097-4636(199808)41:2<289::AID-JBM14>3.0.CO;2-G
   Brunette DM, 2001, TITANIUM MED, P457
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   DETTIN M, 2008, J BIOMED MAT RES A
   Dettin M, 2006, TISSUE ENG, V12, P3509, DOI 10.1089/ten.2006.12.3509
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Franchi M, 2005, MICRON, V36, P665, DOI 10.1016/j.micron.2005.05.010
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Giavaresi G, 2003, J BIOMED MATER RES A, V67A, P112, DOI 10.1002/jbm.a.10044
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Lee SJ, 2000, YONSEI MED J, V41, P704, DOI 10.3349/ymj.2000.41.6.704
   Merolli A, 2006, J MATER SCI-MATER M, V17, P789, DOI 10.1007/s10856-006-9836-z
   Merolli A, 2005, J ORTHOP TRAUMATOL, V6, P179, DOI 10.1007/s10195-005-0105-6
   Merolli A, 2001, J MATER SCI-MATER M, V12, P775, DOI 10.1023/A:1017912716351
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P595, DOI 10.1034/j.1600-0501.2002.130604.x
   Overgaard S, 2000, J ORTHOP RES, V18, P313, DOI 10.1002/jor.1100180221
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008
   PAZZAGLIA UE, 1989, J BIOMED MATER RES, V23, P1289, DOI 10.1002/jbm.820231106
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   RAHN BA, 1971, STAIN TECHNOL, V46, P125, DOI 10.3109/10520297109067836
   Rahn BA, 2003, EUR CELLS MATER, V5, P41
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   RECKER RR, 1983, BONE HISTOMORPHOMETR
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   Schnitzler CM, 2006, CALCIFIED TISSUE INT, V79, P373, DOI 10.1007/s00223-006-0053-z
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Thorwarth M, 2005, BIOMATERIALS, V26, P5648, DOI 10.1016/j.biomaterials.2005.02.023
   Tweden K S, 1995, J Heart Valve Dis, V4 Suppl 1, pS90
NR 47
TC 22
Z9 22
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD OCT
PY 2009
VL 15
IS 10
BP 2917
EP 2926
DI 10.1089/ten.tea.2008.0542
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 503QG
UT WOS:000270553200014
PM 19290802
DA 2018-10-20
ER

PT J
AU Yang, JM
   Chiang, CY
   Wang, HZ
   Yang, CC
AF Yang, Jen Ming
   Chiang, Chin Yuan
   Wang, Hung Zen
   Yang, Chun Chen
TI Two step modification of poly(vinyl alcohol) by UV radiation with
   2-hydroxy ethyl methacrylate and sol-gel process for the application of
   polymer electrolyte membrane
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE Poly(vinyl alcohol); Poly(2-hydroxy ethyl methacrylate); Sol-gel
   process; Ionic conductivity; Alkaline solid polymer electrolyte membrane
ID SBS-G-VP; ALKALINE POLYVINYL-ALCOHOL; DMAEMA COPOLYMER MEMBRANE;
   POLYURETHANE MEMBRANE; POLY(ETHYLENE OXIDE); SECONDARY BATTERIES;
   METHANOL TRANSPORT; POLY(ACRYLIC ACID); BIOMATERIAL USAGE; HYBRID
   MEMBRANES
AB Two step modification of poly(vinyl alcohol) (PVA) by UV radiation and sol-gel process was used to prepare the modified PVA membranes. From the first step modification of PVA by UV radiation with 2-hydroxy ethyl methacrylate (HEMA) monomer, the poly(2-hydroxy ethyl methacrylate) (PHEMA) modified poly(vinyl alcohol), PVAHEMA, was obtained and characterized by Fourier transfer infrared spectra (FTIR) and optical polarizing microscopy for the chemical compositions and morphology. With the second step modification of sot-gel process, the organic-inorganic hybrid sol-gel material, PVAHEMA-SiO(2) was prepared. Both of the modified PVA, (PVAHEMA and PVAHEMA-SiO(2)), were characterized by xray diffraction (XRD), differential scanning calorimetry (DSC), and thermogravimetry analysis (TGA). To prepare the alkaline solid polymer electrolyte, the various PVAHEMA and PVAHEMA-SiO(2) membranes were immersed in 40 wt% KOH solution to form the KOH containing polymer electrolyte membranes And then their performances were conducted with ac impedance spectroscopy to evaluate the ionic conductivity through the membranes. At room temperature, the ionic conductivity increased from 0.044 to 0.073 S/cm for the PVAHEMA membrane; whereas the ionic conductivity was about 0.11 S/cm for the PVAHEMA-SiO(2) membranes. Compared to other reports in references, our hybrid sol-gel membrane is a highly ionic conducting alkaline solid polymer electrolytes membrane. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Yang, Jen Ming; Chiang, Chin Yuan; Wang, Hung Zen] Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
   [Yang, Chun Chen] Ming Chi Univ Technol, Dept Chem Engn, Taipei 243, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
FU National Science Council of the Republic of China; Chang Gung Memorial
   Hospital
FX This work was supported by National Science Council of the Republic of
   China and partial financial support of Chang Gung Memorial Hospital.
CR ANDRIEU X, 1995, ELECTROCHIM ACTA, V40, P2295, DOI 10.1016/0013-4686(95)00181-D
   Asensio JA, 2004, ELECTROCHIM ACTA, V49, P4461, DOI 10.1016/j.electacta.2004.05.002
   Bae B, 2003, J MEMBRANE SCI, V220, P75, DOI 10.1016/S0376-7388(03)00216-3
   Carretta N, 2000, J MEMBRANE SCI, V166, P189, DOI 10.1016/S0376-7388(99)00258-6
   FAUVARQUE JF, 1995, ELECTROCHIM ACTA, V40, P2449, DOI 10.1016/0013-4686(95)00212-W
   FENTON DE, 1973, POLYMER, V14, P589, DOI 10.1016/0032-3861(73)90146-8
   Guinot S, 1998, ELECTROCHIM ACTA, V43, P1163, DOI 10.1016/S0013-4686(97)10015-9
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Kim DS, 2005, SOLID STATE IONICS, V176, P117, DOI 10.1016/j.ssi.2004.07.011
   Kim DS, 2004, J MEMBRANE SCI, V240, P37, DOI 10.1016/j.memsci.2004.04.010
   Kim JH, 2001, J MEMBRANE SCI, V193, P209, DOI 10.1016/S0376-7388(01)00514-2
   Kobayashi T, 1998, SOLID STATE IONICS, V106, P219, DOI 10.1016/S0167-2738(97)00512-2
   Lee HC, 2004, ELECTROCHIM ACTA, V49, P2315, DOI 10.1016/j.electacta.2004.01.012
   Lewandowski A, 2000, SOLID STATE IONICS, V133, P265, DOI 10.1016/S0167-2738(00)00733-5
   Lewandowski A, 2001, ELECTROCHIM ACTA, V46, P2777, DOI 10.1016/S0013-4686(01)00496-0
   Mohamad AA, 2003, SOLID STATE IONICS, V156, P171, DOI 10.1016/S0167-2738(02)00617-3
   Murata K, 2000, ELECTROCHIM ACTA, V45, P1501, DOI 10.1016/S0013-4686(99)00365-5
   Peyser P., 1989, POLYM HDB
   Rajendran S, 2004, MATER LETT, V58, P641, DOI 10.1016/S0167-577X(03)00585-8
   Rhim JW, 2004, J MEMBRANE SCI, V238, P143, DOI 10.1016/j.memsci.2004.03.030
   Sasikumar G., 2004, ELECTROCHIM ACTA, V50, P598
   Shao CL, 2003, MATER LETT, V57, P1579, DOI 10.1016/S0167-577X(02)01036-4
   SIAO J, 2005, POLYMER, V46, P10809
   Subramania A, 2005, J POWER SOURCES, V141, P188, DOI 10.1016/j.powsour.2004.09.001
   Vassal N, 2000, ELECTROCHIM ACTA, V45, P1527, DOI 10.1016/S0013-4686(99)00369-2
   Wright P. V., 1975, British Polymer Journal, V7, P319, DOI 10.1002/pi.4980070505
   Wu GM, 2006, J MEMBRANE SCI, V284, P120, DOI 10.1016/j.memsci.2006.07.025
   Yang CC, 2006, J APPL ELECTROCHEM, V36, P655, DOI 10.1007/s10800-006-9117-z
   Yang CC, 2005, J POWER SOURCES, V152, P303, DOI 10.1016/j.jpowsour.2005.03.004
   Yang CC, 2004, MATER LETT, V58, P33, DOI 10.1016/S0167-577X(03)00409-9
   Yang CC, 2003, J POWER SOURCES, V122, P210, DOI 10.1016/S0378-7753(03)00429-4
   Yang CC, 2002, MATER LETT, V57, P873, DOI 10.1016/S0167-577X(02)00888-1
   Yang CC, 2002, J POWER SOURCES, V109, P22, DOI 10.1016/S0378-7753(02)00038-1
   Yang CC, 2002, J POWER SOURCES, V112, P497, DOI 10.1016/S0378-7753(02)00438-X
   Yang CC, 2006, MAT SCI ENG B-SOLID, V131, P256, DOI 10.1016/j.mseb.2006.04.036
   Yang CC, 2009, J POWER SOURCES, V188, P30, DOI 10.1016/j.jpowsour.2008.11.098
   Yang JM, 2008, J MEMBRANE SCI, V322, P74, DOI 10.1016/j.memsci.2008.05.035
   Yang JM, 1997, ANGEW MAKROMOL CHEM, V251, P49, DOI 10.1002/apmc.1997.052510105
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang JM, 1997, J APPL POLYM SCI, V65, P365, DOI 10.1002/(SICI)1097-4628(19970711)65:2<365::AID-APP17>3.0.CO;2-Z
   Yang JM, 1997, J BIOMED MATER RES, V38, P143
   Yang JM, 1997, ANGEW MAKROMOL CHEM, V251, P61, DOI 10.1002/apmc.1997.052510106
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 2003, J BIOMED MATER RES A, V64A, P138, DOI 10.1002/jbm.a.10245
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 2005, J MEMBRANE SCI, V258, P97, DOI 10.1016/j.memsci.2005.02.033
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 54
TC 21
Z9 22
U1 3
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD SEP 30
PY 2009
VL 341
IS 1-2
BP 186
EP 194
DI 10.1016/j.memsci.2009.06.004
PG 9
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 481AD
UT WOS:000268777800024
DA 2018-10-20
ER

PT J
AU Kim, DH
   Kim, YS
   Amsden, J
   Panilaitis, B
   Kaplan, DL
   Omenetto, FG
   Zakin, MR
   Rogers, JA
AF Kim, Dae-Hyeong
   Kim, Yun-Soung
   Amsden, Jason
   Panilaitis, Bruce
   Kaplan, David L.
   Omenetto, Fiorenzo G.
   Zakin, Mitchell R.
   Rogers, John A.
TI Silicon electronics on silk as a path to bioresorbable, implantable
   devices
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID FIBROIN; FILMS; BIOMATERIAL; DEGRADATION
AB Many existing and envisioned classes of implantable biomedical devices require high performance electronics/sensors. An approach that avoids some of the longer term challenges in biocompatibility involves a construction in which some parts or all of the system resorbs in the body over time. This paper describes strategies for integrating single crystalline silicon electronics, where the silicon is in the form of nanomembranes, onto water soluble and biocompatible silk substrates. Electrical, bending, water dissolution, and animal toxicity studies suggest that this approach might provide many opportunities for future biomedical devices and clinical applications. (C) 2009 American Institute of Physics. [doi: 10.1063/1.3238552]
C1 [Kim, Dae-Hyeong; Kim, Yun-Soung; Rogers, John A.] Univ Illinois, Dept Mat Sci, Urbana, IL 61801 USA.
   [Kim, Dae-Hyeong; Kim, Yun-Soung; Rogers, John A.] Univ Illinois, Dept Engn, Beckman Inst, Urbana, IL 61801 USA.
   [Kim, Dae-Hyeong; Kim, Yun-Soung; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.
   [Amsden, Jason; Panilaitis, Bruce; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zakin, Mitchell R.] Def Adv Res Projects Agcy, Arlington, VA 22203 USA.
   [Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
   [Rogers, John A.] Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61801 USA.
RP Rogers, JA (reprint author), Univ Illinois, Dept Mat Sci, 1304 W Green St, Urbana, IL 61801 USA.
EM jrogers@uiuc.edu
RI Amsden, Jaosn/B-3701-2011; Rogers, John/L-2798-2016
FU MURI Award on Silicon Nanomembranes; U. S. Department of Energy,
   Division of Materials Sciences [DE-FG02-07ER46471]; University of
   Illinois at Urbana-Champaign [DE-FG02-07ER46453]; U. S. Army Research
   Laboratory; U. S. Army Research Office [W911 NF07-1-0618]; DARPA-DSO
FX We thank T. Banks and B. Sankaran for processing by use of facilities at
   the Frederick Seitz Materials Research Laboratory. This material is
   based upon work supported a MURI Award on Silicon Nanomembranes and by
   the U. S. Department of Energy, Division of Materials Sciences under
   Award No. DE-FG02-07ER46471, through the Materials Research Laboratory
   and Center for Microanalysis of Materials (DE-FG02-07ER46453) at the
   University of Illinois at Urbana-Champaign. The aspects of the work
   relating to silk are supported by the U. S. Army Research Laboratory and
   the U. S. Army Research Office under Contract No. W911 NF07-1-0618 and
   by the DARPA-DSO. The views, opinions, and/or findings contained in this
   article/presentation are those of the authors and should not be
   interpreted as representing the official views or policies, either
   expressed or implied, of the Defense Advanced Research Projects Agency
   or the Department of Defense.
CR BAO Z, 2009, COMMUNICATION   0717
   Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995
   Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kim DH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963364
   Kim DH, 2008, P NATL ACAD SCI USA, V105, P18675, DOI 10.1073/pnas.0807476105
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Sun YG, 2007, ADV MATER, V19, P1897, DOI 10.1002/adma.200602223
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wise KD, 2008, P IEEE, V96, P1184, DOI 10.1109/JPROC.2008.922564
   Yeager JD, 2008, J NEUROSCI METH, V173, P279, DOI 10.1016/j.jneumeth.2008.06.024
NR 14
TC 87
Z9 89
U1 8
U2 82
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD SEP 28
PY 2009
VL 95
IS 13
AR 133701
DI 10.1063/1.3238552
PG 3
WC Physics, Applied
SC Physics
GA 502KL
UT WOS:000270458000089
OA Green Published
DA 2018-10-20
ER

PT J
AU Almeida, LH
   Grandini, CR
   Caram, R
AF Almeida, L. H.
   Grandini, C. R.
   Caram, R.
TI Anelastic spectroscopy in a Ti alloy used as biomaterial
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT 15th International Conference on Internal Friction and Mechanical
   Spectroscopy (ICIFMS-15)
CY JUL 20-25, 2008
CL Perugia, ITALY
SP Perugia Univ, Phys Dept, CNISM
DE Anelasticity; Ti alloys; Snoek effect; Interstitials; Biomaterials
ID OXYGEN-OXYGEN INTERACTION; HIGH-DAMPING ALLOYS; INTERNAL-FRICTION; SNOEK
   RELAXATION; INTERSTITIAL ATOMS; BCC METALS; NIOBIUM; NITROGEN
AB Ti and its alloys have been used thoroughly in the production of prostheses and dental implants due to their properties, such as high corrosion resistance, low elasticity modulus and high mechanical strength/density relation. Among the Ti-based alloys, the Ti-35Nb-7Zr-5Ta (TNZT) is one that presents the smallest elasticity modulus, making it an excellent alternative to be used as a biomaterial. In this paper, mechanical spectroscopy measurements were made in TNZT alloys containing several quantities of oxygen and nitrogen in solid solution. Mechanical spectroscopy measurements were made by using a torsion pendulum, operating at an oscillation frequency in the interval 4-30 Hz, temperature in the range 100-700 K, heating rate of about 1 K/min and vacuum lower than 10(-5) Torr. Complex relaxation structures and a reduction in the elasticity modulus were observed for the heat-treated and doped samples. The observed peaks were associated with the interactions of interstitial atoms and the alloy elements. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Almeida, L. H.; Grandini, C. R.] UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
   [Caram, R.] Univ Estadual Campinas, Dept Mat Engn, BR-13083970 Campinas, SP, Brazil.
RP Grandini, CR (reprint author), UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
EM betog@fc.unesp.br
RI Grandini, Carlos Roberto/A-3790-2008; Caram, Rubens/C-2068-2012
OI Grandini, Carlos Roberto/0000-0002-3336-309X; Caram,
   Rubens/0000-0001-6996-5116
CR AHMAD MS, 1970, J PHYS CHEM SOLIDS, V31, P1799, DOI 10.1016/0022-3697(70)90170-8
   Almeida LH, 2004, MAT SCI ENG A-STRUCT, V370, P96, DOI 10.1016/j.msea.2003.08.085
   ALMEIDA LH, 2005, MAT SCI ENG A-STRUCT, V412, P230
   BERRY BS, 1962, ACTA METALL MATER, V10, P271, DOI 10.1016/0001-6160(62)90002-0
   BERRY BS, 1994, J PHYS CHEM SOLIDS, V55, P1479, DOI 10.1016/0022-3697(94)90573-8
   Blanter MS, 2007, SPRINGER SER MATER S, V90, pVII, DOI 10.1007/978-3-540-68758-0
   BOTTA WJ, 1990, ACTA METALL MATER, V38, P391, DOI 10.1016/0956-7151(90)90143-5
   Cantelli R, 2006, MAT SCI ENG A-STRUCT, V442, P5, DOI 10.1016/j.msea.2006.03.130
   CANTELLI R, 1976, APPL PHYS, V9, P153, DOI 10.1007/BF00903952
   FLORENCIO O, 1994, J ALLOY COMPD, V211, P37
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   Grandini CR, 1996, J PHYS IV, V6, P135, DOI 10.1051/jp4:1996827
   Haneczok G, 1998, PHILOS MAG A, V78, P845
   HANECZOK G, 1992, PHYS STATUS SOLIDI B, V172, P557, DOI 10.1002/pssb.2221720207
   KUSHNAREVA NP, 1994, J ALLOY COMPD, V211, P75, DOI 10.1016/0925-8388(94)90451-0
   Miura E, 2003, PHILOS MAG, V83, P2343, DOI 10.1080/0141861031000113334
   Niemeyer TC, 2005, MAT SCI ENG A-STRUCT, V396, P285, DOI 10.1016/j.msea.2005.01.045
   Nowick A. S., 1972, ANELASTIC RELAXATION
   NUMAKURA H, 1995, ACTA METALL MATER, V43, P705, DOI 10.1016/0956-7151(94)00262-G
   Numakura H., 1997, ASTM STP, P383
   SCHALLER R., 2001, MECH SPECTROSCOPY
   Snoek JL, 1941, PHYSICA, V8, P711, DOI 10.1016/S0031-8914(41)90517-7
   SOUZA AC, 2008, J MATER SCI, V43, P1593, DOI DOI 10.1007/S10853-007-2324-0
   Weller M, 2006, MAT SCI ENG A-STRUCT, V442, P21, DOI 10.1016/j.msea.2006.02.232
   WELLER M, 1981, ACTA METALL MATER, V29, P1047, DOI 10.1016/0001-6160(81)90056-0
   WELLER M, 1992, PHYS STATUS SOLIDI B, V172, P145, DOI 10.1002/pssb.2221720115
   WERT CA, 1970, J PHYS CHEM SOLIDS, V31, P1771, DOI 10.1016/0022-3697(70)90167-8
   WERT CA, 1986, J APPL PHYS, V60, P1888, DOI 10.1063/1.337237
   Yin FX, 2007, PHYS SCRIPTA, VT129, P261, DOI 10.1088/0031-8949/2007/T129/058
   Yin FX, 2006, ADV MATER, V18, P1541, DOI 10.1002/adma.200600128
   Yu LM, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174105
   YU LM, 2007, J MATER SCI, V42, P7826
NR 32
TC 14
Z9 15
U1 0
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD SEP 25
PY 2009
VL 521-22
SI SI
BP 59
EP 62
DI 10.1016/j.msea.2008.09.123
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 500UJ
UT WOS:000270330700014
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Niinomi, M
AF Zhou, Ying-Long
   Niinomi, Mitsuo
TI Passive films and corrosion resistance of Ti-Hf alloys in 5% HCI
   solution
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE CP Ti; Ti-Hf alloy; XPS; Passive film; Corrosion resistance
ID ANODIC POLARIZATION PROPERTIES; TITANIUM-ALLOYS; THIN-FILMS; PITTING
   CORROSION; BIOMEDICAL APPLICATIONS; BEHAVIOR; ACID; ELEMENTS;
   REPLACEMENT; TEMPERATURE
AB Ti-Hf alloys with Hf contents of 10, 20, 30, and 40 mass% were prepared by a tri-arc furnace and homogenized at 1273 K for 21.6 ks, and then these alloys were cold rolled into 3-mm-thick plates. The alloy specimens were subjected to a solution treatment in a vacuum at 1223 K for 3.6 ks and then rapidly quenched in ice water before corrosion tests. The corrosion resistance of these alloys was investigated by studying the anodic polarization curves at 310 K in 5% HCI solution to determine the potential use of these alloys in biomedical applications. The passive films formed on the surfaces of the alloys were examined by scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS) analysis. The results reveal that all the Ti-Hf alloys exhibit a passive behavior in 5% HCI solution, which is attributed to the passive film formation of a mixture of both HfO(2) and TiO(2). The corrosion resistance of the Ti-Hf alloys gently increases with the Hf content and the Ti-Hf alloys exhibit better corrosion resistance than commercial pure (CP) Ti-the currently-used metallic biomaterial. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Zhou, Ying-Long] Foshan Univ, Sch Mechatron & Informat Engn, Dept Mechatron Engn, Foshan 528000, Guangdong, Peoples R China.
   [Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Sendai, Miyagi 9808577, Japan.
RP Zhou, YL (reprint author), Foshan Univ, Sch Mechatron & Informat Engn, Dept Mechatron Engn, 18 Jiangwan Yi Rd, Foshan 528000, Guangdong, Peoples R China.
EM yinglongzhou@126.com
RI Niinomi, Mitsuo/B-5965-2011
FU NSFC [10772047/A020206]; Scientific Research Foundation; Returned
   Overseas Chinese Scholars, State Education Ministry of PR China
   [2008/890]
FX The work was partly supported by the NSFC (No.10772047/A020206) and the
   Scientific Research Foundation for the Returned Overseas Chinese
   Scholars, State Education Ministry of PR China (Grant No. 2008/890).
CR Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   *ASM INT HDB COMM, 1987, ASM HDB, V13
   Basame SB, 2000, J ELECTROCHEM SOC, V147, P1376, DOI 10.1149/1.1393364
   BURSTEIN GT, 1995, ELECTROCHIM ACTA, V40, P1881, DOI 10.1016/0013-4686(95)00126-Y
   Cabello G, 2008, J NON-CRYST SOLIDS, V354, P982, DOI 10.1016/j.jnoncrysol.2007.08.014
   Cai Z, 2005, ACTA BIOMATER, V1, P353, DOI 10.1016/j.actbio.2005.02.006
   Capela MV, 2008, J ALLOY COMPD, V465, P479, DOI 10.1016/j.jallcom.2007.10.115
   CASILLAS N, 1994, J ELECTROCHEM SOC, V141, P636, DOI 10.1149/1.2054783
   CASILLAS N, 1993, J ELECTROCHEM SOC, V140, pL142, DOI 10.1149/1.2220897
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   CHIRIGOS J, 1960, METALLURGY HAFNIUM N, P262
   Davis JR, 2000, CORROSION UNDERSTAND
   Domaradzki J, 2006, SURF COAT TECH, V200, P6283, DOI 10.1016/j.surfcoat.2005.11.055
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   Karayan AI, 2008, MATER LETT, V62, P1843, DOI 10.1016/j.matlet.2007.10.028
   KOLMAN DG, 1994, J ELECTROCHEM SOC, V141, P2633, DOI 10.1149/1.2059146
   LAQUE FL, 1963, CORROSION RESISTANCE
   LEVY M, 1969, J ELECTROCHEM SOC, V116, P323, DOI 10.1149/1.2411838
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mardare AI, 2009, ELECTROCHIM ACTA, V54, P5171, DOI 10.1016/j.electacta.2009.01.016
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   McLachlan C, 1983, BIOL ASPECTS METALS, P209
   McLachlan D. R. C., 1983, BIOL ASPECTS METALS, P209
   Metikos Hukovic M., 2003, BIOMATERIALS, V24, P3765
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   *NIST, 2006, XRAY PHOT SPECTR DAT
   Okazaki Y, 1997, MATER T JIM, V38, P78, DOI 10.2320/matertrans1989.38.78
   Okazaki Y, 1997, MATER T JIM, V38, P344, DOI 10.2320/matertrans1989.38.344
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   PRENDERGAST PJ, 1990, J BIOMED ENG, V12, P379, DOI 10.1016/0141-5425(90)90020-N
   SALVAGO G, 1983, CORROS SCI, V23, P515, DOI 10.1016/0010-938X(83)90101-4
   Shankar AR, 2008, J NUCL MATER, V372, P277, DOI 10.1016/j.jnucmat.2007.03.216
   Shreir L., 1963, CORROSION, V1
   SINGH DDN, 1985, J ELECTROCHEM SOC, V132, P378, DOI 10.1149/1.2113843
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493
   STERN M, 1959, J ELECTROCHEM SOC, V106, P755, DOI 10.1149/1.2427492
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002
   TAYLOR DF, 1969, ENCY CHEM TECHNOLOGY, V19, P630
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang YJ, 2004, APPL SURF SCI, V228, P93, DOI 10.1016/j.apsusc.2003.12.028
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
NR 49
TC 13
Z9 13
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP 25
PY 2009
VL 204
IS 1-2
BP 180
EP 186
DI 10.1016/j.surfcoat.2009.07.006
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 504TE
UT WOS:000270639800025
DA 2018-10-20
ER

PT J
AU Ganesh, M
   Dave, RN
   L'Amoreaux, W
   Gross, RA
AF Ganesh, Manoj
   Dave, Rachna N.
   L'Amoreaux, William
   Gross, Richard A.
TI Embedded Enzymatic Biomaterial Degradation
SO MACROMOLECULES
LA English
DT Article
ID ION-PAIRED COMPLEX; LIPASE; POLY(EPSILON-CAPROLACTONE); EXTRACTION;
   MICELLES; BEHAVIOR; MEDIA
C1 [Ganesh, Manoj; Dave, Rachna N.; Gross, Richard A.] NYU, Polytech Inst, Metrotech Ctr 6, NSF I,UCRC Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA.
   [L'Amoreaux, William] CUNY Coll Staten Isl, Staten Isl, NY 10314 USA.
RP Gross, RA (reprint author), NYU, Polytech Inst, Metrotech Ctr 6, NSF I,UCRC Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA.
EM rgross@poly.edu
RI Ganesh, Manoj/I-2434-2014
OI Ganesh, Manoj/0000-0001-8852-3161; L'Amoreaux,
   William/0000-0002-1254-9370
FU National Science Foundation Industry/University Cooperative Research
   Center (NSF-I/UCRC Biocatalysis and Bioprocessing of Macromolecules at
   Polytechnic Institute of NYU
FX The authors thank the National Science Foundation Industry/University
   Cooperative Research Center (NSF-I/UCRC) for Biocatalysis and
   Bioprocessing of Macromolecules at Polytechnic Institute of NYU for
   their Financial Support.
CR Altreuter DH, 2002, ENZYME MICROB TECH, V31, P10, DOI 10.1016/S0141-0229(02)00092-3
   Bankova M, 2002, MACROMOLECULES, V35, P6858, DOI 10.1021/ma0202282
   Bindhu LV, 2003, BIOCHEM ENG J, V15, P47, DOI 10.1016/S1369-703X(02)00173-0
   Bolgen N, 2007, J BIOMED MATER RES B, V81B, P530, DOI 10.1002/jbm.b.30694
   EDWARD R, 1989, PHYS DESK REFERENCE
   Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803
   Gupta S, 2008, J PHARM SCI-US, V97, P22, DOI 10.1002/jps.21177
   Little U, 2009, POLYM DEGRAD STABIL, V94, P213, DOI 10.1016/j.polymdegradstab.2008.11.001
   Liu JG, 2006, BIOPROC BIOSYST ENG, V28, P267, DOI 10.1007/s00449-005-0032-1
   NISIDA H, 1993, J ENVIRON POLYM DEGR, V1, P227
   PARADKAR VM, 1994, BIOTECHNOL BIOENG, V43, P529, DOI 10.1002/bit.260430614
   Pastorino L, 2004, ENZYME MICROB TECH, V35, P321, DOI 10.1016/j.enzmictec.2004.05.005
   Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Tsuji H, 2004, BIOMATERIALS, V25, P5449, DOI 10.1016/j.biomaterials.2003.12.053
   Wang YM, 2005, MACROMOL MATER ENG, V290, P792, DOI 10.1002/mame.200500003
   Wu JC, 2006, J CHEM TECHNOL BIOT, V81, P1003, DOI 10.1002/jctb.1504
NR 17
TC 5
Z9 5
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 22
PY 2009
VL 42
IS 18
BP 6836
EP 6839
DI 10.1021/ma901481h
PG 4
WC Polymer Science
SC Polymer Science
GA 492YR
UT WOS:000269699400002
DA 2018-10-20
ER

PT J
AU Schuessele, A
   Mayr, H
   Tessmar, J
   Goepferich, A
AF Schuessele, A.
   Mayr, H.
   Tessmar, J.
   Goepferich, A.
TI Enhanced bone morphogenetic protein-2 performance on hydroxyapatite
   ceramic surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface modification; hydroxyapatite; BMP-2; biomimetic material;
   ceramics
ID 3-DIMENSIONAL CELL-CULTURE; GROWTH-FACTOR BETA(1); IN-VIVO; OSTEOBLASTIC
   DIFFERENTIATION; TITANIUM SURFACES; TISSUE FORMATION; IMPLANTS;
   BISPHOSPHONATES; BMP-2; RATS
AB The immobilization of biomolecules on biomaterial surfaces allows for the control of their localization and retention. In numerous studies, proteins have been simply adsorbed to enhance the biological performance of various materials in vivo. We investigated the potential of surface modification techniques on hydroxyapatite (HA) ceramic discs in an in vitro approach. A novel method for protein immobilization was evaluated using the aminobisphosphonates pamidronate and alendronate, which are strong Ca chelating agents, and was compared with the established silanization technique. Lysozyme and bone morphogenetic protein-2 (BMP-2) were used to assess the suitability of the two surface modification methods with regard to the enzymatic activity of lysozyme and to the capacity of BMP-2 to stimulate the osteoblastic differentiation of C2C12 mouse myoblasts. After immobilization, a 2.5-fold increase in enzymatic activity of lysozyme was observed compared with the control. The alkaline phosphatase activity per cell stimulated by immobilized BMP-2 was 2.5-fold higher [9 x 10(-6) I.U.] than the growth factor on unmodified surfaces [2-4 x 10(-6) I.U.]. With regard to the increase in protein activity, both procedures lead to equivalent results. Thus, the bisphosphonate-based surface modification represents a safe and easy alternative for the attachment of proteins to HA surfaces. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 959-971, 2009
C1 [Schuessele, A.; Tessmar, J.; Goepferich, A.] Univ Regensburg, Dept Pharmaceut Technol, D-8400 Regensburg, Germany.
   [Mayr, H.] Friedrich Baur Res Inst Biomat, Bayreuth, Germany.
RP Schuessele, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, D-8400 Regensburg, Germany.
EM andrea.schuessele@chemie.uni-regensburg.de
RI Tessmar, Joerg/H-3606-2012; Goepferich, Achim/G-1151-2016
OI Tessmar, Joerg/0000-0001-7057-5369; Goepferich,
   Achim/0000-0002-7646-0252
FU Bayerische Forschungsstiftung (ForTePro)
FX Contract grant sponsor: Bayerische Forschungsstiftung (ForTePro)
CR Akazawa T, 2005, J AM CERAM SOC, V88, P3545, DOI 10.1111/j.1551-2916.2005.00634.x
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   BRUENING C, 1995, J CHEM SOC CHEM COMM, V22, P2323
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Daly SM, 2003, LANGMUIR, V19, P3848, DOI 10.1021/la026690x
   de Groot K, 1998, TISSUE ENG, V4, P337
   Dong GC, 2001, BIOMATERIALS, V22, P3179, DOI 10.1016/S0142-9612(01)00070-9
   Dupraz AMP, 1996, J MATER SCI-MATER M, V7, P731, DOI 10.1007/BF00121408
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Furuzono T, 2001, J BIOMED MATER RES, V56, P9, DOI 10.1002/1097-4636(200107)56:1<9::AID-JBM1073>3.0.CO;2-2
   Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Jennissen HP, 2002, ANN NY ACAD SCI, V961, P139, DOI 10.1111/j.1749-6632.2002.tb03067.x
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   Kajiwara H, 2005, BIOMATERIALS, V26, P581, DOI 10.1016/j.biomaterials.2004.02.072
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Klaeger AJ, 1999, OCUL IMMUNOL INFLAMM, V7, P7, DOI 10.1076/ocii.7.1.7.8108
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Lieb E, 2004, TISSUE ENG, V10, P1414, DOI 10.1089/1076327042500201
   Lieb E, 2004, TISSUE ENG, V10, P1399, DOI 10.1089/1076327042500184
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9
   Liu Q, 1998, J BIOMED MATER RES, V40, P490, DOI 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Liu Q, 1998, J BIOMED MATER RES, V40, P358
   Liu Y, 2003, KEY ENG MAT, V240-2, P667, DOI 10.4028/www.scientific.net/KEM.240-242.667
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Matsumoto T, 2002, BIOMATERIALS, V23, P2241, DOI 10.1016/S0142-9612(01)00358-1
   MEYER J, 2001, Patent No. 2001893238
   Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Puleo D. A., 2004, ENCY BIOMATERIALS BI, P190
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Raiche AT, 2004, J BIOMED MATER RES A, V69A, P342, DOI 10.1002/jbm.a.30006
   Reinholz GG, 2000, CANCER RES, V60, P6001
   Ripamonti U, 1998, PLAST RECONSTR SURG, V101, P227, DOI 10.1097/00006534-199801000-00040
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Sampathkumaran U, 2001, ADV ENG MATER, V3, P401, DOI 10.1002/1527-2648(200106)3:6<401::AID-ADEM401>3.0.CO;2-L
   SAWYER AA, BIOMATERIAL IN PRESS
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Schmidmaier G, 2002, BONE, V30, P816, DOI 10.1016/S8756-3282(02)00740-8
   SCHUESSELE A, 2005, P 9 SEM M CER CELLS, P87
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Stephenson P K, 1991, J Arthroplasty, V6, P51, DOI 10.1016/S0883-5403(06)80157-9
   Tengvall P, 2004, BIOMATERIALS, V25, P2133, DOI 10.1016/j.biomaterials.2003.08.049
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P1115, DOI 10.1021/bp000066y
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P258, DOI 10.1021/bp990154m
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VanderVoort P, 1997, POL J CHEM, V71, P550
   Vasudev DV, 2004, J BIOMED MATER RES A, V69A, P629, DOI 10.1002/jbm.a.30028
   Voggenreiter G, 2001, MATERIALWISS WERKST, V32, P942, DOI 10.1002/1521-4052(200112)32:12<942::AID-MAWE942>3.0.CO;2-9
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Weetall H H, 1976, Methods Enzymol, V44, P134
   Wojcik S M, 1997, Biomed Sci Instrum, V33, P166
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
   Ziegler J, 2002, J BIOMED MATER RES, V59, P422, DOI 10.1002/jbm.1258
NR 70
TC 32
Z9 33
U1 0
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2009
VL 90A
IS 4
BP 959
EP 971
DI 10.1002/jbm.a.31745
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 483CR
UT WOS:000268940100002
PM 18655137
DA 2018-10-20
ER

PT J
AU Bush, KA
   Driscoll, PF
   Soto, ER
   Lambert, CR
   McGimpsey, WG
   Pins, GD
AF Bush, K. A.
   Driscoll, P. F.
   Soto, E. R.
   Lambert, C. R.
   McGimpsey, W. G.
   Pins, G. D.
TI Designing tailored biomaterial surfaces to direct keratinocyte
   morphology, attachment, and differentiation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE extracellular matrix proteins; keratinocytes; self-assembled monolayers;
   collagen; skin substitutes
ID SELF-ASSEMBLED-MONOLAYERS; HUMAN EPIDERMAL-KERATINOCYTES; CROSS-LINKED
   ENVELOPE; CELL-ADHESION; EXTRACELLULAR-MATRIX; SKIN-SUBSTITUTES;
   FIBRONECTIN CONFORMATION; INTEGRIN BINDING; ADSORPTION; CHEMISTRY
AB Precisely engineering the surface chemistry of biomaterials to modulate the adsorption and functionality of biochemical signaling molecules that direct cellular functions is critical in the development of tissue engineered scaffolds. Specifically, this study describes the use of functionalized self-assembled monolayers (SAMs) as a model system to assess the effects of biomaterial surface properties on controlling fibronectin (FN) conformation and concentration as well as keratinocyte function. By systematically analyzing FN adsorption at low and saturated surface densities, we distinguished between SAM-dependent effects of FN concentration and conformation on presenting cellular binding domains that direct cellular functions. Quantitative image analyses of immunostained samples showed that modulating the availability of the FN synergy site directly correlated with changes in keratinocyte attachment, spreading, and differentiation, through integrin-mediated signaling mechanisms. The results of this study will be used to elucidate design features that can be incorporated into dermal equivalents and percutaneous implants to enhance the rate of re-epithelialization and tissue regeneration. Furthermore, these findings indicate that SAM-based model systems are a valuable tool for designing and investigating the development of scaffolds that regulate the conformation of extracellular matrix cues and cellular functions that accelerate the rate of tissue regeneration. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 999-1009, 2009
C1 [Bush, K. A.; Pins, G. D.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
   [Bush, K. A.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA USA.
   [Driscoll, P. F.; McGimpsey, W. G.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA.
   [Soto, E. R.; Lambert, C. R.; McGimpsey, W. G.; Pins, G. D.] Worcester Polytech Inst, Bioengn Inst, Worcester, MA 01609 USA.
RP Pins, GD (reprint author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
EM gpins@wpi.edu
OI Pins, George/0000-0002-8844-8074
FU WPI Research Development Council, WPI Bioengineering Institute; NIH
   [EB005645]
FX Contract grant sponsors: WPI Research Development Council, WPI
   Bioengineering Institute Contract grant sponsor: NIH; contract grant
   number: EB005645
CR ADAMS JC, 1991, J CELL BIOL, V115, P829, DOI 10.1083/jcb.115.3.829
   ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BELL E, 1983, J INVEST DERMATOL, V81, P2
   Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163
   BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323
   Boyce ST, 2001, BURNS, V27, P523, DOI 10.1016/S0305-4179(01)00019-5
   BOYCE ST, 1988, SURGERY, V103, P421
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Bush KA, 2007, J BIOMED MATER RES A, V80A, P444, DOI 10.1002/jbm.a.30933
   Clark RA., 1995, MOL CELLULAR BIOL WO, P3
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   CLARK RAF, 2000, PRINCIPLES TISSUE EN, P857
   CLARK RAF, 1983, J INVEST DERMATOL S, V80, P26
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407
   El Ghalbzouri A, 2004, BIOMATERIALS, V25, P2987, DOI 10.1016/j.biomaterials.2003.09.098
   Elliott JT, 2003, CYTOM PART A, V52A, P90, DOI 10.1002/cyto.a.10025
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GRINNELL F, 1992, J CELL SCI, V101, P1
   Hynes R.O., 1990, FIBRONECTINS, P113, DOI 10.1007/978-1-4612-3264-3_6
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Obedencio GP, 1999, J INVEST DERMATOL, V113, P851, DOI 10.1046/j.1523-1747.1999.00763.x
   Parenteau N, 1996, BIOTECHNOL BIOENG, V52, P3, DOI 10.1002/(SICI)1097-0290(19961005)52:1<3::AID-BIT1>3.3.CO;2-D
   Phillips TJ, 1998, ARCH DERMATOL, V134, P344, DOI 10.1001/archderm.134.3.344
   PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1
   PIERSCHBACHER MD, 1982, J BIOL CHEM, V257, P9593
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SIMON M, 1984, CELL, V36, P827, DOI 10.1016/0092-8674(84)90032-1
   TINOIS E, 1991, EXP CELL RES, V193, P310, DOI 10.1016/0014-4827(91)90102-Z
   Wang H, 2006, J BIOMED MATER RES A, V77A, P672, DOI 10.1002/jbm.a.30586
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 52
TC 12
Z9 12
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2009
VL 90A
IS 4
BP 999
EP 1009
DI 10.1002/jbm.a.32168
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 483CR
UT WOS:000268940100006
PM 18655147
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rodriguez, KJ
   Masters, KS
AF Rodriguez, Karien J.
   Masters, Kristyn S.
TI Regulation of valvular interstitial cell calcification by components of
   the extracellular matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE valvular interstitial cells; calcification; biomaterials; extracellular
   matrix
ID TRANSFORMING-GROWTH-FACTOR; AORTIC-VALVE CALCIFICATION; BIOPROSTHETIC
   HEART-VALVES; FACTOR-BETA; CARDIAC VALVES; PHENOTYPE; ACTIVATION; GELS;
   MINERALIZATION; FIBRONECTIN
AB Understanding the interactions between extracellular matrix (ECM) components and valvular interstitial cells (VICs) is relevant to both treating heart valve disease and designing heart valve tissue engineering scaffolds, yet the VIC-ECM relationship has not been well characterized. Thus, the aim of this study was to characterize VIC-ECM interactions, paying specific attention to whether ECM composition affected the in vitro calcification of VICs. Our results show that the number and size of calcific nodules formed in VIC cultures, as well as the expression of the mineralization markers alkaline phosphatase (ALP) and CBFa1, were highly dependent upon the composition of the culture surface. VICs cultured on certain ECM components, that is, collagen and fibronectin, were resistant to calcification, even upon treatment with mineralization-inducing growth factors. Meanwhile, cultures of VICs on fibrin, laminin, and heparin coatings had a high number of calcified nodules, although only VICs on fibrin expressed significantly elevated levels of ALP and CBFa1. Nodule composition analysis revealed the presence of multiple types of mineralization. Although apoptotic and necrotic cells were more concentrated in nodules, these nodules did contain a strong majority population of viable cells. Characterizing this ECM-dependence of VIC calcification will help us to identify appropriate biomaterial environments for heart valve tissue engineering as well as elucidate mechanisms of valvular disease. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 10431053, 2009
C1 [Rodriguez, Karien J.; Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
RP Masters, KS (reprint author), Univ Wisconsin, Dept Biomed Engn, 1550 Engn Dr 2152, Madison, WI 53706 USA.
EM kmasters@wisc.edu
FU NSF [CBET-0547374]; University of Wisconsin-Madison [T32-HL 07936];
   University of Wisconsin-Madison GERS
FX Contract grant sponsor: University of Wisconsin-Madison GERS
CR Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Bini A, 1999, ARTERIOSCL THROM VAS, V19, P1852, DOI 10.1161/01.ATV.19.8.1852
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Cushing MC, 2005, MATRIX BIOL, V24, P428, DOI 10.1016/j.matbio.2005.06.007
   Cushing MC, 2007, BIOMATERIALS, V28, P3378, DOI 10.1016/j.biomaterials.2007.04.005
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FAVA RA, 1987, J CELL PHYSIOL, V131, P184, DOI 10.1002/jcp.1041310207
   Flanagan TC, 2006, CELLS TISSUES ORGANS, V183, P12, DOI 10.1159/000094902
   Flanagan TC, 2006, BIOMATERIALS, V27, P2233, DOI 10.1016/j.biomaterials.2005.10.031
   Gupta V, 2007, TISSUE ENG, V13, P41, DOI 10.1089/ten.2006.0091
   Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e
   Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x
   Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6
   Jian B, 2003, ANN THORAC SURG, V75, P465
   JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1
   Kaden JJ, 2005, INT J MOL MED, V16, P869
   Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002
   Latif N, 2005, J HEART VALVE DIS, V14, P218
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   MASTERS KS, 2005, APPL CELL IMMOBILISA
   Mathieu P, 2005, J HEART VALVE DIS, V14, P353
   Mikroulis D, 2002, J MATER SCI-MATER M, V13, P885, DOI 10.1023/A:1016556514203
   Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013
   Mohler ER, 2001, CIRCULATION, V103, P1522
   Mulholland DL, 1996, CAN J CARDIOL, V12, P231
   Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116
   Osman L., 2006, CIRCULATION, V114, P1547
   Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841
   Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69
   Ramamurthi A, 2005, BIOMATERIALS, V26, P999, DOI 10.1016/j.biomaterials.2004.04.016
   Srivatsa SS, 1997, J CLIN INVEST, V99, P996, DOI 10.1172/JCI119265
   Taylor PM, 2002, J HEART VALVE DIS, V11, P298
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa
   Watson KE, 1998, ARTERIOSCL THROM VAS, V18, P1964, DOI 10.1161/01.ATV.18.12.1964
   Williams C, 2006, TISSUE ENG, V12, P1489, DOI 10.1089/ten.2006.12.1489
   YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0
   Yang LF, 2005, ATHEROSCLEROSIS, V179, P79, DOI 10.1016/j.atherosclerosis.2004.10.035
NR 40
TC 52
Z9 52
U1 2
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2009
VL 90A
IS 4
BP 1043
EP 1053
DI 10.1002/jbm.a.32187
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 483CR
UT WOS:000268940100010
PM 18671262
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dumas, A
   Moreau, MF
   Gherardi, RK
   Basle, MF
   Chappard, D
AF Dumas, Aline
   Moreau, Marie-Francoise
   Gherardi, Romain K.
   Basle, Michel F.
   Chappard, Daniel
TI Bone grafts cultured with bone marrow stromal cells for the repair of
   critical bone defects: An experimental study in mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tissue engineering; bone marrow stromal cells; osteoblast; xenograft;
   bone defect; GFP
ID MESENCHYMAL STEM-CELLS; IN-VIVO; POROUS HYDROXYAPATITE; TISSUE; MOUSE;
   SIZE; GFP; SUBSTITUTES; HISTOMORPHOMETRY; PURIFICATION
AB Tissue engineering of autologous bone combined with osteoprogenitor cells is a suitable strategy for filling large bone defects. The aim of this study was to evaluate the osteogenicity of a xenogenic bone graft cultured with allogenic bone marrow stromal cells (BMSC) in a mouse critical size craniotomy. Bovine trabecular bone grafts were made free of bone marrow cells or debris and were delipidated. BMSC were harvested from C57BL/6-Tg(ACTbEGFP)1Osb/J mice (GFP(+) cells) and were cultured 14 days on bone grafts in control or osteogenic medium. Engineered grafts were implanted in calvarial defect in C57BL/6 mice. Four groups were studied: graft with BMSC differentiated in osteoblasts (G-Ob), graft with BMSC (G-BMSC), graft without cells (G) and no graft. Calvariae were studied 2 and 8 weeks after implantation by radiographic and histomorphometric analyses. G group: the bone ingrowth was limited to the edges of the defect. The center of the graft was filled by a fibrovascular connective tissue. G-BMSC or G-Ob groups: bone formation occurred early in the center of the defect and did not increase between 2 and 8 weeks; the newly formed woven bone was partially replaced by lamellar bone. The preoperative osteoblastic differentiation of BMSC did not allow faster and better bone regeneration. After 2 weeks, GFP(+) cells were observed around the grafted bone but no GFP(+) osteocyte was present in the newly formed bone. No GFP(+) cell was noted after 8 weeks. However, pre-implantation culture of the biomaterial with allogenic BMSC greatly enhanced the bone regeneration. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 1218-1229, 2009
C1 [Dumas, Aline; Moreau, Marie-Francoise; Basle, Michel F.; Chappard, Daniel] Fac Med, LHEA, INSERM, U922, F-49045 Angers, France.
   [Gherardi, Romain K.] Fac Med, EMI 0011, INSERM, F-94000 Creteil, France.
RP Chappard, D (reprint author), Fac Med, LHEA, INSERM, U922, F-49045 Angers, France.
EM daniel.chappard@univ-angers.fr
CR Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Bareille R, 2000, BIOMATERIALS, V21, P1345, DOI 10.1016/S0142-9612(00)00015-6
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W
   Chappard D, 2005, J BONE MINER METAB, V23, P24, DOI 10.1007/s00774-004-0536-9
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3
   Dumas A, 2006, BIOMATERIALS, V27, P4204, DOI 10.1016/j.biomaterials.2006.03.044
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Hartman EHM, 2005, BIOMATERIALS, V26, P1829, DOI 10.1016/j.biomaterials.2004.06.016
   Imasawa T, 2001, J AM SOC NEPHROL, V12, P1401
   Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132
   Irons H, 2004, CELL TRANSPLANT, V13, P283, DOI 10.3727/000000004783983990
   Kneser U, 2006, J CELL MOL MED, V10, P695, DOI 10.2755/jcmm010.003.06
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Kruyt MC, 2004, J BIOMED MATER RES B, V69B, P113, DOI 10.1002/jbm.b.10073
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEVAI JP, 1996, CLIN ORTHOP RELAT R, P708
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Mendes SC, 2002, J MATER SCI-MATER M, V13, P575, DOI 10.1023/A:1015178827323
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Tada M, 2006, ACTA HISTOCHEM CYTOC, V39, P31, DOI 10.1267/ahc.05051
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Young C, 1999, INT J ORAL MAX IMPL, V14, P72
NR 46
TC 16
Z9 19
U1 2
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2009
VL 90A
IS 4
BP 1218
EP 1229
DI 10.1002/jbm.a.32176
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 483CR
UT WOS:000268940100026
PM 18683231
DA 2018-10-20
ER

PT J
AU Wischke, C
   Neffe, AT
   Steuer, S
   Lendlein, A
AF Wischke, Christian
   Neffe, Axel T.
   Steuer, Susi
   Lendlein, Andreas
TI Evaluation of a degradable shape-memory polymer network as matrix for
   controlled drug release
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Shape-memory polymer; Controlled drug release; Biodegradation; Polymer
   network; Biomaterial
ID BIOMEDICAL APPLICATIONS; NITROFURANTOIN; MICROPARTICLES; MICROSPHERES;
   DELIVERY
AB Degradable shape-memory polymers are multifunctional materials with broad applicability for medical devices. They are designed to acquire their therapeutically relevant shape and mechanical properties after implantation. In this study, the potential of a completely amorphous shape-memory polymer matrix for controlled drug release was comprehensively characterized according to a four step general strategy which provides concepts for validating multifunctional materials for pharmaceutical applications. Independent functionalities are thereby crucial for fully exploiting the potential of the materials. The copolyester urethane network was synthesized by crosslinking star-shaped tetrahydroxy telechelics of oligo[(rac-lactide)-co-glycolide] with an aliphatic diisocyanate. In step 1 of the four step characterization procedure, this material showed the thermal and mechanical properties, which are required for the shape-memory effect under physiological conditions. Shape recovery could be realized by a one-step or a multi-step methodology. In step 2, feasibility of drug loading of pre-formed shape-memory networks has been demonstrated with drugs of different hydrophobicities. The presence of drugs did not disturb the material's functionalities directly after loading (step 3) and under release conditions (step 4). A predictable release of about 90% of the payload in 80 days was observed. Overall, the synthesized amorphous polymer network showed three independent functionalities, i.e., a shape-memory effect combined with biodegradability and controlled drug release. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Wischke, Christian; Neffe, Axel T.; Lendlein, Andreas] GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Wischke, Christian; Neffe, Axel T.; Lendlein, Andreas] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
   [Steuer, Susi] Intervet Innovat GmbH, D-55270 Schwabenheim, Germany.
RP Lendlein, A (reprint author), GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI Wischke, Christian/K-9651-2013; Lendlein, Andreas/K-9553-2013; Neffe,
   Axel/H-6997-2013
OI Wischke, Christian/0000-0001-5531-9033; Lendlein,
   Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990
FU Bundesministerium fur Bildung und Forschung (BMBF) BioFuture Award
   [0311867]
FX The authors thank the Bundesministerium fur Bildung und Forschung (BMBF)
   BioFuture Award 0311867 for financial support and Karolin Schmalzlin for
   help in preparing the manuscript.
CR Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   Baer GM, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-43
   BATES TR, 1974, J PHARM SCI-US, V63, P643, DOI 10.1002/jps.2600630441
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Blasi P, 2005, J CONTROL RELEASE, V108, P1, DOI 10.1016/j.jconrel.2005.07.009
   Blasi P, 2007, AAPS PHARMSCITECH, V8
   BUDAVARI S, 1989, MERCK INDEX
   CADWALLADER DE, 1975, J PHARM SCI, V64, P886, DOI 10.1002/jps.2600640541
   *CHEMSP, CHEMSP DAT
   *DRUG BANK, DRUG BANK DAT, P3
   ELIAS HG, 1990, GRUNDLAGEN, V1, P845
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2004, Patent No. [WO/2004/073690, 2004073690, WO 2004073690 A1]
   LENDLEIN A, 2002, ENCY POLYM SCI TECHN, V4, P125
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   OKADA H, 1994, PHARMACEUT RES, V11, P1143, DOI 10.1023/A:1018936815654
   Olson DA, 2006, J AM CHEM SOC, V128, P13625, DOI 10.1021/ja063092m
   Park HR, 2000, B KOR CHEM SOC, V21, P849
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Sharp AA, 2006, J NEURAL ENG, V3, pL23, DOI 10.1088/1741-2560/3/4/L02
   Small W, 2007, IEEE T BIO-MED ENG, V54, P1657, DOI 10.1109/TBME.2007.892921
   SPURLOCK C H, 1986, Journal of Parenteral Science and Technology, V40, P70
   ULLRICH KJ, 1992, PFLUG ARCH EUR J PHY, V420, P29, DOI 10.1007/BF00378638
   Wischke C, 2006, EUR J PHARM BIOPHARM, V62, P247, DOI 10.1016/j.ejpb.2005.08.015
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
NR 32
TC 123
Z9 128
U1 7
U2 79
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 15
PY 2009
VL 138
IS 3
BP 243
EP 250
DI 10.1016/j.jconrel.2009.05.027
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 497HH
UT WOS:000270048900009
PM 19470395
DA 2018-10-20
ER

PT J
AU Akar, T
   Anilan, B
   Gorgulu, A
   Akar, ST
AF Akar, Tamer
   Anilan, Burcu
   Gorgulu, Asli
   Akar, Sibel Tunali
TI Assessment of cationic dye biosorption characteristics of untreated and
   non-conventional biomass: Pyracantha coccinea berries
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Pyracantha coccinea; Biosorption; Isotherms; Kinetics; Simulated
   wastewater
ID METHYLENE-BLUE BIOSORPTION; AQUEOUS-SOLUTION; BASIC DYE; ADSORPTIVE
   REMOVAL; AGRICULTURAL WASTE; METAL-IONS; AZO-DYE; SORPTION; EQUILIBRIUM;
   KINETICS
AB This work reports on the assessment of the dye methylene blue biosorption properties of Pyracantha coccinea berries under different experimental conditions. Equilibrium and kinetic studies were carried out to determine the biosorption capacity and rate constants. The highest biosorption yield was observed at about pH 6.0, while the biosorption capacity of the biomass decreased with decreasing initial pH values. Batch equilibrium data obtained at different temperatures (15, 25, 35 and 45 degrees C) were modeled by Freundlich, Langmuir and Dubinin-Radushkevich (D-R) isotherms. Langmuir isotherm model fitted the equilibrium data, at the all studied temperatures, better than the other isotherm models indicating monolayer dye biosorption process. The highest monolayer biosorption capacity was found to be 127.50 mg/g dry biomass at 45 degrees C. Kinetic studies indicate that the biosorption process followed the pseudo-second-order model, rather than the pseudo-first-order model. Delta G degrees, Delta H degrees, and Delta S degrees parameters of biosorption show that the process is spontaneous and endothermic in nature. The biosorbent-dye interaction mechanisms were investigated using a combination of Fourier transform infrared spectroscopy and scanning electron microscopy. The biosorption procedure was applied to simulated wastewater including several pollutants. The results obtained indicated that the suggested inexpensive and readily available biomaterial has a good potential for the biosorptive removal of basic dye. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Akar, Tamer; Akar, Sibel Tunali] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
   [Anilan, Burcu; Gorgulu, Asli] Eskisehir Osmangazi Univ, Dept Cemistry Educ, Fac Educ, TR-26480 Eskisehir, Turkey.
RP Akar, T (reprint author), Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
EM takar@ogu.edu.tr
RI Tunali Akar, Sibel/D-8927-2011
OI Tunali Akar, Sibel/0000-0003-4312-3601
CR Akar T, 2008, BIORESOURCE TECHNOL, V99, P3057, DOI 10.1016/j.biortech.2007.06.029
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2007, J HAZARD MATER, V143, P362, DOI 10.1016/j.jhazmat.2006.09.039
   Banat F, 2007, BIORESOURCE TECHNOL, V98, P3017, DOI 10.1016/j.biortech.2006.10.023
   Banat F, 2003, PROCESS BIOCHEM, V39, P193, DOI 10.1016/S0032-9592(03)00065-7
   Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7
   Batzias FA, 2007, J HAZARD MATER, V149, P8, DOI 10.1016/j.jhazmat.2007.03.043
   Benhammou A, 2005, J COLLOID INTERF SCI, V282, P320, DOI 10.1016/j.jcis.2004.08.168
   Cabuk A, 2006, J HAZARD MATER, V136, P317, DOI 10.1016/j.jhazmat.2005.12.019
   Dahiya S, 2008, J HAZARD MATER, V150, P376, DOI 10.1016/j.jhazmat.2007.04.134
   Dubey SS, 2005, SEP PURIF TECHNOL, V41, P21, DOI 10.1016/j.seppur.2004.03.012
   Dubinin M.M., 1947, P ACAD SCI USSR PHYS, V55, P331
   Farah JY, 2007, J HAZARD MATER, V148, P402, DOI 10.1016/j.jhazmat.2007.02.053
   Fico G, 2000, BIOCHEM SYST ECOL, V28, P673, DOI 10.1016/S0305-1978(99)00109-X
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Fu YZ, 2001, BIORESOURCE TECHNOL, V79, P251, DOI 10.1016/S0960-8524(01)00028-1
   Gabr RM, 2008, INT BIODETER BIODEGR, V62, P195, DOI 10.1016/j.ibiod.2008.01.008
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Hamdaoui O, 2008, CHEM ENG J, V143, P73, DOI 10.1016/j.cej.2007.12.018
   Hameed BH, 2008, J HAZARD MATER, V154, P639, DOI 10.1016/j.jhazmat.2007.10.081
   Hameed BH, 2008, COLLOID SURFACE A, V316, P78, DOI 10.1016/j.colsurfa.2007.08.033
   Han RP, 2007, J HAZARD MATER, V141, P156, DOI 10.1016/j.jhazmat.2006.06.107
   Hasany SM, 1996, APPL RADIAT ISOTOPES, V47, P467, DOI 10.1016/0969-8043(95)00310-X
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   Joshi M, 2004, INDIAN J FIBRE TEXT, V29, P239
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   Kaushik P, 2009, ENVIRON INT, V35, P127, DOI 10.1016/j.envint.2008.05.010
   Khokhlova TD, 1997, ADSORPT SCI TECHNOL, V15, P333, DOI 10.1177/026361749701500501
   KOWALEWSKI Z, 1971, PLANTA MED, V19, P311, DOI 10.1055/s-0028-1099647
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Malik PK, 2004, J HAZARD MATER, V113, P81, DOI 10.1016/j.jhazmat.2004.05.022
   Mall ID, 2007, J HAZARD MATER, V143, P386, DOI 10.1016/j.jhazmat.2006.09.059
   Mohan SV, 2007, ECOL ENG, V31, P242, DOI 10.1016/j.ecoleng.2007.07.003
   Mohan SV, 2002, J HAZARD MATER, V90, P189
   Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029
   Nozaki K, 2008, J BIOSCI BIOENG, V105, P69, DOI 10.1263/jbb.105.69
   Ofomaja AE, 2007, PROCESS BIOCHEM, V42, P16, DOI 10.1016/j.procbio.2006.07.005
   Pavan FA, 2008, J HAZARD MATER, V150, P703, DOI 10.1016/j.jhazmat.2007.05.023
   Ramakrishna KR, 1998, WASTE MANAGE, V17, P483, DOI 10.1016/S0956-053X(97)10058-7
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Tsai WT, 2008, J HAZARD MATER, V154, P73, DOI 10.1016/j.jhazmat.2007.09.107
   Tsai WT, 2004, J COLLOID INTERF SCI, V275, P428, DOI 10.1016/j.jcis.2004.02.093
   Tunali S, 2007, J ENVIRON SCI HEAL A, V42, P591, DOI 10.1080/10934520701244359
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Vijayaraghavan K, 2008, BIORESOURCE TECHNOL, V99, P2864, DOI 10.1016/j.biortech.2007.06.008
   Vijayaraghavan K, 2008, DYES PIGMENTS, V76, P726, DOI 10.1016/j.dyepig.2007.01.013
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Won SW, 2008, DYES PIGMENTS, V76, P502, DOI 10.1016/j.dyepig.2006.10.011
NR 52
TC 58
Z9 59
U1 2
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD SEP 15
PY 2009
VL 168
IS 2-3
BP 1302
EP 1309
DI 10.1016/j.jhazmat.2009.03.011
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 473IX
UT WOS:000268200700108
PM 19362415
DA 2018-10-20
ER

PT J
AU Melnikov, P
   Teixeira, AR
   Malzac, A
   Coelho, MD
AF Melnikov, P.
   Teixeira, A. R.
   Malzac, A.
   Coelho, M. de B.
TI Gallium-containing hydroxyapatite for potential use in orthopedics
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Chemical synthesis; X-ray diffraction topography; Thermal
   properties
AB A novel material that may be recommended for grafts and implants stimulating bone growth has been obtained by introducing gallium ions (up to 11.0 mass%) into crystalline lattice of hydroxyapatite. The doping was carried out using gallium nitrate and sodium gallate solutions. In both cases, lattice parameters of gallium-doped hydroxyapatite are identical to those of pure synthetic hydroxyapatite. Gallium does not replace calcium as a result of heterovalent substitution and consequently produces no distortions in the framework of hydroxyapatite matrix. It remains strongly fixed in the form of solid solution of intercalation. According to scanning electron microscopy images gallium insertion does not cause any morphological alterations in hydroxyapatite structure and the product developed meets physico-chemical criteria for biomaterial to be employed in orthopedic practice and local handling of traumatic injuries. Its future usage opens the opportunity to enhance osteosynthesis and calcium retention in loco. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Melnikov, P.; Teixeira, A. R.; Malzac, A.] Univ Fed Mato Grosso do Sul, Fac Med, Dept Clin Surg, BR-79080680 Campo Grande, MS, Brazil.
RP Melnikov, P (reprint author), Univ Fed Mato Grosso do Sul, Fac Med, Dept Clin Surg, Rua Gabinete 560, BR-79080680 Campo Grande, MS, Brazil.
EM petrmelnikov@yahoo.com
FU CNPq
FX The authors are indebted to CNPq (Brazilian agency) for financial
   support.
CR Arnold S, 2001, J MICROSC-OXFORD, V202, P488, DOI 10.1046/j.1365-2818.2001.00831.x
   Bernstein LR, 1998, PHARMACOL REV, V50, P665
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   Gersten J.I., 2001, PHYS CHEM MAT
   HASIRCI V, 2004, MOL ENG TISSUES
   HOLMES RE, 1988, J ORAL MAXIL SURG, V46, P661, DOI 10.1016/0278-2391(88)90109-7
   KOMISSAROVA L, 1996, PHOSPHORUS SULFUR, V111, P3
   LYONS JW, 1960, PHOSPHORUS ITS COMPO, V2
   MANCA SG, 1991, Z NATURFORSCH B, V46, P129
   MELNIKOV P, 2008, P 8 WORLD BIOM C BIO
   Melnikov Petr, 2008, Acta ortop. bras., V16, P54, DOI 10.1590/S1413-78522008000100011
   POUTARD FGE, 1978, NEW TRENDS BIOINORGA
   Sugiyama S, 1999, J SOLID STATE CHEM, V143, P296, DOI 10.1006/jssc.1998.8126
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   2002, INTEGRATED BIOMATERI
NR 15
TC 23
Z9 23
U1 1
U2 23
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD SEP 15
PY 2009
VL 117
IS 1
BP 86
EP 90
DI 10.1016/j.matchemphys.2009.05.046
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 487RC
UT WOS:000269291500018
DA 2018-10-20
ER

PT J
AU Gopi, D
   Indira, J
   Prakash, VCA
   Kavitha, L
AF Gopi, D.
   Indira, J.
   Prakash, V. Collins Arun
   Kavitha, L.
TI Spectroscopic characterization of porous nanohydroxyapatite synthesized
   by a novel amino acid soft solution freezing method
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Hydroxyapatite; Freezing synthesis; Template; Porous; Biomaterials
ID HYDROXYAPATITE NANORODS; SCAFFOLD; NANOPARTICLES
AB In this paper, we have reported a novel method to synthesize nanoporous hydroxyapatite (HAP) powders by freezing organic-inorganic soft solutions. The formation of porous and crystalline HAP nanopowder was achieved via calcining the samples at 600 degrees C followed by sintering at temperatures ranging from 900 degrees C to 1100 degrees C. The samples were analyzed by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopic (SEM) techniques. The results showed the formation of a carbon free nanoporous hydroxyapatite powders due to the decomposition of organic template enclosing the precipitated HAP. It was also observed that the rapid grain growth with retainment of pores while the crystallinity of the HAP nanopowder increased with the increase in sintering temperature which is substantiated from the XRD and SEM results. Such organized porous materials can act as a better biomaterial for bone tissue engineering. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Gopi, D.; Indira, J.; Prakash, V. Collins Arun] Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
   [Kavitha, L.] Periyar Univ, Dept Phys, Salem 636011, Tamil Nadu, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
EM periyaruniversitygopi@yahoo.co.in
RI Louis, Kavitha/B-9313-2017; Gopi, Dhanaraj/A-9163-2012
OI Louis, Kavitha/0000-0002-8893-2050; Gopi, Dhanaraj/0000-0001-6662-1238
FU Department of Science and Technology (DST-SERC), New Delhi, India
   [SR/FTP/ETA-04/2009]; Council of Scientific and Industrial Research
   (CSIR), New Delhi, India
FX One of the authors (D. Gopi) gratefully acknowledges the Department of
   Science and Technology (DST-SERC), New Delhi, India for the young
   scientist fellowship award (Ref. No.: SR/FTP/ETA-04/2009). Another
   author (V. Collins) wishes to thank the Council of Scientific and
   Industrial Research (CSIR), New Delhi, India for the award of senior
   research fellowship (CSIR-SRF).
CR Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   He LH, 2008, ACTA BIOMATER, V4, P577, DOI 10.1016/j.actbio.2007.11.002
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Jun IK, 2006, J AM CERAM SOC, V89, P391, DOI 10.1111/j.1551-2916.2005.00707.x
   Kim HW, 2003, BIOMATERIALS, V24, P3277, DOI 10.1016/S0142-9612(03)00162-5
   Kothapalli CR, 2005, ACTA BIOMATER, V1, P653, DOI 10.1016/j.actbio.2005.06.005
   KWEH SWK, 1999, J MATER PROCESS TECH, V89, P373
   Li YB, 2008, MATER RES BULL, V43, P2318, DOI 10.1016/j.materresbull.2007.08.008
   Liu YK, 2004, MATER CHEM PHYS, V86, P69, DOI 10.1016/j.matchemphys.2004.02.009
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Wei K, 2005, MATER LETT, V59, P220, DOI 10.1016/j.matlet.2004.08.034
   Zhang F, 2005, MATER LETT, V59, P1422, DOI 10.1016/j.matlet.2004.11.058
NR 15
TC 25
Z9 25
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD SEP 15
PY 2009
VL 74
IS 1
BP 282
EP 284
DI 10.1016/j.saa.2009.05.021
PG 3
WC Spectroscopy
SC Spectroscopy
GA 497NC
UT WOS:000270065500046
PM 19525142
DA 2018-10-20
ER

PT J
AU Wotton, FT
   Akoh, JA
AF Wotton, Franchesca T.
   Akoh, Jacob A.
TI Rejection of Permacol (R) mesh used in abdominal wall repair: A case
   report
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Abdominal wound closure; Permacol rejection; Foreign body reaction;
   Biocompatibility
ID COLLAGEN IMPLANTS; HERNIA REPAIR; MODEL; RECONSTRUCTION; CLOSURE
AB Permacol (R) mesh has shown promise when used in abdominal wall repair, especially in the presence of a contaminated surgical field. This biomaterial, derived from porcine dermis collagen, has proposed advantages over synthetic materials due to increased biocompatibility and reduced foreign body reaction within human tissues. However, we present a case report describing a patient who displayed rejection to a Permacol (R) mesh when used in the repair of abdominal wound dehiscence following an emergency laparotomy. Review of the English language literature using PubMed and Medline, showed only two previously published cases of explantation of Permacol (R) due to sepsis or wound breakdown. The authors believe this is the first case of severe foreign body reaction leading to rejection of Permacol (R). Both animal and human studies show conflicting evidence of biocompatibility. There are several reports of successful use of Permacol (R) to repair complex incisional herniae or abdominal walls in the presence of significant contamination. It appears from the literature that Permacol (R) is a promising material, but as we have demonstrated, it has the potential to evoke a foreign body reaction and rejection in certain subjects. (C) 2009 The WJG Press and Baishideng. All rights reserved.
C1 [Wotton, Franchesca T.; Akoh, Jacob A.] Derriford Hosp, Surg & Renal Serv Directorate, Plymouth Hosp NHS Trust, Plymouth PL6 8DH, Devon, England.
RP Akoh, JA (reprint author), Derriford Hosp, Surg & Renal Serv Directorate, Plymouth Hosp NHS Trust, Level 04, Plymouth PL6 8DH, Devon, England.
EM jacob.akoh@phnt.swest.nhs.uk
CR Armellino Mariano Fortunato, 2006, Chir Ital, V58, P627
   Ayubi FS, 2008, HERNIA, V12, P373, DOI 10.1007/s10029-008-0359-z
   Campanelli G, 2008, WORLD J EMERG SURG, V3, DOI 10.1186/1749-7922-3-33
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   Chuo CB, 2008, J PLAST RECONSTR AES, V61, P1378, DOI 10.1016/j.bjps.2007.04.012
   Hammond TM, 2008, BRIT J SURG, V95, P438, DOI 10.1002/bjs.5883
   HSU PW, 2008, J PLAST RECONSTR AES
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Jehle K S, 2007, J Wound Care, V16, P36
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Pentlow A, 2008, PEDIATR TRANSPLANT, V12, P20, DOI 10.1111/j.1399-3046.2007.00824.x
   Petter-Puchner AH, 2008, J SURG RES, V145, P105, DOI 10.1016/j.jss.2007.03.090
   Shaikh FM, 2007, WORLD J SURG, V31, P1966, DOI 10.1007/s00268-007-9174-4
   Shaikh FM, 2007, WORLD J SURG, V31, P1975
   Shaikh FM, 2007, WORLD J SURG, V31, P1973
   Wilshaw SP, 2009, J BIOMED MATER RES B, V88B, P49, DOI 10.1002/jbm.b.31148
NR 18
TC 13
Z9 13
U1 0
U2 1
PU W J G PRESS
PI BEIJING
PA APT 1066, YISHOU GARDEN, NO 58, NORTH LANGXINZHUANG RD, PO BOX 2345,
   BEIJING 100023, PEOPLES R CHINA
SN 1007-9327
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD SEP 14
PY 2009
VL 15
IS 34
BP 4331
EP 4333
DI 10.3748/wjg.15.4331
PG 3
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 494LQ
UT WOS:000269814900015
PM 19750579
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Wheeldon, IR
   Campbell, E
   Banta, S
AF Wheeldon, Ian R.
   Campbell, Elliot
   Banta, Scott
TI A Chimeric Fusion Protein Engineered with Disparate
   Functionalities-Enzymatic Activity and Self-assembly
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE aldo-keto reductase; bifunctional protein; chimeric fusion; enzymatic
   hydrogel; leucine zippers
ID ALDO-KETO REDUCTASE; 2,5-DIKETO-D-GLUCONIC ACID REDUCTASE;
   CELLULOSE-BINDING-DOMAIN; REVERSIBLE HYDROGELS; COFACTOR SPECIFICITY;
   ESCHERICHIA-COLI; BUILDING-BLOCKS; GENE FUSION; COILED-COIL;
   IMMOBILIZATION
AB The fusion of protein domains is an important mechanism in molecular evolution and a valuable strategy for protein engineering. We are interested in creating fusion proteins containing both globular and structural domains so that the final chimeric protein can be utilized to create novel bioactive biomaterials. Interactions between fused domains can be desirable in some fusion protein applications, but in this case the optimal configuration will enable the bioactivity to be unaffected by the structural cross-linking. To explore this concept, we have created a fusion consisting of a thermostable aldo-keto reductase, two alpha-helical leucine zipper domains, and a randomly coiled domain. The resulting protein is bifunctional in that (1) it can self-assemble into a hydrogel material as the terminal leucine zipper domains form interprotein coiled-coil cross-links, and (2) it expresses alcohol dehydrogenase and aldo-keto reductase activity native to AdhD from Pyrococcus furiosus. The kinetic parameters of the enzyme are minimally affected by the addition of the helical appendages, and rheological studies demonstrate that a supramolecular assembly of the bifunctional protein building blocks forms a hydrogel. An active hydrogel is produced at temperatures up to 60 degrees C, and we demonstrate the functionality of the biomaterial by monitoring the oxidation and reduction of the native substrates by the gel. The design of chimeric fusion proteins with both globular and structural domains is an important advancement for the creation of bioactive biomaterials for biotechnology applications such as tissue engineering, bioelectrocatalysis, and biosensing and for the study of native assembled enzyme structures and clustered enzyme systems such as metabolons. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Wheeldon, Ian R.; Campbell, Elliot; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
RP Banta, S (reprint author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
EM sbanta@cheme.columbia.edu
FU AFOSR MURI [FA9550-06-1-0264]
FX Financial support was provided by AFOSR MURI (FA9550-06-1-0264). The
   authors thank Dr. John van der Oost (Wageningen University, the
   Netherlands) and Dr. David Tirrell for their gifts of plasmids pWUR85
   and pQE9AC10Acys, respectively. The authors also thank Mark Blenner and
   Dr. Geza Szilvay for their constructive reviews of the manuscript.
CR Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787
   Banta S, 2002, BIOCHEMISTRY-US, V41, P6226, DOI 10.1021/bi015987b
   Blenner MA, 2008, PROTEIN SCI, V17, P527, DOI 10.1110/ps.073257308
   BULOW L, 1991, TRENDS BIOTECHNOL, V9, P226, DOI 10.1016/0167-7799(91)90075-S
   Calabrese-Barton S., 2004, CHEM REV, V104, P4867
   Cao Y, 2008, CHEM COMMUN, P4144, DOI 10.1039/b806684a
   Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006
   Daunert S, 2007, COLLOID SURFACE B, V58, P20, DOI 10.1016/j.colsurfb.2006.10.020
   Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005
   DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2
   Fishman A, 2002, J MOL CATAL B-ENZYM, V18, P121, DOI 10.1016/S1381-1177(02)00075-9
   Gao S, 2009, BBA-GEN SUBJECTS, V1790, P198, DOI 10.1016/j.bbagen.2009.01.001
   Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   Kennedy SB, 2001, MACROMOLECULES, V34, P8675, DOI 10.1021/ma010768j
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kozma E, 2002, J BIOL CHEM, V277, P16285, DOI 10.1074/jbc.M110808200
   Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250
   LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187
   LESKOVAC V, 2003, COMPREHENSIVE ENZYME
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Machielsen R, 2006, APPL ENVIRON MICROB, V72, P233, DOI 10.1128/AEM.72.1.233-238.2006
   OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T
   Palmore GTR, 1998, J ELECTROANAL CHEM, V443, P155, DOI 10.1016/S0022-0728(97)00393-8
   Pardridge WM, 2008, BIOCONJUGATE CHEM, V19, P1327, DOI 10.1021/bc800148t
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t
   Richins RD, 2000, BIOTECHNOL BIOENG, V69, P591, DOI 10.1002/1097-0290(20000920)69:6<591::AID-BIT2>3.3.CO;2-O
   Sanli G, 2004, PROTEIN SCI, V13, P504, DOI 10.1110/ps.03450704
   Sanli G, 2003, CELL BIOCHEM BIOPHYS, V38, P79, DOI 10.1385/CBB:38:1:79
   SEGEL IH, 1993, WILEY CLASSIC LIB SE
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Shen W, 2005, MACROMOLECULES, V38, P3909, DOI 10.1021/ma048348s
   Shen W, 2007, SOFT MATTER, V3, P99, DOI 10.1039/b610986a
   Shimazu M, 2003, BIOTECHNOL BIOENG, V81, P74, DOI 10.1002/bit.10446
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105
   Tanaka G, 2006, ANAL BIOCHEM, V350, P298, DOI 10.1016/j.ab.2005.12.034
   Wheeldon IR, 2008, P NATL ACAD SCI USA, V105, P15275, DOI 10.1073/pnas.0805249105
   Wheeldon IR, 2007, BIOMACROMOLECULES, V8, P2990, DOI 10.1021/bm700858p
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Xu CY, 2002, MACROMOL BIOSCI, V2, P395, DOI 10.1002/1616-5195(200211)2:8<395::AID-MABI395>3.0.CO;2-9
   Zhang KC, 2005, J AM CHEM SOC, V127, P10136, DOI 10.1021/ja051457h
NR 45
TC 33
Z9 34
U1 0
U2 18
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 11
PY 2009
VL 392
IS 1
BP 129
EP 142
DI 10.1016/j.jmb.2009.06.075
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 498FW
UT WOS:000270123600010
PM 19577577
DA 2018-10-20
ER

PT J
AU Leor, J
   Tuvia, S
   Guetta, V
   Manczur, F
   Castel, D
   Willenz, U
   Petnehazy, O
   Landa, N
   Feinberg, MS
   Konen, E
   Goitein, O
   Tsur-Gang, O
   Shaul, M
   Klapper, L
   Cohen, S
AF Leor, Jonathan
   Tuvia, Shmuel
   Guetta, Victor
   Manczur, Ferenc
   Castel, David
   Willenz, Udi
   Petnehazy, Oers
   Landa, Natali
   Feinberg, Micha S.
   Konen, Eli
   Goitein, Orly
   Tsur-Gang, Orna
   Shaul, Mazal
   Klapper, Lea
   Cohen, Smadar
TI Intracoronary Injection of In Situ Forming Alginate Hydrogel Reverses
   Left Ventricular Remodeling After Myocardial Infarction in Swine
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE biomaterials; heart failure; myocardial infarction; remodeling
ID ASSEMBLING PEPTIDE NANOFIBERS; NEOVASCULATURE FORMATION; PROGNOSTIC
   IMPLICATIONS; ISCHEMIC-MYOCARDIUM; PDGF-BB; DELIVERY; CELLS;
   BIOMATERIALS; ANGIOPLASTY; REPERFUSION
AB Objectives This study sought to determine whether alginate biomaterial can be delivered effectively into the infarcted myocardium by intracoronary injection to prevent left ventricular (LV) remodeling early after myocardial infarction (MI).
   Background Although injectable biomaterials can improve infarct healing and repair, the feasibility and effectiveness of intracoronary injection have not been studied.
   Methods We prepared a calcium cross-linked alginate solution that undergoes liquid to gel phase transition after deposition in infarcted myocardium. Anterior MI was induced in swine by transient balloon occlusion of left anterior descending coronary artery. At 4 days after MI, either alginate solution (2 or 4 ml) or saline was injected selectively into the infarct-related coronary artery. An additional group (n = 19) was treated with incremental volumes of biomaterial (1, 2, and 4 ml) or 2 ml saline and underwent serial echocardiography studies.
   Results Examination of hearts harvested after injection showed that the alginate crossed the infarcted leaky vessels and was deposited as hydrogel in the infarcted tissue. At 60 days, control swine experienced an increase in left ventricular (LV) diastolic area by 44%, LV systolic area by 45%, and LV mass by 35%. In contrast, intracoronary injection of alginate (2 and 4 ml) prevented and even reversed LV enlargement (p < 0.01). Post-mortem analysis showed that the biomaterial (2 ml) increased scar thickness by 53% compared with control (2.9 +/- 0.1 mm vs. 1.9 +/- 0.3 mm; p < 0.01) and was replaced by myofibroblasts and collagen.
   Conclusions Intracoronary injection of alginate biomaterial is feasible, safe, and effective. Our findings suggest a new percutaneous intervention to improve infarct repair and prevent adverse remodeling after reperfused MI. (J Am Coll Cardiol 2009;54:1014-23) (c) 2009 by the American College of Cardiology Foundation
C1 [Leor, Jonathan; Guetta, Victor; Castel, David; Willenz, Udi; Landa, Natali; Feinberg, Micha S.] Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
   [Tuvia, Shmuel; Shaul, Mazal; Klapper, Lea] BiolineRx, Jerusalem, Israel.
   [Manczur, Ferenc] Szent Istvan Univ, Dept Internal Med, Fac Vet Sci, Budapest, Hungary.
   [Petnehazy, Oers] Kaposvar Univ, Inst Diagnost Imaging & Radiat Oncol, Kaposvar, Hungary.
   [Konen, Eli; Goitein, Orly] Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel.
   [Tsur-Gang, Orna; Cohen, Smadar] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
RP Leor, J (reprint author), Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
EM leorj@post.tau.ac.il; scohen@bgu.ac.il
RI COHEN, SMADAR/F-1901-2012; Petnehazy, Ors/D-4824-2017; Leor,
   Jonathan/O-2930-2017
OI Petnehazy, Ors/0000-0001-9698-5753; 
FU BiolineRx, Jerusalem, Israel; Ben-Gurion University of the Negev,
   Beer-Sheva, Israel
FX Supported by a research grant from BiolineRx, Jerusalem, Israel, and
   Ben-Gurion University of the Negev, Beer-Sheva, Israel. Drs. Leor and
   Cohen applied for a patent on injectable alginate for myocardial repair
   via Ben-Gurion University of the Negev, Beer-Sheva, Israel, and are
   advisers of BiolineRx, Jerusalem, Israel. Drs. Tuvia, Shaul, and Klapper
   are employees of BiolineRx, Jerusalem, Israel. Dr. Cohen holds the
   Claire and Harold Oshry Professor Chair in Biotechnology. Drs. Leor and
   Tuvia contributed equally to this work.
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA
   Cabrales P, 2005, AM J PHYSIOL-HEART C, V288, pH1708, DOI 10.1152/ajpheart.00911.2004
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Hung J, 2008, CIRCULATION, V118, pS263, DOI 10.1161/CIRCULATIONAHA.107.756502
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kloner RA, 2008, CIRC RES, V103, P1, DOI 10.1161/CIRCRESAHA.108.180216
   Kofidis T, 2005, CIRCULATION, V112, P1173
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Leor J, 2006, CIRCULATION, V114, pI94, DOI 10.1161/CIRCULATIONAHA.105.000331
   Leor J, 2006, STEM CELLS, V24, P772, DOI 10.1634/stemcells.2005-0212
   Lunde K, 2008, J AM COLL CARDIOL, V51, P674, DOI 10.1016/j.jacc.2007.10.032
   Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568
   Saavedra WF, 2002, J AM COLL CARDIOL, V39, P2069, DOI 10.1016/S0735-1097(02)01890-9
   Sabbah HN, 2008, EUR HEART J, V29, P419
   Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011
   Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302
   Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
NR 36
TC 169
Z9 180
U1 3
U2 43
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD SEP 8
PY 2009
VL 54
IS 11
BP 1014
EP 1023
DI 10.1016/j.jacc.2009.06.010
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 490DG
UT WOS:000269477500008
PM 19729119
OA Bronze
DA 2018-10-20
ER

PT J
AU Han, JO
   Joo, MK
   Jang, JH
   Park, MH
   Jeong, B
AF Han, Jin Ok
   Joo, Min Kyung
   Jang, Ji Hye
   Park, Min Hee
   Jeong, Byeongmoon
TI PVPylated Poly(alanine) as a New Thermogelling Polymer
SO MACROMOLECULES
LA English
DT Article
ID COPOLYMER AQUEOUS-SOLUTIONS; REVERSE THERMAL GELATION; BLOCK-COPOLYMERS;
   TRIBLOCK COPOLYMER; POLY(ETHYLENE GLYCOL); IN-SITU; MULTIBLOCK
   COPOLYMER; SECONDARY STRUCTURE; PEG; POLYPEPTIDE
AB In order to investigate poly(N-vinyl pyrrolidone) as an alternative to poly(ethylene glycol) in preparing a biomedical polymer, we synthesized a series of reverse thermogelling poly(N-vinyl pyrrolidone-b-alanine) (PVP-PA). The amphiphilic polymers consisting of the hydrophilic PVP block and the hydrophobic PA block formed micelles in water and the micelles aggregated as the temperature increased. FTIR spectroscopy, circular dichrosim spectroscopy, and (13)C NMR spectroscopy showed that the aggregation behavior accompanied a change in PA conformation as well as a decrease in the molecular motion of PVPPA. The sol-to-gel transition temperature decreased as the PA block length increased, PVP block length decreased, and L-alanine/DL-alanine ratio of PA increased. This paper suggests that PVP can be a promising alternative to poly(ethylene glycol) in designing a reverse thermogelling biomaterial.
C1 [Han, Jin Ok; Joo, Min Kyung; Jang, Ji Hye; Park, Min Hee; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU Korea Research Foundation [KRF-2008-313-C00590]; Korean government
   [20090080447, R11-2005-008-00000-0]
FX This work was Supported by the Korea Research Foundation (Grant No.
   KRF-2008-313-C00590), and Korea Science and Engineering Foundation
   (KOSEF) grants funded by the Korean government (MEST;Grant Nos.
   20090080447 and R11-2005-008-00000-0).
CR APPEL W, 1968, ANGEW CHEM INT EDIT, V7, P702, DOI 10.1002/anie.196807021
   Arotcarena M, 2002, J AM CHEM SOC, V124, P3787, DOI 10.1021/ja012167d
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Baginska K, 2008, J PEPT SCI, V14, P283, DOI 10.1002/psc.923
   Bartolozzi I, 2007, EUR POLYM J, V43, P4628, DOI 10.1016/j.eurpolymj.2007.08.011
   Benahmed A, 2001, PHARMACEUT RES, V18, P323, DOI 10.1023/A:1011054930439
   Chen C, 2006, BIOMATERIALS, V27, P4804, DOI 10.1016/j.biomaterials.2006.04039
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Choi BG, 2007, J PHYS CHEM B, V111, P7715, DOI 10.1021/jp072970f
   Choi YY, 2009, MACROMOL BIOSCI, V9, P869, DOI 10.1002/mabi.200900095
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Chung TW, 2004, POLYMER, V45, P1591, DOI 10.1016/j.polymer.2003.12.074
   Ding WW, 2008, J PHYS CHEM B, V112, P776, DOI 10.1021/jp076939p
   DOEBBLER GF, 1966, CRYOBIOLOGY, V3, P2, DOI 10.1016/S0011-2240(66)80144-X
   Gaucher G, 2009, BIOMACROMOLECULES, V10, P408, DOI 10.1021/bm801178f
   Hamley IW, 2005, BIOMACROMOLECULES, V6, P1310, DOI 10.1021/bm049286g
   Hwang JY, 2001, BIOMACROMOLECULES, V2, P17, DOI 10.1021/bm005597p
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Jin SP, 2008, EUR POLYM J, V44, P2162, DOI 10.1016/j.eurpolymj.2008.04.017
   Joo MK, 2007, MACROMOLECULES, V40, P5111, DOI 10.1021/ma070008u
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Jun YJ, 2006, ANGEW CHEM INT EDIT, V45, P6173, DOI 10.1002/anie.200601108
   Kamada H, 1999, BIOCHEM BIOPH RES CO, V257, P448, DOI 10.1006/bbrc.1999.0353
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Le Garrec D, 2004, J CONTROL RELEASE, V99, P83, DOI 10.1016/j.jconrel.2004.06.018
   Lecommandoux S, 2001, MACROMOLECULES, V34, P9100, DOI 10.1021/ma010940j
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lim YB, 2008, J MATER CHEM, V18, P723, DOI 10.1039/b711188f
   LOU L, 2004, MACROMOLECULES, V37, P4008
   Lukyanov AN, 2004, ADV DRUG DELIVER REV, V56, P1273, DOI 10.1016/j.addr.2003.12.004
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Nystrom B, 1996, J PHYS CHEM-US, V100, P5433, DOI 10.1021/jp952486p
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Park IK, 2003, J CONTROL RELEASE, V86, P349, DOI 10.1016/S0168-3659(02)00365-6
   Park SH, 2008, MACROMOLECULES, V41, P6486, DOI 10.1021/ma800562s
   Tanodekaew S, 1997, MACROMOL CHEM PHYSIC, V198, P3385, DOI 10.1002/macp.1997.021981105
   TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P181, DOI 10.1016/0005-2736(94)90025-6
   TOWNSEND M W, 1988, Journal of Parenteral Science and Technology, V42, P190
   Vermonden T, 2006, LANGMUIR, V22, P10180, DOI 10.1021/la062224m
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q
   Yang CA, 2009, J MATER CHEM, V19, P3755, DOI 10.1039/b900198k
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 46
TC 13
Z9 13
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 8
PY 2009
VL 42
IS 17
BP 6710
EP 6715
DI 10.1021/ma901089s
PG 6
WC Polymer Science
SC Polymer Science
GA 492DX
UT WOS:000269635900047
DA 2018-10-20
ER

PT J
AU Moreo, P
   Garcia-Aznar, JM
   Doblare, M
AF Moreo, Pedro
   Manuel Garcia-Aznar, Jose
   Doblare, Manuel
TI Bone ingrowth on the surface of endosseous implants. Part 1:
   Mathematical model
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Osseointegration; Implant microtopography; Bone implant; Finite element
   simulation
ID MESENCHYMAL PROGENITOR CELLS; HYDROXYAPATITE-COATED IMPLANTS;
   TITANIUM-ALLOY IMPLANTS; GROWTH-FACTOR-BETA; STEM-CELLS; TISSUE
   DIFFERENTIATION; CHEMOTACTIC MIGRATION; PLATELET INTERACTIONS; TGF-BETA;
   IN-VIVO
AB Osseointegration, understood as an intimate apposition and interdigitation of bone to a biomaterial, is usually regarded as a major condition for the long-term clinical success of bone implants. Clearly, the anchorage of an implant to bone tissue critically relies on the formation of new bone between the implant and the surface of the old peri-implant bone and depends on factors such as the surface microtopography, chemical composition and geometry of the implant, the properties of the surrounding bone and the mechanical loading process. The main contribution of this work is the proposal of a new mathematical framework based on a set of reaction-diffusion equations that try to model the main biological interactions occurring at the surface of implants and is able to reproduce most of the above mentioned biological features of the osseointegration phenomenon. This is a two-part paper. In this first part, a brief biological overview is initially given, followed by the presentation and discussion of the model. In addition, two-dimensional finite element simulations of the bone-in growth process around a dental implant with two different surface properties are included to assess the validity of the model. Numerical solutions show the ability of the model to reproduce features such as contact/distance osteogenesis depending upon the specific surface microtopography. In Part 2 [Moreo, P., Garcia-Aznar, J.M., Doblare, M., 2008. Bone in growth on the surface of endosseous implants. Part 2: influence of mechanical stimulation, type of bone and geometry. J. Theor. Biol., submitted for publication], two simplified versions of the whole model are proposed. An analytical study of the stability of fixed points as well as the existence of travelling wave-type solutions has been done with both simplified models, providing a significant insight into the behaviour of the model and giving clues to interpret the effectiveness of recently proposed clinical therapies. Further more, we also show that, although the mechanical state of the tissue is not directly taken into account in the model equations, it is possible to analyse in detail the effect that mechanical stimulation would have on the predictions of the model. Finally, numerical simulations are also included in the second part of the paper, with the aim of looking into the influence of implant geometry on the osseointegration process. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Moreo, Pedro; Manuel Garcia-Aznar, Jose; Doblare, Manuel] Univ Zaragoza, Aragon Inst Engn Res I3A, Grp Struct Mech & Mat Modelling, Zaragoza, Spain.
   [Moreo, Pedro; Manuel Garcia-Aznar, Jose; Doblare, Manuel] CIBER BBN, Zaragoza, Spain.
RP Garcia-Aznar, JM (reprint author), Univ Zaragoza, Aragon Inst Engn Res I3A, Grp Struct Mech & Mat Modelling, Zaragoza, Spain.
EM jmgaraz@unizar.es
RI Garcia-Aznar, Jose Manuel/F-8256-2010
OI Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; /0000-0001-8741-6452
FU Spanish Ministry of Health through the CIBER-BBN; Spanish Ministry of
   Science and Technology [DPI2006-14669, DPI2006-09692]; FPU
FX The authors gratefully acknowledge the research support of the Spanish
   Ministry of Health through the CIBER-BBN and the Spanish Ministry of
   Science and Technology through Research Projects DPI2006-14669 and
   DPI2006-09692 and the FPU graduate research fellowship program.
CR Ambard D, 2006, EUR J MECH A-SOLID, V25, P927, DOI 10.1016/j.euromechsol.2006.02.006
   Andreykiv A, 2005, J BIOMECH, V38, P1023, DOI 10.1016/j.jbiomech.2004.05.044
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
   Bostrum MP, 1998, CLIN ORTHOP S, V355S, P116
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Cai AQ, 2007, J THEOR BIOL, V245, P576, DOI 10.1016/j.jtbi.2006.10.024
   CLAES LE, 1998, CLIN ORTHOP S, V355, pS132, DOI DOI 10.1097/00003086-199810001-00015
   COFFEY RJ, 1990, ANN NY ACAD SCI, V593, P285, DOI 10.1111/j.1749-6632.1990.tb16120.x
   Cullinane DM, 2003, J EXP BIOL, V206, P2459, DOI 10.1242/jeb.00453
   Daas M, 2008, MED ENG PHYS, V30, P218, DOI 10.1016/j.medengphy.2007.02.005
   DASCH JR, 1989, J IMMUNOL, V142, P1536
   Davies John E, 2003, J Dent Educ, V67, P932
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   DOBLARE M, 2005, ARCH COMPUT METHOD E, V11, P1
   EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Farre J, 2007, GROWTH FACTORS, V25, P71, DOI 10.1080/08977190701345200
   Fiedler J, 2006, BIOCHEM BIOPH RES CO, V345, P1177, DOI 10.1016/j.bbrc.2006.05.034
   Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116
   Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Ganong WF, 2005, REV MED PHYSL
   Garcia-Aznar JM, 2007, J BIOMECH, V40, P1467, DOI 10.1016/j.jbiomech.2006.06.013
   Geris L, 2004, J BIOMECH, V37, P763, DOI 10.1016/j.jbiomech.2003.09.026
   Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023
   Goodacre CJ, 1999, J PROSTHET DENT, V81, P537, DOI 10.1016/S0022-3913(99)70208-8
   Goodman PD, 2005, ANN BIOMED ENG, V33, P780, DOI 10.1007/s10439-005-2951-z
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   GRULER H, 1984, BLOOD CELLS, V10, P61
   Haas R, 2002, CLIN ORAL IMPLAN RES, V13, P38, DOI 10.1034/j.1600-0501.2002.130104.x
   Hayakawa T, 2002, BIOMATERIALS, V23, P1025, DOI 10.1016/S0142-9612(01)00214-9
   Hughes T. J. R., 2000, FINITE ELEMENT METHO
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010
   JONES D, 1995, J BIOCH CELL BIOL, V73, P525
   Joos U, 2006, INT J ORAL MAX SURG, V35, P783, DOI 10.1016/j.ijom.2006.03.013
   Kark LR, 2006, CLIN ORAL IMPLAN RES, V17, P321, DOI 10.1111/j.1600-0501.2005.01189.x
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   LAKEY L, 2000, TISSUE ENG, P137
   Lee DH, 2006, TISSUE ENG, V12, P1577, DOI 10.1089/ten.2006.12.1577
   Liao SH, 2008, COMPUT MED IMAG GRAP, V32, P53, DOI 10.1016/j.compmedimag.2007.09.001
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P611, DOI 10.3109/17453679608997766
   Lind M, 1998, Acta Orthop Scand Suppl, V283, P2
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Liu XY, 2008, BIOMECH MODEL MECHAN, V7, P335, DOI 10.1007/s10237-007-0100-3
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Maini PK, 2004, TISSUE ENG, V10, P475, DOI 10.1089/107632704323061834
   Marco F, 2005, MICRON, V36, P630, DOI 10.1016/j.micron.2005.07.008
   Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180
   Matsuo M, 1999, J PERIODONTOL, V70, P1330, DOI 10.1902/jop.1999.70.11.1330
   MISchenk R, 1994, BONE FORMATION REPAI, P117
   Moreo P, 2007, COMPUT METHOD APPL M, V196, P3300, DOI 10.1016/j.cma.2007.03.020
   MOREO P, 2008, J THEOR BIO IN PRESS
   Moreo P, 2008, ACTA BIOMATER, V4, P613, DOI 10.1016/j.actbio.2007.10.014
   Naert I, 2000, Clin Implant Dent Relat Res, V2, P209, DOI 10.1111/j.1708-8208.2000.tb00119.x
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Oates TW, 2007, INT J ORAL MAX IMPL, V22, P755
   Osborn J. F., 1980, DENT IMPLANTS MAT SY, P111
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Pavlin D, 2000, CALCIFIED TISSUE INT, V67, P163, DOI 10.1007/s00223001105
   Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414, DOI 10.1177/10454411010120050401
   PEREZ MA, 2007, J BIOMECH, DOI DOI 10.1016/J.JBIOMECH.2007.09.013
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Probst A, 1997, J INVEST SURG, V10, P77, DOI 10.3109/08941939709032137
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reina JM, 2007, J BIOMECH, V40, P828, DOI 10.1016/j.jbiomech.2006.03.007
   ROBERTS WE, 1988, J DENT EDUC, V52, P802
   Roiser RN, 1998, CLIN ORTHOP S, V355, P294
   RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165
   Schierano G, 2005, J PERIODONTOL, V76, P1710, DOI 10.1902/jop.2005.76.10.1710
   Schmitt A, 1993, Int J Prosthodont, V6, P197
   Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   SENNERBY L, 1993, J MATER SCI-MATER M, V4, P240, DOI 10.1007/BF00122275
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SOBALLE K, 1992, ACTA ORTHOP SCAND, V63, P128, DOI 10.3109/17453679209154808
   Swider P, 2006, J BIOMECH, V39, P1873, DOI 10.1016/j.jbiomech.2005.05.027
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   VANDER A, 1998, HUMAN PHYSL MECH BOD
   Zienkiewicz OC, 2000, SOLID MECH, V2
NR 87
TC 26
Z9 27
U1 0
U2 13
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
J9 J THEOR BIOL
JI J. Theor. Biol.
PD SEP 7
PY 2009
VL 260
IS 1
BP 1
EP 12
DI 10.1016/j.jtbi.2008.07.040
PG 12
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 559CO
UT WOS:000274798200001
PM 18762197
DA 2018-10-20
ER

PT J
AU Freed, LE
   Engelmayr, GC
   Borenstein, JT
   Moutos, FT
   Guilak, F
AF Freed, Lisa E.
   Engelmayr, George C., Jr.
   Borenstein, Jeffrey T.
   Moutos, Franklin T.
   Guilak, Forshid
TI Advanced Material Strategies for Tissue Engineering Scaffolds
SO ADVANCED MATERIALS
LA English
DT Review
ID ARTICULAR-CARTILAGE REPAIR; MESENCHYMAL STEM-CELLS; TENSION-COMPRESSION
   NONLINEARITY; PERIMYSIAL COLLAGEN-FIBERS; INFARCTED RAT HEARTS;
   IN-VITRO; CARDIAC TISSUE; BIODEGRADABLE POLYMER; COMPOSITE SCAFFOLD;
   POLY(GLYCEROL SEBACATE)
AB Tissue engineering seeks to restore the function of diseased or damaged tissues through the use of cells and biomaterial scaffolds. It is now apparent that the next generation of functional tissue replacements will require advanced material strategies to achieve many of the important requirements for long-term success. Here, we provide representative examples of engineered skeletal and myocardial tissue constructs in which scaffolds were explicitly designed to match native tissue mechanical properties as well as to promote cell alignment. We discuss recent progress in microfluidic devices that can potentially serve as tissue engineering scaffolds, since mass transport via microvascular-like structures will be essential in the development of tissue engineered constructs on the length scale of native tissues. Given the rapid evolution of the field of tissue engineering, it is important to consider the use of advanced materials in light of the emerging role of genetics, growth factors, bioreactors, and other technologies.
C1 [Freed, Lisa E.; Borenstein, Jeffrey T.] Charles Stark Draper Lab, Biomed Engn Grp, Cambridge, MA 02139 USA.
   [Freed, Lisa E.; Engelmayr, George C., Jr.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Moutos, Franklin T.; Guilak, Forshid] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
   [Moutos, Franklin T.; Guilak, Forshid] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
RP Freed, LE (reprint author), Charles Stark Draper Lab, Biomed Engn Grp, 555 Technol Square Mail Stop 32, Cambridge, MA 02139 USA.
EM Lfreed@draper.com
RI Engelmayr, George/I-4368-2012
OI Freed, Lisa/0000-0002-0720-8432; Guilak, Farshid/0000-0001-7380-0330
FU NASA [NNJ04HC72G]; NIH [AR055414, F32HL084968, AR49294, AG15768,
   AR50245, AR48852]; Coulter Foundation; Duke Translational Research
   Institute; Draper Laboratory
FX We thank R. Langer for advice, L. Gibson for many stimulating
   discussions, J. Hsiao for expert SEM preparation, and S. Kangiser for
   help with manuscript preparation. This work was supported by NASA
   (NNJ04HC72G to L. E. F.) and the NIH (AR055414 to L. E. F.; NRSA
   fellowship F32HL084968 to G. C. E.; and AR49294, AG15768, AR50245,
   AR48852 to F. G.), grants from the Coulter Foundation and Duke
   Translational Research Institute for support to F. G., and grants from
   Draper Laboratory for support to J. T B. This article is part of a
   special issue on Regenerative Medicine that is published in honor of
   Prof. Robert Langer on the occasion of his 60<SUP>th</SUP> birthday.
CR Ahsan T, 1999, OSTEOARTHR CARTILAGE, V7, P29, DOI 10.1053/joca.1998.0160
   Akhyari P, 2002, CIRCULATION, V106, P1137
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Armani DK, 2000, J MICROMECH MICROENG, V10, P80, DOI 10.1088/0960-1317/10/1/311
   Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   Augst A, 2008, J R SOC INTERFACE, V5, P929, DOI 10.1098/rsif.2007.1302
   Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Borenstein JT, 2002, BIOMED MICRODEVICES, V4, P167, DOI 10.1023/A:1016040212127
   BORENSTEIN JT, 2009, MAT RES SOC S P, V1139
   Boublik J, 2005, TISSUE ENG, V11, P1122, DOI 10.1089/ten.2005.11.1122
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Brundtland GH, 2003, WHO TECH REP SER, V919, P1
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   Camp JP, 2008, BIOMED MICRODEVICES, V10, P179, DOI 10.1007/s10544-007-9123-x
   Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Feng Zhonggang, 2003, J Artif Organs, V6, P192, DOI 10.1007/s10047-003-0230-z
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Freed LE, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P137, DOI 10.1016/B978-012370615-7/50015-9
   Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   HAAS R, 1984, FEBS LETT, V174, P279, DOI 10.1016/0014-5793(84)81173-4
   Hanley PJ, 1999, J PHYSIOL-LONDON, V517, P831, DOI 10.1111/j.1469-7793.1999.0831s.x
   Hannouche D, 2007, TISSUE ENG, V13, P87, DOI 10.1089/ten.2006.0067
   HAYASHI T, 1972, J BIOCHEM-TOKYO, V72, P749, DOI 10.1093/oxfordjournals.jbchem.a129953
   Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030
   Huang CY, 2005, J BIOMECH, V38, P799, DOI 10.1016/j.jbiomech.2004.05.006
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Ito Y, 2008, ARTIF ORGANS, V32, P36, DOI 10.1111/j.1525-1594.2007.00456.x
   JIANG ZL, 1994, J APPL PHYSIOL, V76, P882
   Kaazempur-Mofrad M. R., 2001, COMPUTATIONAL FLUID, P864
   Khademhosseini A, 2007, BIOMED MICRODEVICES, V9, P149, DOI 10.1007/s10544-006-9013-7
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Krishnan R, 2005, J BIOMECH, V38, P1665, DOI 10.1016/j.jbiomech.2004.07.025
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   LAI WM, 1980, BIORHEOLOGY, V17, P111
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Macchiarelli G, 2002, HISTOL HISTOPATHOL, V17, P699, DOI 10.14670/HH-17.699
   MacKenna DA, 1997, AM J PHYSIOL-HEART C, V273, pH1576
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Martin Y, 2005, BIOMATERIALS, V26, P7481, DOI 10.1016/j.biomaterials.2005.05.057
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7
   Park J, 2005, BIOTECHNOL BIOENG, V90, P632, DOI 10.1002/bit.20463
   POMERANTSEVA I, 2008, J BIOMED MAT RES A
   Pope AJ, 2008, AM J PHYSIOL-HEART C, V295, pH1243, DOI 10.1152/ajpheart.00484.2008
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   RADISIC M, 2006, TISSUE ENG, V12, P1
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588
   Rieppo J, 2008, OSTEOARTHR CARTILAGE, V17, P448
   Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Schmal H, 2008, ORTHOPADE, V37, P424, DOI 10.1007/s00132-008-1258-9
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   Soltz MA, 2000, J BIOMECH ENG-T ASME, V122, P576, DOI 10.1115/1.1324669
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P896, DOI 10.1016/j.joca.2005.05.003
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   VALONEN PK, 2009, T ORTHOP RES SOC, V34, P934
   Vozzi G, 2002, MAT SCI ENG C-BIO S, V20, P43, DOI 10.1016/S0928-4931(02)00011-5
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   Wang GJ, 2007, J MICROMECH MICROENG, V17, P2000, DOI 10.1088/0960-1317/17/10/011
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 105
TC 132
Z9 132
U1 7
U2 132
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD SEP 4
PY 2009
VL 21
IS 32-33
BP 3410
EP 3418
DI 10.1002/adma.200900303
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 495ZS
UT WOS:000269936900016
PM 20882506
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, S. C.
TI Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of
   hydrophobic and hydrophilic drugs for targeted delivery
SO NANOTECHNOLOGY
LA English
DT Article
ID PEPTIDE-AMPHIPHILE NANOFIBERS; MESENCHYMAL STEM-CELLS; TISSUE
   ENGINEERING APPLICATIONS; IN-VITRO; DNA NANOPARTICLES; GENE DELIVERY;
   OSTEOGENIC DIFFERENTIATION; POLYMER THERAPEUTICS; CONTROLLED-RELEASE;
   BONE REGENERATION
AB In recent times self-assembled micellar nanoparticles have been successfully employed in tissue engineering for targeted drug delivery applications. In this review, silk sericin protein from non-mulberry Antheraea mylitta tropical tasar silk cocoons was blended with pluronic F-127 and F-87 in the presence of solvents to achieve self-assembled micellar nanostructures capable of carrying both hydrophilic (FITC-inulin) and hydrophobic (anticancer drug paclitaxel) drugs. The fabricated nanoparticles were subsequently characterized for their size distribution, drug loading capability, cellular uptake and cytotoxicity. Nanoparticle sizes ranged between 100 and 110 nm in diameter as confirmed by dynamic light scattering. Rapid uptake of these particles into cells was observed in in vitro cellular uptake studies using breast cancer MCF-7 cells. In vitro cytotoxicity assay using paclitaxel-loaded nanoparticles against breast cancer cells showed promising results comparable to free paclitaxel drugs. Drug-encapsulated nanoparticle-induced apoptosis in MCF-7 cells was confirmed by FACS and confocal microscopic studies using Annexin V staining. Up-regulation of pro-apoptotic protein Bax, down-regulation of anti-apoptotic protein Bcl-2 and cleavage of regulatory protein PARP through Western blot analysis suggested further drug-induced apoptosis in cells. This study projects silk sericin protein as an alternative natural biomaterial for fabrication of self-assembled nanoparticles in the presence of poloxamer for successful delivery of both hydrophobic and hydrophilic drugs to target sites.
C1 [Mandal, Biman B.; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
FU Department of Biotechnology [BT/PR6035/MED/14/733/2005,
   BT/PR9552/ICD/16/755/2006]; Council of Scientific Industrial Research,
   Government of India, New Delhi; IIT-Kharagpur; EPFL-Lausanne program
FX The Department of Biotechnology and its bioinformatics facility
   (BT/PR6035/MED/14/733/2005, BT/PR9552/ICD/16/755/2006) and the Council
   of Scientific Industrial Research (for a fellowship to BBM), Government
   of India, New Delhi financially supported this work. Financial support
   through the IIT-Kharagpur and EPFL-Lausanne program which was
   coordinated by Professor Promod Rastogi (EPFL) is gratefully
   acknowledged. We are indebted to Professor Jeffrey Alan Hubbell (EPFL),
   Switzerland for permitting us to use his laboratory facility and
   excellent hospitality during our short stay. We also thank Mr Conlin
   O'Neil for his help in TEM analysis and encouragement during the course
   of this study at EPFL, Lausanne.
CR Ahn JS, 2001, J APPL POLYM SCI, V80, P274, DOI 10.1002/1097-4628(20010411)80:2<274::AID-APP1096>3.0.CO;2-G
   Alonso MJ, 2004, BIOMED PHARMACOTHER, V58, P168, DOI 10.1016/j.biopha.2004.01.007
   Amiji MM, 2002, PHARM DEV TECHNOL, V7, P195, DOI 10.1081/PDT-120003487
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Cavallaro G, 2004, MACROMOL BIOSCI, V4, P1028, DOI 10.1002/mabi.200400089
   Cegnar M, 2005, EXPERT OPIN BIOL TH, V5, P1557, DOI 10.1517/14712598.5.12.1557
   CHAWLA JS, 2003, AAPS PHARMSCI, V5
   Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
   Cho KY, 2003, INT J BIOL MACROMOL, V32, P36, DOI 10.1016/S0141-8130(03)00023-0
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Gagandeep S, 1999, CANCER LETT, V136, P109, DOI 10.1016/S0304-3835(98)00388-7
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Grindel JM, 2002, J PHARM SCI-US, V91, P1936, DOI 10.1002/jps.10190
   Hosseinkhani H, 2004, GENE THER, V11, P194, DOI 10.1038/sj.gt.3302159
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hosseinkhani H, 2008, CHEM TODAY, V26, P30
   Hosseinkhani H, 2006, INT J NANOTECHNOL, V3, P416, DOI 10.1504/IJNT.2006.011172
   Hosseinkhani H, 2008, J BIOMED MATER RES A, V85A, P47, DOI 10.1002/jbm.a.31327
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Hosseinkhani H, 2007, TISSUE ENG, V13, P11, DOI 10.1089/ten.2006.0120
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5089, DOI 10.1016/j.biomaterials.2006.05.050
   Hosseinkhani H, 2006, J NANOSCI NANOTECHNO, V6, P2320, DOI 10.1166/jnn.2006.507
   Hosseinkhani H, 2009, CURR DRUG SAF, V4, P79, DOI 10.2174/157488609787354477
   Huff TB, 2007, LANGMUIR, V23, P1596, DOI 10.1021/la062642r
   KABANOV AV, 1995, MACROMOLECULES, V28, P2303, DOI 10.1021/ma00111a026
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kommareddy S, 2005, TECHNOL CANCER RES T, V4, P615, DOI 10.1177/153303460500400605
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Mandal BB, 2009, BIOMED MICRODEVICES, V11, P467, DOI 10.1007/s10544-008-9252-x
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   MCGUIRE WP, 1989, ANN INTERN MED, V11, P1
   MIYAZAKI S, 1995, J PHARM PHARMACOL, V47, P455, DOI 10.1111/j.2042-7158.1995.tb05829.x
   Moghimi SM, 2000, TRENDS BIOTECHNOL, V18, P412, DOI 10.1016/S0167-7799(00)01485-2
   Mooney LM, 2002, BRIT J CANCER, V87, P909, DOI 10.1038/sj.bjc.6600541
   Nagarajan R, 2001, POLYM ADVAN TECHNOL, V12, P23, DOI 10.1002/1099-1581(200101/02)12:1/2<23::AID-PAT75>3.3.CO;2-3
   Nagura Masanobu, 2001, Journal of Insect Biotechnology and Sericology, V70, P149
   Nahar M, 2006, CRIT REV THER DRUG, V23, P259, DOI 10.1615/CritRevTherDrugCarrierSyst.v23.i4.10
   Nishiyama Nobuhiro, 2005, Drug Discov Today Technol, V2, P21, DOI 10.1016/j.ddtec.2005.05.007
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rapoport N, 2003, J CONTROL RELEASE, V91, P85, DOI 10.1016/S0168-3659(03)00218-9
   Schmitt-Sody M, 2003, CLIN CANCER RES, V9, P2335
   SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609
   Shimizu S, 1996, ONCOGENE, V13, P21
   SPENCER CM, 1994, DRUGS, V48, P794, DOI 10.2165/00003495-199448050-00009
   Stratton LP, 1997, J PHARM SCI, V86, P1006, DOI 10.1021/js970034d
   Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   WANG PL, 1993, J PARENT SCI TECHN, V47, P183
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
   YANG J, 2007, IEEE NIH LIF SCI SYS, P92
   Zhang YQ, 2006, J CHEM TECHNOL BIOT, V81, P136, DOI 10.1002/jctb.1370
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhang YQ, 2006, J CONTROL RELEASE, V115, P307, DOI 10.1016/j.jconrel.2006.08.019
   Zhao QH, 2007, NANOMED-NANOTECHNOL, V3, P63, DOI 10.1016/j.nano.2006.11.007
NR 63
TC 47
Z9 47
U1 6
U2 72
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 2
PY 2009
VL 20
IS 35
AR 355101
DI 10.1088/0957-4484/20/35/355101
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 482TL
UT WOS:000268911500001
PM 19671963
DA 2018-10-20
ER

PT J
AU Schneider, A
   Wang, XY
   Kaplan, DL
   Garlick, JA
   Egles, C
AF Schneider, A.
   Wang, X. Y.
   Kaplan, D. L.
   Garlick, J. A.
   Egles, C.
TI Biofunctionalized electrospun silk mats as a topical bioactive dressing
   for accelerated wound heating
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Wound dressing; Wound healing; EGF; Growth factors; Silk fibers
ID EPIDERMAL-GROWTH-FACTOR; KERATINOCYTES IN-VITRO; NANOFIBER MEMBRANES;
   BONE REGENERATION; INDUCED MOTILITY; FACTOR RECEPTOR; FACTOR-ALPHA;
   TISSUE; MODEL; SCAFFOLDS
AB Materials able to deliver topically bioactive molecules represent a new generation of biomaterials. In this article, we describe the use of silk mats, made of electrospun nanoscale silk fibers containing epidermal growth factor (EGF), for the promotion of wound healing processes. In our experiments, we demonstrated that EGF is incorporated into the silk mats and slowly released in a time-dependent manner (25% EGF release in 170 h). We tested these materials using a new model of wounded human skin-equivalents displaying the same structure as human skin and able to heal using the same molecular and cellular mechanisms found in vivo. This human three-dimensional model allows us to demonstrate that the biofunctionalized silk mats, when placed on the wounds as a dressing, aid the healing by increasing the time of wound closure by the epidermal tongue by 90%. The preservation of the structure of the mats during the healing period as demonstrated by electronic microscopy, the biological action of the dressing, as well as the biocompatibility of the silk demonstrate that this biomaterial is a new and very promising material for medical applications, especially for patients suffering from chronic wounds. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Schneider, A.; Garlick, J. A.; Egles, C.] Tufts Univ, Sch Dent Med, Div Canc Biol & Tissue Engn, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA.
   [Wang, X. Y.; Kaplan, D. L.; Garlick, J. A.; Egles, C.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Egles, C (reprint author), Tufts Univ, Sch Dent Med, Div Canc Biol & Tissue Engn, Dept Oral & Maxillofacial Pathol, 55 Kneeland St, Boston, MA 02111 USA.
EM Christophe.egles@tufts.edu
OI EGLES, Christophe/0000-0003-0982-7752
FU Center for Integrated Tissue Engineering at School of Dental Medicine at
   Tufts University; NIH/NIBIB
FX This study was supported by the Center for Integrated Tissue Engineering
   at School of Dental Medicine at Tufts University and NIH/NIBIB funds via
   the P41 Tissue Engineering Resource Center. AS is indebted to the
   Fondation pour la Recherche Medicale for financial support. We are
   grateful to Miss Camille Polidori and Miss Claire Bellemin for
   high-quality technical support.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   BROWN C, 1991, J INVEST DERMATOL, V96, P724, DOI 10.1111/1523-1747.ep12470960
   BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340
   BUCKLEY A, 1987, J SURG RES, V43, P322, DOI 10.1016/0022-4804(87)90088-6
   Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Flasza M, 2007, REGEN MED, V2, P903, DOI 10.2217/17460751.2.6.903
   FRANKLIN JD, 1979, PLAST RECONSTR SURG, V64, P766, DOI 10.1097/00006534-197912000-00003
   Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502
   Garlick JA, 1996, J DENT RES, V75, P912, DOI 10.1177/00220345960750030801
   GARLICK JA, 1994, LAB INVEST, V70, P916
   GARLICK JA, 1994, J INVEST DERMATOL, V103, P554, DOI 10.1111/1523-1747.ep12396847
   Garlick Jonathan A., 1992, Journal of Dermatology (Tokyo), V19, P797
   Gottrup F, 2000, WOUND REPAIR REGEN, V8, P83, DOI 10.1046/j.1524-475x.2000.00083.x
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kano S, 2006, PHARM RES, V23, P329, DOI 10.1007/s11095-006-9141-z
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   KNAUER DJ, 1984, J BIOL CHEM, V259, P5623
   Kurten RC, 2005, AM J PHYSIOL-CELL PH, V288, pC109, DOI 10.1152/ajpcell.00024.2003
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Mustoe T, 2004, AM J SURG, V187, p65S, DOI 10.1016/S0002-9610(03)00306-4
   OKEEFE E, 1982, J INVEST DERMATOL, V78, P482, DOI 10.1111/1523-1747.ep12510246
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Perkins MA, 1996, FUND APPL TOXICOL, V31, P9, DOI 10.1006/faat.1996.0071
   Raja, 2007, Front Biosci, V12, P2849
   Rencker D. H., 1996, NANOTECHNOLOGY, V7, P216
   RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X
   Robinson M K, 2000, Ann N Y Acad Sci, V919, P192
   Rovee DT, 2003, EPIDERMIS WOUND HEAL
   SARRET Y, 1992, J INVEST DERMATOL, V98, P12, DOI 10.1111/1523-1747.ep12493517
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012
   Winter GD, 1972, EPIDERMAL WOUND HEAL, P71
   WOODLEY DT, 1988, J CELL PHYSIOL, V136, P140, DOI 10.1002/jcp.1041360118
   WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 45
TC 193
Z9 199
U1 6
U2 109
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2009
VL 5
IS 7
BP 2570
EP 2578
DI 10.1016/j.actbio.2008.12.013
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 504SF
UT WOS:000270636900022
PM 19162575
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, S. C.
TI Non-mulberry silk gland fibroin protein 3-D scaffold for enhanced
   differentiation of human mesenchymal stem cells into osteocytes
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Non-mulberry silk; Silk fibroin; Scaffolds; Osteogenesis; Stem cells
ID TISSUE ENGINEERING APPLICATIONS; TROPICAL TASAR SILKWORM; MARROW STROMAL
   CELLS; HUMAN BONE-MARROW; IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   ANTHERAEA-MYLITTA; BIOMATERIALS; VIVO; REGENERATION
AB This study investigates the potential of three-dimensional (3-D) scaffolds of wild non-mulberry tropical tasar silk gland fibroin protein as substratum for osteogenic differentiation of human mesenchymal stem cells (hMSCs). The novelty of the study lies in the fabrication of scaffolds from non-bioengineered silk fibroin directly extracted from the glands of non-mulberry tropical tasar silkworms using sodium dodecyl sulfate dissolution protocol and its osteogenic application using single- and double-seeding methods. The scaffolds were mechanically robust and showed homogenous pore distribution within the scaffold. hMSCs were seeded on the scaffolds and were cultured for up to 28 days under static conditions in osteogenic media. Osteogenic differentiation of hMSCs seeded on fibroin scaffolds resulted in extensive mineralization with the formation of large calcium nodules, higher alkaline phosphatase activity and intense von Kossa staining. Real-time studies revealed higher transcript levels for osteopontin (OS) and bone sialoprotein (IBSP) under double-seeded conditions as compared to single-seeded scaffolds. Histological analysis showed the development of osteoblastic cells and large calcified nodules. The development and spreading of nuclei and actin filaments on fibroin matrices were revealed through confocal studies. The results suggest the suitability of non-mulberry silk-fibroin protein 3-D scaffolds as natural biomaterial for potential in vitro bone-tissue engineering applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mandal, Biman B.; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
FU Department of Biotechnology [BT/PR6035/MED/14/733/2005,
   BT/PR9552/ICD/16/755/2006]; Council of Scientific Industrial Research
FX The Department of Biotechnology and its bioinformatics facility
   (BT/PR6035/MED/14/733/2005, BT/PR9552/ ICD/16/755/2006), Council of
   Scientific Industrial Research (for fellowship to B.B.M.), Government of
   India, New Delhi and IIT-EPFL programme financially supported this work.
   We are greatly indebted to Professor Jeffrey Alan Hubbell, Swiss Federal
   Institute of Technology (EPFL), Switzerland, for permitting us to use
   the laboratory, the human MSCs, confocal microscopic facility and for
   his kind hospitality during our short stay. The authors wish to thank
   Lee Seung Tae and Martino MikaEl of the Laboratory for Renerative
   Medicine and Pharmacobiology for their help and support during
   experimentations. S.C.K. is grateful to David Kaplan, Charu Vepari and
   Jeri Kang for introducing the subject area of research during his short
   visit to David Kaplan's laboratory, USA.
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   ASAKURA T, 1984, MACROMOLECULES, V18, P41
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   *ICH, Q3C R3 GUID RES SOLV
   IIZUKA E, 1985, J APPL POLYM SCI APP, V41, P173
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   KAPLAN D, 1994, ACS SYM SER, V544, P16
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim E.S., 2001, FIBER POLYM, V2, P64, DOI DOI 10.1007/BF02875260
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kofron MD, 2004, CURR OPIN BIOTECH, V15, P399, DOI 10.1016/j.copbio.2004.07.004
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P85
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   Riminucci M, 2003, BRAZ J MED BIOL RES, V36, P1027, DOI 10.1590/S0100-879X2003000800008
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stitzel JD, 2001, J BIOMATER APPL, V16, P22, DOI 10.1106/U2UU-M9QH-Y0BB-5GYL
   STRAUSS PG, 1990, J CELL BIOL, V110, P1369, DOI 10.1083/jcb.110.4.1369
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 58
TC 41
Z9 42
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2009
VL 5
IS 7
BP 2579
EP 2590
DI 10.1016/j.actbio.2009.02.033
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 504SF
UT WOS:000270636900023
PM 19345621
DA 2018-10-20
ER

PT J
AU Lin, YC
   Tan, FJ
   Marra, KG
   Jan, SS
   Liu, DC
AF Lin, Yen-Chih
   Tan, Fa-jui
   Marra, Kacey G.
   Jan, Shyh-Shyan
   Liu, Deng-Cheng
TI Synthesis and characterization of collagen/hyaluronan/chitosan composite
   sponges for potential biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Collagen; Chitosan; Hyaluronic acid
ID CHITOSAN-GELATIN SCAFFOLDS; PORE STRUCTURE; COLLAGEN; TISSUE;
   CHONDROCYTES; BIOMATERIAL; THICKNESS; MATRIX; SIZE
AB Cells, scaffolds and growth factors are three main components of a tissue-engineered construct. Collagen type 1, a major protein of the extracellular matrix (ECM) in mammals, is a suitable scaffold material for regeneration. Another important constituent of the ECM, hyaluronic acid (hyaluronan, HA), has been used for medical purposes due to its hydrogel properties and biodegradability. Chitosan is a linear polysaccharide comprised of beta 1- to beta 4-linked D-glucosamine residues, and its potential as a biomaterial is based on its cationic nature and high charge density in solution. This study was conducted to evaluate the characteristics of scaffolds composed of different ratios of type I comb collagen and chitosan with added HA in order to obtain the optimum conditions for the manufacture of collagen-hyaluronan-chitosan (Col-HA-Ch; comprising collagen, HA and chitosan mixed in different ratios: 10:1:0, Col10HACh0; 9:1:1, Col9-HACh1; 8:1:2, Col8HACh2; 7:1:3, Col7HACh3; 6:1:4, Col6HACh4; and 5:1:5, Col5HACh5) composite porous scaffolds. Microstructural observation of the composite scaffolds was performed using scanning electron microscopy. The mean pore diameters ranged from 120 to 182 mu m and decreased as the chitosan composition increased. All scaffolds showed high pore interconnectivity. Swelling ratio measurements showed that all specimens could bind 35- to 40-fold of physiological fluid and still maintain their form and stability. For tensile strength, the optimal ratio of collagen and chitosan was 9:1. Thermal stability was investigated using a differential scanning calorimeter and showed that Col5HACh5 and Col6HACh4 were significantly more stable than the other groups. In enzymatic sensitivity, a steady increase in the biostability of the scaffolds was achieved as the chitosan concentration was increased. In biocompatibility testing, the proliferation of the fibroblasts cultured in Co-HA-Ch tri-copolymer scaffolds was high. Overall, we observed the 9: 1:1 mixing ratio of collagen, hyaluronan and chitosan to be optimal for the manufacture of complex scaffolds. Furthermore, Col-HA-Ch tri-polymer scaffolds, especially Col9HACh1, could be developed as a suitable scaffold material for tissue engineering applications. (C) 2009 Acta Materialia Inc. All rights reserved.
C1 [Lin, Yen-Chih; Tan, Fa-jui; Jan, Shyh-Shyan; Liu, Deng-Cheng] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.
   [Marra, Kacey G.] Univ Pittsburgh, Dept Surg, Div Plast Surg, Pittsburgh, PA USA.
   [Marra, Kacey G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.
   [Marra, Kacey G.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
RP Liu, DC (reprint author), Natl Chung Hsing Univ, Dept Anim Sci, 250 Kao Kuang RD, Taichung 40227, Taiwan.
EM dcliu@dragon.nchu.edu.tw
OI Marra, Kacey/0000-0002-8437-4864
CR Arpornmaeklong P, 2007, INT J ORAL MAX SURG, V36, P328, DOI 10.1016/j.ijom.2006.09.023
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   CHA V, 1994, BIOCHIM BIOPHYS ACTA, V11, P1201
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F
   Hong SR, 2004, J BIOMAT SCI-POLYM E, V15, P201, DOI 10.1163/156856204322793584
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lie M., 2003, BIOMATERIALS, V24, P4833
   LIN YC, 2009, FOOD CHEM UNPUB
   Lin YK, 2007, J BIOMATER APPL, V21, P265, DOI 10.1177/0885328206063502
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MA Z, 2005, BIOMATERIALS, V26, P1255
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   REGINA KP, 1996, J BIOCHEM BIOPH METH, V32, P33
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yan JH, 2007, ARTIF CELL BLOOD SUB, V35, P333, DOI 10.1080/10731190701460200
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
NR 26
TC 98
Z9 103
U1 2
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2009
VL 5
IS 7
BP 2591
EP 2600
DI 10.1016/j.actbio.2009.03.038
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 504SF
UT WOS:000270636900024
PM 19427824
DA 2018-10-20
ER

PT J
AU Thein-Han, WW
   Shah, J
   Misra, RDK
AF Thein-Han, W. W.
   Shah, J.
   Misra, R. D. K.
TI Superior in vitro biological response and mechanical properties of an
   implantable nanostructured biomaterial: Nanohydroxyapatite-silicone
   rubber composite
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silicone rubber elastomer; Nanohydroxyapatite; Nanostructured composite;
   Pre-osteoblasts; Cellular response
ID NANOGRAINED/ULTRAFINE-GRAINED STRUCTURES; BETA-TRICALCIUM PHOSPHATE;
   CALCIUM-PHOSPHATE; CELL ATTACHMENT; RAT CALVARIA; FIBRONECTIN;
   OSTEOBLASTS; TITANIUM; ADHESION; BONE
AB A potential approach to achieving the objective of favorably modulating the biological response of implantable biopolymers combined with good mechanical properties is to consider compounding the biopolymer with a bioactive nanocrystalline ceramic biomimetic material with high surface area. The processing of silicone rubber (SR)-nanohydroxyapatite (nHA) composite involved uniform dispersion of nHA via shear mixing and ultrasonication, followed by compounding at sub-ambient temperature, and high-pressure solidification when the final curing reaction occurs. The high-pressure solidification approach enabled the elastomer to retain the high elongation of SR even in the presence of the reinforcement material, nHA. The biological response of the nanostructured composite in terms of initial cell attachment, cell viability and proliferation was consistently greater on SR-5 wt.% nHA composite surface compared to pure SR. Furthermore, in the nanocomposite, cell spreading, morphology and density were distinctly different from that of pure SR. Pre-osteoblasts grown on SR-nHA were well spread, flat, large in size with a rough cell surface, and appeared as a group. In contrast, these features were less pronounced in SR (e.g. smooth cell surface, not well spread). Interestingly, an immunofluorescence study illustrated distinct fibronectin expression level, and stronger vinculin focal adhesion contacts associated with abundant actin stress fibers in pre-osteoblasts grown on the nanocomposite compared to SR, implying enhanced cell-substrate interaction. This finding was consistent with the total protein content and SDS-PAGE analysis. The study leads us to believe that further increase in nHA content in the SR matrix beyond 5 wt.% will encourage even greater cellular response. The integration of cellular and molecular biology with materials science and engineering described herein provides a direction for the development of a new generation of nanostructured materials. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Thein-Han, W. W.; Shah, J.; Misra, R. D. K.] Univ Louisiana Lafayette, Ctr Struct & Funct Mat, Biomat & Biomed Engn Res Lab, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Ctr Struct & Funct Mat, Biomat & Biomed Engn Res Lab, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Catanese J, 1999, J BIOMED MATER RES, V48, P187, DOI 10.1002/(SICI)1097-4636(1999)48:2<187::AID-JBM13>3.3.CO;2-D
   CATLEDGE SA, 2004, ENCY NANOSCIENCE NAN, V10, P1
   CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z
   Erbe EM, 2001, EUR SPINE J, V10, pS141, DOI 10.1007/s005860100287
   Erlich Mark A, 2003, Facial Plast Surg, V19, P325
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Fray M. E., 2007, J MATER SCI-MATER M, V18, P501
   Globus RK, 1998, J CELL SCI, V111, P1385
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HYNES RO, 1974, CELL, V3, P113, DOI 10.1016/0092-8674(74)90114-7
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   LEICHTER I, 1992, BIOMATERIALS, V13, P478, DOI 10.1016/0142-9612(92)90170-S
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Matrin-Granizo R., 1997, PLAST RECONSTR SURG, V99, P2100
   MEYER U, 1993, CELL MATER, V3, P129
   Misra RDK, 2009, ACTA BIOMATER, V5, P1455, DOI 10.1016/j.actbio.2008.12.017
   Misra RDK, 2009, ADV MATER, V21, P1280, DOI 10.1002/adma.200802478
   NORDAHL J, 1995, CALCIFIED TISSUE INT, V57, P442, DOI 10.1007/BF00301948
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   Polyzois G L, 1995, J Prosthodont, V4, P38, DOI 10.1111/j.1532-849X.1995.tb00313.x
   Rangavittal N, 2000, J BIOMED MATER RES, V51, P660, DOI 10.1002/1097-4636(20000915)51:4<660::AID-JBM14>3.0.CO;2-B
   Romo T, 1998, AESTHET PLAST SURG, V22, P211, DOI 10.1007/s002669900193
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   Starch MS, 2003, J COSMET SCI, V54, P193
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   THEINHAN WW, 2009, SUPERIOR IN VI UNPUB
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Wang J, 2004, J DENT RES, V83, P296, DOI 10.1177/154405910408300405
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Wen JQ, 2008, MATER LETT, V62, P3307, DOI 10.1016/j.matlet.2008.02.032
   WINNARD RG, 1995, J BONE MINER RES, V10, P1969
   Yuan Q, 2008, MAT SCI ENG A-STRUCT, V480, P181, DOI 10.1016/j.msea.2007.07.019
   Yuan Q, 2008, MATER SCI ENG B-ADV, V153, P88, DOI 10.1016/j.mseb.2008.10.031
   Zhou CR, 1999, BIOMATERIALS, V20, P2093, DOI 10.1016/S0142-9612(99)00080-0
NR 40
TC 30
Z9 31
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2009
VL 5
IS 7
BP 2668
EP 2679
DI 10.1016/j.actbio.2009.04.029
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 504SF
UT WOS:000270636900032
PM 19435616
DA 2018-10-20
ER

PT J
AU Liang, HS
   Liang, P
   Xu, Y
   Wu, JN
   Liang, T
   Xu, XP
   Liu, EZ
AF Liang, Hong Sheng
   Liang, Peng
   Xu, Ye
   Wu, Jia Ning
   Liang, Tao
   Xu, Xiao Ping
   Liu, En Zhong
TI Denuded human amniotic membrane seeding bone marrow stromal cells as an
   effective composite matrix stimulates axonal outgrowth of rat neural
   cortical cells in vitro
SO ACTA NEUROCHIRURGICA
LA English
DT Article
DE Stem cell; Amniotic membrane; Axonal outgrowth; Matrix; Biomaterial
ID NEURITE OUTGROWTH; EPITHELIAL-CELLS; STEM-CELLS; SURFACE RECONSTRUCTION;
   TRANSPLANTATION; EXPRESSION; SCAFFOLDS; HYDROGELS; DEFECTS; INTACT
AB Previous studies have shown that axonal outgrowth in the damaged central nervous system is closely related to the local microenvironment. Transplantation of bone marrow stromal cells (BMSC) or BMSC with some biomaterials has been used to treat various central nervous system diseases with some success. In the current study, we investigated if BMSC on denuded human amniotic membrane (DhAM) as a composite matrix could stimulate axonal outgrowth or not.
   After completely removing the cells on the amniotic membrane with a tryptic and mechanical approach, we seeded BMSC on it. The MTS was applied to test the cytotoxicity of DhAM compared with PLGA and PLL. The morphology of the BMSC was observed by light, electronic and laser confocal microscopy. We also used four kinds of substance (PLL, DhAM, BMSC + PLL, BMSC + DhAM) to coculturing with the cortical neurons. Finally, the lengths of axons in each group were studied using the positive axon-specific marker NF-H.
   The DhAM was devoid of cellular components and only its intact basement membrane was left. BMSC grew on the substrate and proliferated with a flat to fusiform morphology. In the MTS test, the results indicated that BMSC cultured in DhAM extract had a high survival rate (> 80%). Moreover, the cortical neural axons in the experimental group (BMSC + DhAM) were longer (287.37 +/- 12.72 mu m) than in the other groups (P < 0.01).
   This study demonstrates that the DhAM was a good carrier to support growth of BMSC and BMSC on DhAM was an effective composite matrix to support the outgrowth of the axons of rat cortical neurons in vitro. Future studies of the use of the composite matrix in disorders are planned.
C1 [Liang, Hong Sheng; Liang, Peng; Wu, Jia Ning; Xu, Xiao Ping; Liu, En Zhong] Harbin Med Coll, Affiliated Hosp 1, Dept Neurosurg, Harbin 150001, Peoples R China.
   [Xu, Ye] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.
   [Liang, Tao] Harbin Med Coll, Affiliated Hosp 1, Dept Digest, Harbin 150001, Peoples R China.
   [Liang, Peng] Minist Hlth China, Key Lab Cell Transplantat, Harbin 150001, Peoples R China.
RP Liang, P (reprint author), Harbin Med Coll, Affiliated Hosp 1, Dept Neurosurg, Harbin 150001, Peoples R China.
EM Liangpengd@Gmail.com
FU National Natural Science Foundation of China [30500517]; Post-graduate
   Foundation of Harbin Medical University [2007003]
FX This study was supported by grants from the National Natural Science
   Foundation of China ( No. 30500517) and Post-graduate Foundation of
   Harbin Medical University ( HCXB No. 2007003). We thank Dr. Lili Liu for
   generously providing PLGA and PLL, and Shangha Pan, Qi Huang, Aili Gao
   for their excellent technical assistance.
CR Baharvand H, 2007, MOL VIS, V13, P1711
   BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0
   Filipas D, 2001, Curr Opin Urol, V11, P267, DOI 10.1097/00042307-200105000-00004
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Ganatra M A, 2003, J Pak Med Assoc, V53, P29
   Han DW, 2005, BIOTECHNOL LETT, V27, P53, DOI 10.1007/s10529-004-6585-2
   Kim JK, 2008, BIOMACROMOLECULES, V9, P149, DOI 10.1021/bm700924n
   Kinoshita S, 2004, ARTIF ORGANS, V28, P22, DOI 10.1111/j.1525-1594.2004.07319.x
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Liu M, 2006, J MOL NEUROSCI, V29, P123, DOI 10.1385/JMN/29:02:123
   Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.000028004/.85651.4F
   Luo Jing-cong, 2004, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V18, P108
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Sakuragawa N, 2001, JPN J PHARMACOL, V85, P20, DOI 10.1254/jjp.85.20
   Sangwan Virender S., 2007, Indian Journal of Ophthalmology, V55, P251
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Tajima F, 2001, BLOOD, V97, P2618, DOI 10.1182/blood.V97.9.2618
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4
   Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Yang L, 2006, CELL TISSUE RES, V326, P69, DOI 10.1007/s00441-006-0208-2
   Yoon SJ, 2007, TISSUE ENG, V13, P1125, DOI 10.1089/ten.2006.0287
NR 29
TC 12
Z9 14
U1 0
U2 3
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-6268
J9 ACTA NEUROCHIR
JI Acta Neurochir.
PD SEP
PY 2009
VL 151
IS 9
BP 1113
EP 1120
DI 10.1007/s00701-009-0322-5
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 487WE
UT WOS:000269307500013
PM 19404575
DA 2018-10-20
ER

PT J
AU Rogalski, A
AF Rogalski, A.
TI Infrared Detectors for the Future
SO ACTA PHYSICA POLONICA A
LA English
DT Article
ID FOCAL-PLANE ARRAYS; MINORITY-CARRIER LIFETIMES; INTEGRATED SENSOR
   ARRAYS; WAVELENGTH; LONG; SUPERLATTICES; HGCDTE; PERFORMANCE; BAND; MBE
AB In the paper, fundamental and technological issues associated with the development and exploitation of the most advanced infrared detector technologies axe discussed. In this class of detectors both photon and thermal detectors are considered. Special attention is directed to HgCdTe ternary alloys on silicon, type-II superlattices, uncooled thermal bolometers, and novel uncooled micromechanical cantilever detectors. Despite serious competition from alternative technologies and slower progress than expected, HgCdTe is unlikely to be seriously challenged for high-performance applications, applications requiring multispectral capability and fast response. However, the nonuniformity is a serious problem in the case of LWIR and VLWIR HgCdTe detectors. In this context, it is predicted that type-II superlattice system seems to be an alternative to HgCdTe in long wavelength spectral region. In well established uncooled imaging, VOx microbolometer arrays are clearly the most used technology. In spite of successful commercialization of uncooled microbolometers, the infrared community is still searching for a platform for thermal imagers that combine affordability, convenience of operation, and excellent performance. Recent advances in microelectromechanical systems have led to the development of uncooled IR detectors operating as micromechanical thermal detectors. Between them the most important axe biomaterial microcantilevers.
C1 Mil Univ Technol, Inst Appl Phys, PL-00908 Warsaw, Poland.
RP Rogalski, A (reprint author), Mil Univ Technol, Inst Appl Phys, S Kaliskiego 2, PL-00908 Warsaw, Poland.
RI Rogalski, Antoni/H-8073-2012
OI Rogalski, Antoni/0000-0002-4985-7297
CR Abedin MN, 2004, P SOC PHOTO-OPT INS, V5543, P239, DOI 10.1117/12.559917
   Aifer E.H., 2006, APPL PHYS LETT, V89
   Aifer EH, 2005, P SOC PHOTO-OPT INS, V5783, P112, DOI 10.1117/12.605228
   Amantea R, 1997, P SOC PHOTO-OPT INS, V3061, P210, DOI 10.1117/12.280340
   Anderson J, 2001, P SOC PHOTO-OPT INS, V4369, P559, DOI 10.1117/12.445315
   BAJAJ J, 2007, P SPIE, V6542
   Balcerak R, 2005, P SOC PHOTO-OPT INS, V5783, P384, DOI 10.1117/12.609465
   Beletic J. W., 2008, P SPIE, V7021
   Bornfreund R, 2007, J ELECTRON MATER, V36, P1085, DOI 10.1007/s11664-007-0177-6
   Brown GJ, 2005, P SOC PHOTO-OPT INS, V5783, P65, DOI 10.1117/12.606621
   Burkle L, 2002, HANDBOOK OF INFRARED DETECTION TECHNOLOGIES, P159, DOI 10.1016/B978-185617388-9/50005-8
   Cabanski W, 2004, P SOC PHOTO-OPT INS, V5406, P184, DOI 10.1117/12.542186
   Canedy CL, 2007, J ELECTRON MATER, V36, P852, DOI [10.1007/s11664-007-0109-5, 10.1007/s11664!007-0109-5]
   CARRANO J, 2004, SPIES OEMAGAZIN 0420
   CAULFIELD JT, 2003, P 32 APPL IM PATT RE, P7
   DATSKOS P, 2006, SPIE NEWSROOM, DOI DOI 10.1117/2.1200608.036
   Delaunay PY, 2008, IEEE J QUANTUM ELECT, V44, P462, DOI 10.1109/JQE.2008.916701
   Delaunay PY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2776353
   Destefanis G, 2007, J ELECTRON MATER, V36, P1031, DOI 10.1007/s11664-007-0168-7
   Goldberg AC, 2001, P SOC PHOTO-OPT INS, V4369, P532, DOI 10.1117/12.445313
   GREIN CH, 1994, APPL PHYS LETT, V65, P2530, DOI 10.1063/1.112626
   GREIN CH, 1992, APPL PHYS LETT, V61, P2905, DOI 10.1063/1.108480
   Grein CH, 1995, J APPL PHYS, V78, P7143, DOI 10.1063/1.360422
   Gunapala SD, 2007, INFRARED PHYS TECHN, V50, P217, DOI 10.1016/j.infrared.2006.10.005
   Gunapala SD, 2005, SEMICOND SCI TECH, V20, P473, DOI 10.1088/0268-1242/20/5/026
   Gunapala SD, 2003, IEEE T ELECTRON DEV, V50, P2353, DOI 10.1109/TED.2003.818818
   GUNAPALA SD, 2007, P SPIE, V6660
   GUNNING WI, 2006, P SPIE, V6232
   GUNNING WJ, 2005, P SOC PHOTO-OPT INS, V5783, P336
   HANSON CM, 2008, P SPIE, V6940
   Hoffman A, 2006, LASER FOCUS WORLD, V42, P81
   Hoffman AW, 2003, P SOC PHOTO-OPT INS, V5167, P194, DOI 10.1117/12.516509
   HOFFMAN CA, 1994, SOLID STATE ELECTRON, V37, P1203, DOI 10.1016/0038-1101(94)90389-1
   Hood A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2747172
   Horn S, 2005, P SOC PHOTO-OPT INS, V5783, P401, DOI 10.1117/12.609467
   Horn S, 2004, P SOC PHOTO-OPT INS, V5406, P332, DOI 10.1117/12.548880
   HUNTER SR, 2008, P SOC PHOTO-OPT INS, V6940, P13
   Jhabvala M, 2003, P SOC PHOTO-OPT INS, V5167, P175, DOI 10.1117/12.505733
   KING DF, 2006, P SPIE, V6206
   Kohin M, 2004, P SOC PHOTO-OPT INS, V5406, P447, DOI 10.1117/12.542482
   LAVRIK N, 2007, P SPIE, V6542
   MAILHIOT C, 1989, J VAC SCI TECHNOL A, V7, P445, DOI 10.1116/1.576201
   Martyniuk P, 2008, PROG QUANT ELECTRON, V32, P89, DOI [10.1016/j.pquantelec.2008.07.001, 10.1016/j.pquantelec.2009.07.001]
   McCarley P, 2001, P SOC PHOTO-OPT INS, V4288, P1, DOI 10.1117/12.429394
   MUNZBERG M, 2006, P SPIE, V6206
   Musca CA, 2005, IEEE ELECTR DEVICE L, V26, P888, DOI 10.1109/LED.2005.859651
   Nguyen BM, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2800808
   Norton P, 2002, OPTO-ELECTRON REV, V10, P159
   Norton P, 2000, P SOC PHOTO-OPT INS, V4130, P226, DOI 10.1117/12.409861
   NORTON PR, 2006, OPTO-ELECTRON REV, V14, P283
   PELLEGRINO J, 2008, 2008 US WORKSH 2 6 M
   Peterson JM, 2006, J ELECTRON MATER, V35, P1283, DOI 10.1007/s11664-006-0255-1
   Phillips J, 2002, J APPL PHYS, V91, P4590, DOI 10.1063/1.1455130
   Rajavel RD, 1998, J ELECTRON MATER, V27, P747, DOI 10.1007/s11664-998-0047-x
   Ratches JA, 2006, FERROELECTRICS, V342, P183, DOI 10.1080/00150190600946351
   Razeghi M, 2005, P SOC PHOTO-OPT INS, V5783, P86, DOI 10.1117/12.605291
   Reago DA, 1999, P SOC PHOTO-OPT INS, V3701, P108, DOI 10.1117/12.352991
   Rehm R, 2005, P SOC PHOTO-OPT INS, V5783, P123, DOI 10.1117/12.603420
   Reine MB, 1998, P SOC PHOTO-OPT INS, V3379, P200, DOI 10.1117/12.317588
   RHIGER DR, 2008, 2008 US WORKSH 2 6 M
   Rogalski A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3099572
   Rogalski A., 2000, INFRARED DETECTORS
   SALERNO JP, 2007, P SPIE, V6542
   Schneider H, 2000, P SOC PHOTO-OPT INS, V4130, P353, DOI 10.1117/12.409877
   Schneider H, 2001, INFRARED PHYS TECHN, V42, P283, DOI 10.1016/S1350-4495(01)00086-X
   Tennant WE, 2001, J ELECTRON MATER, V30, P590, DOI 10.1007/BF02665839
   TIDROW MZ, 1999, OPTO-ELECTRON REV, V7, P283
   Wachter EA, 1996, REV SCI INSTRUM, V67, P3434, DOI 10.1063/1.1147149
   WILSON JA, 1994, P SOC PHOTO-OPT INS, V2274, P117, DOI 10.1117/12.189237
   Yang QK, 2003, P SOC PHOTO-OPT INS, V4999, P448, DOI 10.1117/12.479548
   Zanatta JP, 2000, P SOC PHOTO-OPT INS, V4130, P441, DOI 10.1117/12.409885
   Zhao J, 2005, P SOC PHOTO-OPT INS, V5783, P506, DOI 10.1117/12.606485
   2006, UKTA NEWS        DEC
   2003, OPTO LASER EUROPE
NR 74
TC 69
Z9 79
U1 3
U2 30
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD SEP
PY 2009
VL 116
IS 3
BP 389
EP 406
DI 10.12693/APhysPolA.116.389
PG 18
WC Physics, Multidisciplinary
SC Physics
GA 509PX
UT WOS:000271031600037
OA Bronze
DA 2018-10-20
ER

PT J
AU Martina, B
   Katerina, K
   Miloslava, R
   Jan, G
   Ruta, M
AF Martina, Bajerova
   Katerina, Krejcova
   Miloslava, Rabiskova
   Jan, Gajdziok
   Ruta, Masteikova
TI Oxycellulose: Significant Characteristics in Relation to Its
   Pharmaceutical and Medical Applications
SO ADVANCES IN POLYMER TECHNOLOGY
LA English
DT Article
DE Biodegradable; Biomaterials; Drug delivery systems; Hemostatic agent;
   Oxidized cellulose
ID TEMPO-MEDIATED OXIDATION; OXIDIZED REGENERATED CELLULOSE/COLLAGEN;
   CARBOXYLATED MICROCRYSTALLINE CELLULOSE; IN-VITRO; PERIODATE
   OXYCELLULOSE; NATIVE CELLULOSE; VISCOMETRIC DETERMINATION; DIALDEHYDE
   CONTENT; CELLOURONIC ACID; BLOOD-PLATELETS
AB As a biomaterial, cellulose can be converted into a wide range of derivatives with desired properties for a variety of medical, biomedical, and pharmaceutical applications. The oxidation of cellulose yields oxidized cellulose (OC, oxycellulose, 6-carboxycellulose). OC represents an important class of biocompatible and bioresorbable polymers. In vivo bioabsorption of OC occurs via chemical depolymerization and enzymatic hydrolysis. Despite the fact OC is well established as a hemostatic agent and is widely used in a clinical practice, it still attracts a great interest and its new applications, especially pharmaceutical, are investigated. The present review is focused on characterization of OC's physical and chemical properties. Its synthesis and mechanisms involved in its in vivo and in vitro biodegradation are discussed. Medical and biomedical applications of OC are summarized, and especially its hemostatic, enterosorbent, and wound-healing properties are described. In addition to these applications, OC could be used as a pharmaceutical excipient in solid (e.g., tablets, microparticles), semisolid (e.g., gels), as well as liquid (e.g., suspensions) dosage forms. (C) 2009 Wiley Periodicals, Inc. Adv Polym Techn 28:199-208, 2009; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/adv.20161
C1 [Martina, Bajerova; Katerina, Krejcova; Miloslava, Rabiskova; Jan, Gajdziok; Ruta, Masteikova] Univ Vet & Pharmaceut Sci, Dept Pharmaceut, Fac Pharm, Brno, Czech Republic.
RP Martina, B (reprint author), Univ Vet & Pharmaceut Sci, Dept Pharmaceut, Fac Pharm, Brno, Czech Republic.
EM martina.bajerova@seznam.cz
FU Ministry of Industry and Trade of the Czech Republic [MPO NPV II
   2A-1TP1/073]
FX Contract grant sponsor; Ministry of Industry and Trade of the Czech
   Republic.; Contract grant number: MPO NPV II 2A-1TP1/073.
CR Agoub AA, 2008, CARBOHYD POLYM, V71, P416, DOI 10.1016/j.carbpol.2007.06.013
   Ashton W. H., 1968, United States Patent, Patent No. [3364200, 3,364,200]
   BALA K, 1982, BIOMATERIALS, V3, P97, DOI 10.1016/0142-9612(82)90041-2
   Banker G.S., 1995, US patent, Patent No. 5405953
   BANKER GB, 1996, Patent No. 5580974
   BANKER GS, 1998, Patent No. 5780618
   BANKER GS, 1995, Patent No. 5414079
   BARINKA L, 1978, Patent No. 185366
   Bertocchi C, 1995, CARBOHYD POLYM, V27, P295, DOI 10.1016/0144-8617(95)00065-8
   Calvini P, 2006, VIB SPECTROSC, V40, P177, DOI 10.1016/j.vibspec.2005.08.004
   Calvini P, 2004, CELLULOSE, V11, P99, DOI 10.1023/B:CELL.0000014766.31671.8d
   Calvini P, 2006, CELLULOSE, V13, P571, DOI 10.1007/s10570-005-9035-y
   Chavan VB, 2002, CARBOHYD POLYM, V50, P41, DOI 10.1016/S0144-8617(01)00367-8
   CHEN LF, 1984, Patent No. 480089
   CHOWDHURY PR, 2006, J BIOMED MATER RES A, V76, P300
   Cohen EC, 1986, US Patent Office, Pat., Patent No. 4597960
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   Cullen B, 2002, INT J BIOCHEM CELL B, V34, P1544, DOI 10.1016/S1357-2725(02)00054-7
   CULLEN BM, 2006, Patent No. 2006114565
   CULLEN BM, 2007, Patent No. 2007154530
   Delattre C, 2006, CELLULOSE, V13, P63, DOI 10.1007/s10570-005-9031-2
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V198, P331
   El-Sakhawy M, 2000, POLYM INT, V49, P839, DOI 10.1002/1097-0126(200008)49:8<839::AID-PI463>3.0.CO;2-T
   ENTWISTLE D, 1949, TEXT RES J, V19, P527, DOI 10.1177/004051754901900901
   Frantz VK, 1943, ANN SURG, V119, P116
   Gert EV, 2006, RUSS J APPL CHEM+, V79, P1896, DOI 10.1134/S1070427206110309
   Gert EV, 2005, CELLULOSE, V12, P517, DOI 10.1007/s10570-005-7134-4
   Hart J, 2002, INT J BIOCHEM CELL B, V34, P1557, DOI 10.1016/S1357-2725(02)00062-6
   Hofmann I, 2006, SURF COAT TECH, V201, P2392, DOI 10.1016/j.surfcoat.2006.04.007
   Jelinkova M, 2002, INT IMMUNOPHARMACOL, V2, P1429, DOI 10.1016/S1567-5769(02)00087-5
   Jeschke MG, 2005, WOUND REPAIR REGEN, V13, P324, DOI 10.1111/j.1067-1927.2005.130316.x
   Jin B., 2005, PCT, Patent No. [2005020997, WO/2005/020997]
   Kaputskii FN, 2005, FIBRE CHEM+, V37, P485, DOI 10.1007/s10692-006-0026-z
   KAPUTSKII FN, 1995, COLLOID J+, V57, P42
   Kato K, 1999, J POLYM SCI POL CHEM, V37, P357, DOI 10.1002/(SICI)1099-0518(19990201)37:3<357::AID-POLA13>3.0.CO;2-2
   Kato Y, 2005, J POLYM ENVIRON, V13, P261, DOI 10.1007/s10924-005-4760-8
   Kato Y, 2002, CELLULOSE, V9, P75, DOI 10.1023/A:1015877416414
   Krizova P, 2007, J BIOMED MATER RES A, V82A, P274, DOI 10.1002/jbm.a.31060
   Kumar V, 2002, J BIOMAT SCI-POLYM E, V13, P273, DOI 10.1163/156856202320176529
   Kumar V, 2002, CARBOHYD POLYM, V48, P403, DOI 10.1016/S0144-8617(01)00290-9
   Kumar V, 2001, PHARM DEV TECHNOL, V6, P459, DOI 10.1081/PDT-100002254
   Kumar V, 2001, PHARM DEV TECHNOL, V6, P449, DOI 10.1081/PDT-100002253
   Kumar V, 1999, INT J PHARMACEUT, V184, P219, DOI 10.1016/S0378-5173(99)00098-8
   Kumar V, 2001, ARTIF CELL BLOOD SUB, V29, P203, DOI 10.1081/BIO-100103044
   KUMAR V, 2003, Patent No. 6627749
   KUMAR V, 2004, Patent No. 6800753
   LEWIN M, 1962, J POLYM SCI, V58, P1023, DOI 10.1002/pol.1962.1205816663
   Margutti S, 2001, RESTAURATOR, V22, P67, DOI 10.1515/REST.2001.67
   Milichovsky M, 2008, J APPL POLYM SCI, V107, P2045, DOI 10.1002/app.27232
   Nada AAMA, 2006, J APPL POLYM SCI, V102, P1399, DOI 10.1002/app.24255
   OTTERLEI M, 1992, Patent No. 5169840
   PACSU E, 1945, TEXT RES J, V15, P354, DOI 10.1177/004051754501501002
   PAINTER TJ, 1985, CARBOHYD RES, V140, P61, DOI 10.1016/0008-6215(85)85049-7
   Pameijer CH, 2007, Agents and devices comprising oxidized cellulose fibers for providing blood clotting for wound healing promotion, Patent No. [20,070,190,110, 20070190110, US 20,070,190,110 A1 20070816, CAN 147: 243491]
   PIERCE A, 1987, INT J ORAL MAX SURG, V16, P338, DOI 10.1016/S0901-5027(87)80156-X
   Rysava J, 2003, SENSOR ACTUAT B-CHEM, V90, P243, DOI 10.1016/S0925-4005(03)00035-2
   Saito T, 2006, CARBOHYD POLYM, V65, P435, DOI 10.1016/j.carbpol.2006.01.034
   Saito T, 2005, CARBOHYD POLYM, V61, P414, DOI 10.1016/j.carbpol.2005.05.014
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970
   Santar I, 1998, World Patent Office, Pat., Patent No. 9833822
   SCHMIDT R, 2001, Patent No. 1153618
   Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z
   Schonfelder U, 2005, BIOMATERIALS, V26, P6664, DOI 10.1016/j.biomaterials.2005.04.030
   Sharma JB, 2003, INT J GYNECOL OBSTET, V83, P271, DOI 10.1016/S0020-7292(03)00155-3
   Sheleg SV, 2002, J NEURO-ONCOL, V60, P53, DOI 10.1023/A:1020288015457
   Shibata I, 2003, CELLULOSE, V10, P151, DOI 10.1023/A:1024051514026
   SILCOCK DW, 2004, Patent No. 2399289
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   Stilwell RL, 1997, DRUG TARG D, V7, P291
   Sun B, 2005, CELLULOSE, V12, P59, DOI 10.1023/B:CELL.0000049409.56806.da
   Tahiri C, 2000, CELLULOSE, V7, P177, DOI 10.1023/A:1009276009711
   VARMA AJ, 1995, POLYM DEGRAD STABIL, V49, P245, DOI 10.1016/0141-3910(95)87006-7
   Vicini S, 2004, THERMOCHIM ACTA, V418, P123, DOI 10.1016/j.tca.2003.11.049
   WALIMBE AM, 1978, RES IND, V23, P162
   WATT PW, 2003, Patent No. 0918548
   WHITMORE PM, 1994, J RESTAURATOR, V15, P26
   Wiegand C, 2006, CELLULOSE, V13, P689, DOI 10.1007/s10570-006-9073-0
   WU SHW, 1997, Patent No. 5696101
   YACKEL CE, 1941, Patent No. 2232990
   Yackel EC, 1942, J AM CHEM SOC, V64, P121, DOI 10.1021/ja01253a032
   ZHU L, 2004, AAPS PHARMSCITECH, V70, P1
   Zhu LH, 2001, INT J PHARMACEUT, V223, P35, DOI 10.1016/S0378-5173(01)00725-6
   Zhu LH, 2004, AAPS PHARMSCITECH, V5
   Zimnitsky DS, 2006, J COLLOID INTERF SCI, V295, P33, DOI 10.1016/j.jcis.2005.07.058
   Zimnitsky DS, 2005, J COLLOID INTERF SCI, V285, P502, DOI 10.1016/j.jcis.2004.12.021
   Zimnitsky DS, 2004, J POLYM SCI POL CHEM, V42, P4785, DOI 10.1002/pola.20302
NR 88
TC 24
Z9 25
U1 2
U2 50
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-6679
EI 1098-2329
J9 ADV POLYM TECH
JI Adv. Polym. Technol.
PD FAL
PY 2009
VL 28
IS 3
BP 199
EP 208
DI 10.1002/adv.20161
PG 10
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 534RJ
UT WOS:000272914700006
DA 2018-10-20
ER

PT J
AU Zhang, HN
   Lin, CY
   Hollister, SJ
AF Zhang, Huina
   Lin, Chia-Ying
   Hollister, Scott J.
TI The interaction between bone marrow stromal cells and RGD-modified
   three-dimensional porous polycaprolactone scaffolds
SO BIOMATERIALS
LA English
DT Article
DE RGD peptide; Polycaprolactone; Scaffold; Mesenchymal stem cell; Cell
   adhesion; Cell signaling
ID FOCAL ADHESION KINASE; NF-KAPPA-B; SURFACE MODIFICATION; CHONDROCYTE
   ADHESION; POLY(L-LACTIC ACID); SEEDING EFFICIENCY; PERFUSION CULTURE;
   FLOW PERFUSION; PROLIFERATION; INTEGRINS
AB We previously established a simple method to immobilize the Arg-Gly-Asp (RGD) peptide on Polycaprolactone (PCL) two-dimensional film surfaces that significantly improved bone marrow stromal cell (BMSC) adhesion to these films. The current work extends this modification strategy to three-dimensional (3D) PCL scaffolds to investigate BMSC attachment, cellular distribution and cellularity, signal transduction and survival on the modified PCL scaffold compared to those on the untreated ones. The results demonstrated that treatment of 3D PCL scaffold surfaces with 1,6-hexanediamine introduced the amino functional groups onto the porous PCL scaffold homogenously as detected by a ninhydrin staining method. Followed by the cross-linking reaction, RGDC peptide was successfully immobilized on the surface of PCL scaffold. Although the static seeding method used in this study caused heterogeneous cell distribution, the RGD-modified PCL scaffold still demonstrated the improved BMSC attachment and cellular distribution in the scaffold. More importantly, the integrin-mediated signal transduction FAK-PI3K-Akt pathway was significantly up-regulated by RGD modification and a subsequent increase in cell survival and growth was found in the modified scaffold. The present study introduces an easy method to immobilize RGD peptide on the 3D porous PCL scaffold and provides further evidence that modification of 3D PCL scaffolds with RGD peptides elicits specific cellular responses and improves the final cell-biomaterial interaction. (C) 2009 Published by Elsevier Ltd.
C1 [Zhang, Huina; Lin, Chia-Ying; Hollister, Scott J.] Univ Michigan, Dept Biomed Engn, Scaffold Tissue Engn Grp, Ann Arbor, MI 48109 USA.
   [Zhang, Huina; Lin, Chia-Ying; Hollister, Scott J.] Univ Michigan, Dept Neurosurg & Biomed Engn, Spine Res Lab, Sch Med, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn, Scaffold Tissue Engn Grp, Room 2208,1101 Beal, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
FU NIH [R01 AR 053379]
FX This work was supported by Grant NIH R01 AR 053379. The authors also
   thank Jessica Williams for the scaffold design and fabrication.
CR Abbi S, 2002, HISTOL HISTOPATHOL, V17, P1163, DOI 10.14670/HH-17.1163
   Alvarez-Barreto JF, 2007, MACROMOL BIOSCI, V7, P579, DOI 10.1002/mabi.200600280
   Alves CM, 2008, J BIOMED MATER RES B, V87B, P59, DOI 10.1002/jbm.b.31068
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318
   Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Godbey WT, 2004, BIOMATERIALS, V25, P2799, DOI 10.1016/j.biomaterials.2003.09.056
   Greenwood JA, 1998, MICROSC RES TECHNIQ, V43, P420, DOI 10.1002/(SICI)1097-0029(19981201)43:5<420::AID-JEMT8>3.0.CO;2-B
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6
   Liu ZH, 2007, J BIOMED MATER RES A, V83A, P1110, DOI 10.1002/jbm.a.31453
   Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Paez Juan, 2003, Cancer Treat Res, V115, P145
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Roh JD, 2007, TISSUE ENG, V13, P2743, DOI 10.1089/ten.2007.0171
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215
   Tsai WB, 2006, J MATER SCI-MATER M, V17, P337, DOI 10.1007/s10856-006-8234-x
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   ZHANG H, J BIOMATER IN PRESS
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 35
TC 95
Z9 99
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2009
VL 30
IS 25
BP 4063
EP 4069
DI 10.1016/j.biomaterials.2009.04.015
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 479HP
UT WOS:000268650600003
PM 19487019
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rochet, N
   Balaguer, T
   Boukhechba, F
   Laugier, JP
   Quincey, D
   Goncalves, S
   Carle, GF
AF Rochet, Nathalie
   Balaguer, Thierry
   Boukhechba, Florian
   Laugier, Jean-Pierre
   Quincey, Danielle
   Goncalves, Stephane
   Carle, Georges F.
TI Differentiation and activity of human preosteoclasts on chitosan
   enriched calcium phosphate cement
SO BIOMATERIALS
LA English
DT Article
DE Chitosan; Calcium phosphate cement; Osteoclast; SEM; Acid phosphatase;
   Gene expression
ID TISSUE-ENGINEERING APPLICATIONS; RESISTANT ACID-PHOSPHATASE; HUMAN
   OSTEOBLASTIC CELLS; IN-VITRO; MECHANICAL-PROPERTIES; OSTEOGENIC
   DIFFERENTIATION; BONE-RESORPTION; STROMAL CELLS; SCAFFOLDS;
   PROLIFERATION
AB Chitosan associated to various scaffolds has been shown to promote growth and mineral rich matrix deposition by osteoblasts in vitro, whereas its influence on osteoclast differentiation, which plays also a central role in bone remodeling, has never been described. The purpose of this study was to investigate the differentiation and activity of human preosteoclastic cells on calcium phosphate cement containing 2% chitosan (Cementek (R)/chitosan) compared to the Cementek (R) alone. Human primary osteoclast precursors were cultured directly on both biomaterials in the presence of rhM-CSF and rhRANK-L for 7 days. Using LIVE/DEAD fluorescent assay, tartrate-resistant acid phosphatase staining, scanning electron microscopy and quantitative RT-PCR, we demonstrated that incorporation of chitosan to Cementek (R) does not affect the proliferation and adhesion of preosteoclasts but inhibits the formation of TRACP positive cells and prevents the osteoclastic resorption of the composite biomaterial compared to Cementek (R) alone. This inhibitory effect of chitosan on osteoclast resorption activity should have important implications on bone formation and bone remodeling after in vivo implantation. Indeed, based on the positive results obtained in vivo by several investigators, one can suggest that this property of chitosan can be beneficial for bone regeneration. (c) 2009 Elsevier Ltd. All rights reserved.
C1 [Rochet, Nathalie; Balaguer, Thierry; Boukhechba, Florian; Quincey, Danielle; Carle, Georges F.] Univ Nice Sophia Antipolis, CNRS, GEPITOS, UFR Med, F-06100 Nice, France.
   [Balaguer, Thierry] Hop St Roche, CHU Nice, Serv Chirurg Plast Reparatrice & Esthet, F-06006 Nice, France.
   [Laugier, Jean-Pierre] Univ Nice Sophia Antipolis, UFR Sci, Ctr Commun Microscopie Appl, F-06108 Nice, France.
   [Goncalves, Stephane] TEKNIMED SA, F-31240 Zi Montredon, Lunion, France.
RP Rochet, N (reprint author), Univ Nice Sophia Antipolis, CNRS, GEPITOS, UFR Med, 28 Ave Valombrose, F-06100 Nice, France.
EM rochet@unice.fr
RI ROCHET, Nathalie/N-1819-2018
OI ROCHET, Nathalie/0000-0002-9995-6699
FU Centre National de la Recherche Scientifique (CNRS); TEKNIMED
FX We thank Zeinab M'Roueh for excellent technical assistance. This work
   was supported by grants from the Centre National de la Recherche
   Scientifique (CNRS) and from TEKNIMED.
CR Amaral IF, 2007, J BIOMAT SCI-POLYM E, V18, P469, DOI 10.1163/156856207780425068
   Bonier J.M., 2001, KEY ENG MATER, V192-195, P119
   Cai KY, 2007, J MATER SCI-MATER M, V18, P2017, DOI 10.1007/s10856-007-3151-1
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   Chiu CT, 2007, ARTIF CELL BLOOD SUB, V35, P309, DOI 10.1080/10731190701378626
   Cho MH, 2008, TISSUE ENG PT A, V14, P1099, DOI [10.1089/ten.tea.2007.0305, 10.1089/tea.2007.0305]
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Costa-Pinto AR, 2008, TISSUE ENG PT A, V14, P1049, DOI [10.1089/ten.tea.2007.0153, 10.1089/tea.2007.0153]
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Halleen JM, 2006, CLIN LAB, V52, P499
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Hollberg K, 2002, EXP CELL RES, V279, P227, DOI 10.1006/excr.2002.5612
   Jansen J, 2005, ORTHOP CLIN N AM, V36, P89, DOI 10.1016/j.ocl.2004.06.014
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jung UW, 2007, BIOMED MATER, V2, pS101, DOI 10.1088/1748-6041/2/3/S03
   Kawai T, 2009, J BIOMED MATER RES B, V88B, P264, DOI 10.1002/jbm.b.31177
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim KS, 2008, BIOMATERIALS, V29, P4420, DOI 10.1016/j.biomaterials.2008.08.005
   Li HY, 1999, PHYTOMEDICINE, V6, P305, DOI 10.1016/S0944-7113(99)80050-6
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   LIVAK KJ, 2001, METHOD METHODS, V4, P402
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Nagahata M, 2005, BIOMATERIALS, V26, P5138, DOI 10.1016/j.biomaterials.2005.01.041
   Ohara N, 2004, BIOMATERIALS, V25, P1749, DOI 10.1016/j.biomaterials.2003.08.022
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Padois K, 2007, BIO-MED MATER ENG, V17, P309
   Pan ZH, 2007, J BIOMED MATER RES B, V82B, P246, DOI 10.1002/jbm.b.30727
   Pound JC, 2007, BIOMATERIALS, V28, P2839, DOI 10.1016/j.biomaterials.2007.02.029
   Prabaharan M, 2008, J BIOMATER APPL, V23, P5, DOI 10.1177/0885328208091562
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Sun LM, 2007, J BIOMATER APPL, V21, P299, DOI 10.1177/0885328206063687
   Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001
   Wang J, 2008, J DENT RES, V87, P650, DOI 10.1177/154405910808700713
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Xu HHK, 2007, BIOMATERIALS, V28, P3786, DOI 10.1016/j.biomaterials.2007.05.015
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamada S, 2007, J BIOMED MATER RES A, V83A, P290, DOI 10.1002/jbm.a.31234
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
NR 44
TC 16
Z9 20
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2009
VL 30
IS 26
BP 4260
EP 4267
DI 10.1016/j.biomaterials.2009.04.044
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 485CC
UT WOS:000269097200002
PM 19481081
DA 2018-10-20
ER

PT J
AU Pabbruwe, MB
   Esfandiari, E
   Kafienah, W
   Tarlton, JF
   Hollander, AP
AF Pabbruwe, Moreica B.
   Esfandiari, Ehsanollah
   Kafienah, Wael
   Tarlton, John F.
   Hollander, Anthony P.
TI Induction of cartilage integration by a chondrocyte/collagen-scaffold
   implant
SO BIOMATERIALS
LA English
DT Article
DE Cartilage tissue engineering; Cartilage integration; Collagen
   biomaterial; Cartilage repair; Osteoarthritis
ID TISSUE-ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE; ENZYMATIC TREATMENT;
   REPAIR; TRANSPLANTATION; OSTEOARTHRITIS; STRENGTH; MODEL;
   DIFFERENTIATION
AB The integration of implanted cartilage is a major challenge for the success of tissue engineering protocols. We hypothesize that in order for effective cartilage integration to take place, matrix-free chondrocytes must be induced to migrate between the two tissue surfaces. A chondrocyte/collagen-scaffold implant system was developed as a method of delivering dividing cells at the interface between two cartilage surfaces. Chondrocytes were isolated from bovine nasal septum and seeded onto both surfaces of a collagen membrane to create the chondrocyte/collagen-scaffold implant. A model of two cartilage discs and the chondrocyte/collagen-scaffold sandwiched in between was used to effect integration in vitro. The resulting tissue was analysed histologically and biomechanically. The cartilage-implant-cartilage sandwich appeared macroscopically as one continuous piece of tissue at the end of 40 day cultures. Histological analysis showed tissue continuum across the cartilage-scaffold interface. The integration was dependent on both cells and scaffold. Fluorescent labeling of implanted chondrocytes demonstrated that these cells invade the surrounding mature tissue and drive a remodelling of the extracellular matrix. Using cell-free scaffolds we also demonstrated that some chondrocytes migrated from the natural cartilage into the collagen scaffold. Quantification of integration levels using a histomorphometric repair index showed that the chondrocyte/collagen-scaffold implant achieved the highest repair index compared to controls, reflected functionally through increased tensile strength. In conclusion, cartilage integration can be achieved using a chondrocyte/collagen-scaffold implant that permits controlled delivery of chondrocytes to both host and graft mature cartilage tissues. This approach has the potential to be used therapeutically for implantation of engineered tissue. (c) 2009 Elsevier Ltd. All rights reserved.
C1 [Pabbruwe, Moreica B.; Esfandiari, Ehsanollah; Kafienah, Wael; Hollander, Anthony P.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England.
   [Tarlton, John F.] Univ Bristol, Sch Vet, Bristol BS8 1TD, Avon, England.
RP Kafienah, W (reprint author), Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England.
EM w.z.kafienah@bristol.ac.uk
OI Tarlton, John/0000-0002-4886-6634
FU UK Arthritis Research Campaign (ARC)
FX Funding for this work was provided by a grant from the UK Arthritis
   Research Campaign (ARC).
CR Ahsan T, 1999, OSTEOARTHR CARTILAGE, V7, P29, DOI 10.1053/joca.1998.0160
   Bos PK, 2002, ARTHRITIS RHEUM, V46, P976, DOI 10.1002/art.10208
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Hacker SA, 1997, OSTEOARTHR CARTILAGE, V5, P343, DOI 10.1016/S1063-4584(97)80038-6
   Hangody L, 2001, CLIN ORTHOP RELAT R, pS328, DOI 10.1097/00003086-200110001-00030
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9
   O'Driscoll SW, 2001, CLIN ORTHOP RELAT R, pS397
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Peretti GM, 1999, TISSUE ENG, V5, P317, DOI 10.1089/ten.1999.5.317
   Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790
   Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014
   Redman SN, 2004, OSTEOARTHR CARTILAGE, V12, P106, DOI 10.1016/j.joca.2002.12.001
   REINDEL ES, 1995, J ORTHOPAED RES, V13, P751, DOI 10.1002/jor.1100130515
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Schinagl RM, 1999, J ORTHOPAED RES, V17, P121, DOI 10.1002/jor.1100170118
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Shimizu C, 1998, J RHEUMATOL, V25, P1813
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Trattnig S, 2005, MAGN RESON IMAGING, V23, P779, DOI 10.1016/j.mri.2005.04.010
NR 31
TC 43
Z9 48
U1 2
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2009
VL 30
IS 26
BP 4277
EP 4286
DI 10.1016/j.biomaterials.2009.02.052
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 485CC
UT WOS:000269097200004
PM 19539365
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Fujimoto, KL
   Ma, ZW
   Nelson, DM
   Hashizume, R
   Guan, JJ
   Tobita, K
   Wagner, WR
AF Fujimoto, Kazuro L.
   Ma, Zuwei
   Nelson, Devin M.
   Hashizume, Ryotaro
   Guan, Jianjun
   Tobita, Kimimasa
   Wagner, William R.
TI Synthesis, characterization and therapeutic efficacy of a biodegradable,
   thermoresponsive hydrogel designed for application in chronic infarcted
   myocardium
SO BIOMATERIALS
LA English
DT Article
DE Thermally responsive material; Hydrogel; Biodegradation; Cytotoxicity;
   Cardiac tissue engineering; Smooth muscle cell
ID ARTIFICIAL EXTRACELLULAR-MATRIX; ASSEMBLING PEPTIDE NANOFIBERS;
   LEFT-VENTRICULAR FUNCTION; N-ISOPROPYLACRYLAMIDE; HEART-FAILURE;
   SMOOTH-MUSCLE; COPOLYMERS; MODEL; PATCH; TRANSPLANTATION
AB Injection of a bulking material into the ventricular wall has been proposed as a therapy to prevent progressive adverse remodeling due to high wall stresses that develop after myocardial infarction. Our objective was to design, synthesize and characterize a biodegradable, thermoresponsive hydrogel for this application based on copolymerization of N-isop ropylacryla mid e (NIPAAm), acrylic acid (AAc) and hydroxyethyl methacrylate-poly(trimethylene carbonate) (HEMAPTMC). By evaluating a range of monomer ratios, poly(NIPAAm-co-AAc-co-HEMAPTMC) at a feed ratio of 86/4/10 was shown to be ideal since it formed a hydrogel at 37 degrees C, and gradually became soluble over a 5 month period in vitro through hydrolytic cleavage of the PTMC residues. HEMAPTMC, copolymer and degradation product chemical structures were verified by NMR. No degradation product cytotoxicity was observed in vitro. In a rat chronic infarction model, the infarcted left ventricular (IV) wall was injected with the hydrogel or phosphate buffered saline (PBS). In the PBS group, LV cavity area increased and contractility decreased at 8 wk (p < 0.05 versus pre-injection), while in the hydrogel group both parameters were preserved during this period. Tissue ingrowth was observed in the hydrogel injected area and a thicker IV wall and higher capillary density were found for the hydrogel versus PBS group. Smooth muscle cells with contractile phenotype were also identified in the hydrogel injected IV wall. The designed poly(NIPAAm-co-AAc-co-HEMAPTMC) hydrogel of this report may thus offer an attractive biomaterial-centered treatment option for ischemic cardiomyopathy. (c) 2009 Elsevier Ltd. All rights reserved.
C1 [Fujimoto, Kazuro L.; Ma, Zuwei; Hashizume, Ryotaro; Guan, Jianjun; Tobita, Kimimasa; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Fujimoto, Kazuro L.; Ma, Zuwei; Hashizume, Ryotaro; Guan, Jianjun; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Tobita, Kimimasa] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15219 USA.
   [Nelson, Devin M.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 100 Technol Dr, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
FU National Institutes of Health, NHLBI [HL069368]; Commonwealth of
   Pennsylvania
FX This work was supported by the National Institutes of Health, NHLBI,
   grant #HL069368 and the Commonwealth of Pennsylvania.
CR Batista RJV, 1997, ANN THORAC SURG, V64, P634, DOI 10.1016/S0003-4975(97)00779-0
   Chaudhry PA, 2000, ANN THORAC SURG, V70, P1275, DOI 10.1016/S0003-4975(00)01755-0
   Dor V, 1998, J THORAC CARDIOV SUR, V116, P50, DOI 10.1016/S0022-5223(98)70242-9
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2007, ANN THORAC SURG, V83, P648, DOI 10.1016/j.athoracsur.2006.06.085
   Goldstein Sidney, 1998, Cardiology Clinics, V16, P623, DOI 10.1016/S0733-8651(05)70039-4
   Guan JJ, 2008, BIOMACROMOLECULES, V9, P1283, DOI 10.1021/bm701265j
   Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Kawaguchi AT, 2005, J CARDIAC SURG, V20, pS5, DOI 10.1111/j.1540-8191.2005.00149.x
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Lee BH, 2005, MACROMOL BIOSCI, V5, P629, DOI 10.1002/mabi.200500029
   Lee BH, 2005, POLYM INT, V54, P418, DOI 10.1002/pi.1709
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.00000.39105.49749.6F
   Magovern JA, 2005, SEMIN THORAC CARDIOV, V17, P364, DOI 10.1053/j.semtcvs.2005.09.006
   Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Ohya S, 2005, J BIOMAT SCI-POLYM E, V16, P809, DOI 10.1163/1568562054255736
   Ohya S, 2001, BIOMACROMOLECULES, V2, P856, DOI 10.1021/bm010040a
   Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.04.686
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185
   Rzaev ZMO, 2007, PROG POLYM SCI, V32, P534, DOI 10.1016/j.progpolymsci.2007.01.006
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   WU DQ, 2009, ACS APPL MAT INTERF, V2, P312
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
NR 34
TC 146
Z9 149
U1 7
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2009
VL 30
IS 26
BP 4357
EP 4368
DI 10.1016/j.biomaterials.2009.04.055
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 485CC
UT WOS:000269097200012
PM 19487021
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hillberg, AL
   Holmes, CA
   Tabrizian, M
AF Hillberg, Anna L.
   Holmes, Christina A.
   Tabrizian, Maryam
TI Effect of genipin cross-linking on the cellular adhesion properties of
   layer-by-layer assembled polyelectrolyte films
SO BIOMATERIALS
LA English
DT Article
DE Genipin cross-linking; Layer-by-layer assembly; Cell adhesion;
   Viscoelasticity
ID MULTILAYER FILMS; SUBSTRATE MECHANICS; SURFACES; STIFFNESS; CELLS; SOFT;
   RGD; DIFFERENTIATION; PROLIFERATION; BIOMATERIAL
AB Use of polyelectrolyte multi-layers as biomaterials for cell attachment has been limited due to their gel-like characteristics. Herein, we attempt to improve the cellular adhesion properties of multi-layer films, reduce their gel-like nature and rigidify them through chemical cross-linking with genipin; a natural and non-cytotoxic compound. Chitosan (CH), hyaluronan (HA) and alginate (Alg) were used to assemble [CH-HA](n) CH and [CH-Alg](n) CH films, and the effects of genipin cross-linking on the cell adhesion properties of these multi-layers were investigated. Atomic force microscopy (AFM) confirmed that cross-linking affected each of the films differently. Quartz crystal microbalance with dissipation (QCM-D) revealed that [CH-HA](10) CH films were very viscoelastic, with thicknesses in the range 350-450 nm, while [CH-Alg](10) CH films only grew to thicknesses of similar to 100 nm. These differences were a result of the different growth regimes of these two polyelectrolyte systems. Cell adhesion studies using MC3T3 pre-osteoblasts and rat fibroblastic skin cells, carried out on both films demonstrated vast differences in cell adhesion. [CH-HA](n), CH cross-linked films proved to be highly non-adhesive for pre-osteoblasts and fibroblastic skin cells. Conversely, cross-linking [CH-Alg](n) CH films was shown to dramatically improve pre-osteoblast and rat fibroblastic skin cell adhesion, especially for high bi-layer numbers and using higher concentrations of cross-linker. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Hillberg, Anna L.; Holmes, Christina A.; Tabrizian, Maryam] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   [Tabrizian, Maryam] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Hillberg, Anna L.; Holmes, Christina A.; Tabrizian, Maryam] McGill Univ, CBB, Montreal, PQ H3A 2B2, Canada.
RP Tabrizian, M (reprint author), McGill Univ, Dept Biomed Engn, Duff Med Bldg,3775 Univ St, Montreal, PQ H3A 2B4, Canada.
EM maryam.tabrizian@mcgill.ca
OI Holmes, Christina/0000-0003-0736-0503
FU Canadian Institute of Health Research (CIHR); NSERC Discovery; NSERC
FX This project is Supported by a grant from the Canadian Institute of
   Health Research (CIHR) (Regenerative Medicine and Nanomedicine
   initiative), NSERC Discovery grant and NSERC scholarship. The authors
   would also like to thank FQRNT-regroupement strategique through CBB for
   support.
CR Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   Brunot C, 2008, DENT MATER, V24, P1025, DOI 10.1016/j.dental.2007.11.022
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   David L, 2008, ACTA BIOMATER, V4, P256, DOI 10.1016/j.actbio.2007.08.012
   de Kerchove AJ, 2006, MACROMOLECULES, V39, P6558, DOI 10.1021/ma0527606
   DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0
   Douglas KL, 2006, J CONTROL RELEASE, V115, P354, DOI 10.1016/j.jconrel.2006.08.021
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fatisson J, 2008, LANGMUIR, V24, P3294, DOI 10.1021/1a7023204
   Fuse Y, 2007, DENT MATER J, V26, P814, DOI 10.4012/dmj.26.814
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Hillberg AL, 2006, BIOMACROMOLECULES, V7, P2742, DOI 10.1021/bm060266j
   Jin J, 2004, BIOMACROMOLECULES, V5, P162, DOI 10.1021/bm034286m
   Kokufuta E, 1998, BIOSEPARATION, V7, P241, DOI 10.1023/A:1008003423132
   KRISTEN L, 2004, J BIOMEDICAL MAT R B, V71, P181
   Kumar R.M.N.V., 2000, REACT FUNCT POLYM, V46, P1
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Leguen E, 2007, BIOMOL ENG, V24, P33, DOI 10.1016/j.bioeng.2006.05.023
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Marguerite R, 2008, POLYM INT, V57, P397
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   O'Connell MJ, 2007, POLYMER, V48, P7582, DOI 10.1016/j.polymer.2007.10.036
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peng P, 2007, BIOINTERPHASES, V2, P95, DOI 10.1116/1.2751126
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Salomaki M, 2009, BIOMACROMOLECULES, V10, P294, DOI 10.1021/bm8010177
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Silva CL, 2008, J MEMBRANE SCI, V320, P268, DOI 10.1016/j.memsci.2008.04.011
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Tan HP, 2009, ACTA BIOMATER, V5, P328, DOI 10.1016/j.actbio.2008.07.030
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yuan WY, 2007, LANGMUIR, V23, P13046, DOI 10.1021/la702774a
   Zhou HY, 2008, CARBOHYD POLYM, V73, P265, DOI 10.1016/j.carbpol.2007.11.026
NR 53
TC 74
Z9 77
U1 3
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2009
VL 30
IS 27
BP 4463
EP 4470
DI 10.1016/j.biomaterials.2009.05.026
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 488DX
UT WOS:000269330400003
PM 19520425
DA 2018-10-20
ER

PT J
AU Kim, S
   Gaber, MW
   Zawaski, JA
   Zhang, F
   Richardson, M
   Zhang, XA
   Yang, YZ
AF Kim, Sungwoo
   Gaber, Mostafa W.
   Zawaski, Janice A.
   Zhang, Feng
   Richardson, Mekel
   Zhang, Xin A.
   Yang, Yunzhi
TI The inhibition of glioma growth in vitro and in vivo by a
   chitosan/ellagic acid composite biomaterial
SO BIOMATERIALS
LA English
DT Article
DE Brain cancer; U87 glioblastoma; C6 glioma; Ellagic acid; Chitosan;
   Apoptosis
ID ELLAGIC ACID; DRUG-DELIVERY; MALIGNANT GLIOMA; CISPLATIN/EPINEPHRINE
   GEL; ENDOGENOUS INHIBITORS; CANCER-CELLS; SOLID TUMORS; HUMAN PLASMA;
   POLYMER; BRAIN
AB This study has developed a chitosan-based delivery system to locally administer ellagic acid for brain cancer treatment. We fabricated chitosan/ellagic acid composite films with various concentrations of ellagic acid. In vitro release study was performed by using a UV spectrophotometer, and enzymatic degradation rate was determined by analyzing the increased free amino groups. Viability of brain cancer cells (human U87 glioblastomas and rat C6 glioma cells) was measured via direct and indirect cell culture on the films by MTS assay. Caspase-3 activation, Western blot for p53, and anti-angiogenesis assays were also examined. In the in vivo study, GFP-tagged rat C6 glioma cells were implanted subcutaneously at the right flank region of nude mice and treatments were initiated by implanting the films subcutaneously. Tumor growth was evaluated by measuring tumor volume using a caliper, an ultrasound machine, and an optical imaging system. The chitosan/ellagic acid composite films were enzymatically degradable and exhibited a sustained slow release of ellagic acid. These materials could inhibit the cancer cell growth in an ellagic acid concentration-dependent manner by inducing apoptosis of cancer cells as well as suppressing angiogenesis. These materials also significantly suppressed tumor tissue growth in vivo. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Kim, Sungwoo; Yang, Yunzhi] Univ Texas Hlth Sci Ctr Houston, Houston Biomat Res Ctr, Dept Restorat Dent & Biomat, Houston, TX 77030 USA.
   [Kim, Sungwoo; Gaber, Mostafa W.; Zawaski, Janice A.; Yang, Yunzhi] Univ Tennessee, Ctr Hlth Sci, Sch Biomed Engn & Imaging, Memphis, TN 38163 USA.
   [Zhang, Feng; Richardson, Mekel; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Memphis, TN 38163 USA.
   [Zhang, Feng; Richardson, Mekel; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.
RP Yang, YZ (reprint author), Univ Texas Hlth Sci Ctr Houston, Houston Biomat Res Ctr, Dept Restorat Dent & Biomat, 6516 MD Anderson Blvd,D 4-133, Houston, TX 77030 USA.
EM yunzhi.yang@uth.tmc.edu
RI Zhang, Feng/B-6691-2012
CR Ahn D, 1996, CARCINOGENESIS, V17, P821, DOI 10.1093/carcin/17.4.821
   Au JLS, 2001, J CONTROL RELEASE, V74, P31, DOI 10.1016/S0168-3659(01)00308-X
   Avgeropoulos N G, 1999, Oncologist, V4, P209
   Barch DH, 1996, CARCINOGENESIS, V17, P265, DOI 10.1093/carcin/17.2.265
   Bello L, 2002, CLIN CANCER RES, V8, P3539
   Brem H, 1999, CANCER, V86, P197, DOI 10.1002/(SICI)1097-0142(19990715)86:2<197::AID-CNCR2>3.0.CO;2-6
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   Castro DJ, 2003, HEAD NECK-J SCI SPEC, V25, P717, DOI 10.1002/hed.10261
   Chen FA, 2003, HEAD NECK-J SCI SPEC, V25, P554, DOI 10.1002/hed.10241
   Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441
   Edderkaoui M, 2008, WORLD J GASTROENTERO, V14, P3672, DOI 10.3748/wjg.14.3672
   Ewend MG, 1996, CANCER RES, V56, P5217
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Giussani C, 2003, CANCER RES, V63, P2499
   Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45
   Hammoud DA, 2003, AM J ROENTGENOL, V180, P1469, DOI 10.2214/ajr.180.5.1801469
   Han XZ, 2007, INT J MOL SCI, V8, P950, DOI 10.3390/i8090950
   Harper E, 1999, CLIN CANCER RES, V5, P4242
   Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9
   Keskar V, 2006, J CONTROL RELEASE, V115, P280, DOI 10.1016/j.jconrel.2006.08.014
   Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243
   Khan TA, 2002, J PHARM PHARM SCI, V5, P205
   Kim SA, 2007, CLIN CANCER RES, V13, P253, DOI 10.1158/1078-0432.CCR-06-1154
   Kim S, 2009, J BIOMED MATER RES B, V90B, P145, DOI 10.1002/jbm.b.31266
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   KUMAR MNV, 2004, ENCY BIOMATERIALS BI, P310
   Labrecque L, 2005, CARCINOGENESIS, V26, P821, DOI 10.1093/carcin/bgi024
   LAURA AK, 2001, CANCER RES, V61, P6112
   Li QS, 2004, CANCER RES, V64, P1130, DOI 10.1158/0008-5472.CAN-03-1715
   Losso JN, 2004, J NUTR BIOCHEM, V15, P672, DOI 10.1016/j.jnutbio.2004.06.004
   Lu Z, 2004, CLIN CANCER RES, V10, P7677, DOI 10.1158/1078-0432.CCR-04-1443
   Mertens-Talcott SU, 2005, J NUTR, V135, P609
   Mertens-Talcott SU, 2003, J NUTR, V133, P2669
   Mi FL, 2002, POLYMER, V43, P757, DOI 10.1016/S0032-3861(01)00580-8
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Narayanan BA, 1999, CANCER LETT, V136, P215, DOI 10.1016/S0304-3835(98)00323-1
   Olivi A, 2003, J CLIN ONCOL, V21, P1845, DOI 10.1200/JCO.2003.09.041
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Schwartz LH, 2006, ANN ONCOL, V17, P1018, DOI 10.1093/annonc/mdl058
   Schwartz LH, 2000, J CLIN ONCOL, V18, P2179, DOI 10.1200/JCO.2000.18.10.2179
   Seeram NP, 2006, J NUTR, V136, P2481
   Seeram NP, 2004, CLIN CHIM ACTA, V348, P63, DOI 10.1016/j.cccn.2004.04.029
   Shukla M, 2008, J INFLAMM, V5, P1
   TANGSADTHAKUN C, 2006, MAT MINERALS, V16, P37
   TIEN CL, 2003, J CONTROL RELEASE, V93, P1, DOI DOI 10.1016/S0168-3659
   Vogl TJ, 2002, BRIT J CANCER, V86, P524, DOI 10.1038/sj/bjc/6600116
   WALTER KA, 1994, CANCER RES, V54, P2207
   Westphal M, 2003, ACT NEUR S, V88, P61
   Whitley AC, 2003, BIOCHEM PHARMACOL, V66, P907, DOI 10.1016/S0006-2952(03)00413-1
   Withrow SJ, 2004, ANN SURG ONCOL, V11, P705, DOI 10.1245/ASO.2004.10.008
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
NR 51
TC 35
Z9 35
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2009
VL 30
IS 27
BP 4743
EP 4751
DI 10.1016/j.biomaterials.2009.05.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 488DX
UT WOS:000269330400036
PM 19501395
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Zhou, Y
   Zhu, J
   Dong, SW
   Li, CQ
   Xiang, Q
AF Zhang, Yuan
   Zhou, Yue
   Zhu, Jie
   Dong, Shiwu
   Li, Changqing
   Xiang, Qiang
TI Effect of a Novel Recombinant Protein of FibronectinIII7-10/Cadherin 11
   EC1-2 on Osteoblastic Adhesion and Differentiation
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE bone tissue engineering; fibronectin; cadherin; adhesion; osteoblast
   differentiation
ID CELL-ADHESION; EXTRACELLULAR-MATRIX; PORPHYROMONAS-GINGIVALIS; CADHERIN
   SUPERFAMILY; SYNERGY SITE; OB-CADHERIN; FIBRONECTIN; EXPRESSION;
   SURFACES; FRAGMENT
AB The limitations of specific adhesion and osteoblastic differentiation are current problems in bone tissue engineering. The aim of this study was to investigate the effect of a novel recombinant protein of fibronectin module III7-10/cadherin 11 EC1-2 (rFN/CDH) on cell adhesion and differentiation. Gene coding rFN/CDH was engineered by a homology modeling strategy, and an expression plasmid was constructed by standard DNA techniques. The rFN/CDH protein was expressed in Rosetta-gami (DE3), an improved Escherichia coli system. MC3T3-E1 cell centrifugal adhesive assay indicated that the adhesive capacity of rFN/CDH was significantly improved. Quantitative analysis of two osteogenic markers, osteocalcin mRNA expression and alkaline phosphatase activity, indicated that they were further up-regulated when human mesenchymal stem cells were cultured for 7-10d on rFN/CDH pre-coated surfaces. These results suggest that rFN/CDH possesses an enhanced dual biofunctionality in osteoblastic adhesion and differentiation, and a promising application can be expected in biomimetic strategies and biomaterial development.
C1 [Xiang, Qiang] Third Mil Med Univ, Southwest Hosp, Emergency Dept, Chongqing 400038, Peoples R China.
   [Dong, Shiwu] Third Mil Med Univ, Dept Anat, Chongqing 400038, Peoples R China.
   [Zhu, Jie] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China.
   [Zhang, Yuan; Zhou, Yue; Li, Changqing] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China.
RP Xiang, Q (reprint author), Third Mil Med Univ, Southwest Hosp, Emergency Dept, Gaotanyan St, Chongqing 400038, Peoples R China.
EM qiangx163@yahoo.cn
RI zhu, jie/S-8849-2016
OI zhu, jie/0000-0003-1008-2014
FU National Natural Science Foundation of China [30700892]; Program of the
   Chongqing Science and Technology Commission (CSTC) [2007BB5058];
   National High Technology Research and Development Program of China
   [200602A125]
FX The authors thank Harold P. Erickson of Duke University Medical Center
   and Masatoshi Takeichi of Tokyo University for their gifts of plasmids.
   We are also grateful to Liangming Liu of the Research Institute of
   Surgery for instruction in this study. The study was supported by the
   National Natural Science Foundation of China (no. 30700892), the Program
   of the Chongqing Science and Technology Commission (CSTC, no.
   2007BB5058), and the National High Technology Research and Development
   Program of China (no. 200602A125).
CR AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007
   Azuma H, 2004, J PERIODONTOL, V75, P974, DOI 10.1902/jop.2004.75.7.974
   Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Cai K, 2007, J BIOMED MATER RES A, V82A, P927, DOI 10.1002/jbm.a.31233
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   De A.A., 2000, TRENDS GENET, V16, P389
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957
   Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679
   Kadono H, 1999, INFECT IMMUN, V67, P2841
   Kii I, 2004, J BONE MINER RES, V19, P1840, DOI 10.1359/JBMR.040812
   Kim TI, 2003, BIOTECHNOL LETT, V25, P2007, DOI 10.1023/B:BILE.0000004393.02839.d8
   Lira CBB, 2008, PROTEIN EXPRES PURIF, V61, P220, DOI 10.1016/j.pep.2008.06.007
   Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0
   Mousa SA, 2008, MOL BIOTECHNOL, V38, P33, DOI 10.1007/s12033-007-0072-7
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   OKAZAKI M, 1994, J BIOL CHEM, V269, P12092
   Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512
   Shan WS, 2004, J BIOL CHEM, V279, P55914, DOI 10.1074/jbc.M407827200
   Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579
   Tsuiji H, 2007, J BIOL CHEM, V282, P12871, DOI 10.1074/jbc.M611725200
   Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103
   Yagi T, 2000, GENE DEV, V14, P1169
NR 36
TC 11
Z9 15
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD SEP
PY 2009
VL 73
IS 9
BP 1999
EP 2006
DI 10.1271/bbb.90187
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 504BC
UT WOS:000270586900015
PM 19734674
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhao, J
   Zhang, ZY
   Wang, SY
   Sun, XJ
   Zhang, XL
   Chen, J
   Kaplan, DL
   Jiang, XQ
AF Zhao, Jun
   Zhang, Zhiyuan
   Wang, Shaoyi
   Sun, Xiaojuan
   Zhang, Xiuli
   Chen, Jake
   Kaplan, David L.
   Jiang, Xinquan
TI Apatite-coated silk fibroin scaffolds to healing mandibular border
   defects in canines
SO BONE
LA English
DT Article
DE Tissue engineering; Silk; Apatite; Bone marrow stromal cells; Canine
ID VASCULARIZED BONE-GRAFTS; MESENCHYMAL STEM-CELLS; TISSUE IN-VITRO;
   TRICALCIUM PHOSPHATE; PROTEIN SCAFFOLDS; BOMBYX-MORI; BIOMATERIALS;
   REPAIR; COMPOSITES; IMPLANTS
AB Tissue engineering has become a new approach for repairing bony defects. Highly porous osteoconductive scaffolds perform the important role for the success of bone regeneration. By biomimetic strategy, apatite-coated porous biomaterial based on silk fibroin scaffolds (SS) might provide an enhanced osteogenic environment for bone-related outcomes. To assess the effects of apatite-coated silk fibroin (mSS) biomaterials for bone healing as a tissue engineered bony scaffold, we explored a tissue engineered bony graft using mSS seeded with osteogenically induced autologous bone marrow stromal cells (bMSCs) to repair inferior mandibular border defects in a canine model. The results were compared with those treated with bMSCs/SS constructs, mSS alone, SS alone, autologous mandibular grafts and untreated blank defects. According to radiographic and histological examination, new bone formation was observed from 4 weeks post-operation, and the defect site was completely repaired after 12 months for the bMSCs/mSS group. In the bMSCs/SS group, new bone formation was observed with more residual silk scaffold remaining at the center of the defect compared with the bMSCs/mSS group. The engineered bone with bMSCs/mSS achieved satisfactory bone mineral densities (BMD) at 12 months post-operation close to those of normal mandible (p>0.05). The quantities of newly formed bone area for the bMSCs/mSS group was higher than the bMSCs/SS group (p<0.01), but no significant differences were found when compared with the autograft group (p>0.05). In contrast, bony defects remained in the center with undegraded silk fibroin scaffold and fibrous connective tissue, and new bone only formed at the periphery in the groups treated with mSS or SS alone. The results suggested that apatite-coated silk fibroin scaffolds combined with bMSCs could be successfully used to repair mandibular critical size border defects and the premineralization of these porous silk fibroin protein scaffolds provided an increased osteoconductive environment for bMSCs to regenerate sufficient new bone tissue. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Chen, Jake] Tufts Univ, Div Oral Biol, Boston, MA 02111 USA.
   [Sun, Xiaojuan] Ningxia Med Univ, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Ningxia 750004, Peoples R China.
   [Zhang, Xiuli; Jiang, Xinquan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Stomatol,Shanghai Res Inst Stoma, Shanghai 200011, Peoples R China.
   [Zhao, Jun; Zhang, Zhiyuan; Wang, Shaoyi] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg,Coll Stomatol, Shanghai 200011, Peoples R China.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; xinquanj@yahoo.com.cn
FU National Natural Science Foundation of China [30400502, 30772431];
   Program for New Century Excellent Talents in University [NCET-08-0353];
   Science and Technology Commission of Shanghai Municipality [07DZ22007,
   08410706400, 08JC1414400, 08DZ2271100, S30206]; Shanghai Rising-star
   Program [05QMX1426, 08QH14017]; Shanghai Education Committee [Y0203,
   07SG19]
FX The authors thank Carmen Preda for fabricating the silk scaffolds,
   Lunguo Xia, Wenwen Yu, Qing Chang, Dongxia Ye, Duohong Zou, Ling Xu for
   assistance with animal studies and data collection, as well as Fan Ding
   for helping statistical analysis. This work was supported by National
   Natural Science Foundation of China 30400502, 30772431. Program for New
   Century Excellent Talents in University NCET-08-0353. Science and
   Technology Commission of Shanghai Municipality 07DZ22007, 08410706400,
   08JC1414400, 08DZ2271100, S30206. Shanghai Rising-star Program
   05QMX1426, 08QH14017. Shanghai Education Committee Y0203, 07SG19. We
   also thank NIH DE16710 as well as NIH P41 Tissue Engineering Resource
   Center and the NIH NIBIB (DK) for support of this study.
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ambrosio AMA, 2001, J BIOMED MATER RES, V58, P295, DOI 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.3.CO;2-#
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01.01290.8E
   Ethicon Inc., WOUND CLOS MAN SUT S
   FRIEDLAENDER GE, 1991, J BONE JOINT SURG AM, V73A, P1119, DOI 10.2106/00004623-199173080-00001
   Gerard D, 2006, J ORAL MAXIL SURG, V64, P443, DOI 10.1016/j.joms.2005.11.016
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kuroda S, 2004, J BIOMED MATER RES A, V70A, P66, DOI 10.1002/jbm.a.30062
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Lee SY, 2007, J CELL PHYSIOL, V210, P561, DOI 10.1002/jcp.20890
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Nemzek JA, 1996, CLIN ORTHOP RELAT R, P275
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Petrovic L, 2006, INT J ORAL MAX IMPL, V21, P225
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Ripamonti U, 2006, BIOMATERIALS, V27, P807, DOI 10.1016/j.biomaterials.2005.09.021
   Ripamonti U, 1996, MRS BULL, V21, P36
   Rosa Adalberto Luiz, 2002, Pesqui Odontol Bras, V16, P209, DOI 10.1590/S1517-74912002000300005
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   Sarkar BK, 1995, B MATER SCI, V18, P755, DOI 10.1007/BF02744809
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   Sun XJ, 2008, CLIN ORAL IMPLAN RES, V19, P804, DOI 10.1111/j.1600-0501.2008.01577.x
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   TAYLOR GI, 1983, CLIN PLAST SURG, V10, P185
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vacanti CA, 2001, MRS BULL, V26, P798, DOI 10.1557/mrs2001.207
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang SY, 2009, BIOMATERIALS, V30, P2489, DOI 10.1016/j.biomaterials.2008.12.067
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   WEILAND AJ, 1984, PLAST RECONSTR SURG, V74, P368, DOI 10.1097/00006534-198409000-00006
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
NR 72
TC 72
Z9 83
U1 4
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD SEP
PY 2009
VL 45
IS 3
BP 517
EP 527
DI 10.1016/j.bone.2009.05.026
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 488VK
UT WOS:000269378200018
PM 19505603
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhou, LB
   He, LS
   Shang, HT
   Liu, GC
   Zhao, JL
   Liu, YP
AF Zhou, Libin
   He, Lisheng
   Shang, Hongtao
   Liu, Guicai
   Zhao, Jinlong
   Liu, Yanpu
TI Correction of hemifacial microsomia with the help of mirror imaging and
   a rapid prototyping technique: case report
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
DE Craniofacial deformity; Computer-aided design; Mandibular asymmetry
ID DISTRACTION OSTEOGENESIS; SOFT-TISSUE; RECONSTRUCTION; ATROPHY; DEFECT
AB A 23-year-old man presented with an 8-year history of unilateral hemifacial microsomia. A three-dimensional model of the maxillofacial bones was generated after acquisition of helical computed tomographic data. A customised implant model was designed by projecting a mirror image of the healthy mandible on to the three-dimensional model. A resin model of the implant was then made using a rapid prototyping machine. A polymeric biomaterial was sculpted according to the model and implanted into the affected side of the mandible to restore his facial symmetry. The hemifacial microsomia was corrected and a symmetrical facial contour obtained. No complications developed during the 6-year follow-up. (C) 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Zhou, Libin; He, Lisheng; Shang, Hongtao; Liu, Guicai; Zhao, Jinlong; Liu, Yanpu] Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, Xian 710032, Peoples R China.
RP Zhao, JL (reprint author), Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, 145 Western Changle Rd, Xian 710032, Peoples R China.
EM fmmumario@yahoo.com; jtztzhao@fmmu.edu.cn; liuyanpu@fmmu.edu.cn
CR Hoehnke C, 2007, J PLAST RECONSTR AES, V60, P1138, DOI 10.1016/j.bjps.2007.01.068
   Kahnberg KE, 1997, J CRANIO MAXILL SURG, V25, P254, DOI 10.1016/S1010-5182(97)80062-5
   Lee JW, 2007, J FORMOS MED ASSOC, V106, P244, DOI 10.1016/S0929-6646(09)60247-3
   Meazzini MC, 2005, J CRANIO MAXILL SURG, V33, P370, DOI 10.1016/j.jcms.2005.07.004
   Nasir S, 2008, MICROSURG, V28, P333, DOI 10.1002/micr.20502
   Patterson AR, 2007, BRIT J ORAL MAX SURG, V45, P599, DOI 10.1016/j.bjoms.2007.01.002
   Prahl-Andersen B, 2005, SEMIN ORTHOD, V11, P67
   Sharma RK, 2008, J PLAST RECONSTR AES, V61, P471, DOI 10.1016/j.bjps.2007.12.004
   Wiens JL, 2003, J PROSTHET DENT, V89, P11, DOI 10.1067/mpr.2003.69
NR 9
TC 12
Z9 12
U1 0
U2 8
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD SEP
PY 2009
VL 47
IS 6
BP 486
EP 488
DI 10.1016/j.bjoms.2009.05.001
PG 3
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 494ZV
UT WOS:000269859700014
PM 19545936
DA 2018-10-20
ER

PT J
AU Evensen, NA
   Braun, PC
AF Evensen, Nikki A.
   Braun, Phyllis C.
TI The effects of tea polyphenols on Candida albicans: inhibition of
   biofilm formation and proteasome inactivation
SO CANADIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Candida albicans; tea polyphenols; epigallocathechin-3-gallate (EGCG);
   biofilm; proteasome
ID CANCER PREVENTION; IN-VITRO; ANTIFUNGAL AGENTS; RESISTANCE; GROWTH;
   INFECTIONS; FARNESOL; SIGNALS; STRAIN
AB The adherence of Candida albicans to one another and to various host and biomaterial surfaces is an important prerequisite for the colonization and pathogenesis of this organism. Cells in established biofilms exhibit different phenotypic traits and are inordinately resistant to antimicrobial agents. Recent studies have shown that black and green tea polyphenols exhibit both antimicrobial and strong cancer-preventive properties. Experiments were conducted to determine the effects of these polyphenols on C albicans. Standard growth curves demonstrated a 40% reduction in the growth rate constant (K) with a 2 mg/mL concentration of Polyphenon 60, a green tea extract containing a mixture of polyphenolic compounds. Cultures treated with 1.0 mu mol/L -(-)epigallocatechin-3-gallate (EGCG), the most abundant polyphenol, displayed a 75% reduction of viable cells during biofilm formation. Established biofilms treated with EGCG were also reduced, by 80%, as determined through XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) colorimetric assays. Identical concentrations of epigallocatechin and epicatechin-3-gallate demonstrated similar biofilm inhibition. Further investigations regarding the possible mechanism of polyphenol action indicate that in vivo proteasome activity was significantly decreased when catechin-treated yeast cells were incubated with a fluorogenic peptide substrate that measured proteasomal chymotrypsin-like and peptidyl-glutamyl peptide-hydrolyzing activities. Impairment of proteasomal activity by tea polyphenols contributes to cellular metabolic and structural disruptions that expedite the inhibition of biofilm formation and maintenance by C. albicans.
C1 [Evensen, Nikki A.; Braun, Phyllis C.] Fairfield Univ, Dept Biol, Fairfield, CT 06824 USA.
RP Braun, PC (reprint author), Fairfield Univ, Dept Biol, 1073 N Benson Rd, Fairfield, CT 06824 USA.
EM pcbraun@fairfield.edu
CR AHEARN DG, 1978, ANNU REV MICROBIOL, V32, P59, DOI 10.1146/annurev.mi.32.100178.000423
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Braun PC, 2005, CAN J MICROBIOL, V51, P715, DOI 10.1139/W05-050
   Braun PC, 1999, CAN J MICROBIOL, V45, P353, DOI 10.1139/cjm-45-5-353
   BRAUN PC, 1994, INFECT IMMUN, V62, P4087
   Calderone RA, 2002, CANDIDA CANDIDIASIS
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   Fernandez Murray P, 2000, Arch Biochem Biophys, V375, P211, DOI 10.1006/abbi.1999.1591
   Fujiki H, 1999, J CANCER RES CLIN, V125, P589, DOI 10.1007/s004320050321
   Hara Y, 1997, FOOD AND FREE RADICALS, P49
   HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128
   Hsu Stephen D., 2002, General Dentistry, V50, P140
   Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102
   Madigan MT, 2006, BROCK BIOL MICROORGA, P140
   MANNING M, 1980, J BACTERIOL, V142, P714
   Mercure S, 1996, J CLIN MICROBIOL, V34, P2106
   Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Okabe S, 1997, JPN J CANCER RES, V88, P639, DOI 10.1111/j.1349-7006.1997.tb00431.x
   Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X
   Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001
   Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002
   Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163
   Sinha I, 2007, DEV CELL, V13, P421, DOI 10.1016/j.devcel.2007.06.011
   Yam TS, 1997, FEMS MICROBIOL LETT, V152, P169, DOI 10.1016/S0378-1097(97)00197-3
   Yamamoto T, 1997, CHEM APPL GREEN TEA
   Yang CS, 1999, CANCER EPIDEM BIOMAR, V8, P83
   Yang CS, 1999, NUTRITION, V15, P946
   Yang H, 2008, CURR PROTEIN PEPT SC, V9, P227, DOI 10.2174/138920308784533998
NR 33
TC 39
Z9 41
U1 0
U2 29
PU NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS
PI OTTAWA
PA BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA
SN 0008-4166
J9 CAN J MICROBIOL
JI Can. J. Microbiol.
PD SEP
PY 2009
VL 55
IS 9
BP 1033
EP 1039
DI 10.1139/W09-058
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
GA 513IM
UT WOS:000271315900002
PM 19898545
DA 2018-10-20
ER

PT J
AU Talieri, IC
   Laus, JL
   Coutinho-Netto, J
   Luvizotto, MCR
   de Paula, MC
AF Talieri, Ivia Carmem
   Laus, Jose Luiz
   Coutinho-Netto, Joaquim
   Rui Luvizotto, Maria Cecilia
   de Paula, Meiby Carneiro
TI Natural latex graft in lamellar and penetrating sclerectomies in rabbits
SO CIENCIA RURAL
LA English
DT Article
DE biomaterial; graft; healing; sclera; scleroplasty
ID NECROTIZING SCLERITIS; SYNTHETIC GRAFT; PATCH GRAFT; MANAGEMENT;
   SURGERY; RESECTION; MEMBRANE; DOG
AB The objective of study was to investigate the effects of natural latex with 0.1% of polylysine on lamellar and penetrating scleroctomies in rabbits. Two groups of twelve rabbits each (lamellar GI and penetrating GII) were studied. Scleral square incisions near the limbus were performed on the left eye of each animal. The latex biomembrane was fixed to the recipient sclera and it covered with a conjunctival flap. The clinical evaluations were followed for 60 days. Aplannation tonometry, binocular indirect ophthalmoscopy and slit-lamp biomicroscopy were performed during evaluation. Bright field microscopy and polarization microscopy were employed. Blepharospasm, graft infection, mucoid ocular discharge and chemosis were not observed in either treatment group. The conjunctival hyperemia varied from moderate to hardly noticeable. The postoperative IOP was not statiscally significant, comparing to the preoperative IOP, for GI and GII. The histopathology by polarization microscopy showed that the neoformed tissue was primarily dependent on adjacent vascularized tissues and was constituted by collagen type III. Both groups presented optimum graft adhesion to the receiving sclera. The natural latex biomembrane with 0.1% polylysine constitutes a new alternative for scleral reconstruction. Furthermore, this is a durable material, easy to obtain and manipulate.
C1 [Talieri, Ivia Carmem] Hosp Vet, Ctr Ensino Super Maringa CESUMAR, BR-87014250 Maringa, Parana, Brazil.
   [Laus, Jose Luiz] Univ Estadual Paulista, FCAV, Dept Clin & Cirurgia Vet, Jaboticabal, SP, Brazil.
   [Coutinho-Netto, Joaquim] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil.
   [Rui Luvizotto, Maria Cecilia] UNESP, FMVA, Dept Clin Cirurgia & Reprod Anim, Aracatuba, SP, Brazil.
   [de Paula, Meiby Carneiro] Inst Agron Parana IAPAR, Ponta Grossa, PR, Brazil.
RP Talieri, IC (reprint author), Hosp Vet, Ctr Ensino Super Maringa CESUMAR, BR-87014250 Maringa, Parana, Brazil.
EM iviact@gmail.com
FU CESUMAR (Centro de Ensino Superior de Maringa); CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior)
FX The authors would like to thank: Biochemistry and Immunology Department
   of Ribeirao Preto Medicine College - University of Sao Paulo - USP for
   the donation of the latex biomembrane; CESUMAR (Centro de Ensino
   Superior de Maringa) for financial support and also CAPES (Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior) for providing the
   scholarship.
CR ANDRADE AL, 2004, ARQUIVOS BRASILEIROS, V67, P169, DOI DOI 10.1590/S0004-27492004000100031
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Barrantes E. G., 2005, ACM Transactions on Information and Systems Security, V8, P3, DOI 10.1145/1053283.1053286
   BARROS PSM, 1996, ARQUIVOS BRASILEIROS, V59, P462
   Carpineto P, 2002, EUR J OPHTHALMOL, V12, P553
   DUKEELDER S, 1977, SYSTEM OPHTHALMOLOGY, P995
   Fairbanks Daniella, 2003, Arq. Bras. Oftalmol., V66, P71, DOI 10.1590/S0004-27492003000100014
   Frade MAC, 2001, INT J DERMATOL, V40, P238, DOI 10.1046/j.1365-4362.2001.00977-2.x
   Gopal L, 2003, AM J OPHTHALMOL, V135, P93, DOI 10.1016/S0002-9394(02)01858-5
   GREEN MO, 1995, OPHTHALMOLOGY, V102, P1038
   HUANG WJ, 1994, CORNEA, V13, P82, DOI 10.1097/00003226-199401000-00015
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kaniukov V N, 1999, Morfologiia, V116, P32
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   Ma DHK, 2002, CORNEA, V21, P275, DOI 10.1097/00003226-200204000-00008
   Murdoch JR, 1997, EYE, V11, P43
   Nguyen QD, 1999, INT OPHTHALMOL CLIN, V39, P109, DOI 10.1097/00004397-199903910-00011
   OLIVEIRA JAA, 2003, REV BRAS OTORRINOLAR, V69, P649, DOI DOI 10.1590/S0034-72992003000500010
   Ozcan AA, 2005, CORNEA, V24, P308
   PEZZUTTI S, 2001, ARQUIVOS BRASILEIROS, V64, P563, DOI DOI 10.1590/S0004-27492001000600012
   Pinho Erika Christina Canarim M. de, 2004, Arq. Bras. Oftalmol., V67, P27, DOI 10.1590/S0004-27492004000100005
   POTERIO J, 1999, REV BRASILEIRA ANG S, P156
   SADER SL, 2000, REV BRASILEIRA CIRUR, V15, P338, DOI DOI 10.1590/S0102-76382000000400008
   Skorobohach BJ, 2003, VET OPHTHALMOL, V6, P93, DOI 10.1046/j.1463-5224.2003.00285.x
   SONY P, 2005, GRAEFES ARCH CLIN EX, V6, P1, DOI DOI 10.1007/S00417-005-0178-1
   Sridhar MS, 2002, CORNEA, V21, P305, DOI 10.1097/00003226-200204000-00013
   Ti SE, 2003, OPHTHALMOLOGY, V110, P1126, DOI 10.1016/S0161-6420(03)00260-4
   Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050
   WHITMORE WG, 1990, OPHTHALMIC SURG LAS, V21, P327
   WILKIE DA, 1991, J AM VET MED ASSOC, V198, P1019
NR 30
TC 3
Z9 3
U1 0
U2 0
PU UNIV FEDERAL SANTA MARIA
PI SANTA MARIA
PA UNIV FEDERAL SANTA MARIA, SANTA MARIA, RS 97105.9, BRAZIL
SN 0103-8478
EI 1678-4596
J9 CIENC RURAL
JI Cienc. Rural
PD SEP
PY 2009
VL 39
IS 6
BP 1815
EP 1822
DI 10.1590/S0103-84782009000600027
PG 8
WC Agronomy
SC Agriculture
GA 493GX
UT WOS:000269725100027
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Jakubowicz, J
   Adamek, G
AF Jakubowicz, J.
   Adamek, G.
TI Preparation and properties of mechanically alloyed and electrochemically
   etched porous Ti-6Al-4V
SO ELECTROCHEMISTRY COMMUNICATIONS
LA English
DT Article
DE Ti-6Al-4V; Mechanical alloying; Etching; Biomaterials; Corrosion
   resistance
ID SURFACE; IMPLANTS; OSSEOINTEGRATION; BIOMATERIALS
AB Formation of porous Ti-6Al-4V nanostructure biomaterial was described. The alloy was prepared by mechanical alloying followed by pressing, sintering and subsequent anodic electrochemical etching in 1 M H(3)PO(4) + 2% HF electrolyte at 10 V for 30 min. Mechanically alloyed Ti-6Al-4V has nanostructure with grain size of about 35 nm and large grain boundaries volume fraction, which essentially improve etching process. The electrolyte penetrates sintered compacts through the grain boundaries, resulting in effective material removing and pores formation. The pore diameter reaches up to 60 mu m, which is very attractive for strong bonding with bone. The anodization of the microcrystalline alloy ingot results in selective etching, revealing of the two-phase structure with relatively flat surface. The corrosion properties were investigated in Ringer's solution. Mechanically alloyed samples shows worse corrosion resistance than the bulk microcrystalline alloy ingot, but electrochemical etching results in improving corrosion resistance. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Jakubowicz, J.; Adamek, G.] Poznan Tech Univ, Inst Mat Sci & Engn, PL-60965 Poznan, Poland.
RP Jakubowicz, J (reprint author), Poznan Tech Univ, Inst Mat Sci & Engn, M Sklodowska Curie 5 Sq, PL-60965 Poznan, Poland.
EM jaroslaw.jakubowicz@put.poznan.pl
RI Adamek, Grzegorz/J-3816-2014; Jakubowicz, Jaroslaw/F-7836-2014
OI Jakubowicz, Jaroslaw/0000-0001-6339-0796
FU Polish Ministry of Education and Science [N N507 277536]
FX The financial support of the Polish Ministry of Education and Science
   under the Contract No. N N507 277536 is gratefully acknowledged.
CR Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Brunette D. M., 2001, TITANIUM MED
   Dewidar MM, 2008, J ALLOY COMPD, V454, P442, DOI 10.1016/j.jallcom.2006.12.143
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Hsu RWW, 2004, MAT SCI ENG A-STRUCT, V380, P100, DOI 10.1016/j.msea.2004.03.069
   Jakubowicz J, 2008, ELECTROCHEM COMMUN, V10, P735, DOI 10.1016/j.elecom.2008.02.027
   Jakubowicz J, 2009, ELECTROCHEM COMMUN, V11, P461, DOI 10.1016/j.elecom.2008.12.024
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Narayanan R, 2007, CORROS SCI, V49, P542, DOI 10.1016/j.corsci.2006.06.021
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
NR 11
TC 13
Z9 13
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1388-2481
J9 ELECTROCHEM COMMUN
JI Electrochem. Commun.
PD SEP
PY 2009
VL 11
IS 9
BP 1772
EP 1775
DI 10.1016/j.elecom.2009.07.014
PG 4
WC Electrochemistry
SC Electrochemistry
GA 500ZZ
UT WOS:000270347500012
DA 2018-10-20
ER

PT J
AU Edwards, SL
   Werkmeister, JA
   Ramshaw, JAM
AF Edwards, Sharon L.
   Werkmeister, Jerome A.
   Ramshaw, John A. M.
TI Carbon nanotubes in scaffolds for tissue engineering
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Article
DE carbon nanotube; multiwalled carbon nanotube; scaffold; single-walled
   carbon nanotube; tissue engineering
ID NEURONAL GROWTH; ELECTRICAL-CONDUCTIVITY; BIOCOMPATIBILITY; FABRICATION;
   COMPOSITES; CELLS; YARNS; NANOMATERIALS; CYTOTOXICITY; STIMULATION
AB Carbon nanotubes are hollow graphitic cylinders of nanoscale dimensions. They are electrically conductive, chemically and thermally stable, and exceptionally strong. Given this unique combination of properties there has been much interest in carbon nanotubes, and finding applications for them. One application where this combination of properties may prove useful is in the area of tissue regeneration, incorporating carbon nanotubes into scaffolds for tissue engineering. It is believed that carbon nanotubes may improve scaffold properties and enhance tissue regeneration. This report aims to discuss the suitability of carbon nanotubes as a biomaterial for scaffold production, and the fabrication, properties and performance of carbon nanotube-based scaffolds.
C1 [Edwards, Sharon L.] CSIRO Mat Sci & Engn, Geelong, Vic 3216, Australia.
   [Werkmeister, Jerome A.; Ramshaw, John A. M.] CSIRO Mol & Hlth Technol, Clayton, Vic 3169, Australia.
RP Edwards, SL (reprint author), CSIRO Mat Sci & Engn, Geelong, Vic 3216, Australia.
EM sharon.edwards@csiro.au; jerome.werkmeister@csiro.au;
   john.ramshaw@csiro.au
RI Ramshaw, John/A-9411-2011
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Ajayan PM, 2007, NATURE, V447, P1066, DOI 10.1038/4471066a
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Boccaccini AR, 2007, ADV FUNCT MATER, V17, P2815, DOI 10.1002/adfm.200600887
   Bogdanovich A, 2007, SAMPE J, V43, P6
   Bradford PD, 2008, J COMPOS MATER, V42, P1533, DOI 10.1177/0021998308092206
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031
   Firkowska I, 2006, LANGMUIR, V22, P5427, DOI 10.1021/la053067e
   Firkowska I, 2008, ADV FUNCT MATER, V18, P3765, DOI 10.1002/adfm.200800760
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Garibaldi S, 2006, NANOTECHNOLOGY, V17, P391, DOI 10.1088/0957-4484/17/2/008
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   JELL G, 2008, J MATER CHEM, V18, P1821
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Kawaguchi M, 2006, DENT MATER J, V25, P719, DOI 10.4012/dmj.25.719
   Lobo AO, 2008, MAT SCI ENG C-BIO S, V28, P532, DOI 10.1016/j.msec.2007.04.016
   Lobo AO, 2008, MAT SCI ENG C-BIO S, V28, P264, DOI 10.1016/j.msec.2007.01.003
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Magrez A, 2006, NANO LETT, V6, P1121, DOI 10.1021/nl060162e
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Sorkin R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/1/015101
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Williams DF, WILLIAMS DICT BIOMAT
   Yildirim ED, 2008, J BIOMED MATER RES B, V87B, P406, DOI 10.1002/jbm.b.31118
   Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zawadzak E, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015008
   Zhang DH, 2006, J PHYS CHEM B, V110, P12910, DOI 10.1021/jp061628k
   Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
NR 43
TC 44
Z9 46
U1 5
U2 28
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD SEP
PY 2009
VL 6
IS 5
BP 499
EP 505
DI 10.1586/ERD.09.29
PG 7
WC Engineering, Biomedical
SC Engineering
GA 507TL
UT WOS:000270877700012
PM 19751122
DA 2018-10-20
ER

PT J
AU Samuelsson, R
   Thyrel, M
   Sjostrom, M
   Lestander, TA
AF Samuelsson, Robert
   Thyrel, Mikael
   Sjostrom, Michael
   Lestander, Torbjorn A.
TI Effect of biomaterial characteristics on pelletizing properties and
   biofuel pellet quality
SO FUEL PROCESSING TECHNOLOGY
LA English
DT Article
DE Biomass; Biofuels; Pellet quality; Sawdust; Factorial design
ID SOFTWOOD; MODEL; BARK
AB Sawdust of conifers as a by-product from saw mills is the most commonly used biomaterial for pellet production in Sweden today. Experiences from the biofuel pellet industry indicate that different biomaterial properties influence the final pellet quality. A systematic study was conducted where five factors were varied according to a two level fractional factorial design. The factors were: tree species (Scots pine, Norway spruce); origin of growth-place (latitudes 57 and 64 degrees N); storage time of sawdust (0 and 140 days), moisture content (9 and 12%) and steam treatment (2 and 6 kg/h). The measured responses bulk density and mechanical durability represented the pellet quality while the press current and the fines produced in the pelletizing process were measures of the pelletizing property.
   The results showed that low moisture content and long storage time resulted in increased bulk densities and press currents. For mechanical durability and fines, a long storage time and intermediate moisture contents were found favourable. In addition, indications were found that the reduction of fatty and resin acids during the storage also influenced the pelletizing properties and the pellet quality. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Samuelsson, Robert; Thyrel, Mikael; Lestander, Torbjorn A.] Swedish Univ Agr Sci, Unit Biomass Technol & Chem, SE-90403 Umea, Sweden.
   [Sjostrom, Michael] Umea Univ, Dept Chem, SE-90187 Umea, Sweden.
RP Samuelsson, R (reprint author), Swedish Univ Agr Sci, Unit Biomass Technol & Chem, Box 4097, SE-90403 Umea, Sweden.
EM robert.samuelsson@btk.slu.se
FU Swedish Energy Agency; Swedish Pellet Association (PiR); Kempe
   Foundations and Swedish University of Agricultural Sciences
FX We thank SCA Timber AB and Rorvik Timber AB for the delivered sawdust
   and Neova AB for initial drying of the biornaterials. The Swedish Energy
   Agency, the Swedish Pellet Association (PiR), Kempe Foundations and
   Swedish University of Agricultural Sciences are thanked for financial
   support. Carina Jonsson at SLU Biomass Technology and Chemistry is
   greatly acknowledged for carrying out the chemical analyses of the
   various biornaterials.
CR Arshadi M, 2005, FOREST PROD J, V55, P132
   BRADFIELD J, 1984, FOREST PROD J, V34, P61
   FABORODE MO, 1989, J AGR ENG RES, V42, P165, DOI 10.1016/0021-8634(89)90048-6
   Holm JK, 2007, ENERG FUEL, V21, P2446, DOI 10.1021/ef0701561
   Holm JK, 2006, ENERG FUEL, V20, P2686, DOI 10.1021/ef0503360
   Lehtikangas P, 2001, BIOMASS BIOENERG, V20, P351, DOI 10.1016/S0961-9534(00)00092-1
   MYERS RH, 1986, CLASSICAL MODERN REG, P465
   ODOGHERTY MJ, 1984, J AGR ENG RES, V29, P61, DOI 10.1016/0021-8634(84)90061-1
   Rhen C, 2005, FUEL PROCESS TECHNOL, V87, P11, DOI 10.1016/j.fuproc.2005.03.003
   *SIS CEN TS, 1477412004 SISCENTS
   *SIS CEN TS, 151032006 SISCENTS
   Thomas M, 1996, ANIM FEED SCI TECH, V61, P89, DOI 10.1016/0377-8401(96)00949-2
NR 12
TC 48
Z9 49
U1 3
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-3820
J9 FUEL PROCESS TECHNOL
JI Fuel Process. Technol.
PD SEP
PY 2009
VL 90
IS 9
BP 1129
EP 1134
DI 10.1016/j.fuproc.2009.05.007
PG 6
WC Chemistry, Applied; Energy & Fuels; Engineering, Chemical
SC Chemistry; Energy & Fuels; Engineering
GA 497QU
UT WOS:000270076500011
DA 2018-10-20
ER

PT J
AU Arciola, CR
AF Arciola, Carla Renata
TI New concepts and new weapons in implant infections
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Editorial Material
DE Staphylococcus aureus; Staphylococcus epidermidis; Implant infections;
   Poly-N-acetylglucosamine surface polysaccharide (PNAG); Extracellular
   DNA (eDNA); Dispersin-B; DNase I; Anti-biofilm agents; Quorum sensing
   inhibitors
ID STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; DNA RELEASE; ENTEROCOCCUS-FAECALIS;
   FIBRONECTIN-BINDING; EXTRACELLULAR DNA; AUREUS; INHIBITION; RESISTANCE;
   DEVICES
AB Molecular studies have cast light on new facts about the virulence factors of bacteria responsible for implant infections. Recently, the biofilm matrix has been shown to include a variety of important structural components, including DNA, in addition to polysaccharides and proteins. This finding has stimulated interest in substances able to disrupt biofilms by attacking both the poly-N-acetylglucosamine surface polysaccharide (PNAG) and the extracellular DNA (eDNA), namely, dispersin B, a PNAG-degrading enzyme, and DNase I. The therapeutic potential of these enzymes are reviewed in this issue of IJAO, as well as the ability of the excretions/secretions of the medicinal maggot Lucilia sericata to disrupt Staphylococcus epidermidis biofilms. The activity of bacterial proteases causes the release of eDNA, critical for the early development of biofilms. This complex process, including suicidal and fratricidal mechanisms, is also presented in the current issue of IJAO. The different sensitivities of S. aureus and S. epidermidis to enzymatic anti-biofilm agents and to the host's first line of defense, as well as the importance of knowing the cascade of regulatory genes in bacteria so as to interfere with biofilm production using gene therapy or quorum sensing inhibitors are also discussed in this issue. Other innovative approaches consist in disrupting biofilms by exposing them to photodynamic substances and simultaneously to visible light, and in coating biomaterial surfaces with organic molecules to prevent protein adsorption and biofilm formation. (Int J Artif Organs 2009; 32: 533-6)
C1 [Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   [Arciola, Carla Renata] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
CR Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2009, INT J ARTIF ORGANS, V32, P635
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   COSTERTON JW, 2009, INT J ARTIF ORGANS, V32, P689
   Cotter JJ, 2009, APPL ENVIRON MICROB, V75, P261, DOI 10.1128/AEM.00261-08
   Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038
   Groll J, 2009, INT J ARTIF ORGANS, V32, P655
   Gunther F, 2009, MOL IMMUNOL, V46, P1805, DOI 10.1016/j.molimm.2009.01.020
   GUNTHER F, 2009, INT J ARTIF ORGANS, V32, P565
   Harris LG, 2009, INT J ARTIF ORGANS, V32, P555
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Jager S, 2009, INT J ARTIF ORGANS, V32, P584
   Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6
   Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545
   Kiran MD, 2008, INT J ARTIF ORGANS, V31, P761
   Kiran MD, 2009, INT J ARTIF ORGANS, V32, P592
   Montanaro L, 2008, INT J ARTIF ORGANS, V31, P771
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104
   Sbarra MS, 2009, INT J ARTIF ORGANS, V32, P574
   Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08
   Thomas VC, 2009, INT J ARTIF ORGANS, V32, P537
   Vadyvaloo V, 2005, INT J ARTIF ORGANS, V28, P1069
NR 26
TC 31
Z9 31
U1 1
U2 12
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2009
VL 32
IS 9
BP 533
EP 536
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 520NL
UT WOS:000271851700001
PM 19856268
DA 2018-10-20
ER

PT J
AU Strauss, J
   Liu, YT
   Camesano, TA
AF Strauss, Joshua
   Liu, Yatao
   Camesano, Terri A.
TI Bacterial adhesion to protein-coated surfaces: An AFM and QCM-D study
SO JOM
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; ATOMIC-FORCE MICROSCOPY;
   STAPHYLOCOCCUS-EPIDERMIDIS; ESCHERICHIA-COLI; FIBRONECTIN; ADSORPTION;
   DEPOSITION; FILMS
AB Bacterial adhesion to biomaterials, mineral surfaces, or other industrial surfaces is strongly controlled by the way bacteria interact with protein layers or organic matter and other biomolecules that coat the materials. Despite this knowledge, many studies of bacterial adhesion are performed under clean conditions, instead of in the presence of proteins or organic molecules. We chose fetal bovine serum (FBS) as a model protein, and prepared FBS films on quartz crystals. The thickness of the FBS layer was characterized using atomic force microscopy (AFM) imaging under liquid and quartz crystal microbalance with dissipation (QCM-D). Next, we characterized how the model biomaterial surface would interact with the nocosomial pathogen Staphylococcus epidermidis. An AFM probe was coated with S. epidermidis cells and used to probe a gold slide that had been coated with FBS or another protein, fibronectin (FN). These experiments show that AFM and QCM-D can be used in complementary ways to study the complex interactions between bacteria, proteins, and surfaces.
C1 [Strauss, Joshua; Liu, Yatao; Camesano, Terri A.] Worcester Polytech Inst, Dept Chem Engn, Life Sci & Bioengn Ctr, Worcester, MA 01609 USA.
RP Strauss, J (reprint author), Worcester Polytech Inst, Dept Chem Engn, Life Sci & Bioengn Ctr, Gateway Pk,100 Inst Rd, Worcester, MA 01609 USA.
EM terric@wpi.edu
RI Liu, Yatao/D-1702-2010
OI Liu, Yatao/0000-0003-3623-1030
FU National Science Foundation [BES 0238627]
FX We would like to thank the National Science Foundation (BES 0238627) for
   partial support of this research.
CR Balnois E, 1999, ENVIRON SCI TECHNOL, V33, P3911, DOI 10.1021/es990365n
   Cooper MA, 2007, J MOL RECOGNIT, V20, P154, DOI 10.1002/jmr.826
   Cristancho L, 2008, VET MICROBIOL, V126, P200, DOI 10.1016/j.vetmic.2007.06.012
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   Gunning AP, 1996, J COLLOID INTERF SCI, V183, P600, DOI 10.1006/jcis.1996.0584
   Hansma HG, 2004, CURR OPIN STRUC BIOL, V14, P380, DOI 10.1016/j.sbi.2004.05.005
   HANSMA HG, 1994, ANNU REV BIOPH BIOM, V23, P115, DOI 10.1146/annurev.bb.23.060194.000555
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F., 1999, Proceedings of the 1999 Joint Meeting of the European Frequency and Time Forum and the IEEE International Frequency Control Symposium (Cat. No.99CH36313), P966, DOI 10.1109/FREQ.1999.841467
   Hook F., 2005, BTI MOL BIOL, P8
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Kuzniatsova T, 2007, MICROPOR MESOPOR MAT, V103, P102, DOI 10.1016/j.micromeso.2007.01.042
   Kwon KD, 2006, ENVIRON SCI TECHNOL, V40, P7739, DOI 10.1021/es061715q
   Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044
   Liu YT, 2007, LANGMUIR, V23, P7134, DOI 10.1021/la700575u
   Malmstrom J, 2007, LANGMUIR, V23, P9760, DOI 10.1021/la701233y
   Polonio RE, 2001, ANTIMICROB AGENTS CH, V45, P3262, DOI 10.1128/AAC.45.11.3262-3266.2001
   Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125
   RECHENDORFF K, 2007, J APPL PHYS, P101
   Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Strachan NJC, 2006, INT J FOOD MICROBIOL, V112, P129, DOI 10.1016/j.ijfoodmicro.2006.06.021
   STRAUSS J, 2008, ACS SYM SER, V984, P79
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Xiao XD, 2000, LANGMUIR, V16, P8153, DOI 10.1021/la000770o
NR 27
TC 12
Z9 12
U1 5
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
J9 JOM-US
JI JOM
PD SEP
PY 2009
VL 61
IS 9
BP 71
EP 74
DI 10.1007/s11837-009-0138-z
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 496FA
UT WOS:000269953700014
DA 2018-10-20
ER

PT J
AU Labastida-Polito, A
   Pina-Barba, C
   Romero-Valdovinos, MG
   Tello-Solis, SR
AF Labastida-Polito, Ariana
   Pina-Barba, Cristina
   Romero-Valdovinos, Mirza G.
   Tello-Solis, Salvador R.
TI Physicochemical properties of collagen sheet from bovine femur
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE Bovine bone; Type I collagen; Biomaterial
ID BONE; CONFORMATION; PROTEINS
AB Purpose: In the present study collagen sheets were prepared from the spongy part of the bovine femur and characterized from the physicochemical point of view.
   Methods: The physicochemical properties of the collagen sheets were studied using scanning electronic microscopy (SEM) and thermogravimetrical analysis (TGA).
   Results: The SEM studies showed that the collagen sheets are porous and exhibit a fibrous nature. The TGA study revealed that the collagen sheets are a two-phase system containing a protein and a mineral phase. In order to determine the collagen type present in the sample, the sheets were dissolved and studied by circular dichroism (CD) and electrophoresis techniques. The results obtained showed that the nature of the collagen is type I.
   Conclusions: The type I collagen sheets from bovine femur isolated in this study are proposed as a biomaterial for medical applications, for example, as an osteoinductive material or they could be used as a bone substitute. (Journal of Applied Biomaterials & Biomechanics 2009; 7: 200-4)
C1 [Labastida-Polito, Ariana; Tello-Solis, Salvador R.] Univ Autonoma Metropolitana Iztapalapa, Dept Chem, Area Biophys Chem, Mexico City 09340, DF, Mexico.
   [Pina-Barba, Cristina] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
   [Romero-Valdovinos, Mirza G.] Gen Hosp Dr Manuel Gea Gonzalez, Mol Biol & Hystocompatibil Dept, Mexico City, DF, Mexico.
RP Tello-Solis, SR (reprint author), Hosp Gen Gea Gonzalez, Dept Biol Mol & Histocompatibilidad, Calzada Tlalpan 4800, Mexico City 14000, DF, Mexico.
EM srts@xanum.uam.mx
RI Pina, Cristina/K-2026-2012
OI Romero Valdovinos, Mirza/0000-0003-0522-8357
FU CONACyT (Mexico); DGAPA-UNAM [IN104008]
FX Ariana Labastida-Polito thanks CONACyT (Mexico), for the scholarship.
   Thanks also to Nelly Medina Molotla, Omar Novelo Peralta, Carlos Flores
   Morales, Esteban Fregoso Israel for their technical support. The project
   IN104008 was supported by DGAPA-UNAM.
CR BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bhowmik R, 2007, J MATER SCI, V42, P8795, DOI 10.1007/s10853-007-1914-1
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Cruz Gabriela Alessandra da, 2007, Braz. Dent. J., V18, P129, DOI 10.1590/S0103-64402007000200008
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2
   LANE D, 1998, ANTIBODIES LAB MANUA, P471
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MEGHJI S, 1992, BRIT DENT J, V172, P235, DOI 10.1038/sj.bdj.4807835
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105
   Ripamonti U, 1998, PLAST RECONSTR SURG, V101, P227, DOI 10.1097/00006534-199801000-00040
   SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303
   Sano A, 1998, ADV DRUG DELIV REV, V31, P247
   Sastry TP, 2007, CLIN BIOCHEM, V40, P907, DOI 10.1016/j.clinbiochem.2007.04.011
   SILVA T, 2005, J AGR FOOD CHEM, V5, P7802
   VANDERREST M, 1991, FASEB J, V5, P2814
   Zhang ZK, 2006, J SOC LEATH TECH CH, V90, P23
NR 22
TC 3
Z9 3
U1 0
U2 2
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD SEP-DEC
PY 2009
VL 7
IS 3
BP 200
EP 204
PG 5
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 551UF
UT WOS:000274235300008
PM 20740430
DA 2018-10-20
ER

PT J
AU Helm, AT
   Kerin, C
   Ghalayini, SRA
   McLauchlan, GJ
AF Helm, Anthony T.
   Kerin, Cronan
   Ghalayini, Simon R. A.
   McLauchlan, George J.
TI Preliminary Results of an Uncemented Trabecular Metal Tibial Component
   in Total Knee Arthroplasty
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE total knee arthroplasty; uncemented; trabecular metal
ID POROUS TANTALUM BIOMATERIAL; FOLLOW-UP; 14-YEAR; REPLACEMENT
AB Trabecular metal has several theoretical advantages for the long-term Survival of a tibial component. We report the results of a prospective cohort of 105 consecutive primary total knee arthroplasties using an uncemented trabecular metal (tantalum) tibial component at a minimum 3-year follow-up (range, 36-56 months). There was a significant improvement in Oxford Knee scores and Short Form-12 scores postoperatively. There was no radiolucency at the implant-bone interface on any postoperative radiograph. There has been one (1%) revision of the tibial component for trauma. The 3-year results using this prosthesis are as good as those published for the commonly used cemented prostheses. Longer follow-up is required to see whether these results are maintained over time.
C1 [Helm, Anthony T.; Kerin, Cronan; Ghalayini, Simon R. A.; McLauchlan, George J.] Lancashire Teaching Hosp NHS Trust, Dept Orthopaed Surg, Preston PR2 9HT, Lancs, England.
RP Helm, AT (reprint author), Lancashire Teaching Hosp NHS Trust, Dept Orthopaed Surg, Sharoe Green Lane, Preston PR2 9HT, Lancs, England.
CR Akizuki S, 2003, J BONE JOINT SURG BR, V85B, P1123, DOI 10.1302/0301-620X.85B8.13836
   [Anonymous], 2010, SWEDISH KNEE ARTHROP
   Australian Orthopaedic Association National Joint Replacement Registry, AUSTR ORTH ASS NAT J
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Goldberg VM, 2004, CLIN ORTHOP RELAT R, P214, DOI 10.1097/01.blo.0000148572.95121.f0
   Ritter MA, 2001, CLIN ORTHOP RELAT R, P51
   Rodricks DJ, 2007, J BONE JOINT SURG AM, V89A, P89, DOI 10.2106/JBJS.E.00492
   Sorrells RB, 2004, J BONE JOINT SURG AM, V86A, P2156, DOI 10.2106/00004623-200410000-00005
   Weir DJ, 1996, J BONE JOINT SURG BR, V78B, P907, DOI 10.1302/0301-620X78B6.6678
NR 10
TC 11
Z9 12
U1 0
U2 0
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD SEP
PY 2009
VL 24
IS 6
BP 941
EP 944
DI 10.1016/j.arth.2008.06.018
PG 4
WC Orthopedics
SC Orthopedics
GA 491VB
UT WOS:000269607400017
PM 18672343
DA 2018-10-20
ER

PT J
AU Ma, X
   Wu, XM
   Wu, YP
   Liu, J
   Xiong, Z
   Lv, R
   Yan, YN
   Wang, J
   Li, D
AF Ma, Xing
   Wu, Xiaoming
   Wu, Yaoping
   Liu, Jian
   Xiong, Zhuo
   Lv, Rong
   Yan, Yongnian
   Wang, Jun
   Li, Dan
TI Posterolateral Spinal Fusion in Rabbits Using a RP-based
   PLGA/TCP/Col/BMSCs-OB Biomimetic Grafting Material
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE rapid prototyping (RP); scaffold; bone marrow stromal cells (BMSCs);
   spine fusion; rabbit; tissue engineering
ID MESENCHYMAL STEM-CELLS; BONE; TISSUE; SCAFFOLDS; DIFFERENTIATION;
   ANGIOGENESIS; PHOSPHATE; HYDROGEL; GELATIN; SYSTEMS
AB Three-dimensional highly porous poly(DL-lactic-co-glycolic acid)/tricalcium phosphate (PLGA/TCP) scaffolds were fabricated using a rapid prototyping technique (RP). The 3D rhombic lamellar PLGA/TCP carriers (20 mm x 20 mm x 3 mm) subsequently were coated with collagen type I (Col) to produce PLGA/TCP/Col composites. Both the RP-based PLGA/TCP scaffolds and the PLGA/TCP/Col composites were observed by scanning electron microscopy. Forty New Zealand white rabbits were equally randomized into 2 groups (group A and group B) and bilaterally underwent posterolateral intertransverse process arthrodesis at the L4-L5 level using the following graft materials: In group A, PLGA/TCP/Col/BMSCs-OB composites (on the right side, group A1, n = 20) and autogenous iliac bone grafts (on the left side, group A2, n = 20) were used; In group B, PLGA/TCP scaffolds plus fresh autogenous bone marrow (on the right side, group B1, n = 20) and PLGA/TCP scaffolds alone (on the left side, group B2, n = 20) were utilized. In group A1, rabbit bone marrow stromal cells (BMSCs) were isolated and cultured under the osteogenic conditions (BMSCs-OB). Structural PLGA/TCP/Col composites then were efficiently loaded with BMSCs-OB and cultured 5 days to make PLGA/TCP/Col/BMSCs-OB biomaterials. Rabbits were sacrificed after 12-week follow-up and the spinal fusion were evaluated by a general observation, a manual palpation test, histological analyses and radiography. As a result, RP established PLGA/TCP scaffolds with appropriate biomaterial properties including satisfactory microstructure, inter-connectivity and porosity. Modifications to the structural highly porous PLGA/TCP scaffolds with Col (PLGA/TCP/Col) essentially increased the affinity of the carriers to seeding cells. In group A1, radiological evaluation revealed strong ability of new bone formation and bony fusion in the implanted sites and histological analyses showed highly cellular bone marrow between the newly formed trabecular bone was present in the fusion mass. In group A2, there was a reduced amount of newly formed bone. In group B1, only a few bony fusions were obtained. In group B2, PLGA/TCP scaffolds were biocompatible and biodegradable; whereas, no newly formed bone or bony fusion was found. Twelve weeks after surgery, spinal fusion rates in groups of A1, A2, B1, and B2 were 70.0%(14/20), 45.0%(9/20), 15.8%(3/19), and 0%(0/19), respectively. The rates of fusion were significantly higher in groups of A1 and A2 compared with groups of B1 and B2 (p<0.01), and there was no significant difference of fusion rate between group A1 and group A2 (p>0.05). Therefore, RP-based 3D PLGA/TCP/Col/BMSCs-OB biomaterial holds promise as a bone grafting substitute for spinal fusion. Our attempts may provide a novel method for biofabrication of the bionic construct.
C1 [Ma, Xing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Orthopaed, Xian 710061, Peoples R China.
   [Ma, Xing; Wu, Yaoping; Liu, Jian; Lv, Rong; Wang, Jun; Li, Dan] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed Surg, Xian 710032, Peoples R China.
   [Ma, Xing; Wu, Yaoping; Liu, Jian; Lv, Rong; Wang, Jun; Li, Dan] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.
   [Wu, Xiaoming] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.
   [Xiong, Zhuo; Yan, Yongnian] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
RP Liu, J (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed Surg, Xian 710032, Peoples R China.
EM yangwangma@yahoo.cn
FU Hi-tech Research and Development Program of China [715009-0160];
   National Natural Science Funds of China [30300356, 50577067]
FX We would like to thank the Hi-tech Research and Development Program of
   China for supporting this work under grant number 715009-0160. This work
   is also supported by the National Natural Science Funds of China under
   grant number 30300356, 50577067. Ma, X. and Wu, X. had equal
   contributions to this article.
CR Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Erickson BP, 2008, CLIN ORTHOP RELAT R, V466, P210, DOI 10.1007/s11999-007-0017-2
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kawazoe N, 2009, J BIOACT COMPAT POL, V24, P25, DOI 10.1177/0883911508099439
   Kyriakidou K, 2008, J BIOACT COMPAT POL, V23, P227, DOI 10.1177/0883911508091905
   Liu Gang, 2004, Chin J Traumatol, V7, P358
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Ma X, 2009, MATER SCI FORUM, V626-627, P553, DOI 10.4028/www.scientific.net/MSF.626-627.553
   Ma X, 2009, J BIOACT COMPAT POL, V24, P146, DOI 10.1177/0883911509103830
   Ma Xing, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P571
   Ma Xing, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P795
   Machado CB, 2007, BIOMED MATER, V2, P124, DOI 10.1088/1748-6041/2/2/010
   Miao XG, 2008, ACTA BIOMATER, V4, P638, DOI 10.1016/j.actbio.2007.10.006
   Minamide A, 2007, SPINE, V32, P1067, DOI 10.1097/01.brs.0000261626.32999.8a
   Rhee JM, 2007, SPINE, V32, P2980, DOI 10.1097/BRS.0b013e31815cd464
   Robey Pamela Gehron, 2007, V140, P83
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Xiong Z, 2005, RAPID PROTOTYPING J, V11, P160, DOI 10.1108/13552540510601282
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Xu W, 2008, J BIOACT COMPAT POL, V23, P103, DOI 10.1177/0883911507088271
   Xu W, 2007, J BIOACT COMPAT POL, V22, P363, DOI 10.1177/0883911507079451
   Yan YN, 2005, J BIOACT COMPAT POL, V20, P259, DOI 10.1177/0883911505053658
   Yao R, 2009, J BIOACT COMPAT POL, V24, P5, DOI 10.1177/0883911508099367
   Yee Albert Juang Ming, 2006, Spine J, V6, P391, DOI 10.1016/j.spinee.2005.10.017
   Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025
NR 28
TC 9
Z9 10
U1 1
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD SEP
PY 2009
VL 24
IS 5
BP 457
EP 472
DI 10.1177/0883911509343497
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 491HP
UT WOS:000269569800004
DA 2018-10-20
ER

PT J
AU Betz, MW
   Caccamese, JF
   Coletti, DP
   Sauk, JJ
   Fisher, JP
AF Betz, Martha W.
   Caccamese, John F.
   Coletti, Domenick P.
   Sauk, John J.
   Fisher, John P.
TI Tissue response and orbital floor regeneration using cyclic acetal
   hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE orbital floor; bone tissue engineering; biomaterials; hydrogel; cyclic
   acetal
ID POROUS POLYETHYLENE IMPLANTS; BONE MORPHOGENETIC PROTEIN-2;
   POLY(PROPYLENE FUMARATE) SCAFFOLDS; BLOWOUT FRACTURE; TITANIUM MESH;
   ECTOPIC BONE; RECONSTRUCTION; BIOMATERIALS; GROWTH; DELIVERY
AB Orbital floor injuries are a common form of traumatic craniofacial injury that may not heal properly through the body's endogenous response. Reconstruction is often necessary, and an optimal method does not exist. We propose a tissue engineering approach for orbital bone repair based upon a cyclic acetal biomaterial formed from 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) and poly(ethylene glycol) diacrylate (PEGDA). The EHD monomer and PEGDA polymer may be fabricated into an EH-PEG hydrogel by radical polymerization. The objectives of this work were to Study (1) the tissue response to EH-PEG hydrogels in an orbital bone defect and (2) the induction of bone formation by delivery of bone morphogenetic protein-2 (BMP-2) from EH-PEG hydrogels. EH-PEG hydrogeis were fabricated and implanted into an 8-mm, rabbit orbital floor defect. Experimental groups included unloaded EH-PEG hydrogels, and EH-PEG hydrogels containing 0.25 mu g and 2.5 mu g BMP-2/implant. Results demonstrated that the unloaded hydrogel was initially bordered by a fibrin clot and then by fibrous encapsulation. BMP-2 loaded EH-PEG hydrogels, independent of concentration, were surrounded by fibroblasts at both time points. Histological analysis also demonstrated that significant bone growth was present at the 2.5 mu g BMP-2/implant group at 28 days. This work demonstrates that the EH-PEG construct is a viable option for use and delivery of BMP-2 in vivo. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 819-829, 2009
C1 [Betz, Martha W.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Caccamese, John F.; Coletti, Domenick P.; Fisher, John P.] Univ Maryland, Sch Dent, Dept Oral & Maxillofacial Surg, Baltimore, MD 21201 USA.
   [Sauk, John J.] Univ Maryland, Dept Pathol, Sch Dent, Baltimore, MD 21201 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
FU National Science Foundation [BES 0448684, BES 0632188]
FX Contract grant sponsor: National Science Foundation; contract grant
   numbers: BES 0448684, BES 0632188
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640
   Burm JS, 2005, PLAST RECONSTR SURG, V116, P962, DOI 10.1097/01.prs.0000178046.71684.fe
   Burnstine Michael A, 2003, Curr Opin Ophthalmol, V14, P236, DOI 10.1097/00055735-200310000-00002
   Chan ZSH, 2005, NEURAL PROCESS LETT, V21, P207, DOI 10.1007/s11063-005-1084-6
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Degat MC, 2009, J BIOMED MATER RES A, V88A, P174, DOI 10.1002/jbm.a.31884
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085
   Eski M, 2006, J CRANIOFAC SURG, V17, P1059, DOI 10.1097/01.scs.0000235111.92988.b2
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Folkestad L, 2006, INT J ORAL MAX SURG, V35, P499, DOI 10.1016/j.ijom.2006.01.016
   Fonseca RJ, 2000, ORAL MAXILLOFACIAL S, V3, P205
   GUERRA MF, 2000, J ORAL MAXILLOFAC SU, V58, P1366
   Guerra MFM, 2000, J ORAL MAXIL SURG, V58, P1361, DOI 10.1053/joms.2000.18266
   Hong Y, 2006, J BIOMED MATER RES A, V79A, P913, DOI 10.1002/jbm.a.30837
   Inoda H, 2007, INT J ORAL MAX SURG, V36, P39, DOI 10.1016/j.ijom.2006.07.011
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jansen J A, 1994, J Invest Surg, V7, P123, DOI 10.3109/08941939409015356
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Kofron MD, 2006, ADV DRUG DELIVER REV, V58, P555, DOI 10.1016/j.addr.2006.03.008
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Kontio RK, 2006, PLAST RECONSTR SURG, V118, P1365, DOI 10.1097/01.prs.0000244519.26368.4c
   Kosaka M, 2004, J CRANIO MAXILL SURG, V32, P374, DOI 10.1016/j.jcms.2004.06.006
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Manolidis S, 2002, J CRANIOFAC SURG, V13, P726, DOI 10.1097/01.SCS
   MANOLIDIS S, 2002, SPINE, V13, P738
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Metzger MC, 2007, INT J ORAL MAX SURG, V36, P45, DOI 10.1016/j.ijom.2006.07.013
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Ng SGJ, 2001, EYE, V15, P578
   Ozturk S, 2005, J CRANIOFAC SURG, V16, P973, DOI 10.1097/01.scs.0000179744.91165.3a
   POLLEY JW, 1987, PLAST RECONSTR SURG, V79, P39
   Rinna C, 2005, J CRANIOFAC SURG, V16, P968, DOI 10.1097/01.scs.0000186308.16795.8b
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   Schon R, 2006, INT J ORAL MAX SURG, V35, P990, DOI 10.1016/j.ijom.2006.06.018
   Sinikovic B, 2007, INT J ORAL MAX SURG, V36, P54, DOI 10.1016/j.ijom.2006.07.014
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Villarreal PM, 2002, PLAST RECONSTR SURG, V109, P886
   Villarreal PM, 2002, PLAST RECONSTR SURG, V109, P877, DOI 10.1097/00006534-200203000-00007
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
NR 54
TC 19
Z9 19
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2009
VL 90A
IS 3
BP 819
EP 829
DI 10.1002/jbm.a.32131
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 482CB
UT WOS:000268860100022
PM 18615468
DA 2018-10-20
ER

PT J
AU Lam, CXF
   Hutmacher, DW
   Schantz, JT
   Woodruff, MA
   Teoh, SH
AF Lam, Christopher X. F.
   Hutmacher, Dietmar W.
   Schantz, Jan-Thorsten
   Woodruff, Maria Ann
   Teoh, Swee Hin
TI Evaluation of polycaprolactone scaffold degradation for 6 months in
   vitro and in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydrolytic degradation; in vitro and in vivo degradation; tri-calcium
   phosphate; polycaprolactone; scaffolds
ID POLY(L-LACTIDE) BONE PLATES; HYDROLYTIC DEGRADATION; ALIPHATIC
   POLYESTERS; TISSUE; POLY(EPSILON-CAPROLACTONE); FIXATION; DEVICES;
   SCREWS
AB The use of polycaprolactone (PCL) as a biomaterial, especially in the fields of drug delivery and tissue engineering, has enjoyed significant growth. Understanding how such a device or scaffold eventually degrades in vivo is paramount as the defect site regenerates and remodels. Degradation studies of three-dimensional PCL and PCL-based composite scaffolds were conducted in vitro (in phosphate buffered saline) and in vivo (rabbit model). Results up to 6 months are reported. All samples recorded virtually no molecular weight changes after 6 months, with a maximum mass loss of only about 7% from the PCL-composite scaffolds degraded in vivo, and a minimum of 1% from PCL scaffolds. Overall, crystallinity increased slightly because of the effects of polymer recrystallization. This was also a contributory factor for the observed stiffness increment in some of the samples, while only the PCL-composite scaffold registered a decrease. Histological examination of the in vivo samples revealed good biocompatibility, with no adverse host tissue reactions up to 6 months. Preliminary results of medical-grade PCL scaffolds, which were implanted for 2 years in a critical-sized rabbit calvarial defect site, are also reported here and support our scaffold design goal for gradual and late molecular weight decreases combined with excellent long-term biocompatibility and bone regeneration. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 906-919, 2009
C1 [Hutmacher, Dietmar W.; Woodruff, Maria Ann] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.
   [Lam, Christopher X. F.; Schantz, Jan-Thorsten; Woodruff, Maria Ann] Natl Univ Singapore, Div Bioengn, Singapore 117574, Singapore.
   [Schantz, Jan-Thorsten] Natl Univ Singapore, Div Plast Surg, Singapore 119074, Singapore.
   [Teoh, Swee Hin] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   [Schantz, Jan-Thorsten] Tech Univ Munich, Dept Plast & Hand Surg, Rechts Isar Med Ctr, D-81675 Munich, Germany.
RP Hutmacher, DW (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.
EM dietmar.hutmacher@qut.edu.au
RI Lam, Christopher/B-6537-2009; Woodruff, Maria/J-1247-2012
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134; Woodruff,
   Maria/0000-0002-4909-5288
FU Biomedical Research Council [R-397-000-613-305]
FX Contract grant sponsor: Biomedical Research Council, contract grant
   number: R-397-000-613-305
CR BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   GINDE RM, 1987, J APPL POLYM SCI, V33, P2411, DOI 10.1002/app.1987.070330712
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GOPFERICH A, 1995, EUR J PHARM BIOPHARM, V41, P81
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang MH, 2006, J APPL POLYM SCI, V102, P1681, DOI 10.1002/app.24196
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Lam CXF, 2007, POLYM INT, V56, P718, DOI 10.1002/pi.2195
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li SM, 1996, J BIOMAT SCI-POLYM E, V7, P817
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Perrin D., 1998, HDB BIODEGRADABLE PO, P63
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Sanger C, 2007, J CRANIOFAC SURG, V18, P926, DOI 10.1097/scs.0b013e3180a771e9
   Schantz JT, 2003, TISSUE ENG, V9, pS113, DOI 10.1089/10763270360697021
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 22
TC 203
Z9 206
U1 4
U2 88
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2009
VL 90A
IS 3
BP 906
EP 919
DI 10.1002/jbm.a.32052
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 482CB
UT WOS:000268860100030
PM 18646204
DA 2018-10-20
ER

PT J
AU Feyerabend, F
   Siemers, C
   Willumeit, R
   Rosler, J
AF Feyerabend, Frank
   Siemers, Carsten
   Willumeit, Regine
   Roesler, Joachim
TI Cytocompatibility of a free machining titanium alloy containing
   lanthanum
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium alloy; lanthanum; machinability; corrosion; cytocompatibility;
   biomaterial biomedical application
ID GIANT UNILAMELLAR VESICLES; CHRONIC-RENAL-FAILURE; RARE-EARTH COMPOUNDS;
   IN-VITRO; CELL LINES; CORROSION; APOPTOSIS; MACROPHAGES; CARBONATE; LA3+
AB Titanium alloys like Ti6Al4V are widely used in medical engineering. However, the mechanical and chemical properties of titanium alloys lead to poor machinability, resulting in high production costs of medical products. To improve the machinability of Ti6Al4V, 0.9%, of the rare earth element lanthanum (La) was added. The microstructure, the mechanical, and the corrosion properties were determined. Lanthanum containing alloys exhibited discrete particles of cubic lanthanum. The mechanical properties and corrosion resistance were slightly decreased but are still sufficient for many applications in the field of medical engineering. in vitro experiments with mouse macrophages (RAW 264.7) and human bone-derived cells (MG-63, HBDC) were performed and revealed that macrophages showed a dose response below and above a LaCl3 concentration of 200 mu M, while MG-63 and HBDC tolerated three times higher concentrations without reduction of viability. The viability of cells cultured on disks of the materials showed no differences between the reference and the lanthanum containing alloy. We therefore propose that lanthanum containing alloy appears to be a good alternative for biomedical applications, where machining of parts is necessary. (C) 2008 Wiley Periodical, Inc. J Biomed Mater Res 90A: 931-939, 2009
C1 [Feyerabend, Frank; Willumeit, Regine] GKSS Forschungszentrum Geesthacht GmbH, Dept Macromol Struct Res, Inst Mat Res, D-21502 Geesthacht, Germany.
   [Siemers, Carsten; Roesler, Joachim] Tech Univ Carolo Wilhelmina Braunschweig, Inst Mat Sci, D-38106 Braunschweig, Germany.
RP Feyerabend, F (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Dept Macromol Struct Res, Inst Mat Res, Max Planck Str 1, D-21502 Geesthacht, Germany.
EM frank.feyerabend@gkss.de
RI Feyerabend, Frank/A-1124-2010; Willumeit, Regine/I-8029-2013
OI Feyerabend, Frank/0000-0001-9532-0207; Willumeit,
   Regine/0000-0002-6004-6946
FU EU [HPRN-CT-2002-00198/DEFINO]
FX Contract grant sponsor: EU (project HPRN-CT-2002-00198/DEFINO)
CR Behets GJ, 2004, J AM SOC NEPHROL, V15, P2219, DOI 10.1097/01.ASN.0000133022.32912.95
   Bervoets ARJ, 2006, BONE, V38, P803, DOI 10.1016/j.bone.2005.11.022
   Cen HW, 2006, CHEMOSPHERE, V62, P810, DOI 10.1016/j.chemosphere.2005.05.008
   COURT SA, 1988, ACTA METALL MATER, V36, P1585, DOI 10.1016/0001-6160(88)90226-X
   Dai YC, 2002, IN VITRO CELL DEV-AN, V38, P373
   Damment SJP, 2005, MUTAGENESIS, V20, P29, DOI 10.1093/mutage/gei003
   DAS T, 1988, BIOL TRACE ELEM RES, V18, P201, DOI 10.1007/BF02917504
   Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5
   Gallagher JA, 2003, METH MOLEC MED, V80, P3
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7
   JACKSON AG, 1988, MATER SCI ENG, V98, P239, DOI 10.1016/0025-5416(88)90162-0
   Ji YJ, 2000, BIOMED ENVIRON SCI, V13, P287
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   KONITZER DG, 1984, P INT C RAP QUENCH M, V5, P953
   Li FB, 2005, CHEMOSPHERE, V59, P787, DOI 10.1016/j.chemosphere.2004.11.019
   Li YW, 2005, BIOMATERIALS, V26, P1081, DOI 10.1016/j.biomaterials.2004.04.018
   PETERS M, 2002, TITAN TITANLEGIERUNG, P528
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002
   ROSLER J, 2005, Patent No. 10332078
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   Southwick FS, 2003, CELL MOTIL CYTOSKEL, V54, P41, DOI 10.1002/cm.10083
   Tanaka A, 1989, J Osaka Dent Univ, V23, P111
   Tanaka T, 2004, LANGMUIR, V20, P5160, DOI 10.1021/la049681s
   Tanaka T, 2002, BBA-BIOMEMBRANES, V1564, P173, DOI 10.1016/S0005-2736(02)00444-3
   Tanaka T, 2001, BBA-BIOMEMBRANES, V1515, P189, DOI 10.1016/S0005-2736(01)00413-8
   Tsaryk R, 2007, BIOMATERIALS, V28, P806, DOI 10.1016/j.biomaterials.2006.09.033
   Wang K, 1999, COORDIN CHEM REV, V190, P297, DOI 10.1016/S0010-8545(99)00072-7
   Williams D, 2001, Med Device Technol, V12, P8
   Yasakau KA, 2006, J PHYS CHEM B, V110, P5515, DOI 10.1021/jp0560664
   Yu SW, 2005, J CELL BIOCHEM, V94, P508, DOI 10.1002/jcb.20303
NR 35
TC 12
Z9 12
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2009
VL 90A
IS 3
BP 931
EP 939
DI 10.1002/jbm.a.32151
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 482CB
UT WOS:000268860100032
PM 18646202
DA 2018-10-20
ER

PT J
AU Dobner, S
   Bezuidenhout, D
   Govender, P
   Zilla, P
   Davies, N
AF Dobner, Stephan
   Bezuidenhout, Deon
   Govender, Padmini
   Zilla, Peter
   Davies, Neil
TI A Synthetic Non-degradable Polyethylene Glycol Hydrogel Retards Adverse
   Post-infarct Left Ventricular Remodeling
SO JOURNAL OF CARDIAC FAILURE
LA English
DT Article
DE Myocardial infarction biomaterial
ID ACUTE MYOCARDIAL-INFARCTION; CONGESTIVE-HEART-FAILURE; TRIAL;
   DYSFUNCTION; MATRIX; MORBIDITY; MORTALITY; DELIVERY; COLLAGEN; MODEL
AB Background: Left ventricular remodeling after myocardial infarction is a key component of heart failure and it has long been postulated that it may result from increased wall stress. It has recently been suggested that an injectable, non-degradable polymer may limit pathological remodeling in a manner analogous to that of cardiac support devices. We have tested a non-degradable polyethylene glycol (PEG) gel in a rat infarction model.
   Methods and Results: After permanent ligation of the left anterior descending artery in male Wistar rats, PEG gel reagents were injected into the infarcted region and polymerized in situ. At 4 weeks, fractional shortening and infarct volume were unchanged relative to a saline injected control, but the infarct-induced left ventricular end-diastolic diameter (LVEDD) increase was substantially reduced (43%, P < .05) and wall thinning was completely prevented. At 13 weeks, the LVEDD were similar for both saline- and PEG-injected hearts. The non-degradable PEG gels did elicit a macrophage-based inflammatory reaction.
   Conclusions: The injection of non-degradable synthetic gel was effective in ameliorating pathological remodeling in the immediate postinfarction healing phase, but was unable to prevent the dilation that occurred at later stages in the healed heart. (J Cardiac Fail 2009;15:629-636)
C1 [Dobner, Stephan; Bezuidenhout, Deon; Govender, Padmini; Zilla, Peter; Davies, Neil] Univ Cape Town, Cardiovasc Res Unit, Chris Barnard Div Cardiothorac Surg, Dept Hlth Sci, ZA-7925 Cape Town, South Africa.
RP Davies, N (reprint author), Univ Cape Town, Cardiovasc Res Unit, Chris Barnard Div Cardiothorac Surg, Dept Hlth Sci, 203 Cape Heart Ctr,Anzio Rd, ZA-7925 Cape Town, South Africa.
EM Neil.Davies@uct.ac.za
RI Bezuidenhout, Deon/B-8656-2009
OI Bezuidenhout, Deon/0000-0001-8052-7491
FU Medtronic Inc.; Technology and Human Resources for Industry Program
   (THRIP [TP2007080700007]; National Research Foundation, South Africa
FX Supported by collaborative funding from Medtronic Inc., and by a grant
   from the Technology and Human Resources for Industry Program (THRIP)
   TP2007080700007, National Research Foundation, South Africa.
CR BALL SG, 1993, LANCET, V342, P821
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496
   Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1
   GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573
   GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079
   HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   KONSTAM MA, 1993, CIRCULATION, V88, P2277, DOI 10.1161/01.CIR.88.5.2277
   Konstam MA, 2005, AM J CARDIOL, V96, P867, DOI 10.1016/j.amjcard.2005.05.037
   Konstam MA, 2002, J CARD FAIL, V8, pS506, DOI 10.1054/jcaf.2002.130303
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacMahon S, 1997, LANCET, V349, P375
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546
   McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3
   McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4
   Nicolosi GL, 1996, EUR HEART J, V17, P1646
   Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007
   Tirelli N, 2002, J Biotechnol, V90, P3
   Twardowski T, 2007, CURR PHARM DESIGN, V13, P3608, DOI 10.2174/138161207782794176
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 41
TC 81
Z9 84
U1 0
U2 15
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 1071-9164
EI 1532-8414
J9 J CARD FAIL
JI J. Card. Fail.
PD SEP
PY 2009
VL 15
IS 7
BP 629
EP 636
DI 10.1016/j.cardfail.2009.03.003
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 493RN
UT WOS:000269755700011
PM 19700140
DA 2018-10-20
ER

PT J
AU Yang, TL
   Young, TH
AF Yang, Tsung-Lin
   Young, Tai-Horng
TI Chitosan cooperates with mesenchyme-derived factors inregulating
   salivary gland epithelial morphogenesis
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE chitosan; salivary gland; epithelium; morphogenesis; branching
ID MEMBRANE-LIKE SUBSTRATUM; BRANCHING MORPHOGENESIS; SUBMANDIBULAR-GLAND;
   IN-VITRO; GROWTH-FACTOR; EMBRYONIC MICE; MAMMARY-GLAND; MOUSE;
   DERIVATIVES; CELLS
AB Chitosan is a widely used biocompatible biomaterial in the tissue regeneration, but its utility and application in the tissue morphogenesis of salivary gland remains unclear. The study aimed to explore the effects of chitosan on the epithelial morphogenesis of submandibular gland (SMG). With chitosan, the branching morphogenesis of the whole SMG explant was facilitated, and the morphogenetic-promoting effects of mesenchymal tissue on SMG were further enhanced. Furthermore, chitosan was competent to induce recombined SMG epithelium to form branches in the serum-free condition independently. In the presence of chitosan, the morphogenetic efficacy of mesenchyme-derived growth factors responsible for epithelial morphogenesis including fibroblast growth factors 7, fibroblast growth factor 10 and hepatocyte growth factor increased. The specific epithelial phenotype induced by individual growth factor, which was required for the accomplishment of salivary epithelial morphogenesis, was promoted by chitosan. Moreover, the proliferative and the chemotactic properties of these growth factors towards the SMG epithelia were also reinforced by chitosan. Therefore, in orchestrating and intensifying the essential mesenchyme-derived growth factors, chitosan is versatile in mediating SMG epithelium to form a predetermined phenotype more efficiently and comprehensively. This study suggested that chitosan is a morphogenetic-regulating biomaterial for salivary tissue, which might be useful for the future salivary gland investigation and regeneration.
C1 [Yang, Tsung-Lin; Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
   [Yang, Tsung-Lin; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Yang, Tsung-Lin] Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan.
   [Yang, Tsung-Lin] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Otolaryngol, Touliu, Tunlin, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
EM thyoung@ntu.edu.tw
OI YANG, TSUNG-LIN/0000-0001-6521-8631
FU National Science Council of the Republic of China; National Taiwan
   University Hospital
FX The authors thank National Science Council of the Republic of China and
   National Taiwan University Hospital for their financial support of this
   research.
CR BALL WD, 1974, J EXP ZOOL, V188, P277, DOI 10.1002/jez.1401880304
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   BERNFIELD MR, 1972, J CELL BIOL, V52, P664, DOI 10.1083/jcb.52.3.664
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Hieda Y, 1997, DEV GROWTH DIFFER, V39, P1
   Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172
   Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039
   Hosokawa Y, 1999, DEV GROWTH DIFFER, V41, P207
   Ikari T, 2003, DEV DYNAM, V228, P173, DOI 10.1002/dvdy.10377
   Ishihara Masayuki, 2006, Current Drug Delivery, V3, P351, DOI 10.2174/156720106778559047
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Iwai K, 1998, DEV GROWTH DIFFER, V40, P327
   Jaskoll T, 2001, BMC Dev Biol, V1, P5, DOI 10.1186/1471-213X-1-5
   Kadoya Yuichi, 2005, Anatomical Science International, V80, P71, DOI 10.1111/j.1447-073x.2005.00102.x
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   KRATOCHWIL K, 1969, DEV BIOL, V20, P46, DOI 10.1016/0012-1606(69)90004-9
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079
   Le Visage C, 2004, TISSUE ENG, V10, P1426, DOI 10.1089/1076327042500247
   LU S, 2004, J APPL POLYM SCI, V91, P1357
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Masuoka K, 2005, BIOMATERIALS, V26, P3277, DOI 10.1016/j.biomaterials.2004.07.061
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Morita K, 1999, DEV DYNAM, V215, P148
   NAKANISHI Y, 1993, DEV GROWTH DIFFER, V35, P371
   NOGAWA H, 1991, DEVELOPMENT, V112, P855
   Noguchi Y, 2006, DEV DYNAM, V235, P403, DOI 10.1002/dvdy.20651
   Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x
   Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7
   SAKAKURA T, 1976, SCIENCE, V194, P1439, DOI 10.1126/science.827022
   Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   TAKAHASHI Y, 1991, DEVELOPMENT, V111, P327
   THOMPSON HA, 1982, DEV BIOL, V89, P417, DOI 10.1016/0012-1606(82)90330-X
   Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006
   TYLER MS, 1977, J EMBRYOL EXP MORPH, V38, P37
   Umeda Y, 2001, DEV BIOL, V237, P202, DOI 10.1006/dbio.2001.0351
   Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305
   Warde P, 2002, INT J RADIAT ONCOL, V54, P9, DOI 10.1016/S0360-3016(02)02890-0
   Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123
   Xie WM, 2001, BIOORG MED CHEM LETT, V11, P1699, DOI 10.1016/S0960-894X(01)00285-2
   Yang TL, 2008, BIOMATERIALS, V29, P2501, DOI 10.1016/j.biomaterials.2008.02.014
NR 45
TC 11
Z9 11
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1582-1838
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD SEP
PY 2009
VL 13
IS 9A
BP 2853
EP 2863
DI 10.1111/j.1582-4934.2008.00425.x
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 528JH
UT WOS:000272439700010
PM 18627424
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Garrocho-Rangel, A
   Flores, H
   Silva-Herzog, D
   Rosales-Ibanez, R
   Pozos-Guillen, AJ
AF Garrocho-Rangel, Arturo
   Flores, Hector
   Silva-Herzog, Daniel
   Rosales-Ibanez, Raul
   Pozos-Guillen, Amaury J.
TI Direct Pulp Capping in Primary Molars with Enamel Matrix Derivative:
   Report of a Case
SO JOURNAL OF CLINICAL PEDIATRIC DENTISTRY
LA English
DT Article
DE direct pulp capping; primary molars; enamel matrix derivative
ID PERIODONTAL-LIGAMENT CELLS; PRIMARY TEETH; REPARATIVE DENTIN
AB Enamel Matrix Derivative (EMD) is a rich amelogenin and amelin biomaterial that has been demonstrated to induce a reparative process similar to normal odontogenesis when placed in contact with pulp tissue. However; its effects in pulp capping on primacy teeth has not been previously reported. The aim of the present case report is to present the favorable clinical and radiographic findings of a primary molar treated with direct pulp capping (DPC) and using EMD as capping material in a 6-year-old girl. Results: After 12 months, there was no sign or symptom indicative of treatment failure, such as pain, gingival swelling, sinus tract, sensitivity to percussion or palpation, abnormal mobility, widening of periodontal space, internal or external root resorption, or supporting bone or furcal area radiolucencies.
C1 [Garrocho-Rangel, Arturo; Rosales-Ibanez, Raul; Pozos-Guillen, Amaury J.] Univ Autonoma San Luis Potosi, Fac Estomatol, Pediat Dent Postgrad Program, San Luis Protosi 78290, Mexico.
   [Flores, Hector; Silva-Herzog, Daniel] Univ Autonoma San Luis Potosi, Fac Estomatol, Endodont Postgrad Program, San Luis Protosi 78290, Mexico.
RP Pozos-Guillen, AJ (reprint author), Univ Autonoma San Luis Potosi, Fac Estomatol, Pediat Dent Postgrad Program, Av Dr Manuel Nava 2,Zona Univ, San Luis Protosi 78290, Mexico.
EM apozos@uaslp.mx
OI Pozos-Guillen, Amaury/0000-0003-2314-8465
CR BECERRA L, 2005, ODONTOPEDIATRIA BASE
   BRITTO LR, 2002, REV FAC ODONTOL BAUR, V10, P201
   ESPOSITO M, 2005, COCHRANE DB SYST REV, V19
   FUKS A, 2000, DENT CLINICS N AM
   Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Igarashi R, 2003, J ELECTRON MICROSC, V52, P227, DOI 10.1093/jmicro/52.2.227
   Ishizaki NT, 2003, J ENDODONT, V29, P176, DOI 10.1097/00004770-200303000-00003
   KENNEDY D, 1989, ODONTOLOGIA PEDIAT
   KOPEL HM, 1992, J DENT CHILD, V59, P141
   Kopel HM, 1997, J DENT CHILD, V64, P327
   Lyngstadaas SP, 2001, J CLIN PERIODONTOL, V28, P181, DOI 10.1034/j.1600-051x.2001.028002181.x
   Murray PE, 2003, INT ENDOD J, V36, P106, DOI 10.1046/j.1365-2591.2003.00632.x
   Nakamura Y, 2001, Adv Dent Res, V15, P105
   Nakamura Y, 2002, INT ENDOD J, V35, P407, DOI 10.1046/j.1365-2591.2002.00556.x
   OLSSON H, 2005, INT ENDOD J, V38, P189
   Papagerakis P, 2003, BONE, V32, P228, DOI 10.1016/S8756-3282(02)00978-X
   Sabbarini J, 2007, PEDIATR DENT, V29, P475
   Tuna D, 2008, INT ENDOD J, V41, P273, DOI 10.1111/j.1365-2591.2007.01339.x
   TURNER C, 1987, J DENT CHILD, V54, P423
   Wilson TG, 1999, PERIODONTAL REGENERA
   YAMAMURA T, 1985, J DENT RES, V64, P530, DOI 10.1177/002203458506400406
NR 23
TC 1
Z9 1
U1 0
U2 3
PU JOURNAL PEDODONTICS INC
PI BIRMINGHAM
PA 5724 HIGHWAY 280 EAST, BIRMINGHAM, AL 35242 USA
SN 1053-4628
J9 J CLIN PEDIATR DENT
JI J. Clin. Pediatr. Dent.
PD FAL
PY 2009
VL 34
IS 1
BP 9
EP 12
DI 10.17796/jcpd.34.1.n318h1j671741161
PG 4
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA 517BY
UT WOS:000271589000002
PM 19953802
DA 2018-10-20
ER

PT J
AU Thorstenson, JB
   Petersen, LK
   Narasimhan, B
AF Thorstenson, Jon B.
   Petersen, Latrisha K.
   Narasimhan, Balaji
TI Combinatorial/High Throughput Methods for the Determination of
   Polyanhydride Phase Behavior
SO JOURNAL OF COMBINATORIAL CHEMISTRY
LA English
DT Article
ID DRUG-DELIVERY; BIOERODIBLE POLYANHYDRIDES; COPOLYMERS;
   PHOTOPOLYMERIZATION; DEGRADATION; MORPHOLOGY; SCATTERING; POLYMERS;
   BLENDS
AB Combinatorial methods have been developed to study the phase behavior of biodegradable polyanhydrides for drug delivery applications. The polyanhydrides of interest are poly[1,6-bis(p-carboxyphenoxy) hexane] (CPH) and poly[sebacic anhydride] (SA). Both continuous and discrete polymer blend libraries were fabricated by using it combination of solution-based gradient deposition and rapid prototyping. Blend compositions were characterized via a high throughput transmission Fourier transform infrared (FTIR) sampling technique and compared against theoretical mass balance predictions. To obtain phase diagrams of CPH/SA, the effect of blend composition and annealing temperature oil the miscibility of the blend was studied. This gradient library was observed with optical microscopy in order to determine Cloud points. These results were compared with it theoretical phase diagram obtained from Flory-Huggins theory and with atomic force microscopy (AFM) experiments on blend libraries and the agreement between the methods was very good. The high throughput method demonstrates that the CPH/USA system exhibits upper critical Solution temperature behavior These libraries are amenable to other high throughput applications in biomaterials science including cell viability, cell activation, and protein/biomaterial interactions.
C1 [Thorstenson, Jon B.; Petersen, Latrisha K.; Narasimhan, Balaji] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
RP Narasimhan, B (reprint author), Iowa State Univ, Dept Chem & Biol Engn, 2035 Sweeney Hall, Ames, IA 50011 USA.
RI Narasimhan, Balaji/A-5487-2008
OI Narasimhan, Balaji/0000-0002-7955-5353
FU Institute for Combinatorial Discovery at Iowa State University
FX The authors acknowledge financial support from the Institute for
   Combinatorial Discovery at Iowa State University.
CR Cabral JT, 2005, MEAS SCI TECHNOL, V16, P191, DOI 10.1088/0957-0233/16/1/025
   Cabral JT, 2004, LANGMUIR, V20, P10020, DOI 10.1021/la049501e
   Conix A, 1966, MACROMOL SYNTHESES, V2, P95
   DEVORE JL, 2000, PROBABILITY STAT ENG, P1
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   Eidelman N, 2004, J RES NATL INST STAN, V109, P219, DOI 10.6028/jres.109.014
   Gorga RE, 2002, J POLYM SCI POL PHYS, V40, P255, DOI 10.1002/polb.10090
   Harrison C, 2004, J MICROMECH MICROENG, V14, P153, DOI 10.1088/0960-1317/14/1/021
   Khoury C, 2002, LAB CHIP, V2, P50, DOI 10.1039/b109344d
   Kipper MJ, 2005, MACROMOLECULES, V38, P1989, DOI 10.1021/ma047661r
   Kipper MJ, 2005, MACROMOLECULES, V38, P8468, DOI 10.1021/ma051267r
   Kipper MJ, 2005, J POLYM SCI POL PHYS, V43, P463, DOI 10.1002/polb.20351
   Kipper MJ, 2004, POLYMER, V45, P3329, DOI 10.1016/j.polymer.2004.03.052
   Kipper MJ, 2002, BIOMATERIALS, V23, P4405, DOI 10.1016/S0142-9612(02)00181-3
   Larobina D, 2002, AICHE J, V48, P2960, DOI 10.1002/aic.690481221
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   Leugers A, 2003, J COMB CHEM, V5, P238, DOI 10.1021/cc0200944
   Martin TP, 2006, CHEM VAPOR DEPOS, V12, P685, DOI 10.1002/cvde.200606495
   Meredith JC, 2000, MACROMOLECULES, V33, P5760, DOI 10.1021/ma0004662
   Narasimhan B, 2004, ADV CHEM EN, V29, P169, DOI 10.1016/S0065-2377(03)29006-2
   PEPPAS NA, 1994, SCIENCE, V263, P5154
   Shen E, 2001, BIOMATERIALS, V22, P201, DOI 10.1016/S0142-9612(00)00175-7
   Shen E, 2002, J CONTROL RELEASE, V82, P115, DOI 10.1016/S0168-3659(02)00125-6
   Simon CG, 2004, MACROMOL RAPID COMM, V25, P2003, DOI 10.1002/marc.200400395
   SIMON CG, 2005, BIOMATERIALS, V26, P6909
   Sormana JL, 2004, MACROMOLECULES, V37, P2186, DOI 10.1021/ma035385v
   VOGEL B, 2005, J COMB CHEM, P7921
NR 27
TC 10
Z9 10
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-4766
J9 J COMB CHEM
JI J. Comb. Chem.
PD SEP-OCT
PY 2009
VL 11
IS 5
BP 820
EP 828
DI 10.1021/cc900039k
PG 9
WC Chemistry, Applied; Chemistry, Medicinal; Chemistry, Multidisciplinary
SC Chemistry; Pharmacology & Pharmacy
GA 492LB
UT WOS:000269656500008
PM 19691268
OA Green Published
DA 2018-10-20
ER

PT J
AU Ripamonti, U
   Ferretti, C
   Teare, J
   Blann, L
AF Ripamonti, Ugo
   Ferretti, Carlo
   Teare, June
   Blann, Leandra
TI Transforming Growth Factor-beta Isoforms and the Induction of Bone
   Formation: Implications for Reconstructive Craniofacial Surgery
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Review
DE Bone induction; bone morphogenetic proteins; transforming growth
   factor-beta proteins; smart biomimetic matrices; muscle-derived stem
   cells; myoendothelial cells; tissue engineering
ID PRIMATE PAPIO-URSINUS; PERIODONTAL TISSUE REGENERATION; HUMAN OSTEOGENIC
   PROTEIN-1; MUSCLE-DERIVED CELLS; MEDIATED GENE-THERAPY; STEM-CELLS;
   ENDOCHONDRAL BONE; MORPHOGENETIC PROTEIN; RECAPITULATING DEVELOPMENT;
   EXTRACELLULAR-MATRIX
AB Cranicfacial skeletal reconstruction remains a challenging problem despite major molecular and surgical developments in the understanding of bone formation by induction. The induction of bone formation has been a critical topic of research across the planet. The bone induction principle identified important cues for tissue engineering of bone, namely, osteogenic soluble molecular signals, the bone morphogenetic and osteogenic proteins, and insoluble signals or substrata including biomimetic bioactive matrices and responding stem cells. In primates, and in primates only, the osteogenic soluble molecular signals that initiate the induction of bone formation additionally include the 3 mammalian transforming growth factor-beta (TGF-beta) isoforms, members of the TGF-beta supergene family. The mammalian TGF-beta isoforms, when implanted in the rectus abdominis muscle of the nonhuman primate Papio ursinus, induce rapid and substantial endochondral bone formation resulting in large corticalized ossicles by day 30 after heterotopic implantation; in calvarial defects of the same nonhuman primates, identical or higher doses of the TGF-beta protein do not induce bone formation because of the overexpression of Smad-6 and Smad-7, gene product inhibitors of the TGF-beta signaling pathway. The addition of minced fragments of autogenous rectus abdominis muscle partially restores the osteoinductive activity of the human TGF-beta(3) isoform resulting in the induction of bone formation in the treated calvarial defects. Recombinant human TGF-beta(3) delivered by Matrigel matrix and implanted in class II and III furcation defects of mandibular molars of P ursinus induce periodontal tissue regeneration. The addition of minced fragments of autogenous rectus abdominis muscle significantly enhances cementogenesis. This review highlights the induction of bone formation by the osteogenic proteins of the TGF-beta superfamily in the nonhuman primate P ursinus and reviews combinatorial applications of myoblastic/myogenic stem cell-based therapeutics for bone induction and morphogenesis. The recruitment of myoendothelial cells is also discussed in the light of the intrinsic and spontaneous induction of bone formation by smart biomaterial matrices that induce bone differentiation in heterotopic extraskeletal sites of P. ursinus without the exogenous application of the osteogenic soluble molecular signals of the TGF-beta superfamily.
C1 [Ripamonti, Ugo] Univ Witwatersrand, Bone Res Unit, Sch Med, ZA-2193 Johannesburg, South Africa.
RP Ripamonti, U (reprint author), Univ Witwatersrand, Bone Res Unit, Sch Med, 7 York Rd, ZA-2193 Johannesburg, South Africa.
EM ugo.ripamonti@wits.ac.za
FU South African Medical Research Council; University of the Witwatersrand,
   Johannesburg
FX This work on "Bone: Formation by Autoinduction" has been continuously
   supported by the South African Medical Research Council and the
   University of the Witwatersrand, Johannesburg, since 1994 when opening
   the Bone Research Laboratory attached to the medical school of the
   university The authors thank the doctoral and postdoctoral students,
   scientists, technologists, research officers, and visiting professors
   from Europe and the United States for significantly contributing to the
   pleiotropic discoveries of the now Bone Research Unit. In particular,
   the authors thank M. R. Urist, A. H. Reddi, and B. van den Heever for
   the introduction to the fascinating phenomenon of "Bone: Formation by
   Autoinduction" and for establishing unique undecalcified histology and
   microphotography; techniques, respectively The authors thank the
   Materials Science & Manufacturing Technology group of the Council for
   Scientific and Industrial Research (Pretoria) for the preparation of the
   biomimetic bioceramic matrices for heterotopic and orthotopic
   implantation in P. ursinus.
CR Cooper GM, 2009, PLAST RECONSTR SURG, V123, p94S, DOI 10.1097/PRS.0b013e318191c05b
   Corsi K, 2004, CURR GENOMICS, V5, P7, DOI 10.2174/1389202043490005
   Dal Mas I, 2007, J CELL MOL MED, V11, P852
   Deasy BM, 2004, CURR OPIN BIOTECH, V15, P419, DOI 10.1016/j.copbio.2004.08.004
   Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169
   Duneas N, 1998, GROWTH FACTORS, V15, P259, DOI 10.3109/08977199809017482
   Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x
   FOLKMAN J, 1988, AM J PATHOL, V130, P393
   Friedlaender GE, 2001, J BONE JOINT SURG S1, V83, P151
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Gazzerro E, 2007, J BIOL CHEM, V282, P31549, DOI 10.1074/jbc.M701317200
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Habal MB, 2008, J CRANIOFAC SURG, V19, P1193, DOI 10.1097/SCS.0b013e318186a8a1
   Habal MB, 2009, J CRANIOFAC SURG, V20, P4, DOI 10.1097/SCS.0b013e31819551f8
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Heliotis M, 2006, INT J ORAL MAX SURG, V35, P265, DOI 10.1016/j.ijom.2005.07.013
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Kimelman N, 2007, TISSUE ENG, V13, P1135, DOI 10.1089/ten.2007.0096
   Lavender G, 1938, SURG GYNECOL OBSTET, V67, P705
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Lensch MW, 2006, STEM CELL REV, V2, P185, DOI 10.1007/s12015-006-0047-2
   LEVANDER G, 1945, NATURE, V155, P148, DOI 10.1038/155148a0
   LEVANDER G, 1946, NATURE, V3992, P587
   Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4
   Lu HH, 2003, BIOCHEM BIOPH RES CO, V305, P882, DOI 10.1016/S0006-291X(03)00858-1
   Miyazono K, 2000, J CELL SCI, V113, P1101
   Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6
   Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080
   MOSS ML, 1958, SCIENCE, V127, P755, DOI 10.1126/science.127.3301.755
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   NOGAMI H, 1975, CALC TISS RES, V19, P153, DOI 10.1007/BF02563999
   Onichtchouk D, 1999, NATURE, V401, P480
   OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x
   PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D
   PARALKAR VM, 1990, J BIOL CHEM, V265, P17281
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REDDI AH, 1984, EXTRACELLULAR MATRIX, P375
   REDDI AH, 1994, J CELL BIOCHEM, V65, P147
   REDDI AH, 1997, CELL, V89, P309
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   Ripamonti U, 2000, GROWTH FACTORS, V17, P269, DOI 10.3109/08977190009028971
   Ripamonti U, 1996, J BONE MINER RES, V11, P938
   Ripamonti U, 1997, J BONE MINER RES, V12, P1584, DOI 10.1359/jbmr.1997.12.10.1584
   Ripamonti U, 2007, TISSUE ENG, V13, P51, DOI 10.1089/ten.2006.0167
   Ripamonti U, 2005, J CELL MOL MED, V9, P911, DOI 10.1111/j.1582-4934.2005.tb00388.x
   Ripamonti U, 2006, BIOMATERIALS, V27, P807, DOI 10.1016/j.biomaterials.2005.09.021
   Ripamonti U, 2004, SKELETON: BIOCHEMICAL, GENETIC, AND MOLECULAR INTERACTIONS IN DEVELOPMENT AND HOMEOSTASIS, P217
   Ripamonti U, 2004, J CELL MOL MED, V8, P169, DOI 10.1111/j.1582-4934.2004.tb00272.x
   Ripamonti U, 2002, S AFR J SCI, V98, P361
   Ripamonti U, 2009, J PERIODONTAL RES, V44, P141, DOI 10.1111/j.1600-0765.2008.01158.x
   Ripamonti U, 2008, J CELL MOL MED, V12, P2609, DOI 10.1111/j.1582-4934.2008.00312.x
   Ripamonti U, 2009, J PERIODONTAL RES, V44, P81, DOI 10.1111/j.1600-0765.2008.01086.x
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   RIPAMONTI U, 1993, MATRIX, V13, P491, DOI 10.1016/S0934-8832(11)80115-0
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Ripamonti U, 2000, J BONE MINER RES, V15, P1798, DOI 10.1359/jbmr.2000.15.9.1798
   Ripamonti U, 2008, PLASTIC SURG INDICAT, P363
   RIPAMONTI U, 1996, BONE MORPHOGENETIC P, P131
   RIPAMONTI U, 2007, PLAST RECONSTR SURG, V120, P1
   RIPAMONTI U, 2001, J BONE JOINT SURG AM, V83, P16
   RIPAMONTI U, 2004, PHARM BIOTECHNOLOGY, P281
   Ripamonti U., 2006, P 6 INT C BON MORPH, P1
   RIPAMONTI U, 2004, ENCY HORMONES, P80
   RIPAMONTI U, 1995, ADV PLAST RECONSTR S, V11, P47
   Ripamonti U., 1990, HDB BIOACTIVE CERAMI, VII, P245
   Ripamonti Ugo, 2007, Oral Maxillofac Surg Clin North Am, V19, P575, DOI 10.1016/j.coms.2007.07.006
   Ripamonti U, 2008, J CELL MOL MED, V12, P1029, DOI 10.1111/j.1582-4934.2007.00126.x
   Ripamonti U, 2006, J ANAT, V209, P447, DOI 10.1111/j.1469-7580.2006.00635.x
   Ripamonti U, 2009, J CELL MOL MED, V13, P2953, DOI 10.1111/j.1582-4934.2008.00562.x
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   SAMPATH TK, 1993, P NATL ACAD SCI USA, V90, P6004, DOI 10.1073/pnas.90.13.6004
   SAMPATH TK, 1981, P NATL ACAD SCI USA, V78, P75599
   SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V52, P447, DOI 10.1007/BF00571335
   Shen HC, 2004, BONE, V34, P982, DOI 10.1016/j.bone.2004.01.028
   Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031
   Spemann H., 1938, EMBRYONIC DEV INDUCT
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Stupp SI, 2005, MRS BULL, V30, P546, DOI 10.1557/mrs2005.148
   Sun JS, 2005, BIOMATERIALS, V26, P3953, DOI 10.1016/j.biomaterials.2004.10.016
   Teare JA, 2008, J PERIODONTAL RES, V43, P1, DOI 10.1111/j.1600-0765.2007.00987.x
   Thomadakis G, 1999, EUR J ORAL SCI, V107, P368, DOI 10.1046/j.0909-8836.1999.eos107508.x
   TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402
   Turgeman G, 2002, CURR OPIN MOL THER, V4, P390
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Urist MR, 1968, CLIN ORTHOP RELAT R, V59, P243
   Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Young BH, 2002, CLIN ORTHOP S, V403, P243
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334
NR 101
TC 44
Z9 47
U1 1
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD SEP
PY 2009
VL 20
IS 5
BP 1544
EP 1555
DI 10.1097/SCS.0b013e3181b09ca6
PG 12
WC Surgery
SC Surgery
GA 501GK
UT WOS:000270369000050
PM 19816294
DA 2018-10-20
ER

PT J
AU Canales, BK
   Higgins, L
   Markowski, T
   Anderson, L
   Li, QA
   Monga, M
AF Canales, Benjamin K.
   Higgins, LeeAnn
   Markowski, Todd
   Anderson, Lorraine
   Li, Qin A.
   Monga, Manoj
TI Presence of Five Conditioning Film Proteins Are Highly Associated with
   Early Stent Encrustation
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article; Proceedings Paper
CT 26th World Congress of Endourology
CY 2008
CL Shanghai, PEOPLES R CHINA
ID TAMM-HORSFALL GLYCOPROTEIN; URETERAL STENTS; LIGHT-CHAINS; IN-VIVO;
   BIOMATERIAL; ADSORPTION; EXPRESSION; FIBRINOGEN; SURFACES; ADHESION
AB Purpose: Ureteral stents are susceptible to biofilm formation and crystal deposition, especially in stone formers. To identify proteins responsible for this accumulation, we compared conditioning film proteomes obtained from human ureteral stents with and without encrustation.
   Materials and Methods: Twenty-seven Bard Inlay (TM) hydrophilic ureteral stents were removed after ureteroscopy. Stent encrustation was quantified by visual analog score 0 ( none) to 4 ( heavy) and further categorized as nonencrusted (scores 0 and 1; n=22) or encrusted (scores 2, 3, and 4; n=5). Stent conditioning film was sampled and digested with trypsin, and peptide tandem mass spectrometry data were acquired using liquid chromatography. After protein identification, unconditional exact tests were used to compare categorical variables versus encrustation outcome. Stone analysis and follow-up metabolic urine profiles were examined to identify additional risk factors for stent encrustation.
   Results: More than 300 unique proteins with >95% confidence were identified. Proteins alpha-1 anti-trypsin, Ig kappa, IgH G1, and histone H2b and H3a were found to be highly associated with stent encrustation (p<0.05), while Tamm-Horsfall protein and histone H2a were found to have a marginal association (p<0.1). Patients with early stent encrustation were more likely to have mixed stone analysis (p=0.03) and low urinary volumes (p<0.01).
   Conclusion: Immunoglobulins and Tamm-Horsfall protein are common urinary proteins that appear to non-selectively bind early onto ureteral stent surfaces. Histones, nuclear DNA-condensing proteins, likely contribute to stent encrustation because of their unique net positive charge and may represent a potential clinical target for encrustation prevention.
C1 [Canales, Benjamin K.] Univ Florida, Dept Urol, Gainesville, FL 32610 USA.
   [Canales, Benjamin K.; Monga, Manoj] Univ Minnesota, Dept Urol, Minneapolis, MN USA.
   [Higgins, LeeAnn; Markowski, Todd; Anderson, Lorraine] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA.
   [Li, Qin A.] Univ Florida, Dept Epidemiol & Hlth Policy Res, Div Biostat, Gainesville, FL 32610 USA.
RP Canales, BK (reprint author), Univ Florida, Dept Urol, 1600 SW Archer Rd,POB 100247, Gainesville, FL 32610 USA.
EM benjamin.canales@urology.ufl.edu
FU NIDDK NIH HHS [R01 DK065658-03S1]
CR Ashburner M., 2002, GENE ONTOLOGY CONSOR, V25, P25, DOI DOI 10.1038/75556
   Canales BK, 2008, J ENDOUROL, V22, P1161, DOI 10.1089/end.2007.0440
   Chew BH, 2004, NAT CLIN PRACT UROL, V1, P44, DOI 10.1038/ncpuro0014
   Choong S, 2000, BJU INT, V86, P935, DOI 10.1046/j.1464-410x.2000.00949.x
   Eisenberg D, 2003, P NATL ACAD SCI USA, V100, P11207, DOI 10.1073/pnas.2034522100
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215
   Holmberg M, 2008, J MATER SCI-MATER M, V19, P2179, DOI 10.1007/s10856-007-3318-9
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Huang ZQ, 1997, J CLIN INVEST, V99, P732, DOI 10.1172/JCI119218
   HULTON CSJ, 1990, CELL, V63, P631, DOI 10.1016/0092-8674(90)90458-Q
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kapphahn RJ, 2003, BIOCHEMISTRY-US, V42, P15310, DOI 10.1021/bi034774e
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   Klassen RBS, 2005, J APPL PHYSIOL, V98, P257, DOI 10.1152/japplphysiol.01090.2003
   Mouzakis DE, 2006, J ENDOUROL, V20, P64, DOI 10.1089/end.2006.20.64
   Riedl CR, 1999, EUR UROL, V36, P53, DOI 10.1159/000019927
   Santin M, 1999, BIOMATERIALS, V20, P1245, DOI 10.1016/S0142-9612(99)00026-5
   Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6
   THOMAS DBL, 1993, KIDNEY INT, V44, P423, DOI 10.1038/ki.1993.260
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yates JR, 2004, BIOTECHNIQUES, V36, P917, DOI 10.2144/04366TE01
NR 23
TC 17
Z9 18
U1 1
U2 6
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD SEP
PY 2009
VL 23
IS 9
BP 1437
EP 1442
DI 10.1089/end.2009.0389
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 492CW
UT WOS:000269633000014
PM 19698053
OA Green Published
DA 2018-10-20
ER

PT J
AU Kim, EJ
   Shim, G
   Kim, K
   Kwon, IC
   Oh, YK
   Shim, CK
AF Kim, Eun-Joong
   Shim, Gayong
   Kim, Kwangmyeung
   Kwon, Ick Chan
   Oh, Yu-Kyoung
   Shim, Chang-Koo
TI Hyaluronic acid complexed to biodegradable poly L-arginine for targeted
   delivery of siRNAs
SO JOURNAL OF GENE MEDICINE
LA English
DT Article
DE biodegradable cationic polymer; hyaluronic acid; poly L-arginine; siRNA
   delivery
ID INTERFERING RNA DELIVERY; DRUG-DELIVERY; THERAPEUTICS; NANOPARTICLES;
   CYTOTOXICITY; DOXORUBICIN; RECEPTOR; SYSTEM; CELLS; CD44
AB Background Small interfering RNA (siRNA) has been recognized as a new therapeutic drug to treat various diseases by inhibition of oncogene or viral gene expression. Because hyaluronic acid (HA) has been described as a biocompatible biomaterial, we tested the nanoparticles formed by electrostatic complexation of negatively-charged HA and cationic Poly L-arginine (PLR) for siRNA delivery systems.
   Methods Different electrostatic complexes of HA and PLR (HPs) were formulated: HP101 with 50% (w/w) HA and HP110 with 9% (w/w) HA.
   Results Gel retardation assays showed that HP101 and HP110 could form complexes with siRNAs. The diameters of these complexes were less than 200 nm. Cellular delivery efficiency of siRNAs by HPs depended on cell surface CD44 density. The HP-mediated delivery of siRNAs was highest in WM266.4 cells followed by B16F10 cells and COS-7 cells, in parallel with CD44 surface densities of these cell lines. TC(50) values (i.e. the HP concentrations at which 50% of cells were viable after treatment) were used as indicators of cytotoxicity. HP101 showed TC50 values that were 2-fold and 23-fold higher than those of HP110 and PLR, respectively. After delivery into cells, siRNA exerted target-specific RNA interference effects on mRNA and protein levels. Three days after treatment of red fluorescent protein (RFP)-expressing B16F10 cells with RFP-specific siRNA complexed to HP101, cellular fluorescence signals were reduced. intratumoral administration of RFP-specific siRNA via HP101 delivery significantly reduced the expression of RFP in tumor tissues.
   Conclusions HP101 may function as a biocompatible polymeric carrier of siRNAs and have possible application to localized siRNA delivery in vivo. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Shim, Gayong; Oh, Yu-Kyoung] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136713, South Korea.
   [Kim, Eun-Joong; Shim, Chang-Koo] Seoul Natl Univ, Coll Pharm, Natl Res Lab Transporters, Res Inst Pharmaceut Sci, Seoul, South Korea.
   [Kim, Eun-Joong; Shim, Chang-Koo] Seoul Natl Univ, Coll Pharm, Dept Pharmaceut, Seoul, South Korea.
   [Kim, Kwangmyeung; Kwon, Ick Chan] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul, South Korea.
RP Oh, YK (reprint author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136713, South Korea.
EM ohyk@korea.ac.kr; ckshim@snu.ac.kr
RI Shim, Gayong/S-5423-2017; Oh, Yu Kyoung/G-8754-2013
FU Ministry of Education, Science and Technology
   [F104AA01000308A0101-00310]; Korea Science and Engineering Foundation
   [R01-2007-000-20475-0]; National Research Laboratory
   [ROA-006-000-10290-0]
FX This study was financially supported by grants from the Ministry of
   Education, Science and Technology (F104AA01000308A0101-00310), from the
   Basic Research Program of Korea Science and Engineering Foundation
   (KOSEF R01-2007-000-20475-0) and from the National Research Laboratory
   (ROA-006-000-10290-0).
CR Bonsted Anette, 2008, V434, P171, DOI 10.1007/978-1-60327-248-3_11
   Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839
   de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310
   de la Fuente M, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI 10.1167/iovs.07-1077
   Eliaz RE, 2001, CANCER RES, V61, P2592
   Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129
   Han SE, 2009, J DRUG TARGET, V17, P123, DOI [10.1080/10611860802472461, 10.1080/10611860802472461 ]
   Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008
   Kim SH, 2009, MOL PHARMACEUT, V6, P718, DOI 10.1021/mp800161e
   Lee H, 2007, J CONTROL RELEASE, V119, P245, DOI 10.1016/j.jconrel.2007.02.011
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010
   Nguyen T, 2008, CURR OPIN MOL THER, V10, P158
   Park IK, 2007, J GENE MED, V9, P691, DOI 10.1002/jgm.1062
   Peer D, 2004, NEOPLASIA, V6, P343, DOI 10.1593/neo.03460
   Platt VM, 2008, MOL PHARMACEUT, V5, P474, DOI 10.1021/mp800024g
   Sato A, 2007, BIOMATERIALS, V28, P1434, DOI 10.1016/j.biomaterials.2006.11.010
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Sun TM, 2008, BIOMATERIALS, V29, P4348, DOI 10.1016/j.biomaterials.2008.07.036
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Vandenbroucke RE, 2008, J GENE MED, V10, P783, DOI 10.1002/jgm.1202
   Yadav AK, 2008, J DRUG TARGET, V16, P91, DOI [10.1080/10611860701794296, 10.1080/10611860802095494 ]
   Zhang SB, 2007, J CONTROL RELEASE, V123, P1, DOI 10.1016/j.jconrel.2007.07.016
NR 23
TC 41
Z9 45
U1 0
U2 35
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1099-498X
J9 J GENE MED
JI J. Gene. Med.
PD SEP
PY 2009
VL 11
IS 9
BP 791
EP 803
DI 10.1002/jgm.1352
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 497FQ
UT WOS:000270043300006
PM 19569085
OA Bronze
DA 2018-10-20
ER

PT J
AU Paulino, AT
   Guilherme, MR
   de Almeida, EAMS
   Pereira, AGB
   Muniz, EC
   Tambourgi, EB
AF Paulino, Alexandre T.
   Guilherme, Marcos R.
   de Almeida, Elisangela A. M. S.
   Pereira, Antonio G. B.
   Muniz, Edvani C.
   Tambourgi, Elias B.
TI One-pot synthesis of a chitosan-based hydrogel as a potential device for
   magnetic biomaterial
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE Chitosan; Hydrogel; Magnetic biomaterial
ID MOSSBAUER; POLYSACCHARIDE; POLYMERS; INSULIN; WATER
AB This describes the cross-linking/co-polymerization reaction of chitosan ( CS), acrylic acid (AAc), and N, N'-methylenebisacrylamide (MBA) in the presence of citrate-covered-gamma-Fe(2)O(3) nanoparticules. A gelling process was verified by means of spectroscopic methods; Fourier transform infrared (FT-IR) and solid-state (13)C-CP/MAS nuclear magnetic resonance (NMR). The corresponding signals of the gelling process, in the (13)C NMR spectra, for the magnetic hydrogel were shifted to lower values due to embedding of the citrate-covered-gamma-Fe(2)O(3) nanoparticules. The X-ray diffraction (XRD) confirmed that the crystallinity of the magnetic hydrogel exhibited a different crystalline structure to that without magnetic properties. The Mossbauer and magnetization analysis revealed that the magnetic hydrogel displays a high lattice strain, due to bonded iron atom covalence and superparamagnetism. From scanning electronic microscope (SEM) micrographs, no separation phase coexists between the magnetic nanoparticules and cross-linked hydrogel, indicating an excellent dispersion throughout the hydrogel. The swelling rate was dependent on the cross-linking degree of the hydrogel and ionic strength of the aqueous solution. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Paulino, Alexandre T.; Guilherme, Marcos R.; Tambourgi, Elias B.] Univ Estadual Campinas, Fac Engn Quim, Dept Engn Sistemas Quim, Campinas, SP, Brazil.
   [de Almeida, Elisangela A. M. S.; Pereira, Antonio G. B.; Muniz, Edvani C.] Univ Estadual Maringa, GMPC, Dept Quim, Maringa, Parana, Brazil.
RP Paulino, AT (reprint author), Univ Estadual Campinas, Fac Engn Quim, Dept Engn Sistemas Quim, Ave Albert Einstein 500, Campinas, SP, Brazil.
EM atpaulino10@gmail.com
RI Guilherme, Marcos/J-6008-2012; Basso Pereira, Antonio
   Guilherme/B-1041-2012; Tambourgi, Elias/E-1863-2012; Paulino,
   Alexandre/B-8075-2013; Inomat, Inct/H-9989-2013
OI Tambourgi, Elias/0000-0002-4734-9723; Paulino,
   Alexandre/0000-0001-7076-2797; Guilherme, Marcos/0000-0002-4260-5660;
   Muniz, Edvani/0000-0001-6685-1519
FU Fundaca o de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil)
   [2008/00285-7]; CAPES Brazil; CNPq-Brazil
FX ATP and EBT gratefully acknowledge the Fundaca o de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP-Brazil) for the postdoctorate fellowship
   (Process no. 2008/00285-7). MRG gratefully acknowledges the
   FAPESP-Brazil for the post-doctorate fellowship. ECM, EAMSA and AGBP
   gratefully acknowledge the CAPES Brazil and CNPq-Brazil for financial
   support.
CR Arai J, 1998, J MAGN MAGN MATER, V177, P515, DOI 10.1016/S0304-8853(97)00348-X
   Dorkoosh FA, 2002, INT J PHARM, V247, P47, DOI 10.1016/S0378-5173(02)00361-7
   Dorkoosh FA, 2002, EUR J PHARM SCI, V15, P433, DOI 10.1016/S0928-0987(02)00028-3
   Dubois E, 1999, J CHEM PHYS, V111, P7147, DOI 10.1063/1.480007
   Guilherme MR, 2007, J APPL POLYM SCI, V105, P2903, DOI 10.1002/app.26287
   Guilherme MR, 2003, POLYMER, V44, P4213, DOI 10.1016/S0032-3861(03)00370-7
   Kato N, 1997, J INTEL MAT SYST STR, V8, P588, DOI 10.1177/1045389X9700800703
   Kuzmann E, 1999, PHYSICA C, V312, P45, DOI 10.1016/S0921-4534(98)00670-4
   LAPSHIN RV, 1995, REV SCI INSTRUM, V66, P4718, DOI 10.1063/1.1145314
   Liu XQ, 2007, IEEE T MAGN, V43, P2462, DOI 10.1109/TMAG.2007.894004
   Ma D, 2008, J PHYS CHEM B, V112, P6315, DOI 10.1021/jp7115627
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   Massart R., 1982, [No title captured], Patent No. [4.329 241, 4329241, 4 329 241]
   MASSART R, 1979, Patent No. 7918842
   MURAOKA TK, 2004, ECLET QUIM, V29, P27
   Paneva D., 2004, E-POLYMERS, V60, P1
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   PAULINO AT, 2007, E-POLYMERS, V122, P1
   Reis AV, 2006, POLYMER, V47, P2023, DOI 10.1016/j.polymer.2006.01.058
   Saravanan P, 2008, INTERMETALLICS, V16, P636, DOI 10.1016/j.intermet.2008.01.011
   SORESCU M, 1997, MATER LETT, V30, P288
   Zenonos C, 2002, PHYS CHEM CHEM PHYS, V4, P5421, DOI 10.1039/b202155b
   Zhang L, 1996, NANOSTRUCT MATER, V7, P437, DOI 10.1016/0965-9773(96)00015-3
NR 23
TC 26
Z9 29
U1 2
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD SEP
PY 2009
VL 321
IS 17
BP 2636
EP 2642
DI 10.1016/j.jmmm.2009.03.078
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 450XX
UT WOS:000266436400028
DA 2018-10-20
ER

PT J
AU Torres-Sanchez, C
   Corney, JR
AF Torres-Sanchez, Carmen
   Corney, Jonathan R.
TI Toward Functionally Graded Cellular Microstructures
SO JOURNAL OF MECHANICAL DESIGN
LA English
DT Article
CT Conference on Smart Materials, Adaptive Structures and Intelligent
   Systems
CY OCT 28-30, 2008
CL Washington, DC
SP ASME
DE design for manufacture; functionally graded materials; manufacturing
   processes; porosity; porous materials; structural engineering
ID MECHANICAL-PROPERTIES; FABRICATION; ULTRASOUND; POROSITY; DESIGN; FOAMS;
   BIOMATERIALS; SCAFFOLDS; DIFFUSION
AB The design of multifunctional materials offers great potential for numerous applications in areas ranging from biomaterial science to structural engineering. Functionally graded microstructures (e.g., polymeric foams) are those whose porosity (i.e., ratio of the void to the solid volume of a material) is engineered to meet specific requirements such as a superior mechanical, thermal, and acoustic behavior. The controlled distribution of pores within the matrix, as well as their size, wall thickness, and interconnectivity are directly linked to the porous materials properties. There are emerging design and analysis methods of cellular materials but their physical use is restricted by current manufacturing technologies. Although a huge variety of foams can be manufactured with homogeneous porosity, for heterogeneous foams there are no generic processes for controlling the distribution of porosity throughout the resulting matrix. This paper describes work to develop an innovative and flexible process for manufacturing engineered cellular structures. Ultrasound was applied during specific foaming stages of a polymeric (polyurethane) melt, and this affected both the cellular architecture and distribution of the pore size, resulting in a controlled distribution that can be designed for specific purposes, once the polymeric foam solidified. The experimental results demonstrate that porosity (i.e., volume fraction) varies in direct proportion to the acoustic pressure magnitude of the ultrasonic signal.
C1 [Torres-Sanchez, Carmen; Corney, Jonathan R.] Univ Strathclyde, DMEM, Glasgow G1 1XJ, Lanark, Scotland.
RP Torres-Sanchez, C (reprint author), Univ Strathclyde, DMEM, James Weir Bldg, Glasgow G1 1XJ, Lanark, Scotland.
EM carmen.torres@strath.ac.uk; jonathan.corney@strath.ac.uk
RI Torres-Sanchez, Carmen/A-8213-2010
OI Torres-Sanchez, Carmen/0000-0002-1649-2068
CR ALBERS VM, 1965, HDB U PARK, V2
   Balasubramaniam K, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336771
   Boccaccini AR, 1999, J POROUS MAT, V6, P369, DOI 10.1023/A:1009673814848
   Cheeke J. D. N., 2002, FUNDAMENTALS APPL UL
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   CRUM LA, 1980, J ACOUST SOC AM, V68, P203, DOI 10.1121/1.384624
   Dutta D., 2001, J COMPUT INF SCI ENG, V1, P60, DOI DOI 10.1115/1.1355029
   FLOROS JD, 1994, FOOD TECHNOL-CHICAGO, V48, P79
   Font R, 2002, J APPL POLYM SCI, V85, P1945, DOI 10.1002/app.10745
   Gallego-Juarez JA, 2000, ULTRASONICS, V38, P331, DOI 10.1016/S0041-624X(99)00183-3
   GALLEGOJUAREZ JA, 2001, P WORLD C ULTR IEEE, P571
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Hu Y, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2829894
   Jackson TR, 1999, MATER DESIGN, V20, P63, DOI 10.1016/S0261-3069(99)00011-4
   LEIGHTON TG, 1995, ULTRASON SONOCHEM, V2, pS123, DOI 10.1016/1350-4177(95)00021-W
   Malcolm AA, 2007, J MATER PROCESS TECH, V192, P391, DOI 10.1016/j.jmatprotec.2007.04.041
   Mano JF, 2005, MAT SCI ENG C-BIO S, V25, P93, DOI 10.1016/j.msec.2005.01.001
   Mason TJ, 2004, ULTRASON SONOCHEM, V11, P205, DOI 10.1016/j.ultsonch.2004.01.025
   Montminy MD, 2004, J COLLOID INTERF SCI, V280, P202, DOI 10.1016/j.jcis.2004.07.032
   Mulet A, 2003, FOOD SCI TECHNOL INT, V9, P215, DOI 10.1177/108201303034641
   Nagel RL, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2992062
   Peng HX, 2000, J EUR CERAM SOC, V20, P807, DOI 10.1016/S0955-2219(99)00229-0
   Pitt William G, 2004, Expert Opin Drug Deliv, V1, P37, DOI 10.1517/17425247.1.1.37
   Price GJ, 2002, EUR POLYM J, V38, P1531, DOI 10.1016/S0014-3057(02)00039-3
   Raum K, 2006, PHYS MED BIOL, V51, P747, DOI 10.1088/0031-9155/51/3/018
   ROJAS AJ, 1982, POLYM ENG SCI, V22, P840, DOI 10.1002/pen.760221310
   Sadagopan D, 1997, J MECH DESIGN, V119, P494, DOI 10.1115/1.2826395
   Seepersad CC, 2006, J MECH DESIGN, V128, P1285, DOI 10.1115/1.2338575
   Seepersad CC, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2829876
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Torres-Sanchez C, 2008, ULTRASON SONOCHEM, V15, P408, DOI 10.1016/j.ultsonch.2007.05.002
   TORRESSAACUTENC.C, 2008, THESIS HERIOTWATT U
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Wang Hongqing V., 2005, THESIS GEORGIA I TEC
   Yan YN, 2003, MATER LETT, V57, P2623, DOI 10.1016/S0167-577X(02)01339-3
   YOSHIZAWA M, 2004, P IEEE ULTR S, V1, P1769
   Zhang XD, 1999, J COLLOID INTERF SCI, V215, P270, DOI 10.1006/jcis.1999.6233
   Zhang Y, 2007, J MECH DESIGN, V129, P553, DOI 10.1115/1.2712223
NR 38
TC 7
Z9 7
U1 2
U2 10
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1050-0472
J9 J MECH DESIGN
JI J. Mech. Des.
PD SEP
PY 2009
VL 131
IS 9
AR 091011
DI 10.1115/1.3158985
PG 7
WC Engineering, Mechanical
SC Engineering
GA 485NY
UT WOS:000269131500012
DA 2018-10-20
ER

PT J
AU Yun, C
   You, J
   Kim, J
   Huh, J
   Kim, E
AF Yun, Chijung
   You, Jungmok
   Kim, Jeonghun
   Huh, June
   Kim, Eunkyoung
TI Photochromic fluorescence switching from diarylethenes and its
   applications
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS
LA English
DT Review
DE Photochromism; Diarylethene; Photoswitching; Fluorescence; Optical
   memory; Bioapplications
ID REFRACTIVE-INDEX CHANGE; OPTICAL-DATA STORAGE; HIGHLY FLUORESCENT;
   MOLECULAR SWITCHES; 1,2-DITHIENYLETHENE PHOTOCHROMES; REVERSIBLE
   PHOTOCYCLIZATION; AMORPHOUS DIARYLETHENES; MODULATION PROPERTIES;
   REACTION DYNAMICS; QUANTUM YIELD
AB The review describes the photochromic and fluorescent characteristics of various diarylethene (DAET) derivatives, and presents recent research into their applications. This comprises a discussion of the optical characteristics of some DAET-based molecules exhibiting red, green, or blue (RGB) colors or fluorescence. Molecular calculations of the optical properties of DAET interpret intriguing experimental observations and predict photochemical or photophysical properties. In particular, stabilization of HOMO in the BTFOn (n = 1, 2, 3, 4) increases the energy difference between the HOMO and the LUMO, which leads to the blue-shift of absorption and emission hands as the number of oxygen attached to sulfur (n) increases. Various devices and application studies have been designed as photon-mode systems based on photochemical control of the fluorescence energy. The photochromic DAET materials have shown promise as optical data storage, switching devices, and biological applications such as the development of biomaterial sensors, analysis of biological dynamics, and live cell imaging. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Yun, Chijung; You, Jungmok; Kim, Jeonghun; Huh, June; Kim, Eunkyoung] Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
RP Kim, E (reprint author), Yonsei Univ, Dept Chem & Biomol Engn, 262 Seongsanno, Seoul 120749, South Korea.
EM eunkim@yonsei.ac.kr
RI Kim, Jeonghun/I-7164-2015; Kim, Eunkyoung/G-8420-2012
OI Kim, Jeonghun/0000-0001-6325-0507; 
FU Korea government (MEST) [R11-2007-050-01001-0]
FX This work was supported by the Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korea government (MEST) (No.
   R11-2007-050-01001-0).
CR Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506
   Asano Y, 2004, J AM CHEM SOC, V126, P12112, DOI 10.1021/ja035035o
   Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x
   Belser P, 2006, ADV FUNCT MATER, V16, P195, DOI 10.1002/adfm.200500247
   Bens AT, 1998, EUR J ORG CHEM, P2333
   Biteau J, 1998, CHEM MATER, V10, P1945, DOI 10.1021/cm980106h
   Bosanac T, 2001, ANGEW CHEM INT EDIT, V40, P1875, DOI 10.1002/1521-3773(20010518)40:10<1875::AID-ANIE1875>3.0.CO;2-5
   Bouas-Laurent H, 2001, PURE APPL CHEM, V73, P639, DOI 10.1351/pac200173040639
   Brown G. H., 1971, PHOTOCHROMISM
   Carreon JR, 2007, BIOORG MED CHEM LETT, V17, P5182, DOI 10.1016/j.bmcl.2007.06.097
   Chauvin J, 2001, JPN J APPL PHYS 1, V40, P2518, DOI 10.1143/JJAP.40.2518
   Chen DZ, 2006, J MOL STRUC-THEOCHEM, V774, P77, DOI 10.1016/j.theochem.2006.07.010
   Chen Y, 2004, CHEMPHYSCHEM, V5, P564, DOI 10.1002/cphc.200301021
   Cho H, 2002, MACROMOLECULES, V35, P8684, DOI 10.1021/ma025576i
   CHO H, 2002, J KOREAN SOC IMAGING, V8, P29
   Cho SY, 2003, OPT MATER, V21, P279, DOI 10.1016/S0925-3467(02)00150-7
   Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778
   Clark AE, 2006, J PHYS CHEM A, V110, P3790, DOI 10.1021/jp056904u
   CLAUDIA CC, 2006, ADV MATER, V18, P2910
   Conley NR, 2008, J PHYS CHEM B, V112, P11878, DOI 10.1021/jp806698p
   Crana J.C., 1998, ORGANIC PHOTOCHROMIC
   de Jong JJD, 2004, SCIENCE, V304, P278, DOI 10.1126/science.1095353
   Durr H., 1990, PHOTOCHROMISM MOL SY
   Durr H., 1992, PHOTOCHROMISM MOL SY
   Endtner JM, 2000, J AM CHEM SOC, V122, P3037, DOI 10.1021/ja9938736
   Ern J, 2001, J PHYS CHEM A, V105, P1741, DOI 10.1021/jp0031956
   FCLLING J, 2008, SMALL, V4, P134
   Feringa BL, 2000, CHEM REV, V100, P1789, DOI 10.1021/cr9900228
   Fernandez-Acebes A, 1999, CHEM-EUR J, V5, P3285, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3285::AID-CHEM3285>3.0.CO;2-Q
   FISSI A, 1989, MACROMOLECULES, V22, P1115, DOI 10.1021/ma00193a019
   Fukaminato T, 2004, J AM CHEM SOC, V126, P14843, DOI 10.1021/ja047169n
   Fukaminato T, 2008, CHEM COMMUN, P3924, DOI 10.1039/b804137g
   Fukaminato T, 2007, J AM CHEM SOC, V129, P5932, DOI 10.1021/ja069131b
   Fukaminato T, 2006, ADV MATER, V18, P3225, DOI 10.1002/adma.200601222
   Giestas L, 2005, EUR J ORG CHEM, P4187, DOI 10.1002/ejoc.200500318
   Giordano L, 2000, MOLECULES, V5, P591, DOI 10.3390/50300591
   Giordano L, 2002, J AM CHEM SOC, V124, P7481, DOI 10.1021/ja016969k
   Goldberg A, 2003, J PHYS CHEM A, V107, P4982, DOI 10.1021/jp0213553
   Guillaumont D, 2002, J PHYS CHEM A, V106, P7222, DOI 10.1021/jp021060p
   Gust D, 2006, CHEM COMMUN, P1169, DOI 10.1039/b514836k
   HANAZAWA M, 1992, CHEM COMMUN, P206
   Hania PR, 2002, J PHYS CHEM A, V106, P8498, DOI [10.1021/jp020903+, 10.1021/jp020903]
   Higashiguchi K, 2005, J AM CHEM SOC, V127, P8922, DOI 10.1021/ja051467i
   Hu HY, 2007, J PHOTOCH PHOTOBIO A, V189, P307, DOI 10.1016/j.jphotochem.2007.02.020
   IRIE M, 1988, J ORG CHEM, V53, P803, DOI 10.1021/jo00239a022
   Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d
   Irie M, 2002, NATURE, V420, P759, DOI 10.1038/420759a
   IRIE M, 1990, ADV POLYM SCI, V94, P27
   Irie M, 1999, CHEM COMMUN, P747, DOI 10.1039/a809410a
   Irie M, 1995, J ORG CHEM, V60, P8305, DOI 10.1021/jo00130a035
   Irie M, 1997, TETRAHEDRON, V53, P12263, DOI 10.1016/S0040-4020(97)00558-9
   IRIE M, 1992, APPL PHOTOCHROMIC PO, P174
   Jacquemin D, 2006, CHEM PHYS LETT, V429, P147, DOI 10.1016/j.cplett.2006.08.028
   Jeong YC, 2006, CHEM COMMUN, P1881, DOI 10.1039/b600754f
   Jeong YC, 2006, MACROMOLECULES, V39, P3106, DOI 10.1021/ma0602167
   Jeong YC, 2005, B KOR CHEM SOC, V26, P1675
   Jeong YC, 2005, CHEM COMMUN, P2503, DOI 10.1039/b501324k
   Jeong YC, 2007, TETRAHEDRON, V63, P3173, DOI 10.1016/j.tet.2007.02.007
   Jeong YC, 2006, MACROMOL RAPID COMM, V27, P1769, DOI 10.1002/marc.200600461
   Jeong YC, 2006, TETRAHEDRON, V62, P5855, DOI 10.1016/j.tet.2006.04.029
   Jiang GY, 2006, CHEM MATER, V18, P235, DOI 10.1021/cm052251i
   KAWAI T, 1995, APPL PHYS LETT, V67, P795, DOI 10.1063/1.115470
   Kawata S, 2000, CHEM REV, V100, P1777, DOI 10.1021/cr980073p
   Kim E, 1998, MACROMOLECULES, V31, P5726, DOI 10.1021/ma980419y
   Kim E, 1999, MACROMOLECULES, V32, P4855, DOI 10.1021/ma9903409
   Kim E, 2006, J MATER CHEM, V16, P1384, DOI 10.1039/b517175j
   Kim E, 2005, MOL CRYST LIQ CRYST, V431, P581, DOI 10.1080/15421400590947540
   KIM E, 2007, OPT SCI TECHNOL, V11, P4
   Kim E, 2006, TETRAHEDRON, V62, P6814, DOI 10.1016/j.tet.2006.04.089
   KIM J, 2008, SPIE, V7118
   Kim J, 2008, MOL CRYST LIQ CRYST, V491, P67, DOI 10.1080/15421400802328956
   Kim MS, 2003, OPT MATER, V21, P271, DOI 10.1016/S0925-3467(02)00148-9
   Kim MS, 2001, CHEM LETT, P702, DOI 10.1246/cl.2001.702
   Kinoshita K, 1997, APPL PHYS LETT, V70, P2940, DOI 10.1063/1.118750
   Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760
   Kodani T, 2000, J AM CHEM SOC, V122, P9631, DOI 10.1021/ja001350o
   Lee J, 2007, TETRAHEDRON LETT, V48, P249, DOI 10.1016/j.tetlet.2006.11.039
   Li ZX, 2008, J PHYS CHEM C, V112, P5190, DOI 10.1021/jp711613y
   Liu Y, 2003, CHEM PHYS LETT, V373, P338, DOI 10.1016/S0009-2614(03)00628-6
   Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200
   Maiti M, 1999, J LUMIN, V82, P259, DOI 10.1016/S0022-2313(99)00062-9
   Majumdar D, 1999, J CHEM PHYS, V111, P5866, DOI 10.1063/1.479881
   Matsubara K, 2007, ANGEW CHEM INT EDIT, V46, P1688, DOI 10.1002/anie.200603554
   Matsuda K, 2000, CHEM LETT, P16
   Misra T, 2001, SPECTROCHIM ACTA A, V57, P2795, DOI 10.1016/S1386-1425(01)00467-X
   MORADPOUR A, 1993, J CHEM SOC PERK T 1, P7, DOI 10.1039/p19930000007
   Morimitsu K, 2004, TETRAHEDRON LETT, V45, P1155, DOI 10.1016/j.tetlet.2003.12.005
   Moriyama Y, 2005, ORG LETT, V7, P3315, DOI 10.1021/ol051149o
   Muraoka T, 2003, J AM CHEM SOC, V125, P5612, DOI 10.1021/ja034994f
   Murguly E, 2001, ANGEW CHEM INT EDIT, V40, P1752, DOI 10.1002/1521-3773(20010504)40:9<1752::AID-ANIE17520>3.3.CO;2-N
   Myles AJ, 2002, ADV FUNCT MATER, V12, P167, DOI 10.1002/1616-3028(200203)12:3<167::AID-ADFM167>3.0.CO;2-M
   NAKAMURA S, 1988, J ORG CHEM, V53, P6136, DOI 10.1021/jo00261a035
   Norikane Y, 2004, ORG LETT, V6, P2595, DOI 10.1021/ol049082c
   Norsten TB, 2001, J AM CHEM SOC, V123, P1784, DOI 10.1021/ja005639h
   Odo Y, 2007, CHEM LETT, V36, P240, DOI 10.1246/cl.2007.240
   Odo Y, 2006, CHEM-EUR J, V12, P4283, DOI 10.1002/chem.200501292
   Oh H, 2008, J NANOSCI NANOTECHNO, V8, P4616, DOI 10.1166/jnn.2008.IC36
   Oh HJ, 2008, MACROMOLECULES, V41, P7160, DOI 10.1021/ma800691y
   PETER G, 2002, PHOTOREFLECTIVE MAT, V2
   Pu SZ, 2008, TETRAHEDRON, V64, P2576, DOI 10.1016/j.tet.2008.01.025
   Raymo FM, 2005, J PHYS CHEM A, V109, P7343, DOI 10.1021/jp052440o
   Raymo FM, 2005, CHEM SOC REV, V34, P327, DOI 10.1039/b400387j
   Sasaki K, 1997, APPL PHYS LETT, V71, P434, DOI 10.1063/1.119571
   Schafer LV, 2007, ANGEW CHEM INT EDIT, V46, P530, DOI 10.1002/anie.200602315
   Shim S, 2007, J PHYS CHEM A, V111, P8910, DOI 10.1021/jp0715528
   Shishido A, 1997, J PHYS CHEM B, V101, P2806, DOI 10.1021/jp9638393
   Soh N, 2007, CHEM COMMUN, P5206, DOI 10.1039/b713663c
   STRICKLER JH, 1991, OPT LETT, V16, P1780, DOI 10.1364/OL.16.001780
   Takeshita M, 1998, CHEM LETT, P1123, DOI 10.1246/cl.1998.1123
   Tamura H, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2171688
   Tanifuji N, 2005, ORG LETT, V7, P3777, DOI 10.1021/ol051463i
   TANIO N, 1994, JPN J APPL PHYS 1, V33, P1550, DOI 10.1143/JJAP.33.1550
   Tian H, 2004, CHEM SOC REV, V33, P85, DOI 10.1039/b302356g
   Tian H, 2002, ADV MATER, V14, P918, DOI 10.1002/1521-4095(20020618)14:12<918::AID-ADMA918>3.0.CO;2-Y
   Tian H, 2008, J MATER CHEM, V18, P1617, DOI 10.1039/b713216f
   Toriumi A, 1998, OPT LETT, V23, P1924, DOI 10.1364/OL.23.001924
   Tsivgoulis GM, 1996, CHEM-EUR J, V2, P1399, DOI 10.1002/chem.19960021112
   Uchida K, 2003, ADV MATER, V15, P121, DOI 10.1002/adma.200390023
   Uchida K, 2002, J MOL STRUC-THEOCHEM, V579, P115, DOI 10.1016/S0166-1280(01)00722-9
   UCHIDA K, 1990, B CHEM SOC JPN, V63, P1311, DOI 10.1246/bcsj.63.1311
   UCHIDA K, 1992, B CHEM SOC JPN, V65, P430, DOI 10.1246/bcsj.65.430
   Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756
   WATANABE K, 1992, CHEM LETT, P1233, DOI 10.1246/cl.1992.1233
   Xie N, 2007, J MATER CHEM, V17, P861, DOI 10.1039/b613558g
   Yagi K, 2003, CHEM LETT, V32, P848, DOI 10.1246/cl.2003.848
   Yagi K, 2001, J ORG CHEM, V66, P5419, DOI 10.1021/jo010267w
   Yamaguchi T, 2004, CHEM COMMUN, P1010, DOI 10.1039/b401207k
   Yamaguchi T, 1997, J AM CHEM SOC, V119, P6066, DOI 10.1021/ja970200j
   Yan SF, 2008, EUR J ORG CHEM, P2531, DOI 10.1002/ejoc.200800125
   YOUN C, 2008, NEWS INFORM CHEM ENG, V26, P526
   Zhang M, 2007, J AM CHEM SOC, V129, P10322, DOI 10.1021/ja073140i
   Zhao H, 2008, J PHOTOCH PHOTOBIO A, V200, P74, DOI 10.1016/j.jphotochem.2008.06.010
   Zhou XH, 2004, CHEM LETT, V33, P1006, DOI 10.1246/cl.2004.1006
   Zhou ZG, 2006, ORG LETT, V8, P3911, DOI 10.1021/ol061370g
   Zou Y, 2008, J AM CHEM SOC, V130, P15750, DOI 10.1021/ja8043163
NR 135
TC 196
Z9 198
U1 13
U2 173
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-5567
EI 1873-2739
J9 J PHOTOCH PHOTOBIO C
JI J. Photochem. Photobiol. C-Photochem. Rev.
PD SEP
PY 2009
VL 10
IS 3
BP 111
EP 129
DI 10.1016/j.jphotochemrev.2009.05.002
PG 19
WC Chemistry, Physical
SC Chemistry
GA 528ZZ
UT WOS:000272486800001
DA 2018-10-20
ER

PT J
AU Bai, W
   Chen, DL
   Li, Q
   Chen, HC
   Zhang, SL
   Huang, XC
   Xiong, CD
AF Bai, Wei
   Chen, Dongliang
   Li, Qing
   Chen, Hechun
   Zhang, Shenglan
   Huang, Xiaochuan
   Xiong, Cheng-Dong
TI In vitro hydrolytic degradation of poly(para-dioxanone) with high
   molecular weight
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE Poly(para-dioxanone); Degradation; Molecular weight; Biomaterial; Bars
ID POLY-P-DIOXANONE; POLYGLYCOLIC ACID; POLY(P-DIOXANONE); CRYSTALLIZATION;
   POLYDIOXANONE; MORPHOLOGY; COPOLYMER; BEHAVIORS; SUTURE; NEAT
AB The in vitro hydrolytic degradation of high molecular weight poly (para-dioxanone) was studied by examining the changes of weight retention, water absorption, pH value, tensile strength, break elongation, thermal properties, and morphology of high molecular weight PPDO in phosphate buffered saline (PBS) (pH 7.44) at 37A degrees C for 8 weeks. During the degradation, all samples' weight retention decreased and water absorption increased significantly, whereas hydrolysis rate of PPDO bars varied with molecular weight. Compared with lower molecular weight samples, higher molecular weight PPDO samples exhibited higher hydrolysis rate. The samples' glass transition temperature (Tg) decreased notably, while the degrees of crystallinity (Dc) increased. The samples almost totally lost their tensile strengths and breaking elongation after 4 weeks of degradation. The results suggested that the stability of PPDO in vitro hydrolytic degradation increased with the increase of molecular weight.
C1 [Bai, Wei; Chen, Dongliang; Li, Qing; Chen, Hechun; Zhang, Shenglan; Xiong, Cheng-Dong] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Bai, Wei] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
   [Huang, Xiaochuan] Sichuan Univ, Chengdu 610064, Peoples R China.
RP Xiong, CD (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM xcd1633@yahoo.com.cn
CR Andjelic S, 2001, J APPL POLYM SCI, V79, P742, DOI 10.1002/1097-4628(20010124)79:4<742::AID-APP190>3.3.CO;2-A
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   CACHIA VV, 1999, Patent No. 5893850
   Chen SC, 2006, POLYMER, V47, P32, DOI 10.1016/j.polymer.2005.10.008
   Chen SC, 2007, J BIOMED MATER RES A, V80A, P453, DOI 10.1002/jbm.a.30938
   CHU CC, 1988, J BIOMED MATER RES, V22, P699, DOI 10.1002/jbm.820220804
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   FORSCHNER TC, 1997, Patent No. 9721753
   FRAUNHOFER JA, 1985, J BIOMED MATER RES, V19, P595
   Gertzman A., 1986, US Pat., Patent No. 4591630
   Im JN, 2007, POLYM DEGRAD STABIL, V92, P667, DOI 10.1016/j.polymdegradstab.2006.12.011
   Ishikiriyama K, 1998, J MACROMOL SCI PHYS, VB37, P27, DOI 10.1080/00222349808220453
   LIN HL, 1993, J BIOMED MATER RES, V27, P153, DOI 10.1002/jbm.820270204
   MATTEI PV, 1984, Patent No. 4440789
   Nishida H, 2000, POLYM DEGRAD STABIL, V68, P271, DOI 10.1016/S0141-3910(00)00010-0
   Ooi CP, 2002, J BIOMED MATER RES, V63, P280, DOI 10.1002/jbm.10180
   Pezzin APT, 2006, J APPL POLYM SCI, V101, P1899, DOI 10.1002/app.23646
   Pezzin APT, 2002, POLYM DEGRAD STABIL, V78, P405, DOI 10.1016/S0141-3910(02)00174-X
   RAY JA, 1981, SURG GYNECOL OBSTET, V153, P497
   Sabino MA, 2000, POLYM DEGRAD STABIL, V69, P209, DOI 10.1016/S0141-3910(00)00062-8
   Sabino MA, 2004, BIOMACROMOLECULES, V5, P358, DOI 10.1021/bm034367i
   Sabino MA, 2002, POLYM BULL, V48, P291, DOI 10.1007/s00289-002-0039-6
   Sabino MA, 2001, POLYM DEGRAD STABIL, V73, P541, DOI 10.1016/S0141-3910(01)00126-4
   Sabino MA, 2000, MACROMOL CHEM PHYSIC, V201, P2687, DOI 10.1002/1521-3935(20001201)201:18<2687::AID-MACP2687>3.0.CO;2-#
   Tomihata K, 1998, POLYM DEGRAD STABIL, V59, P13, DOI 10.1016/S0141-3910(97)00183-3
   Yang KK, 2006, J APPL POLYM SCI, V100, P2331, DOI 10.1002/app.23003
   Yang KK, 2004, MATER CHEM PHYS, V87, P218, DOI 10.1016/j.matchemphys.2004.05.038
   Yang KK, 2002, J MACROMOL SCI-POL R, VC42, P373, DOI 10.1081/MC-120006453
   YU JM, 1996, ACTA POLYM SIN, V6, P675
   Yuan XY, 2002, POLYM DEGRAD STABIL, V75, P45, DOI 10.1016/S0141-3910(01)00203-8
NR 30
TC 11
Z9 16
U1 1
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
J9 J POLYM RES
JI J. Polym. Res.
PD SEP
PY 2009
VL 16
IS 5
BP 471
EP 480
DI 10.1007/s10965-008-9250-y
PG 10
WC Polymer Science
SC Polymer Science
GA 481DG
UT WOS:000268786700002
DA 2018-10-20
ER

PT J
AU Spoerl, E
   Zubaty, V
   Terai, N
   Pillunat, LE
   Raiskup, F
AF Spoerl, Eberhard
   Zubaty, Viktoria
   Terai, Naim
   Pillunat, Lutz E.
   Raiskup, Frederik
TI Influence of High-dose Cortisol on the Biomechanics of Incubated Porcine
   Corneal Strips
SO JOURNAL OF REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT 4th International Congress of Corneal Cross Linking
CY DEC 05-06, 2008
CL Dresden, GERMANY
ID COLLAGEN CROSS-LINKING; MATRIX METALLOPROTEINASES;
   MECHANICAL-PROPERTIES; IN-VITRO; KERATOCONUS; HYDROCORTISONE;
   CORTICOSTEROIDS; GENDER; STRESS; AGE
AB PURPOSE: To investigate the change in biomechanical properties of the cornea induced by high-dose hydrocortisone.
   METHODS: The influence of hydrocortisone was investigated in 12 fresh porcine corneas incubated in culture medium of 2.5 mu M of hydrocortisone for 7 days. Twelve additional porcine corneas incubated in culture medium without hydrocortisone for the same time served as the control group. Strips of cornea were cut and the stress-strain relationship was measured in a biomaterial tester. Young's modulus was calculated.
   RESULTS: After incubation, the thickness of the cornea was 1120 +/- 130 mu m in the control group and 1320 +/- 90 mu m in the hydrocortisone group. The hydrocortisone-treated corneas were 18% thicker compared to the control corneas. However, the difference in the biomechanical stress value at 10% strain was significantly larger. In the control group, the stress value measured 122 +/- 40 kPa, and in the hydrocortisone group, it measured 77 +/- 19 kPa (P=.003), representing a reduction of the corneal stiffness by 37% due to hydrocortisone treatment. Young's modulus was reduced by 42.8% from 2.90 +/- 1.10 MPa in the control group to 1.66 +/- 0.49 in the hydrocortisone group.
   CONCLUSIONS: Hydrocortisone is a modulating factor of the biomechanical properties of the cornea. The significance of the cortisol status of the patient and its influence on the biomechanical stability of the cornea should be considered in the development of keratectasia in keratoconus or after refractive surgery. [J Refract Surg. 2009;25:S794-S798.] doi:10.3928/1081597X-20090813-06
C1 [Zubaty, Viktoria; Terai, Naim; Pillunat, Lutz E.; Raiskup, Frederik] Carl Gustav Carus Univ Hosp, Dept Ophthalmol, D-01307 Dresden, Germany.
RP Spoerl, E (reprint author), Carl Gustav Carus Univ Hosp, Dept Ophthalmol, Fetscherstr 74, D-01307 Dresden, Germany.
EM eberhard.spoerl@uniklinikum-dresden.de
CR Abalain JH, 2000, CORNEA, V19, P474, DOI 10.1097/00003226-200007000-00014
   Amano S, 2008, JPN J OPHTHALMOL, V52, P334, DOI 10.1007/s10384-008-0554-6
   Assiri AA, 2005, BRIT J OPHTHALMOL, V89, P1403, DOI 10.1136/bjo.2005.074955
   BECHRAKIS N, 1994, CORNEA, V13, P73, DOI 10.1097/00003226-199401000-00012
   Bilgihan K, 2000, EYE, V14, P231, DOI 10.1038/eye.2000.60
   Bourcier T, 1999, INVEST OPHTH VIS SCI, V40, P1061
   BROWN SI, 1970, AM J OPHTHALMOL, V70, P744, DOI 10.1016/0002-9394(70)90494-0
   Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010
   Choe KH, 2003, AM J RESP CRIT CARE, V167, P1516, DOI 10.1164/rccm.200210-1207OC
   COLBURN WA, 1980, J CLIN PHARMACOL, V20, P428, DOI 10.1002/j.1552-4604.1980.tb01715.x
   Cury PR, 2007, J PERIODONTOL, V78, P1309, DOI 10.1902/jop.2007.060225
   Dahl R, 2006, RESP MED, V100, P1307, DOI 10.1016/j.rmed.2005.11.020
   DEOBALDIAFARUGG, 2007, 25 C EUR SOC CAT REF
   DOANE MG, 1978, AM J OPHTHALMOL, V85, P383, DOI 10.1016/S0002-9394(14)77735-9
   Dursun D, 2001, CORNEA, V20, P668, DOI 10.1097/00003226-200108000-00024
   Ertan A, 2008, CORNEA, V27, P1109, DOI 10.1097/ICO.0b013e31817f815a
   FERRETTI JL, 1992, CALCIFIED TISSUE INT, V50, P49, DOI 10.1007/BF00297297
   Gatzioufas Z, 2008, J ENDOCRINOL INVEST, V31, P262, DOI 10.1007/BF03345600
   Hafezi F, 2008, J CATARACT REFR SURG, V34, P1219, DOI 10.1016/j.jcrs.2008.02.036
   HIGUCHI M, 1985, SPINE, V10, P297, DOI 10.1097/00007632-198505000-00001
   Hillegass JM, 2008, TOXICOL SCI, V102, P413, DOI 10.1093/toxsci/kfn010
   Hochman B, 2008, AESTHET PLAST SURG, V32, P705, DOI 10.1007/s00266-008-9152-8
   Huscher D, 2009, ANN RHEUM DIS, V68, P1119, DOI 10.1136/ard.2008.092163
   Kalra S, 2007, CLIN INVEST MED, V30, pE103, DOI 10.25011/cim.v30i2.986
   KASAVINA B S, 1977, Byulleten' Eksperimental'noi Biologii i Meditsiny, V84, P38
   KASAVINA BS, 1977, B EXP BIOL MED+, V83, P458, DOI 10.1007/BF00807475
   KIESS W, 1995, PEDIATR RES, V37, P502, DOI 10.1203/00006450-199504000-00020
   Kim WJ, 1999, EXP EYE RES, V69, P475, DOI 10.1006/exer.1999.0719
   Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006
   Komatsu K, 2002, CONNECT TISSUE RES, V43, P581, DOI 10.1080/03008200290001311
   Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4
   Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004
   LAHOUD S, 1987, CAN J OPHTHALMOL, V22, P230
   Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253
   Mackiewicz Z, 2006, CORNEA, V25, P603, DOI 10.1097/01.ico.0000208820.32614.00
   MCDONALD TO, 1970, INVEST OPHTH VISUAL, V9, P703
   McGhee CNJ, 2002, DRUG SAFETY, V25, P33, DOI 10.2165/00002018-200225010-00004
   Mendelson JH, 2008, NEUROPSYCHOPHARMACOL, V33, P749, DOI 10.1038/sj.npp.1301455
   Olchowik G, 2008, FOLIA HISTOCHEM CYTO, V46, P373, DOI 10.2478/v10042-008-0081-9
   Qureshi AC, 2007, CLIN ENDOCRINOL, V66, P632, DOI 10.1111/j.1365-2265.2007.02784.x
   Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039
   REILLY JM, 1990, ARCH SURG-CHICAGO, V125, P707
   Schrot S, 2005, BIOPHYS J, V89, P3904, DOI 10.1529/biophysj.104.058750
   Seck-Gassama, 2000, Dakar Med, V45, P30
   Seppala HPS, 2006, CORNEA, V25, P325, DOI 10.1097/01.ico.0000183534.22522.39
   Smith VA, 2006, BBA-MOL BASIS DIS, V1762, P431, DOI 10.1016/j.bbadis.2006.01.010
   Spoerl E, 2008, J REFRACT SURG, V24, pS737
   Spoerl E, 2007, BRIT J OPHTHALMOL, V91, P1547, DOI 10.1136/bjo.2007.124388
   Steptoe A, 2006, INT J PSYCHOPHYSIOL, V59, P228, DOI 10.1016/j.ijpsycho.2005.10.011
   SUGAR J, 1974, ARCH OPHTHALMOL-CHIC, V92, P248, DOI 10.1001/archopht.1974.01010010256018
   THALASSELIS A, 1988, AM J OPTOM PHYS OPT, V65, P499
   Unlu N, 1998, J OCUL PHARMACOL TH, V14, P273, DOI 10.1089/jop.1998.14.273
   WALCHER K, 1976, ARCH ORTHOP TRAUM SU, V84, P1
   Yokoyama K, 2008, ENDOCR J, V55, P405, DOI 10.1507/endocrj.K07E-063
   Zanon E, 1992, Handchir Mikrochir Plast Chir, V24, P100
NR 55
TC 13
Z9 14
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 1081-597X
EI 1938-2391
J9 J REFRACT SURG
JI J. Refractive Surg.
PD SEP
PY 2009
VL 25
IS 9
BP S794
EP S798
DI 10.3928/1081597X-20090813-06
PG 5
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 494LL
UT WOS:000269814300008
PM 19772253
DA 2018-10-20
ER

PT J
AU Lee, S
   Obata, A
   Kasuga, T
AF Lee, Sungho
   Obata, Akiko
   Kasuga, Toshihiro
TI Ion release from SrO-CaO-TiO2-P2O5 glasses in Tris buffer solution
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Calcium phosphate glass; Strontium; Structure; Ion release; Biomaterial
ID CALCIUM-PHOSPHATE CERAMICS; STRONTIUM RANELATE; MECHANICAL-PROPERTIES;
   TITANIUM-ALLOYS; INVERT GLASSES; IN-VITRO; BONE; IMPLANT; CELLS
AB SrO-containing calcium phosphate invert glasses, (60-x)CaO center dot xSrO center dot 30P(2)O(5)center dot 7Na(2)O center dot 3TiO(2) (mol%, x = 0-60), which are expected to inhibit bone resorption by osteoclast and enhance bone formation, were prepared and their ion release behaviors in Tris buffer solution were estimated. The glass containing 20 mol% of SrO showed the smallest amount of the dissolved ions in the present work. Laser Raman spectra showed that the peaks of phosphate groups and TiOy polyhedral groups red-shifted with increasing the SrO content in the glasses. The shift was suggested to be due to decrease in bonding strength between cations and phosphate groups or TiOy polyhedral groups in the glasses. In the case of the glasses containing SrO over 20 mol%, no shifts of Raman peaks due to the TiOy polyhedra were observed. The TiOy (y = 4 or 6) polyhedra in the glasses can coordinate with cations up to 18 mol% since they contain 3 mol% of TiO2. Sr2+ ions are supposed from the shift behavior of the Raman peaks to preferentially coordinate with the TiOy polyhedra; the formation of this structure would induce decrease in the ion amounts released from the glasses containing 0-20 mol% of SrO. (C)2009 The Ceramic Society of Japan. All rights reserved.
C1 [Lee, Sungho; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Dept Frontier Mat, Grad Sch Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Grad Sch Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp
RI Lee, Sungho/T-1734-2017
OI Lee, Sungho/0000-0002-4367-9573
CR Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   Baron R, 2002, EUR J PHARMACOL, V450, P11, DOI 10.1016/S0014-2999(02)02040-X
   BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8
   Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020
   Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Kasuga T, 2003, J AM CERAM SOC, V86, P1031, DOI 10.1111/j.1151-2916.2003.tb03415.x
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kasuga T, 1998, J MATER RES, V13, P3357, DOI 10.1557/JMR.1998.0455
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KISHIOKA A, 1974, B CHEM SOC JPN, V47, P2493, DOI 10.1246/bcsj.47.2493
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   MARRIE PJ, 2006, BONE, V38, pS10
   MARRIE PJ, 2007, BONE, V40, pS5
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   NELSON BN, 1979, J CHEM PHYS, V71, P2739, DOI 10.1063/1.438679
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   ROUSE GB, 1978, J NON-CRYST SOLIDS, V28, P193, DOI 10.1016/0022-3093(78)90006-6
   SAKKA S, 1989, J NON-CRYST SOLIDS, V112, P64, DOI 10.1016/0022-3093(89)90494-8
   Takahashi N, 2003, J BONE MINER RES, V18, P1082, DOI 10.1359/jbmr.2003.18.6.1082
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   XYONS ID, 2000, J BIOMED MATER RES, V276, P461
NR 28
TC 15
Z9 15
U1 0
U2 6
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD SEP
PY 2009
VL 117
IS 1369
BP 935
EP 938
DI 10.2109/jcersj2.117.935
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 496NR
UT WOS:000269981800003
OA Bronze
DA 2018-10-20
ER

PT J
AU Jin, SC
   Baek, HS
   Woo, YI
   Lee, MH
   Kim, JS
   Park, JC
   Park, YH
   Rah, DK
   Chung, KH
   Lee, SJ
   Han, IH
AF Jin, Soo Chang
   Baek, Hyun Sook
   Woo, Yeon I.
   Lee, Mi Hee
   Kim, Jung-Sung
   Park, Jong-Chul
   Park, Young Hwan
   Rah, Dong Kyun
   Chung, Kie-Hyung
   Lee, Seung Jin
   Han, In Ho
TI Beneficial Effects of Microwave-Induced Argon Plasma Treatment on
   Cellular Behaviors of Articular Chondrocytes Onto Nanofibrous Silk
   Fibroin Mesh
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE nanofibrous silk fibroin; chondrocytes; cartilage; microwave-induced
   argon plasma; cytocompatibility
ID ATMOSPHERIC-PRESSURE; SURFACE MODIFICATION; ION-IMPLANTATION; FILMS;
   CELLS; DIFFERENTIATION; STERILIZATION; DEPOSITION; SCAFFOLDS; ADHESION
AB Silk fibroin scaffolds were examined as a biomaterial option for tissue-engineered cartilage-like tissue. In tissue engineering for cartilage repair using a scaffold, initial chondrocyte-material interactions are important for the following cell behaviors. In this study, the surface of nanofibrous silk fibroin (NSF) meshes was modified by a microwave-induced argon plasma treatment in order to improve the cytocompatibility of the meshes used as cartilaginous grafts. In addition, the effects of a plasma treatment on the cellular behavior of chondrocytes on NSF were examined. The plasma treatment resulted in an increase in the hydrophilicity of NSF meshes Suggesting that the cytocompatibility of the mesh might be improved. Furthermore, the human articular chondrocytes showed higher viability on the surface-modified NSF meshes. These results suggest that the surface modification of NSF meshes by plasma can enhance the cellular behavior of chondrocytes and may be used in tissue engineering.
C1 [Jin, Soo Chang; Baek, Hyun Sook; Woo, Yeon I.; Lee, Mi Hee; Kim, Jung-Sung; Park, Jong-Chul] Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
   [Jin, Soo Chang; Woo, Yeon I.; Lee, Mi Hee; Kim, Jung-Sung; Park, Jong-Chul] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
   [Park, Young Hwan] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Coll Agr & Life Sci, Seoul 151742, South Korea.
   [Rah, Dong Kyun] Yonsei Univ, Coll Med, Dept Plast & Reconstruct Surg, Seoul 120752, South Korea.
   [Chung, Kie-Hyung] Korea Accelerator & Plasma Res Assoc, Phys Technol Lab, Gangwon Do 269843, South Korea.
   [Lee, Seung Jin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea.
   [Han, In Ho] Korea Univ, Inst Clin Dent Res, Seoul 136701, South Korea.
RP Park, JC (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
EM parkjc@yuhs.ac
FU Korea Science & Engineering Foundation (KOSEF) [2005-00009]
FX This study was supported by the Nano-Bio R&D program [Platform
   technologies for organ/tissue regeneration (Regenomics), Grant No.
   2005-00009] of the Korea Science & Engineering Foundation (KOSEF).
CR Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Chan-Park MB, 2002, J ADHES SCI TECHNOL, V16, P1883, DOI 10.1163/15685610260427665
   Chen JY, 2004, SURF COAT TECH, V186, P270, DOI 10.1016/j.surfcoat.2004.02.050
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Jeong L, 2009, INT J BIOL MACROMOL, V44, P222, DOI 10.1016/j.ijbiomac.2008.12.008
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Lee KY, 2005, SURF COAT TECH, V193, P35, DOI 10.1016/j.surfcoat.2004.07.034
   Lin L, 2008, ARTHRITIS RHEUM-US, V58, P1067, DOI 10.1002/art.23380
   Ozcan C, 2007, J BIOMAT SCI-POLYM E, V18, P759, DOI 10.1163/156856207781034124
   Park BJ, 2003, PHYS PLASMAS, V10, P4539, DOI 10.1063/1.1613655
   Pesskova V, 2007, J MATER SCI-MATER M, V18, P465
   Sacristan J, 2000, POLYMER, V41, P5577, DOI 10.1016/S0032-3861(99)00784-3
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   Sun XF, 2008, ANAL CHEM, V80, P856, DOI 10.1021/ac701948n
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Yokota T, 2007, SURF COAT TECH, V201, P8048, DOI 10.1016/j.surfcoat.2006.03.051
NR 20
TC 13
Z9 13
U1 1
U2 8
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD SEP
PY 2009
VL 17
IS 9
BP 703
EP 708
DI 10.1007/BF03218931
PG 6
WC Polymer Science
SC Polymer Science
GA 506JH
UT WOS:000270770600011
DA 2018-10-20
ER

PT J
AU Johari, NA
   Kudin, TIT
   Ali, AMM
   Winie, T
   Yahya, MZA
AF Johari, N. A.
   Kudin, T. I. T.
   Ali, A. M. M.
   Winie, T.
   Yahya, M. Z. A.
TI Studies on cellulose acetate-based gel polymer electrolytes for proton
   batteries
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Functional Materials and Devices
CY JUN 16-19, 2008
CL Kuala Lumpur, MALAYSIA
DE Cellulose acetate; Gel polymer electrolyte; Protonic battery; OCV;
   Discharge
ID CELLS
AB Biomaterial-based cellulose is biodegradable, biocompatible and possesses good mechanical properties. Previous studies have proven that it can be used as the separator for various kinds of batteries, such as lead-acid batteries, silver-zinc rechargeable batteries, as an additive for preparation of pasted zinc electrodes for zinc-air batteries and as binders/surface modifiers for graphite anodes for lithium batteries. However, it never intensively been used as a polymer electrolyte in advanced batteries. Substantial progress has been made in the development of proton conductors with high ionic conductivity. Hence, proton batteries can be considered as cost effective alternatives for battery applications. The present study involves the fabrication and characterisation of gelled cellulose polymer proton battery with the configuration Zn/composite cellulose electrolytes/MnO(2). The open circuit voltage (OCV) of the cell is similar to 1.6 V. The constancy of OCV was tested for over 24 h. The discharge capacity was 24.65 mA h for 0.5 mA and 22.41 mA h for 1 mA.
C1 [Johari, N. A.; Kudin, T. I. T.; Ali, A. M. M.; Winie, T.; Yahya, M. Z. A.] Univ Teknol MARA, Fac Sci Appl, Ion Mat & Devices iMADE Res Lab, Shah Alam 40450, Malaysia.
RP Yahya, MZA (reprint author), Univ Teknol MARA, Fac Sci Appl, Ion Mat & Devices iMADE Res Lab, Shah Alam 40450, Malaysia.
EM mzay@salam.uitm.edu.my
RI Ali, Ab Malik Marwan/L-5742-2017
OI Ali, Ab Malik Marwan/0000-0002-0191-9575; YAHYA, MUHD ZU
   AZHAN/0000-0003-1129-0552; Winie, Tan/0000-0002-9186-5055
CR DAFLER JR, 1977, J APPL POLYM SCI, V21, P2551, DOI 10.1002/app.1977.070210921
   Lewis HL, 1999, J POWER SOURCES, V80, P61, DOI 10.1016/S0378-7753(99)00063-4
   Mohamed SN, 2008, J POWER SOURCES, V183, P351, DOI 10.1016/j.jpowsour.2008.04.048
   Munshi M. Z. A., 1995, HDB SOLID STATE BATT
   Ng LS, 2006, J POWER SOURCES, V163, P382, DOI 10.1016/j.jpowsour.2006.09.042
   Singh B, 2005, SOLID STATE IONICS, V176, P1577, DOI 10.1016/j.ssi.2005.05.001
   YAP SC, 2007, SOLID STATE LETT, V10, pA139
   Yue Z, 2003, SOLID STATE IONICS, V156, P155, DOI 10.1016/S0167-2738(02)00595-7
NR 8
TC 12
Z9 12
U1 7
U2 47
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD SEP
PY 2009
VL 13
IS 3
BP 232
EP 234
DI 10.1179/143307509X440389
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 491JE
UT WOS:000269573900029
DA 2018-10-20
ER

PT J
AU Zakaria, FA
   Marsad, NH
   Manaf, AYA
   Villamil, M
   Montes, T
   Carretero, C
   Mikan, J
AF Zakaria, F. A.
   Marsad, N. H.
   Manaf, A. Y. Abdul
   Villamil, M.
   Montes, T.
   Carretero, C.
   Mikan, J.
TI Characterisation of carbonated apatite for possible application in
   biomedical implants
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Functional Materials and Devices
CY JUN 16-19, 2008
CL Kuala Lumpur, MALAYSIA
DE Carbonate apatite; Hydroxyapatite; Simulated body fluid; Compressive
   strength; Precipitation
ID HYDROXYAPATITE; BONE; SUBSTITUTION; CERAMICS
AB Hard tissue diseases and defects, e. g. osteoporosis and osteoarthritis, are some of the most significant medical conditions that lead to the extensive need for the use of appropriate synthetic materials. Although hydroxyapatite has been widely used as osteoconductive biomaterial; carbonated apatite are more similar to the inorganic component of bone. Bone, dentine and dental enamel contain carbonated apatite of different compositions with a few per cent of carbonate ions (from 2 to 8 wt-%). It is well known that hydroxyapatite structure can host carbonate ions at two different sites: site A, where they substitute OH 2 ion, and site B, where they replace PO(4)(3-) ions. In this work, A+B-site replacement carbonated apatite was obtained with carbonate content of 6 to 7 wt-%. When immersed in simulated body fluid, scanning electron images showed the ability to mineralise new apatite within 0.5 days of immersion.
C1 [Zakaria, F. A.; Marsad, N. H.; Manaf, A. Y. Abdul] SIRIM Berhad, Adv Mat Res Ctr, Kulim 09000, Kedah, Malaysia.
   [Villamil, M.; Montes, T.; Carretero, C.; Mikan, J.] Univ Mil Nueva Granada, Fac Med, Bogota, Colombia.
RP Zakaria, FA (reprint author), SIRIM Berhad, Adv Mat Res Ctr, Lot 34,Jalan Hitech 2-3,Kulim Hitech Pk, Kulim 09000, Kedah, Malaysia.
EM mspfaz@gmail.com
CR Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   Gibson IR, 2002, J MATER SCI-MATER M, V13, P685, DOI 10.1023/A:1015793927364
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Krajewski A, 2005, J MOL STRUCT, V744, P221, DOI 10.1016/j.molstruc.2004.10.044
   Kumar TSS, 2000, BIOMATERIALS, V21, P1623
   Lafon JP, 2008, J EUR CERAM SOC, V28, P139, DOI 10.1016/j.jeurceramsoc.2007.06.009
   LEGEROS RZ, 1965, NATURE, V206, P403, DOI DOI 10.1038/206403A0
   Murugan R, 2006, ACTA BIOMATER, V2, P201, DOI 10.1016/j.actbio.2005.09.005
   OONISHI H, 1989, BIOCERAMICS, V1, P157
   Oyane A, 2003, J BIOMED MATER RES A, V64A, P339, DOI 10.1002/jbm.a.10426
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   Shi DL, 2002, J BIOMED MATER RES, V63, P71, DOI 10.1002/jbm.10087
   Suetsugu Y, 2000, J SOLID STATE CHEM, V155, P292, DOI 10.1006/jssc.2000.8887
   Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i
   ZAKARIA FA, 2000, THESIS U BATH UK
NR 17
TC 0
Z9 3
U1 0
U2 5
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD SEP
PY 2009
VL 13
IS 3
BP 309
EP 312
DI 10.1179/143307509X440613
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 491JE
UT WOS:000269573900052
DA 2018-10-20
ER

PT J
AU Abe, C
   Sakamoto, F
   Ohtsu, N
   Ashino, T
   Wagatsuma, K
AF Abe, Chikage
   Sakamoto, Fuyuki
   Ohtsu, Naofumi
   Ashino, Tetsuya
   Wagatsuma, Kazuaki
TI Quantitative Evaluation of Calcium Phosphate on Surface of Titanium by
   X-ray Fluorescence Analysis
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE calcium phosphate; metallic titanium; X-ray fluorescence; inductively
   coupled plasma optical emission spectrometry; metallic biomaterial
ID CHEMICALLY TREATED TITANIUM; SIMULATED BODY-FLUID; BIOACTIVE MATERIALS;
   HYDROGEN-PEROXIDE; APATITE FORMATION; IMPLANTS; ALLOYS; METAL;
   ATTACHMENT; SUBSTRATE
AB A quantitative analysis of calcium phosphate (CP) layers deposited on metallic titanium substrates was carried out by X-ray fluorescence spectrometry (XRF) in order to evaluate the osteogenic capability of metallic biomaterials. The titanium substrates were prepared by NaOH and heat treatments, and then, they were soaked in Hanks' balanced saline solution (HBSS) at 310 K, leading to the deposition of a CP layer on the sample surface. The resulting samples were analyzed by XRF, and the amount of Ca and P in the CP layers was determined by inductively coupled plasma optical emission spectrometry (ICP-OES). As a result, calibration curves were obtained for determining the amounts of Ca. P and the CP deposition; the XRF quantification of the CP layers was carried out with good accuracy. [doi:10.2320/matertrans.M2009158]
C1 [Abe, Chikage; Sakamoto, Fuyuki; Ashino, Tetsuya; Wagatsuma, Kazuaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Ohtsu, Naofumi] Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan.
RP Abe, C (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI Ashino, Tetsuya/B-9979-2011; Wagatsuma, Kazuaki/B-3079-2012; Ohtsu,
   Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Hirakata LM, 2003, BIO-MED MATER ENG, V13, P247
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Kokubo T, 2009, J EUR CERAM SOC, V29, P1267, DOI 10.1016/j.jeurceramsoc.2008.08.004
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Liu XY, 2002, BIOMATERIALS, V23, P4065, DOI 10.1016/S0142-9612(02)00143-6
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136
   Ohtsu N, 2007, J MATER SCI-MATER M, V18, P1009, DOI 10.1007/s10856-006-0114-x
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   Steflik DE, 1998, J BIOMED MATER RES, V39, P611, DOI 10.1002/(SICI)1097-4636(19980315)39:4<611::AID-JBM16>3.0.CO;2-9
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Stoch A, 2000, J MOL STRUCT, V555, P375, DOI 10.1016/S0022-2860(00)00623-2
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
NR 24
TC 5
Z9 5
U1 0
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD SEP
PY 2009
VL 50
IS 9
BP 2297
EP 2301
DI 10.2320/matertrans.M2009158
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 512JA
UT WOS:000271242900029
OA Bronze
DA 2018-10-20
ER

PT J
AU Takahashi, A
   Hisatomi, H
AF Takahashi, Akira
   Hisatomi, Hisashi
TI Hydrophilic monomers suppress the adsorption of plasma protein onto a
   poly(vinylidene fluoride) membrane
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE dialysis; hemopurification; hydrophilic monomer; surface modification
ID DIALYSIS; BLOOD; SURFACES; CONTACT
AB Dialysis is the single most important therapy for chronic kidney disease. However, protein adsorption onto hemodialysis membranes promotes clot formation. The aim of the present Study was to develop a surface-modified membrane which suppresses protein adsorption. Using plasma polymerization. hydrophilic N-vinyl pyrrolidone (VP) and acryloyl morpholine (ACMO) were polymerized oil hydrophobic poly(vinylidene fluoride) (PVDF) Surfaces. PVDF is employed as a biomaterial owing to its extraordinary durability. These membranes were then characterized using static contact angle measurement. ATR-FTIR spectra and polyacrylamide, L,vel electrophoresis. The surface-modified PVDF membranes showed a transition of the surface from relatively hydrophobic to hydrophilic. Less proteins were adsorbed oil the VP and ACMO grafted PVDF Surfaces than oil the unmodified membrane and the commercially available hemodialysis membrane. In conclusion. VP and ACMO grafted PVDF membranes have a high potential for the inhibition of protein adsorption ill high-performance hemopurification devices.
C1 [Takahashi, Akira; Hisatomi, Hisashi] Seikei Univ, Dept Mat & Life Sci, Lab Cellular & Mol Biochem, Musashino, Tokyo 1808633, Japan.
RP Hisatomi, H (reprint author), Seikei Univ, Dept Mat & Life Sci, Lab Cellular & Mol Biochem, 3-3-1 Kichijoji Kija Machi, Musashino, Tokyo 1808633, Japan.
EM hisatomi@st.seikei.ac.jp
CR Ademovic Z, 2002, BIOMOL ENG, V19, P177, DOI 10.1016/S1389-0344(02)00020-5
   Belgacem O, 2002, J MASS SPECTROM, V37, P1118, DOI 10.1002/jms.372
   Bowry SK, 2002, INT J ARTIF ORGANS, V25, P447
   DEQUEIROZ AAA, 1995, J BIOMAT SCI-POLYM E, V7, P523, DOI 10.1163/156856295X00580
   Garrett Q, 2000, INVEST OPHTH VIS SCI, V41, P1687
   Hansch GM, 1996, NEPHROL DIAL TRANSPL, V11, P2453, DOI 10.1093/oxfordjournals.ndt.a027214
   Hoenich NA, 2007, INT J ARTIF ORGANS, V30, P964
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Kalltorp M, 2000, J MATER SCI-MATER M, V11, P191, DOI 10.1023/A:1008935826310
   Maeda Y, 2002, MACROMOLECULES, V35, P10172, DOI 10.1021/ma020945w
   Qiu Y, 2007, INT J ARTIF ORGANS, V30, P828
   Ronco C, 2001, INT J ARTIF ORGANS, V24, P726
   Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161
   Rovira-Bru M, 2001, J COLLOID INTERF SCI, V235, P70, DOI 10.1006/jcis.2000.7355
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Soltys PJ, 1998, BLOOD PURIFICAT, V16, P123, DOI 10.1159/000014325
   Sotiropoulou M, 2005, BIOMACROMOLECULES, V6, P1835, DOI 10.1021/bm050061v
   Vienken J, 2002, INT J ARTIF ORGANS, V25, P470
   Ye SH, 2003, BIOMATERIALS, V24, P4143, DOI 10.1016/S0142-9612(03)00296-5
NR 19
TC 5
Z9 5
U1 1
U2 13
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
J9 MOL MED REP
JI Mol. Med. Rep.
PD SEP-OCT
PY 2009
VL 2
IS 5
BP 749
EP 752
DI 10.3892/mmr_00000167
PG 4
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA 481TU
UT WOS:000268835600011
PM 21475896
OA Bronze
DA 2018-10-20
ER

PT J
AU Cordas, CM
   Lourenco, NMT
   Vidinha, P
   Afonso, CAM
   Barreiros, S
   Fonseca, LP
   Cabral, JMS
AF Cordas, C. M.
   Lourenco, N. M. T.
   Vidinha, P.
   Afonso, C. A. M.
   Barreiros, S.
   Fonseca, Luis P.
   Cabral, Joaquim M. S.
TI New conducting biomaterial based on Ion Jelly (R) technology for
   development of a new generation of biosensors
SO NEW BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Vidinha, P.; Afonso, C. A. M.] Inst Super Tecn, CQFM, P-1049001 Lisbon, Portugal.
   [Barreiros, S.] Univ Nova Lisboa, Fac Ciencias & Tecnol, DQ, REQUIMTE, P-2829516 Caparica, Portugal.
RI REQUIMTE, AL/H-9106-2013; Lourenco, Nuno/K-5088-2012; Mateus Afonso,
   Carlos Alberto/M-7833-2013; iMed.ULisboa, BioOrgChem/B-4209-2014; PTMS,
   RNEM/C-1589-2014; Chaves, Pedro/K-1288-2013; Institute of Chemistry -
   USP, Dept. of Chemistry/B-8988-2012; Barreiros, Susana/A-7892-2012;
   vidinha, Pedro/H-3426-2013; REQUIMTE, LAQV/N-9835-2013; Caparica,
   cqfb_staff/H-2611-2013; REQUIMTE, CENG/M-4555-2013; Cabral,
   Joaquim/G-2052-2010; Cordas, Cristina/C-2722-2012; iMed.ULisboa,
   iMed.ULisboa/C-6292-2014
OI Lourenco, Nuno/0000-0001-9329-2724; Mateus Afonso, Carlos
   Alberto/0000-0002-7284-5948; Barreiros, Susana/0000-0002-7268-5892;
   vidinha, Pedro/0000-0002-3907-4969; Cabral, Joaquim/0000-0002-2405-5845;
   Cordas, Cristina/0000-0002-7892-8955; P. Fonseca,
   Luis/0000-0001-8429-6977
NR 0
TC 1
Z9 1
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
J9 NEW BIOTECHNOL
JI New Biotech.
PD SEP
PY 2009
VL 25
SU 1
BP S138
EP S139
DI 10.1016/j.nbt.2009.06.458
PG 2
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 649HU
UT WOS:000281760100334
DA 2018-10-20
ER

PT J
AU Kirkpatrick, CJ
AF Kirkpatrick, C. J.
TI Biomaterial-based approaches and adult stem cells
SO NEW BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Kirkpatrick, C. J.] Johannes Gutenberg Univ Mainz, Inst Pathol, RepairLab, D-6500 Mainz, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
J9 NEW BIOTECHNOL
JI New Biotech.
PD SEP
PY 2009
VL 25
SU 1
BP S21
EP S21
DI 10.1016/j.nbt.2009.06.054
PG 1
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 649HU
UT WOS:000281760100049
DA 2018-10-20
ER

PT J
AU Kul'chin, YN
   Voznesenski, SS
   Bukin, OA
   Bezverbnyi, AV
   Drozdov, AL
   Nagorny, IG
   Galkina, AN
AF Kul'chin, Yu. N.
   Voznesenski, S. S.
   Bukin, O. A.
   Bezverbnyi, A. V.
   Drozdov, A. L.
   Nagorny, I. G.
   Galkina, A. N.
TI Spicules of glass sponges as a new type of self-organizing natural
   photonic crystal
SO OPTICS AND SPECTROSCOPY
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Laser Optics
CY JUN 23-28, 2008
CL St Petersburg, RUSSIA
ID FIBER; SUPERCONTINUUM; GENERATION; SKELETON; PULSES
AB The results of studying the optical characteristics of basal spicules of sea glass sponges Hyalonema sieboldi are presented. These objects are shown to be a natural nanocomposite biomaterial and to consist of a large number of axial layers of hydrated quartz that possesses a number of unique optical properties. It is found that, upon the excitation of spicules by second-harmonic pulses from an Nd:YAG laser, a considerable increase in the fluorescence intensity in the long-wavelength range with a maximum at 770 nm, saturation and anomalously large fluorescence lifetimes are observed. It has been shown experimentally that spicules exposed to femtosecond radiation pulses exhibit nonlinear optical properties. Based on the data obtained, it is concluded that spicules of glass sponges are a new type of self-organizing natural photonic crystals and are a promising object for photonics.
C1 [Kul'chin, Yu. N.; Voznesenski, S. S.; Bukin, O. A.; Bezverbnyi, A. V.; Nagorny, I. G.; Galkina, A. N.] Russian Acad Sci, Far E Branch, Inst Automat & Control Proc, Vladivostok 690041, Russia.
   [Drozdov, A. L.] Russian Acad Sci, Inst Marine Biol, Far E Branch, Vladivostok 690041, Russia.
RP Kul'chin, YN (reprint author), Russian Acad Sci, Far E Branch, Inst Automat & Control Proc, Vladivostok 690041, Russia.
EM alexb62@mail.ru
RI Kulchin, Yuri/J-9058-2014; Nagorny, Ivan/I-8211-2012; Galkina,
   Anna/Q-3118-2016
OI Kulchin, Yuri/0000-0002-8750-4775; Nagorny, Ivan/0000-0001-8376-1881;
   Galkina, Anna/0000-0002-0489-4342
CR Agrawal G. P., 1995, NONLINEAR FIBER OPTI
   Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Apolonski A, 2002, J OPT SOC AM B, V19, P2165, DOI 10.1364/JOSAB.19.002165
   Berge L, 2007, REP PROG PHYS, V70, P1633, DOI 10.1088/0034-4885/70/10/R03
   Boyd R. W., 2003, NONLINEAR OPTICS
   Gaeta AL, 2000, PHYS REV LETT, V84, P3582, DOI 10.1103/PhysRevLett.84.3582
   Gorelik VS, 2007, QUANTUM ELECTRON+, V37, P409, DOI [10.1070/QE2007v037n05ABEH013478, 10.1070/QE2007v037n05A13EH013478]
   Hartl I, 2001, OPT LETT, V26, P608, DOI 10.1364/OL.26.000608
   Holzwarth R, 2000, PHYS REV LETT, V85, P2264, DOI 10.1103/PhysRevLett.85.2264
   KODAMA Y, 1987, IEEE J QUANTUM ELECT, V23, P510, DOI 10.1109/JQE.1987.1073392
   Kul'chin YN, 2008, QUANTUM ELECTRON+, V38, P51, DOI 10.1070/QE2008v038n01ABEH013579
   KULCHIN YN, 2008, PISMA ZH TEKH FIZ, V34, P7
   Maslov DV, 2006, QUANTUM ELECTRON+, V36, P163, DOI 10.1070/QE2006v036n02ABEH012791
   Muller WEG, 2006, BIOSENS BIOELECTRON, V21, P1149, DOI 10.1016/j.bios.2005.04.017
   Smirnov S, 2006, OPT FIBER TECHNOL, V12, P122, DOI 10.1016/j.yofte.2005.07.004
   Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395
   YEH P, 1978, J OPT SOC AM, V68, P1196, DOI 10.1364/JOSA.68.001196
NR 18
TC 6
Z9 6
U1 1
U2 7
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0030-400X
J9 OPT SPECTROSC+
JI Opt. Spectrosc.
PD SEP
PY 2009
VL 107
IS 3
BP 442
EP 447
DI 10.1134/S0030400X09090227
PG 6
WC Optics; Spectroscopy
SC Optics; Spectroscopy
GA 505TX
UT WOS:000270721500022
DA 2018-10-20
ER

PT J
AU Broz, A
   Baresova, V
   Kromka, A
   Rezek, B
   Kalbacova, M
AF Broz, A.
   Baresova, V.
   Kromka, A.
   Rezek, B.
   Kalbacova, M.
TI Strong influence of hierarchically structured diamond nanotopography on
   adhesion of human osteoblasts and mesenchymal cells
SO PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium on Flexible and Transparent Electronics - From Materials to
   Devices held at the E-MRS Fall Meeting
CY SEP 15-18, 2008
CL Warsaw, POLAND
ID NANOCRYSTALLINE DIAMOND
AB We investigate the influence of different roughnesses (20, 270, and 500 nm) of silicone substrates hermetically coated with the same nanocrystalline diamond (NCD) films on adhesion (1 h) and viability (48 h) of human mesenchymal stromal cells (MSC) and human osteoblasts (SAOS-2). MSC adhere similarly on all NCD surfaces and control polystyrene (PS), however, their metabolic activity on NCD surfaces is increased. Osteoblasts adhere on NCD in significantly higher numbers than on PS and their adhesion is inversely proportional to increasing substrate roughness. Their metabolic activity is decreased on nano/microrough NCD surfaces in contrast to MSC. The data show that NCD is a suitable biomaterial and can control cell adhesion and growth. (C) 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
C1 [Broz, A.; Baresova, V.; Kalbacova, M.] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12853 2, Czech Republic.
   [Broz, A.; Baresova, V.; Kalbacova, M.] Gen Univ Hosp Prague, Prague 12853 2, Czech Republic.
   [Kromka, A.; Rezek, B.] Acad Sci Czech Republic, Inst Phys, Prague 16253 6, Czech Republic.
RP Broz, A (reprint author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Ke Karlovu 2, Prague 12853 2, Czech Republic.
EM abroz@lf1.cuni.cz
RI Rezek, Bohuslav/F-7403-2014; Broz, Antonin/N-7552-2015; Kromka,
   Alexander/G-9139-2014; Baresova, Veronika/H-4931-2017; Hubalek
   Kalbacova, Marie/G-2307-2017
OI Rezek, Bohuslav/0000-0002-0378-4598; Kromka,
   Alexander/0000-0002-3531-6748; Baresova, Veronika/0000-0001-8989-6090;
   Hubalek Kalbacova, Marie/0000-0002-3886-2218
CR Amaral M, 2008, J BIOMED MATER RES A, V87A, P91, DOI 10.1002/jbm.a.31742
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Kalbacova M, 2007, PHYS STATUS SOLIDI B, V244, P4356, DOI 10.1002/pssb.200776166
   Meyer U, 1997, BIOCHEM CELL BIOL, V75, P81, DOI 10.1139/bcb-75-1-81
   Pytlik R, 2009, BIOMATERIALS, V30, P3415, DOI 10.1016/j.biomaterials.2009.03.001
   Rezek B, 2007, PHYS STATUS SOLIDI A, V204, P2888, DOI 10.1002/pssa.200776317
   Rubio-Retama J, 2006, LANGMUIR, V22, P5837, DOI 10.1021/la060167r
   Yang L, 2009, J BIOMED MATER RES A, V91A, P548, DOI 10.1002/jbm.a.32227
NR 8
TC 10
Z9 10
U1 1
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1862-6300
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Mat.
PD SEP
PY 2009
VL 206
IS 9
BP 2038
EP 2041
DI 10.1002/pssa.200982203
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 502FD
UT WOS:000270440100019
DA 2018-10-20
ER

PT J
AU Stanescu, VN
   Olteanu, M
   Florea-Spiroiu, M
   Vuluga, Z
AF Stanescu, Viorica-Niculina
   Olteanu, Mihaela
   Florea-Spiroiu, Manuela
   Vuluga, Zina
TI FRACTAL PROPERTIES OF COLLAGEN/CHITOSAN/MONTMORILLONITE MEMBRANES
SO REVUE ROUMAINE DE CHIMIE
LA English
DT Article
DE fractal dimension; collagen; chitosan; montmorilonite
ID MONTMORILLONITE; BIOMATERIAL; COLLAGEN; CHITOSAN
AB The aim of this study was to obtain membranes with improved properties from natural, and biodegradable biopolymers with interstratified montmorillonite nanolayers and to apply the fractal concepts to the image profiles of the biopolymeric composite membranes. Organic-inorganic hybrid membranes were prepared starting from collagen (COL), chitosan (CH) and montmorillonite (MMT) with and without addition of plasticizer (PL). The structure of the hybrid membranes was characterized by X-ray diffraction (XRD), SEM (scanning electron microscopy) and fractal analysis. Based on X-ray diffraction measurements, the basal spacing of the polymer/montmorillonite was much larger than that of the natural silicate as a result of intercalating polymer chains into the gallery spaces. The collagen/chitosan/montmorillonite membranes are designed to develop new bionanocomposites.
C1 [Stanescu, Viorica-Niculina; Olteanu, Mihaela; Florea-Spiroiu, Manuela] Univ Bucharest, Dept Phys Chem, Bucharest 030018, Romania.
   [Vuluga, Zina] Natl Inst Res & Dev Chem & Petrochem ICECHIM, Bucharest 060021, Romania.
RP Stanescu, VN (reprint author), Univ Bucharest, Dept Phys Chem, 4-12 Regina Elisabeta Blvd, Bucharest 030018, Romania.
EM viorstanescu@yahoo.com
CR AHVENAINEN R, 2003, NOVEL FOOD PACKAGING, P525
   An JH, 2007, APPL CLAY SCI, V36, P256, DOI 10.1016/j.clay.2006.11.001
   AVNIR D, 1985, J COLLOID INTERF SCI, V103, P112, DOI 10.1016/0021-9797(85)90082-7
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Manoratne CH, 2006, INT J ELECTROCHEM SC, V1, P32
   Olteanu M, 2008, REV ROUM CHIM, V53, P157
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   ROUQUEROL J, 1994, PURE APPL CHEM, V66, P1739, DOI 10.1351/pac199466081739
   STANESCU V, 2008, AUB CHIM, V17, P47
   TRANDAFIR V, 2007, BIOPRODUSE PE BAZA C, P99
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang SF, 2005, POLYM DEGRAD STABIL, V90, P123, DOI 10.1016/j.polymdegradstab.2005.03.001
   Wang ZG, 2007, J MEMBRANE SCI, V304, P8, DOI 10.1016/j.memsci.2007.05.012
   Yeh MH, 2005, JPN J APPL PHYS 1, V44, P6847, DOI 10.1143/JJAP.44.6847
NR 15
TC 3
Z9 3
U1 1
U2 6
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 0035-3930
J9 REV ROUM CHIM
JI Rev. Roum. Chim.
PD SEP
PY 2009
VL 54
IS 9
BP 767
EP 771
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 546YA
UT WOS:000273850000009
DA 2018-10-20
ER

PT J
AU de la Portilla, F
   Vega, J
   Rada, R
   Segovia-Gonzales, MM
   Cisneros, N
   Maldonado, VH
   Espinosa, E
AF de la Portilla, F.
   Vega, J.
   Rada, R.
   Segovia-Gonzales, M. M.
   Cisneros, N.
   Maldonado, V. H.
   Espinosa, E.
TI Evaluation by three-dimensional anal endosonography of injectable
   silicone biomaterial (PTQ (TM)) implants to treat fecal incontinence:
   long-term localization and relation with the deterioration of the
   continence
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Review
DE Silicone; Fecal incontinence; Migration; Endosonography
ID SPHINCTER DYSFUNCTION; PERIANAL INJECTION; POLYDIMETHYLSILOXANE;
   MIGRATION; REFLUX; PASTE
AB The purposes of the study were the long-term evaluation of silicone implants with three-dimensional (3D) anal endosonography and its correlation with anal incontinence.
   Fifteen patients were injected with silicone because of anal incontinence and co-existing internal anal sphincter disruption (n = 8) or thinning (n = 7). The evaluation was performed with the Wexner score and 3D anal endosonographies.
   Forty-four implants were performed. The endosonography at 3 months detected that all the implants were properly located. At 24 months, it detected 37/44 implants of initially injected and 33/37 were properly located. Four of 37 implants had moved and 7/44 were neither in the anus nor in the rectum. A total of 8/15 patients had their implants correctly placed. Globally, silicone implants significantly improved fecal continence.
   The silicone implants might have moved or even be lost. The continence deterioration suffered by most patients after the first year of the injection has no relation with the localization and number of implants that the patients have.
C1 [de la Portilla, F.; Vega, J.; Rada, R.; Cisneros, N.; Maldonado, V. H.; Espinosa, E.] Hosp Juan Ramon Jimenez, Coloproctol Unit, Dept Gen Surg, Huelva 21005, Spain.
   [Segovia-Gonzales, M. M.] Pablo de Olavide Univ, Dept Econ Quantitat Methods & Econ Hist, Seville, Spain.
RP de la Portilla, F (reprint author), Hosp Juan Ramon Jimenez, Coloproctol Unit, Dept Gen Surg, Ronda Norte S-N, Huelva 21005, Spain.
EM delaportilla@ucphuelva.com
RI IBIS, COLOPROCTOLOGIA/H-9797-2016; MAESTRE, VICTORIA/E-9943-2015
OI Portilla de Juan, Fernando de la/0000-0003-0603-2911
CR Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   HENLY DR, 1992, J UROLOGY, V147, P376
   Kumar D, 1998, BRIT J SURG, V85, P978
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Nijhuis PH, 1998, DIS COLON RECTUM, V41, P624, DOI 10.1007/BF02235272
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   Rao SSC, 2004, GASTROENTEROLOGY, V126, pS14, DOI 10.1053/j.gastro.2003.10.013
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   SMITH DP, 1994, J UROLOGY, V152, P1221, DOI 10.1016/S0022-5347(17)32552-1
   Spyrou M, 2005, Tech Coloproctol, V9, P87, DOI 10.1007/s10151-005-0203-8
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   *UR, PROD OV
NR 19
TC 11
Z9 12
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1123-6337
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD SEP
PY 2009
VL 13
IS 3
BP 195
EP 199
DI 10.1007/s10151-009-0502-6
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 495BB
UT WOS:000269863100003
PM 19603140
DA 2018-10-20
ER

PT J
AU Peters, A
   Brey, DM
   Burdick, JA
AF Peters, Anthony
   Brey, Darren M.
   Burdick, Jason A.
TI High-Throughput and Combinatorial Technologies for Tissue Engineering
   Applications
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID EMBRYONIC STEM-CELLS; DEGRADABLE POLYMER LIBRARY; HYALURONIC-ACID
   HYDROGELS; ESTER) NETWORK PROPERTIES; FLIGHT MASS-SPECTROMETRY; DRUG
   DISCOVERY; GENE DELIVERY; BIOMATERIAL INTERACTIONS; AUTOMATED SYNTHESIS;
   SYNTHETIC-POLYMERS
AB As the field of tissue engineering progresses, new technology is essential to accelerate the identification of potentially translatable approaches for the repair of tissues damaged due to disease or trauma. The development of high-throughput and combinatorial technologies is helping to speed up research that is applicable to all aspects of the tissue engineering paradigm. This diverse technology can be used for both the rapid synthesis of polymers and their characterization with respect to local and bulk properties in a high-throughput fashion. The interactions of cells with many diverse materials in both two-and three-dimensions can be assessed rapidly through the use of microarrays and rapid outcome measures and with microfluidic devices for investigation of soluble factor and material combinations. Finally, small molecule screening of large libraries is being used to identify molecules that exhibit control over cell behavior, including stem cell differentiation. All of these approaches are aimed to move beyond traditional iterative methods to identify unique materials and molecules that would not have been identified otherwise. Although much of this work is only applicable for in vitro studies, future methods may translate into rapid screening of these approaches in vivo.
C1 [Peters, Anthony; Brey, Darren M.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
CR Abramson SD, 2005, J BIOMED MATER RES A, V73A, P116, DOI 10.1002/jbm.a.30266
   Akinc A, 2003, J AM CHEM SOC, V125, P5316, DOI 10.1021/ja034429c
   Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Ashley KM, 2003, POLYMER, V44, P769, DOI 10.1016/S0032-3861(02)00779-6
   Beers KL, 2003, LANGMUIR, V19, P3935, DOI 10.1021/la026751r
   Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364
   Brey DM, 2008, J BIOMED MATER RES A, V85A, P731, DOI 10.1002/jbm.a.31494
   Brey DM, 2008, ACTA BIOMATER, V4, P207, DOI 10.1016/j.actbio.2007.10.002
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Broderick S, 2008, JOM-US, V60, P56, DOI 10.1007/s11837-008-0035-x
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Chang KH, 2004, BIOTECHNOL BIOENG, V88, P287, DOI 10.1002/bit.20242
   Charmot D, 2001, ABSTR PAP AM CHEM S, V222, pU307
   Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   DAVIS CH, 2003, POLYM MAT SCI ENG, V88, P386
   Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302
   Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Goldberg M, 2008, ADV DRUG DELIVER REV, V60, P971, DOI 10.1016/j.addr.2008.02.005
   GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001
   Gravert DJ, 1998, J AM CHEM SOC, V120, P9481, DOI 10.1021/ja980241v
   Hansen JK, 2005, ANN OTO RHINOL LARYN, V114, P662, DOI 10.1177/000348940511400902
   Harper G, 2004, COMB CHEM HIGH T SCR, V7, P63, DOI 10.2174/138620704772884832
   Hawker CJ, 2001, ABSTR PAP AM CHEM S, V222, pU323
   Hoogenboom R, 2003, MACROMOL RAPID COMM, V24, P16
   Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v
   Huang AH, 2008, ANN BIOMED ENG, V36, P1909, DOI 10.1007/s10439-008-9562-4
   Hwang CM, 2008, LANGMUIR, V24, P6845, DOI 10.1021/la800253b
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   James K, 1999, BIOMATERIALS, V20, P2203, DOI 10.1016/S0142-9612(99)00151-9
   JANDA KD, 1994, P NATL ACAD SCI USA, V91, P10779, DOI 10.1073/pnas.91.23.10779
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2007, BIOMED MICRODEVICES, V9, P149, DOI 10.1007/s10544-006-9013-7
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   Kholodovych V, 2004, POLYMER, V45, P7367, DOI 10.1016/j.polymer.2004.09.002
   Kholodovych V, 2008, POLYMER, V49, P2435, DOI 10.1016/j.polymer.2008.03.032
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Lanzendorfer M, 2001, ABSTR PAP AM CHEM S, V221, pU323
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee PJ, 2007, BIOTECHNOL PROGR, V23, P946, DOI 10.1021/bp070053l
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g
   Lynn DM, 2001, J AM CHEM SOC, V123, P8155, DOI 10.1021/ja016288p
   Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186
   Mandenius CF, 2008, BIOTECHNOL PROGR, V24, P1191, DOI [10.1002/btpr.67, 10.1021/bp.67]
   Meier MAR, 2004, MACROMOL RAPID COMM, V25, P21, DOI 10.1002/marc.200300147
   Meier MAR, 2003, J COMB CHEM, V5, P369, DOI 10.1021/cc020101o
   Meier MAR, 2003, RAPID COMMUN MASS SP, V17, P2349, DOI 10.1002/rcm.1195
   Meier MAR, 2003, RAPID COMMUN MASS SP, V17, P713, DOI 10.1002/rcm.961
   Meredith JC, 2000, MACROMOLECULES, V33, P5760, DOI 10.1021/ma0004662
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Pasch H, 2003, MACROMOL RAPID COMM, V24, P104, DOI 10.1002/marc.200390005
   Pernagallo S, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034112
   Potyrailo RA, 2005, J COMB CHEM, V7, P190, DOI 10.1021/cc049920u
   Potyrailo RA, 2003, ANAL CHEM, V75, P4676, DOI 10.1021/ac034296d
   Potyrailo RA, 2003, J COMB CHEM, V5, P472, DOI 10.1021/cc030022s
   Potyrailo RA, 2003, MACROMOL RAPID COMM, V24, P124
   Potyrailo RA, 2002, ANGEW CHEM INT EDIT, V41, P4230, DOI 10.1002/1521-3773(20021115)41:22<4230::AID-ANIE4230>3.0.CO;2-V
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010
   Sanchez-Martin RM, 2004, CURR TOP MED CHEM, V4, P653, DOI 10.2174/1568026043451113
   Schmatloch S, 2002, ABSTR PAP AM CHEM S, V224, pU514
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Smith AP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015503
   Smith AP, 2001, J POLYM SCI POL PHYS, V39, P2141, DOI 10.1002/polb.1188
   Smith JR, 2005, QSAR COMB SCI, V24, P99, DOI 10.1002/qsar.200420062
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   Stafford CM, 2003, ABSTR PAP AM CHEM S, V226, pU478
   Swalley SE, 2006, ANAL BIOCHEM, V351, P122, DOI 10.1016/j.ab.2005.11.046
   Treiser MD, 2007, BIOTECHNIQUES, V43, P361, DOI 10.2144/000112533
   Tuchbreiter A, 2003, MACROMOL MATER ENG, V288, P29, DOI 10.1002/mame.200290030
   Tuchbreiter A, 2001, J COMB CHEM, V3, P598, DOI 10.1021/cc010033q
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Tye H, 2004, DRUG DISCOV TODAY, V9, P485, DOI 10.1016/S1359-6446(04)03086-7
   Underhill GH, 2007, CURR OPIN CHEM BIOL, V11, P357, DOI 10.1016/j.cbpa.2007.05.036
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i
   Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908
   Yan YN, 2005, BIOMATERIALS, V26, P5864, DOI 10.1016/j.biomaterials.2005.02.027
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54
   Zhang HQ, 2002, ABSTR PAP AM CHEM S, V224, pU394
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104
NR 99
TC 44
Z9 44
U1 2
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD SEP
PY 2009
VL 15
IS 3
BP 225
EP 239
DI 10.1089/ten.teb.2009.0049
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 491YW
UT WOS:000269621100002
PM 19290801
DA 2018-10-20
ER

PT J
AU Norman, LL
   Stroka, K
   Aranda-Espinoza, H
AF Norman, Leann L.
   Stroka, Kimberly
   Aranda-Espinoza, Helim
TI Guiding Axons in the Central Nervous System: A Tissue Engineering
   Approach
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID SPINAL-CORD-INJURY; CHONDROITIN SULFATE PROTEOGLYCANS; MAGNETICALLY
   ALIGNED COLLAGEN; ENHANCED NEURITE OUTGROWTH; GROWTH-FACTOR RECEPTOR;
   FOCAL ADHESION KINASE; ADULT TRANSGENIC MICE; REACTIVE ASTROCYTES;
   CARBON NANOTUBES; NEURONAL GROWTH
AB Complete axon regeneration after trauma or disease is largely unsuccessful in the central nervous system. With the fast developing advances in tissue engineering and biomaterials, many investigations have identified promising approaches for guiding axonal extension. This review highlights a variety of these approaches and describes the biomaterial properties and signaling mechanisms involved in the fabrication of optimal guidance platforms. The vast majority of axonal regeneration approaches limit themselves to observe how axons elongate and migrate in response to signaling molecules presented on the substrate materials, or more recently, in response to different chemical and mechanical substrate properties. Many of these studies are encouraging in the hope of regenerating axons after disease or injury; however, numerous barriers remain. Here we illustrate the need to optimize a permissive heterogeneous environment for axon elongation using tissue engineering approaches and a thorough understanding of the mechanical properties of the substrate, mechanotaxis, and both attractive and repulsive signaling mechanisms.
C1 [Norman, Leann L.; Stroka, Kimberly; Aranda-Espinoza, Helim] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Norman, LL (reprint author), Univ Maryland, Fischell Dept Bioengn, Room 3244 Jeong H Kim Engn Bldg 225, College Pk, MD 20742 USA.
EM lmatta@umd.edu
FU NSF [CMMI-0643783]; Department of Defense CREST Graduate Fellowship
FX This work was supported by NSF Grant CMMI-0643783 to H. A. E., an NSF
   Graduate Research Fellowship to K. S., and a Department of Defense CREST
   Graduate Fellowship to L.L.N.
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   AGUAYO AJ, 1981, J EXP BIOL, V95, P231
   AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X
   ANDERSON PN, 2007, MODEL ORGANISMS SPIN, P3
   Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1
   Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711
   Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007
   Bray GM, 1987, PROG BRAIN RES <D>, V71, P373
   BRAY GM, 1987, J EXP BIOL, V132, P5
   Bridgman PC, 2001, J NEUROSCI, V21, P6159
   Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3
   Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3
   CAJAL SR, 1890, ANAT ANZEIGER, V21, P609
   Cao X, 2003, NEUROSCIENCE, V122, P381, DOI 10.1016/j.neuroscience.2003.08.018
   Cao X, 2002, J BIOMAT SCI-POLYM E, V13, P623, DOI 10.1163/156856202320269120
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595
   Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085
   CHENG H, SCIENCE, V273, P510
   CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267
   Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z
   Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esch T, 1999, J NEUROSCI, V19, P6417
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Fawcett JW, 1998, TRENDS NEUROSCI, V21, P179, DOI 10.1016/S0166-2236(98)01241-7
   FAWCETT JW, 2006, BRAIN REPAIR, P11
   FITCH MT, 2000, DEGENERATION REGENER
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Han DW, 2005, BIOTECHNOL LETT, V27, P53, DOI 10.1007/s10529-004-6585-2
   Haq F, 2006, BIOTECHNOL PROGR, V22, P133, DOI 10.1021/bp0501625
   Hayman MW, 2004, BIOCHEM BIOPH RES CO, V314, P483, DOI 10.1016/j.bbrc.2003.12.135
   HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   JURGA M, 2009, TISSUE EN A IN PRESS
   KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201
   Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105
   Kennedy TE, 2000, BIOCHEM CELL BIOL, V78, P569, DOI 10.1139/bcb-78-5-569
   Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879
   Ketschek AR, 2007, DEV NEUROBIOL, V67, P1305, DOI 10.1002/dneu.20455
   Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9
   Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Kofron CM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016002
   Kohmura E, 1999, BRAIN RES, V849, P235, DOI 10.1016/S0006-8993(99)02163-0
   Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161
   Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852
   Krieglstein K, 2006, ADV EXP MED BIOL, V557, P1
   Kubo T, 2008, J NEUROCHEM, V105, P113, DOI 10.1111/j.1471-4159.2007.05125.x
   Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014
   Lander C, 1997, J NEUROSCI, V17, P1928
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007
   Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862
   Lin PW, 2005, J BIOMED MATER RES B, V75B, P146, DOI 10.1002/jbm.b.30276
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   LOCHTER A, 1995, J NEUROSCI RES, V42, P145, DOI 10.1002/jnr.490420202
   Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827
   Maskery S, 2005, ANNU REV BIOMED ENG, V7, P187, DOI 10.1146/annurev.bioeng.7.060804.100446
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   MCCAIG CD, 1991, EXP PHYSIOL, V76, P473, DOI 10.1113/expphysiol.1991.sp003514
   Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2<281::AID-NEU16>3.3.CO;2-W
   Moon LDF, 2001, NAT NEUROSCI, V4, P465
   Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165
   Nishio Y, 2006, J NEUROSURG-SPINE, V5, P424, DOI 10.3171/spi.2006.5.5.424
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Offenhausser A, 2007, SOFT MATTER, V3, P290, DOI 10.1039/b607615g
   OLIVER T, 1995, CELL MOTIL CYTOSKEL, V31, P225, DOI 10.1002/cm.970310306
   OLSON HE, 2009, TISSUE EN A IN PRESS
   Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699
   POWELL EM, 1990, BRAIN RES, V515, P309, DOI 10.1016/0006-8993(90)90612-F
   Putnam AJ, 2003, AM J PHYSIOL-CELL PH, V284, pC627, DOI 10.1152/ajpcell.00137.2002
   Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x
   Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9
   Richardson P M, 1991, Curr Opin Neurobiol, V1, P401, DOI 10.1016/0959-4388(91)90061-B
   Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9
   ROSSI F, 2007, MODEL ORGANISMS SPIN, P51
   Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Saltzman W, 2004, TISSUE ENG PRINCIPLE
   Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Sharma HS, 2007, CURR PHARM DESIGN, V13, P1841
   Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Skaper SD, 2005, ANN NY ACAD SCI, V1053, P376, DOI 10.1196/annals.1344.032
   SNOW DH, 2007, INT S NEUR REG PAC G, P602
   Song M, 2007, ANN BIOMED ENG, V35, P1812, DOI 10.1007/s10439-007-9348-0
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Verdu E, 2002, RESTOR NEUROL NEUROS, V20, P169
   Vogt AK, 2003, BIOTECHNOL PROGR, V19, P1562, DOI 10.1021/bp034016f
   Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649
   Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Whittlesey KJ, 2006, BIOMATERIALS, V27, P2477, DOI 10.1016/j.biomaterials.2005.11.016
   Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007
   Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2
   Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082
   Woerly S, 1996, NEUROSCI LETT, V205, P197, DOI 10.1016/0304-3940(96)12349-1
   Woerly S, 2000, NEUROSURG REV, V23, P59
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 152
TC 27
Z9 28
U1 0
U2 22
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD SEP
PY 2009
VL 15
IS 3
BP 291
EP 305
DI 10.1089/ten.teb.2009.0114
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 491YW
UT WOS:000269621100006
PM 19435403
DA 2018-10-20
ER

PT J
AU Shamis, Y
   Patel, S
   Taube, A
   Morsi, Y
   Sbarski, I
   Shramkov, Y
   Croft, RJ
   Crawford, RJ
   Ivanova, EP
AF Shamis, Yury
   Patel, Shital
   Taube, Alex
   Morsi, Yos
   Sbarski, Igor
   Shramkov, Yury
   Croft, Rodney J.
   Crawford, Russell J.
   Ivanova, Elena P.
TI A New Sterilization Technique of Bovine Pericardial Biomaterial Using
   Microwave Radiation
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; CROSS-LINKING; DESTRUCTION;
   INACTIVATION; SURVIVAL; TISSUE; ENERGY; FOODS; CELLS
AB Bioprosthetic valves created from chemically treated natural tissues such as bovine pericardial biomaterial are used as heart valve scaffolds. Methods currently available for sterilization of biomaterial for transplantation include the application of gamma radiation and chemical sterilants. These techniques, however, can be problematic because they can be expensive and lead to a reduction in tissue integrity. Therefore, improved techniques are needed that are cost effective and do not disrupt the physical properties, functionality, and lifespan of the valvular leaflets. This study examined a novel technique using nonthermal microwave radiation that could lead to the inactivation of bacteria in bovine pericardial biomaterial without compromising valve durability. Two common pathogenic species of bacteria, Escherichia coli and Staphylococcus aureus, were used as test microorganisms. Optimized microwave parameters were used to determine whether inactivation of pathogenic bacteria from bovine pericardium could be achieved. In addition, the effect of microwave sterilization on tissue integrity was examined. The mechanical properties (assessed using dynamic mechanical analysis) and tensile strength testing (using a Universal Tensile Tester) as well as thermal analysis (using thermogravimetric analysis and differential scanning calorimetry) indicated that microwave sterilization did not compromise the functionality of bovine pericardial biomaterial. Scanning electron microscopy imaging and cytotoxicity testing also confirmed that the structure and biocompatibility of transplant biomaterial remained unaltered after the sterilization process. Results from the application of this new microwave (MW) sterilization technique to bovine pericardium showed that near-complete inactivation of the contaminant bacteria was achieved. It is concluded that nonthermal inactivation of pathogenic bacteria from bovine pericardial biomaterial could be achieved using microwave radiation.
C1 [Croft, Rodney J.] Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia.
   [Shamis, Yury; Croft, Rodney J.] Australian Ctr Radiofrequency Bioeffects Res, Melbourne, Vic, Australia.
RP Ivanova, EP (reprint author), Swinburne Univ Technol, POB 218, Hawthorn, Vic 3122, Australia.
EM eivanova@swin.edu.au
RI Crawford, Russell/E-7367-2011
OI Crawford, Russell/0000-0003-1054-5285
FU Australian Centre for Radiofrequency Bioeffects Research (ACRBR)
FX The authors thankfully acknowledge the support from the Australian
   Centre for Radiofrequency Bioeffects Research (ACRBR).
CR An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   Atmaca S, 1996, Acta Microbiol Immunol Hung, V43, P371
   Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4
   BLANCO JF, 1974, POULTRY SCI, V53, P1823, DOI 10.3382/ps.0531823
   BOOKWALTER GN, 1982, J FOOD SCI, V47, P1683, DOI 10.1111/j.1365-2621.1982.tb05011.x
   DARDANONI L, 1985, J BIOELECTRICITY, V4, P171, DOI 10.3109/15368378509040371
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   DREYFUSS MS, 1980, APPL ENVIRON MICROB, V39, P13
   Eastlund Ted, 2006, Cell and Tissue Banking, V7, P147, DOI 10.1007/s10561-006-0003-z
   Farber JM, 1998, J FOOD PROTECT, V61, P1465, DOI 10.4315/0362-028X-61.11.1465
   FUJIKAWA H, 1992, APPL ENVIRON MICROB, V58, P920
   GRUNDLER W, 1982, BRIT J CANCER, V45, P206
   HANDANDINCER A, 2004, CRIT REV MICROBIOL, V30, P197
   HEDDLESON RA, 1994, J FOOD PROTECT, V57, P1025, DOI 10.4315/0362-028X-57.11.1025
   HEDDLESON RA, 1994, J FOOD SCI, V59, P447, DOI 10.1111/j.1365-2621.1994.tb06987.x
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hyland G. J., 1998, Engineering Science and Education Journal, V7, P261, DOI 10.1049/esej:19980606
   KENNETH R, 1995, HDB BIOL EFFECTS ELE
   Kozempel M, 2000, J FOOD PROCESS PRES, V24, P287, DOI 10.1111/j.1745-4549.2000.tb00420.x
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Pakhomov AG, 1998, BIOELECTROMAGNETICS, V19, P393, DOI 10.1002/(SICI)1521-186X(1998)19:7<393::AID-BEM1>3.0.CO;2-X
   POTHAKAMURY UR, 1995, FOOD RES INT, V28, P167, DOI 10.1016/0963-9969(95)90801-G
   SAMARKETU SP, 1996, AS PAC MICR C B, V2, P155
   SHAMIS Y, 2008, J FOOD ENG, V4, P1
   Shazman A., 2007, Food Chemistry, V103, P444, DOI 10.1016/j.foodchem.2006.08.024
   Stuchly MA, 1990, BIOL EFFECTS MED APP
   Sung HW, 1997, J BIOMED MATER RES, V37, P376, DOI 10.1002/(SICI)1097-4636(19971205)37:3<376::AID-JBM8>3.0.CO;2-I
   THUERY J, 1985, MICROWAVES IND SCI M
   WELT BA, 1994, APPL ENVIRON MICROB, V60, P482
   Woo IS, 2000, APPL ENVIRON MICROB, V66, P2243, DOI 10.1128/AEM.66.5.2243-2247.2000
NR 31
TC 11
Z9 13
U1 0
U2 7
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD SEP
PY 2009
VL 15
IS 3
BP 445
EP 454
DI 10.1089/ten.tec.2008.0350
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 489LX
UT WOS:000269422700014
PM 19563253
DA 2018-10-20
ER

PT J
AU Sauerbier, S
   Palmowski, M
   Vogeler, M
   Nagursky, H
   Al-Ahmad, A
   Fisch, D
   Hennig, J
   Schmelzeisen, R
   Gutwald, R
   Fasol, U
AF Sauerbier, Sebastian
   Palmowski, Moritz
   Vogeler, Michael
   Nagursky, Heiner
   Al-Ahmad, Ali
   Fisch, Dagmar
   Hennig, Juergen
   Schmelzeisen, Rainer
   Gutwald, Ralf
   Fasol, Ulrike
TI Onset and Maintenance of Angiogenesis in Biomaterials: In Vivo
   Assessment by Dynamic Contrast-Enhanced MRI
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID SINUS LIFT OPERATION; MAXILLARY; BONE; TUMORS; QUANTIFICATION; MARROW;
   BLOOD; PHASE; CELLS; GRAFT
AB Objective: To describe dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a practical tool for longitudinal assessment of angiogenesis in biomaterials.
   Background: There is a lack of suitable methods for in vivo evaluation of the integration of biomaterials in a clinical setting. In oncology, DCE-MRI is used for the longitudinal monitoring of altered tumor angiogenesis during therapy. Thus, we investigated whether DCE-MRI enables to assess the integration of biomaterials over time.
   Methods: The tested material was bovine bone matrix applied in a bilateral sinus lift procedure in combination with concentrated mononuclear cells, including mesenchymal stem cells and autologous thrombin. To assess the development of new blood vessels inside the biomaterial, DCE-MRI was carried out before and 11, 25, 53, and 104 days after surgery. Perfusionparameters were calculated according to the model of Tofts.
   Results: Analysis of the data revealed increasing parameters for perfusion and blood supply within the transplant over time. It was possible to determine the values for each transplantation site and each point of time separately.
   Conclusion: DCE-MRI is appropriate to repetitively survey angiogenesis and integration of biomaterials in patients. It seems appropriate as a valuable indicator of treatment response or failure, with consecutive adaption of the therapy regime.
C1 [Sauerbier, Sebastian; Vogeler, Michael; Schmelzeisen, Rainer; Gutwald, Ralf] Univ Hosp Freiburg, Dept Oral & Craniomaxillofacial Surg, Freiburg, Germany.
   [Palmowski, Moritz] Rhein Westfal TH Aachen, Dept Diagnost Radiol, Aachen, Germany.
   [Palmowski, Moritz] Rhein Westfal TH Aachen, Inst Expt Mol Imaging, Aachen, Germany.
   [Nagursky, Heiner] Univ Hosp Freiburg, Hard Tissue Res Lab, Dept Oral & Maxillofacial Surg, Freiburg, Germany.
   [Al-Ahmad, Ali] Univ Hosp Freiburg, Dept Operat Dent, Cell Lab, Freiburg, Germany.
   [Fisch, Dagmar; Hennig, Juergen; Fasol, Ulrike] Univ Hosp Freiburg, Dept Diagnost Radiol, Freiburg, Germany.
RP Sauerbier, S (reprint author), Univ Klin Zahn Mund & Kieferheilkunde, Abt Klin & Poliklin Mund Kiefer & Gesichtschirurg, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM sebastian.sauerbier@uniklinik-freiburg.de
RI Hennig, Jurgen/F-2424-2010
OI Schmelzeisen, Rainer/0000-0002-9686-6989
FU Geistlich Biomaterials
FX This study was not supported by any grant. Geistlich Biomaterials funded
   the animal trials that were necessary to develop the augmentation
   method.
CR Badhe SP, 2008, J SHOULDER ELB SURG, V17, p35S, DOI 10.1016/j.jse.2007.08.005
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161
   Drevs J, 2007, J CLIN ONCOL, V25, P3045, DOI 10.1200/JCO.2006.07.2066
   Ehrhart N, 2008, CLIN ORTHOP RELAT R, V466, P1897, DOI 10.1007/s11999-008-0293-5
   FASOL U, 2007, ANGIOGENESEINHIBITIO, P56
   Gray CF, 2001, CLIN ORAL IMPLAN RES, V12, P526, DOI 10.1034/j.1600-0501.2001.120514.x
   Gray CF, 1999, BRIT J ORAL MAX SURG, V37, P285, DOI 10.1054/bjom.1999.0073
   Gray CF, 2000, DENTOMAXILLOFAC RAD, V29, P154, DOI 10.1038/sj.dmfr.4600518
   Jaquiery C, 2005, ANN SURG, V242, P859, DOI 10.1097/01.sla.0000189572.02554.2c
   Jemt T, 1993, Int J Oral Maxillofac Implants, V8, P635
   Kiessling F, 2004, NEOPLASIA, V6, P213, DOI 10.1593/neo.03394
   Kiessling F, 2007, EUR RADIOL, V17, P2136, DOI 10.1007/s00330-006-0566-x
   Nandi SK, 2008, J VET SCI, V9, P183, DOI 10.4142/jvs.2008.9.2.183
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ramponi S, 2008, J MAGN RESON IMAGING, V27, P872, DOI 10.1002/jmri.21293
   Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3
   Scheffler K, 2003, MAGNET RESON MED, V49, P781, DOI 10.1002/mrm.10421
   Scheffler K, 2001, MAGNET RESON MED, V45, P720, DOI 10.1002/mrm.1097
   SCHENK RK, 1991, PROBLEMATIK KNOCHENE
   Schulze D, 2005, J CRANIO MAXILL SURG, V33, P19, DOI 10.1016/j.jcms.2004.07.004
   Senel FC, 2006, BRIT J ORAL MAX SURG, V44, P511, DOI 10.1016/j.bjoms.2006.02.004
   SENNERBY L, 1992, International Journal of Oral and Maxillofacial Implants, V7, P62
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S
   TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 27
TC 5
Z9 5
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD SEP
PY 2009
VL 15
IS 3
BP 455
EP 462
DI 10.1089/ten.tec.2008.0626
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 489LX
UT WOS:000269422700015
PM 19348591
DA 2018-10-20
ER

PT J
AU Beatty, MF
   Bhattacharyya, R
   Sarangi, S
AF Beatty, M. F.
   Bhattacharyya, R.
   Sarangi, S.
TI Small amplitude, free longitudinal vibrations of a load on a finitely
   deformed stress-softening spring with limiting extensibility
SO ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK
LA English
DT Article
DE Mullins effect; stress-softening; limiting extensibility; limited
   elasticity; small longitudinal oscillation; Gent model; Demiray model;
   Zuniga-Beatty model; biological tissue
ID RUBBER ELASTICITY; CONSTITUTIVE MODELS; CHAIN EXTENSIBILITY; CYLINDRICAL
   TUBE; EXTENSION; DEFORMATION; ELASTOMERS; INFLATION; MECHANICS; TISSUES
AB A constitutive theory for a general class of incompressible, isotropic stress-softening, limited elastic rubberlike materials is introduced. The model is applied to study the small amplitude, free longitudinal vibrational frequency of a load about a suspended static equilibrium stretch of a finitely deformed, stress-softening spring with limiting extensibility. A number of physical results, including bounds on the frequency, are reported. It is proved, for example, that the normalized vibrational frequency for the ideally elastic neo-Hookean oscillator is a lower bound for the normalized frequency of every incompressible, isotropic stress-softening, limited elastic oscillator within the general class. All results are illustrated for the special limited elastic Gent and the purely elastic Demiray biomaterial models, both with stress-softening characterized by a ZA(0)A +/- iga-Beatty front factor damage function. The results for both stress-softening models are compared with experimental data for several gum rubbers and thoracic aortic tissue provided by others; and, overall, it is found that the stress-softening, limited elastic Gent model best characterizes the data.
C1 [Beatty, M. F.] Univ Nebraska, Lexington, KY 40591 USA.
   [Bhattacharyya, R.; Sarangi, S.] Indian Inst Technol, Dept Mech Engn, Kharagpur 721302, W Bengal, India.
RP Beatty, MF (reprint author), Univ Nebraska, POB 910215, Lexington, KY 40591 USA.
EM mbeatty2@unl.edu; rbmail@mech.iitkgp.ernet.in;
   somsara@mech.iitkgp.ernet.in
CR ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6
   Beatty M.F., 2008, Q J MECH AP IN PRESS, V61, P373, DOI DOI 10.1093/QJMAM/HBN007
   Beatty M. F., 1987, APPL MECH REV, V40, P1699
   Beatty MF, 2000, J MECH PHYS SOLIDS, V48, P1931, DOI 10.1016/S0022-5096(99)00085-X
   Beatty MF, 2003, J ELASTICITY, V70, P65, DOI 10.1023/B:ELAS.0000005553.38563.91
   Beatty MF, 2003, MATH MECH SOLIDS, V8, P481, DOI 10.1177/108128603034475
   Beatty MF, 2000, J ELASTICITY, V59, P369, DOI 10.1023/A:1011007522361
   BEATTY MF, 1983, ARCH RATION MECH AN, V83, P195
   Beatty MF, 2000, Z ANGEW MATH PHYS, V51, P984
   BEATTY MF, 2000, CONTRIBUTIONS CONTIN, P25
   BEATTY MF, 1996, NONLINEAR EFFECTS FL, V45, P13
   BEATTY MF, 1987, IMA VOLUMES MATH APP, V4, P43
   Beatty MF, 2008, MATH MECH SOLIDS, V13, P375, DOI 10.1177/1081286507076405
   Beatty MF, 2009, INT J ENG SCI, V47, P1110, DOI 10.1016/j.ijengsci.2008.06.009
   Boyce MC, 1996, RUBBER CHEM TECHNOL, V69, P781, DOI 10.5254/1.3538401
   DEMIRAY H, 1976, INT J ENG SCI, V14, P789, DOI 10.1016/0020-7225(76)90063-X
   DEMIRAY H, 1972, J BIOMECH, V5, P309, DOI 10.1016/0021-9290(72)90047-4
   Dickie RA, 1971, T SOC RHEOL, V15, P91
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Horgan CO, 2003, BIOMECH MODEL MECHAN, V1, P251, DOI 10.1007/s10237-002-0022-z
   Horgan CO, 2002, J ELASTICITY, V68, P167, DOI 10.1023/A:1026029111723
   Horgan CO, 2004, P ROY SOC A-MATH PHY, V460, P1737, DOI 10.1098/rspa.2003.1248
   Horgan CO, 2002, MATH MECH SOLIDS, V7, P353, DOI 10.1177/108128028477
   Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1
   Humphrey JD, 2002, CARDIOVASCULAR SOLID
   James HM, 1943, J CHEM PHYS, V11, P455, DOI 10.1063/1.1723785
   JOHNSON MA, 1995, INT J ENG SCI, V33, P223, DOI 10.1016/0020-7225(94)E0052-K
   JOHNSON MA, 1993, CONTINUUM MECH THERM, V5, P83, DOI 10.1007/BF01141446
   KILIAN HG, 1981, POLYMER, V22, P209, DOI 10.1016/0032-3861(81)90200-7
   Krishnaswamy S, 2000, INT J ENG SCI, V38, P1397, DOI 10.1016/S0020-7225(99)00125-1
   Krishnaswamy S, 2001, Q J MECH APPL MATH, V54, P295, DOI 10.1093/qjmam/54.2.295
   LAWTON RW, 1951, J APPL PHYS, V22, P1340, DOI 10.1063/1.1699863
   Mullins L, 1957, RUBBER CHEM TECHNOL, V30, P555, DOI DOI 10.5254/1.3542705
   MULLINS L, 1947, J RUBBER RES, V16, P275, DOI DOI 10.5254/1.3546914
   Ogden RW, 2001, INT J NONLINEAR MECH, V36, P477, DOI 10.1016/S0020-7462(00)00080-9
   Ogden RW, 1999, P ROY SOC A-MATH PHY, V455, P2861, DOI 10.1098/rspa.1999.0431
   Sarangi S, 2008, J ELASTICITY, V92, P115, DOI 10.1007/s10659-007-9154-9
   TRELOAR LRG, 1954, T FARADAY SOC, V50, P881, DOI 10.1039/tf9545000881
   Truesdell C., 1965, NONLINEAR FIELD THEO, V3
   WANG MC, 1952, J CHEM PHYS, V20, P1144, DOI 10.1063/1.1700682
   Zuniga A.E., 2005, POLYMER, V46, P3496
   Zuniga A.E., 2003, MECCANICA, V38, P419
   Zuniga AE, 2002, Z ANGEW MATH PHYS, V53, P794, DOI 10.1007/PL00022513
NR 45
TC 7
Z9 7
U1 2
U2 3
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 0044-2275
J9 Z ANGEW MATH PHYS
JI Z. Angew. Math. Phys.
PD SEP
PY 2009
VL 60
IS 5
BP 971
EP 1006
DI 10.1007/s00033-008-8127-6
PG 36
WC Mathematics, Applied
SC Mathematics
GA 486QJ
UT WOS:000269212400008
DA 2018-10-20
ER

PT J
AU Neira, IS
   Kolen'ko, YV
   Lebedev, OI
   Van Tendeloo, G
   Gupta, HS
   Matsushita, N
   Yoshimura, M
   Guitian, F
AF Neira, Ines S.
   Kolen'ko, Yury V.
   Lebedev, Oleg I.
   Van Tendeloo, Gustaaf
   Gupta, Himadri S.
   Matsushita, Nobuhiro
   Yoshimura, Masahiro
   Guitian, Francisco
TI Rational synthesis of a nanocrystalline calcium phosphate cement
   exhibiting rapid conversion to hydroxyapatite
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium phosphate cement; Rapid conversion; Nanostructure; Mechanical
   properties; Nanoindentation; Osteoblast cell culture
ID TETRACALCIUM PHOSPHATE; IN-VIVO; BONE CEMENTS; NANOINDENTATION;
   CRYSTALS; BEHAVIOR; BEARING; TISSUE; LOAD
AB The rational synthesis, comprehensive characterization. and mechanical and micromechanical properties of a calcium phosphate cement are presented. Hydroxyapatite cement biomaterial was synthesized from reactive sub-micrometer-sized dicalcium phosphate dihydrate and tetracalcium phosphate via a dissolution-precipitation reaction using water as the liquid phase. As a result nanostructured, Ca-deficient and carbonated B-type hydroxyapatite is formed. The cement shows good processibility, sets in 22 +/- 2 min and entirely transforms to the end product after 6 h of setting reaction, one of the highest conversion rates among previously reported for calcium phosphate cements based on dicalcium and tetracalcium phosphates. The combination of all elucidated physical-chemical traits leads to an essential bioactivity and biocompatibility of the cement, as revealed by in vitro acellular simulated body fluid and cell culture studies.
   The compressive strength of the produced cement biomaterial was established to be 25 +/- 3 MPa. Furthermore. nanoindentation tests were performed directly on the cement to probe its local elasticity and plasticity at sub-micrometer/micrometer level. The measured elastic modulus and hardness were established to be E(s) = 23 +/- 3.5 and H = 0.7 +/- 0.2 GPa, respectively. These values are in close agreement with those reported in literature for trabecular and cortical bones, reflecting good elastic and plastic coherence between synthesized cement biomaterial and human bones. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Neira, Ines S.; Guitian, Francisco] Univ Santiago de Compostela, Inst Ceram Galicia, E-15782 Santiago De Compostela, Spain.
   [Neira, Ines S.; Kolen'ko, Yury V.; Matsushita, Nobuhiro; Yoshimura, Masahiro] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
   [Neira, Ines S.; Gupta, Himadri S.] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.
   [Lebedev, Oleg I.; Van Tendeloo, Gustaaf] Univ Antwerp, B-2020 Antwerp, Belgium.
RP Neira, IS (reprint author), Univ Santiago de Compostela, Inst Ceram Galicia, Avda Mestre Mateo,S-N, E-15782 Santiago De Compostela, Spain.
EM ines.sanchez@usc.es
RI Yoshimura, Masahiro/H-5938-2011; Kolen'ko, Yury/P-5890-2015; Lebedev,
   Oleg/B-4443-2014; Matsushita, Nobuhiro/F-9416-2014; Gupta,
   Himadri/J-2129-2012
OI Yoshimura, Masahiro/0000-0003-1810-0301; Kolen'ko,
   Yury/0000-0001-7493-1762; Gupta, Himadri Shikhar/0000-0003-2201-8933
FU Spanish Ministry of Education and Science [MAT2002-03857]; European
   Union Marie Curie EST Fellowship [MEST-CT-2004-504465]; European Union
   Framework 6 Program
FX The authors thank C. Pilz and K. P. Kommareddy for help with cell
   culture experiment. We also thank Dr. A. V. Olenev, Dr. K. A. Kovnir,
   and T. P. B. Cotter for helpful discussions. This work was partially
   supported by the Spanish Ministry of Education and Science
   (MAT2002-03857), the European Union Marie Curie EST Fellowship on
   Biomimetic Systems (MEST-CT-2004-504465) and the European Union
   Framework 6 Program under a contract for an integrated Infrastructure
   Initiative (Reference 026019 ESTEEM).
CR Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Biehl V, 2001, MATERIALWISS WERKST, V32, P137, DOI 10.1002/1521-4052(200102)32:2<137::AID-MAWE137>3.3.CO;2-Z
   Bohner M, 2007, J MATER CHEM, V17, P3980, DOI 10.1039/b706411j
   BROWN WE, 1965, J RES NBS A PHYS CH, VA 69, P547, DOI 10.6028/jres.069A.059
   BROWN WE, 1985, Patent No. 4518430
   Burguera EF, 2005, KEY ENG MAT, V284-286, P15, DOI 10.4028/www.scientific.net/KEM.284-286.15
   Burguera EF, 2004, J BIOMED MATER RES A, V71A, P275, DOI 10.1002/jbm.a.30153
   DOROZHKIN SV, 2002, ANGEW CHEM INT EDIT, V41, P2130
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gbureck U, 2004, J AM CERAM SOC, V87, P311, DOI 10.1111/j.1551-2916.2004.00311.x
   Greish YE, 2003, J BIOMED MATER RES B, V67B, P632, DOI 10.1002/jbm.b.10056
   GRENOBLE DE, 1972, J BIOMEW MAT RES, P3
   GUO XE, 2001, BONE MECH HDB, P10
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1982, BIOCOMPATIBILITY ORT, V2, P129
   ISHIKAWA K, 1995, J MATER SCI-MATER M, V6, P528, DOI 10.1007/BF00151034
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   Lewis G, 2008, J BIOMED MATER RES B, V87B, P286, DOI 10.1002/jbm.b.31092
   Li XD, 2002, MATER CHARACT, V48, P11
   Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6
   MIYAMOTO Y, 1995, BIOMATERIALS, V16, P855, DOI 10.1016/0142-9612(95)94147-D
   Monma H., 1987, GYPSUM LIME, V210, P287
   MORENO EDGARD C., 1960, SOIL SCI SOC AMER PROC, V24, P94
   Nakamoto K., 1997, INFRARED RAMAN SPE B, P54
   Ni GX, 2007, J BIOMED MATER RES A, V83A, P570, DOI 10.1002/jbm.a.31294
   Ni GX, 2006, BIOMATERIALS, V27, P1963, DOI 10.1016/j.biomaterials.2005.09.044
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PERLOFF A, 1956, SCIENCE, V124, P583, DOI 10.1126/science.124.3222.583-a
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   SENNA M, 1989, PART PART SYST CHAR, V6, P163, DOI 10.1002/ppsc.19890060127
   Sun LM, 2005, KEY ENG MAT, V284-286, P23, DOI 10.4028/www.scientific.net/KEM.284-286.23
   Turner C. H., 2001, BONE MECH HDB, P7
   Xu HHK, 2004, BIOMATERIALS, V25, P4615, DOI 10.1016/j.biomaterials.2003.12.058
NR 40
TC 17
Z9 17
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 31
PY 2009
VL 29
IS 7
BP 2124
EP 2132
DI 10.1016/j.msec.2009.04.011
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 498RD
UT WOS:000270159200008
DA 2018-10-20
ER

PT J
AU Dubey, DK
   Tomar, V
AF Dubey, Devendra K.
   Tomar, Vikas
TI Role of hydroxyapatite crystal shape in nanoscale mechanical behavior of
   model tropocollagen-hydroxyapatite hard biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Strengthening and mechanisms; Biological material; Constitutive
   behavior; Molecular simulations; Texture effect
ID COLLAGEN-LIKE PEPTIDE; X-RAY-SCATTERING; MOLECULAR-DYNAMICS;
   BIOLOGICAL-MATERIALS; ELASTIC PROPERTIES; YOUNGS MODULUS; BONE; FIBRILS;
   WATER; FRACTURE
AB Shape of mineral (e.g. hydroxyapatite (HAP) or aragonite) crystais can be a strong determinant of the nanoscale strength of hard biological materials such as bone. dentin, and nacre. This work presents an understanding of the effect of HAP shape variation on nanoscale strength of model TC-HAP biomaterials. For this purpose, 3-dimensional molecular dynamics analyses of direction dependent tensile deformation in two structurally distinct TC-HAP cells with HAP crystals in needle shaped configuration and plate shaped configuration are performed. Analyses point out that the peak interfacial strength for failure is the highest for supercells with plate shaped HAP crystals. In addition, the plate shaped HAP crystals result in the localization of peak stress over a larger length scale indicating higher fracture strength. Peak strength during transverse loading is always found to be lower than that during the longitudinal loading. However, interfacial strength shows a reverse trend. Overall, analyses point out that HAP crystal shape along with the optimal direction of applied loading with respect to the TC-HAP orientation strongly influence biomaterial strength at the nanoscale. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Dubey, Devendra K.; Tomar, Vikas] Univ Notre Dame, Notre Dame, IN 46556 USA.
RP Tomar, V (reprint author), Univ Notre Dame, Notre Dame, IN 46556 USA.
EM vikas.tomar@nd.edu
FU University of Notre Dame's
FX Authors acknowledge the support from the University of Notre Dame's
   startup support funds.
CR ANDERSON D, 2005, THESIS U TARONTO
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Berryman JG, 2005, J MECH PHYS SOLIDS, V53, P2141, DOI 10.1016/j.jmps.2005.05.004
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   BILTZ RM, 1969, J BONE JOINT SURG AM, VA 51, P456, DOI 10.2106/00004623-196951030-00003
   Bonucci E, 2000, MECH TESTING BONE BO
   Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Currey J.D., 2002, BONES STRUCTURE MECH
   Dubey DK, 2009, ACTA BIOMATER, V5, P2704, DOI 10.1016/j.actbio.2009.02.035
   DUBEY DK, J MECH PHYS SO UNPUB
   DUBEY DK, 2009, J PHYS COND IN PRESS
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Gupta HS, 2006, INT J FRACTURE, V139, P425, DOI 10.1007/s10704-006-6635-y
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   Handgraaf JW, 2006, PROTEINS, V64, P711, DOI 10.1002/prot.21019
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   HUANG CC, 1998, FERR PAC S BIOC, P349
   Israelowitz M, 2005, PROTEIN ENG DES SEL, V18, P329, DOI 10.1093/protein/gzi037
   Jager I, 2000, BIOPHYS J, V79, P1737
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Klein TE, 1999, BIOPOLYMERS, V49, P167
   Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Lorenzo AC, 2005, J BIOMECH, V38, P1527, DOI 10.1016/j.jbiomech.2004.07.011
   MATSUSHIMA N, 1982, JPN J APPL PHYS 1, V21, P186, DOI 10.1143/JJAP.21.186
   MUELLER KH, 1966, J BONE JOINT SURG AM, VA 48, P140, DOI 10.2106/00004623-196648010-00014
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Radmer RJ, 2006, BIOPHYS J, V90, P578, DOI 10.1529/biophysj.105.065276
   Rodriguez-Navarro AB, 2006, J STRUCT BIOL, V156, P355, DOI 10.1016/j.jsb.2006.04.009
   SASAKI N, 1995, J BIOMECH, V28, P809, DOI 10.1016/0021-9290(94)00130-V
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024
   TIMMINS PA, 1977, CALC TISS RES, V23, P1, DOI 10.1007/BF02012759
   Tomar V, 2007, J MECH PHYS SOLIDS, V55, P1053, DOI 10.1016/j.jmps.2006.10.005
   Vesentini S, 2005, BIOMECH MODEL MECHAN, V3, P224, DOI 10.1007/s10237-004-0064-5
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
   Zhou M, 2003, P ROY SOC A-MATH PHY, V459, P2347, DOI 10.1098/rspa.2003.1127
NR 54
TC 24
Z9 24
U1 2
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 31
PY 2009
VL 29
IS 7
BP 2133
EP 2140
DI 10.1016/j.msec.2009.04.015
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 498RD
UT WOS:000270159200009
DA 2018-10-20
ER

PT J
AU Lu, Q
   Hu, K
   Feng, QL
   Cui, FZ
AF Lu, Qiang
   Hu, Kun
   Feng, QingLing
   Cui, Fuzhai
TI Growth of fibroblast and vascular smooth muscle cells in
   fibroin/collagen scaffold
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Fibroin; Collagen; Cell culture; Biomaterial; Biocompatibility
ID SILK FIBROIN NET; FILMS; ATTACHMENT; HYDROGELS; MATRICES; CULTURE
AB In our recent study, a novel fibroin/collagen scaffold with improved mechanical properties and controllable porous structure was prepared through freeze-drying method. In this research, the cyto-compatibility was further studied, using fibroblast and vascular smooth muscle cells (VSMC) as the model cells. MTT results indicated that the growth of fibroblast and VSMC both further improved in the fibroin/collagen scaffold than in pure fibroin scaffolds. The confocal and SEM results showed that fibroblast cells and VSMCs had better adhesion and spreading properties in the fibroin/collagen scaffolds. Although further studies, such as the extracellular matrix production and the functional gene expression. are necessary to clarify the biocompatibility of the fibroin/collagen scaffolds, the present results indicate that the fibroin/collagen scaffold is a new scaffold material suitable for tissue engineering. On the other hand, the mild and allaqueous preparation processes also make it possible to embed different growth factors inside the scaffolds to maximize cell functions and the formation of specific tissues. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Lu, Qiang; Hu, Kun; Feng, QingLing; Cui, Fuzhai] Tsinghua Univ, Adv Mat Lab, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Feng, QL (reprint author), Tsinghua Univ, Adv Mat Lab, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
FU National Basic Research Program of China [2005CB623905]; Foundation of
   Analysis and Testing in Tsinghua University
FX This work is supported by the National Basic Research Program of China
   (No. 2005CB623905) and the Foundation of Analysis and Testing in
   Tsinghua University.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lu Q, 2004, CHEM J CHINESE U, V25, P1752
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Lv Q, 2008, J APPL POLYM SCI, V109, P1577, DOI 10.1002/app.24546
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Zhang JC, 2005, POLYMER, V46, P4979, DOI 10.1016/j.polymer.20058.02.120
NR 28
TC 18
Z9 20
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 31
PY 2009
VL 29
IS 7
BP 2239
EP 2245
DI 10.1016/j.msec.2009.05.014
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 498RD
UT WOS:000270159200025
DA 2018-10-20
ER

PT J
AU Tian, YS
   Kim, HJ
   Kim, HM
AF Tian, Yu Shun
   Kim, Hyun Jung
   Kim, Hyun-Man
TI Rho-associated kinase (ROCK) inhibition reverses low cell activity on
   hydrophobic surfaces
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Hydrophobicity; Rho-associated kinase; Y-27632; Osteoblast; Cell cycle;
   Migration; Adhesion; Tissue engineering; Biomaterial
ID SMOOTH-MUSCLE-CELLS; ACRYLIC-ACID; PROTEIN-RHO; GTPASES; MOTILITY;
   ADHESION; Y-27632; PROLIFERATION; EXPRESSION; MORPHOLOGY
AB Hydrophobic polymers do not offer an adequate scaffold surface for cells to attach, migrate, proliferate, and differentiate. Thus, hydrophobic scaffolds for tissue engineering have traditionally been physicochemically modified to enhance cellular activity. However, modifying the surface by chemical or physical treatment requires Supplementary engineering procedures. In the present study, regulation of a cell signal transduction pathway reversed the low Cellular activity on a hydrophobic surface without Surface modification. inhibition of Rho-associated kinase (ROCK) by Y-27632 markedly enhanced adhesion, Migration, and proliferation of osteoblastic cells cultured on a hydrophobic polystyrene Surface. ROCK inhibition regulated cell-cycle-related molecules on the hydrophobic Surface. This inhibition also decreased expression of the inhibitors of cyclin-dependent kinases such as p21(cip1) and p27(kip1) and increased expression of cyclin A and D. These results indicate that defective cellular activity on the hydrophobic Surface can be reversed by the control of a cell signal transduction pathway Without physicochemical surface modification. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Kim, Hyun-Man] Seoul Natl Univ, Sch Dent, Dept Oral Histol & Dev Biol, Lab Study Mol Biointerfaces, Seoul 110749, South Korea.
   Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
RP Kim, HM (reprint author), Seoul Natl Univ, Sch Dent, Dept Oral Histol & Dev Biol, Lab Study Mol Biointerfaces, Seoul 110749, South Korea.
EM hyunmkim@snu.ac.kr
FU Education, Ministry of Science and Technology, Korea; Korean Science and
   Engineering Foundation; Seoul National University
FX This work was supported by a research grant from the Education, Ministry
   of Science and Technology, Korea and the Korean Science and Engineering
   Foundation through the Intellectual Biointerface Engineering Center
   (IBEC) at Seoul National University.
CR Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Chang YZ, 2002, CIRC RES, V91, P390, DOI 10.1161/01.RES.0000033524.92083.64
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chung TW, 2006, ARTIF ORGANS, V30, P35, DOI 10.1111/j.1525-1594.2006.00178.x
   Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05
   Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168
   Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x
   Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396
   Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587
   Iwamoto H, 2000, J HEPATOL, V32, P762, DOI 10.1016/S0168-8278(00)80245-7
   Kiian I, 2003, THROMB HAEMOSTASIS, V89, P904
   Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006
   Leung T, 1996, MOL CELL BIOL, V16, P5313
   Liao DK, 2007, J CARDIOVASC PHARM, V50, P17
   Liu B, 2002, SURGERY, V132, P317, DOI 10.1067/msy.2002.125786
   Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c
   Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456
   Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425
   Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128
   Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.athersclerosis.2005.04.023
   Safinia L, 2005, BIOMATERIALS, V26, P7537, DOI 10.1016/j.biomaterials.2005.05.078
   Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007
   Ying L, 2003, BIOMACROMOLECULES, V4, P157, DOI 10.1021/bm025676w
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
NR 30
TC 17
Z9 18
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 28
PY 2009
VL 386
IS 3
BP 499
EP 503
DI 10.1016/j.bbrc.2009.06.087
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 474DH
UT WOS:000268262100017
PM 19545543
DA 2018-10-20
ER

PT J
AU Anseth, KS
AF Anseth, Kristi S.
TI BIOT 187-Tailoring biomaterial niches for tissue regeneration
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Dept Chem Engn, Boulder, CO 80309 USA.
EM kristi.anseth@colorado.edu
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 16
PY 2009
VL 238
MA 187-BIOT
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V16HY
UT WOS:000207861901756
DA 2018-10-20
ER

PT J
AU Cai, L
   Wang, SF
AF Cai, Lei
   Wang, Shanfeng
TI Roles of crosslinking density and crystallinity in tuning injectable
   biomaterial properties
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Cai, Lei; Wang, Shanfeng] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM lcai@utk.edu; swang16@utk.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 16
PY 2009
VL 238
MA 437-PMSE
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V16HY
UT WOS:000207861905709
DA 2018-10-20
ER

PT J
AU Dupas-Bruzek, C
   Robbe, O
   Addad, A
   Turrell, S
   Derozier, D
AF Dupas-Bruzek, C.
   Robbe, O.
   Addad, A.
   Turrell, S.
   Derozier, D.
TI Transformation of medical grade silicone rubber under Nd:YAG and excimer
   laser irradiation: First step towards a new miniaturized nerve electrode
   fabrication process
SO APPLIED SURFACE SCIENCE
LA English
DT Review
DE Poly-dimethylsiloxane; Silicone rubber; Irradiation and laser ablation;
   Physical and chemical transformation
ID SPECTROSCOPIC ANALYSIS; SURFACE MODIFICATION; VISUAL PROSTHESIS;
   POLY(DIMETHYLSILOXANE); BIOCOMPATIBILITY; RAMAN; STIMULATION; POLYMERS;
   PDMS
AB Medical grade silicone rubber, poly-dimethylsiloxane (PDMS) is a widely used biomaterial. Like for many polymers, its surface can be modified in order to change one or several of its properties which further allow this surface to be functionalized. Laser-induced surface modi. cation of PDMS under ambient conditions is an easy and powerful method for the surface modi. cation of PDMS without altering its bulk properties. In particular, we profit from both UV laser inducing surface modi. cation and of UV laser micromachining to develop a first part of a new process aiming at increasing the number of contacts and tracks within the same electrode surface to improve the nerve selectivity of implantable self sizing spiral cuff electrodes. The second and last part of the process is to further immerse the engraved electrode in an autocatalytic Pt bath leading in a selective Pt metallization of the laser irradiated tracks and contacts and thus to a functionalized PDMS surface. In the present work, we describe the different physical and chemical transformations of a medical grade PDMS as a function of the UV laser and of the irradiation conditions used. We show that the ablation depths, chemical composition, structure and morphology vary with (i) the laser wavelength (using an excimer laser at 248 nm and a frequency-quadrupled Nd:YAG laser at 266 nm), (ii) the conditions of irradiation and (iii) the pulse duration. These different modified properties are expected to have a strong influence on the nucleation and growth rates of platinum which govern the adhesion and the thickness of the Pt layer on the electrodes and thus the DC resistance of tracks. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Dupas-Bruzek, C.; Robbe, O.; Addad, A.; Turrell, S.; Derozier, D.] USTL, F-59655 Villeneuve Dascq, France.
   [Dupas-Bruzek, C.; Derozier, D.] CNRS, FR 2416, CERLA, Lab Phys Lasers Atomes & Mol,UMR 8523, F-75700 Paris, France.
   [Robbe, O.; Turrell, S.] CNRS, FR 2416, CERLA, LASIR,UMR 8516, F-75700 Paris, France.
   [Addad, A.] CNRS, UMR 8008, LSPES, F-75700 Paris, France.
RP Dupas-Bruzek, C (reprint author), USTL, F-59655 Villeneuve Dascq, France.
EM catherine.dupas@univ-lille1.fr
OI Cristini-Robbe, odile/0000-0003-4639-3770
FU European Commission [026602]; Ministere charge de la Recherche; Region
   Nord-Pas de Calais; Fonds Europeen de Developpement Economique des
   Regions
FX The development of the new process to fabricate nerve electrodes is a
   project funded by the European Commission (FP6-IST-STREP, Implantable
   Multicontact Active Nerve Electrode IMANE Contract No. 026602). The
   Centre d'Etudes et de Recherche Lasers et Applications (CERLA) is
   supported by the Ministere charge de la Recherche, the Region Nord-Pas
   de Calais, and the Fonds Europeen de Developpement Economique des
   Regions.
CR Abbasi F, 2004, INT J ADHES ADHES, V24, P247, DOI 10.1016/j.ijadhadh.2003.10.006
   Abbasi F, 2003, J POLYM SCI POL PHYS, V41, P2145, DOI 10.1002/polb.10559
   Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Archambeau C, 2004, ARTIF INTELL MED, V32, P183, DOI 10.1016/j.artmed.2004.02.004
   BEEZER AE, 1966, J CHEM SOC A, P514, DOI 10.1039/j19660000514
   Brinkmann M, 2001, CHEM MATER, V13, P967, DOI 10.1021/cm000732q
   Delbeke J, 2002, ARTIF ORGANS, V26, P232, DOI 10.1046/j.1525-1594.2002.06939.x
   DUPASBRUZEK C, J APPL PHYS UNPUB
   Fallahi D, 2003, J APPL POLYM SCI, V88, P2522, DOI 10.1002/app.11952
   Graubner VM, 2006, APPL SURF SCI, V252, P4781, DOI 10.1016/j.apsusc.2005.07.123
   Hillborg H, 1999, IEEE T DIELECT EL IN, V6, P703, DOI 10.1109/94.798127
   Jayes L, 2003, ANAL CHEM, V75, P742, DOI 10.1021/ac026012f
   Khorasani MT, 2004, J APPL POLYM SCI, V91, P2042, DOI 10.1002/app.13355
   Khorasani MT, 1999, RADIAT PHYS CHEM, V55, P685, DOI 10.1016/S0969-806X(99)00212-1
   Khorasani MT, 1996, RADIAT PHYS CHEM, V47, P881, DOI 10.1016/0969-806X(95)00166-U
   Kim H, 1999, LANGMUIR, V15, P3499, DOI 10.1021/la970039q
   MATSUDA K, 1993, BIOMATERIALS, V14, P1030, DOI 10.1016/0142-9612(93)90197-A
   Mirzadeh H, 2004, J BIOMED MATER RES B, V68B, P191, DOI 10.1002/jbm.b.20011
   MIRZADEH H, 1994, DIE ANGEW MAKROMOL C, V218, P23
   NEU TR, 1993, BIOMATERIALS, V14, P459, DOI 10.1016/0142-9612(93)90149-V
   Ouyang M, 2000, J MEMBRANE SCI, V177, P177, DOI 10.1016/S0376-7388(00)00471-3
   Palma C, 1999, APPL SURF SCI, V138, P24, DOI 10.1016/S0169-4332(98)00382-1
   Romero E, 2001, MED BIOL ENG COMPUT, V39, P90, DOI 10.1007/BF02345271
   Takao H, 2004, APPL PHYS A-MATER, V79, P1571, DOI 10.1007/s00339-004-2850-4
   TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108
   Veraart C, 1998, BRAIN RES, V813, P181, DOI 10.1016/S0006-8993(98)00977-9
   Vince V, 2004, J BIOMAT SCI-POLYM E, V15, P173, DOI 10.1163/156856204322793566
NR 27
TC 29
Z9 29
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 15
PY 2009
VL 255
IS 21
BP 8715
EP 8721
DI 10.1016/j.apsusc.2009.06.025
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 477GF
UT WOS:000268506100001
DA 2018-10-20
ER

PT J
AU Lampe, KJ
   Namba, RM
   Silverman, TR
   Bjugstad, KB
   Mahoney, MJ
AF Lampe, Kyle J.
   Namba, Rachael M.
   Silverman, Tyler R.
   Bjugstad, Kimberly B.
   Mahoney, Melissa J.
TI Impact of Lactic Acid on Cell Proliferation and Free Radical-Induced
   Cell Death in Monolayer Cultures of Neural Precursor Cells
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE lactic acid; neural precursor cell; reactive oxygen species;
   biomaterial; biodegradable; redox
ID OXYGEN RADICALS; IN-VITRO; LACTATE; DIFFERENTIATION; PYRUVATE; NEURONS;
   SURVIVAL; BRAIN; PHOTOPOLYMERIZATION; CYTOCOMPATIBILITY
AB Biomaterials prepared from polyesters of lactic acid and glycolic acid, or a mixture of the two, degrade in the presence of water into the naturally occurring metabolites, lactic acid and glycolic acid. While the lactic acid degradation product that is released from biomaterials is well tolerated by the body, lactic acid can influence the metabolic function of cells; it can serve as an energy substrate for cells, and has been shown to have antioxidant properties. Neural precursor cells, a cell population of considerable interest as a source of cells for neural tissue regeneration strategies, generate a high amount of reactive oxygen species, and when associated with a degradable biomaterial, may be impacted by released lactic acid. In this work, the effect of lactic acid on a neural cell population containing proliferative neural precursor cells was examined in monolayer culture. Lactic acid was found to scavenge exogenously added free radicals produced in the. presence of either hydrogen peroxide or a photoinitiator (12959) commonly utilized in the preparation of photopolymerizable biomaterials. In addition to its effect on exogenously added free radicals, lactic acid reduced intracellular redox state, increased the Proliferation of the cell population, and modified the cell composition. The findings of this study provide insight into the role that lactic acid plays naturally on developing neural cells and are also of interest to biomaterials scientists that are focused on the development of degradable lactic-acid-based polymers for cell culture devices. The effect of lactic acid on other cell populations may differ and should be characterized to best understand how cells function in degradable cell culture devices. Biotechnol. Bioeng. 2009;103: 1214-1223. (C) 2009 Wiley Periodicals, Inc.
C1 [Lampe, Kyle J.; Silverman, Tyler R.; Mahoney, Melissa J.] Univ Colorado, Dept Biol & Chem Engn, Boulder, CO 80309 USA.
   [Namba, Rachael M.] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA.
   [Bjugstad, Kimberly B.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA.
RP Mahoney, MJ (reprint author), Univ Colorado, Dept Biol & Chem Engn, 424 UCB, Boulder, CO 80309 USA.
EM melissa.mahoney@colorado.edu
OI Bjugstad, Kimberly/0000-0002-0473-5413
FU NIH [R01 NS052597-02]
FX The authors would like lo thank NIH or their support (R01 NS052597-02)
   and the U.S. Department of Educations Graduate Assistantships in Areas
   of National Need Program for fellowship to K.J.L. They wo uild also like
   to thank Dr. Linda Watkins for providing the qRT-PCR primer sequences.
CR ALBERTI PW, 1998, NOISE HEALTH, V1, P1
   ANBAR M, 1967, INT J APPL RADIAT IS, V18, P493, DOI 10.1016/0020-708X(67)90115-9
   Armstrong RJE, 2000, CELL TRANSPLANT, V9, P55, DOI 10.1177/096368970000900108
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074
   DEGROOT MJM, 1995, MOL CELL BIOCHEM, V146, P147, DOI 10.1007/BF00944607
   Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x
   FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504
   GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879
   Groussard C, 2000, J APPL PHYSIOL, V89, P169
   Halliwell B, 1999, FREE RADICALS BIOL M
   Hashimoto JG, 2004, BIOTECHNIQUES, V36, P54, DOI 10.2144/04361BM06
   Herz H, 1997, FREE RADICAL RES, V26, P19, DOI 10.3109/10715769709097781
   Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0
   KLOOSTERBOER JG, 1988, ADV POLYM SCI, V84, P1
   KWCON SM, 2001, BIOSCIENCE REP, V21, P341
   LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529
   Mallet RT, 2000, P SOC EXP BIOL MED, V223, P136, DOI 10.1046/j.1525-1373.2000.22319.x
   MCCORD JM, 1978, ANN INTERN MED, V89, P122, DOI 10.7326/0003-4819-89-1-122
   O'Brien AK, 2006, MACROMOLECULES, V39, P2501, DOI 10.1021/ma0518631
   Oka S, 2004, BRAIN RES, V1030, P94, DOI 10.1016/j.brainres.2004.09.062
   Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961
   Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552
   RUTZ HP, 1995, INT J RADIAT ONCOL, V31, P525, DOI 10.1016/0360-3016(94)00362-O
   Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x
   Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797
   Studer L, 1998, NAT NEUROSCI, V1, P290
   Studer L, 2000, J NEUROSCI, V20, P7377
   Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087
   Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005
   VICARIO C, 1992, J NEUROCHEM, V59, P32, DOI 10.1111/j.1471-4159.1992.tb08872.x
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   YANAGIDA S, 1995, CIRC RES, V77, P773, DOI 10.1161/01.RES.77.4.773
NR 33
TC 35
Z9 36
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG 15
PY 2009
VL 103
IS 6
BP 1214
EP 1223
DI 10.1002/bit.22352
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 474EC
UT WOS:000268264300016
PM 19408314
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nagura, M
   Nomura, Y
   Gotok, Y
   Ckkosti, Y
AF Nagura, Masanobu
   Nomura, Yasutoshi
   Gotok, Yasuo
   Ckkosti, Yutaka
TI Anti-Thrombogenicity of Styrene-Butadiene-Styrene Triblock Copolymer
   Grafted with Poly(ethylene glycol)s
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE SBS; PEG; graft; microphase-separation; anti-thrombogenecity
ID SBS-G-VP; PHOSPHOLIPID POLAR GROUPS; BLOOD COMPATIBILITY;
   PLATELET-ADHESION; BIOMATERIAL USAGE; IN-VITRO; SURFACE; POLYMERS;
   POLYURETHANE; IMMOBILIZATION
AB We transformed hydrophobic/hydrophobic styrene/butadiene/styrene tri-block copolymer (SBS) to hydrophobic / hydrophilic microphase-separated surfaces by grafting with hydrophilic poly(ethylene glycol) (PEG) on poly(butadiene) (PB) domain via hydrocarboxylation and hydrobromination and investigated the anti-thrombogenicity of these surfaces. In the case of SBS cast film from toluene solution, PEG was densely grafted because of the development of an unevenness on the order of several 10 rim on the surface, which had a huge surface area in comparison with poly(butadiene) rubber with its uniformly smooth surface. Grafted PEG (molecular weight = 600) was found to clearly inhibit adhesion and activation of platelets and coagulation of the whole blood component, which is indicative of anti-thrombogenicity. These properties correspond to a surface coated by a copolymer of 2-methacryloyl-oxyethyl phosphorylcholine and n-butyl methacrylate, which is well known to be the best excellent anti-thrombogenic material in the world. Melt-molded SBS film, which also has an uneveness on the order of several 10 nm, showed similar excellent anti-thrombogenicity. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 113: 2462-2476, 2009
C1 [Nagura, Masanobu; Nomura, Yasutoshi; Gotok, Yasuo; Ckkosti, Yutaka] Shinshu Univ, Fac Text Sci & Technol, Matsumoto, Nagano, Japan.
RP Nagura, M (reprint author), Shinshu Univ, Fac Text Sci & Technol, Matsumoto, Nagano, Japan.
EM mnagura@shinshu-u.ac.jp
FU Ministry of Education, Japan [18500363]
FX Contract grant sponsor: Ministry of Education, Japan; contract grant
   number: 18500363.
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   CENNI E, 1995, BIOMATERIALS, V16, P973, DOI 10.1016/0142-9612(95)94903-X
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Ishihara K, 1998, MAT SCI ENG C-BIO S, V6, P253, DOI 10.1016/S0928-4931(98)00059-9
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   LELSH MD, 1986, POLYURETHANES MED
   Lukac I, 1998, POLYM DEGRAD STABIL, V61, P79, DOI 10.1016/S0141-3910(97)00134-1
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   NARAYANAN P, 1993, J MATER CHEM, V13, P19
   Nie FQ, 2004, POLYMER, V45, P399, DOI 10.1016/j.polymer.2003.11.007
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   OH SJ, 2001, J COLLOID INTERF SCI, P238
   OKANO T, 1979, KOBUNSHI RONBUNSHU, V36, P209, DOI 10.1295/koron.36.209
   Okkema A.Z., 1990, BIOMATERIALS, P3
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Sancheza MDR, 2005, INT ADHES ADHES, V25, P358
   SATO N, 1998, HARMFUL SIDE EFFECTS
   SEFTON MV, 1976, J BIOMED MATER RES, V10, P33, DOI 10.1002/jbm.820100105
   Senshu K, 1997, MACROMOLECULES, V30, P4421, DOI 10.1021/ma9616219
   SHIMIZU K, 2006, REP TOKYO METROPOLIT, V1, P110
   *SOC POL SCI JAP, 1985, POL EXP, P14
   Wan M, 2004, J MATER SCI-MATER M, V15, P1079, DOI 10.1023/B:JMSM.0000046389.87287.3f
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   Yoshikawa C, 2005, MACROMOLECULES, V38, P4604, DOI 10.1021/ma047556h
   Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   Zhu AP, 2007, APPL SURF SCI, V253, P3247, DOI 10.1016/j.apsusc.2006.07.036
NR 37
TC 7
Z9 8
U1 3
U2 18
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2009
VL 113
IS 4
BP 2462
EP 2476
DI 10.1002/app.30027
PG 15
WC Polymer Science
SC Polymer Science
GA 457PU
UT WOS:000266945300050
DA 2018-10-20
ER

PT J
AU Pehlivan, E
   Altuna, T
   Cetin, S
   Bhanger, MI
AF Pehlivan, Erol
   Altuna, Tuerkan
   Cetin, Serpil
   Bhanger, M. Iqbal
TI Lead sorption by waste biomass of hazelnut and almond shell
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Hazelnut; Almond; Shell; Sorption; Isotherm; Lead ion
ID HEAVY-METAL BIOSORPTION; AQUEOUS-SOLUTIONS; ACTIVATED CARBON; TOXIC
   METALS; REMOVAL; IONS; ADSORPTION; CADMIUM; COPPER; HUSK
AB The potential to remove Pb(2+) ion from aqueous solutions using the shells of hazelnut (HNS) (Corylus avellana) and almond (AS) (Prunus dulcis) through biosorption was investigated in batch experiments. The main parameters influencing Pb(2+) ion sorption on HNS and AS were: initial metal ion concentration. amount of adsorbent, contact time and pH value of solution. The influences of initial Pb(2+) ion concentration (0.1-1.0 mM), pH (2-9), contact time (10-240 min) and adsorbent amount (0.1-1.0 g) have been investigated. Equilibrium isotherms have been measured and modelled. Adsorption of Pb(2+) ions was in all cases pH-dependent showing a maximum at equilibrium pH values between 6.0 and 7.0, depending on the biomaterial, that corresponded to equilibrium pH values of 6.0 for HNS and 7.0 for AS. The equilibrium sorption capacities of HNS and AS were 28.18 and 8.08 mg/g for lead, respectively after equilibrium time of 2 h. The adsorption data fit well with the Langmuir isotherm model and the experimental result inferred that adsorption, chelation and ion exchange are major adsorption mechanisms for binding Pb(2+) ion to the sorbents. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Pehlivan, Erol; Altuna, Tuerkan; Cetin, Serpil] Selcuk Univ, Dept Chem Engn, TR-42079 Konya, Turkey.
   [Bhanger, M. Iqbal] Univ Sindh, Natl Ctr Excellence Analyt Chem, Jamshoro 76080, Pakistan.
RP Pehlivan, E (reprint author), Selcuk Univ, Dept Chem Engn, TR-42079 Konya, Turkey.
EM erolpehlivan@gmail.com
RI Bhangar, Iqbal/F-6952-2015
FU Selcuk University Scientific Research Foundation [05101014/2005]
FX We express our thanks to the Selcuk University Scientific Research
   Foundation, which has financed the project (05101014/2005), a part of
   which is presented in this study.
CR Agarwal GS, 2006, BIORESOURCE TECHNOL, V97, P949, DOI 10.1016/j.biortech.2005.04.030
   AlAsheh S, 1997, J HAZARD MATER, V56, P35, DOI 10.1016/S0304-3894(97)00040-X
   *ASTM, 1983, ASTM ANN BOOK AM SOC, P1102
   Babarinde NAA, 2006, INT J PHYS SCI, V1, P23
   Baes C. F., 1976, HYDROLYSIS CATIONS
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Basso MC, 2002, IND ENG CHEM RES, V41, P3580, DOI 10.1021/ie020023h
   Bhattacharya AK, 2006, CHEM ENG J, V123, P43, DOI 10.1016/j.cej.2006.06.012
   CHUI ZC, 1999, IND WASTEWATER TREAT, P82
   Cloirec P., 2002, ENVIRON SCI TECHNOL, V36, P67
   Crist RH, 1996, ENVIRON SCI TECHNOL, V30, P2456, DOI 10.1021/es950569d
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Figueira MM, 2000, WATER RES, V34, P196, DOI 10.1016/S0043-1354(99)00120-7
   Gaballah I, 1998, J GEOCHEM EXPLOR, V62, P241, DOI 10.1016/S0375-6742(97)00068-X
   Gode F, 2006, J HAZARD MATER, V136, P330, DOI 10.1016/j.jhazmat.2005.12.021
   Guo XY, 2008, J HAZARD MATER, V151, P134, DOI 10.1016/j.jhazmat.2007.05.065
   Hanafiah M. A. K., 2007, J BIOL SCI, V7, P222
   Ho YS, 2004, HYDROMETALLURGY, V73, P55, DOI 10.1016/j.hydromet.2003.07.008
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   IQBAL M, 2002, BIORESOURCE TECHNOL, V81, P153
   Johnson PD, 2002, WASTE MANAGE, V22, P471, DOI 10.1016/S0956-053X(01)00036-8
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kobya M, 2004, BIORESOURCE TECHNOL, V91, P317, DOI 10.1016/j.biortech.2003.07.001
   Laszlo J. A., 1994, J APPL POLYM SCI, V52, P521
   Lee B. G., 2004, Journal of Natural Fibers, V1, P97, DOI 10.1300/J395v01n01_07
   Li Q, 2007, J HAZARD MATER, V141, P163, DOI 10.1016/j.jhazmat.2006.06.109
   Li SG, 2004, FUEL PROCESS TECHNOL, V85, P1201, DOI 10.1016/j.fuproc.2003.11.043
   Liu MH, 2002, J APPL POLYM SCI, V84, P478, DOI 10.1002/app.10114
   LOW KS, 1995, BIORESOURCE TECHNOL, V51, P227, DOI 10.1016/0960-8524(94)00123-I
   Low KS, 2000, PROCESS BIOCHEM, V36, P59, DOI 10.1016/S0032-9592(00)00177-1
   Madoni P, 1996, WATER RES, V30, P135, DOI 10.1016/0043-1354(95)00124-4
   Marzal P, 1996, J CHEM TECHNOL BIOT, V66, P279, DOI 10.1002/(SICI)1097-4660(199607)66:3<279::AID-JCTB506>3.3.CO;2-B
   Meunier N, 2003, BIORESOURCE TECHNOL, V90, P255, DOI 10.1016/S0960-8524(03)00129-9
   Nassar MM, 1997, CHEM ENG J, V66, P223, DOI 10.1016/S1385-8947(96)03193-2
   OKIEIMEN FE, 1991, J CHEM TECHNOL BIOT, V51, P97
   ORHAN Y, 1993, WATER SCI TECHNOL, V28, P247
   Pehlivan E, 2007, FUEL PROCESS TECHNOL, V88, P99, DOI 10.1016/j.fuproc.2006.09.004
   Pehlivan E, 2006, ENERG SOURCE PART A, V28, P1493, DOI 10.1080/15567030600817936
   Pehlivan E, 2006, J HAZARD MATER, V135, P193, DOI 10.1016/j.jhazmat.2005.11.049
   Pehlivan E, 2006, ENERG SOURCE PART A, V28, P1099, DOI 10.1080/009083190910451
   PINO H, 2006, SEP SCI TECHNOL, V41, P3141
   Prasad MNV, 2000, ENVIRON POLLUT, V110, P277, DOI 10.1016/S0269-7491(99)00306-1
   Quek SY, 1998, WATER SA, V24, P251
   Robinson T, 2002, BIORESOURCE TECHNOL, V85, P43, DOI 10.1016/S0960-8524(02)00070-6
   ROWELL RM, 2006, ECOWOOD 2006 2 INT C
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Singh KK, 2006, BIORESOURCE TECHNOL, V97, P2124, DOI 10.1016/j.biortech.2005.09.016
   Tan WT, 1998, ENVIRON TECHNOL LETT, V9, P1223
   Villaescusa I, 2004, WATER RES, V38, P992, DOI 10.1016/j.watres.2003.10.040
   Volesky B., 2000, BIOSORPTION HEAVY ME
   Wing RE, 1996, IND CROP PROD, V5, P301, DOI 10.1016/S0926-6690(96)00030-1
   Zulkali MMD, 2006, J CHEM TECHNOL BIOT, V81, P1324, DOI 10.1002/jctb.1429
NR 52
TC 120
Z9 128
U1 1
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD AUG 15
PY 2009
VL 167
IS 1-3
BP 1203
EP 1208
DI 10.1016/j.jhazmat.2009.01.126
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 461KX
UT WOS:000267267000176
PM 19272708
DA 2018-10-20
ER

PT J
AU Lei, B
   Chen, XF
   Wang, YJ
   Zhao, N
AF Lei, Bo
   Chen, Xiaofeng
   Wang, Yingjun
   Zhao, Naru
TI Synthesis and in vitro bioactivity of novel mesoporous hollow bioactive
   glass microspheres
SO MATERIALS LETTERS
LA English
DT Article
DE Sol-gel preparation; Sintering; Hollow microspheres; Bioactive glass;
   Bioactivity; Biomaterials
ID DRUG-DELIVERY; SILICA
AB The remarkable tissue-repairing bioactivity and biocompatibility of bioactive glass make it suitable for a wide range of applications. Here, novel mesoporous hollow bioactive glass microspheres (MHBGMs) with a uniform diameter range of 2-5 mu m were prepared by a sol-gel method. Structural characterization indicated that the shell of hollow sphere had a mesopore size range between 2 and 10 nm and a thickness about 500 nm. The in vitro bioactivity test indicated that the novel structure exhibited high in vitro bioactivity. The uniform microspherical morphology and mesoporous hollow structure of MHBGMs. together with their high bioactivity, turn them into a good candidate as an injectable and drug-loading biomaterial for in vivo tissue regeneration and drug control release. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chen, Xiaofeng] S China Univ Technol, Biomat Res Inst, Coll Mat Sci & Engn, Guangzhou 510640, Peoples R China.
   S China Univ Technol, Minist Educ, Key Lab Specially Funct Mat, Guangzhou 510640, Peoples R China.
RP Chen, XF (reprint author), S China Univ Technol, Biomat Res Inst, Coll Mat Sci & Engn, Guangzhou 510640, Peoples R China.
EM leiboaray@yahoo.com.cn; chenxf@scut.edu.cn
RI Lei, Bo/B-9463-2009
FU National Natural Science Foundation of China [50672028, 50830101,
   50732003]
FX The research was supported by the National Natural Science Foundation of
   China (Grant No. 50672028) and the key project of the National Natural
   Science Foundation of China (Grant Nos. 50830101 and 50732003).
CR Doadrio AL, 2004, J CONTROL RELEASE, V97, P125, DOI 10.1016/j.jcornel.2004.03.005
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Horcajada P, 2004, MICROPOR MESOPOR MAT, V68, P105, DOI 10.1016/j.micromeso.2003.12.012
   Huang WH, 2009, J MATER SCI-MATER M, V20, P123, DOI 10.1007/s10856-008-3554-7
   Kang SW, 2006, J BIOMAT SCI-POLYM E, V17, P925, DOI 10.1163/156856206777996862
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Komlev VS, 2003, SCI TECHNOL ADV MAT, V4, P503, DOI 10.1016/j.stam.2003.11.007
   Manzano M, 2008, CHEM ENG J, V137, P30, DOI 10.1016/j.cej.2007.07.078
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   SLOWING H, 2007, ADV FUNCT MATER, V17, P1225
   Trewyn BG, 2004, NANO LETT, V4, P2139, DOI 10.1021/nl048774r
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   Wu W, 2009, COLLOID SURFACE A, V334, P131, DOI 10.1016/j.colsurfa.2008.10.043
   Zhang A, 2008, CRYST GROWTH DES, V8, P2402, DOI 10.1021/cg701257x
NR 16
TC 38
Z9 43
U1 2
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG 15
PY 2009
VL 63
IS 20
BP 1719
EP 1721
DI 10.1016/j.matlet.2009.04.041
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 467FW
UT WOS:000267724500025
DA 2018-10-20
ER

PT J
AU Rim, NG
   Lee, JH
   Jeong, SI
   Lee, BK
   Kim, CH
   Shin, H
AF Rim, Nae Gyune
   Lee, Ji Hye
   Jeong, Sung In
   Lee, Bu Kyu
   Kim, Chun Ho
   Shin, Heungsoo
TI Modulation of Osteogenic Differentiation of Human Mesenchymal Stem Cells
   by Poly[(L-lactide)-co-(epsilon-caprolactone)]/Gelatin Nanofibers
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE gelatin; human mesenchymal stem cells (hMSCs); nanofibers; osteogenic
   differentiation; poly[(L-lactide)-co-(epsilon-caprolactone)]
ID IN-VITRO; BIOMEDICAL APPLICATIONS; PROGENITOR CELLS; SCAFFOLDS; GROWTH;
   COLLAGEN; COMPOSITE; ADHESION; GELATIN; VIVO
AB Developing biomaterial scaffolds to elicit specific cell responses is important in many tissue engineering applications. We hypothesized that the chemical composition of the scaffold may be a key determinant for the effective induction of differentiation in human mesenchymal stem cells (hMSCs). In this study, electrospun nanofibers with different chemical compositions were fabricated using poly[(L-lactide)-co-(epsilon-caprolactone)] (PLCL) and gelatin. Scanning electron microscopy (SEM) images showed a randomly arranged structure of nanofibers with diameters ranging from 400 nm to 600 nm. The incorporation of gelatin in the nanofibers stimulated the adhesion and osteogenic differentiation of hMSCs. For example, the well-stretched and polygonal morphology of hMSCs was observed on the gelatin-containing nanofibers, while the cells cultured on the PLCL nanofibers were contracted. The DNA content and alkaline phosphatase activity were significantly increased on the PLCL/gelatin blended nanofibers. Expression of osteogenic genes including alkaline phosphatase (ALP), osteocalcin (OCN), and collagen type I-alpha 2 (Col I-alpha 2) were also upregulated in cells cultured on nanofibers with gelatin. Mineralization of hMSCs was analyzed by von Kossa staining and the amount of calcium was significantly enhanced on the gelatin-incorporated nanofibers. These results suggest that the chemical composition of the underlying scaffolds play a key role in regulating the osteogenic differentiation of hMSCs.
C1 [Rim, Nae Gyune; Lee, Ji Hye; Shin, Heungsoo] Hanyang Univ, Dept Bioengn, Hanyang Fus Mat Program, Coll Engn, Seoul 133791, South Korea.
   [Jeong, Sung In] Hanyang Univ, Dept Chem Engn, Coll Engn, Seoul 133791, South Korea.
   [Lee, Bu Kyu] Univ Ulsan, Dept Oral & Maxillofacial Surg, Asan Med Ctr, Coll Med, Seoul 138736, South Korea.
   [Kim, Chun Ho] Korea Inst Radiol & Med Sci, Lab Tissue Engn, Seoul 139240, South Korea.
RP Shin, H (reprint author), Hanyang Univ, Dept Bioengn, Hanyang Fus Mat Program, Coll Engn, 17 Haengdang Dong, Seoul 133791, South Korea.
EM hshin@hanyang.ac.kr
FU Korea government (MOST) [2008-01224, 20090062253]
FX This work was partially supported by a grant from the Korea Science and
   Engineering Foundation (KOSEF) funded by the Korea government (MOST)
   (No. 2008-01224) (to H. Shin) and by Nuclear Research & Development
   Program of the Korea Science and Engineering Foundation (KOSEF) grant
   funded by the Korean government (MEST) (No. 20090062253) (to C. H. Kim).
CR Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hyonchol K, 2002, COLLOID SURFACE B, V25, P33, DOI 10.1016/S0927-7765(01)00299-5
   Jeong SI, 2004, BIOMACROMOLECULES, V5, P1303, DOI 10.1021/bm049921i
   Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Wu BM, 1996, J CONTROL RELEASE, V40, P77, DOI 10.1016/0168-3659(95)00173-5
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 48
TC 31
Z9 33
U1 0
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG 11
PY 2009
VL 9
IS 8
BP 795
EP 804
DI 10.1002/mabi.200800358
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 487QR
UT WOS:000269290400007
PM 19434677
DA 2018-10-20
ER

PT J
AU Wang, J
AF Wang, Joseph
TI Biomolecule-Functionalized Nanowires: From Nanosensors to Nanocarriers
SO CHEMPHYSCHEM
LA English
DT Review
DE hybrid systems; materials science; nanobiotechnology; nanowires; surface
   chemistry
ID BARCODED METAL NANOWIRES; GOLD NANORODS; ELECTRICAL DETECTION;
   ELECTROCHEMICAL BIOSENSORS; TEMPLATE SYNTHESIS; DNA HYBRIDIZATION;
   THERAPY; DELIVERY; ARRAYS; SENSOR
AB The unique properties of nanowires offer excellent prospects for designing a new generation of devices and systems exhibiting novel functions. This Review discusses recent scientific accomplishments in the preparation of nanowire-biomaterial hybrids and their potential applications as nanosensors, nanoactuators and nanocarriers. Nanowires can be readily functionalized with various biochemicals through different linkage chemistries. Such integration of nanowires and biomolecules leads to novel hybrid systems which couple the recognition or catalytic properties of biomaterials with the attractive, electronic and structural characteristics of nanowires. Receptor functionalized nanowires are particularly attractive for direct real-time label-free electrical detection of biomolecular interactions. The unique control over the microstructure of nanowires, and particularly the design of multisegment nanowires, offer spatially defined regions for the defined organization of different biomoleucules. This allows the resulting nanowires to perform several tasks simulataneously, and opens the door to a variety of important applications in the areas of nanobioelectronics and nanomedicine. For example, multisegment nanowires designed for nanomedicine applications can couple the selective targeting, therapy, and imaging functions. Such spatially defined anchoring of different biorecognition sites provides also distinct opportunities for the self assembly of nanowires into predetermined designs. The opportunities and challenges involved in designing such nanowire-biomaterial hybrid systems and devices are discussed in the following sections.
C1 Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
RP Wang, J (reprint author), Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
EM josephwang@ucsd.edu
RI Wang, Joseph/C-6175-2011
FU NSF [CHE 0840684]
FX The author acknowledges financial support from NSF (Grant CHE 0840684).
CR Bangar MA, 2009, ELECTROANAL, V21, P61, DOI 10.1002/elan.200804372
   Bentley AK, 2005, J CHEM EDUC, V82, P765, DOI 10.1021/ed082p765
   Bunimovich YL, 2006, J AM CHEM SOC, V128, P16323, DOI 10.1021/ja065923u
   Chen WW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206102
   Cui Y., 2001, SCIENCE, V293, P5533
   Eghtedari M, 2009, NANO LETT, V9, P287, DOI 10.1021/nl802915q
   Gao ZQ, 2007, ANAL CHEM, V79, P3291, DOI 10.1021/ac061808q
   Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b
   Hou SF, 2005, NANO LETT, V5, P231, DOI 10.1021/nl048305p
   Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h
   Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a
   Huang YF, 2008, ANAL CHEM, V80, P567, DOI 10.1021/ac702322j
   Huff TB, 2007, LANGMUIR, V23, P1596, DOI 10.1021/la062642r
   Hurst SJ, 2006, ANGEW CHEM INT EDIT, V45, P2672, DOI 10.1002/anie.200504025
   Keating CD, 2003, ADV MATER, V15, P451, DOI 10.1002/adma.200390105
   Laocharoensuk R, 2007, CHEM COMMUN, P3362, DOI 10.1039/b708313k
   Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t
   Loaiza O. A., 2007, ANGEW CHEM INT EDIT, V119, P1530
   Loaiza OA, 2007, ANGEW CHEM INT EDIT, V46, P1508, DOI 10.1002/anie.200604082
   Mallouk T. E., 2009, SCI AM, P72
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   Mbindyo JKN, 2001, ADV MATER, V13, P249, DOI 10.1002/1521-4095(200102)13:4<249::AID-ADMA249>3.0.CO;2-9
   Meenach SA, 2007, SMALL, V3, P239, DOI 10.1002/smll.200600362
   Melosh NA, 2003, SCIENCE, V300, P112, DOI 10.1126/science.1081940
   Morrow TJ, 2009, SCIENCE, V323, P352, DOI 10.1126/science.1165921
   Nicewarner-Pena S, 2001, SCIENCE, V294, P147
   Oyelere AK, 2007, BIOCONJUGATE CHEM, V18, P1490, DOI 10.1021/bc070132i
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   Patolsky F, 2006, ANAL CHEM, V78, P4260, DOI 10.1021/ac069419j
   Patolsky F, 2005, MATER TODAY, V8, P20, DOI 10.1016/S1369-7021(05)00791-1
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Ramanathan K, 2005, J AM CHEM SOC, V127, P496, DOI 10.1021/ja044486l
   Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585
   Salem AK, 2004, NANO LETT, V4, P1163, DOI 10.1021/nl049462r
   Salem AK, 2003, NAT MATER, V2, P668, DOI 10.1038/nmat974
   Stoermer RL, 2006, J AM CHEM SOC, V128, P16892, DOI 10.1021/ja0658261
   TOK JBH, 2006, ANGEW CHEM, V118, P7054
   Tok JBH, 2006, ANGEW CHEM INT EDIT, V45, P6900, DOI 10.1002/anie.200601104
   Tong L, 2009, PHOTOCHEM PHOTOBIOL, V85, P21, DOI 10.1111/j.1751-1097.2008.00507.x
   von Maltzahn G, 2009, CANCER RES, V69, P3892, DOI 10.1158/0008-5472.CAN-08-4242
   Walton ID, 2002, ANAL CHEM, V74, P2240, DOI 10.1021/ac020073w
   Wanekaya AK, 2006, ELECTROANAL, V18, P533, DOI 10.1002/elan.200503449
   Wang J, 2008, ELECTROANAL, V20, P611, DOI 10.1002/elan.200704120
   Wang J, 2005, ANALYST, V130, P421, DOI 10.1039/b414248a
   Wang J, 2003, ANAL CHEM, V75, P6218, DOI 10.1021/ac034730b
   Wang J, 2008, J MATER CHEM, V18, P4017, DOI 10.1039/b803807d
   Wang J, 2009, ACS NANO, V3, P4, DOI 10.1021/nn800829k
   Wang RH, 2008, NANO LETT, V8, P2625, DOI 10.1021/nl080366q
   Wang X, 2008, NANO LETT, V8, P398, DOI 10.1021/nl071180e
   Wijaya A, 2009, ACS NANO, V3, P80, DOI 10.1021/nn800702n
   Wildt B, 2006, LANGMUIR, V22, P10528, DOI 10.1021/la061184j
   Zang JF, 2007, ELECTROANAL, V19, P1008, DOI 10.1002/elan.200603808
   Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138
NR 53
TC 57
Z9 57
U1 1
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1439-4235
J9 CHEMPHYSCHEM
JI ChemPhysChem
PD AUG 3
PY 2009
VL 10
IS 11
BP 1748
EP 1755
DI 10.1002/cphc.200900377
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 481NH
UT WOS:000268817800005
PM 19575484
DA 2018-10-20
ER

PT J
AU MaHam, A
   Tang, ZW
   Wu, H
   Wang, J
   Lin, YH
AF MaHam, Aihui
   Tang, Zhiwen
   Wu, Hong
   Wang, Jun
   Lin, Yuehe
TI Protein-Based Nanomedicine Platforms for Drug Delivery
SO SMALL
LA English
DT Review
DE drug-delivery systems; nanomedicine; protein cages; tumors
ID HEAT-SHOCK-PROTEIN; COWPEA MOSAIC-VIRUS; METASTATIC BREAST-CANCER;
   ALBUMIN-BOUND PACLITAXEL; IN-VIVO EVALUATION; METHANOCOCCUS-JANNASCHII;
   TUMOR VASCULATURE; CONTRAST AGENTS; BUILDING-BLOCKS; PHAGE DISPLAY
AB Protein-based nanomedicine platforms for drug delivery comprise naturally self-assembled protein subunits of the same protein or a combination of proteins making up a complete system. They are ideal for drug-delivery platforms due to their biocompatibility and biodegradability coupled with low toxicity. A variety of proteins have been used and characterized for drug-delivery systems, including the ferritin/apoferritin protein cage, plant-derived viral capsids, the small Heat shock protein (sHsp) cage, albumin, soy and whey protein, collagen, and gelatin. There are many different types and shapes that have been prepared to deliver drug molecules using protein-based platforms, including various protein cages, microspheres, nanoparticles, hydrogels, films, minirods, and minipellets. The protein cage is the most newly developed biomaterial for drug delivery and therapeutic applications. The uniform size, multifunctionality, and biodegradability push it to the frontier of drug delivery. In. this Review, the recent strategic development of drug delivery is discussed with emphasis on polymer-based, especially protein-based, nanomedicine platforms for drug delivery. The advantages and disadvantages are also discussed for each type of protein-based drug-delivery system.
C1 [MaHam, Aihui; Tang, Zhiwen; Wu, Hong; Wang, Jun; Lin, Yuehe] Pacific NW Natl Lab, Richland, WA 99352 USA.
RP Lin, YH (reprint author), Pacific NW Natl Lab, Richland, WA 99352 USA.
EM Yuehe.Lin@pnl.gov
RI Lin, Yuehe/D-9762-2011; Tang, Xiaolei/B-8585-2011
OI Lin, Yuehe/0000-0003-3791-7587; 
FU Pacific Northwest National Laboratory (PNNL); U.S. Department of Energy
   (DOE)'s Office of Biological and Environmental Research
   [DE-AC05-76RL01830]
FX This work is supported by a laboratory-directed research and development
   program at Pacific Northwest National Laboratory (PNNL). Part of the
   research described in this paper was performed at the Environmental
   Molecular Sciences Laboratory, a national scientific user facility
   sponsored by the U.S. Department of Energy (DOE)'s Office of Biological
   and Environmental Research and located at PNNL. PNNL is operated by
   Battelle for DOE under Contract DE-AC05-76RL01830.
CR ADLERMOORE J, 1994, BONE MARROW TRANSPL, V14, pS3
   Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P
   Ajani JA, 2000, CANCER J, V6, P78
   Allen M, 2005, MAGN RESON MED, V54, P807, DOI 10.1002/mrm.20614
   Allen M, 2003, INORG CHEM, V42, P6300, DOI 10.1021/ic0343657
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   ARVINTE T, 1987, BIOCHEMISTRY-US, V26, P765, DOI 10.1021/bi00377a017
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   Barnhill HN, 2007, J AM CHEM SOC, V129, P7799, DOI 10.1021/ja069148u
   Basu G, 2003, J BIOL INORG CHEM, V8, P721, DOI 10.1007/s00775-003-0470-7
   Beaulieu L, 2002, BIOMACROMOLECULES, V3, P239, DOI 10.1021/bm010082z
   Berthold A, 1998, EUR J PHARM BIOPHARM, V45, P23, DOI 10.1016/S0939-6411(97)00119-7
   Blum AS, 2005, SMALL, V1, P702, DOI 10.1002/smll.200500021
   Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200
   Bressler NM, 2002, AM J OPHTHALMOL, V133, P168, DOI 10.1016/S0002-9394(01)01237-5
   Brown KC, 2004, CHEM BIOL, V11, P1033, DOI 10.1016/j.chembiol.2004.08.004
   Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g
   Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118
   Chatterji A, 2004, BIOCONJUGATE CHEM, V15, P807, DOI 10.1021/bc0402888
   Chen LY, 2008, BIOMATERIALS, V29, P3750, DOI 10.1016/j.biomaterials.2008.05.025
   Chen LY, 2006, BIOMATERIALS, V27, P4646, DOI 10.1016/j.biomaterials.2006.04.037
   Cortesi R, 2002, BIOMATERIALS, V23, P2283, DOI 10.1016/S0142-9612(01)00362-3
   DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233
   Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223
   Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211
   DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54
   Douglas T, 2000, INORG CHEM, V39, P1828, DOI 10.1021/ic991269q
   Drummond DC, 1999, PHARMACOL REV, V51, P691
   Duclairoir C, 2003, INT J PHARM, V253, P133, DOI 10.1016/S0378-5173(02)00701-9
   Duclairoir C, 2002, J MICROENCAPSUL, V19, P53, DOI 10.1080/02652040110055207
   Dujardin E, 2003, NANO LETT, V3, P413, DOI 10.1021/nl034004o
   Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958
   ELIAS DJ, 1990, CANCER RES, V50, P4154
   Flenniken ML, 2006, CHEM BIOL, V13, P161, DOI 10.1016/j.chembiol.2005.11.007
   Flenniken ML, 2005, CHEM COMMUN, P447, DOI 10.1039/b413435d
   Flenniken ML, 2003, NANO LETT, V3, P1573, DOI 10.1021/nl034786l
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   Furgeson DY, 2006, J CONTROL RELEASE, V110, P362, DOI 10.1016/j.jconrel.2005.10.006
   Glantz MJ, 1999, CLIN CANCER RES, V5, P3394
   Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   Gunasekaran S, 2006, J APPL POLYM SCI, V99, P2470, DOI 10.1002/app.22838
   GUTIERREZMERINO C, 1995, BIOCHEMISTRY-US, V34, P4846, DOI 10.1021/bi00014a042
   Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657
   Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9
   Hooker JM, 2004, J AM CHEM SOC, V126, P3718, DOI 10.1021/ja031790q
   Hufton SE, 1999, J IMMUNOL METHODS, V231, P39, DOI 10.1016/S0022-1759(99)00139-8
   Ibrahim NK, 2005, J CLIN ONCOL, V23, P6019, DOI 10.1200/JCO.2005.11.013
   Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038
   Jenning V, 2000, INT J PHARM, V199, P167, DOI 10.1016/S0378-5173(00)00378-1
   Kaiser CR, 2007, INT J NANOMED, V2, P715
   Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838
   Khopade AJ, 2000, J BIOMATER APPL, V14, P389, DOI 10.1106/GQAH-RV8H-HDXP-W9PL
   Khor IW, 2002, J VIROL, V76, P4412, DOI 10.1128/JVI.76.9.4412-4419.2002
   Kim KK, 1998, J STRUCT BIOL, V121, P76, DOI 10.1006/jsbi.1998.3969
   Kim KK, 1998, NATURE, V394, P595
   Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129
   Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199
   Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010
   Kuijpers AJ, 2000, J CONTROL RELEASE, V67, P323, DOI 10.1016/S0168-3659(00)00221-2
   Kuijpers AJ, 2000, BIOMATERIALS, V21, P1763, DOI 10.1016/S0142-9612(00)00064-8
   Kurose T, 2007, POLYM ENG SCI, V47, P374, DOI 10.1002/pen.20716
   LAGUZZA BC, 1989, J MED CHEM, V32, P548, DOI 10.1021/jm00123a007
   Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483
   LATHA MS, 1995, J MICROENCAPSUL, V12, P7, DOI 10.3109/02652049509051122
   Latha MS, 2000, CONTRACEPTION, V61, P329, DOI 10.1016/S0010-7824(00)00113-X
   LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0
   Lee ES, 2005, NANO LETT, V5, P325, DOI 10.1021/nl0479987
   Lee LA, 2006, NANOMED-NANOTECHNOL, V2, P137, DOI 10.1016/j.nano.2006.07.009
   LEE TK, 1981, SCIENCE, V213, P233, DOI 10.1126/science.6787705
   LENTZ BR, 1982, BIOCHEMISTRY-US, V21, P6799, DOI 10.1021/bi00269a028
   Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368
   Liepold L, 2007, MAGN RESON MED, V58, P871, DOI 10.1002/mrm.21307
   Liu GD, 2007, ANAL CHEM, V79, P5614, DOI 10.1021/ac070086f
   Liu GD, 2006, ANAL CHEM, V78, P7417, DOI 10.1021/ac060653j
   Liu GD, 2006, CHEMBIOCHEM, V7, P1315, DOI 10.1002/cbic.200600225
   Liu GD, 2006, SMALL, V2, P1139, DOI 10.1002/smll.200600206
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Loo L, 2008, CHEM COMMUN, P88, DOI 10.1039/b714748a
   Lu W, 2007, J CONTROL RELEASE, V118, P38, DOI 10.1016/j.jconrel.2006.11.015
   Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Matsuoka J, 1988, T AM SOC ART INT ORG, V34, P729
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B
   Metzmacher I, 2007, EUR J PHARM BIOPHARM, V67, P349, DOI 10.1016/j.ejpb.2007.02.013
   MOON MH, 1993, J PHARMACEUT BIOMED, V11, P911, DOI 10.1016/0731-7085(93)80049-7
   Muvaffak A, 2004, J BIOMED MATER RES B, V71B, P295, DOI 10.1002/jbm.b.30092
   Nam KT, 2004, NANO LETT, V4, P23, DOI 10.1021/nl0347536
   Park HY, 1998, INT J PHARM, V175, P231, DOI 10.1016/S0378-5173(98)00289-0
   Park JW, 2004, SEMIN ONCOL, V31, P196, DOI 10.1053/j.seminoncol.2004.08.009
   Park PSH, 2004, FEBS LETT, V567, P344, DOI 10.1016/j.febslet.2004.03.124
   Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Rae CS, 2005, VIROLOGY, V343, P224, DOI 10.1016/j.virol.2005.08.017
   Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+
   Raja KS, 2003, CHEMBIOCHEM, V4, P1348, DOI 10.1002/cbic.200300759
   Reichen J, 1999, NEWS PHYSIOL SCI, V14, P117
   Ren Y, 2007, BIOCONJUGATE CHEM, V18, P836, DOI 10.1021/bc060361p
   ROSENBERG M, 1993, FOOD STRUCT, V12, P31
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724
   Ruoslahti E, 2000, SEMIN CANCER BIOL, V10, P435, DOI 10.1006/scbi.2000.0334
   Schlick TL, 2005, J AM CHEM SOC, V127, P3718, DOI 10.1021/ja046239n
   Schwarz C, 1999, J MICROENCAPSUL, V16, P205, DOI 10.1080/026520499289185
   Scott CE, 1997, J CATAL, V166, P333, DOI 10.1006/jcat.1997.1526
   Singh P, 2007, J CONTROL RELEASE, V120, P41, DOI 10.1016/j.jconrel.2007.04.003
   Singh P, 2006, DRUG DEVELOP RES, V67, P23, DOI 10.1002/ddr.20064
   Sola GAR, 2000, RADIOCHIM ACTA, V88, P157, DOI 10.1524/ract.2000.88.3-4.157
   Soto CM, 2004, ELECTROPHORESIS, V25, P2901, DOI 10.1002/elps.200306029
   Strable E, 2004, NANO LETT, V4, P1385, DOI 10.1021/nl0493850
   Subirade M, 1998, INT J BIOL MACROMOL, V23, P241, DOI 10.1016/S0141-8130(98)00052-X
   Suci PA, 2007, LANGMUIR, V23, P12280, DOI 10.1021/la7021424
   Suci PA, 2007, CHEM BIOL, V14, P387, DOI 10.1016/j.chembiol.2007.02.006
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V54, P125, DOI 10.1016/S0939-6411(02)00046-2
   Tolcher AW, 1999, J CLIN ONCOL, V17, P478, DOI 10.1200/JCO.1999.17.2.478
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   TRAIL PA, 1993, SCIENCE, V261, P212, DOI 10.1126/science.8327892
   TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772
   UADIA P, 1984, CANCER RES, V44, P4263
   Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168
   Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690
   Umamaheshwari RB, 2004, J CONTROL RELEASE, V99, P27, DOI 10.1016/j.jconrel.2004.06.006
   Vasey PA, 1999, CLIN CANCER RES, V5, P83
   Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459
   Wang Q, 2003, BIOCONJUGATE CHEM, V14, P38, DOI 10.1021/bc025587g
   Wang Q, 2002, CHEM BIOL, V9, P813, DOI 10.1016/S1074-5521(02)00166-7
   WILLMOTT N, 1989, J PHARM PHARMACOL, V41, P433, DOI 10.1111/j.2042-7158.1989.tb06496.x
   WILLMOTT N, 1992, J PHARM PHARMACOL, V44, P472, DOI 10.1111/j.2042-7158.1992.tb03649.x
   Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114
   Wu H, 2008, J NANOSCI NANOTECHNO, V8, P2316, DOI 10.1166/jnn.2008.177
   Wu H, 2008, J MATER CHEM, V18, P1779, DOI 10.1039/b717613a
   Young M, 2008, ANNU REV PHYTOPATHOL, V46, P361, DOI 10.1146/annurev.phyto.032508.131939
NR 137
TC 261
Z9 264
U1 16
U2 282
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD AUG 3
PY 2009
VL 5
IS 15
BP 1706
EP 1721
DI 10.1002/smll.200801602
PG 16
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 482TP
UT WOS:000268911900001
PM 19572330
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Perry, CC
   Patwardhan, SV
   Deschaume, O
AF Perry, Carole C.
   Patwardhan, Siddharth V.
   Deschaume, Olivier
TI From biominerals to biomaterials: the role of biomolecule-mineral
   interactions
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT Meeting on Bionanotechnology II - From Biomolecular Assembly to
   Applications
CY JAN 07-09, 2009
CL Robinson Coll, Cambridge, ENGLAND
HO Robinson Coll
DE biomaterial; biomineral; biomolecule; inorganic material; mineral
ID AMINO-ACIDS; THALASSIOSIRA-PSEUDONANA; NANOMATERIAL SYNTHESIS; BINDING
   POLYPEPTIDES; PROTEIN ADSORPTION; BARIUM SULFATES; PEPTIDES; SURFACE;
   SILICA; INTERFACE
AB Interactions between inorganic materials and biomolecules at the molecular level, although complex, are commonplace. Examples include biominerals, which are, in most cases, facilitated by and in contact with biomolecules; implantable biomaterials; and food and drug handling. The effectiveness of these functional materials is dependent on the interfacial properties, i.e. the extent of molecular level 'association' with biomolecules. The present article gives information on biomolecule-inorganic material interactions and illustrates our current understanding using selected examples. The examples include (i) mechanism of biointegration: the role of surface chemistry and protein adsorption, (ii) towards improved aluminium-containing materials, and (iii) understanding the bioinorganic interface: experiment and modelling. A wide range of experimental techniques (microscopic, spectroscopic, particle sizing, thermal methods and solution methods) are used by the research group to study interactions between (bio)molecules and molecular and colloidal species that are coupled with computational simulation studies to gain as much information as possible on the molecular-scale interactions. our goal is to uncover the mechanisms underpinning any interactions and to identify 'rules' or 'guiding principles' that could be used to explain and hence predict behaviour for a wide range of (bio)molecule-mineral systems.
C1 [Perry, Carole C.; Patwardhan, Siddharth V.; Deschaume, Olivier] Nottingham Trent Univ, Sch Sci & Technol, Biomol & Mat Interface Res Grp, Nottingham NG11 8NS, England.
RP Perry, CC (reprint author), Nottingham Trent Univ, Sch Sci & Technol, Biomol & Mat Interface Res Grp, Clifton Lane, Nottingham NG11 8NS, England.
EM carole.perry@ntu.ac.uk
RI Patwardhan, Siddharth/B-5037-2009
OI Patwardhan, Siddharth/0000-0002-4958-8840; Perry, Professor
   Carole/0000-0003-1517-468X; Deschaume, Olivier/0000-0001-6222-0947
FU Engineering and Physical Sciences Research Council [EP/E048439/1];
   Biotechnology and Biological Sciences Research Council
CR Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k
   ANDERSON OR, 1990, PHILOS T R SOC LON B, V239, P81
   Asuri P, 2006, CURR OPIN BIOTECH, V17, P562, DOI 10.1016/j.copbio.2006.09.002
   Baeuerlein E., 2000, BIOMINERALIZATION BI
   Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f
   Bergfors E., 2004, Journal of Allergy and Clinical Immunology, V113, pS294, DOI 10.1016/j.jaci.2004.01.535
   Berkowitz J, 2005, WATER RES, V39, P3918, DOI 10.1016/j.watres.2005.06.025
   Braun R, 2002, J BIOMAT SCI-POLYM E, V13, P747, DOI 10.1163/156856202760197384
   Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269
   Brutchey RL, 2008, CHEM REV, V108, P4915, DOI 10.1021/cr078256b
   Coradin T, 2001, COLLOID SURFACE B, V21, P329, DOI 10.1016/S0927-7765(01)00143-6
   CURRIE HA, 2007, HYBRID MAT SYNTHESIS, P255
   Currie HA, 2007, ANN BOT-LONDON, V100, P1383, DOI 10.1093/aob/mcm247
   Deschaume O, 2008, NEW J CHEM, V32, P1346, DOI 10.1039/b805406c
   Deschaume O, 2006, LANGMUIR, V22, P10078, DOI 10.1021/la061285h
   Evans JS, 2003, CURR OPIN COLLOID IN, V8, P48, DOI 10.1016/S1359-0294(03)00009-8
   Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200
   Ghiringhelli LM, 2008, J AM CHEM SOC, V130, P13460, DOI 10.1021/ja804350v
   Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y
   Hong GY, 2009, ACS APPL MATER INTER, V1, P388, DOI 10.1021/am800099z
   HUGHES NP, 1989, PROC R SOC SER B-BIO, V238, P223, DOI 10.1098/rspb.1989.0078
   Imamura K, 2000, J COLLOID INTERF SCI, V229, P237, DOI 10.1006/jcis.2000.7016
   Kacar T, 2009, ADV MATER, V21, P295, DOI 10.1002/adma.200801877
   Kriplani U, 2005, CURR OPIN BIOTECH, V16, P470, DOI 10.1016/j.copbio.2005.07.001
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   MANN S, 1989, BIOMINERALIZATION
   Mann S, 2001, BIOMINERALIZATION PR
   Matsunaga T, 2003, TRENDS MICROBIOL, V11, P536, DOI 10.1016/j.tim.2003.09.008
   Merzlyak A, 2006, CURR OPIN CHEM BIOL, V10, P246, DOI 10.1016/j.cbpa.2006.04.008
   Muller WEG, 2006, MICRON, V37, P107, DOI 10.1016/j.micron.2005.09.003
   MULLER WEG, 2003, SILICON BIOMINERALIZ
   Naik RR, 2002, J NANOSCI NANOTECHNO, V2, P95, DOI 10.1166/jnn.2002.074
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Oren EE, 2007, BIOINFORMATICS, V23, P2816, DOI 10.1093/bioinformatics/btm436
   PERRY CC, 1988, EXPERIENTIA, V44, P638, DOI 10.1007/BF01941024
   PERRY CC, 1984, PROC R SOC SER B-BIO, V222, P427, DOI 10.1098/rspb.1984.0075
   Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291
   Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130
   PERRY CC, 1989, BIOMINERALIZATION CH, P223
   Rimola A, 2008, LANGMUIR, V24, P14027, DOI 10.1021/la8029352
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764
   Tamerler C, 2007, MAT SCI ENG C-BIO S, V27, P558, DOI 10.1016/j.msec.2006.05.046
   Thai CK, 2004, BIOTECHNOL BIOENG, V87, P129, DOI 10.1002/bit.20149
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Whaley SR, 2000, NATURE, V405, P665
   WILCOCK JR, 1988, PROC R SOC SER B-BIO, V233, P393, DOI 10.1098/rspb.1988.0029
   WILCOCK JR, 1989, PROC R SOC SER B-BIO, V238, P203, DOI 10.1098/rspb.1989.0077
   Willett RL, 2005, P NATL ACAD SCI USA, V102, P7817, DOI 10.1073/pnas.0408565102
NR 52
TC 10
Z9 10
U1 0
U2 23
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD AUG
PY 2009
VL 37
BP 687
EP 691
DI 10.1042/BST0370687
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 482QC
UT WOS:000268902800010
PM 19614576
OA Bronze
DA 2018-10-20
ER

PT J
AU Lawson, MC
   Shoemaker, R
   Hoth, KB
   Bowman, CN
   Anseth, KS
AF Lawson, McKinley C.
   Shoemaker, Richard
   Hoth, Kevin B.
   Bowman, Christopher N.
   Anseth, Kristi S.
TI Polymerizable Vancomycin Derivatives for Bactericidal Biomaterial
   Surface Modification: Structure-Function Evaluation
SO BIOMACROMOLECULES
LA English
DT Article
ID LIVING RADICAL POLYMERIZATION; BIODEGRADABLE ANTIMICROBIAL POLYMER;
   ANTIBACTERIAL ACTIVITY; GLYCOPEPTIDE ANTIBIOTICS; MOLECULAR RECOGNITION;
   PHOSPHONIUM SALTS; BLOCK COPOLYMERS; BINDING; MODEL; DIMERIZATION
AB Surface modification of implantable biomaterials with biologically active functionalities, including antimicrobials, has wide potential for addressing implant-related design problems. Here, four polymerizable vancomycin derivatives bearing either acrylamide or poly(ethylene glycol) (PEG)-acrylate were synthesized and then polymerized through a surface-mediated reaction. Functionalization of vancomycin at either the V(3) or the X(1) position decreased monomeric activity by 6-75-fold depending on the modification site and the nature of the adduct (P < 0.08 for all comparisons). A 5000 Da PEG chain showed an order of magnitude decrease in activity relative to a 3400 Da counterpart. Molecular dynamics computational simulations were used to explore the mechanisms of this decreased activity. Assays were also conducted to demonstrate the utility of a living radical photopolymerization to create functional, polymeric surfaces with these monomers and to demonstrate surface-based activity against Staphylococcus epidermidis. In particular, the vancomycin-PEG-acrylate derivatives demonstrated a 7-8 log reduction in bacterial colony forming units (CFU) with respect to nonfunctionalized control surfaces.
C1 [Lawson, McKinley C.; Hoth, Kevin B.; Bowman, Christopher N.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Lawson, McKinley C.] Univ Colorado, Sch Med, Med Scientist Training Program, MD Ph D Program, Denver, CO 80220 USA.
   [Shoemaker, Richard] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
RI Bowman, Christopher/B-1490-2008; Shoemaker, Richard/M-7409-2013
OI Bowman, Christopher/0000-0001-8458-7723; Shoemaker,
   Richard/0000-0002-0805-1449
FU National Science Foundation [DE 16523]; U.S. Department of Education
FX The authors wish to acknowledge the National Science Foundation for
   partial support of this research through Grant DE 16523, and the U.S.
   Department of Education for a GAANN fellowship to M.C.L.
CR Arimoto H, 1999, CHEM COMMUN, P1361, DOI 10.1039/a903529j
   Arimoto H, 2001, TETRAHEDRON LETT, V42, P3347, DOI 10.1016/S0040-4039(01)00429-4
   Balasundaram G, 2007, MACROMOL BIOSCI, V7, P635, DOI 10.1002/mabi.200600270
   Barnes K, 2007, J APPL POLYM SCI, V105, P2306, DOI 10.1002/app.26280
   Boneca IG, 2003, EXPERT OPIN THER TAR, V7, P311, DOI 10.1517/eott.7.3.311.22432
   Chen LB, 2007, J BIOMED MATER RES B, V83B, P589, DOI 10.1002/jbm.b.30832
   CHIRIFE J, 1983, ANTIMICROB AGENTS CH, V24, P409, DOI 10.1128/AAC.24.3.409
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Diana J, 2006, RAPID COMMUN MASS SP, V20, P685, DOI 10.1002/rcm.2364
   Dizman B, 2005, BIOMACROMOLECULES, V6, P514, DOI 10.1021/bm049383+
   Frommelt L, 2000, INTERFACES TOTAL HIP, P153
   Gao BJ, 2007, J BIOMAT SCI-POLYM E, V18, P531, DOI 10.1163/156856207780852523
   GERHARD U, 1993, J AM CHEM SOC, V115, P232, DOI 10.1021/ja00054a033
   Griffin JH, 2003, J AM CHEM SOC, V125, P6517, DOI 10.1021/ja021293s
   Hanssen AD, 2005, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000175713.30506.77
   Harris BP, 2006, MACROMOLECULES, V39, P2764, DOI 10.1021/ma0512051
   HARRIS DC, 1996, QUANTITATIVE CHEM AN
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P169
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Hutchison JB, 2004, LAB CHIP, V4, P658, DOI 10.1039/b405985a
   IKEDA T, 1986, ANTIMICROB AGENTS CH, V30, P132, DOI 10.1128/AAC.30.1.132
   Ishizu K, 2004, J POLYM SCI POL CHEM, V42, P76, DOI 10.1002/pola.10982
   Jaffer F, 2002, BIOMATERIALS, V23, P1707, DOI 10.1016/S0142-9612(01)00298-8
   JOHNSON AW, 1972, J ANTIBIOT, V25, P292, DOI 10.7164/antibiotics.25.292
   KANAZAWA A, 1994, J APPL POLYM SCI, V53, P1237, DOI 10.1002/app.1994.070530910
   KANNAN R, 1988, J AM CHEM SOC, V110, P2946, DOI 10.1021/ja00217a042
   Kaya I, 2006, J APPL POLYM SCI, V102, P3327, DOI 10.1002/app.24801
   KAZMAIER PM, 1995, MACROMOLECULES, V28, P1841, DOI 10.1021/ma00110a018
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Lawson MC, 2007, CLIN ORTHOP RELAT R, P96, DOI 10.1097/BLO.0b013e3180986706
   Liang J, 2007, J IND MICROBIOL BIOT, V34, P157, DOI 10.1007/s10295-006-0181-5
   Liang J, 2005, J APPL POLYM SCI, V97, P1161, DOI 10.1002/app.21814
   Lim SH, 2004, CARBOHYD RES, V339, P313, DOI 10.1016/j.carres.2003.10.024
   Loll PJ, 2000, ANNU REV BIOPH BIOM, V29, P265, DOI 10.1146/annurev.biophys.29.1.265
   Lu GQ, 2007, REACT FUNCT POLYM, V67, P355, DOI 10.1016/j.reactfunctpolym.2007.01.008
   Luo J, 2006, J BIOMED MATER RES A, V77A, P823, DOI 10.1002/jbm.a.30689
   Mendez JA, 2002, J BIOMED MATER RES, V61, P66, DOI 10.1002/jbm.10142
   Moon WS, 2003, J APPL POLYM SCI, V90, P2933, DOI 10.1002/app.13019
   Moon WS, 2003, J APPL POLYM SCI, V90, P1797, DOI 10.1002/app.12813
   Nakamura K, 1996, TETRAHEDRON LETT, V37, P191, DOI 10.1016/0040-4039(95)02112-4
   NAKAMURA K, 1995, TETRAHEDRON LETT, V36, P8625, DOI 10.1016/0040-4039(95)01858-F
   Nicolaou KC, 2001, CHEM-EUR J, V7, P3824, DOI 10.1002/1521-3765(20010903)7:17<3824::AID-CHEM3824>3.0.CO;2-1
   Nonaka T, 1997, J APPL POLYM SCI, V66, P1621
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P133
   OTSU T, 1984, J MACROMOL SCI CHEM, VA21, P961, DOI 10.1080/00222338408056585
   OTSU T, 1982, POLYM BULL, V7, P45
   OTSU T, 1989, EUR POLYM J, V25, P643, DOI 10.1016/0014-3057(89)90023-2
   OTSU T, 1982, POLYM BULL, V7, P197
   PAN L, 2006, J POLYM ENVIRON, V15, P57
   Park ES, 2001, J APPL POLYM SCI, V80, P728, DOI 10.1002/1097-4628(20010502)80:5<728::AID-APP1149>3.3.CO;2-Z
   Park ES, 2001, INT BIODETER BIODEGR, V47, P209, DOI 10.1016/S0964-8305(01)00058-0
   Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45
   Patel JS, 1999, ANGEW MAKROMOL CHEM, V271, P24
   Popa A, 2003, REACT FUNCT POLYM, V55, P151, DOI 10.1016/S1381-5148(02)00224-9
   POPIENIEK PH, 1991, J AM CHEM SOC, V113, P2264, DOI 10.1021/ja00006a053
   Prabhu S, 2007, J BIOMED MATER RES A, V80A, P732, DOI 10.1002/jbm.a.31053
   Rao JH, 1999, CHEM BIOL, V6, P353, DOI 10.1016/S1074-5521(99)80047-7
   Ryu WH, 2007, BIOMED MICRODEVICES, V9, P845, DOI 10.1007/s10544-007-9097-8
   Sebra RP, 2007, ACTA BIOMATER, V3, P151, DOI 10.1016/j.actbio.2006.07.010
   Sebra RP, 2005, LANGMUIR, V21, P10907, DOI 10.1021/la052101m
   Song MJ, 2003, INT BIODETER BIODEGR, V52, P107, DOI 10.1016/S0964-8305(03)00032-5
   STEWART J, 1995, CALCULUS, P482
   Tasker LH, 2007, CLIN ORTHOP RELAT R, P243, DOI 10.1097/BLO.0b013e31803125f4
   Thamizharasi S, 2002, EUR POLYM J, V38, P551, DOI 10.1016/S0014-3057(01)00196-3
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x
   WALTHO JP, 1989, J AM CHEM SOC, V111, P2475, DOI 10.1021/ja00189a017
   WILLIAMS DH, 1977, J AM CHEM SOC, V99, P2768, DOI 10.1021/ja00450a058
   WILLIAMS DH, 1993, P NATL ACAD SCI USA, V90, P1172, DOI 10.1073/pnas.90.4.1172
   Williams DH, 1998, SCIENCE, V280, P711, DOI 10.1126/science.280.5364.711
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   Worley SD, 1996, TRENDS POLYM SCI, V4, P364
   Yao NH, 2005, J COMB CHEM, V7, P123, DOI 10.1021/cc0498783
   Yoshida O, 2002, BIOORG MED CHEM LETT, V12, P3027, DOI 10.1016/S0960-894X(02)00664-9
NR 76
TC 35
Z9 36
U1 0
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD AUG
PY 2009
VL 10
IS 8
BP 2221
EP 2234
DI 10.1021/bm900410a
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 479LR
UT WOS:000268661400026
PM 19606854
OA Bronze, Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Hindi, KM
   Ditto, AJ
   Panzner, MJ
   Medvetz, DA
   Han, DS
   Hovis, CE
   Hilliard, JK
   Taylor, JB
   Yun, YH
   Cannon, CL
   Youngs, WJ
AF Hindi, Khadijah M.
   Ditto, Andrew J.
   Panzner, Matthew J.
   Medvetz, Douglas A.
   Han, Daniel S.
   Hovis, Christine E.
   Hilliard, Julia K.
   Taylor, Jane B.
   Yun, Yang H.
   Cannon, Carolyn L.
   Youngs, Wiley J.
TI The antimicrobial efficacy of sustained release silver-carbene
   complex-loaded L-tyrosine polyphosphate nanoparticles: Characterization,
   in vitro and in vivo studies
SO BIOMATERIALS
LA English
DT Article
DE Antimicrobial; Silver; Controlled drug release; Nanoparticle; Cystic
   fibrosis
ID POTENTIAL BIOMATERIAL APPLICATIONS; PSEUDOMONAS-AERUGINOSA;
   MOLECULAR-WEIGHT; MICROSPHERES; TOBRAMYCIN; INFECTIONS; BIOFILM;
   RESISTANCE; DEVICE; AG(I)
AB The pressing need to treat multi-drug resistant bacteria in the chronically infected lungs of cystic fibrosis (CF) patients has given rise to novel nebulized antimicrobials. We have synthesized a silver-carbene complex (SCC10) active against a variety of bacterial strains associated with CIF and chronic lung infections. Our studies have demonstrated that SCC10-loaded into L-tyrosine polyphosphate nanoparticles (LTP NPs) exhibits excellent antimicrobial activity in vitro and in vivo against the CF relevant bacteria Pseudomonas aeruginosa. Encapsulation of SCC10 in LTP NPs provides sustained release of the antimicrobial over the course of several days translating into efficacious results in vivo with only two administered doses over a 72 h period. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Ditto, Andrew J.; Yun, Yang H.] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Hindi, Khadijah M.; Panzner, Matthew J.; Medvetz, Douglas A.; Youngs, Wiley J.] Univ Akron, Dept Chem, Akron, OH 44325 USA.
   [Han, Daniel S.; Hovis, Christine E.; Hilliard, Julia K.; Taylor, Jane B.; Cannon, Carolyn L.] Washington Univ, Sch Med, Dept Pediat, St Louis, MI 63110 USA.
RP Yun, YH (reprint author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
EM yy@uakron.edu; cannon_c@kids.wustl.edu; youngs@uakron.edu
RI Yun, Yang/C-1937-2009
OI Yun, Yang/0000-0001-5447-8833
FU University of Akron (Firestone Fellowship); Washington University School
   of Medicine; National Institute of Allergies and Infectious Diseases [1
   R01 A106785601]; National Institute of General Medical Sciences [5 R01
   GM086895-02]; National Science Foundation [CHE-8808587, CHE-9977144,
   CHE-0116041]; Ohio Board of Regents
FX This work was supported by the University of Akron (Firestone
   Fellowship), Washington University School of Medicine, the National
   Institute of Allergies and Infectious Diseases (1 R01 A106785601), and
   the National Institute of General Medical Sciences (5 R01 GM086895-02).
   We thank the National Science Foundation (CHE-8808587 and CHE-9977144)
   for funds used to purchase the Varian Gemini 300 MHz and the Varian
   INOVA 400 MHz NMZ instruments used in this work. We would like to
   acknowledge the National Science Foundation (CHE-0116041) and the Ohio
   Board of Regents for funds used to purchase the Bruker-Nonius Apex CCD
   X-ray diffractometer used in this research.
CR Beaulac C, 1996, ANTIMICROB AGENTS CH, V40, P665, DOI 10.1128/AAC.40.3.665
   Bjarnsholt T, 2007, APMIS, V115, P921, DOI 10.1111/j.1600-0463.2007.apm_646.x
   Chern CS, 1997, POLYMER, V38, P1977, DOI 10.1016/S0032-3861(96)00708-2
   Ditto AJ, 2009, INT J PHARM, V368, P199, DOI 10.1016/j.ijpharm.2008.10.019
   Garrison JC, 2005, CHEM REV, V105, P3978, DOI 10.1021/cr050004s
   Geller DE, 2003, CHEST, V123, P28, DOI 10.1378/chest.123.1.28
   Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545
   Herrmann WA, 1997, ANGEW CHEM INT EDIT, V36, P2162, DOI 10.1002/anie.199721621
   Hindi KM, 2008, J MED CHEM, V51, P1577, DOI 10.1021/jm0708679
   Kascatan-Nebioglu A, 2007, COORDIN CHEM REV, V251, P884, DOI 10.1016/j.ccr.2006.08.019
   Kascatan-Nebioglu A, 2006, J MED CHEM, V49, P6811, DOI 10.1021/jm060711t
   Keegan ME, 2006, J CONTROL RELEASE, V110, P574, DOI 10.1016/j.jconrel.2005.11.004
   Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805
   Lansdow AB., 2002, J WOUND CARE, V11, P125
   Lee ES, 2007, BIOMATERIALS, V28, P2754, DOI 10.1016/j.biomaterials.2007.01.049
   Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/jb.179.19.6127-6132.1997
   Lin IJB, 2007, COORDIN CHEM REV, V251, P642, DOI 10.1016/j.ccr.2006.09.004
   Marier JF, 2003, J ANTIMICROB CHEMOTH, V52, P247, DOI 10.1093/jac/dkg317
   Martin AR, 2007, J AEROSOL SCI, V38, P246, DOI 10.1016/j.jaerosci.2006.11.002
   MEDSHITOV R, 1997, NATURE, V388, P394
   Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059
   Melaiye A, 2005, EXPERT OPIN THER PAT, V15, P125, DOI 10.1517/13543776
   MODAK SM, 1983, PANMINERVA MED, V25, P181
   Ouchi T, 1998, POLYMER, V39, P5171, DOI 10.1016/S0032-3861(97)10020-9
   Owusu-Ababio G, 1999, J CONTROL RELEASE, V57, P151, DOI 10.1016/S0168-3659(98)00113-8
   Pai VB, 2001, PEDIATR PULM, V32, P314, DOI 10.1002/ppul.1125
   Patton John S, 2004, Proc Am Thorac Soc, V1, P338, DOI 10.1513/pats.200409-049TA
   Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012
   Pimay J. P., 2003, J CLIN MICROBIOL, V41, P1192
   Sakagami M, 2001, J CONTROL RELEASE, V77, P117, DOI 10.1016/S0168-3659(01)00475-8
   Sandor M, 2001, J CONTROL RELEASE, V76, P297, DOI 10.1016/S0168-3659(01)00446-1
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Schlottmann SA, 2006, J IMMUNOL METHODS, V309, P75, DOI 10.1016/j.jim.2005.11.019
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Sengupta A., 2003, THESIS U AKRON AKRON
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Stringer JL, 1996, J CONTROL RELEASE, V42, P195, DOI 10.1016/0168-3659(96)01457-5
   Tamilvanan S, 2008, J CONTROL RELEASE, V128, P2, DOI 10.1016/j.jconrel.2008.01.006
   van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019
   WELSH MJ, 2001, METABOLIC MOL BASES, V3, P5121
   Zhang GF, 2007, J AEROSOL MED, V20, P408, DOI 10.1089/jam.2007.0622
NR 42
TC 92
Z9 93
U1 3
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2009
VL 30
IS 22
BP 3771
EP 3779
DI 10.1016/j.biomaterials.2009.03.044
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461OM
UT WOS:000267277400016
PM 19395021
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lei, P
   Padmashali, RM
   Andreadis, ST
AF Lei, Pedro
   Padmashali, Roshan M.
   Andreadis, Stelios T.
TI Cell-controlled and spatially arrayed gene delivery from fibrin
   hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Fibrin hydrogels; Fibrinolysis; Matrix-mediated transfection;
   Cell-controlled gene delivery; Transfection microarrays
ID ENHANCES NEURITE EXTENSION; ENGINEERED BLOOD-VESSELS; GROWTH-FACTOR
   GENE; IN-VITRO; STEM-CELLS; TRANSGENE EXPRESSION; CONTROLLED-RELEASE;
   MEDIA EQUIVALENT; DNA DELIVERY; MATRICES
AB We investigated fibrin-mediated gene transfer by embedding pDNA within the hydrogel during polymerization and using two modes of gene transfection with cells placed either on the surface (2D transfection) or within the hydrogel (3D transfection). Using this model, we found that cell transfection depended strongly on the local cell-pDNA microenvironment as defined by the 2D vs. 3D context, target cell type and density, as well as fibrinogen and pDNA concentrations. When cells were embedded within the fibrin matrix lipofectamine-induced cell death decreased significantly, especially at low target cell density. Addition of fibrinolytic inhibitors decreased gene transfer in a dose-dependent manner, suggesting that fibrin degradation may be necessary for efficient gene transfer. We also provided proof-of-concept that fibrin-mediated gene transfer can be used for spatially localized gene delivery, which is required in cell-transfection microarrays. When lipoplex-containing hydrogels were spotted in an array format gene transfer was strictly confined to pDNA-containing fibrin spots with no cross-contamination between neighboring sites. Collectively, our data suggest that fibrin may be used as a biomaterial to deliver genes in an efficient, cell-controlled and spatially localized manner for potential applications in vitro or in vivo. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Lei, Pedro; Padmashali, Roshan M.; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA.
   [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall, Amherst, NY 14260 USA.
EM sandread@eng.buffalo.edu
FU National Institutes of Health [R01 EB 000876-01]; National Science
   Foundation [BES-0354626]; New York Stem Cell Science Funding Program
   (NYSTEM)
FX This work was supported by grants from the National Institutes of Health
   (R01 EB 000876-01), National Science Foundation (BES-0354626) and the
   New York Stem Cell Science Funding Program (NYSTEM) to S.T.A.
CR Andree C, 2001, TISSUE ENG, V7, P757, DOI 10.1089/107632701753337708
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Bajaj BG, 2005, MOL THER, V11, P969, DOI 10.1016/j.ymthe.2004.10.023
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   Bolliet C, 2008, TISSUE ENG PT C-METH, V14, P207, DOI 10.1089/ten.tec.2008.0168
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   Bruns H, 2005, TISSUE ENG, V11, P1718, DOI 10.1089/ten.2005.11.1718
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Chung TW, 2006, INT J PHARM, V311, P122, DOI 10.1016/j.ijpharm.2005.12.038
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   Delehanty JB, 2004, ANAL CHEM, V76, P7323, DOI 10.1021/ac049259g
   Escamez MJ, 2008, J INVEST DERMATOL, V128, P1565, DOI 10.1038/sj.jid.5701217
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Geer DJ, 2003, J INVEST DERMATOL, V121, P1210, DOI 10.1046/j.1523-1747.2003.12512.x
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Hankemeier S, 2009, TISSUE ENG PT A, V15, P1019, DOI 10.1089/ten.tea.2008.0046
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Kang SW, 2008, BIOMATERIALS, V29, P1109, DOI 10.1016/j.biomaterials.2007.11.004
   Kongkaneramit L, 2008, J PHARMACOL EXP THER, V325, P969, DOI 10.1124/jpet.107.136077
   Liu JY, 2007, CARDIOVASC RES, V75, P618, DOI 10.1016/j.cardiores.2007.04.018
   Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703
   Ochiya T, 1999, NAT MED, V5, P707
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Reinisalo M, 2006, J CONTROL RELEASE, V110, P437, DOI 10.1016/j.jconrel.2005.10.003
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Saul JM, 2007, BIOMATERIALS, V28, P4705, DOI 10.1016/j.biomaterials.2007.07.026
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Schillinger U, 2008, PHARM RES-DORD, V25, P2946, DOI 10.1007/s11095-008-9719-8
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   Trentin D, 2005, J CONTROL RELEASE, V102, P263, DOI 10.1016/j.jconrel.2004.09.029
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 50
TC 69
Z9 70
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2009
VL 30
IS 22
BP 3790
EP 3799
DI 10.1016/j.biomaterials.2009.03.049
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461OM
UT WOS:000267277400018
PM 19395019
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Sivarasu, S
   Mathew, L
AF Sivarasu, Sudesh
   Mathew, Lazar
TI KINEMATIC ANALYSIS AND 3D FINITE ELEMENT ANALYSIS OF A MOBILE-BEARING
   ARTIFICIAL HIGH FLEXION KNEE
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE Artificial knee; Total knee arthroplasty; Finite element modeling;
   Biomaterials; Design optimization; 3D modeling; Simulation; Design
   validation
AB Total knee arthroplasty (TKA) has been the end-time surgical procedure for pain relief and movement restoration in cases of severe arthritis. The knee implant design plays a vital role in deciding the activity levels of a patient after total knee replacement (TKR). In about 90% of younger patients undergoing the knee replacement surgeries, the restriction is not from the subject but from the implant design. This paper discusses parameters affecting the activity levels after TKR. It also briefs the design aspects of a novel knee design that allows the normal high flexion activity even after TKR.
   The application of finite element modeling in medical applications has been evolving as the field of high importance especially in the development of medical devices. The TKA has been in existence for over six decades till now. The generic artificial knee implants used in the TKA have the restriction in its range of motion of about 90 degrees. A new design allowing flexion extension range of over 120 degrees was designed with a view to facilitate partial squatting and the same is used for the analysis purpose. The loading conditions of 10 times the body weight are considered. The finite element analyses of the designs were carried out based on standard biomaterial used in orthopedic implants. In this paper, we have discussed the results of analyses of an artificial knee with titanium (Ti) alloy. The results of the analyses were used in identifying areas of extreme stresses within the design and the spot prone for higher deformation. Based on these results, slight modi. cation on the designs was carried out. The results are also verified whether the body is within the linear deformation levels. As the results obtained were very satisfactory, the models have been recommended for prototyping.
C1 [Sivarasu, Sudesh; Mathew, Lazar] VIT Univ, Sch Biotechnol Chem & Biomed Engn, Vellore 632014, Tamil Nadu, India.
RP Sivarasu, S (reprint author), VIT Univ, Sch Biotechnol Chem & Biomed Engn, Vellore 632014, Tamil Nadu, India.
EM sudeshsivarasu@yahoo.co.in
RI Sivarasu, Sudesh/E-8738-2013
OI Sivarasu, Sudesh/0000-0002-0812-568X
CR Dennis DA, 1996, CLIN ORTHOP RELAT R, P107
   DENNIS DA, 1996, P AM SOC ORTH SURG S
   DENNIS DA, 1996, ORTHOPEDIC T
   GLORIA B, 2004, APPL ENG MECH MED
   Hoff WA, 1998, CLIN BIOMECH, V13, P455, DOI 10.1016/S0268-0033(98)00009-6
   Hoff WA, 1996, THIRD IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION - WACV '96, PROCEEDINGS, P181, DOI 10.1109/ACV.1996.572053
   MARIANA EK, 2005, SUMM BIOENGINEERING
   SAROJAK M, 1999, P 36 ROCK MOUNT BIOE
   SAROJAK ME, 1999, P ORTH RES SOC AN CA
   STIEHL JB, 1995, J BONE JOINT SURG BR, V77B, P884
   STIEHL JB, 1996, J CONT ORTHOP
   SUDESH S, 2008, MODELING ARTIFICIAL, P138
   Sudesh S, 2007, LIFE SCI SYSTEMS APP, P112
   Walker S A, 1996, Biomed Sci Instrum, V32, P143
   WALKER SA, 1996, P ANN ROCK MOUNT BIO, P143
NR 15
TC 3
Z9 3
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD AUG
PY 2009
VL 21
IS 4
BP 279
EP 285
DI 10.4015/S1016237209001337
PG 7
WC Engineering, Biomedical
SC Engineering
GA 481WL
UT WOS:000268843200007
DA 2018-10-20
ER

PT J
AU Asplund, M
   Thaning, E
   Lundberg, J
   Sandberg-Nordqvist, AC
   Kostyszyn, B
   Inganas, O
   von Holst, H
AF Asplund, M.
   Thaning, E.
   Lundberg, J.
   Sandberg-Nordqvist, A. C.
   Kostyszyn, B.
   Inganas, O.
   von Holst, H.
TI Toxicity evaluation of PEDOT/biomolecular composites intended for neural
   communication electrodes
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID SILICON MICROELECTRODE ARRAYS; CONDUCTING POLYMER; HYALURONIC-ACID;
   IN-VITRO; SURFACE MODIFICATION; FIBRIN GELS;
   POLY(3,4-ETHYLENEDIOXYTHIOPHENE); BIOCOMPATIBILITY; PROBES; REGENERATION
AB Electrodes coated with the conducting polymer poly(3,4-ethylene dioxythiophene) (PEDOT) possess attractive electrochemical properties for stimulation or recording in the nervous system. Biomolecules, added as counter ions in electropolymerization, could further improve the biomaterial properties, eliminating the need for surfactant counter ions in the process. Such PEDOT/biomolecular composites, using heparin or hyaluronic acid, have previously been investigated electrochemically. In the present study, their biocompatibility is evaluated. An agarose overlay assay using L929 fibroblasts, and elution and direct contact tests on human neuroblastoma SH-SY5Y cells are applied to investigate cytotoxicity in vitro. PEDOT: heparin was further evaluated in vivo through polymer-coated implants in rodent cortex. No cytotoxic response was seen to any of the PEDOT materials tested. The examination of cortical tissue exposed to polymer-coated implants showed extensive glial scarring irrespective of implant material (Pt:polymer or Pt). However, quantification of immunological response, through distance measurements from implant site to closest neuron and counting of ED1+ cell density around implant, was comparable to those of platinum controls. These results indicate that PEDOT: heparin surfaces were non-cytotoxic and show no marked difference in immunological response in cortical tissue compared to pure platinum controls.
C1 [Asplund, M.; Thaning, E.; von Holst, H.] Royal Inst Technol, Sch Technol & Hlth, Div Neuron Engn, SE-14152 Huddinge, Sweden.
   [Lundberg, J.] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Sect Neuroradiol,R2 02 NKK Lab, SE-17176 Stockholm, Sweden.
   [Sandberg-Nordqvist, A. C.] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Sect Clin CNS Res, SE-17176 Stockholm, Sweden.
   [Kostyszyn, B.] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Ctr Hearing & Commun Res, SE-17176 Stockholm, Sweden.
   [Inganas, O.] Linkoping Univ, IFM, SE-58183 Linkoping, Sweden.
   [von Holst, H.] Karolinska Inst, Inst Lab Med & Clin Neurosci, Neurosurg Sect, SE-17176 Stockholm, Sweden.
RP Asplund, M (reprint author), Royal Inst Technol, Sch Technol & Hlth, Div Neuron Engn, SE-14152 Huddinge, Sweden.
EM maria.asplund@sth.kth.se
OI Asplund, Maria/0000-0001-8779-7478; Inganas, Olle/0000-0002-6243-1450
FU Center of Organic Bioelectronics
FX The authors gratefully acknowledge Malin Vallgarda for performing the
   elution tests and Britt-Meijer at Karolinska Institutet for help with
   animal experiments, tissue collection and a lot of helpful advice with
   the immunohistochemical assays. This work was also supported by the
   Strategic Research Foundation SSF through OBOE, the Center of Organic
   Bioelectronics.
CR Asplund M, 2008, BIOINTERPHASES, V3, P83, DOI 10.1116/1.2998407
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bobacka J, 2000, J ELECTROANAL CHEM, V489, P17, DOI 10.1016/S0022-0728(00)00206-0
   Cenni E, 1999, TOXICOL IN VITRO, V13, P801, DOI 10.1016/S0887-2333(99)00058-2
   COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x
   Fonner JM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034124
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Isaksson J, 2007, NAT MATER, V6, P673, DOI 10.1038/nmat1963
   Kim BC, 2000, POLYMER, V41, P1783, DOI 10.1016/S0032-3861(99)00308-0
   KIM BC, 2004, J BIOMED MATER RES A, V71, pS577
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Maynard EM, 2000, J NEUROSCI METH, V97, P93, DOI 10.1016/S0165-0270(00)00159-X
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nyberg T, 2002, BIOMED MICRODEVICES, V4, P43, DOI 10.1023/A:1014219828983
   Nyberg T, 2007, J NEUROSCI METH, V160, P16, DOI 10.1016/j.jneumeth.2006.08.008
   Ozgenel GY, 2003, MICROSURG, V23, P575, DOI 10.1002/micr.10209
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Sakiyama SE, 1999, FASEB J, V13, P2214
   VIAN L, 1995, TOXICOL IN VITRO, V9, P185, DOI 10.1016/0887-2333(94)00200-E
   Wang KK, 1998, MICROSURG, V18, P270, DOI 10.1002/(SICI)1098-2752(1998)18:4<270::AID-MICR11>3.0.CO;2-V
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Xiao YH, 2006, APPL BIOCHEM BIOTECH, V128, P117, DOI 10.1385/ABAB:128:2:117
   Xiao YH, 2004, SENSOR ACTUAT B-CHEM, V99, P437, DOI 10.1016/j.snb.2003.12.067
   YAMATO H, 1995, J ELECTROANAL CHEM, V397, P163, DOI 10.1016/0022-0728(95)04156-8
   Yang JY, 2005, ACTA BIOMATER, V1, P125, DOI 10.1016/j.actbio.2004.09.006
   Yang JY, 2004, SENSOR ACTUAT A-PHYS, V113, P204, DOI 10.1016/j.sna.2004.02.029
NR 33
TC 75
Z9 75
U1 1
U2 55
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2009
VL 4
IS 4
AR 045009
DI 10.1088/1748-6041/4/4/045009
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 482FW
UT WOS:000268871000018
PM 19636110
DA 2018-10-20
ER

PT J
AU Mao, K
   Yang, Y
   Li, JT
   Hao, LB
   Tang, PF
   Wang, Z
   Wen, N
   Du, MK
   Wang, JF
   Wang, Y
AF Mao, Keya
   Yang, Yun
   Li, Jiangtao
   Hao, Libo
   Tang, Peifu
   Wang, Zheng
   Wen, Ning
   Du, Mingkui
   Wang, Jifang
   Wang, Yan
TI Investigation of the histology and interfacial bonding between
   carbonated hydroxyapatite cement and bone
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENT; SCREW FIXATION; IN-VIVO; APATITE;
   RECONSTRUCTION; BEHAVIOR; GLASS
AB An ideal bone implant should facilitate the formation of a new bone layer as an osteo-integrated interface between bone and the implanted biomaterials. In the present work, the interface between carbonated hydroxyapatite (CHA) cement and bone was evaluated by interfacial bonding strength measurements and histological characterizations. CHA cement was implanted into a mongrel dog's femoral supracondylar and below the tibial plateau area, and was then tested ex vivo by, respectively, detaching and pullout experiments. Polymethylmethacrylate ( PMMA) was used as a control. CHA cement could be directly injected and solidified in situ to repair bone defects. Histology results showed that CHA bonded with bone through gradual remodeling and was replaced by new bone tissue, which is an attribute for excellent biocompatibility. The interfacial bonding strength increased with implantation time. After 16 weeks implantation, the measured detaching force and the pullout force between CHA and bone were 281 +/- 16 N and 512.5 +/- 14.5 N, respectively. These values were several times higher compared to 5 days implantation. In contrast, the control showed a fibrous microstructure between PMMA and bone, and the detaching force and the pullout force decreased with implantation time. The results strongly suggest that CHA can form a better osteo-integrated interface compared to PMMA, and could be used as an ideal biomaterial for bone defect repair.
C1 [Mao, Keya; Hao, Libo; Tang, Peifu; Wang, Zheng; Wen, Ning; Du, Mingkui; Wang, Jifang; Wang, Yan] Gen Hosp Peoples Liberat Army, Dept Orthoped, Beijing 100853, Peoples R China.
   [Yang, Yun; Li, Jiangtao] Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100084, Peoples R China.
RP Wang, Y (reprint author), Gen Hosp Peoples Liberat Army, Dept Orthoped, 28 Fuxing Rd, Beijing 100853, Peoples R China.
EM yanwang1961@yahoo.com
FU National Natural Science Foundation of People's Republic of China
   [39670731, 50772132]
FX This work was supported by a research grant (numbers 39670731 and
   50772132) from the National Natural Science Foundation of People's
   Republic of China. The authors wish to thank Dr Gang Li, Queen's
   University Belfast, for a critical reading and providing editorial
   assistance.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Brown PW, 1986, CEMENTS RES PROGR, P352
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Guo H, 2007, BIOMED MATER, V2, pS153, DOI 10.1088/1748-6041/2/3/S13
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Hankermeyer CR, 2002, BIOMATERIALS, V23, P743, DOI 10.1016/S0142-9612(01)00179-X
   Hannink G, 2008, J BIOMED MATER RES B, V85B, P478, DOI 10.1002/jbm.b.30969
   Kamitakahara M, 2007, BIOMED MATER, V2, pR17, DOI 10.1088/1748-6041/2/4/R01
   Kobayashi M, 1998, J BIOMED MATER RES, V42, P223, DOI 10.1002/(SICI)1097-4636(199811)42:2<223::AID-JBM7>3.0.CO;2-R
   Leung KS, 2006, J BIOMED MATER RES B, V78B, P153, DOI 10.1002/jbm.b.30467
   Liao S, 2007, BIOINSPIR BIOMIM, V2, P37, DOI 10.1088/1748-3182/2/3/001
   Mao KY, 2005, J BIOACT COMPAT POL, V20, P541, DOI 10.1177/0883911505059040
   Ohtsuki C, 2007, J TISSUE ENG REGEN M, V1, P33, DOI 10.1002/term.3
   Schliephake H, 2003, J BIOMED MATER RES A, V64A, P225, DOI 10.1002/jbm.a.10363
   Seah RKH, 2009, ANAL CHEM, V81, P1442, DOI 10.1021/ac802234t
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   Tas AC, 2008, J MATER SCI-MATER M, V19, P2231, DOI 10.1007/s10856-007-3326-9
   Wang Y, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015012
   Yazu N, 2005, J ORTHOP SCI, V10, P56, DOI 10.1007/s00776-004-0862-8
   Zaffe D, 2003, J BIOMED MATER RES A, V64A, P365, DOI 10.1002/jbm.a.10366
NR 22
TC 10
Z9 12
U1 2
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2009
VL 4
IS 4
AR 045003
DI 10.1088/1748-6041/4/4/045003
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 482FW
UT WOS:000268871000012
PM 19531870
DA 2018-10-20
ER

PT J
AU Liu, E
   Treiser, MD
   Patel, H
   Sung, HJ
   Roskov, KE
   Kohn, J
   Becker, ML
   Moghe, PV
AF Liu, Er
   Treiser, Matthew D.
   Patel, Hiral
   Sung, Hak-Joon
   Roskov, Kristen E.
   Kohn, Joachim
   Becker, Matthew L.
   Moghe, Prabhas V.
TI High-Content Profiling of Cell Responsiveness to Graded Substrates Based
   on Combinatorially Variant Polymers
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
ID TYROSINE-DERIVED POLYCARBONATES; ACTIN STRESS FIBERS; DEGRADABLE
   BIOMATERIALS; MATERIALS SCIENCE; PROTEIN; PROLIFERATION; RHO;
   CYTOSKELETON; CHEMISTRY; SURFACES
AB We have developed a novel approach combining high information and high throughput analysis to characterize cell adhesive responses to biomaterial substrates possessing gradients in surface topography. These gradients were fabricated by subjecting thin film blends of tyrosine-derived polycarbonates, i.e. poly(DTE carbonate) and poly(DTO carbonate) to a gradient temperature annealing protocol. Saos-2 cells engineered with a green fluorescent protein (GFP) reporter for farnesylation (GFP-f) were cultured on the gradient substrates to assess the effects of nanoscale surface topology and roughness that arise during the phase separation process on cell attachment and adhesion strength. The high throughput imaging approach allowed us to rapidly identify the "global" and "high content" structure-property relationships between cell adhesion and biomaterial properties such as polymer chemistry and topography. This study found that cell attachment and spreading increased monotonically with DTE content and were significantly elevated at the position with intermediate regions corresponding to the highest "gradient" of surface roughness, while GFP-f farnesylation intensity descriptors were sensitively altered by surface roughness, even in cells with comparable levels of spreading.
C1 [Liu, Er; Treiser, Matthew D.; Patel, Hiral; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Sung, Hak-Joon; Kohn, Joachim] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.
   [Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
   [Roskov, Kristen E.; Becker, Matthew L.] Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM moghe@rutgers.edu
RI Liu, Er/H-8441-2012
OI Liu, Er/0000-0001-7858-1333
FU NIH [P41 EB001046]; NSF [DGE 0333196]; New Jersey Center for
   Biomaterials; NSF NIST Summer Undergraduate Research Fellowship ( KER);
   Equipment Lease Fund; Strategic Resource Opportunity Award; Academic
   Excellence Fund at Rutgers University
FX We acknowledge Dr. Robert Dubin's assistance with the cell transfection
   studies; pEGFP-f was a gift from Danny Reinberg ( Rutgers University).
   This work was supported by NIH grant no. P41 EB001046 ( RESBIO;
   Integrated Resources for Polymeric Materials), NSF grant no. DGE 0333196
   ( IGERT on Biointerfaces), and the New Jersey Center for Biomaterials.
   The authors gratefully acknowledge a NSF NIST Summer Undergraduate
   Research Fellowship ( KER). Additional support was received from
   Equipment Lease Fund, Strategic Resource Opportunity Award, and Academic
   Excellence Fund at Rutgers University.
CR Abramson SD, 2005, J BIOMED MATER RES A, V73A, P116, DOI 10.1002/jbm.a.30266
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Bailey LO, 2006, J BIOMED MATER RES A, V76A, P491, DOI 10.1002/jbm.a.30527
   BECKER ML, 2006, BIOMAT FORUM, V3, P8
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 2001, ADV DRUG DELIVER REV, V53, P123, DOI 10.1016/S0169-409X(01)00224-1
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Foster R, 1996, MOL CELL BIOL, V16, P2689
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Huang S, 2002, EXP CELL RES, V275, P255, DOI 10.1006/excr.2002.5504
   James K, 1999, BIOMATERIALS, V20, P2203, DOI 10.1016/S0142-9612(99)00151-9
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Lin NJ, 2007, DENT MATER, V23, P1211, DOI 10.1016/j.dental.2006.11.020
   Lin-Gibson S, 2006, BIOMATERIALS, V27, P1711, DOI 10.1016/j.biomaterials.2005.10.040
   Liu E, 2007, J BIOMED MATER RES B, V82B, P284, DOI 10.1002/jbm.b.30732
   Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200
   Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meier MAR, 2006, SOFT MATTER, V2, P371, DOI 10.1039/b518304a
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   MURTHY NS, 2006, J APPL PHYS, V100, P12
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   PRENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193, DOI 10.1128/MCB.14.6.4193
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8
   RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Schubert US, 2004, MACROMOL RAPID COMM, V25, P19, DOI 10.1002/marc.200390106
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Sousa A, 2006, LANGMUIR, V22, P6286, DOI 10.1021/la053081r
   Stafford CM, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2173072
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sung FJ, 2005, BIOMATERIALS, V26, P4557, DOI 10.1016/j.biomaterials.2004.11.034
   Treiser MD, 2007, BIOTECHNIQUES, V43, P361, DOI 10.2144/000112533
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
NR 46
TC 7
Z9 7
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PD AUG
PY 2009
VL 12
IS 7
BP 646
EP 655
DI 10.2174/138620709788923737
PG 10
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 482UT
UT WOS:000268915000002
PM 19531022
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mei, L
   Busscher, HJ
   van der Mei, HC
   Chen, YX
   de Vries, J
   Ren, YJ
AF Mei, Li
   Busscher, Henk J.
   van der Mei, Henny C.
   Chen, Yangxi
   de Vries, Joop
   Ren, Yijin
TI Oral bacterial adhesion forces to biomaterial surfaces constituting the
   bracket-adhesive-enamel junction in orthodontic treatment
SO EUROPEAN JOURNAL OF ORAL SCIENCES
LA English
DT Article
DE atomic force microscopy; bacterial adhesion; biofilm; dental adhesive;
   stainless steel
ID STREPTOCOCCUS-MUTANS; CARIOGENIC STREPTOCOCCI; IN-VITRO; APPLIANCES;
   ADHERENCE; PREVALENCE; MICROSCOPE; SUBSTRATA; SOBRINUS; BIOFILM
AB Bacterial adhesion to biomaterial surfaces constituting the bracket-adhesive-enamel junction represents a growing problem in orthodontics, because bacteria can adversely affect treatment by causing demineralization of the enamel surface around the brackets. It is important to know the forces with which bacteria adhere to the surfaces of these junction materials, as the strength of these forces will determine how easy it will be to remove the bacteria. We compared the adhesion forces of five initially colonizing and four cariogenic strains of bacteria to an orthodontic adhesive, stainless steel, and enamel, with and without a salivary conditioning film. Adhesion forces were determined using atomic force microscopy and a bacterial probe. In the absence of a salivary conditioning film, the strongest bacterial adhesion forces occurred to the adhesive surface (-2.9 to -6.9 nN), while adhesion forces to the enamel surfaces were lowest (-0.8 to -2.7 nN). In the presence of a salivary conditioning film, adhesion forces were reduced strongly, to less than 1 nN, and the differences between the various materials were reduced. Generally, however, initial colonizers of dental hard surfaces presented stronger adhesion forces to the different materials (-4.7 and -0.6 nN in the absence and presence of a salivary conditioning film, respectively) than cariogenic strains (-1.8 and -0.5 nN).
C1 [Mei, Li; Busscher, Henk J.; van der Mei, Henny C.; de Vries, Joop] Univ Groningen, Dept Biomed Engn, Univ Med Ctr Groningen, NL-9700 AD Groningen, Netherlands.
   [Mei, Li; Chen, Yangxi] Sichuan Univ, Dept Orthodont, W China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Mei, Li; Ren, Yijin] Univ Groningen, Dept Orthodont, Univ Med Ctr Groningen, NL-9700 AD Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Dept Biomed Engn, Univ Med Ctr, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
RI mei, li/B-6657-2016
FU China Scholarship Council
FX The first author gratefully acknowledges the research scholarship from
   the China Scholarship Council and thanks Prof. A. Sandham and Dr B. Zhu
   for their kind support. The authors furthermore thank Minie
   Rustema-Abbing and Rene Dijkstra for their technical assistance.
   Conflict of interest: none.
CR Ahn SJ, 2007, AM J ORTHOD DENTOFAC, V131, P736, DOI 10.1016/j.ajodo.2005.06.036
   Ahn SJ, 2006, ANGLE ORTHOD, V76, P869, DOI 10.2319/080805-270
   ARTUN J, 1986, EUR J ORTHODONT, V8, P229, DOI 10.1093/ejo/8.4.229
   Attin R, 2005, EUR J ORTHODONT, V27, P489, DOI 10.1093/ejo/cji018
   Biesbrock Aaron R, 2002, J Clin Dent, V13, P198
   Brusca MI, 2007, ANGLE ORTHOD, V77, P331, DOI 10.2319/032706-124
   Burnham NA, 2003, NANOTECHNOLOGY, V14, P1, DOI 10.1088/0957-4484/14/1/301
   BUSSCHER HJ, 1992, J DENT RES, V71, P491, DOI 10.1177/00220345920710031301
   Cisar J O, 1997, Adv Dent Res, V11, P168
   De Siate A, 1991, Minerva Stomatol, V40, P101
   DESOET JJ, 1991, CARIES RES, V25, P116, DOI 10.1159/000261353
   Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905
   FORSBERG C-M, 1991, European Journal of Orthodontics, V13, P416
   Fournier A, 1998, AM J ORTHOD DENTOFAC, V114, P414, DOI 10.1016/S0889-5406(98)70186-6
   GLANTZ PO, 1971, J COLLOID INTERF SCI, V37, P281, DOI 10.1016/0021-9797(71)90294-3
   GLANTZ PO, 1971, ACTA ODONTOL SCAND, V29, P539, DOI 10.3109/00016357109026332
   GORELICK L, 1982, AM J ORTHOD DENTOFAC, V81, P93, DOI 10.1016/0002-9416(82)90032-X
   GWINNETT AJ, 1979, AM J ORTHOD DENTOFAC, V75, P667, DOI 10.1016/0002-9416(79)90098-8
   Hagg U, 2004, EUR J ORTHODONT, V26, P623, DOI 10.1093/ejo/26.6.623
   Jucker BA, 1998, ENVIRON SCI TECHNOL, V32, P2909, DOI 10.1021/es980211s
   Lendenmann U, 2000, Adv Dent Res, V14, P22
   Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x
   Mahapatro A, 2006, LANGMUIR, V22, P901, DOI 10.1021/la052817h
   Mendez-Vilas A, 2006, ANTON LEEUW INT J G, V89, P495, DOI 10.1007/s10482-005-9048-4
   Mitchell L, 1992, Br J Orthod, V19, P199
   MIZRAHI E, 1982, AM J ORTHOD DENTOFAC, V82, P62, DOI 10.1016/0002-9416(82)90548-6
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400.3409.2003
   Papaioannou W, 2007, ANGLE ORTHOD, V77, P1090, DOI 10.2319/091706-375.1
   PRATTTERPSTRA IH, 1989, J DENT RES, V68, P463, DOI 10.1177/00220345890680030501
   Schatzle M, 2009, EUR J ORTHODONT, V31, P103, DOI 10.1093/ejo/cjn070
   Steinberg D, 2004, J ORAL REHABIL, V31, P1041, DOI 10.1111/j.1365-2842.2004.01350.x
   Turkkahraman H, 2005, ANGLE ORTHOD, V75, P231
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   van der Mei HC, 2008, APPL ENVIRON MICROB, V74, P5511, DOI 10.1128/AEM.01119-08
   van Gastel J, 2007, J CLIN PERIODONTOL, V34, P423, DOI 10.1111/j.1600-051X.2007.01070.x
   van Nieuw Amerongen A., 2004, CARIES RES, V38, P247
   VANOSS CJ, 1972, J RETICULOENDOTH SOC, V12, P283
   Xu CP, 2007, LANGMUIR, V23, P9423, DOI 10.1021/la701477w
   Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v
NR 40
TC 33
Z9 35
U1 2
U2 21
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0909-8836
J9 EUR J ORAL SCI
JI Eur. J. Oral Sci.
PD AUG
PY 2009
VL 117
IS 4
BP 419
EP 426
DI 10.1111/j.1600-0722.2009.00648.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 471BW
UT WOS:000268029400012
PM 19627354
DA 2018-10-20
ER

PT J
AU Tao, HR
   Fan, HB
AF Tao, Huiren
   Fan, Hongbin
TI Implantation of amniotic membrane to reduce postlaminectomy epidural
   adhesions
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE Laminectomy; Epidural fibrosis; Amniotic membrane; Dura mater
ID BACK SURGERY SYNDROME; CAUDA-EQUINA SYNDROME; LUMBAR DISC SURGERY;
   ASYMPTOMATIC PATIENTS; PERIDURAL FIBROSIS; LAMINECTOMY MODEL; FAT GRAFT;
   DISKECTOMY; FUSION; PAIN
AB Postlaminectomy epidural adhesion is implicated as a main cause of "failed back surgery syndrome'' and associated with increased risk of complications during revision surgery. Various materials acting as mechanical barriers to reduce fibroblasts infiltration into epidural space have met with limited success. In present research, amniotic membrane (AM) was studied to investigate its effects on reducing epidural scar adhesion after laminectomy in a canine model. Laminectomy sites were created at L-1, L-3, L-5, and L-7 levels in 24 adult mongrel dogs. Freeze dried AM (FAM), cross-linked AM (CAM), and autologous free fat (AFF) were implanted, respectively, at a randomly assigned site in each dog with the remaining untreated site serving as internal control. The animals were sacrificed at 1, 6, and 12 weeks postoperatively. Then, gross pathologic observation including scar amount and adhesion tenacity, qualitative histology evaluation, and quantitative histology analysis were compared. Gross observation demonstrated that scar amount and adhesion tenacity of CAM group were significantly lower in comparison with those of FAM and non-treatment groups. A white, slightly vascularized CAM layer covered the dura mater without tenacious scar adhesion. The histology analysis also indicated reduced fibroblasts infiltration and consequent epidural fibrosis, which were similar to the results of AFF group. In conclusion, the CAM is effective in reducing epidural fibrosis and scar adhesion after laminectomy in canine model. It is a promising biomaterial for future clinical applications.
C1 [Tao, Huiren; Fan, Hongbin] Fourth Mil Med Univ, Dept Orthopaed & Traumatol, Xi Jing Hosp, Xian 710032, Peoples R China.
RP Fan, HB (reprint author), Fourth Mil Med Univ, Dept Orthopaed & Traumatol, Xi Jing Hosp, Xian 710032, Peoples R China.
EM fanhb75@yahoo.com.cn
CR ANNERTZ M, 1995, SPINE, V20, P449, DOI 10.1097/00007632-199502001-00007
   Bertagnoli R, 2006, J NEUROSURG-SPINE, V4, P91, DOI 10.3171/spi.2006.4.2.91
   Coskun E, 2000, EUR SPINE J, V9, P218, DOI 10.1007/s005860000144
   Duggal N, 2004, NEUROSURGERY, V54, P636, DOI 10.1227/01.NEU.0000107423.87889.9E
   Einhaus SL, 1997, SPINE, V22, P1440, DOI 10.1097/00007632-199707010-00003
   Fischgrund J S, 2000, J Am Acad Orthop Surg, V8, P339
   Fritsch EW, 1996, SPINE, V21, P626, DOI 10.1097/00007632-199603010-00017
   Gorgulu A, 2004, NEUROSURG REV, V27, P181, DOI 10.1007/s10143-003-0310-9
   Hasegawa T, 2007, J DERMATOL, V34, P328, DOI 10.1111/j.1346-8138.2007.00281.x
   Hieb LD, 2001, SPINE, V26, P748, DOI 10.1097/00007632-200104010-00009
   Imran Y., 2005, SMJ Singapore Medical Journal, V46, P25
   Jacob A, 2002, LARYNGOSCOPE, V112, P37, DOI 10.1097/00005537-200201000-00007
   Kanamori M, 2001, SPINE, V26, P2264, DOI 10.1097/00007632-200110150-00019
   Kato Tsuyoshi, 2005, Spine J, V5, P479, DOI 10.1016/j.spinee.2005.01.010
   Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539
   Kumar TR, 2003, J BIOMAT SCI-POLYM E, V14, P689, DOI 10.1163/156856203322274941
   LAROCCA H, 1974, J BONE JOINT SURG BR, VB 56, P545
   Lee CH, 2007, CLIN NEUROL NEUROSUR, V109, P667, DOI 10.1016/j.clineuro.2007.05.015
   Liu S, 2002, J NEUROSURG, V97, P69, DOI 10.3171/spi.2002.97.1.0069
   MACKAY MA, 1995, SPINE, V20, P1793, DOI 10.1097/00007632-199508150-00008
   MAYER PJ, 1989, J BONE JOINT SURG AM, V71A, P1090, DOI 10.2106/00004623-198971070-00018
   Miyamoto K, 2006, SPINE, V31, pE91, DOI 10.1097/01.brs.0000199902.80607.ce
   Nygaard OP, 1999, ACTA NEUROCHIR, V141, P619, DOI 10.1007/s007010050351
   PRUSICK VR, 1988, J BONE JOINT SURG AM, V70A, P1256, DOI 10.2106/00004623-198870080-00023
   Rennekampff H O, 1994, J Invest Surg, V7, P187, DOI 10.3109/08941939409018285
   Robertson J T, 1996, Eur Spine J, V5 Suppl 1, pS2, DOI 10.1007/BF00298565
   Ross JS, 1996, NEUROSURGERY, V38, P855, DOI 10.1227/00006123-199604000-00053
   Sabuncuoglu H, 2007, SPINE J, V7, P459, DOI 10.1016/j.spinee.2006.06.398
   Shih HN, 2004, J BIOMED MATER RES B, V71B, P421, DOI 10.1002/jbm.b.30106
   Tatsui CE, 2006, J NEUROSURG-SPINE, V4, P51, DOI 10.3171/spi.2006.4.1.51
   Tosi GM, 2005, J CELL PHYSIOL, V202, P849, DOI 10.1002/jcp.20181
   von Versen-Hoeynck Frauke, 2004, Cell and Tissue Banking, V5, P45, DOI 10.1023/B:CATB.0000022276.47180.96
   Welch WC, 2002, J NEUROSURG, V97, P413, DOI 10.3171/spi.2002.97.4.0413
   Winkelmuller M, 1996, J NEUROSURG, V85, P458, DOI 10.3171/jns.1996.85.3.0458
   Zafar M, 2007, JCPSP-J COLL PHYSICI, V17, P107
   ZOHAR Y, 1987, LARYNGOSCOPE, V97, P978
   Zou XN, 2004, EUR SPINE J, V13, P157, DOI 10.1007/s00586-003-0645-5
NR 37
TC 40
Z9 45
U1 2
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD AUG
PY 2009
VL 18
IS 8
BP 1202
EP 1212
DI 10.1007/s00586-009-1013-x
PG 11
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 488TC
UT WOS:000269371900017
PM 19404691
OA Green Published
DA 2018-10-20
ER

PT J
AU Tamma, R
   Colaianni, G
   Camerino, C
   Di Benedetto, A
   Greco, G
   Strippoli, M
   Vergari, R
   Grano, A
   Mancini, L
   Mori, G
   Colucci, S
   Grano, M
   Zallone, A
AF Tamma, Roberto
   Colaianni, Graziana
   Camerino, Claudia
   Di Benedetto, Adriana
   Greco, Giovanni
   Strippoli, Maurizio
   Vergari, Rosaria
   Grano, Antonella
   Mancini, Lucia
   Mori, Giorgio
   Colucci, Silvia
   Grano, Maria
   Zallone, Alberta
TI Microgravity during spaceflight directly affects in vitro
   osteoclastogenesis and bone resorption
SO FASEB JOURNAL
LA English
DT Article
DE mechanical forces; osteoporosis; bone remodeling
ID MESENCHYMAL STEM-CELLS; MODELED MICROGRAVITY; SPACE-FLIGHT; INCREASES;
   DIFFERENTIATION; PROLIFERATION; ADIPOGENESIS; OSTEOBIOLOGY; STRAIN;
   LEVEL
AB During space flight, severe losses of bone mass are observed. Both bone formation and resorption are probably involved, but their relative importance remains unclear. The purpose of this research is to understand the role of osteoclasts and their precursors in microgravity-induced bone loss. Three experiments on isolated osteoclasts (OCs) and on their precursors, OSTEO, OCLAST, and PITS, were launched in the FOTON-M3 mission. The OSTEO experiment was conducted for 10 d in microgravity within bioreactors with a perfusion system, where the differentiation of precursors, cultured on a synthetic 3-dimensional bonelike biomaterial, skelite, toward mature OCs was assessed. In OCLAST and in PITS experiments, differentiated OCs were cultured on devitalized bovine bone slices for 4 d in microgravity. All of the experiments were replicated on ground in the same bioreactors, and OCLAST also had an inflight centrifuge as a control. Gene expression in microgravity, compared with ground controls, demonstrated a severalfold increase in genes involved in osteoclast maturation and activity. Increased bone resorption, proved by an increased amount of collagen telopeptides released VS ground and centrifuge control, was also found. These results indicate for the first time osteoclasts and their precursors as direct targets for microgravity and mechanical forces.-Tamma, R., Colaianni, G., Camerino, C., Di Benedetto, A., Greco, G., Strippoli, M., Vergari, R., Grano, A., Mancini, L., Mori, G., Colucci, S., Grano, M., Zallone, A. Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption. FASEB J. 23, 2549-2554 (2009)
C1 [Tamma, Roberto; Colaianni, Graziana; Camerino, Claudia; Di Benedetto, Adriana; Greco, Giovanni; Strippoli, Maurizio; Vergari, Rosaria; Grano, Antonella; Mancini, Lucia; Mori, Giorgio; Colucci, Silvia; Grano, Maria; Zallone, Alberta] Univ Bari, Sch Med, Dept Human Anat & Histol, I-70124 Bari, Italy.
RP Zallone, A (reprint author), Univ Bari, Sch Med, Dept Human Anat & Histol, Piazza G Cesare 11, I-70124 Bari, Italy.
EM a.zallone@anatomia.uniba.it
RI tamma, roberto/C-3679-2016; Mori, Giorgio/P-1370-2014
OI Mori, Giorgio/0000-0001-6731-0247; Colucci, Silvia/0000-0001-9970-3539;
   Grano, Maria/0000-0002-7121-5899; Colaianni,
   Graziana/0000-0001-8501-5399; Camerino, Claudia/0000-0001-7217-9327
FU Italian Space Agency (Osteporosis and Muscle Atrophy project); European
   Space Agency (European Research in Space and Terrestrial Osteoporosis,
   Microgravity Applied Project)
FX This work was supported by grants from the Italian Space Agency
   (Osteporosis and Muscle Atrophy project) and from the European Space
   Agency (European Research in Space and Terrestrial Osteoporosis,
   Microgravity Applied Project) to A.Z.
CR Basso N, 2005, BONE, V36, P173, DOI 10.1016/bone.2004.09.016
   Caillot-Augusseau A, 2000, CLIN CHEM, V46, P1136
   Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x
   Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6
   Grigoriev A I, 1998, Aviakosm Ekolog Med, V32, P21
   Hughes-Fulford M, 2001, J Gravit Physiol, V8, pP1
   Hughes-Fulford M, 2006, J CELL BIOCHEM, V99, P435, DOI 10.1002/jcb.20883
   Kumei Y, 2006, ANN NY ACAD SCI, V1090, P311, DOI 10.1196/annals.1378.034
   LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33
   Marie PJ, 2000, CALCIFIED TISSUE INT, V67, P2, DOI 10.1007/s00223001088
   Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611
   Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120
   Rucci N, 2007, J CELL BIOCHEM, V100, P464, DOI 10.1002/jcb.21059
   Sibonga JD, 2007, BONE, V41, P973, DOI 10.1016/j.bone.2007.08.022
   Vico L, 2001, CALCIFIED TISSUE INT, V68, P1, DOI 10.1007/BF02684996
   Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156
NR 16
TC 51
Z9 65
U1 1
U2 12
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD AUG
PY 2009
VL 23
IS 8
BP 2549
EP 2554
DI 10.1096/fj.08-127951
PG 6
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 481UE
UT WOS:000268836700023
PM 19329761
DA 2018-10-20
ER

PT J
AU Prasad, HS
AF Prasad, Hari S.
TI Bone Regeneration With Autologous Biomaterial; Rapid Induction of Vital
   New Bone in Maxillary Sinus Floor by Platelet Concentrate Alone at 23x
   Baseline (PRP23x): A Case Report (vol 18, pg 210, 2009)
SO IMPLANT DENTISTRY
LA English
DT Correction
CR Smith AE, 2009, IMPLANT DENT, V18, P210, DOI 10.1097/ID.0b013e318198d3f9
NR 1
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD AUG
PY 2009
VL 18
IS 4
BP CP2
EP CP2
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 481VA
UT WOS:000268838900001
DA 2018-10-20
ER

PT J
AU Kokkinos, PA
   Zarkadis, IK
   Kletsas, D
   Deligianni, DD
AF Kokkinos, Petros A.
   Zarkadis, Ioannis K.
   Kletsas, Dimitris
   Deligianni, Despina D.
TI Effects of physiological mechanical strains on the release of growth
   factors and the expression of differentiation marker genes in human
   osteoblasts growing on Ti-6Al-4V
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mechanical strain; DNA synthesis; Ti-6Al-4V; human bone marrow
   osteoblasts; gene expression
ID SMOOTH-MUSCLE-CELLS; IN-VITRO; TRANSCRIPTION FACTOR; MC3T3-E1 CELLS;
   DNA-SYNTHESIS; OSTEOCALCIN; PROLIFERATION; TITANIUM; STRESS;
   DEXAMETHASONE
AB Mechanical loading factors at the bone-implant interface are critical for the osseointegration and clinical Success of the implant. The aim of the present investigation was to study the effects of mechanical strain on the orthopedic biomaterial Ti-6Al-4V/osteoblast interface, using an in vitro model. Homogeneous strain was applied to human bone marrow derived osteoblasts, (HBMDOs) cultured on Ti-6Al-4V, at physiological levels (strain magnitudes 500 microstrain (mu epsilon) and 1000 mu epsilon, at frequencies of load application 0.5 Hz and 1. Hz), by a mechanostimulatory system, based on the principle Of four-point bending. Semi-quantitative reverse transcription-polymerase chain reaction (sqRT-PCR) was used to determine the mRNA expression of Cbfa1 and osteocalcin at different loading conditions. The release of growth factors as a response to stretch was also investigated by transferring stretch-conditioned media to nonstretched cells and by measuring their effect on the regulation of DNA synthesis. Mechanical loading was found to contribute to the regulation of osteoblast differentiation by influencing the level of the osteoblast-specific transcription factor Cbfa1, both at the mRNA and protein level, and also the level of osteocalcin, which is regarded as the most osteoblast-specific gene. Both genes were differentially expressed shortly after the application of different mechanical stimuli, in terms of strain frequency, magnitude, and time interval. Media conditioned from mechanically stressed HBMDOs stimulate DNA synthesis more intensely compared to media conditioned from unstressed Control cultures, indicating that mechanical strain induces the release of a mitogenic potential that regulates cell proliferation. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 387-395, 2009
C1 [Kokkinos, Petros A.; Deligianni, Despina D.] Univ Patras, Dept Aeronaut & Mech Engn, Biomed Engn Lab, GR-26500 Patras, Greece.
   [Zarkadis, Ioannis K.] Univ Patras, Sch Med, Dept Biol, GR-26500 Patras, Greece.
   [Kletsas, Dimitris] Natl Ctr Sci Res Demokritos, Inst Biol, Lab Cell Proliferat & Ageing, Athens 15310, Greece.
RP Deligianni, DD (reprint author), Univ Patras, Dept Aeronaut & Mech Engn, Biomed Engn Lab, GR-26500 Patras, Greece.
EM deligian@mech.upatras.gr
RI Kletsas, Dimitris/F-6953-2010
FU Research Committee of the University of Patras
FX Contract grant sponsor: Research Committee of the University of Patras
CR Basso N, 2002, BONE, V30, P347, DOI 10.1016/S8756-3282(01)00678-0
   Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971
   Brand R A, 2001, J Orthop Sci, V6, P295, DOI 10.1007/s007760100051
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X
   Di Palma F, 2004, BIOMATERIALS, V25, P2565, DOI 10.1016/j.biomaterials.2003.09-026
   Di Palma F, 2003, BIOMATERIALS, V24, P3139, DOI 10.1016/S0142-9612(03)00152-2
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581
   Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   Hipper A, 2000, PFLUG ARCH EUR J PHY, V440, P19, DOI 10.1007/s004240051017
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P499, DOI 10.1016/j.joms.2004.07.023
   Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1
   Kaspar D., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P161
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kletsas D, 1998, FEBS LETT, V430, P358, DOI 10.1016/S0014-5793(98)00695-4
   Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y
   Labat B, 2000, BIOMATERIALS, V21, P1275, DOI 10.1016/S0142-9612(00)00013-2
   Mo XY, 2004, J BONE MINER METAB, V22, P264, DOI 10.1007/s00774-003-0478-7
   Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4
   Petermann AT, 2002, KIDNEY INT, V61, P40, DOI 10.1046/j.1523-1755.2002.00102.x
   Porter RM, 2003, J CELL BIOCHEM, V90, P13, DOI 10.1002/jcb.10592
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Raymond MH, 1999, GENOMICS, V60, P210, DOI 10.1006/geno.1999.5893
   Robling AG, 2000, J BONE MINER RES, V15, P1596, DOI 10.1359/jbmr.2000.15.8.1596
   Sudhir K, 2001, AM J HYPERTENS, V14, P1128, DOI 10.1016/S0895-7061(01)02189-6
   Tang LL, 2004, J BIOMECH, V37, P157, DOI 10.1016/S0021-9290(03)00237-9
   Turner CH, 1997, J BIOMECH, V30, P555, DOI 10.1016/S0021-9290(97)84505-8
   Walboomers XF, 2004, J BIOMED MATER RES A, V69A, P131, DOI 10.1002/jbm.a.20127
   Winter LC, 2002, ANN BIOMED ENG, V30, P1242, DOI 10.1114/1.1529195
   Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4
   Wyckoff MH, 2005, J CLIN ENDOCR METAB, V90, P1233, DOI 10.1210/jc.2004-0251
   Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200
   Yang L, 2003, CHINESE MED J-PEKING, V116, P1357
   Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200
NR 39
TC 11
Z9 12
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2009
VL 90A
IS 2
BP 387
EP 395
DI 10.1002/jbm.a.32105
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 468JP
UT WOS:000267814100009
PM 18523952
DA 2018-10-20
ER

PT J
AU Schliephake, H
   Zghoul, N
   Jager, V
   van Griensven, M
   Zeichen, J
   Gelinsky, M
   Wulfing, T
AF Schliephake, H.
   Zghoul, N.
   Jaeger, V.
   van Griensven, M.
   Zeichen, J.
   Gelinsky, M.
   Wuelfing, T.
TI Effect of seeding technique and scaffold material on bone formation in
   tissue-engineered constructs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE trabecular bone cells; scaffolds; osteogenesis; dynamic culturing
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PERFUSION BIOREACTOR
   SYSTEM; IN-VITRO; MINERALIZED COLLAGEN; FLOW PERFUSION; OSTEOGENIC
   DIFFERENTIATION; 3-DIMENSIONAL SCAFFOLDS; TRICALCIUM PHOSPHATE; POROUS
   SCAFFOLDS
AB The aim of the present study was to test the hypothesis that both scaffold material and the type of call culturing contribute to the results of in vivo osteogenesis in tissue-engineered constructs in an interactive manner. CaCO(3) scaffolds and mineralized collagen scaffolds were seeded with human trabecular bone cells at a density of 5 x 10(6) cells/cm(3) and were left to attach under standard conditions for 24 h. Subsequently, they were submitted to static and dynamic Culturing for 14 days (groups III and IV, respectively). Dynamic culturing was carried out in a continuous flow perfusion bioreactor. Empty scaffolds and scaffolds that were seeded with cells and kept under standard conditions for 24 h served as controls (groups I and H, respectively). Five scaffolds of each biomaterial and from each group were implanted into the gluteal muscles of mu rats for 6 weeks. Osteogenesis was assessed quantitatively by histomorphometry and expression of osteocalcin (OC) and vascular endothelial growth factor (VEGF) was determined by immunohistochemistry. CaCO(3) scaffolds exhibited 15.8% (SD 3.1) of newly formed bone after Static Culture and 22.4%, (SD 8.2) after dynamic Culture. Empty control scaffolds did not show bond formation, and scaffolds after 24 h of standard conditions produced 8.2% of newly formed bone (SD 4.0). Differences between the controls and the scaffolds cultured for 14 days were significant, but there was no significant difference between static and dynamic culturing. Mineralized collagen scaffolds did not show bone formation in any group. There was a significant difference in the expression of OC within the scaffolds submitted to static versus dynamic culturing in the CaCO(3) scaffolds. VEGF expression did not show significant differences between static and dynamic Culturing in the two biomaterials tested. It is concluded that within the limitations of the study the type of biomaterial had the dominant effect on in vivo bone formation in small tissue-engineered scaffolds. The culture period additionally affected the amount of bone formed, whereas the type of Culturing may have had a positive effect on the expression of osteogenic markers but not on the quantity of bone formation. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 429-437, 2009
C1 [Schliephake, H.; Wuelfing, T.] Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany.
   [Zghoul, N.; Jaeger, V.] Helmholtz Ctr Infect Res, Div Struct Biol, Braunschweig, Germany.
   [van Griensven, M.; Zeichen, J.] Hannover Med Sch, Dept Expt Trauma Surg, D-3000 Hannover, Germany.
   [Gelinsky, M.] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, Dresden, Germany.
RP Schliephake, H (reprint author), Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany.
EM schliephake.henning@med.uni-goettingen.de
RI van Griensven, Martijn/F-5808-2012; Gelinsky, Michael/A-9680-2012
OI van Griensven, Martijn/0000-0001-5104-9881; Gelinsky,
   Michael/0000-0001-9075-5121; , Nadia/0000-0002-9455-9846
FU Deutsche Forschungsgemeinschaft (DFG) [Schl 368/10-1, Schl 368/10-2, MA
   852/7-2, MA 852/7/3]
FX Contract grant sponsor: Deutsche Forschungsgemeinschaft (DFG); contract
   grant numbers: Schl 368/10-1, Schl 368/10-2, MA 852/7-2, MA 852/7/3
CR Barthold M, 2005, Animal Cell Technology Meets Genomics, P199
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   Burmeister B, 2003, EUR CELLS MAT S2, V5, P18
   Claase MB, 2007, J MATER SCI-MATER M, V18, P1299, DOI 10.1007/s10856-006-0077-y
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Gelinsky M, 2004, MATERIALWISS WERKST, V35, P229, DOI 10.1002/mawe.200400732
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   JACQUIERY C, 2005, ANN SURG, V242, P859
   Jager V, 1988, Cytotechnology, V1, P319, DOI 10.1007/BF00365077
   Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Kitagawa T, 2006, BIOTECHNOL BIOENG, V93, P947, DOI 10.1002/bit.20797
   Materna T, 2008, CLIN ORAL IMPLAN RES, V19, P379, DOI 10.1111/j.1600-0501.2007.01483.x
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Niemeyer P, 2006, CYTOTHERAPY, V8, P354, DOI 10.1080/14653240600845187
   Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Scaglione S, 2006, BIOTECHNOL BIOENG, V93, P181, DOI 10.1002/bit.20677
   SCHMITH LG, 1974, CALCIF TISS RES, V14, P333
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Sochaga LA, 2006, TISSUE ENG, V12, P1851
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   Wang JY, 2006, BIOMATERIALS, V27, P2738, DOI 10.1016/j.biomaterials.2005.12.005
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
   Zhao F, 2005, BIOTECHNOL BIOENG, V91, P482, DOI 10.1002/bit.20532
NR 33
TC 15
Z9 18
U1 0
U2 22
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2009
VL 90A
IS 2
BP 429
EP 437
DI 10.1002/jbm.a.32104
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 468JP
UT WOS:000267814100014
PM 18523951
DA 2018-10-20
ER

PT J
AU Jiang, XJ
   Wang, T
   Li, XY
   Wu, DQ
   Zheng, ZB
   Zhang, JF
   Chen, JL
   Peng, B
   Jiang, H
   Huang, CX
   Zhang, XZ
AF Jiang, Xue-Jun
   Wang, Tao
   Li, Xiao-Yan
   Wu, De-Qun
   Zheng, Zhao-Bin
   Zhang, Jin-Feng
   Chen, Jin-Ling
   Peng, Bin
   Jiang, Hong
   Huang, Congxin
   Zhang, Xian-Zheng
TI Injection of a novel synthetic hydrogel preserves left ventricle
   function after myocardial infarction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE myocardial infarction; hydrogel injection; LV function preservation;
   scar expansion
ID SKELETAL MYOBLASTS; CARDIAC-FUNCTION; HEART-FAILURE; IN-VITRO; CELLS;
   CARDIOMYOCYTES; DELIVERY; TISSUE
AB Myocardial infarction (MI) and the subsequent heart failure remain one of the leading causes of morbidity and mortality world wide. A number of studies have demonstrated that bioderived materials improve cardiac function after implantation because of their angiogenic potential. In this study, we hypothesized that injection of biomaterials into infarcted myocardium can preserve left ventricular (LV) function through its prevention of paradoxical systolic bulging. To test this hypothesis, infarction was induced in rabbit myocardium by coronary artery ligation. After I week, 200-mu L alpha-cyclodextrin (alpha-CD)/MPEG-PCL-MPEG hydrogel was injected into the infarcted myocardium. Injection of phosphate buffered saline (PBS) served as controls. Twenty-eight days after the treatment, histological analysis indicated that the injection of hydrogel prevented scar expansion and wall thinning compared with the control (p < 0.05) without more microvessel density in infarcted myocardium (p = 0.70). LV ejection fraction, determined by echocardiography, was significantly greater in the hydrogel-treated group (56.09% +/- 8.42%) than the control group (37.26% +/- 6.36%, p = 0.001). The LV end-diastolic and end-systolic diameters were 2.07 +/- 0.33 cm and 1.74 +/- 0.30 cm, respectively, in the control group. Smaller LV end-diastolic diameter (1.61 +/- 0.26 cm, p = 0.005) and smaller end-systolic diameter (1.17 +/- 0.23 cm, p = 0.001) were found in the hydrogel-treated group. These results suggest that alpha-CD/MPEG-PCL-MPEG hydrogel could serve as an injectable biomaterial that prevents LV remodeling and dilation for the treatment of MI. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 472-477,2009
C1 [Jiang, Xue-Jun; Wang, Tao; Li, Xiao-Yan; Zheng, Zhao-Bin; Zhang, Jin-Feng; Chen, Jin-Ling; Peng, Bin; Jiang, Hong; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
   [Wu, De-Qun; Zhang, Xian-Zheng] Wuhan Univ, Dept Chem, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
RP Jiang, XJ (reprint author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
EM xjjiang@yahoo.com
RI WANG, TAO/B-1888-2013
FU National Key Basic Research Program of China [2005CB623903]
FX Contract grant sponsor: National Key Basic Research Program of China;
   contract grant number: 2005CB623903
CR Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   COLUCCI WS, 1997, AM J CARDIOL, V80, P15
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   HUANG NF, 2005, TISSUE ENG, V11, P860
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kofidis T, 2005, CIRCULATION, V112, P1173
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li H, 2006, BIOMACROMOLECULES, V7, P1951, DOI 10.1021/bm060064n
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   MELINDA C, 2007, SCIENCE, V316, P1133
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Park JS, 2004, MACROMOLECULES, V37, P6786, DOI 10.1021/ma049677n
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   *US NIH, 1996, NIH PUBL, V25, P34
   Xu HX, 2004, CYTOTHERAPY, V6, P204, DOI 10.1080/14653240410006013
   Zhang XZ, 2002, LANGMUIR, V18, P2013, DOI 10.1021/la011325b
NR 25
TC 60
Z9 62
U1 1
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2009
VL 90A
IS 2
BP 472
EP 477
DI 10.1002/jbm.a.32118
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 468JP
UT WOS:000267814100019
PM 18546187
DA 2018-10-20
ER

PT J
AU Dulgar-Tulloch, AJ
   Bizios, R
   Siegel, RW
AF Dulgar-Tulloch, A. J.
   Bizios, R.
   Siegel, R. W.
TI Human mesenchymal stem cell adhesion and proliferation in response to
   ceramic chemistry and nanoscale topography
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stem cell; nanophase; ceramic; cell adhesion; cell
   proliferation; grain size; material chemistry; material topography
ID OSTEOBLAST ADHESION; MYOGENIC DIFFERENTIATION; NANOPHASE CERAMICS;
   SURFACE-CHEMISTRY; INTEGRIN; BONE; PHOSPHORYLATION; HYDROXYLAPATITE;
   MICROSTRUCTURE; NANOTOPOGRAPHY
AB Modification of the chemistry and surface topography of nanophase ceramics was used to provide biomaterial formulations designed to direct the adhesion and proliferation of human mesenchymal stem cells (HMSCs). HMSC adhesion was dependent upon both the substrate chemistry and grain size, but not on surface roughness or crystal phase. Specifically, cell adhesion on alumina and hydroxyapatite was significantly reduced on the 50 and 24 rim surfaces, as compared with the 1500 and 200 nm surfaces, but adhesion on titania substrates was independent of grain size. HMSC proliferation was minimal on the 50 and 24 nm substrates of any chemistry tested, and thus significantly lower than the densities observed on either the 1500 or 200 nm surfaces after 3 or more consecutive days of culture. Furthermore, HMSC proliferation was enhanced on the 200 nm substrates, compared with results obtained on the 1500 rim substrates after 7 or more days of culture. HMSC proliferation was independent of both substrate surface roughness and crystal phase. Rat osteoblast and fibroblast adhesion and proliferation exhibited similar trends to that of HMSCs on all substrates tested. These results demonstrated the potential of nanophase ceramic surfaces to modulate functions of HMSCs, which are pertinent to biomedical applications such as implant materials and devices. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 586-594, 2009
C1 [Dulgar-Tulloch, A. J.; Siegel, R. W.] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.
   [Dulgar-Tulloch, A. J.; Bizios, R.; Siegel, R. W.] Rensselaer Polytech Inst, Rensselaer Nanotechnol Ctr, Troy, NY 12180 USA.
   [Bizios, R.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
RP Dulgar-Tulloch, AJ (reprint author), GE Biosci, Global Res Ctr, Niskayuna, NY 12309 USA.
EM dulgar@research.ge.com
FU Philip Morris USA; National Science Foundation [DMR-0117792]
FX Contract grant sponsor: The Nanoscale Science and Engineering Initiative
   of the National Science Foundation; contract grant number: DMR-0117792
CR AHN ES, 2000, T SOC BIOMATER, V23, P255
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Ballard J.D., 2005, THESIS RENSSELAER PO
   BALLARD JD, 2006, ENCY BIOMEDICAL ENG, V4, P2489
   BOETTIGER D, 1995, DEV BIOL, V169, P261, DOI 10.1006/dbio.1995.1142
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139
   Dugina V, 2001, J CELL SCI, V114, P3285
   DULGARTULLOCH AJ, 2003, MAT RES SOC S P, V740
   DULGARTULLOCH AJ, 2005, THESIS RENSSELAER PO
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Hilliard J. E., 1964, METAL PROGR, V85, P99
   *INT CTR DIFFR DAT, 1993, POWD DIFFR FIL
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392
   McManus AJ, 2005, J BIOMED MATER RES A, V72A, P98, DOI 10.1002/jbm.a.30204
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   NAKAHARA H, 1991, EXP CELL RES, V195, P492, DOI 10.1016/0014-4827(91)90401-F
   Nishimura N, 1998, J MATER SCI-MATER M, V9, P99, DOI 10.1023/A:1008851115846
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Price RL, 2003, J BIOMED MATER RES A, V67A, P1284, DOI 10.1002/jbm.a.20011
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Ter Brugge PJ, 2002, TISSUE ENG, V8, P321, DOI 10.1089/107632702753725076
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Webster T.J., 1998, BIOCERAMICS, P273
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, SCRIPTA MATER, V44, P1639, DOI 10.1016/S1359-6462(01)00873-9
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Zhao L, 2005, J BIOMATER APPL, V19, P237, DOI 10.1177/0885328205047218
NR 40
TC 69
Z9 70
U1 1
U2 20
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2009
VL 90A
IS 2
BP 586
EP 594
DI 10.1002/jbm.a.32116
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 468JP
UT WOS:000267814100031
PM 18563822
DA 2018-10-20
ER

PT J
AU Lowmunkong, R
   Sohmura, T
   Suzuki, Y
   Matsuya, S
   Ishikawa, K
AF Lowmunkong, Rungnapa
   Sohmura, Taiji
   Suzuki, Yumiko
   Matsuya, Shigeki
   Ishikawa, Kunio
TI Fabrication of Freeform Bone-Filling Calcium Phosphate Ceramics by
   Gypsum 3D Printing Method
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE rapid prototyping; freeform fabrication; bioceramic; gypsum; calcium
   phosphate; hydroxyapatite; beta-TCP
ID HYDROXYAPATITE; SUBSTITUTES; SCAFFOLDS; IMPLANTS
AB Transformation of gypsum model fabricated by three-dimensional printing (3DP) into hydroxyapatite (HA) by treating in ammonium phosphate solution is possible. However, 3DP powder supplied by the manufacturer contains unknown additives which may be questionable for biomaterials. Accordingly, pure plaster of Paris (POP) powder was used for fabrication in the present study. For accurate fabrication, reduction of supplied binder ink to 80% of standard amount for 3DP powder supplied by the manufacturer was found to be the optimal condition for POP fabrication. Transformation from POP to HA was done by immersing into 1 mol/L ammonium phosphate solution. However, preheating of fabricated POP specimen at 200 degrees C for 30 min to change from calcium sulfate dihydrate into calcium sulfate hemihydrate could accelerate the transformation into HA effectively. To increase compressive strength, HA transformed specimen was sintering at 1150 degrees C for 3 h. The compressive strength increased four times comparing with as transformed HA specimen. However, crystal structure was transformed to beta-TCP due to the chemical reaction between the transformed HA and remained phosphate from ammonium phosphate solution at the sintering temperature. A sophisticated application of the present 3DP method to fabricate the freeforM bioceramic for osseous defect was attempted, and jaw bone defect filling biomaterial of beta-TCP and scaffold with macroporous structures Could be fabricated. Present 3DP method has possibility to fabricate freeform bioceramic for osseous defect or scaffold. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Pan B: Appl Biomater 90B: 531-539, 2009
C1 [Lowmunkong, Rungnapa; Sohmura, Taiji] Osaka Univ, Div Oromaxillofacial Regenerat, Course Integrated Oral Sci & Stomatol, Grad Sch Dent, Suita, Osaka 5650871, Japan.
   [Suzuki, Yumiko; Ishikawa, Kunio] Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, Fukuoka 8128582, Japan.
   [Matsuya, Shigeki] Fukuoka Dent Coll, Dept Dent Engn, Sawara Ku, Fukuoka 8140193, Japan.
RP Sohmura, T (reprint author), Osaka Univ, Div Oromaxillofacial Regenerat, Course Integrated Oral Sci & Stomatol, Grad Sch Dent, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM sohmurat@dent.osaka-u.ac.jp
CR AOKI H, 1999, MARVELOUS BIOMATERIA, P80
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   FRAME JW, 1975, J DENT, V3, P77
   Gbureck U, 2008, J MATER SCI-MATER M, V19, P1559, DOI 10.1007/s10856-008-3373-x
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Gu YW, 2004, BIOMATERIALS, V25, P4127, DOI 10.1016/j.biomaterials.2003.11.030
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Juang HY, 1996, BIOMATERIALS, V17, P2059, DOI 10.1016/0142-9612(96)88882-X
   KATO T, 2003, THESIS TOKUSHIMA U
   Khalyfa A, 2007, J MATER SCI-MATER M, V18, P909, DOI 10.1007/s10856-006-0073-2
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Levy RA, 1997, AM J NEURORADIOL, V18, P1522
   Lowmunkong R, 2007, J BIOMED MATER RES B, V80B, P386, DOI 10.1002/jbm.b.30609
   Mimura K, 2004, DENT MATER J, V23, P353, DOI 10.4012/dmj.23.353
   OH CW, 1998, J ORTHOP SURG, V6, P1
   PELTIER L F, 1961, Clin Orthop, V21, P1
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Tieliewuhan Y, 2004, DENT MATER J, V23, P258, DOI 10.4012/dmj.23.258
NR 20
TC 23
Z9 25
U1 3
U2 87
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2009
VL 90B
IS 2
BP 531
EP 539
DI 10.1002/jbm.b.31314
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472FD
UT WOS:000268114200006
PM 19145633
DA 2018-10-20
ER

PT J
AU Wiegand, C
   Abel, M
   Ruth, P
   Wilhelms, T
   Schulze, D
   Norgauer, J
   Hipler, UC
AF Wiegand, Cornelia
   Abel, Martin
   Ruth, Peter
   Wilhelms, Tim
   Schulze, Daniel
   Norgauer, Johannes
   Hipler, Uta-Christina
TI Effect of the Sterilization Method on the Performance of Collagen Type I
   on Chronic Wound Parameters In Vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE collagen type I; irradiation; ethylene oxide; sterilization; chronic
   wound
ID GAMMA-IRRADIATION; OXIDATIVE STRESS; GROWTH-FACTOR; ULCERS; MATRIX;
   OXIDE; BIOMATERIAL; ENVIRONMENT; SUPEROXIDE; PROTEASES
AB In the treatment of chronic wounds, it is necessary to establish a physiological wound milieu to improve healing. Application of collagen as wound dressing has been described as beneficial as it possesses the ability to reduce elevated levels of proteases, cytokines, and free radicals. Consequently, a wide range of wound dressings based on collagen have been developed. Native collagen is susceptible to alterations because of influences during the production process; to minimize effects on the molecule itself collagen wound dressings are usually aseptically produced. Common sterilization methods (autoclaving, irradiation, and ethylene oxide (EtO) treatment) can induce changes in the protein chemistry and physical properties, potentially affecting the absorption rate, mechanical strength, or performance. In this study, we have evaluated the influence of gamma- and beta-irradiation as well as EtO sterilization on the binding capacity of collagen type I for selected proteases and cytokines associated with nonhealing wounds. Although a pronounced effect on the physical properties of the collagen was found, there was no significant loss in the binding affinity for polymorphonuclear elastase, matrix metalloproteinase-2, and interleukin-1 beta, or in the antioxidant capacity. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 90B: 710-719, 2009
C1 [Wiegand, Cornelia; Norgauer, Johannes; Hipler, Uta-Christina] Hosp Med Ctr Jena, Dept Dermatol & Dermatol Allergy, D-07740 Jena, Germany.
   [Abel, Martin] Lohmann & Rauscher GmbH & Co KG, Regulatory Affairs Div, D-56579 Rengsdorf, Germany.
   [Ruth, Peter; Wilhelms, Tim; Schulze, Daniel] Lohmann & Rauscher GmbH & Co KG, Div Res, D-56564 Neuwied, Germany.
RP Wiegand, C (reprint author), Hosp Med Ctr Jena, Dept Dermatol & Dermatol Allergy, D-07740 Jena, Germany.
EM c.wiegand@med.uni-jena.de
CR Barrick B, 1999, WOUND REPAIR REGEN, V7, P410, DOI 10.1046/j.1524-475X.1999.00410.x
   BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620
   Bushell JA, 2005, J CONTROL RELEASE, V110, P49, DOI 10.1016/j.jconrel.2005.09.009
   CHEN SM, 1997, WOUND REPAIR REGEN, V5, P23
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   DORMANSMITH V, 1997, BIOCOMPATIBILITY ASS, P101
   FAMDALE RW, 2004, J THROMB HAEMOST, V2, P561
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 2006, EUR J PHARM BIOPHARM, V63, P176, DOI 10.1016/j.ejpb.2005.11.007
   Harris I R, 1995, Exp Dermatol, V4, P342, DOI 10.1111/j.1600-0625.1995.tb00058.x
   He CF, 1999, WOUND REPAIR REGEN, V7, P97, DOI 10.1046/j.1524-475X.1999.00097.x
   Herold S, 2001, CHIMIA, V55, P870
   Herrick S, 1997, LAB INVEST, V77, P281
   James TJ, 2003, WOUND REPAIR REGEN, V11, P172, DOI 10.1046/j.1524-475X.2003.11304.x
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Lodish H., 2000, MOL CELL BIOL
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Moseley R, 2003, BIOMATERIALS, V24, P1549, DOI 10.1016/S0142-9612(02)00540-9
   Nwomeh BC, 1998, CLIN PLAST SURG, V25, P341
   Olde Damink L. H. H., 1995, Journal of Biomedical Materials Research, V29, P149
   Ovington L, 2002, WOUNDS, V14, P3
   Pekkarinen T, 2004, INT ORTHOP, V28, P97, DOI 10.1007/s00264-003-0524-z
   Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Requena J.R., 2001, P NATL ACAD SCI USA, V98, P68
   Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1
   Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511
   Schonfelder U, 2005, BIOMATERIALS, V26, P6664, DOI 10.1016/j.biomaterials.2005.04.030
   Schultz GS, 1998, WOUNDS, V10, p1F
   Singer A. J., 1999, NEW ENGL J MED, V341, P783
   SKIENS WE, 1980, RADIAT PHYS CHEM, V15, P45
   Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
   Vorauer-Uhl K, 2002, WOUND REPAIR REGEN, V10, P366, DOI 10.1046/j.1524-475X.2002.t01-1-10605.x
   Wagner WR, 1996, J SURG RES, V66, P100, DOI 10.1006/jsre.1996.0379
   Yager DR, 1999, WOUND REPAIR REGEN, V7, P433, DOI 10.1046/j.1524-475X.1999.00433.x
NR 41
TC 33
Z9 33
U1 2
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2009
VL 90B
IS 2
BP 710
EP 719
DI 10.1002/jbm.b.31338
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472FD
UT WOS:000268114200028
PM 19213054
DA 2018-10-20
ER

PT J
AU Qian, Y
   Yao, GF
   Lin, Z
   Chen, JM
   Fan, Y
   Davey, T
   Xu, JK
   Zheng, MH
AF Qian, Yu
   Yao, Guanfeng
   Lin, Zhen
   Chen, Jimin
   Fan, Ying
   Davey, Tamara
   Xu, Jiake
   Zheng, Minghao
TI Natural Bone Collagen Scaffold Combined with OP-1 for Bone Formation
   Induction In Vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone graft; scaffolds; animal model; spinal implant
ID SPINAL-FUSION; INTERBODY FUSION; GRAFT SUBSTITUTE; LUMBAR FUSION;
   COMPLICATIONS; RHBMP-2; MATRIX; OUTCOMES; SURGERY; SAFETY
AB The scaffold is a key element to osteogenic tissue engineering as it provides a microenvironment for bone formation. Natural bone collagen scaffold (NBCS) is a novel biomaterial scaffold acid-extracted from organic human bone. The objective of this study was to characterize NBCS and evaluate the osteoconductivity of the scaffold, in combination with osteogenic protein-1 (OP-1), using a rabbit posteolateral lumbar fusion model. Thirty two rabbits were divided into 4 experimental groups, autograft, NBCS alone, OP-1 alone or NBCS combined with OP-1. Bone formation was evaluated by micro-CT, quantitative histological analysis, immunohistochemistry and semi-quantitative RT-PCR at 6 weeks postoperatively. By scanning electronic microscope, we showed that NBCS maintains a porous, interconnecting microarchitecture. Micro-CT analysis demonstrated that NBCS combined with OP-1 significantly induced (p < 0.01) bone formation at the fusion site as compared to control groups. This was confirmed by quantitative histological analysis which demonstrated that the NBCS combined with OP-1 significantly enhanced bone matrix area (17.7 mm(2)) (p < 0.05) and bone marrow cavity size (71.3 mm(2)) (P < 0.05) as compared to the controls. Immunohistochemical assessment and RT-PCR also demonstrated that NBCS combined with OP-1 enhanced type I collagen and osteonectin expression. Together, these results suggest that NBCS is an effective scaffold for osteogenesis, and combined with growth factors such as OP-1, possesses both osteoconductive and osteoinductive properties that are sufficient for bone regeneration. (C) 2009 Wiley Periodicals. Inc. J Biomed Mater Res Part B: Appl Biomater 90B: 778-7887 2009
C1 [Qian, Yu; Yao, Guanfeng; Lin, Zhen; Chen, Jimin; Davey, Tamara; Xu, Jiake; Zheng, Minghao] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia.
   [Qian, Yu] Shaoxing Peoples Hosp, Dept Orthopaed, Shaoxing 312000, Zhejiang, Peoples R China.
   [Yao, Guanfeng] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Orthopaed, Shantou 515041, Guangdong, Peoples R China.
   [Lin, Zhen] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Orthopaed Surg, Guangzhou 510080, Guangdong, Peoples R China.
   [Fan, Ying] Perth Bone & Tissue Bank, Perth, WA 6009, Australia.
RP Zheng, MH (reprint author), Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia.
EM minghao.zheng@uwa.edu.au
RI Abel, Tamara/D-1433-2011
CR [Anonymous], 2001, FED REGISTER, V66, P5447
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   *FDA, 2004, EL DET DON HUM CELLS, P29786
   Furlan JC, 2007, J NEUROSURG-SPINE, V7, P486, DOI 10.3171/SPI-07/09/486
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Grauer JN, 2001, SPINE, V26, P127, DOI 10.1097/00007632-200101150-00004
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Jeppsson C, 1999, ACTA ORTHOP SCAND, V70, P559, DOI 10.3109/17453679908997842
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   KUHN DA, 1986, CLIN ORTHOP RELAT R, P224
   LIPMAN NS, 1990, LAB ANIM SCI, V40, P395
   Louis-Ugbo J, 2004, SPINE, V29, P360, DOI 10.1097/01.BRS.0000090823.12652.F9
   Magin MN, 2001, SPINE, V26, P469, DOI 10.1097/00007632-200103010-00009
   Meyer U, 1998, J MATER SCI-MATER M, V9, P301, DOI 10.1023/A:1008894612021
   Molteni A, 1999, CELL TISSUE RES, V295, P523, DOI 10.1007/s004410051258
   Morone MA, 1998, SPINE, V23, P159, DOI 10.1097/00007632-199801150-00003
   Paramore CG, 1999, NEUROSURGERY, V44, P1151, DOI 10.1097/00006123-199905000-00134
   PARAMORE CG, 1999, NEUROSURGERY, V44, P1155
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Sandhu HS, 2002, SPINE, V27, P567, DOI 10.1097/00007632-200203150-00003
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Skaggs DL, 2000, SPINE, V25, P2400, DOI 10.1097/00007632-200009150-00021
   Slosar PJ, 2007, SPINE J, V7, P301, DOI 10.1016/j.spinee.2006.10.015
   Sun Tian-sheng, 2004, Chin J Traumatol, V7, P18
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x
   WILTSE LL, 1968, J BONE JOINT SURG AM, VA 50, P919, DOI 10.2106/00004623-196850050-00004
NR 35
TC 3
Z9 3
U1 1
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2009
VL 90B
IS 2
BP 778
EP 788
DI 10.1002/jbm.b.31347
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472FD
UT WOS:000268114200036
PM 19283832
DA 2018-10-20
ER

PT J
AU Millon, LE
   Oates, CJ
   Wan, WK
AF Millon, Leonardo E.
   Oates, Christine J.
   Wan, Wankei
TI Compression Properties of Polyvinyl Alcohol - Bacterial Cellulose
   Nanocomposite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE hydrogel; polyvinyl alcohol; bacterial cellulose; nanocomposite;
   unconfined compressive properties; soft tissue; articular cartilage
ID H ARTIFICIAL MENISCUS; ARTICULAR-CARTILAGE; BIOMEDICAL APPLICATIONS;
   UNCONFINED COMPRESSION; IN-VIVO; HYDROGEL; REPLACEMENT; MECHANICS;
   FIBERS; JOINT
AB Despite the established use of total joint replacement for the treatment of advanced degeneration of articular cartilage, component loosening due to wear and osteolysis limits the lifespan of these joint prostheses. In the present study, nanocomposites consisting of poly(vinyl alcohol) (PVA) and bacterial cellulose (BC) nanofibers were investigated as possible improved cartilage replacement materials. Nanocomposites were synthesized by adding small amounts (<1%) of BC to PVA, and subjecting the mixture to thermal cycling. The mechanical properties of the resulting material were evaluated using unconfined compression testing. By the addition of BC nanofibers to the PVA matrix, a nanocomposite with a wide range of compressive mechanical properties control was obtained, with elastic modulus values similar to those reported for native articular cartilage. The nanocomposite also showed improved strain-rate dependence and adequate viscoelastic properties. The PVA-BC nanocomposite is therefore a promising biomaterial to be considered as a possible replacement material for localized articular cartilage injuries and other orthopedic applications such as intervertebral discs. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 90B: 922-929, 2009
C1 [Millon, Leonardo E.; Wan, Wankei] Univ Western Ontario, Biomed Engn Grad Program, London, ON N6A 5B9, Canada.
   [Millon, Leonardo E.; Oates, Christine J.; Wan, Wankei] Univ Western Ontario, Fordham Ctr Biomed Engn, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Biomed Engn Grad Program, London, ON N6A 5B9, Canada.
EM wkwan@eng.uwo.ca
FU Natural Science and Engineering Research Council of Canada (NSERC)
FX The authors thank Natural Science and Engineering Research Council of
   Canada (NSERC) for financial support. They are also grateful to the
   University Machine Shop for fabrication of molds and testing
   attachments. They express their special thanks to Ganesh Guhados for his
   help with bacterial cellulose production. They express their thanks to
   Kenneth Wong for obtaining the SEM micrographs.
CR Bodugoz-Senturk H, 2008, BIOMATERIALS, V29, P141, DOI 10.1016/j.biomaterials.2007.09.015
   Chang N, 2000, WEAR, V241, P109, DOI 10.1016/S0043-1648(00)00393-8
   Charlton DC, 2008, TISSUE ENG PT A, V14, P207, DOI 10.1089/ten.a.2006.0344
   Choi J, 2007, BIOMATERIALS, V28, P772, DOI 10.1016/j.biomaterials.2006.09.049
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   De Santis R, 2004, COMPOS SCI TECHNOL, V64, P861, DOI 10.1016/j.compscitech.2003.09.008
   DiSilvestro MR, 2001, J BIOMECH ENG-T ASME, V123, P198, DOI 10.1115/1.1351887
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   El Fray M, 2007, EUR POLYM J, V43, P2035, DOI 10.1016/j.eurpolymj.2007.02.024
   Grant C, 2006, BIOTECHNOL PROGR, V22, P1400, DOI 10.1021/bp060181u
   Gu Zheng-Qiu, 1998, Bio-Medical Materials and Engineering, V8, P75
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Joseph G, 2003, J CHEM TECHNOL BIOT, V78, P964, DOI 10.1002/jctb.869
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kobayashi M, 2004, BIO-MED MATER ENG, V14, P505
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Millon LE, 2007, MACROMOLECULES, V40, P3655, DOI 10.1021/ma062781f
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   OLOYEDE A, 1992, CONNECT TISSUE RES, V27, P211, DOI 10.3109/03008209209006997
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Ricciardi R, 2005, CHEM MATER, V17, P1183, DOI 10.1021/cm048632y
   Ricciardi R, 2004, MACROMOLECULES, V37, P9510, DOI 10.1021/ma048418v
   Setton LA, 1999, OSTEOARTHR CARTILAGE, V7, P2, DOI 10.1053/joca.1998.0170
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438
   Xu FL, 2004, J MATER SCI, V39, P5669, DOI 10.1023/B:JMSC.0000040074.64787.b3
   Zheng YD, 2007, J COMPOS MATER, V41, P2071, DOI 10.1177/0021998307074126
NR 38
TC 33
Z9 34
U1 5
U2 48
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2009
VL 90B
IS 2
BP 922
EP 929
DI 10.1002/jbm.b.31364
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472FD
UT WOS:000268114200052
PM 19360889
DA 2018-10-20
ER

PT J
AU Bai, W
   Chen, DL
   Zhang, ZP
   Li, Q
   Zhang, DJ
   Xiong, CD
AF Bai, Wei
   Chen, Dongliang
   Zhang, Zhiping
   Li, Qing
   Zhang, Dujuan
   Xiong, Chengdong
TI Poly(para-Dioxanone)/Inorganic Particle Composites as a Novel
   Biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE poly(para-dioxanone); inorganic particles; composites; bioactive
   material; morphology; bioresorbable
ID MECHANICAL-PROPERTIES; CRYSTALLIZATION BEHAVIOR; POLY(L-LACTIDE)
   COMPOSITES; HYDROLYTIC DEGRADATION; POLY(P-DIOXANONE); HYDROXYAPATITE;
   NANOCOMPOSITES; SIZE; NUCLEATION; COPOLYMERS
AB In this work, poly(para-dioxanone) (PPDO) was mixed with 1% (by weight) calcium carbonate (CaCO(3)) beta-tricalcium phosphate (beta-TCP), or calcium sulphate dihydrate (CSD) by solution co-precipitation. Samples were compression molded into bars using a platen-vulcanizing press. The morphology, thermal and mechanical properties, and crystalline structure of the composites were investigated using differential scanning calorimetry, polarized optical microscopy, scanning electron microscopy, and X-ray diffraction. All results suggest that three types of inorganic particle in this system promote the crystallinity of PPDO and act as an effective nucleating agent: the relative degree of crystallinity of PPDO increased from 30.74% to 100%, and the crystallization temperature of PPDO was increased by 18 degrees C. On the other hand, the mechanical properties of PPDO were changed by the presence of inorganic particles: the tensile strength of PPDO/CSD increased by 11.46%. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 90B: 945-951, 2009
C1 [Bai, Wei; Chen, Dongliang; Zhang, Zhiping; Li, Qing; Zhang, Dujuan; Xiong, Chengdong] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Bai, Wei; Zhang, Dujuan] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
RP Xiong, CD (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM xcd1633@yahoo.com.cn
FU The Chinese Academy of Sciences
FX Contract grant sponsor: The Chinese Academy of Sciences (West Light
   Foundation)
CR [白威 BAI Wei], 2008, [合成化学, Chinese Journal of Synthetic Chemistry], V16, P394
   CACHIA VV, 1999, Patent No. 5893850
   Cheng H. C., 2007, CHIN POLYM B, V19, P41
   Debnath S, 2004, DENT MATER, V20, P677, DOI 10.1016/j.dental.2003.12.001
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   FILLON B, 1993, J POLYM SCI POL PHYS, V31, P1395, DOI 10.1002/polb.1993.090311014
   FORSCHNER TC, 1997, Patent No. 9721753
   Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Gertzman A., 1986, US Pat., Patent No. 4591630
   Gonzalez J, 2002, EUR POLYM J, V38, P2465, DOI 10.1016/S0014-3057(02)00120-9
   He JY, 2008, POLYMER, V49, P3993, DOI 10.1016/j.polymer.2008.07.015
   Hu GJ, 2008, J APPL POLYM SCI, V108, P4080, DOI 10.1002/app.28048
   Huang FY, 2005, J POLYM SCI POL CHEM, V43, P2298, DOI 10.1002/pola.20707
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kwon SC, 2008, COMPOS PART B-ENG, V39, P740, DOI 10.1016/j.compositesb.2007.02.030
   Lai Q, 2005, REACT FUNCT POLYM, V65, P309, DOI 10.1016/j.reactfunctpolym.2005.07.003
   Liu AX, 2008, ACTA BIOMATER, V4, P1005, DOI 10.1016/j.actbio.2008.02.013
   MATTEI PV, 1984, Patent No. 4440789
   MULLER A, 1968, Patent No. 3410665
   Muller AJ, 2005, ADV POLYM SCI, V190, P1, DOI 10.1007/12_001
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Nilsson M, 2002, J BIOMED MATER RES, V61, P600, DOI 10.1002/jbm.10268
   Osman MA, 2004, MACROMOL RAPID COMM, V25, P1540, DOI 10.1002/marc.2004.00254
   Pan PJ, 2007, J APPL POLYM SCI, V105, P1511, DOI 10.1002/app.26407
   Park JM, 2004, COMPOS SCI TECHNOL, V64, P847, DOI 10.1016/j.composcitech.2003.09.009
   Sabino MA, 2004, BIOMACROMOLECULES, V5, P358, DOI 10.1021/bm034367i
   Sabino MA, 2002, POLYM BULL, V48, P291, DOI 10.1007/s00289-002-0039-6
   Sabino MA, 2000, MACROMOL CHEM PHYSIC, V201, P2687, DOI 10.1002/1521-3935(20001201)201:18<2687::AID-MACP2687>3.0.CO;2-#
   Saujanya C, 2002, MACROMOL MATER ENG, V287, P272, DOI 10.1002/1439-2054(20020401)287:4<272::AID-MAME272>3.0.CO;2-J
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Siviour CR, 2004, J MATER SCI, V39, P1255, DOI 10.1023/B:JMSC.0000013883.45092.45
   Tomihata K, 1998, POLYM DEGRAD STABIL, V59, P13, DOI 10.1016/S0141-3910(97)00183-3
   Ural E, 2000, BIOMATERIALS, V21, P2147, DOI 10.1016/S0142-9612(00)00098-3
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   Vivekchand SRC, 2006, NANOTECHNOLOGY, V17, pS344, DOI 10.1088/0957-4484/17/11/S19
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   Wacharawichanant S, 2008, POLYM TEST, V27, P971, DOI 10.1016/j.polymertesting.2008.08.012
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Xu L, 2008, IRAN POLYM J, V17, P407
   Yang KK, 2002, J MACROMOL SCI-POL R, VC42, P373, DOI 10.1081/MC-120006453
   Zeng L., 2005, EUR POLYM J, V41, P1243
   Zeng Q, 2008, EUR POLYM J, V44, P465, DOI 10.1016/j.eurpolymj.2007.11.008
   Zubitur M, 2008, PHYS STATUS SOLIDI A, V205, P1515, DOI 10.1002/pssa.200778120
NR 45
TC 10
Z9 13
U1 1
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2009
VL 90B
IS 2
BP 945
EP 951
DI 10.1002/jbm.b.31367
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472FD
UT WOS:000268114200055
PM 19360890
DA 2018-10-20
ER

PT J
AU Petrie, TA
   Reyes, CD
   Burns, KL
   Garcia, AJ
AF Petrie, Timothy A.
   Reyes, Catherine D.
   Burns, Kellie L.
   Garcia, Andres J.
TI Simple application of fibronectin-mimetic coating enhances
   osseointegration of titanium implants
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE fibronectin; osseointegration; coating; integrins; biomimetic; implant
ID MESENCHYMAL STEM-CELLS; CALVARIAL OSTEOBLAST DIFFERENTIATION; TOTAL
   JOINT ARTHROPLASTY; FOCAL ADHESION KINASE; BONE-FORMATION;
   EXTRACELLULAR-MATRIX; INTEGRIN BINDING; I COLLAGEN; BIOMATERIAL
   SURFACES; GROWTH
AB Integrin-mediated cell adhesion to biomolecules adsorbed onto biomedical devices regulates device integration and performance. Because of the central role of integrin-fibronectin (FN) interactions in osteoblastic function and bone formation, we evaluated the ability of FN-inspired biomolecular coatings to promote osteoblastic differentiation and implant osseointegration. Notably, these biomolecular coatings relied on physical adsorption of FN-based ligands onto biomedical-grade titanium as a simple, clinically translatable strategy to functionalize medical implants. Surfaces coated with a recombinant fragment of FN spanning the central cell binding domain enhanced osteoblastic differentiation and mineralization in bone marrow stromal cell cultures and increased implant osseointegration in a rat cortical bone model compared to passively adsorbed arginine-glycine-aspartic acid peptides, serum proteins and full-length FN. Differences in biological responses correlated with integrin binding specificity and signalling among surface coatings. This work validates a simple, clinically translatable, surface biofunctionalization strategy to enhance biomedical device integration.
C1 [Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU NIH [R01 EB-004496]; Arthritis Foundation; Georgia Tech/Emory NSF ERC on
   the Engineering of Living Tissues [EEC-9731643]; Medtronic Foundation
FX This work was funded by the NIH (R01 EB-004496), Arthritis Foundation
   and Georgia Tech/Emory NSF ERC on the Engineering of Living Tissues
   (EEC-9731643). T.A.P. acknowledges support from the Medtronic
   Foundation. The authors gratefully acknowledge Wasatch Histo Consultants
   for histology and M. Mathews for implant machining.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y
   AUBIN JE, 1996, PRINCIPLES BONE BIOL, P69
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bernhardt R, 2005, BIOMATERIALS, V26, P3009, DOI 10.1016/j.biomaterials.2004.08.030
   Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6
   Chung EH, 2006, J BIOMED MATER RES A, V79A, P815, DOI 10.1002/jbm.a.30809
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   De Ranieri A, 2005, BONE, V37, P55, DOI 10.1016/j.bone.2005.03.011
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Elmengaard B, 2005, J BIOMED MATER RES A, V75A, P249, DOI 10.1002/jbm.a.30301
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Guillot PV, 2007, J CELL MOL MED, V11, P935, DOI 10.1111/j.1582-4934.2007.00106.x
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   KAY JF, 1988, J BIOMED MATER RES, V22, P1127, DOI 10.1002/jbm.820221206
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 2006, BIOMATERIALS, V27, P807, DOI 10.1016/j.biomaterials.2005.09.021
   Ripamonti U, 2008, J CELL MOL MED, V12, P1029, DOI 10.1111/j.1582-4934.2007.00126.x
   Ripamonti U, 2007, PLAST RECONSTR SURG, V120, P1796, DOI 10.1097/01.prs.0000287133.43718.89
   Roche P, 1999, BONE, V24, P329, DOI 10.1016/S8756-3282(98)00194-X
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   Sumner DR, 2006, J BONE JOINT SURG AM, V88A, P806, DOI 10.2106/JBJS.E.00846
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
NR 60
TC 43
Z9 47
U1 1
U2 19
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1582-1838
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD AUG
PY 2009
VL 13
IS 8B
BP 2602
EP 2612
DI 10.1111/j.1582-4934.2008.00476.x
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 525CN
UT WOS:000272190800085
PM 18752639
OA Green Published, Bronze, Green Accepted
DA 2018-10-20
ER

PT J
AU Ouyang, CX
   Xu, HY
   Wang, WC
   Yang, HJ
   Xu, WL
AF Ouyang, Chenxi
   Xu, Haiye
   Wang, Weici
   Yang, Hongjun
   Xu, Weilin
TI In vivo histocompatibility evaluation of polyurethane membrane modified
   by superfine silk-fibroin powder
SO JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL
   SCIENCES
LA English
DT Article
DE polyurethane; superfine silk-fibroin powder; polytetrafluoroethylene;
   histocompatibility
ID DIAMETER VASCULAR GRAFTS; BLEND FILM; HEPARIN
AB In this study, a novel polyurethane membrane, modified by superfine silk-fibroin powder, was prepared for small-diameter vascular grafting. Scanning electron microscopy, transmission electron microscopy, and histological examination were applied to evaluate histocompatibility of this polyurethane membrane. The polyurethane membrane was compared with polytetrafluoroethylene material. A pseudomembrane and gap formed between polytetrafluoroethylene and the surrounding tissues, and no cells infiltrated or grew into the polytetrafluoroethylene material. On the contrary, superfine silk-fibroin powder/polyurethane blend membrane merged tightly with the surrounding tissues without gaps, and cells infiltrated and grew into the material. Moreover, the negative effects of superfine silk-fibroin powder/polyurethane blend membrane on cells were less than those of its polytetrafluoroethylene counterpart. Our findings indicated that the superfine silk-fibroin powder/polyurethane blend membrane has better histocompatibility than polytetrafluoroethylene membrane. It is concluded that the superfine silk-fibroin powder/polyurethane blend membrane is a promising biomaterial for small-diameter prosthesis.
C1 [Xu, Haiye; Xu, Weilin] Wuhan Univ Sci & Engn, Minist Educ, Key Lab Green Proc & Funct Text, Wuhan 430073, Peoples R China.
   [Ouyang, Chenxi; Wang, Weici] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Vasc Surg, Wuhan 430022, Peoples R China.
   [Yang, Hongjun] Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
RP Xu, WL (reprint author), Wuhan Univ Sci & Engn, Minist Educ, Key Lab Green Proc & Funct Text, Wuhan 430073, Peoples R China.
EM ouyangchx@yahoo.com
FU Ministry of Science and Technology of China [2009CB526400]
FX This project was supported by a grant from the 973 Program of Ministry
   of Science and Technology of China (No. 2009CB526400).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Kang IK, 1997, BIOMATERIALS, V18, P1099, DOI 10.1016/S0142-9612(97)00035-5
   Khorasani MT, 2006, J BIOMED MATER RES A, V77A, P253, DOI 10.1002/jbm.a.30613
   Li Y., 2006, US. Patent, Patent No. 7000858
   Lv Q, 2005, POLYM INT, V54, P1076, DOI [10.1002/pi.1814, 10.1002/pi.l814]
   Lv Q, 2003, BIOMATERIALS, V24, P3915, DOI 10.1016/S0142-9612(03)00266-7
   Ma XL, 2006, J BIOMED MATER RES B, V78B, P89, DOI 10.1002/jbm.b.30466
   MAN M, 2004, J MATER SCI-MATER M, V15, P1079
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Wang X, 2006, FIBER POLYM, V7, P250, DOI 10.1007/BF02875681
   Wang XW, 2007, WORLD J SURG, V31, P682, DOI 10.1007/s00268-006-0731-z
   Xu WL, 2007, MACROMOL MATER ENG, V292, P674, DOI 10.1002/mame.200600491
   Yan Y, 2007, J BIOACT COMPAT POL, V22, P323, DOI 10.1177/0883911507078386
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
   Zuo BQ, 2007, J APPL POLYM SCI, V106, P53, DOI 10.1002/app.26653
NR 18
TC 4
Z9 5
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1672-0733
J9 J HUAZHONG U SCI-MED
JI J. Huazhong Univ. Sci. Tech.-Med.
PD AUG
PY 2009
VL 29
IS 4
BP 508
EP 511
DI 10.1007/s11596-009-0423-7
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 480YG
UT WOS:000268772600023
PM 19662372
DA 2018-10-20
ER

PT J
AU Hussein, MZ
   Azmin, WHWN
   Mustafa, M
   Yahaya, AH
AF Hussein, Mohd Zobir
   Azmin, Wan Haizum Wan Nor
   Mustafa, Muskhazli
   Yahaya, Asmah Hj
TI Bacillus cereus as a biotemplating agent for the synthesis of zinc oxide
   with raspberry- and plate-like structures
SO JOURNAL OF INORGANIC BIOCHEMISTRY
LA English
DT Article
DE Hydrothermal; Complexation; Biotemplating agent; Zinc oxide;
   Nanobiotechnology
ID BACTERIAL SURFACES; HYDROTHERMAL SYNTHESIS; ZNO NANOPARTICLES; METAL
   ADSORPTION; SUBTILIS; GROWTH; SUSPENSIONS; INSIGHTS; IRON; FE
AB Currently the development of green chemistry approach with the use of biomaterial-based activities of microbial cells in the synthesis of various nanostructures has attracted a great attention. In this study, we report on the use of bacterium, Bacillus cereus as a biotemplating agent for the formation of zinc oxide nanoparticles with raspberry- and plate-like structures through a simple thermal decomposition of zinc acetate by maintaining the original pH of the reaction mixtures. Possible mechanism on the formation of the nanostructures is proposed based on the surface chemistry and biochemistry processes involved organic-inorganic interactions between zinc oxide and the microbial cells. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Hussein, Mohd Zobir] Univ Putra Malaysia, Inst Adv Technol ITMA, Adv Mat & Nanotechnol Lab, Fac Sci, Serdang 43400, Selangor, Malaysia.
   [Hussein, Mohd Zobir; Azmin, Wan Haizum Wan Nor; Yahaya, Asmah Hj] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia.
   [Mustafa, Muskhazli] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia.
RP Hussein, MZ (reprint author), Univ Putra Malaysia, Inst Adv Technol ITMA, Adv Mat & Nanotechnol Lab, Fac Sci, Serdang 43400, Selangor, Malaysia.
EM mzobir@putra.upm.edu.my
OI HUSSEIN, MOHD ZOBIR/0000-0002-0741-261X
FU MOSTI [03-01-04-SF0120]
FX The support of this research by MOSTI, Grant No. 03-01-04-SF0120 is
   gratefully acknowledged. WHWA thanks MOHEJUPM for GRF.
CR Akyol A, 2004, APPL CATAL B-ENVIRON, V54, P19, DOI 10.1016/j.apcatb.2004.05.021
   Barabesi C, 2007, J BACTERIOL, V189, P228, DOI 10.1128/JB.01450-06
   Baruwati B, 2006, SENSOR ACTUAT B-CHEM, V119, P676, DOI 10.1016/j.snb.2006.01.028
   Borrok D, 2004, CHEM GEOL, V209, P107, DOI 10.1016/j.chemgeo.2004.04.025
   CAMPBELL NA, 2002, BIOLOGY, P112
   Chen L, 2007, CRYST RES TECHNOL, V42, P881, DOI 10.1002/crat.200710933
   Chen XC, 2008, COLLOID SURFACE B, V61, P170, DOI 10.1016/j.colsurfb.2007.08.002
   Choudhury R, 2001, CURR SCI INDIA, V81, P768
   Daneshvar N, 2007, SEP PURIF TECHNOL, V58, P91, DOI 10.1016/j.seppur.2007.07.016
   Degen A, 2000, J EUR CERAM SOC, V20, P667, DOI 10.1016/S0955-2219(99)00203-4
   DOVE PM, 2003, BIOMINERALIZATION RE
   Ehrlich HL, 1996, CHEM GEOL, V132, P5, DOI 10.1016/S0009-2541(96)00035-6
   Fein JB, 1997, GEOCHIM COSMOCHIM AC, V61, P3319, DOI 10.1016/S0016-7037(97)00166-X
   Fein JB, 2001, GEOCHIM COSMOCHIM AC, V65, P4267, DOI 10.1016/S0016-7037(01)00721-9
   Fein JB, 2002, CHEM GEOL, V182, P265, DOI 10.1016/S0009-2541(01)00294-7
   Fortin D, 1998, AM MINERAL, V83, P1399, DOI 10.2138/am-1998-11-1229
   Foti M, 1997, J CELL BIOL, V139, P37, DOI 10.1083/jcb.139.1.37
   Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019
   Gilbert A, 1997, J CELL SCI, V110, P3105
   Godlewska-Zylkiewicz B, 2006, ANAL BIOANAL CHEM, V384, P114, DOI 10.1007/s00216-005-0142-2
   Huczko A, 2000, APPL PHYS A-MATER, V70, P365, DOI 10.1007/s003390051050
   Hussein M. Z. B., 2005, J MATER SCI, V40, P6325
   Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709
   Jian-hua P, 2007, J ENVIRON SCI, V19, P403
   Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6
   KONHAUSER K, 2007, INTRO GEOMICROBIOLOG, P93
   Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001
   Mann S, 2001, BIOMINERALIZATION PR
   Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002
   Pierre JL, 1999, BIOMETALS, V12, P195, DOI 10.1023/A:1009252919854
   Singh S, 2007, J PHYS D APPL PHYS, V40, P6312, DOI 10.1088/0022-3727/40/20/S15
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   Ybarra GR, 1999, J HAZARDOUS SUBSTANC, V2, P1
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
   Zhang Z, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL FREQUENCY CONTROL SYMPOSIUM AND EXPOSITION, VOLS 1 AND 2, P545
   Zhou H, 2007, MICROPOR MESOPOR MAT, V100, P322, DOI 10.1016/j.micromeso.2006.11.020
NR 36
TC 19
Z9 22
U1 1
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0162-0134
J9 J INORG BIOCHEM
JI J. Inorg. Biochem.
PD AUG
PY 2009
VL 103
IS 8
BP 1145
EP 1150
DI 10.1016/j.jinorgbio.2009.05.016
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
SC Biochemistry & Molecular Biology; Chemistry
GA 482CJ
UT WOS:000268861100005
PM 19577306
DA 2018-10-20
ER

PT J
AU Ji, QX
   Chen, XG
   Zhao, QS
   Liu, CS
   Cheng, XJ
   Wang, LC
AF Ji, Qiu Xia
   Chen, Xi Guang
   Zhao, Qing Sheng
   Liu, Cheng Sheng
   Cheng, Xiao Jie
   Wang, Ling Chong
TI Injectable thermosensitive hydrogel based on chitosan and quaternized
   chitosan and the biomedical properties
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MOLECULAR-WEIGHT; ANTIMICROBIAL RESISTANCE; POLY(ETHYLENE GLYCOL);
   ANTIBIOTIC-RESISTANCE; GRAFTED CHITOSAN; DELIVERY-SYSTEM; DRUG-DELIVERY;
   COPOLYMER; BIOMATERIAL; MICROFLORA
AB A novel injectable thermosensitive hydrogel (CS-HTCC/alpha beta-GP) was successfully designed and prepared using chitosan (CS), quaternized chitosan (HTCC) and alpha,beta-glycerophosphate (alpha,beta-GP) without any additional chemical stimulus. The gelation point of CS-HTCC/alpha beta-GP can be set at a temperature close to normal body temperature or other temperature above 25A degrees C. The transition process can be controlled by adjusting the weight ratio of CS to HTCC, or different final concentration of alpha,beta-GP. The optimum formulation is (CS + HTCC) (2% w/v), CS/HTCC (5/1 w/w) and alpha,beta-GP 8.33% or 9.09% (w/v), where the sol-gel transition time was 3 min at 37A degrees C. The drug released over 3 h from the CS-HTCC/alpha,beta-GP thermosensitive hydrogel in artificial saliva pH 6.8. In addition, CS-HTCC/alpha,beta-GP thermosensitive hydrogel exhibited stronger antibacterial activity towards two periodontal pathogens (Porphyromonas gingivalis, P.g and Prevotella intermedia, P.i). CS-HTCC/alpha, beta-GP thermosensitive hydrogel was a considerable candidate as a local drug delivery system for periodontal treatment.
C1 [Ji, Qiu Xia; Chen, Xi Guang; Zhao, Qing Sheng; Liu, Cheng Sheng; Cheng, Xiao Jie] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Shandong, Peoples R China.
   [Ji, Qiu Xia] Qingdao Univ, Affiliated Hosp, Coll Med, Qingdao 266001, Shandong, Peoples R China.
   [Wang, Ling Chong] Nanjing Univ Tradit Chinese Med, Res Inst Chinese Med & Pharmacol, Nanjing 210029, Jiangsu, Peoples R China.
RP Chen, XG (reprint author), Ocean Univ China, Coll Marine Life Sci, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.
EM xgchen@ouc.edu.cn
RI Liu, Chengsheng/L-5296-2018
OI Liu, Chengsheng/0000-0002-1454-0193
FU International S&T Cooperation Program of China [2008DFA31640]; Ministry
   of Education of the People's Republic of China [20070423013]; Natural
   Science Foundation of Shandong Province [Y2006C110]; Youth Foundation of
   Health Department of Shandong Province [2007QZ021]
FX We would like to thank the financial support of International S&T
   Cooperation Program of China (2008DFA31640); Ministry of Education of
   the People's Republic of China (20070423013); the Natural Science
   Foundation of Shandong Province (No. Y2006C110) and the Youth Foundation
   of Health Department of Shandong Province (No. 2007QZ021).
CR Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Chen XG, 2002, J AGR FOOD CHEM, V50, P5915, DOI 10.1021/jf020151g
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431
   Ganji F, 2008, CARBOHYD POLYM, V74, P435, DOI 10.1016/j.carbpol.2008.03.017
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   Harrison JW, 1998, QUINTESSENCE INT, V29, P151
   Harrison JW, 1998, QUINTESSENCE INT, V29, P223
   *ISO, 1993, 10271 ISO TR
   Jia ZS, 2001, CARBOHYD RES, V333, P1, DOI 10.1016/S0008-6215(01)00112-4
   Jumaa M, 2002, EUR J PHARM BIOPHARM, V53, P115, DOI 10.1016/S0939-6411(01)00191-6
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim KW, 2003, J FOOD PROTECT, V66, P1495, DOI 10.4315/0362-028X-66.8.1495
   Lagarce F, 2005, EUR J PHARM BIOPHARM, V61, P171, DOI 10.1016/j.ejpb.2005.04.004
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Loesche WJ, 1996, J DENT RES, V75, P1432, DOI 10.1177/00220345960750070101
   Ma Zhi-wei, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P273
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   *NAT COMM CLIN LAB, 2001, METH ANT SUSC TEST A
   National Committee for Clinical Laboratory Standards, 2000, METH DIL ANT SUSC TE
   Qin CQ, 2002, REACT FUNCT POLYM, V50, P165
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   Sanal Y, 2002, J CLIN PERIODONTOL, V29, P929, DOI 10.1034/j.1600-051X.2002.291008.x
   Sandri G, 2005, INT J PHARM, V297, P146, DOI 10.1016/j.ijpharm.2005.03.017
   Schmitz T, 2008, INT J PHARMACEUT, V347, P79, DOI 10.1016/j.ijpharm.2007.06.040
   Slots J, 1996, J DENT RES, V75, P1338, DOI 10.1177/00220345960750060201
   van Winkelhoff AJ, 2000, J CLIN PERIODONTOL, V27, P79, DOI 10.1034/j.1600-051x.2000.027002079.x
   Walker CB, 1996, PERIODONTOL 2000, V10, P79, DOI 10.1111/j.1600-0757.1996.tb00069.x
   Wu J, 2007, BIOMATERIALS, V28, P2220, DOI 10.1016/j.biomaterials.2006.12.024
   Xu HY, 2006, BIOMATERIALS, V27, P3125, DOI 10.1016/j.biomaterials.2006.01.012
   Zhou HY, 2008, CARBOHYD POLYM, V73, P265, DOI 10.1016/j.carbpol.2007.11.026
NR 35
TC 24
Z9 28
U1 7
U2 52
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2009
VL 20
IS 8
BP 1603
EP 1610
DI 10.1007/s10856-009-3729-x
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472BE
UT WOS:000268103300003
PM 19322644
DA 2018-10-20
ER

PT J
AU Macocinschi, D
   Filip, D
   Vlad, S
   Cristea, M
   Butnaru, M
AF Macocinschi, Doina
   Filip, Daniela
   Vlad, Stelian
   Cristea, Mariana
   Butnaru, Maria
TI Segmented biopolyurethanes for medical applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CROSS-LINKED BLENDS; BLOOD COMPATIBILITY; MECHANICAL-PROPERTIES; POLYMER
   NETWORKS; POLYURETHANES; BIOMATERIALS; SURFACE; BIOCOMPATIBILITY;
   IMMOBILIZATION; URETHANE)S
AB Polyurethanes are one of the most popular groups of biomaterials applied for medical devices. Their segmented block copolymeric character endows them a wide range of versatility in terms of tailoring their physical properties, blood and tissue compatibility. Polyester- and polyether-urethanes have been modified with hydroxypropyl cellulose aiming the change of their surface and bulk characteristics to confer them biomaterial qualities. In this respect, dynamic contact angle measurements, dynamic mechanical analyses accompanied by mechanical testing have been done. Platelet adhesion test has been carried out in vitro and the use of hydroxypropyl cellulose in the polyurethane matrix reduces the platelet adhesion and therefore recommends them as candidates for biocompatible materials.
C1 [Macocinschi, Doina; Filip, Daniela; Vlad, Stelian; Cristea, Mariana] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
   [Butnaru, Maria] Gr T Popa Univ Med & Pharm, Fac Med Bioengn, Iasi 700115, Romania.
RP Macocinschi, D (reprint author), Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
EM eradro2002@yahoo.com
RI Butnaru, Maria/I-8195-2016; Vlad, Stelian/C-3430-2011; Filip,
   Daniela/F-6636-2013; Macocinschi, Doina/C-2565-2012; Cristea,
   Mariana/M-7541-2013
OI Vlad, Stelian/0000-0002-5895-438X
FU Ministry of Education and Research-Exploratory Research
   [PN-II-ID-PCE-988/2008]
FX The authors are grateful for the financial support, to Ministry of
   Education and Research-Exploratory Research Projects, Code:
   PN-II-ID-PCE-988/2008.
CR Abraham GA, 2002, BIOMATERIALS, V23, P1625, DOI 10.1016/S0142-9612(01)00289-7
   Adhikari R., 2003, EUR CELLS MATER, V5, P1
   Bajpai AK, 2005, POLYM INT, V54, P304, DOI 10.1002/pi.1673
   COOPER S, 1997, POLYURETHANES BIOMED
   Gao SJ, 2001, MACROMOLECULES, V34, P2202, DOI 10.1021/ma001766m
   GAST AP, 1986, MACROMOLECULES, V19, P686, DOI 10.1021/ma00157a035
   Hanada T, 2001, MACROMOL CHEM PHYSIC, V202, P97, DOI 10.1002/1521-3935(20010101)202:1<97::AID-MACP97>3.0.CO;2-C
   Heijkants RGJC, 2005, BIOMATERIALS, V26, P4219, DOI 10.1016/j.biomaterials.2004.11.005
   Hsu SH, 2005, MACROMOL BIOSCI, V5, P246, DOI 10.1002/mabi.200400163
   Huang J, 2002, POLYMER, V43, P2287, DOI 10.1016/S0032-3861(02)00028-9
   KAJIWARA K, 1974, MACROMOLECULES, V7, P121, DOI 10.1021/ma60037a023
   Korematsu A, 1999, ACTA POLYM, V50, P363
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LELAH MD, 1999, POLYURETHANES MED
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Lligadas G, 2007, BIOMACROMOLECULES, V8, P686, DOI 10.1021/bm060977h
   Lupu M, 2007, POLYM INT, V56, P389, DOI 10.1002/pi.2163
   MACOCINSCHI D, 2008, 062 E POLYM, P1
   Macocinschi D, 2009, J MATER SCI-MATER M, V20, P775, DOI 10.1007/s10856-008-3626-8
   MERRILL EW, 1982, ADV CHEM SER, V199, P95
   Mondal S, 2006, POLYM INT, V55, P1013, DOI 10.1002/pi.2026
   Napper DH, 1983, STERIC STABILIZATION
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Plank H., 1987, PROGR BIOMEDICAL ENG, V3
   Raschip IE, 2009, POLYM INT, V58, P4, DOI 10.1002/pi.2468
   Sekkar V, 2000, POLYMER, V41, P6773, DOI 10.1016/S0032-3861(00)00011-2
   SIREAR AK, 1997, THERMAL CHARACTERIZA, V1, P970
   SPATHIS GD, 1991, J APPL POLYM SCI, V43, P613, DOI 10.1002/app.1991.070430323
   Vermette P., 2001, BIOMEDICAL APPL POLY
   Wang LF, 2005, COLLOID SURFACE B, V41, P249, DOI 10.1016/j.colsurfb.2004.12.014
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Yoo HJ, 2005, BIOMATERIALS, V26, P2877, DOI 10.1016/j.biomaterials.2004.09.001
   Yoo HJ, 2004, J APPL POLYM SCI, V91, P2348, DOI 10.1002/app.13377
   Yoon SS, 2005, POLYM BULL, V53, P339, DOI 10.1007/s00289-005-0355-8
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 35
TC 36
Z9 41
U1 1
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2009
VL 20
IS 8
BP 1659
EP 1668
DI 10.1007/s10856-009-3731-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472BE
UT WOS:000268103300010
PM 19296207
DA 2018-10-20
ER

PT J
AU Cassell, AM
   Li, J
   Nguyen-Vu, TB
   Koehne, JE
   Chen, H
   Andrews, R
   Meyyappan, M
AF Cassell, Alan M.
   Li, Jun
   Nguyen-Vu, Thuy-Duong Barbara
   Koehne, Jessica E.
   Chen, Hua
   Andrews, Russell
   Meyyappan, M.
TI Vertically Aligned Carbon Nanofibers: Interconnecting Solid State
   Electronics with Biosystems
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Nanoneuroscience - Nanoeuroprotection and
   Nanoeurotoxicity
CY AUG 20-26, 2007
CL Killithea, GREECE
DE Neural Interface; Carbon Nanofiber; Vertically Aligned; Polypyrrole;
   Nucleic Acid Detection; Electrochemical Methods; Neurotransmitter;
   Dopamine; Implantable Electrode; PC12 Cells; Biocompatibility
ID NANOTUBE NANOELECTRODE ARRAYS; CONDUCTING-POLYMER; NUCLEIC-ACIDS; DNA
   ANALYSIS; ELECTROCHEMISTRY; ELECTROCATALYSIS; FABRICATION; BIOSENSORS;
   RELEASE; FIELD
AB Vertically aligned carbon nanofibers (VACNFs) are grown directly on prefabricated electronic circuits with nanoscale precision. Utilizing the free-standing nanofiber array geometry, we have demonstrated the detection of nucleic acids to construct an ultrasensitive electrochemical sensor. Extending this technology towards in vivo applications, we have modified the free-standing VACNF arrays in order to achieve a multifunctional three dimensional (3-D) matrix that interpenetrates the neuronal network of PC12 cells. We found that PC12 cells cultured on the nanofiber arrays can form an extended neural network upon proper chemical and biochemical modification. The soft 3-D nanofiber array architecture provides a novel platform to fine-tune the topographical, mechanical, chemical, and electrical cues at sub-cellular scales. This biomaterial platform can be used for both fundamental studies of nanomaterial-cell interactions and the development of multifunctional, chronically stable implantable devices. The application of these devices and potential utility as a multifunctional platform for neurophysiology and biochemical studies will be discussed.
C1 [Cassell, Alan M.; Nguyen-Vu, Thuy-Duong Barbara; Koehne, Jessica E.; Chen, Hua; Andrews, Russell; Meyyappan, M.] Univ Calif Santa Cruz, UARC, NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.
   [Li, Jun] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA.
RP Cassell, AM (reprint author), Univ Calif Santa Cruz, UARC, NASA, Ames Res Ctr, M-S 229-1, Moffett Field, CA 94035 USA.
RI Li, Jun/H-7771-2013
OI Li, Jun/0000-0002-3689-8946; Nguyen-Vu, T.D. Barbara/0000-0002-4708-1982
FU NINDS NIH HHS [5 R21 NS047721]
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Armistead PM, 2000, ANAL CHEM, V72, P3764, DOI 10.1021/ac000051e
   Boczkowski J, 2007, NANOMEDICINE-UK, V2, P407, DOI 10.2217/17435889.2.4.407
   Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301
   Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351
   Campbell JK, 1999, J AM CHEM SOC, V121, P3779, DOI 10.1021/ja990001v
   Chen J. H., 2002, SYNTHETIC MET, V125, P289
   Cruden BA, 2003, J APPL PHYS, V94, P4070, DOI 10.1063/1.1601293
   CUI X, 2003, BIOMATERIALS, V24, P177
   Dresselhaus M.S., 1996, SCI FULLERENES CARBO
   EBBESEN TW, 1997, CARBON NANOTUBES PRE
   FAN FRF, 1995, SCIENCE, V267, P871, DOI 10.1126/science.267.5199.871
   Heaton RJ, 2001, P NATL ACAD SCI USA, V98, P3701, DOI 10.1073/pnas.071623998
   Heller MJ, 1996, IEEE ENG MED BIOL, V15, P100, DOI 10.1109/51.486725
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kim HM, 2004, CURR APPL PHYS, V4, P577, DOI 10.1016/j.cap.2004.01.022
   Koehne J, 2004, J MATER CHEM, V14, P676, DOI 10.1039/b311728f
   Koehne J, 2003, NANOTECHNOLOGY, V14, P1239, DOI 10.1088/0957-4484/14/12/001
   Koehne JE, 2004, CLIN CHEM, V50, P1886, DOI 10.1373/clinchem.2004.036285
   Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367
   Li J, 2003, NANO LETT, V3, P597, DOI 10.1021/nl0340677
   Li J, 2003, APPL PHYS LETT, V82, P2491, DOI 10.1063/1.1566791
   Li J, 2002, APPL PHYS LETT, V81, P910, DOI 10.1063/1.1496494
   Lin YH, 2004, NANO LETT, V4, P191, DOI 10.1021/nl0347233
   McCreery R.L., 1991, ELECTROANALYTICAL CH, V17, P221
   Meyyappan M., 2004, CARBON NANOTUBES SCI
   Musameh M, 2002, ELECTROCHEM COMMUN, V4, P743, DOI 10.1016/S1388-2481(02)00451-4
   Nguyen CV, 2002, NANO LETT, V2, P1079, DOI 10.1021/nl025689f
   Nguyen-Vu TDB, 2007, IEEE T BIO-MED ENG, V54, P1121, DOI 10.1109/TBME.2007.891169
   Nguyen-Vu TDB, 2006, SMALL, V2, P89, DOI 10.1002/smll.200500175
   NIMNI ME, 1988, BIOCHEMISTRY-US, V1, P143
   NIMNI ME, 1988, BIOCH BIOMECHANICS, V2, P50
   Nugent JM, 2001, NANO LETT, V1, P87, DOI 10.1021/nl005521z
   Patolsky F, 2006, NANOMEDICINE-UK, V1, P51, DOI 10.2217/17435889.1.1.51
   PENNER RM, 1990, SCIENCE, V250, P1118, DOI 10.1126/science.250.4984.1118
   POPOVICH ND, 2002, INTERFACE, V11, P30
   Saito R., 1998, PHYS PROPERTIES CARB
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sistare MF, 1999, J PHYS CHEM B, V103, P10718, DOI 10.1021/jp992940f
   Tomanek D., 2000, SCI APPL NANOTUBES
   Umek RM, 2001, J MOL DIAGN, V3, P74, DOI 10.1016/S1525-1578(10)60655-1
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Wang J, 2003, J AM CHEM SOC, V125, P2408, DOI 10.1021/ja028951v
   WIGHTMAN RM, 1981, ANAL CHEM, V53, P1125
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
NR 47
TC 7
Z9 7
U1 0
U2 14
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2009
VL 9
IS 8
BP 5038
EP 5046
DI 10.1166/jnn.2009.GR06
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 470QO
UT WOS:000267994100069
PM 19928183
DA 2018-10-20
ER

PT J
AU Stan, GE
AF Stan, G. E.
TI Adherent functional graded hydroxylapatite coatings produced by
   sputtering deposition techniques
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Biomaterial; coatings; hydroxylapatite; sputtering techniques;
   functional graded material; adherence
ID HYDROXYAPATITE COATINGS; IMMERSION BEHAVIOR; IMPLANTS; TITANIUM;
   BIOCERAMICS; INTERFACE; ALLOYS; FILMS
AB The aim of this paper was to study the influence of crystallization heat treatments up to 750 degrees C, upon the integrity and structure of hydroxylapatite thin films. Two different types of hydroxylapatite coatings were investigated: abrupt structures prepared by magnetron sputtering and respectively functional graded structures deposited by a co-sputtering technique. A clear dependence was noticed between adherence values and annealing temperature and was correlated with the SEM, XRD and FTIR results. X-ray diffraction and FTIR measurements showed that the hydroxylapatite coatings annealed at 400 degrees C were less crystalline, similar to biological apatites. Over 550 degrees C, the apatite coatings obtained were well crystallized and preferentially oriented on (002) HA crystal plane. The adherence of HA coating increased with annealing the temperature up to 550 degrees C due to diffusion phenomena. At 550 degrees C the adhesion test results indicated better adhesion values in case of functional graded structures (> 85 MPa) in comparison with abrupt ones (similar to 70 MPa). At 750 degrees C an adherence decreasing occurred for both types of structures. This is mainly due to the effect of a significant thermal stress owed to the mismatch of the thermal expansion coefficients between the crystallized HA and Ti substrate. The presence of rutile lines in XRD spectrum suggests an increasing of the diffusion phenomena and a strong substrate oxidation at the HAM interface with annealing temperature.
C1 Natl Inst Mat Phys, Bucharest 077125, Romania.
RP Stan, GE (reprint author), Natl Inst Mat Phys, POB MG-7, Bucharest 077125, Romania.
EM George_stan@infim.ro
RI Stan, George/B-5690-2011
OI Stan, George/0000-0003-0289-8988
FU  [PN09-450103];  [PNII 71110/2007]
FX The financial support of PN09-450103 and PNII 71110/2007 research
   programs is acknowledged.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Chen MF, 2007, SURF COAT TECH, V201, P5688, DOI 10.1016/j.surfcoat.2006.07.057
   Cheng K, 2005, SURF COAT TECH, V198, P242, DOI 10.1016/j.surfcoat.2004.10.024
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   Ding SJ, 2003, BIOMATERIALS, V24, P4233, DOI 10.1016/S0142-9612(03)00315-6
   Ding SJ, 1999, J BIOMED MATER RES, V47, P551, DOI 10.1002/(SICI)1097-4636(19991215)47:4<551::AID-JBM12>3.0.CO;2-C
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   Ergun C, 2004, ACTA MATER, V52, P4767, DOI 10.1016/j.actamat.2004.06.032
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   Guillemot F, 2005, EXPERT REV MED DEVIC, V2, P741, DOI 10.1586/17434440.2.6.741
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Inagaki M, 2003, SURF COAT TECH, V173, P1, DOI 10.1016/S0257-8972(03)00513-9
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mercioniu I, 2007, J OPTOELECTRON ADV M, V9, P2535
   Nelea V, 2007, J MATER SCI-MATER M, V18, P2347, DOI 10.1007/s10856-007-3135-1
   Park E, 1998, MATER LETT, V36, P38, DOI 10.1016/S0167-577X(97)00287-5
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   SIMA LE, 2008, ROM J BIOCHEM, V45, P122
   Socrates G., 2007, INFRARED RAMAN CHARA
   Stan GE, 2009, APPL SURF SCI, V255, P9132, DOI 10.1016/j.apsusc.2009.06.117
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Ueda R, 2000, J CERAM SOC JPN, V108, P865, DOI 10.2109/jcersj.108.1261_865
   Verestiuc L, 2004, J CRYST GROWTH, V264, P483, DOI 10.1016/j.jcrysgro.2004.01.015
   Wang CX, 2001, BIOMATERIALS, V22, P1619, DOI 10.1016/S0142-9612(00)00319-7
   Wang CX, 2001, NUCL INSTRUM METH B, V179, P364, DOI 10.1016/S0168-583X(01)00585-7
   Wasa K, 2003, THIN FILM MAT TECHNO
NR 34
TC 20
Z9 20
U1 1
U2 5
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD AUG
PY 2009
VL 11
IS 8
BP 1132
EP 1138
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 493GR
UT WOS:000269724200015
DA 2018-10-20
ER

PT J
AU Rivera, JA
   Fetter, G
   Banos, L
   Guzman, J
   Bosch, P
AF Rivera, J. A.
   Fetter, G.
   Banos, L.
   Guzman, J.
   Bosch, P.
TI New hydroxyapatite-hydrotalcite composites I. synthesis
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article
DE Hydrotalcite; Hydroxyapatite; Composite; Microwave irradiation;
   Biomaterial; Catalyst; Bone
ID LAYERED DOUBLE HYDROXIDES; MICROWAVE; CATALYSTS; FLUORAPATITE
AB The synthesis and characterization of original materials, composed by hydrotalcite and hydroxyapatite, is discussed. All the syntheses were carried out in presence of microwave irradiation during the crystallization step. The interactions between the two compounds depend on the synthesis procedure. If hydroxyapatite is incorporated to hydrotalcite, the first compound is encapsulated by hydrotalcite. Instead, if hydroxyapatite is first prepared, the resulting solid is essentially a hydrotalcite with interlayered hydroxyapatite. When the composite material is synthesized by a simultaneous coprecipitation, the small clusters of hydroxyapatite and hydrotalcite are homogeneously dispersed. Consequently, the specific surface area and the particle size vary.
C1 [Rivera, J. A.; Fetter, G.] Univ Autonoma Puebla, Fac Ciencias Quim, Puebla 72570, Mexico.
   [Banos, L.; Guzman, J.; Bosch, P.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
RP Fetter, G (reprint author), Univ Autonoma Puebla, Fac Ciencias Quim, Blvd 18 Sur & Av San Claudio, Puebla 72570, Mexico.
EM geolarfetter@yahoo.com.mx
FU CONACYT
FX The authors gratefully acknowledge the financial support of CONACYT.
CR Benito P, 2006, J SOLID STATE CHEM, V179, P3784, DOI 10.1016/j.jssc.2006.08.010
   Bergada O, 2007, MICROPOR MESOPOR MAT, V101, P363, DOI 10.1016/j.micromeso.2006.11.033
   Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K
   Climent MJ, 2004, J CATAL, V225, P316, DOI 10.1016/j.jcat.2004.04.027
   DRIESSENS FCM, 2000, BIOMINERALS, P41
   Du LC, 2007, POLYM COMPOSITE, V28, P131, DOI 10.1002/pc.20279
   Elazarifi N, 2004, CATAL TODAY, V98, P161, DOI 10.1016/j.cattod.2004.07.030
   Fetter G, 2001, J POROUS MAT, V8, P227, DOI 10.1023/A:1012292807651
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   Katsuki H, 1999, J AM CERAM SOC, V82, P2257
   Komarneni S, 1996, J MATER RES, V11, P1866, DOI 10.1557/JMR.1996.0236
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Lopez T, 1997, MATER LETT, V31, P311, DOI 10.1016/S0167-577X(96)00296-0
   Milev AS, 2004, LANGMUIR, V20, P1888, DOI 10.1021/la0355601
   Mori K, 2003, J AM CHEM SOC, V125, P11460, DOI 10.1021/ja0302533
   Olanrewaju J, 2000, MATER LETT, V45, P307, DOI 10.1016/S0167-577X(00)00123-3
   Paredes SP, 2006, J MATER SCI, V41, P3377, DOI 10.1007/s10853-005-5347-4
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   Prinetto F, 2000, CATAL TODAY, V55, P103, DOI 10.1016/S0920-5861(99)00230-8
   Rivera JA, 2007, APPL CATAL A-GEN, V316, P207, DOI 10.1016/j.apcata.2006.09.031
   Rivera JA, 2006, MICROPOR MESOPOR MAT, V89, P306, DOI 10.1016/j.micromeso.2005.10.041
   Rives V, 1999, COORDIN CHEM REV, V181, P61, DOI 10.1016/S0010-8545(98)00216-1
   Simon P, 2005, J MATER CHEM, V15, P4992, DOI 10.1039/b504977f
   Smahi A, 2003, APPL CATAL A-GEN, V250, P151, DOI 10.1016/S0926-860X(03)00254-0
   Tichit D, 2002, J MATER CHEM, V12, P3832, DOI 10.1039/b203376n
   Uota M, 2005, LANGMUIR, V21, P4724, DOI 10.1021/la050029m
   Wang SL, 2000, AM MINERAL, V85, P739, DOI 10.2138/am-2000-5-612
   Wang YF, 2006, J COLLOID INTERF SCI, V301, P19, DOI 10.1016/j.jcis.2006.04.061
   Zapata B, 2001, INT J INORG MATER, V3, P23, DOI 10.1016/S1466-6049(00)00097-0
NR 30
TC 8
Z9 10
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
J9 J POROUS MAT
JI J. Porous Mat.
PD AUG
PY 2009
VL 16
IS 4
BP 401
EP 408
DI 10.1007/s10934-008-9227-6
PG 8
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 464DZ
UT WOS:000267486700005
DA 2018-10-20
ER

PT J
AU Brown, EM
AF Brown, Eleanor M.
TI COLLAGEN - A NATURAL SCAFFOLD FOR BIOLOGY AND ENGINEERING
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
CT 105th Annual Meeting of the American-Leather-Chemists-Association
CY JUN 18-21, 2009
CL Wheeling, WV
SP Amer Leather Chem Assoc
ID 3-DIMENSIONAL-ENERGY MINIMIZED MODELS; MOLECULAR-DYNAMICS SIMULATIONS; I
   COLLAGEN; CROSS-LINKING; TRIPLE-HELIX; TERMINAL TELOPEPTIDES;
   THERMAL-STABILITY; NEUTRAL SALTS; C-TELOPEPTIDE; HIDE POWDER
AB Collagen, the most abundant protein in mammals, constitutes a quarter of the animal's total weight. The unique structure of fibrous collagens, a long triple helix that further associates into fibers, provides an insoluble scaffold that gives strength and form to the skin, tendons, bones, cornea and teeth. The ready availability, to meat eaters, of animal skins that Would putrefy, if left untreated, led to man's earliest venture into biomaterials engineering and resulted In the production Of leather. Through empirical methods, a number of tanning agents with a variety of properties were identified. The methods for production of leather evolved over several centuries as art and engineering with little understanding of the underlying science. Scientific advances of the twentieth century, including increasing use of collagen in medical biomaterial research, began to provide a basis for understanding the relationship between collagen structure and function in both biology and technology.
   During the past 20 years, leather researchers at ERRC have used experimental and theoretical approaches to investigate several methods for stabilizing collagen structure. This research, which includes studies of mineral and vegetable tannages, enzyme-catalyzed and aldehyde-based covalent crosslinks, electrostatic and hydrophobic interactions, will be reviewed. Insight gained from these studies and those of other leather and biomaterials scientists will be evaluated as steps toward a still elusive, comprehensive mechanism for stabilization of collagen in leather and other biomaterials.
C1 ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Brown, EM (reprint author), ARS, USDA, Eastern Reg Res Ctr, 600 E Mermaid Lane, Wyndmoor, PA 19038 USA.
EM eleanor.brown@ars.usda.gov
CR BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   BAILEY DG, 1981, J AM LEATHER CHEM AS, V76, P204
   BORASKY R, 1952, J AM LEATHER CHEM AS, V47, P312
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Bronco S, 2006, J PHYS CHEM B, V110, P13227, DOI 10.1021/jp061776a
   Bronco S, 2004, J PHYS CHEM B, V108, P10101, DOI 10.1021/jp049172z
   Brown EM, 2008, J AM LEATHER CHEM AS, V103, P290
   Brown EM, 2005, J AM LEATHER CHEM AS, V100, P401
   Brown EM, 2004, J AM LEATHER CHEM AS, V99, P376
   Brown EM, 2003, J AM LEATHER CHEM AS, V98, P408
   Brown EM, 1999, J AM LEATHER CHEM AS, V94, P59
   BROWN EM, 1993, J AM LEATHER CHEM AS, V88, P2
   Brown EM, 1997, J AM LEATHER CHEM AS, V92, P225
   Brown EM, 2000, J PROTEIN CHEM, V19, P85, DOI 10.1023/A:1007074314686
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Bulo RE, 2007, MACROMOL BIOSCI, V7, P234, DOI 10.1002/mabi.200600208
   Buttar D, 1997, J AM LEATHER CHEM AS, V92, P185
   Cappelli C, 2005, CHIRALITY, V17, P577, DOI 10.1002/chir.20210
   Castaneda L, 2008, BIOMACROMOLECULES, V9, P3383, DOI 10.1021/bm800793z
   CHEN JM, 1991, J AM LEATHER CHEM AS, V86, P475
   CHEN JM, 1991, J AM LEATHER CHEM AS, V86, P487
   CHEN JM, 1991, J PROTEIN CHEM, V10, P535, DOI 10.1007/BF01025482
   CHU CC, 2001, POLYM BIOMATERIALS, pCH19
   Covington A.D., 2003, P 27 C INT UN LEATH, P148
   De Simone A, 2008, BIOCHEM BIOPH RES CO, V372, P121, DOI 10.1016/j.bbrc.2008.04.190
   Ding K, 2007, J AM LEATHER CHEM AS, V102, P164
   Ding K, 2006, J AM LEATHER CHEM AS, V101, P362
   EIKENBERRY EF, 1980, J MOL BIOL, V144, P397, DOI 10.1016/0022-2836(80)90098-4
   FEAIRHELLER SH, 1991, J AM LEATHER CHEM AS, V86, P171
   FEAIRHELLER SH, 1979, P 16 C INT UN LEATH, P79
   Fennen J, 1998, J SOC LEATH TECH CH, V82, P5
   FILACHION EM, 1961, J AM LEATHER CHEM AS, V56, P200
   FILACHIONE EM, 1959, JALCA, V54, P668
   Furuichi K, 2006, CHEM MATER, V18, P229, DOI 10.1021/cm052213z
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   George A, 1999, P INDIAN AS-CHEM SCI, V111, P121
   GUSTAVSON KH, 1949, ADV PROTEIN CHEM, V5, P354
   HAPPICH ML, 1971, J AM LEATHER CHEM AS, V66, P364
   Harlan J W, 1977, Adv Exp Med Biol, V86A, P425
   HENSHILWOOD CS, 2001, J HUM EVOL, V41, P678
   HULMES DJS, 1981, P NATL ACAD SCI-BIOL, V78, P3567, DOI 10.1073/pnas.78.6.3567
   HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1
   KADLER K, 1994, PROTEIN PROFILES, V1, P535
   King G, 1996, PROTEIN ENG, V9, P43, DOI 10.1093/protein/9.1.43
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   Lastowka A, 2005, J AM LEATHER CHEM AS, V100, P196
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Loo RW, 2008, LANGMUIR, V24, P13276, DOI 10.1021/la803041v
   Maffia Gennaro J., 2003, United States Patent, Patent No. 6660829
   Maffia GJ, 2004, J AM LEATHER CHEM AS, V99, P164
   Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b
   Malone JP, 2004, PROTEINS, V54, P206, DOI 10.1002/prot.10526
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MILLER MH, 1980, MACROMOLECULES, V13, P910, DOI 10.1021/ma60076a028
   Mogilner IG, 2002, J MOL GRAPH MODEL, V21, P209, DOI 10.1016/S1093-3263(02)00145-6
   Monti S, 2005, J PHYS CHEM B, V109, P11389, DOI 10.1021/jp0440941
   Monti S, 2007, J PHYS CHEM C, V111, P6086, DOI 10.1021/jp070266t
   NA GC, 1986, BIOCHEMISTRY-US, V25, P958, DOI 10.1021/bi00353a003
   NA GC, 1989, BIOCHEMISTRY-US, V28, P7161, DOI 10.1021/bi00444a005
   NAGHSKI J, 1967, LEATHER MANUF, V84, P40
   NUTTING GC, 1948, J AM LEATHER CHEM AS, V43, P96
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   OTTER A, 1988, BIOCHEMISTRY-US, V27, P3560, DOI 10.1021/bi00410a006
   Qi PX, 2002, J AM LEATHER CHEM AS, V97, P235
   QUIMBY D, 1975, J AM LEATHER CHEM AS, V70, P510
   Ramachandran G. N., 1967, TREATIES COLLAGEN
   Ramasami T, 2001, J AM LEATHER CHEM AS, V96, P290
   SCHOLNICK F, 1992, J AM LEATHER CHEM AS, V87, P333
   Siggel L, 2006, J AM LEATHER CHEM AS, V101, P179
   Siggel L, 2007, J AM LEATHER CHEM AS, V102, P333
   Sistiabudi R, 2007, J PHYS CHEM C, V111, P11676, DOI 10.1021/jp072757j
   SMITH JW, 1968, NATURE, V219, P157, DOI 10.1038/219157a0
   Stuart K, 2009, BIOMACROMOLECULES, V10, P25, DOI 10.1021/bm800888u
   Sun M, 2008, LANGMUIR, V24, P5418, DOI 10.1021/la703292h
   SUSI H, 1971, J AM LEATHER CHEM AS, V66, P508
   Takenouchi K., 1981, J SOC LEATHER TECHN, V75, P190
   TAYLOR MM, 1989, J AM LEATHER CHEM AS, V84, P71
   TAYLOR MM, 1986, J AM LEATHER CHEM AS, V81, P43
   TAYLOR MM, 1991, J AM LEATHER CHEM AS, V86, P199
   Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   VANDERREST M, 1991, FASEB J, V5, P2814
   VIOLA SJ, 1966, JALCA, V61, P661
   WILSON JA, 1928, JALCA, V24, P157
   WILSON JA, 1943, J AM LEATHER CHEM AS, V38, P20
   WILSON JA, 1919, JALCA, V14, P450
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   1974, TANNING EXTRACT PROD, pCH1
NR 89
TC 6
Z9 7
U1 1
U2 12
PU AMER LEATHER CHEMISTS ASSOC
PI LUBBOCK
PA TEXAS TECH UNIV, BOX 45300, LUBBOCK, TX 79409-5300 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD AUG
PY 2009
VL 104
IS 8
BP 275
EP 285
PG 11
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 479ZH
UT WOS:000268700500003
DA 2018-10-20
ER

PT J
AU Trommer, RM
   Santos, LA
   Bergmann, CP
AF Trommer, R. M.
   Santos, L. A.
   Bergmann, C. P.
TI Nanostructured hydroxyapatite powders produced by a flame-based
   technique
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Calcium phosphate; Hydroxyapatite; Powder; Flame
ID CALCIUM-PHOSPHATE CERAMICS; PARTICLE FORMATION; COATINGS; APATITE; FILMS
AB In this work we reported the production of hydroxyapatite (RA) powder, one of the most studied calcium phosphates in the bioceramics field, using a cost-effective apparatus, composed by three major components: the atomization device, the pilot and main flames and finally the powder collector system. Calcium acetate and ammonium phosphate, diluted in ethanol and water, were used as salts in the precursor solution. The Ca/P molar ratio in the precursor solution was 1.65, equivalent to biological hydroxyapatite. After its production and collection, HA powder was calcined at 600 degrees C for 2 h. X-ray diffraction analysis pointed to the formation of crystalline hydroxyapatite powders. Carbonate was identified in the powders by Fourier-transform infrared (FTIR) spectroscopy. Scanning electronic microscopy (SEM) showed that the powders were composed of spherical primary particles and secondary aggregates, with the morphology unchanged after calcination. By transmission electronic microscopy (TEM), it was observed that the crystallite size of the primary particles was 24.8 +/- 5.8 nm. for the calcined powder. The specific surface area was 15.03 +/- 6.4 and 26.50 +/- 7.6 m(2)/g, for the as-synthetized and calcined powder respectively. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Trommer, R. M.; Bergmann, C. P.] Ceram Mat Lab, BR-90035190 Porto Alegre, RS, Brazil.
   [Santos, L. A.] Biomat Lab, BR-91501970 Porto Alegre, RS, Brazil.
RP Trommer, RM (reprint author), Ceram Mat Lab, Av Osvaldo Aranha 99-705, BR-90035190 Porto Alegre, RS, Brazil.
EM rafael_trommer@yahoo.com.br
RI Trommer, Rafael/D-4156-2015; Biofabris, Inct/I-2418-2013; Perez
   Bergmann, Carlos/F-2225-2010
OI Trommer, Rafael/0000-0002-1599-0583; Perez Bergmann,
   Carlos/0000-0002-8951-8943
FU Brazilian Agency CNPq - Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico
FX The authors gratefully acknowledge the financial support of the
   Brazilian Agency CNPq - Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico. In addition, the CME - Centro de Microscopia Eletronica
   of Federal University of Rio Grande do Sul - is hereby acknowledged for
   kindly helping in the electron microscopy procedures.
CR Adanez J, 1999, FUEL, V78, P583, DOI 10.1016/S0016-2361(98)00186-0
   Andrade AL, 2006, QUIM NOVA, V29, P100, DOI 10.1590/S0100-40422006000100019
   AOKI IH, 1991, SCI MED APPL HYDROXY
   Balamurugan A, 2006, MATER LETT, V60, P2288, DOI 10.1016/j.matlet.2005.12.126
   Balamurugan A, 2006, CERAM-SILIKATY, V50, P27
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Edelstein A, 1996, NANOMATERIALS SYNTHE
   GAYDON AG, 1953, FLAMES THEIR STRUCTU
   HAMMARI E, 2007, MATER CHEM PHYS, V104, P448
   Han YC, 2004, MATER RES BULL, V39, P25, DOI 10.1016/j.materresbull.2003.09.022
   Hench L. L., 1993, ADV SERIES CERAMICS
   Jalota S, 2005, J AM CERAM SOC, V88, P3353, DOI 10.1111/j.1551-2916.2005.00623.x
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   KWEH SWK, 1999, J MATER PROCESS TECH, V89, P373
   Leeuwenburgh SCG, 2006, BIOMATERIALS, V27, P3368, DOI 10.1016/j.biomaterials.2006.01.052
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Loher S, 2005, CHEM MATER, V17, P36, DOI 10.1021/cm048776c
   Mukherjee ST, 2008, J ALLOY COMPD, V466, P493, DOI 10.1016/j.jallcom.2007.11.070
   Pratsinis SE, 1998, PROG ENERG COMBUST, V24, P197, DOI 10.1016/S0360-1285(97)00028-2
   Pratsinis SE, 1996, POWDER TECHNOL, V88, P267, DOI 10.1016/S0032-5910(96)03130-0
   Qiu CF, 2008, CERAM INT, V34, P1747, DOI 10.1016/j.ceramint.2007.06.001
   RAJABIZAMANI AH, 2008, MAT SCI ENG B-SOLID, P1326
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Rigo E. C. S., 2007, REV DENT PRESS PERIO, V1, P39
   Roth P, 2007, P COMBUST INST, V31, P1773, DOI 10.1016/j.proci.2006.08.118
   Santos ML, 2005, ECLET QUIM, V30, P29
   Solla EL, 2005, APPL SURF SCI, V248, P360, DOI 10.1016/j.apsusc.2005.03.053
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Trommer RM, 2007, SURF COAT TECH, V201, P9587, DOI 10.1016/j.surfcoat.2007.04.028
   ULRICH GD, 1971, COMBUST SCI TECHNOL, V4, P47, DOI 10.1080/00102207108952471
NR 30
TC 23
Z9 25
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2009
VL 29
IS 6
BP 1770
EP 1775
DI 10.1016/j.msec.2009.02.006
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 485RA
UT WOS:000269140200002
DA 2018-10-20
ER

PT J
AU An, J
   Wang, DS
   Luo, QZ
   Yuan, XY
AF An, Jing
   Wang, Desong
   Luo, Qingzhi
   Yuan, Xiaoyan
TI Antimicrobial active silver nanoparticles and silver/polystyrene
   core-shell nanoparticles prepared in room-temperature ionic liquid
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silver nanoparticles; Polystyrene; Core-shell nanoparticles; Ionic
   liquid; Antimicrobial activity
ID FERRITE COMPOSITE NANOPARTICLES; BIOMATERIAL SYSTEM; PHOTOCATALYTIC
   SHELL; ESCHERICHIA-COLI; MAGNETIC CORE; POLYMERIZATION; PARTICLES;
   COPPER; GOLD; FILM
AB Uniform silver nanoparticles and silver/polystyrene core-shell nanoparticles were successfully synthesized in a room temperature ionic liquid, 1-n-butyl-3-methylimidazolium tetra fluoroborate ([BMIM]center dot BF(4)). [BMIM]center dot BF(4) plays a protective role to prevent the nanoparticles from aggregation during the preparation process. Transmission electron micrographs confirm that both silver nanoparticles and core-shell nanoparticles are regular spheres with the sizes in the range of 5-15 nm and 15-25 nm, respectively. The X-ray diffraction analysis reveals the face-centered cubic geometry of silver nanoparticles. The as-prepared nanoparticles were also characterized by Fourier transform infrared spectroscopy, Raman spectroscopy, UV-vis diffuse reflectance spectroscopy and X-ray photoelectron spectroscopy. In addition, antimicrobial activities against E. coli and S. aureus were studied and the results show that both silver nanoparticles and core-shell nanoparticles possess excellent antimicrobial activities. The antimicrobial mechanism of the as-prepared nanoparticles was discussed. Crown Copyright (C) 2009 Published by Elsevier B.V. All rights reserved.
C1 [An, Jing; Wang, Desong; Luo, Qingzhi] Hebei Univ Sci & Technol, Sch Sci, Hebei 050018, Shijiazhuang, Peoples R China.
   [An, Jing; Yuan, Xiaoyan] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Wang, DS (reprint author), Hebei Univ Sci & Technol, Sch Sci, Hebei 050018, Shijiazhuang, Peoples R China.
EM dswang06@126.com
RI Desong, Wang/J-9105-2013; Dom, Rekha/B-7113-2012
FU Nature Science Foundation of Hebei Province [E2008000699]
FX The authors are grateful for the support of this research by the Nature
   Science Foundation of Hebei Province (Grant no. E2008000699).
CR Dellinger TM, 2004, CHEM MATER, V16, P2201, DOI 10.1021/cm0349194
   Dong AG, 2002, CHEM COMMUN, P350, DOI 10.1039/b110164c
   Dupont J, 2004, ANGEW CHEM INT EDIT, V43, P5296, DOI 10.1002/anie.200460431
   Dyson PJ, 2002, APPL ORGANOMET CHEM, V16, P495, DOI 10.1002/aoc.337
   ELHAGAHMED MO, 2006, J ORGANOMET CHEM, V691, P1055
   Gogoi SK, 2006, LANGMUIR, V22, P9322, DOI 10.1021/la060661v
   HAO E, 2002, J AM CHEM SOC, V124, P1518
   He ST, 2001, LANGMUIR, V17, P1571, DOI 10.1021/la001239w
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Liang GD, 2007, MAT SCI ENG B-SOLID, V142, P55, DOI 10.1016/j.mseb.2007.06.028
   Liu P, 2006, COLLOID SURFACE A, V291, P155, DOI 10.1016/j.colsurfa.2006.05.007
   Liu WJ, 2006, J SOLID STATE CHEM, V179, P1253, DOI 10.1016/j.jssc.2006.01.042
   Maillard M, 2003, J PHYS CHEM B, V107, P2466, DOI 10.1021/jp022357q
   Mallick K, 2006, MAT SCI ENG C-BIO S, V26, P87, DOI 10.1016/j.msec.2005.06.004
   Manna A, 2001, LANGMUIR, V17, P6000, DOI 10.1021/la010389j
   Nakashima T, 2003, J AM CHEM SOC, V125, P6386, DOI 10.1021/ja034954b
   Olivier-Bourbigou H, 2002, J MOL CATAL A-CHEM, V182, P419, DOI 10.1016/S1381-1169(01)00465-4
   Paulo A. Z., 1996, POLYHEDRON, V15, P1217
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   SANPUI P, 2008, INT J FOOD MICROBIOL, V31, P142
   Scheeren CW, 2006, J PHYS CHEM B, V110, P13011, DOI 10.1021/jp0623037
   Scheeren CW, 2003, INORG CHEM, V42, P4738, DOI 10.1021/ic034453r
   Sondi I, 2003, J COLLOID INTERF SCI, V260, P75, DOI 10.1016/S0021-9797(02)00205-9
   Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Swatloski RP, 2002, GREEN CHEM, V4, P81, DOI 10.1039/b108905f
   Torres FJ, 2007, J PHYS CHEM B, V111, P6327, DOI 10.1021/jp072257q
   Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042
   Wang DB, 2005, MATER LETT, V59, P1760, DOI 10.1016/j.matlet.2005.01.061
   Whitehead JA, 2007, HYDROMETALLURGY, V88, P109, DOI 10.1016/j.hydromet.2007.03.009
   Xu W, 2003, J PHYS CHEM B, V107, P6170, DOI 10.1021/jp0275894
   XUA JZ, 2004, MAT SCI ENG C-BIO S, V24, P833
   Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007
   Yoon M, 2005, MATER CHEM PHYS, V91, P104, DOI 10.1016/j.matchemphys.2004.10.059
   Zhang K, 2005, MATER LETT, V59, P3682, DOI 10.1016/j.matlet.2005.06.063
   Zhang Y, 2008, ENVIRON SCI TECHNOL, V42, P1724, DOI 10.1021/es0713983
   Zhang ZQ, 2000, J PHYS CHEM B, V104, P1176, DOI 10.1021/jp991569t
NR 41
TC 32
Z9 32
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2009
VL 29
IS 6
BP 1984
EP 1989
DI 10.1016/j.msec.2009.03.015
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 485RA
UT WOS:000269140200036
DA 2018-10-20
ER

PT J
AU Ernstberger, T
   Buchhorn, G
   Heidrich, G
AF Ernstberger, Thorsten
   Buchhorn, Gottfried
   Heidrich, Gabert
TI Artifacts in spine magnetic resonance imaging due to different
   intervertebral test spacers: an in vitro evaluation of magnesium versus
   titanium and carbon-fiber-reinforced polymers as biomaterials
SO NEURORADIOLOGY
LA English
DT Article
DE Magnesium alloys; Innovative biomaterials; Interbody test implants; MRI
   artifacting
ID INTERBODY FUSION; PEDICLE SCREWS; LUMBAR SPINE; IMPLANT; CAGES; MRI;
   INSTRUMENTATION; PARAMETERS; QUALITY; ALLOYS
AB Introduction Intervertebral spacers are made of different materials, which can affect the postfusion magnetic imaging (MRI) scans. Susceptibility artifacts especially for metallic implants can decrease the image quality. This study aimed to determine whether magnesium as a lightweight and biocompatible metal is suitable as a biomaterial for spinal implants based on its MRI artifacting behavior.
   Materials and methods To compare artifacting behaviors, we implanted into one porcine cadaveric spine different test spacers made of magnesium, titanium, and carbon-fiber-reinforced polymers (CFRP). All test spacers were scanned using two T1-TSE MRI sequences. The artifact dimensions were traced on all scans and statistically analyzed.
   Results The total artifact volume and median artifact area of the titanium spacers were statistically significantly larger than magnesium spacers (p<0.001), while magnesium and CFRP spacers produced almost identical artifacting behaviors (p>0.05).
   Conclusion Our results suggest that spinal implants made with magnesium alloys will behave more like CFRP devices in MRI scans. Given its osseoconductive potential as a metal, implant alloys made with magnesium would combine the advantages to the two principal spacer materials currently used but without their limitations, at least in terms of MRI artifacting.
C1 [Ernstberger, Thorsten] Klinikum Bad Bramstedt, Ctr Spinal Surg, D-24576 Bad Bramstedt, Germany.
   [Buchhorn, Gottfried] Univ Gottingen, Dept Orthoped Surg, Biomat Lab, D-37075 Gottingen, Germany.
   [Heidrich, Gabert] Univ Gottingen, Dept Diagnost Radiol, D-37075 Gottingen, Germany.
RP Ernstberger, T (reprint author), Klinikum Bad Bramstedt, Ctr Spinal Surg, Oskar Alexander Str 26, D-24576 Bad Bramstedt, Germany.
EM ernstberger@klinikumbb.de
CR BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030
   DEBATIN JF, 1992, INVEST RADIOL, V27, P198, DOI 10.1097/00004424-199203000-00003
   Diedrich O, 2001, ZBL NEUROCHIR, V62, P106, DOI 10.1055/s-2001-21796
   ERNSTBERGER T, 2006, EUR SPINE J, V7, P1
   Ernstberger T, 2007, SPINE J, V7, P353, DOI 10.1016/j.spinee.2006.03.016
   Ernstberger T, 2007, NEURORADIOLOGY, V49, P103, DOI 10.1007/s00234-006-0161-5
   Henk C B, 1999, Top Magn Reson Imaging, V10, P247, DOI 10.1097/00002142-199908000-00006
   Kuklo TR, 2006, J SPINAL DISORD TECH, V19, P376, DOI 10.1097/01.bsd.0000203945.03922.f6
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Malik AS, 2001, ACTA RADIOL, V42, P291, DOI 10.1034/j.1600-0455.2001.042002291.x
   McAfee PC, 2005, SPINE, V30, pS60, DOI 10.1097/01.brs.0000155578.62680.dd
   Ortiz O, 1996, NEUROSURGERY, V38, P741, DOI 10.1227/00006123-199604000-00022
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   RAUZZINO MJ, 1999, NEUROSURG FOCUS, V15, pE7
   Rudisch A, 1998, SPINE, V23, P692, DOI 10.1097/00007632-199803150-00009
   RUPP R, 1993, SPINE, V18, P379
   Schreiner U, 2000, Z ORTHOP GRENZGEB, V138, P540, DOI 10.1055/s-2000-9598
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomsen M, 2001, ORTHOPADE, V30, P540, DOI 10.1007/s001320170063
   Troitskii VV, 1944, KHIRURGIIA, V8, P41
   Trouillier Hans, 2006, Acta Orthop Belg, V72, P460
   VACCARO AR, 1994, SPINE, V19, P1237, DOI 10.1097/00007632-199405310-00008
   Van Goethem JWM, 2002, NEURORADIOLOGY, V44, P723, DOI 10.1007/s00234-002-0790-2
   Waldman ID, 2005, AM J MED GENET B, V138B, P144
   Wang JC, 1997, J SPINAL DISORD, V10, P27
   Wang JC, 1998, SPINE, V23, P1684, DOI 10.1097/00007632-199808010-00014
   Znamenskii MS, 1945, KHIRURGIIA, V12, P60
NR 27
TC 18
Z9 18
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-3940
J9 NEURORADIOLOGY
JI Neuroradiology
PD AUG
PY 2009
VL 51
IS 8
BP 525
EP 529
DI 10.1007/s00234-009-0537-4
PG 5
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 484AB
UT WOS:000269013900004
PM 19468722
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Mohammadi, H
   Boughner, D
   Millon, LE
   Wan, WK
AF Mohammadi, H.
   Boughner, D.
   Millon, L. E.
   Wan, W. K.
TI Design and simulation of a poly(vinyl alcohol)-bacterial cellulose
   nanocomposite mechanical aortic heart valve prosthesis
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE finite element method; mechanical heart valves; poly(vinyl alcohol);
   bacterial cellulose; soft tissue; anisotropy; non-linearity
ID STRESS-ANALYSIS; LEAFLET; CAVITATION; MODEL
AB In this study, a polymeric aortic heart valve made of poly(vinyl alcohol) (PVA)-bacterial cellulose (BC) nanocomposite is simulated and designed using a hyperelastic non-linear anisotropic material model. A novel nanocomposite biomaterial combination of 15 wt % PVA and 0.5 wt % BC is developed in this study. The mechanical properties of the synthesized PVA-BC are similar to those of the porcine heart valve in both the principal directions. To design the geometry of the leaflets an advance surfacing technique is employed. A Galerkin-based non-linear finite element method is applied to analyse the mechanical behaviour of the leaflet in the closing and opening phases under physiological conditions. The model used in this study can be implemented in mechanical models for any soft tissues such as articular cartilage, tendon, and ligament.
C1 [Mohammadi, H.; Boughner, D.; Millon, L. E.; Wan, W. K.] Univ Western Ontario, Fac Engn, Dept Biomed Engn, London, ON N6A 5B9, Canada.
   [Boughner, D.] London Hlth Sci Ctr, London, ON, Canada.
   [Wan, W. K.] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Mohammadi, H (reprint author), Univ Western Ontario, Fac Engn, Dept Biomed Engn, London, ON N6A 5B9, Canada.
EM hmohamm3@uwo.ca
RI Boughner, Derek/G-3282-2011
FU Canadian Institutes of Health Research
FX The authors thank the Integrated Manufacturing Technology Institute and
   the Virtual Environment Technology Centre for providing technical
   supports and facilities to achieve this project. The authors also thank
   the Canadian Institutes of Health Research for funding this project.
CR Beck A, 2001, J HEART VALVE DIS, V10, P1
   BURRIESCI G, 1999, J BIOMECH, V10, P707
   De Hart J, 2004, J BIOMECH, V37, P303, DOI 10.1016/S0021-9290(03)00293-8
   GERALD F, 1993, CURVES SURFACES COMP
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   Grande-Allen KJ, 2001, IEEE T BIO-MED ENG, V48, P647, DOI 10.1109/10.923783
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   He ZM, 2001, J HEART VALVE DIS, V10, P666
   JIANG H, 2003, J MED ENG PHYS, V24, P267
   KEISER R, 2004, P VIS MOD VIS VMV 04, P315
   Kim H, 2006, J BIOMECH ENG-T ASME, V128, P717, DOI 10.1115/1.2244578
   KNIERBEIN B, 1992, J BIOMED ENG, V14, P275, DOI 10.1016/0141-5425(92)90001-2
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   LEAT ME, 1994, MED ENG PHYS, V16, P470, DOI 10.1016/1350-4533(94)90071-X
   Li J, 2001, J BIOMECH, V34, P1279, DOI 10.1016/S0021-9290(01)00092-6
   Luo XY, 2003, J BIOMECH ENG-T ASME, V125, P735, DOI 10.1115/1.1614821
   Mackay TG, 1996, BIOMATERIALS, V17, P1857, DOI 10.1016/0142-9612(95)00242-1
   MERCER JL, 1973, J THORAC CARDIOV SUR, V65, P511
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Mohammadi H, 2006, MED ENG PHYS, V28, P122, DOI 10.1016/j.medengphy.2005.03.013
   Mohammadi H, 2008, P I MECH ENG H, V222, P1115, DOI 10.1243/09544119JEIM432
   NISTAL F, 1990, J THORAC CARDIOVASC, V99, P1047
   Patterson EA, 1996, J MED ENG TECHNOL, V20, P95, DOI 10.3109/03091909609008387
   ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9
   Sripathi VC, 2004, ANN THORAC SURG, V77, P844, DOI 10.1016/S0003-4975(03)01518-2
   *U W ONT HEART VAL, 1997, WHAT DOES REAL HEART
   WIJSMULLER EG, 1990, INT J ARTIF ORGANS, V13, P503
   Yoganathan A P, 1994, J Heart Valve Dis, V3, P571
NR 29
TC 26
Z9 27
U1 2
U2 20
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD AUG
PY 2009
VL 223
IS H6
BP 697
EP 711
DI 10.1243/09544119JEIM493
PG 15
WC Engineering, Biomedical
SC Engineering
GA 491JG
UT WOS:000269574100006
PM 19743636
DA 2018-10-20
ER

PT J
AU Choe, HC
   Saji, VS
   Ko, YM
AF Choe, Han-Cheol
   Saji, Viswanathan S.
   Ko, Yeong-Mu
TI Mechanical properties and corrosion resistance of low rigidity
   quaternary titanium alloy for biomedical applications
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE Ti-35Nb-5Ta-7Zr; biomaterial; mechanical properties; corrosion
ID IN-VITRO; TA
AB Electrochemical corrosion of Ti-35Nb-5Ta-7Zr alloy fabricated by arc melting and heat treatment process was studied in 0.9% NaCl at (37 +/- 1) degrees C. Phase and microstructure of the fabricated alloy were investigated using X-ray diffractometer and scanning electron microscope. Mechanical properties such as yield strength and elastic modulus of the alloy were determined by tensile test. Potentiodynamic polarization technique and impedance spectroscopy were employed to study the corrosion behavior. The results of the study were compared with those obtained for Ti-6Al-4V commercial alloy. The result of the study supports feasibility of Ti-35Nb-5Ta-7Zr alloy for implant applications.
C1 [Choe, Han-Cheol; Saji, Viswanathan S.; Ko, Yeong-Mu] Chosun Univ, Dept Dent Mat, Coll Dent, Kwangju 501759, South Korea.
RP Choe, HC (reprint author), Chosun Univ, Dept Dent Mat, Coll Dent, Kwangju 501759, South Korea.
EM hcchoe@chosun.ac.kr
RI Viswanathan S., Saji/H-8533-2015
OI Viswanathan S., Saji/0000-0003-1724-0011
CR *ASTM, 2000, 3 ASTM
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Jatsy M., 1993, J APPL BIOMATER, V4, P273
   Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Okazaki Y, 2001, CURR OPIN SOLID ST M, V5, P45, DOI 10.1016/S1359-0286(00)00025-5
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Qazi JI, 2004, JOM-US, V56, P49, DOI 10.1007/s11837-004-0253-9
   Raman V, 2006, ELECTROCHEM COMMUN, V8, P1309, DOI 10.1016/j.elecom.2006.06.004
   Rosa S, 2001, BRAZ J CHEM ENG, V18, P47, DOI 10.1590/S0104-66322001000100005
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P370, DOI 10.1016/j.msec.2005.04.003
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
NR 17
TC 9
Z9 10
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD AUG
PY 2009
VL 19
IS 4
BP 862
EP 865
DI 10.1016/S1003-6326(08)60365-9
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 485CV
UT WOS:000269099300016
DA 2018-10-20
ER

PT J
AU Ranjan, A
   Webster, TJ
AF Ranjan, Ashwini
   Webster, Thomas J.
TI Increased endothelial cell adhesion and elongation on micron-patterned
   nano-rough poly(dimethylsiloxane) films
SO NANOTECHNOLOGY
LA English
DT Article
ID SILICONE SURFACES; POLY(LACTIC-CO-GLYCOLIC ACID); TITANIUM SURFACES;
   FOCAL CONTACT; FEATURES; BEHAVIOR; SPECIFICITY; TOPOGRAPHY; MECHANISMS;
   STRESS
AB The success of synthetic vascular grafts is largely determined by their ability to promote vital endothelial cell functions such as adhesion, alignment, proliferation, and extracellular matrix (ECM) deposition. Developing such biomaterials requires the design and fabrication of materials that mimic select properties of native extracellular matrices. Furthermore, cells of the native endothelium have elongated and aligned morphology in the direction of blood flow, yet few materials promote this type of morphology initially, but rather rely on blood flow to orient endothelial cells. Therefore, the objective of this in vitro study was to design a biomaterial that mimics the conditions of the micro-and nano-environment of vascular intima tissue suitable for endothelial cell adhesion and elongation to improve the efficacy of small synthetic vascular grafts. Towards this end, patterned poly(dimethylsiloxane) (PDMS) films consisting of periodic arrays of nano-grooves (500 nm), with spacings ranging from 22 to 80 mu m, and alternating nano-and micron roughness were fabricated using a novel electron beam physical vapor deposition method followed by polymer casting. By varying pattern spacing, the area of micron-and nano-rough surface was controlled. In vitro rat aortic endothelial cell adhesion and elongation studies indicated that endothelial cell function was enhanced on patterned PDMS surfaces with the widest spacing and greatest surface area of nano-roughness, as compared to more narrow pattern spacings and non-patterned PDMS surfaces. Specifically, endothelial cells adherent on PDMS patterned films of the widest spacing (greatest nano-rough area) displayed almost twice as much elongation as cells on non-patterned surfaces. For these reasons, the present study highlighted design criteria (the use of micron patterns of nano-features on PDMS) that may contribute to the intelligent design of new-generation vascular grafts.
C1 [Ranjan, Ashwini; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
   [Webster, Thomas J.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA.
RP Webster, TJ (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
EM Thomas_Webster@brown.edu
FU National Institutes of Health [1R21AG027521]
FX The authors would like to thank the National Institutes of Health (Grant
   No. 1R21AG027521) for funding, Dr Robbert Creton and Mr Geoffrey
   Williams for help with fluorescence microscopy, Dr Michael Jibitsky at
   the Microelectronics Facility, and Dr Anthony McCormick at the Electron
   Microscope Facility of Brown University.
CR ABBOTT WM, 1993, J VASC SURG, V17, P746, DOI 10.1016/0741-5214(93)90120-B
   BARRON V, 2006, J MATER SCI, V18, P1973
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, P171
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   CHU CFL, 1999, BIOCHIM BIOPHYS ACTA, V3, P479
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   DAVIES PF, 1993, CIRC RES, V72, P239, DOI 10.1161/01.RES.72.2.239
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jiang XY, 2002, LANGMUIR, V18, P3273, DOI 10.1021/la011668+
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   MACKAY J, 2005, ATLAS HEART DIS STRO
   Mathur AB, 2003, J BIOMED MATER RES A, V66A, P729, DOI 10.1002/jbm.a.10581
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Molitor P, 2001, INT J ADHES ADHES, V21, P129, DOI 10.1016/S0143-7496(00)00044-0
   Moretti M, 2004, J MATER SCI-MATER M, V15, P1159, DOI 10.1023/B:JMSM.0000046400.18607.72
   NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275
   NOLLERT MU, 1991, BIOTECHNOL BIOENG, V38, P588, DOI 10.1002/bit.260380605
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van Kooten TG, 1999, TISSUE ENG, V5, P223
   Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
NR 29
TC 36
Z9 36
U1 2
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD JUL 29
PY 2009
VL 20
IS 30
AR 305102
DI 10.1088/0957-4484/20/30/305102
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 468LW
UT WOS:000267821000002
PM 19581692
DA 2018-10-20
ER

PT J
AU Skopinska-Wisniewska, J
   Sionkowska, A
   Kaminska, A
   Kaznica, A
   Jachimiak, R
   Drewa, T
AF Skopinska-Wisniewska, J.
   Sionkowska, A.
   Kaminska, A.
   Kaznica, A.
   Jachimiak, R.
   Drewa, T.
TI Surface characterization of collagen/elastin based biomaterials for
   tissue regeneration
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Collagen; Elastin; Surface modification; UV-irradiation
ID COLLAGEN/PVP BLENDED FILMS; EXTRACELLULAR-MATRIX; CROSS-LINKING;
   IN-VITRO; ULTRAVIOLET-IRRADIATION; RECONSTITUTED COLLAGEN; DERMAL
   SUBSTITUTE; PROTEIN RELEASE; UV-RADIATION; CELL-CULTURE
AB Collagen and elastin are the main proteins of extracellular matrix. Collagen plays a crucial role in tensile strength of tissues, whereas elastin provides resilience to many organs. Both biopolymers are readily available and biocompatible. These properties point out that collagen and elastin are good components of materials for many potential medical applications. The surface properties of biomaterials play an important role in biomedicine as the majority of biological reactions occur on the surface of implanted materials. One of the methods of surface modi. cation is UV-irradiation. The exposition of the biomaterial on ultraviolet light can alterate surface properties of the materials, their chemical stability, swelling properties and mechanical properties as well.
   The aim of our work was to study the surface properties and biocompatibility of new collagen/elastin based biomaterials and consideration of the influence of ultraviolet light on these properties.
   The surface properties of collagen/elastin based biomaterials modified by UV-irradiation were studied using the technique of atomic force microscopy (AFM) and contact angle measurements. On the basis of the results the surface free energy and its polar component was calculated using Owens-Wendt method. To assess the biological performance of films based on collagen, elastin and their blends, the response of 3T3 cell was investigated.
   It was found that the surface of collagen/elastin film is enriched in less polar component-collagen. Exposition on UV light increases polarity of collagen/elastin based films, due to photooxidation process. The AFM images have shown that topography and roughness of the materials had been also affected by UV-irradiation. The changes in surface properties influence on interaction between the material's surface and cells. The investigation of 3T3 cells grown on films based on collagen, elastin and their blends, leads to the conclusion that higher content of elastin in biomaterial promotes the cell adhesion and their viability on the surface. Also the suitable dose of UV light (1, 2 h) improves the biocompatibility of the materials. (C) 2009 Elsevier B. V. All rights reserved.
C1 [Skopinska-Wisniewska, J.; Sionkowska, A.; Kaminska, A.] Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
   [Kaznica, A.; Jachimiak, R.; Drewa, T.] Nicholas Copernicus Univ, Coll Med, PL-85092 Bydgoszcz, Poland.
RP Skopinska-Wisniewska, J (reprint author), Nicholas Copernicus Univ, Fac Chem, Gagarin 7, PL-87100 Torun, Poland.
EM joanna@chem.uni.torun.pl
RI Skopinska-Wisniewska, Joanna/O-6445-2015; Sionkowska, Alina/I-5599-2014
FU Ministry of Science (MNII, Poland) [N507 3495325]
FX Financial support from the Ministry of Science (MNII, Poland) Grant no.
   N N507 3495325 is gratefully acknowledged.
CR Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Bellingham CM, 2004, CURR OPIN SOLID ST M, V8, P135, DOI 10.1016/j.cossms.2004.01.007
   BELLINGHAM CM, 2002, ELASTOMERIC PROTEINS, P39
   Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8
   BONZON N, 1995, BIOMATERIALS, V16, P881, DOI 10.1016/0142-9612(95)94151-A
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   BUTTAFOCO L, 2005, J BIOMED MATER RES B, P357
   Cao H, 2008, J MATER SCI-MATER M, V19, P567, DOI [10.1007/s10856-007-3281-5, 10.1007/S10856-007-3281-5]
   Chan BP, 2008, ACTA BIOMATER, V4, P1627, DOI 10.1016/j.actbio.2008.06.007
   Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Dutoya S, 1998, BIOMATERIALS, V19, P147, DOI 10.1016/S0142-9612(97)00214-7
   Enever PAJ, 2002, J SURG RES, V105, P160, DOI 10.1006/jsre.2002.6372
   Engbers-Buijtenhuijs P, 2006, BIOMATERIALS, V27, P2390, DOI 10.1016/j.biomaterials.2005.10.016
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   GREGORY KW, 2000, Patent No. 6110212
   Gunasekaran Subramanian, 1995, P1267
   Habermehl J, 2005, MACROMOL BIOSCI, V5, P821, DOI 10.1002/mabi.200500102
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hiles M, 2006, INT UROGYNECOL J, V17, pS39, DOI 10.1007/s00192-006-0104-z
   Hsu FY, 2005, J MATER SCI-MATER M, V16, P341, DOI 10.1007/s10856-005-0633-x
   Jarman-Smith M, 2004, BIOCHEM ENG J, V20, P217, DOI 10.1016/j.bej.2003.09.016
   Jiang B, 2006, BIOMATERIALS, V27, P15, DOI 10.1016/j.biomaterials.2005.05.091
   Kaminska A, 1996, J PHOTOCH PHOTOBIO A, V96, P123, DOI 10.1016/1010-6030(95)04278-4
   Klein B, 2001, J MATER SCI-MATER M, V12, P419, DOI 10.1023/A:1011249020155
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   Li B, 2002, J MUSCLE RES CELL M, V23, P561, DOI 10.1023/A:1023474909980
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   OBITABOT ET, 2000, Patent No. 6046160
   Ohan MP, 2002, J BIOMED MATER RES, V60, P384, DOI 10.1002/jbm.10111
   Park J., 2007, BIOMATERIALS INTRO
   Park J. B., 2003, BIOMATERIALS PRINCIP
   RABAUD M, 1993, Patent No. 5223420
   Rajan N, 2008, BIOTECHNOL PROGR, V24, P884, DOI 10.1002/btpr.3
   ROTHSTEIN A, 2004, Patent No. 6765086
   Sai P, 2000, BURNS, V26, P54
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Silver Frederick H., 1995, P1245
   SIMONESCU DT, 2006, BIOMATERIALS, V27, P702
   Sionkowska A, 2006, APPL SURF SCI, V253, P1970, DOI 10.1016/j.apsusc.2006.03.048
   Sionkowska A, 2004, SURF SCI, V566, P608, DOI 10.1016/j.susc.2004.05.114
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V67, P79, DOI 10.1016/S0141-3910(99)00084-1
   Sionkowska A, 2007, J PHOTOCH PHOTOBIO B, V86, P186, DOI 10.1016/j.jphotobiol.2006.09.004
   Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V85, P79, DOI 10.1016/j.jphotobiol.2006.05.005
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   SOSKEL NT, 1987, METHOD ENZYMOL, V144, P196
   Vardaxis NJ, 1996, BIOMATERIALS, V17, P1489, DOI 10.1016/0142-9612(96)89773-0
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Yao CC, 2007, J MATER SCI-MATER M, V18, P1969, DOI 10.1007/s10856-007-3093-7
   Yunoki S, 2007, J MATER SCI-MATER M, V18, P2179, DOI 10.1007/s10856-007-3011-z
NR 62
TC 29
Z9 29
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUL 15
PY 2009
VL 255
IS 19
BP 8286
EP 8292
DI 10.1016/j.apsusc.2009.05.127
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 466VZ
UT WOS:000267692900018
DA 2018-10-20
ER

PT J
AU Chiba, A
   Lee, SH
   Matsumoto, H
   Nakamura, M
AF Chiba, Akihiko
   Lee, Sang-Hak
   Matsumoto, Hiroaki
   Nakamura, Mitsuru
TI Construction of processing map for biomedical Co-28Cr-6Mo-0.16N alloy by
   studying its hot deformation behavior using compression tests
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Co-Cr-Mo alloy; Biomaterial; Hot deformation; Processing map
ID CO-CR-MO; IMPLANT ALLOY; SUPERALLOY
AB The high-temperature deformation behavior of Co-28Cr-6Mo-0.16N alloy was investigated by carrying out compression tests for determination of the optimum hot-forging conditions; the tests were carried out in the temperature range of 1000-1200 degrees C and strain rates ranging from 0.01 to 50 s(-1) with a height reduction of 50%. The optimum hot-working conditions were decided from the processing map based on the dynamic materials model (DMM). Dynamic recrystallization (DRX) occurred over the entire temperature and strain rate range. However, uniformly sized grains were formed for strain rates higher than 10 s(-1), which is considered the optimum hot-working condition. The characteristic microstructures predicted from the processing map agreed well with the results of microstructural observations. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Chiba, Akihiko; Matsumoto, Hiroaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Lee, Sang-Hak] Iwate Ind Promot Ctr, Morioka, Iwate 0200852, Japan.
   [Nakamura, Mitsuru] Iwate Univ, Fac Engn, Dept Die Mold & Casting Engn, Morioka, Iwate 0208551, Japan.
RP Chiba, A (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM a.chiba@imr.tohoku.ac.jp
RI Chiba, Akihiko/D-1326-2011
FU Ministry of Education, Science and Culture of Japan
FX This research was supported by Cooperation of Innovative Technology and
   Advanced Research in Evolutional Area from the Ministry of Education,
   Science and Culture of Japan.
CR CHAUDHURY PK, 1993, ATLAS FORMABILITY HA, V188, P63
   Chiba A, 1999, PHILOS MAG A, V79, P1533, DOI 10.1080/01418619908210378
   Cong Dahn N., 1984, Acta Metallurgica, V32, P1317
   DIETER GE, 1976, MECH METALLURGY, P138
   DOBBS HS, 1983, J MATER SCI, V18, P391, DOI 10.1007/BF00560627
   Garcia ADJS, 1999, METALL MATER TRANS A, V30, P1177, DOI 10.1007/s11661-999-0267-6
   Hsu HC, 2003, J MATER PROCESS TECH, V138, P231, DOI 10.1016/S0924-0136(03)00077-3
   Kartika I, 2009, METALL MATER TRANS A, V40A, P1457, DOI 10.1007/s11661-009-9829-x
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   Medyanik SN, 2007, J MECH PHYS SOLIDS, V55, P1439, DOI 10.1016/j.jmps.2006.12.006
   Monajati H, 2005, METALL MATER TRANS A, V36A, P895, DOI 10.1007/s11661-005-0284-z
   OH SI, 1992, METALL TRANS A, V23, P963, DOI 10.1007/BF02675571
   Prasad YVRK, 2003, J MATER ENG PERFORM, V12, P638, DOI 10.1361/105994903322692420
   PRASAD YVRK, 1984, METALL TRANS A, V15, P1883, DOI 10.1007/BF02664902
   RAJ R, 1981, METALL TRANS A, V12, P1089, DOI 10.1007/BF02643490
   Ramanathan S, 2006, MAT SCI ENG A-STRUCT, V441, P321, DOI 10.1016/j.msea.2006.08.044
   Rodriguez P., 1984, Bulletin of Materials Science, V6, P653, DOI 10.1007/BF02743993
   SalinasRodriguez A, 1996, J BIOMED MATER RES, V31, P409, DOI 10.1002/(SICI)1097-4636(199607)31:3<409::AID-JBM16>3.0.CO;2-D
   Shettlemore MG, 2001, BIOMATERIALS, V22, P2215, DOI 10.1016/S0142-9612(00)00410-5
   Ziegler H, 1965, PROGR SOLID MECH, V4, P91
NR 20
TC 40
Z9 40
U1 2
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUL 15
PY 2009
VL 513-14
BP 286
EP 293
DI 10.1016/j.msea.2009.02.044
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 452YP
UT WOS:000266577400040
DA 2018-10-20
ER

PT J
AU Zou, YQ
   Rossi, NAA
   Kizhakkedathu, JN
   Brooks, DE
AF Zou, Yuquan
   Rossi, Nicholas A. A.
   Kizhakkedathu, Jayachandran N.
   Brooks, Donald E.
TI Barrier Capacity of Hydrophilic Polymer Brushes To Prevent Hydrophobic
   Interactions: Effect of Graft Density and Hydrophilicity
SO MACROMOLECULES
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; ATOMIC-FORCE MICROSCOPY; HUMAN
   SERUM-ALBUMIN; PROTEIN ADSORPTION; MOLECULAR-WEIGHT; CELL-ADHESION;
   BLOOD-PLASMA; SINGLE-MOLECULE; CHAIN-LENGTH; SURFACE
AB The performance of biomaterials in contact with biological systems can be greatly affected by hydrophobic interactions at the interface between the biomaterial surface and surrounding biomolecules. Polymer brushes can function as a protective layer, preventing such interfacial hydrophobic interactions. In this paper, a systematic study of the barrier properties of a hydrophilic polymer brush is made by investigating the influence of graft density and its chemical nature (hydrophilicity/hydrophobicity) on hydrophobic interactions with the surface. To achieve this, it series of novel thermoresponsive poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide (PDMDOMA) polymer brushes were grown from silicon wafers via surface-initiated atom transfer radical polymerization. Without changing graft density or degree of polymerization, the hydrophilicity of the PDMDOMA brushes was manipulated by partial or complete hydrolysis or the pendent dioxolane moieties. A lower critical solution temperature (LCST) was observed at 22-24 degrees C, below which the PDMDOMA brush was Found to be in a hydrated state (amphiphilic), while at temperatures above the LCST, the PDMDOMA brush formed a collapsed. more hydrophobic structure. A physical method was developed to analyze the ability of these brushes to act as a barrier against hydrophobic interactions based on AFM force-distance measurements. The adhesive forces between the Si(3)N(4) tip and the silicon wafer surface upon (a) modification with ATRP initiator, (b) grafting of PDMDOMA brushes, and (c) partial and complete hydrolysis of PDMDOMA were investigated. Hydrophobic interactions decreased after each modification, while graft density and the degree of hydrolysis increased the barrier function of the surface layer. In particular, when graft density was above 0.22 chains/nm(2), the barrier capacity completely counteracted the hydrophobic interactions, as evidenced from the disappearance of the adhesive force in AFM measurements. Further Studies revealed that the barrier property its assessed by AFM correlated well with the wettability of the surfaces.
C1 [Zou, Yuquan; Rossi, Nicholas A. A.; Kizhakkedathu, Jayachandran N.; Brooks, Donald E.] Univ British Columbia, Ctr Blood Res, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada.
   [Brooks, Donald E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada.
RP Kizhakkedathu, JN (reprint author), Univ British Columbia, Ctr Blood Res, Dept Pathol & Lab Med, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.
EM jay@pathology.ubc.ca; don.brooks@ubc.ca
OI Brooks, Donald/0000-0002-7946-4320
FU Canadian Institutes of Health Research (CIHR); Canadian Blood Services
   (CBS); Canada Foundation for Innovation (CFI); Natural Sciences and
   Engineering Council,; Michael Smith Foundation for Health Research
   (MSFHR); Canada Foundation for Innovation; Michael Smith Foundation for
   Health Research
FX Financial support front Canadian Institutes of Health Research (CIHR),
   Canadian Blood Services (CBS), Canada Foundation for Innovation (CFI),
   the Natural Sciences and Engineering Council, and the Michael Smith
   Foundation for Health Research (MSFHR) is gratefully acknowledged.
   Theauthors thank the LMB Macromolecular Hub at the UBC Centel- for Blood
   Research for the use of their research facilities. These facilities are
   supported in part by grants from the Canada Foundation for Innovation
   and the Michael Smith Foundation for Health Research. J.N.K. is the
   recipient of CBS/Cll-lR new investigator award in transfusion science.
CR Alarcon CDH, 2005, J MATER CHEM, V15, P2089, DOI 10.1039/b419142k
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Arieh B. N., 1980, HYDROPHOBIC INTERACT
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Bhat RR, 2005, ADV MATER, V17, P2802, DOI 10.1002/adma.200500858
   Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162
   Coelho MAN, 2003, LANGMUIR, V19, P7544, DOI 10.1021/la034445n
   Cuenot S, 2006, MACROMOLECULES, V39, P8428, DOI 10.1021/ma060824m
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Dimitrov I, 2007, PROG POLYM SCI, V32, P1275, DOI 10.1016/j.progpolymsci.2007.07.001
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   Geisler M, 2008, LANGMUIR, V24, P1350, DOI 10.1021/la702341j
   Goodman D, 2004, LANGMUIR, V20, P6238, DOI 10.1021/la030692y
   Goodman D, 2004, LANGMUIR, V20, P3297, DOI 10.1021/la036164l
   Goodman D, 2004, LANGMUIR, V20, P2333, DOI 10.1021/la035843t
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Inglis W, 2001, LANGMUIR, V17, P7402, DOI 10.1021/la010511e
   Ishida N, 2006, J COLLOID INTERF SCI, V297, P513, DOI 10.1016/j.jcis.2005.10.068
   Jisr RM, 2005, ANGEW CHEM INT EDIT, V44, P782, DOI 10.1002/anie.200461645
   Jones DM, 2002, ADV MATER, V14, P1130, DOI 10.1002/1521-4095(20020816)14:16<1130::AID-ADMA1130>3.0.CO;2-7
   Kainthan RK, 2008, BIOMATERIALS, V29, P1693, DOI 10.1016/j.biomaterials.2007.11.030
   Kizhakkedathu JN, 2009, LANGMUIR, V25, P3794, DOI 10.1021/la803690q
   KOOTEN TGV, 2004, BIOMATERIALS, V25, P1735
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3
   Lappegard KT, 2005, ANN THORAC SURG, V79, P917, DOI 10.1016/j.athoracsur.2004.08.015
   Luzinov I, 2004, PROG POLYM SCI, V29, P635, DOI 10.1016/j.progpolymsci.2004.03.001
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Matyjaszewski K, 1999, MACROMOLECULES, V32, P8716, DOI 10.1021/ma991146p
   Mei Y, 2005, LANGMUIR, V21, P12309, DOI 10.1021/la050668x
   Meyer EE, 2006, P NATL ACAD SCI USA, V103, P15739, DOI 10.1073/pnas.0606422103
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533
   Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502
   REID DS, 1969, NATURE, V224, P1293, DOI 10.1038/2241293b0
   Singh N, 2007, BIOMATERIALS, V28, P763, DOI 10.1016/j.biomaterials.2006.09.036
   Sonnenberg L, 2007, LANGMUIR, V23, P6660, DOI 10.1021/la063682y
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Videm V, 2004, BIOMATERIALS, V25, P43, DOI 10.1016/S0142-9612(03)00470-8
   Wang DA, 2002, BIOCONJUGATE CHEM, V13, P792, DOI 10.1021/bc0255079
   Wang MJ, 2006, POLYMER, V47, P2548, DOI 10.1016/j.polymer.2005.12.086
   WARE JA, 1991, BLOOD, V78, P1713
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu T, 2003, MACROMOLECULES, V36, P2448, DOI 10.1021/ma0257189
   Yamamoto S, 2000, MACROMOLECULES, V33, P5608, DOI 10.1021/ma991988o
   Yamamoto S, 2000, MACROMOLECULES, V33, P5995, DOI 10.1021/ma000225u
   Yeh PYJ, 2008, LANGMUIR, V24, P4907, DOI 10.1021/la702867t
   Zou YQ, 2008, MACROMOLECULES, V41, P5393, DOI 10.1021/ma8006703
   Zou YQ, 2009, MACROMOLECULES, V42, P3258, DOI 10.1021/ma8025699
NR 57
TC 41
Z9 41
U1 0
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 14
PY 2009
VL 42
IS 13
BP 4817
EP 4828
DI 10.1021/ma901055t
PG 12
WC Polymer Science
SC Polymer Science
GA 472NJ
UT WOS:000268138500067
DA 2018-10-20
ER

PT J
AU Bartlett, L
   Nowak, M
   Ho, YH
AF Bartlett, Lynne
   Nowak, Madeleine
   Ho, Yik-Hong
TI Impact of fecal incontinence on quality of life
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Quality of life; Fecal incontinence; Rural health; Colorectal cancer;
   Urogynecology
ID INJECTABLE SILICONE BIOMATERIAL; ANAL INCONTINENCE;
   URINARY-INCONTINENCE; RISK-FACTORS; J-POUCH; PREVALENCE; EPIDEMIOLOGY;
   CONSTIPATION; DYSFUNCTION; SPHINCTER
AB AIM: To explore the impact of fecal incontinence (FI) on quality of life (QOL) of patients attending urogynecology and colorectal clinics (CCs).
   METHODS: Cross-sectional study of 154 patients (27 male) with FI, who attended the clinics at a regional hospital in North Queensland, Australia in 2003 and 2004, and completed the Fecal Incontinence Quality of Life Scale (FIQL: 1 = very affected; 4 = not affected).
   RESULTS: More than 22% of patients had their QOL affected severely by FI. Patients reported that they had not previously been asked about FI by a medical practitioner nor did they voluntarily disclose its presence. The median FIQL scores for all participants were: lifestyle = 3.24; coping = 2.23; depression = 2.42; and embarrassment = 2.33. Increasing frequency of soiling had a negative effect on all four FIQL scales (P < 0.001) as did the quantity of soiling (P < 0.01). Female CC patients had poorer FIQL scores than urogynecology clinic patients for lifestyle (P = 0.015), coping (P = 0.004) and embarrassment (P = 0.009), but not depression (P = 0.062), despite having experienced FI for a shorter period.
   CONCLUSION: Failure to seek treatment for FI degrades the quality of patients' lives over time. FI assessment tools should incorporate the quantity of fecal loss. (C) 2009 The WJG Press and Baishideng. All rights reserved.
C1 [Bartlett, Lynne] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Fecal Incontinence Res Grp, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
   [Ho, Yik-Hong] James Cook Univ, Sch Med & Dent, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
RP Bartlett, L (reprint author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Fecal Incontinence Res Grp, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
EM lynne.bartlett@jcu.edu.au
FU James Cook University Program [2003]; Cancer Council Queensland
FX Supported by A James Cook University Program Grant (2003) and A Cancer
   Council Queensland scholarship
CR Avery KNL, 2007, J UROLOGY, V177, P39, DOI 10.1016/j.juro.2006.08.075
   Bartlett L, 2007, Tech Coloproctol, V11, P251, DOI 10.1007/s10151-007-0360-z
   Baxter NN, 2003, DIS COLON RECTUM, V46, P1591, DOI 10.1097/013DCR.0000098906.61097.1C
   Bharucha AE, 2004, ALIMENT PHARM THERAP, V20, P355, DOI 10.1111/j.1365-2036.2004.02028.x
   Bordeianou L, 2008, COLORECTAL DIS, V10, P273, DOI 10.1111/j.1463-1318.2007.01288.x
   Boreham MK, 2005, AM J OBSTET GYNECOL, V192, P1637, DOI 10.1016/j.ajog.2004.11.030
   Colquhoun P, 2006, WORLD J SURG, V30, P1925, DOI 10.1007/s00268-006-0531-5
   Colquhoun PHD, 2004, DIS COLON RECTUM, V47, P538, DOI 10.1007/s10350-003-0074-x
   Damon H, 2004, GASTROEN CLIN BIOL, V28, P16, DOI 10.1016/S0399-8320(04)94835-X
   Deutekom M, 2005, COLORECTAL DIS, V7, P263, DOI 10.1111/j.1463-1318.2005.00772.x
   Deutekom M, 2005, SCAND J GASTROENTERO, V40, P552, DOI 10.1080/00365520510012172
   DROSSMAN DA, 1986, DIGEST DIS SCI, V31, P1221, DOI 10.1007/BF01296523
   Edwards NI, 2001, AGE AGEING, V30, P503, DOI 10.1093/ageing/30.6.503
   ENCK P, 1991, INT J COLORECTAL DIS, V6, P143, DOI 10.1007/BF00341234
   FUJITA S, 1992, DIS COLON RECTUM, V35, P1030, DOI 10.1007/BF02252992
   Ho Yik-Hong, 2005, Aust J Rural Health, V13, P28, DOI 10.1111/j.1440-1854.2004.00642.x
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   Kalantar JS, 2002, MED J AUSTRALIA, V176, P54
   Lam TCF, 1999, COLORECTAL DIS, V1, P197
   Landefeld CS, 2008, ANN INTERN MED, V148, P449, DOI 10.7326/0003-4819-148-6-200803180-00210
   LEIGH RJ, 1982, LANCET, V1, P1349
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056
   Park JG, 2005, WORLD J GASTROENTERO, V11, P2570, DOI 10.3748/wjg.v11.i17.2570
   Pla-Marti V, 2007, COLORECTAL DIS, V9, P90, DOI 10.1111/j.1463-1318.2006.01128.x
   *QUEENSL HLTH, TOWNSV HOSP
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P16, DOI DOI 10.1007/BF02237236]
   Rockwood T, 2008, DIS COLON RECTUM, V51, P1434, DOI 10.1007/s10350-008-9280-x
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   Rullier E, 2004, GASTROEN CLIN BIOL, V28, P562, DOI 10.1016/S0399-8320(04)95012-9
   Stevens TK, 2003, CLEV CLIN J MED, V70, P441, DOI 10.3949/ccjm.70.5.441
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Whitehead WE, 2005, GASTROENTEROLOGY, V129, P6, DOI 10.1053/j.gastro.2005.05.043
   WHITEHEAD WE, 2009, GASTROENTEROLOGY
NR 36
TC 44
Z9 45
U1 0
U2 1
PU W J G PRESS
PI BEIJING
PA APT 1066, YISHOU GARDEN, NO 58, NORTH LANGXINZHUANG RD, PO BOX 2345,
   BEIJING 100023, PEOPLES R CHINA
SN 1007-9327
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JUL 14
PY 2009
VL 15
IS 26
BP 3276
EP 3282
DI 10.3748/wjg.15.3276
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 471AE
UT WOS:000268023100011
PM 19598304
OA Green Published
DA 2018-10-20
ER

PT J
AU Krebs, MD
   Jeon, O
   Alsberg, E
AF Krebs, Melissa D.
   Jeon, Oju
   Alsberg, Eben
TI Localized and Sustained Delivery of Silencing RNA from Macroscopic
   Biopolymer Hydrogels
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID IN-VIVO; DNA DELIVERY; SIRNA; INTERFERENCE; THERAPY; CANCER
AB The ability to silence the expression of specific genes at a particular location of the body would provide a powerful new therapeutic too[ for treatment of diseases such as cancer or for use in regenerative medicine. RNA interference (RNAi) is a gene silencing mechanism where specific mRNA molecules that are complementary to short interfering RNA (siRNA) are degraded, thus inhibiting gene expression at the post-transcriptional level. However, the use of siRNA has not yet realized its full clinical potential due to degradation in vivo, the difficulty retaining siRNA at the site of interest, and the relatively short-term effect it has on rapidly dividing cells. In this work a new paradigm is presented that will allow for the localized delivery of siRNA that is controlled and sustained over time, thus allowing cells at the site of interest to be directly exposed to a gradual release of bioactive siRNA. To accomplish this, three different types of macroscopic, degradable biomaterial hydrogel. scaffolds were employed: calcium crosslinked alginate, photocrosslinked alginate, and collagen. Differing rates of release from these hydrogels were achieved, and the ability of the released siRNA to knock down the expression of GFP in cells that constitutively express this protein was shown. Furthermore, the ability to encapsulate cells within these materials and achieve sustained gene silencing of these incorporated cells was demonstrated. These biopolymer hydrogels are injectable and, therefore, can be delivered in a minimally invasive manner, and they can serve as delivery vehicles for both siRNA and transplanted cell populations.
C1 [Krebs, Melissa D.; Jeon, Oju; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Jeon, Oju/K-7227-2018; Krebs, Melissa/L-4878-2015
OI Jeon, Oju/0000-0003-3972-9272; Krebs, Melissa/0000-0002-5170-7116;
   Alsberg, Eben/0000-0002-3487-4625
FU National Brain Tumor Foundation; Ohio Department of Development
   [08-081]; Ellison Medical Foundation; National Science Foundation
FX The authors thank Kathleen Sutter for technical assistance and
   gratefully acknowledge funding support for this work from the National
   Brain Tumor Foundation (E.A.), Biomedical Research and Technology
   Transfer Grant 08-081 from the Ohio Department of Development (E.A.),
   the Ellison Medical Foundation (E.A.), and a National Science Foundation
   Graduate Research Fellowship (M.D.K.).
CR Aigner A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71659
   Bi J. X., 2002, Journal of Biotechnology, V93, P231, DOI 10.1016/S0168-1656(01)00400-X
   Chen YC, 2008, EXPERT OPIN DRUG DEL, V5, P1301, DOI 10.1517/17425240802568505 
   De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Gao ZY, 2006, PLAST RECONSTR SURG, V118, P1328, DOI 10.1097/01.prs.0000239537.77870.2c
   Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021
   Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27
   Pardridge WM, 2004, EXPERT OPIN BIOL TH, V4, P1103, DOI 10.1517/14712598.4.7.1103
   Rutz S, 2004, ARTHRITIS RES THER, V6, P78, DOI 10.1086/ar1168
   Ryther RCC, 2005, GENE THER, V12, P5, DOI 10.1038/sj.gt.3302356
   Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101
NR 17
TC 103
Z9 104
U1 0
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUL 8
PY 2009
VL 131
IS 26
BP 9204
EP +
DI 10.1021/ja9037615
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 466AT
UT WOS:000267633300033
PM 19530653
DA 2018-10-20
ER

PT J
AU Rusu, MC
   Ichim, IC
   Popa, M
   Rusu, D
   Rusu, M
AF Rusu, Marius Ciprian
   Ichim, Ionut Cameliu
   Popa, Marcel
   Rusu, Daniela
   Rusu, Mihai
TI Radiopaque acrylic bone cement with bromine-containing acrylic monomer.
   II
SO E-POLYMERS
LA English
DT Article
ID WATER-ABSORPTION CHARACTERISTICS; IODINE-CONTAINING MONOMERS;
   BARIUM-SULFATE; P/L RATIO; METHACRYLATE; POLYMETHYLMETHACRYLATE;
   POLYMERIZATION; FORMULATIONS; BIOMATERIAL; SHRINKAGE
AB Bromine-containing methacrylate, 2-(2-bromoisobutyryloxy) ethyl methacrylate (BIEM), had been used in the formulation of acrylic radiopaque cements. The effect of this monomer incorporated into the liquid phase of acrylic bone cement (ABC), on the curing parameters, thermal properties, water absorption, density, compression tests and radiopacity was studied. A decrease of maximum temperature and an increase of the setting time were observed with the addition of the bromine-containing monomer in the radiolucent cement composition. Adding BIEM in radiolucent ABCs composition results in the decrease of glass transition temperature and increase in its thermal stability. The ABCs modified with bromine-containing comonomer are characterized by polymerization shrinkage lower than the radiolucent cement. Addition of bromine-containing comonomer in radiolucent ABC composition determines the increase of compressive strength. The ABCs modified with bromine-containing comonomer proved to be radiopaque.
C1 [Rusu, Marius Ciprian; Ichim, Ionut Cameliu; Popa, Marcel; Rusu, Mihai] Gh Asachi Tech Univ Iasi, Dept Nat & Synthet Polymers, Fac Chem Engn, Iasi 700050, Romania.
   [Rusu, Daniela] Ecole Mines Douai, Polymer & Composites Technol & Mech Engn Dept, F-59508 Douai, France.
RP Rusu, M (reprint author), Gh Asachi Tech Univ Iasi, Dept Nat & Synthet Polymers, Fac Chem Engn, D Mangeron St,71A, Iasi 700050, Romania.
EM mrusu@ch.tuiasi.ro
RI RUSU, Mihai/C-2257-2008; RUSU, Daniela/A-6918-2008
OI RUSU, Mihai/0000-0002-4143-6818; RUSU, Daniela/0000-0001-6475-6841
CR Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1
   ALLEN PEM, 1992, EUR POLYM J, V28, P347, DOI 10.1016/0014-3057(92)90252-W
   Artola A, 2003, BIOMATERIALS, V24, P4071, DOI 10.1016/S0142-9612(03)00298-9
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   BERRIEJ A, 1968, WATER POLYM
   BOWEN RL, 1982, J DENT RES, V61, P654, DOI 10.1177/00220345820610050701
   BRADEN M, 1984, BIOMATERIALS, V5, P369, DOI 10.1016/0142-9612(84)90038-3
   Breusch SJ, 2003, ORTHOPADE, V32, P41, DOI 10.1007/s00132-002-0411-0
   CEVANTESUC JM, 2005, J BIOMATERIALS, V26, P4063
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHARNLEY J, 1970, ACRYLIC CEMENT ORTHO
   Coleman MM, 1991, SPECIFIC INTERACTION
   Crank J., 1956, MATH DIFFUSION
   DAVY KWM, 1997, POLYM INT, V43, P142
   DEB S, 1995, BIOMATERIALS, V16, P1095, DOI 10.1016/0142-9612(95)98906-U
   Deb S, 1999, J BIOMED MATER RES, V48, P719, DOI 10.1002/(SICI)1097-4636(1999)48:5<719::AID-JBM18>3.0.CO;2-H
   DiMaio FR, 2002, ORTHOPEDICS, V25, P1399
   Ginebra MP, 2002, BIOMATERIALS, V23, P1873, DOI 10.1016/S0142-9612(01)00314-3
   HASS SS, 1975, J BONE JOINT SURG AM, V57, P380
   Ichim IC, 2007, E-POLYMERS
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   JEFFERISS CD, 1975, J BONE JOINT SURG BR, V57, P511
   KRAUSE WR, 1988, ENCY MED DEVICES INS, V1, P491
   KUHN KD, 2000, BONE CEMENTS, P245
   KUSY RP, 1978, J BIOMED MATER RES, V12, P271, DOI 10.1002/jbm.820120304
   LABELLA R, 1992, BIOMATERIALS, V13, P937, DOI 10.1016/0142-9612(92)90117-7
   LANTENSCHLAGER EP, 1974, J BIOMED MAT RES S, V5, P185
   Larraz E, 2005, BIOMACROMOLECULES, V6, P2058, DOI 10.1021/bm050055z
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2005, J BIOMED MATER RES B, V73B, P77, DOI 10.1002/jbm.b.30176
   LEWIS G, 2000, 2000 ANN BOOK ASTM S, P55
   LEWIS G, 1992, ISO58331992
   LOSHACK S, 1953, J AM CHEM ASS, V75, P544
   MANERO JM, 2004, J ENG MED, V218, P3
   MEYER PR, 1973, J BONE JOINT SURG AM, VA 55, P149, DOI 10.2106/00004623-197355010-00015
   Molino LN, 1996, J BIOMED MATER RES, V31, P131, DOI 10.1002/(SICI)1097-4636(199605)31:1<131::AID-JBM14>3.0.CO;2-Q
   MOLNAR EJ, 1968, J DENT RES, V47, P665, DOI 10.1177/00220345680470042701
   Nicholas MKD, 2007, J MATER SCI-MATER M, V18, P1407, DOI 10.1007/s10856-007-0125-2
   NIZIHOU A, 1998, POWDER TECHNOL, V99, P60
   PARK JB, 1992, BIOMATERIALS INTRO, P154
   Pascual B, 1999, J BIOMED MATER RES, V48, P447, DOI 10.1002/(SICI)1097-4636(1999)48:4<447::AID-JBM8>3.0.CO;2-I
   Pascual B, 1999, BIOMATERIALS, V20, P465, DOI 10.1016/S0142-9612(98)00192-6
   Pascual B, 1999, BIOMATERIALS, V20, P453, DOI 10.1016/S0142-9612(98)00191-4
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   RAVELL PA, 1998, J BIOMATERIALS, V19, P1579
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   ROSE E E, 1958, J Am Dent Assoc, V56, P375
   Rusu MC, 2008, J MATER SCI-MATER M, V19, P2609, DOI 10.1007/s10856-007-3357-2
   Rusu MC, 2006, MATER PLAST, V43, P215
   Silikas N, 2005, BIOMATERIALS, V26, P197, DOI 10.1016/j.biomaterials.2004.02.028
   THANNER J, 1995, ACTA ORTHOP SCAND, V66, P207, DOI 10.3109/17453679508995525
   Vazquez B, 2002, J BIOMED MATER RES, V63, P88, DOI 10.1002/jbm.10092
   Vazquez B, 1999, BIOMATERIALS, V20, P2047, DOI 10.1016/S0142-9612(99)00108-8
   Ward IM, 1993, INTRO MECH PROPERTIE
   Yang JM, 1997, BIOMATERIALS, V18, P1293, DOI 10.1016/S0142-9612(97)00060-4
NR 55
TC 0
Z9 0
U1 0
U2 5
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD JUL 7
PY 2009
AR 086
PG 15
WC Polymer Science
SC Polymer Science
GA 467AJ
UT WOS:000267707800001
DA 2018-10-20
ER

PT J
AU Servoli, E
   Maniglio, D
   Aguilar, MR
   Motta, A
   Vazquez, B
   Roman, JS
   Migliaresi, C
AF Servoli, Eva
   Maniglio, Devid
   Aguilar, Maria Rosa
   Motta, Antonella
   Vazquez, Blanca
   Roman, Julio San
   Migliaresi, Claudio
TI Comparative Methods for the Evaluation of Protein Adsorption
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adsorption; atomic force microscopy (AFM); biological applications of
   polymers; proteins; surfaces
ID SURFACE-PLASMON RESONANCE; ATOMIC-FORCE MICROSCOPY; SELF-ASSEMBLED
   MONOLAYERS; SILK FIBROIN; MOLECULAR-WEIGHT; BIOMATERIALS; SPECTROSCOPY;
   RECOGNITION; BINDING; FILMS
AB AFM, Immunogold labeling and SPR have been successfully applied to the analysis of protein adsorption on fibroin substrates, chosen as a paradigmatic biomaterial. The process was evaluated both under static and dynamic conditions, also considering the effect of protein competition. AFM via antibody-modified tips provided maps of protein adsorption and information on protein-protein interactions. Double labeling Immunogold imaged protein distribution upon competitive adsorption. SPR described the dynamics of the process, offering also quantitative data both from individual and two-component protein solutions. The integration of these analytical techniques and the critical evaluation of the results can provide a detailed description of protein adsorption.
C1 [Servoli, Eva; Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38100 Trento, Italy.
   [Servoli, Eva; Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, INSTM Res Unit, I-38100 Trento, Italy.
   [Aguilar, Maria Rosa; Vazquez, Blanca; Roman, Julio San] CSIC, Inst Polymer Sci & Technol, E-28006 Madrid, Spain.
RP Servoli, E (reprint author), Univ Trent, Dept Mat Engn & Ind Technol, Via Mesiano 77, I-38100 Trento, Italy.
EM servolie@ing.unitn.it
RI Maniglio, Devid/C-4187-2014; Aguilar, Maria Rosa/C-2593-2014
OI Maniglio, Devid/0000-0002-1653-861X; Aguilar, Maria
   Rosa/0000-0001-7395-5754; Motta, Antonella/0000-0003-4893-6863; Vazquez,
   Blanca/0000-0001-5539-8026
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Aguilar MR, 2004, MACROMOL BIOSCI, V4, P631, DOI 10.1002/mabi.200400039
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Bowen WR, 2000, BIOTECHNOL LETT, V22, P893, DOI 10.1023/A:1005604028444
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   Flores SM, 2006, SURF SCI, V600, P2847, DOI 10.1016/j.susc.2006.04.047
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C
   KARLSSON R, 1995, ANAL BIOCHEM, V228, P274, DOI 10.1006/abio.1995.1350
   Lechuga LM, 2000, QUIM ANAL, V19, P54
   MCCLARY KB, 2000, J BIOMED MATER RES, V50, P42
   MOSS J, 1996, CURR DIAGN PATHOL, V3, P211
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   Pernodet N, 2003, J BIOMED MATER RES A, V64A, P684, DOI 10.1002/jbm.a.10394
   PUTNAM FW, 1984, PLASMA PROTEINS, V4, P25608
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Santin M, 2002, J BIOACT COMPAT POL, V17, P195, DOI 10.1106/0883911`02026326
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Servoli E, 2008, MACROMOL BIOSCI, V8, P1126, DOI 10.1002/mabi.200800110
   Sigal GB, 1997, LANGMUIR, V13, P2749, DOI 10.1021/la961024f
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Willemsen OH, 2000, BIOPHYS J, V79, P3267, DOI 10.1016/S0006-3495(00)76559-3
NR 34
TC 4
Z9 4
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL 7
PY 2009
VL 9
IS 7
BP 661
EP 670
DI 10.1002/mabi.200800301
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 470GH
UT WOS:000267962700005
PM 19226562
DA 2018-10-20
ER

PT J
AU Marquez, SP
   Martinez, VS
   Ambrose, WM
   Wang, J
   Gantxegui, NG
   Schein, O
   Elisseeff, J
AF Ponce Marquez, Sara
   Saez Martinez, Virginia
   Ambrose, Winnette McIntosh
   Wang, Jennie
   Garagorri Gantxegui, Nerea
   Schein, Oliver
   Elisseeff, Jennifer
TI Decellularization of bovine corneas for tissue engineering applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cornea; Biomaterial; Decellularized; Tissue engineering; Collagen
ID HUMAN AMNIOTIC MEMBRANE; OCULAR SURFACE RECONSTRUCTION; ENDOTHELIAL-CELL
   ADHERENCE; EPITHELIAL-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; STEM-CELLS;
   ADHESION; COLLAGENASE; HYDROGELS
AB Scaffolds derived from processed tissues offer viable alternatives to synthetic polymers as biological scaffolds for regenerative medicine. Tissue-derived scaffolds provide an extracellular matrix (ECM) as the starting material for wound healing and the functional reconstruction of tissues, offering a potentially valuable approach for the replacement of damaged or missing tissues. Additionally, acellular tissue may provide a natural microenvironment for host-cell migration and the induction of stem cell differentiation to contribute to tissue regeneration. There are a number of processing methods that aim to stabilize and provide an immunologically inert tissue scaffold. Furthermore, these tissue-processing methods can often be applied to xenogenic transplants because the essential components of the ECM are often maintained between species. In this study, we applied several tissue-processing protocols to the cornea in order to obtain a decellularized cornea matrix that maintained the clarity and mechanical properties of the native tissue. Histology, mechanical testing and electron microscopy techniques were used to assess the cell extraction process and the organization of the remaining ECM. In vitro cell seeding experiments confirmed the processed corneas' biocompatibility. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ponce Marquez, Sara; Saez Martinez, Virginia; Ambrose, Winnette McIntosh; Wang, Jennie; Elisseeff, Jennifer] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   [Ponce Marquez, Sara; Saez Martinez, Virginia; Garagorri Gantxegui, Nerea] Inasmet Tecnalia, Hlth Unit, Donostia San Sebastian, Spain.
   [Schein, Oliver] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA.
RP Elisseeff, J (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Clark Hall 106,3400 N Charles St, Baltimore, MD 21218 USA.
EM jhe@jhu.edu
FU Inaki Goenaga Scholarships for Technological Centers; Basque Government;
   Johns Hopkins University; Inasmet Foundation
FX The authors thank the Inaki Goenaga Scholarships for Technological
   Centers, the ETORTEK Program of the Basque Government, the Department of
   Biomedical Engineering of the Johns Hopkins University and Inasmet
   Foundation, for their financial and technical support.
CR Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Berman, 1975, Int Ophthalmol Clin, V15, P49, DOI 10.1097/00004397-197501540-00006
   Berryhill BL, 2001, INVEST OPHTH VIS SCI, V42, P1201
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   Chipev CC, 2000, CELL DEATH DIFFER, V7, P166, DOI 10.1038/sj.cdd.4400605
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Garagorri N, 2008, ACTA BIOMATER, V4, P1139, DOI 10.1016/j.actbio.2008.05.007
   GNADINGE.MC, 1969, AM J OPHTHALMOL, V68, P478
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   HAN S, 1992, ANAL BIOCHEM, V201, P336, DOI 10.1016/0003-2697(92)90348-B
   HARPER E, 1970, BIOCHEM BIOPH RES CO, V41, P482, DOI 10.1016/0006-291X(70)90531-0
   Hayashi S, 2002, J MORPHOL, V254, P247, DOI 10.1002/jmor.10030
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higa K, 2005, CORNEA, V24, P206, DOI 10.1097/01.ico.0000133999.45262.83
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Imoto Y, 2003, JPN J OPHTHALMOL, V47, P444, DOI 10.1016/S0021-5155(03)00135-7
   Jacob JT, 2005, J BIOMED MATER RES B, V72B, P198, DOI 10.1002/jbm.b.30131
   Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110
   Keelan JA, 2000, PLACENTA, V21, P38, DOI 10.1053/plac.1999.0451
   KIGASAWA K, 1995, JPN J OPHTHALMOL, V39, P35
   KIM JC, 1995, CORNEA, V14, P473
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259
   MCCULLEY JP, 1970, ARCH OPHTHALMOL-CHIC, V84, P516
   McFetridge PS, 2004, ASAIO J, V50, P591, DOI 10.1097/01.MAT.0000144365.22025.9B
   McFetridge PS, 2004, J BIOMED MATER RES A, V70A, P224, DOI 10.1002/jbm.a.30060
   Merrett K, 2001, J BIOMAT SCI-POLYM E, V12, P647, DOI 10.1163/156856201316883467
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Witcher J, 2001, B WORLD HEALTH ORGAN, V79, P214
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405
NR 42
TC 54
Z9 55
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1839
EP 1847
DI 10.1016/j.actbio.2009.02.011
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900001
PM 19286434
DA 2018-10-20
ER

PT J
AU Ailenberg, M
   Sefton, MV
AF Ailenberg, Menachem
   Sefton, Michael V.
TI Effect of a matrix metalloproteinase sequestering biomaterial on Caco-2
   epithelial cell barrier integrity in vitro
SO ACTA BIOMATERIALIA
LA English
DT Article
DE MI Theramer (TM) biomaterial beads; Matrix metalloproteinases;
   Epithelial barrier; Actin cytoskeleton
ID INFLAMMATORY-BOWEL-DISEASE; CANCER-THERAPY; SERTOLI-CELLS; INHIBITOR;
   COLLAGENASE; GELATINASE; ACTIVATION; COLITIS
AB A novel matrix metalloproteinase sequestering biomaterial (MI Theramer (TM) beads) restored the epithelial barrier in a double chamber in vitro test system after disruption by Cytochalasin D and the secretion of the metalloproteinase MMP-2. MI beads are chemically modified (hydroxamated) poly(methacrylic acid-co-methyl methacrylate). We are exploring the utility of this material in inflammatory bowel disease (IBD), in which one manifestation is a compromised intestinal epithelial barrier. In a first step towards this goal we incubated MI beads (or polymethyl methacrylate control beads) with Caco-2 epithelial cells and mesenchymal 3T3 fibroblasts on two sides of a Matrigel (R)-coated filter and used Cytochalasin D (Cyto D) to activate MMP-2 (secreted by the 3T3 cells), disrupt actin filaments of Caco-2 cells and render the epithelial barrier leaky, as measured by dextran fluorescein equilibration. Addition of MI beads to Cyto D-treated cells inhibited active MMP-2 and prevented equilibration of dextran fluorescein. This study is the first step in showing a potential benefit to local (as opposed to systemic) inhibition of metalloproteinases in IBD or other intestinal inflammatory diseases. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ailenberg, Menachem; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
FU Natural Sciences and Engineering Research Council; Ontario Research and
   Development Challenge Fund (ORDCF)
FX We acknowledge the financial support of the Natural Sciences and
   Engineering Research Council and the Ontario Research and Development
   Challenge Fund (ORDCF), the latter through the Advanced Regenerative
   Tissue Engineering Centre at Sunnybrook Health Science Centre and the
   University of Toronto. Some of the ORDCF funding was matched to support
   provided by Rimon Therapeutics Limited among other Ontario based
   companies. MVS is Chief Scientific Officer of Rimon Therapeutics and has
   a financial interest in that company.
CR AILENBERG M, 1988, ENDOCRINOLOGY, V122, P2613, DOI 10.1210/endo-122-6-2613
   Ailenberg M, 1996, BIOCHEM J, V313, P879, DOI 10.1042/bj3130879
   AILENBERG M, 1989, ENDOCRINOLOGY, V124, P1399, DOI 10.1210/endo-124-3-1399
   AILENBERG M, 1991, BIOCHEM J, V279, P75, DOI 10.1042/bj2790075
   AILENBERG M, 1994, J AM SOC NEPHROL, V4, P1760
   AILENBERG M, 2002, BIOCHIM BIOPHYS ACTA, P1
   Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100
   Di Sebastiano P, 2001, DIGESTION, V63, P234, DOI 10.1159/000051895
   INFANTEDUARTE C, 2000, CELL MICROBIOL, V2, P11
   LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   Medina C, 2001, SCAND J GASTROENTERO, V36, P1314
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Naito Y, 2004, INFLAMM RES, V53, P462, DOI 10.1007/s00011-004-1281-1
   Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821
   Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043
   OVERALL CM, 1990, J BIOL CHEM, V265, P21141
   Pantoja LG, 2000, INFECT IMMUN, V68, P6478, DOI 10.1128/IAI.68.11.6478-6481.2000
   Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030
   Skarja GA, 2009, BIOMATERIALS, V30, P1890, DOI 10.1016/j.biomaterials.2008.12.040
   Sykes AP, 1999, ALIMENT PHARM THERAP, V13, P1535
   Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047
   Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005
   Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387
NR 24
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1898
EP 1904
DI 10.1016/j.actbio.2009.02.028
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900007
PM 19307161
DA 2018-10-20
ER

PT J
AU Chang, KY
   Cheng, LW
   Ho, GH
   Huang, YP
   Lee, YD
AF Chang, Kuo-Yung
   Cheng, Li-Wei
   Ho, Guan-Huei
   Huang, Yun-Peng
   Lee, Yu-Der
TI Fabrication and characterization of poly(gamma-glutamic
   acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for
   cartilage tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Articular cartilage; Poly(gamma-glutamic acid); Chondroitin sulfate;
   Poly(epsilon-caprolactone)
ID IN-VITRO; POLY(L-GLUTAMIC ACID); BIOLOGICAL GLUE; DRUG-DELIVERY;
   PORE-SIZE; DEGRADATION; CELL; POLYCAPROLACTONE; CHONDROCYTES; COMPOSITES
AB The development of blended biomacromolecule and polyester scaffolds can potentially be used in many tissue engineering applications. This study was to develop a poly(gamma-glutamic acid)-graft-chondroitin sulfate-blend-poly(epsilon-caprolactone) (gamma-PGA-g-CS/PCL) composite biomaterial as a scaffold for cartilage tissue engineering. Chondroitin sulfate (CS) was grafted to gamma-PGA, forming a gamma-PGA-g-CS copolymer with 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide (EDC) system. The gamma-PGA-g-CS copolymers were then blended with PCL to yield a porous gamma-PGA-g-CS/PCL scaffold by salt leaching. These blended scaffolds were characterized by (1)H NMR, ESCA, water-binding capacity, mechanical test, degradation rate and CS assay. The results showed that with gamma-PGA-g-CS as a component, the water-binding capacity and the degradation rate of the scaffolds would substantially increase. During a 4 week period of culture, the mechanical stability of gamma-PGA-g-CS/PCL scaffolds was raised gradually and chondrocytes were induced to function normally in vitro. Furthermore, a larger amount of secreted GAGS was present in the gamma-PGA-g-CS/PCL matrices than in the control (PCL), as revealed by Alcian blue staining of the histochemical sections. Thus, gamma-PGA-g-CS/PCL matrices exhibit excellent biodegradation and biocompatibility for chondrocytes and have potential in tissue engineering as temporary substitutes for articular cartilage regeneration. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chang, Kuo-Yung; Cheng, Li-Wei; Lee, Yu-Der] Natl Tsing Hua Univ 101, Dept Chem Engn, Hsinchu 300, Taiwan.
   [Ho, Guan-Huei; Huang, Yun-Peng] Vedan Enterprise Corp, Taichung 433, Taiwan.
RP Lee, YD (reprint author), Natl Tsing Hua Univ 101, Dept Chem Engn, Sect 2,Kuang Fu Rd, Hsinchu 300, Taiwan.
EM ydlee@che.nthu.edu.tw
FU Ministry of Economic Affairs of the Republic of China, Taiwan
   [95-EC-17-A-17-S1-0009]
FX The authors thank the Ministry of Economic Affairs of the Republic of
   China, Taiwan, for financially supporting this research under Contract
   No. 95-EC-17-A-17-S1-0009 of the Technology Development Program.
CR AYAD S, 1994, EXTRACELLULAR MATRIX
   Bei JZ, 1997, POLYM ADVAN TECHNOL, V8, P693, DOI 10.1002/(SICI)1099-1581(199711)8:11<693::AID-PAT702>3.0.CO;2-B
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   Chen C, 2005, EUR POLYM J, V41, P958, DOI 10.1016/j.eurpolymj.2004.12.002
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Humphreys TR, 1996, DERMATOL SURG, V22, P693, DOI 10.1111/j.1524-4725.1996.tb00619.x
   INGBER D, 1993, PHYS FORCES MAMMALIA, V2
   Ishizeki K, 2000, TISSUE CELL, V32, P207, DOI 10.1054/tice.2000.0106
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   Kavlock KD, 2007, ACTA BIOMATER, V3, P475, DOI 10.1016/j.actbio.2007.02.001
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kuberka M, 2002, INT J ARTIF ORGANS, V25, P67
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   Kunioka M, 1998, POLYM DEGRAD STABIL, V59, P33, DOI 10.1016/S0141-3910(97)00181-X
   Lazzeri L, 2006, J MATER SCI-MATER M, V17, P1211, DOI 10.1007/s10856-006-0594-8
   Lee CT, 2006, BIOMACROMOLECULES, V7, P2200, DOI 10.1021/bm060451x
   Lee CT, 2006, J MATER SCI-MATER M, V17, P1411, DOI 10.1007/s10856-006-0617-5
   Li C, 2000, CLIN CANCER RES, V6, P2829
   Li LH, 2004, J APPL POLYM SCI, V91, P274, DOI 10.1002/app.12954
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Liang HF, 2006, BIOMATERIALS, V27, P2051, DOI 10.1016/j.biomaterials.2005.10.027
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mucci A, 2000, CARBOHYD POLYM, V41, P37, DOI 10.1016/S0144-8617(99)00075-2
   Multani AS, 1997, ANTICANCER RES, V17, P4269
   Murakami S, 2006, BIOMACROMOLECULES, V7, P2122, DOI 10.1021/bm0600264
   Mustin C., 1993, APPL SURF SCI, V68, P147
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Olabarrieta I, 2001, POLYMER, V42, P4401, DOI 10.1016/S0032-3861(00)00680-7
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   Otani Y, 1998, BIOMATERIALS, V19, P2167, DOI 10.1016/S0142-9612(98)00123-9
   Otani Y, 1998, BIOMATERIALS, V19, P2091, DOI 10.1016/S0142-9612(98)00121-5
   Pena J, 2006, J BIOMED MATER RES A, V76A, P788, DOI 10.1002/jbm.a.30547
   PENKOVA K, 1996, J BIOCHEM BIOPH METH, V32, P33
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Wu CS, 2005, POLYMER, V46, P147, DOI 10.1016/j.polymer.2004.11.013
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Xiong XB, 2007, BIOMACROMOLECULES, V8, P874, DOI 10.1021/bm060967g
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 52
TC 58
Z9 68
U1 3
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1937
EP 1947
DI 10.1016/j.actbio.2009.02.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900012
PM 19282262
DA 2018-10-20
ER

PT J
AU Park, KM
   Lee, SY
   Joung, YK
   Na, JS
   Lee, MC
   Park, KD
AF Park, Kyung Min
   Lee, Sang Young
   Joung, Yoon Ki
   Na, Jae Sik
   Lee, Myung Chul
   Park, Ki Dong
TI Thermosensitive chitosan-Pluronic hydrogel as an injectable cell
   delivery carrier for cartilage regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue engineering; Chitosan; Injectable hydrogel; Thermosensitive;
   Cartilage regeneration
ID TISSUE-ENGINEERED CARTILAGE; IN-VITRO; ARTICULAR-CARTILAGE;
   EXTRACELLULAR-MATRIX; CHONDROCYTE; BIOMATERIALS; PROLIFERATION; GELS;
   TRANSPLANTATION; PHENOTYPE
AB Injectable hydrogels have been studied for potential applications for articular cartilage regeneration. In this study, a thermosensitive chitosan-Pluronic (CP) hydrogel was designed as an injectable cell delivery carrier for cartilage regeneration. The CP conjugate was synthesized by grafting Pluronic onto chitosan using EDC/NHS chemistry. The sol-gel phase transition and mechanical properties of the CP hydrogel were examined by rheological experiments. The CP solution underwent a sol-gel transition around 25 degrees C at which the storage modulus (G) approaches 10(4) Pa, highlighting the potential of this material as an injectable scaffold for cartilage regeneration. The CP hydrogel was formed rapidly by increasing the temperature. The morphology of the dried CP hydrogel was observed by scanning electron microscopy. In vitro cell culture was performed using bovine chondrocytes. The proliferation of bovine chondrocytes and the amount of synthesized glycosaminoglycan increased for 28 days. These results suggested that the CP hydrogel has potential as an injectable cell delivery carrier for cartilage regeneration and could serve as a new biomaterial for tissue engineering. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Park, Kyung Min; Joung, Yoon Ki; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Lee, Sang Young; Lee, Myung Chul] Seoul Natl Univ, Dept Orthoped Surg, Coll Med, Seoul 110744, South Korea.
   [Na, Jae Sik] Kwangwoon Univ, Dept Chem Engn, Seoul 139701, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, 5 Wonchun Dong, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
RI Lee, Myung Chul/J-2779-2012
OI joung, yoon ki/0000-0001-8661-481X
FU Ministry of Health and Welfare, Republic of Korea
   [02-PJ3-PG6-EVII-0002]; Ministry of Science and Technology, Republic of
   Korea [13020214]
FX This study was supported by a grant from the Korea Health 21 R&D
   Project, Ministry of Health and Welfare, Republic of Korea
   (02-PJ3-PG6-EVII-0002) and the Nano-Biotechnology Project (Regenomics),
   Ministry of Science and Technology, Republic of Korea (13020214).
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Barnewitz D, 2006, BIOMATERIALS, V27, P2882, DOI 10.1016/j.biomaterials.2006.01.008
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P124, DOI 10.1016/j.msec.2005.08.042
   Chung HJ, 2005, MACROMOL SYMP, V224, P275, DOI 10.1002/masy.200550624
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   DePALMA ANTHONY F., 1966, CLIN ORTHOP RELATED RES, V48, P229
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   Gerard C, 2005, J MATER SCI-MATER M, V16, P541, DOI 10.1007/s10856-005-0530-3
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Hong PD, 1998, POLYMER, V39, P5809, DOI 10.1016/S0032-3861(98)00031-7
   Hong Y, 2007, ACTA BIOMATER, V3, P23, DOI 10.1016/j.actbio.2006.06.007
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Kim SH, 2000, J BIOMED MATER RES, V53, P258, DOI 10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Martinez-Ruvalcaba A, 2007, CARBOHYD POLYM, V67, P586, DOI 10.1016/j.carbpol.2006.06.033
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P165, DOI 10.3109/17453679608994664
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Nisbet DR, 2006, BIOPHYS CHEM, V121, P14, DOI 10.1016/j.bpc.2005.12.005
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park KM, 2008, COLLOID SURFACE B, V63, P1, DOI 10.1016/j.colsurfb.2007.10.024
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Ting V, 1998, ANN PLAS SURG, V40, P413, DOI 10.1097/00000637-199804000-00016
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Wu H, 2008, ACTA BIOMATER, V4, P76, DOI 10.1016/j.actbio.2007.06.010
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
NR 40
TC 178
Z9 188
U1 16
U2 124
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1956
EP 1965
DI 10.1016/j.actbio.2009.01.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900014
PM 19261553
DA 2018-10-20
ER

PT J
AU Serrano, MC
   Pagani, R
   Vallet-Regi, M
   Pena, J
   Comas, JV
   Portoles, MT
AF Serrano, Maria-Concepcion
   Pagani, Raffaella
   Vallet-Regi, Maria
   Pena, Juan
   Comas, Juan-Valentin
   Portoles, Maria-Teresa
TI Nitric oxide production by endothelial cells derived from blood
   progenitors cultured on NaOH-treated polycaprolactone films: A
   biofunctionality study
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Endothelial progenitor cell; Poly(epsilon-caprolactone); Nitric oxide;
   Reactive oxygen species; Intracellular calcium
ID POLY(EPSILON-CAPROLACTONE) FILMS; OXIDATIVE STRESS; IN-VITRO;
   PLATELET-ADHESION; IDENTIFICATION; DIFFERENTIATION; REGENERATION;
   FIBROBLASTS; MEMBRANE; SCAFFOLD
AB Poly(epsilon-caprolactone) (PCL) is a biodegradable polyester whose biocompatibility has been widely demonstrated both in vivo and in vitro. In the last few years, our group has confirmed that NaOH-treated PCL films can serve as a suitable biomaterial for vascular tissue engineering by supporting the culture of primary vascular cells and, more recently, endothelial-like EC2 cells derived from endothelial progenitor cells (EPC). In the present study, NO production in basal conditions and after stimulation with different agents has been evaluated and related to the reactive oxygen species (ROS) content and the intracellular calcium levels on EC2 cells cultured on NaOH-treated PCL films. The results obtained demonstrate that EC2 seeded on NaOH-treated PCL films enhance the basal NO levels and show a faster, more intense response to physiological stimuli such as VEGF, bradykinin and thrombin than vein endothelial cells (ECv). This result could be indicative of a better capacity of EC2 cells to maintain their endothelial functionality when seeded on polymers. On the other hand, the culture of both EC2 and ECv cells on NaOH-treated PCL films induces a significant increase in both ROS content and intracellular calcium that is balanced out through the stimulation of NO production in these cells. In conclusion, these results demonstrate the ability of NaOH-treated PCL films to support endothelial cell production of nitric oxide and reinforce the idea of considering the endothelial-like EC2 cells derived from blood progenitors as an adequate source of endothelial cells to functionalize vascular grafts. Furthermore, NaOH-treated PCL films could be considered as a promising cellular NO production-inducing biomaterial for vascular tissue engineering applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Serrano, Maria-Concepcion; Pagani, Raffaella; Portoles, Maria-Teresa] Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, E-28040 Madrid, Spain.
   [Vallet-Regi, Maria; Pena, Juan] Univ Complutense, Dept Inorgan & Bioinorgan Chem, Fac Pharm, E-28040 Madrid, Spain.
   [Vallet-Regi, Maria; Pena, Juan] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain.
   [Comas, Juan-Valentin] Hosp Univ 12 Octubre, Pediat Heart Inst, Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, Ciudad Univ S-N, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; pena, juan/E-5913-2018; Serrano, Maria
   Concepcion/D-7442-2014; Portoles, Maria Teresa/U-1678-2017
OI Vallet-Regi, Maria/0000-0002-6104-4889; pena, juan/0000-0002-5992-908X;
   Serrano, Maria Concepcion/0000-0002-5010-644X; Portoles, Maria
   Teresa/0000-0002-9681-0184
FU Fundacion MMA; Comunidad de Madrid [S-0505/MAT/0324]
FX This study was supported by research grants from Fundacion MMA
   (2004-033) and from Comunidad de Madrid (S-0505/MAT/0324). The authors
   wish to express their thanks to Dr. G.A. Ameer for scientific assistance
   and the staff from the Electronic Microscopy and Flow Cytometry Center
   (CAI, UCM, Spain) and the Flow Cytometry Service (CNIC, Carlos III
   Institute, Spain) for the assistance with the confocal microscopy and
   flow cytometry studies.
CR Allen J, 2008, TISSUE ENG PT A, V14, P183, DOI 10.1089/ten.a.2007.0265
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Berges A, 2003, ACTA CARDIOL, V58, P119, DOI 10.2143/AC.58.2.2005264
   Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje
   Ciccolini F, 2001, MOL CELL NEUROSCI, V17, P895, DOI 10.1006/mcne.2001.0980
   DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3
   Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u
   FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193
   Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X
   Mo X, 2006, INT J ARTIF ORGANS, V29, P790
   MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5
   Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2
   Ng KW, 2007, J BIOMAT SCI-POLYM E, V18, P925, DOI 10.1163/156856207781367693
   Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   RUBANYI GM, 1988, ANN NY ACAD SCI, V522, P226
   Rubbo H, 1995, Biochem Soc Symp, V61, P33
   Sanchez FA, 2006, AM J PHYSIOL-HEART C, V291, pH1058, DOI 10.1152/ajpheart.00370.2006
   Serrano MC, 2006, BIOMATERIALS, V27, P4706, DOI 10.1016/j.biomaterials.2006.05.007
   Serrano MC, 2008, J BIOMED MATER RES A, V87A, P964, DOI 10.1002/jbm.a.31728
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   Serrano MC, 2005, MACROMOL BIOSCI, V5, P415, DOI 10.1002/mabi.200400214
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI [10.1007/s10787-007-0013-x, 10.1007/s10787-007-0013-2]
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Udall J N, 1987, Adv Exp Med Biol, V216A, P821
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Wu YD, 2007, J BIOMED MATER RES A, V81A, P956, DOI 10.1002/jbm.a.31105
   WYATT AW, 2004, BIOCH SOC S, V71, P143
   Yamamoto H, 2008, ANN HEMATOL, V87, P87, DOI 10.1007/s00277-007-0381-8
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yamashita JK, 2007, TRENDS CARDIOVAS MED, V17, P59, DOI 10.1016/j.tcm.2007.01.001
NR 37
TC 20
Z9 20
U1 3
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 2045
EP 2053
DI 10.1016/j.actbio.2009.02.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900022
PM 19332384
DA 2018-10-20
ER

PT J
AU Saji, VS
   Choe, HC
   Brantley, WA
AF Saji, Viswanathan S.
   Choe, Han Cheol
   Brantley, William A.
TI An electrochemical study on self-ordered nanoporous and nanotubular
   oxide on Ti-35Nb-5Ta-7Zr alloy for biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanotubes; Anodization; Ti-35Nb-5Ta-7Zr; Biomaterial; Corrosion
ID ANODIC-OXIDATION; TIO2 NANOTUBES; TITANIUM-ALLOYS; TA6V ALLOY;
   ELECTROLYTES; ANODIZATION; ARRAYS; LAYERS; ORGANIZATION; GROWTH
AB Highly ordered nanoporous and nanotubular oxide layers were developed on low-rigidity beta Ti-35Nb-5Ta-7Zr alloy by controlled DC anodization in electrolyte containing 1 M H(3)PO(4) and 0.5 wt.% NaF at room temperature. The as-formed and crystallized nanotubes were characterized by electron microscopy, energy-dispersive X-ray spectrometry and X-ray diffraction. The electrochemical passivation behavior of the nanoporous and nanotubular oxide surfaces were investigated in Ringer's solution at 37 +/- 1 degrees C employing a potentiodynamic polarization technique and impedance spectroscopy. The diameters of the as-formed nanotubes were in the range of 30-80 nm. The nanotubular surface exhibited passivation behavior similar to that of the nanoporous surface. However, the corrosion current density was considerably higher for the nanotubular alloy. The surface after nanotube formation seemed to favor an immediate and effective passivation. Electrochemical impedance spectra were simulated by equivalent circuits and the results were discussed with regard to biomedical applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Saji, Viswanathan S.; Choe, Han Cheol] Chosun Univ, Dept Dent Mat, Sch Dent, Kwangju 501759, South Korea.
   [Saji, Viswanathan S.; Choe, Han Cheol] Chosun Univ, Res Ctr Nanointerface Activat Biomat, Sch Dent, Kwangju 501759, South Korea.
   [Brantley, William A.] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA.
RP Choe, HC (reprint author), Chosun Univ, Dept Dent Mat, Sch Dent, Kwangju 501759, South Korea.
EM hcchoe@chosun.ac.kr
RI Viswanathan S., Saji/H-8533-2015
OI Viswanathan S., Saji/0000-0003-1724-0011
CR *ASTM, 2000, R58350 UNS ASTM
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   CHOE HC, 2008, P NSTI NAN BOST, V1, P454
   Feng XJ, 2007, ELECTROCHEM COMMUN, V9, P2403, DOI 10.1016/j.elecom.2007.07.007
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Ivasishin OM, 2005, MAT SCI ENG A-STRUCT, V405, P296, DOI 10.1016/j.msea.2005.06.027
   Jakubowicz J, 2008, ELECTROCHEM COMMUN, V10, P735, DOI 10.1016/j.elecom.2008.02.027
   Kubota S, 2004, J MATER SCI-MATER M, V15, P1031, DOI 10.1023/B:JMSM.0000042689.78768.77
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Macak JM, 2007, ELECTROCHEM COMMUN, V9, P1783, DOI 10.1016/j.elecom.2007.04.002
   Macak JM, 2005, J BIOMED MATER RES A, V75A, P928, DOI 10.1002/jbm.a.30501
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Munoz AG, 2007, J SOLID STATE ELECTR, V11, P1077, DOI 10.1007/s10008-006-0241-9
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Okazaki Y, 2001, CURR OPIN SOLID ST M, V5, P45, DOI 10.1016/S1359-0286(00)00025-5
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Richert L, 2008, ADV MATER, V20, P1488, DOI 10.1002/adma.200701428
   Saji VS, 2007, CURR SCI INDIA, V92, P51
   Sieber I, 2005, ELECTROCHEM COMMUN, V7, P97, DOI 10.1016/j.elecom.2004.11.012
   Sieber IV, 2005, J ELECTROCHEM SOC, V152, pC639, DOI 10.1149/1.1997153
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Tsuchiya H, 2004, ELECTROCHEM COMMUN, V6, P1131, DOI 10.1016/j.elecom.2004.09.003
   Tsuchiya H, 2006, ELECTROCHIM ACTA, V52, P94, DOI 10.1016/j.electacta.2006.03.087
   Varghese OK, 2003, SENSOR ACTUAT B-CHEM, V93, P338, DOI 10.1016/S0925-4005(03)00222-3
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Yasuda K, 2007, J ELECTROCHEM SOC, V154, pC472, DOI 10.1149/1.2749091
   Yasuda K, 2007, ADV MATER, V19, P1757, DOI 10.1002/adma.200601912
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 34
TC 66
Z9 66
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 2303
EP 2310
DI 10.1016/j.actbio.2009.02.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900049
PM 19289307
DA 2018-10-20
ER

PT J
AU Higgins, DM
   Basaraba, RJ
   Hohnbaum, AC
   Lee, EJ
   Grainger, DW
   Gonzalez-Juarrero, M
AF Higgins, David M.
   Basaraba, Randall J.
   Hohnbaum, April C.
   Lee, Eric J.
   Grainger, David W.
   Gonzalez-Juarrero, Mercedes
TI Localized Immunosuppressive Environment in the Foreign Body Response to
   Implanted Biomaterials
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID GROWTH-FACTOR-BETA; GIANT-CELL FORMATION; IN-VIVO; ADHERENT MACROPHAGES;
   SURFACE-CHEMISTRY; DENDRITIC CELLS; CYTOKINE; TISSUE; ACTIVATION;
   EXPRESSION
AB The implantation of synthetic biomaterials initiates the foreign body response (FBR), which is characterized by macrophage infiltration, foreign body giant cell formation, and fibrotic encapsulation of the implant. The FBR is orchestrated by a complex network of immune modulators, including diverse cell types, soluble mediators, and unique cell surface interactions. The specific tissue locations, expression patterns, and spatial distribution of these immune modulators around the site of implantation are not clear. This study describes a model for studying the FBR in vivo and specifically evaluates the spatial relationship of immune modulators. We modified a biomaterials implantation in vivo model that allowed for cross-sectional in situ analysis of the FBR. Immunohistochemical techniques were used to determine the localization of soluble mediators, ie, interleukin (11)4, IL-13, IL-10, IL-6, transforming growth factor-beta, tumor necrosis factor-alpha, interferon-gamma, and MCP-1; specific cell types, ie, macrophages, neutrophils, fibroblasts, and lymphocytes; and cell surface markers, ie, F4/80, CD11b, CD11c, and Ly-6C, at early, middle, and late stages of the FBR in subcutaneous implant sites. The cytokines IL-4, IL-13, IL-10, and transforming growth factor-beta were localized to implant-adherent cells that included macrophages and foreign body giant cells. A better understanding of the FBR in vivo will allow the development of novel strategies to enhance biomaterial implant design to achieve better performance and safety of biomedical devices at the site of implant. (Am J Pathol 2009, 175:161-170; DOI: 10.2353/ajpath.2009.080962)
C1 [Higgins, David M.; Basaraba, Randall J.; Hohnbaum, April C.; Lee, Eric J.; Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Grainger, David W.] Univ Utah, Hlth Sci Ctr, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT USA.
RP Gonzalez-Juarrero, M (reprint author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM malba@mail.colostate.edu
FU National Institutes of Health [R01 EB000894]
FX Supported by National Institutes of Health grant R01 EB000894.
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   AlSaffar N, 1997, J MATER SCI-MATER M, V8, P641, DOI 10.1023/A:1018575504518
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 2000, BIOMATERIALS FACTORS, P89
   ANDERSON JM, 2007, SEMIN IMMUNOL, P86
   ATHANASOU NA, 1990, J CLIN PATHOL, V43, P997, DOI 10.1136/jcp.43.12.997
   BORDER WA, 1994, NEW ENGL J MED, V331, P1286
   Brandt E, 2000, J LEUKOCYTE BIOL, V68, P125
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Calvo P, 1997, BIOMATERIALS, V18, P1305, DOI 10.1016/S0142-9612(97)00061-6
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DOUSSIS IA, 1992, J CLIN PATHOL, V45, P398, DOI 10.1136/jcp.45.5.398
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   GORDON S, 1974, J EXP MED, V139, P1228, DOI 10.1084/jem.139.5.1228
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Higgins DM, 2008, J IMMUNOL, V180, P4892, DOI 10.4049/jimmunol.180.7.4892
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407
   Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770
   Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806
   Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231
   Konittinen YT, 2006, INT J PERIODONT REST, V26, P135
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113
   Li AG, 2007, J BIOMED MATER RES A, V82A, P498, DOI 10.1002/jbm.a.31168
   Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737
   Lim SM, 2008, J BIOMAT SCI-POLYM E, V19, P453, DOI 10.1163/156856208783719482
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P869, DOI 10.1001/jama.283.7.869
   MIRESLUIS AR, 1998, INTERLEUKIN 4 CYTOKI, P51
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Ochoa MT, 2008, J INVEST DERMATOL, V128, P2225, DOI 10.1038/jid.2008.56
   Pan H, 2008, BIOMATERIALS, V29, P1583, DOI 10.1016/j.biomaterials.2007.12.005
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rollins BJ, 1997, BLOOD, V90, P909
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Scheidbach H, 2004, SURG ENDOSC, V18, P211, DOI 10.1007/s00464-003-8113-1
   Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009
   Ward WK, 2008, J BIOMAT SCI-POLYM E, V19, P1065, DOI 10.1163/156856208784909408
   Woerly G, 2002, J LEUKOCYTE BIOL, V72, P769
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yuan HT, 2003, AM J PATHOL, V163, P2289, DOI 10.1016/S0002-9440(10)63586-9
NR 54
TC 73
Z9 75
U1 2
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JUL
PY 2009
VL 175
IS 1
BP 161
EP 170
DI 10.2353/ajpath.2009.080962
PG 10
WC Pathology
SC Pathology
GA 464MG
UT WOS:000267508600015
PM 19528351
OA Green Published
DA 2018-10-20
ER

PT J
AU Kim, K
   Dean, D
   Mikos, AG
   Fisher, JP
AF Kim, Kyobum
   Dean, David
   Mikos, Antonios G.
   Fisher, John P.
TI Effect of Initial Cell Seeding Density on Early Osteogenic Signal
   Expression of Rat Bone Marrow Stromal Cells Cultured on Cross-Linked
   Poly(propylene fumarate) Disks
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TITANIUM FIBER MESH; IN-VITRO; GROWTH-FACTOR;
   OSTEOBLASTIC DIFFERENTIATION; MORPHOGENETIC PROTEINS; SCAFFOLD
   FABRICATION; EXTRACELLULAR-MATRIX; TISSUE FORMATION; BMP-2
AB The intercellular signaling mechanisms among a transplanted cell population are largely determined by the cell population itself as well as the Surrounding environment. Changes in cell-to-cell paracrine signaling distance can be obtained by altering cell density, and signal expression of growth factors can be enhanced by auto/paracrine signal transduction. To examine these relationships, we investigated the effect of cell seeding density on viability, proliferation, differentiation, and the endogenous osteogenic signal expression among rat bone marrow stromal cells (BMSCs) cultured on a 2D disk. Rat BMSCs were isolated from rats and then Cultured for 8 days on biodegradable poly(propylene fumarate) disks with three different seeding densities (0.06, 0.15, and 0.30 million cells/disk). At days 1, 4, and 8, viability by live/dead fluorescent staining, DNA amount, osteogenic differentiation by alkaline phosphatase and osteocalcin mRNA expression, calcium deposition, and osteogenic growth factor mRNA expression were assayed. Osteogenic signal expression was evaluated using quantitative reverse transcriptase-polymerase chain reaction, and signals of interest include bone morphogenetic protein-2, transforming growth factor-beta(1), fibroblast growth factor-2, and platelet-derived growth factor-A. The results from this study demonstrate that rat BMSCs were viable over 8 days without being affected by cell density and that both cell proliferation rate and early osteogenic differentiation were stimulated by lower cell seeding density. Most importantly, this study has demonstrated for the first time that the temporal gene expression profiles of endogenous growth factors can be controlled by altering the initial cell seeding density on poly(propylene fumarate) disks. Therefore, our results suggest that changes in the paracrine signal distance by altering cell seeding density may be a useful strategy to optimize the cell-biomaterial construct microenvironments to enhance the osteogenic signal expression.
C1 [Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Kim, Kyobum] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Dean, David] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA.
   [Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Kim, Kyobum/D-3485-2011; Dean, David/F-9605-2017; Fisher,
   John/F-8078-2012
OI Dean, David/0000-0002-1217-3764; 
FU National Institutes of Health [R01-DE013740]; National Science
   Foundation [CBET 0448684]
FX This work was supported by the National Institutes of Health
   (R01-DE013740) and the National Science Foundation (CBET 0448684):
CR Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Banoub RW, 1996, CANCER LETT, V108, P35, DOI 10.1016/S0304-3835(96)04367-4
   Bitar M, 2008, BIOMACROMOLECULES, V9, P129, DOI 10.1021/bm701112w
   CANALIS E, 1989, J CELL PHYSIOL, V140, P530, DOI 10.1002/jcp.1041400319
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Goldstein AS, 2001, TISSUE ENG, V7, P817, DOI 10.1089/107632701753337753
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Horch RA, 2004, BIOMACROMOLECULES, V5, P1990, DOI 10.1021/bm049768s
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kruyt M, 2008, TISSUE ENG PT A, V14, P1283, DOI 10.1089/ten.tea.2008.1505
   Lee JW, 2007, MICROELECTRON ENG, V84, P1702, DOI 10.1016/j.mee.2007.01.267
   Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lieb E, 2004, TISSUE ENG, V10, P1414, DOI 10.1089/1076327042500201
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shanti RM, 2007, J ORAL MAXIL SURG, V65, P1640, DOI 10.1016/j.joms.2007.04.008
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Toh YC, 2005, BIOMATERIALS, V26, P4149, DOI 10.1016/j.biomaterials.2004.10.033
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   van der Zande M, 2008, J BIOMED MATER RES A, V86A, P788, DOI 10.1002/jbm.a.31645
   Vehof JWM, 2001, TISSUE ENG, V7, P373, DOI 10.1089/10763270152436436
   Zhou YF, 2006, J BIOMED MATER RES A, V78A, P183, DOI 10.1002/jbm.a.30685
NR 45
TC 85
Z9 89
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2009
VL 10
IS 7
BP 1810
EP 1817
DI 10.1021/bm900240k
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 472NR
UT WOS:000268139300019
PM 19469498
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tang, H
   Xu, ZF
   Qin, X
   Wu, B
   Wu, LH
   Zhao, XW
   Li, YL
AF Tang, Hua
   Xu, Zhifei
   Qin, Xiong
   Wu, Bin
   Wu, Lihui
   Zhao, XueWei
   Li, Yulin
TI Chest wall reconstruction in a canine model using polydioxanone mesh,
   demineralized bone matrix and bone marrow stromal cells
SO BIOMATERIALS
LA English
DT Article
DE Chest wall; Tissue engineering; PDO; DBM; BMSCs; Canine model
ID BETA-TRICALCIUM PHOSPHATE; POLY-L-LACTIDE; TISSUE-RESPONSE; IN-VITRO;
   REPAIR; SCAFFOLD; GRAFT; FLAP; RESECTION; STRENGTH
AB Extensive chest wall defect reconstruction remains a challenging problem for surgeons. In the past several years, little progress has been made in this area. in this study, a biodegradable polydioxanone (PDO) mesh and demineralized bone matrix (DBM) seeded with osteogenically induced bone marrow stromal cells (BMSCs) were used to reconstruct a 6 cm x 5.5 cm chest wall defect. Four experimental groups were evaluated (n=6 per group): polydioxanone (PDO) mesh/DBMs/BMSCs group, polydioxanone (PDO) mesh/DBMs group, polydioxanone (PDO) mesh group, and a blank group (no materials) in a canine model. All the animals survived except those in the blank group. In all groups receiving biomaterial implants, the polydioxanone (PDO) mesh completely degraded at 24 weeks and was replaced by fibrous tissue with thickness close to that of the normal intercostal tissue (P > 0.05). In the polydioxanone (PDO) mesh/DBMs/BMSCs group, new bone formation and bone-union were observed by radiographic and histological examination. More importantly, the reconstructed rib could maintain its original radian and achieve satisfactory biomechanics close to normal ribs in terms of bending stress (P > 0.05). However, in the other two groups, fibrous tissue was observed in the defect and junctions, and the reconstructed ribs were easily distorted under an outer force. Based on these results, a surgical approach utilizing biodegradable polydioxanone (PDO) mesh in combination with DBMs and BMSCs could repair the chest wall defect not only in function but also in structure. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Tang, Hua; Xu, Zhifei; Qin, Xiong; Wu, Bin; Wu, Lihui; Zhao, XueWei] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, Shanghai 200003, Peoples R China.
   [Li, Yulin] Donghua Univ, Shanghai, Peoples R China.
RP Xu, ZF (reprint author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, 415 Fengyang Rd, Shanghai 200003, Peoples R China.
EM xu_zhi_fei@yahoo.com.cn
FU National Science foundation of China (NSFC) [30571847]; Shanghai Science
   and Technology Development Foundation [08ZRI404900]
FX This work was funded by National Science foundation of China (NSFC)
   (30571847) and Shanghai Science and Technology Development Foundation
   (08ZRI404900).
CR Akhavani MA, 2007, PLAST RECONSTR SURG, V119, P761, DOI 10.1097/01.prs.0000254925.42803.32
   Arnold PG, 1996, PLAST RECONSTR SURG, V98, P804, DOI 10.1097/00006534-199610000-00008
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Deschamps C, 1999, J THORAC CARDIOV SUR, V117, P588, DOI 10.1016/S0022-5223(99)70339-9
   Garreta E, 2007, BIOMOL ENG, V24, P75, DOI 10.1016/j.bioeng.2006.05.017
   Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018
   HIDALGO DA, 1993, ANN PLAS SURG, V30, P375, DOI 10.1097/00000637-199304000-00017
   Horio H, 2005, SURG TODAY, V35, P73, DOI 10.1007/s00595-004-2868-4
   Hoshino M, 2007, PLAST RECONSTR SURG, V119, P1431, DOI 10.1097/01.prs.0000256319.89619.c8
   Isik AF, 2007, ACTA CHIR BELG, V107, P313, DOI 10.1080/00015458.2007.11680063
   Jonsson P, 1998, Sarcoma, V2, P143, DOI 10.1080/13577149877894
   Klinge U, 2001, BIOMATERIALS, V22, P1415, DOI 10.1016/S0142-9612(00)00299-4
   Kontio R, 2005, INT J ORAL MAX SURG, V34, P766, DOI 10.1016/j.ijom.2005.04.027
   KROLL SS, 1993, ANN PLAS SURG, V31, P303, DOI 10.1097/00000637-199310000-00003
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Lin H, 2008, BIOMATERIALS, V29, P1189, DOI 10.1016/j.biomaterials.2007.11.032
   Lindsey RW, 2006, J ORTHOP RES, V24, P1438, DOI 10.1002/jor.20154
   LINDSEY RW, 1993, CHN ORTHOP RELAT RES, V291, P303
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mansour KA, 2002, ANN THORAC SURG, V73, P1720, DOI 10.1016/S0003-4975(02)03527-0
   MATSUI T, 1994, J THORAC CARDIOV SUR, V108, P162
   Matsusaki M, 2007, BIOMATERIALS, V28, P2729, DOI 10.1016/j.biomaterials.2007.02.015
   MCCORMACK PM, 1989, SURG CLIN N AM, V69, P965
   MURAGLIA A, 1998, BONE, V22, P131
   Novoa Nuria, 2005, Interact Cardiovasc Thorac Surg, V4, P250, DOI 10.1510/icvts.2004.103432
   Ohno K, 1998, ANN THORAC SURG, V66, P1805, DOI 10.1016/S0003-4975(98)00922-9
   PUMA F, 1992, ANN THORAC SURG, V53, P408, DOI 10.1016/0003-4975(92)90259-7
   Qin X, 2008, EUR J CARDIO-THORAC, V34, P870, DOI 10.1016/j.ejcts.2008.06.038
   Rathinam S, 2004, EUR J CARDIO-THORAC, V26, P197, DOI 10.1016/j.ejcts.2004.03.022
   RUDOLPHY VJ, 1991, ANN THORAC SURG, V52, P821, DOI 10.1016/0003-4975(91)91218-K
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   van Geel AN, 1998, EUR J SURG, V164, P305
   Weyant MJ, 2006, ANN THORAC SURG, V81, P279, DOI 10.1016/j.athoracsur.2005.07.001
   WHITAKER LA, 1979, PLAST RECONSTR SURG, V64, P198, DOI 10.1097/00006534-197908000-00011
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
NR 41
TC 14
Z9 17
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 19
BP 3224
EP 3233
DI 10.1016/j.biomaterials.2009.02.007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 454GS
UT WOS:000266671000002
PM 19233465
DA 2018-10-20
ER

PT J
AU Grellier, M
   Granja, PL
   Fricain, JC
   Bidarra, SJ
   Renard, M
   Bareille, R
   Bourget, C
   Amedee, J
   Barbosa, MA
AF Grellier, Maritie
   Granja, Pedro L.
   Fricain, Jean-Christophe
   Bidarra, Silvia J.
   Renard, Martine
   Bareille, Reine
   Bourget, Chantal
   Amedee, Joelle
   Barbosa, Mario A.
TI The effect of the co-immobilization of human osteoprogenitors and
   endothelial cells within alginate microspheres on mineralization in a
   bone defect
SO BIOMATERIALS
LA English
DT Article
DE Osteoprogenitors; Endothelial cells; Co-culture; Alginate; Cell
   immobilization; Vascular endothelial growth factor (VEGF)
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTORS; STROMAL CELLS; IN-VITRO;
   DIFFERENTIATION; ANGIOGENESIS; SCAFFOLDS; HYDROGELS; VEGF; BIOMATERIALS
AB Bone regeneration seems to be dependant on cell communication between osteogenic and endothelial cells arising from surrounding blood vessels. This study aims to determine whether endothelial cells can regulate the osteogenic potential of osteoprogenitor cells in vitro and in vivo, in a long bone defect, when co-immobilized in alginate microspheres. Alginate is a natural polymer widely used as a biomaterial for cell encapsulation. Human osteoprogenitors (HOP) from bone marrow mesenchymal stem cells were immobilized alone or together with human umbilical vein endothelial cells (HUVEC) inside irradiated, oxidized and RGD-grafted alginate microspheres. Immobilized cells were cultured in dynamic conditions and cell metabolic activity increased during three weeks. The gene expression of alkaline phosphatase and osteocalcin, both specific markers of the osteoblastic phenotype, and mineralization deposits were upregulated in co-immobilized HOPs and HUVECs, comparing to the immobilization of monocultures. VEGF secretion was also increased when HOPs were co-immobilized with HUVECs. Microspheres containing co-cultures were further implanted in a bone defect and bone formation was analysed by mu CT and histology at 3 and 6 weeks post-implantation. Mineralization was observed inside and around the implanted microspheres containing the immobilized cells. However, when HOPs were co-immobilized with HUVECs, mineralization significantly increased. These findings demonstrate that co-immobilization of osteogenic and endothelial cells within RGD-grafted alginate microspheres provides a promising strategy for bone tissue engineering. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Grellier, Maritie; Fricain, Jean-Christophe; Bareille, Reine; Bourget, Chantal; Amedee, Joelle] INSERM, U577, Bordeaux, France.
   [Grellier, Maritie; Fricain, Jean-Christophe; Bareille, Reine; Bourget, Chantal; Amedee, Joelle] Univ Bordeaux 2, UMR S577, F-33076 Bordeaux, France.
   [Grellier, Maritie; Granja, Pedro L.; Bidarra, Silvia J.; Barbosa, Mario A.] INEB, Div Biomat, P-4150180 Oporto, Portugal.
   [Renard, Martine] Hop Xavier Arnozan, PTIB, Ctr Invest Clin Innovat Technol Biomat, INSERM,CHU Bordeaux,CIT802 Biomat, F-33600 Pessac, France.
   [Barbosa, Mario A.] Univ Porto, Fac Engn, Dept Mat & Met Engn, P-4100 Oporto, Portugal.
RP Grellier, M (reprint author), INSERM, U577, Bordeaux, France.
EM maritie.grellier@inserm.fr
RI Barbosa, Mario/F-5964-2011; Bidarra, Silvia/J-8421-2013; VILAMITJANA
   AMEDEE, Joelle/F-3369-2013; Granja, Pedro/B-1685-2008
OI Barbosa, Mario/0000-0003-3568-7482; Granja, Pedro/0000-0003-2761-4929;
   Bidarra, Silvia/0000-0002-1515-9597
FU French Ministry "de l'Enseignement Superieur et de la Recherche";
   Portuguese Foundation for Science and Technology
   [POCI/SAU-BMA/55556/2004]
FX This work was supported by grants from INSERM ANR PNano, "Agence de
   Biomedecine", the French Ministry "de l'Enseignement Superieur et de la
   Recherche" and from the Portuguese Foundation for Science and Technology
   (FCT; POCI/SAU-BMA/55556/2004). The authors thank Isabel Carvalho and
   Meriem Lamghari for their technical help and David Mooney for helpful
   discussions.
CR Abbah SA, 2006, BIOCHEM BIOPH RES CO, V347, P185, DOI 10.1016/j.bbrc.2006.06.072
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barrias CC, 2005, J BIOMED MATER RES A, V74A, P545, DOI 10.1002/jbm.a.30348
   Bjerre L, 2008, BIOMATERIALS, V29, P2616, DOI 10.1016/j.biomaterials.2008.03.003
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Cheng C, 2007, BIOCHEM BIOPH RES CO, V358, P342, DOI 10.1016/j.bbrc.2007.04.147
   CLARKIN CE, 2007, J CELL PHYSL
   Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Leal D, 2008, CARBOHYD RES, V343, P308, DOI 10.1016/j.carres.2007.10.016
   LU HH, 2008, J BIOMED MAT RES A
   Lubiatowski P, 2006, TRANSPLANT P, V38, P320, DOI 10.1016/j.transproceed.2005.12.012
   Mann V., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P408
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   STIEHLER M, 2008, J BIOMED MAT RES A
   Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
NR 34
TC 124
Z9 129
U1 2
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 19
BP 3271
EP 3278
DI 10.1016/j.biomaterials.2009.02.033
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 454GS
UT WOS:000266671000007
PM 19299013
DA 2018-10-20
ER

PT J
AU Chen, YC
   Lee, DC
   Hsiao, CY
   Chung, YF
   Chen, HC
   Thomas, JP
   Pong, WF
   Tai, NH
   Lin, IN
   Chiu, IM
AF Chen, Ying-Chieh
   Lee, Don-Ching
   Hsiao, Chao-Yang
   Chung, Yu-Fen
   Chen, Huang-Chin
   Thomas, Joseph P.
   Pong, Way-Faung
   Tai, Nyan-Hwa
   Lin, I-Nan
   Chiu, Ing-Ming
TI The effect of ultra-nanocrystalline diamond films on the proliferation
   and differentiation of neural stem cells
SO BIOMATERIALS
LA English
DT Article
DE Neural stem cells; Neural differentiation; Ultra-nanocrystalline
   diamond; ECM
ID THIN-FILMS; IN-VITRO; ULTRANANOCRYSTALLINE DIAMOND; STEM/PROGENITOR
   CELLS; SURFACE MODIFICATION; BIOCOMPATIBILITY; GROWTH; NEUROGENESIS;
   REPLACEMENT; EXPRESSION
AB The interaction of ultra-nanocrystalline diamond (UNCD) with neural stem cells (NSCs) has been studied along with its surface modification in order to improve its function as a biomaterial. Hydrogen- and oxygen-terminated UNCD films were compared with standard grade polystyrene in terms of their impact on the growth, expansion and differentiation of NSCs. When NSCs were cultured on these substrates in low serum and without any differentiating factors, hydrogen-terminated UNCD films spontaneously induced cell proliferation and neuronal differentiation. Oxygen-terminated UNCD films were also shown to further improve neural differentiation, with a preference to differentiate into oligodendrocytes. Hence, controlling the surface properties of UNCD could manipulate the differentiation of NSCs for different biomedical applications. These observations raise the potential for the use of UNCD as a biomaterial for central nervous system transplantation and tissue engineering. (c) 2009 Elsevier Ltd. All rights reserved.
C1 [Chen, Ying-Chieh; Thomas, Joseph P.; Tai, Nyan-Hwa] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
   [Chen, Ying-Chieh; Lee, Don-Ching; Hsiao, Chao-Yang; Chung, Yu-Fen; Chiu, Ing-Ming] Natl Hlth Res Inst, Inst Cellular & Syst Med, Jhunan 35053, Miaoli, Taiwan.
   [Chen, Huang-Chin; Pong, Way-Faung; Lin, I-Nan] Tamkang Univ, Dept Phys, Tamsui 251, Taiwan.
   [Chiu, Ing-Ming] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.
RP Tai, NH (reprint author), Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
EM nhtai@mx.nthu.edu.tw; ingming@nhri.org.tw
RI Chiu, Ing-Ming/B-1534-2008
OI Thomas, Joseph P/0000-0001-6455-908X
FU National Science Council, Taiwan [NSC-95-2221-E-007-062MY3]
FX The authors are grateful to the National Science Council, Taiwan for the
   support of this research under NSC-95-2221-E-007-062MY3.
CR Amaral M, 2008, J BIOMED MATER RES A, V87A, P91, DOI 10.1002/jbm.a.31742
   Ariano P, 2005, DIAM RELAT MATER, V14, P669, DOI 10.1016/j.diamond.2004.11.021
   Armstrong RJE, 2000, CELL TRANSPLANT, V9, P139, DOI 10.1177/096368970000900202
   Arunkumar AI, 2002, PROTEIN SCI, V11, P1050, DOI 10.1110/ps.2270102
   Auciello O, 2004, J PHYS-CONDENS MAT, V16, pR539, DOI 10.1088/0953-8984/16/16/R02
   Bithell A, 2005, CLIN SCI, V108, P13, DOI 10.1042/CS20040276
   Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131
   Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256
   Chen RS, 2009, BIOMATERIALS, V30, P541, DOI 10.1016/j.biomaterials.2008.09.054
   Chen YC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838303
   Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015
   Chiu IM, 2000, ONCOGENE, V19, P6229, DOI 10.1038/sj.onc.1204021
   Christoph E. N., 2007, J PHYS D, V40, P6443
   Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558
   Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Flaumenhaft R, 1991, CURR OPIN CELL BIOL, V3, P817, DOI 10.1016/0955-0674(91)90055-4
   Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Hamers RJ, 2005, DIAM RELAT MATER, V14, P661, DOI 10.1016/j.diamond.2004.09.018
   Hartl A, 2004, NAT MATER, V3, P736, DOI 10.1038/nmat1204
   Hsu YC, 2009, DEV DYNAM, V238, P302, DOI 10.1002/dvdy.21753
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005
   Keblinski P, 1998, MRS BULL, V23, P36, DOI 10.1557/S0883769400029353
   Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   LECHLEITNER T, 2008, BIOMATERIALS, V29, P2433
   Lee YC, 2008, DIAM RELAT MATER, V17, P446, DOI 10.1016/j.diamond.2007.08.025
   Lee YC, 2005, DIAM RELAT MATER, V14, P296, DOI 10.1016/j.diamond.2004.10.015
   MATTHEW JD, 2004, BIOMATERIALS, V25, P5415
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010
   Pollard SM, 2006, CEREB CORTEX S1, V16, pi112
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758
   Ruiz A, 2008, BIOMATERIALS, V29, P4766, DOI 10.1016/j.biomaterials.2008.08.017
   Schwahn HN, 2001, GRAEF ARCH CLIN EXP, V239, P961, DOI 10.1007/s004170100368
   Song SJ, 2007, J CELL BIOCHEM, V100, P402, DOI 10.1002/jcb.21068
   Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006
   Steinmuller-Nethl D, 2006, BIOMATERIALS, V27, P4547, DOI 10.1016/j.biomaterials.2006.04.036
   WILLIAM CC, 2008, BIOMATERIALS, V29, P3461
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xiao XC, 2006, J BIOMED MATER RES B, V77B, P273, DOI 10.1002/jbm.b.30448
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
   Zurn AD, 1996, J NEUROSCI RES, V44, P133, DOI 10.1002/(SICI)1097-4547(19960415)44:2<133::AID-JNR5>3.0.CO;2-E
NR 47
TC 53
Z9 53
U1 3
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 20
BP 3428
EP 3435
DI 10.1016/j.biomaterials.2009.03.058
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 455FR
UT WOS:000266744100008
PM 19406465
DA 2018-10-20
ER

PT J
AU Lee, JY
   Choo, JE
   Choi, YS
   Suh, JS
   Lee, SJ
   Chung, CP
   Park, YJ
AF Lee, Jue-Yeon
   Choo, Jung-Eun
   Choi, Young-Suk
   Suh, Jin-Sook
   Lee, Seung-Jin
   Chung, Chong-Pyoung
   Park, Yoon-Jeong
TI Osteoblastic differentiation of human bone marrow stromal cells in
   self-assembled BMP-2 receptor-binding peptide-amphiphiles
SO BIOMATERIALS
LA English
DT Article
DE Osteopromotive domain (OPD); BMP-2; Peptide-amphiphiles; Nanofibers;
   Scaffold; Osteoblastic differentiation
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; IN-VITRO;
   EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION; MOLECULAR
   ARCHITECTURE; BIOMATERIAL SCAFFOLDS; VERSATILE SCAFFOLD;
   CONTROLLED-RELEASE; CRYSTAL-STRUCTURE
AB Self-assembled nanostructures consisting of BMP receptor-binding peptides, termed osteopromotive domains (OPDs), and hydrophobic alkyl chains were fabricated with the aim of developing three-dimensional scaffolding materials for osteoblastic differentiation. OPD peptide was identified from BMP-2 and had an affinity for BMP receptors thereby inducing differentiation of human bone marrow stromal cells into osteoblastic cells. The peptide-hydrophobic alkyl chain amphiphiles were designed to mimic nanofibrous extracellular structures and to add osteogenic ligands to enhance osteoblastic cell function. The OPD peptide-amphiphiles (OPDAs) that end with the alkylation of the N-terminus of the OPD peptide were synthesized by standard solid phase chemistry. The self-assembly was triggered by mixing OPDA solution with calcium ions. Observation using scanning electron microscopy (SEM) revealed the formation of nanofibrous structures with extremely high aspect ratios and high surface areas. The FT-IR and circular dichroism (CD) spectro photometry demonstrated that self-assembled nanofibers have a beta-sheet structure. The activation of Smad, an osteoblastic differentiation marker. was obtained in the cell culture gel of self-assembled OPDA; therefore, the intracellular signal transduction for osteogenesis was performed like an OPD peptide. Cell survival was supported in the OPDA gel for 10 days, and osteoblastic differentiation of human bone marrow stromal cells (hBMSCs) was evident as demonstrated by calcein staining and ALP activity measurement. These results revealed that self-assembled OPDA maintained osteogenic activity by the surface-exposed OPD peptide. Taken together, the self-assembled OPDA nanofibrous gel can be utilized as a cell culture scaffold in bone regeneration. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Lee, Jue-Yeon; Choo, Jung-Eun; Choi, Young-Suk; Suh, Jin-Sook; Park, Yoon-Jeong] Seoul Natl Univ, Sch Dent, Dept Craniomaxillofacial Reconstruct Sci, Seoul 110749, South Korea.
   [Lee, Jue-Yeon; Choo, Jung-Eun; Choi, Young-Suk; Suh, Jin-Sook; Chung, Chong-Pyoung; Park, Yoon-Jeong] Seoul Natl Univ, Sch Dent, IBEC, Seoul, South Korea.
   [Lee, Jue-Yeon; Chung, Chong-Pyoung; Park, Yoon-Jeong] NIBEC, Res Ctr, Seoul, South Korea.
   [Lee, Seung-Jin] Ewha Womans Univ, Coll Pharm, Dept Pharm, Seoul, South Korea.
   [Chung, Chong-Pyoung] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul, South Korea.
RP Park, YJ (reprint author), Seoul Natl Univ, Sch Dent, Dept Craniomaxillofacial Reconstruct Sci, 28-22 Yongon Dong, Seoul 110749, South Korea.
EM parkyj@snu.ac.kr
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Bull SR, 2005, BIOCONJUGATE CHEM, V16, P1343, DOI 10.1021/bc050153h
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007
   Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Iba K, 2004, J BONE MINER METAB, V22, P594, DOI 10.1007/s00774-004-0528-9
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Kihara T, 2004, BIOCHEM BIOPH RES CO, V316, P943, DOI 10.1016/j.bbrc.2004.02.134
   Kim H, 2005, BIOCHEM BIOPH RES CO, V332, P1053, DOI 10.1016/j.bbrc.2005.05.051
   Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   Kubelka J, 2001, J AM CHEM SOC, V123, P12048, DOI 10.1021/ja0116627
   Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351
   Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040
   Lee JY, 2009, BIOTECHNOL APPL BIOC, V52, P69, DOI 10.1042/BA20070169
   Lee YM, 2003, J PERIODONTOL, V74, P865, DOI 10.1902/jop.2003.74.6.865
   Lou J, 2000, BIOCHEM BIOPH RES CO, V268, P757, DOI 10.1006/bbrc.2000.2210
   Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Park JB, 2007, J PERIODONTOL, V78, P2150, DOI 10.1902/jop.2007.070108
   Park JB, 2007, J PERIODONTOL, V78, P157, DOI 10.1902/jop.2007.060200
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Seol YJ, 2006, J BIOMED MATER RES A, V77A, P599, DOI 10.1002/jbm.a.30639
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Wada R, 2006, BBA-GEN SUBJECTS, V1760, P841, DOI 10.1016/j.bbagen.2005.12.025
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 48
TC 44
Z9 46
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 21
BP 3532
EP 3541
DI 10.1016/j.biomaterials.2009.03.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 458HR
UT WOS:000267007300004
PM 19345406
DA 2018-10-20
ER

PT J
AU Bernstein, P
   Dong, M
   Corbeil, D
   Gelinsky, M
   Gunther, KP
   Fickert, S
AF Bernstein, Peter
   Dong, Meng
   Corbeil, Denis
   Gelinsky, Michael
   Guenther, Klaus-Peter
   Fickert, Stefan
TI Pellet Culture Elicits Superior Chondrogenic Redifferentiation than
   Alginate-Based Systems
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE cartilage tissue engineering; alginate; chitosan; fibrin; pellet
ID HUMAN ARTICULAR CHONDROCYTES; GENE-EXPRESSION; STEM-CELLS; CARTILAGE
   FORMATION; SOX9 EXPRESSION; IN-VITRO; DIFFERENTIATION; COLLAGEN;
   MICROMASS; REPAIR
AB Although pellet culture and encapsulation of chondrocytes into gel-like biomaterials have lead to major advances in cartilage tissue engineering, a quantitative comparative characterization of cellular differentiation behavior during those cultivation procedures has not yet been performed. Our study therefore aimed at answering the following question: is the redifferentiation pathway of chondrocytes altered by slight changes in the type of alginate biomaterial (pure alginate, alginate-fibrin, alginate-chitosan) and how do the cells behave in comparison to biomaterial-free (pellet) three-dimensional culturing? Monolayer-expanded chondrocytes from healthy adult porcine knee joints were cultivated in alginate, alginate-chitosan, alginate-fibrin beads and as pellets up to 4 weeks. Quantitative PCR and Immunohistology were used to assess chondrogenic markers. Alginate-fibrin-encapsulated chondrocytes behaved almost like monolayer chondrocytes. Alginate- and alginate-chitosan encapsulation lead to a low chondrogenic marker gene expression. Although all 3D-cultured chondrocytes showed a considerable amount of Sox9 expression, only pellet cultivation lead to a sufficient Collagen II expression. This puts the usage of alginate-cultivated cartilage tissue engineering constructs under question. Fibrin addition is not beneficial for chondrogenic differentiation. Sox9 and Collagen H behave differently, depending upon the surrounding 3D-environment. (C) 2009 American Institute of Chemical Engineers Biotechnol. Prog., 25: 1146-1152, 2009
C1 [Bernstein, Peter; Dong, Meng; Guenther, Klaus-Peter] Tech Univ Dresden, Dept Orthopaed Surg, Univ Hosp Carl Gustav Carus Dresden, Fac Med, D-01307 Dresden, Germany.
   [Dong, Meng; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, D-01307 Dresden, Germany.
   [Gelinsky, Michael] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
   [Fickert, Stefan] Univ Heidelberg, Dept Orthopaed Surg, Fac Clin Med Mannheim, D-68167 Mannheim, Germany.
RP Bernstein, P (reprint author), Tech Univ Dresden, Dept Orthopaed Surg, Univ Hosp Carl Gustav Carus Dresden, Fac Med, D-01307 Dresden, Germany.
EM peter.bernstein@uniklinikum-dresden.de
RI Corbeil, Denis/A-6519-2010; Gelinsky, Michael/A-9680-2012
OI Gelinsky, Michael/0000-0001-9075-5121; Corbeil,
   Denis/0000-0003-1181-3659
CR Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0
   Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Banu N, 2007, J BIOMED MATER RES A, V80A, P257, DOI 10.1002/jbm.a.30931
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bi WM, 1999, NAT GENET, V22, P85
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bradham DM, 1998, CLIN ORTHOP RELAT R, P239
   Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Heywood HK, 2004, TISSUE ENG, V10, P1467, DOI 10.1089/ten.2004.10.1467
   Hoemann CD, 2002, ANAL BIOCHEM, V300, P1, DOI 10.1006/abio.2001.5436
   HOYLAND JA, 1991, BONE MINER, V15, P151, DOI 10.1016/0169-6009(91)90005-K
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hu JC, 2005, BIOMATERIALS, V26, P2001, DOI 10.1016/j.biomaterials.2004.06.008
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kelly DJ, 2007, J MATER SCI-MATER M, V18, P273, DOI 10.1007/s10856-006-0689-2
   Kulyk WM, 2000, EXP CELL RES, V255, P327, DOI 10.1006/excr.1999.4784
   Kypriotou M, 2003, DNA CELL BIOL, V22, P119, DOI 10.1089/104454903321515922
   Lefebvre V., 2001, OSTEOARTHR CARTILAGE, V9, P69
   LI Z, 2005, J BIOMED MATER RES A, V75, P458
   Mandl EW, 2004, TISSUE ENG, V10, P109, DOI 10.1089/107632704322791754
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Perka C, 2000, J BIOMED MATER RES, V49, P305, DOI 10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.0.CO;2-9
   Rahman MS, 2001, TISSUE ENG, V7, P781, DOI 10.1089/107632701753337726
   Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002
   Robinson D, 2001, CELL TRANSPLANT, V10, P203
   ROZEN S, 2000, BIOINFORMATICS METHO, P365, DOI DOI 10.1385/1-59259-192-2:365
   Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738
   Shum Lillian, 2003, Birth Defects Research, V69, P102, DOI 10.1002/bdrc.10012
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004
   Tare RS, 2005, BIOCHEM BIOPH RES CO, V333, P609, DOI 10.1016/j.bbrc.2005.05.117
   Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200
   Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
NR 49
TC 29
Z9 30
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JUL-AUG
PY 2009
VL 25
IS 4
BP 1146
EP 1152
DI 10.1002/btpr.186
PG 7
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 489EO
UT WOS:000269403000030
PM 19572391
DA 2018-10-20
ER

PT J
AU Caplan, MR
   Shah, MM
AF Caplan, Michael R.
   Shah, Miti M.
TI Translating Biomaterial Properties to Intracellular Signaling
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Biocompatible materials; Integrins; Signal transduction; Systems biology
   Mathematical model; Principal component analysis; Bayesian analysis;
   Chemical models
ID EPIDERMAL-GROWTH-FACTOR; STEM-CELL FATE; EXTRACELLULAR-MATRIX;
   ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; MOLECULAR-BASIS; INTEGRINS;
   NETWORKS; ADHESION; SURFACE
AB Bioactive materials present important micro-environmental cues that induce specific intracellular signaling responses which ultimately determine cell behavior. For example, vascular endothelial cells on a normal vessel wall resist inflammation and thrombosis, but the same cells seeded on an artificial vascular graft or stent do not. What makes these cells behave so differently when they are adhered to different materials? Intracellular signaling from integrins and other cell-surface receptors is an important part of the answer, but these signaling responses constitute a highly-branched, interconnected network of molecules. In order to perform rational design of biomaterials, one must understand how altering the properties of the material (micro-environment) causes changes in cell behavior, and this in turn requires understanding the complex signaling response. Systems biology and mathematical modeling aid analysis of the connectivity of this network. This review summarizes applicable systems biology and mathematical modeling techniques including ordinary differential equations-based models, principal component analysis, and Bayesian networks. Next covered is biomaterials research which studies the intracellular signaling responses generated by variation of biomaterial properties. Finally, the review details ways in which modeling has been or could be applied to better understand the link between biomaterial properties and intracellular signaling.
C1 [Caplan, Michael R.; Shah, Miti M.] Arizona State Univ, Harrington Dept Bioengn, Ctr Intervent Biomat, Tempe, AZ 85287 USA.
RP Caplan, MR (reprint author), Arizona State Univ, Harrington Dept Bioengn, Ctr Intervent Biomat, POB 879709, Tempe, AZ 85287 USA.
EM Michael.Caplan@asu.edu
FU NIH [R21 EB004386]; Arizona Biomedical Research Commission [0916];
   National Institute of Dental and Craniofacial Research [K22 DE014846]
FX This study was supported by the NIH (R21 EB004386), the Arizona
   Biomedical Research Commission (# 0916), and a Career Development and
   Faculty Transition Award to M. R. C. from the National Institute of
   Dental and Craniofacial Research (K22 DE014846).
CR Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Alford SK, 2009, J BIOMED MATER RES A, V88A, P205, DOI 10.1002/jbm.a.31885
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8
   Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162
   COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110
   *EIG INC, PLS TOOLB MAN
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998
   Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   JENKINS DD, 2005, NANOSCALE TECHNOLOGY
   Jolliffe I. T, 2002, SPRINGER SERIES STAT
   Jones JL, 1999, J CLIN PATHOL-MOL PA, V52, P208
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169
   KLEIN S, 1993, MOL BIOL CELL, V4, P973
   Lauffenburger D. A., 1993, RECEPTORS MODELS BIN, P365
   Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t
   Maheshwari G, 1999, BIOPHYS J, V76, P2814, DOI 10.1016/S0006-3495(99)77435-7
   Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   PLATT MO, J CELL PHYS IN PRESS
   Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101
   Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Rotundo RF, 2002, AM J PHYSIOL-LUNG C, V282, pL316, DOI 10.1152/ajplung.00145.2000
   Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0
   Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Takahashi N, 1999, CIRC RES, V84, P1194, DOI 10.1161/01.RES.84.10.1194
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   TRUSKEY GA, 2004, TRANSPORT PHENOMENAI
   Wacker BK, 2006, BIOMACROMOLECULES, V7, P1335, DOI 10.1021/bm050948r
   Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056
   Yeh CH, 1999, EXP CELL RES, V251, P57, DOI 10.1006/excr.1999.4560
NR 51
TC 15
Z9 15
U1 0
U2 11
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD JUL
PY 2009
VL 54
IS 1-3
BP 1
EP 10
DI 10.1007/s12013-009-9048-5
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 459LI
UT WOS:000267103400001
PM 19390790
DA 2018-10-20
ER

PT J
AU Yang, F
   Mei, Y
   Langer, R
   Anderson, DG
AF Yang, Fan
   Mei, Ying
   Langer, Robert
   Anderson, Daniel G.
TI High Throughput Optimization of Stem Cell Microenvironments
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
ID GENE DELIVERY; SMALL MOLECULES; CATIONIC POLYMERS; ADIPOSE-TISSUE;
   BIOMATERIALS; MICROARRAYS; LIBRARY; DIFFERENTIATION; THERAPY; CANCER
AB Stem cells have great potential as cell sources for regenerative medicine due to both their self-renewal and multi-lineage differentiation capacity. Despite advances in the field of stem cell biology, major challenges remain before stem cells can be widely used for therapeutic purposes. One challenge is to develop reproducible methods to control stem cell growth and differentiation. The niche in which stem cells reside is a complex, multi-factorial environment. In contrast to using cells alone, biomaterials can provide initial structural support, and allow cells to adhere, proliferate and differentiate in a three-dimensional environment. Researchers have incorporated signals into the biomaterials that can promote desired cell functions in a spatially and temporally controlled manner. Despite progress in biomaterial design and methods to modulate cellular behavior, many of the complex signal networks that regulate cell-material interactions remain unclear. Due to the vast numbers of material properties to be explored and the complexity of cell-surface interactions, it is often difficult to optimize stem cell microenvironments using conventional, iterative approaches. To address these challenges, high throughput screening of combinatorial libraries has emerged as a novel approach to achieve rapid screening with reduced materials and costs. In this review, we discuss recent research in the area of high throughput approaches for characterization and optimization of cellular interactions with their microenvironments. In contrast to conventional approaches, screening combinatorial libraries can result in the discovery of unexpected material solutions to these complex problems.
C1 [Yang, Fan; Mei, Ying; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Langer, Robert; Anderson, Daniel G.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA.
RP Yang, F (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM fyang4@mit.edu
FU NIAMS NIH HHS [F32 AR056567, F32 AR056567-01]
CR Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848
   Bhat RR, 2005, ADV MATER, V17, P2802, DOI 10.1002/adma.200500858
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009
   BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828
   Chen MH, 2007, EXPERT REV MOL DIAGN, V7, P281, DOI 10.1586/14737159.7.3.281
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k
   Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100
   Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   Green JJ, 2006, BIOCONJUGATE CHEM, V17, P1162, DOI 10.1021/bc0600968
   Harris BP, 2006, LANGMUIR, V22, P4467, DOI 10.1021/la053417x
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacBeath G, 2000, SCIENCE, V289, P1760
   Matsumoto T, 2006, ADV BIOCHEM ENG BIOT, V102, P113, DOI 10.1007/b137207
   Mei Y, 2006, J BIOMED MATER RES A, V79A, P974, DOI 10.1002/jbm.a.30883
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Metallo CM, 2007, BIOTECHNOL PROGR, V23, P18, DOI 10.1021/bp060350a
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Peng WD, 2007, PROSTATE, V67, P855, DOI 10.1002/pros.20576
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924
   Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Wagner E, 2004, BIOMED PHARMACOTHER, V58, P152, DOI 10.1016/j.biopha.2004.01.003
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
   Zugates GT, 2007, MOL THER, V15, P1306, DOI 10.1038/sj.mt.6300132
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 56
TC 27
Z9 27
U1 0
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PD JUL
PY 2009
VL 12
IS 6
BP 554
EP 561
DI 10.2174/138620709788681916
PG 8
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 474BC
UT WOS:000268256200003
PM 19601753
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Su, J
   Meredith, JC
AF Su, Jing
   Meredith, J. Carson
TI Local Histogram Analysis: Detecting Cell-Microstructure Interactions on
   Combinatorial Biomaterial Libraries
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; POLYMER SURFACES; SUBSTRATE MICROTOPOGRAPHY;
   GEOMETRIC CONTROL; DIFFERENTIATION; PROLIFERATION; TOPOGRAPHY; ADHESION;
   DESIGN; GROWTH
AB Increasingly, combinatorial libraries are used to screen large numbers of complex chemically- and physically-patterned polymers against cell response. There is a strong need to extract meaningful relationships between cell function and material surface features from these experiments. A novel high-throughput cell-material screening strategy, based upon local cell-feature analysis (LCFA) was applied to screen osteoblast proliferation behavior on combinatorial libraries of phase-separated PLGA and PCL. Traditional factor importance analysis, which uses summary statistical inference to identify significant variables, indicated that one controlling material surface feature was PCL diameter. However, the summary statistic analysis was unable to uncover more subtle relationships. The LCFA method, based on histograms of distances between cells and microstructures, was able to identify non-linear, discrete relationships between proliferation, PCL diameter, and cell-PCL distance. LCFA provides an advantage in that a distribution function is not assumed, but rather is developed from the data. Using these results, we propose a model for classifying the material-microstructure interactions, in which small PCL islands far from the cell nucleus act as holders for attachment and large islands close to cells act to shape the cell.
C1 [Meredith, J. Carson] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
   [Su, Jing] Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
RP Meredith, JC (reprint author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
EM Carson.Meredith@chbe.gatech.edu
RI Yu, Chengfei/A-2538-2012; Su, Jing/B-3171-2013; Meredith,
   Carson/B-3323-2009
OI Meredith, Carson/0000-0003-2519-5003; Su, Jing/0000-0003-4917-6173
FU NIH [R21 RR17425-01, 1R21 HK072039-01]
FX The authors gratefully acknowledge helpful guidance from Professor
   Andres Garcia and financial support from NIH ( NCRR# R21 RR17425-01 and
   NHLBI# 1R21 HK072039-01).
CR Akinc A, 2003, J AM CHEM SOC, V125, P5316, DOI 10.1021/ja034429c
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Boltau M, 1998, NATURE, V391, P877
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel ME, 1998, NATURE, V392, P730
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dean DD, 2002, J BONE MINER RES, V17, pS399
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   HUANG S, 1998, MOL BIOL CELL, V9
   IOST A, 2003, THERMEC 2003 1, V426, P3031
   Kennedy SW, 2002, ABSTR PAP AM CHEM S, V224, pU237
   Kholodovych V, 2004, POLYMER, V45, P7367, DOI 10.1016/j.polymer.2004.09.002
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   Raz P, 2004, J BIOMED MATER RES A, V71A, P217, DOI 10.1002/jbm.a.30134
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   Smith JR, 2004, J CHEM INF COMP SCI, V44, P1088, DOI 10.1021/ci0499774
   SU J, 2009, BMC BIOINFORMA UNPUB
   SU J, 2006, COMBINATORIAL METHOD
   Sung FJ, 2005, BIOMATERIALS, V26, P4557, DOI 10.1016/j.biomaterials.2004.11.034
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wang L, 2005, J BONE MINER RES, V20, pS363
   Washburn NR, 2004, ABSTR PAP AM CHEM S, V227, pU557
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
NR 45
TC 4
Z9 4
U1 0
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PD JUL
PY 2009
VL 12
IS 6
BP 626
EP 633
DI 10.2174/138620709788681880
PG 8
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 474BC
UT WOS:000268256200010
PM 19601760
DA 2018-10-20
ER

PT J
AU Santhi, T
   Manonmani, S
   Ravi, S
AF Santhi, T.
   Manonmani, S.
   Ravi, S.
TI Uptake of Cationic Dyes from Aqueous Solution by Biosorption onto
   Granular Muntingia calabura
SO E-JOURNAL OF CHEMISTRY
LA English
DT Article
DE Muntingia calabura; Biosorption; Methylene blue; Methylene red;
   Malachite green
ID ORANGE PEEL; METAL-IONS; ADSORPTION; REMOVAL; EQUILIBRIUM; ADSORBENT;
   SORPTION
AB A new, low cost, locally available biomaterial was tested for its ability to remove cationic dyes from aqueous solution. A granule prepared from a mixture of leafs, fruits and twigs of Muntingia calabura had been utilized as a sorbent for uptake of three cationic dyes, methylene blue (MB), methylene red (MR) and malachite green (MG). The effects of various experimental parameters (e.g., contact time, dye concentration, adsorbent dose and pH) were investigated and optimal experimental conditions were ascertained. Above the value of initial pH 6, three dyes studied could be removed effectively. The isothermal data fitted the Langmuir and Freundlich isotherm models for all three dyes sorption. The biosorption processes followed the pseudo-first order rate kinetics. The results in this study indicated that Muntingia calabura was an attractive candidate for removing cationic dyes from the dye wastewater.
C1 [Santhi, T.] Karpagam Univ, Dept Chem, Coimbatore 641021, Tamil Nadu, India.
   [Manonmani, S.] PSG Coll Arts & Sci, Dept Chem, Coimbatore 641014, Tamil Nadu, India.
RP Santhi, T (reprint author), Karpagam Univ, Dept Chem, Coimbatore 641021, Tamil Nadu, India.
EM ravisubban@rediffmail.com
CR Arami M, 2005, J COLLOID INTERF SCI, V288, P371, DOI 10.1016/j.jcis.2005.03.020
   Brown P, 2000, ADV ENVIRON RES, V4, P19, DOI 10.1016/S1093-0191(00)00004-6
   Dhakal RP, 2005, SEP PURIF TECHNOL, V42, P219, DOI 10.1016/j.seppur.2004.07.016
   Ghimire K. N., 2001, CHITIN CHITOSAN RES, V7, P61
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Husseien M, 2007, J APPL SCI RES, V3, P1352
   Kumar KV, 2007, DYES PIGMENTS, V74, P595, DOI 10.1016/j.dyepig.2006.03.026
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Kweon DK, 2001, CARBOHYD POLYM, V46, P171, DOI 10.1016/S0144-8617(00)00300-3
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Senthilkumaar S, 2005, J COLLOID INTERF SCI, V284, P78, DOI 10.1016/j.jcis.2004.09.027
   Singh KK, 2006, BIORESOURCE TECHNOL, V97, P2124, DOI 10.1016/j.biortech.2005.09.016
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
NR 15
TC 9
Z9 9
U1 0
U2 1
PU WWW PUBL PTE
PI TAMIL NADU
PA KHADAR BLDG, NEAR SHIFA HOSP, ADIRAMPATTINAM, TAMIL NADU, 614 701, INDIA
SN 0973-4945
J9 E-J CHEM
JI E-J. Chem.
PD JUL-SEP
PY 2009
VL 6
IS 3
BP 737
EP 742
DI 10.1155/2009/927406
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 468BD
UT WOS:000267787400019
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Swanson, BO
   Anderson, SP
   DiGiovine, C
   Ross, RN
   Dorsey, JP
AF Swanson, Brook O.
   Anderson, Stuart P.
   DiGiovine, Caitlin
   Ross, Rachel N.
   Dorsey, John P.
TI The evolution of complex biomaterial performance: The case of spider
   silk
SO INTEGRATIVE AND COMPARATIVE BIOLOGY
LA English
DT Article; Proceedings Paper
CT SICB Meeting 2009
CY JAN 03-07, 2009
CL Boston, MA
ID ORB-WEAVING SPIDERS; CLAVIPES DRAGLINE SILK; FIBROIN GENE FAMILY;
   MECHANICAL-PROPERTIES; CAPTURE-SILK; TENSILE PROPERTIES; PROTEINS; WEB;
   ARANEAE; SPUN
AB Spider silk is a high-performance biomaterial with exceptional mechanical properties and over half a century of research into its mechanics, structure, and biology. Recent research demonstrates that it is a highly variable class of materials that differs across species and individuals in complex and interesting ways. Here, we review recent literature on mechanical variation and evolution in spider silk. We then present new data on material properties of silk from nine species of spiders in the Mesothelae and Mygalomorphae, the two basal clades of spiders. Silk from spiders in the Araneomorphae (true spiders where most previous research on silk has focused) is significantly stronger and therefore much tougher than the silk produced by spiders in the basal groups. These data support the hypothesis that the success and diversity seen in araneomorph spiders is associated with the evolution of this high-performance fiber. This comparative approach shows promise as a way to understand complex, high-performance biomaterials.
C1 [Swanson, Brook O.; Anderson, Stuart P.; DiGiovine, Caitlin; Ross, Rachel N.; Dorsey, John P.] Gonzaga Univ, Dept Biol, Spokane, WA 99203 USA.
RP Swanson, BO (reprint author), Gonzaga Univ, Dept Biol, Spokane, WA 99203 USA.
EM swansonb@gonzaga.edu
CR Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x
   Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x
   Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x
   Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487
   Coddington J. A., 2004, ASSEMBLING TREE LIFE
   CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025
   CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x
   Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292
   DENNY M, 1976, J EXP BIOL, V65, P483
   Dicko C, 2004, BIOMACROMOLECULES, V5, P2105, DOI 10.1021/bm034486y
   FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325
   Foelix R. F, 1996, BIOL SPIDERS
   Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102
   Garland T, 1999, AM ZOOL, V39, P374
   GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051
   Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745
   GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503
   GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464
   Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3
   Garrido MA, 2002, POLYMER, V43, P4495, DOI 10.1016/S0032-3861(02)00254-9
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Glisovic A, 2007, APPL PHYS A-MATER, V87, P63, DOI 10.1007/s00339-006-3849-9
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Knight DP, 2002, PHILOS T R SOC B, V357, P155, DOI 10.1098/rstb.2001.1030
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Opell BD, 2000, BIOL J LINN SOC, V70, P107, DOI 10.1006/bijl.1999.0390
   Opell BD, 2001, EVOL ECOL RES, V3, P567
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072
   Platnick N. I., 1991, AM MUS NOVIT, V3016, P1
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1
   Selden PA, 1996, NATURE, V379, P498, DOI 10.1038/379498b0
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u
   TIAN MZ, 2004, BIOMACROMOLECULES, V5, P675
   Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   Wainwright SA, 1976, MECH DESIGN ORGANISM
   WORK RW, 1978, T AM MICROSC SOC, V97, P180, DOI 10.2307/3225590
   WORK RW, 1977, T AM MICROSC SOC, V96, P170, DOI 10.2307/3226094
   WORK RW, 1987, J ARACHNOL, V15, P65
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang Y, 2005, ADV MATER, V17, P84, DOI 10.1002/adma.200400344
   Zemlin JC, 1968, 6929CM US ARM NAT LA
NR 68
TC 24
Z9 25
U1 0
U2 16
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1540-7063
J9 INTEGR COMP BIOL
JI Integr. Comp. Biol.
PD JUL
PY 2009
VL 49
IS 1
BP 21
EP 31
DI 10.1093/icb/icp013
PG 11
WC Zoology
SC Zoology
GA 465QO
UT WOS:000267602100004
PM 21669843
OA Bronze
DA 2018-10-20
ER

PT J
AU Wang, XQ
   Yao, X
   Zhu, ZA
   Tang, TT
   Dai, KR
   Sadovskaya, I
   Flahaut, S
   Jabbouri, S
AF Wang, Xiaoqing
   Yao, Xiao
   Zhu, Zhen'an
   Tang, Tingting
   Dai, Kerong
   Sadovskaya, Irina
   Flahaut, Sigrid
   Jabbouri, Said
TI Effect of berberine on Staphylococcus epidermidis biofilm formation
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Berberine; Staphylococcus epidermidis; Biofilm; Confocal laser scanning
   microscopy; Scanning electron microscopy
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CANDIDA-ALBICANS; MULTIDRUG PUMP;
   IN-VITRO; INFECTION; AUREUS; AGENTS; CATHETERS; DISEASE; MODEL
AB Staphylococcus epidermidis is one of the main causes of medical device-related infections owing to its adhesion and biofilm-forming abilities on biomaterial surfaces. Berberine is an isoquinoline-type alkaloid isolated from Coptidis rhizoma (huang lian in Chinese) and other herbs with many activities against various disorders. Although the inhibitory effects of berberine on planktonic bacteria have been investigated in a few studies, the capacity of berberine to inhibit biofilm formation has not been reported to date. In this study, we observed that berberine is bacteriostatic for S. epidermidis and that sub-minimal inhibitory concentrations of berberine blocked the formation of S. epidermidis biofilm. Using viability assays and berberine uptake testing, berberine at a concentration of 15-30 mu g/mL was shown to inhibit bacterial metabolism. Data from this study also indicated that modest concentrations of berberine (30-45 mu g/mL) were sufficient to exhibit an antibacterial effect and to inhibit biofilm formation significantly, as shown by the tissue culture plate (TCP) method, confocal laser scanning microscopy and scanning electron microscopy for both S. epidermidis ATCC 35984 and a clinical isolate strain SE243. Although the mechanisms of bacterial killing and inhibition of biofilm formation are not fully understood, data from this investigation indicated a potential application for berberine as an adjuvant therapeutic agent for the prevention of biofilm-related infections. (C) 2008 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
C1 [Wang, Xiaoqing; Zhu, Zhen'an; Tang, Tingting; Dai, Kerong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthopaed Surg, Shanghai 200011, Peoples R China.
   [Yao, Xiao] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China.
   [Sadovskaya, Irina; Flahaut, Sigrid; Jabbouri, Said] Univ Littoral Cote dOpale, Lab Rech Biomat & Biotechnol, F-32327 Boulogne Sur Mer, France.
RP Zhu, ZA (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthopaed Surg, Shanghai 200011, Peoples R China.
EM zhuzhenan2006@hotmail.com
RI Tang, Tingting/B-1361-2013; Jabbouri, Said/N-6672-2014
OI Tang, Tingting/0000-0002-1670-7452; Jabbouri, Said/0000-0003-1354-494X;
   yan, wei/0000-0001-5575-7017
FU National Natural Science Foundation of China [30700852]; National High
   Technology Research and Development Program of China [2006AA02A137]
FX This work was supported by a grant from the National Natural Science
   Foundation of China (No. 30700852) and a grant from the National High
   Technology Research and Development Program of China (No. 2006AA02A137).
   The study sponsors were not involved in the study design, in the
   collection, analysis and interpretation of data, in writing of the
   manuscript, or in the decision to submit the manuscript for publication.
CR Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344
   Ando E, 2004, ACTA MED OKAYAMA, V58, P207
   Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665.4684.2004
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006
   Camara M, 2002, LANCET INFECT DIS, V2, P667, DOI 10.1016/S1473-3099(02)00447-4
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Farooq M, 1999, J SURG RES, V87, P57, DOI 10.1006/jsre.1999.5729
   Flemming H.-C., 2000, BIOFILMS RECENT ADV, P19
   Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7
   Gilbert P, 1997, Adv Dent Res, V11, P160
   Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085
   Hsieh PC, 1998, P NATL ACAD SCI USA, V95, P6602, DOI 10.1073/pnas.95.12.6602
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   INMAN RD, 1984, AM J MED, V77, P47, DOI 10.1016/0002-9343(84)90434-0
   Iwasa K, 2001, J NAT PROD, V64, P896, DOI 10.1021/np000554f
   JENNINGS BR, 1983, BIOPHYS STRUCT MECH, V10, P71, DOI 10.1007/BF00535543
   Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002
   Lewis K, 2001, J MOL MICROB BIOTECH, V3, P247
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448
   Musumeci R, 2003, INT J ANTIMICROB AG, V22, P48, DOI 10.1016/S0924-8579(03)00085-2
   Park KD, 2006, BIOORG MED CHEM LETT, V16, P3913, DOI 10.1016/j.bmcl.2006.05.033
   Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667
   Peck KR, 2003, CHEMOTHERAPY, V49, P189, DOI 10.1159/000071143
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   RAAD II, 1992, CLIN INFECT DIS, V15, P197, DOI 10.1093/clinids/15.2.197
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Rupp ME, 1994, CLIN INFECT DIS, V19, P244
   Severina II, 2001, IUBMB LIFE, V52, P321, DOI 10.1080/152165401317291183
   Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597
   Wikler M. A., 2006, M7A7 CLSI
   Yi ZB, 2007, J PHARMACEUT BIOMED, V44, P301, DOI 10.1016/j.jpba.2007.02.018
   Yu HH, 2005, J MED FOOD, V8, P454, DOI 10.1089/jmf.2005.8.454
   Yu Y, 2007, BIOORG MED CHEM LETT, V17, P1855, DOI 10.1016/j.bmcl.2007.01.032
   Zeng XH, 2003, AM J CARDIOL, V92, P173, DOI 10.1016/S0002-9149(03)00533-2
   Zhu Cai-lian, 2006, Shanghai Kou Qiang Yi Xue, V15, P434
NR 40
TC 72
Z9 76
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JUL
PY 2009
VL 34
IS 1
BP 60
EP 66
DI 10.1016/j.ijantimicag.2008.10.033
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 458KZ
UT WOS:000267020800010
PM 19157797
DA 2018-10-20
ER

PT J
AU Reinis, A
   Kroica, J
   Berzina-Cimdina, L
   Vetra, J
   Kuznecova, V
   Stunda, A
   Jakovlevs, D
   Rostoka, D
AF Reinis, A.
   Kroica, J.
   Berzina-Cimdina, L.
   Vetra, J.
   Kuznecova, V.
   Stunda, A.
   Jakovlevs, D.
   Rostoka, D.
TI Staphylococcus epidermidis and Pseudomonas aeruginosa adhesion and
   colonisation intensity on a biomaterial with various crystallisation
   degrees and modified surfaces in an in vitro study
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Meeting Abstract
CT 26th International Congress of Chemotherapy and Infection
CY JUN 18-21, 2009
CL Toronto, CANADA
C1 [Reinis, A.; Kroica, J.; Vetra, J.; Kuznecova, V.; Rostoka, D.] Riga Stradins Univ, Riga, Latvia.
   [Berzina-Cimdina, L.] Riga Tech Univ, Riga, Latvia.
NR 0
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JUL
PY 2009
VL 34
MA O62
BP S22
EP S22
DI 10.1016/S0924-8579(09)70209-2
PG 1
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 470DR
UT WOS:000267955200063
DA 2018-10-20
ER

PT J
AU Velard, F
   Laurent-Maquin, D
   Guillaume, C
   Bouthors, S
   Jallot, E
   Nedelec, JM
   Belaaouaj, A
   Laquerriere, P
AF Velard, F.
   Laurent-Maquin, D.
   Guillaume, C.
   Bouthors, S.
   Jallot, E.
   Nedelec, J. M.
   Belaaouaj, A.
   Laquerriere, P.
TI ZINC DOPED HYDROXYAPATITE AS IMMUNOMODULATORY BIOMATERIAL
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Velard, F.; Laurent-Maquin, D.; Guillaume, C.; Bouthors, S.] INSERM, UMRS926, Reims, France.
   [Jallot, E.] CNRS, UMR6533, Aubiere, France.
   [Nedelec, J. M.] CNRS, UMR6002, Aubiere, France.
   [Belaaouaj, A.] URCA EA4303, Reims, France.
   [Laquerriere, P.] CNRS, UMR7178, Strasbourg, France.
RI NEDELEC, jean-marie/A-6920-2008; Laquerriere, Patrice/P-1025-2016;
   Bentaher, Abderrazzak/F-6531-2018; Bentaher, Abderrazzaq/M-4424-2017
OI NEDELEC, jean-marie/0000-0002-8243-6849; Laquerriere,
   Patrice/0000-0001-7637-9094; 
NR 0
TC 4
Z9 4
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2009
VL 32
IS 7
BP 457
EP 458
PG 2
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 485KY
UT WOS:000269121300257
DA 2018-10-20
ER

PT J
AU Niemiec-Cyganek, A
   Baranska, A
   Nozynski, J
   Pawlus-Lachecka, L
   Wilczek, P
   Wszolek, J
   Kudrjavtseva, JA
   Barbarash, LS
AF Niemiec-Cyganek, A.
   Baranska, A.
   Nozynski, J.
   Pawlus-Lachecka, L.
   Wilczek, P.
   Wszolek, J.
   Kudrjavtseva, J. A.
   Barbarash, L. S.
TI CHEMICAL-FIXED ACELLULAR PORCINE TISSUE AS BIOMATERIAL FOR TISSUE
   ENGINEERING
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Niemiec-Cyganek, A.; Baranska, A.; Nozynski, J.; Pawlus-Lachecka, L.; Wilczek, P.; Wszolek, J.] Fdn Cardiac Surg Dev, Zabrze, Poland.
RI Kudryavtseva, Yuliya/H-8434-2017
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2009
VL 32
IS 7
BP 459
EP 459
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 485KY
UT WOS:000269121300265
DA 2018-10-20
ER

PT J
AU Madhumathi, K
   Shalumon, KT
   Rani, VVD
   Tamura, H
   Furuike, T
   Selvamurugan, N
   Nair, SV
   Jayakumar, R
AF Madhumathi, K.
   Shalumon, K. T.
   Rani, V. V. Divya
   Tamura, H.
   Furuike, T.
   Selvamurugan, N.
   Nair, S. V.
   Jayakumar, R.
TI Wet chemical synthesis of chitosan hydrogel-hydroxyapatite composite
   membranes for tissue engineering applications
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan hydrogel membranes; Composite membranes; Tissue engineering;
   Hydroxyapatite; Biomaterials
ID ALTERNATE SOAKING PROCESS; BONE-FORMATION; SCAFFOLDS; CHITIN;
   DEPOSITION; RELEASE; CALCIUM; BIOMATERIALS; BIOACTIVITY; COATINGS
AB Chitosan, a deacetylated derivative of chitin is a commonly studied biomaterial for tissue-engineering applications due to its biocompatibility, biodegradability, low toxicity, antibacterial activity, wound healing ability and haemostatic properties. However, chitosan has poor mechanical strength due to which its applications in orthopedics are limited. Hydroxyapatite (HAp) is a natural inorganic component of bone and teeth and has mechanical strength and osteoconductive property. In this work, HAp was deposited on the surface of chitosan hydrogel membranes by a wet chemical synthesis method by alternatively soaking the membranes in CaCl(2) (pH 7.4) and Na(2)HPO(4) solutions for different time intervals. These chitosan hydrogel-HAp membranes were characterized using SEM, AFM, EDS, FT-IR and XRD analyses. MTT assay was done to evaluate the biocompatibility of these membranes using MG-63 osteosarcoma cells. The biocompatibility studies suggest that chitosan hydrogel-HAp composite membranes can be useful for tissue-engineering applications. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Madhumathi, K.; Shalumon, K. T.; Rani, V. V. Divya; Selvamurugan, N.; Nair, S. V.; Jayakumar, R.] Amrita Viswa Vidyapeetham Univ, Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci, Kochi 682026, India.
   [Tamura, H.; Furuike, T.] Kansai Univ, Fac Chem Mat & Bioengn, Osaka 5648680, Japan.
   [Tamura, H.; Furuike, T.] Kansai Univ, High Technol Res Ctr, Osaka 5648680, Japan.
RP Jayakumar, R (reprint author), Amrita Viswa Vidyapeetham Univ, Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci, Kochi 682026, India.
EM rjayakumar@aims.amrita.edu
FU Department of Science and Technology, Government of India
FX This work was supported by the Department of Science and Technology,
   Government of India, under the Nanoscience and Nanotechnology Initiative
   program monitored by Dr. C. N. R. Rao.
CR AMARAL F, 2006, J BIOMED SCI POLYM E, V16, P1575
   ANDREW CA, 1998, J BIOMED MATER RES, V41, P5451
   ARAI K, 1968, B TOKAI REGIONAL FIS, V56, P89
   Beppu MM, 2003, MAT SCI ENG C-BIO S, V23, P651, DOI 10.1016/j.msec.2003.08.002
   Bigi A, 1998, BIOMATERIALS, V19, P739, DOI 10.1016/S0142-9612(97)00194-4
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Guibal E, 2005, PROG POLYM SCI, V30, P71, DOI 10.1016/j.progpolymsci.2004.12.001
   JARCHO M, 1977, J BIOENG, V1, P79
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jayakumar R, 2009, INT J BIOL MACROMOL, V44, P107, DOI 10.1016/j.ijbiomac.2008.10.010
   Jayakumar R., 2006, ASIAN CHITIN J, V2, P91
   Jin HH, 2008, MATER LETT, V62, P1630, DOI 10.1016/j.matlet.2007.09.043
   Jonathan ZK, 1999, J APPL POLYM SCI, V72, P1721
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Li JJ, 2008, MATER LETT, V62, P3220, DOI 10.1016/j.matlet.2008.02.072
   Madhumathi K, 2009, INT J BIOL MACROMOL, V44, P1, DOI 10.1016/j.ijbiomac.2008.09.013
   Maeda Y, 2008, INT J BIOL MACROMOL, V42, P463, DOI 10.1016/j.ijbiomac.2008.03.002
   Malette W.G., 1986, CHITIN NATURE TECHNO, P435
   Manara S, 2008, INORG CHIM ACTA, V361, P1634, DOI 10.1016/j.ica.2007.03.044
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   THEINHAN WW, ACTA BIOMAT IN PRESS
   Valagao Amadeu do Serro Ana Paula, 2000, Journal of Biomedical Materials Research, V49, P345, DOI 10.1002/(SICI)1097-4636(20000305)49:3<345::AID-JBM7>3.0.CO;2-R
   Viala S, 1998, ANN CHIM-SCI MAT, V23, P69, DOI 10.1016/S0151-9107(98)80025-1
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
NR 39
TC 85
Z9 96
U1 2
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL 1
PY 2009
VL 45
IS 1
BP 12
EP 15
DI 10.1016/j.ijbiomac.2009.03.011
PG 4
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 456EY
UT WOS:000266825500003
PM 19447253
DA 2018-10-20
ER

PT J
AU Miyamoto, K
   Atarashi, M
   Kadozono, H
   Shibata, M
   Koyama, Y
   Okai, M
   Inakuma, A
   Kitazono, E
   Kaneko, H
   Takebayashi, T
   Horiuchi, T
AF Miyamoto, Keiichi
   Atarashi, Masaki
   Kadozono, Hideki
   Shibata, Masakazu
   Koyama, Yoshihiro
   Okai, Masanori
   Inakuma, Akinobu
   Kitazono, Eiichi
   Kaneko, Hiroaki
   Takebayashi, Takafumi
   Horiuchi, Takashi
TI Creation of cross-linked electrospun isotypic-elastin fibers controlled
   cell-differentiation with new cross-linker
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Tissue engineering; Elastin; Vascular smooth muscle cells;
   Differentiation; Electrospinning
ID HUMAN TROPOELASTIN; COLLAGEN; RECEPTOR; ATHEROSCLEROSIS; COACERVATION;
   BIOMATERIAL; MATRICES; TISSUES
AB Effective application of elastin materials for vascular grafts in tissue engineering requires these materials to retain the elastic and biological properties of native elastin. To clarify the influence of soluble elastin isotypes on vascular smooth muscle cells (VSMCs), soluble elastin was prepared from insoluble elastin by hydrolysis with oxalic acid. Its fractions were separated and classified into three isotypes. Elastin retaining 2.25 mol% of cross-linked structures exhibited significant differentiation of VSMCs, which adhered to the elastin with contraction phenotypes similar to that of native elastin, causing proliferation to cease. This trend was more strongly demonstrated in cotton-like elastin fibers with a new cross-linker. The results suggest that elastin isotypes could be applied as new effective biomaterials for suppressing intimal hyperplasia in vascular grafts. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Miyamoto, Keiichi; Atarashi, Masaki; Kadozono, Hideki; Shibata, Masakazu; Koyama, Yoshihiro; Okai, Masanori; Inakuma, Akinobu; Takebayashi, Takafumi; Horiuchi, Takashi] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie 5148507, Japan.
   [Kitazono, Eiichi; Kaneko, Hiroaki] Teijin Ltd, TEIJIN Technol Innovat Ctr, Tokyo 1918512, Japan.
RP Miyamoto, K (reprint author), Mie Univ, Grad Sch Engn, Div Chem Mat, 1577 Kurima Machiya Cho, Tsu, Mie 5148507, Japan.
EM miyamoto@chem.mie-u.ac.jp
FU Ministry of Education, Science, Sports and Culture of Japan [16390359]
FX Part of this study was supported by a Grant-in-Aid for Basic Scientific
   Research (B) No. 16390359 of the Ministry of Education, Science, Sports
   and Culture of Japan.
CR Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200
   ELENE PM, 2001, CARDIOVASC RES, V52, P372
   FRANZBLAU C, 1981, CELL BIOL EXTRACELLU, P65
   INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680
   JACOB MP, 1985, METHODS CONNECTIVE T, V4, P921
   Kaibara K, 1996, BIOPOLYMERS, V39, P189, DOI 10.1002/(SICI)1097-0282(199608)39:2<189::AID-BIP7>3.0.CO;2-L
   Kaibara K, 2000, BIOPOLYMERS, V53, P369, DOI 10.1002/(SICI)1097-0282(20000415)53:5<369::AID-BIP2>3.3.CO;2-X
   KIMBERLY TC, 2003, BIOMACROMOLECULES, V4, P572
   KOERT PD, 2000, ANAT REC, V258, P1
   LAURA P, 2006, TISSUE CELL, V38, P111
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Maeda I, 2007, J PEPT SCI, V13, P263, DOI 10.1002/psc.845
   Martino M, 2001, BIOPOLYMERS, V59, P29, DOI 10.1002/1097-0282(200107)59:1<29::AID-BIP1003>3.0.CO;2-F
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Miyamoto K, 2001, PROTEIN PEPTIDE LETT, V8, P231, DOI 10.2174/0929866013409481
   NATHALIE FW, 2001, CELL MOTIL CYTOSKEL, V49, P130
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011
   PARTRIDGE SM, 1964, BIOCHEM J, V93, P30
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   RUCKER RB, 1982, METHOD ENZYMOL, V82, P650
   SATYAJIT KK, 2003, DEVELOPMENT, V130, P411
   SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445
   Spofford CM, 2003, J BIOMECH, V36, P645, DOI 10.1016/S0021-9290(02)00442-6
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Toonkool P, 2001, J BIOL CHEM, V276, P28042, DOI 10.1074/jbc.M103391200
   Tranquillo RT, 2002, ANN NY ACAD SCI, V961, P251, DOI 10.1111/j.1749-6632.2002.tb03094.x
   Umeda H, 2001, J BIOL CHEM, V276, P12579, DOI 10.1074/jbc.M009744200
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   XIAOYI W, 2005, BIOMACROMOLECULES, V6, P3037
   YAMAGUCHI Y, 1987, J CHROMATOGR-BIOMED, V422, P53, DOI 10.1016/0378-4347(87)80439-5
NR 40
TC 21
Z9 24
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL 1
PY 2009
VL 45
IS 1
BP 33
EP 41
DI 10.1016/j.ijbiomac.2009.03.014
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 456EY
UT WOS:000266825500007
PM 19447257
DA 2018-10-20
ER

PT J
AU Kumirska, J
   Weinhold, MX
   Steudte, S
   Thoming, J
   Brzozowski, K
   Stepnowski, P
AF Kumirska, Jolanta
   Weinhold, Mirko X.
   Steudte, Stephanie
   Thoeming, Jorg
   Brzozowski, Krzysztof
   Stepnowski, Piotr
TI Determination of the pattern of acetylation of chitosan samples:
   Comparison of evaluation methods and some validation parameters
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Pattern of acetylation; NMR spectroscopy; Some validation
   parameters
ID DEACETYLATED CHITINS CHITOSANS; FIELD NMR-SPECTROSCOPY; DERIVATIVES;
   CHEMISTRY; BLOCK
AB Chitosan is a linear copolymer consisting of glucosamine and N-acetylglucosamine units. its specific biological features make it a very attractive biomaterial for diverse applications in both pharmaceutics and medicine. The pattern of acetylation of chitosan samples (P(A)) can strongly influence their biomedical activities. So far, three methods of determining the P(A) value of chitosan samples, based on NMR spectroscopy, have been developed. Chitosans with a degree of acetylation (F(A)) from 0.02 to 0.48 were used to compare these methods. The most suitable and specific method of P(A) determination was (13)C NMR based on the intensities of carbon C-5 signals. Some validation parameters-specificity, sensitivity, precision (repeatability and reproducibility)-were established. The intra- and inter-day precision of this method depended on the degree of acetylation of the chitosan samples. It was found to be specific, sensitive, repeatable and reproducible. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kumirska, Jolanta; Brzozowski, Krzysztof; Stepnowski, Piotr] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland.
   [Weinhold, Mirko X.; Steudte, Stephanie; Thoeming, Jorg] Univ Bremen, UFT Ctr Environm Res & Sustainable Technol, D-28359 Bremen, Germany.
RP Kumirska, J (reprint author), Univ Gdansk, Fac Chem, Sobieskiego 18-19, PL-80952 Gdansk, Poland.
EM kumirska@chem.univ.gda.pl
RI Steudte, Stephanie/A-2811-2013; Thoming, Jorg/N-7067-2014
OI Thoming, Jorg/0000-0002-5374-114X; Brzozowski,
   Krzysztof/0000-0001-8693-1452; Stepnowski, Piotr/0000-0001-5022-6962;
   Kumirska, Jolanta/0000-0003-1211-1114
FU Polish Ministry of Research and Higher Education [BW/8000-5-0123-8,
   DS/8200-4-0085-9]
FX The authors express their gratitude for the financial support provided
   by the Polish Ministry of Research and Higher Education under grants
   BW/8000-5-0123-8 and DS/8200-4-0085-9.
CR AIBA S, 1991, INT J BIOL MACROMOL, V13, P40, DOI 10.1016/0141-8130(91)90008-I
   AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7
   Berth G, 1998, CARBOHYD POLYM, V36, P205, DOI 10.1016/S0144-8617(98)00029-0
   BOVEY P, 1996, NMR POLYM
   Chopra S, 2006, J PHARM PHARMACOL, V58, P1021, DOI 10.1211/jpp.58.8.0002
   Cobas JC, 2003, CONCEPT MAGN RESON A, V19A, P80, DOI 10.1002/cmr.a.10089
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Kato Yoshinori, 2003, Current Pharmaceutical Biotechnology, V4, P303, DOI 10.2174/1389201033489748
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumirska J, 2009, J PHARMACEUT BIOMED, V50, P587, DOI 10.1016/j.jpba.2008.09.048
   KURITA K, 1977, MAKROMOL CHEM, V178, P3197
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   MIREAU A, 1996, PRACTICAL GUIDE UNDE
   Muzzarelli RAA, 1996, CARBOHYD POLYM, V29, P309, DOI 10.1016/S0144-8617(96)00033-1
   Niekraszewicz A, 2005, FIBRES TEXT EAST EUR, V13, P16
   No HK, 2000, REV ENVIRON CONTAM T, V163, P1
   Ottoy MH, 1996, CARBOHYD POLYM, V29, P17
   Peniche C, 2003, MACROMOL BIOSCI, V3, P511, DOI 10.1002/mabi.200300019
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   VARUM KM, 1991, CARBOHYD RES, V217, P19, DOI 10.1016/0008-6215(91)84113-S
   VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2
   WEINHOLD MX, 2007, J ADV CHITIN SCI, V10, P66
NR 26
TC 5
Z9 5
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL 1
PY 2009
VL 45
IS 1
BP 56
EP 60
DI 10.1016/j.ijbiomac.2009.04.002
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 456EY
UT WOS:000266825500010
DA 2018-10-20
ER

PT J
AU Maccauro, G
   Bianchino, G
   Sangiorgi, S
   Magnani, G
   Marotta, D
   Manicone, PF
   Raffaelli, L
   Iommetti, PR
   Stewart, A
   Cittadini, A
   Sgambato, A
AF Maccauro, G.
   Bianchino, G.
   Sangiorgi, S.
   Magnani, G.
   Marotta, D.
   Manicone, P. F.
   Raffaelli, L.
   Iommetti, P. Rossi
   Stewart, A.
   Cittadini, A.
   Sgambato, A.
TI DEVELOPMENT OF A NEW ZIRCONIA-TOUGHENED ALUMINA: PROMISING MECHANICAL
   PROPERTIES AND ABSENCE OF IN VITRO CARCINOGENICITY
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE ceramics; carcinogenicity; biocompatibility
ID DNA-DAMAGE; ARTHROPLASTY; FRACTURE; CELLS; HEAD
AB High purity alumina as well as zirconia ceramics have been widely used as orthopaedic implant biomaterials and dental devices displaying optimal, but sometimes exclusive, mechanical properties. In order to combine the advantages of alumina and zirconia ceramic materials different types of composites have been developed in which either zirconia is dispersed in an alumina matrix or vice versa. Orthopaedic and dental implant biomaterials are expected to be in contact with living tissues for a long period of time and their long term toxicity must. be carefully evaluated. In this study we report the development of a high performance chromia-doped Zirconia Toughened Alumina (ZTA) material which displays promising mechanical properties in terms of hardness, strength and fracture toughness that make it suitable for prosthesis even for small joints. The long-term biocompatibility of this material was also evaluated, mainly in terms of DNA damage, mutagenicity and cancerogenetic potential in mammalian cells. The results obtained suggest that this new ZTA material does not display any long-term carcinogenic effect and it is suitable for biomedical applications from a cancerogenetic point of view. In conclusion, we report the development of a new chromia-doped ZTA material with interesting properties both from a mechanical and a biocompatibility point of view which warrant further studies on its suitability as a candidate biomaterial for orthopaedic implants and dental devices.
C1 [Manicone, P. F.; Raffaelli, L.; Iommetti, P. Rossi] Univ Cattolica Sacro Cuore, Inst Clin Dent, I-00168 Rome, Italy.
   [Maccauro, G.; Marotta, D.] Univ Cattolica Sacro Cuore, Dept Orthopaed & Traumatol, I-00168 Rome, Italy.
   [Bianchino, G.; Cittadini, A.; Sgambato, A.] Univ Cattolica Sacro Cuore, Inst Gen Pathol, I-00168 Rome, Italy.
   [Bianchino, G.; Cittadini, A.; Sgambato, A.] Univ Cattolica Sacro Cuore, Canc Res Ctr, I-00168 Rome, Italy.
   [Bianchino, G.; Cittadini, A.; Sgambato, A.] Canc Referral Ctr Basilicata CROB IRCCS, Potenza, Italy.
   [Sangiorgi, S.; Magnani, G.; Stewart, A.] Faenza Res Ctr, ENEA, Faenza, Italy.
RP Raffaelli, L (reprint author), Univ Cattolica Sacro Cuore, Inst Clin Dent, Largo A Gemelli 8, I-00168 Rome, Italy.
EM lraffaelli@rm.unicatt.it
OI Sgambato, Alessandro/0000-0002-9487-4563; Manicone, Paolo
   Francesco/0000-0003-0283-2903; MACCAURO, Giulio/0000-0002-7359-268X
FU EU [GRD1-199-10585]
FX This work was supported by the EU project GRD1-199-10585 "HYPERCER".
CR Burger W., 1997, KERAM Z, V49, P1067
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   GRISS P, 1973, J BIOMED MATER RES, V7, P453, DOI 10.1002/jbm.820070328
   HE C, 1993, WEAR, V162, P314, DOI 10.1016/0043-1648(93)90514-M
   LANDOLPH JR, 1979, P NATL ACAD SCI USA, V76, P930, DOI 10.1073/pnas.76.2.930
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Manicone P F, 2007, Int J Immunopathol Pharmacol, V20, P9
   Piconi C, 2006, J MATER SCI-MATER M, V17, P289, DOI 10.1007/s10856-006-7316-0
   Piconi C, 2005, KEY ENG MAT, V284-286, P979, DOI 10.4028/www.scientific.net/KEM.284-286.979
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   REZNIKOFF CA, 1973, CANCER RES, V33, P3239
   RYU RKN, 1987, CLIN ORTHOP RELAT R, P207
   Satoh Y, 1990, BIOCERAMICS, V3, P101
   Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Takami Y, 1997, J BIOMED MATER RES, V36, P381, DOI 10.1002/(SICI)1097-4636(19970905)36:3<381::AID-JBM12>3.0.CO;2-H
   WILLIAMS DF, 1992, BIOMATERIALS TISSUE, P525
NR 19
TC 20
Z9 20
U1 0
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JUL-SEP
PY 2009
VL 22
IS 3
BP 773
EP 779
DI 10.1177/039463200902200323
PG 7
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA 510WV
UT WOS:000271125100023
PM 19822094
OA Bronze
DA 2018-10-20
ER

PT J
AU Lopattananon, N
   Songkaew, S
   Thongruang, W
   Seadan, M
AF Lopattananon, N.
   Songkaew, S.
   Thongruang, W.
   Seadan, M.
TI Sustainable Biocomposites from Rice Flour and Sisal Fiber: Effect of
   Fiber Loading, Length and Alkali Treatment
SO INTERNATIONAL POLYMER PROCESSING
LA English
DT Article
ID PINEAPPLE LEAF FIBER; REINFORCED POLYPROPYLENE COMPOSITES;
   MECHANICAL-PROPERTIES; THERMOPLASTIC STARCH; EPOXY COMPOSITES; NATURAL
   FIBERS; POLYESTER COMPOSITES; PLASTICIZED STARCH; RUBBER COMPOSITES;
   WATER-ABSORPTION
AB Rice flour was modified with water and glycerol in singles-crew extruder to obtain bioplastic of low manufacturing cost. Sisal fibers were used as reinforcing fillers to enhance rice flour-bored bioplastic properties. The effects of short sisal fiber content (5 to 20 wt.%), length (0.2 to 6 mm) and alkali treatment (5 % w/v NaOH) on the moisture content, tensile properties, impact properties, dynamic mechanical properties and morphology of the biocomposites were studied. The results showed that incorporation of the sisal fibers with a fixed fiber length into the bioplastics improved moisture resistance, tensile strength, impact strength and storage modulus, and that the improvement level increased with increasing sisal fiber content. The optimum reinforcement was achieved at 20 wt.% of fiber loading and 4 mm long fibers. The tensile strength of the biocomposite was about 4 times more than that of the neat rice flour-based bioplastic. The use of 5 % NaOH aqueous solution further improved the moisture resistance and mechanical properties of the biocomposites, mainly resulting from better interfacial adhesion between the sisal fiber and rice flour matrix. Furthermore, the performance of the rice flour-based bioplastics synergistically combined with the sisal fibers suggests that they have great potential in development of environmentally friendly/sustainable biomaterial products from renewable resources.
C1 [Lopattananon, N.; Songkaew, S.] Prince Songkla Univ, Fac Sci & Technol, Dept Rubber Technol & Polymer Sci, Pattani 94000, Thailand.
   [Thongruang, W.] Prince Songkla Univ, Fac Engn, Dept Mech Engn, Hat Yai, Thailand.
   [Seadan, M.] Silpakorn Univ, Fac Sci, Dept Phys, Nakhon Prathom, Thailand.
RP Lopattananon, N (reprint author), Prince Songkla Univ, Fac Sci & Technol, Dept Rubber Technol & Polymer Sci, Pattani 94000, Thailand.
EM lnatinee@bunga.pn.psu.ac.th
FU National Science and Technology Development Agency (NSTDA); Ministry of
   Science and Technology (Thailand) [F 31-315-18-01]; Graduate School.
   Prince of Songkla University, Thailand
FX The authors gratefully acknowledge the financial Support from the
   National Science and Technology Development Agency (NSTDA). Ministry of
   Science and Technology (Thailand) for the research grant to contract
   number F 31-315-18-01 and the special scholarship granted by Graduate
   School. Prince of Songkla University, Thailand to Ms Suweeraya Songkeau.
CR Alvarez VA, 2004, J APPL POLYM SCI, V91, P4007, DOI 10.1002/app.13561
   Alvarez VA, 2006, COMPOS PART A-APPL S, V37, P1672, DOI 10.1016/j.compositesa.2005.10.005
   Averous L, 2001, POLYMER, V42, P6565, DOI 10.1016/S0032-3861(01)00125-2
   Averous L, 2004, CARBOHYD POLYM, V56, P111, DOI 10.1016/j.carbpol.2003.11.015
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Cardoso MB, 2007, CARBOHYD POLYM, V70, P160, DOI 10.1016/j.carbpol.2007.03.014
   COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302
   Curvelo AAS, 2001, CARBOHYD POLYM, V45, P183, DOI 10.1016/S0144-8617(00)00314-3
   Devi LU, 1997, J APPL POLYM SCI, V64, P1739
   Dufresne A, 1998, MACROMOLECULES, V31, P2693, DOI 10.1021/ma971532b
   FUJII T, 1975, J JPN SOC COMP MAT, V1, P35
   Funke U, 1998, POLYM DEGRAD STABIL, V59, P293, DOI 10.1016/S0141-3910(97)00163-8
   Gaspar M, 2005, POLYM DEGRAD STABIL, V90, P563, DOI 10.1016/j.polymdegradstab.2005.03.012
   JOSEPH K, 1993, J APPL POLYM SCI, V47, P1731, DOI 10.1002/app.1993.070471003
   Joseph PV, 1999, COMPOS SCI TECHNOL, V59, P1625, DOI 10.1016/S0266-3538(99)00024-X
   Joseph PV, 2003, COMPOS PART A-APPL S, V34, P253, DOI 10.1016/S1359-835X(02)00185-9
   Liu WJ, 2005, POLYMER, V46, P2710, DOI 10.1016/j.polymer.2005.01.027
   Lopattananon N, 2008, J APPL POLYM SCI, V110, P433, DOI 10.1002/app.28496
   Lopattananon N, 2006, J APPL POLYM SCI, V102, P1974, DOI 10.1002/app.24584
   Lourdin D, 1997, J APPL POLYM SCI, V63, P1047, DOI 10.1002/(SICI)1097-4628(19970222)63:8<1047::AID-APP11>3.0.CO;2-3
   Ma XF, 2005, CARBOHYD POLYM, V62, P19, DOI 10.1016/j.carbpol.2005.07.015
   Mali S, 2005, CARBOHYD POLYM, V60, P283, DOI 10.1016/j.carbpol.2005.01.003
   Martins MA, 2004, J APPL POLYM SCI, V91, P670, DOI 10.1002/app.13210
   Martins MA, 2003, J APPL POLYM SCI, V89, P2507, DOI 10.1002/app.12285
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   Mohanty AK, 2001, COMPOS INTERFACE, V8, P313, DOI 10.1163/156855401753255422
   MUKHERJEE PS, 1984, J MATER SCI, V19, P3925, DOI 10.1007/BF00980755
   Mukhopadhyay S, 2008, POLYM DEGRAD STABIL, V93, P2048, DOI 10.1016/j.polymdegradstab.2008.02.018
   Oksman K, 2002, J APPL POLYM SCI, V84, P2358, DOI 10.1002/app.10475
   Rodriguez-Gonzalez FJ, 2004, CARBOHYD POLYM, V58, P139, DOI 10.1016/j.carbpol.2004.06.002
   Rong MZ, 2001, COMPOS SCI TECHNOL, V61, P1437, DOI 10.1016/S0266-3538(01)00046-X
   Sarazin P, 2008, POLYMER, V49, P599, DOI 10.1016/j.polymer.2007.11.029
   Sreekumar PA, 2007, COMPOS SCI TECHNOL, V67, P453, DOI 10.1016/j.compscitech.2006.08.025
   Towo AN, 2008, COMPOS SCI TECHNOL, V68, P925, DOI 10.1016/j.compscitech.2007.08.022
   Wollerdorfer M, 1998, IND CROP PROD, V8, P105, DOI 10.1016/S0926-6690(97)10015-2
   Zarate CN, 2003, J APPL POLYM SCI, V89, P2714, DOI 10.1002/app.12404
   ZELEZNAK KJ, 1987, CEREAL CHEM, V64, P121
NR 37
TC 3
Z9 3
U1 1
U2 12
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0930-777X
J9 INT POLYM PROC
JI Int. Polym. Process.
PD JUL
PY 2009
VL 24
IS 3
BP 272
EP 279
DI 10.3139/217.2258
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 479VM
UT WOS:000268689500008
DA 2018-10-20
ER

PT J
AU Yeh, LK
   Chen, YH
   Chiu, CS
   Hu, FR
   Young, TH
   Wang, IJ
AF Yeh, Lung-Kun
   Chen, Yi-Hsin
   Chiu, Chih-Sheng
   Hu, Fung-Rong
   Young, Tai-Horng
   Wang, I-Jong
TI The phenotype of bovine corneal epithelial cells on chitosan membrane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; amniotic membrane; corneal epithelial cells
ID STEVENS-JOHNSON-SYNDROME; HUMAN AMNIOTIC MEMBRANE; SURFACE
   RECONSTRUCTION; CELLULAR GROWTH; OCULAR SURFACE; STEM-CELLS;
   TRANSPLANTATION; PROLIFERATION; ADHESION; HYPOPYON
AB Corneal wound healing is one of the major issues in ocular surface reconstruction and ocular surface diseases. Amniotic membrane (AM) transplantation is an excellent treatment modality to promote corneal wound healing and treat corneal diseases. It is interesting and valuable to search for another synthetic and biocompatible for the study of mechanism of AM and the treatment of ocular surface disorders. Chitosan, the second-most abundant polymer in nature, has many biological advantages such as biocompatibility, biodegradability, hemostatic activity, and wound-healing property to be used as biomedical applications. The purpose of this project is to evaluate the phenotype of cultured corneal epithelial cells in vitro on synthetic chitosan membrane (CM). We cultivated bovine corneal epithelial cells on CM and AM, and then evaluated their phenotypes. The viability of the respective cell cultures was invetigated using the 3-[4,5-dimethylrhiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. The cytotoxicity of CM and AM to corneal epithelial cells Was evaluated by lactate dehydrogenase (LDH) assay. The morphology of cultivated corneal epithelial cells on CM and AM was observed by scanning electron microscopy. Additionally, immunocytochemical stainings were used to confirm the phenotype of corneal epithelial cells. In MTT and LDH assays we found that the CM Can support the growth of cultured corneal epithelial cells in good condition with minimal toxicity. The SEM and immunohistocytochemistry, showed that the phenotype of corneal epithelial cells is compatible with that of AM. We conclude that the CM has the potential to be a suitable biomaterial for treating ocular surface disorders. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A:18-26, 2009
C1 [Hu, Fung-Rong; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Yeh, Lung-Kun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.
   [Yeh, Lung-Kun] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei 10764, Taiwan.
   [Chen, Yi-Hsin; Young, Tai-Horng] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.
   [Chiu, Chih-Sheng; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Chiu, Chih-Sheng; Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
RP Wang, IJ (reprint author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
EM ljong@ms8.hinet.net
OI HU, FUNG-RONG/0000-0002-2102-5317; Wang, I-Jong/0000-0002-3045-0614
FU Taiwan NSC [923112B002004, 933112B002031, 943112B002007, 932314B002090,
   942314B002043, 94WHK0500128]
FX Taiwan NSC; contract grant numbers: 923112B002004, 933112B002031,
   943112B002007, 932314B002090, 942314B002043, 94WHK0500128
CR Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K
   AZAD AK, 2004, J BIOMED MATER RES B, V69, pB216
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   Evans MDM, 2003, J BIOMED MATER RES A, V64A, P357, DOI 10.1002/jbm.a.10341
   Gabler B, 2000, OPHTHALMOLOGY, V107, P1344, DOI 10.1016/S0161-6420(00)00167-6
   George A, 2002, BIOMATERIALS, V23, P1369, DOI 10.1016/S0142-9612(01)00257-5
   GERDES J, 1984, J IMMUNOL, V133, P1710
   Honavar SG, 2000, OPHTHALMOLOGY, V107, P975, DOI 10.1016/S0161-6420(00)00026-9
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   KOJI K, 1993, ADV CHITIN CHITOSAN, P9
   Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   LIU CY, 1994, J BIOL CHEM, V269, P24627
   MARKEY ML, 1989, CHITIN CHITOSAN, P713
   Messmer EM, 2001, OPHTHALMOLOGY, V108, P1714, DOI 10.1016/S0161-6420(01)00734-5
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUZZARELLI R, 1994, IN VIVO BIOCH SIGNIF, P179
   MUZZARELLI RA, 1999, BIOCH HISTOLOGY CLIN
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235
   STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755
   Sweeney DF, 2003, INVEST OPHTH VIS SCI, V44, P3301, DOI 10.1167/iovs.02-0561
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
NR 31
TC 20
Z9 21
U1 1
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 18
EP 26
DI 10.1002/jbm.a.32077
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700002
PM 18481792
DA 2018-10-20
ER

PT J
AU Dettin, M
   Bagno, A
   Gambaretto, R
   Iucci, G
   Conconi, MT
   Tuccitto, N
   Menti, AM
   Grandi, C
   Di Bello, C
   Licciardello, A
   Polzonetti, G
AF Dettin, Monica
   Bagno, Andrea
   Gambaretto, Roberta
   Iucci, Giovanna
   Conconi, Maria Teresa
   Tuccitto, Nunzio
   Menti, Anna Michela
   Grandi, Claudio
   Di Bello, Carlo
   Licciardello, Antonino
   Polzonetti, Giovanni
TI Covalent surface modification of titanium oxide with different adhesive
   peptides: Surface characterization and osteoblast-like cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomimetic surface; biomaterial; peptide; cell adhesion; surface
   characterization
ID CHEMICAL-MODIFICATION; IN-VITRO; ATTACHMENT; RGD; BIOMATERIALS; FILM
AB A fundamental goal in the field of implantology is the design of innovative devices suitable foil promoting, implant-to-tissue integration. This result can be achieved by means of surface modifications aimed at optimizing tissue regeneration. In the framework of oral and orthopedic implantology, surface modifications concern both the optimization of titanium/titanium alloy surface roughness and the attachment of biochemical factors able to guide cellular adhesion and/or growth. This article focuses on the covalent attachment of two different adhesive peptides to rough titanium disks. The capability of biomimetic surfaces to increase osteoblast adhesion and the specificity of their biological activity due to the presence of cell adhesion signal-motif have also been investigated. In addition, surface analyses by profilometry, X-ray photoelectron spectroscopy, and time of flight-secondary ion mass spectrometry have been carried out to investigate the effects and modifications induced by grafting procedures. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 35-45, 2009
C1 [Dettin, Monica; Bagno, Andrea; Gambaretto, Roberta; Di Bello, Carlo] Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
   [Iucci, Giovanna; Polzonetti, Giovanni] Univ Roma Tre, Dept Phys, I-00146 Rome, Italy.
   [Conconi, Maria Teresa; Menti, Anna Michela; Grandi, Claudio] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy.
   [Tuccitto, Nunzio; Licciardello, Antonino] Univ Catania, Dept Chem Sci, I-95125 Catania, Italy.
RP Dettin, M (reprint author), Univ Padua, Dept Chem Proc Engn, Via Marzolo 9, I-35131 Padua, Italy.
EM monica.dettin@unipd.it
RI Licciardello, Antonino/A-6614-2011
OI Licciardello, Antonino/0000-0001-5146-8971; Bagno,
   Andrea/0000-0002-4296-3601; Tuccitto, Nunzio/0000-0003-4129-0406
CR Bagno A, 2004, BIOMATERIALS, V25, P2437, DOI 10.1016/j.biomaterials.2003.09.018
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V1
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   Dettin M, 1998, J PEPT SCI, V4, P436, DOI 10.1002/(SICI)1099-1387(199811)4:7<436::AID-PSC163>3.0.CO;2-C
   Dettin M, 2006, TISSUE ENG, V12, P3509, DOI 10.1089/ten.2006.12.3509
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Koo LY, 2002, J CELL SCI, V115, P1423
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   LUNA LG, 1968, MANUAL HISTOLOGIC ST, P174
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Moulder J. F., 1996, HDB XRAY PHOTOELECTR
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   SCHMIDT M, 1991, FRESEN J ANAL CHEM, V341, P412, DOI 10.1007/BF00321947
   Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Yokose S, 1996, ENDOCRINOLOGY, V137, P469, DOI 10.1210/en.137.2.469
NR 27
TC 29
Z9 29
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 35
EP 45
DI 10.1002/jbm.a.32064
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700004
PM 18481788
DA 2018-10-20
ER

PT J
AU Walpole, AR
   Xia, ZD
   Wilson, CW
   Triffitt, JT
   Wilshaw, PR
AF Walpole, Andrew R.
   Xia, Zhidao
   Wilson, Crispian W.
   Triffitt, James T.
   Wilshaw, Peter R.
TI A novel nano-porous alumina biomaterial with potential for loading with
   bioactive materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE anodic aluminium oxide (AAO); titanium; nano-porous; osteoblastic cells
ID NANOPHASE CERAMICS; HYDROXYAPATITE COATINGS; OSTEOBLAST ADHESION; ANODIC
   ALUMINA; IN-VITRO; ARTHROPLASTY; FABRICATION; INTERFACE; MEMBRANES;
   STRENGTHS
AB Nano-porous alumina, with the potential for being loaded with bioactive materials, has been proposed as a novel material for coating implants. In this study, the shear strength of the interface between such nano-porous anodic aluminium oxide (AAO) coatings and titanium substrates, their biocompatibility, and their potential for pore loading have been investigated. An interface shear strength in excess of 29 MPa was obtained which is comparable with that of conventional plasma sprayed hydroxyapatite implant coatings. The viability and differentiation of MG63 osteoblastic cells co-cultured on the coating was found to be broadly comparable to that of similar cells co-cultured on conventional bioinort implant materials such as titanium and fully dense alumina. Extensive pore loading with silica nano-particles of different sizes and in different combinations was demonstrated throughout the thickness of AAO layers 1 mu m and 60 mu m thick. This work has demonstrated, that with suitable choice of pore filling materials, this novel coating might simultaneously combat infection, encourage bone regeneration, and secure fixation of the implant to bone. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 46-54, 2009
C1 [Walpole, Andrew R.; Wilson, Crispian W.; Wilshaw, Peter R.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England.
   [Xia, Zhidao; Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX1 3PH, England.
RP Wilshaw, PR (reprint author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.
EM peter.wilshaw@materials.ox.ac.uk
OI Xia, Zhidao/0000-0002-2047-7282; Wilshaw, Peter R/0000-0002-3864-6064
CR Aubin Jane E., 1996, P51
   BAUN WL, 1980, J MATER SCI, V15, P2749, DOI 10.1007/BF00550542
   Briggs EP, 2004, J MATER SCI-MATER M, V15, P1021, DOI 10.1023/B:JMSM.0000042688.33507.12
   BRUNSKI JB, 1991, BONE-BIOMATERIAL INTERFACE, P391
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Choong C, 2004, FOOD BIOPROD PROCESS, V82, P117, DOI 10.1205/0960308041614864
   Ding SJ, 2001, BIOMATERIALS, V22, P833, DOI 10.1016/S0142-9612(00)00247-7
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   ELDRIDGE JDJ, 2000, INTERFACES TOTAL HIP, P71
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   Fischer H, 2005, BIOMATERIALS, V26, P6151, DOI 10.1016/j.biomaterials.2005.04.038
   FURNEAUX RC, 1989, NATURE, V337, P147, DOI 10.1038/337147a0
   Green DJ, 1998, INTRO MECH PROPERTIE
   GRISS P, 1975, J BIOMED MATER RES, V9, P177, DOI 10.1002/jbm.820090421
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   Gu YW, 2004, BIOMATERIALS, V25, P3177, DOI 10.1016/j.biomaterials.2003.09.101
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   JARCHO M, 1977, J BIOENG, V1, P79
   Kamada K, 2004, ELECTROCHEM SOLID ST, V7, pB25, DOI 10.1149/1.1758932
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Li Y, 2000, J VAC SCI TECHNOL B, V18, P994, DOI 10.1116/1.591314
   Munz D., 1999, CERAMICS MECH PROPER
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Oh IK, 2005, J MATER SCI-MATER M, V16, P635, DOI 10.1007/s10856-005-2534-4
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   OSULLIVAN JP, 1970, PROC R SOC LON SER-A, V317, P511, DOI 10.1098/rspa.1970.0129
   PARK JB, 1992, BIOMATERIALS INTRO
   Phung LH, 2004, MACROMOL SYMP, V210, P349, DOI 10.1002/masy.200450639
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Ridgeway S, 2005, J BONE JOINT SURG BR, V87B, P844, DOI 10.1302/0301-620X.87B6.15121
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   SHIRKHANZADEH M, 1994, MATER LETT, V18, P211, DOI 10.1016/0167-577X(94)90233-X
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Tonino AJ, 2003, ACTA ORTHOP SCAND, V74, P365, DOI 10.1080/00016470310014328
   Walpole AR, 2003, MATERIALWISS WERKST, V34, P1064, DOI 10.1002/mawe.200300707
   Webster T.J., 1998, BIOCERAMICS, P273
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WILSON CW, 2005, IMPROVED BONE IMPL 2
NR 46
TC 28
Z9 29
U1 1
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 46
EP 54
DI 10.1002/jbm.a.32067
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700005
PM 18481790
DA 2018-10-20
ER

PT J
AU Filova, E
   Brynda, E
   Riedel, T
   Bacakova, L
   Chlupac, J
   Lisa, V
   Houska, M
   Dyr, JE
AF Filova, Elena
   Brynda, Eduard
   Riedel, Tomas
   Bacakova, Lucie
   Chlupac, Jaroslav
   Lisa, Vera
   Houska, Milan
   Dyr, Jan E.
TI Vascular endothelial cells on two- and three-dimensional fibrin
   assemblies for biomaterial coatings
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE artificial fibrin networks; surface modification; nanostructure;
   endothelial cells; von Willebrand factor
ID GROWTH-FACTOR; ANGIOGENESIS; LOCALIZATION; SCAFFOLD; MATRIX; GEL
AB Various techniques for coating synthetic surfaces with fibrin structures were tested for seeding bovine pulmonary artery endothelial cells (EC). Two-dimensional fibrin (Fb) structures (2D 17b) were obtained by successively repeating adsorption of fibrinogen) (Fbg), incubating the surface with thrombin (Thr) solution, and inhibiting surface attached Thr. Three-dimensional fibrin networks immobilized at the surface (3D Fb) were formed by catalytic action of surface-attached thrombin on an ambient Fbg solution. Ultra-thin 3D Fbs were obtained if thrombin inhibitors antithrombin III and heparin were added into an Fbg solution. The formation of surface fibrin structures was observed in situ using surface plasmon resonance. The morphology of the structures was studied by transmission and phology scanning electron microscopy. A polylactide fibrous scaffold was modified with a surface fibrin film without filling the inner pores with a bulk gel. The growth of EC seeded on a polystyrene surface coated with the Fb films was evaluated by the number and and morphology of the adhering ECs and the concentration of beta-actin, vinculin, alpha((sic))-intergrin, and and von Willebrand factor (vWF). The best initial cell spreading after 1 day was observed on 2D Fb and ultra-thin 3D Fb. The highest concentration of vWF, a marker Of EC differentiation, was observed after 3 days on thick 3D Fbs. The highest EC population densities after 7 days were observed on 2D Fb and thick 3D Fb. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 55-69, 2009
C1 [Filova, Elena; Bacakova, Lucie; Chlupac, Jaroslav; Lisa, Vera] Acad Sci Czech Republic, Inst Physiol, Dept Growth & Differentiat Cell Populat, CR-14220 Prague 4, Czech Republic.
   [Filova, Elena; Bacakova, Lucie; Chlupac, Jaroslav] Cardiovasc Res Ctr, Prague 14220 4, Czech Republic.
   [Brynda, Eduard; Riedel, Tomas; Houska, Milan] Acad Sci Czech Republic, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic.
   [Riedel, Tomas; Dyr, Jan E.] Inst Hematol & Blood Transfus, Prague 12800 2, Czech Republic.
RP Filova, E (reprint author), Acad Sci Czech Republic, Inst Physiol, Dept Growth & Differentiat Cell Populat, Videnska 1083, CR-14220 Prague 4, Czech Republic.
EM filova@biomed.cas.cz
RI Riedel, Tomas/H-6777-2014; Bacakova, Lucie/C-2664-2012; Houska,
   Milan/H-6809-2014; Dyr, Jan/G-5580-2017; Brynda, Eduard/H-6818-2014;
   Filova, Elena/C-2209-2012
OI Riedel, Tomas/0000-0002-2971-6956; Bacakova, Lucie/0000-0002-1818-9484;
   Houska, Milan/0000-0001-6668-8870; Dyr, Jan/0000-0002-7970-5868;
   Chlupac, Jaroslav/0000-0003-1482-6105
CR Bense CA, 1999, J BIOMED MATER RES, V46, P305, DOI 10.1002/(SICI)1097-4636(19990905)46:3<305::AID-JBM1>3.0.CO;2-A
   BRYNDA E, 1986, J COLLOID INTERF SCI, V113, P164, DOI 10.1016/0021-9797(86)90216-X
   Cardon A, 2000, ANN VASC SURG, V14, P543, DOI 10.1007/s100169910102
   CHEN YP, 1995, BLOOD, V86, P2606
   CHLUPAC J, 2006, ENG BIOMATER, V9, P10
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   COLMAN RW, 2005, HEMOSTASIS THROMBOSI
   Di Cera E, 2003, CHEST, V124, P11, DOI [10.1378/chest.124.3_suppl.11S, DOI 10.1378/CHEST.124.3_SUPPL.11S]
   Dyr JE, 1998, SENSOR ACTUAT B-CHEM, V51, P268, DOI 10.1016/S0925-4005(98)00204-4
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030
   Jackson MR, 2001, AM J SURG, V182, P1
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x
   MOLA A, 2005, BIOMATERIALS, V26, P3113
   RIEDEL T, 2004, 43 MICR POL BIOM BIO, pPC46
   RUBENS FD, 1993, THROMB HAEMOSTASIS, V69, P130
   Sahni A, 2000, BLOOD, V96, P3772
   Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Tsurupa G, 2001, ANN NY ACAD SCI, V936, P328
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   WEISEL JW, 1986, J ULTRA MOL STRUCT R, V96, P176, DOI 10.1016/0889-1605(86)90019-4
   WOLBERG AS, 2007, BLOOD REV, V21, P132
   Xue L, 2002, SURGERY, V132, P259, DOI 10.1067/msy.2002.125720
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 28
TC 22
Z9 22
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 55
EP 69
DI 10.1002/jbm.a.32065
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700006
PM 18481789
DA 2018-10-20
ER

PT J
AU Rodriguez, A
   MacEwan, SR
   Meyerson, H
   Kirk, JT
   Anderson, JM
AF Rodriguez, Analiz
   MacEwan, Sarah R.
   Meyerson, Howard
   Kirk, James T.
   Anderson, James M.
TI The foreign body reaction in T-cell-deficient mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE foreign body response; IL-4; IL-13; T lymphocyte; biomaterials
ID IN-VIVO BIOCOMPATIBILITY; MAST-CELLS; SURFACE-CHEMISTRY; MACROPHAGE
   FUSION; GIANT-CELLS; INTERLEUKIN-4; BIOMATERIALS; CYTOKINE; LYMPHOKINE;
   ACTIVATION
AB The role(s) of T lymphocytes in the foreign body response has not been thoroughly elucidated. Lymphocytes are known to augment macrophage adhesion and fusion in vitro. Furthermore, T lymphocytes are a possible source of the cytokine, IL-4 and IL-13, which induce macrophage fusion. In this study, we used BALB/c mice and BALB/c (nu/nu) nude mice to investigate foreign body giant cell (FBGC) formation in T-cell-deficient setting. Mice were implanted with Elasthane 80A (PEU), silicone rubber (SR), or poly(ethylene terephthalate) (PET) for 7, 14, or 21 days using the cage implant system. Exudate cells and IL-4 and IL-13 levels in exudate supernatants were analyzed by flow cytometry and a multiplex immunoassay, respectively, at Days 7, 14, and 21. Macrophage adhesion and fusion on material surfaces were analyzed using optical microscopy. T-cell-deficient mice had lower total leukocyte concentration at the biomaterial implant site at all time points. Adherent cell density was comparable between normal and T-cell-deficient mice except in the PEU group at Day 21. However, percent fusion, average nuclei per FBGC, and FBGC morphology were comparable between normal and T-cell-deficient mice. IL-4 was not detected in any sample, but IL-13 levels were also comparable between normal and T-cell-deficient mice indicating Th2-polarized T-cells are not the sole source of this cytokine. We have shown that there, are pathways that do not require thymus-matured T lymphocytes, which lead to a normal foreign body response to biomaterials in a murine model. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 106-113, 2009
C1 [Rodriguez, Analiz; Meyerson, Howard; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [MacEwan, Sarah R.; Kirk, James T.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), 2103 Cornell Rd,Wolstein Res Bldg 5104, Cleveland, OH 44106 USA.
EM jma6@case.edu
OI MacEwan, Sarah/0000-0002-4365-6232
FU NIBIB NIH HHS [R56 EB000282, R01 EB000282, EB-000282]; NIGMS NIH HHS
   [T32 GM007250, T32-GM07250]
CR Al-Saffar N, 1998, J MATER SCI-MATER M, V9, P849, DOI 10.1023/A:1008952329788
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063
   Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MACEWAN MR, 2005, 30 ANN M SOC BIOM ME
   McNally AK, 1996, AM J PATHOL, V149, P975
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Metwali A, 2002, EUR J IMMUNOL, V32, P1242, DOI 10.1002/1521-4141(200205)32:5<1242::AID-IMMU1242>3.0.CO;2-7
   Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x
   Miosge L, 2007, CURR OPIN IMMUNOL, V19, P194, DOI 10.1016/j.coi.2007.02.008
   MORENO JL, 2007, J LEUKOC BIOL
   Nasser S, 2007, ORTHOPEDICS, V30, P89
   PAUL WE, 1991, BLOOD, V77, P1859
   RODRIGUEZ A, 2007, J BIOMED MATER RES A, V852, P556
   Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x
   Shelburne CP, 2001, IMMUNOL REV, V179, P82, DOI 10.1034/j.1600-065X.2001.790109.x
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
NR 30
TC 27
Z9 27
U1 2
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 106
EP 113
DI 10.1002/jbm.a.32050
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700010
PM 18491378
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Orefice, R
   Hench, L
   Brennan, A
AF Orefice, Rodrigo
   Hench, Larry
   Brennan, Anthony
TI Evaluation of the interactions between collagen and the surface of a
   bioactive glass during in vitro test
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioactive glasses; collagen; adsorption; afm
ID ATOMIC-FORCE MICROSCOPY; ADHESION FORCES; AFM; QUANTIFICATION; SILICA;
   CELL; POLYSTYRENE
AB Interactions between biomaterials and the body environment usually determine the lifetime and performance of biomedical devices used as implants. Among a variety of different types of interactions that occur whenever bio-materials are implanted into the body, adsorption of biomacromolcules onto the surface of biomaterials can guide other relevant processes such as cell attachment, cell differentiation, cell proliferation, tissue growth and biomaterials degradation. In this work, fundamental mechanisms associated with the interactions between collagen and the surface of biomaterials were studied by using Atomic Force Microscopy (AFM). The ultimate goal of this work is to isolate and simulate phenomena occurring at the molecular level, when biological entities are brought in contact with biomaterials. These results can then be used to design and test new biomedical devices. This Manuscript reports the evaluation of interaction between collagen and the surface of bioactive glasses. These bioactive glasses are known to bond to soft and hard tissues through the formation of a hydroxy-carbonate-apatite layer. Collagen was grafted onto AFM cantilevers. AFM force-displacement curves were obtained using these modified tips against the surface of a bioactive glass at different stages of an in vitro test performed in a stimulated body fluid. The results showed that the structure of the bioactive glass surface affects the adsorption of collagen on the biomaterial. The magnitude of the adhesion force measured is highly dependent on the deposition of a hydroxyl-carbonate-apatite at the surface of the glass. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 114-120, 2009
C1 [Orefice, Rodrigo] Univ Fed Minas Gerais, Dept Met & Mat Sci, BR-30160030 Belo Horizonte, MG, Brazil.
   [Hench, Larry] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Brennan, Anthony] Univ Florida, Dept Mat Sci & Eng & Biomed Engn, Gainesville, FL 32611 USA.
RP Orefice, R (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Sci, R Espirito Santo 35-206, BR-30160030 Belo Horizonte, MG, Brazil.
EM rorefice@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056
CR ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   Curran MD, 1999, J NON-CRYST SOLIDS, V249, P62, DOI 10.1016/S0022-3093(99)00237-9
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   Dupont-Gillain CC, 2003, SURF SCI, V539, P145, DOI 10.1016/S0039-6028(03)00779-9
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hyonchol K, 2002, COLLOID SURFACE B, V25, P33, DOI 10.1016/S0927-7765(01)00299-5
   Kim H, 2003, ULTRAMICROSCOPY, V97, P359, DOI 10.1016/S0304-3991(03)00061-5
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   Lu SQ, 2006, POLYMER, V47, P2539, DOI 10.1016/j.polymer.2005.11.095
   Lubarsky GV, 2004, SURF SCI, V558, P135, DOI 10.1016/j.susc.2004.03.054
   MOSBACH K, 1976, METHOD ENZYMOL, P44
   MOY VT, 1994, SCIENCE, V266, P297
   Orefice RL, 2006, MACROMOL MATER ENG, V291, P377, DOI 10.1002/mame.200500322
   Orefice R, 2007, J BIOMED MATER RES A, V80A, P565, DOI 10.1002/jbm.a.30948
   PARK JB, 1992, BIOMATERIALS INTRO
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003
   Ratner B.D., 2004, BIOMATERIALS SCI
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Sokolov I, 2006, J COLLOID INTERF SCI, V300, P475, DOI 10.1016/j.jcis.2006.04.023
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
NR 26
TC 13
Z9 14
U1 1
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 114
EP 120
DI 10.1002/jbm.a.32080
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700011
PM 18491395
DA 2018-10-20
ER

PT J
AU Inanc, B
   Arslan, YE
   Seker, S
   Elcin, AE
   Elcin, YM
AF Inanc, Buelend
   Arslan, Y. Emre
   Seker, Suekran
   Elcin, A. Eser
   Elcin, Y. Murat
TI Periodontal ligament cellular structures engineered with electrospun
   poly(DL-lactide-co-glycolide) nanofibrous membrane scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PLGA nanofibers; cell sheets; electrospinning; human periodontal
   ligament cells; tissue engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO; TISSUE; FIBROBLASTS; REGENERATION;
   MODEL
AB Periodontal tissue engineering is expected to overcome the limitations associated with the existing regenerative techniques tor the treatment of periodontal defects involving alveolar bone, cementum, and periodontal ligament. Cell-based tissue engineering approaches involve the utilization of in vitro expanded cells with regenerative capacity and their delivery to the appropriate sites via biomaterial scaffolds. The aim of this study was to establish living periodontal ligament cell-containing structures on electrospun poly(DL-lactic-co-glycolic acid) (PLGA) nanofiber membrane scaffolds, assess their viability and characteristics, and engineer multilayered structures amenable to easy handling. Human periodontal ligament (hPDL) cells were expanded in explant culture and then characterized morphologically and immunohistochemically. PLGA nanofiber membranes were prepared by the electrospinning process; mechanical tensile properties were determined, surface topography, nanofiber size, and porosity status were investigated with SEM. Cells were seeded on the membranes at similar to 50,000 cell/cm(2) and cultured for 21 days either in expansion or in osteogenic induction medium. Cell adhesion and viability were demonstrated using SEM and MTT, respectively, and osteogenic differentiation was determined with IHC and immunohistomorphometric evaluation of osteopontin, osteocalcin, and bone sialoprotein marker expression. At days 3, 6, 9, and 12 additional cell membrane layers were deposited on the existing ones and multilayered hybrid structures were established. Results indicate the feasibility of periodontal ligament cell-containing, tissue-like structures engineering with PDL cells and electrospun nanofiber PLGA scaffolds supporting cell adhesion, viability and osteogenic differentiation properties of cells in hybrid structures amenable to macroscopic handling. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 186-19-5, 2009
C1 [Inanc, Buelend; Arslan, Y. Emre; Seker, Suekran; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Fac Sci, Tissue Engn & Biomat Lab, TR-06100 Ankara, Turkey.
   [Inanc, Buelend; Arslan, Y. Emre; Seker, Suekran; Elcin, A. Eser; Elcin, Y. Murat] Inst Biotechnol, TR-06100 Ankara, Turkey.
   [Elcin, A. Eser] Gazi Univ, Div Biol Educ, GEF, TR-06100 Ankara, Turkey.
RP Elcin, YM (reprint author), Ankara Univ, Fac Sci, Tissue Engn & Biomat Lab, TR-06100 Ankara, Turkey.
EM elcin@science.ankara.edu.tr
RI ARSLAN, Yavuz Emre/M-2907-2016
OI ARSLAN, Yavuz Emre/0000-0003-3445-1814; Elcin, Yasar
   Murat/0000-0003-1037-0825
CR AGRAWAL SM, 2001, J BIOMED MATER RES, V55, P145
   Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003
   Benatti BB, 2007, J BIOSCI BIOENG, V103, P1, DOI 10.1263/jbb.103.1
   ELEIN YM, 2003, TISSUE ENG STEM CELL
   Engelmayr GC, 2006, J BIOMECH ENG-T ASME, V128, P610, DOI 10.1115/1.2205371
   Fisher RJ, 2007, ADV BIOCHEM ENG BIOT, V103, P1, DOI 10.1007/10_018
   Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605
   Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Inanc B, 2006, TISSUE ENG, V12, P257, DOI 10.1089/ten.2006.12.257
   Inanc B, 2007, J BIOMED MATER RES A, V82A, P917, DOI 10.1002/jbm.a.31213
   Kao Richard T, 2005, J Calif Dent Assoc, V33, P205
   Kramer PR, 2004, J DENT RES, V83, P27, DOI 10.1177/154405910408300106
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   LI WJ, 2006, TISSUE CELL ORGAN EN, V9, P135
   LIU X, 2005, J BIOMED MATER RES A, V71, P84
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nakahara Taka, 2006, Dent Clin North Am, V50, P265, DOI 10.1016/j.cden.2005.11.004
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Sawa Y, 2000, TISSUE CELL, V32, P163, DOI 10.1054/tice.2000.0100
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yang YQ, 2006, FRONT BIOSCI, V11, P776, DOI 10.2741/1835
NR 25
TC 50
Z9 54
U1 2
U2 30
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 186
EP 195
DI 10.1002/jbm.a.32066
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700018
PM 18491392
DA 2018-10-20
ER

PT J
AU Perrotti, V
   Nicholls, BM
   Horton, MA
   Piattelli, A
AF Perrotti, Vittoria
   Nicholls, Brian M.
   Horton, Michael A.
   Piattelli, Adriano
TI Human osteoclast formation and activity on a xenogenous bone mineral
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone substitute materials; confocal microscopy; ELISA; osteoclasts;
   resorption
ID CALCIUM-PHOSPHATE CERAMICS; BOVINE BONE; IN-VITRO; SYNTHETIC
   HYDROXYAPATITE; SUBSTITUTE BIOMATERIALS; VITRONECTIN RECEPTOR;
   HISTOLOGIC-FINDINGS; SEALING ZONE; RESORPTION; INTERFACE
AB To date, the majority of studies on bone substitute materials have investigated their regenerative properties; however, little is known about their resorption processes, forasmuch as it is believed that the ideal biomaterial for bone regeneration must be completely resorbable. This study is aimed at defining, the in vitro resorption potential of human osteoclasts (OCLs) on a xenogenous bone mineral (XBM). Peripheral blood mortonuclear cells from healthy volunteers were used to generate OCLs in vitro in the presence of macrophage colony stimulating factor and receptor activator of NF-kappa B ligand on bovine bone slices and XBM. By using morphologic and biochemical methods, we observed that OCL formation occurred on XBM and these cells were positive for the major OCL marker. Regarding OCL activity, resorption pits were detected on XBM by reflection and confocal microscopy. However, biochemical analysis revealed that collagen degradation at day 14 and was significantly lower in XBM supernatants when compared to bovine bone, suggesting that XBM underwent a much slower resorption over time. These findings demonstrate that OCLs are generated on, attach to, and resorb XBM through more slowly than native bone, and suggest that cultured human OCLs could be used as a model for comparing resorption rates of bone substitute materials. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 238-246, 2009
C1 [Perrotti, Vittoria; Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Perrotti, Vittoria; Nicholls, Brian M.; Horton, Michael A.] UCL, London Ctr Nanotechnol, London, England.
   [Perrotti, Vittoria; Nicholls, Brian M.; Horton, Michael A.] UCL, Ctr Nanomed, London, England.
RP Piattelli, A (reprint author), Via Vestini 13, I-66100 Chieti, Italy.
EM apiattelli@unich.it
FU Wellcome Trust
CR Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   GROSS UM, 1990, BIOMATERIALS, V11, P83
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawahara H, 2004, J MATER SCI-MATER M, V15, P1297, DOI 10.1007/s10856-004-5738-0
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Lader CS, 2001, BRIT J HAEMATOL, V112, P430, DOI 10.1046/j.1365-2141.2001.02437.x
   LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179
   LAKKAKORPI PT, 1993, J CELL SCI, V104, P663
   Lane JM, 1998, AAOS INSTR COURS LEC, V47, P525
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Massey HM, 1999, BRIT J HAEMATOL, V106, P167
   Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586
   Nakamura I, 1999, J CELL SCI, V112, P3985
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Swiontkowski M, 1999, LANCET S1, V353, pS128
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
NR 35
TC 27
Z9 27
U1 1
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 238
EP 246
DI 10.1002/jbm.a.32079
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700023
PM 18496862
DA 2018-10-20
ER

PT J
AU Sarkar, D
   Yailg, JC
   Sen Gupta, A
   Lopina, ST
AF Sarkar, Debanjan
   Yailg, Jui-Chen
   Sen Gupta, Anirban
   Lopina, Stephanie T.
TI Synthesis and characterization of L-tyrosine based polyurethanes for
   biomaterial applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE amino acid; L-tyrosine; polyurethanes; biomaterial; tissue engineering
ID ELASTOMERS; POLYCARBONATES; COPOLYMERS; POLYARYLATES; DESIGN; FILMS
AB The use of amino acid based polymers for biomaterial applications enhance biocompatibility and ensure biodegradability. Two polyurethanes based on L-tyrosine based diphenolic dipeptide, desaminotyrosyl tyrosine hexyl ester as chain extender are synthesized with polyethylene glycol (PEG) and polycaprolactone diol (PCL) as soft segment and hexamethylene diisocyanate as diisocyanate. The chemical structure and molecular characteristics of the polymers were studied by H-1 NMR, FTIR, and gel permeation chromatography. Results of DSC and TGA analysis were used for examining the thermal behavior of the polyurethanes. In addition, DSC results were used to analyze the morphology of the polymers, which shows characteristic microphase behavior of the polyurethanes. The tensile properties of the polyurethanes are primarily controlled by the soft segment and are higher in PCL based polymers. Contact angle, water vapor permeation, release of model drug, and water absorption characteristics of the polymers were studied and analyzed in terms of structure of the polyurethanes. In vitro degradation studies show that PEG based polyurethane is more degradable than PCL based polyurethane. The difference in the soft segment structure offers significant variation in the properties of the polyurethanes. These polyurethanes show the potential for use in a variety of biomaterial applications including tissue engineering. (C) 2008 Wiley Periodical, Inc. J Biomed Mater Res 90A: 263-271, 2009.
C1 [Sarkar, Debanjan; Yailg, Jui-Chen; Sen Gupta, Anirban; Lopina, Stephanie T.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
EM lopina@uakron.edu
RI Sarkar, Debanjan/C-6093-2017
OI Sarkar, Debanjan/0000-0002-6666-3152
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   ANDERSON JM, 1985, BIOCOMPATIBILITY TIS, P67
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   HESKETH TR, 1980, POLYM ENG SCI, V20, P190, DOI 10.1002/pen.760200304
   Hu Y, 2001, J APPL POLYM SCI, V81, P1624, DOI 10.1002/app.1593.abs
   KEMNITZER J, 1997, HDB BIODEGRADABLE PO, P251
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1991, POLYM DRUG DRUG DEVI, P155
   Kohn J., 1984, POLYM MAT SCI ENG, P817
   Lelah M. D., 1986, POLYURETHANES MED
   LI C, 1989, MACROMOLECULES, V22, P2029, DOI 10.1021/ma00195a001
   PANCHENE JP, 2000, PRINCIPLES TISSUE EN, P263
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shen E, 2001, BIOMATERIALS, V22, P201, DOI 10.1016/S0142-9612(00)00175-7
   SIEGMANN A, 1987, POLYM ENG SCI, V27, P1187, DOI 10.1002/pen.760271512
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Wang SH, 2003, MACROMOL SYMP, V197, P255, DOI 10.1002/masy.200350723
NR 22
TC 52
Z9 53
U1 3
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 263
EP 271
DI 10.1002/jbm.a.32095
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700026
PM 18496869
DA 2018-10-20
ER

PT J
AU Jarrell, JD
   Dolly, B
   Morgan, JR
AF Jarrell, John D.
   Dolly, Brandon
   Morgan, Jeffrey R.
TI Controlled release of vanadium from titanium oxide coatings for improved
   integration of soft tissue implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE metal ion release; titanium oxide; fibroblast; bioactivity; sol-gel
   techniques
ID STAINLESS-STEEL; VANADATE; ORGANIZATION; FIBROBLASTS; INTERFACE;
   APOPTOSIS; STRENGTH; INSULIN; RATS
AB This study evaluates the potential of titanium oxide coatings for short-term delivery of vanadium for improved wound healing around implants. Titanium and vanadium oxides are bioactive agents that elicit different bioresponses in cells, ranging from implant integration and reduction of inflammation to modulation of cell proliferation and morphology. These oxides were combined in biomaterial coatings using metal-organic precursors and rapidly screened in cell-culture microplates to establish how vanadium-loading influences cell proliferation and morphology. Twenty-eight-day elution studies indicated that there was a controlled release of vanadium from stable titanium oxide matrices. Elution profiles were mathematically modeled for vanadium loading of 20-1.25% up to a period of 28 days. Scanning electron microscopy and energy dispersive spectroscopy of the coatings indicated that the vanadium was present as a nanoscale dispersion and not segregated micron-scale islands. The study confirmed that the observed bioresponse of cells was modulated by the soluble release of vanadium into the surrounding medium. Controlled release of vandium from titania coating may be used to influence soft-tissue integration of implants by modulating cell proliferation, attachment, inflammation, and wound healing dynainics. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 272-281, 2009
C1 [Jarrell, John D.; Dolly, Brandon; Morgan, Jeffrey R.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
RP Jarrell, JD (reprint author), Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
EM msa_ri@verizon.net
OI Jarrell, John/0000-0001-8179-9456; Morgan, Jeffrey/0000-0002-7546-3443
CR BJURSTEN LM, 1991, INT WORKSH OSS SKEL, P25
   Brand RM, 1997, INT J PHARM, V146, P115, DOI 10.1016/S0378-5173(96)04781-3
   BRAND RM, 2000, AAPS PHARMSCI, V2, pF35
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Chen J, 2006, KNEE SURG SPORT TR A, V14, P750, DOI 10.1007/s00167-006-0043-8
   Cortizo AM, 1997, BIOMETALS, V10, P127, DOI 10.1023/A:1018335324447
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   Ehrlich HP, 2001, PLAST RECONSTR SURG, V107, P471, DOI 10.1097/00006534-200102000-00024
   Ehrlich HP, 1999, ARCH SURG-CHICAGO, V134, P494, DOI 10.1001/archsurg.134.5.494
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Garcia-Vicente S, 2007, DIABETES, V56, P486, DOI 10.2337/db06-0269
   Guo Zijian, 1999, Angew Chem Int Ed Engl, V38, P1512, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1512::AID-ANIE1512>3.0.CO;2-Y
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Huang CS, 2000, J BIOL CHEM, V275, P32516, DOI 10.1074/jbc.M005366200
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1554
   JARRELL JD, 2007, ORTHOPAEDIC RES SOC, V32, P1590
   Jarrell JD, 2007, J BIOMED MATER RES A, V83A, P853, DOI 10.1002/jbm.a.31446
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   Mackay DJD, 2003, WOUND REPAIR REGEN, V11, P204, DOI 10.1046/j.1524-475X.2003.11309.x
   Moyer KE, 2003, EXP MOL PATHOL, V75, P80, DOI 10.1016/S0014-4800(03)00031-5
   Overgaard L, 1998, J BONE JOINT SURG BR, V80B, P888, DOI 10.1302/0301-620X.80B5.8101
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   SHECHTER Y, 1999, DIABETES, V39, P1
   Srivastava AK, 2000, MOL CELL BIOCHEM, V206, P177, DOI 10.1023/A:1007075204494
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   Suzuki R, 2003, J BIOMED MATER RES A, V66A, P396, DOI 10.1002/jbm.a.10001
   SUZUKI R, 2000, CLIN ORTOP REL RES, V372, P280
   Takada Y, 2004, J PHARMACOL EXP THER, V311, P1249, DOI 10.1124/jpet.104.070839
   Thompson KH, 2006, J INORG BIOCHEM, V100, P1925, DOI 10.1016/j.jinorgbio.2006.08.016
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   ZIEGLER G, 2006, Patent No. 0161256
NR 36
TC 13
Z9 13
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 272
EP 281
DI 10.1002/jbm.a.32093
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700027
PM 18496866
DA 2018-10-20
ER

PT J
AU Zhao, XB
   Courtney, JM
AF Zhao, Xiaobin
   Courtney, James M.
TI Novel "anchor modification" of polymeric biomaterial surfaces by the
   utilization of cyclodextrin inclusion complex supramolecules
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE plasticized poly (vinyl chloride); surface modification; protein
   adsorption; cyclodextrins; cyclodextrin inclusion complex;
   supramolecules
ID ALPHA-CYCLODEXTRIN; COPOLYMERS; CHLORIDE; OXIDE
AB In this article, a novel approach for the surface modification of polymeric biomaterials by the utilization of supramolecules was studied. The supramolecules selected were cyclodextrin inclusion complexes (CICs). The biomaterial selected for surface modification was plasticized poly (vinyl chloride) (PVC-P). Results indicate that when the CICs were blended into PVC-P, they tend to migrate and "anchor" on the surface to achieve a remarkable protein-resistant surface, with improved blood compatibility. In comparison with a physical mixture of cyclodextrins and a "guest" molecule, such as poly(ethylene oxide) (PEO)-poly(propylene oxide) (PPO)-PEO and PPO-PEO-PPO for PVC-P modification, CICs modified PVC-P are more consistent in processing and achieve reproducible surface characteristics. Based on this study, a novel "anchor modification" was proposed regarding CICs modified surface. This "anchor modification" is likely to reduce plasticizer extraction from PVC-P and also can be utilized for the modification of polymers other than PVC-P. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 282-291, 2009
C1 [Zhao, Xiaobin; Courtney, James M.] Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
RP Zhao, XB (reprint author), Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
EM xiaobin.zhao@strath.ac.uk
CR Courtney JM, 1999, PERFUSION-UK, V14, P263, DOI 10.1177/026765919901400405
   Gaitano GG, 1997, J PHYS CHEM B, V101, P710, DOI 10.1021/jp961996w
   Harada A, 1997, CARBOHYD POLYM, V34, P183, DOI 10.1016/S0144-8617(97)00023-4
   HARADA A, 1990, MACROMOLECULES, V23, P2821, DOI 10.1021/ma00212a039
   HARADA A, 1990, J CHEM SOC CHEM COMM, P1321
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x
   Lemos-Senna E, 1998, INT J PHARM, V170, P119, DOI 10.1016/S0378-5173(98)00147-1
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li JT, 1996, ADV CHEM SER, V248, P61
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   TOPCHIEVA IN, 1994, VYSOKOMOL SOEDIN, V36, P271
   TOPCHIEVA IN, 1993, VYSOKOMOL SOEDIN A, V35, P395
   Zhao XB, 2003, J MATER SCI-MATER M, V14, P905, DOI 10.1023/A:1025690828200
   Zhao X, 2008, J MATER SCI-MATER M, V19, P713, DOI 10.1007/s10856-007-3191-6
   Zhao XB, 2007, J BIOMED MATER RES A, V80A, P539, DOI 10.1002/jbm.a.30925
NR 16
TC 4
Z9 4
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 282
EP 291
DI 10.1002/jbm.a.32020
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700028
PM 18508336
DA 2018-10-20
ER

PT J
AU Munoz-Pinto, DJ
   Bulick, AS
   Hahn, MS
AF Munoz-Pinto, Dany J.
   Bulick, Allen S.
   Hahn, Mariah S.
TI Uncoupled investigation of scaffold modulus and mesh size on smooth
   muscle cell behavior
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyethylene glycol hydrogels; cell-biomaterial interactions; modulus;
   mesh size; rational scaffold design
ID POLY(ETHYLENE GLYCOL) HYDROGELS; DIAMETER VASCULAR GRAFTS; MESENCHYMAL
   STEM-CELLS; GENE-EXPRESSION; CHONDROCYTE METABOLISM; ENDOTHELIAL-CELLS;
   DIFFERENTIATION; NETWORKS; PROTEIN; RHOA
AB Although scaffold material properties are known to critically impact cell behavior, it has proven difficult to correlate specific cell responses to isolated scaffold parameters, inhibiting rational design of scaffold material properties. The aim of this study was to validate a systematic approach for evaluating the influence of initial scaffold modulus and mesh size on cell extracellular matrix (ECM) deposition and phenotype. Poly(ethylene glycol) diacrylate (PEGDA) hydrogels were selected for this study because of their tunable material properties. Following screening of six distinct PEGDA hydrogels, three formulations were identified which permitted uncoupled investigation of scaffold mesh size and modulus within the target incremental modulus range of similar to 100-300 kPa. Smooth muscle cells (SMCs) Were encapsulated within these three formulations, and cell ECM deposition and phenotype were evaluated following 21 days of culture. Although elastin content appeared to be correlated with scaffold mesh size mid modulus to a similar degree, levels of collagen and serum response factor (SRF), a key regulator of SMC phenotype, were more strongly correlated with mesh size. To gain insight into the cell signaling underlying these observed correlations, variations in cell metabolic state and in RhoA signaling were semi-quantitatively evaluated. Both RhoA activity, which is largely modulated by scaffold mechanics in 2D, and cell metabolic activity were highly correlated with hydrogel mesh size. These results indicate that the effects of scaffold mechanics on RhoA activity in 3D may be distinct from those in 2D and underscore the need for uncoupled investigation of scaffold parameters on cell behavior. Furthermore, the present data suggest that RhoA signaling and cell metabolic regulation may be closely linked. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 303-316, 2009
C1 [Munoz-Pinto, Dany J.; Bulick, Allen S.; Hahn, Mariah S.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.
   [Hahn, Mariah S.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RP Hahn, MS (reprint author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.
EM mhahn@tamu.edu
RI Hahn, Mariah/G-3998-2014
OI Hahn, Mariah/0000-0001-8794-129X
CR Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   BURKEL WE, 1989, MED PROG TECHNOL, V14, P165
   Calo LA, 2007, J HYPERTENS, V25, P259, DOI 10.1097/HJH.0b013e328010d4d2
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   Carson JA, 2003, BBA-GENE STRUCT EXPR, V1628, P133, DOI 10.1016/S0167-4781(03)00122-2
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GOODRICH RP, 1992, P NATL ACAD SCI USA, V89, P967, DOI 10.1073/pnas.89.3.967
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Hahn MS, 2007, ANN BIOMED ENG, V35, P190, DOI 10.1007/s10439-006-9099-3
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   KEMPEZINSKI R, 2000, VASCULAR SURG
   Kibbe MR, 2000, J VASC SURG, V31, P1214, DOI 10.1067/mva.2000.105006
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598
   Koh WG, 2003, ANAL CHEM, V75, P5783, DOI 10.1021/ac034773s
   Lee HJ, 2007, ONCOGENE, V26, P173, DOI 10.1038/sj.onc.1209774
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Lu X, 2004, AM J PHYSIOL-HEART C, V287, pH1663, DOI 10.1152/ajpheart.00226.2004
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t
   Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814
   MIANO M, 2007, AM J PHYSIOL-CELL PH, V292, pC70
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Ren XD, 2000, METHOD ENZYMOL, V325, P264
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382
   Watkins AW, 2005, MACROMOLECULES, V38, P1326, DOI 10.1021/ma0475232
   Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287
   Weirich J, 2001, CELL CALCIUM, V29, P359, DOI 10.1054/ceca.2001.0198
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Won JS, 2003, J NEUROSCI, V23, P7470
   Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200
   Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X
NR 56
TC 31
Z9 31
U1 2
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 303
EP 316
DI 10.1002/jbm.a.32492
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700030
PM 19402139
DA 2018-10-20
ER

PT J
AU Aboushwareb, T
   Eberli, D
   Ward, C
   Broda, C
   Holcomb, J
   Atala, A
   Van Dyke, M
AF Aboushwareb, Tamer
   Eberli, Daniel
   Ward, Catherine
   Broda, Christopher
   Holcomb, John
   Atala, Anthony
   Van Dyke, Mark
TI A Keratin Biomaterial Gel Hemostat Derived from Human Hair: Evaluation
   in a Rabbit Model of Lethal Liver Injury
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE keratin; hemostasis; hemostat; liver injury; hemorrhage
ID GROIN INJURY; VENOUS HEMORRHAGE; HEPATIC-INJURY; ANIMAL-MODEL;
   BLOOD-LOSS; SWINE; DRESSINGS; WOOL; SURVIVAL; BANDAGE
AB Effective hemostatic dressings that are compatible with tissues are needed. Keratins are a class of biomaterials that can be derived by extraction of proteins from human hair. We have recently discovered that keratin biomaterials have hemostatic characteristics and hypothesize that a keratin hydrogel having the ability to absorb fluid and bind cells may be an effective hemostat. The goal of this study was to test a keratin hydrogel and evaluate it compared to current hemostats. Thirty-two New Zealand white rabbits received a lethal liver injury. Eight animals each were assigned to negative control, QuickClotu (R), HemCon (R) bandage, and keratin treatment groups. Vital stats and other data were recorded during surgery and all surviving animals were sacrificed after 72 h. Histology was conducted on all surviving animals. Twenty-four-hour survival rates were 0%, 62.5%, 62.5%, anti 75% for the negative control, QuickClot, HemCon, and keratin groups, respectively. Other outcomes included blood loss, mean arterial pressure, heart rate, shock index, and liver histology. All of the hemostats were statistically better than the negative control group at late operative time points. The keratin group consistently performed as well as, or better than, the commercial hemostats. Histology showed an interesting healing response at the hemostat-liver interface in the keratin group. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Apt Biomater 90B: 45-54, 2009
C1 [Aboushwareb, Tamer; Eberli, Daniel; Ward, Catherine; Broda, Christopher; Atala, Anthony; Van Dyke, Mark] Wake Forest Univ, Wake Forest Inst Regenerat Med, Sch Med, Winston Salem, NC 27157 USA.
   [Holcomb, John] USA, Inst Surg Res, Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA.
RP Van Dyke, M (reprint author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Sch Med, Winston Salem, NC 27157 USA.
EM mavandyk@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Ahuja N, 2006, J TRAUMA, V61, P1312, DOI 10.1097/01.ta.0000240597.42420.8f
   Alam HB, 2004, J TRAUMA, V56, P974, DOI 10.1097/01.TA.0000127763.90890.31
   Alam HB, 2003, J TRAUMA, V54, P1077, DOI 10.1097/01.TA.0000068258.99048.70
   Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   BENNETT HPJ, 1986, J CHROMATOGR, V359, P221, DOI 10.1016/0021-9673(86)80076-0
   Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029
   Carson JL, 2002, TRANSFUS MED REV, V16, P187, DOI 10.1053/tmrv.2002.33461
   Connolly RJ, 2004, J TRAUMA, V57, pS26, DOI 10.1097/01.TA.0000136746.97192.B2
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   de Queiroz AAA, 2003, J BIOMED MATER RES A, V64A, P147, DOI 10.1002/jbm.a.10265
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Goddard DR, 1934, J BIOL CHEM, V106, P605
   ITO H, 1982, KOBUNSHI RONBUNSHU, V39, P249, DOI 10.1295/koron.39.249
   Kheirabadi BS, 2005, J TRAUMA, V59, P25, DOI 10.1097/01.TA.0000171458.72037.EE
   King DR, 2004, J TRAUMA, V57, P756, DOI 10.1097/01.TA.0000147501.64610.AF
   Martinowitz U, 2001, J TRAUMA, V50, P721, DOI 10.1097/00005373-200104000-00021
   MIES HH, 1987, J CHROMATOGR, V405, P365, DOI 10.1016/S0021-9673(01)81778-7
   Neel S, 1991, MED SUPPORT US ARMY
   Neuffer MC, 2004, MIL MED, V169, P716, DOI 10.7205/MILMED.169.9.716
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Peake JB, 2005, NEW ENGL J MED, V352, P219, DOI 10.1056/NEJMp048312
   Pusateri AE, 2004, J TRAUMA, V57, P555, DOI 10.1097/01.TA.0000136155.97758.CD
   Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71
   Robinson Kathy, 2004, J Emerg Nurs, V30, P160, DOI 10.1016/j.jen.2004.01.004
   Rothwell SW, 2003, THROMB RES, V108, P335
   Schreiber MA, 2002, J TRAUMA, V53, P252, DOI 10.1097/01.TA.0000022087.35916.9F
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   SIMMONDS DH, 1958, TEXT RES J, V28, P314
   Sondeen JL, 2003, J TRAUMA, V54, P280, DOI 10.1097/01.TA.0000037431.19185.B4
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Turner AS, 2002, J BIOMED MATER RES, V63, P37, DOI 10.1002/jbm.10081
   Vournakis JN, 2003, J SURG RES, V113, P1, DOI 10.1016/S0022-4804(03)00161-6
   Zimmerman L. M., 1993, GREAT IDEAS HIST SUR
NR 36
TC 63
Z9 64
U1 5
U2 51
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2009
VL 90B
IS 1
BP 45
EP 54
DI 10.1002/jbm.b.31251
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461UU
UT WOS:000267298500006
PM 18988274
DA 2018-10-20
ER

PT J
AU Heiss, C
   Kraus, R
   Peters, F
   Henn, W
   Schnabelrauch, M
   Berg, A
   Pautzsch, T
   Weisser, J
   Schnettler, R
AF Heiss, C.
   Kraus, R.
   Peters, F.
   Henn, W.
   Schnabelrauch, M.
   Berg, A.
   Pautzsch, T.
   Weisser, J.
   Schnettler, R.
TI Development of a Bioresorbable Self-Hardening Bone Adhesive Based on a
   Composite Consisting of Polylactide Methacrylates and beta-Tricalcium
   Phosphate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adhesion; bone regeneration; calcium phosphate; composite; polylactic
   acid
ID ALKYLENE BIS(DILACTOYL)-METHACRYLATE; IN-VIVO; SCREW AUGMENTATION;
   APATITE
AB In this work, a novel bioresorbable bone adhesive based on radically polymerizable polylactide with methacrylate endgroups known from polymethylmethacrylate (PMMA) cements and varying amounts of bioresorbable/biodegradable lactide moieties was developed. The swelling and degradation properties as well as the hardening time, viscosity, and adhesion properties (tension and shear resistance) were subsequently measured in vitro and optimized. For a broad use in surgery the handling properties, the shelf life and the storage temperature are important issues. The finally developed material consists of three substances that have to be mixed to start the reaction: a highly viscous mixture of oligomers and two beta-tricalcium phosphate (beta-TCP, Cerasorl (R)) powders with the radical starter and the promoter. The material has a processing time of 2 min and is completely cured after another minute. The tension and shear resistance of the material is 3.1-13.9 MPa that will decrease by storing the substance in a humid atmosphere. Degradation experiments showed a mass loss of 20-35% during the first 5 weeks. Tests with MC3T3-E1 cells showed an increase of the alkaline phosphatase activity over a period of 14 days. The mechanical and handling properties and the in vitro data are showing a promising biomaterial for bone regeneration. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 90B: 55-66, 2009
C1 [Heiss, C.; Kraus, R.; Schnettler, R.] Univ Hosp Giessen Marburg, Dept Trauma Surg, Lab Expt Trauma Surg, D-35385 Giessen, Germany.
   [Peters, F.; Henn, W.] Curasan AG, D-63801 Kleinostheim, Bavaria, Germany.
   [Schnabelrauch, M.; Berg, A.; Pautzsch, T.; Weisser, J.] INNOVENT Technol Entwicklung eV, D-07745 Jena, Germany.
RP Heiss, C (reprint author), Univ Hosp Giessen Marburg, Dept Trauma Surg, Lab Expt Trauma Surg, D-35385 Giessen, Germany.
EM christian.heiss@chiru.med.uni-giessen.de
FU German Ministry of Economy and Employment [KA 01432011-11-5]
FX Contract grant sponsor: German Ministry of Economy and Employment;
   Contract grant number: KA 01432011-11-5
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   BRANDEIS E, 1993, J MATER SCI-MATER M, V4, P543, DOI 10.1007/BF00125591
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   GIEBEL G, 1981, BIOMED TECH, V26, P35, DOI 10.1515/bmte.1981.26.3.35
   Grossterlinden L, 2006, BIOMATERIALS, V27, P3379, DOI 10.1016/j.biomaterials.2006.01.051
   Heiss C, 2005, BIOMATERIALS, V26, P1389, DOI 10.1016/j.biomaterials.2004.04.048
   Heiss C, 2004, BIOMED TECH, V49, P163, DOI 10.1515/BMT.2004.031
   Heiss C, 2006, EUR J TRAUMA, V32, P141
   *ICDD, 2005, 55898 ICDD
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P701, DOI 10.1002/jbm.10024
   Ignatius AA, 2005, J BIOMED MATER RES B, V75B, P128, DOI 10.1002/jbm.b.30274
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   KUHN KD, 2000, BONE CEMENTS
   LEEMANN RA, 1961, SCHWEIZ MED WSCHR, V91, P908
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   Peters F, 2004, MATERIALWISS WERKST, V35, P203, DOI 10.1022/mawe.200400735
   RIETZ K A, 1964, Acta Chir Scand, V128, P387
   VENKATA MN, 2004, BIOMATERIALS, V25, P3283
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
NR 20
TC 7
Z9 7
U1 1
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2009
VL 90B
IS 1
BP 55
EP 66
DI 10.1002/jbm.b.31252
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461UU
UT WOS:000267298500007
PM 18985775
DA 2018-10-20
ER

PT J
AU Tseng, SJ
   Lee, YH
   Chen, ZH
   Lin, HH
   Lin, CY
   Tang, SC
AF Tseng, S-ja
   Lee, Ying-Hui
   Chen, Zhi-Hao
   Lin, Hui-Hao
   Lin, Chih-Yung
   Tang, Shiue-Cheng
TI Integration of optical clearing and optical sectioning microscopy for
   three-dimensional imaging of natural biomaterial scaffolds in thin
   sections
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE confocal microscopy; collagen; chitosan; cellulose; three-dimensional
   (3-D) microscopy
ID DROSOPHILA MUSHROOM BODY; BOVINE SERUM-ALBUMIN; TISSUE; CHITOSAN;
   TOMOGRAPHY; CELLULOSE; DELIVERY; COLLAGEN; BINDING; AGENTS
AB The intrinsic turbidity of scaffolds formed by natural biomaterials such as collagen fibers prevents high-resolution light microscopy in depth. In this research, we have developed a new method of using light microscopy for penetrative three-dimensional (3-D) visualization of scaffolds formed by collagen, chitosan, or cellulose. First, we applied an optical-clearing solution, FocusClear, to permeate and reduce the turbidity of the scaffolds. The improved photon penetration allowed fluorophores for efficient excitation and emission in the FocusClear solution. Confocal microscopy was applied to achieve cellular-level resolution up to 350 mu m for both the fibroblast/collagen and the osteoblast/chitosan constructs and micrometer-level resolution up to 40 mu m for the cellulose membrane. The depth of imaging of the cellulose membrane was further improved to 80 mu m using two-photon microscopy. Significantly, these voxel-based confocal/two-photon micrographs allowed postrecording image processing via Amira projection algorithms for 3-D visualization and analysis of the scanned region. Although this optical method remains limited in viewing block scaffolds in thin sections, our approach provides a non-invasive way to microscopically examine the scaffold structure, which would be a valuable tool to studying biomaterials and their interactions with the molecule/cell of interest within the scaffold in an integrated fashion. (C) 2009 Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.3158998]
C1 [Tseng, S-ja; Lee, Ying-Hui; Chen, Zhi-Hao; Tang, Shiue-Cheng] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   [Lin, Hui-Hao; Lin, Chih-Yung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.
   [Lin, Hui-Hao; Lin, Chih-Yung] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan.
RP Tang, SC (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
EM sctang@che.nthu.edu.tw
RI Tseng, S.-Ja/F-9414-2012
OI Tseng, S.-Ja/0000-0002-1299-7202
FU National Science Council, Taiwan [NSC 96-3112-B-007-005, NSC
   97-2221-E-007-041-MY2]; National Tsing Hua University, Taiwan
FX This work was supported in part by grants from the National Science
   Council, Taiwan (NSC 96-3112-B-007-005 and NSC 97-2221-E-007-041-MY2)
   and the Research Development Program, National Tsing Hua University,
   Taiwan. We thank Dr. Ann-Shyn Chiang and Dr. Hsiu-Ming Chang at NTHU for
   supporting the imaging techniques.
CR Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ferrando M, 2005, J MEMBRANE SCI, V250, P283, DOI 10.1016/j.memsci.2004.10.043
   Gareau DS, 2004, J BIOMED OPT, V9, P254, DOI 10.1117/1.1645798
   Genina EA, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2899149
   Ghosn MG, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907699
   Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3
   Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818
   Jiang JY, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2899153
   LaComb R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907207
   Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817
   Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006
   Liu YC, 2003, METHODS, V30, P86, DOI 10.1016/S1046-2023(03)00010-0
   Mao ZZ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2892684
   MOULTON K, 2005, J BIOMED OPT, V11
   MURATA M, 1993, BIOSCI BIOTECH BIOCH, V57, P43, DOI 10.1271/bbb.57.43
   Oldham M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907968
   Oldham M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2709858
   Sakhalkar HS, 2007, PHYS MED BIOL, V52, P2035, DOI 10.1088/0031-9155/52/8/001
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P2665, DOI 10.1021/bm7006983
   Schulmerich MV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2892687
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Tseng SJ, 2007, BIOCONJUGATE CHEM, V18, P1383, DOI 10.1021/bc060382j
   van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045
   Vargas G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907327
   Veerman C, 2003, INT J BIOL MACROMOL, V31, P139, DOI 10.1016/S0141-8130(02)00074-0
   Vogel G, 2008, SCIENCE, V322, P176, DOI 10.1126/science.322.5899.176
   Wang RKK, 2001, J OPT SOC AM B, V18, P948, DOI 10.1364/JOSAB.18.000948
   Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008
   Wang ZH, 2008, J MEMBRANE SCI, V310, P141, DOI 10.1016/j.memsci.2007.10.048
   Wickramasinghe SR, 2006, J MEMBRANE SCI, V281, P609, DOI 10.1016/j.memsci.2006.04.032
   Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005
   Yeh AT, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2166381
NR 37
TC 13
Z9 13
U1 0
U2 5
PU SPIE-SOC PHOTOPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL-AUG
PY 2009
VL 14
IS 4
AR 044004
DI 10.1117/1.3158998
PG 9
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 503MV
UT WOS:000270540100011
PM 19725716
DA 2018-10-20
ER

PT J
AU Makaya, K
   Terada, S
   Ohgo, K
   Asakura, T
AF Makaya, Kumiko
   Terada, Shinichi
   Ohgo, Kosuke
   Asakura, Tetsuo
TI Comparative study of silk fibroin porous scaffolds derived from
   salt/water and sucrose/hexafluoroisopropanol in cartilage formation
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Biomaterial; Tissue engineering; Bombyx mori; Silk fibroin; Cartilage;
   Scaffold
ID IN-VITRO; BOMBYX-MORI; AURICULAR RECONSTRUCTION; FIBROBLAST CELLS;
   GROWTH; FILMS; ATTACHMENT; FIBERS; CHONDROCYTES; DEGRADATION
AB The purpose of this study is to create a new silk fibroin scaffold with sufficient three-dimensional morphology and porous structure for cartilage formation. We have applied sucrose particles sized around 300 to 500 pm as porogens compared to equal-sized salt particles. After the porogen was leached out with water, scaffolds were prepared with fibroin derived from sucrose/hexafluoroisopropanol (Su/H) or salt/water (Sa/W) based composites. A compression test indicated that the Sa/W fibroin was much harder than the Su/H fibroin, but a protease enzyme digested the Sa/W fibroin more quickly than Su/H fibroin. Rabbit ear chondrocytes were seeded onto the scaffolds for 4-8 week in vitro culture and histological analyses were performed. The distribution of cartilage formation in Safranin O staining was more homogenous in Su/H fibroin than that of Sa/W fibroin. The overall amount of cartilage was significantly better in the Su/H fibroin than that in the Sa/W fibroin. However, the inner structure of pore wall in the Sa/W fibroin was rough and microporous with cartilage matrix deposition, while that in the Su/H fibroin was thin and homogenous. Since mature cartilage gradually regenerates to fill the porous space, slowly degradable Su/H fibroin should be a better candidate for cartilage formation. (C) 2009, The Society for Biotechnology, Japan. All rights reserved.
C1 [Makaya, Kumiko; Ohgo, Kosuke; Asakura, Tetsuo] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
   [Terada, Shinichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Chiba 2768524, Japan.
RP Asakura, T (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
EM asakura@cc.tuat.ac.jp
RI Asakura, Tetsuo/B-9970-2013
FU Scientific Research [18105007]
FX T. A. acknowledges partial support from Grants-in-Aid for Scientific
   Research (S) (No. 18105007), Japan.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Asakura T. K., 1994, ENCY AGR SCI
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   DAL PI, 2003, TISSUE ENG, V9, P1113
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   Habiballah JA, 2000, SAUDI MED J, V21, P1173
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MIN L, 2008, J BIOMED MATER RES A, V87, P1010
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Romo Thomas 3rd, 2006, Facial Plast Surg Clin North Am, V14, P129, DOI 10.1016/j.fsc.2006.01.006
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Terada S, 2005, ANN PLAS SURG, V55, P196, DOI 10.1097/01.sap.0000164388.33965.4e
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
NR 31
TC 67
Z9 74
U1 1
U2 36
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUL
PY 2009
VL 108
IS 1
BP 68
EP 75
DI 10.1016/j.jbiosc.2009.02.015
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 487LD
UT WOS:000269274800014
PM 19577196
DA 2018-10-20
ER

PT J
AU Jeong, Y
   Joo, MK
   Bahk, KH
   Choi, YY
   Kim, HT
   Kim, WK
   Lee, HJ
   Sohn, YS
   Jeong, B
AF Jeong, Yuri
   Joo, Min Kyung
   Bahk, Kyung Hyun
   Choi, Yun Young
   Kim, Ho-Tae
   Kim, Won-Ki
   Lee, Hwa Jeong
   Sohn, Youn Soo
   Jeong, Byeongmoon
TI Enzymatically degradable temperature-sensitive polypeptide as a new
   in-situ gelling biomaterial
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Sol-gel transition; Polypeptide; Enzymatic degradability; Polymer;
   Hydrogel
ID COPOLYMER AQUEOUS-SOLUTIONS; BOVINE BETA-LACTOGLOBULIN; HYBRID
   BLOCK-COPOLYMERS; REVERSIBLE HYDROGELS; PHASE-TRANSITION; DRUG-DELIVERY;
   PEPTIDE; GELATION; PEG; SEQUENCES
AB We are reporting a poly (ethylene glycol) -block-poly(alanine-co-phenyl alanine) (PEG-PAF) aqueous solution that undergoes sol-to-gel transition as the temperature increases. The sol-to-gel transition was observed at as low a concentration as 3.0-7.0 wt%. Micellar aggregation accompanying small conformational changes of the peptide from random coils to beta-sheets is suggested as the sol-to-gel transition mechanism of the PEG-PAF aqueous solution. The PEG-PAF is stable in phosphate buffered saline, however, it degraded in the subcutaneous layer of rats. In vitro study showed that proteolytic enzymes such as cathepsin B, cathepsin C, and elastase that are present in the subcutaneous layer of the mammalian tissue might be responsible for the degradation of the polymer in rats. As a feasibility study of this material, a single shot of an aqueous insulin formulation (13.8 mg insulin/kg) showed a hypoglycemic effect over 18 days in rats. The current functional polypeptide may be very promising as an in-situ gelling system for tissue engineering, cell/stem cell therapy, and drug delivery. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Jeong, Yuri; Joo, Min Kyung; Bahk, Kyung Hyun; Choi, Yun Young; Sohn, Youn Soo; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 120750, South Korea.
   [Kim, Ho-Tae] Kumoh Natl Inst Technol, Dept Appl Chem, Yangho Dong 730701, Gumi, South Korea.
   [Kim, Won-Ki] Korea Univ, Dept Neurosci, Seoul, South Korea.
   [Lee, Hwa Jeong] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU Korea Research Foundation [KRF-2008-313-C00590]; Korea government (MEST)
   [R11-2005-008-00000-00, R01-2007-000-20141-0]; Seoul Science Fellowship
FX This work was supported by the Korea Research Foundation (Grant number
   KRF-2008-313-C00590), Korea Science and Engineering Foundation grant
   (KOSEF) funded by the Korea government (MEST) (Grant:
   R11-2005-008-00000-00 and R01-2007-000-20141-0). YJ and MKJ equally
   contributed to the paper. MKJ was supported by the Seoul Science
   Fellowship.
CR Booth C, 2000, MACROMOL RAPID COMM, V21, P501, DOI 10.1002/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R
   Braga PC, 2006, PHARMACOLOGY, V77, P130, DOI 10.1159/000093790
   Charman SA, 2000, J PHARM SCI, V89, P168, DOI 10.1002/(SICI)1520-6017(200002)89:2<168::AID-JPS4>3.0.CO;2-Q
   Cheng V, 2007, J APPL POLYM SCI, V106, P1201, DOI 10.1002/app.26760
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Gezimati J, 1996, J AGR FOOD CHEM, V44, P804, DOI 10.1021/jf950445k
   Hamley IW, 2008, ADV MATER, V20, P4394, DOI 10.1002/adma.200800266
   Hamley IW, 2005, BIOMACROMOLECULES, V6, P1310, DOI 10.1021/bm049286g
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hong YH, 2007, J AGR FOOD CHEM, V55, P5653, DOI 10.1021/jf070564n
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 2003, J PHYS CHEM B, V107, P10032, DOI 10.1021/jp027339n
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2001, CHEM COMMUN, P1516, DOI 10.1039/b102819g
   Jeong Y, 2007, ADV MATER, V19, P3947, DOI 10.1002/adma.200700149
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Klok HA, 2002, ANGEW CHEM INT EDIT, V41, P1509, DOI 10.1002/1521-3773(20020503)41:9<1509::AID-ANIE1509>3.0.CO;2-K
   Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   Lim YB, 2007, ANGEW CHEM INT EDIT, V46, P3475, DOI 10.1002/anie.200604576
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MCSWINEY M, 1994, FOOD HYDROCOLLOID, V8, P441, DOI 10.1016/S0268-005X(09)80087-8
   Morihara Y, 2005, J POLYM SCI POL CHEM, V43, P6048, DOI 10.1002/pola.21097
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Sarvestani AS, 2007, BIOMACROMOLECULES, V8, P406, DOI 10.1021/bm060648p
   Soyez H, 1996, ADV DRUG DELIVER REV, V21, P81, DOI 10.1016/S0169-409X(96)00400-0
   Takeuchi Y, 2006, J POLYM SCI POL CHEM, V44, P671, DOI 10.1002/pola.21189
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Yamaoka T, 2003, BIOMACROMOLECULES, V4, P1680, DOI 10.1021/bm0341201
   Yang H, 2006, LANGMUIR, V22, P8553, DOI 10.1021/la061238p
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
NR 43
TC 89
Z9 92
U1 4
U2 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 1
PY 2009
VL 137
IS 1
BP 25
EP 30
DI 10.1016/j.jconrel.2009.03.008
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 465XY
UT WOS:000267624900006
PM 19306901
DA 2018-10-20
ER

EF